PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brewster, LM; Berentzen, CA; van Montfrans, GA				Brewster, L. M.; Berentzen, C. A.; van Montfrans, G. A.			CHRISTMAS 2011: ORAL TRADITIONS High salt meals in staff canteens of salt policy makers: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIETARY SALT; METAANALYSIS; DISEASE; SODIUM	Objective To assess the salt content of hot meals served at the institutions of salt policy makers in the Netherlands. Design Observational study. Setting 18 canteens at the Department of Health, the Health Council, the Food and Consumer Product Safety Authority, university hospitals, and affiliated non-university hospitals. Intervention A standard hot meal collected from the institutional staff canteens on three random days. Main outcome measure Salt content of the meals measured with an ion selective electrode assay. Results The mean salt content of the meals (7.1 g, SE 0.2 g) exceeded the total daily recommended salt intake of 6 g and was high at all locations: 6.9 g (0.4 g) at the Department of Health and National Health Council; 6.0 g (0.9 g) at the Food and Consumer Product Safety Authority; 7.4 g (0.5 g) at university hospital staff canteens; and 7.0 g (0.3 g) at non-university hospital staff canteens. With data from a national food consumption survey, the estimated total mean daily salt intake in people who ate these meals was 15.4 g. This translates into a 23-36% increase in premature cardiovascular mortality compared with people who adhere to the recommended levels of salt intake. Conclusion If salt policy makers eat at their institutional canteens they might consume too much salt, which could put their health at risk.	[Brewster, L. M.; Berentzen, C. A.; van Montfrans, G. A.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Brewster, L. M.; van Montfrans, G. A.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Brewster, L. M.] Univ Amsterdam, Acad Med Ctr, Dept Social Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Brewster, LM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	l.m.brewster@amc.uva.nl	Brewster, Lizzy M/K-7675-2019	Brewster, Lizzy M/0000-0002-7434-0038				Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; European Commission Directorate General Health Consumers Directorate C, 2010, EV EUR PLATF ACT DIE; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Food and Drug administration, 2008, GUID IND LAB GUID RE; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; Health Council of the Netherlands, 2006, GUID HLTH DIET; MATTES RD, 1991, J AM COLL NUTR, V10, P383; Mitchell RK, 1997, ACAD MANAGE REV, V22, P853, DOI 10.2307/259247; National Institute for Health and Clinical Excellence, 2010, PREV CARD DIS POP LE; Ocke MC, 2003, RESULTATEN VOEDSELCO; Pathman DE, 1996, MED CARE, V34, P873, DOI 10.1097/00005650-199609000-00002; SHORTT C, 1988, EUR J CLIN NUTR, V42, P605; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115; WHO Expert Committee on Problems Related to Alcohol Consumption, 2007, World Health Organ Tech Rep Ser, P1	17	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2011	343								d7352	10.1136/bmj.d7352	http://dx.doi.org/10.1136/bmj.d7352			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868QK	22187322	Green Published, hybrid			2022-12-24	WOS:000298538200001
J	Hughes, V				Hughes, Virginia			MICROENVIRONMENT Neighbourhood watch	NATURE			English	Editorial Material							CELL-LINES; MYELOMA; ADHESION											Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; UCHIYAMA H, 1993, BLOOD, V82, P3712; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913	3	12	12	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S48	S49		10.1038/480S48a	http://dx.doi.org/10.1038/480S48a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169803				2022-12-24	WOS:000298033000008
J	Kumar, S; Duester, G				Kumar, Sandeep; Duester, Gregg			SnapShot: Retinoic Acid Signaling	CELL			English	Editorial Material									[Kumar, Sandeep; Duester, Gregg] Sanford Burnham Med Res Inst, Dev & Aging Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Kumar, S (corresponding author), Sanford Burnham Med Res Inst, Dev & Aging Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Duester, Gregg/0000-0003-4335-3650	NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR032045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062848] Funding Source: NIH RePORTER; NCRR NIH HHS [R21 RR032045-01, R21 RR032045] Funding Source: Medline; NIGMS NIH HHS [R01 GM062848, R01 GM062848-08] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Diez del Corral R, 2003, NEURON, V40, P65; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; Matt N, 2005, DEVELOPMENT, V132, P4789, DOI 10.1242/dev.02031; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059	12	25	27	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1422	U233		10.1016/j.cell.2011.11.034	http://dx.doi.org/10.1016/j.cell.2011.11.034			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153083	Green Accepted, Bronze			2022-12-24	WOS:000298148100029
J	Williams, E				Williams, Eric			Environmental effects of information and communications technologies	NATURE			English	Article							INDUSTRIAL ECOLOGY; ENERGY USE; CONSUMPTION; MICROCHIP; IMPACTS; INPUT	The digital revolution affects the environment on several levels. Most directly, information and communications technology (ICT) has environmental impacts through the manufacturing, operation and disposal of devices and network equipment, but it also provides ways to mitigate energy use, for example through smart buildings and teleworking. At a broader system level, ICTs influence economic growth and bring about technological and societal change. Managing the direct impacts of ICTs is more complex than just producing efficient devices, owing to the energetically expensive manufacturing process, and the increasing proliferation of devices needs to be taken into account.	Rochester Inst Technol, Golisano Inst Sustainabil, Rochester, NY 14623 USA	Rochester Institute of Technology	Williams, E (corresponding author), Rochester Inst Technol, Golisano Inst Sustainabil, Rochester, NY 14623 USA.	exwgis@rit.edu	Williams, Eric/J-4282-2012	Williams, Eric/0000-0002-6352-2928	US National Science Foundation [CBET-0731067]	US National Science Foundation(National Science Foundation (NSF))	This work was in supported in part by the US National Science Foundation via grant CBET-0731067 in the Environmental Sustainability program.	Allenby BR, 2008, J IND ECOL, V12, P267, DOI 10.1111/j.1530-9290.2008.00051.x; Audirac I, 2005, INT REGIONAL SCI REV, V28, P119, DOI 10.1177/0160017604273624; Ayres R. U., 2005, Structural Change and Economic Dynamics, V16, P181, DOI 10.1016/j.strueco.2003.10.003; Basel Action Network, 2002, EXP HARM HIGH TECH T; Basel Action Network, 2005, DIG DUMP EXP REUS AB; Baumann H., 2004, LIFE CYCLE ASSESSMEN; Boice JD, 2010, J OCCUP ENVIRON MED, V52, P1082, DOI 10.1097/JOM.0b013e3181f7e520; Boyd SB, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014011; Boyd SB, 2009, ENVIRON SCI TECHNOL, V43, P7303, DOI 10.1021/es901514n; BUCHERT M, 2009, CRITICAL METALS SUST; Bullard C.W., 1978, RESOUR ENERGY, V1, P267, DOI DOI 10.1016/0165-0572(78)90008-7; BULLARD CW, 1975, ENERG POLICY, V3, P268, DOI 10.1016/0301-4215(75)90035-X; Carnegie Mellon University Green Design Institute, 2011, EC INP OUTP LIF CYCL; Chisholm M., 2007, REUTERS NEWS SE 0611; Deng LQ, 2011, J CLEAN PROD, V19, P1198, DOI 10.1016/j.jclepro.2011.03.004; Deng LQ, 2011, J IND ECOL, V15, P108, DOI 10.1111/j.1530-9290.2010.00306.x; Graedel T., 2009, IND ECOLOGY SUSTAINA; Greening LA, 2000, ENERG POLICY, V28, P389, DOI 10.1016/S0301-4215(00)00021-5; Greenpeace Research Laboratories, 2007, MISS CALL IPHONES HA; Grubler A, 1998, TECHNOLOGY GLOBAL CH; Hendrickson CT, 2006, ENV LIFE CYCLE ASSES; Hertwich EG, 2005, J IND ECOL, V9, P85, DOI 10.1162/1088198054084635; Hilty L.M., 2008, INFORM TECHNOLOGY SU, DOI [10.4324/9781315641980-8, DOI 10.4324/9781315641980-8]; Kawamoto K., 2001, LBNL45917; Keoleian G.A., 2000, J IND ECOL, V4, P135, DOI [DOI 10.1162/108819800569726, 10.1162/108819800569726]; Kurzweil R., 2005, SINGULARITY IS NEAR; Leontief WW, 1936, REV ECON STATISTICS, V18, P105, DOI 10.2307/1927837; Lipsey R.G., 1998, GEN PURPOSE TECHNOLO; Matthews HS, 2005, J INFRASTRUCT SYST, V11, P21, DOI 10.1061/(ASCE)1076-0342(2005)11:1(21); Meyers RJ, 2010, ENERG BUILDINGS, V42, P563, DOI 10.1016/j.enbuild.2009.10.026; Mokhtarian PL, 1998, URBAN STUD, V35, P215, DOI 10.1080/0042098984952; Mol APJ, 2006, ENVIRON PLANN C, V24, P497, DOI 10.1068/c0508j; Moore G., 1965, ELECTRONICS, V38, P114, DOI [DOI 10.1109/N-SSC.2006.4785860, DOI 10.1109/JPROC.1998.658762]; Nordbrand S, 2009, OUT CONTROL E WASTE; Ok Z., 2009, P IEEE INT S SUST SY; Organisation for Economic Co-operation and Development, 2003, ICT EC GROWTH EV OEC; Roth K., 2007, ENERGY CONSUMPTION C; Shaw Susan D., 2010, Reviews on Environmental Health, V25, P261; Toxics Link, 2003, SCRAPP HIGH TECH MYT; Tsydenova O, 2011, WASTE MANAGE, V31, P45, DOI 10.1016/j.wasman.2010.08.014; US Environmental Protection Agency, 2011, EN STAR; VANENGELENBURG BCW, 1994, ENERG POLICY, V22, P648, DOI 10.1016/0301-4215(94)90058-2; Warren P., 2009, GUARDIAN        0708; Wikoff DS, 2011, HANDB ENVIRON CHEM, V16, P19, DOI 10.1007/698_2010_97; Williams E, 2004, ENVIRON SCI TECHNOL, V38, P6166, DOI 10.1021/es035152j; Williams E., 2011, THERMODYNAMICS DESTR, P190; Williams E., 2003, P 1 INT WORKSH SUST, P69; Williams ED, 2002, ENVIRON SCI TECHNOL, V36, P5504, DOI 10.1021/es025643o; Williams ED, 2004, THIN SOLID FILMS, V461, P2, DOI 10.1016/j.tsf.2004.02.049; Williams E, 2008, ENVIRON SCI TECHNOL, V42, P6446, DOI 10.1021/es702255z; Williams ED, 2009, J IND ECOL, V13, P928, DOI 10.1111/j.1530-9290.2009.00170.x; Worrell E, 1999, LBNL41724; Yu JL, 2010, ENVIRON SCI TECHNOL, V44, P3232, DOI 10.1021/es903350q	53	116	118	8	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2011	479	7373					354	358		10.1038/nature10682	http://dx.doi.org/10.1038/nature10682			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	848OA	22094696				2022-12-24	WOS:000297059700036
J	Green, DR; Van Houten, B				Green, Douglas R.; Van Houten, Bennett			SnapShot: Mitochondrial Quality Control	CELL			English	Editorial Material							DEATH; DNA		[Green, Douglas R.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; [Van Houten, Bennett] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA	St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Green, DR (corresponding author), St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA.		Green, Douglas R/N-8083-2018; Van Houten, Bennett/K-2284-2019	Green, Douglas R/0000-0002-7332-1417; 	NIAID NIH HHS [R01 AI040646, R01 AI040646-16] Funding Source: Medline; NIGMS NIH HHS [R37 GM052735-21, R37 GM052735] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052735] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Green DR, 2011, MEANS END APOPTOSIS; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	9	43	49	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 11	2011	147	4							950.e1	10.1016/j.cell.2011.10.036	http://dx.doi.org/10.1016/j.cell.2011.10.036			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22078889	Green Accepted, Bronze			2022-12-24	WOS:000296902300028
J	Weiss, RB; Atkins, JF				Weiss, Robert B.; Atkins, John F.			Translation Goes Global	SCIENCE			English	Editorial Material							MESSENGER-RNA; IDENTIFICATION; ACT		[Weiss, Robert B.; Atkins, John F.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Atkins, John F.] Natl Univ Ireland Univ Coll Cork, BioSci Inst, Cork, Ireland	Utah System of Higher Education; University of Utah; University College Cork	Weiss, RB (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	bob.weiss@genetics.utah.edu; j.atkins@ucc.ie		Atkins, John/0000-0001-7933-0165				CRICK FH, 1961, NATURE, V192, P1227, DOI 10.1038/1921227a0; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Ivanov IP, 2010, P NATL ACAD SCI USA, V107, P18056, DOI 10.1073/pnas.1009269107; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Malarkannan S, 1999, IMMUNITY, V10, P681, DOI 10.1016/S1074-7613(00)80067-9; NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Zong Q, 1999, P NATL ACAD SCI USA, V96, P10632, DOI 10.1073/pnas.96.19.10632	14	13	15	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1509	1510		10.1126/science.1216974	http://dx.doi.org/10.1126/science.1216974			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	862LE	22174241				2022-12-24	WOS:000298091400040
J	Delude, C				Delude, Cathryn			TUMORIGENESIS Testing ground for cancer stem cells	NATURE			English	Editorial Material																		Brennan SK, 2009, J MOL MED, V87, P1079, DOI 10.1007/s00109-009-0531-7; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Kirshner J, 2008, BLOOD, V112, P2935, DOI 10.1182/blood-2008-02-142430	3	31	34	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S43	S45		10.1038/480S43a	http://dx.doi.org/10.1038/480S43a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22169801	Bronze			2022-12-24	WOS:000298033000006
J	Epstein, AM; Jha, AK; Orav, EJ				Epstein, Arnold M.; Jha, Ashish K.; Orav, E. John			The Relationship between Hospital Admission Rates and Rehospitalizations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; DISEASE MANAGEMENT PROGRAMS; MEDICARE BENEFICIARIES; READMISSION RATES; SOCIOECONOMIC-STATUS; ADMINISTRATIVE DATA; 30-DAY READMISSION; RANDOMIZED-TRIALS; TRANSITIONAL CARE; CLINICAL-OUTCOMES	BACKGROUND Efforts to reduce hospital readmissions have focused primarily on improving transitional care. Yet variation in readmission rates may more closely reflect variation in the underlying hospitalization rates than differences in the quality of care during and after discharge. METHODS We used national Medicare data to calculate, for each local hospital referral region (HRR), the 30-day, 60-day, and 90-day readmission rates among patients discharged with congestive heart failure or pneumonia. We also calculated population-based all-cause admission rates among Medicare enrollees in each HRR. We examined the variation in HRR readmission rates that was explained by overall hospitalization rates versus differences in patients' coexisting conditions, quality of discharge planning, physician supply, and bed supply. RESULTS HRR readmission rates ranged from 11 to 32% for congestive heart failure and from 8 to 27% for pneumonia. In univariate analyses, all-cause admission rates accounted for the highest proportion of regional variation in readmission rates for congestive heart failure (28%, 34%, and 37% at 30, 60, and 90 days, respectively); the next highest proportions were explained by case mix (11%, 15%, and 18%) and the number of cardiologists per capita (12%, 14%, and 15%). Results for pneumonia were similar, except that the number of pulmonologists per capita accounted for a lower proportion of the variation (6%, 8%, and 7%, respectively). In multivariate analyses, admission rates accounted for 16 to 24% of the variation for congestive heart failure and 11 to 20% for pneumonia; no other factor accounted for more than 6%. CONCLUSIONS We found a substantial association between regional rates of rehospitalization and overall admission rates. Programs directed at shared savings from lower utilization of hospital services might be more successful in reducing readmissions than programs initiated to date. (Funded by the Commonwealth Fund.)	[Epstein, Arnold M.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Epstein, Arnold M.; Jha, Ashish K.; Orav, E. John] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Epstein, AM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	aepstein@hsph.harvard.edu	Hug, Balthasar L./G-1568-2010		Commonwealth Fund	Commonwealth Fund	Supported by the Commonwealth Fund.	[Anonymous], 2011, SUPPL SENS CAR; Ashton CM, 1997, MED CARE, V35, P1044, DOI 10.1097/00005650-199710000-00006; Auerbach AD, 2010, J AM COLL SURGEONS, V211, P601, DOI 10.1016/j.jamcollsurg.2010.07.006; Auerbach AD, 2009, ANN INTERN MED, V150, P696, DOI 10.7326/0003-4819-150-10-200905190-00007; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Chin MH, 1997, AM J CARDIOL, V79, P1640, DOI 10.1016/S0002-9149(97)00214-2; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Dartmouth Medical School Center for the Evaluative Clinical Sciences, 1998, DARTM ATL HLTH CAR; Deswal A, 2004, J AM COLL CARDIOL, V43, P778, DOI 10.1016/j.jacc.2003.10.033; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Elliott MN, 2005, HEALTH SERV RES, V40, P2096, DOI 10.1111/j.1475-6773.2005.00476.x; Felker GM, 2004, J CARD FAIL, V10, P460, DOI 10.1016/j.cardfail.2004.02.011; FISHER ES, 1994, NEW ENGL J MED, V331, P989, DOI 10.1056/NEJM199410133311506; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Gonseth J, 2004, EUR HEART J, V25, P1570, DOI 10.1016/j.ehj.2004.04.022; Gwadry-Sridhar FH, 2004, ARCH INTERN MED, V164, P2315, DOI 10.1001/archinte.164.21.2315; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; HoltzEakin D, 2004, COMMUNICATION   1013; Hummel SL, 2010, CIRC-HEART FAIL, V3, P244, DOI 10.1161/CIRCHEARTFAILURE.109.884098; Jencks SF, 2011, NEW ENGL J MED, V364, P1582; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; Jovicic Aleksandra, 2006, BMC Cardiovasc Disord, V6, P43, DOI 10.1186/1471-2261-6-43; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; Joynt KE, 2011, CIRC-CARDIOVASC QUAL, V4, P53, DOI 10.1161/CIRCOUTCOMES.110.950964; Koelling TM, 2005, CIRCULATION, V111, P179, DOI 10.1161/01.CIR.0000151811.53450.B8; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 1997, ARCH INTERN MED, V157, P99, DOI 10.1001/archinte.157.1.99; Krumholz HM, 2002, J AM COLL CARDIOL, V39, P83, DOI 10.1016/S0735-1097(01)01699-0; Krumholz HM, 2000, AM HEART J, V139, P72, DOI 10.1016/S0002-8703(00)90311-9; Lappe JM, 2004, ANN INTERN MED, V141, P446, DOI 10.7326/0003-4819-141-6-200409210-00010; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; O'Malley AJ, 2005, HEALTH SERV RES, V40, P2162, DOI 10.1111/j.1475-6773.2005.00470.x; O'Malley AJ, 2005, HEALTH SERV RES, V40, P2078, DOI 10.1111/j.1475-6773.2005.00471.x; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Philbin EF, 1999, J AM COLL CARDIOL, V33, P1560, DOI 10.1016/S0735-1097(99)00059-5; Philbin EF, 2001, AM J CARDIOL, V87, P1367, DOI 10.1016/S0002-9149(01)01554-5; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; PHILLIPS CO, 2004, JAMA-J AM MED ASSOC, V292, P1022; Rathore SS, 2006, AM HEART J, V152, P371, DOI 10.1016/j.ahj.2005.12.002; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Schneider J K, 1993, Clin Nurs Res, V2, P41, DOI 10.1177/105477389300200105; Smith DM, 2000, J CLIN EPIDEMIOL, V53, P1113, DOI 10.1016/S0895-4356(00)00236-5; Stewart S, 1998, ARCH INTERN MED, V158, P1067, DOI 10.1001/archinte.158.10.1067; Wennberg John E, 2002, Health Aff (Millwood), VSuppl Web Exclusives, pW96; Yamokoski LM, 2007, J CARD FAIL, V13, P8, DOI 10.1016/j.cardfail.2006.10.002; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	53	199	203	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2011	365	24					2287	2295		10.1056/NEJMsa1101942	http://dx.doi.org/10.1056/NEJMsa1101942			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861PN	22168643				2022-12-24	WOS:000298031800009
J	Feinmann, J				Feinmann, Jane			BMJ CHRISTMAS APPEAL Pulse oximeters for all	BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com							0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2011	343								d8085	10.1136/bmj.d8085	http://dx.doi.org/10.1136/bmj.d8085			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865NO	22171350				2022-12-24	WOS:000298317800002
J	Zhu, PJ; Huang, W; Kalikulov, D; Yoo, JW; Placzek, AN; Stoica, L; Zhou, HY; Bell, JC; Friedlander, MJ; Krnjevic, K; Noebels, JL; Costa-Mattioli, M				Zhu, Ping Jun; Huang, Wei; Kalikulov, Djanenkhodja; Yoo, Jong W.; Placzek, Andon N.; Stoica, Loredana; Zhou, Hongyi; Bell, John C.; Friedlander, Michael J.; Krnjevic, Kresimir; Noebels, Jeffrey L.; Costa-Mattioli, Mauro			Suppression of PKR Promotes Network Excitability and Enhanced Cognition by Interferon-gamma-Mediated Disinhibition	CELL			English	Article							DEPENDENT PROTEIN-KINASE; TERM SYNAPTIC PLASTICITY; RAT HIPPOCAMPAL SLICE; CA1 PYRAMIDAL CELLS; IFN-GAMMA; MEMORY CONSOLIDATION; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; GABAERGIC NEURONS; TRANSGENIC MICE	The double-stranded RNA-activated protein kinase (PKR) was originally identified as a sensor of virus infection, but its function in the brain remains unknown. Here, we report that the lack of PKR enhances learning and memory in several behavioral tasks while increasing network excitability. In addition, loss of PKR increases the late phase of long-lasting synaptic potentiation (L-LTP) in hippocampal slices. These effects are caused by an interferon-gamma (IFN-gamma)-mediated selective reduction in GABAergic synaptic action. Together, our results reveal that PKR finely tunes the network activity that must be maintained while storing a given episode during learning. Because PKR activity is altered in several neurological disorders, this kinase presents a promising new target for the treatment of cognitive dysfunction. As a first step in this direction, we show that a selective PKR inhibitor replicates the Pkr(-/-) phenotype in WT mice, enhancing long-term memory storage and L-LTP.	[Zhu, Ping Jun; Huang, Wei; Kalikulov, Djanenkhodja; Placzek, Andon N.; Stoica, Loredana; Zhou, Hongyi; Friedlander, Michael J.; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zhu, Ping Jun; Huang, Wei; Stoica, Loredana; Zhou, Hongyi; Costa-Mattioli, Mauro] Baylor Coll Med, Ctr Addict Learning & Memory, Houston, TX 77030 USA; [Yoo, Jong W.; Noebels, Jeffrey L.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Bell, John C.] Ottawa Hlth Res Inst, Ottawa, ON K1H 8L6, Canada; [Krnjevic, Kresimir] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Ottawa; Ottawa Hospital Research Institute; McGill University	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	costamat@bcm.edu		Noebels, Jeffrey/0000-0002-2887-0839	Searle award [09-SSP-211]; George and Cynthia Mitchell Foundation; Baylor IDDRC; NINDS [NS 29709]; NICHD [HD24064]; NEI [EY12782]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076708, R01NS029709] Funding Source: NIH RePORTER	Searle award; George and Cynthia Mitchell Foundation; Baylor IDDRC; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Buzsaki, H. Zoghbi, and M. Rasband for comments on an early version of the manuscript. This work was supported by funds to M.C.-M. (Searle award 09-SSP-211; George and Cynthia Mitchell Foundation, Baylor IDDRC), J.L.N. (NINDS NS 29709, NICHD HD24064, Baylor IDDRC), and M.J.F. (NEI EY12782). The authors declare no competing financial interests.	Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; ABRAHAM WC, 1986, NEUROSCI LETT, V70, P217, DOI 10.1016/0304-3940(86)90466-0; Hangya B, 2009, J NEUROSCI, V29, P8094, DOI 10.1523/JNEUROSCI.5665-08.2009; Bando Y, 2005, NEUROCHEM INT, V46, P11, DOI 10.1016/j.neuint.2004.07.005; Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866; Beenhakker MP, 2009, NEURON, V62, P612, DOI 10.1016/j.neuron.2009.05.015; Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; BUCHMEIER NA, 1985, P NATL ACAD SCI USA, V82, P7404, DOI 10.1073/pnas.82.21.7404; Buzsaki G, 2006, RYTHMS BRAIN; Carnevalli LS, 2006, BIOCHEM J, V397, P187, DOI 10.1042/BJ20051643; CHAVEZNORIEGA LE, 1989, NEUROSCI LETT, V104, P58, DOI 10.1016/0304-3940(89)90329-7; Cohen-Chalamish S, 2009, NAT CHEM BIOL, V5, P896, DOI 10.1038/nchembio.234; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Couturier J, 2010, J BIOL CHEM, V285, P1272, DOI 10.1074/jbc.M109.041954; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Getts DR, 2007, J NEUROCHEM, V103, P1019, DOI 10.1111/j.1471-4159.2007.04798.x; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gusev PA, 2001, J NEUROPHYSIOL, V86, P881, DOI 10.1152/jn.2001.86.2.881; HAEFELY W, 1990, NEUROCHEM RES, V15, P169, DOI 10.1007/BF00972207; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Heaton P, 2004, J CHILD PSYCHOL PSYC, V45, P899, DOI 10.1111/j.1469-7610.2004.t01-1-00284.x; Holmes GL, 2006, EPILEPSY BEHAV, V8, P504, DOI 10.1016/j.yebeh.2005.11.014; Hughes JR, 2010, EPILEPSY BEHAV, V17, P147, DOI 10.1016/j.yebeh.2009.12.014; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; Ingrand S, 2007, FEBS LETT, V581, P4473, DOI 10.1016/j.febslet.2007.08.022; IZQUIERDO I, 1991, TRENDS PHARMACOL SCI, V12, P260, DOI 10.1016/0165-6147(91)90567-C; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Mann EO, 2010, NAT NEUROSCI, V13, P205, DOI 10.1038/nn.2464; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; McGaugh JL, 2009, PSYCHOPHARMACOLOGY, V202, P3, DOI 10.1007/s00213-008-1285-6; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULLER M, 1993, BRAIN RES, V619, P157, DOI 10.1016/0006-8993(93)91607-T; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Paquet C, 2009, J NEUROPATH EXP NEUR, V68, P190, DOI 10.1097/NEN.0b013e318196cd7c; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Peel AL, 2003, NEUROBIOL DIS, V14, P52, DOI 10.1016/S0969-9961(03)00086-X; Peel AL, 2001, HUM MOL GENET, V10, P1531, DOI 10.1093/hmg/10.15.1531; Price MG, 2009, J NEUROSCI, V29, P8752, DOI 10.1523/JNEUROSCI.0915-09.2009; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; SCHREIBER RD, 1985, J IMMUNOL, V134, P1609; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steriade M, 2005, ELECTROENCEPHALOGRAP, P505; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0	60	138	151	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1384	1396		10.1016/j.cell.2011.11.029	http://dx.doi.org/10.1016/j.cell.2011.11.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153080	Green Accepted, Bronze			2022-12-24	WOS:000298148100025
J	Zhou, CK; Slaughter, BD; Unruh, JR; Eldakak, A; Rubinstein, B; Li, R				Zhou, Chuankai; Slaughter, Brian D.; Unruh, Jay R.; Eldakak, Amr; Rubinstein, Boris; Li, Rong			Motility and Segregation of Hsp104-Associated Protein Aggregates in Budding Yeast	CELL			English	Article							IMAGE CORRELATION SPECTROSCOPY; SACCHAROMYCES-CEREVISIAE; DAMAGED PROTEINS; ACTIN CYTOSKELETON; CHAPERONE HSP104; CELL-GROWTH; LIFE-SPAN; DISAGGREGATION; INHERITANCE; MECHANISM	During yeast cell division, aggregates of damaged proteins are segregated asymmetrically between the bud and the mother. It is thought that protein aggregates are cleared from the bud via actin cable-based retrograde transport toward the mother and that Bni1p formin regulates this transport. Here, we examined the dynamics of Hsp104-associated protein aggregates by video microscopy, particle tracking, and image correlation analysis. We show that protein aggregates undergo random walk without directional bias. Clearance of heat-induced aggregates from the bud does not depend on formin proteins but occurs mostly through dissolution via Hsp104p chaperon. Aggregates formed naturally in aged cells also exhibit random walk but do not dissolve during observation. Although our data do not disagree with a role for actin or cell polarity in aggregate segregation, modeling suggests that their asymmetric inheritance can be a predictable outcome of aggregates' slow diffusion and the geometry of yeast cells.	[Zhou, Chuankai; Slaughter, Brian D.; Unruh, Jay R.; Eldakak, Amr; Rubinstein, Boris; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Zhou, Chuankai; Li, Rong] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers.org		Unruh, Jay/0000-0003-3077-4990	NIH [RO1-GM057063]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057063] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank I. Pinto for assistance with yeast strain construction, J. Zhu and A. Box for help with aged cell sorting, A. Das for assistance in microscopy, and B. Liu and T. Nystrom for kindly providing their Hsp104-GFP strain. This work was supported by NIH grant RO1-GM057063 to R. L.	ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; Bosl B, 2006, J STRUCT BIOL, V156, P139, DOI 10.1016/j.jsb.2006.02.004; Chen CY, 2003, EXP GERONTOL, V38, P1051, DOI 10.1016/S0531-5565(03)00186-4; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; EGILMEZ NK, 1989, J BACTERIOL, V171, P37, DOI 10.1128/jb.171.1.37-42.1989; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Gehlen LR, 2011, CURR BIOL, V21, P25, DOI 10.1016/j.cub.2010.12.016; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Knorre DA, 2010, CELL CYCLE, V9, P4501, DOI 10.4161/cc.9.22.13683; Kolin DL, 2006, BIOPHYS J, V91, P3061, DOI 10.1529/biophysj.106.082768; LEW DJ, 1995, CURR OPIN GENET DEV, V5, P17, DOI 10.1016/S0959-437X(95)90048-9; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Tran PT, 2004, METHODS, V33, P220, DOI 10.1016/j.ymeth.2003.11.017; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899	30	97	98	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1186	1196		10.1016/j.cell.2011.11.002	http://dx.doi.org/10.1016/j.cell.2011.11.002			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118470	Green Accepted, Bronze			2022-12-24	WOS:000297376600027
J	Spence, D				Spence, Des			FROM THE FRONTLINE Out of hours care: a call for continuity	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2012	344								e279	10.1136/bmj.e279	http://dx.doi.org/10.1136/bmj.e279			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877SI	22236600				2022-12-24	WOS:000299202500007
J	Xi, QR; Wang, ZX; Zaromytidou, AI; Zhang, XHF; Chow-Tsang, LF; Liu, JX; Kim, H; Barlas, A; Manova-Todorova, K; Kaartinen, V; Studer, L; Mark, W; Patel, DJ; Massague, J				Xi, Qiaoran; Wang, Zhanxin; Zaromytidou, Alexia-Ileana; Zhang, Xiang H. -F.; Chow-Tsang, Lai-Fong; Liu, Jing X.; Kim, Hyesoo; Barlas, Afsar; Manova-Todorova, Katia; Kaartinen, Vesa; Studer, Lorenz; Mark, Willie; Patel, Dinshaw J.; Massague, Joan			A Poised Chromatin Platform for TGF-beta Access to Master Regulators	CELL			English	Article							EMBRYONIC STEM-CELLS; PHD FINGER; UBIQUITIN LIGASE; BINDING MODULES; HISTONE H3K4ME3; SMAD4; TRANSCRIPTION; TIF1-GAMMA; CANCER; DIFFERENTIATION	Specific chromatin marks keep master regulators of differentiation silent yet poised for activation by extracellular signals. We report that nodal TGF-beta signals use the poised histone mark H3K9me3 to trigger differentiation of mammalian embryonic stem cells. Nodal receptors induce the formation of companion Smad4-Smad2/3 and TRIM33-Smad2/3 complexes. The PHD-Bromo cassette of TRIM33 facilitates binding of TRIM33-Smad2/3 to H3K9me3 and H3K18ac on the promoters of mesendoderm regulators Gsc and Mixl1. The crystal structure of this cassette, bound to histone H3 peptides, illustrates that PHD recognizes K9me3, and Bromo binds an adjacent K18ac. The interaction between TRIM33Smad2/3 and H3K9me3 displaces the chromatin-compacting factor HP1g, making nodal response elements accessible to Smad4-Smad2/3 for Pol II recruitment. In turn, Smad4 increases K18 acetylation to augment TRIM33-Smad2/3 binding. Thus, nodal effectors use the H3K9me3 mark as a platform to switch master regulators of stem cell differentiation from the poised to the active state.	[Xi, Qiaoran; Zaromytidou, Alexia-Ileana; Zhang, Xiang H. -F.; Chow-Tsang, Lai-Fong; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Wang, Zhanxin; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Kim, Hyesoo; Studer, Lorenz] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Kaartinen, Vesa] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; Howard Hughes Medical Institute	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	massaguj@mskcc.org	Kaartinen, Vesa/AAU-5396-2021; Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; Zhang, Xiang/0000-0002-5674-8670; Kaartinen, Vesa/0000-0002-9432-510X; Massague, Joan/0000-0001-9324-8408	National Cancer Institute; NIH [NS052671, CA34610]; Starr Foundation; NYSTEM; Abby Rockefeller Mauze Trust; Maloris Foundation; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P30CA008748, R37CA034610, K99CA151293, R01CA034610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052671] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; NYSTEM; Abby Rockefeller Mauze Trust; Maloris Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank E.J. Robertson, D. Rifkin, and Y. Kang for reagents; W. He, E. P. Papapetrou, S. Acharyya, and C.J. David for helpful discussions; A. Viale for valuable help with microarray analysis; P. Y. Chen, S. Francis, and N. Fan for technical help; and the staff at beamline 24ID-C of the Advanced Photon Source at the Argonne National Laboratory and beamline X25 of the National Synchrotron Light Source at the Brookhaven National Laboratory, for assistance with data collection. Support for the MSKCC Transgenic Mouse Core, Genomics Core, and Molecular Cytology Core was provided by the National Cancer Institute. L. S. is supported by NIH Grant NS052671 as well as funds from the Starr Foundation and from NYSTEM. D.J.P. is supported by funds from the Abby Rockefeller Mauze Trust and the Maloris Foundation, as well as funds from the Leukemia and Lymphoma Society and the Starr Foundation. J.M. is supported by NIH Grant CA34610, and is a Howard Hughes Medical Institute Investigator.	Agricola E, 2011, MOL CELL, V43, P85, DOI 10.1016/j.molcel.2011.05.020; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dunn NR, 2005, GENE DEV, V19, P152, DOI 10.1101/gad.1243205; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Hart AH, 2002, DEVELOPMENT, V129, P3597; Hart AH, 2005, BIOCHEM BIOPH RES CO, V333, P1361, DOI 10.1016/j.bbrc.2005.06.044; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kwon SH, 2008, MOL CELLS, V26, P217; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morsut L, 2010, DEVELOPMENT, V137, P2571, DOI 10.1242/dev.053801; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Vincent DF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000575; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	44	206	212	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1511	1524		10.1016/j.cell.2011.11.032	http://dx.doi.org/10.1016/j.cell.2011.11.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196728	Green Accepted, Bronze			2022-12-24	WOS:000298403400016
J	Rosenblum, MD; Gratz, IK; Paw, JS; Lee, K; Marshak-Rothstein, A; Abbas, AK				Rosenblum, Michael D.; Gratz, Iris K.; Paw, Jonathan S.; Lee, Karen; Marshak-Rothstein, Ann; Abbas, Abul K.			Response to self antigen imprints regulatory memory in tissues	NATURE			English	Article							T-CELLS; IN-VIVO; EXPRESSION; AUTOANTIGEN; HOMEOSTASIS; AUTOIMMUNE; DEPLETION; DISEASES; MICE	Immune homeostasis in tissues is achieved through a delicate balance between pathogenic T-cell responses directed at tissue-specific antigens and the ability of the tissue to inhibit these responses. The mechanisms by which tissues and the immune system communicate to establish and maintain immune homeostasis are currently unknown. Clinical evidence suggests that chronic or repeated exposure to self antigen within tissues leads to an attenuation of pathological autoimmune responses, possibly as a means to mitigate inflammatory damage and preserve function. Many human organ-specific autoimmune diseases are characterized by the initial presentation of the disease being the most severe, with subsequent flares being of lesser severity and duration(1). In fact, these diseases often spontaneously resolve, despite persistent tissue autoantigen expression(2). In the practice of antigen-specific immunotherapy, allergens or self antigens are repeatedly injected in the skin, with a diminution of the inflammatory response occurring after each successive exposure(3). Although these findings indicate that tissues acquire the ability to attenuate autoimmune reactions upon repeated responses to antigens, the mechanism by which this occurs is unknown. Here we show that upon expression of self antigen in a peripheral tissue, thymus-derived regulatory T cells (T-reg cells) become activated, proliferate and differentiate into more potent suppressors, which mediate resolution of organ-specific autoimmunity in mice. After resolution of the inflammatory response, activated T-reg cells are maintained in the target tissue and are primed to attenuate subsequent autoimmune reactions when antigen is re-expressed. Thus, T-reg cells function to confer 'regulatory memory' to the target tissue. These findings provide a framework for understanding how T-reg cells respond when exposed to self antigen in peripheral tissues and offer mechanistic insight into how tissues regulate autoimmunity.	[Gratz, Iris K.; Paw, Jonathan S.; Abbas, Abul K.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Rosenblum, Michael D.; Paw, Jonathan S.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94115 USA; [Lee, Karen] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA; [Marshak-Rothstein, Ann] Univ Massachusetts, Div Rheumatol, Dept Med, Worcester, MA 01655 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; University of Massachusetts System; University of Massachusetts Worcester	Abbas, AK (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	Abul.Abbas@ucsf.edu	Gratz, Iris K/L-6267-2015	Gratz, Iris K/0000-0001-7470-7277	Dermatology Foundation; UCSF Department of Dermatology; NIH [P01 AI35297, R01 AI73656, U19 AI56388, AR055634]; Scleroderma Research Foundation; Austrian Science Fund (FWF) [J2997-B13]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073656, U19AI056388, P01AI035297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055634, K08AR062064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM058724] Funding Source: NIH RePORTER	Dermatology Foundation; UCSF Department of Dermatology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Benetiz for assistance with animal husbandry, S. Isakson for genotyping, S.-w. Jiang and M. Lee for cell sorting, and K. Ravid and G. Martin for derivation of TRE-TGO transgenic mice. We thank S. Ziegler, Benaroya Research Institute, for transgenic mice. M. D. R. is supported by a Dermatology Foundation Career Development Award and the UCSF Department of Dermatology. This work was partially funded through NIH grants P01 AI35297, R01 AI73656 and U19 AI56388 (to A. K. A.); NIH grant AR055634 to (A.M.-R.); and the Scleroderma Research Foundation (A.M.-R.). I. K. G. is supported by an Erwin Schroedinger Fellowship from the Austrian Science Fund (FWF), J2997-B13.	Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Dudda JC, 2008, J EXP MED, V205, P1559, DOI 10.1084/jem.20072594; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; James WD, 2006, ANDREWS DIS SKIN CLI, V10th, P308; Kurtulus S, 2010, IMMUNOL REV, V236, P54, DOI 10.1111/j.1600-065X.2010.00920.x; Lara-Corrales I, 2010, SEMIN CUTAN MED SURG, V29, P85, DOI 10.1016/j.sder.2010.03.005; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mouquet H, 2008, TISSUE ANTIGENS, V71, P464, DOI 10.1111/j.1399-0039.2008.01020.x; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Tenorio EP, 2011, FEMS IMMUNOL MED MIC, V62, P362, DOI 10.1111/j.1574-695X.2011.00805.x; Sabatos-Peyton CA, 2010, CURR OPIN IMMUNOL, V22, P609, DOI 10.1016/j.coi.2010.08.006; Saff RR, 2004, J IMMUNOL, V172, P6598, DOI 10.4049/jimmunol.172.11.6598; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Wada N, 2011, J INVEST DERMATOL, V131, P410, DOI 10.1038/jid.2010.330; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	17	205	213	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					538	U164		10.1038/nature10664	http://dx.doi.org/10.1038/nature10664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22121024	Green Accepted			2022-12-24	WOS:000298318000064
J	Ruder, TD; Thali, Y; Bucher, M; Cottier, A; Thali, MJ; Hatch, GM				Ruder, Thomas D.; Thali, Yannick; Bucher, Matthias; Cottier, Annie; Thali, Michael J.; Hatch, Gary M.			CHRISTMAS 2011: DIAGNOSIS The writing's on the wall for Sherlock	BRITISH MEDICAL JOURNAL			English	Editorial Material							STATURE; LENGTH		[Ruder, Thomas D.; Bucher, Matthias; Thali, Michael J.] Univ Zurich, Inst Forens Med, CH-8057 Zurich, Switzerland; [Ruder, Thomas D.; Thali, Yannick] Univ Bern, Inst Forens Med, Bern, Switzerland; [Cottier, Annie] Univ Bern, Dept English, Bern, Switzerland; [Hatch, Gary M.] Univ New Mexico, Off Med Investigator, Albuquerque, NM 87131 USA	University of Zurich; University of Bern; University of Bern; University of New Mexico	Ruder, TD (corresponding author), Univ Zurich, Inst Forens Med, Winterthurerstr 190-52, CH-8057 Zurich, Switzerland.	thomas_ruder@hotmail.com		Ruder, Thomas/0000-0002-3110-9143				Conan Doyle A., 2018, STUDY SCARLET AMAZON; Doyle, 1888, STUDY SCARLET; Doyle Arthur Conan, 2001, STUDY SCARLET; Jasuja OP, 1997, FORENSIC SCI INT, V86, P181, DOI 10.1016/S0379-0738(97)00038-8; JASUJA OP, 1993, FORENSIC SCI INT, V61, P1, DOI 10.1016/0379-0738(93)90244-5; Klinger Leslie S., 2005, NEW ANNOTATED SHERLO; WAGNER JE, 2006, SCI SHERLOCK HOLMES	7	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2011	343								d7406	10.1136/bmj.d7406	http://dx.doi.org/10.1136/bmj.d7406			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868QK	22187185	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000298538200002
J	Aiken, AM; Mturi, N; Njuguna, P; Mohammed, S; Berkley, JA; Mwangi, I; Mwarumba, S; Kitsao, BS; Lowe, BS; Morpeth, SC; Hall, AJ; Khandawalla, I; Scott, JAG				Aiken, Alexander M.; Mturi, Neema; Njuguna, Patricia; Mohammed, Shebe; Berkley, James A.; Mwangi, Isaiah; Mwarumba, Salim; Kitsao, Barnes S.; Lowe, Brett S.; Morpeth, Susan C.; Hall, Andrew J.; Khandawalla, Iqbal; Scott, J. Anthony G.		Kilifi Bacteraemia Surveillance	Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi District Hospital, Kenya: a prospective cohort study	LANCET			English	Article							CARE-ASSOCIATED INFECTION; DEVELOPING-COUNTRIES; MALAWIAN CHILDREN; BLOOD-TRANSFUSION; SALMONELLA; SEPTICEMIA; MORTALITY; OUTBREAK; TANZANIA; FEATURES	Background In sub-Saharan Africa, community-acquired bacteraemia is an important cause of illness and death in children. Our aim was to establish the magnitude and causes of hospital-acquired (nosocomial) bacteraemia in African children. Methods We reviewed prospectively collected surveillance data of 33 188 admissions to Kilifi District Hospital, Kenya, between April 16, 2002, and Sept 30, 2009. We defined bacteraemia as nosocomial if it occurred 48 h or more after admission. We estimated the per-admission risk, daily rate, effect on mortality, and microbial cause of nosocomial bacteraemia and analysed risk factors by multivariable Cox regression. The effect on morbidity was measured as the increase in hospital stay by comparison with time-matched patients without bacteraemia. Findings The overall risk of nosocomial bacteraemia during this period was 5.9/1000 admissions (95% CI 5.2-6.9) but we recorded an underlying rise in risk of 27% per year. The incidence was 1.0/1000 days in hospital (0.87-1.14), which is about 40 times higher than that of community-acquired bacteraemia in the same region. Mortality in patients with nosocomial bacteraemia was 53%, compared with 24% in community-acquired bacteraemia and 6% in patients without bacteraemia. In survivors, nosocomial bacteraemia lengthened hospital stay by 10.1 days (3.0-17.2). Klebsiella pneumoniae, Escherichia coli, Staphylococcus aureus, Acinetobacter spp, group D streptococci, and Pseudomonas aeruginosa accounted for three-quarters of nosocomial infections. Nosocomial bacteraemia was significantly associated with severe mal nutrition (hazard ratio 2.52, 95% CI 1.79-3.57) and blood transfusion in children without severe anaemia (4.99; 3.39-7.37). Interpretation Our findings show that although nosocomial bacteraemia is rare, it has serious effects on morbidity and mortality, and the microbiological causes are distinct from those of community-acquired bacteraemia. Nosocomial infections are largely unrecognised or undocumented as a health risk in low-income countries, but they are likely to become public health priorities as awareness of their occurrence increases and as other prominent childhood diseases are progressively controlled.	[Aiken, Alexander M.; Mturi, Neema; Njuguna, Patricia; Mohammed, Shebe; Berkley, James A.; Mwangi, Isaiah; Mwarumba, Salim; Kitsao, Barnes S.; Lowe, Brett S.; Morpeth, Susan C.; Scott, J. Anthony G.] Kenya Med Res Inst Wellcome Trust Res Programme, Kilifi, Kenya; [Aiken, Alexander M.; Hall, Andrew J.] London Sch Hyg & Trop Med, London WC1, England; [Mturi, Neema; Njuguna, Patricia; Mohammed, Shebe; Khandawalla, Iqbal] Kilifi Dist Hosp, Minist Med Serv, Kilifi, Kenya; [Berkley, James A.; Lowe, Brett S.; Morpeth, Susan C.; Scott, J. Anthony G.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Aiken, AM (corresponding author), POB 43640, Nairobi 00100, Kenya.	aaiken@nairobi.kemri-wellcome.org	Aiken, Alexander/AAP-7661-2021	Aiken, Alexander/0000-0003-3372-9036; Berkley, James/0000-0002-1236-849X	Wellcome Trust; Kenya Medical Research Institute-Wellcome Trust; Wellcome Trust of Great Britain [085042, 081835]	Wellcome Trust(Wellcome TrustEuropean Commission); Kenya Medical Research Institute-Wellcome Trust; Wellcome Trust of Great Britain(Wellcome Trust)	Wellcome Trust.; Surveillance at Kilifi District Hospital is funded by the Kenya Medical Research Institute-Wellcome Trust Research Programme. AA and JAGS are supported by research fellowships from the Wellcome Trust of Great Britain (grant numbers 085042 and 081835, respectively). We thank Kilifi District Hospital clinical team and laboratory staff for their involvement in data collection and the ICT staff of the Kenya Medical Research Institute-Wellcome Trust Research Programme for their diligent work on data entry and data management. This study is published with the permission of the Director of Kenya Medical Research Institute.	AIKEN CGA, 1992, ARCH DIS CHILD, V67, P595, DOI 10.1136/adc.67.5.595; Allegranzi B, 2007, INFECT CONT HOSP EP, V28, P1323, DOI 10.1086/521656; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; [Anonymous], 2000, T R SOC TROP MED S1, V94, pS1; Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; Bejon P, 2008, AM J CLIN NUTR, V88, P1626, DOI 10.3945/ajcn.2008.26510; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Blomberg B, 2005, J CLIN MICROBIOL, V43, P745, DOI 10.1128/JCM.43.2.745-749.2005; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Callas PW, 1998, AM J IND MED, V33, P33; COTTON MF, 1992, S AFR MED J, V81, P87; de Irala-Estevez J, 2001, INTENS CARE MED, V27, P1254, DOI 10.1007/s001340101007; Hassall O, 2009, TRANSFUSION, V49, P2594, DOI 10.1111/j.1537-2995.2009.02344.x; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Iregbu K C, 2007, Afr J Med Med Sci, V36, P225; *MIN MED SERV KEN, 2010, NAT INF PREV CONTR G; MURPHY SA, 1994, E AFR MED J, V71, P271; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Pedro R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-307; Pittet D, 2008, J HOSP INFECT, V68, P285, DOI 10.1016/j.jhin.2007.12.013; Rosenthal VD, 2011, LANCET, V377, P186, DOI 10.1016/S0140-6736(10)62005-3; Schulgen G, 2000, J CLIN EPIDEMIOL, V53, P409, DOI 10.1016/S0895-4356(99)00182-1; Tagny CT, 2008, TRANSFUSION, V48, P1256, DOI 10.1111/j.1537-2995.2008.01697.x; Vaagland H, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-35; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; Walsh AL, 2002, T ROY SOC TROP MED H, V96, P276, DOI 10.1016/S0035-9203(02)90098-2; Wisplinghoff H, 2003, PEDIATR INFECT DIS J, V22, P686, DOI 10.1097/01.inf.0000078159.53132.40; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	30	86	87	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 10	2011	378	9808					2021	2027		10.1016/S0140-6736(11)61622-X	http://dx.doi.org/10.1016/S0140-6736(11)61622-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863DY	22133536	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000298144200026
J	Strid, J; Sobolev, O; Zafirova, B; Polic, B; Hayday, A				Strid, Jessica; Sobolev, Olga; Zafirova, Biljana; Polic, Bojan; Hayday, Adrian			The Intraepithelial T Cell Response to NKG2D-Ligands Links Lymphoid Stress Surveillance to Atopy	SCIENCE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; NKT CELLS; NKG2D; EXPRESSION; LIGANDS; ASTHMA; MICE	Epithelial cells respond to physicochemical damage with up-regulation of major histocompatibility complex-like ligands that can activate the cytolytic potential of neighboring intraepithelial T cells by binding the activating receptor, NKG2D. The systemic implications of this lymphoid stress-surveillance response, however, are unknown. We found that antigens encountered at the same time as cutaneous epithelial stress induced strong primary and secondary systemic, T helper 2 (T(H)2)-associated atopic responses in mice. These responses required NKG2D-dependent communication between dysregulated epithelial cells and tissue-associated lymphoid cells. These data are germane to uncertainty over the afferent induction of T(H)2 responses and provide a molecular framework for considering atopy as an important component of the response to tissue damage and carcinogenesis.	[Strid, Jessica; Sobolev, Olga; Hayday, Adrian] Canc Res UK, London Res Inst, London WC2A 3LY, England; [Strid, Jessica; Sobolev, Olga; Hayday, Adrian] Kings Coll London, Guys Hosp, Sch Med, Peter Gorer Dept Immunobiol, London SE1 9RT, England; [Zafirova, Biljana; Polic, Bojan] Univ Rijeka, Sch Med, Dept Histol & Embryol, HR-51000 Rijeka, Croatia	Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Rijeka	Hayday, A (corresponding author), Canc Res UK, London Res Inst, London WC2A 3LY, England.	adrian.hayday@kcl.ac.uk	Polic, Bojan/B-8622-2014	Polic, Bojan/0000-0003-3930-9630; HAYDAY, ADRIAN/0000-0002-9495-5793; Strid, Jessica/0000-0003-3690-2201	Wellcome Trust; National Institute of Health Research cBRC; Croatian Ministry of Science, Education and Sports [062-0621261-1271]	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research cBRC; Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	We thank M. Girardi, M. L. Michel, and M. Wencker for materials and advice; A. Yates for statistical assistance; P. Vantourout, G. Turchinovich, and R. Tigelaar for discussions; S. Diebold and C. Reis e Sousa for mice; and for funding, a Wellcome Trust Programme grant (A. H. and J.S.), a National Institute of Health Research cBRC grant (A. H. and O.S.), and Croatian Ministry of Science, Education and Sports grant 062-0621261-1271 (B.Z. and B. P.). The data reported in this paper are tabulated in the main paper and the supporting online material.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Herrick CA, 2003, J IMMUNOL, V170, P2488, DOI 10.4049/jimmunol.170.5.2488; Iwamura C, 2010, CURR OPIN IMMUNOL, V22, P807, DOI 10.1016/j.coi.2010.10.008; Lisbonne M, 2003, J IMMUNOL, V171, P1637, DOI 10.4049/jimmunol.171.4.1637; McCoy KD, 2006, IMMUNITY, V24, P329, DOI 10.1016/j.immuni.2006.01.013; Nishijima T, 1997, J INVEST DERMATOL, V109, P175, DOI 10.1111/1523-1747.ep12319282; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; PROFET M, 1991, Q REV BIOL, V66, P23, DOI 10.1086/417049; Strid J, 2004, EUR J IMMUNOL, V34, P2100, DOI 10.1002/eji.200425196; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Takada A, 2008, J IMMUNOL, V180, P1678, DOI 10.4049/jimmunol.180.3.1678; Le TA, 2011, INT ARCH ALLERGY IMM, V155, P31, DOI 10.1159/000318679; Van Hemelrijck M, 2010, CANCER CAUSE CONTROL, V21, P1657, DOI 10.1007/s10552-010-9594-6; Vemijlen D., 2007, J IMMUNOL, V178, P4304; WEN L, 1994, NATURE, V369, P654, DOI 10.1038/369654a0; WOOD LC, 1992, J CLIN INVEST, V90, P482, DOI 10.1172/JCI115884; Woodward AL, 2001, J ALLERGY CLIN IMMUN, V107, P359, DOI 10.1067/mai.2001.112695; Wu WH, 2010, J ALLERGY CLIN IMMUN, V126, P290, DOI 10.1016/j.jaci.2010.05.024; Zhang TT, 2010, P NATL ACAD SCI USA, V107, P3040, DOI 10.1073/pnas.0915072107	25	108	111	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1293	1297		10.1126/science.1211250	http://dx.doi.org/10.1126/science.1211250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144628	Green Accepted			2022-12-24	WOS:000297553600055
J	Bohlen, CJ; Chesler, AT; Sharif-Naeini, R; Medzihradszky, KF; Zhou, S; King, D; Sanchez, EE; Burlingame, AL; Basbaum, AI; Julius, D				Bohlen, Christopher J.; Chesler, Alexander T.; Sharif-Naeini, Reza; Medzihradszky, Katalin F.; Zhou, Sharleen; King, David; Sanchez, Elda E.; Burlingame, Alma L.; Basbaum, Allan I.; Julius, David			A heteromeric Texas coral snake toxin targets acid-sensing ion channels to produce pain	NATURE			English	Article							CAPSAICIN RECEPTOR; SENSORY NEURONS; VENOMS; MICE; CONTRIBUTES; CURRENTS; STIMULI; ASICS; TRPV1	Natural products that elicit discomfort or pain represent invaluable tools for probing molecular mechanisms underlying pain sensation(1). Plant-derived irritants have predominated in this regard, but animal venoms have also evolved to avert predators by targeting neurons and receptors whose activation produces noxious sensations(2-6). As such, venoms provide a rich and varied source of small molecule and protein pharmacophores(7,8) that can be exploited to characterize and manipulate key components of the pain-signalling pathway. With this in mind, here we perform an unbiased in vitro screen to identify snake venoms capable of activating somatosensory neurons. Venom from the Texas coral snake (Micrurus tener tener), whose bite produces intense and unremitting pain(9), excites a large cohort of sensory neurons. The purified active species (MitTx) consists of a heteromeric complex between Kunitz- and phospholipase-A2-like proteins that together function as a potent, persistent and selective agonist for acid-sensing ion channels (ASICs), showing equal or greater efficacy compared with acidic pH. MitTx is highly selective for the ASIC1 subtype at neutral pH; under more acidic conditions (pH < 6.5), MitTx massively potenti ates (>100-fold) proton-evoked activation of ASIC2a channels. These observations raise the possibility that ASIC channels function as coincidence detectors for extracellular protons and other, as yet unidentified, endogenous factors. Purified MitTx elicits robust pain-related behaviour in mice by activation of ASIC1 channels on capsaicin-sensitive nerve fibres. These findings reveal a mechanism whereby snake venoms produce pain, and highlight an unexpected contribution of ASIC1 channels to nociception.	[Bohlen, Christopher J.; Chesler, Alexander T.; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Sharif-Naeini, Reza; Basbaum, Allan I.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Medzihradszky, Katalin F.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Zhou, Sharleen; King, David] Univ Calif Berkeley, Howard Hughes Med Inst, Mass Spectrometry Lab, Berkeley, CA 94720 USA; [Sanchez, Elda E.] Texas A&M Univ, Dept Chem, Kingsville, TX 78363 USA; [Sanchez, Elda E.] Texas A&M Univ, Natl Nat Toxins Res Ctr, Kingsville, TX 78363 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Texas A&M University System; Texas A&M University Kingsville; Texas A&M University System; Texas A&M University Kingsville	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	david.julius@ucsf.edu	Chesler, Alexander/V-2748-2019	Chesler, Alexander/0000-0002-3131-0728; Sanchez, Elda E./0000-0001-5222-8873	Ruth Kirschstein NIH [F31NS065597]; NIH from the UCSF Cardiovascular Research Institute; Canadian Institutes of Health Research; Howard Hughes Medical Institute; NIH [NCRR P41RR001614, NCRR P40RR018300-09, NINDS R01NS065071]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, P40RR018300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065071, F31NS065597] Funding Source: NIH RePORTER	Ruth Kirschstein NIH; NIH from the UCSF Cardiovascular Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Price and M. Welsh for providing ASIC1 and ASIC3 knockout mice; Y. Kelly and J. Poblete for technical assistance; C. Williams for assisting with homology models; F. Findeisen, L. Ma and D. Minor for assistance with ITC experiments; R. Nicoll and members of the Julius laboratory for discussion and comments. This work was supported by a Ruth Kirschstein NIH predoctoral fellowship (F31NS065597 to C. B.), an NIH postdoctoral training grant from the UCSF Cardiovascular Research Institute (to A. C.), a postdoctoral fellowship from the Canadian Institutes of Health Research (to R.S.-N.), the Howard Hughes Medical Institute (K. F. M. and A. L. B.), and the NIH (NCRR P41RR001614 to A. L. B., NCRR P40RR018300-09 to E. S. and NINDS R01NS065071 to D.J.).	Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; CHAHL LA, 1975, PAIN, V1, P3, DOI 10.1016/0304-3959(75)90003-2; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Doley R, 2009, CELL MOL LIFE SCI, V66, P2851, DOI 10.1007/s00018-009-0050-2; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; Mebs D., 2002, VENOMOUS POISONOUS A; Morgan DL, 2007, SOUTH MED J, V100, P152, DOI 10.1097/01.smj.0000253596.39121.19; NISHIOKA SA, 1993, ANN TROP MED PARASIT, V87, P429, DOI 10.1080/00034983.1993.11812791; Poirot O, 2006, J PHYSIOL-LONDON, V576, P215, DOI 10.1113/jphysiol.2006.113035; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; SCHMIDT JO, 1982, ANNU REV ENTOMOL, V27, P339, DOI 10.1146/annurev.en.27.010182.002011; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	30	236	245	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					410	U167		10.1038/nature10607	http://dx.doi.org/10.1038/nature10607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22094702	Green Accepted, Green Submitted			2022-12-24	WOS:000297059700048
J	O'Conor, R				O'Conor, Rory			CLIMATE CHANGE Lessons from strategy game modelling climate change	BRITISH MEDICAL JOURNAL			English	Letter												rory.oconor@wdpct.nhs.uk						Godlee F., 2011, BMJ-BRIT MED J, V343, pd6789	1	0	0	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 15	2011	343								d7379	10.1136/bmj.d7379	http://dx.doi.org/10.1136/bmj.d7379			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854LU	22089746				2022-12-24	WOS:000297497000017
J	Steinbrook, R				Steinbrook, Robert			Science, Politics, and Over-the-Counter Emergency Contraception	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FDA		Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Yale University	Steinbrook, R (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,I-456 SHM,POB 208008, New Haven, CT 06520 USA.	rsteinbrook@attglobal.net						Abma Joyce C, 2010, Vital Health Stat 23, P1; [Anonymous], 2011, STATEMENT FDA COMMIS; [Anonymous], 2011, KATHLEEN SEBELIUS MA; [Anonymous], 2011, NEW GOVT DATA FINDS; Eaton Danice K., 2010, Morbidity and Mortality Weekly Report, V59, P1; Hamburg MA, 2009, NEW ENGL J MED, V360, P2493, DOI 10.1056/NEJMp0903764; Hamilton B. E., 2011, BIRTHS PRELIMINARY D; Raymond EG, 2009, CONTRACEPTION, V79, P199, DOI 10.1016/j.contraception.2008.09.004; Steinbrook R, 2004, NEW ENGL J MED, V350, P2327, DOI 10.1056/NEJMp048135; Steinbrook R, 2004, NEW ENGL J MED, V350, P1454, DOI 10.1056/NEJMhpr033416	10	7	7	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2012	307	4					365	366		10.1001/jama.2011.1957	http://dx.doi.org/10.1001/jama.2011.1957			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881EP	22182592				2022-12-24	WOS:000299464000019
J	Bhattacharjee, S; Stahelin, RV; Speicher, KD; Speicher, DW; Haldar, K				Bhattacharjee, Souvik; Stahelin, Robert V.; Speicher, Kaye D.; Speicher, David W.; Haldar, Kasturi			Endoplasmic Reticulum PI(3)P Lipid Binding Targets Malaria Proteins to the Host Cell	CELL			English	Article							RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; EFFECTOR PROTEINS; ERYTHROCYTE; PARASITES; VIRULENCE; SIGNAL; EXPORT; ORGANIZATION; MEMBRANE	Hundreds of effector proteins of the human malaria parasite Plasmodium falciparum constitute a "secretome" carrying a host-targeting (HT) signal, which predicts their export from the intracellular pathogen into the surrounding erythrocyte. Cleavage of the HT signal by a parasite endoplasmic reticulum (ER) protease, plasmepsin V, is the proposed export mechanism. Here, we show that the HT signal facilitates export by recognition of the lipid phosphatidylinositol-3-phosphate (PI(3)P) in the ER, prior to and independent of protease action. Secretome HT signals, including those of major virulence determinants, bind PI(3)P with nanomolar affinity and amino acid specificities displayed by HT-mediated export. PI(3)P-enriched regions are detected within the parasite's ER and colocalize with endogenous HT signal on ER precursors, which also display high-affinity binding to PI(3)P. A related pathogenic oomycete's HT signal export is dependent on PI(3)P binding, without cleavage by plasmepsin V. Thus, PI(3)P in the ER functions in mechanisms of secretion and pathogenesis.	[Bhattacharjee, Souvik; Haldar, Kasturi] Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Bhattacharjee, Souvik; Haldar, Kasturi] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Speicher, Kaye D.; Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Speicher, Kaye D.; Speicher, David W.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University South Bend; The Wistar Institute; The Wistar Institute	Haldar, K (corresponding author), Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA.	khaldar@nd.edu	Haldar, Kasturi/C-6685-2014; Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863	NIH [HL069630, AI039071, HL078826, AI081077, HL038794, CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038794, R01HL069630, P01HL078826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039071, R01AI081077] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was conceived by K.H., R.V.S., and S.B., and the experiments were planned by K.H., R.V.S., S.B., D.W.S., and K.D.S. S.B., R.V.S., and K.D.S. conducted the experiments. K.H., R.V.S., and S.B. wrote the paper with input from all authors. We thank Yi Xue and Jordan L. Scott for excellent technical assistance, Andrew Osborne (University College of London) for helpful discussions, and Caroline Furtado Junqueira for help in figure representation. We would also like to thank Lennell Reynolds Jr., the Cell Imaging Facility at Northwestern University, and William Archer at the University of Notre Dame for help with electron microscopy. This work was partially supported by NIH grants HL069630, AI039071, HL078826 (K.H.); AI081077 (R.V.S.); HL038794 (D.W.S.) and CA10815 (Wistar Proteomics Core Facility).	Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; CRARY JL, 1992, MOL BIOCHEM PARASIT, V53, P185, DOI 10.1016/0166-6851(92)90020-K; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Duffy PE, 2003, CURR OPIN MICROBIOL, V6, P371, DOI 10.1016/S1369-5274(03)00090-0; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; ELMENDORF HG, 1993, PARASITOL TODAY, V9, P98, DOI 10.1016/0169-4758(93)90216-3; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lopez-Estrano C, 2003, P NATL ACAD SCI USA, V100, P12402, DOI 10.1073/pnas.2133080100; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Osborne AR, 2010, MOL BIOCHEM PARASIT, V171, P25, DOI 10.1016/j.molbiopara.2010.01.003; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Tawk L, 2010, EUKARYOT CELL, V9, P1519, DOI 10.1128/EC.00124-10; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Wiser MF, 1997, P NATL ACAD SCI USA, V94, P9108, DOI 10.1073/pnas.94.17.9108; World Health Organization, 2010, MALARIAREPORT	35	89	94	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 20	2012	148	1-2					201	212		10.1016/j.cell.2011.10.051	http://dx.doi.org/10.1016/j.cell.2011.10.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265412	Bronze, Green Accepted			2022-12-24	WOS:000299540700025
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: medical nutrition	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], NUTR SUPPORT ADULTS	1	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2012	344								e451	10.1136/bmj.e451	http://dx.doi.org/10.1136/bmj.e451			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888YZ	22257980				2022-12-24	WOS:000300041900007
J	Nauman, J; Janszky, I; Vatten, LJ; Wisloff, U				Nauman, Javaid; Janszky, Imre; Vatten, Lars J.; Wisloff, Ulrik			Temporal Changes in Resting Heart Rate and Deaths From Ischemic Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; SYSTOLIC DYSFUNCTION BEAUTIFUL; PLACEBO-CONTROLLED TRIAL; NORD-TRONDELAG HEALTH; MIDDLE-AGED MEN; HYPERTENSIVE PATIENTS; PHYSICAL-ACTIVITY; RISK-FACTOR; BLOOD-PRESSURE; ALL-CAUSE	Context Resting heart rate (RHR) has long been recognized as an independent predictor of cardiovascular risk. However, whether temporal changes in RHR influence the risk of death from ischemic heart disease (IHD) in the general population is not known. Objective To assess the association of long-term longitudinal changes in RHR with the risk of dying from IHD. Design, Settings, and Participants A prospective cohort study of 13 499 men and 15 826 women without known cardiovascular disease in Norway. Resting heart rate was measured on 2 occasions around 10 years apart in the Nord-Trondelag County Health Study. The second RHR measurement was obtained between August 1995 and June 1997, with subsequent mortality follow-up until December 31, 2008. A total of 60 participants were lost to follow-up, all due to emigration from Norway. Using Cox regression analyses, adjusted hazard ratios (AHRs) were estimated of death from IHD related to changes in RHR over time. In a corresponding analysis, death from all causes also was assessed. Results During a mean (SD) of 12 (2) years of follow-up, 3038 people died, and 388 deaths were caused by IHD. An increase in RHR was associated with increased risk of death from IHD. Compared with participants with a RHR of less than 70 beats/min at both measurements (8.2 deaths/10 000 person-years), the AHR was 1.9 (95% CI, 1.0-3.6) for participants with a RHR of less than 70 beats/min at the first measurement but greater than 85 beats/min at the second measurement (17.2 deaths/10 000 person-years). For participants with RHRs between 70 and 85 beats/min at the first measurement and greater than 85 beats/min at the second measurement (17.4 deaths/10 000 person-years), the AHR was 1.8 (95% CI, 1.2-2.8). The association of change in RHR with IHD mortality was not linear (P=.003 for quadratic trend), suggesting that a decrease in RHR showed no general mortality benefit. Excluding the first 3 years of follow-up did not substantially alter the findings. The associations for total mortality were similar but generally weaker than those observed for IHD mortality. Conclusion Among men and women without known cardiovascular disease, an increase in RHR over a 10-year period was associated with increased risk of death from IHD and also for all-cause mortality. JAMA. 2011;306(23):2579-2587	[Wisloff, Ulrik] Norwegian Univ Sci & Technol, Fac Med, KG Jebsen Ctr Exercise Med, Medisinsk Tekn Forskningssenter, N-7491 Trondheim, Norway; [Nauman, Javaid; Wisloff, Ulrik] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7491 Trondheim, Norway; [Janszky, Imre; Vatten, Lars J.] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, N-7491 Trondheim, Norway; [Janszky, Imre] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Karolinska Institutet	Wisloff, U (corresponding author), Norwegian Univ Sci & Technol, Fac Med, KG Jebsen Ctr Exercise Med, Medisinsk Tekn Forskningssenter, POB 8905, N-7491 Trondheim, Norway.	ulrik.wisloff@ntnu.no	Vatten, Lars/AAF-9380-2022; Nauman, Javaid/AAF-2284-2019; Wisloff, Ulrik/K-2899-2012; Vatten, Lars/AFK-2073-2022	Nauman, Javaid/0000-0003-1347-2448; Wisloff, Ulrik/0000-0002-7211-3587	K. G. Jebsen Foundation; Norwegian Council of Cardiovascular Disease; Norwegian Research Council; St Olav's University Hospital, Trondheim; Torstein Erbo's Foundation, Trondheim; Liaison Committee; Central Norway Regional Health Authority; Norwegian University of Science and Technology; Swedish Council of Working Life and Social Research	K. G. Jebsen Foundation; Norwegian Council of Cardiovascular Disease; Norwegian Research Council(Research Council of NorwayEuropean Commission); St Olav's University Hospital, Trondheim; Torstein Erbo's Foundation, Trondheim; Liaison Committee; Central Norway Regional Health Authority; Norwegian University of Science and Technology; Swedish Council of Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	The present study was supported by grants from K. G. Jebsen Foundation, the Norwegian Council of Cardiovascular Disease, the Norwegian Research Council (Funding for Outstanding Young Investigators awarded to Dr Wisloff), Funds for Cardiovascular and Medical Research at St Olav's University Hospital, Trondheim, the Torstein Erbo's Foundation, Trondheim, the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (Dr Janszky), and by the Swedish Council of Working Life and Social Research (Dr Janszky).	Black A, 2006, HEART, V92, P468, DOI 10.1136/hrt.2005.067777; Bohm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7; Cook S, 2006, EUR HEART J, V27, P2387, DOI 10.1093/eurheartj/ehl259; Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190; Dietrich DF, 2007, INT J EPIDEMIOL, V36, P834, DOI [10.1093/ije/dymo31, 10.1093/ije/dym031]; DYER AR, 1980, AM J EPIDEMIOL, V112, P736, DOI 10.1093/oxfordjournals.aje.a113046; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; ERIKSSEN J, 1979, EUR J APPL PHYSIOL O, V42, P61, DOI 10.1007/BF00421105; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Jouven X, 2009, AM J CARDIOL, V103, P279, DOI 10.1016/j.amjcard.2008.08.071; Kolloch R, 2008, EUR HEART J, V29, P1327, DOI 10.1093/eurheartj/ehn123; Kurtze N, 2007, EUR J EPIDEMIOL, V22, P379, DOI 10.1007/s10654-007-9110-9; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; Midthjell K, 1999, DIABETES CARE, V22, P1813, DOI 10.2337/diacare.22.11.1813; Mozaffarian D, 2005, CIRCULATION, V112, P1945, DOI 10.1161/CIRCULATIONAHA.105.556886; Mozaffarian D, 2006, J AM COLL CARDIOL, V48, P478, DOI 10.1016/j.jacc.2006.03.048; Okin PM, 2010, EUR HEART J, V31, P2271, DOI 10.1093/eurheartj/ehq225; Palatini P, 1999, HYPERTENSION, V33, P622, DOI 10.1161/01.HYP.33.2.622; Palatini P, 2002, ARCH INTERN MED, V162, P2313, DOI 10.1001/archinte.162.20.2313; Paul L, 2010, HYPERTENSION, V55, P567, DOI 10.1161/HYPERTENSIONAHA.109.144808; RUNCIE CJ, 1990, INTENS CARE MED, V16, P317, DOI 10.1007/BF01706357; Sandercock GRH, 2008, J SPORT SCI, V26, P1171, DOI 10.1080/02640410802004930; Shishehbor MH, 2006, JAMA-J AM MED ASSOC, V295, P784, DOI 10.1001/jama.295.7.784; Stensvold D, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-109	28	135	141	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2579	2587		10.1001/jama.2011.1826	http://dx.doi.org/10.1001/jama.2011.1826			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864YQ	22187277				2022-12-24	WOS:000298276800019
J	Spence, JD; Stampfer, MJ				Spence, J. David; Stampfer, Meir J.			Understanding the Complexity of Homocysteine Lowering With Vitamins The Potential Role of Subgroup Analyses	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; STROKE PREVENTION; RECURRENT STROKE; RISK; INTERVENTION; THERAPY		[Spence, J. David] Univ Western Ontario, Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, London, ON N6G 2V2, Canada; [Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Stampfer, Meir J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Stampfer, Meir J.] Harvard Univ, Sch Med, Boston, MA USA	Western University (University of Western Ontario); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Spence, JD (corresponding author), Univ Western Ontario, Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, 1400 Western Rd, London, ON N6G 2V2, Canada.	dspence@robarts.ca	Spence, J. David/K-6396-2013	Spence, J. David/0000-0001-7478-1098				House AA, 2010, JAMA-J AM MED ASSOC, V303, P1603, DOI 10.1001/jama.2010.490; Hsu FC, 2011, NEUROLOGY, V77, P1543, DOI 10.1212/WNL.0b013e318233b1f9; Rimm EB, 2011, LANCET, V378, P544, DOI 10.1016/S0140-6736(11)61057-X; Spence D, 2009, LANCET, V373, P1006, DOI 10.1016/S0140-6736(09)60604-8; Spence JD, 2007, LANCET NEUROL, V6, P830, DOI 10.1016/S1474-4422(07)70219-3; Spence JD, 2005, STROKE, V36, P2404, DOI 10.1161/01.STR.0000185929.38534.f3; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Veeranna V, 2011, J AM COLL CARDIOL, V58, P1025, DOI 10.1016/j.jacc.2011.05.028; Vogiatzoglou A, 2009, CLIN CHEM, V55, P2198, DOI 10.1373/clinchem.2009.128678; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	10	60	62	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2610	2611		10.1001/jama.2011.1834	http://dx.doi.org/10.1001/jama.2011.1834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864YQ	22187282				2022-12-24	WOS:000298276800024
J	Ahmed, U; Spyridis, N; Wong, ICK; Sharland, M; Long, PF				Ahmed, Umar; Spyridis, Nikos; Wong, Ian C. K.; Sharland, Mike; Long, Paul F.		Improving Children's Antibiotic Pr	CHRISTMAS 2011: ORAL TRADITIONS Dosing of oral penicillins in children: is big child=half an adult, small child=half a big child, baby=half a small child still the best we can do?	BRITISH MEDICAL JOURNAL			English	Editorial Material							OTITIS-MEDIA; PRIMARY-CARE; RESISTANCE; COHORT		[Ahmed, Umar; Wong, Ian C. K.; Long, Paul F.] Univ London, Sch Pharm, Ctr Paediat Pharm Res, London WC1H 9JP, England; [Ahmed, Umar] Boots Chemist, London, England; [Spyridis, Nikos; Sharland, Mike] St George Hosp, Paediat Infect Dis Unit, London, England; [Spyridis, Nikos] Univ Athens, P & A Kyriakou Childrens Hosp, Athens, Greece; [Wong, Ian C. K.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Long, Paul F.] Kings Coll London, Inst Pharmaceut Sci, London WC2R 2LS, England; [Long, Paul F.] Kings Coll London, Dept Chem, London WC2R 2LS, England	University of London; University College London; University of London School of Pharmacy; St Georges University London; National & Kapodistrian University of Athens; University of Hong Kong; University of London; King's College London; University of London; King's College London	Long, PF (corresponding author), Univ London, Sch Pharm, Ctr Paediat Pharm Res, London WC1H 9JP, England.	paul.long@kcl.ac.uk						[Anonymous], 1963, BMJ-BRIT MED J, V2, P1577; [Anonymous], 2009, HIV MED, V10, P591; Buchnan JL., 1946, LANCET, V248, P560; Chung A, 2007, BMJ-BRIT MED J, V335, P429, DOI 10.1136/bmj.39274.647465.BE; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Electronic Medicines Compendium, 2011, SUMM PROD CHAR AM PA; EMERY JL, 1949, BRIT MED J, V1, P1110, DOI 10.1136/bmj.1.4616.1110; HAUSMANN E, 1953, Wien Med Wochenschr, V103, P725; Henderson JL, 1946, LANCET, V247, P922; HOFFMAN WS, 1948, J PEDIATR-US, V32, P1, DOI 10.1016/S0022-3476(48)80123-X; Keith T, 2010, CURR OPIN INFECT DIS, V23, P242, DOI 10.1097/QCO.0b013e328338c46d; KNUDSEN LF, 1945, J BACTERIOL, V50, P187, DOI 10.1128/JB.50.2.187-200.1945; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Menson EN, 2006, BMJ-BRIT MED J, V332, P1183, DOI 10.1136/bmj.332.7551.1183; MOSELEY JH, 1948, ARCH DIS CHILD, V23, P93, DOI 10.1136/adc.23.114.93; NMH Information Centre, HLTH SURV ENGL 2009; SPITZY K H, 1955, Wien Klin Wochenschr, V67, P212; SUCHETTKAYE AI, 1947, BMJ-BRIT MED J, V2, P953, DOI 10.1136/bmj.2.4536.953; Thompson PL, 2009, ARCH DIS CHILD, V94, P337, DOI 10.1136/adc.2008.147579; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; WHEATLEY D, 1958, BRIT MED J, V2, P907, DOI 10.1136/bmj.2.5101.907; Young BA., 1947, BRIT MED J, Vviii, P290	22	5	6	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2011	343								d7803	10.1136/bmj.d7803	http://dx.doi.org/10.1136/bmj.d7803			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888WF	22174326	Green Submitted			2022-12-24	WOS:000300034600007
J	Rosu, S; Libuda, DE; Villeneuve, AM				Rosu, Simona; Libuda, Diana E.; Villeneuve, Anne M.			Robust Crossover Assurance and Regulated Interhomolog Access Maintain Meiotic Crossover Number	SCIENCE			English	Article							DNA BREAK REPAIR; CROSSING-OVER; C-ELEGANS; MEIOSIS; RECOMBINATION; MECHANISM; INTERFERENCE; HOMEOSTASIS; SYNAPSIS	Most organisms rely on interhomolog crossovers (COs) to ensure proper meiotic chromosome segregation but make few COs per chromosome pair. By monitoring repair events at a defined double-strand break (DSB) site during Caenorhabditis elegans meiosis, we reveal mechanisms that ensure formation of the obligate CO while limiting CO number. We find that CO is the preferred DSB repair outcome in the absence of inhibitory effects of other (nascent) recombination events. Thus, a single DSB per chromosome pair is largely sufficient to ensure CO formation. Further, we show that access to the homolog as a repair template is regulated, shutting down simultaneously for both CO and noncrossover (NCO) pathways. We propose that regulation of interhomolog access limits CO number and contributes to CO interference.	[Rosu, Simona; Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Libuda, Diana E.; Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Villeneuve, AM (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	annev@stanford.edu		Libuda, Diana/0000-0002-4944-1814	NIH [R01GM67268]; Helen Hay Whitney Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067268, T32GM007790] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge V. Robert, E. Jorgensen, and J.-L. Bessereau for sharing data and strains central to the Mos1 assay before publication and thank K. Zawadzki and S. Mlynarczyk-Evans for comments on the manuscript and M. Zetka, J. Culotti, A. Dernburg, and Caenorhabditis Genetics Center for reagents and strains. This work was supported by NIH grant R01GM67268 to A. M. V. and a Helen Hay Whitney Fellowship to D. E. L. Author contributions: Most experiments were conceived and data analyzed by S. R. and A. M. V. S. R. performed all experiments except for those in figs. S2D and S4, which were performed and analyzed by D.E.L.	Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Hyppa RW, 2010, CELL, V142, P243, DOI 10.1016/j.cell.2010.05.041; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kelly KO, 2000, GENETICS, V156, P617; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Martinez-Perez E, 2009, CURR OPIN GENET DEV, V19, P105, DOI 10.1016/j.gde.2009.02.005; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Robert VJ, 2008, GENETICS, V180, P673, DOI 10.1534/genetics.108.089698; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112	17	87	88	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1286	1289		10.1126/science.1212424	http://dx.doi.org/10.1126/science.1212424			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144627	Green Accepted			2022-12-24	WOS:000297553600053
J	Hammond, P				Hammond, Phil			SEXUAL HEALTH Warts and all at last: HPV vaccination	BRITISH MEDICAL JOURNAL			English	Editorial Material												hamm82@msn.com						[Anonymous], 2006, LANCET, V368, P1212; *BRIT ASS SEX HLTH, 2011, BASHH WELC HPV VACC, pD3482; FAIRLEY CK, 2010, 2010 AUSTR SEX HLTH, pD3482; *GLAXOSMITHKLINE, GLAXOSMITHKLINE STAT, pD3482; HAMMOND P, 2011, PRIVATE EYE, V1282, P12; Hammond P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2186; Jit M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5775; Kmietowicz Z, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7694	8	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2011	343								d7779	10.1136/bmj.d7779	http://dx.doi.org/10.1136/bmj.d7779			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RQ	22131211				2022-12-24	WOS:000298037300005
J	Armache, KJ; Garlick, JD; Canzio, D; Narlikar, GJ; Kingston, RE				Armache, Karim-Jean; Garlick, Joseph D.; Canzio, Daniele; Narlikar, Geeta J.; Kingston, Robert E.			Structural Basis of Silencing: Sir3 BAH Domain in Complex with a Nucleosome at 3.0 angstrom Resolution	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; HISTONE H3; MATING LOCI; TELOMERIC HETEROCHROMATIN; PROTEIN INTERACTIONS; GENETIC-ANALYSIS; CORE PARTICLE; N-TERMINUS; YEAST; CHROMATIN	Gene silencing is essential for regulating cell fate in eukaryotes. Altered chromatin architectures contribute to maintaining the silenced state in a variety of species. The silent information regulator (Sir) proteins regulate mating type in Saccharomyces cerevisiae. One of these proteins, Sir3, interacts directly with the nucleosome to help generate silenced domains. We determined the crystal structure of a complex of the yeast Sir3 BAH (bromo-associated homology) domain and the nucleosome core particle at 3.0 angstrom resolution. We see multiple molecular interactions between the protein surfaces of the nucleosome and the BAH domain that explain numerous genetic mutations. These interactions are accompanied by structural rearrangements in both the nucleosome and the BAH domain. The structure explains how covalent modifications on H4K16 and H3K79 regulate formation of a silencing complex that contains the nucleosome as a central component.	[Armache, Karim-Jean; Garlick, Joseph D.; Kingston, Robert E.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Armache, Karim-Jean; Garlick, Joseph D.; Kingston, Robert E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Canzio, Daniele; Narlikar, Geeta J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Canzio, Daniele] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94158 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kingston@molbio.mgh.harvard.edu			NIH [GM043901]; Human Frontier Science Program; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048405, R01GM043901] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM043901 from NIH (to R. E. K.). K-J.A. was supported in part by a fellowship from the Human Frontier Science Program. We thank the staff at Beamlines 24-IDC/E at Argonne National Laboratory, especially K. Rajashankar and F. Murphy, for excellent assistance with data collection. We thank R. Sternglanz for BAH domain constructs. We thank T. Schwartz for use of the high-throughput crystallization facility, as well as helpful discussions and critical reading of the manuscript. We thank F. Winston for critical reading of the manuscript. We thank S. Jenni and D. Kostrewa for helpful discussions; S. Tan and K. Luger for help with technical aspects of forming nucleosomes; J. Cochrane, S. Bowman, S. Miller, M. Simon, and K. Bouazoune for critical reading of the manuscript, and members of the Kingston laboratory for helpful discussions. Coordinates and structure factors have been deposited in the Protein Data Bank with accession code 3TU4.	APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Buchberger JR, 2008, MOL CELL BIOL, V28, P6903, DOI 10.1128/MCB.01210-08; Connelly JJ, 2006, MOL CELL BIOL, V26, P3256, DOI 10.1128/MCB.26.8.3256-3265.2006; Dai JBA, 2010, GENETICS, V186, P813, DOI 10.1534/genetics.110.118489; Ehrentraut S, 2011, GENE DEV, V25, P1835, DOI 10.1101/gad.17175111; Fry CJ, 2006, MOL CELL BIOL, V26, P9045, DOI 10.1128/MCB.00248-06; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Hou ZG, 2006, PROTEIN SCI, V15, P1182, DOI 10.1110/ps.052061006; Johnson A, 2009, MOL CELL, V35, P769, DOI 10.1016/j.molcel.2009.07.030; JOHNSON LM, 1992, EMBO J, V11, P2201, DOI 10.1002/j.1460-2075.1992.tb05279.x; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; King DA, 2006, J BIOL CHEM, V281, P20107, DOI 10.1074/jbc.M512588200; Kyriss MNM, 2010, MOL CELL BIOL, V30, P3503, DOI 10.1128/MCB.00290-10; Liaw H, 2006, MOL CELL BIOL, V26, P7616, DOI 10.1128/MCB.01082-06; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Liu C, 1996, GENETICS, V143, P81; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; MAHONEY DJ, 1989, MOL CELL BIOL, V9, P4621, DOI 10.1128/MCB.9.11.4621; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009; McBryant SJ, 2008, MOL CELL BIOL, V28, P3563, DOI 10.1128/MCB.01389-07; McBryant SJ, 2006, BIOCHEMISTRY-US, V45, P15941, DOI 10.1021/bi061693k; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; NASMYTH KA, 1982, CELL, V30, P567, DOI 10.1016/0092-8674(82)90253-7; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Norris A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000301; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Oppikofer M, 2011, EMBO J, V30, P2610, DOI 10.1038/emboj.2011.170; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; Park JH, 2002, NAT GENET, V32, P273, DOI 10.1038/ng982; Park Y, 1998, GENETICS, V150, P977; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Sampath V, 2009, MOL CELL BIOL, V29, P2532, DOI 10.1128/MCB.01682-08; SCHNELL R, 1986, MOL CELL BIOL, V6, P494, DOI 10.1128/MCB.6.2.494; Singer MS, 1998, GENETICS, V150, P613; Stone EM, 2000, GENETICS, V155, P509; SUSSEL L, 1991, P NATL ACAD SCI USA, V88, P7749, DOI 10.1073/pnas.88.17.7749; Tanny JC, 2004, MOL CELL BIOL, V24, P6931, DOI 10.1128/MCB.24.16.6931-6946.2004; Thompson JS, 2003, GENETICS, V163, P447; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Yu Q, 2011, GENETICS, V188, P291, DOI 10.1534/genetics.111.127886	52	175	175	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 18	2011	334	6058					977	982		10.1126/science.1210915	http://dx.doi.org/10.1126/science.1210915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CA	22096199	Green Accepted			2022-12-24	WOS:000297101800056
J	Mitka, M				Mitka, Mike			Evidence Fails to Support ECG Screening for Those Without Heart Disease Symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item							ELECTROCARDIOGRAPHY											Chou R, 2011, ANN INTERN MED, V155, P375, DOI 10.7326/0003-4819-155-6-201109200-00006; Lauer MS, 2011, ANN INTERN MED, V155, P395, DOI 10.7326/0003-4819-155-6-201109200-00011	2	2	2	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 16	2011	306	19					2080	2080		10.1001/jama.2011.1665	http://dx.doi.org/10.1001/jama.2011.1665			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YU	22089708				2022-12-24	WOS:000297013000003
J	Jackevicius, CA; Chou, MM; Ross, JS; Shah, ND; Krumholz, HM				Jackevicius, Cynthia A.; Chou, Mindy M.; Ross, Joseph S.; Shah, Nilay D.; Krumholz, Harlan M.			Generic Atorvastatin and Health Care Costs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jackevicius, Cynthia A.] Western Univ Hlth Sci, Pomona, CA 91766 USA; [Jackevicius, Cynthia A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Univ Toronto, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Chou, Mindy M.] Indian Hlth Serv, San Fidel, NM USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale Univ, Sch Med, New Haven, CT USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale New Haven Med Ctr, New Haven, CT 06504 USA; [Shah, Nilay D.] Mayo Clin, Rochester, MN USA	Western University of Health Sciences; University of Toronto; University of Toronto; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Yale University; Yale University; Mayo Clinic	Jackevicius, CA (corresponding author), Western Univ Hlth Sci, Pomona, CA 91766 USA.		, Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320	NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL105270] Funding Source: Medline; NIA NIH HHS [K08 AG032886, K08 AG032886-04] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Food and Drug Administration, 2011, OR BOOK APPR DRUG PR; Kale MS, 2011, ARCH INTERN MED, V171, P1856, DOI 10.1001/archinternmed.2011.501; Peterson M., 2011, PFIZER MAY GET GENER; Stiles S., TIE ANNOUNCED SATURN; 2011, IMS HLTH        0407	5	52	54	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2012	366	3					201	204		10.1056/NEJMp1113112	http://dx.doi.org/10.1056/NEJMp1113112			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877RZ	22149736	Green Accepted			2022-12-24	WOS:000299201400004
J	Moynihan, R				Moynihan, Ray			REALITY CHECK Forget sponsorship and free trips-welcome to Pharmacare	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Association of the British Pharmaceutical Industry, 2009, ABPI GUID NOT JOINT; Department of Health Association of British Pharmaceutical Industries, 2010, MOV SPONS JOINT WORK; Healy D, 2006, PLOS MED, V3, P441, DOI 10.1371/journal.pmed.0030185; Johnson & Johnson, FORM 10 Q Q REP FIL; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; McCartney M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7685; Moynihan R., 2011, CRIKEY          0526; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352	8	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2012	344								d8316	10.1136/bmj.d8316	http://dx.doi.org/10.1136/bmj.d8316			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874UF	22218100				2022-12-24	WOS:000298982900027
J	Rosenbaum, L; Lamas, D				Rosenbaum, Lisa; Lamas, Daniela			Facing a "Slow-Motion Disaster" - The UN Meeting on Noncommunicable Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], PREV CONTR NCDS PRIO; World Health Organization, WORLD HLTH STAT 2009	2	41	41	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2011	365	25					2345	2348		10.1056/NEJMp1112235	http://dx.doi.org/10.1056/NEJMp1112235			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865OM	22087629				2022-12-24	WOS:000298320200011
J	Graber, C				Graber, Cynthia			AETIOLOGY The path to disease	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S54	S55		10.1038/480S54a	http://dx.doi.org/10.1038/480S54a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169806	Bronze			2022-12-24	WOS:000298033000012
J	Bukowski, R; Carpenter, M; Conway, D; Coustan, D; Dudley, DJ; Goldenberg, RL; Hogue, CJR; Koch, MA; Parker, CB; Pinar, H; Reddy, UM; Saade, GR; Silver, RM; Stoll, BJ; Varner, MW; Willinger, M				Bukowski, Radek; Carpenter, Marshall; Conway, Deborah; Coustan, Donald; Dudley, Donald J.; Goldenberg, Robert L.; Hogue, Carol J. Rowland; Koch, Matthew A.; Parker, Corette B.; Pinar, Halit; Reddy, Uma M.; Saade, George R.; Silver, Robert M.; Stoll, Barbara J.; Varner, Michael W.; Willinger, Marian		Stillbirth Collaborative Res Netwo	Causes of Death Among Stillbirths	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RACIAL DISPARITY; PRENATAL-CARE; UNITED-STATES; RATES; RISK; CLASSIFICATION; MORTALITY; TRENDS; BIRTH	Context Stillbirth affects 1 in 160 pregnancies in the United States, equal to the number of infant deaths each year. Rates are higher than those of other developed countries and have stagnated over the past decade. There is significant racial disparity in the rate of stillbirth that is unexplained. Objective To ascertain the causes of stillbirth in a population that is diverse by race/ethnicity and geography. Design, Setting, and Participants A population-based study from March 2006 to September 2008 with surveillance for all stillbirths at 20 weeks or later in 59 tertiary care and community hospitals in 5 catchment areas defined by state and county boundaries to ensure access to at least 90% of all deliveries. Termination of a live fetus was excluded. Standardized evaluations were performed at delivery. Main Outcome Measures Medical history, fetal postmortem and placental pathology, karyotype, other laboratory tests, systematic assignment of causes of death. Results Of 663 women with stillbirth enrolled, 500 women consented to complete postmortem examinations of 512 neonates. A probable cause of death was found in 312 stillbirths (60.9%; 95% CI, 56.5%-65.2%) and possible or probable cause in 390 (76.2%; 95% CI, 72.2%-79.8%). The most common causes were obstetric conditions (150 [29.3%; 95% CI, 25.4%-33.5%]), placental abnormalities (121 [23.6%; 95% CI, 20.1%-27.6%]), fetal genetic/structural abnormalities (70 [13.7%; 95% CI, 10.9%-17.0%]), infection (66 [12.9%; 95% CI, 10.2%-16.2%]), umbilical cord abnormalities (53 [10.4%; 95% CI, 7.9%-13.4%]), hypertensive disorders (47 [9.2%; 95% CI, 6.9%-12.1%]), and other maternal medical conditions (40 [7.8%; 95% CI, 5.7%-10.6%]). A higher proportion of stillbirths in non-Hispanic black women compared with non-Hispanic white and Hispanic ones was associated with obstetric complications (43.5% [50] vs 23.7% [85]; difference, 19.8%; 95% CI, 9.7%-29.9%; P < .001) and infections (25.2% [29] vs 7.8% [28]; difference, 17.4%; 95% CI, 9.0%-25.8%; P < .001). Stillbirths occurring intrapartum and early in gestation were more common in non-Hispanic black women. Sources most likely to provide positive information regarding cause of death were placental histology (268 [52.3%; 95% CI, 47.9%-56.7%]), perinatal postmortem examination (161 [31.4%; 95% CI, 27.5%-35.7%]), and karyotype (32 of 357 with definitive results [9%; 95% CI, 6.3%-12.5%]). Conclusions A systematic evaluation led to a probable or possible cause in the majority of stillbirths. Obstetric conditions and placental abnormalities were the most common causes of stillbirth, although the distribution differed by race/ethnicity. JAMA. 2011;306(22):2459-2468	[Silver, Robert M.; Varner, Michael W.] Univ Utah, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Salt Lake City, UT 84132 USA; [Silver, Robert M.; Varner, Michael W.] Intermt Healthcare, Maternal Fetal Med, Salt Lake City, UT USA; [Bukowski, Radek; Saade, George R.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX USA; [Carpenter, Marshall; Coustan, Donald] Brown Univ, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Providence, RI 02912 USA; [Conway, Deborah; Dudley, Donald J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, Div Maternal Fetal Med, San Antonio, TX 78229 USA; [Goldenberg, Robert L.] Drexel Univ, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Hogue, Carol J. Rowland] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Hogue, Carol J. Rowland] Emory Univ, Womens & Childrens Ctr, Atlanta, GA 30322 USA; [Koch, Matthew A.; Parker, Corette B.] RTI Int, Div Hlth Sci, Stat & Epidemiol Unit, Res Triangle Pk, NC USA; [Pinar, Halit] Brown Univ, Sch Med, Dept Pathol & Lab Med, Div Perinatal & Pediat Pathol, Providence, RI 02912 USA; [Reddy, Uma M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pregnancy & Perinatol Branch, NIH, Bethesda, MD USA; [Stoll, Barbara J.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Stoll, Barbara J.] Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA USA	Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; University of Texas System; University of Texas Medical Branch Galveston; Brown University; University of Texas System; University of Texas Health San Antonio; Drexel University; Emory University; Rollins School Public Health; Emory University; Research Triangle Institute; Brown University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Emory University; Children's Healthcare of Atlanta (CHOA)	Silver, RM (corresponding author), Univ Utah, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, 30 N 1900 E,Room 2B200, Salt Lake City, UT 84132 USA.	bsilver@hsc.utah.edu	/AAO-2076-2020; Bukowski, Radek/B-6976-2013; Hogue, Carol J/H-5442-2012; Varner, Michael/K-9890-2013	Varner, Michael/0000-0001-9455-3973	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [U10-HD045953, U10-HD045925, U10-HD045952, U10-HDO45955, U10-HD045944, U01-HD045954]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD045954, U10HD045944, U10HD045925, U10HD045953, U10HD045952] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grant funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): U10-HD045953 Brown University; U10-HD045925 Emory University; U10-HD045952 University of Texas Medical Branch at Galveston; U10-HDO45955 University of Texas Health Sciences Center at San Antonio; U10-HD045944 University of Utah Health Sciences Center; and U01-HD045954 RTI International, RTP.	[Anonymous], 2009, Obstet Gynecol, V113, P748, DOI 10.1097/AOG.0b013e31819e9ee2; Carey JC, 2000, INT J GYNECOL OBSTET, V69, P173, DOI 10.1016/S0020-7292(99)00219-2; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Dudley DJ, 2010, OBSTET GYNECOL, V116, P254, DOI 10.1097/AOG.0b013e3181e7d975; Fiscella K, 2004, MATERN CHILD HLTH J, V8, P45, DOI 10.1023/B:MACI.0000025726.53515.65; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Froen JF, 2010, STILLBIRTH UNDERSTAN, P1; Graafmans WC, 2001, BRIT J OBSTET GYNAEC, V108, P1237, DOI 10.1111/j.1471-0528.2001.00291.x; Hankins G, 2002, SEMIN PERINATOL, V26, P1, DOI 10.1053/sper.2002.29840; Health Data OECD, 2008, HLTH DATA OECD 2008; Healthy People 2010, 2011, UND IMPR HLTH OBJ IM, VI; Healthy People 2010, 2011, UND IMPR HLTH OBJ IM; Healy AJ, 2006, OBSTET GYNECOL, V107, P625, DOI 10.1097/01.AOG.0000201978.83607.96; Heuser CC, 2010, OBSTET GYNECOL, V116, P1296, DOI 10.1097/AOG.0b013e3181fb8838; Hogue CJR, 2011, SEMIN PERINATOL, V35, P221, DOI 10.1053/j.semperi.2011.02.019; Korteweg FJ, 2008, OBSTET GYNECOL, V111, P865, DOI 10.1097/AOG.0b013e31816a4ee3; Korteweg FJ, 2009, OBSTET GYNECOL, V114, P809, DOI 10.1097/AOG.0b013e3181b72ebe; Macdorman Marian F, 2008, NCHS Data Brief, P1; MacDorman Marian F, 2009, Natl Vital Stat Rep, V57, P1; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Parast MM, 2008, HUM PATHOL, V39, P948, DOI 10.1016/j.humpath.2007.10.032; Parker CB, 2011, PAEDIATR PERINAT EP, V25, P425, DOI 10.1111/j.1365-3016.2011.01218.x; Pinar H, 2012, AM J PERINAT, V29, P187, DOI 10.1055/s-0031-1284228; Pinar H, 2011, AM J PERINAT, V28, P781, DOI 10.1055/s-0031-1281509; Silver RM, 2007, AM J OBSTET GYNECOL, V196, P433, DOI 10.1016/j.ajog.2006.11.041; Varli IH, 2008, ACTA OBSTET GYN SCAN, V87, P1202, DOI 10.1080/00016340802460271; Vintzileos AM, 2002, OBSTET GYNECOL, V99, P483, DOI 10.1016/S0029-7844(01)01758-6; Walsh CA, 2008, J MATERN-FETAL NEO M, V21, P493, DOI 10.1080/14767050802086669; Willinger M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.057	31	276	280	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2459	2468		10.1001/jama.2011.1823	http://dx.doi.org/10.1001/jama.2011.1823			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860YB	22166605	Green Accepted, Bronze			2022-12-24	WOS:000297983300019
J	Meister, S; Plouffe, DM; Kuhen, KL; Bonamy, GMC; Wu, T; Barnes, SW; Bopp, SE; Borboa, R; Bright, AT; Che, JW; Cohen, S; Dharia, NV; Gagaring, K; Gettayacamin, M; Gordon, P; Groessl, T; Kato, N; Lee, MCS; McNamara, CW; Fidock, DA; Nagle, A; Nam, TG; Richmond, W; Roland, J; Rottmann, M; Zhou, B; Froissard, P; Glynne, RJ; Mazier, D; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Zhou, YY; Chatterjee, A; Diagana, TT; Winzeler, EA				Meister, Stephan; Plouffe, David M.; Kuhen, Kelli L.; Bonamy, Ghislain M. C.; Wu, Tao; Barnes, S. Whitney; Bopp, Selina E.; Borboa, Rachel; Bright, A. Taylor; Che, Jianwei; Cohen, Steve; Dharia, Neekesh V.; Gagaring, Kerstin; Gettayacamin, Montip; Gordon, Perry; Groessl, Todd; Kato, Nobutaka; Lee, Marcus C. S.; McNamara, Case W.; Fidock, David A.; Nagle, Advait; Nam, Tae-gyu; Richmond, Wendy; Roland, Jason; Rottmann, Matthias; Zhou, Bin; Froissard, Patrick; Glynne, Richard J.; Mazier, Dominique; Sattabongkot, Jetsumon; Schultz, Peter G.; Tuntland, Tove; Walker, John R.; Zhou, Yingyao; Chatterjee, Arnab; Diagana, Thierry T.; Winzeler, Elizabeth A.			Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery	SCIENCE			English	Article							METHEMOGLOBINEMIA; INFECTIONS; RESISTANCE; MUTATIONS; TARGETS	Most malaria drug development focuses on parasite stages detected in red blood cells, even though, to achieve eradication, next-generation drugs active against both erythrocytic and exo-erythrocytic forms would be preferable. We applied a multifactorial approach to a set of >4000 commercially available compounds with previously demonstrated blood-stage activity (median inhibitory concentration < 1 micromolar) and identified chemical scaffolds with potent activity against both forms. From this screen, we identified an imidazolopiperazine scaffold series that was highly enriched among compounds active against Plasmodium liver stages. The orally bioavailable lead imidazolopiperazine confers complete causal prophylactic protection (15 milligrams/kilogram) in rodent models of malaria and shows potent in vivo blood-stage therapeutic activity. The open-source chemical tools resulting from our effort provide starting points for future drug discovery programs, as well as opportunities for researchers to investigate the biology of exo-erythrocytic forms.	[Meister, Stephan; Bopp, Selina E.; Bright, A. Taylor; Dharia, Neekesh V.; Winzeler, Elizabeth A.] Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA; [Plouffe, David M.; Kuhen, Kelli L.; Bonamy, Ghislain M. C.; Wu, Tao; Barnes, S. Whitney; Borboa, Rachel; Che, Jianwei; Cohen, Steve; Gagaring, Kerstin; Gordon, Perry; Groessl, Todd; Kato, Nobutaka; McNamara, Case W.; Nagle, Advait; Richmond, Wendy; Roland, Jason; Zhou, Bin; Glynne, Richard J.; Tuntland, Tove; Walker, John R.; Zhou, Yingyao; Chatterjee, Arnab; Winzeler, Elizabeth A.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Bright, A. Taylor] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Gettayacamin, Montip] Armed Forces Res Inst Med Sci AFRIMS, Dept Vet Med, Bangkok 10400, Thailand; [Lee, Marcus C. S.; Fidock, David A.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Fidock, David A.] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY 10032 USA; [Nam, Tae-gyu; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Rottmann, Matthias] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Rottmann, Matthias] Univ Basel, CH-4003 Basel, Switzerland; [Froissard, Patrick; Mazier, Dominique] INSERM, U945, Paris, France; [Froissard, Patrick; Mazier, Dominique] Univ Paris 06, UMR S 945, Paris, France; [Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France; [Sattabongkot, Jetsumon] AFRIMS, Dept Entomol, Bangkok 10400, Thailand; [Diagana, Thierry T.] Novartis Inst Trop Dis, Singapore, Singapore; [Nam, Tae-gyu] Hanyang Univ, Coll Pharm, Ansan 426791, Gyeonggi do, South Korea; [Wu, Tao] Life Technol, Carlsbad, CA 92008 USA; [Nam, Tae-gyu] Gyeonggi Bio Ctr, Suwon 443270, Gyeonggi do, South Korea	Scripps Research Institute; Novartis; University of California System; University of California San Diego; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Columbia University; Columbia University; Scripps Research Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Novartis; Hanyang University; Thermo Fisher Scientific	Winzeler, EA (corresponding author), Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA.	winzeler@scripps.edu	Dharia, Neekesh/AAC-1245-2020; Meister, Stephan/M-6608-2014; Prachumsri, Jetsumon/AAZ-7732-2021; Winzeler, Elizabeth/AAP-6752-2020	Dharia, Neekesh/0000-0001-5048-067X; Meister, Stephan/0000-0003-2436-7037; Winzeler, Elizabeth/0000-0002-4049-2113; Rottmann, Matthias/0000-0002-2207-7899; Fidock, David/0000-0001-6753-8938; Bopp, Selina/0000-0002-9412-9766; Sattabongkot, Jetsumon/0000-0002-3938-4588; Lee, Marcus/0000-0002-4973-0915; Bonamy, Ghislain/0000-0002-2826-5225	Keck Foundation; NIH [R01AI090141, R01 AI079709]; Deutsche Forschungsgemeinschaft [ME 3528/1-1]; Medicines for Malaria Venture; Wellcome Trust [WT078285]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090141, R01AI079709] Funding Source: NIH RePORTER	Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medicines for Malaria Venture; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank I. Sherman for helpful comments on the manuscript, members of the New York University Insectary for providing infected mosquitoes and C. Fischli for P. berghei efficacy testing. The whole genome sequencing data has been deposited at the National Center for Biotechnology Information (NCBI) Sequence Read Archive database (http://trace.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?) with the project accession no. SRA045972.1. The microarray data has been deposited at the NCBI Gene Expression Omnibus database (www.ncbi.nlm.nih.gov/geo/) with the accession no. GSE32485. The assay data was deposited at the ChEMBL-Neglected Tropical Disease (ChEMBL-NTD) archive (www.ebi.ac.uk/chemblntd/) with the accession nos. CHEMBL1789904, CHEMBL1789905, and CHEMBL1789906. E. A. W. is supported by the Keck Foundation and by the NIH (grant R01AI090141). S. M. was supported by Deutsche Forschungsgemeinschaft (ME 3528/1-1). Funding for M. C. S. L. and D. A. F. is provided in part by the Medicines for Malaria Venture and the NIH (grant R01 AI079709). We gratefully acknowledge translational research support (WT078285) from the Wellcome Trust and funding from the Medicines for Malaria Venture to the Genomics Institute of the Novartis Research Foundation, the Swiss Tropical and Public Health Institute, and the Novartis Institute for Tropical Diseases. All compounds disclosed are either commercially available from compound vendors (vendor identifications can be sourced from the ChEmbl database), or, if members of the imidazolopiperazine series are required, they will be provided by materials transfer agreement. A materials transfer agreement will be provided by P. Froissard and INSERM-UMR945 for requests for the HepG2-CD81-eGFP cell line.	Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Charman SA, 2011, P NATL ACAD SCI USA, V108, P4400, DOI 10.1073/pnas.1015762108; COHEN RJ, 1968, NEW ENGL J MED, V279, P1127, DOI 10.1056/NEJM196811212792102; Coleman MD, 1996, DRUG SAFETY, V14, P394, DOI 10.2165/00002018-199614060-00005; Crowther GJ, 2011, MOL BIOCHEM PARASIT, V175, P21, DOI 10.1016/j.molbiopara.2010.08.005; DAVIDSON DE, 1981, B WORLD HEALTH ORGAN, V59, P463; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Dong YX, 2010, J MED CHEM, V53, P481, DOI 10.1021/jm901473s; Gagaring K., 2010, CHEMBL NTD; Gego A, 2006, ANTIMICROB AGENTS CH, V50, P1586, DOI 10.1128/AAC.50.4.1586-1589.2006; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Mazier D, 2009, NAT REV DRUG DISCOV, V8, P854, DOI 10.1038/nrd2960; Nam T.-G., 2011, ACS CHEM BIOL; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Sweeney AW, 2004, AM J TROP MED HYG, V71, P187, DOI 10.4269/ajtmh.2004.71.2.0700187; Talisuna AO, 2004, CLIN MICROBIOL REV, V17, P235, DOI 10.1128/CMR.17.1.235-254.2004; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; Wang P, 2004, MOL BIOCHEM PARASIT, V135, P77, DOI 10.1016/j.molbiopara.2004.01.008; Wang P, 1997, MOL MICROBIOL, V23, P979, DOI 10.1046/j.1365-2958.1997.2821646.x; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2011, GUID TREATM MAL, P194; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu T, 2011, J MED CHEM, V54, P5116, DOI 10.1021/jm2003359; Yalaoui S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000010; Yan SF, 2005, J CHEM INF MODEL, V45, P1784, DOI 10.1021/ci0502808	30	235	239	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2011	334	6061					1372	1377		10.1126/science.1211936	http://dx.doi.org/10.1126/science.1211936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22096101	Green Accepted			2022-12-24	WOS:000297787700044
J	Parada, LV				Vargas Parada, Laura			Life lessons	NATURE			English	Editorial Material							INFLUENZA; VACCINATE											Briand S, 2011, PUBLIC HEALTH, V125, P247, DOI 10.1016/j.puhe.2010.12.007; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Nabel GJ, 2011, NATURE, V471, P157, DOI 10.1038/471157a; Nalluswami Kumar, 2011, Morbidity and Mortality Weekly Report, V60, P1213; Stohr K, 2010, NATURE, V465, P161, DOI 10.1038/465161a	6	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					S11	S13		10.1038/480S11a	http://dx.doi.org/10.1038/480S11a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	857TR	22158294	Green Published			2022-12-24	WOS:000297744200008
J	Gugelmann, HM; Perrone, J				Gugelmann, Hallam M.; Perrone, Jeanmarie			Can Prescription Drug Monitoring Programs Help Limit Opioid Abuse?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OVERDOSE; RATES		[Gugelmann, Hallam M.; Perrone, Jeanmarie] Hosp Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Perrone, Jeanmarie] Hosp Univ Penn, Div Med Toxicol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Gugelmann, HM (corresponding author), Hosp Univ Penn, Dept Emergency Med, 3400 Spruce St, Philadelphia, PA 19104 USA.	hallamg@gmail.com						[Anonymous], 2011, EPIDEMIC RESPONDING; Baehren DF, 2010, ANN EMERG MED, V56, P19, DOI 10.1016/j.annemergmed.2009.12.011; *CDCP, UN DRUG POIS US; Manchikanti L, 2010, PAIN PHYSICIAN, V13, P401; Martyres RF, 2004, MED J AUSTRALIA, V180, P211, DOI 10.5694/j.1326-5377.2004.tb05887.x; National Alliance for Model State Drug Laws (NAMSDL), 2011, PRESCR DRUG MON PROG; Paulozzi LJ, 2006, AM J PREV MED, V31, P506, DOI 10.1016/j.amepre.2006.08.017; Paulozzi LJ, 2011, PAIN MED, V12, P747, DOI 10.1111/j.1526-4637.2011.01062.x; Simeone R.H., 2006, EVALUATION PRESCRIPT; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1299, DOI 10.1001/jama.2011.401	10	86	86	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2011	306	20					2258	2259		10.1001/jama.2011.1712	http://dx.doi.org/10.1001/jama.2011.1712			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851GD	22110107				2022-12-24	WOS:000297255500026
J	Brassard, G				Brassard, Gilles			QUANTUM INFORMATION The conundrum of secure positioning	NATURE			English	Editorial Material									Univ Montreal, Dept Informat & Rech Operat, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Brassard, G (corresponding author), Univ Montreal, Dept Informat & Rech Operat, Montreal, PQ H3C 3J7, Canada.	brassard@iro.umontreal.ca	Brassard, Gilles/K-5725-2019					BEIGI S, 2011, PREPRINT; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Brands S., 1993, LNCS, P344, DOI DOI 10.1007/3-540-48285-7; Brassard G, 1984, P IEEE INT C COMP SY, V175, P8; Buhrman H, 2011, LECT NOTES COMPUT SC, V6841, P429, DOI 10.1007/978-3-642-22792-9_24; CHANDRAN N, 2010, PREPRINT; Chandran N, 2009, LECT NOTES COMPUT SC, V5677, P391, DOI 10.1007/978-3-642-03356-8_23; DIEKS D, 1982, PHYS LETT A, V92, P271, DOI 10.1016/0375-9601(82)90084-6; Kent A.P., 2006, U.S. patent, Patent No. [7,075,438, 7075438]; Kent A, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.022335; Kent A, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.012326; Malaney RA, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.042319; Schrodinger E, 1935, P CAMB PHILOS SOC, V31, P555, DOI 10.1017/S0305004100013554; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0	14	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					307	308		10.1038/479307a	http://dx.doi.org/10.1038/479307a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	848OA	22094688				2022-12-24	WOS:000297059700029
J	Mechtler, TP; Stary, S; Metz, TF; De Jesus, VR; Greber-Platzer, S; Pollak, A; Herkner, KR; Streubel, B; Kasper, DC				Mechtler, Thomas P.; Stary, Susanne; Metz, Thomas F.; De Jesus, Victor R.; Greber-Platzer, Susanne; Pollak, Arnold; Herkner, Kurt R.; Streubel, Berthold; Kasper, David C.			Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria	LANCET			English	Article							TANDEM MASS-SPECTROMETRY; DRIED BLOOD SPOTS; FABRY-DISEASE; INBORN-ERRORS; POMPE-DISEASE; NEWBORN; METABOLISM; DIAGNOSIS; ASSAY; REPLACEMENT	Background The interest in neonatal screening for lysosomal storage disorders has increased substantially because of newly developed enzyme replacement therapies, the need for early diagnosis, and technical advances. We tested for Gaucher's disease, Pompe's disease, Fabry's disease, and Niemann-Pick disease types A and B in an anonymous prospective nationwide screening study that included genetic mutation analysis to assess the practicality and appropriateness of including these disorders in neonatal screening panels. Methods Specimens from dried blood spots of 34 736 newborn babies were collected consecutively from January, 2010 to July, 2010, as part of the national routine Austrian newborn screening programme. Anonymised samples were analysed for enzyme activities of acid beta-glucocerebrosidase, alpha-galactosidase, alpha-glucosidase, and acid sphingomyelinase by electrospray ionisation tandem mass spectrometry. Genetic mutation analyses were done in samples with suspected enzyme deficiency. Findings All 34 736 samples were analysed successfully by the multiplex screening assay. Low enzyme activities were detected in 38 babies. Mutation analysis confirmed lysosomal storage disorders in 15 of them. The most frequent mutations were found for Fabry's disease (1 per 3859 births), followed by Pompe's disease (1 per 8684), and Gaucher's disease (1 per 17 368). The positive predictive values were 32% (95% CI 16-52), 80% (28-99), and 50% (7-93), respectively. Mutational analysis detected predominantly missense mutations associated with a late-onset phenotype. Interpretation The combined overall proportion of infants carrying a mutation for lysosomal storage disorders was higher than expected. Neonatal screening for lysosomal storage disorders is likely to raise challenges for primary health-care providers. Furthermore, the high frequency of late-onset mutations makes lysosomal storage disorders a broad health problem beyond childhood.	[Mechtler, Thomas P.; Metz, Thomas F.; Greber-Platzer, Susanne; Pollak, Arnold; Herkner, Kurt R.; Kasper, David C.] Med Univ Vienna, Dept Pediat & Adolescent Med, A-1090 Vienna, Austria; [Stary, Susanne; Streubel, Berthold] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria; [De Jesus, Victor R.] Ctr Dis Control & Prevent, Newborn Screening & Mol Biol Branch, Atlanta, GA USA	Medical University of Vienna; Medical University of Vienna; Centers for Disease Control & Prevention - USA	Streubel, B (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, A-1090 Vienna, Austria.	berthold.streubel@meduniwien.ac.at	Greber-Platzer, Susanne/AAT-1972-2021; Kasper, David/B-9054-2012	Greber-Platzer, Susanne/0000-0002-3706-8370; 	Austrian Ministry of Health, Family, and Women; Austrian Ministry of Health, Family, and Women [GZ 20.501/40-3 IV/A/2007]	Austrian Ministry of Health, Family, and Women; Austrian Ministry of Health, Family, and Women	This work was supported by grants from the Austrian Ministry of Health, Family, and Women (GZ 20.501/40-3 IV/A/2007). The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.	Beck M, 2001, J INHERIT METAB DIS, V24, P47, DOI 10.1023/A:1012463605992; Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Beck M, 2010, IUBMB LIFE, V62, P33, DOI 10.1002/iub.284; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Bombard Y, 2010, EUR J HUM GENET, V18, P751, DOI 10.1038/ejhg.2010.13; CHACE DH, 1993, CLIN CHEM, V39, P66; Chien YH, 2009, PEDIATRICS, V124, pE1116, DOI 10.1542/peds.2008-3667; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; CLSI, 2009, NEWB SCREEN PRET LOW; Dajnoki A, 2008, CLIN CHEM, V54, P1624, DOI 10.1373/clinchem.2008.107722; Dajnoki A, 2010, CLIN CHIM ACTA, V411, P1428, DOI 10.1016/j.cca.2010.03.009; De Jesus VR, 2010, SEMIN PERINATOL, V34, P125, DOI 10.1053/j.semperi.2009.12.003; De Jesus VR, 2009, CLIN CHEM, V55, P158, DOI 10.1373/clinchem.2008.111864; Duffey TA, 2010, CLIN CHEM, V56, P1854, DOI 10.1373/clinchem.2010.152009; Duffner PK, 2009, PEDIATR NEUROL, V40, P245, DOI 10.1016/j.pediatrneurol.2008.11.010; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fletcher JM, 2006, J INHERIT METAB DIS, V29, P405, DOI 10.1007/s10545-006-0246-7; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Hwu WL, 2010, J INHERIT METAB DIS, V33, P381, DOI 10.1007/s10545-010-9130-6; Kasper DC, 2010, WIEN KLIN WOCHENSCHR, V122, P607, DOI 10.1007/s00508-010-1457-3; Kasper DC, 2010, RAPID COMMUN MASS SP, V24, P986, DOI 10.1002/rcm.4496; Legini E, 2011, CLIN CHIM ACTA, V412, P343, DOI 10.1016/j.cca.2010.11.006; Li YJ, 2004, CLIN CHEM, V50, P638, DOI 10.1373/clinchem.2003.028381; Lin HY, 2009, CIRC-CARDIOVASC GENE, V2, P450, DOI 10.1161/CIRCGENETICS.109.862920; Maier EM, 2006, ACTA PAEDIATR, V95, P30, DOI 10.1080/08035320600618809; Matern D, 2007, J INHERIT METAB DIS, V30, P585, DOI 10.1007/s10545-007-0691-y; Mehta A, 2010, QJM-INT J MED, V103, P641, DOI 10.1093/qjmed/hcq117; Mehta A, 2009, LANCET, V374, P1986, DOI 10.1016/S0140-6736(09)61493-8; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Metz TF, 2011, CLIN CHEM, V57, P1286, DOI 10.1373/clinchem.2011.164640; Millington DS, 2010, SEMIN PERINATOL, V34, P163, DOI 10.1053/j.semperi.2009.12.008; Moammar H, 2010, ANN SAUDI MED, V30, P271, DOI 10.4103/0256-4947.65254; Monserrat L, 2007, J AM COLL CARDIOL, V50, P2399, DOI 10.1016/j.jacc.2007.06.062; Park JK, 2002, CLIN GENET, V61, P32, DOI 10.1034/j.1399-0004.2002.610106.x; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; Simonaro CM, 2002, AM J HUM GENET, V71, P1413, DOI 10.1086/345074; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X; Wang RY, 2011, GENET MED, V13, P457, DOI 10.1097/GIM.0b013e318211a7e1; Wenger DA, 2003, ARCH NEUROL-CHICAGO, V60, P322, DOI 10.1001/archneur.60.3.322; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5; Zhang XK, 2008, CLIN CHEM, V54, P1725, DOI 10.1373/clinchem.2008.104711; Zhou H, 2011, J PEDIAT, V159, P7	44	189	207	2	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2012	379	9813					335	341		10.1016/S0140-6736(11)61266-X	http://dx.doi.org/10.1016/S0140-6736(11)61266-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889BA	22133539				2022-12-24	WOS:000300047300040
J	Katada, S; Imhof, A; Sassone-Corsi, P				Katada, Sayako; Imhof, Axel; Sassone-Corsi, Paolo			Connecting Threads: Epigenetics and Metabolism	CELL			English	Article							HISTONE ACETYLATION; CIRCADIAN CONTROL; PHOSPHORYLATION; COMPLEXES; GROWTH; GENE	Chromatin-modifying enzymes have long been proposed to be the authors of an epigenetic language, but the origin and meaning of the messages they write in chromatin are still mysterious. Recent studies suggesting that the effects of diet can be passed on epigenetically to offspring add weight to the idea that histones act as metabolic sensors, converting changes in metabolism into stable patterns of gene expression. The challenge will now be to understand how localized fluctuations in levels of metabolites control chromatin modifiers in space and time, translating a dynamic metabolic state into a histone map.	[Katada, Sayako; Imhof, Axel; Sassone-Corsi, Paolo] Univ Calif Irvine, Sch Med, Ctr Epigenet & Metab, Irvine, CA 92697 USA; [Imhof, Axel] Univ Munich, Adolf Butenandt Inst, Munich Ctr Integrated Prot Sci, D-80336 Munich, Germany	University of California System; University of California Irvine; University of Munich	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Sch Med, Ctr Epigenet & Metab, Irvine, CA 92697 USA.	psc@uci.edu	Imhof, Axel/AAU-5313-2021	Imhof, Axel/0000-0003-2993-8249; Katada, Sayako/0000-0002-0466-0466				Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Bancaud A, 2009, EMBO J, V28, P3785, DOI 10.1038/emboj.2009.340; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Turner BM, 2009, PHILOS T R SOC B, V364, P3403, DOI 10.1098/rstb.2009.0125; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	28	227	232	2	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					24	28		10.1016/j.cell.2012.01.001	http://dx.doi.org/10.1016/j.cell.2012.01.001			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265398	Bronze			2022-12-24	WOS:000299540700010
J	Drdla-Schutting, R; Benrath, J; Wunderbaldinger, G; Sandkuhler, J				Drdla-Schutting, Ruth; Benrath, Justus; Wunderbaldinger, Gabriele; Sandkuehler, Juergen			Erasure of a Spinal Memory Trace of Pain by a Brief, High-Dose Opioid Administration	SCIENCE			English	Article							LONG-TERM POTENTIATION; EVOKED FIELD POTENTIALS; DORSAL-HORN; PHOSPHORYLATION SITES; SYNAPTIC PLASTICITY; GLUR1 SUBUNIT; LATE-PHASE; RECEPTOR; INDUCTION; MECHANISMS	Painful stimuli activate nociceptive C fibers and induce synaptic long-term potentiation (LTP) at their spinal terminals. LTP at C-fiber synapses represents a cellular model for pain amplification (hyperalgesia) and for a memory trace of pain. m-Opioid receptor agonists exert a powerful but reversible depression at C-fiber synapses that renders the continuous application of low opioid doses the gold standard in pain therapy. We discovered that brief application of a high opioid dose reversed various forms of activity-dependent LTP at C-fiber synapses. Depotentiation involved Ca(2+)-dependent signaling and normalization of the phosphorylation state of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. This also reversed hyperalgesia in behaving animals. Opioids thus not only temporarily dampen pain but may also erase a spinal memory trace of pain.	[Drdla-Schutting, Ruth; Benrath, Justus; Wunderbaldinger, Gabriele; Sandkuehler, Juergen] Med Univ Vienna, Dept Neurophysiol, Ctr Brain Res, A-1090 Vienna, Austria	Medical University of Vienna	Sandkuhler, J (corresponding author), Med Univ Vienna, Dept Neurophysiol, Ctr Brain Res, A-1090 Vienna, Austria.	juergen.sandkuehler@meduniwien.ac.at	Sandkühler, Jürgen/B-6648-2012	Sandkühler, Jürgen/0000-0002-5209-485X; Drdla-Schutting, Ruth/0000-0003-0645-986X	Vienna Science and Technology Fund, Austria [LS07-040]	Vienna Science and Technology Fund, Austria	This work was supported by grant no. LS07-040 from the Vienna Science and Technology Fund, Austria, to J.S. Remifentanil was kindly provided by GlaxoSmithKline, Austria. The authors declare no conflicts of interest.	Asiedu MN, 2011, J NEUROSCI, V31, P6646, DOI 10.1523/JNEUROSCI.6286-10.2011; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Chung HJ, 2000, J NEUROSCI, V20, P7258; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Drdla R, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-18; Fang L, 2003, NEUROSCIENCE, V122, P237, DOI 10.1016/S0306-4522(03)00526-8; Heinke B, 2011, J NEUROSCI, V31, P1313, DOI 10.1523/JNEUROSCI.4060-10.2011; Heinl C, 2011, J NEUROSCI, V31, P16748, DOI 10.1523/JNEUROSCI.3491-11.2011; Hu NW, 2003, J NEUROPHYSIOL, V89, P2354, DOI 10.1152/jn.01027.2002; Huang CC, 2001, J BIOL CHEM, V276, P48108, DOI 10.1074/jbc.M106388200; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Jhamandas KH, 1996, J NEUROSCI, V16, P2758; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Terman GW, 2001, J NEUROPHYSIOL, V85, P485, DOI 10.1152/jn.2001.85.2.485; Wang Y, 2011, NEUROCHEM RES, V36, P170, DOI 10.1007/s11064-010-0288-y; Willis WD, 2009, EXP BRAIN RES, V196, P5, DOI 10.1007/s00221-009-1760-2; Yang HW, 2004, J NEUROPHYSIOL, V91, P1122, DOI 10.1152/jn.00735.2003; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	28	64	69	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					235	238		10.1126/science.1211726	http://dx.doi.org/10.1126/science.1211726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246779				2022-12-24	WOS:000299033100058
J	Cassidy, J				Cassidy, Jane			LOBBY WATCH The Sugar Bureau	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi2@googlemail.com							0	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2012	344								d8315	10.1136/bmj.d8315	http://dx.doi.org/10.1136/bmj.d8315			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874UF	22218099				2022-12-24	WOS:000298982900026
J	Yudkin, JS; Lipska, KJ; Montori, VM				Yudkin, John S.; Lipska, Kasia J.; Montori, Victor M.			The idolatry of the surrogate	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK; OUTCOMES; QUALITY; DEATH		[Yudkin, John S.] UCL, London WC1E 6BT, England; [Lipska, Kasia J.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Div Endocrinol & Diabet, Dept Med, Rochester, MN USA; [Montori, Victor M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	University of London; University College London; Yale University; Mayo Clinic; Mayo Clinic	Yudkin, JS (corresponding author), UCL, London WC1E 6BT, England.	j.yudkin@ucl.ac.uk	Yudkin, John S/C-1988-2008	Montori, Victor/0000-0003-0595-2898				[Anonymous], 1991, OPHTHALMOLOGY, V98, P823; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Calvert M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1870; Chew EY, 2011, NEW ENGL J MED, V364, P190; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gerstein HC, 2000, LANCET, V355, P253; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Hemmingsen B, 2011, COCHRANE DB SYST REV, V2; Institute of Medicine, 2010, EV BIOM SURR ENDP CH; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lehman R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4805; Mazhar K, 2011, OPHTHALMOLOGY, V118, P649, DOI 10.1016/j.ophtha.2010.08.003; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; O'Connor PJ, 2011, DIABETES CARE, V34, P1651, DOI 10.2337/dc11-0735; Shah ND, 2010, NEW ENGL J MED, V363, P2081, DOI 10.1056/NEJMp1011042; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Timbie JW, 2010, ARCH INTERN MED, V170, P1037, DOI 10.1001/archinternmed.2010.150; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z; Yudkin JS, 2011, NEW ENGL J MED, V364, P2260, DOI 10.1056/NEJMc1104826; Yudkin JS, 2011, LANCET, V377, P1220, DOI 10.1016/S0140-6736(10)61112-9; Yudkin JS, 1999, DIABETIC MED, V16, P219, DOI 10.1046/j.1464-5491.1999.00026.x	27	125	125	2	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 28	2011	343								d7995	10.1136/bmj.d7995	http://dx.doi.org/10.1136/bmj.d7995			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874TM	22205706				2022-12-24	WOS:000298981000001
J	Hombauer, H; Srivatsan, A; Putnam, CD; Kolodner, RD				Hombauer, Hans; Srivatsan, Anjana; Putnam, Christopher D.; Kolodner, Richard D.			Mismatch Repair, But Not Heteroduplex Rejection, Is Temporally Coupled to DNA Replication	SCIENCE			English	Article							CELL NUCLEAR ANTIGEN; SACCHAROMYCES-CEREVISIAE; INSTABILITY; GENOME; MSH6; RECONSTITUTION; REARRANGEMENTS; RECOMBINATION; RECOGNITION; PROTEOLYSIS	In eukaryotes, it is unknown whether mismatch repair (MMR) is temporally coupled to DNA replication and how strand-specific MMR is directed. We fused Saccharomyces cerevisiae MSH6 with cyclins to restrict the availability of the Msh2-Msh6 mismatch recognition complex to either S phase or G2/M phase of the cell cycle. The Msh6-S cyclin fusion was proficient for suppressing mutations at three loci that replicate at mid-S phase, whereas the Msh6-G2/M cyclin fusion was defective. However, the Msh6-G2/M cyclin fusion was functional for MMR at a very late-replicating region of the genome. In contrast, the heteroduplex rejection function of MMR during recombination was partially functional during both S phase and G2/M phase. These results indicate a temporal coupling of MMR, but not heteroduplex rejection, to DNA replication.	[Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Canc, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Inst Genom Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu	Srivatsan, Anjana/S-1518-2017; Srivatsan, Anjana/Q-6312-2017; Hombauer, Hans/B-9712-2019	Srivatsan, Anjana/0000-0003-1645-7075; Srivatsan, Anjana/0000-0003-1645-7075; Putnam, Christopher/0000-0002-6145-1265; Hombauer, Hans/0000-0002-2100-564X	NIH [GM50006]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH grant GM50006 (to R.D.K.).	Chen C, 1999, MOL CELL BIOL, V19, P7801; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Datta A, 1996, MOL CELL BIOL, V16, P1085; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hendrickson C, 2001, CURR BIOL, V11, P1781, DOI 10.1016/S0960-9822(01)00564-4; Hombauer H, 2011, CELL, V147, P1040, DOI 10.1016/j.cell.2011.10.025; Hood JK, 2001, J CELL SCI, V114, P589; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Langston LD, 2006, MOL CELL, V23, P155, DOI 10.1016/j.molcel.2006.05.034; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; MATIC I, 1995, CELL, V80, P507, DOI 10.1016/0092-8674(95)90501-4; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; ORRWEAVER TL, 1985, MICROBIOL REV, V49, P33, DOI 10.1128/MMBR.49.1.33-58.1985; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	25	90	91	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1713	1716		10.1126/science.1210770	http://dx.doi.org/10.1126/science.1210770			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194578	Green Accepted			2022-12-24	WOS:000298344000070
J	Schefuss, E; Kuhlmann, H; Mollenhauer, G; Prange, M; Patzold, J				Schefuss, Enno; Kuhlmann, Holger; Mollenhauer, Gesine; Prange, Matthias; Paetzold, Juergen			Forcing of wet phases in southeast Africa over the past 17,000 years	NATURE			English	Article							TERRESTRIAL; VARIABILITY; CLIMATE; RECORD; PLANTS; PROXY	Intense debate persists about the climatic mechanisms governing hydrologic changes in tropical and subtropical southeast Africa since the Last Glacial Maximum, about 20,000 years ago. In particular, the relative importance of atmospheric and oceanic processes is not firmly established(1-5). Southward shifts of the intertropical convergence zone (ITCZ) driven by high-latitude climate changes have been suggested as a primary forcing(2,3), whereas other studies infer a predominant influence of Indian Ocean sea surface temperatures on regional rainfall changes(4,5). To address this question, a continuous record representing an integrated signal of regional climate variability is required, but has until now been missing. Here we show that remote atmospheric forcing by cold events in the northern high latitudes appears to have been the main driver of hydro-climatology in southeast Africa during rapid climate changes over the past 17,000 years. Our results are based on a reconstruction of precipitation and river discharge changes, as recorded in a marine sediment core off the mouth of the Zambezi River, near the southern boundary of the modern seasonal ITCZ migration. Indian Ocean sea surface temperatures did not exert a primary control over southeast African hydrologic variability. Instead, phases of high precipitation and terrestrial discharge occurred when the ITCZ was forced southwards during Northern Hemisphere cold events, such as Heinrich stadial 1 (around 16,000 years ago) and the Younger Dryas (around 12,000 years ago), or when local summer insolation was high in the late Holocene, that is, during the past 4,000 years.	[Schefuss, Enno; Kuhlmann, Holger; Mollenhauer, Gesine; Prange, Matthias; Paetzold, Juergen] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Schefuss, Enno; Kuhlmann, Holger; Mollenhauer, Gesine; Prange, Matthias; Paetzold, Juergen] Univ Bremen, Fac Geosci, D-28359 Bremen, Germany; [Mollenhauer, Gesine] Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany	University of Bremen; University of Bremen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Schefuss, E (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany.	schefuss@uni-bremen.de	Mollenhauer, Gesine/AAD-8167-2019; Mollenhauer, Gesine/B-5190-2015; Schefuß, Enno/A-7101-2015; Patzold, Jurgen/D-5111-2017	Mollenhauer, Gesine/0000-0001-5138-564X; Mollenhauer, Gesine/0000-0001-5138-564X; Schefuß, Enno/0000-0002-5960-930X; Kuhlmann, Holger/0000-0001-8932-7031; Patzold, Jurgen/0000-0001-8074-4103	DFG Research Center/Cluster of Excellence 'The Ocean in the Earth System'; DFG [Sche903/8]	DFG Research Center/Cluster of Excellence 'The Ocean in the Earth System'(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by the DFG Research Center/Cluster of Excellence 'The Ocean in the Earth System' and DFG grant Sche903/8. Laboratory assistance was provided by K. Siedenberg, M. Segl, W. Bevern, B. Meyer-Schack and R. Kreutz. We thank R. Schneider for logistical support and S. Weldeab for sample preparation for radiocarbon analyses. Comments by Y. Huang and J. Russell improved the manuscript.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Beilfuss R., 2001, 2 INT CRAN FDN; Beilfuss R., 2001, 3 INT CRAN FDN; Broccoli AJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024546; Burrough SL, 2009, EARTH-SCI REV, V96, P313, DOI 10.1016/j.earscirev.2009.07.001; Castaneda IS, 2007, GEOLOGY, V35, P823, DOI 10.1130/G23916A.1; Clement AC, 2008, REV GEOPHYS, V46, DOI 10.1029/2006RG000204; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; Ehleringer J.R., 2002, ENCY GLOBAL ENV CHAN, V2, P186; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Frankenberg C, 2009, SCIENCE, V325, P1374, DOI 10.1126/science.1173791; Gasse F, 2008, QUATERNARY SCI REV, V27, P2316, DOI 10.1016/j.quascirev.2008.08.027; Gimeno L, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043712; Hopmans EC, 2004, EARTH PLANET SC LETT, V224, P107, DOI 10.1016/j.epsl.2004.05.012; Hou JZ, 2007, ORG GEOCHEM, V38, P977, DOI 10.1016/j.orggeochem.2006.12.009; Johnson TC, 2002, SCIENCE, V296, P113, DOI 10.1126/science.1070057; Jury MR, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000507; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lewis SC, 2010, CLIM PAST, V6, P325, DOI 10.5194/cp-6-325-2010; Nicholson SE, 2000, GLOBAL PLANET CHANGE, V26, P137, DOI 10.1016/S0921-8181(00)00040-0; Partridge TC, 1997, QUATERNARY SCI REV, V16, P1125, DOI 10.1016/S0277-3791(97)00005-X; Risi C, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009943; Sachse D, 2006, ORG GEOCHEM, V37, P469, DOI 10.1016/j.orggeochem.2005.12.003; Schefuss E, 2005, NATURE, V437, P1003, DOI 10.1038/nature03945; Schulz H, 2011, MAR GEOL, V286, P21, DOI 10.1016/j.margeo.2011.05.003; Stager JC, 2011, SCIENCE, V331, P1299, DOI 10.1126/science.1198322; Still C. J., 2010, UNDERSTANDING MOVEME, P179; Thomas DSG, 2009, QUATERNARY SCI REV, V28, P526, DOI 10.1016/j.quascirev.2008.10.023; Thomas DSG, 2002, QUATERNARY SCI REV, V21, P783, DOI 10.1016/S0277-3791(01)00127-5; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485	30	197	199	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					509	512		10.1038/nature10685	http://dx.doi.org/10.1038/nature10685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22193106				2022-12-24	WOS:000298318000057
J	Gluckman, PD; Bergstrom, CT				Gluckman, Peter D.; Bergstrom, Carl T.			CHRISTMAS 2011: FOOD FOR THOUGHT Evolutionary biology within medicine: a perspective of growing value	BRITISH MEDICAL JOURNAL			English	Editorial Material							RESISTANCE; HOSPITALS; DISEASE; HEALTH		[Gluckman, Peter D.] Univ Auckland, Liggins Inst, Ctr Human Evolut Adaptat & Dis, Auckland 1142, New Zealand; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Natl Res Ctr Growth & Dev, Auckland 1142, New Zealand; [Bergstrom, Carl T.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Bergstrom, Carl T.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Auckland; University of Auckland; University of Washington; University of Washington Seattle; The Santa Fe Institute	Gluckman, PD (corresponding author), Univ Auckland, Liggins Inst, Ctr Human Evolut Adaptat & Dis, Private Bag 92019, Auckland 1142, New Zealand.	pd.gluckman@auckland.ac.nz	Bergstrom, Carl T./H-2299-2011	Bergstrom, Carl T./0000-0002-2070-385X	NIGMS NIH HHS [5U01GM07649] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AAMC-HHMI Scientific Foundation for Future Physicians Committee, 2009, SCI FDN FUT PHYS; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Bergstrom CT, 2008, EVOLUTION HLTH DIS, P125; Gluckman P, 2011, PUBERTY ADOLESCENCE; Gluckman PD, 2006, TRENDS ENDOCRIN MET, V17, P7, DOI 10.1016/j.tem.2005.11.006; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; Gluckman PD, 2009, PRINCIPLES EVOLUTION; Gluckman PD, 2006, MISMATCH WHY OUR WOR; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Kaza U, 2007, CURR ALLERGY ASTHM R, V7, P182, DOI 10.1007/s11882-007-0019-x; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kuzawa CW, 2007, ADIPOSE TISSUE ADIPO, P207; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; MARKS IM, 1994, ETHOL SOCIOBIOL, V15, P247, DOI 10.1016/0162-3095(94)90002-7; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Nesse RM, 2008, EVOL APPL, V1, P28, DOI 10.1111/j.1752-4571.2007.00006.x; Nesse RM, 2011, EVOL APPL, V4, P264, DOI 10.1111/j.1752-4571.2010.00181.x; Nesse RM, 2010, P NATL ACAD SCI USA, V107, P1800, DOI 10.1073/pnas.0906224106; Nesse RM, 1995, WHY WE GET SICK NEW; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; Stearns SC, 2008, EVOLUTION HLTH DIS; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082	24	8	8	1	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 19	2011	343								d7671	10.1136/bmj.d7671	http://dx.doi.org/10.1136/bmj.d7671			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868QI	22184558	Green Published			2022-12-24	WOS:000298537800001
J	Deweerdt, S				Deweerdt, Sarah			ANIMAL MODELS Towards a myeloma mouse	NATURE			English	Editorial Material							MULTIPLE-MYELOMA; CELLS											Calimeri T, 2011, LEUKEMIA, V25, P707, DOI 10.1038/leu.2010.300; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Hu JS, 2010, BLOOD, V116, P1524, DOI 10.1182/blood-2010-02-269126; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913	6	18	22	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S38	S39		10.1038/480S38a	http://dx.doi.org/10.1038/480S38a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22169799	Bronze			2022-12-24	WOS:000298033000004
J	Holzbaur, ELF; Scherer, SS				Holzbaur, Erika L. F.; Scherer, Steven S.			Microtubules, Axonal Transport, and Neuropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROTEINS		[Holzbaur, Erika L. F.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Scherer, Steven S.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Holzbaur, ELF (corresponding author), Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065712, R01NS055284] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS055284, U54 NS065712] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Almeida-Souza L, 2011, J NEUROSCI, V31, P15320, DOI 10.1523/JNEUROSCI.3266-11.2011; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993	5	31	32	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2011	365	24					2330	2332		10.1056/NEJMcibr1112481	http://dx.doi.org/10.1056/NEJMcibr1112481			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861PN	22168648	Green Accepted			2022-12-24	WOS:000298031800017
J	Hatziapostolou, M; Polytarchou, C; Aggelidou, E; Drakaki, A; Poultsides, GA; Jaeger, SA; Ogata, H; Karin, M; Struhl, K; Hadzopoulou-Cladaras, M; Iliopoulos, D				Hatziapostolou, Maria; Polytarchou, Christos; Aggelidou, Eleni; Drakaki, Alexandra; Poultsides, George A.; Jaeger, Savina A.; Ogata, Hisanobu; Karin, Michael; Struhl, Kevin; Hadzopoulou-Cladaras, Margarita; Iliopoulos, Dimitrios			An HNF4 alpha-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis	CELL			English	Article							HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; INTESTINAL EPITHELIAL-CELLS; OXIDATIVE STRESS; TRANSCRIPTION FACTORS; STAT3 ACTIVATION; ELEGANS GENOME; CANCER; CARCINOMA; EXPRESSION; MICRORNA	Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is essential for liver development and hepatocyte function. Here, we show that transient inhibition of HNF4 alpha initiates hepatocellular transformation through a microRNA-inflammatory feedback loop circuit consisting of miR-124, IL6R, STAT3, miR-24, and miR-629. Moreover, we show that, once this circuit is activated, it maintains suppression of HNF4 alpha and sustains oncogenesis. Systemic administration of miR-124, which modulates inflammatory signaling, prevents and suppresses hepatocellular carcinogenesis by inducing tumor-specific apoptosis without toxic side effects. As we also show that this HNF4 alpha circuit is perturbed in human hepatocellular carcinomas, our data raise the possibility that manipulation of this microRNA feedback-inflammatory loop has therapeutic potential for treating liver cancer.	[Hatziapostolou, Maria; Polytarchou, Christos; Iliopoulos, Dimitrios] Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; [Hatziapostolou, Maria; Polytarchou, Christos; Iliopoulos, Dimitrios] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Struhl, Kevin] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Aggelidou, Eleni; Hadzopoulou-Cladaras, Margarita] Aristotle Univ Thessaloniki, Dept Genet Dev & Mol Biol, Dev Biol Lab, Sch Biol, Thessaloniki 54124, Greece; [Drakaki, Alexandra] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med, Boston, MA 02215 USA; [Poultsides, George A.] Stanford Univ, Med Ctr, Dept Surg, Stanford, CA 94305 USA; [Jaeger, Savina A.] Novartis Inst Biomed Res, Dept Dev Mol Pathways, Cambridge, MA 02139 USA; [Ogata, Hisanobu; Karin, Michael] Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Sch Med, La Jolla, CA 92093 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Aristotle University of Thessaloniki; Harvard University; Beth Israel Deaconess Medical Center; Stanford University; Novartis; University of California System; University of California San Diego	Iliopoulos, D (corresponding author), Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA.	dimitrios_iliopoulos@dfci.harvard.edu	Aggelidou, Eleni/GQZ-2215-2022; Hatziapostolou, Maria/N-1820-2015; Iliopoulos, Dimitrios/AAE-9106-2019	Hatziapostolou, Maria/0000-0003-2493-7028; 	DFCI CIA; National Institutes of Health [RO1-CA118165, P42-ES0100337]; NATIONAL CANCER INSTITUTE [R01CA118165] Funding Source: NIH RePORTER	DFCI CIA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by DFCI CIA start-up funds to D.I. and research grants to M.K. from the National Institutes of Health (RO1-CA118165 and P42-ES0100337). We would like to thank the Nikon Imaging Center at Harvard Medical School for their help with light microscopy. Also, we would like to thank Hye-Jung Kim for her assistance with the flow cytometry analysis and Virgilio Garcia for his technical support.	Ahn SH, 2008, INFLAMM BOWEL DIS, V14, P908, DOI 10.1002/ibd.20413; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Cattin AL, 2009, MOL CELL BIOL, V29, P6294, DOI 10.1128/MCB.00939-09; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Colletti M, 2009, GASTROENTEROLOGY, V137, P660, DOI 10.1053/j.gastro.2009.05.038; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Darsigny M, 2010, CANCER RES, V70, P9423, DOI 10.1158/0008-5472.CAN-10-1697; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fabbri M, 2011, JAMA-J AM MED ASSOC, V305, P59, DOI 10.1001/jama.2010.1919; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jiang R., 2011, 22 PROMOTES HUMAN HE; Kardassis D, 1997, ARTERIOSCL THROM VAS, V17, P222, DOI 10.1161/01.ATV.17.1.222; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Marcil V, 2010, J BIOL CHEM, V285, P40448, DOI 10.1074/jbc.M110.155358; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Polytarchou C, 2008, MOL CELL BIOL, V28, P7451, DOI 10.1128/MCB.00688-08; Ptashne M, 2009, CURR BIOL, V19, pR234, DOI 10.1016/j.cub.2009.02.015; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Tacke RS, 2011, J BIOL CHEM, V286, P10847, DOI 10.1074/jbc.M110.217653; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Xu L, 2001, CANCER RES, V61, P3176; Yin C, 2008, HEPATOLOGY, V48, P1528, DOI 10.1002/hep.22510; ZHONG WM, 1993, EMBO J, V12, P537, DOI 10.1002/j.1460-2075.1993.tb05685.x; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	44	372	397	2	76	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1233	1247		10.1016/j.cell.2011.10.043	http://dx.doi.org/10.1016/j.cell.2011.10.043			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153071	Green Accepted, Bronze			2022-12-24	WOS:000298148100014
J	Lipworth, W; Kerridge, I; Brett, J; Day, R				Lipworth, Wendy; Kerridge, Ian; Brett, Jonathan; Day, Richard			How clinical and research failures lead to suboptimal prescribing: the example of chronic gout	BRITISH MEDICAL JOURNAL			English	Editorial Material							ASYMPTOMATIC HYPERURICEMIA; ALLOPURINOL; MANAGEMENT; BENZBROMARONE; INDICATORS; GUIDELINES; COLCHICINE; ADHERENCE		[Lipworth, Wendy] Univ New S Wales, Australian Inst Hlth Innovat, Sydney, NSW 2052, Australia; [Lipworth, Wendy; Kerridge, Ian] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia; [Brett, Jonathan; Day, Richard] St Vincents Hosp, Darlinghurst, NSW 2010, Australia	University of New South Wales Sydney; University of Sydney; St Vincents Hospital Sydney	Lipworth, W (corresponding author), Univ New S Wales, Australian Inst Hlth Innovat, Sydney, NSW 2052, Australia.	w.lipworth@unsw.edu.au	Day, Richard/D-8699-2011	Day, Richard/0000-0002-6045-6937; Brett, Jonathan/0000-0003-3065-7495; Kerridge, Ian/0000-0001-7445-4660; Lipworth, Wendy/0000-0002-0234-657X				Becker MA, 2008, CURR OPIN RHEUMATOL, V20, P167, DOI 10.1097/BOR.0b013e3282f54d03; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Flaker GC, 2004, J INTERV CARD ELECTR, V10, P21, DOI 10.1023/B:JICE.0000011342.26830.5f; Gutierrez-Macias A, 2005, BMJ-BRIT MED J, V331, P623, DOI 10.1136/bmj.331.7517.623; HANDE KR, 1984, AM J MED, V76, P47, DOI 10.1016/0002-9343(84)90743-5; HARRIS CM, 1995, J CLIN EPIDEMIOL, V48, P1153, DOI 10.1016/0895-4356(94)00244-K; Harrold LR, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2659; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Kesselheim AS, 2010, NEW ENGL J MED, V362, P2045, DOI 10.1056/NEJMp1003126; Krishnan E, 2008, J RHEUMATOL, V35, P498; Lee MHH, 2008, DRUG SAFETY, V31, P643, DOI 10.2165/00002018-200831080-00002; Lindsay K, 2011, JCR-J CLIN RHEUMATOL, V17, P1, DOI 10.1097/RHU.0b013e318204a8f9; Lipworth WL, 2011, MED J AUSTRALIA, V195, P371, DOI 10.5694/mja11.10708; Mikuls TR, 2005, RHEUMATOLOGY, V44, P1038, DOI 10.1093/rheumatology/keh679; Mikuls TR, 2004, ARTHRITIS RHEUM-US, V50, P937, DOI 10.1002/art.20102; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Perry ME, 2010, RHEUMATOLOGY, V49, P2233, DOI 10.1093/rheumatology/keq143; Reinders MK, 2009, ANN RHEUM DIS, V68, P892, DOI 10.1136/ard.2008.091462; Reinders MK, 2009, ANN RHEUM DIS, V68, P51, DOI 10.1136/ard.2007.083071; Reinders MK, 2010, CLIN INTERV AGING, V5, P7; Riedel AA, 2004, J RHEUMATOL, V31, P1575; Roddy E, 2007, ANN RHEUM DIS, V66, P1311, DOI 10.1136/ard.2007.070755; Roddy E, 2007, NAT CLIN PRACT RHEUM, V3, P443, DOI 10.1038/ncprheum0556; Singh JA, 2009, ANN RHEUM DIS, V68, P1265, DOI 10.1136/ard.2008.092619; Stamp LK, 2011, ARTHRITIS RHEUM-US, V63, P412, DOI 10.1002/art.30119; Terkeltaub RA, 2010, ARTHRITIS RHEUM-US, V62, P1060, DOI 10.1002/art.27327; *UK CLIN PHARM ASS, 2011, UKCPA POS STAT INTR	28	9	11	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 1	2011	343								d7459	10.1136/bmj.d7459	http://dx.doi.org/10.1136/bmj.d7459			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RV	22134968	Green Submitted			2022-12-24	WOS:000298037800001
J	Punukollu, M; Harnden, A; Tulloh, R				Punukollu, Mallika; Harnden, Anthony; Tulloh, Robert			EASILY MISSED? Coarctation of the aorta in the newborn	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONGENITAL HEART-DISEASE; INFANCY; MALFORMATIONS; MANAGEMENT		[Punukollu, Mallika] Gartnavel Royal Hosp, Kershaw Unit, Glasgow G12 0XH, Lanark, Scotland; [Harnden, Anthony] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; [Tulloh, Robert] Univ Hosp Bristol NHS Fdn Trust, Bristol Congenital Heart Ctr, Bristol BS2 8BJ, Avon, England	Gartnavel Royal Hospital; University of Oxford; University of Bristol	Punukollu, M (corresponding author), Gartnavel Royal Hosp, Kershaw Unit, Glasgow G12 0XH, Lanark, Scotland.	mpunukollu@gmail.com		Tulloh, Robert/0000-0002-3180-6993				ABUHARB M, 1994, ARCH DIS CHILD-FETAL, V71, pF179, DOI 10.1136/fn.71.3.F179; ABUHARB M, 1994, ARCH DIS CHILD, V71, P3, DOI 10.1136/adc.71.1.3; Ainsworth SB, 1999, ARCH DIS CHILD-FETAL, V80, pF43, DOI 10.1136/fn.80.1.F43; Chang RKR, 2008, ARCH PEDIAT ADOL MED, V162, P969, DOI 10.1001/archpedi.162.10.969; Crossland DS, 2004, ARCH DIS CHILD-FETAL, V89, pF325, DOI 10.1136/adc.2003.034322; de-Wahl Granelli Anne, 2009, BMJ, V338, pa3037, DOI 10.1136/bmj.a3037; Deanfield J, 2003, EUR HEART J, V24, P1035, DOI 10.1016/S0195-668X(03)00131-3; GERSONY WM, 1983, J PEDIATR-US, V102, P895, DOI 10.1016/S0022-3476(83)80022-5; Gregory J, 1999, ARCH DIS CHILD, V80, pF46, DOI 10.1136/fn.80.1.F46; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Ing FF, 1996, PEDIATRICS, V98, P378; Knowles R, 2005, HEALTH TECHNOL ASSES, V9, P1; Massin MM, 2006, POSTGRAD MED J, V82, P468, DOI 10.1136/pgmj.2005.044495; MENON G, 1985, ARCH DIS CHILD, V60, P1134, DOI 10.1136/adc.60.12.1134; National Institute for Health and Clinical Excellence, 2006, POSTN CAR ROUT POSTN; PRESBITERO P, 1987, BRIT HEART J, V57, P462; Rao P Syamasundar, 2005, Curr Cardiol Rep, V7, P425, DOI 10.1007/s11886-005-0060-0; Roos-Hesselink JW, 2003, HEART, V89, P1074, DOI 10.1136/heart.89.9.1074; STEWART AB, 1993, BRIT HEART J, V69, P65; Tank S, 2004, BOMBAY HOSP J, V46, P141; Turkvatan A, 2009, DIAGN INTERV RADIOL, V15, P269, DOI 10.4261/1305-3825.DIR.2434-08.1; WARD KE, 1990, PEDIATRICS, V86, P972; Warnes CA, 2008, CIRCULATION, V118, P2395, DOI [10.1161/CIRCULATIONAHA.108.190811, 10.1016/j.jacc.2008.10.001]; Wren C, 1999, ARCH DIS CHILD-FETAL, V80, pF49, DOI 10.1136/fn.80.1.F49	24	0	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 16	2011	343								d6838	10.1136/bmj.d6838	http://dx.doi.org/10.1136/bmj.d6838			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854LV	22088486				2022-12-24	WOS:000297497100001
J	Shennan, AH; Redman, C; Cooper, C; Milne, F				Shennan, Andrew H.; Redman, Christopher; Cooper, Carol; Milne, Fiona			Are most maternal deaths from pre-eclampsia avoidable?	LANCET			English	Editorial Material							ECLAMPSIA		[Shennan, Andrew H.] Kings Coll London, Maternal & Fetal Res Unit, St Thomas Hosp, London SE1 7EH, England; [Redman, Christopher] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Cooper, Carol] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, Sch Med, London, England; [Milne, Fiona] Act Preeclampsia, Leicester, Leics, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Imperial College London	Shennan, AH (corresponding author), Kings Coll London, Maternal & Fetal Res Unit, St Thomas Hosp, London SE1 7EH, England.	andrew.shennan@kcl.ac.uk		Shennan, Andrew/0000-0001-5273-3132				[Anonymous], 2011, NEV EV LIST 2011 12; ANSARI MZ, 1995, EUR J EPIDEMIOL, V11, P447, DOI 10.1007/BF01721231; Chappell LC, 2010, BJOG-INT J OBSTET GY, V117, P695, DOI 10.1111/j.1471-0528.2010.02507.x; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Henderson J, 2000, J Health Serv Res Policy, V5, P69; Martin JN, 2005, OBSTET GYNECOL, V105, P246, DOI 10.1097/01.AOG.0000151116.84113.56; Milne F, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3129; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Schutte JM, 2010, BJOG-INT J OBSTET GY, V117, P399, DOI 10.1111/j.1471-0528.2009.02382.x; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Visintin C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c2207; Wallis AB, 2008, AM J HYPERTENS, V21, P521, DOI 10.1038/ajh.2008.20; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089	13	42	47	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2012	379	9827					1686	1687		10.1016/S0140-6736(11)60785-X	http://dx.doi.org/10.1016/S0140-6736(11)60785-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937KX	22177535				2022-12-24	WOS:000303658500009
J	Zhang, WY; Du, J; Evans, SL; Yu, YK; Yu, XF				Zhang, Wenyan; Du, Juan; Evans, Sean L.; Yu, Yunkai; Yu, Xiao-Fang			T-cell differentiation factor CBF-beta regulates HIV-1 Vif-mediated evasion of host restriction	NATURE			English	Article							VIRUS TYPE-1 VIF; E3 UBIQUITIN LIGASE; ANTIVIRAL ACTIVITY; ENZYME APOBEC3G; RUNT DOMAIN; SOCS-BOX; DEGRADATION; COMPLEX; BINDING; PROTEIN	The human APOBEC3 cytidine deaminases are potent inhibitors of diverse retroviruses, including human immunodeficiency virus-1 (HIV-1)(1-6). HIV-1 Vif forms an E3 ubiquitin ligase complex with cullin 5 (CUL5), elongin B and elongin C (7-9), which promotes the polyubiquitination and degradation of APOBEC3 substrates(7,10-14). Here we demonstrate in human T cells that core binding factor beta (CBF-beta) is a key regulator of the evasion of HIV-1 from the host defence mediated by APOBEC3. CBF-beta, the non-DNA-binding subunit of a heterodimeric transcription factor, regulates the folding and DNA-binding activity of partner RUNX family proteins, which have important roles in the development and differentiation of diverse cell types, including T lymphocytes(15,16). In our study, knockdown of endogenous CBF-beta blocked Vif-induced APOBEC3G polyubiquitination and degradation. CBF-beta was not required for the interaction between Vif and APOBEC3G, yet was essential for the assembly of the Vif-CUL5 E3-ubiquitin-ligase complex. CBF-beta proved to be a unique regulator of primate lentiviral Vif and not a general component of the CUL5 E3 ubiquitin ligase. We show that Vif and CBF-beta physically interact, and that the amino-terminal region of Vif is required for this interaction. Furthermore, interactions with Vif required regions in CBF-beta that are not involved in RUNX protein binding(17-19). Considering the importance of the interaction between Vif and CBF-beta, disrupting this interaction represents an attractive pharmacological intervention against HIV-1.	[Zhang, Wenyan; Du, Juan; Yu, Xiao-Fang] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130021, Jilin Province, Peoples R China; [Du, Juan; Evans, Sean L.; Yu, Yunkai; Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Yu, XF (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130021, Jilin Province, Peoples R China.	xfyu@jhsph.edu			Chinese Ministry of Science and Technology [2012CB911100]; Chinese Ministry of Education [IRT1016]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; NIAID [2R56AI62644-6]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China); Key Laboratory of Molecular Virology, Jilin Province, China; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Strebel, A. Friedman, N. Speck, D. Yue, R. Siliciano, M. Malim, R. Harris, T. Inoue and D. Gabuzda for critical reagents; T. Wang, K. Zhao, X. Zhou and A. Zhen for technical assistance; R. Markham, J. Margolick and J. Bream for thoughtful discussions; and D. McClellan for editorial assistance. We also wish to thank staff within the Mass Spectrometry Core and the Institute for Basic Biomedical Sciences Microscope Facility at Johns Hopkins School of Medicine for their technical assistance. The following reagents were obtained through the AIDS Research and Reference Reagents Program, Division of AIDS, NIAID, NIH: monoclonal antibodies against HIV-1 p24 (B. Chesebro and H. Chen), pNL4-3 (M. Martin), pcDNA-hVif (S. Bour and K. Strebel), antiserum to HIV-1 Vif (D. Gabuzda) and MAGI-CCR5 cells (J. Overbaugh). This work was supported in part by funding from the Chinese Ministry of Science and Technology (2012CB911100) and Chinese Ministry of Education (IRT1016), the Key Laboratory of Molecular Virology, Jilin Province (20102209), China, and a grant (2R56AI62644-6) from the NIAID.	Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Cao WS, 1998, J BIOL CHEM, V273, P31534, DOI 10.1074/jbc.273.47.31534; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; He ZW, 2008, J MOL BIOL, V381, P1000, DOI 10.1016/j.jmb.2008.06.061; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Luo K, 2007, FASEB J, V21, P1742, DOI 10.1096/fj.06-7241com; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Mehle A, 2007, J VIROL, V81, P13235, DOI 10.1128/JVI.00204-07; Navarro F, 2004, CURR OPIN IMMUNOL, V16, P477, DOI 10.1016/j.coi.2004.05.006; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Schrofelbauer B, 2006, J VIROL, V80, P5984, DOI 10.1128/JVI.00388-06; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Yan JL, 2004, NAT STRUCT MOL BIOL, V11, P901, DOI 10.1038/nsmb819; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zhang WY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003963	30	192	198	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					376	379		10.1038/nature10718	http://dx.doi.org/10.1038/nature10718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22190036				2022-12-24	WOS:000299210600045
J	Farrell, L				Farrell, Liam			THE BEST MEDICINE Big tits	BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2012	344								e68	10.1136/bmj.e68	http://dx.doi.org/10.1136/bmj.e68			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877SI	22236602				2022-12-24	WOS:000299202500001
J	Phelan, EA; Borson, S; Grothaus, L; Balch, S; Larson, EB				Phelan, Elizabeth A.; Borson, Soo; Grothaus, Louis; Balch, Steven; Larson, Eric B.			Association of Incident Dementia With Hospitalizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE SENSITIVE CONDITIONS; ALZHEIMERS-DISEASE; PREVENTABLE HOSPITALIZATIONS; HEALTH-CARE; OLDER PATIENTS; MEDICARE; RISK; POPULATION; DIAGNOSIS; ILLNESS	Context Dementia is associated with increased rates and often poorer outcomes of hospitalization, including worsening cognitive status. New evidence is needed to determine whether some admissions of persons with dementia might be potentially preventable. Objective To determine whether dementia onset is associated with higher rates of or different reasons for hospitalization, particularly for ambulatory care-sensitive conditions (ACSCs), for which proactive outpatient care might prevent the need for a hospital stay. Design, Setting, and Participants Retrospective analysis of hospitalizations among 3019 participants in Adult Changes in Thought (ACT), a longitudinal cohort study of adults aged 65 years or older enrolled in an integrated health care system. All participants had no dementia at baseline and those who had a dementia diagnosis during biennial screening contributed nondementia hospitalizations until diagnosis. Automated data were used to identify all hospitalizations of all participants from time of enrollment in ACT until death, disenrollment from the health plan, or end of follow-up, whichever came first. The study period spanned February 1, 1994, to December 31, 2007. Main Outcome Measures Hospital admission rates for patients with and without dementia, for all causes, by type of admission, and for ACSCs. Results Four hundred ninety-four individuals eventually developed dementia and 427 (86%) of these persons were admitted at least once; 2525 remained free of dementia and 1478 (59%) of those were admitted at least once. The unadjusted all-cause admission rate in the dementia group was 419 admissions per 1000 person-years vs 200 admissions per 1000 person-years in the dementia-free group. After adjustment for age, sex, and other potential confounders, the ratio of admission rates for all-cause admissions was 1.41 (95% confidence interval [CI], 1.23-1.61; P<.001), while for ACSCs, the adjusted ratio of admission rates was 1.78 (95% CI, 1.38-2.31; P<.001). Adjusted admission rates classified by body system were significantly higher in the dementia group for most categories. Adjusted admission rates for all types of ACSCs, including bacterial pneumonia, congestive heart failure, dehydration, duodenal ulcer, and urinary tract infection, were significantly higher among those with dementia. Conclusion Among our cohort aged 65 years or older, incident dementia was significantly associated with increased risk of hospitalization, including hospitalization for ACSCs. JAMA. 2012;307(2):165-172 www.jama.com	[Phelan, Elizabeth A.] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98104 USA; [Phelan, Elizabeth A.] Univ Washington, Dept Hlth Serv, Sch Publ Hlth & Community Med, Seattle, WA 98104 USA; [Borson, Soo] Univ Washington, Dept Psychiat, Div Geriatr Psychiat, Seattle, WA 98104 USA; [Grothaus, Louis; Balch, Steven; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Phelan, EA (corresponding author), Univ Washington, Dept Med, Div Gerontol & Geriatr Med, 325 9th Ave,Box 359755, Seattle, WA 98104 USA.	phelane@uw.edu			National Institute on Aging (NIA); Paul Beeson Physician Faculty Scholars in Aging Research; University of Washington Alzheimer's Disease Research Center (NIA) [P50 AG 005136]; NIA [UO1 AG 06781]; NATIONAL INSTITUTE ON AGING [K23AG020982, U01AG006781, P50AG005136] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Paul Beeson Physician Faculty Scholars in Aging Research; University of Washington Alzheimer's Disease Research Center (NIA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was conducted while Dr Phelan was a K23 recipient from the National Institute on Aging (NIA) and a Paul Beeson Physician Faculty Scholars in Aging Research Award recipient. Dr Borson received support from the University of Washington Alzheimer's Disease Research Center (NIA grant P50 AG 005136). ACT is supported by NIA grant UO1 AG 06781 (principal investigator: Dr Larson).	Albert SM, 1999, J GERONTOL A-BIOL, V54, pM267, DOI 10.1093/gerona/54.5.M267; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; BILLINGS J, 1993, HEALTH AFFAIR, V12, P162, DOI 10.1377/hlthaff.12.1.162; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Bradford A, 2009, ALZ DIS ASSOC DIS, V23, P306, DOI 10.1097/WAD.0b013e3181a6bebc; Breitner JCS, 2009, NEUROLOGY, V72, P1899, DOI 10.1212/WNL.0b013e3181a18691; BRESLOW NE, 1983, J AM STAT ASSOC, V78, P1, DOI 10.2307/2287093; Breslow NE, 1996, J AM STAT ASSOC, V91, P14, DOI 10.2307/2291379; Bynum JPW, 2004, J AM GERIATR SOC, V52, P187, DOI 10.1111/j.1532-5415.2004.52054.x; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Culler SD, 1998, MED CARE, V36, P804, DOI 10.1097/00005650-199806000-00004; Davison A., 2003, STAT MODELS; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Fishman PA, 2003, MED CARE, V41, P84, DOI 10.1097/00005650-200301000-00011; Gutterman EM, 1999, J AM GERIATR SOC, V47, P1065, DOI 10.1111/j.1532-5415.1999.tb05228.x; Harris DP, 2009, J AM GERIATR SOC, V57, P2209, DOI 10.1111/j.1532-5415.2009.02572.x; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Hill J, 2005, J ALZHEIMERS DIS, V8, P43; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; JORM AF, 1988, BRIT J PSYCHIAT, V152, P209, DOI 10.1192/bjp.152.2.209; Kruzikas D.T., 2000, HCUP FACT BOOK; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Larson E B, 1990, Aging (Milano), V2, P404; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; LEFEVRE F, 1992, ARCH INTERN MED, V152, P2074, DOI 10.1001/archinte.152.10.2074; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P704, DOI 10.1176/appi.ajp.157.5.704; Malone DC, 2009, AM J MANAG CARE, V15, P481; McCall N, 2001, HEALTH CARE FINANC R, V22, P127; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Natalwala A, 2008, DEMENT GERIATR COGN, V26, P499, DOI 10.1159/000171044; Oster A, 2003, MED CARE, V41, P198, DOI 10.1097/00005650-200302000-00002; Rudolph JL, 2010, J AM GERIATR SOC, V58, P1542, DOI 10.1111/j.1532-5415.2010.02924.x; Russo CA, 2006, HOSP ELDERLY POPULAT; Sager MA, 1996, J AM GERIATR SOC, V44, P251, DOI 10.1111/j.1532-5415.1996.tb00910.x; Saha S, 2007, MED CARE, V45, P712, DOI 10.1097/MLR.0b013e318053717c; Saunders KW, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P223; Taylor DH, 2004, J GERONTOL A-BIOL, V59, P762; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Tuppin P, 2009, DEMENT GERIATR COGN, V28, P225, DOI 10.1159/000238394; US Food and Drug Administration, NAT DRUG COD DIR; WAGNER EH, 1995, PATIENT EDUC COUNS, V26, P225, DOI 10.1016/0738-3991(95)00761-N; WEISSMAN JS, 1992, JAMA-J AM MED ASSOC, V268, P2388, DOI 10.1001/jama.268.17.2388; Zhan CL, 2004, HEALTH SERV RES, V39, P345, DOI 10.1111/j.1475-6773.2004.00231.x; Zhao Y, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-108	47	294	295	3	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2012	307	2					165	172		10.1001/jama.2011.1964	http://dx.doi.org/10.1001/jama.2011.1964			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	875NP	22235087	Bronze, Green Accepted			2022-12-24	WOS:000299038300028
J	Morison, J; Kwok, R; Peralta-Ferriz, C; Alkire, M; Rigor, I; Andersen, R; Steele, M				Morison, James; Kwok, Ron; Peralta-Ferriz, Cecilia; Alkire, Matt; Rigor, Ignatius; Andersen, Roger; Steele, Mike			Changing Arctic Ocean freshwater pathways	NATURE			English	Article							BEAUFORT GYRE; ICE; TEMPERATURE; VARIABILITY; RUNOFF; MODEL	Freshening in the Canada basin of the Arctic Ocean began in the 1990s(1,2) and continued(3) to at least the end of 2008. By then, the Arctic Ocean might have gained four times as much fresh water as comprised the Great Salinity Anomaly(4,5) of the 1970s, raising the spectre of slowing global ocean circulation(6). Freshening has been attributed to increased sea ice melting(1) and contributions from runoff(7), but a leading explanation has been a strengthening of the Beaufort High-a characteristic peak in sea level atmospheric pressure(2,8)-which tends to accelerate an anticyclonic (clockwise) wind pattern causing convergence of fresh surface water. Limited observations have made this explanation difficult to verify, and observations of increasing freshwater content under a weakened Beaufort High suggest that other factors(2) must be affecting freshwater content. Here we use observations to show that during a time of record reductions in ice extent from 2005 to 2008, the dominant freshwater content changes were an increase in the Canada basin balanced by a decrease in the Eurasian basin. Observations are drawn from satellite data (sea surface height and ocean-bottom pressure) and in situ data. The freshwater changes were due to a cyclonic (anticlockwise) shift in the ocean pathway of Eurasian runoff forced by strengthening of the west-to-east Northern Hemisphere atmospheric circulation characterized by an increased Arctic Oscillation(9) index. Our results confirm that runoff is an important influence on the Arctic Ocean and establish that the spatial and temporal manifestations of the runoff pathways are modulated by the Arctic Oscillation, rather than the strength of the wind-driven Beaufort Gyre circulation.	[Morison, James; Peralta-Ferriz, Cecilia; Alkire, Matt; Rigor, Ignatius; Andersen, Roger; Steele, Mike] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; [Kwok, Ron] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Washington; University of Washington Seattle; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Morison, J (corresponding author), Univ Washington, Appl Phys Lab, Polar Sci Ctr, 1013 NE 40th St, Seattle, WA 98105 USA.	morison@apl.washington.edu	Kwok, Ronald/L-3968-2019; Kwok, Ron/A-9762-2008	Kwok, Ronald/0000-0003-4051-5896; Kwok, Ron/0000-0003-4051-5896; Steele, Michael/0000-0001-5083-1775	NSF [OPP 0352754]; NASA [NNX08AH62G]; Jet Propulsion Laboratory, California Institute of Technology; NASA MEASURES;  [ARC-0634226];  [ARC-0856330]; Directorate For Geosciences [0856177, 1022475, 1022710] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Jet Propulsion Laboratory, California Institute of Technology; NASA MEASURES; ; ; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported chiefly by NSF grants OPP 0352754, ARC-0634226, ARC-0856330 and NASA grant NNX08AH62G. R. K. was supported at the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA. GRACE ocean data were processed by D. P. Chambers, supported by the NASA MEASURES Program. We thank the NASA ICESat and GRACE programmes, K. Falkner, R. Collier, M. McPhee, W. Ermold, L. de Steur, A. Proshutinsky and the Beaufort Gyre Exploration Project, J. Toole and R. Krishfield and the Ice Tethered Profiler project at WHOI, and W. Smethie of the Switchyard project for the observations that made this work possible.	Alkire MB, 2010, DEEP-SEA RES PT I, V57, P1432, DOI 10.1016/j.dsr.2010.07.011; Bingham RJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032662; Carmack EC, 1997, DEEP-SEA RES PT II, V44, P1487, DOI 10.1016/S0967-0645(97)00056-8; Chambers DP, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027296; Chambers DP, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002914; DICKSON RR, 1988, PROG OCEANOGR, V20, P103, DOI 10.1016/0079-6611(88)90049-3; Ekwurzel B, 2001, J GEOPHYS RES-OCEANS, V106, P9075, DOI 10.1029/1999JC000024; *EWG, 1997, JOINT US RUSS ATL AR; Koldunov NV, 2010, J CLIMATE, V23, P2520, DOI 10.1175/2009JCLI3065.1; Kwok R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046063; Kwok R, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005312; Lique C, 2011, J CLIMATE, V24, P1705, DOI 10.1175/2010JCLI3762.1; Macdonald RW, 1999, GEOPHYS RES LETT, V26, P2223, DOI 10.1029/1999GL900508; McPhee MG, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037525; McPhee MG, 1998, GEOPHYS RES LETT, V25, P1729, DOI 10.1029/98GL00933; Morison J, 1998, DEEP-SEA RES PT I, V45, P15, DOI 10.1016/S0967-0637(97)00025-3; Morison J, 2000, ARCTIC, V53, P359; Morison J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029016; Proshutinsky A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015847; Proshutinsky A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005104; Proshutinsky AY, 1997, J GEOPHYS RES-OCEANS, V102, P12493, DOI 10.1029/97JC00738; Rabe B, 2011, DEEP-SEA RES PT I, V58, P173, DOI 10.1016/j.dsr.2010.12.002; Serreze MC, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003424; Shindell DT, 1999, NATURE, V399, P452, DOI 10.1038/20905; Steele M, 1998, J GEOPHYS RES-OCEANS, V103, P10419, DOI 10.1029/98JC00580; Steele M, 2007, J CLIMATE, V20, P403, DOI 10.1175/JCLI4022.1; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Vinogradova NT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028588; Walsh JE, 2008, J CLIMATE, V21, P6156, DOI 10.1175/2008JCLI2163.1; Willis JK, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004517; Yamamoto-Kawai M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003858	31	291	302	3	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2012	481	7379					66	70		10.1038/nature10705	http://dx.doi.org/10.1038/nature10705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22222749				2022-12-24	WOS:000298836900030
J	Volk, RJ; Wolf, AMD				Volk, Robert J.; Wolf, Andrew M. D.			Grading the New US Preventive Services Task Force Prostate Cancer Screening Recommendation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY		[Volk, Robert J.] Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med, Div Gen Internal Med, Houston, TX 77230 USA; [Wolf, Andrew M. D.] Univ Virginia, Sch Med, Dept Med, Div Med Geriatr & Palliat Care, Charlottesville, VA 22908 USA	University of Texas System; UTMD Anderson Cancer Center; University of Virginia	Volk, RJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med, Div Gen Internal Med, POB 301402, Houston, TX 77230 USA.	bvolk@mdanderson.org		Volk, Robert/0000-0001-8811-5854				American Urological Assocation, 2009, AM UR ASS PROST SPEC; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; McNaughton-Collins MF, 2011, NEW ENGL J MED, V365, P1951, DOI 10.1056/NEJMp1111894; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; U.S. Preventive Services Task Force, 2011, SCREEN PROST CANC US; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066	8	19	19	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2715	2716		10.1001/jama.2011.1893	http://dx.doi.org/10.1001/jama.2011.1893			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22203540				2022-12-24	WOS:000298484000022
J	Appel, A				Appel, Adrianne			DRUGS More shots on target	NATURE			English	Editorial Material																			0	15	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S40	S42		10.1038/480S40a	http://dx.doi.org/10.1038/480S40a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22169800	Bronze			2022-12-24	WOS:000298033000005
J	Graham-Rowe, D				Graham-Rowe, Duncan			OVERVIEW Multiple lines of attack	NATURE			English	Editorial Material																		Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837	1	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S34	S35		10.1038/480S34a	http://dx.doi.org/10.1038/480S34a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169797	Bronze			2022-12-24	WOS:000298033000002
J	Maningat, P; Breslow, JL				Maningat, Patricia; Breslow, Jan L.			Needed: Pragmatic Clinical Trials for Statin-Intolerant Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Maningat, Patricia; Breslow, Jan L.] Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Maningat, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.							Fernandez Genaro, 2011, Cleve Clin J Med, V78, P393, DOI 10.3949/ccjm.78a.10073; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Ware JH, 2011, NEW ENGL J MED, V364, P1685, DOI 10.1056/NEJMp1103502	4	65	66	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2011	365	24					2250	2251		10.1056/NEJMp1112023	http://dx.doi.org/10.1056/NEJMp1112023			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861PN	22085320				2022-12-24	WOS:000298031800003
J	Lucchinetti, CF; Popescu, BFG; Bunyan, RF; Moll, NM; Roemer, SF; Lassmann, H; Bruck, W; Parisi, JE; Scheithauer, BW; Giannini, C; Weigand, SD; Mandrekar, J; Ransohoff, RM				Lucchinetti, Claudia F.; Popescu, Bogdan F. G.; Bunyan, Reem F.; Moll, Natalia M.; Roemer, Shanu F.; Lassmann, Hans; Brueck, Wolfgang; Parisi, Joseph E.; Scheithauer, Bernd W.; Giannini, Caterina; Weigand, Stephen D.; Mandrekar, Jay; Ransohoff, Richard M.			Inflammatory Cortical Demyelination in Early Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-CELL FOLLICLES; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CERVICAL LYMPH-NODES; DIAGNOSTIC-CRITERIA; CEREBROSPINAL-FLUID; DENDRITIC CELLS; MATTER ATROPHY; CHOROID-PLEXUS; LESIONS; PATHOLOGY	BACKGROUND Cortical disease has emerged as a critical aspect of the pathogenesis of multiple sclerosis, being associated with disease progression and cognitive impairment. Most studies of cortical lesions have focused on autopsy findings in patients with long-standing, chronic, progressive multiple sclerosis, and the noninflammatory nature of these lesions has been emphasized. Magnetic resonance imaging studies indicate that cortical damage occurs early in the disease. METHODS We evaluated the prevalence and character of demyelinating cortical lesions in patients with multiple sclerosis. Cortical tissues were obtained in passing during biopsy sampling of white-matter lesions. In most cases, biopsy was done with the use of stereotactic procedures to diagnose suspected tumors. Patients with sufficient cortex (138 of 563 patients screened) were evaluated for cortical demyelination. Using immunohistochemistry, we characterized cortical lesions with respect to demyelinating activity, inflammatory infiltrates, the presence of meningeal inflammation, and a topographic association between cortical demyelination and meningeal inflammation. Diagnoses were ascertained in a subgroup of 77 patients (56%) at the last follow-up visit (at a median of 3.5 years). RESULTS Cortical demyelination was present in 53 patients (38%) (104 lesions and 222 tissue blocks) and was absent in 85 patients (121 tissue blocks). Twenty-five patients with cortical demyelination had definite multiple sclerosis (81% of 31 patients who underwent long-term follow-up), as did 33 patients without cortical demyelination (72% of 46 patients who underwent long-term follow-up). In representative tissues, 58 of 71 lesions (82%) showed CD3+ T-cell infiltrates, and 32 of 78 lesions (41%) showed macrophage-associated demyelination. Meningeal inflammation was topographically associated with cortical demyelination in patients who had sufficient meningeal tissue for study. CONCLUSIONS In this cohort of patients with early-stage multiple sclerosis, cortical demyelinating lesions were frequent, inflammatory, and strongly associated with meningeal inflammation. (Funded by the National Multiple Sclerosis Society and the National Institutes of Health.)	[Lucchinetti, Claudia F.; Popescu, Bogdan F. G.; Bunyan, Reem F.; Roemer, Shanu F.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Parisi, Joseph E.; Scheithauer, Bernd W.; Giannini, Caterina] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Weigand, Stephen D.; Mandrekar, Jay] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Moll, Natalia M.; Ransohoff, Richard M.] Cleveland Clin, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA; [Moll, Natalia M.; Ransohoff, Richard M.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA; [Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Brueck, Wolfgang] Univ Gottingen, Univ Med Ctr, Gottingen, Germany; [Brueck, Wolfgang] Univ Gottingen, Dept Neuropathol, Univ Med Ctr, Gottingen, Germany; [Brueck, Wolfgang] Univ Gottingen, Inst Multiple Sclerosis Res, Hertie Fdn, Gottingen, Germany	Mayo Clinic; Mayo Clinic; Mayo Clinic; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Medical University of Vienna; University of Gottingen; University of Gottingen; University of Gottingen	Lucchinetti, CF (corresponding author), Mayo Clin, Coll Med, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.	lucchinetti.claudia@mayo.edu; ransohr@ccf.org	Giannini, Caterina/AAB-7551-2022; Lassmann, Hans/Z-2269-2019; Calabrese, Massimiliano/I-6195-2012	Lassmann, Hans/0000-0001-8617-5052; 	National Multiple Sclerosis Society (NMSS) [RG3185-B-3]; National Institutes of Health [1R01NS049577, P50NS38667]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038667, R01NS049577] Funding Source: NIH RePORTER	National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from the National Multiple Sclerosis Society (NMSS RG3185-B-3, to Dr. Lucchinetti) and the National Institutes of Health (1R01NS049577, to Dr. Lucchinetti, and P50NS38667, to Dr. Ransohoff).	Absinta M, 2011, NEUROLOGY, V76, P910, DOI 10.1212/WNL.0b013e31820f2e69; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Bo L, 2003, MULT SCLER, V9, P323, DOI 10.1191/1352458503ms917oa; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; BROWNELL B, 1962, J NEUROL NEUROSUR PS, V25, P315, DOI 10.1136/jnnp.25.4.315; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Calabrese M, 2009, MULT SCLER J, V15, P933, DOI 10.1177/1352458509106510; Calabrese M, 2009, NEUROLOGY, V72, P1330, DOI 10.1212/WNL.0b013e3181a0fee5; Calabrese M, 2009, MULT SCLER J, V15, P36, DOI 10.1177/1352458508096686; Calabrese M, 2008, J NEUROL, V255, P581, DOI 10.1007/s00415-008-0752-7; Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Calabrese M, 2011, EXPERT REV NEUROTHER, V11, P425, DOI 10.1586/ERN.10.155; Calabrese M, 2010, NAT REV NEUROL, V6, P438, DOI 10.1038/nrneurol.2010.93; Corcione A, 2004, P NATL ACAD SCI USA, V101, P11064, DOI 10.1073/pnas.0402455101; Dalton CM, 2004, BRAIN, V127, P1101, DOI 10.1093/brain/awh126; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; Filippi M, 2010, NEUROLOGY, V75, P1988, DOI 10.1212/WNL.0b013e3181ff96f6; HART MN, 1975, J NEUROL NEUROSUR PS, V38, P585, DOI 10.1136/jnnp.38.6.585; Hatterer E, 2006, BLOOD, V107, P806, DOI 10.1182/blood-2005-01-0154; Kidd D, 1999, BRAIN, V122, P17, DOI 10.1093/brain/122.1.17; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Kutzelnigg A, 2006, J NEUROL SCI, V245, P123, DOI 10.1016/j.jns.2005.09.021; LASSMANN H, 1978, ACTA NEUROCHIR, V43, P35; LASSMANN H, 1981, J NEUROL SCI, V50, P109, DOI 10.1016/0022-510X(81)90046-0; Lovato L, 2011, BRAIN, V134, P534, DOI 10.1093/brain/awq350; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 2008, BRAIN, V131, P1759, DOI 10.1093/brain/awn098; Lumsden CE, 1970, HDB CLINICAL NEUROLO, P217; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Merkler D, 2006, BRAIN, V129, P1972, DOI 10.1093/brain/awl135; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Pittock SJ, 2005, J NEUROL NEUROSUR PS, V76, P1693, DOI 10.1136/jnnp.2004.060624; Popescu BFG, 2011, NEUROLOGY, V76, P1705, DOI 10.1212/WNL.0b013e31821a44f1; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rudick RA, 2009, J NEUROL SCI, V282, P106, DOI 10.1016/j.jns.2008.11.018; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Tallantyre EC, 2010, J MAGN RESON IMAGING, V32, P971, DOI 10.1002/jmri.22115; Tardif CL, 2010, LECT NOTES COMPUT SC, V6363, P181; van Zwam M, 2009, J MOL MED, V87, P273, DOI 10.1007/s00109-008-0421-4; VASS K, 1986, ACTA NEUROPATHOL, V70, P149, DOI 10.1007/BF00691433; Vercellino M, 2005, J NEUROPATH EXP NEUR, V64, P1101, DOI 10.1097/01.jnen.0000190067.20935.42; Vrenken H, 2008, J MAGN RESON IMAGING, V28, P1309, DOI 10.1002/jmri.21559; Wegner C, 2006, NEUROLOGY, V67, P960, DOI 10.1212/01.wnl.0000237551.26858.39; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74	50	716	739	1	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2011	365	23					2188	2197		10.1056/NEJMoa1100648	http://dx.doi.org/10.1056/NEJMoa1100648			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857PQ	22150037	Green Published, Green Accepted			2022-12-24	WOS:000297731400004
J	Benjamin, M; Gibbs, S				Benjamin, Malvyn; Gibbs, Simon			A PATIENT'S JOURNEY Amyloidosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gibbs, Simon] UCL Med Sch, Natl Amyloidosis Ctr, London NW3 2PF, England	University of London; University College London	Gibbs, S (corresponding author), UCL Med Sch, Natl Amyloidosis Ctr, Royal Free Campus, London NW3 2PF, England.	s.gibbs@ucl.ac.uk	Gibbs, Simon/K-4974-2019						0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 16	2011	343								d6326	10.1136/bmj.d6326	http://dx.doi.org/10.1136/bmj.d6326			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892DT	22088395	Bronze			2022-12-24	WOS:000300267600001
J	Brelidze, TI; Carlson, AE; Sankaran, B; Zagotta, WN				Brelidze, Tinatin I.; Carlson, Anne E.; Sankaran, Banumathi; Zagotta, William N.			Structure of the carboxy-terminal region of a KCNH channel	NATURE			English	Article							LONG-QT SYNDROME; FUNCTIONAL-PROPERTIES; POTASSIUM CHANNELS; HERG; ACTIVATION; DOMAIN; VALIDATION	The KCNH family of ion channels, comprising ether-a-go-go (EAG), EAG-related gene (ERG), and EAG-like (ELK) K+-channel subfamilies, is crucial for repolarization of the cardiac action potential(1), regulation of neuronal excitability(2) and proliferation of tumour cells(3). The carboxy-terminal region of KCNH channels contains a cyclic-nucleotide-binding homology domain (CNBHD) and C-linker that couples the CNBHD to the pore(4). The C-linker/CNBHD is essential for proper function and trafficking of ion channels in the KCNH family(5-9). However, despite the importance of the C-linker/CNBHD for the function of KCNH channels, the structural basis of ion-channel regulation by the C-linker/CNBHD is unknown. Here we report the crystal structure of the C-linker/CNBHD of zebrafish ELK channels at 2.2-angstrom resolution. Although the overall structure of the C-linker/CNBHD of ELK channels is similar to the cyclic-nucleotide-binding domain (CNBD) structure of the related hyperpolarization-activated cyclic-nucleotide-modulated (HCN) channels(10), there are marked differences. Unlike the CNBD of HCN, the CNBHD of ELK displays a negatively charged electrostatic profile that explains the lack of binding and regulation of KCNH channels by cyclic nucleotides(4,11). Instead of cyclic nucleotide, the binding pocket is occupied by a short beta-strand. Mutations of the beta-strand shift the voltage dependence of activation to more depolarized voltages, implicating the beta-strand as an intrinsic ligand for the CNBHD of ELK channels. In both ELK and HCN channels the C-linker is the site of virtually all of the intersubunit interactions in the C-terminal region. However, in the zebrafish ELK structure there is a reorientation in the C-linker so that the subunits form dimers instead of tetramers, as observed in HCN channels. These results provide a structural framework for understanding the regulation of ion channels in the KCNH family by the C-linker/CNBHD and may guide the design of specific drugs.	[Brelidze, Tinatin I.; Carlson, Anne E.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Sch Med, Seattle, WA 98195 USA; [Sankaran, Banumathi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zagotta, WN (corresponding author), Univ Washington, Dept Physiol & Biophys, Sch Med, Box 357290, Seattle, WA 98195 USA.	zagotta@u.washington.edu	Carlson, Anne/I-9495-2019	Carlson, Anne/0000-0003-2724-1325; Brelidze, Tinatin/0000-0003-3046-8184	Howard Hughes Medical Institute; National Institutes of Health (NIH) [R01 EY010329, F32 HL095241]; NIH, National Institute of General Medical Sciences; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL095241] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank M. Munari, S. Camp, S. Cunnington and G. Sheridan for excellent technical assistance. We thank the beamline staff at the Advanced Light Source (ALS) and especially P. Zwart for help with data analysis. We also thank the members of the Zagotta laboratory for helpful discussions. This work was supported by the Howard Hughes Medical Institute, National Institutes of Health (NIH) grant R01 EY010329 (W.N.Z.) and NIH grant F32 HL095241 (A. E. C.). The Berkeley Center for Structural Biology is supported in part by the NIH, National Institute of General Medical Sciences and the Howard Hughes Medical Institute. The ALS is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Altieri SL, 2008, J MOL BIOL, V381, P655, DOI 10.1016/j.jmb.2008.06.011; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Becchetti A, 2002, EUR J NEUROSCI, V16, P415, DOI 10.1046/j.1460-9568.2002.02079.x; Brelidze TI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012523; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Camacho J, 2006, CANCER LETT, V233, P1, DOI 10.1016/j.canlet.2005.02.016; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engeland B, 1998, J PHYSIOL-LONDON, V513, P647, DOI 10.1111/j.1469-7793.1998.647ba.x; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Schunke S, 2011, P NATL ACAD SCI USA, V108, P6121, DOI 10.1073/pnas.1015890108; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Stevens L, 2009, EUR BIOPHYS J BIOPHY, V38, P523, DOI 10.1007/s00249-009-0402-8; Trudeau MC, 1999, J NEUROSCI, V19, P2906; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang XF, 2010, NAT NEUROSCI, V13, P1056, DOI 10.1038/nn.2610; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061; Zou AR, 2003, AM J PHYSIOL-CELL PH, V285, pC1356, DOI 10.1152/ajpcell.00179.2003	38	97	97	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2012	481	7382					530	U147		10.1038/nature10735	http://dx.doi.org/10.1038/nature10735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22230959	Green Accepted			2022-12-24	WOS:000299471800045
J	Gourlay, ML; Fine, JP; Preisser, JS; May, RC; Li, CX; Lui, LY; Ransohoff, DF; Cauley, JA; Ensrud, KE				Gourlay, Margaret L.; Fine, Jason P.; Preisser, John S.; May, Ryan C.; Li, Chenxi; Lui, Li-Yung; Ransohoff, David F.; Cauley, Jane A.; Ensrud, Kristine E.		Study Osteoporotic Fractures Res	Bone-Density Testing Interval and Transition to Osteoporosis in Older Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REPLACEMENT THERAPY; CANCER; FRACTURES; INFERENCE; ADULT	BACKGROUND Although bone mineral density (BMD) testing to screen for osteoporosis (BMD T score, -2.50 or lower) is recommended for women 65 years of age or older, there are few data to guide decisions about the interval between BMD tests. METHODS We studied 4957 women, 67 years of age or older, with normal BMD (T score at the femoral neck and total hip, -1.00 or higher) or osteopenia (T score, -1.01 to -2.49) and with no history of hip or clinical vertebral fracture or of treatment for osteoporosis, followed prospectively for up to 15 years. The BMD testing interval was defined as the estimated time for 10% of women to make the transition to osteoporosis before having a hip or clinical vertebral fracture, with adjustment for estrogen use and clinical risk factors. Transitions from normal BMD and from three subgroups of osteopenia (mild, moderate, and advanced) were analyzed with the use of parametric cumulative incidence models. Incident hip and clinical vertebral fractures and initiation of treatment with bisphosphonates, calcitonin, or raloxifene were treated as competing risks. RESULTS The estimated BMD testing interval was 16.8 years (95% confidence interval [CI], 11.5 to 24.6) for women with normal BMD, 17.3 years (95% CI, 13.9 to 21.5) for women with mild osteopenia, 4.7 years (95% CI, 4.2 to 5.2) for women with moderate osteopenia, and 1.1 years (95% CI, 1.0 to 1.3) for women with advanced osteopenia. CONCLUSIONS Our data indicate that osteoporosis would develop in less than 10% of older, postmenopausal women during rescreening intervals of approximately 15 years for women with normal bone density or mild osteopenia, 5 years for women with moderate osteopenia, and 1 year for women with advanced osteopenia. (Funded by the National Institutes of Health.)	[Gourlay, Margaret L.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27599 USA; [Fine, Jason P.; Preisser, John S.; May, Ryan C.] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Ransohoff, David F.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Li, Chenxi] Univ N Carolina, N Carolina Translat & Clin Sci Inst, Chapel Hill, NC 27599 USA; [Lui, Li-Yung] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Cauley, Jane A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Ensrud, Kristine E.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Univ Minnesota, Div Epidemiol, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Minneapolis Vet Affairs Hlth Care Syst, Dept Med, Minneapolis, MN USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; California Pacific Medical Center; California Pacific Medical Center Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Gourlay, ML (corresponding author), Univ N Carolina, Dept Family Med, Aycock Bldg,Manning Dr, Chapel Hill, NC 27599 USA.	margaret_gourlay@med.unc.edu	Li, Chenxi/D-1004-2015	Cauley, Jane A/0000-0003-0752-4408; Ensrud, Kristine/0000-0002-9069-3036	National Institutes of Health [K23RR024685, AG05407, AR35582, AG05394, AR35584, AR35583, R01 AG005407, R01 AG027576-22, 2 R01 AG005394-22A1, 2 R01 AG027574-22A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR024685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035582, R01AR035584, R01AR035583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027576, R01AG027574, R01AG005394, R01AG005407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a grant (K23RR024685) from the National Institutes of Health. The Study of Osteoporotic Fractures is supported by grants (AG05407, AR35582, AG05394, AR35584, AR35583, R01 AG005407, R01 AG027576-22, 2 R01 AG005394-22A1, and 2 R01 AG027574-22A1) from the National Institutes of Health.	American College of Obstetricians and Gynecologists, 2008, ACOG PRACT B; [Anonymous], 2010, CLIN GUID PREV TREAT; Bonnick SL, 2010, MENOPAUSE, V17, P25, DOI [10.1097/gme.0b013e3181c617e6, 10.1097/gme.0b013e3181e617e6]; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Fine J P, 2001, Biostatistics, V2, P85, DOI 10.1093/biostatistics/2.1.85; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Frost SA, 2009, J BONE MINER RES, V24, P1800, DOI [10.1359/JBMR.090514, 10.1359/jbmr.090514]; Greendale GA, 2002, ARCH INTERN MED, V162, P665, DOI 10.1001/archinte.162.6.665; Hillier TA, 2007, ARCH INTERN MED, V167, P155, DOI 10.1001/archinte.167.2.155; Hodgson Stephen F, 2003, Endocr Pract, V9, P544; Hudgens M, 2011, U N CAROLINA CHAPPEL; Jeong JH, 2006, J R STAT SOC C-APPL, V55, P187, DOI 10.1111/j.1467-9876.2006.00532.x; Jeong JH, 2007, BIOSTATISTICS, V8, P184, DOI 10.1093/biostatistics/kxj040; Kanis JA, 2009, BONE, V44, P734, DOI 10.1016/j.bone.2009.01.373; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Lee M, 2011, STAT MED, V30, P3221, DOI 10.1002/sim.4349; Lewiecki EM, 2008, BONE, V43, P1115, DOI 10.1016/j.bone.2008.08.106; Lim LS, 2009, AM J PREV MED, V36, P366, DOI 10.1016/j.amepre.2009.01.013; Lindsey JC, 1999, STAT MED, V18, P890, DOI 10.1002/(SICI)1097-0258(19990415)18:7<890::AID-SIM90>3.0.CO;2-7; Looker AC, 2010, J BONE MINER RES, V25, P64, DOI 10.1359/jbmr.090706; Partridge AH, 2009, NEW ENGL J MED, V361, P2499, DOI 10.1056/NEJMp0911288; Peng L, 2007, BIOMETRIKA, V94, P735, DOI 10.1093/biomet/asm059; SAS Institute, 2008, SAS STAT 9 2 US GUID; Sawaya GF, 2009, NEW ENGL J MED, V361, P2503, DOI 10.1056/NEJMp0911380; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71	28	165	170	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2012	366	3					225	233		10.1056/NEJMoa1107142	http://dx.doi.org/10.1056/NEJMoa1107142			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877RZ	22256806	Green Published, Green Accepted			2022-12-24	WOS:000299201400008
J	Fineberg, HV				Fineberg, Harvey V.			CHRISTMAS 2011: EVOLUTION Neo-evolution: is Homo sapiens ready?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Natl Acad Sci, Inst Med, Washington, DC 20418 USA	National Academies of Sciences, Engineering & Medicine	Fineberg, HV (corresponding author), Natl Acad Sci, Inst Med, Washington, DC 20418 USA.	fineberg@nas.edu							0	1	1	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2011	343								d7649	10.1136/bmj.d7649	http://dx.doi.org/10.1136/bmj.d7649			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874TF	22189128				2022-12-24	WOS:000298980300002
J	Carlo, WA; McDonald, SA; Fanaroff, AA; Vohr, BR; Stoll, BJ; Ehrenkranz, RA; Andrews, WW; Wallace, D; Das, A; Bell, EF; Walsh, MC; Laptook, AR; Shankaran, S; Poindexter, BB; Hale, EC; Newman, NS; Davis, AS; Schibler, K; Kennedy, KA; Sanchez, PJ; Van Meurs, KP; Goldberg, RN; Watterberg, KL; Faix, RG; Frantz, ID; Higgins, RD				Carlo, Waldemar A.; McDonald, Scott A.; Fanaroff, Avroy A.; Vohr, Betty R.; Stoll, Barbara J.; Ehrenkranz, Richard A.; Andrews, William W.; Wallace, Dennis; Das, Abhik; Bell, Edward F.; Walsh, Michele C.; Laptook, Abbot R.; Shankaran, Seetha; Poindexter, Brenda B.; Hale, Ellen C.; Newman, Nancy S.; Davis, Alexis S.; Schibler, Kurt; Kennedy, Kathleen A.; Sanchez, Pablo J.; Van Meurs, Krisa P.; Goldberg, Ronald N.; Watterberg, Kristi L.; Faix, Roger G.; Frantz, Ivan D., III; Higgins, Rosemary D.		Eunice Kennedy Shriver Natl Inst C	Association of Antenatal Corticosteroids With Mortality and Neurodevelopmental Outcomes Among Infants Born at 22 to 25 Weeks' Gestation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT INFANTS; EXTREMELY PRETERM INFANTS; DEVELOPMENTAL-DISABILITY; SURVIVAL; AGE; EPICURE; CARE	Context Current guidelines, initially published in 1995, recommend antenatal corticosteroids for mothers with preterm labor from 24 to 34 weeks' gestational age, but not before 24 weeks due to lack of data. However, many infants born before 24 weeks' gestation are provided intensive care. Objective To determine if use of antenatal corticosteroids is associated with improvement in major outcomes for infants born at 22 and 23 weeks' gestation. Design, Setting, and Participants Cohort study of data collected prospectively on inborn infants with a birth weight between 401 g and 1000 g (N=10 541) born at 22 to 25 weeks' gestation between January 1, 1993, and December 31, 2009, at 23 academic perinatal centers in the United States. Certified examiners unaware of exposure to antenatal corticosteroids performed follow-up examinations on 4924 (86.5%) of the infants born between 1993 and 2008 who survived to 18 to 22 months. Logistic regression models generated adjusted odds ratios (AORs), controlling for maternal and neonatal variables. Main Outcome Measures Mortality and neurodevelopmental impairment at 18 to 22 months' corrected age. Results Death or neurodevelopmental impairment at 18 to 22 months was significantly lower for infants who had been exposed to antenatal corticosteroids and were born at 23 weeks' gestation (83.4% with exposure to antenatal corticosteroids vs 90.5% without exposure; AOR, 0.58 [95% CI, 0.42-0.80]), at 24 weeks' gestation (68.4% with exposure to antenatal corticosteroids vs 80.3% without exposure; AOR, 0.62 [95% CI, 0.49-0.78]), and at 25 weeks' gestation (52.7% with exposure to antenatal corticosteroids vs 67.9% without exposure; AOR, 0.61 [95% CI, 0.50-0.74]) but not in those infants born at 22 weeks' gestation (90.2% with exposure to antenatal corticosteroids vs 93.1% without exposure; AOR, 0.80 [95% CI, 0.29-2.21]). If the mothers had received antenatal corticosteroids, the following events occurred significantly less in infants born at 23, 24, and 25 weeks' gestation: death by 18 to 22 months; hospital death; death, intraventricular hemorrhage, or periventricular leukomalacia; and death or necrotizing enterocolitis. For infants born at 22 weeks' gestation, the only outcome that occurred significantly less was death or necrotizing enterocolitis (73.5% with exposure to antenatal corticosteroids vs 84.5% without exposure; AOR, 0.54 [95% CI, 0.30-0.97]). Conclusion Among infants born at 23 to 25 weeks' gestation, antenatal exposure to corticosteroids compared with nonexposure was associated with a lower rate of death or neurodevelopmental impairment at 18 to 22 months. JAMA. 2011;306(21):2348-2358	[Carlo, Waldemar A.] Univ Alabama Birmingham, Dept Pediat, Women & Infants Ctr 9380, Birmingham, AL 35249 USA; [Carlo, Waldemar A.; Andrews, William W.] Childrens Hosp Alabama, Birmingham, AL USA; [McDonald, Scott A.; Wallace, Dennis] RTI Int, Stat & Epidemiol Unit, Res Triangle Pk, NC USA; [Fanaroff, Avroy A.; Walsh, Michele C.; Newman, Nancy S.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Vohr, Betty R.; Laptook, Abbot R.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Stoll, Barbara J.; Hale, Ellen C.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Stoll, Barbara J.; Hale, Ellen C.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Ehrenkranz, Richard A.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Das, Abhik] RTI Int, Stat & Epidemiol Unit, Rockville, MD USA; [Bell, Edward F.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Shankaran, Seetha] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Poindexter, Brenda B.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Davis, Alexis S.; Van Meurs, Krisa P.] Stanford Univ, Sch Med, Dept Pediat, Div Neonatal & Dev Med, Palo Alto, CA 94304 USA; [Davis, Alexis S.; Van Meurs, Krisa P.] Lucile Packard Childrens Hosp, Palo Alto, CA USA; [Schibler, Kurt] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA; [Kennedy, Kathleen A.] Univ Texas Med Sch, Dept Pediat, Houston, TX USA; [Sanchez, Pablo J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Goldberg, Ronald N.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Watterberg, Kristi L.] Univ New Mexico, Hlth Sci Ctr, Dept Pediat, Albuquerque, NM 87131 USA; [Faix, Roger G.] Univ Utah, Sch Med, Dept Pediat, Div Neonatol, Salt Lake City, UT USA; [Frantz, Ivan D., III] Tufts Med Ctr, Floating Hosp Children, Div Newborn Med, Dept Pediat, Boston, MA USA; [Higgins, Rosemary D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA	University of Alabama System; University of Alabama Birmingham; Research Triangle Institute; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Brown University; Women & Infants Hospital Rhode Island; Emory University; Children's Healthcare of Atlanta (CHOA); Yale University; Research Triangle Institute; University of Iowa; Wayne State University; Indiana University System; Indiana University Bloomington; Stanford University; Lucile Packard Children's Hospital (LPCH); University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas; Duke University; University of New Mexico; University of New Mexico's Health Sciences Center; Utah System of Higher Education; University of Utah; Floating Hospital For Children; Tufts Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Carlo, WA (corresponding author), Univ Alabama Birmingham, Dept Pediat, Women & Infants Ctr 9380, 1700 6th Ave S, Birmingham, AL 35249 USA.	wcarlo@peds.uab.edu	Myers, Gary J/I-4901-2013; Wallace, Dennis/AAR-7005-2021; Das, Abhik/AAF-1883-2020	Myers, Gary J/0000-0003-4317-015X; Das, Abhik/0000-0003-2722-0479; McDonald, Scott/0000-0002-0054-1099; Bell, Edward/0000-0002-5568-0889	F. Hoffman-LaRoche Ltd; Astellas; Ikaria; Ikaria Biosynexus; National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD027851, UG1HD034216, U01HD040636, U10HD027871, U10HD021364, U10HD034216, U10HD053124, U10HD021385, U10HD040689, U10HD040461, U10HD021373, U10HD036790, U10HD040492, U10HD027880, U10HD053109, U10HD027853, U10HD027856, U10HD027904, U10HD053089, UG1HD053089, U10HD053119] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD021397, U10HD034167, U10HD021415, U10HD040521, U10HD040498] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979, M01RR002172, UL1RR024139, M01RR008084, UL1RR025744, M01RR007122, M01RR006022, UL1RR024160, UL1RR025761, UL1RR025008, M01RR002635, UL1RR025764] Funding Source: NIH RePORTER	F. Hoffman-LaRoche Ltd; Astellas(Astellas Pharmaceuticals); Ikaria; Ikaria Biosynexus; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Carlo reported that he is a board member of Mednax. Dr Sanchez reported that he received study funding from F. Hoffman-LaRoche Ltd and Astellas for his work on the Collaborative Antiviral Study Group. Dr van Meurs reported that she received consulting fees, honorarium, and equipment support from Ikaria; travel, accommodations, and meeting expenses paid for by Actelion and Ikaria; and payment from legal firms for expert testimony for various lawsuits. Dr Faix reported that he serves on a data and safety monitoring board and receives funding from Ikaria Biosynexus. No other authors reported disclosures.; The National Institutes of Health and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) provided grant support for the Neonatal Research Network's Generic Database and Follow-up Studies.	Abbasi S, 2010, AM J PERINAT, V27, P61, DOI 10.1055/s-0029-1223269; [Anonymous], 2011, Obstet Gynecol, V117, P422, DOI 10.1097/AOG.0b013e31820eee00; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Bottoms SF, 1997, AM J OBSTET GYNECOL, V176, P960, DOI 10.1016/S0002-9378(97)70386-7; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; Crowther CA, 2007, NEW ENGL J MED, V357, P1179, DOI 10.1056/NEJMoa071152; Figueras-Aloy J, 2005, AM J PERINAT, V22, P441, DOI 10.1055/s-2005-916332; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; Hayes EJ, 2008, OBSTET GYNECOL, V111, P921, DOI 10.1097/AOG.0b013e318169ce2d; Hintz SR, 2011, PEDIATRICS, V127, P62, DOI 10.1542/peds.2010-1150; Hofmeyr GJ., ANTENATAL ADM CORTIC; Kollee LAA, 2009, BJOG-INT J OBSTET GY, V116, P1481, DOI 10.1111/j.1471-0528.2009.02235.x; Lee BH, 2008, PEDIATRICS, V121, P289, DOI 10.1542/peds.2007-1103; Lockwood CJ, 2007, GUIDELINES PERINATAL; Mercier CE, 2010, NEONATOLOGY, V97, P329, DOI 10.1159/000260136; MORI R, 2011, J PEDIAT, V159, pE1; Mori R, 2011, J PEDIATR-US, V159, P110, DOI 10.1016/j.jpeds.2010.12.039; Onland W, 2011, AM J PERINAT, V28, P33, DOI 10.1055/s-0030-1262509; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Stephens BE, 2010, PEDIATRICS, V125, P1152, DOI 10.1542/peds.2009-1922; Stiles AD, 2007, NEW ENGL J MED, V357, P1248, DOI 10.1056/NEJMe078161; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Vohr BR, 2005, PEDIATRICS, V116, P635, DOI 10.1542/peds.2004-2247; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204; Wapner RJ, 2007, NEW ENGL J MED, V357, P1190, DOI 10.1056/NEJMoa071453; Wood NS, 2005, ARCH DIS CHILD-FETAL, V90, P134, DOI 10.1136/adc.2004.052407; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	30	237	245	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2011	306	21					2348	2358		10.1001/jama.2011.1752	http://dx.doi.org/10.1001/jama.2011.1752			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856YH	22147379	Bronze, Green Accepted			2022-12-24	WOS:000297680300020
J	Moscrop, A				Moscrop, Andrew			MEDICINE AND THE MEDIA Scans, misogyny, and miscarriage	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2JD, England	University of Oxford	Moscrop, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2JD, England.	andrewmoscrop@yahoo.com							0	2	2	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2011	343								d7960	10.1136/bmj.d7960	http://dx.doi.org/10.1136/bmj.d7960			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874EV	22162503				2022-12-24	WOS:000298939100006
J	Prieto-Alhambra, D; Javaid, MK; Judge, A; Murray, D; Carr, A; Cooper, C; Arden, NK				Prieto-Alhambra, Daniel; Javaid, M. Kassim; Judge, Andrew; Murray, David; Carr, Andy; Cooper, Cyrus; Arden, Nigel K.			Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							CONTROLLED-TRIAL; DOUBLE-BLIND; REPLACEMENT; PROSTHESES; MIGRATION; FRACTURE; OSTEOARTHRITIS; THERAPIES; EFFICACY; DATABASE	Objectives To test whether bisphosphonate use is related to improved implant survival after total arthroplasty of the knee or hip. Design Population based retrospective cohort study. Setting Primary care data from the United Kingdom. Participants All patients undergoing primary total arthroplasty of the knee (n=18 726) or hip (n=23 269) in 1986-2006 within the United Kingdom's General Practice Research Database. We excluded patients with a history of hip fracture before surgery or rheumatoid arthritis, and individuals younger than 40 years at surgery. Intervention Bisphosphonate users were classified as patients with at least six prescriptions of bisphosphonates or at least six months of prescribed bisphosphonate treatment with more than 80% adherence before revision surgery. Outcome measures Revision arthroplasties occurring after surgery, identified by READ and OXMIS codes. Parametric survival models were used to determine effects on implant survival with propensity score adjustment to account for confounding by indication. Results Of 41 995 patients undergoing primary hip or knee arthroplasty, we identified 1912 bisphosphonate users, who had a lower rate of revision at five years than non-users (0.93% (95% confidence interval 0.52% to 1.68%) v 1.96% (1.80% to 2.14%)). Implant survival was significantly longer in bisphosphonate users than in non-users in propensity adjusted models (hazard ratio 0.54 (0.29 to 0.99); P=0.047) and had an almost twofold increase in time to revision after hip or knee arthroplasty (time ratio 1.96 (1.01 to 3.82)). Assuming 2% failure over five years, we estimated that the number to treat to avoid one revision was 107 for oral bisphosphonates. Conclusions In patients undergoing lower limb arthroplasty, bisphosphonate use was associated with an almost twofold increase in implant survival time. These findings require replication and testing in experimental studies for confirmation.	[Prieto-Alhambra, Daniel; Javaid, M. Kassim; Judge, Andrew; Murray, David; Carr, Andy; Cooper, Cyrus; Arden, Nigel K.] Univ Oxford, Oxford NIHR Musculoskeletal Biomed Res Unit, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Prieto-Alhambra, Daniel] Inst Catalat Salut, Barcelona, Spain; [Prieto-Alhambra, Daniel] IMIM, URFOA, Barcelona, Spain; [Prieto-Alhambra, Daniel] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Prieto-Alhambra, Daniel] IDIAP, Primary Care Res Inst, Barcelona, Spain; [Arden, Nigel K.] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England	University of Oxford; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona; University of Southampton	Arden, NK (corresponding author), Univ Oxford, Oxford NIHR Musculoskeletal Biomed Res Unit, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England.	nigel.arden@ndorms.ox.ac.uk		Prieto-Alhambra, Daniel/0000-0002-3950-6346; Javaid, Muhammad/0000-0001-7985-0048; Cooper, Cyrus/0000-0003-3510-0709; Judge, Andrew/0000-0003-3015-0432	National Institute for Health Research (NIHR) [RP-PG-0407-10064]; NIHR Biomedical Research Unit; Nuffield Orthopaedic Centre; University of Oxford; Institut Catala de la Salut-IDIAP Jordi Gol via the Institut Municipal d'Investigacio Medica; Merck, Sharpe and Dohme; Novartis; Southampton Rheumatology Trust; Alliance for Better Bone Health; Amgen; Merck Sharp and Dohme; Servier; Eli Lilly; GlaxoSmithKline; National Institute for Health Research [RP-PG-0407-10064] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Biomedical Research Unit(National Institute for Health Research (NIHR)); Nuffield Orthopaedic Centre; University of Oxford; Institut Catala de la Salut-IDIAP Jordi Gol via the Institut Municipal d'Investigacio Medica; Merck, Sharpe and Dohme(Merck & Company); Novartis(Novartis); Southampton Rheumatology Trust; Alliance for Better Bone Health; Amgen(Amgen); Merck Sharp and Dohme(Merck & Company); Servier(Servier); Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10064). The study also received funding from the NIHR Biomedical Research Unit into Musculoskeletal Disease, Nuffield Orthopaedic Centre, and University of Oxford; Institut Catala de la Salut-IDIAP Jordi Gol (via a grant for a research fellowship at the Institut Municipal d'Investigacio Medica); and Merck, Sharpe and Dohme, Novartis, and Southampton Rheumatology Trust (via unrestricted educational grants).; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that: DP-A, AJ, and AC have no conflicts of interest; MKJ, NKA, and CC have received honorariums, held advisory board positions (which involved receipt of fees), and received consortium research grants, respectively, from: Novartis and Alliance for Better Health and Lilly; Merck, Merck Sharp and Dohme, Roche, Novartis, Smith and Nephew, Q-MED, Nicox, Servier, GlaxoSmithKline, Schering-Plough, Pfizer, and Rottapharm; and Alliance for Better Bone Health, Amgen, Novartis, Merck Sharp and Dohme, Servier, Eli Lilly, and GlaxoSmithKline; they have no other relationships or activities that could appear to have influenced the submitted work.	Abu-Amer Y, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2170; ANTHONY PP, 1990, J BONE JOINT SURG BR, V72, P971, DOI 10.1302/0301-620X.72B6.2246300; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; Brankin E, 2006, CURR MED RES OPIN, V22, P1249, DOI 10.1185/030079906X112688; Cox C, 2007, STAT MED, V26, P4352, DOI 10.1002/sim.2836; Curtis JR, 2008, OSTEOPOROSIS INT, V19, P1613, DOI 10.1007/s00198-008-0604-4; de Steiger RN, 2010, ACTA ORTHOP, V81, P72, DOI 10.3109/17453671003667176; Felsenberg D, 2006, NAT CLIN PRACT ENDOC, V2, P662, DOI 10.1038/ncpendmet0348; Friedl G, 2009, J BONE JOINT SURG AM, V91A, P274, DOI 10.2106/JBJS.G.01193; Goodship AE, 2008, J ORTHOP RES, V26, P693, DOI 10.1002/jor.20533; Hansson U, 2009, ACTA ORTHOP, V80, P41, DOI 10.1080/17453670902804968; HARRIS WH, 1990, NEW ENGL J MED, V323, P725, DOI 10.1056/NEJM199009133231106; Hilding M, 2007, ACTA ORTHOP, V78, P795, DOI 10.1080/17453670710014572; Hilding M, 2006, ACTA ORTHOP, V77, P912, DOI 10.1080/17453670610013213; Hossain F, 2010, CLIN ORTHOP RELAT R, V468, P1221, DOI 10.1007/s11999-009-1204-0; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Lin T, 2011, OSTEOPOROS INT; Lloyd BD, 2009, J GERONTOL A-BIOL, V64, P599, DOI 10.1093/gerona/glp003; Murphy LB, 2010, OSTEOARTHR CARTILAGE, V18, P1372, DOI 10.1016/j.joca.2010.08.005; National Joint Registry, 2009, 6 NAT JOINT REG; National Joint Registry, 2010, 7 NAT JOINT REG; Normand SLT, 2005, BMJ-BRIT MED J, V330, P1021, DOI 10.1136/bmj.330.7498.1021; Prieto-Alhambra D, 2011, OSTEOPOROSIS INT, V22, P1555, DOI 10.1007/s00198-010-1368-1; Prieto-Alhambra D, 2011, ANN RHEUM DIS, V70, P134, DOI 10.1136/ard.2010.131110; Reginster JY, 2011, DRUGS, V71, P65, DOI 10.2165/11587570-000000000-00000; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Sambrook Philip, 2006, Aust Fam Physician, V35, P801; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Sibanda N, 2008, PLOS MED, V5, P1398, DOI 10.1371/journal.pmed.0050179; Tannen RL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b81; Thillemann TM, 2010, BONE, V46, P946, DOI 10.1016/j.bone.2010.01.377; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Zeng Y, 2011, ORTHOPEDICS, V34	34	70	78	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2011	343								d7222	10.1136/bmj.d7222	http://dx.doi.org/10.1136/bmj.d7222			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EU	22147909	hybrid, Green Published, Green Submitted			2022-12-24	WOS:000298939000006
J	Meisel, C; Meisel, A				Meisel, Christian; Meisel, Andreas			Suppressing Immunosuppression after Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTIONS; CELLS		[Meisel, Christian] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Meisel, Andreas] Charite, Dept Neurol, Neurocure Clin Res Ctr, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Meisel, C (corresponding author), Charite, Inst Med Immunol, D-13353 Berlin, Germany.			Meisel, Christian/0000-0003-0222-991X; Meisel, Andreas/0000-0001-7233-5342				Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; van de Beek D, 2009, ARCH NEUROL-CHICAGO, V66, P1076, DOI 10.1001/archneurol.2009.176; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301	5	71	74	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2011	365	22					2134	2136		10.1056/NEJMcibr1112454	http://dx.doi.org/10.1056/NEJMcibr1112454			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854MO	22129259				2022-12-24	WOS:000297499000016
J	Diringer, E				Diringer, Elliot			Letting go of Kyoto	NATURE			English	Editorial Material									[Diringer, Elliot] Ctr Climate & Energy Solut, Arlington, VA USA		Diringer, E (corresponding author), Ctr Climate & Energy Solut, Arlington, VA USA.	diringere@c2es.org							0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					291	292		10.1038/479291a	http://dx.doi.org/10.1038/479291a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	848OA	22094672	Bronze			2022-12-24	WOS:000297059700014
J	Chevrier, N; Mertins, P; Artyomov, MN; Shalek, AK; Iannacone, M; Ciaccio, MF; Gat-Viks, I; Tonti, E; DeGrace, MM; Clauser, KR; Garber, M; Eisenhaure, TM; Yosef, N; Robinson, J; Sutton, A; Andersen, MS; Root, DE; von Andrian, U; Jones, RB; Park, H; Carr, SA; Regev, A; Amit, I; Hacohen, N				Chevrier, Nicolas; Mertins, Philipp; Artyomov, Maxim N.; Shalek, Alex K.; Iannacone, Matteo; Ciaccio, Mark F.; Gat-Viks, Irit; Tonti, Elena; DeGrace, Marciela M.; Clauser, Karl R.; Garber, Manuel; Eisenhaure, Thomas M.; Yosef, Nir; Robinson, Jacob; Sutton, Amy; Andersen, Mette S.; Root, David E.; von Andrian, Ulrich; Jones, Richard B.; Park, Hongkun; Carr, Steven A.; Regev, Aviv; Amit, Ido; Hacohen, Nir			Systematic Discovery of TLR Signaling Components Delineates Viral-Sensing Circuits	CELL			English	Article							POLO-LIKE KINASES; BETA GENE-EXPRESSION; TOLL-LIKE RECEPTORS; INTERFERON-BETA; AUTOIMMUNE-DISEASES; I INTERFERON; CELLS; INHIBITORS; RESPONSES; PHOSPHORYLATION	Deciphering the signaling networks that underlie normal and disease processes remains a major challenge. Here, we report the discovery of signaling components involved in the Toll-like receptor (TLR) response of immune dendritic cells (DCs), including a previously unkown pathway shared across mammalian antiviral responses. By combining transcriptional profiling, genetic and small-molecule perturbations, and phosphoproteomics, we uncover 35 signaling regulators, including 16 known regulators, involved in TLR signaling. In particular, we find that Polo-like kinases (Plk) 2 and 4 are essential components of antiviral pathways in vitro and in vivo and activate a signaling branch involving a dozen proteins, among which is Tnfaip2, a gene associated with autoimmune diseases but whose role was unknown. Our study illustrates the power of combining systematic measurements and perturbations to elucidate complex signaling circuits and discover potential therapeutic targets.	[Chevrier, Nicolas; Mertins, Philipp; Artyomov, Maxim N.; Gat-Viks, Irit; DeGrace, Marciela M.; Clauser, Karl R.; Garber, Manuel; Eisenhaure, Thomas M.; Yosef, Nir; Root, David E.; Carr, Steven A.; Regev, Aviv; Amit, Ido; Hacohen, Nir] Broad Inst MIT& Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Chevrier, Nicolas; DeGrace, Marciela M.; Eisenhaure, Thomas M.; Amit, Ido; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Chevrier, Nicolas; DeGrace, Marciela M.; Amit, Ido; Hacohen, Nir] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Chevrier, Nicolas] Harvard Univ, Sch Med, Div Med Sci, Grad Program Immunol, Boston, MA 02115 USA; [Iannacone, Matteo; Tonti, Elena; von Andrian, Ulrich] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Iannacone, Matteo; Tonti, Elena; von Andrian, Ulrich] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Artyomov, Maxim N.; Gat-Viks, Irit; Yosef, Nir; Regev, Aviv; Amit, Ido] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02142 USA; [Shalek, Alex K.; Robinson, Jacob; Sutton, Amy; Andersen, Mette S.; Park, Hongkun] Harvard Univ, Dept Chem, Cambridge, MA 02138 USA; [Shalek, Alex K.; Robinson, Jacob; Sutton, Amy; Andersen, Mette S.; Park, Hongkun] Harvard Univ, Dept Chem Biol, Cambridge, MA 02138 USA; [Ciaccio, Mark F.; Jones, Richard B.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Shalek, Alex K.; Robinson, Jacob; Sutton, Amy; Andersen, Mette S.; Park, Hongkun] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Ciaccio, Mark F.; Jones, Richard B.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Iannacone, Matteo; Tonti, Elena] Ist Sci San Raffaele, Div Immunol Infect Dis & Transplantat, I-20132 Milan, Italy	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; University of Chicago; Harvard University; University of Chicago; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Amit, I (corresponding author), Broad Inst MIT& Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	ido.amit@weizmann.ac.il; nhacohen@partners.org	Park, Hongkun/R-9842-2019; von Andrian, Ulrich H/A-5775-2008; Iannacone, Matteo/I-8507-2018; Carr, Steven A./AAH-8366-2019; Shalek, Alex/Y-2434-2019	Park, Hongkun/0000-0001-9576-8829; Iannacone, Matteo/0000-0002-9370-2671; Shalek, Alex/0000-0001-5670-8778; Tonti, Elena/0000-0001-5002-7613; Clauser, Karl/0000-0002-1052-9456	NIH [U54 AI057159, DP2 OD002230, P50 HG006193]; Boehringer Ingelheim Fonds; Human Frontier Science Program Organization; American Physicians Fellowship for Medicine in Israel; Burroughs Wellcome Fund; Sloan Foundation; HHMI; NIH Chicago Center for Systems Biology [P50 GM081892-03]; American Cancer Society Illinois Division; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026688] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002230] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Human Frontier Science Program Organization(Human Frontier Science Program); American Physicians Fellowship for Medicine in Israel; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Sloan Foundation(Alfred P. Sloan Foundation); HHMI(Howard Hughes Medical Institute); NIH Chicago Center for Systems Biology; American Cancer Society Illinois Division(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the members of the Hacohen and Regev laboratories, O. Takeuchi, B. Beutler, D. Mathis, P. Anderson, L. Glimcher, and D. Bartel for valuable discussions and comments; L. Gaffney and L. Solomon for assistance with figures and artwork; and S. Gupta and the Broad Genetic Analysis Platform for microarray processing. This work was supported by NIH grant U54 AI057159, the NIH New Innovator Award DP2 OD002230 (N.H.), and NIH P50 HG006193 (A. R., N.H.); a Ph.D fellowship from the Boehringer Ingelheim Fonds (N.C.); the Human Frontier Science Program Organization and a Claire and Emanuel G. Rosenblatt Award from the American Physicians Fellowship for Medicine in Israel (I. A.); NIH Pioneer Awards (A. R., H. P.); and a Career Award at the Scientific Interface from the Burroughs Wellcome Fund, the Sloan Foundation, and HHMI (A. R.). A. R. is an investigator of the Merkin Foundation for Stem Cell Research at the Broad Institute. This work was partially supported by a pilot award from the NIH Chicago Center for Systems Biology P50 GM081892-03 to R.B.J. and an award from the American Cancer Society Illinois Division to R.B.J.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang J, 2010, EMBO J, V29, P2395, DOI 10.1038/emboj.2010.118; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Cizmecioglu O, 2008, CELL CYCLE, V7, P3548, DOI 10.4161/cc.7.22.7071; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fraser IDC, 2009, NAT IMMUNOL, V10, P327, DOI 10.1038/ni.1711; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hrincius ER, 2010, CELL MICROBIOL, V12, P831, DOI 10.1111/j.1462-5822.2010.01436.x; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; Kuan AP, 1999, IMMUNOGENETICS, V49, P79, DOI 10.1007/s002510050466; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; Mross K, 2008, J CLIN ONCOL, V26, P5511, DOI 10.1200/JCO.2008.16.1547; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Seeburg DP, 2005, ONCOGENE, V24, P292, DOI 10.1038/sj.onc.1208277; Shalek AK, 2010, P NATL ACAD SCI USA, V107, P1870, DOI 10.1073/pnas.0909350107; Sharma K, 2010, J PROTEOME RES, V9, P2539, DOI 10.1021/pr901192p; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Vitour D, 2009, J BIOL CHEM, V284, P21797, DOI 10.1074/jbc.M109.018275; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Weintz G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.29; Xiao NM, 2009, J IMMUNOL, V183, P7975, DOI 10.4049/jimmunol.0902718; Ye JQ, 2011, NAT CHEM BIOL, V7, P25, DOI 10.1038/NCHEMBIO.476; Zhang WQ, 2010, MOL BIOL CELL, V21, P2500, DOI 10.1091/mbc.E09-08-0715	45	140	149	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 11	2011	147	4					853	867		10.1016/j.cell.2011.10.022	http://dx.doi.org/10.1016/j.cell.2011.10.022			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22078882	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000296902300018
J	Deary, IJ; Yang, J; Davies, G; Harris, SE; Tenesa, A; Liewald, D; Luciano, M; Lopez, LM; Gow, AJ; Corley, J; Redmond, P; Fox, HC; Rowe, SJ; Haggarty, P; McNeill, G; Goddard, ME; Porteous, DJ; Whalley, LJ; Starr, JM; Visscher, PM				Deary, Ian J.; Yang, Jian; Davies, Gail; Harris, Sarah E.; Tenesa, Albert; Liewald, David; Luciano, Michelle; Lopez, Lorna M.; Gow, Alan J.; Corley, Janie; Redmond, Paul; Fox, Helen C.; Rowe, Suzanne J.; Haggarty, Paul; McNeill, Geraldine; Goddard, Michael E.; Porteous, David J.; Whalley, Lawrence J.; Starr, John M.; Visscher, Peter M.			Genetic contributions to stability and change in intelligence from childhood to old age	NATURE			English	Article							COMMON SNPS EXPLAIN; LATER LIFE; COGNITIVE DECLINE; LARGE PROPORTION; HUMAN HEIGHT; HERITABILITY; ABILITIES; VARIANCE; MODELS	Understanding the determinants of healthy mental ageing is a priority for society today(1,2). So far, we know that intelligence differences show high stability from childhood to old age(3,4) and there are estimates of the genetic contribution to intelligence at different ages(5,6). However, attempts to discover whether genetic causes contribute to differences in cognitive ageing have been relatively uninformative(7-10). Here we provide an estimate of the genetic and environmental contributions to stability and change in intelligence across most of the human lifetime. We used genome-wide single nucleotide polymorphism (SNP) data from 1,940 unrelated individuals whose intelligence was measured in childhood (age 11 years) and again in old age (age 65, 70 or 79 years)(11,12). We use a statistical method that allows genetic (co)variance to be estimated from SNP data on unrelated individuals(13-17). We estimate that causal genetic variants in linkage disequilibrium with common SNPs account for 0.24 of the variation in cognitive ability change from childhood to old age. Using bivariate analysis, we estimate a genetic correlation between intelligence at age 11 years and in old age of 0.62. These estimates, derived from rarely available data on lifetime cognitive measures, warrant the search for genetic causes of cognitive stability and change.	[Deary, Ian J.; Davies, Gail; Liewald, David; Luciano, Michelle; Lopez, Lorna M.; Gow, Alan J.; Corley, Janie; Redmond, Paul] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Deary, Ian J.; Davies, Gail; Harris, Sarah E.; Liewald, David; Luciano, Michelle; Lopez, Lorna M.; Gow, Alan J.; Porteous, David J.; Starr, John M.; Visscher, Peter M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Yang, Jian; Visscher, Peter M.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Harris, Sarah E.; Tenesa, Albert; Porteous, David J.] Western Gen Hosp, Inst Genet & Mol Med, Med Genet Sect, Mol Med Ctr, Edinburgh EH4 2XU, Midlothian, Scotland; [Tenesa, Albert; Rowe, Suzanne J.] Univ Edinburgh, Sch Vet Studies, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland; [McNeill, Geraldine; Whalley, Lawrence J.] Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland; [Redmond, Paul] Univ Aberdeen, Rowett Inst Nutr & Hlth, Nutr & Epigenet Grp, Aberdeen AB21 9SB, Scotland; [Goddard, Michael E.] Australia & Victorian Dept Primary Ind, Bundoora, Vic 3083, Australia; [Goddard, Michael E.] Univ Melbourne, Dept Food & Agr Syst, Parkville, Vic 3011, Australia; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; [Visscher, Peter M.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	University of Edinburgh; University of Edinburgh; QIMR Berghofer Medical Research Institute; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Aberdeen; University of Aberdeen; University of Melbourne; University of Edinburgh; University of Queensland; University of Queensland	Deary, IJ (corresponding author), Univ Edinburgh, Dept Psychol, 7 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.	i.deary@ed.ac.uk; peter.visscher@uq.edu.au	Porteous, David J/C-7289-2013; Rowe, Suzanne/HGF-1418-2022; Gow, Alan J/A-6070-2009; Yang, Jian/A-5852-2010; Haggarty, Paul/C-1696-2009; Porteous, David/AAA-3446-2021; whalley, lawrence j/E-9019-2011; Luciano, Michelle/F-7277-2010; Lopez, Lorna/AAR-4912-2020; Lopez, Lorna M/F-7265-2010; Deary, Ian J/C-6297-2009; Visscher, Peter/ABB-6151-2020	Porteous, David J/0000-0003-1249-6106; Rowe, Suzanne/0000-0001-8727-5960; Gow, Alan J/0000-0002-3320-4531; Yang, Jian/0000-0003-2001-2474; Porteous, David/0000-0003-1249-6106; Luciano, Michelle/0000-0003-0935-7682; Lopez, Lorna/0000-0002-0241-9783; Deary, Ian J/0000-0002-1733-263X; Visscher, Peter/0000-0002-2143-8760; Tenesa, Albert/0000-0003-4884-4475; Goddard, Michael/0000-0001-9917-7946; McNeill, Geraldine/0000-0003-0373-650X	Australian Research Council; National Health and Medical Research Council; BBSRC; EPSRC; ESRC; MRC; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0700704] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Medical Research Council [G0700704, G0700704B] Funding Source: researchfish; Chief Scientist Office [CZB/4/505, ETM/55] Funding Source: researchfish	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	We thank the cohort participants who contributed to these studies. Genotyping of the ABC1936, LBC1921 and LBC1936 cohorts and the analyses conducted here were supported by the UK's Biotechnology and Biological Sciences Research Council (BBSRC). Phenotype collection in the LBC1921 was supported by the BBSRC, The Royal Society and The Chief Scientist Office of the Scottish Government. Phenotype collection in the LBC1936 was supported by Research Into Ageing (continues as part of Age UK's The Disconnected Mind project). Phenotype collection in the ABC1936 was supported by the BBSRC, the Wellcome Trust and the Alzheimer's Research Trust. The Australian-based researchers acknowledge support from the Australian Research Council and the National Health and Medical Research Council. M. L. is a Royal Society of Edinburgh/Lloyds TSB Foundation for Scotland Personal Research Fellow. The work was undertaken in The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698), for which funding from the BBSRC, EPSRC, ESRC and MRC is gratefully acknowledged.	Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8; Deary IJ, 2002, NATURE, V418, P932, DOI 10.1038/418932a; Finkel D, 2009, DEV PSYCHOL, V45, P820, DOI 10.1037/a0015332; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Gow AJ, 2011, PSYCHOL AGING, V26, P232, DOI 10.1037/a0021072; Harris SE, 2011, TRENDS COGN SCI, V15, P388, DOI 10.1016/j.tics.2011.07.004; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lee T, 2010, BRAIN RES REV, V64, P1, DOI 10.1016/j.brainresrev.2010.02.001; Mcgue M, 2007, TWIN RES HUM GENET, V10, P255, DOI 10.1375/twin.10.2.255; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; Reynolds CA, 2005, DEV PSYCHOL, V41, P3, DOI 10.1037/0012-1649.41.1.3; Tucker-Drob EM, 2011, NEUROPSYCHOLOGY, V25, P368, DOI 10.1037/a0022348; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	27	173	175	3	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 9	2012	482	7384					212	215		10.1038/nature10781	http://dx.doi.org/10.1038/nature10781			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	888HI	22258510	Green Accepted			2022-12-24	WOS:000299994100037
J	Artaxo, P				Artaxo, Paulo			Break down boundaries in climate research	NATURE			English	Editorial Material									Univ Sao Paulo, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo	Artaxo, P (corresponding author), Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.	artaxo@if.usp.br	Artaxo, Paulo/E-8874-2010	Artaxo, Paulo/0000-0001-7754-3036					0	10	11	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 19	2012	481	7381					239	239		10.1038/481239a	http://dx.doi.org/10.1038/481239a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	877VK	22258570				2022-12-24	WOS:000299210600004
J	Alibhai, SMH; Yun, LS; Cheung, AM; Paszat, L				Alibhai, Shabbir M. H.; Yun, Lingsong; Cheung, Angela M.; Paszat, Lawrence			Screening for Osteoporosis in Men Receiving Androgen Deprivation Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							PROSTATE-CANCER		[Alibhai, Shabbir M. H.] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Cheung, Angela M.] Univ Hlth Network, Osteoporosis Program, Toronto, ON, Canada; [Yun, Lingsong; Paszat, Lawrence] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Alibhai, SMH (corresponding author), Univ Hlth Network, Dept Med, Toronto, ON, Canada.	shabbir.alibhai@uhn.on.ca		Cheung, Angela M./0000-0001-8332-0744; Alibhai, Shabbir/0000-0001-7815-6046	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Alibhai SMH, 2009, J CLIN ONCOL, V27, P3452, DOI 10.1200/JCO.2008.20.0923; Duncan Graeme G, 2006, Can J Urol, V13, P2962; Ito K, 2010, ANN INTERN MED, V152, P621, DOI 10.7326/0003-4819-152-10-201005180-00002; Shahinian VB, 2005, CANCER-AM CANCER SOC, V103, P1615, DOI 10.1002/cncr.20955; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Yee EFT, 2007, J GEN INTERN MED, V22, P1305, DOI 10.1007/s11606-007-0291-4	6	38	38	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2012	307	3					255	256		10.1001/jama.2011.2022	http://dx.doi.org/10.1001/jama.2011.2022			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877EY	22253389				2022-12-24	WOS:000299161200017
J	Mitchell, SL; Black, BS; Ersek, M; Hanson, LC; Miller, SC; Sachs, GA; Teno, JM; Morrison, RS				Mitchell, Susan L.; Black, Betty S.; Ersek, Mary; Hanson, Laura C.; Miller, Susan C.; Sachs, Greg A.; Teno, Joan M.; Morrison, R. Sean			Advanced Dementia: State of the Art and Priorities for the Next Decade	ANNALS OF INTERNAL MEDICINE			English	Article							NURSING-HOME RESIDENTS; END-STAGE DEMENTIA; ADVANCED COGNITIVE IMPAIRMENT; RANDOMIZED CONTROLLED-TRIAL; ADVANCED ALZHEIMERS-DISEASE; COMMUNITY-DWELLING PERSONS; FEEDING-TUBE INSERTION; LIFE CARE; HEALTH-CARE; ANTIBIOTIC-TREATMENT	Dementia is a leading cause of death in the United States. This article outlines the current understanding of advanced dementia and identifies research priorities for the next decade. Research over the past 25 years has largely focused on describing the experience of patients with advanced dementia. This work has delineated abundant opportunities for improvement, including greater recognition of advanced dementia as a terminal illness, better treatment of distressing symptoms, increased access to hospice and palliative care services, and less use of costly and aggressive treatments that may be of limited clinical benefit. Addressing those opportunities must be the overarching objective for the field in the coming decade. Priority areas include designing and testing interventions that promote high-quality, goal-directed care; health policy research to identify strategies that incentivize cost-effective and evidencebased care; implementation studies of promising interventions and policies; and further development of disease-specific outcome measures. There is great need and opportunity to improve outcomes, contain expenditures, reduce disparities, and better coordinate care for the millions of persons in the United States who have advanced dementia.	[Mitchell, Susan L.] Inst Aging Res, Boston, MA 02131 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; Berman Inst Bioeth, Baltimore, MD 21205 USA; Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; Univ N Carolina, Ctr Aging & Hlth, Chapel Hill, NC 27599 USA; Brown Univ, Program Publ Hlth, Providence, RI 02912 USA; Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; Indiana Univ Sch Med, Indianapolis, IN 46202 USA; Indiana Univ Aging Res, Regenstrief Inst, Indianapolis, IN 46202 USA; Mt Sinai Sch Med, New York, NY 10029 USA	Johns Hopkins University; University of Pennsylvania; University of North Carolina; University of North Carolina Chapel Hill; Brown University; Brown University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Icahn School of Medicine at Mount Sinai	Mitchell, SL (corresponding author), Inst Aging Res, 1200 Ctr St, Boston, MA 02131 USA.		Miller, Susan/J-5450-2014; MUÑOZ, ROSA ANA/H-3964-2018	Miller, Susan/0000-0003-2008-6385; MUÑOZ, ROSA ANA/0000-0002-7504-2163; Hanson, Laura/0000-0001-5120-6058; Ersek, Mary/0000-0002-0520-311X	National Palliative Care Research Center; National Institute on Aging [K24AG033640, K24AG022345]; National Institutes of Health; National Institutes of Health, National Institute on Aging; DEMeasure; New York Department of Health, National Institutes of Health; Alzheimer's Association; Agency for Healthcare Research and Quality; Retirement Research Foundation; NATIONAL INSTITUTE ON AGING [K24AG033640, K24AG022345] Funding Source: NIH RePORTER	National Palliative Care Research Center; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DEMeasure; New York Department of Health, National Institutes of Health; Alzheimer's Association(Alzheimer's Association); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Retirement Research Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Palliative Care Research Center and grants K24AG033640 (Dr. Mitchell) and K24AG022345 (Dr. Morrison) from the National Institute on Aging.; Dr. Mitchell: Grant (money to institution): National Institutes of Health. Dr. Black: Employment: Johns Hopkins University; Grant (money to institution): National Institutes of Health, National Institute on Aging; Royalties: DEMeasure. Dr. Ersek: Grant (money to institution): National Institutes of Health; Support to travel to meetings for the study or other purposes: National Palliative Care Research Center. Grants/grants pending: New York Department of Health, National Institutes of Health. Dr. Miller: Support for travel to meetings for the study or other purposes: National Palliative Care Research Center; Support for travel to meetings for the study or other purposes (money to institution): National Palliative Care Research Center; Grants/grants pending: Alzheimer's Association; Grants/grants pending (money to institution): Alzheimer's Association. Dr. Sachs: Support for travel to meetings for the study or other purposes (money to institution): National Palliative Care Research Center; Consultancy: CVS Caremark; Grants/grants pending (money to institution): National Institutes of Health, Agency for Healthcare Research and Quality, Alzheimer's Association, National Palliative Care Research Center, Retirement Research Foundation. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum~M11-2121.	Ahronheim JC, 1996, ARCH INTERN MED, V156, P2094, DOI 10.1001/archinte.156.18.2094; Ahronheim JC, 2001, J AM GERIATR SOC, V49, P148, DOI 10.1046/j.1532-5415.2001.49035.x; Alzheimer's Associatio, 2011, 2001 ALZH DIS FACTS; Aminoff Bechor Zvi, 2005, Am J Hosp Palliat Care, V22, P344, DOI 10.1177/104990910502200507; Aminoff BZ, 2006, AGE AGEING, V35, P597, DOI 10.1093/ageing/afl067; [Anonymous], 1996, Hosp J, V11, P47; Black BS, 2006, ALZ DIS ASSOC DIS, V20, P283, DOI 10.1097/01.wad.0000213854.04861.cc; Chen JH, 2006, J AM GERIATR SOC, V54, P290, DOI 10.1111/j.1532-5415.2005.00524.x; D'Agata E, 2008, ARCH INTERN MED, V168, P357, DOI 10.1001/archinternmed.2007.104; Di Giulio P, 2008, J PALLIAT MED, V11, P1023, DOI 10.1089/jpm.2008.0020; Engel SE, 2006, J AM GERIATR SOC, V54, P1567, DOI 10.1111/j.1532-5415.2006.00900.x; FABISZEWSKI KJ, 1990, JAMA-J AM MED ASSOC, V263, P3168, DOI 10.1001/jama.263.23.3168; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; FRIED TR, 1995, J GEN INTERN MED, V10, P246, DOI 10.1007/BF02599879; Gessert CE, 2000, J AM GERIATR SOC, V48, P1593, DOI 10.1111/j.1532-5415.2000.tb03869.x; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; Givens JL, 2010, ARCH INTERN MED, V170, P1102, DOI 10.1001/archinternmed.2010.181; Givens JL, 2009, J AM GERIATR SOC, V57, P1149, DOI 10.1111/j.1532-5415.2009.02304.x; Goldfeld KS, 2011, ARCH INTERN MED, V171, P824, DOI 10.1001/archinternmed.2010.478; Gozalo P, 2011, NEW ENGL J MED, V365, P1212, DOI 10.1056/NEJMsa1100347; HANRAHAN P, 1995, J AM GERIATR SOC, V43, P56, DOI 10.1111/j.1532-5415.1995.tb06243.x; Hanson LC, 2011, J AM GERIATR SOC, V59, P2009, DOI 10.1111/j.1532-5415.2011.03629.x; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Kiely DK, 2006, ALZ DIS ASSOC DIS, V20, P176, DOI 10.1097/00002093-200607000-00009; Kiely DK, 2010, J AM GERIATR SOC, V58, P2284, DOI 10.1111/j.1532-5415.2010.03185.x; Kiely DK, 2001, J AM GERIATR SOC, V49, P1346, DOI 10.1046/j.1532-5415.2001.49263.x; Loeb M, 2005, BRIT MED J, V331, P669, DOI 10.1136/bmj.38602.586343.55; Loeb M, 2006, JAMA-J AM MED ASSOC, V295, P2503, DOI 10.1001/jama.295.21.2503; Lopez RP, 2010, ARCH INTERN MED, V170, P83, DOI 10.1001/archinternmed.2009.467; LUCHINS DJ, 1993, J AM GERIATR SOC, V41, P25; Marsh GW, 2000, APPL NURS RES, V13, P187, DOI 10.1053/apnr.2000.7654; McCarthy EP, 2000, J AM GERIATR SOC, V48, pS110, DOI 10.1111/j.1532-5415.2000.tb03120.x; McCarthy M, 1997, INT J GERIATR PSYCH, V12, P404; Mehr DR, 2003, GERONTOLOGIST, V43, P85, DOI 10.1093/geront/43.suppl_2.85; Meier DE, 2001, ARCH INTERN MED, V161, P594, DOI 10.1001/archinte.161.4.594; Miller SC, 2004, J AM GERIATR SOC, V52, P1284, DOI 10.1111/j.1532-5415.2004.52357.x; Miller SC, 2001, AM J MED, V111, P38, DOI 10.1016/S0002-9343(01)00747-1; Miller SC, 2002, J AM GERIATR SOC, V50, P507, DOI 10.1046/j.1532-5415.2002.50118.x; Mitchell SL, 1997, ARCH INTERN MED, V157, P327, DOI 10.1001/archinte.157.3.327; Mitchell SL, 2004, ARCH INTERN MED, V164, P321, DOI 10.1001/archinte.164.3.321; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Mitchell SL, 2003, JAMA-J AM MED ASSOC, V290, P73, DOI 10.1001/jama.290.1.73; Mitchell SL, 2003, J AM GERIATR SOC, V51, P75, DOI 10.1034/j.1601-5215.2002.51021.x; Mitchell SL, 2004, JAMA-J AM MED ASSOC, V291, P2734, DOI 10.1001/jama.291.22.2734; Mitchell SL, 2007, JAMA-J AM MED ASSOC, V298, P2527, DOI 10.1001/jama.298.17.jrr70001; Mitchell SL, 2007, J AM GERIATR SOC, V55, P432, DOI 10.1111/j.1532-5415.2007.01086.x; Mitchell Susan L, 2003, J Am Med Dir Assoc, V4, P27, DOI 10.1097/00130535-200301000-00005; Mitchell SL, 2010, JAMA-J AM MED ASSOC, V304, P1929, DOI 10.1001/jama.2010.1572; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Mitchell Susan L, 2004, J Palliat Med, V7, P808, DOI 10.1089/jpm.2004.7.808; Monteleoni C, 2004, BMJ-BRIT MED J, V329, P491, DOI 10.1136/bmj.329.7464.491; Morrison RS, 2000, JAMA-J AM MED ASSOC, V284, P47, DOI 10.1001/jama.284.1.47; Morrison RS, 1998, J PAIN SYMPTOM MANAG, V15, P91, DOI 10.1016/S0885-3924(97)00261-3; National Center for Health Statistics, 2011, NAT CTR HLTH STAT NA; National Hospice and Palliative Care Organization, 2010, FACTS FIG; Ouslander JG, 2011, NEW ENGL J MED, V365, P1165, DOI 10.1056/NEJMp1105449; Pop-Vicas A, 2008, J AM GERIATR SOC, V56, P1276, DOI 10.1111/j.1532-5415.2008.01787.x; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Sachs GA, 2004, J GEN INTERN MED, V19, P1057, DOI 10.1111/j.1525-1497.2004.30329.x; Schonwetter Ronald S, 2003, Am J Hosp Palliat Care, V20, P105, DOI 10.1177/104990910302000208; Shega JW, 2008, J PAIN SYMPTOM MANAG, V35, P499, DOI 10.1016/j.jpainsymman.2007.06.011; Shega JW, 2006, J AM GERIATR SOC, V54, P1892, DOI 10.1111/j.1532-5415.2006.00986.x; Shega JW, 2004, J PAIN SYMPTOM MANAG, V28, P585, DOI 10.1016/j.jpainsymman.2004.04.012; Teno JM, 2002, JAMA-J AM MED ASSOC, V287, P3211, DOI 10.1001/jama.287.24.3211; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM, 2011, J AM GERIATR SOC, V59, P1531, DOI 10.1111/j.1532-5415.2011.03505.x; Teno JM, 2011, J AM GERIATR SOC, V59, P881, DOI 10.1111/j.1532-5415.2011.03385.x; Teno JM, 2009, J PALLIAT MED, V12, P359, DOI 10.1089/jpm.2008.0168; van der Steen JT, 2007, J AM MED DIR ASSOC, V8, P464, DOI 10.1016/j.jamda.2007.05.004; van der Steen JT, 2006, J CLIN EPIDEMIOL, V59, P970, DOI 10.1016/j.jclinepi.2005.12.005; van der Steen JT, 2010, J ALZHEIMERS DIS, V22, P37, DOI 10.3233/JAD-2010-100744; van der Steen JT, 2004, J AM GERIATR SOC, V52, P691, DOI 10.1111/j.1532-5415.2004.52204.x; van der Steen JT, 2002, ARCH INTERN MED, V162, P1753, DOI 10.1001/archinte.162.15.1753; Volandes AE, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2159; VOLICER BJ, 1993, J AM GERIATR SOC, V41, P535, DOI 10.1111/j.1532-5415.1993.tb01891.x; VOLICER L, 1986, JAMA-J AM MED ASSOC, V256, P2210, DOI 10.1001/jama.256.16.2210; Volicer L, 2001, ALZ DIS ASSOC DIS, V15, P194, DOI 10.1097/00002093-200110000-00005; VOLICER L, 1994, J GERONTOL, V49, pM223, DOI 10.1093/geronj/49.5.M223; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1097/00130535-200301000-00002; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Zhu CW, 2006, NEUROLOGY, V66, P1021, DOI 10.1212/01.wnl.0000204189.18698.c7	82	106	108	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2012	156	1	1				45	U95		10.7326/0003-4819-156-1-201201030-00008	http://dx.doi.org/10.7326/0003-4819-156-1-201201030-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	872VK	22213494	Green Accepted, Green Published			2022-12-24	WOS:000298837600007
J	Hunter, DN				Hunter, D. N.			PERSONAL VIEW Follow surgical checklists and take time out, especially in a crisis	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Brompton Hosp, London SW3 6NP, England	Royal Brompton Hospital	Hunter, DN (corresponding author), Royal Brompton Hosp, London SW3 6NP, England.	d.hunter@rbht.nhs.uk						2008, BRIT MED J, V337, DOI DOI 10.1136/BMJ.A2370	1	9	10	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 30	2011	343								d8194	10.1136/bmj.d8194	http://dx.doi.org/10.1136/bmj.d8194			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874TQ	22209820				2022-12-24	WOS:000298981400002
J	DiPersio, JF				DiPersio, John F.			Diabetic Stem-Cell "Mobilopathy"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington Univ, Sch Med, Div Oncol, St Louis, MO 63130 USA	Washington University (WUSTL)	DiPersio, JF (corresponding author), Washington Univ, Sch Med, Div Oncol, St Louis, MO 63130 USA.							DiPersio JF, 2009, J CLIN ONCOL, V27, P4767, DOI 10.1200/JCO.2008.20.7209; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Pusic I, 2008, BIOL BLOOD MARROW TR, V14, P1045, DOI 10.1016/j.bbmt.2008.07.004; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016	5	69	71	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2011	365	26					2536	2538		10.1056/NEJMcibr1112347	http://dx.doi.org/10.1056/NEJMcibr1112347			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868SD	22204729	Green Published			2022-12-24	WOS:000298544600016
J	Kim, Y; Sharov, AA; McDole, K; Cheng, M; Hao, H; Fan, CM; Gaiano, N; Ko, MSH; Zheng, Y				Kim, Youngjo; Sharov, Alexei A.; McDole, Katie; Cheng, Melody; Hao, Haiping; Fan, Chen-Ming; Gaiano, Nicholas; Ko, Minoru S. H.; Zheng, Yixian			Mouse B-Type Lamins Are Required for Proper Organogenesis But Not by Embryonic Stem Cells	SCIENCE			English	Article							NUCLEAR LAMINA; DIFFERENTIATION; ORGANIZATION; EXPRESSION; GENE; PROLIFERATION; PERIPHERY; DEFECTS	B-type lamins, the major components of the nuclear lamina, are believed to be essential for cell proliferation and survival. We found that mouse embryonic stem cells (ESCs) do not need any lamins for self-renewal and pluripotency. Although genome-wide lamin-B binding profiles correlate with reduced gene expression, such binding is not directly required for gene silencing in ESCs or trophectoderm cells. However, B-type lamins are required for proper organogenesis. Defects in spindle orientation in neural progenitor cells and migration of neurons probably cause brain disorganizations found in lamin-B null mice. Thus, our studies not only disprove several prevailing views of lamin-Bs but also establish a foundation for redefining the function of the nuclear lamina in the context of tissue building and homeostasis.	[Sharov, Alexei A.; Ko, Minoru S. H.] NIA, Dev Genom & Aging Sect, Genet Lab, NIH, Baltimore, MD 21224 USA; [Kim, Youngjo; Fan, Chen-Ming; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Kim, Youngjo; McDole, Katie; Zheng, Yixian] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [McDole, Katie; Fan, Chen-Ming; Zheng, Yixian] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Cheng, Melody; Gaiano, Nicholas] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Hao, Haiping] Johns Hopkins Univ, Sch Med, Microarray Core Facil, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ko, MSH (corresponding author), NIA, Dev Genom & Aging Sect, Genet Lab, NIH, Baltimore, MD 21224 USA.	kom@grc.nia.nih.gov; zheng@ciwemb.edu	Ko, Minoru S. H./B-7969-2009	Ko, Minoru S. H./0000-0002-3530-3015; Hao, Haiping/0000-0002-8826-1568	National Institute on Aging; Howard Hughes Medical Institute;  [R01 GM056312]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000662, ZIAAG000655] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B. Van Steensel and H. Niwa for reagents, M. Sepanski for electron microscopy, O. Martin for technical support, C. Liu (National Heart, Lung, and Blood Institute) for mouse targeting, and the members of the Zheng lab for critical comments. Supported in part by the Intramural Research Program of National Institute on Aging (A. A. S. and M. S. H. K.) and R01 GM056312 (Y.Z.). Y.Z. is supported by the Howard Hughes Medical Institute. A patent (7510850) regarding the use of Xenopus egg extracts to isolate and study the lamin-B spindle matrix is held by The Carnegie Institution for Science.	Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Coffinier C, 2011, MOL BIOL CELL, V22, P4683, DOI 10.1091/mbc.E11-06-0504; Coffinier C, 2010, P NATL ACAD SCI USA, V107, P5076, DOI 10.1073/pnas.0908790107; Cohen TV, 2008, CURR TOP DEV BIOL, V84, P351, DOI 10.1016/S0070-2153(08)00607-8; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Goodman B, 2010, J BIOL CHEM, V285, P35238, DOI 10.1074/jbc.M110.140749; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Ma L, 2009, NAT CELL BIOL, V11, P246, DOI 10.1038/ncb1832; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Osouda S, 2005, DEV BIOL, V284, P219, DOI 10.1016/j.ydbio.2005.05.022; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; ROBER RA, 1989, DEVELOPMENT, V105, P365; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Yamada M, 2010, CELL ADHES MIGR, V4, P180, DOI 10.4161/cam.4.2.10715; Yang SH, 2011, HUM MOL GENET, V20, P3537, DOI 10.1093/hmg/ddr266; Zheng YX, 2010, NAT REV MOL CELL BIO, V11, P529, DOI 10.1038/nrm2919	26	178	186	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1706	1710		10.1126/science.1211222	http://dx.doi.org/10.1126/science.1211222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22116031	Green Accepted			2022-12-24	WOS:000298344000068
J	Gravitz, L				Gravitz, Lauren			DIAGNOSTICS The early bird	NATURE			English	Editorial Material																			0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S36	S37		10.1038/480S36a	http://dx.doi.org/10.1038/480S36a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169798	Bronze			2022-12-24	WOS:000298033000003
J	McDonald, F				McDonald, Frank			Watching the players at the climate poker table	NATURE			English	Editorial Material												fmcd@eircom.net							0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					293	293		10.1038/480293a	http://dx.doi.org/10.1038/480293a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22170643	Bronze			2022-12-24	WOS:000298033000018
J	Feldman, S				Feldman, Sarah			Making Sense of the New Cervical-Cancer Screening Guidelines	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Feldman, S (corresponding author), Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA.		FELDMAN, SARAH/F-8423-2013; Feldman, Sarah/AAJ-2457-2020	FELDMAN, SARAH/0000-0002-1671-9365; 				*AM SOC COLP CERV, CERV CANC SCREEN PRE; [Anonymous], 2009, Obstet Gynecol, V114, P1409, DOI 10.1097/AOG.0b013e3181c6f8a4; *PREV SERV TASK FO, OPP PUBL COMM; VESCO KK, 2011, ANN INTERN MED  1017	4	19	19	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2011	365	23					2145	2147		10.1056/NEJMp1112532	http://dx.doi.org/10.1056/NEJMp1112532			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857PQ	22111669				2022-12-24	WOS:000297731400012
J	Welfare, M				Welfare, Mark			NICE's recommendations for thromboembolism are not evidence based	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Welfare, Mark] Northumbria Healthcare NHS Fdn Trust, N Shields NE29 8NH, Tyne & Wear, England; [Welfare, Mark] Univ Newcastle, N Tyneside Gen Hosp, N Shields NE29 8NH, Tyne & Wear, England	Newcastle University - UK	Welfare, M (corresponding author), Northumbria Healthcare NHS Fdn Trust, N Shields NE29 8NH, Tyne & Wear, England.	mark.welfare@nhct.nhs.uk						2007, ANN INT MED, V146, P278	1	18	18	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2011	343								d6452	10.1136/bmj.d6452	http://dx.doi.org/10.1136/bmj.d6452			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861SP	22162381				2022-12-24	WOS:000298039800007
J	Ng, SW; Bakowski, D; Nelson, C; Mehta, R; Almeyda, R; Bates, G; Parekh, AB				Ng, Siaw-Wei; Bakowski, Daniel; Nelson, Charmaine; Mehta, Ravi; Almeyda, Robert; Bates, Grant; Parekh, Anant B.			Cysteinyl leukotriene type I receptor desensitization sustains Ca2+-dependent gene expression	NATURE			English	Article							ACTIVATED CALCIUM CURRENT; BASOPHILIC LEUKEMIA-CELLS; TYROSINE KINASE SYK; DEPENDENT INACTIVATION; FEEDBACK INHIBITION; CA2+ CHANNELS; RBL-2H3 CELLS; C-FOS; CRAC; EXOCYTOSIS	Receptor desensitization is a universal mechanism to turn off a biological response; in this process, the ability of a physiological trigger to activate a cell is lost despite the continued presence of the stimulus. Receptor desensitization of G-protein-coupled receptors involves uncoupling of the receptor from its G-protein or second-messenger pathway followed by receptor internalization(1). G-protein-coupled cysteinyl leukotriene type I (CysLT1) receptors regulate immune-cell function and CysLT1 receptors are an established therapeutic target for allergies, including asthma(2). Desensitization of CysLT1 receptors arises predominantly from protein-kinase-C-dependent phosphorylation of three serine residues in the receptor carboxy terminus(3). Physiological concentrations of the receptor agonist leukotriene C-4 (LTC4) evoke repetitive cytoplasmic Ca2+ oscillations, reflecting regenerative Ca2+ release from stores, which is sustained by Ca2+ entry through store-operated calcium-release-activated calcium (CRAC) channels(4). CRAC channels are tightly linked to expression of the transcription factor c-fos(5), a regulator of numerous genes important to cell growth and development(6). Here we show that abolishing leukotriene receptor desensitization suppresses agonist-driven gene expression in a rat cell line. Mechanistically, stimulation of non-desensitizing receptors evoked prolonged inositol-trisphosphate-mediated Ca2+ release, which led to accelerated Ca2+-dependent slow inactivation of CRAC channels and a subsequent loss of excitation-transcription coupling. Hence, rather than serving to turn off a biological response, reversible desensitization of a Ca2+ mobilizing receptor acts as an 'on' switch, sustaining long-term signalling in the immune system.	[Ng, Siaw-Wei; Bakowski, Daniel; Nelson, Charmaine; Mehta, Ravi; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Almeyda, Robert; Bates, Grant] John Radcliffe Hosp, Dept Ear Nose Throat Surg, Oxford OX3 9DH, England	University of Oxford; University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk		Mehta, Ravi/0000-0001-8211-1721	Medical Research Council; BBSRC-Glaxo-Smith-Kline; Medical Research Council [G1000813] Funding Source: researchfish; MRC [G1000813] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC-Glaxo-Smith-Kline(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council grant support to A. B. P. S.-W. N. held a BBSRC-Glaxo-Smith-Kline studentship. We thank G. Miesenboeck and J. Putney for comments on the manuscript.	Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Deshpande DA, 2007, FASEB J, V21, P2335, DOI 10.1096/fj.06-8060com; Di Capite J, 2009, J ALLERGY CLIN IMMUN, V124, P1014, DOI 10.1016/j.jaci.2009.08.030; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Di Capite J, 2009, FASEB J, V23, P894, DOI 10.1096/fj.08-118935; Fierro L, 1999, J MEMBRANE BIOL, V168, P9, DOI 10.1007/s002329900493; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; Glitsch MD, 2002, J PHYSIOL-LONDON, V539, P93, DOI 10.1113/jphysiol.2001.012826; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; KASAI H, 1994, TRENDS NEUROSCI, V17, P95, DOI 10.1016/0166-2236(94)90112-0; Naik S, 2005, J BIOL CHEM, V280, P8722, DOI 10.1074/jbc.M413014200; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; OZAWA K, 1993, J BIOL CHEM, V268, P2280; OZAWA K, 1993, J BIOL CHEM, V268, P1749; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; RAZIN E, 1994, P NATL ACAD SCI USA, V91, P7722, DOI 10.1073/pnas.91.16.7722; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stephan V, 1997, CELL SIGNAL, V9, P65, DOI 10.1016/S0898-6568(96)00093-9; TAKASAKA T, 1986, ACTA OTO-LARYNGOL, P39; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	25	31	31	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 2	2012	482	7383					111	U144		10.1038/nature10731	http://dx.doi.org/10.1038/nature10731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884RN	22230957	Green Accepted			2022-12-24	WOS:000299726000046
J	Hatcher, S; Arroll, B				Hatcher, Simon; Arroll, Bruce			THERAPEUTICS Newer antidepressants for the treatment of depression in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							2ND-GENERATION ANTIDEPRESSANTS; METAANALYSIS; OUTCOMES; SEVERITY; BENEFITS; DISORDER; ANXIETY; HARMS; RISK; CARE		[Hatcher, Simon] Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand	University of Auckland	Hatcher, S (corresponding author), Univ Auckland, Dept Psychol Med, Private Bag 92019, Auckland 1, New Zealand.	s.hatcher@auckland.ac.nz						Andrade C, 2010, J CLIN PSYCHIAT, V71, P1565, DOI 10.4088/JCP.09r05786blu; [Anonymous], 2008, Drug Ther Bull, V46, P29, DOI 10.1136/dtb.2008.03.0009; Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144; Arroll B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007954; Arroll B, 2009, J PRIM HEALTH CARE, V1, P26, DOI 10.1071/HC09026; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Cameron IM, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X583209; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Connolly KR, 2011, DRUGS, V71, P43, DOI 10.2165/11587620-000000000-00000; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Fountoulakis KN, 2011, INT J NEUROPSYCHOPH, V14, P405, DOI 10.1017/S1461145710000957; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gartlehner G, 2011, ANN INTERN MED, V155, P772, DOI 10.7326/0003-4819-155-11-201112060-00009; Gartlehner G, 2008, DRUG SAFETY, V31, P851, DOI 10.2165/00002018-200831100-00004; Gentile S, 2011, J AFFECT DISORDERS, V128, P1, DOI 10.1016/j.jad.2010.02.125; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Hawton K, 2010, BRIT J PSYCHIAT, V196, P354, DOI 10.1192/bjp.bp.109.070219; Hetrick SE, 2010, CURR OPIN PSYCHIATR, V23, P53, DOI 10.1097/YCO.0b013e328334bc92; Horder J, 2010, J PSYCHOPHARMACOL; Kendrick T, 2009, HLTH TECHNOL ASSESS, V13; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Lam RW, 2009, J AFFECT DISORDERS, V117, pS26, DOI 10.1016/j.jad.2009.06.041; Mark TL, 2011, AM J GERIAT PSYCHIAT, V19, P211, DOI 10.1097/JGP.0b013e3181f1803d; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; National Institute for Health and Clinical Excellence, 2009, TREATM MAN DEPR AD U; National Institute for Health and Clinical Excellence, 2007, ANT POSTN MENT HLTH; Nease DE, 2003, J FAM PRACTICE, V52, P118; Nutt DJ, 2009, J PSYCHOPHARMACOL, V23, P343, DOI 10.1177/0269881109105498; Pagura J, 2011, J CLIN PSYCHIAT, V72, P494, DOI 10.4088/JCP.09m05776blu; Reid S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1468; Taylor MJ, 2006, ARCH GEN PSYCHIAT, V63, P1217, DOI 10.1001/archpsyc.63.11.1217; Wu P, 2007, PSYCHIAT SERV, V58, P349, DOI 10.1176/appi.ps.58.3.349	33	9	9	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2012	344								d8300	10.1136/bmj.d8300	http://dx.doi.org/10.1136/bmj.d8300			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888ZA	22262785				2022-12-24	WOS:000300042000007
J	Heravi-Moussavi, A; Anglesio, MS; Cheng, SWG; Senz, J; Yang, W; Prentice, L; Fejes, AP; Chow, C; Tone, A; Kalloger, SE; Hamel, N; Roth, A; Ha, G; Wan, ANC; Maines-Bandiera, S; Salamanca, C; Pasini, B; Clarke, BA; Lee, AF; Lee, CH; Zhao, CQ; Young, RH; Aparicio, SA; Sorensen, PHB; Woo, MMM; Boyd, N; Jones, SJM; Hirst, M; Marra, MA; Gilks, B; Shah, SP; Foulkes, WD; Morin, GB; Huntsman, DG				Heravi-Moussavi, Alireza; Anglesio, Michael S.; Cheng, S. -W. Grace; Senz, Janine; Yang, Winnie; Prentice, Leah; Fejes, Anthony P.; Chow, Christine; Tone, Alicia; Kalloger, Steve E.; Hamel, Nancy; Roth, Andrew; Ha, Gavin; Wan, Adrian N. C.; Maines-Bandiera, Sarah; Salamanca, Clara; Pasini, Barbara; Clarke, Blaise A.; Lee, Anna F.; Lee, Cheng-Han; Zhao, Chengquan; Young, Robert H.; Aparicio, Samuel A.; Sorensen, Poul H. B.; Woo, Michelle M. M.; Boyd, Niki; Jones, Steven J. M.; Hirst, Martin; Marra, Marco A.; Gilks, Blake; Shah, Sohrab P.; Foulkes, William D.; Morin, Gregg B.; Huntsman, David G.			Recurrent Somatic DICER1 Mutations in Nonepithelial Ovarian Cancers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GRANULOSA-CELL TUMORS; EXPRESSION; MICRORNAS; PROGNOSIS; SELECTION; DROSHA; FOXL2	BACKGROUND Germline truncating mutations in DICER1, an endoribonuclease in the RNase III family that is essential for processing microRNAs, have been observed in families with the pleuropulmonary blastoma-family tumor and dysplasia syndrome. Mutation carriers are at risk for nonepithelial ovarian tumors, notably sex cord-stromal tumors. METHODS We sequenced the whole transcriptomes or exomes of 14 nonepithelial ovarian tumors and noted closely clustered mutations in the region of DICER1 encoding the RNase IIIb domain of DICER1 in four samples. We then sequenced this region of DICER1 in additional ovarian tumors and in certain other tumors and queried the effect of the mutations on the enzymatic activity of DICER1 using in vitro RNA cleavage assays. RESULTS DICER1 mutations in the RNase IIIb domain were found in 30 of 102 nonepithelial ovarian tumors (29%), predominantly in Sertoli-Leydig cell tumors (26 of 43, or 60%), including 4 tumors with additional germline DICER1 mutations. These mutations were restricted to codons encoding metal-binding sites within the RNase IIIb catalytic centers, which are critical for microRNA interaction and cleavage, and were somatic in all 16 samples in which germline DNA was available for testing. We also detected mutations in 1 of 14 nonseminomatous testicular germ-cell tumors, in 2 of 5 embryonal rhabdomyosarcomas, and in 1 of 266 epithelial ovarian and endometrial carcinomas. The mutant DICER1 proteins had reduced RNase IIIb activity but retained RNase IIIa activity. CONCLUSIONS Somatic missense mutations affecting the RNase IIIb domain of DICER1 are common in nonepithelial ovarian tumors. These mutations do not obliterate DICER1 function but alter it in specific cell types, a novel mechanism through which perturbation of microRNA processing may be oncogenic. (Funded by the Terry Fox Research Institute and others.)	[Huntsman, David G.] Univ British Columbia, British Columbia Canc Agcy, Ovarian Canc Res Program, Vancouver, BC V5Z 4E6, Canada; [Heravi-Moussavi, Alireza; Cheng, S. -W. Grace; Roth, Andrew; Ha, Gavin; Wan, Adrian N. C.; Maines-Bandiera, Sarah; Salamanca, Clara; Aparicio, Samuel A.; Sorensen, Poul H. B.; Jones, Steven J. M.; Marra, Marco A.; Shah, Sohrab P.; Morin, Gregg B.; Huntsman, David G.] Univ British Columbia, British Columbia Canc Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Chow, Christine; Kalloger, Steve E.; Gilks, Blake; Huntsman, David G.] Univ British Columbia, Vancouver Gen Hosp, Genet Pathol Evaluat Ctr, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Huntsman, David G.] Univ British Columbia, Ctr Translat & Appl Genom, British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Jones, Steven J. M.; Marra, Marco A.; Morin, Gregg B.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Anglesio, Michael S.; Lee, Anna F.; Lee, Cheng-Han; Aparicio, Samuel A.; Sorensen, Poul H. B.; Gilks, Blake; Shah, Sohrab P.; Huntsman, David G.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Hamel, Nancy; Foulkes, William D.] McGill Univ, Dept Oncol, Program Canc Genet, Montreal, PQ, Canada; [Hamel, Nancy; Foulkes, William D.] McGill Univ, Dept Human Genet, Program Canc Genet, Montreal, PQ, Canada; [Cheng, S. -W. Grace; Fejes, Anthony P.; Jones, Steven J. M.; Hirst, Martin; Marra, Marco A.; Morin, Gregg B.] Univ British Columbia, British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Hamel, Nancy; Foulkes, William D.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Foulkes, William D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Pasini, Barbara] Univ Turin, Dept Genet, Turin, Italy; [Pasini, Barbara] Univ Turin, Dept Biol, Turin, Italy; [Pasini, Barbara] Univ Turin, Dept Biochem, Turin, Italy; [Clarke, Blaise A.] Univ Toronto, Fac Med, Dept Lab Med, Toronto, ON, Canada; [Clarke, Blaise A.] Univ Toronto, Dept Pathobiol, Fac Med, Toronto, ON, Canada; [Zhao, Chengquan] Univ Pittsburgh, Magee Womens Hosp, Dept Pathol, Med Ctr, Pittsburgh, PA 15213 USA; [Young, Robert H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Young, Robert H.] Harvard Univ, Sch Med, Boston, MA USA	British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia; McGill University; McGill University; British Columbia Cancer Agency; University of British Columbia; McGill University; Lady Davis Institute; McGill University; University of Turin; University of Turin; University of Turin; University of Toronto; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Huntsman, DG (corresponding author), Univ British Columbia, British Columbia Canc Agcy, Ovarian Canc Res Program, Rm 3427,600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.	gmorin@bcgsc.ca; dhuntsma@bccancer.bc.ca	Marra, Marco A/B-5987-2008; Ha, Gavin/N-1984-2019; Jones, Steven J/C-3621-2009; Huntsman, David/ABE-6082-2020; Hamel, Nancy/L-5122-2016; Hirst, Martin/B-7684-2016; Pasini, Barbara/AHI-2004-2022; Morin, Gregg B/E-9123-2012; Foulkes, William D./AAR-9586-2021	Marra, Marco A/0000-0001-7146-7175; Ha, Gavin/0000-0001-7578-7272; Jones, Steven J/0000-0003-3394-2208; Hamel, Nancy/0000-0001-8971-0428; Pasini, Barbara/0000-0002-4373-1212; Morin, Gregg B/0000-0001-8949-4374; Foulkes, William D./0000-0001-7427-4651; Aparicio, Samuel/0000-0002-0487-9599; Clarke, Blaise/0000-0002-2585-8391; Lee, Anna/0000-0002-6703-0656; Anglesio, Michael/0000-0003-1639-5003	Terry Fox Research Institute; British Columbia Cancer Foundation; Vancouver General Hospital-University of British Columbia Hospital Foundation; Canadian Institutes of Health Research; Genome Canada; Michael Smith Foundation for Health Research; Marsha Rivkin Centre for Ovarian Cancer Research; Susan G. Komen for the Cure; Weekend to End Women's Cancer; Ovarian Cancer Research Program of British Columbia (OvCaRe), Ovarian Cancer Canada; National Cancer Institute through the Cooperative Human Tissue Network; Gynecologic Oncology Group	Terry Fox Research Institute; British Columbia Cancer Foundation; Vancouver General Hospital-University of British Columbia Hospital Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Marsha Rivkin Centre for Ovarian Cancer Research; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Weekend to End Women's Cancer; Ovarian Cancer Research Program of British Columbia (OvCaRe), Ovarian Cancer Canada; National Cancer Institute through the Cooperative Human Tissue Network; Gynecologic Oncology Group	Supported by grants from the Terry Fox Research Institute, the British Columbia Cancer Foundation, the Vancouver General Hospital-University of British Columbia Hospital Foundation, the Canadian Institutes of Health Research, Genome Canada, the Michael Smith Foundation for Health Research, the Marsha Rivkin Centre for Ovarian Cancer Research, Susan G. Komen for the Cure, and the Weekend to End Women's Cancer. The contributing tumor banks were supported by the Ovarian Cancer Research Program of British Columbia (OvCaRe), Ovarian Cancer Canada, and the National Cancer Institute through the Cooperative Human Tissue Network and the Gynecologic Oncology Group.	Al-Agha OM, 2011, AM J SURG PATHOL, V35, P484, DOI 10.1097/PAS.0b013e31820a406c; Bahubeshi A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002493; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Colombo N, 2009, ANN ONCOL, V20, P24, DOI 10.1093/annonc/mdp118; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Foulkes WD, 2011, HUM MUTAT, V32, P1381, DOI 10.1002/humu.21600; Frio TR, 2011, JAMA-J AM MED ASSOC, V305, P68, DOI 10.1001/jama.2010.1910; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; HORWICH A, 1991, J CLIN ONCOL, V9, P62, DOI 10.1200/JCO.1991.9.1.62; Iida A, 2011, INVEST OPHTH VIS SCI, V52, P3008, DOI 10.1167/iovs.10-6428; Jamieson S, 2010, MODERN PATHOL, V23, P1477, DOI 10.1038/modpathol.2010.145; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Kim GJ, 2010, INT J DEV BIOL, V54, P867, DOI 10.1387/ijdb.092874gk; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Merritt WM, 2010, NEW ENGL J MED, V363, P1877; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mudhasani R, 2011, J CELL PHYSIOL, V226, P1399, DOI 10.1002/jcp.22475; Nagalakshmi VK, 2011, KIDNEY INT, V79, P317, DOI 10.1038/ki.2010.385; Noland CL, 2011, MOL CELL, V43, P110, DOI 10.1016/j.molcel.2011.05.028; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Sand M, 2010, CANCER INVEST, V28, P649, DOI 10.3109/07357901003630918; Schultz KAP, 2011, GYNECOL ONCOL, V122, P246, DOI 10.1016/j.ygyno.2011.03.024; Sekine S, 2009, GASTROENTEROLOGY, V136, P2304, DOI 10.1053/j.gastro.2009.02.067; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Slade I, 2011, J MED GENET, V48, P273, DOI 10.1136/jmg.2010.083790; Takeshita D, 2007, J MOL BIOL, V374, P106, DOI 10.1016/j.jmb.2007.08.069; Ulbright TM, 1999, UROL CLIN N AM, V26, P611, DOI 10.1016/S0094-0143(05)70202-0; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	40	294	310	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2012	366	3					234	242		10.1056/NEJMoa1102903	http://dx.doi.org/10.1056/NEJMoa1102903			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877RZ	22187960	Bronze			2022-12-24	WOS:000299201400009
J	Tilg, H				Tilg, Herbert			Diet and Intestinal Immunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ARYL-HYDROCARBON RECEPTOR		[Tilg, Herbert] Med Univ Innsbruck, Christian Doppler Res Lab Gut Inflammat, Innsbruck, Austria; [Tilg, Herbert] Acad Teaching Hosp, Hall In Tirol, Austria	Medical University of Innsbruck	Tilg, H (corresponding author), Med Univ Innsbruck, Christian Doppler Res Lab Gut Inflammat, Innsbruck, Austria.		Hug, Balthasar L./G-1568-2010					Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Kiss EA, 2011, SCIENCE         1027; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491	5	24	25	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					181	183		10.1056/NEJMcibr1113158	http://dx.doi.org/10.1056/NEJMcibr1113158			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874VA	22236230				2022-12-24	WOS:000298985000016
J	Snyder, L				Snyder, Lois		Amer Coll Phys Ethics	American College of Physicians Ethics Manual Sixth Edition	ANNALS OF INTERNAL MEDICINE			English	Article							CONCIERGE MEDICINE; INDUSTRY RELATIONS; PALLIATIVE CARE; OF-PHYSICIANS; PATIENT; HEALTH; COMMUNICATION; CONSULTATION; OBLIGATIONS; PRINCIPLES	Medicine, law, and social values are not static. Reexamining the ethical tenets of medicine and their application in new circumstances is a necessary exercise. The sixth edition of the American College of Physicians (ACP) Ethics Manual covers emerging issues in medical ethics and revisits older ones that are still very pertinent. It reflects on many of the ethical tensions in medicine and attempts to shed light on how existing principles extend to emerging concerns. In addition, by reiterating ethical principles that have provided guidance in resolving past ethical problems, the Manual may help physicians avert future problems. The Manual is not a substitute for the experience and integrity of individual physicians, but it may serve as a reminder of the shared duties of the medical profession.	[Snyder, Lois] Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Snyder, L (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	lsnyder@acponline.org			ACP; American Medical Group Association Hypertention Learning Foundation; Medical College of Wisconsin; RWF; NIH; HRSA; Komen; GlaxoSmithKline; American Cancer Society	ACP; American Medical Group Association Hypertention Learning Foundation; Medical College of Wisconsin(General Electric); RWF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Komen(Susan G. Komen Breast Cancer Foundation); GlaxoSmithKline(GlaxoSmithKline); American Cancer Society(American Cancer Society)	Financial support for the development of the Manual came exclusively from the ACP operating budget.; Ms. Snyder: Other relationships: Member of Society of General Internal Medicine Ethics Committee. Dr. Hood: Employment: ACP (president-elect, 2010-2012); Grants/grants pending: American Medical Group Association Hypertention Learning Foundation; Payment for lectures including service on speakers bureaus: American Society of Nephrology; Stock/stock options: mutual funds. Dr. Kutty: Employment: The Medical College of Wisconsin; Royalties: Wolters Kluwer; Stock/stock options: Medtronic. Dr. Fins: Support for travel to meetings for the study or other purposes: ACP; Board membership: ACP Foundation; Employment: Weill Cornell; Grants/grants pending: RWF; Payment for lectures including service on speakers bureaus: various entities; Royalties: Jones and Bartlett; Payment for development of educational presentations: Weill Cornell. Dr. Lopez: Grant: NIH, HRSA, Komen; Consulting fee or honorarium: GlaxoSmithKline; Grants/grants pending: American Cancer Society, NIH, Komen. Dr. Braddock: Board membership: Foundation for Informed Medical Decision Making. Dr. Calvano: Travel/accommodations/meeting expenses unrelated to activities listed: ACP. Dr. Faber-Langendoen: Support for travel to meetings for the study or other purposes: ACP; Employment: SUNY Upstate Medical University; Travel/accommodations/meeting expenses unrelated to activities listed: ACP. Dr. Herrin: Payment for lectures including service on speakers bureaus: Gentech Speakers Bureau. Dr. Mir: Employment: NSLUHS. Dr. Moreno: Support for travel to meetings for the study or other purposes: ACP; Other relationships: Governor, American College of Legal Medicine (February 2011-present); member and pro bono consultant, Physicians for Human Rights (1997-present); member of Board of Directors and President Elect, Texas Chapter of the ACP and ACP Services; pro bono advisor, Center for Survivors of Torture. Mr. Pasha: Support for travel to meetings for the study or other purposes: ACP. Dr. Turner: Employment: Annals of Internal Medicine Executive Deputy Editor, November 2009-November 2010. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M11-1111.	Amdur RJ, 2002, I REV BOARD MANAGEME; Amer College Physicians, 2004, ANN INTERN MED, V141, P226, DOI 10.7326/0003-4819-141-3-200408030-00015; American College of Legal Medicine, 2001, LEG MED; American College of Physicians Ethics Manual, 1989, ANN INTERN MED, V111, P327; American College of Physicians Ethics Manual, 1989, ANN INTERN MED, V111, P245; American Medical Association, 1999, AMA COD MED ETH; American Medical Association, 2006, AMA COD MED ETH; American Medical Association, 2011, GUID PHYS PAT EL COM, P28; Annas GJ, 2009, NEW ENGL J MED, V361, P196, DOI 10.1056/NEJMhle0811035; ANNAS GJ, 1991, NEW ENGL J MED, V324, P1210, DOI 10.1056/NEJM199104253241711; [Anonymous], 2001, PAT ED CAR END LIF P; [Anonymous], 2003, NIH PUBL; [Anonymous], 2001, PAT ED CAR END OF LI; [Anonymous], PHYS ORDERS LIFE SUS; [Anonymous], 2011, COMP ACCR MAN HOSP C; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; [Anonymous], 2000, RECR HUM SUBJ SAMPL; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Aulisio MP, 2000, ANN INTERN MED, V133, P59, DOI 10.7326/0003-4819-133-1-200007040-00012; Beauchamp TL, 2008, PRINCIPLES BIOMEDICA, V6th; Berger JT, 2008, ANN INTERN MED, V149, P48, DOI 10.7326/0003-4819-149-1-200807010-00010; Berger JT, 2005, CANCER INVEST, V23, P94, DOI 10.1081/CNV-200046398; Berger JT, 2001, J CLIN ETHIC, V12, P375; Boisaubin EV, 2001, AM J MED SCI, V322, P31, DOI 10.1097/00000441-200107000-00006; Braddock CH, 2005, J GEN INTERN MED, V20, P1057, DOI 10.1111/j.1525-1497.2005.00217.x; Braddock CH, PATIENT CTR IN PRESS; Brendel DH, 2007, HARVARD REV PSYCHIAT, V15, P43, DOI 10.1080/10673220701298399; BUCHAN ML, 1995, J CLIN ETHIC, V6, P53; BURNUM JF, 1991, NEW ENGL J MED, V324, P1130, DOI 10.1056/NEJM199104183241611; Carlisle J, 2006, J MED ETHICS, V32, P133, DOI 10.1136/jme.2004.011262; Carnahan SJ, 2007, J LAW MED ETHICS, V35, P211, DOI 10.1111/j.1748-720X.2007.00125.x; Carrillo JE, 1999, ANN INTERN MED, V130, P829, DOI 10.7326/0003-4819-130-10-199905180-00017; Carroll RJ, 1999, ACP ASIM OBSERVE JAN; Casarett D, 2005, NEW ENGL J MED, V353, P2607, DOI 10.1056/NEJMsb052907; Cassarett D, 2001, ACP OBSERVER     MAR; Chretien KC, 2009, JAMA-J AM MED ASSOC, V302, P1309, DOI 10.1001/jama.2009.1387; Council for International Organizations of Medical Sciences, 2002, Bull Med Ethics, P17; Council of Medical Specialty Societies, 2011, VOL COD INT COMP; Coyle SL, 2002, ANN INTERN MED, V136, P396, DOI 10.7326/0003-4819-136-5-200203050-00014; Coyle SL, 2002, ANN INTERN MED, V136, P403, DOI 10.7326/0003-4819-136-5-200203050-00015; Crawley LM, 2001, PHYS GUIDE END LIFE, P35; Crook ED, 2005, ETHICAL CHOICES CASE, P148; Daugherty CK, 2008, J CLIN ONCOL, V26, P1371, DOI 10.1200/JCO.2007.13.5335; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Department of Health and Human Services, 1995, INT MISC RES REP COM; Drazen JM, 2010, ANN INTERN MED, V152, P125, DOI [10.7326/0003-4819-152-2-200901190-00160, 10.7326/0000605-200901190-00160]; Drazen JM, 2000, NEW ENGL J MED, V343, P1643, DOI 10.1056/NEJM200011303432212; Eastwood GL, 2009, J GEN INTERN MED, V24, P1333, DOI 10.1007/s11606-009-1127-1; Eggly S, 2006, J CLIN ONCOL, V24, P716, DOI 10.1200/JCO.2005.03.0577; Farber N, 2011, DIFFICULT PATIENT SH; Federation of State Medical Boards of the United States, 2002, MOD GUID APP US INT; Fins JJ, 2005, J PAIN SYMPTOM MANAG, V29, P55, DOI 10.1016/j.jpainsymman.2004.07.004; Fins JJ, 2004, ARCH NEUROL-CHICAGO, V61, P1354, DOI 10.1001/archneur.61.9.1354; Fletcher JC, 1996, J CLIN ETHIC, V7, P122; Fontanarosa PB, 2005, JAMA-J AM MED ASSOC, V294, P110, DOI 10.1001/jama.294.1.110; Gazelle G, 1998, NEW ENGL J MED, V338, P467, DOI 10.1056/NEJM199802123380712; Geller G, 1997, JAMA-J AM MED ASSOC, V277, P1467, DOI 10.1001/jama.277.18.1467; Ginsburg J, 2001, ANN INTERN MED, V134, P787, DOI 10.7326/0003-4819-136-9-200205070-00023; Groves James E., 2002, Prim Care Companion J Clin Psychiatry, V4, P215; Herrin V, 2000, ACP ASIM OBSERVE FEB; Hochman M, 2010, JAMA-J AM MED ASSOC, V303, P951, DOI 10.1001/jama.2010.240; Institute of Medicine, 1997, APP DEATH IMPR CAR E; Institute of Medicine, 2009, GUID EST CRIS STAND; Institute of Medicine, 1999, ERR IS HUM BUILD SAF; International Committee of Medical Journal Editors, 2011, BIOM J UNPUB; Jain SH, 2009, NEW ENGL J MED, V361, P649, DOI 10.1056/NEJMp0901277; Jecker N. S., 2007, FEMINISM MORAL THEOR, V2nd; Jonsen A.R., 1998, BIRTH BIOETHICS; Juarez JA, 2006, FAM MED, V38, P97; Kahn MW, 2009, NEW ENGL J MED, V361, P442, DOI 10.1056/NEJMp0902021; Karlawish JHT, 1999, ANN INTERN MED, V130, P835, DOI 10.7326/0003-4819-130-10-199905180-00018; Karlawish JHT, 2003, NEW ENGL J MED, V348, P1389, DOI 10.1056/NEJMsb030172; Kirschner N, 2010, PATIENT CTR MED HOM; Lampert R, 2010, HRS EXP CONS STAT M; LaPuma J, 1995, Trends Health Care Law Ethics, V10, P73; Lee LM, 2009, JAMA-J AM MED ASSOC, V302, P82, DOI 10.1001/jama.2009.958; LIND SE, 1988, CLIN RES, V36, P546; Lo B, 1999, ANN INTERN MED, V130, P772, DOI 10.7326/0003-4819-130-9-199905040-00018; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; Lyckholm LJ, 1998, JAMA-J AM MED ASSOC, V280, P1944, DOI 10.1001/jama.280.22.1944; Mann JM, 1999, HLTH HUM RIGHTS READ; Mattke Angela, 2009, Acad Med, V84, P191, DOI 10.1097/01.ACM.0000345394.25069.61; McGuire AL, 2006, SCIENCE, V312, P370, DOI 10.1126/science.1125339; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; MCMURRAY RJ, 1991, JAMA-J AM MED ASSOC, V266, P2741, DOI 10.1001/jama.1991.03470190089035; Mitnick S, 2010, J GEN INTERN MED, V25, P255, DOI 10.1007/s11606-009-1206-3; Nahan RL, 2007, 18 NAT CTR HLTH STAT; *NAT CTR COMPL ALT, WHAT IS COMPL ALT ME; National Commission on Correctional Health Care, 1996, CHARG INM FEE HLTH C; New York State Department of Health/New York State Task Force on Life & the Law, 2007, ALL VENT INFL PAND; Nunez AE, 2000, ACAD MED, V75, P1071, DOI 10.1097/00001888-200011000-00011; ORENTLICHER D, 1992, JAMA-J AM MED ASSOC, V267, P2366; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; Pellegrino ED, 1999, JAMA-J AM MED ASSOC, V282, P984, DOI 10.1001/jama.282.10.984; Povar GJ, 1999, ANN INTERN MED, V131, P863, DOI 10.7326/0003-4819-131-11-199912070-00012; Povar GJ, 2004, ANN INTERN MED, V141, P131, DOI 10.7326/0003-4819-141-2-200407200-00012; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; Rich EC, 2004, J GEN INTERN MED, V19, P273, DOI 10.1111/j.1525-1497.2004.30401.x; Roter DL, 1997, JAMA-J AM MED ASSOC, V277, P350, DOI 10.1001/jama.277.4.350; Sabatino CP, 1999, J LAW MED ETHICS, V27, P297, DOI 10.1111/j.1748-720X.1999.tb01465.x; Salzman JG, 2007, ANN EMERG MED, V50, P448, DOI 10.1016/j.annemergmed.2006.10.013; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Shelley BM, 2009, ANN FAM MED, V7, P139, DOI 10.1370/afm.947; Snyder L, 2007, BIOMED ETHICS REV, P1, DOI 10.1007/978-1-59745-381-3; SNYDER L, 1990, ANN INTERN MED, V112, P802, DOI 10.7326/0003-4819-112-11-802; Snyder L, 2001, ANN INTERN MED, V135, P209, DOI 10.7326/0003-4819-135-3-200108070-00015; Snyder L, 1998, J AM GERIATR SOC, V46, P378, DOI 10.1111/j.1532-5415.1998.tb01058.x; SNYDER L, 1990, ANN INTERN MED, V113, P789, DOI 10.7326/0003-4819-113-10-789; Snyder L, 1996, ETHICAL CHOICES CASE, P105; Snyder L, 2005, ETHICAL CHOICES CASE, P130; Snyder L, 2005, ETHICAL CHOICES CASE, P77; Snyder L, 2001, PHYS GUIDE END OF LI; Snyder L, 2007, ANN INTERN MED, V147, P792, DOI 10.7326/0003-4819-147-11-200712040-00011; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Steinbrook R, 2008, NEW ENGL J MED, V359, P2513, DOI 10.1056/NEJMp0809394; Stillman M, 2010, ANN INTERN MED, V152, P391, DOI 10.7326/0003-4819-152-6-201003160-00009; Stott D, 2008, STUDENT BMJ, V16, P280; Sulmasy DP, 2007, J AM GERIATR SOC, V55, P1981, DOI 10.1111/j.1532-5415.2007.01473.x; Sulmasy DP, 2010, JAMA-J AM MED ASSOC, V304, P1946, DOI 10.1001/jama.2010.1595; Sulmasy DP, 1999, ARCH INTERN MED, V159, P545, DOI 10.1001/archinte.159.6.545; SULMASY DP, 1992, ANN INTERN MED, V116, P920, DOI 10.7326/0003-4819-116-11-920; Thompson LA, 2008, J GEN INTERN MED, V23, P954, DOI 10.1007/s11606-008-0538-8; Tulsky JA, 1997, ACP OBSERVER     MAR; Turton FE, 2008, ANN INTERN MED, V148, P887, DOI 10.7326/0003-4819-148-11-200806030-00022; Turton FE, 2007, ANN INTERN MED, V146, P469, DOI 10.7326/0003-4819-146-6-200703200-00019; United Nations, 1955, 1 C PREV CRIM TREATM; Veatch R. M., 2000, TRANSPLANTATION ETHI; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Veterans Health Administration's National Center for Ethics in Health Care, 2010, M CHALL PAND INFL ET; Weiner J, 2005, ETHICAL CHOICES CASE, P136; Weiner J, 2005, ETHICAL CHOICES CASE, P99; Weiner J, 2005, ETHICAL CHOICES CASE, P143; WHITE LJ, 1988, ANN INTERN MED, V108, P460, DOI 10.7326/0003-4819-108-3-460; WHITE LJ, 1989, ANN INTERN MED, V111, P843, DOI 10.7326/0003-4819-111-10-843; Williams MA, 2003, CRIT CARE MED, V31, P1568, DOI 10.1097/01.CCM.0000063090.21056.A6; World Health Organization, 2009, PAND INFL PREP RESP	136	207	210	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2012	156	1	2						73	10.7326/0003-4819-156-1-201201031-00001	http://dx.doi.org/10.7326/0003-4819-156-1-201201031-00001			32	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	886SP	22213573				2022-12-24	WOS:000299874500001
J	Jadad, AR; To, MJ; Emara, M; Jones, J				Jadad, Alejandro R.; To, Matthew J.; Emara, Mohamed; Jones, Jennifer			Consideration of Multiple Chronic Diseases in Randomized Controlled Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Jadad, Alejandro R.; To, Matthew J.; Emara, Mohamed; Jones, Jennifer] Univ Hlth Network, Ctr Hlth Wellness & Canc Survivorship, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Jadad, AR (corresponding author), Univ Hlth Network, Ctr Hlth Wellness & Canc Survivorship, Toronto, ON, Canada.	ajadad@ehealthinnovation.org						Anderson G, CHRONIC CARE MAKING; Jadad AR, PEOPLE LIVE MULTIPLE; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460, DOI 10.1177/003335491112600403; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; Weiss KB, 2007, J GEN INTERN MED, V22, P374, DOI 10.1007/s11606-007-0379-x	5	65	65	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2670	2672		10.1001/jama.2011.1886	http://dx.doi.org/10.1001/jama.2011.1886			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22203536	Bronze			2022-12-24	WOS:000298484000016
J	Liao, Y; Pourzal, R; Wimmer, MA; Jacobs, JJ; Fischer, A; Marks, LD				Liao, Y.; Pourzal, R.; Wimmer, M. A.; Jacobs, J. J.; Fischer, A.; Marks, L. D.			Graphitic Tribological Layers in Metal-on-Metal Hip Replacements	SCIENCE			English	Article							DIAMOND-LIKE CARBON; TRIBOCHEMICAL REACTION; AMORPHOUS-CARBON; WEAR MECHANISMS; JOINT BEARINGS; UNITED-STATES; IN-VITRO; FILMS; LUBRICATION; PROSTHESES	Arthritis is a leading cause of disability, and when nonoperative methods have failed, a prosthetic implant is a cost-effective and clinically successful treatment. Metal-on-metal replacements are an attractive implant technology, a lower-wear alternative to metal-on-polyethylene devices. Relatively little is known about how sliding occurs in these implants, except that proteins play a critical role and that there is a tribological layer on the metal surface. We report evidence for graphitic material in the tribological layer in metal-on-metal hip replacements retrieved from patients. As graphite is a solid lubricant, its presence helps to explain why these components exhibit low wear and suggests methods of improving their performance; simultaneously, this raises the issue of the physiological effects of graphitic wear debris.	[Liao, Y.; Jacobs, J. J.; Marks, L. D.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60201 USA; [Pourzal, R.; Fischer, A.] Univ Duisburg Essen, Duisburg, Germany; [Wimmer, M. A.; Jacobs, J. J.; Fischer, A.] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA	Northwestern University; University of Duisburg Essen; Rush University	Marks, LD (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60201 USA.	l-marks@northwestern.edu	Marks, Laurence/B-7527-2009; Jacobs, Joshua/AGG-8284-2022	Pourzal, Robin/0000-0001-9610-4864; Jacobs, Joshua/0000-0003-3902-7334	NIH [1RC2AR058993-01]; Zimmer Holdings; Medtronics; Spinal Motion; Zimmer Winterthur; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR058993] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zimmer Holdings; Medtronics; Spinal Motion; Zimmer Winterthur; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the NIH on grant number 1RC2AR058993-01. Northwestern University Atomic and Nanoscale Experimental Center and Biological Imaging Facility are acknowledged for the use of their facilities. We thank K. Shull, K. Wahl, and R. Leapman for invaluable comments and M. Morlock, Hamburg, Germany, for retrievals. The authors have no competing financial interests. As full disclosure of real or potential conflicts of interest, J.J.J. has funding from Zimmer Holdings, Medtronics, and Spinal Motion; consults for Zimmer, Medtronics, Johnson and Johnson, Spinal Motion, and Implant Protection; and has stock options in Implant Protection. A. F. has funding from Zimmer Winterthur and consults for Zimmer, Abbot Vascular, and Ceramtec.	BERGER SD, 1988, PHIL MAG LETT, V57, P285, DOI 10.1080/09500838808214715; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Chan FW, 1996, CLIN ORTHOP RELAT R, P96; Chu PK, 2006, MATER CHEM PHYS, V96, P253, DOI 10.1016/j.matchemphys.2005.07.048; CUOMO JJ, 1991, APPL PHYS LETT, V58, P466, DOI 10.1063/1.104609; Dowson D, 2000, P I MECH ENG C-J MEC, V214, P75, DOI 10.1243/0954406001522822; Egerton R.F., 2011, ELECT ENERGY LOSS SP; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Ferrari AC, 2004, PHILOS T R SOC A, V362, P2477, DOI 10.1098/rsta.2004.1452; Field SK, 2004, TRIBOL INT, V37, P949, DOI 10.1016/j.triboint.2004.07.012; FINK J, 1983, SOLID STATE COMMUN, V47, P687, DOI 10.1016/0038-1098(83)90635-X; Heuberger MP, 2005, BIOMATERIALS, V26, P1165, DOI 10.1016/j.biomaterials.2004.05.020; Jacobsson S. A., 1996, CLIN ORTHOP RELAT R, V329, pS60; Kocijan A, 2003, J MATER SCI-MATER M, V14, P69, DOI 10.1023/A:1021505621388; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P164, DOI 10.1302/0301-620X.93B2.25099; M'ndange-Pfupfu A, 2011, DIAM RELAT MATER, V20, P1143, DOI 10.1016/j.diamond.2011.06.028; Maskiewicz VK, 2010, J BIOMED MATER RES B, V94B, P429, DOI 10.1002/jbm.b.31671; McKellop H, 1996, CLIN ORTHOP RELAT R, pS128, DOI 10.1097/00003086-199608001-00013; Mishina H, 2008, WEAR, V265, P655, DOI 10.1016/j.wear.2007.12.006; OECD/ European Union, 2010, HLTH GLANC EUR 2010; PAPPAS DL, 1992, J APPL PHYS, V71, P5675, DOI 10.1063/1.350501; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; Scholes SC, 2006, P I MECH ENG H, V220, P687, DOI 10.1243/09544119JEIM21; Scholes SC, 2000, P I MECH ENG H, V214, P49, DOI 10.1243/0954411001535237; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; UNSWORTH A, 1978, PHYS MED BIOL, V23, P253, DOI 10.1088/0031-9155/23/2/004; Wimmer MA, 2003, WEAR, V255, P1007, DOI 10.1016/S0043-1648(03)00127-3; Wimmer MA, 2001, WEAR, V250, P129, DOI 10.1016/S0043-1648(01)00654-8; Wimmer MA, 2010, J ORTHOP RES, V28, P436, DOI 10.1002/jor.21020; WOODMAN JL, 1984, J BIOMED MATER RES, V18, P99, DOI 10.1002/jbm.820180110; Yan Y, 2006, J PHYS D APPL PHYS, V39, P3206, DOI 10.1088/0022-3727/39/15/S11; Yen BK, 1996, WEAR, V192, P208, DOI 10.1016/0043-1648(95)06807-4	33	146	151	4	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1687	1690		10.1126/science.1213902	http://dx.doi.org/10.1126/science.1213902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194573				2022-12-24	WOS:000298344000062
J	Jiang, J				Jiang, Jessie			PATENTS Protecting China's national treasure	NATURE			English	Editorial Material																			0	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S93	S93		10.1038/480S93a	http://dx.doi.org/10.1038/480S93a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190090	Bronze			2022-12-24	WOS:000298318000006
J	Corless, CL				Corless, Christopher L.			Personalized Cancer Diagnostics	SCIENCE			English	Editorial Material									Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Corless, CL (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.	corlessc@ohsu.edu						Beadling C, 2011, J MOL DIAGN, V13, P504, DOI 10.1016/j.jmoldx.2011.04.003; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Su ZL, 2011, J MOL DIAGN, V13, P74, DOI 10.1016/j.jmoldx.2010.11.010; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497	5	18	19	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1217	1218		10.1126/science.1216427	http://dx.doi.org/10.1126/science.1216427			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144608				2022-12-24	WOS:000297553600029
J	Shah, JR				Shah, Julian R.			Should we treat lower urinary tract symptoms without a definitive diagnosis? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							URODYNAMIC EVALUATION; MEN; DYSFUNCTION		[Shah, Julian R.] Inst Urol, London, England; [Shah, Julian R.] Univ Coll London Hosp, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Shah, JR (corresponding author), Inst Urol, London, England.	pjrshah@hotmail.com						Coyne KS, 2009, BJU INT, V103, P24, DOI 10.1111/j.1464-410X.2009.08438.x; Dib PT, 2008, UROL INT, V80, P378, DOI 10.1159/000132695; Dowling C M, 2008, Ir Med J, V101, P203; Gomes CM, 2008, UROL INT, V81, P129, DOI 10.1159/000144049; Harding C, 2007, EUR UROL, V52, P186, DOI 10.1016/j.eururo.2006.11.009; Nitti VW, 1996, J UROLOGY, V155, P263, DOI 10.1016/S0022-5347(01)66614-X; Parsons BA, 2011, WORLD J UROL, V29, P191, DOI 10.1007/s00345-009-0488-8; Parsons JK, 2010, CURR BLADDER DYSFUNC, V5, P212, DOI 10.1007/s11884-010-0067-2; Patel NS, 2009, INT J CLIN PRACT, V63, P1734, DOI 10.1111/j.1742-1241.2009.02138.x; Rodrigues P, 2009, UROL INT, V83, P404, DOI 10.1159/000251179; Sexton CC, 2011, INT J CLIN PRACT, V65, P567, DOI 10.1111/j.1742-1241.2010.02626.x; Sriplakich Supon, 2007, Journal of the Medical Association of Thailand, V90, P2326; Steele GS, 2000, J UROLOGY, V164, P344, DOI 10.1016/S0022-5347(05)67356-9; Thomas AW, 2005, BJU INT, V96, P1301, DOI 10.1111/j.1464-410X.2005.05815.x; Toh KL, 2006, INT J UROL, V13, P520, DOI 10.1111/j.1442-2042.2006.01347.x	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2011	343								d6058	10.1136/bmj.d6058	http://dx.doi.org/10.1136/bmj.d6058			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EO	22134966				2022-12-24	WOS:000298938400004
J	Kim, C; Schmidt, T; Cho, EG; Ye, F; Ulmer, TS; Ginsberg, MH				Kim, Chungho; Schmidt, Thomas; Cho, Eun-Gyung; Ye, Feng; Ulmer, Tobias S.; Ginsberg, Mark H.			Basic amino-acid side chains regulate transmembrane integrin signalling	NATURE			English	Article							MEMBRANE-PROTEINS; ACTIVATION; COMPLEX; ALPHA-IIB-BETA-3; RESIDUES; SEGMENT; DOMAINS	Side chains of Lys/Arg near transmembrane domain (TMD)(1-3) membrane-water interfaces can 'snorkel', placing their positive charge near negatively charged phospholipid head groups(4-6); however, snorkelling's functional effects are obscure. Integrin beta TMDs have such conserved basic amino acids. Here we use NMR spectroscopy(7,8) to show that integrin beta(3)(Lys 716) helps determine beta(3) TMD topography. The alpha(IIb)beta(3) TMD structure indicates that precise beta(3) TMD crossing angles enable the assembly of outer and inner membrane 'clasps' that hold the ab TMD together to limit transmembrane signalling(9). Mutation of beta(3)(Lys 716) caused dissociation of alpha(IIb)beta(3) TMDs and integrin activation. To confirm that altered topography of beta(3)(Lys 716) mutants activated alpha(IIb)beta(3), we used directed evolution of beta(3)(K716A) to identify substitutions restoring default state. Introduction of Pro(711) at the midpoint of beta(3) TMD (A711P) increased alpha(IIb)beta(3) TMD association and inactivated integrin alpha(IIb)beta(3)(A711P, K716A). beta(3)(Pro 711) introduced a TMD kink of 30 +/- 1 degrees precisely at the border of the outer and inner membrane clasps, thereby decoupling the tilt between these segments. Thus, widely occurring snorkelling residues in TMDs can help maintain TMD topography and membrane-embedding, thereby regulating transmembrane signalling.	[Kim, Chungho; Ye, Feng; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Schmidt, Thomas; Ulmer, Tobias S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Cho, Eun-Gyung] Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of Southern California; Sanford Burnham Prebys Medical Discovery Institute	Ginsberg, MH (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	tulmer@usc.edu; mhginsberg@ucsd.edu	ye, Fangmao/A-7438-2012		National Institutes of Health of the USA; National Institutes of Health [HL089726]; American Institute for Cancer Research;  [HL078784];  [HL57900];  [AR27214]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078784, R01HL106489, P01HL057900, R01HL089726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027214, R01AR027214] Funding Source: NIH RePORTER	National Institutes of Health of the USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health of the USA. T. S. U. acknowledges support from the National Institutes of Health (HL089726) and M. H. G. was supported by HL078784, HL57900 and AR27214. C. K. is a recipient of a postdoctoral fellowship from the American Institute for Cancer Research.	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Krishnakumar SS, 2007, J MOL BIOL, V374, P1251, DOI 10.1016/j.jmb.2007.10.032; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Stefansson A, 2004, J BIOL CHEM, V279, P21200, DOI 10.1074/jbc.M400771200; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; Strandberg E, 2002, BIOCHEMISTRY-US, V41, P7190, DOI 10.1021/bi012047i; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; VONHEIJNE G, 1994, ANNU REV BIOPH BIOM, V23, P167; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	25	95	97	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					209	+		10.1038/nature10697	http://dx.doi.org/10.1038/nature10697			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22178926	Green Accepted			2022-12-24	WOS:000298981200041
J	Yuan, P; Leonetti, MD; Hsiung, YC; MacKinnon, R				Yuan, Peng; Leonetti, Manuel D.; Hsiung, Yichun; MacKinnon, Roderick			Open structure of the Ca2+ gating ring in the high-conductance Ca2+-activated K+ channel	NATURE			English	Article							ACTIVATED POTASSIUM CHANNELS; HUMAN BK CHANNEL; SMOOTH-MUSCLE; RCK DOMAIN; QUATERNARY AMMONIUM; CRYSTAL-STRUCTURE; CALCIUM; BLOCK; MECHANISM; COMPLEX	High-conductance voltage-and Ca2+-activated K+ channels function in many physiological processes that link cell membrane voltage and intracellular Ca2+ concentration, including neuronal electrical activity, skeletal and smooth muscle contraction, and hair cell tuning(1-8). Like other voltage-dependent K+ channels, Ca2+-activated K+ channels open when the cell membrane depolarizes, but in contrast to other voltage-dependent K+ channels, they also open when intracellular Ca2+ concentrations rise. Channel opening by Ca2+ is made possible by a structure called the gating ring, which is located in the cytoplasm. Recent structural studies have defined the Ca2+-free, closed, conformation of the gating ring, but the Ca2+-bound, open, conformation is not yet known(9). Here we present the Ca2+-bound conformation of the gating ring. This structure shows how one layer of the gating ring, in response to the binding of Ca2+, opens like the petals of a flower. The degree to which it opens explains how Ca2+ binding can open the transmembrane pore. These findings present a molecular basis for Ca2+ activation of K+ channels and suggest new possibilities for targeting the gating ring to treat conditions such as asthma and hypertension.	[Yuan, Peng; Leonetti, Manuel D.; Hsiung, Yichun; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu	Yuan, Peng/A-7643-2012	Yuan, Peng/0000-0002-5660-225X; Leonetti, Manuel/0000-0002-4881-405X	American Asthma Foundation [07-0127]	American Asthma Foundation	We thank staff members at NSLS X29, Brookhaven National Laboratory, for beamline assistance, and members of the MacKinnon laboratory for discussion. We thank P. Hoff and members of the Gadsby laboratory for help with oocyte preparation. R. M. is an investigator in the Howard Hughes Medical Institute. The research is supported by the American Asthma Foundation grant 07-0127.	Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; BAKKER EP, 1987, J BACTERIOL, V169, P3743, DOI 10.1128/jb.169.8.3743-3749.1987; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Dong JB, 2005, J BIOL CHEM, V280, P41716, DOI 10.1074/jbc.M508144200; Echols N, 2003, NUCLEIC ACIDS RES, V31, P478, DOI 10.1093/nar/gkg104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; JONES TR, 1993, J APPL PHYSIOL, V74, P1879, DOI 10.1152/jappl.1993.74.4.1879; Kaczorowski GJ, 1996, J BIOENERG BIOMEMBR, V28, P255, DOI 10.1007/BF02110699; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Li WY, 2006, J GEN PHYSIOL, V128, P423, DOI 10.1085/jgp.200609521; Li WY, 2004, J GEN PHYSIOL, V124, P43, DOI 10.1085/jgp.200409067; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MIURA M, 1992, AM REV RESPIR DIS, V146, P132, DOI 10.1164/ajrccm/146.1.132; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petkov GV, 2001, J PHYSIOL-LONDON, V537, P443, DOI 10.1111/j.1469-7793.2001.00443.x; Pico A. R., 2003, THESIS ROCKEFELLER U; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tang QY, 2009, J GEN PHYSIOL, V134, P409, DOI 10.1085/jgp.200910251; Wilkens CM, 2006, J GEN PHYSIOL, V128, P347, DOI 10.1085/jgp.200609579; Wu RS, 2010, KIDNEY INT, V78, P963, DOI 10.1038/ki.2010.325; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhou Y, 2011, P NATL ACAD SCI USA, V108, P12161, DOI 10.1073/pnas.1104150108	38	103	108	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					94	U105		10.1038/nature10670	http://dx.doi.org/10.1038/nature10670			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22139424	Green Accepted			2022-12-24	WOS:000298836900036
J	Carothers, JM; Goler, JA; Juminaga, D; Keasling, JD				Carothers, James M.; Goler, Jonathan A.; Juminaga, Darmawi; Keasling, Jay D.			Model-Driven Engineering of RNA Devices to Quantitatively Program Gene Expression	SCIENCE			English	Article							SYNTHETIC BIOLOGY; RIBOZYMES; MOLECULES	The models and simulation tools available to design functionally complex synthetic biological devices are very limited. We formulated a design-driven approach that used mechanistic modeling and kinetic RNA folding simulations to engineer RNA-regulated genetic devices that control gene expression. Ribozyme and metabolite-controlled, aptazyme-regulated expression devices with quantitatively predictable functions were assembled from components characterized in vitro, in vivo, and in silico. The models and design strategy were verified by constructing 28 Escherichia coli expression devices that gave excellent quantitative agreement between the predicted and measured gene expression levels (r = 0.94). These technologies were applied to engineer RNA-regulated controls in metabolic pathways. More broadly, we provide a framework for studying RNA functions and illustrate the potential for the use of biochemical and biophysical modeling to develop biological design methods.	[Carothers, James M.; Juminaga, Darmawi; Keasling, Jay D.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Carothers, James M.; Juminaga, Darmawi; Keasling, Jay D.] Joint Bioenergy Inst, Emeryville, CA 95608 USA; [Goler, Jonathan A.; Keasling, Jay D.] Univ Calif Berkeley, Synthet Biol Engn Res Ctr, Berkeley, CA 94720 USA; [Goler, Jonathan A.; Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Lawrence Berkeley Natl Lab, Berkeley & Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Carothers, James/0000-0001-6728-7833	Synthetic Biology Engineering Research Center (SynBERC) through NSF [0540879]; JBEI through Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; JBEI through U.S. Department of Energy [DE-AC02-05CH11231]; Jane Coffin Childs Postdoctoral Fellowship	Synthetic Biology Engineering Research Center (SynBERC) through NSF; JBEI through Lawrence Berkeley National Laboratory; JBEI through U.S. Department of Energy; Jane Coffin Childs Postdoctoral Fellowship	Thanks to J. C. Anderson for the pLASC-lacpw plasmid; S. Lee and M. Hajimorad for technical advice; Y. Kapoor for technical assistance; and G. Bokinsky, W. Holtz, N. Hillson, and L. Katz for manuscript comments. D. J. and J. D. K. filed a provisional application for a U. S. Patent on the shikimate production module. Expression device sequences are presented in the supporting online material and in the Joint BioEnergy Institute (JBEI) Public Parts Registry at http://registry.jbei.org. Plasmids will be available from http://addgene.org upon publication. Supported by the Synthetic Biology Engineering Research Center (SynBERC) through NSF grant 0540879 and by JBEI through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. J. M. C. was supported in part by a Jane Coffin Childs Postdoctoral Fellowship.	Benenson Y, 2009, CURR OPIN BIOTECH, V20, P471, DOI 10.1016/j.copbio.2009.08.002; Carothers JM, 2010, NUCLEIC ACIDS RES, V38, P2736, DOI 10.1093/nar/gkq082; Carothers JM, 2009, CURR OPIN BIOTECH, V20, P498, DOI 10.1016/j.copbio.2009.08.001; Chen X, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000620; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Duffy JL, 2007, BIOORG MED CHEM LETT, V17, P2879, DOI 10.1016/j.bmcl.2007.02.066; Flamm C, 2008, MONATSH CHEM, V139, P447, DOI 10.1007/s00706-008-0895-3; Garst AD, 2009, BBA-GENE REGUL MECH, V1789, P584, DOI 10.1016/j.bbagrm.2009.06.004; Hazen RM, 2007, P NATL ACAD SCI USA, V104, P8574, DOI 10.1073/pnas.0701744104; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Isambert H, 2009, METHODS, V49, P189, DOI 10.1016/j.ymeth.2009.06.005; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Link KH, 2007, BIOL CHEM, V388, P779, DOI 10.1515/BC.2007.105; Liu CC, 2010, SCIENCE, V330, P1185, DOI 10.1126/science.1199495; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Mehl RA, 2003, J AM CHEM SOC, V125, P935, DOI 10.1021/ja0284153; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Saito H, 2009, INT J BIOCHEM CELL B, V41, P398, DOI 10.1016/j.biocel.2008.08.017; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Saltelli A., 2008, GLOBAL SENSITIVITY A; Sarlaslani FS, 2007, ANNU REV MICROBIOL, V61, P51, DOI 10.1146/annrev.micro.61.080706.093248; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Zhang J, 2010, BIOCHEMISTRY-US, V49, P9123, DOI 10.1021/bi1012645	29	138	143	2	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1716	1719		10.1126/science.1212209	http://dx.doi.org/10.1126/science.1212209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194579				2022-12-24	WOS:000298344000071
J	Nakano, S; Stillman, B; Horvitz, HR				Nakano, Shunji; Stillman, Bruce; Horvitz, H. Robert			Replication-Coupled Chromatin Assembly Generates a Neuronal Bilateral Asymmetry in C. elegans	CELL			English	Article							NEWLY SYNTHESIZED HISTONES; NUCLEOSOME CORE PARTICLE; CAENORHABDITIS-ELEGANS; DNA-REPLICATION; BINDING-PROTEIN; GENE; INVERSUS; COMPLEX; BRAIN; MICE	Although replication-coupled chromatin assembly is known to be important for the maintenance of patterns of gene expression through sequential cell divisions, the role of replication-coupled chromatin assembly in controlling cell differentiation during animal development remains largely unexplored. Here we report that the CAF-1 protein complex, an evolutionarily conserved histone chaperone that deposits histone H3-H4 proteins onto replicating DNA, is required to generate a bilateral asymmetry in the C. elegans nervous system. A mutation in 1 of 24 C. elegans histone H3 genes specifically eliminates this aspect of neuronal asymmetry by causing a defect in the formation of a histone H3-H4 tetramer and the consequent inhibition of CAF-1-mediated nucleosome formation. Our results reveal that replication-coupled nucleosome assembly is necessary to generate a bilateral asymmetry in C. elegans neuroanatomy and suggest that left-right asymmetric epigenetic regulation can establish bilateralasymmetry in the nervous system.	[Nakano, Shunji; Horvitz, H. Robert] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Nakano, Shunji; Horvitz, H. Robert] MIT, Dept Biol, Cambridge, MA 02139 USA; [Stillman, Bruce] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Cold Spring Harbor Laboratory	Horvitz, HR (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	horvitz@mit.edu	Nakano, Shunji/I-7211-2014	Nakano, Shunji/0000-0002-6565-9450; Stillman, Bruce/0000-0002-9453-4091	NIH National Center for Research Resources (NCRR), for strains; Howard Hughes Medical Institute; National Cancer Institute [CA13106]; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	NIH National Center for Research Resources (NCRR), for strains; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Wendel for her help with the supercoiling assay; A. Fire for expression vectors; the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR), for strains; N. An, R. Droste, and T. Ljungars for technical assistance; and D. Denning, K. Boulias, and M. Nakano for comments about the manuscript. H.R.H. is an Investigator of the Howard Hughes Medical Institute and the David H. Koch Professor of Biology at MIT. This work was supported by the Howard Hughes Medical Institute and a grant from the National Cancer Institute (CA13106).	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Armakolas A, 2007, SCIENCE, V315, P100, DOI 10.1126/science.1129429; Beck K, 2009, J EXP MED, V206, P2271, DOI 10.1084/jem.20090756; BRENNER S, 1974, GENETICS, V77, P71; BURHANS WC, 1990, CELL, V62, P955, DOI 10.1016/0092-8674(90)90270-O; EDGLEY ML, 2006, GENETIC BALANCERS, DOI DOI 10.1895/WORM-BOOK.1.89.1; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Escalante-Mead PR, 2003, J AUTISM DEV DISORD, V33, P539, DOI 10.1023/A:1025887713788; Grigsby MF, 2008, DEV BIOL, V319, P100, DOI 10.1016/j.ydbio.2008.04.013; Hamada H, 2008, DEV GROWTH DIFFER, V50, pS71, DOI 10.1111/j.1440-169X.2008.01008.x; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Hummel K. P., 1959, Journal of Heredity, V50, P9; JACKSON V, 1988, BIOCHEMISTRY-US, V27, P2109, DOI 10.1021/bi00406a044; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Kawakami R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001945; LEFFAK IM, 1977, CELL, V12, P837, DOI 10.1016/0092-8674(77)90282-3; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Li XB, 2007, SCHIZOPHR RES, V96, P14, DOI 10.1016/j.schres.2007.07.013; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nakano S, 2010, DEVELOPMENT, V137, P4017, DOI 10.1242/dev.058834; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Pettitt J, 2002, J CELL SCI, V115, P857; Priess J. R., 1997, C ELEGANS 2; Pujadas G, 2011, DIFFERENTIATION, V82, P66, DOI 10.1016/j.diff.2011.05.006; Quivy JP, 2001, EMBO J, V20, P2015, DOI 10.1093/emboj/20.8.2015; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Richards KL, 2000, MOL BIOL CELL, V11, P1887, DOI 10.1091/mbc.11.5.1887; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994	47	69	81	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2011	147	7					1525	1536		10.1016/j.cell.2011.11.053	http://dx.doi.org/10.1016/j.cell.2011.11.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22177093	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000298403400017
J	Chowdhury, BA; Seymour, SM; Michele, TM; Durmowicz, AG; Liu, DM; Rosebraugh, CJ				Chowdhury, Badrul A.; Seymour, Sally M.; Michele, Theresa M.; Durmowicz, Anthony G.; Liu, Dongmei; Rosebraugh, Curtis J.			The Risks and Benefits of Indacaterol - The FDA's Review	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chowdhury, Badrul A.; Seymour, Sally M.; Michele, Theresa M.; Durmowicz, Anthony G.] US FDA, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Liu, Dongmei] US FDA, Off Biostat, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Rosebraugh, Curtis J.] US FDA, Off Drug Evaluat 2, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Chowdhury, BA (corresponding author), US FDA, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							Barnes PJ, 2010, PULM PHARMACOL THER, V23, P165, DOI 10.1016/j.pupt.2010.01.003; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; European Medicines Agency, HUM MED ONBR BREEZH; Food and Drug Administration, DRUGS FDA FDA APPR D; *FOOD DRUG ADM, M MAT MARCH 8 2011 M	5	34	38	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2011	365	24					2247	2249		10.1056/NEJMp1109621	http://dx.doi.org/10.1056/NEJMp1109621			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861PN	22168640				2022-12-24	WOS:000298031800002
J	Graves, JA; Curtis, R; Gruber, J				Graves, John A.; Curtis, Rick; Gruber, Jonathan			Balancing Coverage Affordability and Continuity under a Basic Health Program Option	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Graves, John A.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Curtis, Rick] Inst Hlth Policy Solut, Washington, DC USA; [Gruber, Jonathan] MIT, Cambridge, MA 02139 USA	Vanderbilt University; Massachusetts Institute of Technology (MIT)	Graves, JA (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.							Short PF, 2011, REALIZING HLTH REFOR; Sommers BD, 2011, HEALTH AFFAIR, V30, P228, DOI 10.1377/hlthaff.2010.1000	2	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2011	365	24					E44	U107		10.1056/NEJMp1111863	http://dx.doi.org/10.1056/NEJMp1111863			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861PN	22129219				2022-12-24	WOS:000298031800005
J	Daniel, SB; Lovegrove, MC; Shehab, N; Richards, CL				Budnitz, Daniel S.; Lovegrove, Maribeth C.; Shehab, Nadine; Richards, Chesley L.			Emergency Hospitalizations for Adverse Drug Events in Older Americans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEPARTMENT VISITS; MEDICATION USE; ADMISSIONS; SURVEILLANCE; SAFETY	BACKGROUND Adverse drug events are important preventable causes of hospitalization in older adults. However, nationally representative data on adverse drug events that result in hospitalization in this population have been limited. METHODS We used adverse-event data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project (2007 through 2009) to estimate the frequency and rates of hospitalization after emergency department visits for adverse drug events in older adults and to assess the contribution of specific medications, including those identified as high-risk or potentially inappropriate by national quality measures. RESULTS On the basis of 5077 cases identified in our sample, there were an estimated 99,628 emergency hospitalizations (95% confidence interval [CI], 55,531 to 143,724) for adverse drug events in U. S. adults 65 years of age or older each year from 2007 through 2009. Nearly half of these hospitalizations were among adults 80 years of age or older (48.1%; 95% CI, 44.6 to 51.6). Nearly two thirds of hospitalizations were due to unintentional overdoses (65.7%; 95% CI, 60.1 to 71.3). Four medications or medication classes were implicated alone or in combination in 67.0% (95% CI, 60.0 to 74.1) of hospitalizations: warfarin (33.3%), insulins (13.9%), oral antiplatelet agents (13.3%), and oral hypoglycemic agents (10.7%). High-risk medications were implicated in only 1.2% (95% CI, 0.7 to 1.7) of hospitalizations. CONCLUSIONS Most emergency hospitalizations for recognized adverse drug events in older adults resulted from a few commonly used medications, and relatively few resulted from medications typically designated as high-risk or inappropriate. Improved management of antithrombotic and antidiabetic drugs has the potential to reduce hospitalizations for adverse drug events in older adults.	[Budnitz, Daniel S.; Lovegrove, Maribeth C.; Shehab, Nadine] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; [Richards, Chesley L.] Ctr Dis Control & Prevent, Off Prevent Healthcare, Atlanta, GA 30333 USA; [Richards, Chesley L.] Emory Univ, Sch Med, Div Geriatr & Gerontol, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University	Daniel, SB (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd NE,Mailstop A-24, Atlanta, GA 30333 USA.	dbudnitz@cdc.gov	Hug, Balthasar L./G-1568-2010	Budnitz, Daniel/0000-0002-0136-2623; Shehab, Nadine/0000-0001-8700-8539				Agency for Healthcare Research and Quality, HCUPNET HEALTHC COST; [Anonymous], HEALTHC EFF DAT INF; [Anonymous], PATT MED US US 2006; [Anonymous], 2002, NAT EL INJ SURV SYST; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Buie VC, 2010, VITAL HLTH STAT, V13, P168; Burt CW, 2002, HEALTH AFFAIR, V21, P206, DOI 10.1377/hlthaff.21.4.206; Centers for Disease Control and Prevention, BRIDG RAC POP EST US; Centers for Disease Control and Prevention, AMB HLTH CAR DAT; Curtiss FR, 2011, J MANAGE CARE PHARM, V17, P60, DOI 10.18553/jmcp.2011.17.1.60; ElDesoky Ehab S, 2007, Am J Ther, V14, P488, DOI 10.1097/01.mjt.0000183719.84390.4d; Fick, 2004, ARCH INTERN MED, V164, P298; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Gage BF, 2009, NEW ENGL J MED, V361, P1200, DOI 10.1056/NEJMe0906886; Goulding MR, 2004, ARCH INTERN MED, V164, P305, DOI 10.1001/archinte.164.3.305; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; HealthCare. gov, PARTN PAT BETT CAR L; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; Jha AK, 2001, PHARMACOEPIDEM DR S, V10, P113, DOI 10.1002/pds.568; Jhung MA, 2007, MED CARE, V45, pS96, DOI 10.1097/MLR.0b013e318041f737; Kim MM, 2010, PHARMACOEPIDEM DR S, V19, P731, DOI 10.1002/pds.1953; Kish L, 1995, SCI 1995; Kocher R, 2010, ANN INTERN MED, V153, P536, DOI 10.7326/0003-4819-153-8-201010190-00274; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; McDonnell PJ, 2002, ANN PHARMACOTHER, V36, P1331, DOI 10.1345/aph.1A333; McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4; National Quality Forum, NQF END STAND; Onder G, 2002, J AM GERIATR SOC, V50, P1962, DOI 10.1046/j.1532-5415.2002.50607.x; Page Robert L 2nd, 2006, Am J Geriatr Pharmacother, V4, P297; Pogach L, 2010, JAMA-J AM MED ASSOC, V303, P2076, DOI 10.1001/jama.2010.655; Shehab N, 2010, ARCH INTERN MED, V170, P1926, DOI 10.1001/archinternmed.2010.407; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; Spinler SA, 2009, PHARMACOTHERAPY, V29, P812, DOI 10.1592/phco.29.7.812; Steinman MA, 2011, J AM GERIATR SOC, V59, P1513, DOI 10.1111/j.1532-5415.2011.03500.x; Streiff MB, 2010, ANN PHARMACOTHER, V44, P733, DOI 10.1345/aph.1M666; Wachter RM, 2010, HEALTH AFFAIR, V29, P165, DOI 10.1377/hlthaff.2009.0785; Wears RL, 2010, ANN EMERG MED, V55, P511, DOI 10.1016/j.annemergmed.2010.01.018; Wu WK, 2003, AM J HEALTH-SYST PH, V60, P253, DOI 10.1093/ajhp/60.3.253; Zhang YT, 2010, NEW ENGL J MED, V363, P1985, DOI 10.1056/NEJMp1010220	41	1084	1113	1	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2011	365	21					2002	2012		10.1056/NEJMsa1103053	http://dx.doi.org/10.1056/NEJMsa1103053			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851PF	22111719	Bronze			2022-12-24	WOS:000297282600010
J	Blendon, RJ; Kim, MK; Benson, JM				Blendon, Robert J.; Kim, Minah Kang; Benson, John M.			The Public, Political Parties, and Stem-Cell Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blendon, Robert J.; Kim, Minah Kang; Benson, John M.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Blendon, Robert J.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; [Kim, Minah Kang] Ewha Womans Univ, Seoul, South Korea	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Ewha Womans University	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							[Anonymous], 2010, EUR 73 1 BIOT; Cohen IG, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1105088; JAN T, 2011, BOSTON GLOBE    0807; Nisbet MC, 2005, INT J PUBLIC OPIN R, V17, P90, DOI 10.1093/ijpor/edh058	4	13	13	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2011	365	20					1853	1856		10.1056/NEJMp1110340	http://dx.doi.org/10.1056/NEJMp1110340			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	848HG	22087677				2022-12-24	WOS:000297041900002
J	Mak, ANS; Bradley, P; Cernadas, RA; Bogdanove, AJ; Stoddard, BL				Mak, Amanda Nga-Sze; Bradley, Philip; Cernadas, Raul A.; Bogdanove, Adam J.; Stoddard, Barry L.			The Crystal Structure of TAL Effector PthXo1 Bound to Its DNA Target	SCIENCE			English	Article							ORYZAE PV.-ORYZAE; III EFFECTORS; RECOGNITION; SPECIFICITY; PROTEINS; PATHOGEN; REPEAT; GENE	DNA recognition by TAL effectors is mediated by tandem repeats, each 33 to 35 residues in length, that specify nucleotides via unique repeat-variable diresidues (RVDs). The crystal structure of PthXo1 bound to its DNA target was determined by high-throughput computational structure prediction and validated by heavy-atom derivatization. Each repeat forms a left-handed, two-helix bundle that presents an RVD-containing loop to the DNA. The repeats self-associate to form a right-handed superhelix wrapped around the DNA major groove. The first RVD residue forms a stabilizing contact with the protein backbone, while the second makes a base-specific contact to the DNA sense strand. Two degenerate amino-terminal repeats also interact with the DNA. Containing several RVDs and noncanonical associations, the structure illustrates the basis of TAL effector-DNA recognition.	[Mak, Amanda Nga-Sze; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98019 USA; [Bradley, Philip] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Cernadas, Raul A.; Bogdanove, Adam J.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Iowa State University	Stoddard, BL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N,A3-025 Seattle, Seattle, WA 98019 USA.	bstoddar@fhcrc.org	De Bruyn, Hugo/B-3628-2018; Bogdanove, Adam/ABE-6252-2020	De Bruyn, Hugo/0000-0003-0200-9546; 	NIH [RL1 0CA833133, R01GM098861, R01 GM088277]; NSF [0820831]; Searles Scholars Fellowship; Northwest Genome Engineering Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088277, R01GM098861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Searles Scholars Fellowship; Northwest Genome Engineering Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by NIH (grants RL1 0CA833133 to B.L.S., R01GM098861 to B.L.S. and A.J.B., and R01 GM088277 to P.H.B.), NSF grant 0820831 to A.J.B., and a Searles Scholars Fellowship to P.H.B. A.N-S.M. was supported by a training grant from the Northwest Genome Engineering Consortium. We thank the staff of the Advanced Light Source beamline 5.0.2 and L. Doyle, B. Shen, R. Takeuchi, J. Bolduc, and C. Schmidt for technical assistance and advice; T. Edwards and M. Clifton for collecting SeMet data; and C. Pabo for helpful discussion. A.J.B. is an inventor on a patent application titled "TAL effector-mediated DNA modification" (US-2011/0145940-A1 and PCT/US2010/059932). This intellectual property, co-owned by Iowa State University and the University of Minnesota, has been licensed to Cellectis. The refined coordinates and corresponding x-ray intensities for the PthXo1-DNA structure have been deposited in the RCSB Protein Database (accession code 3UGM).	Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Hopcroft NH, 2004, J MOL BIOL, V338, P43, DOI 10.1016/j.jmb.2004.02.038; Jimenez-Menendez N, 2010, NAT STRUCT MOL BIOL, V17, P891, DOI 10.1038/nsmb.1859; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2010, NEW PHYTOL, V187, P1048, DOI 10.1111/j.1469-8137.2010.03217.x; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Yu YH, 2011, MOL PLANT MICROBE IN, V24, P1102, DOI 10.1094/MPMI-11-10-0254	16	373	448	5	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069					716	719		10.1126/science.1216211	http://dx.doi.org/10.1126/science.1216211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22223736	Green Accepted			2022-12-24	WOS:000300047100052
J	Knott, SRV; Peace, JM; Ostrow, AZ; Gan, Y; Rex, AE; Viggiani, CJ; Tavare, S; Aparicio, OM				Knott, Simon R. V.; Peace, Jared M.; Ostrow, A. Zachary; Gan, Yan; Rex, Alexandra E.; Viggiani, Christopher J.; Tavare, Simon; Aparicio, Oscar M.			Forkhead Transcription Factors Establish Origin Timing and Long-Range Clustering in S. cerevisiae	CELL			English	Article							EUKARYOTIC REPLICATION ORIGINS; CHROMOSOMAL DNA-REPLICATION; CELL-CYCLE; HISTONE DEACETYLASE; GENE-EXPRESSION; GENOME-WIDE; FHA DOMAIN; CHROMATIN; INITIATION; ACTIVATION	The replication of eukaryotic chromosomes is organized temporally and spatially within the nucleus through epigenetic regulation of replication origin function. The characteristic initiation timing of specific origins is thought to reflect their chromatin environment or sub-nuclear positioning, however the mechanism remains obscure. Here we show that the yeast Forkhead transcription factors, Fkh1 and Fkh2, are global determinants of replication origin timing. Forkhead regulation of origin timing is independent of local levels or changes of transcription. Instead, we show that Fkh1 and Fkh2 are required for the clustering of early origins and their association with the key initiation factor Cdc45 in G1 phase, suggesting that Fkh1 and Fkh2 selectively recruit origins to emergent replication factories. Fkh1 and Fkh2 bind Fkh-activated origins, and interact physically with ORC, providing a plausible mechanism to cluster origins. These findings add a new dimension to our understanding of the epigenetic basis for differential origin regulation and its connection to chromosomal domain organization.	[Knott, Simon R. V.; Peace, Jared M.; Ostrow, A. Zachary; Gan, Yan; Rex, Alexandra E.; Viggiani, Christopher J.; Tavare, Simon; Aparicio, Oscar M.] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA; [Tavare, Simon] Univ Cambridge, Dept Oncol, Cambridge CB2 1TN, England	University of Southern California; University of Cambridge	Aparicio, OM (corresponding author), Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.	oaparici@usc.edu		Aparicio, Oscar/0000-0002-5591-0277	USC Epigenome Center; Whittier Foundation; NIH [5R01-GM065494, 3R01-GM065494-S1, P50-HG02790]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065494] Funding Source: NIH RePORTER	USC Epigenome Center; Whittier Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank: J. Aparicio, M. Arbeitman, C. Fox, and M. Michael for critical evaluation of the manuscript; M. Arbeitman for sharing equipment; S.P. Bell for purified ORC and antibody; L. Chen for valuable insight; J. Dalton for help with microscopy; C. Fox for plasmids, strains, antibody, and helpful discussion; R. Kalhor for the 4C protocol and invaluable advice; U. Keich for helpful discussion; and M. Hampsey, D. Kowalski and R. Young for strains. This work was funded by a pilot grant from the USC Epigenome Center sponsored by the Whittier Foundation (to O.M.A), NIH grants 5R01-GM065494 and 3R01-GM065494-S1 (to O.M.A.), and P50-HG02790 (to S.R.V.K. and S.T.).	Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Boros J, 2003, NUCLEIC ACIDS RES, V31, P2279, DOI 10.1093/nar/gkg347; Cadoret JC, 2008, P NATL ACAD SCI USA, V105, P15837, DOI 10.1073/pnas.0805208105; Chang VK, 2004, MOL CELL BIOL, V24, P6514, DOI 10.1128/MCB.24.14.6514-6524.2004; Chen YH, 2009, BIOINFORMATICS, V25, P2514, DOI 10.1093/bioinformatics/btp486; Danis E, 2004, NAT CELL BIOL, V6, P721, DOI 10.1038/ncb1149; Darieva Z, 2003, CURR BIOL, V13, P1740, DOI 10.1016/j.cub.2003.08.053; Darieva Z, 2010, MOL CELL, V38, P29, DOI 10.1016/j.molcel.2010.02.030; DILLER JD, 1994, TRENDS BIOCHEM SCI, V19, P320, DOI 10.1016/0968-0004(94)90070-1; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Eaton ML, 2010, GENE DEV, V24, P748, DOI 10.1101/gad.1913210; FERGUSON BM, 1992, CELL, V68, P333, DOI 10.1016/0092-8674(92)90474-Q; Flanagan JF, 1999, NUCLEIC ACIDS RES, V27, P2022, DOI 10.1093/nar/27.9.2022; Friedman KL, 1996, GENE DEV, V10, P1595, DOI 10.1101/gad.10.13.1595; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Gondor A, 2009, NAT REV GENET, V10, P269, DOI 10.1038/nrg2555; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Heun P, 2001, J CELL BIOL, V152, P385, DOI 10.1083/jcb.152.2.385; Hiratani L, 2009, CURR OPIN GENET DEV, V19, P142, DOI 10.1016/j.gde.2009.02.002; Hollenhorst PC, 2001, GENE DEV, V15, P2445, DOI 10.1101/gad.906201; Hu FF, 2008, GENETICS, V179, P863, DOI 10.1534/genetics.108.086611; Hu YF, 1999, GENE DEV, V13, P637, DOI 10.1101/gad.13.6.637; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Keich U, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-372; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Knott SRV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-305; Knott SRV, 2009, EPIGENETICS-US, V4, P262; Knott SRV, 2009, GENE DEV, V23, P1077, DOI 10.1101/gad.1784309; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; Li R, 1998, MOL CELL BIOL, V18, P1296, DOI 10.1128/MCB.18.3.1296; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; MacAlpine D, 2005, CHROMOSOME RES, V13, P309, DOI 10.1007/s10577-005-1508-1; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Meister P, 2007, EMBO J, V26, P1315, DOI 10.1038/sj.emboj.7601538; Miotto B, 2007, M S-MED SCI, V23, P735, DOI 10.1051/medsci/20072389735; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Morozov AV, 2007, P NATL ACAD SCI USA, V104, P7068, DOI 10.1073/pnas.0701356104; Murakami H, 2010, CELL CYCLE, V9, P3233, DOI 10.4161/cc.9.16.12599; Pappas DL, 2004, GENE DEV, V18, P769, DOI 10.1101/gad.1173204; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; Pic-Taylor A, 2004, MOL CELL BIOL, V24, P10036, DOI 10.1128/MCB.24.22.10036-10046.2004; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Sequeira-Mendes J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000446; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Sun KM, 2002, GENE DEV, V16, P2085, DOI 10.1101/gad.994902; Unnikrishnan A, 2010, NAT STRUCT MOL BIOL, V17, P430, DOI 10.1038/nsmb.1780; Viggiani C.J., 2010, COLD SPRING HARB PRO; Viggiani CJ, 2006, YEAST, V23, P1045, DOI 10.1002/yea.1406; Viggiani Christopher J., 2009, V521, P255, DOI [10.1007/978-1-60327-815-7_14, 10.1007/978-1-60327-817-5_14]; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Weber JM, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-100; Weinreich M, 2004, BBA-GENE STRUCT EXPR, V1677, P142, DOI 10.1016/j.bbaexp.2003.11.015	69	135	136	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					99	111		10.1016/j.cell.2011.12.012	http://dx.doi.org/10.1016/j.cell.2011.12.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265405	Green Accepted, Bronze			2022-12-24	WOS:000299540700017
J	Brown, MJ; Cruickshank, JK; MacDonald, TM				Brown, Morris J.; Cruickshank, J. Kennedy; MacDonald, Thomas M.			Navigating the shoals in hypertension: discovery and guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AMBULATORY BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; MORTALITY; DIAGNOSIS; RISK; VARIABILITY; TRIAL; HOME; SPIRONOLACTONE; AMLODIPINE		[Brown, Morris J.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Cruickshank, J. Kennedy] Kings Coll London, London SE1 9NH, England; [Cruickshank, J. Kennedy] St Thomas Hosp, London SE1 9NH, England; [MacDonald, Thomas M.] Ninewells Hosp & Med Sch, Med Res Inst, Med Monitoring Unit, Dundee DD1 9SY, Scotland; [MacDonald, Thomas M.] Ninewells Hosp & Med Sch, Med Res Inst, Hypertens Res Ctr, Dundee DD1 9SY, Scotland	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Dundee; University of Dundee	Brown, MJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England.	m.j.brown@cai.cam.ac.uk		MacDonald, Thomas/0000-0001-5189-6669				British Hypertension Society, 2011, BEN SALT RED AR CLEA; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Brown MJ, 2011, HEART, V97, P1547, DOI 10.1136/heartjnl-2011-300710; Brown MJ, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4697; Brown MJ, 2011, LANCET, V377, P312, DOI 10.1016/S0140-6736(10)62003-X; Chapman N, 2007, HYPERTENSION, V49, P839, DOI 10.1161/01.HYP.0000259805.18468.8c; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dickerson JEC, 1999, LANCET, V353, P2008, DOI 10.1016/S0140-6736(98)07614-4; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Glen SK, 1996, LANCET, V348, P654, DOI 10.1016/S0140-6736(96)02303-3; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Head Geoffrey A, 2010, BMJ, V340, pc1104, DOI 10.1136/bmj.c1104; Hodgkinson J, 2011, BMJ, V342, pd3621, DOI 10.1136/bmj.d3621; Hood SJ, 2007, CIRCULATION, V116, P268, DOI 10.1161/CIRCULATIONAHA.107.690396; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lovibond K, 2011, LANCET, V378, P1219, DOI 10.1016/S0140-6736(11)61184-7; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mancia G, 1997, LANCET, V349, P454, DOI 10.1016/S0140-6736(96)07099-7; Mancia G, 1995, J HYPERTENS, V13, P1377; Mancia G, 2006, HYPERTENSION, V47, P846, DOI 10.1161/01.HYP.0000215363.69793.bb; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; NICE, 2019, HYP AD DIAGN MAN; NICE British Hypertension Society, 2006, HYP MAN HYP AD PRIM; Poulter NR, 2005, LANCET, V366, P907, DOI 10.1016/S0140-6736(05)67186-3; Rawlins M, CLIN PHARM IN PRESS; Ritchie LD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5644; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Stergiou GS, 2011, AM J HYPERTENS, V24, P123, DOI 10.1038/ajh.2010.194; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Turnbull F, 2003, LANCET, V362, P1527; Verdecchia P, 2007, CIRCULATION, V115, P2091, DOI 10.1161/CIRCULATIONAHA.107.697086; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Webb AJS, 2011, STROKE, V42, P2860, DOI 10.1161/STROKEAHA.110.611566; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683	38	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2012	344								d8218	10.1136/bmj.d8218	http://dx.doi.org/10.1136/bmj.d8218			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877SR	22246268				2022-12-24	WOS:000299203500013
J	Huldtgren, T; Cunningham, JA; Yin, CY; Stampanoni, M; Marone, F; Donoghue, PCJ; Bengtson, S				Huldtgren, Therese; Cunningham, John A.; Yin, Chongyu; Stampanoni, Marco; Marone, Federica; Donoghue, Philip C. J.; Bengtson, Stefan			Fossilized Nuclei and Germination Structures Identify Ediacaran "Animal Embryos" as Encysting Protists	SCIENCE			English	Article							IN-VITRO; PALEONTOLOGY; MICROFOSSILS; EVOLUTION; PISCES; ORIGIN; ALGAE; NOV; GEN	Globular fossils showing palintomic cell cleavage in the Ediacaran Doushantuo Formation, China, are widely regarded as embryos of early metazoans, although metazoan synapomorphies, tissue differentiation, and associated juveniles or adults are lacking. We demonstrate using synchrotron-based x-ray tomographic microscopy that the fossils have features incompatible with multicellular metazoan embryos. The developmental pattern is comparable with nonmetazoan holozoans, including germination stages that preclude postcleavage embryology characteristic of metazoans. We conclude that these fossils are neither animals nor embryos. They belong outside crown-group Metazoa, within total-group Holozoa (the sister clade to Fungi that includes Metazoa, Choanoflagellata, and Mesomycetozoea) or perhaps on even more distant branches in the eukaryote tree. They represent an evolutionary grade in which palintomic cleavage served the function of producing propagules for dispersion.	[Cunningham, John A.; Donoghue, Philip C. J.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Huldtgren, Therese; Bengtson, Stefan] Swedish Museum Nat Hist, Dept Palaeozool, S-10405 Stockholm, Sweden; [Huldtgren, Therese] Stockholm Univ, Dept Geol Sci, S-10691 Stockholm, Sweden; [Yin, Chongyu] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Stampanoni, Marco; Marone, Federica] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Stampanoni, Marco] Univ Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland; [Bengtson, Stefan] Swedish Museum Nat Hist, Nord Ctr Earth Evolut, S-10405 Stockholm, Sweden; [Stampanoni, Marco] ETH, CH-8092 Zurich, Switzerland	University of Bristol; Swedish Museum of Natural History; Stockholm University; Chinese Academy of Geological Sciences; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; Swedish Museum of Natural History; Swiss Federal Institutes of Technology Domain; ETH Zurich	Donoghue, PCJ (corresponding author), Univ Bristol, Dept Earth Sci, Wills Mem Bldg, Bristol BS8 1RJ, Avon, England.	phil.donoghue@bristol.ac.uk; stefan.bengtson@nrm.se	Stampanoni, Marco/AAZ-3033-2021; Stampanoni, Marco/J-4099-2013; Stampanoni, Marco/GRR-9695-2022; Donoghue, Philip/A-3873-2008; Marone, Federica/J-4420-2013	Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Donoghue, Philip/0000-0003-3116-7463; Bengtson, Stefan/0000-0003-0206-5791; Cunningham, John/0000-0002-2870-1832	Swedish Research Council; Natural Environment Research Council; Ministry of Science and Technology of China; National Natural Science Foundation of China; EU; Paul Scherrer Institute; NERC [NE/F00348X/1] Funding Source: UKRI; Natural Environment Research Council [NE/F00348X/1] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EU(European Commission); Paul Scherrer Institute; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank S. Xiao, T. Cavalier-Smith, and B. Landfald for discussion; T. Hode and Z. Yue for field-work collaboration; A. Groso for assistance with the srXTM work; and P. Varvarigos and D. Elliott for the use of fig. S7. The work was supported by the Swedish Research Council, Natural Environment Research Council, Ministry of Science and Technology of China, National Natural Science Foundation of China, EU FP7, and the Paul Scherrer Institute. Figured or measured specimens are deposited at the Swedish Museum of Natural History and the Museum of Earth Science, Chinese Academy of Geological Sciences. The srXTM investigations were conducted at the X04SA and X02DA (TOMCAT) beamlines of the Swiss Light Source. The data were visualized and analyzed by using Avizo software. Data are available in the SOM. S. B. and P.C.J.D. designed the research and wrote the paper; T. H. found the nucleic structures, prepared the corresponding visualizations, and wrote the specimen descriptions in the SOM; J.A.C. found the propagule-like structures and performed taphonomic analyses and volumetric measurements; C.Y. and S. B. did the field work; C.Y. provided the additional data from Hubei; and M. S., F. M., S. B. and P.C.J.D. designed the srXTM experiments.	Bailey JV, 2007, NATURE, V446, pE10, DOI 10.1038/nature05754; Bailey JV, 2007, NATURE, V445, P198, DOI 10.1038/nature05457; Bonner John Tyler, 1998, Integrative Biology, V1, P27; Chen JY, 2006, SCIENCE, V312, P1644, DOI 10.1126/science.1125964; Chen JY, 2009, P NATL ACAD SCI USA, V106, P19056, DOI 10.1073/pnas.0904805106; Cohen PA, 2009, P NATL ACAD SCI USA, V106, P6519, DOI 10.1073/pnas.0902322106; Donoghue PCJ, 2007, NATURE, V445, P155, DOI 10.1038/nature05520; ELBRACHTER M, 1988, HELGOLANDER MEERESUN, V42, P593, DOI 10.1007/BF02365629; Franco-Sierra A, 1999, PARASITOL RES, V85, P562, DOI 10.1007/s004360050596; GREEN KJ, 1981, J CELL BIOL, V91, P743, DOI 10.1083/jcb.91.3.743; Hagadorn JW, 2006, SCIENCE, V314, P291, DOI 10.1126/science.1133129; Hanamura K, 2001, ZOOL SCI, V18, P381, DOI 10.2108/zsj.18.381; Herron MD, 2010, J PHYCOL, V46, P316, DOI 10.1111/j.1529-8817.2009.00803.x; Horodyski R.J., 1992, P185; Leander BS, 2008, J EUKARYOT MICROBIOL, V55, P59, DOI 10.1111/j.1550-7408.2008.00308.x; Liu Peng-ju, 2009, Acta Geoscientia Sinica, V30, P457; Marshall WL, 2011, PROTIST, V162, P33, DOI 10.1016/j.protis.2010.06.002; Mendoza L, 1999, MYCOPATHOLOGIA, V148, P9, DOI 10.1023/A:1007108910025; Mendoza L, 2002, ANNU REV MICROBIOL, V56, P315, DOI 10.1146/annurev.micro.56.012302.160950; Mikhailov KV, 2009, BIOESSAYS, V31, P758, DOI 10.1002/bies.200800214; Molloy DP, 2005, DIS AQUAT ORGAN, V65, P237, DOI 10.3354/dao065237; Pekkarinen M, 2003, J NAT HIST, V37, P1155, DOI 10.1080/00222930110120999; Raff EC, 2008, P NATL ACAD SCI USA, V105, P19360, DOI 10.1073/pnas.0810106105; RAGHUKUMAR S, 1987, BOT MAR, V30, P83, DOI 10.1515/botm.1987.30.1.83; Rose Annkatrin, 2008, V9, P207, DOI 10.1007/7089_2007_128; Schiffbauer JD, 2012, GEOLOGY, V40, P223, DOI 10.1130/G32546.1; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Xiao SH, 2002, PALEOBIOLOGY, V28, P244, DOI 10.1666/0094-8373(2002)028<0244:MTAMON>2.0.CO;2; Xiao SH, 2007, NATURE, V446, pE9, DOI 10.1038/nature05753; Xiao SH, 2007, GEOLOGY, V35, P115, DOI 10.1130/G23277A.1; Xue Yao-song, 1995, Acta Palaeontologica Sinica, V34, P688; Yin CY, 2004, ACTA PALAEONTOL POL, V49, P1; Yin LM, 2007, NATURE, V446, P661, DOI 10.1038/nature05682; Yin ZJ, 2013, PRECAMBRIAN RES, V225, P44, DOI 10.1016/j.precamres.2011.08.011	34	115	125	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1696	1699		10.1126/science.1209537	http://dx.doi.org/10.1126/science.1209537			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194575				2022-12-24	WOS:000298344000065
J	Tomasello, M; Call, J				Tomasello, Michael; Call, Josep			Methodological Challenges in the Study of Primate Cognition	SCIENCE			English	Editorial Material								Laboratory studies of primate cognition face the problem that captive populations of a species are not always comparable, and generalizations to natural populations are never certain. Studies of primate cognition in the field face the problem that replications are expensive and difficult, and again different populations are not always comparable. To help remedy these problems, we recommend the creation of data banks where primary data and videotapes may be deposited (perhaps as a requirement of publication) to facilitate cross-examination, replication, and, eventually, the pooling of data across investigators.	[Tomasello, Michael; Call, Josep] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	Max Planck Society	Tomasello, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	tomas@eva.mpg.de; call@eva.mpg.de		Call Balaguer, Josep/0000-0002-8597-8336				Cheney D. L., 1990, MONKEYS SEE WORLD IN; Inoue S, 2007, CURR BIOL, V17, pR1004, DOI 10.1016/j.cub.2007.10.027; MCGREW WC, 1989, COMP SOCIOECOLOGY BE, P457; MENZEL CR, 1991, ANIM BEHAV, V41, P397, DOI 10.1016/S0003-3472(05)80840-1; Miller G, 2010, SCIENCE, V329, P890, DOI 10.1126/science.329.5994.890-b; Ryan MJ, 2011, SCIENCE, V334, P1229, DOI 10.1126/science.1214532; SAVAGERUMBAUGH ES, 1993, MONOGRAFS SOC RES CH, V233, P3; Tomasello M, 1997, PRIMATE COGNITION; Visalberghi E, 2009, CURR BIOL, V19, P213, DOI 10.1016/j.cub.2008.11.064	9	35	37	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1227	1228		10.1126/science.1213443	http://dx.doi.org/10.1126/science.1213443			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144614				2022-12-24	WOS:000297553600035
J	Mitchell, AD; Studdert, DM				Mitchell, Andrew D.; Studdert, David M.			Plain Packaging of Tobacco Products in Australia A Novel Regulation Faces Legal Challenge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mitchell, Andrew D.; Studdert, David M.] Univ Melbourne, Melbourne Law Sch, Parkville, Vic 3052, Australia	University of Melbourne	Studdert, DM (corresponding author), Univ Melbourne, Melbourne Law Sch, 207 Bouverie St, Parkville, Vic 3052, Australia.	d.studdert@unimelb.edu.au	Mitchell, Andrew D/AAO-3714-2021; Studdert, David/AAF-3116-2021	Mitchell, Andrew D/0000-0001-8399-8563; Studdert, David/0000-0003-0585-5537				[Anonymous], PAR CONV PROT IND PR; [Anonymous], ROL MED PROM RED TOB; [Anonymous], WORLD TRAD ORG MIN C; Gervais D, ANAL COMPATIBILITY C; Kerr C, 2011, AUSTRALIAN      1114; [No title captured]	6	25	25	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2012	307	3					261	262		10.1001/jama.2011.2009	http://dx.doi.org/10.1001/jama.2011.2009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877EY	22253391				2022-12-24	WOS:000299161200020
J	Miller, DC; Hollenbeck, BK				Miller, David C.; Hollenbeck, Brent K.			Missing the Mark on Prostate-Specific Antigen Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CANCER MORTALITY		[Miller, David C.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Miller, DC (corresponding author), Univ Michigan, Dept Urol, 2800 Plymouth Rd,NCRC Bldg 520,3rd Floor, Ann Arbor, MI 48109 USA.	dcmiller@umich.edu						Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Carroll PR, 2005, J UROLOGY, V173, P1061, DOI 10.1097/01.ju.0000156838.67623.10; Collin SM, 2008, LANCET ONCOL, V9, P445, DOI 10.1016/S1470-2045(08)70104-9; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Phillips C, STUDY QUESTIONS BENE; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; US Preventive Services Task Force, SCREEN PROST CANC US; Walter LC, 2006, JAMA-J AM MED ASSOC, V296, P2336, DOI 10.1001/jama.296.19.2336	10	15	15	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2719	2720		10.1001/jama.2011.1879	http://dx.doi.org/10.1001/jama.2011.1879			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22203542				2022-12-24	WOS:000298484000024
J	Lota, AS; Manisty, CH; Sutton, R; Francis, DP				Lota, Amrit S.; Manisty, Charlotte H.; Sutton, Richard; Francis, Darrel P.			CHRISTMAS 2011: PROFESSIONAL MATTERS When is a "free" registrar in clinic not free?	BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To investigate whether using registrars (doctors undergoing higher specialist training, whose salary is reimbursed) rather than consultants in outpatient clinics saves money Design Development of a formula calculating the economic breakeven point and application to retrospective audit data from 273 outpatient consultations. Setting General cardiology outpatient clinic in a secondary and tertiary referral NHS hospital. Outcomes Difference in probability of a registrar and a consultant making a diagnostic decision that completes a clinical episode. Use of UK costings for consultant salaries and outpatient attendances to determine the economic breakeven point. Results The formula showed that if a registrar's episode completing probability is 12 percentage points lower than that of a consultant, then using a registrar costs the hospital more. Real life data showed that episode completion probabilities are 43 percentage points lower for registrars than for consultants (26% versus 69%, 95% CI 32% to 54%, P<0.0001). Conclusion It is wrong to assume that external reimbursement of registrar salaries makes them a money saving option for staffing clinics. The apparent service role of a registrar can be a disservice.	[Lota, Amrit S.; Manisty, Charlotte H.; Sutton, Richard; Francis, Darrel P.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1LA, England	Imperial College London	Lota, AS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1LA, England.	amrit.lota@doctors.org.uk	Manisty, Charlotte/AAN-3723-2021	Manisty, Charlotte/0000-0003-0245-7090	British Heart Foundation [FS/10/38/28268] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		[Anonymous], 2011, BMJ CAREERS; Department of Health, NHS PAYM RES 2010 11; KASHIWAGI DT, 2011, AM J MED QUAL   0810; Medford ARL, 2008, QUAL SAF HEALTH CARE, V17, P79, DOI 10.1136/qshc.2007.023234; ROBINSON S, 2011, NHS INNOVATIONS 0125; Virgil, AENEID, VII; WYNNE K, 2009, BMJ CAREERS	7	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2011	343								d7869	10.1136/bmj.d7869	http://dx.doi.org/10.1136/bmj.d7869			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868QK	22187189				2022-12-24	WOS:000298538200010
J	Stanaway, FF; Gnjidic, D; Blyth, FM; Le Couteur, DG; Naganathan, V; Waite, L; Seibel, MJ; Handelsman, DJ; Sambrook, PN; Cumming, RG				Stanaway, Fiona F.; Gnjidic, Danijela; Blyth, Fiona M.; Le Couteur, David G.; Naganathan, Vasi; Waite, Louise; Seibel, Markus J.; Handelsman, David J.; Sambrook, Philip N.; Cumming, Robert G.			CHRISTMAS 2011: DEATH'S DOMINION How fast does the Grim Reaper walk? Receiver operating characteristics curve analysis in healthy men aged 70 and over	BRITISH MEDICAL JOURNAL			English	Editorial Material							OLDER-ADULTS; OSTEOPOROTIC FRACTURES; BODY-COMPOSITION; GAIT SPEED; INDEX	Objective To determine the speed at which the Grim Reaper (or Death) walks. Design Population based prospective study. Setting Older community dwelling men living in Sydney, Australia. Participants 1705 men aged 70 or more participating in CHAMP (Concord Health and Ageing in Men Project). Main outcome measures Walking speed (m/s) and mortality. Receiver operating characteristics curve analysis was used to calculate the area under the curve for walking speed and determine the walking speed of the Grim Reaper. The optimal walking speed was estimated using the Youden index (sensitivity+specificity-1), a common summary measure of the receiver operating characteristics curve, and represents the maximum potential effectiveness of a marker. Results The mean walking speed was 0.88 (range 0.15-1.60) m/s. The highest Youden index (0.293) was observed at a walking speed of 0.82 m/s (2 miles (about 3 km) per hour), corresponding to a sensitivity of 63% and a specificity of 70% for mortality. Survival analysis showed that older men who walked faster than 0.82 m/s were 1.23 times less likely to die (95% confidence interval 1.10 to 1.37) than those who walked slower (P=0.0003). A sensitivity of 1.0 was obtained when a walking speed of 1.36 m/s (3 miles (about 5 km) per hour) or greater was used, indicating that no men with walking speeds of 1.36 m/s or greater had contact with Death. Conclusion The Grim Reaper's preferred walking speed is 0.82 m/s (2 miles (about 3 km) per hour) under working conditions. As none of the men in the study with walking speeds of 1.36 m/s (3 miles (about 5 km) per hour) or greater had contact with Death, this seems to be the Grim Reaper's most likely maximum speed; for those wishing to avoid their allotted fate, this would be the advised walking speed.	[Gnjidic, Danijela; Blyth, Fiona M.; Le Couteur, David G.; Naganathan, Vasi; Waite, Louise; Handelsman, David J.; Sambrook, Philip N.; Cumming, Robert G.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Stanaway, Fiona F.; Cumming, Robert G.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Gnjidic, Danijela] Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW, Australia; [Gnjidic, Danijela] Royal N Shore Hosp, Dept Aged Care, Sydney, NSW, Australia; [Gnjidic, Danijela; Blyth, Fiona M.; Le Couteur, David G.; Naganathan, Vasi; Waite, Louise; Cumming, Robert G.] Concord Hosp, Ctr Educ & Res Ageing, Sydney, NSW, Australia; [Blyth, Fiona M.] Sax Inst, Sydney, NSW, Australia; [Le Couteur, David G.; Seibel, Markus J.; Handelsman, David J.] Concord Hosp, ANZAC Res Inst, Sydney, NSW, Australia; [Sambrook, Philip N.] Royal N Shore Hosp, Inst Bone & Joint Res, Kolling Inst Med Res, Sydney, NSW, Australia	University of Sydney; University of Sydney; Royal North Shore Hospital; University of Sydney; Royal North Shore Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Gnjidic, D (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.	danijela.gnjidic@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Handelsman, David/AAR-9580-2021; Ekanayake, Kanchana/P-8817-2016; Cumming, Robert G/R-1548-2016	Cumming, Robert G/0000-0002-0261-6103; Le Couteur, David/0000-0002-4227-5817; Waite, Louise/0000-0001-9056-6996; Naganathan, Vasikaran/0000-0001-7243-0796; Seibel, Markus J/0000-0002-2701-378X; Handelsman, David/0000-0002-4200-7476	Australian National Health and Medical Research Council [301916]; Sydney Medical School Foundation; Ageing and Alzheimer's Research Foundation	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical School Foundation; Ageing and Alzheimer's Research Foundation	The CHAMP study is funded by the Australian National Health and Medical Research Council (grant No 301916), Sydney Medical School Foundation, and Ageing and Alzheimer's Research Foundation. The funding source had no involvement in the study design, analysis, interpretation, or decision to submit this work.	Andrew SG, 1989, AUST J AGEING, V8, P31; Bergman I, 1957, 7 INSEGLET; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; Cumming RG, 2009, INT J EPIDEMIOL, V38, P374, DOI 10.1093/ije/dyn071; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gnjidic D., 2011, ANN MED; Gnjidic D, 2009, BRIT J CLIN PHARMACO, V68, P97, DOI 10.1111/j.1365-2125.2009.03411.x; Longfellow HW., 1902, COMPLETE POETICAL WO, P345; NGUYEN T, 1993, BRIT MED J, V307, P1111, DOI 10.1136/bmj.307.6912.1111; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Pratchett T., 1985, COLOUR MAGIC; Pratchett T., 1998, MORT; Pratchett Terry, 1992, REAPER MAN; Rosano C, 2008, J AM GERIATR SOC, V56, P1618, DOI 10.1111/j.1532-5415.2008.01856.x; Rowling J.K, 2007, HARRY POTTER DEATHLY; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923	18	67	67	2	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2011	343								d7679	10.1136/bmj.d7679	http://dx.doi.org/10.1136/bmj.d7679			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888WF	22174324	hybrid, Green Published			2022-12-24	WOS:000300034600009
J	Shen, SZ; Crowley, JL; Wang, Y; Bowring, SA; Erwin, DH; Sadler, PM; Cao, CQ; Rothman, DH; Henderson, CM; Ramezani, J; Zhang, H; Shen, YN; Wang, XD; Wang, W; Mu, L; Li, WZ; Tang, YG; Liu, XL; Liu, LJ; Zeng, Y; Jiang, YF; Jin, YG				Shen, Shu-zhong; Crowley, James L.; Wang, Yue; Bowring, Samuel A.; Erwin, Douglas H.; Sadler, Peter M.; Cao, Chang-qun; Rothman, Daniel H.; Henderson, Charles M.; Ramezani, Jahandar; Zhang, Hua; Shen, Yanan; Wang, Xiang-dong; Wang, Wei; Mu, Lin; Li, Wen-zhong; Tang, Yue-gang; Liu, Xiao-lei; Liu, Lu-jun; Zeng, Yong; Jiang, Yao-fa; Jin, Yu-gan			Calibrating the End-Permian Mass Extinction	SCIENCE			English	Article							TRIASSIC BOUNDARY; BIOTIC CRISIS; SOUTH CHINA; CARBON-CYCLE; MARINE; EVENT; RECOVERY; COAL; OCEANS; ROCKS	The end-Permian mass extinction was the most severe biodiversity crisis in Earth history. To better constrain the timing, and ultimately the causes of this event, we collected a suite of geochronologic, isotopic, and biostratigraphic data on several well-preserved sedimentary sections in South China. High-precision U-Pb dating reveals that the extinction peak occurred just before 252.28 +/- 0.08 million years ago, after a decline of 2 per mil (parts per thousand) in delta(13)C over 90,000 years, and coincided with a delta(13)C excursion of -5 parts per thousand that is estimated to have lasted <= 20,000 years. The extinction interval was less than 200,000 years and synchronous in marine and terrestrial realms; associated charcoal-rich and soot-bearing layers indicate widespread wildfires on land. A massive release of thermogenic carbon dioxide and/or methane may have caused the catastrophic extinction.	[Shen, Shu-zhong; Wang, Yue; Cao, Chang-qun; Zhang, Hua; Shen, Yanan; Wang, Xiang-dong; Wang, Wei; Mu, Lin; Li, Wen-zhong; Liu, Xiao-lei; Liu, Lu-jun; Jin, Yu-gan] Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Peoples R China; [Crowley, James L.; Bowring, Samuel A.; Rothman, Daniel H.; Ramezani, Jahandar] MIT, Dept Earth Atmospher & Planetary Sci, Boston, MA 02130 USA; [Crowley, James L.] Boise State Univ, Dept Geosci, Boise, ID 83725 USA; [Erwin, Douglas H.] Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Erwin, Douglas H.] Santa Fe Inst, Santa Fe, NM 87591 USA; [Sadler, Peter M.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Rothman, Daniel H.] MIT, Lorenz Ctr, Cambridge, MA 02139 USA; [Henderson, Charles M.] Univ Calgary, Dept Geosci, Calgary, AB T2N 1N4, Canada; [Shen, Yanan] Univ Sci & Technol China, Sch Earth & Space Sci, CAS Key Lab Crust Mantle Mat & Environm, Hefei 230026, Peoples R China; [Li, Wen-zhong] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic 3125, Australia; [Tang, Yue-gang] China Univ Min & Technol, Dept Geol, Beijing 100083, Peoples R China; [Liu, Xiao-lei] Univ Bremen, D-28359 Bremen, Germany; [Zeng, Yong] China Univ Min & Technol, Sch Resources & Geosci, Xuzhou 221008, Jiangsu, Peoples R China; [Jiang, Yao-fa] Jiangsu Geol Survey Architectural Inst, Xuzhou 221116, Jiangsu, Peoples R China	Chinese Academy of Sciences; Massachusetts Institute of Technology (MIT); Idaho; Boise State University; Smithsonian Institution; Smithsonian National Museum of Natural History; The Santa Fe Institute; University of California System; University of California Riverside; Massachusetts Institute of Technology (MIT); University of Calgary; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Deakin University; China University of Mining & Technology; University of Bremen; China University of Mining & Technology	Shen, SZ (corresponding author), Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, 39 E Beijing Rd, Nanjing 210008, Peoples R China.	szshen@nigpas.ac.cn; sbowring@mit.edu	WANG, Wei/H-4825-2011; Shen, Shuzhong/D-8214-2011; Shen, Yanan/L-3724-2018	Shen, Shuzhong/0000-0001-8380-0692; Sadler, Peter/0000-0002-7728-0042; Crowley, James/0000-0001-5069-0773; Erwin, Douglas/0000-0003-2518-5614; Shen, Yanan/0000-0001-8343-6763	National Natural Science Foundation of China; National Basic Research Program of China [2006CB806400, 2011CB808905]; Chinese Academy of Sciences (CAS)/State Administration of Foreign Experts Affairs of China (SAFEA); CAS [KZCX2-YW-Q08-4]; basic research program of Jiangsu Province for the Nanjing Group [BK2010022]; U.S. National Aeronautics and Space Administration (NASA) Astrobiology Institute; NASA [NNX09AM88G, NNA08CN84A]; Natural Sciences and Engineering Research Council of Canada (NSERC)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences (CAS)/State Administration of Foreign Experts Affairs of China (SAFEA)(Chinese Academy of Sciences); CAS(Chinese Academy of Sciences); basic research program of Jiangsu Province for the Nanjing Group; U.S. National Aeronautics and Space Administration (NASA) Astrobiology Institute(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by National Natural Science Foundation of China, the National Basic Research Program of China (2006CB806400, 2011CB808905), the Chinese Academy of Sciences (CAS)/State Administration of Foreign Experts Affairs of China (SAFEA) International Partnership Program, and CAS grants KZCX2-YW-Q08-4 and BK2010022 of the basic research program of Jiangsu Province for the Nanjing Group. Further support was provided by a U.S. National Aeronautics and Space Administration (NASA) Astrobiology Institute Grant (to S. A. B. and D. H. E.), NASA Exobiology Program grant NNX09AM88G (to C. Q. C.), NASA grant NNA08CN84A (to D. H. R.), and a Discovery Grant of the Natural Sciences and Engineering Research Council of Canada (NSERC) (to C. M. H.). All data are available in the supporting online material. Author contributions: This paper is dedicated to Prof. Y. G. Jin, who initiated the China-U.S. joint research with S. A. B. and D. H. E. S. A. B., D. H. E., S.Z.S., and Y. W. wrote the paper with inputs from J.L.C., C. M. H., D. H. R., and P. M. S. All geochronologic ages were produced by S. A. B. and J.L.C. Diversity pattern analysis using CONOP was carried out by Y. W. and P. M. S. with the database established by Y. W. and S.Z.S. Biostratigraphy was analyzed by S.Z.S., C. M. H., and Y. W. Carbon isotope dynamic model based on the Meishan section was conducted by D. H. R. with the data from C. Q. C. All data from the terrestrial and transitional sections were analyzed by S.Z.S. and other coauthors of the Nanjing group. All authors joined in field work and contributed to the interpretation of the data.	Algeo TJ, 2011, PALAEOGEOGR PALAEOCL, V308, P1, DOI 10.1016/j.palaeo.2011.01.011; Becker L, 2001, SCIENCE, V291, P1530, DOI 10.1126/science.1057243; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; Brennecka GA, 2011, P NATL ACAD SCI USA, V108, P17631, DOI 10.1073/pnas.1106039108; Cao CQ, 2009, EARTH PLANET SC LETT, V281, P188, DOI 10.1016/j.epsl.2009.02.012; de Wit MJ, 2002, J GEOL, V110, P227, DOI 10.1086/338411; Erwin D. H, 1993, GREAT PALEOZOIC CRIS; ERWIN DH, 2005, EXTINCTION; Grasby SE, 2011, NAT GEOSCI, V4, P104, DOI [10.1038/ngeo1069, 10.1038/NGEO1069]; Grice K, 2005, SCIENCE, V307, P706, DOI 10.1126/science.1104323; Holser W. T., 1988, CHEM CYCLES EVOLUTIO, P105; Huey RB, 2005, SCIENCE, V308, P398, DOI 10.1126/science.1108019; Isozaki Y, 1997, SCIENCE, V276, P235, DOI 10.1126/science.276.5310.235; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; Kamo SL, 2003, EARTH PLANET SC LETT, V214, P75, DOI 10.1016/S0012-821X(03)00347-9; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Krull ES, 2004, PALAEOGEOGR PALAEOCL, V204, P297, DOI 10.1016/S0031-0182(03)00732-6; Looy CV, 2001, P NATL ACAD SCI USA, V98, P7879, DOI 10.1073/pnas.131218098; Milkov AV, 2004, EARTH-SCI REV, V66, P183, DOI 10.1016/j.earscirev.2003.11.002; Mundil R, 2001, EARTH PLANET SC LETT, V187, P131, DOI 10.1016/S0012-821X(01)00274-6; Mundil R, 2004, SCIENCE, V305, P1760, DOI 10.1126/science.1101012; Nabbefeld B, 2010, APPL GEOCHEM, V25, P1374, DOI 10.1016/j.apgeochem.2010.06.008; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Payne JL, 2007, GEOL SOC AM BULL, V119, P771, DOI 10.1130/B26091.1; Peng YQ, 2006, J ASIAN EARTH SCI, V28, P291, DOI 10.1016/j.jseaes.2005.10.007; RENNE PR, 1995, SCIENCE, V269, P1413, DOI 10.1126/science.269.5229.1413; Retallack GJ, 1996, GEOL SOC AM BULL, V108, P195, DOI 10.1130/0016-7606(1996)108<0195:GCGBPT>2.3.CO;2; Retallack GJ, 2008, J GEOL, V116, P1, DOI 10.1086/524120; Riccardi A, 2007, PALAEOGEOGR PALAEOCL, V248, P73, DOI 10.1016/j.palaeo.2006.11.010; Sephton MA, 2005, GEOLOGY, V33, P941, DOI 10.1130/G21784.1; Shen Shu Zhong, 2006, Palaeoworld, V15, P3, DOI 10.1016/j.palwor.2006.03.005; Shen WJ, 2011, GEOCHIM COSMOCHIM AC, V75, P1992, DOI 10.1016/j.gca.2011.01.027; Svensen H, 2009, EARTH PLANET SC LETT, V277, P490, DOI 10.1016/j.epsl.2008.11.015; Thomas BM, 2004, AUST J EARTH SCI, V51, P423, DOI 10.1111/j.1400-0952.2004.01066.x; Twitchett RJ, 2001, GEOLOGY, V29, P351, DOI 10.1130/0091-7613(2001)029<0351:RASCOM>2.0.CO;2; Visscher H, 2011, GEOLOGY, V39, P883, DOI 10.1130/G32178.1; Ward PD, 2005, SCIENCE, V307, P709, DOI 10.1126/science.1107068; Xie SC, 2007, GEOLOGY, V35, P1083, DOI 10.1130/G24224A.1; Yin HF, 2007, GLOBAL PLANET CHANGE, V55, P1, DOI 10.1016/j.gloplacha.2006.06.005	39	538	628	25	570	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1367	1372		10.1126/science.1213454	http://dx.doi.org/10.1126/science.1213454			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22096103				2022-12-24	WOS:000297787700043
J	Nagib, DA; MacMillan, DWC				Nagib, David A.; MacMillan, David W. C.			Trifluoromethylation of arenes and heteroarenes by means of photoredox catalysis	NATURE			English	Article							FLUORINE; ELECTROCHEMISTRY; COMPLEXES	Modern drug discovery relies on the continual development of synthetic methodology to address the many challenges associated with the design of new pharmaceutical agents(1). One such challenge arises from the enzymatic metabolism of drugs in vivo by cytochrome P450 oxidases, which use single-electron oxidative mechanisms to rapidly modify small molecules to facilitate their excretion(2). A commonly used synthetic strategy to protect against in vivo metabolism involves the incorporation of electron-withdrawing functionality, such as the trifluoromethyl (CF3) group, into drug candidates(3). The CF3 group enjoys a privileged role in the realm of medicinal chemistry because its incorporation into small molecules often enhances efficacy by promoting electrostatic interactions with targets, improving cellular membrane permeability, and increasing robustness towards oxidative metabolism of the drug(4-6). Although common pharmacophores often bear CF3 motifs in an aromatic system, access to such analogues typically requires the incorporation of the CF3 group, or a surrogate moiety, at the start of a multi-step synthetic sequence. Here we report a mild, operationally simple strategy for the direct trifluoromethylation of unactivated arenes and heteroarenes through a radical-mediated mechanism using commercial photocatalysts and a household light bulb. We demonstrate the broad utility of this transformation through addition of CF3 to a number of heteroaromatic and aromatic systems. The benefit to medicinal chemistry and applicability to late-stage drug development is also shown through examples of the direct trifluoromethylation of widely prescribed pharmaceutical agents.	[Nagib, David A.; MacMillan, David W. C.] Princeton Univ, Dept Chem, Merck Ctr Catalysis, Frick Lab 192, Princeton, NJ 08540 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Dept Chem, Merck Ctr Catalysis, Frick Lab 192, Princeton, NJ 08540 USA.	dmacmill@princeton.edu	Nagib, David A/B-6618-2014	Nagib, David/0000-0002-2275-6381	NIH General Medical Sciences [R01 01 GM093213-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093213] Funding Source: NIH RePORTER	NIH General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by the NIH General Medical Sciences (R01 01 GM093213-01) and gifts from Merck, Amgen, Abbott and Bristol-Myers Squibb. We thank C. Kraml and N. Byrne of Lotus Separations LLC for their development of preparatory supercritical fluid chromatography (SFC) methods and for the separation of all three CF<INF>3</INF>-Lipitor analogues.	ANDRIEUX CP, 1990, J AM CHEM SOC, V112, P3509, DOI 10.1021/ja00165a040; BHATIA K, 1974, J PHYS CHEM-US, V78, P2335; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; DEXTER DL, 1972, CANCER RES, V32, P247; Dolbier WR, 1997, TOP CURR CHEM, V192, P97; Filler R., 1993, ORGANOFLUORINE COMPO; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Heaton C. A., 1989, J FLUORINE CHEM, V45, P86; Heaton CA, 2001, J FLUORINE CHEM, V107, P1, DOI 10.1016/S0022-1139(00)00324-9; Ji YN, 2011, P NATL ACAD SCI USA, V108, P14411, DOI 10.1073/pnas.1109059108; JURIS A, 1988, COORDIN CHEM REV, V84, P85, DOI 10.1016/0010-8545(88)80032-8; KAMIGATA N, 1994, J CHEM SOC PERK T 1, P1339, DOI 10.1039/p19940001339; KAMIGATA N, 1990, CHEM LETT, P649, DOI 10.1246/cl.1990.649; LANGLOIS BR, 1991, TETRAHEDRON LETT, V32, P7525, DOI 10.1016/0040-4039(91)80524-A; Li J. J., 2010, MODERN DRUG SYNTHESI; Montellano P. R. O., 2005, CYTOCHROMEP450 STRUC; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Nagib DA, 2009, J AM CHEM SOC, V131, P10875, DOI 10.1021/ja9053338; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Oishi M, 2009, CHEM COMMUN, P1909, DOI 10.1039/b823249k; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Roth BD, 2002, PROGR MED CHEM, V40, P1, DOI 10.1016/S0079-6468(08)70080-8; SKARDA V, 1984, J CHEM SOC PERK T 2, P1309, DOI 10.1039/p29840001309; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293; Wang XS, 2010, J AM CHEM SOC, V132, P3648, DOI 10.1021/ja909522s; Wiehn MS, 2010, J FLUORINE CHEM, V131, P951, DOI 10.1016/j.jfluchem.2010.06.020; Xu J, 2011, CHEM COMMUN, V47, P4300, DOI 10.1039/c1cc10359h; Yoon TP, 2010, NAT CHEM, V2, P527, DOI [10.1038/NCHEM.687, 10.1038/nchem.687]	30	976	994	6	630	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2011	480	7376					224	228		10.1038/nature10647	http://dx.doi.org/10.1038/nature10647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22158245	Green Accepted			2022-12-24	WOS:000297744200047
J	Palmer, R				Palmer, Roxanne			Lines of defence	NATURE			English	Editorial Material																			0	11	11	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					S9	S10		10.1038/480S9a	http://dx.doi.org/10.1038/480S9a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	857TR	22158299	Bronze			2022-12-24	WOS:000297744200007
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Worst cases of patient care in the NHS	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				2011, BRIT MED J, V343, DOI DOI 10.1136/BMJ.D7237	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 23	2011	343								d7592	10.1136/bmj.d7592	http://dx.doi.org/10.1136/bmj.d7592			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857NE	22113570				2022-12-24	WOS:000297724400009
J	Walkey, AJ; Wiener, RS; Ghobrial, JM; Curtis, LH; Benjamin, EJ				Walkey, Allan J.; Wiener, Renda Soylemez; Ghobrial, Joanna M.; Curtis, Lesley H.; Benjamin, Emelia J.			Incident Stroke and Mortality Associated With New-Onset Atrial Fibrillation in Patients Hospitalized With Severe Sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE ISCHEMIC-STROKE; INTENSIVE-CARE-UNIT; MYOCARDIAL-INFARCTION; PULMONARY-ARTERY; ICD-9-CM CODES; RISK SCORE; INFECTION; ACCURACY; ARRHYTHMIAS; MANAGEMENT	Context New-onset atrial fibrillation (AF) has been reported in 6% to 20% of patients with severe sepsis. Chronic AF is a known risk factor for stroke and death, but the clinical significance of new-onset AF in the setting of severe sepsis is uncertain. Objective To determine the in-hospital stroke and in-hospital mortality risks associated with new-onset AF in patients with severe sepsis. Design and Setting Retrospective population-based cohort of California State Inpatient Database administrative claims data from nonfederal acute care hospitals for January 1 through December 31, 2007. Patients Data were available for 3 144 787 hospitalized adults. Severe sepsis (n=49 082 [1.56%]) was defined by validated International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code 995.92. New-onset AF was defined as AF that occurred during the hospital stay, after excluding AF cases present at admission. Main Outcome Measures A priori outcome measures were in-hospital ischemic stroke (ICD-9-CM codes 433, 434, or 436) and mortality. Results Patients with severe sepsis were a mean age of 69 (SD, 16) years and 48% were women. New-onset AF occurred in 5.9% of patients with severe sepsis vs 0.65% of patients without severe sepsis (multivariable-adjusted odds ratio [OR], 6.82; 95% CI, 6.54-7.11; P < .001). Severe sepsis was present in 14% of all new-onset AF in hospitalized adults. Compared with severe sepsis patients without new-onset AF, patients with new-onset AF during severe sepsis had greater risks of in-hospital stroke (75/2896 [2.6%] vs 306/46 186 [0.6%] strokes; adjusted OR, 2.70; 95% CI, 2.05-3.57; P < .001) and in-hospital mortality (1629 [56%] vs 18 027 [39%] deaths; adjusted relative risk, 1.07; 95% CI, 1.04-1.11; P < .001). Findings were robust across 2 definitions of severe sepsis, multiple methods of addressing confounding, and multiple sensitivity analyses. Conclusion Among patients with severe sepsis, patients with new-onset AF were at increased risk of in-hospital stroke and death compared with patients with no AF and patients with preexisting AF. JAMA. 2011;306(20):2248-2255 Published online November 13, 2011. doi:10.1001/jama.2011.1615	[Walkey, Allan J.; Wiener, Renda Soylemez] Boston Univ, Sch Med, Ctr Pulm, Div Pulm & Crit Care Med, Boston, MA 02118 USA; [Walkey, Allan J.; Wiener, Renda Soylemez; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; [Wiener, Renda Soylemez] Edith Nourse Rogers Mem Vet Adm Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA 01730 USA; [Wiener, Renda Soylemez] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03756 USA; [Ghobrial, Joanna M.] Univ Washington, Sch Med, Dept Med, Div Cardiol, Seattle, WA 98195 USA; [Curtis, Lesley H.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Curtis, Lesley H.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Benjamin, Emelia J.] NHLBI, Framingham, MA USA; [Benjamin, Emelia J.] Boston Univ, Framingham Heart Study, Framingham, MA USA	Boston University; Boston University; Boston University; Boston University; Dartmouth College; University of Washington; University of Washington Seattle; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study	Walkey, AJ (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Div Pulm & Crit Care Med, R-304, Boston, MA 02118 USA.	alwalkey@bu.edu	Wiener, Renda/AAO-1557-2020; Hug, Balthasar L./G-1568-2010; Benjamin, Emelia/E-7103-2011	Walkey, Allan/0000-0003-4685-6894; Wiener, Renda/0000-0001-7712-2135; Benjamin, Emelia/0000-0003-4076-2336	Boston University Clinical Translational Research Institute [UL1RR025771]; Evans Center for Interdisciplinary Biomedical Research ARC on Atrial Fibrillation at Boston University; National Heart, Lung, and Blood Institute [1R01HL092577, 1RC1HL101056, 1R01 HL102214]; National Cancer Institute [K07 CA138772]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [K07CA138772] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092577, R01HL102214, RC1HL101056] Funding Source: NIH RePORTER	Boston University Clinical Translational Research Institute; Evans Center for Interdisciplinary Biomedical Research ARC on Atrial Fibrillation at Boston University; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by grant UL1RR025771 from the Boston University Clinical Translational Research Institute (Dr Walkey); by the Evans Center for Interdisciplinary Biomedical Research ARC on Atrial Fibrillation at Boston University (http://www.bumc.bu.edu/evanscenteribr/) (Drs Walkey, Curtis, and Benjamin); by National Heart, Lung, and Blood Institute grants 1R01HL092577 and 1RC1HL101056 (Dr Benjamin) and 1R01 HL102214 (Drs Curtis and Benjamin); by National Cancer Institute grant K07 CA138772 (Dr Wiener); and by the Department of Veterans Affairs (Dr Wiener).	Agency for Healthcare Research and Quality, OV STAT INP DAT SID; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2008, AM J RESP CRIT CARE, V178, P20, DOI 10.1164/rccm.200701-031OC; Arora S, 2007, ANAESTH INTENS CARE, V35, P707, DOI 10.1177/0310057X0703500508; ARTUCIO H, 1990, CRIT CARE MED, V18, P1383, DOI 10.1097/00003246-199012000-00015; Benesch C, 1997, NEUROLOGY, V49, P660, DOI 10.1212/WNL.49.3.660; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Buch P, 2003, EUR RESPIR J, V21, P1012, DOI 10.1183/09031936.03.00051502; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chamberlain AM, 2011, AM J CARDIOL, V107, P85, DOI 10.1016/j.amjcard.2010.08.049; Christian SA, 2008, J CRIT CARE, V23, P532, DOI 10.1016/j.jcrc.2007.09.005; Coffey R, 2006, 200601 HCUP; Elijovich L, 2009, J STROKE CEREBROVASC, V18, P185, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.005; Elkind MSV, 2011, STROKE, V42, P1851, DOI 10.1161/STROKEAHA.110.608588; Fatema K, 2009, AM J HEMATOL, V84, P499, DOI 10.1002/ajh.21459; Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; GIBBS HR, 1992, J SURG ONCOL, V50, P224, DOI 10.1002/jso.2930500405; Glance LG, 2006, HEALTH SERV RES, V41, P1413, DOI 10.1111/j.1475-6773.2006.00554.x; Glance LG, 2006, HEALTH SERV RES, V41, P231, DOI 10.1111/j.1475-6773.2005.00419.x; Glazer NL, 2007, ARCH INTERN MED, V167, P246, DOI 10.1001/archinte.167.3.246; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Goodman S, 2007, ANESTH ANALG, V104, P880, DOI 10.1213/01.ane.0000255759.41131.05; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; Hidalgo JD, 2004, BONE MARROW TRANSPL, V34, P615, DOI 10.1038/sj.bmt.1704623; Kreutz RP, 2005, J THROMB HAEMOST, V3, P2108, DOI 10.1111/j.1538-7836.2005.01474.x; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Meierhenrich R, 2010, CRIT CARE, V14, DOI 10.1186/cc9057; Parsons LS, 2000, P 25 ANN SAS US GROU, P1166; Poulose JT, 2009, AM J RESP CRIT CARE, V179, pA4691; Quan H, 2004, J CLIN EPIDEMIOL, V57, P366, DOI 10.1016/j.jclinepi.2003.01.002; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Salman Salam, 2008, J Intensive Care Med, V23, P178, DOI 10.1177/0885066608315838; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; STODDARD MF, 1995, J AM COLL CARDIOL, V25, P452, DOI 10.1016/0735-1097(94)00396-8; Suissa S, 2003, AM J RESP CRIT CARE, V168, P49, DOI 10.1164/rccm.200210-1231OC; SYRJANEN J, 1988, BRIT MED J, V296, P1156, DOI 10.1136/bmj.296.6630.1156; SYRJANEN J, 1989, SCAND J INFECT DIS, V21, P285, DOI 10.3109/00365548909035698; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213; Winkelmayer WC, 2011, J AM SOC NEPHROL, V22, P349, DOI 10.1681/ASN.2010050459; Zeerleder S, 2005, CHEST, V128, P2864, DOI 10.1378/chest.128.4.2864; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; Zurru MC, 2009, STROKE, V40, P1986, DOI 10.1161/STROKEAHA.108.535559	46	290	299	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2011	306	20					2248	2255		10.1001/jama.2011.1615	http://dx.doi.org/10.1001/jama.2011.1615			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851GD	22081378	Green Accepted			2022-12-24	WOS:000297255500024
J	Greenwood, JP; Maredia, N; Younger, JF; Brown, JM; Nixon, J; Everett, CC; Bijsterveld, P; Ridgway, JP; Radjenovic, A; Dickinson, CJ; Ball, SG; Plein, S				Greenwood, John P.; Maredia, Neil; Younger, John F.; Brown, Julia M.; Nixon, Jane; Everett, Colin C.; Bijsterveld, Petra; Ridgway, John P.; Radjenovic, Aleksandra; Dickinson, Catherine J.; Ball, Stephen G.; Plein, Sven			Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial	LANCET			English	Article							ARTERY-DISEASE; MYOCARDIAL-PERFUSION; MULTICENTER; ANGIOGRAPHY; CARDIOLOGY; COMMITTEE; ISCHEMIA; RESERVE; CARE	Background In patients with suspected coronary heart disease, single-photon emission computed tomography (SPECT) is the most widely used test for the assessment of myocardial ischaemia, but its diagnostic accuracy is reported to be variable and it exposes patients to ionising radiation. The aim of this study was to establish the diagnostic accuracy of a multi parametric cardiovascular magnetic resonance (CMR) protocol with x-ray coronary angiography as the reference standard, and to compare CMR with SPECT, in patients with suspected coronary heart disease. Methods In this prospective trial patients with suspected angina pectoris and at least one cardiovascular risk factor were scheduled for CMR, SPECT, and invasive x-ray coronary angiography. CMR consisted of rest and adenosine stress perfusion, cine imaging, late gadolinium enhancement, and MR coronary angiography. Gated adenosine stress and rest SPECT used Tc-99m tetrofosmin. The primary outcome was diagnostic accuracy of CMR. This trial is registered at controlled-trials.com, number ISRCTN77246133. Findings In the 752 recruited patients, 39% had significant CHD as identified by x-ray angiography. For multiparametric CMR the sensitivity was 86.5% (95% CI 81.8-90.1), specificity 83.4% (79.5-86.7), positive predictive value 77.2%, (72.1-81.6) and negative predictive value 90.5% (87.1-93.0). The sensitivity of SPECT was 66.5% (95% CI 60.4-72.1), specificity 82.6% (78.5-86.1), positive predictive value 71.4% (65.3-76.9), and negative predictive value 79.1% (74.8-82.8). The sensitivity and negative predictive value of CMR and SPECT differed significantly (p<0.0001 for both) but specificity and positive predictive value did not (p=0.916 and p=0.061, respectively). Interpretation CE-MARC is the largest, prospective, real world evaluation of CMR and has established CMR's high diagnostic accuracy in coronary heart disease and CMR's superiority over SPECT. It should be adopted more widely than at present for the investigation of coronary heart disease.	[Greenwood, John P.; Maredia, Neil; Younger, John F.; Bijsterveld, Petra; Radjenovic, Aleksandra; Ball, Stephen G.; Plein, Sven] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England; [Greenwood, John P.; Maredia, Neil; Younger, John F.; Bijsterveld, Petra; Radjenovic, Aleksandra; Ball, Stephen G.; Plein, Sven] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [Brown, Julia M.; Nixon, Jane; Everett, Colin C.] Univ Leeds, Clin Trials Res Unit, Leeds, W Yorkshire, England; [Ridgway, John P.] Leeds Gen Infirm, Dept Med Phys, Leeds LS1 3EX, W Yorkshire, England; [Dickinson, Catherine J.] Leeds Gen Infirm, Dept Nucl Cardiol, Leeds LS1 3EX, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; Leeds General Infirmary; University of Leeds; Leeds General Infirmary; University of Leeds	Greenwood, JP (corresponding author), Leeds Gen Infirm, Dept Cardiol, G Floor,Jubilee Wing,Great George St, Leeds LS1 3EX, W Yorkshire, England.	j.greenwood@leeds.ac.uk	Radjenovic, Aleksandra/F-2341-2014	Radjenovic, Aleksandra/0000-0002-1742-6863; brown, julia/0000-0002-2719-7064; Bijsterveld, Petra/0000-0002-9257-5850; Younger, John/0000-0002-3860-4972; Plein, Sven/0000-0002-0997-4384	British Heart Foundation; British Heart Foundation [RG/05/004/18607] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	British Heart Foundation.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Al-Saadi N, 2000, CIRCULATION, V101, P1379, DOI 10.1161/01.CIR.101.12.1379; [Anonymous], CARD DIS; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Giang TH, 2004, EUR HEART J, V25, P1657, DOI 10.1016/j.ehj.2004.06.037; Greenwood JP, 2007, HEART, V93, P1363, DOI 10.1136/hrt.2006.106427; Greenwood JP, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-62; Hamon M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-29; Hendel RC, 2006, J NUCL CARDIOL, V13, P177, DOI 10.1016/j.nuclcard.2006.08.013; Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003; Henzlova MJ, 2006, J NUCL CARDIOL, V13, pe80, DOI DOI 10.1016/j.nuclcard.2006.08.011; Holly TA, 2010, J NUCL CARDIOL, V17, P941, DOI 10.1007/s12350-010-9246-y; Hundley WG, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-5; Hundley WG, 2010, CIRCULATION, V121, P2462, DOI 10.1161/CIR.0b013e3181d44a8f; Ishida N, 2003, RADIOLOGY, V229, P209, DOI 10.1148/radiol.2291021118; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866; Klem I, 2006, J AM COLL CARDIOL, V47, P1630, DOI 10.1016/j.jacc.2005.10.074; Klem I, 2008, JACC-CARDIOVASC IMAG, V1, P436, DOI 10.1016/j.jcmg.2008.03.010; Kwong RY, 2003, CIRCULATION, V107, P531, DOI 10.1161/01.CIR.0000047527.11221.29; Mowatt G, 2004, HEALTH TECHNOL ASSES, V8, P1; NICE, MYOC PERF SCINT DIAG; Paetsch I, 2004, CIRCULATION, V110, P835, DOI 10.1161/01.CIR.0000138927.00357.FB; Panting JR, 2001, J MAGN RESON IMAGING, V13, P192; Plein S, 2004, J AM COLL CARDIOL, V44, P2173, DOI 10.1016/j.jacc.2004.08.056; Schwitter J, 2001, CIRCULATION, V103, P2230; Schwitter J, 2008, EUR HEART J, V29, P480, DOI 10.1093/eurheartj/ehm617; Shaw LJ, 2006, J AM COLL CARDIOL, V47, p4S, DOI 10.1016/j.jacc.2005.01.072; Tilkemeier PL, 2009, J NUCL CARDIOL, V16, P650, DOI [10.1007/s12350-009-9095-8, DOI 10.1007/S12350-009-9095-8]; Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096; Wolff SD, 2004, CIRCULATION, V110, P732, DOI 10.1161/01.CIR.0000138106.84335.62	32	736	756	3	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2012	379	9814					453	460		10.1016/S0140-6736(11)61335-4	http://dx.doi.org/10.1016/S0140-6736(11)61335-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AF	22196944	Bronze, Green Published			2022-12-24	WOS:000300187800035
J	Costello, C; Gerber, LR; Gaines, S				Costello, Christopher; Gerber, Leah R.; Gaines, Steven			Conservation science: A market approach to saving the whales	NATURE			English	Editorial Material									[Costello, Christopher; Gaines, Steven] Univ Calif Santa Barbara, Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Gerber, Leah R.] Arizona State Univ, Ecol Evolut & Environm Sci Fac, Sch Life Sci, Tempe, AZ 85281 USA	University of California System; University of California Santa Barbara; Arizona State University; Arizona State University-Tempe	Costello, C (corresponding author), Univ Calif Santa Barbara, Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	costello@bren.ucsb.edu	Gaines, Steven/Y-3234-2019	Gerber, Leah/0000-0002-6763-6842				Anderson T, 2011, ANNU REV RESOUR ECON, V3, P159, DOI 10.1146/annurev-resource-083110-120056; [Anonymous], CATCH LIM CATCH TAK; Black R., 2008, BBC NEWS        0617; CLARK CW, 1982, MAR POLICY, V6, P103, DOI 10.1016/0308-597X(82)90065-3; Gerber LR, 2000, AM SCI, V88, P316, DOI 10.1511/2000.29.773; Goulder LH, 2010, J ENVIRON ECON MANAG, V60, P161, DOI 10.1016/j.jeem.2010.06.002; Haltuch MA, 2009, FISH RES, V100, P42, DOI 10.1016/j.fishres.2009.03.001; Pershing AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012444	8	20	20	0	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					139	140		10.1038/481139a	http://dx.doi.org/10.1038/481139a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	874TO	22237092	Bronze			2022-12-24	WOS:000298981200015
J	Libert, S; Pointer, K; Bell, EL; Das, A; Cohen, DE; Asara, JM; Kapur, K; Bergmann, S; Preisig, M; Otowa, T; Kendler, KS; Chen, XN; Hettema, JM; van den Oord, EJ; Rubio, JP; Guarente, L				Libert, Sergiy; Pointer, Kelli; Bell, Eric L.; Das, Abhirup; Cohen, Dena E.; Asara, John M.; Kapur, Karen; Bergmann, Sven; Preisig, Martin; Otowa, Takeshi; Kendler, Kenneth S.; Chen, Xiangning; Hettema, John M.; van den Oord, Edwin J.; Rubio, Justin P.; Guarente, Leonard			SIRT1 Activates MAO-A in the Brain to Mediate Anxiety and Exploratory Drive	CELL			English	Article							INTERNATIONAL HAPMAP PROJECT; CALORIE RESTRICTION; PSYCHIATRIC-DISORDERS; ASSOCIATION; CONTRIBUTES; PLASTICITY; PHENOTYPES; RATIONALE; INTERVIEW; COGNITION	SIRT1 is a NAD(+)-dependent deacetylase that governs a number of genetic programs to cope with changes in the nutritional status of cells and organisms. Behavioral responses to food abundance are important for the survival of higher animals. Here we used mice with increased or decreased brain SIRT1 to show that this sirtuin regulates anxiety and exploratory drive by activating transcription of the gene encoding the monoamine oxidase A (MAO-A) to reduce serotonin levels in the brain. Indeed, treating animals with MAO-A inhibitors or selective serotonin reuptake inhibitors (SSRIs) normalized anxiety differences between wild-type and mutant animals. SIRT1 deacetylates the brain-specific helix-loop-helix transcription factor NHLH2 on lysine 49 to increase its activation of the MAO-A promoter. Both common and rare variations in the SIRT1 gene were shown to be associated with risk of anxiety in human population samples. Together these data indicate that SIRT1 mediates levels of anxiety, and this regulation may be adaptive in a changing environment of food availability.	[Libert, Sergiy; Pointer, Kelli; Bell, Eric L.; Das, Abhirup; Cohen, Dena E.; Guarente, Leonard] MIT, Dept Biol, Paul F Glenn Lab, Cambridge, MA 02139 USA; [Cohen, Dena E.] HHMI Harvard Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Asara, John M.] Dept Med, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kapur, Karen; Bergmann, Sven] Univ Lausanne, Dept Med Genet, CH-1015 Lausanne, Switzerland; [Kapur, Karen; Bergmann, Sven] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Preisig, Martin] CHU Vaudois, Dept Psychiat, CH-1011 Lausanne, Switzerland; [Otowa, Takeshi; Kendler, Kenneth S.; Chen, Xiangning; Hettema, John M.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA 23298 USA; [van den Oord, Edwin J.] Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Dept Pharm, Richmond, VA 23298 USA; [Rubio, Justin P.] GlaxoSmithKline R&D, Quantitat Sci, Stevenage SG1 2NY, Herts, England	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Virginia Commonwealth University; Virginia Commonwealth University; GlaxoSmithKline	Guarente, L (corresponding author), MIT, Dept Biol, Paul F Glenn Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu	Libert, Sergiy/D-8136-2016; Colaus, PsyColaus/K-6607-2013; Das, Abhirup/AAF-5129-2019; Kendler, Kenneth/AAF-2876-2019; Bell, Eric/F-6368-2012	Libert, Sergiy/0000-0003-2497-5390; Pointer, Kelli/0000-0001-9383-0000; Das, Abhirup/0000-0003-1866-457X; RUBIO, JUSTIN/0000-0003-3750-917X; Preisig, Martin/0000-0001-5689-4259; Bergmann, Sven/0000-0002-6785-9034	Leukemia and Lymphoma Society [5089-09]; NIH; Glenn Foundation for Medical Research; Swiss National Science Foundation [3200B0-105993, 3200B0-118308, 33CSC0-122661, 31003A_130691]; GlaxoSmithKline; Swiss Institute of Bioinformatics; European Framework Project 6; National Center for Research Resources [UL1RR031990]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049492, R01MH040828] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GlaxoSmithKline(GlaxoSmithKline); Swiss Institute of Bioinformatics; European Framework Project 6; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to acknowledge Vincent Mooser, Federica Tozzi, Kijuong Song, James Ellis, Enrique Castelao, and Carol Prescott for their contribution to the provision, analysis, and interpretation of human genetic data; and Xuemei Yang for help with mass spectrometry. This work was supported by the fellowship from Leukemia and Lymphoma Society (5089-09) to S. L. and grants from the NIH and a gift from the Glenn Foundation for Medical Research to L. G. The PsyCoLaus study was supported by grants from the Swiss National Science Foundation (#3200B0-105993, #3200B0-118308, #33CSC0-122661) and from GlaxoSmithKline. S. B. was supported by the Swiss National Science Foundation (#31003A_130691), the Swiss Institute of Bioinformatics, and the European Framework Project 6. We are grateful to Mid-Atlantic Twin Registry (MATR) for the ascertainment of VATSPSUD subjects for the replication study. The MATR was supported by grant UL1RR031990 from the National Center for Research Resources. J.R. works for GlaxoSmithKline. L. G. consults for Sirtris (GSK company).	Abe N, 2011, J PSYCHIATR RES, V45, P1106, DOI 10.1016/j.jpsychires.2011.01.016; Aklillu E, 2009, PHARMACOGENET GENOM, V19, P267, DOI 10.1097/FPC.0b013e328328d4d3; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blehar MC, 1994, ARCH GEN PSYCHIAT, V51, P63; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; BROWN L, 1992, P NATL ACAD SCI USA, V89, P8492, DOI 10.1073/pnas.89.18.8492; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chen D, 2008, EXP GERONTOL, V43, P1086, DOI 10.1016/j.exger.2008.08.050; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Coyle CA, 2002, PHYSIOL BEHAV, V77, P387, DOI 10.1016/S0031-9384(02)00885-5; CUNHA JM, 1978, PHARMACOLOGY, V16, P259, DOI 10.1159/000136777; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; FRANKOVA S, 1968, J NUTR, V96, P477; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Good DJ, 2008, EXERC SPORT SCI REV, V36, P187, DOI 10.1097/JES.0b013e31818782dd; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Hettema JM, 2008, BIOL PSYCHIAT, V64, P302, DOI 10.1016/j.biopsych.2008.03.014; Kendler KS, 2001, PSYCHOL MED, V31, P989, DOI 10.1017/S0033291701004226; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kishi T, 2010, J AFFECT DISORDERS, V126, P167, DOI 10.1016/j.jad.2010.04.003; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Minor RK, 2008, BEHAV BRAIN RES, V189, P202, DOI 10.1016/j.bbr.2007.12.030; Nordquist N, 2010, UPSALA J MED SCI, V115, P2, DOI 10.3109/03009730903573246; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Preisig M, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-9; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Spielberger C.D., 1983, MANUAL STATE TRAIT A; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Von Frijtag JC, 2000, BEHAV BRAIN RES, V117, P137, DOI 10.1016/S0166-4328(00)00300-4; Weed JL, 1997, PHYSIOL BEHAV, V62, P97, DOI 10.1016/S0031-9384(97)00147-9; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	40	157	165	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1459	1472		10.1016/j.cell.2011.10.054	http://dx.doi.org/10.1016/j.cell.2011.10.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22169038	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000298403400012
J	Brawley, O; Byers, T; Chen, A; Pignone, M; Ransohoff, D; Schenk, M; Smith, R; Sox, H; Thorson, AG; Wender, R				Brawley, Otis; Byers, Tim; Chen, Amy; Pignone, Michael; Ransohoff, David; Schenk, Maryjean; Smith, Robert; Sox, Harold; Thorson, Alan G.; Wender, Richard			New American Cancer Society Process for Creating Trustworthy Cancer Screening Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE GUIDELINES; COLORECTAL-CANCER; PHYSICIANS	Guidelines for cancer screening written by different organizations often differ, even when they are based on the same evidence. Those dissimilarities can create confusion among health care professionals, the general public, and policy makers. The Institute of Medicine (IOM) recently released 2 reports to establish new standards for developing more trustworthy clinical practice guidelines and conducting systematic evidence reviews that serve as their basis. Because the American Cancer Society (ACS) is an important source of guidance about cancer screening for both health care practitioners and the general public, it has revised its methods to create a more transparent, consistent, and rigorous process for developing and communicating guidelines. The new ACS methods align with the IOM principles for trustworthy clinical guideline development by creating a single generalist group for writing the guidelines, commissioning independent systematic evidence reviews, and clearly articulating the benefits, limitations, and harms associated with a screening test. This new process should ensure that ACS cancer screening guidelines will continue to be a trustworthy source of information for both health care practitioners and the general public to guide clinical practice, personal choice, and public policy about cancer screening. JAMA. 2011;306(22):2495-2499	[Brawley, Otis; Smith, Robert] Amer Canc Soc, Atlanta, GA 30329 USA; [Byers, Tim] Colorado Sch Publ Hlth, Aurora, CO USA; [Chen, Amy] Emory Univ, Sch Med, Dept Otolaryngol & Head & Neck Surg, Atlanta, GA USA; [Pignone, Michael] Univ N Carolina, Sch Med, Dept Gen Internal Med, Chapel Hill, NC USA; [Ransohoff, David] Univ N Carolina, Sch Med, Clin Res Curriculum, Chapel Hill, NC USA; [Schenk, Maryjean] Wayne State Univ, Sch Med, Detroit, MI USA; [Sox, Harold] Dartmouth Med Sch, Dartmouth Inst, W Lebanon, NH USA; [Thorson, Alan G.] Creighton Univ, Dept Surg, Omaha, NE 68178 USA; [Thorson, Alan G.] Univ Nebraska, Omaha, NE 68182 USA; [Wender, Richard] Thomas Jefferson Univ, Jefferson Med Coll, Dept Family Med, Philadelphia, PA 19107 USA	American Cancer Society; Colorado School of Public Health; Emory University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Wayne State University; Dartmouth College; Creighton University; University of Nebraska System; Jefferson University	Byers, T (corresponding author), Mail Stop B-119,13001 E 17th Pl, Aurora, CO 80045 USA.	Tim.Byers@ucdenver.edu	Smith, Robert/AAB-6682-2020	Pignone, Michael/0000-0002-6657-7342				Agency for Healthcare Research and Quality, NAT GUID CLEAR; Burda BU, 2011, J CLIN EPIDEMIOL, V64, P968, DOI 10.1016/j.jclinepi.2010.12.005; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Han PKJ, 2011, MED CARE, V49, P139, DOI 10.1097/MLR.0b013e318202858e; Institute of Medicine, 2011, CLIN PRACT GUID WE C; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; National Cancer Institute, STAT CANC LEG DAT; Nonprofit Brand Institute, 2011, 2 HLTH CHAR RANK AM; Zapka JM, 2011, CANCER EPIDEM BIOMAR, V20, P509, DOI 10.1158/1055-9965.EPI-10-0749	10	71	72	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2495	2499		10.1001/jama.2011.1800	http://dx.doi.org/10.1001/jama.2011.1800			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860YB	22166609				2022-12-24	WOS:000297983300023
J	Rao, V				Rao, Veena			Commentary: Cultural change is essential	BRITISH MEDICAL JOURNAL			English	Editorial Material									Natl Rural Hlth Mission NRHM, Directorate Hlth & Family Welf Serv, Bangalore 560009, Karnataka, India		Rao, V (corresponding author), Natl Rural Hlth Mission NRHM, Directorate Hlth & Family Welf Serv, Bangalore 560009, Karnataka, India.	nobel_6@hotmail.com						[Anonymous], 2005, NAT FAM HLTH SURV 3; *MIN FIN, 2011, EC SURV 2011; *NAT NUTR MON BUR, 2000, TECHN REP NAT NUTR M, V20; *NAT NUTR MON BUR, REP SURV 1988 98 199; *NAT NUTR MON BUR, 2000, TECHN REP NAT NUTR M, V21; *NAT NUTR MON BUR, 2000, TECHN REP NAT NUTR M, V22; *NAT SAMPL SURV OF, 2011, 66 ROUND SURV JUL 20; Ramalingaswami V., 1996, ASIAN ENIGMA PROGR N; UNICEF, 2011, STAT WORLDS CHILDR 2	9	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 11	2011	343								d7242	10.1136/bmj.d7242	http://dx.doi.org/10.1136/bmj.d7242			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	848NY	22080489				2022-12-24	WOS:000297059500001
J	Barnett, BE; Ciocca, ML; Goenka, R; Barnett, LG; Wu, JM; Laufer, TM; Burkhardt, JK; Cancro, MP; Reiner, SL				Barnett, Burton E.; Ciocca, Maria L.; Goenka, Radhika; Barnett, Lisa G.; Wu, Junmin; Laufer, Terri M.; Burkhardt, Janis K.; Cancro, Michael P.; Reiner, Steven L.			Asymmetric B Cell Division in the Germinal Center Reaction	SCIENCE			English	Article							T-LYMPHOCYTE DIVISION; BCL-6; ANTIGEN; DIFFERENTIATION; INFLAMMATION; EXPRESSION; RESPONSES	Lifelong antibody responses to vaccination require reorganization of lymphoid tissue and dynamic intercellular communication called the germinal center reaction. B lymphocytes undergo cellular polarization during antigen stimulation, acquisition, and presentation, which are critical steps for initiating humoral immunity. Here, we show that germinal center B lymphocytes asymmetrically segregate the transcriptional regulator Bcl6, the receptor for interleukin-21, and the ancestral polarity protein atypical protein kinase C to one side of the plane of division, generating unequal inheritance of fate-altering molecules by daughter cells. Germinal center B lymphocytes from mice with a defect in leukocyte adhesion fail to divide asymmetrically. These results suggest that motile cells lacking constitutive attachment can receive provisional polarity cues from the microenvironment to generate daughter cell diversity and self-renewal.	[Barnett, Burton E.; Ciocca, Maria L.; Wu, Junmin; Reiner, Steven L.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Goenka, Radhika; Burkhardt, Janis K.; Cancro, Michael P.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Barnett, Burton E.; Ciocca, Maria L.; Barnett, Lisa G.; Wu, Junmin; Laufer, Terri M.; Reiner, Steven L.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Laufer, Terri M.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Burkhardt, Janis K.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	sreiner@columbia.edu		Cancro, Michael/0000-0002-8659-3227; Burkhardt, Janis/0000-0002-8176-1375	NIH [AI042370, AI076458, T32GM07229, T32HD007516, 3T32GM007170-36S1, T32AI055428, AI065644]; U.S. Department of Defense [W81WWXWH1010185]; Veterans Administration [BX000435]; Abramson family; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007532, R01AI042370, R01AI061699, R01AI076458, R56AI076458, T32AI055428, R01AI065644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007170, T32GM007229] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); Veterans Administration(US Department of Veterans Affairs); Abramson family; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank J. Chaix, S. Gordon, M. Paley, and L. Rupp for assistance. We are grateful for funding from the NIH (grants AI042370 and AI076458 to S. L. R., T32GM07229 to B. E. B., T32HD007516 and 3T32GM007170-36S1 to M. L. C., T32AI055428 to R. G., and AI065644 to J.K.B.), the U.S. Department of Defense (grant W81WWXWH1010185 to M. P. C.), Veterans Administration (grant BX000435 to T. M. L.), and the Abramson family (to S. L. R.). The data reported in this paper are tabulated in the main paper and in the supporting online material. The authors declare no conflicts of interest.	Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; FISCHER A, 1986, J IMMUNOL, V136, P3198; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Oliaro J, 2010, J IMMUNOL, V185, P367, DOI 10.4049/jimmunol.0903627; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yuseff MI, 2011, IMMUNITY, V35, P361, DOI 10.1016/j.immuni.2011.07.008	19	68	71	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 20	2012	335	6066					342	344		10.1126/science.1213495	http://dx.doi.org/10.1126/science.1213495			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878RE	22174128	Green Accepted, Green Submitted			2022-12-24	WOS:000299273400049
J	Moynihan, R				Moynihan, Ray			SUSTAINABLE HEALTHCARE The greening of medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Challacombe B., 2008, BMJ-BRIT MED J, V336, P1173; Charlesworth A, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6520; Connor A, 2011, CLIN MED, V11, P242, DOI 10.7861/clinmedicine.11-3-242; Health Care Without Harm, 2011, GLOBAL GREEN HLTH HO; NHS Sustainable Development Unit, 2009, SAV CARB IMPR HLTH U; NHS Sustainable Development Unit, 2010, SAV CARB IMPR HLTH U; Pencheon D, 2009, J HEALTH SERV RES PO, V14, P2, DOI 10.1258/jhsrp.2008.008147; Raffle AE, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4596; Sneyd JR, 2010, ANAESTHESIA, V65, P435, DOI 10.1111/j.1365-2044.2010.06332.x; *STOCKH COUNT COUN, 2009, ENV CLASS PHARM; Stockholm Environment Institute ARUP NHS Sustainable Development Unit, 2010, CO2E RED POT NHS ENG; Stockholm Environment Institute NHS Sustainable Development Unit, 2009, NHS SUST DEV UN NHS; Zander A, 2011, J PUBLIC HEALTH-UK, V33, P272, DOI 10.1093/pubmed/fdq048	13	7	7	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2012	344								d8360	10.1136/bmj.d8360	http://dx.doi.org/10.1136/bmj.d8360			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888YP	22250219				2022-12-24	WOS:000300040900009
J	Bowden-Jones, H; George, S				Bowden-Jones, Henrietta; George, Sanju			A PATIENT'S JOURNEY Gambling addiction	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bowden-Jones, Henrietta] Cent NW London NHS Fdn Trust, Addict Directorate, London NW1 2PL, England; [Bowden-Jones, Henrietta] Univ London Imperial Coll Sci Technol & Med, Dept Med, London SW7 2AZ, England; [Bowden-Jones, Henrietta] Natl Problem Gambling Clin, London W1D 3HZ, England; [George, Sanju] Birmingham & Solihull Mental Hlth NHS Fdn Trust, Birmingham B37 7UR, W Midlands, England	Imperial College London	Bowden-Jones, H (corresponding author), Cent NW London NHS Fdn Trust, Addict Directorate, London NW1 2PL, England.	h.bowden-jones02@imperial.ac.uk							0	4	4	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 30	2011	343								d7789	10.1136/bmj.d7789	http://dx.doi.org/10.1136/bmj.d7789			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874TQ	22209819	Bronze			2022-12-24	WOS:000298981400001
J	Coulson, T; MacNulty, DR; Stahler, DR; Vonholdt, B; Wayne, RK; Smith, DW				Coulson, Tim; MacNulty, Daniel R.; Stahler, Daniel R.; vonHoldt, Bridgett; Wayne, Robert K.; Smith, Douglas W.			Modeling Effects of Environmental Change on Wolf Population Dynamics, Trait Evolution, and Life History	SCIENCE			English	Article							ECOLOGICAL DYNAMICS; YELLOWSTONE; WOLVES; PREDATION; SIZE; SELECTION; CLIMATE; GROWTH; RATES; ELK	Environmental change has been observed to generate simultaneous responses in population dynamics, life history, gene frequencies, and morphology in a number of species. But how common are such eco-evolutionary responses to environmental change likely to be? Are they inevitable, or do they require a specific type of change? Can we accurately predict eco-evolutionary responses? We address these questions using theory and data from the study of Yellowstone wolves. We show that environmental change is expected to generate eco-evolutionary change, that changes in the average environment will affect wolves to a greater extent than changes in how variable it is, and that accurate prediction of the consequences of environmental change will probably prove elusive.	[Coulson, Tim] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [MacNulty, Daniel R.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Stahler, Daniel R.; Smith, Douglas W.] Natl Pk Serv, Yellowstone Ctr Resources, Yellowstone Natl Pk, WY 82190 USA; [vonHoldt, Bridgett] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Wayne, Robert K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA	Imperial College London; University of Minnesota System; University of Minnesota Twin Cities; United States Department of the Interior; University of California System; University of California Irvine; University of California System; University of California Los Angeles	Coulson, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Silwood Pk, Ascot SL5 7PY, Berks, England.	t.coulson@imperial.ac.uk	MacNulty, Dan/L-3965-2016; Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003	European Research Council; Wellcome Trust; Royal Society; Natural Environment Research Council; Wolfson Foundation; NSF; Natural Environment Research Council [NE/I023783/1] Funding Source: researchfish; NERC [NE/I023783/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wolfson Foundation; NSF(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	T.C. acknowledges the European Research Council, the Wellcome Trust, the Royal Society, the Natural Environment Research Council, and the Wolfson Foundation for funding that supported the development of theory. D. R. M., R. K. W., and D. W. S. thank NSF for support (separate grants to R. K. W. and D. W. S.). Thanks to T. Ezard, J.-M. Gaillard, A. Malo, A. Ozgul, S. Schindler, I. Smallegange, and four anonymous reviewers for comments on an earlier version of the manuscript. D. W. S. and D. R. S. run the Yellowstone wolf project and along with D. R. M. conducted or oversaw all data collection. B. V. conducted genotyping under the supervision of R. K. W. D. R. M. and D. R. S. compiled the data file, and along with T. C. and D. W. S. planned model structure and statistical analyses. T. C. conducted analysis and modeling. T. C. and D. R. M. wrote the paper with input from all coauthors. Functional forms and parameter values for the model on which this paper is based are available in the SOM; data, results, and the R code to run simulations are available on Dryad (http://datadryad.org, doi:10.5061/dryad.bp23483h).	Adler PB, 2010, ECOL LETT, V13, P1019, DOI 10.1111/j.1461-0248.2010.01496.x; Almberg ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007042; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Beschta RL, 2010, RESTOR ECOL, V18, P380, DOI 10.1111/j.1526-100X.2008.00450.x; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Caswell H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020809; Childs DZ, 2004, P ROY SOC B-BIOL SCI, V271, P425, DOI 10.1098/rspb.2003.2597; Coulson T, 2004, TRENDS ECOL EVOL, V19, P359, DOI 10.1016/j.tree.2004.05.008; Coulson T, 2003, EVOLUTION, V57, P2879, DOI 10.1111/j.0014-3820.2003.tb01528.x; Coulson T, 2010, J ANIM ECOL, V79, P1226, DOI 10.1111/j.1365-2656.2010.01734.x; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fuller JA, 2007, J WILDLIFE MANAGE, V71, P1924, DOI 10.2193/2006-200; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Kauffman MJ, 2010, ECOLOGY, V91, P2742, DOI 10.1890/09-1949.1; MacNulty DR, 2009, ECOL LETT, V12, P1347, DOI 10.1111/j.1461-0248.2009.01385.x; MacNulty DR, 2009, J ANIM ECOL, V78, P532, DOI 10.1111/j.1365-2656.2008.01517.x; Mech LD, 2001, J WILDLIFE MANAGE, V65, P998, DOI 10.2307/3803048; Miller DA, 2011, ECOLOGY, V92, P1658; Pinheiro J, 2001, MIXED EFFECTS MODELS; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Rees M, 2009, ECOL MONOGR, V79, P575, DOI 10.1890/08-1474.1; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; SCHMITZ OJ, 1985, CAN J ZOOL, V63, P1130, DOI 10.1139/z85-171; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Tuljapurkar S, 2003, AM NAT, V162, P489, DOI 10.1086/378648; Vucetich JA, 2005, OIKOS, V111, P259, DOI 10.1111/j.0030-1299.2005.14180.x	30	150	150	0	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1275	1278		10.1126/science.1209441	http://dx.doi.org/10.1126/science.1209441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144626				2022-12-24	WOS:000297553600050
J	Sheeran, J				Sheeran, Josette			Preventing hunger: Sustainability not aid	NATURE			English	Editorial Material									United Nations World Food Programme, I-00148 Rome, Italy		Sheeran, J (corresponding author), United Nations World Food Programme, I-00148 Rome, Italy.	wfpinfo@wfp.org							0	7	7	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					469	470		10.1038/479469a	http://dx.doi.org/10.1038/479469a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	851QI	22113674	Bronze			2022-12-24	WOS:000297285600025
J	Spence, D				Spence, Des			FROM THE FRONTLINE The painful truth: deaths and misuse of prescribed drugs	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Aggarwal VR, 2010, PAIN, V149, P354, DOI 10.1016/j.pain.2010.02.040; Aggarwal VR, 2006, INT J EPIDEMIOL, V35, P468, DOI 10.1093/ije/dyi265; [Anonymous], 2011, POL IMP PRESCR PAINK; CAVE D, 2008, NY TIMES        0614; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; OSPINA M, 2002, PREVALENCE CHRONIC P; SZALAVITZ M, 2011, TIME HEALTHLAND 0629	7	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 16	2011	343								d7403	10.1136/bmj.d7403	http://dx.doi.org/10.1136/bmj.d7403			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854LV	22088400				2022-12-24	WOS:000297497100007
J	Kashuba, ADM; Patterson, KB; Dumond, JB; Cohen, MS				Kashuba, Angela D. M.; Patterson, Kristine B.; Dumond, Julie B.; Cohen, Myron S.			Pre-exposure prophylaxis for HIV prevention: how to predict success	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; ADHERENCE; MARAVIROC; TISSUE		[Kashuba, Angela D. M.; Dumond, Julie B.] Univ N Carolina, UNC Ctr AIDS Res Clin Pharmacol & Analyt Chem Cor, Div Pharmacotherapy & Expt Therapeut, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Patterson, Kristine B.; Cohen, Myron S.] Univ N Carolina, Ctr Infect Dis, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kashuba, ADM (corresponding author), Univ N Carolina, UNC Ctr AIDS Res Clin Pharmacol & Analyt Chem Cor, Div Pharmacotherapy & Expt Therapeut, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA.	akashuba@unc.edu			NIAID NIH HHS [U01 AI095031, P30 AI050410] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095031, P30AI050410] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baeton J., 2011, 6 IAS C JUL 17 20 RO; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Berg KM, 2006, JAIDS-J ACQ IMM DEF, V43, pS79, DOI 10.1097/01.qai.0000248337.97814.66; Brown KC, 2011, J INFECT DIS, V203, P1484, DOI 10.1093/infdis/jir059; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dumond JB, 2009, JAIDS-J ACQ IMM DEF, V51, P546, DOI 10.1097/QAI.0b013e3181ae69c5; FEMem-PrEP Project, FHI360 FEMEM PREP PR; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haberer JE, 2010, AIDS BEHAV, V14, P1340, DOI 10.1007/s10461-010-9799-4; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Liu HH, 2006, JAIDS-J ACQ IMM DEF, V43, pS104, DOI 10.1097/01.qai.0000245888.97003.a3; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Thigpen M., 2011, 6 IAS C JUL 17 20 RO	14	51	52	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 30	2012	379	9835					2409	2411		10.1016/S0140-6736(11)61852-7	http://dx.doi.org/10.1016/S0140-6736(11)61852-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	967NV	22153566	Green Accepted			2022-12-24	WOS:000305915900007
J	Periago, MR; Frieden, TR; Tappero, JW; De Cock, KM; Aasen, B; Andrus, JK				Periago, Mirta Roses; Frieden, Thomas R.; Tappero, Jordan W.; De Cock, Kevin M.; Aasen, Bernt; Andrus, Jon K.			Elimination of cholera transmission in Haiti and the Dominican Republic	LANCET			English	Editorial Material							INTERVENTIONS; BENEFITS; MEXICO		[Periago, Mirta Roses; Andrus, Jon K.] Pan Amer Hlth Org, Washington, DC 20037 USA; [Frieden, Thomas R.] Ctr Dis Control & Prevent, Off Director, Atlanta, GA USA; [Tappero, Jordan W.; De Cock, Kevin M.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Aasen, Bernt] United Nations Childrens Fund, Latin Amer & Caribbean Off, Panama City, Panama	Pan American Health Organization; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Andrus, JK (corresponding author), Pan Amer Hlth Org, Washington, DC 20037 USA.	andrusjo@paho.org		Frieden, Thomas/0000-0002-4759-2256				Andrus JK, 2009, AM J LAW MED, V35, P311, DOI 10.1177/009885880903500204; Gaffga NH, 2007, AM J TROP MED HYG, V77, P705, DOI 10.4269/ajtmh.2007.77.705; Gutierrez G, 1996, B WORLD HEALTH ORGAN, V74, P189; Haiti earthquake PDNA: assessment of damage losses general and sectoral needs, 2010, HAIT EARTHQ PDNA ASS; Haller L, 2007, J WATER HEALTH, V5, P467, DOI 10.2166/wh.2007.008; Inter-American Development Bank, HAIT COUNTR UPD; Inter-American Development Bank, 2010, DRINK WAT SAN MILL D; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; Ministere de Sante Publique et de la Population, 2011, RAPP JOURN MSPP EV D; Ministry of Public Health of the Dominican Republic, 2011, WEEKL EP B; Sepulveda J, 2006, INT J INFECT DIS, V10, P4, DOI 10.1016/j.ijid.2005.05.005; Tappero JW, 2011, EMERG INFECT DIS, V17, P2087, DOI 10.3201/eid1711.110827; WHO UNICEF, 2010, PROGR SAN DRINK WAT	13	26	26	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 21	2012	379	9812					E12	E13		10.1016/S0140-6736(12)60031-2	http://dx.doi.org/10.1016/S0140-6736(12)60031-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879FW	22240408				2022-12-24	WOS:000299316100001
J	Appleby, J				Appleby, John			DATA BRIEFING Reducing greenhouse gas emissions: on target?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London W1G 0AN, England		Appleby, J (corresponding author), Kings Fund, London W1G 0AN, England.	j.appleby@kingsfund.org.uk						NHS Sustainable Development Unit, 2008, SAV CARB IMPR HLTH N; NHS Sustainable Development Unit, 2011, SAV CARB IMPR HLTH U; NHS Sustainable Development Unit, SUST NHS HL IN PRESS; UN Statistics Division, 2011, ENV IND GREENH GAS E	4	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2012	344								e376	10.1136/bmj.e376	http://dx.doi.org/10.1136/bmj.e376			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888YZ	22258106				2022-12-24	WOS:000300041900011
J	Palese, P				Palese, Peter			Don't censor life-saving science	NATURE			English	Editorial Material									Mt Sinai Sch Med, Dept Microbiol, New York, NY USA	Icahn School of Medicine at Mount Sinai	Palese, P (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY USA.	peter.palese@mssm.edu		Palese, Peter/0000-0002-0337-5823				Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392	1	21	21	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					115	115		10.1038/481115a	http://dx.doi.org/10.1038/481115a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	874TO	22237069	Bronze			2022-12-24	WOS:000298981200004
J	Hutchinson, JR; Delmer, C; Miller, CE; Hildebrandt, T; Pitsillides, AA; Boyde, A				Hutchinson, John R.; Delmer, Cyrille; Miller, Charlotte E.; Hildebrandt, Thomas; Pitsillides, Andrew A.; Boyde, Alan			From Flat Foot to Fat Foot: Structure, Ontogeny, Function, and Evolution of Elephant "Sixth Toes"	SCIENCE			English	Article							AFRICAN; BIOMECHANICS; OSTEOLOGY; LIMB	Several groups of tetrapods have expanded sesamoid (small, tendon-anchoring) bones into digit-like structures ("predigits"), such as pandas' "thumbs." Elephants similarly have expanded structures in the fat pads of their fore- and hindfeet, but for three centuries these have been overlooked as mere cartilaginous curiosities. We show that these are indeed massive sesamoids that employ a patchy mode of ossification of a massive cartilaginous precursor and that the predigits act functionally like digits. Further, we reveal clear osteological correlates of predigit joint articulation with the carpals/tarsals that are visible in fossils. Our survey shows that basal proboscideans were relatively "flat-footed" (plantigrade), whereas early elephantiforms evolved the more derived "tip-toed" (subunguligrade) morphology, including the predigits and fat pad, of extant elephants. Thus, elephants co-opted sesamoid bones into a role as false digits and used them for support as they changed their foot posture.	[Hutchinson, John R.; Miller, Charlotte E.; Pitsillides, Andrew A.] Royal Vet Coll, Dept Vet Basic Sci, Hatfield AL9 7TA, Herts, England; [Hutchinson, John R.; Miller, Charlotte E.; Pitsillides, Andrew A.] Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; [Hutchinson, John R.; Miller, Charlotte E.; Pitsillides, Andrew A.] Univ London Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England; [Hutchinson, John R.; Miller, Charlotte E.; Pitsillides, Andrew A.] Univ London Royal Vet Coll, Struct & Mot Lab, London NW1 0TU, England; [Delmer, Cyrille] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Hildebrandt, Thomas] Leibniz Inst Zoo & Wildlife Res, Forsch Verbund Berlin eV, D-10252 Berlin, Germany; [Boyde, Alan] Queen Mary Univ London, Barts & London Sch Med & Dent, London E1 4NS, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; Natural History Museum London; Leibniz Institut fur Zoo und Wildtierforschung; University of London; Queen Mary University London	Hutchinson, JR (corresponding author), Royal Vet Coll, Dept Vet Basic Sci, Hatfield AL9 7TA, Herts, England.		Miller, Charlotte/ABH-5780-2020; Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038; Miller, Charlotte E/0000-0002-8428-8392	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C516844/1, BB/H002782/1]; Arthritis Research UK; Veterinary Advisory Committee of the UK Horserace Betting Levy Board; BBSRC [BB/H002782/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H002782/1, BB/C516844/1] Funding Source: researchfish; Versus Arthritis [18768] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Arthritis Research UK(Versus Arthritis); Veterinary Advisory Committee of the UK Horserace Betting Levy Board; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis)	We thank the staff of the Structure and Motion Laboratory of the Royal Veterinary College for assistance and three anonymous reviewers for constructive criticism. Many individuals assisted with the collection of the cadaveric data; we particularly thank the European-based zoos that provided the specimens and G. Fritsch for CT scans done in Germany. O. Cosar, R. Weller, A. Wilson, and K. Jespers assisted with the ex vivo loading experiments. J. Molnar assisted with Figs. 1 to 4 and the movies. This project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (grants BB/C516844/1 and BB/H002782/1 to J. R. H.). Additionally, A. A. P. appreciates funding from Arthritis Research UK and the BBSRC, and A. B. was supported by the Veterinary Advisory Committee of the UK Horserace Betting Levy Board. The data reported in this paper are tabulated in the SOM. The authors declare no conflicts of interest.	BIEWENER AA, 1990, SCIENCE, V250, P1097, DOI 10.1126/science.2251499; Blair Patrick, 1710, PHILOS T, V27, P53, DOI [10.1098/rstl.1710.0008, DOI 10.1098/RSTL.1710.0008]; Bonnan MF, 2005, LIFE O PAST, P346; Boyde A, 1999, CALCIFIED TISSUE INT, V64, P185, DOI 10.1007/s002239900600; CARRIER DR, 1994, SCIENCE, V265, P651, DOI 10.1126/science.8036513; Clifford AB, 2010, J VERTEBR PALEONTOL, V30, P1827, DOI 10.1080/02724634.2010.521216; Court Nicholas, 1993, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V226, P125; Davis D. D., 1964, Fieldiana Zoology Memoir, V3, P1; Delmer C, 2009, ACTA PALAEONTOL POL, V54, P561, DOI 10.4202/app.2007.0036; Endo H, 1999, J ANAT, V195, P295, DOI 10.1046/j.1469-7580.1999.19520295.x; Fabrezi M, 2001, ZOOL J LINN SOC-LOND, V131, P227, DOI 10.1006/zjls.2000.0234; Galis F, 2001, TRENDS ECOL EVOL, V16, P637, DOI 10.1016/S0169-5347(01)02289-3; Gheerbrant E, 2009, CR PALEVOL, V8, P281, DOI 10.1016/j.crpv.2008.08.003; Gheerbrant E, 2009, P NATL ACAD SCI USA, V106, P10717, DOI 10.1073/pnas.0900251106; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; GOULD SJ, 1978, NAT HIST, V87, P20; Hutchinson JR, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P23, DOI 10.1007/978-4-431-76933-0_3; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Michilsens F, 2009, J ZOOL, V279, P236, DOI 10.1111/j.1469-7998.2009.00611.x; Miller CE, 2008, J R SOC INTERFACE, V5, P465, DOI 10.1098/rsif.2007.1220; Mitgutsch C, 2012, BIOL LETTERS, V8, P74, DOI 10.1098/rsbl.2011.0494; Neuville H., 1935, Arch Mus Paris (6), V13, P111; Prochel J, 2004, J ANAT, V205, P99, DOI 10.1111/j.0021-8782.2004.00321.x; Sanchez-Villagra MR, 2005, ZOOLOGY, V108, P3, DOI 10.1016/j.zool.2004.07.006; Scholz MN, 2008, J EXP BIOL, V211, P3266, DOI 10.1242/jeb.018812; SMUTS MMS, 1993, ONDERSTEPOORT J VET, V60, P1; SMUTS MMS, 1994, ONDERSTEPOORT J VET, V61, P51; von Bardeleben K., 1894, P ZOOL SOC LOND, V1894, P354; Weissengruber GE, 2006, J ANAT, V209, P781, DOI 10.1111/j.1469-7580.2006.00648.x	29	52	52	2	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1699	1703		10.1126/science.1211437	http://dx.doi.org/10.1126/science.1211437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194576	Green Published			2022-12-24	WOS:000298344000066
J	Angus, DC				Angus, Derek C.			The Search for Effective Therapy for Sepsis Back to the Drawing Board?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Angus, DC (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, 3550 Terrace St,604 Scaife Hall, Pittsburgh, PA 15261 USA.	angusdc@upmc.edu	Angus, Derek C/E-9671-2012					Angus DC, 2010, JAMA-J AM MED ASSOC, V304, P1833, DOI 10.1001/jama.2010.1546; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Beutler BA, NOBEL PRIZE PHYSL ME; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Matsuyama K, EISAIS SEPSIS DRUG E; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; XIGRIS DROTRECOGIN A	10	186	199	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2614	2615		10.1001/jama.2011.1853	http://dx.doi.org/10.1001/jama.2011.1853			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864YQ	22187284				2022-12-24	WOS:000298276800026
J	King, BL; Gillis, JA; Carlisle, HR; Dahn, RD				King, Benjamin L.; Gillis, J. Andrew; Carlisle, Heather R.; Dahn, Randall D.			A Natural Deletion of the HoxC Cluster in Elasmobranch Fishes	SCIENCE			English	Article							GENE CLUSTERS; GNATHOSTOMES; EVOLUTION; INSIGHTS		[King, Benjamin L.; Carlisle, Heather R.; Dahn, Randall D.] Mt Desert Isl Biol Lab, Kathryn W Davis Ctr Regenerat Biol & Med, Salsbury Cove, ME 04672 USA; [Gillis, J. Andrew] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	Mount Desert Island Biological Laboratory; University of Cambridge	King, BL (corresponding author), Mt Desert Isl Biol Lab, Kathryn W Davis Ctr Regenerat Biol & Med, Salsbury Cove, ME 04672 USA.	bking@mdibl.org	King, Benjamin/AAI-1492-2019	King, Benjamin/0000-0001-6463-1336; Gillis, Andrew/0000-0003-2062-3777	National Center for Research Resources, NIH [P20RR016463]; Newton International Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016463] Funding Source: NIH RePORTER	National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Newton International Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank B. Kingham for genome sequencing. B. L. K., H. R. C., and R. D. D. were funded by the National Center for Research Resources, NIH (P20RR016463). J.A.G. was funded by a Newton International Fellowship. The skate genome was sequenced by the North East Cyberinfrastructure Consortium. Sequence data are available at the National Center for Biotechnology Information in Gene Expression Omnibus (GSE26235), GenBank (AESE010000000), and Sequence Read Archive (SRA026856).	Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Oulion S, 2010, MOL BIOL EVOL, V27, P2829, DOI 10.1093/molbev/msq172; Ravi V, 2009, P NATL ACAD SCI USA, V106, P16327, DOI 10.1073/pnas.0907914106; Smith JJ, 2010, CHROMOSOMA, V119, P381, DOI 10.1007/s00412-010-0263-z; Suemori H, 2000, DEV BIOL, V220, P333, DOI 10.1006/dbio.2000.9651; Woltering JM, 2006, NAT GENET, V38, P601, DOI 10.1038/ng0606-601	6	45	45	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1517	1517		10.1126/science.1210912	http://dx.doi.org/10.1126/science.1210912			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174244	Green Accepted			2022-12-24	WOS:000298091400043
J	Berglund, J				Berglund, Jennifer			ORTHOPAEDICS Structural support	NATURE			English	Editorial Material																		Berenson J, 2011, LANCET ONCOL, V12, P225, DOI 10.1016/S1470-2045(11)70008-0; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Francis M. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P2	3	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S56	S57		10.1038/480S56a	http://dx.doi.org/10.1038/480S56a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169807				2022-12-24	WOS:000298033000013
J	Reuter, M; Berninger, P; Chuma, S; Shah, H; Hosokawa, M; Funaya, C; Antony, C; Sachidanandam, R; Pillai, RS				Reuter, Michael; Berninger, Philipp; Chuma, Shinichiro; Shah, Hardik; Hosokawa, Mihoko; Funaya, Charlotta; Antony, Claude; Sachidanandam, Ravi; Pillai, Ramesh S.			Miwi catalysis is required for piRNA amplification-independent LINE1 transposon silencing	NATURE			English	Article							PIWI-INTERACTING RNAS; MALE GERM-CELLS; DNA METHYLATION; CHROMATOID BODIES; FAMILY-MEMBERS; PATHWAY; PROTEIN; MICE; GENE; SPERMATOGENESIS	Repetitive-element-derived Piwi-interacting RNAs (piRNAs)(1,2) act together with Piwi proteins Mili (also known as Piwil2) and Miwi2 (also known as Piwil4) in a genome defence mechanism that initiates transposon silencing via DNA methylation in the mouse male embryonic germ line. This silencing depends on the participation of the Piwi proteins in a slicer-dependent piRNA amplification pathway and is essential for male fertility(3,4). A third Piwi family member, Miwi (also known as Piwil1), is expressed in specific postnatal germ cells and associates with a unique set of piRNAs of unknown function(5-7). Here we show that Miwi is a small RNA-guided RNase (slicer) that requires extensive complementarity for target cleavage in vitro. Disruption of its catalytic activity in mice by a single point mutation causes male infertility, and mutant germ cells show increased accumulation of LINE1 retrotransposon transcripts. We provide evidence for Miwi slicer activity directly cleaving transposon messenger RNAs, offering an explanation for the continued maintenance of repeat-derived piRNAs long after transposon silencing is established in germline stem cells. Furthermore, our study supports a slicer-dependent silencing mechanism that functions without piRNA amplification. Thus, Piwi proteins seem to act in a two-pronged mammalian transposon silencing strategy: one promotes transcriptional repression in the embryo, the other reinforces silencing at the post-transcriptional level after birth.	[Reuter, Michael; Berninger, Philipp; Pillai, Ramesh S.] European Mol Biol Lab, F-38042 Grenoble, France; [Reuter, Michael; Berninger, Philipp; Pillai, Ramesh S.] CNRS, UJF, EMBL Int Unit, UMI Virus Host Cell Interact UVHCI 3265, F-38042 Grenoble, France; [Chuma, Shinichiro; Hosokawa, Mihoko] Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Chuma, Shinichiro; Hosokawa, Mihoko] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto 6068501, Japan; [Shah, Hardik; Sachidanandam, Ravi] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Antony, Claude] European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Kyoto University; Kyoto University; Icahn School of Medicine at Mount Sinai; European Molecular Biology Laboratory (EMBL)	Pillai, RS (corresponding author), European Mol Biol Lab, 6 Rue Jules Horowitz,BP 181, F-38042 Grenoble, France.	pillai@embl.fr	sachidanandam, ravi/Q-6916-2019; antony, claude/K-5342-2013	sachidanandam, ravi/0000-0001-9844-4459; Fredriksson Funaya, Charlotta/0000-0003-1375-1287	Deutsche Forschungsgemeinschaft (DFG); Agence National de la Recherche (ANR) (piRmachines); European Union (European Research Council, ERC); EMBL	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Agence National de la Recherche (ANR) (piRmachines)(French National Research Agency (ANR)); European Union (European Research Council, ERC)(European Research Council (ERC)); EMBL	We thank S. Cusack for initial support for the project and discussions. We thank D. O'Carroll and S. Khochbin for help with mouse experiments; J. Xiol and N. Nakatsuji for helpful discussions; D. O'Carroll, S. Martin, S. Kistler and R. Balhorn for antibodies. We thank the Mouse Biology Unit, European Molecular Biology Laboratory (EMBL) Monterotondo and EMBL facilities (Gene, Proteomics, Protein Expression and Purification). This work was supported by a Deutsche Forschungsgemeinschaft (DFG) postdoctoral fellowship to M. R. and grants to R. S. P. from Agence National de la Recherche (ANR) (piRmachines) and the European Union (European Research Council, ERC Starting Grant, pisilence). The R. S. P. laboratory is supported by the EMBL.	Ahmed EA, 2007, DNA REPAIR, V6, P1243, DOI 10.1016/j.dnarep.2007.02.011; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Berninger P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-46; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Caron C, 2005, PROG MOLEC, V38, P65; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chuma S, 2006, P NATL ACAD SCI USA, V103, P15894, DOI 10.1073/pnas.0601878103; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; HEIDARAN MA, 1988, J CELL BIOL, V106, P1427, DOI 10.1083/jcb.106.5.1427; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2006, J CELL SCI, V119, P2819, DOI 10.1242/jcs.03022; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Lee K, 1995, P NATL ACAD SCI USA, V92, P12451, DOI 10.1073/pnas.92.26.12451; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Olson A J, 2008, Pac Symp Biocomput, P126; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; STANKER LH, 1987, HYBRIDOMA, V6, P293, DOI 10.1089/hyb.1987.6.293; Tanaka T, 2011, P NATL ACAD SCI USA, V108, P10579, DOI 10.1073/pnas.1015447108; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Vasileva A, 2009, CURR BIOL, V19, P630, DOI 10.1016/j.cub.2009.02.047; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wen J, 2008, BIOCHEM SOC T, V36, P514, DOI 10.1042/BST0360514	47	274	285	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2011	480	7376					264	U154		10.1038/nature10672	http://dx.doi.org/10.1038/nature10672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22121019				2022-12-24	WOS:000297744200056
J	Nguyen, USDT; Zhang, YQ; Zhu, YY; Niu, JB; Zhang, B; Felson, DT				Nguyen, Uyen-Sa D. T.; Zhang, Yuqing; Zhu, Yanyan; Niu, Jingbo; Zhang, Bin; Felson, David T.			Increasing Prevalence of Knee Pain and Symptomatic Knee Osteoarthritis: Survey and Cohort Data	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-BACK-PAIN; FRAMINGHAM OSTEOARTHRITIS; REPLACEMENT; BURDEN; TRENDS; HIP; US; DISABILITY; OBESITY; ADULTS	Background: A recent surge in knee replacements is assumed to be due to aging and increased obesity of the U.S. population. Objective: To assess whether age, obesity, and change in radiographic knee osteoarthritis explain the trend in knee pain and osteoarthritis. Design: Cross-sectional, using data from 6 NHANES (National Health and Nutrition Examination Survey) surveys between 1971 and 2004 and from 3 examination periods in the FOA (Framingham Osteoarthritis) Study between 1983 through 2005. Setting: U.S. population. Participants: NHANES participants (white or African American; aged 60 to 74 years) and FOA Study participants (mostly white; aged >= 70 years) were included. Measurements: NHANES participants were asked about pain in or around the knee on most days. In the FOA Study, participants were asked about knee pain and had bilateral weight-bearing anteroposterior knee radiography to define radiographic knee osteoarthritis. Radiographic evidence and self-reported pain were used to define symptomatic knee osteoarthritis. The age- and age- and body mass index (BMI)-adjusted prevalences of knee pain and osteoarthritis at later examinations were compared with that of earlier examinations by using the ratio of the prevalence estimates. Results: Age- and BMI-adjusted prevalence of knee pain increased by about 65% in NHANES from 1974 to 1994 among non-Hispanic white and Mexican American men and women and among African American women. In the FOA Study, the age- and BMI-adjusted prevalence of knee pain and symptomatic knee osteoarthritis approximately doubled in women and tripled in men over 20 years. No such trend was observed in the prevalence of radiographic knee osteoarthritis in FOA Study participants. After age adjustment, additional adjustment for BMI resulted in a 10% to 25% decrease in the prevalence ratios for knee pain and symptomatic knee osteoarthritis. Limitations: Differences in sampling of FOA Study participants over time or birth cohort effects cannot be ruled out as possible explanations of the increased reporting of knee pain. Increases in prevalence at the last interval in the FOA Study might be due to differences in cohort membership by interval. Conclusion: Results suggest that the prevalence of knee pain has increased substantially over 20 years, independent of age and BMI. Obesity accounted for only part of this increase. Symptomatic knee osteoarthritis increased but radiographic knee osteoarthritis did not.	[Felson, David T.] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Boston University; Harvard University; Brigham & Women's Hospital	Felson, DT (corresponding author), Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, 650 Albany St,Suite X200, Boston, MA 02118 USA.			Zhang, Yuqing/0000-0001-7954-1149; Niu, Jingbo/0000-0002-6170-1965; Nguyen, Uyen-Sa/0000-0003-2715-9073; Felson, David/0000-0002-2668-2447	National Institutes of Health (NIH) [AR47785, AG18393]; American College of Rheumatology Research and Education Foundation; National Heart, Lung, and Blood Institute, National Institutes of Health (NHLBI/NIH) [N01-HC-25195]; National Institute on Aging; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health; National Heart, Lung, and Blood Institute; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018393] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Rheumatology Research and Education Foundation; National Heart, Lung, and Blood Institute, National Institutes of Health (NHLBI/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Institutes of Health (NIH AR47785 and AG18393) and an American College of Rheumatology Research and Education Foundation Rheumatology Scientist Development Award (Dr. Nguyen). The Framingham Heart Study was funded by the National Heart, Lung, and Blood Institute, National Institutes of Health (NHLBI/NIH contract N01-HC-25195), and the FOA Study was funded by the National Institute on Aging and National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health.; American College of Rheumatology Research and Education Foundation and National Institutes of Health. The FOA Study was funded by the National Heart, Lung, and Blood Institute (for the parent Framingham Heart Study), National Institute on Aging, and National Institute of Arthritis and Musculoskeletal and Skin Diseases (FOA Study), National Institutes of Health.	[Anonymous], NATL HLTH NUTR EXAMI; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2005, MMWR-MORBID MORTAL W, V54, P179; Centers for Disease Control and Prevention National Center for Health Statistics, 1971, NATL HLTH NUTR EX SU; Cisternas M. G., 2009, Morbidity and Mortality Weekly Report, V58, P133; Culliford DJ, 2010, J BONE JOINT SURG BR, V92B, P130, DOI 10.1302/0301-620X.92B1.22654; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1064, DOI 10.1002/1529-0131(199806)41:6<1064::AID-ART13>3.0.CO;2-K; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Grotle M, 2008, J RHEUMATOL, V35, P677; Hunter DJ, 2008, ANN RHEUM DIS, V67, P1545, DOI 10.1136/ard.2007.076810; Jinks C, 2002, PAIN, V100, P55, DOI 10.1016/S0304-3959(02)00239-7; Kim S, 2008, ARTHRIT RHEUM-ARTHR, V59, P481, DOI 10.1002/art.23525; Kopec JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P929, DOI 10.1002/art.23827; Leijon O, 2009, OCCUP ENVIRON MED, V66, P137, DOI 10.1136/oem.2008.040337; Leveille SG, 2005, AM J PUBLIC HEALTH, V95, P1607, DOI 10.2105/AJPH.2004.060418; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Marks R, 2007, OBESITY, V15, P1867, DOI 10.1038/oby.2007.221; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Rubin DB, 2004, MULTIPLE IMPUTATION; Wang CY, 2010, AM J EPIDEMIOL, V171, P426, DOI 10.1093/aje/kwp412; Zeni JA, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-86	25	318	331	0	43	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2011	155	11					725	U135		10.7326/0003-4819-155-11-201112060-00004	http://dx.doi.org/10.7326/0003-4819-155-11-201112060-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860ZS	22147711	Green Accepted			2022-12-24	WOS:000297988400001
J	Hannisdal, B; Peters, SE				Hannisdal, Bjarte; Peters, Shanan E.			Phanerozoic Earth System Evolution and Marine Biodiversity	SCIENCE			English	Article							SEA-LEVEL CHANGES; FOSSIL RECORD; ORGANIC-CARBON; SULFUR; ORIGINATION; EXTINCTIONS; DIVERSITY; SEDIMENTS; HISTORY; CLIMATE	The Phanerozoic fossil record of marine animal diversity covaries with the amount of marine sedimentary rock. The extent to which this covariation reflects a geologically controlled sampling bias remains unknown. We show that Phanerozoic records of seawater chemistry and continental flooding contain information on the diversity of marine animals that is independent of sedimentary rock quantity and sampling. Interrelationships among variables suggest long-term interactions among continental flooding, sulfur and carbon cycling, and macroevolution. Thus, mutual responses to interacting Earth systems, not sampling biases, explain much of the observed covariation between Phanerozoic patterns of sedimentation and fossil biodiversity. Linkages between biodiversity and environmental records likely reflect complex biotic responses to changing ocean redox conditions and long-term sea-level fluctuations driven by plate tectonics.	[Hannisdal, Bjarte] Univ Bergen, Dept Earth Sci, Ctr Geobiol, N-5007 Bergen, Norway; [Peters, Shanan E.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA	University of Bergen; University of Wisconsin System; University of Wisconsin Madison	Hannisdal, B (corresponding author), Univ Bergen, Dept Earth Sci, Ctr Geobiol, Allegaten 41, N-5007 Bergen, Norway.	bjarte.hannisdal@geo.uib.no	Peters, Shanan E/A-5620-2013	Peters, Shanan E/0000-0002-3346-4317	NSF [EAR-0819931]	NSF(National Science Foundation (NSF))	We thank J. Alroy, B. Wilkinson, M. Foote, and two anonymous reviewers for helpful comments, and J. Alroy for his suggestion to use SQS and for the generous contribution he made by executing the Paleobiology Database download and analysis at http://paleodb.org. All data used herein are archived in (23). Supported by NSF grant EAR-0819931 (S. E. P.). This is Paleobiology Database publication 146.	Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Alroy J, 2010, PALAEONTOLOGY, V53, P1211, DOI 10.1111/j.1475-4983.2010.01011.x; BERNER RA, 1983, GEOCHIM COSMOCHIM AC, V47, P855, DOI 10.1016/0016-7037(83)90151-5; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; CANFIELD DE, 1994, CHEM GEOL, V114, P315, DOI 10.1016/0009-2541(94)90061-2; Cardenas AL, 2010, NAT GEOSCI, V3, P430, DOI 10.1038/NGEO869; CLAYPOOL GE, 1980, CHEM GEOL, V28, P199, DOI 10.1016/0009-2541(80)90047-9; Finnegan S, 2011, SCIENCE, V331, P903, DOI 10.1126/science.1200803; GARRELS RM, 1974, MAR CHEM, P303; Hallam A, 1999, EARTH-SCI REV, V48, P217, DOI 10.1016/S0012-8252(99)00055-0; Hannisdal B, 2011, AM J SCI, V311, P315, DOI 10.2475/04.2011.02; Hannisdal B, 2010, J GEOL, V118, P111, DOI 10.1086/650180; Haq BU, 2008, SCIENCE, V322, P64, DOI 10.1126/science.1161648; Heim NA, 2011, GEOL SOC AM BULL, V123, P620, DOI 10.1130/B30215.1; Kampschulte A, 2004, CHEM GEOL, V204, P255, DOI 10.1016/j.chemgeo.2003.11.013; Mayhew PJ, 2008, P ROY SOC B-BIOL SCI, V275, P47, DOI 10.1098/rspb.2007.1302; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; Meyers SR, 2011, EARTH PLANET SC LETT, V303, P174, DOI 10.1016/j.epsl.2010.12.044; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Prokoph A, 2008, EARTH-SCI REV, V87, P113, DOI 10.1016/j.earscirev.2007.12.003; RAUP D M, 1976, Paleobiology, V2, P289; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; Smith AB, 2005, BIOL LETT-UK, V1, P443, DOI 10.1098/rsbl.2005.0345; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Stanley SM, 2010, P NATL ACAD SCI USA, V107, P19185, DOI 10.1073/pnas.1012833107; VEIZER J, 1980, GEOCHIM COSMOCHIM AC, V44, P579, DOI 10.1016/0016-7037(80)90250-1; Wu NP, 2010, GEOCHIM COSMOCHIM AC, V74, P2053, DOI 10.1016/j.gca.2009.12.012	30	145	151	2	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1121	1124		10.1126/science.1210695	http://dx.doi.org/10.1126/science.1210695			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116884				2022-12-24	WOS:000297313900047
J	Mitka, M				Mitka, Mike			Statin Therapy in Primary CVD Prevention Remains a Hot-button Topic for Some	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item							CHOLESTEROL											Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Green LA, 2010, ARCH INTERN MED, V170, P1007, DOI 10.1001/archinternmed.2010.168; MINDER MC, 2011, ARCH INTERN MED, V171, P1594; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Redberg R, 2011, ARCH INTERN MED, V171, P619, DOI 10.1001/archinternmed.2010.465; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646	6	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 16	2011	306	19					2077	2078		10.1001/jama.2011.1664	http://dx.doi.org/10.1001/jama.2011.1664			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YU	22089707				2022-12-24	WOS:000297013000002
J	Castets, M; Broutier, L; Molin, Y; Brevet, M; Chazot, G; Gadot, N; Paquet, A; Mazelin, L; Jarrosson-Wuilleme, L; Scoazec, JY; Bernet, A; Mehlen, P				Castets, Marie; Broutier, Laura; Molin, Yann; Brevet, Marie; Chazot, Guillaume; Gadot, Nicolas; Paquet, Armelle; Mazelin, Laetitia; Jarrosson-Wuilleme, Loraine; Scoazec, Jean-Yves; Bernet, Agnes; Mehlen, Patrick			DCC constrains tumour progression via its dependence receptor activity	NATURE			English	Article							COLORECTAL TUMORIGENESIS; CANCER; GENE; ACTIVATION; APOPTOSIS; IDENTIFICATION; MECHANISM; MODEL; GAPS; MICE	The role of deleted in colorectal carcinoma (DCC) as a tumour suppressor has been a matter of debate for the past 15 years. DCC gene expression is lost or markedly reduced in the majority of advanced colorectal cancers(1) and, by functioning as a dependence receptor, DCC has been shown to induce apoptosis unless engaged by its ligand, netrin-1 (ref. 2). However, so far no animal model has supported the view that the DCC loss-of-function is causally implicated as predisposing to aggressive cancer development(3). To investigate the role of DCC-induced apoptosis in the control of tumour progression, here we created a mouse model in which the pro-apoptotic activity of DCC is genetically silenced. Although the loss of DCC-induced apoptosis in this mouse model is not associated with a major disorganization of the intestines, it leads to spontaneous intestinal neoplasia at a relatively low frequency. Loss of DCC-induced apoptosis is also associated with an increase in the number and aggressiveness of intestinal tumours in a predisposing APC mutant context, resulting in the development of highly invasive adenocarcinomas. These results demonstrate that DCC functions as a tumour suppressor via its ability to trigger tumour cell apoptosis.	[Castets, Marie; Broutier, Laura; Molin, Yann; Chazot, Guillaume; Mazelin, Laetitia; Jarrosson-Wuilleme, Loraine; Bernet, Agnes; Mehlen, Patrick] Univ Lyon, Apoptosis Canc & Dev Lab, Ctr Leon Berard,Ctr Cancerol Lyon,INSERM,U1052, Equipe Labellise La Ligue,LabEX DEVweCAN,CNRS,UMR, F-69008 Lyon, France; [Brevet, Marie; Gadot, Nicolas; Paquet, Armelle; Scoazec, Jean-Yves] Univ Lyon, Hop Edouard Herriot, Endocrine Differentiat Lab,CNRS,UMR5286, Hosp Civils Lyon,Ctr Cancerol Lyon,INSERM,U1052, F-69437 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mehlen, P (corresponding author), Univ Lyon, Apoptosis Canc & Dev Lab, Ctr Leon Berard,Ctr Cancerol Lyon,INSERM,U1052, Equipe Labellise La Ligue,LabEX DEVweCAN,CNRS,UMR, F-69008 Lyon, France.	patrick.mehlen@lyon.unicancer.fr	Castets, Marie/L-2059-2018; BROUTIER, Laura/X-8536-2019; Bernet, Agnes/GSN-2702-2022; Mazelin, Laetitia/AAD-9319-2020	BROUTIER, Laura/0000-0001-5163-5573; Mazelin, Laetitia/0000-0002-4001-2132; BREVET, Marie/0000-0003-2275-691X	Ligue Contre le Cancer; INCA; ANR; IP ApoSys; LabEX DEVweCAN [ANR-10-LABX-61]	Ligue Contre le Cancer(Ligue nationale contre le cancer); INCA(Institut National du Cancer (INCA) France); ANR(French National Research Agency (ANR)); IP ApoSys; LabEX DEVweCAN	We wish to thank D. E. Bredesen and J.-G. Delcros for critical reading of the manuscript. We thank C. H. Herbreteau and C. Bonod-Bidaud for their initial involvement in this work and the animal facility staff for animal care. We thank the ICS for the generation of the DCC mutant mice. We thank the LMT (Laboratoire des Modeles Tumoraux) and AniPath for the analysis of animal models. This work was supported by institutional grants from the Ligue Contre le Cancer, INCA, ANR, IP ApoSys and the LabEX DEVweCAN (ANR-10-LABX-61).	Bernet A, 2007, GASTROENTEROLOGY, V133, P1840, DOI 10.1053/j.gastro.2007.08.009; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Ghoumari AM, 2000, EUR J NEUROSCI, V12, P2935, DOI 10.1046/j.1460-9568.2000.00186.x; Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13; Kiesslich R, 2007, GASTROENTEROLOGY, V133, P1769, DOI 10.1053/j.gastro.2007.09.011; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mehlen P, 2004, J CLIN ONCOL, V22, P3420, DOI 10.1200/JCO.2004.02.019; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Roush W, 1997, SCIENCE, V276, P534, DOI 10.1126/science.276.5312.534; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Watson AJM, 2005, GASTROENTEROLOGY, V129, P902, DOI 10.1053/j.gastro.2005.06.015	18	76	77	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					534	U259		10.1038/nature10708	http://dx.doi.org/10.1038/nature10708			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22158121				2022-12-24	WOS:000300770500052
J	Mayer, KH; Krakower, D				Mayer, Kenneth H.; Krakower, Douglas			Antiretroviral Medication and HIV Prevention: New Steps Forward and New Questions	ANNALS OF INTERNAL MEDICINE			English	Article								During the past 2 years, several pivotal clinical trials have proven that the use of antiretrovirals by HIV-infected and at-risk uninfected persons can decrease the probability of HIV being transmitted sexually. The initial chemoprophylaxis studies evaluated tenofovir administered topically or orally (with or without emtricitabine). However, several questions remain. Some subsequent primary prevention studies did not replicate the results of the initial studies, raising questions about differences in the behaviors of participants in each study (in particular about medication adherence), as well as whether pharmacologic or local mucosal factors might explain the variable efficacy estimates. Other antiretrovirals and delivery systems are being evaluated to maximize the efficacy of primary chemoprophylactic approaches. At present, increasing access to antiretroviral treatment globally is a priority, because expanding access to medication that can prevent morbidity and mortality is itself an important public health goal and may reasonably be expected to decrease HIV incidence. However, for treatment as prevention to be maximally effective, increases in HIV testing, health care workers, and infrastructure are needed, in addition to medications and laboratory support for clinical monitoring. A combination of approaches is needed to most quickly decrease the current trends in HIV incidence, including early diagnosis and initiation of treatment for HIV-infected persons. These approaches can be coupled with appropriately tailored interventions for populations at greatest risk for infection (for example, men who have sex with men and sex workers), including male circumcision, behavioral interventions, and chemoprophylaxis. However, a substantial gap exists between current expenditures and unmet needs, which suggests that mobilization of political will is needed for this combination approach to be successful.	Fenway Hlth, Boston, MA USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Fenway Health; Harvard University; Beth Israel Deaconess Medical Center	Mayer, KH (corresponding author), Fenway Community Hlth, 1340 Boylson St, Boston, MA 02215 USA.	kmayer@fenwayhealth.org			HIV Clinical Research Fellowship (NIAID) [AI 007433]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433] Funding Source: NIH RePORTER	HIV Clinical Research Fellowship (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Krakower is supported by the Harvard T32 postdoctoral HIV Clinical Research Fellowship (NIAID AI 007433).	Abbas U, 2011, 18 C RETR OPP INF BO; [Anonymous], 6 INT AIDS SOC C HIV; [Anonymous], 18 C RETR OPP INF BO; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; FACTS Consortium, 2011, FACTS 001 STUD; Family Health International, FEM PREP JUN 2011 UP; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kashuba AD, 2011, LANCET; Office of the Press Secretary The White House, 2011, FACT SHEET BEG END A; Thigpen MC, 2011, 6 INT AIDS SOC C HIV; UNAIDS, 2010, REP GLOB AIDS EP 201	13	11	11	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4					312	U105		10.7326/0003-4819-156-4-201202210-00383	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-00383			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896YO	22250077	Green Accepted			2022-12-24	WOS:000300607600009
J	Fouchier, R; Osterhaus, AB; Steinbruner, J; Yuen, KY; Henderson, DA; Klotz, L; Sylvester, ED				Fouchier, Ron; Osterhaus, A. B.; Steinbruner, John; Yuen, Kwok-Yung; Henderson, D. A.; Klotz, Lynn; Sylvester, E. D.			The fight over flu	NATURE			English	Editorial Material									[Fouchier, Ron; Osterhaus, A. B.] Erasmus MC, Rotterdam, Netherlands; [Steinbruner, John] Univ Maryland, Ctr Int & Secur Studies Maryland, College Pk, MD USA; [Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Chair Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Henderson, D. A.] Univ Pittsburgh, Ctr Biosecur, Med Ctr, Pittsburgh, PA 15260 USA; [Klotz, Lynn; Sylvester, E. D.] Ctr Arms Control & Non Proliferat, Washington, DC USA; [Klotz, Lynn; Sylvester, E. D.] Arizona State Univ, Walter Cronkite Sch Journalism, Tempe, AZ 85287 USA	Erasmus University Rotterdam; Erasmus MC; University System of Maryland; University of Maryland College Park; University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Arizona State University; Arizona State University-Tempe	Fouchier, R (corresponding author), Erasmus MC, Rotterdam, Netherlands.		Fouchier, Ron A/A-1911-2014; Ebright, Richard/O-3321-2019	Fouchier, Ron A/0000-0001-8095-2869; Ebright, Richard/0000-0001-8915-7140; Yuen, Kwok-yung/0000-0002-2083-1552	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000986] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		2012, NATURE, V481, P9; 2011, NATURE, V480, P421	2	20	20	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 19	2012	481	7381					257	259						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	877VK	22246325	Bronze, Green Published			2022-12-24	WOS:000299210600013
J	Pizzo, PA; Clark, NM				Pizzo, Philip A.; Clark, Noreen M.			Alleviating Suffering 101-Pain Relief in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pizzo, Philip A.] Stanford Univ, Off Dean, Sch Med, Stanford, CA 94305 USA; [Clark, Noreen M.] Univ Michigan, Ctr Managing Chron Dis, Ann Arbor, MI 48109 USA	Stanford University; University of Michigan System; University of Michigan	Pizzo, PA (corresponding author), Stanford Univ, Off Dean, Sch Med, Stanford, CA 94305 USA.							Institute of Medicine, 2011, REL PAIN AM BLU TRAN	1	142	144	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2012	366	3					197	199		10.1056/NEJMp1109084	http://dx.doi.org/10.1056/NEJMp1109084			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877RZ	22256802				2022-12-24	WOS:000299201400002
J	Gill, TM; Gahbauer, EA; Murphy, TE; Han, L; Allore, HG				Gill, Thomas M.; Gahbauer, Evelyne A.; Murphy, Terrence E.; Han, Ling; Allore, Heather G.			Risk Factors and Precipitants of Long-Term Disability in Community Mobility A Cohort Study of Older Persons	ANNALS OF INTERNAL MEDICINE			English	Article							LIFE-STYLE INTERVENTIONS; LOWER-EXTREMITY FUNCTION; BODY-MASS INDEX; SUBSEQUENT DISABILITY; PHYSICAL PERFORMANCE; MAINTAINING MOBILITY; RESTRICTED ACTIVITY; BATHING DISABILITY; DRIVING CESSATION; RANDOMIZED-TRIAL	Background: Relatively little is known about why older persons develop long-term disability in community mobility. Objective: To identify the risk factors and precipitants for long-term disability in walking a quarter mile and driving a car. Design: Prospective cohort study from March 1998 to December 2009. Setting: Greater New Haven, Connecticut. Participants: 641 persons, aged 70 years or older, who were active drivers or nondisabled in walking a quarter mile. Persons who were physically frail were oversampled. Measurements: Candidate risk factors were assessed every 18 months. Disability in community mobility and exposure to potential precipitants, including illnesses or injuries leading to hospitalization or restricted activity, were assessed every month. Disability that lasted 6 or more consecutive months was considered long-term. Results: 318 (56.0%) and 269 (53.1%) participants developed long-term disability in walking and driving, respectively. Seven risk factors were independently associated with walking disability and 8 were associated with driving disability; the strongest associations for each outcome were found for older age and lower score on the Short Physical Performance Battery. The precipitants had a large effect on long-term disability, with multivariate hazard ratios for each outcome greater than 6.2 for hospitalization and greater than 2.4 for restricted activity. The largest differences in absolute risk were generally observed in participants with a specific risk factor who were subsequently hospitalized. Limitations: The observed associations may not be causal. The severity of precipitants was not assessed. The effect of the precipitants may have been underestimated because their exposure after the initial onset of disability was not evaluated. Conclusion: Long-term disability in community mobility is common among older persons. Multiple risk factors, together with subsequent precipitants, greatly increase the likelihood of long-term mobility disability.	[Gill, Thomas M.] Yale Univ, Sch Med, Adler Geriatr Assessment Ctr, New Haven, CT 06504 USA	Yale University	Gill, TM (corresponding author), Yale Univ, Sch Med, Adler Geriatr Assessment Ctr, 20 York St, New Haven, CT 06504 USA.	thomas.gill@yale.edu; heather.allore@yale.edu	Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368; Allore, Heather/0000-0001-7685-8175	National Institute on Aging [R37AG17560, K24AG021507]; National Institutes of Health [P30AG21342]; National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [P30AG021342, K24AG021507, R37AG017560] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By grant R37AG17560 from the National Institute on Aging and Midcareer Investigator Award in Patient-Oriented Research K24AG021507 from the National Institute on Aging (Dr. Gill). The study was conducted at the Yale Claude D. Pepper Older Americans Independence Center (funded by National Institutes of Health grant P30AG21342).; National Institute on Aging, National Institutes of Health.	[Anonymous], 1955, ARCH OPHTHALMOL-CHIC, V54, P462; Baker PS, 2003, J AM GERIATR SOC, V51, P1610, DOI 10.1046/j.1532-5415.2003.51512.x; BENICHOU J, 1990, BIOMETRICS, V46, P813, DOI 10.2307/2532098; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Brown CJ, 2009, ANN INTERN MED, V150, P372, DOI 10.7326/0003-4819-150-6-200903170-00005; Bruce ML, 2001, AM J GERIAT PSYCHIAT, V9, P102, DOI 10.1176/appi.ajgp.9.2.102; Chaves PHM, 2000, ARCH INTERN MED, V160, P2525, DOI 10.1001/archinte.160.16.2525; Clark DO, 1998, J AGING HEALTH, V10, P422, DOI 10.1177/089826439801000402; CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036; Daniels R, 2010, EUR J AGEING, V7, P37, DOI 10.1007/s10433-010-0141-9; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; Edwards JD, 2008, J GERONTOL B-PSYCHOL, V63, pP6, DOI 10.1093/geronb/63.1.P6; Edwards JD, 2009, J GERONTOL A-BIOL, V64, P1290, DOI 10.1093/gerona/glp114; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fragoso CAV, 2008, J AM GERIATR SOC, V56, P1014, DOI 10.1111/j.1532-5415.2008.01687.x; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gill TM, 2008, J AM GERIATR SOC, V56, P436, DOI 10.1111/j.1532-5415.2007.01603.x; Gill TM, 2007, J AM GERIATR SOC, V55, P534, DOI 10.1111/j.1532-5415.2007.01099.x; Gill TM, 2006, J GERONTOL A-BIOL, V61, P821, DOI 10.1093/gerona/61.8.821; Gill TM, 2011, J GERONTOL A-BIOL, V66, P1238, DOI 10.1093/gerona/glr142; Gill TM, 2009, J AM GERIATR SOC, V57, P1850, DOI 10.1111/j.1532-5415.2009.02443.x; Gill TM, 2006, J AM GERIATR SOC, V54, P248, DOI 10.1111/j.1532-5415.2005.00586.x; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; Gill TM, 2006, ARCH INTERN MED, V166, P418, DOI 10.1001/.418; GILL TM, 1995, J AM GERIATR SOC, V43, P603, DOI 10.1111/j.1532-5415.1995.tb07192.x; Gill TM, 2002, J AM GERIATR SOC, V50, P1492, DOI 10.1046/j.1532-5415.2002.50403.x; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1993, AM J EPIDEMIOL, V137, P845, DOI 10.1093/oxfordjournals.aje.a116746; Guralnik JM, 2001, J AM GERIATR SOC, V49, P1463, DOI 10.1046/j.1532-5415.2001.4911238.x; Hardy SE, 2005, ARCH INTERN MED, V165, P106, DOI 10.1001/archinte.165.1.106; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Hardy SE, 2011, J GEN INTERN MED, V26, P130, DOI 10.1007/s11606-010-1543-2; Harrell FEJr, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-1-4757-3462-1; Ho SC, 1997, J GERONTOL A-BIOL, V52, pM356, DOI 10.1093/gerona/52A.6.M356; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Iezzoni LI, 2003, WALKING FAILS MOBILI; Katula JA, 2007, J AM GERIATR SOC, V55, P674, DOI 10.1111/j.1532-5415.2007.01136.x; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; LACROIX AZ, 1993, AM J EPIDEMIOL, V137, P858, DOI 10.1093/oxfordjournals.aje.a116747; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093; LICHTENSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V259, P2875, DOI 10.1001/jama.259.19.2875; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Marottoli RA, 1999, PRINCIPLES GERIATRIC, P267; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Rantanen T, 2001, J AM GERIATR SOC, V49, P21, DOI 10.1046/j.1532-5415.2001.49005.x; Reid MC, 2003, J AM GERIATR SOC, V51, P1092, DOI 10.1046/j.1532-5415.2003.51357.x; Rich MW, 2001, J GERONTOL A-BIOL, V56, pM88, DOI 10.1093/gerona/56.2.M88; Shumway-Cook A, 2003, J AM GERIATR SOC, V51, P393, DOI 10.1046/j.1532-5415.2003.51114.x; Straus SE, 2002, JAMA-J AM MED ASSOC, V288, P1396, DOI 10.1001/jama.288.11.1396; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Tinetti ME, 2002, JAMA-J AM MED ASSOC, V287, P2098, DOI 10.1001/jama.287.16.2098; U.S. Census Bureau, 2011, AM FACTFINDER; Wang ML, 2006, BIOMETRICAL J, V48, P302, DOI 10.1002/bimj.200510188; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9; Webber SC, 2010, GERONTOLOGIST, V50, P443, DOI 10.1093/geront/gnq013	64	113	114	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2012	156	2					131	W25		10.7326/0003-4819-156-2-201201170-00009	http://dx.doi.org/10.7326/0003-4819-156-2-201201170-00009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	894IW	22250144	Green Accepted			2022-12-24	WOS:000300421400004
J	Room, R; Reuter, P				Room, Robin; Reuter, Peter			How well do international drug conventions protect public health?	LANCET			English	Article							ILLICIT OPIOID USE; TRENDS; POLICIES; BURDEN; ABUSE	The Single Convention on Narcotic Drugs in 1961 aimed to eliminate the illicit production and non-medical use of cannabis, cocaine, and opioids, an aim later extended to many pharmaceutical drugs. Over the past 50 years international drug treaties have neither prevented the globalisation of the illicit production and non-medical use of these drugs, nor, outside of developed countries, made these drugs adequately available for medical use. The system has also arguably worsened the human health and wellbeing of drug users by increasing the number of drug users imprisoned, discouraging effective countermeasures to the spread of HIV by injecting drug users, and creating an environment conducive to the violation of drug users' human rights. The international system has belatedly accepted measures to reduce the harm from injecting drug use, but national attempts to reduce penalties for drug use while complying with the treaties have often increased the number of drug users involved with the criminal justice system. The international treaties have also constrained national policy experimentation because they require nation states to criminalise drug use. The adoption of national policies that are more aligned with the risks of different drugs and the effectiveness of controls will require the amendment of existing treaties, the formulation of new treaties, or withdrawal of states from existing treaties and re-accession with reservations.	[Room, Robin] Univ Melbourne, Ctr Alcohol Policy Res, Turning Point Alcohol & Drug Ctr, Melbourne, Vic 3065, Australia; [Room, Robin] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic 3065, Australia; [Reuter, Peter] Univ Maryland, Sch Publ Policy, College Pk, MD 20742 USA; [Reuter, Peter] Univ Maryland, Dept Criminol, College Pk, MD 20742 USA	Turning Point Alcohol & Drug Centre - Australia; University of Melbourne; University of Melbourne; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Room, R (corresponding author), Univ Melbourne, Ctr Alcohol Policy Res, Turning Point Alcohol & Drug Ctr, 54-62 Gertrude St, Melbourne, Vic 3065, Australia.	robinr@turningpoint.org.au	Room, Robin/ABF-7460-2021; Room, Robin/ABH-8505-2020	Room, Robin/0000-0002-5618-385X; 	Victorian Department of Health; Foundation for Alcohol Research and Education (FARE)	Victorian Department of Health; Foundation for Alcohol Research and Education (FARE)	RR has been provided with support for travel by the Beckley Foundation for drug policy research project meetings and reports. RR's professorship is supported by the Victorian Department of Health and the Foundation for Alcohol Research and Education (FARE), and his research by FARE and government research grants. PR has been provided with travel support and honoraria by the Beckley Foundation for drug policy research project meetings and reports.	Babor T., 2010, DRUG POLICY PUBLIC G; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Begg SVT, 2003, BURDEN DIS INJURY AU, pPHE82; Bewley-Taylor D, 2010, INT NARCOTICS CONTRO; Braithwaite J., 2000, GLOBAL BUSINESS REGU, P539; Bruun K., 1975, GENTLEMENS CLUB INT; Burci Gian Luca, 2004, WORLD HLTH ORG, P124; Carstairs C, 2005, DRUG ALCOHOL REV, V24, P57, DOI 10.1080/09595230500125179; Caulkins JP, 2006, CRIME DELINQUENCY, V52, P619, DOI 10.1177/0011128705284793; Compton WM, 2006, DRUG ALCOHOL DEPEN, V81, P103, DOI 10.1016/j.drugalcdep.2005.05.009; Costa AM, 2009, WORLD DRUG REPORT 20, P1; Costa AM, 2011, MAKING DRUG CONTROL; Courtwright DT, 2010, BIOSOCIETIES, V5, P137, DOI 10.1057/biosoc.2009.3; de Cordoba J, 2011, MEXICO DEATH TOLL DR; Degenhardt L, 2006, DRUG ALCOHOL REV, V25, P403, DOI 10.1080/09595230600868504; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Donnelly N, 2011, EFFECTS CANNABIS EXP; Elliott Richard, 2005, Health Hum Rights, V8, P104, DOI 10.2307/4065336; European Monitoring Centre for Drugs and Drug Addiction, 2011, ANN REP 2010 STAT DR; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fetherston J, 2011, EFFECTS W AUSTR CANN; Fischer B, 1997, PUBLIC HEALTH, V111, P271, DOI 10.1016/S0033-3506(97)00053-X; Fischer B, 2007, ADDICTION, V102, P499, DOI 10.1111/j.1360-0443.2006.01738.x; Fischer B, 2006, CAN MED ASSOC J, V175, P1385, DOI 10.1503/cmaj.060729; Fong GT, 2006, TOB CONTROL, V15, P1, DOI 10.1136/tc.2006.017244; Golub Andrew, 2007, Criminol Public Policy, V6, P131, DOI 10.1111/j.1745-9133.2007.00426.x; Gorman DA, 2007, INT J DRUG POLICY, V18, P160, DOI 10.1016/j.drugpo.2006.10.001; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Helfer L, 2006, YALE J INT L, V31, P367; Helfer LR, 2005, VA LAW REV, V91, P1579; Hibell B, 2007 ESPAD REPORT SU; Hughes CE, 2010, BRIT J CRIMINOL, V50, P999, DOI 10.1093/bjc/azq038; International Drug Policy Consortium, 2010, 2009 COMM NARC DRUGS; International Drug Policy Consortium, 2010, 2010 COMM NARC DRUGS; International Drug Policy Consortium, 2010, 2007 COMM NARC DRUGS; International Drug Policy Consortium, 2010, WHY IS OUTC UN DRUG; International Narcotics Control Board, REP INT NARC CONTR B; Jelsma M, 2011, BOLIVIAS DENUNCIATIO; Jelsma M, 2011, DEV INT DRUG CONTROL; Kilmer B, 2011, ALTERED STATE ASSESS; Kleiman M, 2009, BRUTE FORCE FAILS; Kleiman M, 1992, EXCESS DRUG POLICY R; Korf DJ, 2002, ADDICT BEHAV, V27, P851, DOI 10.1016/S0306-4603(02)00291-5; Krajewski, 1999, INT J DRUG POLICY, V10, P328; Kuziemko Y, 2004, J PUBLIC ECON, V88, P2043, DOI 10.1016/S0047-2727(03)00020-3; MacCoun R, 1997, SCIENCE, V278, P47, DOI 10.1126/science.278.5335.47; MacCoun RJ., 2001, DRUG WAR HERESIES LE; McAllister William., 2000, DRUG DIPLOMACY 20 CE; O'Keefe K, 2011, MARIJUANA USE YOUNG; Office of National Drug Control Policy, 2010, WHAT AM US SPEND ILL; ProCon.org, 2011, MAN PEOPL US US MED; Rehm J, COSTS SUBSTANCE ABUS; Reuter P, 2006, ADDICTION, V101, P315, DOI 10.1111/j.1360-0443.2005.01336.x; Reuter P, 2001, ADDICTION, V96, P373, DOI 10.1046/j.1360-0443.2001.9633731.x; Reuter P, 2010, ASSESSING CHANGES GL; Reuter P., 2009, REPORT GLOBAL ILLICI; Room R, 2005, J PSYCHOACTIVE DRUGS, V37, P373, DOI 10.1080/02791072.2005.10399810; Room R, 1999, SUBST USE MISUSE, V34, P1689, DOI 10.3109/10826089909039422; Room R., 2010, CANNABIS POLICY MOVI; Room R, 2006, DRUG ALCOHOL REV, V25, P581, DOI 10.1080/09595230600944503; Room Robin, 2006, Soc Hist Alcohol Drugs, V21, P276; Samuels D, 2010, KUSH MED MARIJUANA I; Seblova J, 2005, J EMERG MED, V28, P95, DOI 10.1016/j.jemermed.2004.05.010; Strang J, 2012, LANCET, V379, P71, DOI 10.1016/S0140-6736(11)61674-7; Transnational Institute, 2010, TNI DRUGS DEM PROGR; United Nations Offi ce on Drugs and Crime, 2010, COERC COH TREAT DRUG; United Nations Office on Drugs and Crime, 2010, RESP DRUG US HIV IR; United Nations Office on Drugs and Crime, WORLD DRUG REP 2009; United Nations Office on Drugs and Crime, WORLD DRUG REP 2010; WHO, 2010, IMPR ACC MED CONTR I; WHO Expert Committee on Drug Dependence, 2010, 28 WHO EXP COMM DRUG; WHO Expert Committee on Drug Dependence, 2010, 33 WHO EXP COMM DRUG; Zabransky T, 2011, PAD IMPACT ANAL PROJ	74	72	72	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2012	379	9810					84	91		10.1016/S0140-6736(11)61423-2	http://dx.doi.org/10.1016/S0140-6736(11)61423-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	873WC	22225673				2022-12-24	WOS:000298913000040
J	Seeley, TD; Visscher, PK; Schlegel, T; Hogan, PM; Franks, NR; Marshall, JAR				Seeley, Thomas D.; Visscher, P. Kirk; Schlegel, Thomas; Hogan, Patrick M.; Franks, Nigel R.; Marshall, James A. R.			Stop Signals Provide Cross Inhibition in Collective Decision-Making by Honeybee Swarms	SCIENCE			English	Article							NEST-SITE SELECTION; VIBRATIONAL SIGNALS; BEE SWARMS; NEUROBIOLOGY; CHOICE; DANCE	Honeybee swarms and complex brains show many parallels in how they make decisions. In both, separate populations of units (bees or neurons) integrate noisy evidence for alternatives, and, when one population exceeds a threshold, the alternative it represents is chosen. We show that a key feature of a brain-cross inhibition between the evidence-accumulating populations-also exists in a swarm as it chooses its nesting site. Nest-site scouts send inhibitory stop signals to other scouts producing waggle dances, causing them to cease dancing, and each scout targets scouts' reporting sites other than her own. An analytic model shows that cross inhibition between populations of scout bees increases the reliability of swarm decision-making by solving the problem of deadlock over equal sites.	[Seeley, Thomas D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Visscher, P. Kirk] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Schlegel, Thomas; Franks, Nigel R.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Hogan, Patrick M.; Marshall, James A. R.] Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England; [Hogan, Patrick M.; Marshall, James A. R.] Univ Sheffield, Kroto Res Inst, Sheffield S1 4DP, S Yorkshire, England	Cornell University; University of California System; University of California Riverside; University of Bristol; University of Sheffield; University of Sheffield	Seeley, TD (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	tds5@cornell.edu	Franks, Nigel/AAG-8207-2019	Franks, Nigel/0000-0001-8139-9604; Marshall, James/0000-0002-1506-167X	Cornell Agriculture Experiment Station [NYC-191522]; University of California-Riverside [CA-R*-ENT-6892-H]; UK Biotechnology and Biological Sciences Research Council [BB/G02166X/1]; BBSRC [BB/G02166X/2, BB/G02166X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [E19832, BB/G02166X/1, BB/G02166X/2] Funding Source: researchfish	Cornell Agriculture Experiment Station; University of California-Riverside(University of California System); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the staff of the Shoals Marine Laboratory for general assistance and D. Pais for useful discussions on dynamical systems theory. This work was supported by Cornell Agriculture Experiment Station grant NYC-191522 (T. D. S.), University of California-Riverside grant CA-R*-ENT-6892-H (P. K. V.), and UK Biotechnology and Biological Sciences Research Council grant BB/G02166X/1 (J.A.R.M. and N.R.F.). The data on how scouts performing waggle dances receive stop signals are tabulated in the supporting online material (SOM). The data on who produces stop signals and when they are produced are shown in Fig. 2.	Bogacz R, 2007, TRENDS COGN SCI, V11, P118, DOI 10.1016/j.tics.2006.12.006; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; KIRCHNER WH, 1993, BEHAV ECOL SOCIOBIOL, V33, P169, DOI 10.1007/BF00216597; LINDAUER M, 1955, Z VERGL PHYSIOL, V37, P263, DOI 10.1007/BF00303153; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; MICHELSEN A, 1986, BEHAV ECOL SOCIOBIOL, V18, P207, DOI 10.1007/BF00290824; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; NIEH JC, 1993, BEHAV ECOL SOCIOBIOL, V33, P51, DOI 10.1007/BF00164346; Passino KM, 2008, BEHAV ECOL SOCIOBIOL, V62, P401, DOI 10.1007/s00265-007-0468-1; Pastor KA, 2005, ETHOLOGY, V111, P775, DOI 10.1111/j.1439-0310.2005.01116.x; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Seeley T.D., 2010, HONEYBEE DEMOCRACY; Seeley TD, 2006, AM SCI, V94, P220, DOI 10.1511/2006.59.220; Seeley TD, 2004, BEHAV ECOL SOCIOBIOL, V56, P594, DOI 10.1007/s00265-004-0814-5; Seeley TD, 2003, BEHAV ECOL SOCIOBIOL, V54, P511, DOI 10.1007/s00265-003-0664-6; Seeley TD, 2003, BEHAV ECOL SOCIOBIOL, V53, P417, DOI 10.1007/s00265-003-0598-z; Seeley TD, 2001, J COMP PHYSIOL A, V187, P667, DOI 10.1007/s00359-001-0243-0; Seeley TD, 2008, J EXP BIOL, V211, P3691, DOI 10.1242/jeb.021071; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9	23	221	225	4	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2012	335	6064					108	111		10.1126/science.1210361	http://dx.doi.org/10.1126/science.1210361			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22157081				2022-12-24	WOS:000298846200062
J	McMichael, L				McMichael, Louise			PRACTICE POINTER Skin camouflage	BRITISH MEDICAL JOURNAL			English	Editorial Material									British Assoc Skin Camouflage, Stourbridge DY9 9QA, England		McMichael, L (corresponding author), British Assoc Skin Camouflage, Stourbridge DY9 9QA, England.	louise.mcmichael@tiscali.co.uk						*ALL PART PARL GRO, 2003, REP ENQ IMP SKIN DIS; [Anonymous], 2005, EUR J DERMATOL, V15, P284; British Association of Skin Camouflage, 2010, COV PRINC ART PAR SK; Gawkrodger D. J., 2002, DERMATOLOGY ILLUSTRA; Holme SA, 2002, BRIT J DERMATOL, V147, P956; Schofield J., 2009, SKIN CONDITIONS UK H; Sreedhar K, 2009, OPEN DERMATOL J, V3, P54	7	10	10	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 5	2012	344								d7921	10.1136/bmj.d7921	http://dx.doi.org/10.1136/bmj.d7921			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874UH	22223831				2022-12-24	WOS:000298983100006
J	Kelch, BA; Makino, DL; O'Donnell, M; Kuriyan, J				Kelch, Brian A.; Makino, Debora L.; O'Donnell, Mike; Kuriyan, John			How a DNA Polymerase Clamp Loader Opens a Sliding Clamp	SCIENCE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROCESSIVITY FACTOR; REPLICATION SYSTEM; DELTA-SUBUNIT; GAMMA-COMPLEX; ATP BINDING; MECHANISM; HYDROLYSIS; REPLISOME	Processive chromosomal replication relies on sliding DNA clamps, which are loaded onto DNA by pentameric clamp loader complexes belonging to the AAA+ family of adenosine triphosphatases (ATPases). We present structures for the ATP-bound state of the clamp loader complex from bacteriophage T4, bound to an open clamp and primer-template DNA. The clamp loader traps a spiral conformation of the open clamp so that both the loader and the clamp match the helical symmetry of DNA. One structure reveals that ATP has been hydrolyzed in one subunit and suggests that clamp closure and ejection of the loader involves disruption of the ATP-dependent match in symmetry. The structures explain how synergy among the loader, the clamp, and DNA can trigger ATP hydrolysis and release of the closed clamp on DNA.	[Kelch, Brian A.; Makino, Debora L.; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kelch, Brian A.; Makino, Debora L.; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Kuriyan, John] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Rockefeller University; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu		O'Donnell, Michael/0000-0001-9002-4214	U.S. Department of Energy [DE-AC03-76SF00098]; NIH [F32-087888, R01-GM308839, R01-GM45547]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045547, R01GM038839, F32GM087888] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Morikawa for providing the molecular envelope from the electron microscopic reconstruction of the archaeal clamp loader complex, P. von Hippel, S. Tsutakawa, and S. Benkovic as well as Kuriyan lab members for helpful discussions. We thank K. Engel for creating Fig. 6, K. Simonetta for providing E. coli clamp loader protein for ADP-BeF<INF>x</INF> titrations, and the staff at Beamlines 8.2.1, 8.2.2 and 8.3.1 of the Advanced Light Source, which is supported by U.S. Department of Energy under contract DE-AC03-76SF00098. This work was partially supported by NIH grants F32-087888 (B. K.), R01-GM308839 (M. OD.), and R01-GM45547 (J.K.). The authors declare no conflict of interest. B. K., D. M. and J.K. designed experiments. B. K. and D. M. performed experiments. B. K., D. M., M. OD., and J.K. analyzed the data. B. K. and J.K. wrote the paper. Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 3U5Z, 3U60, and 3U61 for crystal forms I, II, and III, respectively.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Alley SC, 1999, BIOCHEMISTRY-US, V38, P7696, DOI 10.1021/bi9827971; Bailey S, 2006, CELL, V126, P893, DOI 10.1016/j.cell.2006.07.027; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; FEDOROFF OY, 1993, J MOL BIOL, V233, P509, DOI 10.1006/jmbi.1993.1528; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goedken ER, 2005, NAT STRUCT MOL BIOL, V12, P183, DOI 10.1038/nsmb889; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Helt CE, 2005, CELL CYCLE, V4, P529, DOI 10.4161/cc.4.4.1598; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; JARVIS TC, 1989, J BIOL CHEM, V264, P12717; JARVIS TC, 1989, J BIOL CHEM, V264, P12709; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028; McNally R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-3; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Neuwald AF, 1999, GENOME RES, V9, P27; ONRUST R, 1991, J BIOL CHEM, V266, P21681; Oyama T, 2001, MOL CELL, V8, P455, DOI 10.1016/S1097-2765(01)00328-8; Pietroni P, 2001, J MOL BIOL, V309, P869, DOI 10.1006/jmbi.2001.4687; Pietroni P, 2008, J BIOL CHEM, V283, P28338, DOI 10.1074/jbc.M804371200; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; SANCAR A, 1993, SCIENCE, V259, P1415, DOI 10.1126/science.8451638; Seybert A, 2006, EMBO J, V25, P2209, DOI 10.1038/sj.emboj.7601093; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; YOUNG MC, 1992, BIOCHEMISTRY-US, V31, P8675, DOI 10.1021/bi00152a001; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103	44	120	122	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1675	1680		10.1126/science.1211884	http://dx.doi.org/10.1126/science.1211884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194570	Green Accepted			2022-12-24	WOS:000298344000059
J	Rosset, P				Rosset, Peter			Preventing hunger: Change economic policy	NATURE			English	Editorial Material							FOOD; AGRICULTURE; MOVEMENT		[Rosset, Peter] Ctr Study Rural Change Mexico CECCAM, Oaxaca, Mexico		Rosset, P (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	rosset@globalalternatives.org	Rosset, Peter M./G-5317-2014	Rosset, Peter M./0000-0002-1253-1066				Badgley C, 2007, RENEW AGR FOOD SYST, V22, P86, DOI 10.1017/S1742170507001640; Martinez-Torres ME, 2010, J PEASANT STUD, V37, P149, DOI 10.1080/03066150903498804; Food and Agriculture Organization of the United Nations (FAO), 2011, STATE FOOD INSECURIT; Ghosh J, 2010, J AGRAR CHANGE, V10, P72, DOI 10.1111/j.1471-0366.2009.00249.x; Rosset PM, 2011, J PEASANT STUD, V38, P161, DOI 10.1080/03066150.2010.538584; Rosset P., 2011, Development (London), V54, P21, DOI 10.1057/dev.2010.102; Rosset P., 2009, Bulletin of Science, Technology and Society, V29, P189, DOI 10.1177/0270467609333733; ROSSET PM, 2006, FOOD IS DIFFERENT	8	15	17	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					472	473		10.1038/479472a	http://dx.doi.org/10.1038/479472a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	851QI	22113676	Bronze			2022-12-24	WOS:000297285600027
J	Mokkonen, M; Kokko, H; Koskela, E; Lehtonen, J; Mappes, T; Martiskainen, H; Mills, SC				Mokkonen, Mikael; Kokko, Hanna; Koskela, Esa; Lehtonen, Jussi; Mappes, Tapio; Martiskainen, Henna; Mills, Suzanne C.			Negative Frequency-Dependent Selection of Sexually Antagonistic Alleles in Myodes glareolus	SCIENCE			English	Article							GENETIC-VARIATION; CONFLICT; FITNESS; CONSEQUENCES; DIMORPHISM; EVOLUTION	Sexually antagonistic genetic variation, where optimal values of traits are sex-dependent, is known to slow the loss of genetic variance associated with directional selection on fitness-related traits. However, sexual antagonism alone is not sufficient to maintain variation indefinitely. Selection of rare forms within the sexes can help to conserve genotypic diversity. We combined theoretical models and a field experiment with Myodes glareolus to show that negative frequency-dependent selection on male dominance maintains variation in sexually antagonistic alleles. In our experiment, high-dominance male bank voles were found to have low-fecundity sisters, and vice versa. These results show that investigations of sexually antagonistic traits should take into account the effects of social interactions on the interplay between ecology and evolution, and that investigations of genetic variation should not be conducted solely under laboratory conditions.	[Mokkonen, Mikael; Mappes, Tapio] Univ Jyvaskyla, Ctr Excellence Evolutionary Res, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland; [Kokko, Hanna; Lehtonen, Jussi] Australian Natl Univ, Ctr Excellence Biol Interact, Div Evolut Ecol & Genet, Res Sch Biol, Canberra, ACT 0200, Australia; [Koskela, Esa; Martiskainen, Henna] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland; [Lehtonen, Jussi] Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; [Mills, Suzanne C.] Univ Perpignan, Lab Excellence CORAIL, USR CRIOBE 3278, CBETM,CNRS EPHE, F-66860 Perpignan, France	University of Jyvaskyla; Australian National University; University of Jyvaskyla; University of Helsinki; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Perpignan Via Domitia	Mokkonen, M (corresponding author), Univ Jyvaskyla, Ctr Excellence Evolutionary Res, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland.	mikael.mokkonen@gmail.com	Mills, Suzanne/K-5538-2012; Kokko, Hanna/C-7861-2009; Mappes, Tapio/B-9780-2013	Mills, Suzanne/0000-0001-8948-3384; Mappes, Tapio/0000-0002-5936-7355; Lehtonen, Jussi/0000-0001-5260-1041; Kokko, Hanna/0000-0002-5772-4881	Academy of Finland [115961, 119200, 218107, 132190, 103508, 108566]; Vanamo Biological Society; Ehrnrooth Foundation; Australian Research Council; Australian National University; Finnish Cultural Foundation; Emil Aaltonen Foundation; Centre of Excellence in Evolutionary Research, University of Jyvaskyla	Academy of Finland(Academy of Finland); Vanamo Biological Society; Ehrnrooth Foundation; Australian Research Council(Australian Research Council); Australian National University(Australian National University); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Emil Aaltonen Foundation; Centre of Excellence in Evolutionary Research, University of Jyvaskyla	Supported by Academy of Finland grants 115961, 119200, and 218107 (E. K.), 132190 (T. M.), and 103508 and 108566 (S. C. M.); the Vanamo Biological Society and Ehrnrooth Foundation (M. M.); the Australian Research Council and Australian National University (H. K. and J.L.); the Finnish Cultural Foundation and Emil Aaltonen Foundation (J.L.); and the Centre of Excellence in Evolutionary Research, University of Jyvaskyla. We thank the staff of the Experimental Animal Unit and Konnevesi Research Station, University of Jyvaskyla; R. Nara and H. Pietilainen for logistical support; T. Laaksonen, V. Lummaa, and three anonymous reviewers for comments; and C. Soulsbury for statistical advice. The authors declare no conflicts of interest. All co-authors designed this study; M. M., E. K., T. M. and H. M. collected and analyzed the empirical data; J.L. analyzed theoretical results with input from all authors; and M. M. led the preparation of the manuscript with input from all co-authors. Authors after the first author are listed in alphabetical order. Data have been deposited in the Dryad Repository (doi:10.5061/dryad.6m0f6870).	Albert AYK, 2005, SCIENCE, V310, P119, DOI 10.1126/science.1115328; Arnqvist G, 2011, EVOLUTION, V65, P2111, DOI 10.1111/j.1558-5646.2011.01270.x; Arnqvist Goran, 2005, pUnpaginated; Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; Bedhomme Stephanie, 2007, P185; Bijma P, 2010, J EVOLUTION BIOL, V23, P194, DOI 10.1111/j.1420-9101.2009.01895.x; Birkhead TR, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P1; Calisi RM, 2009, HORM BEHAV, V56, P1, DOI 10.1016/j.yhbeh.2009.02.010; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Connallon T, 2010, EVOLUTION, V64, P1671, DOI 10.1111/j.1558-5646.2009.00934.x; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; Delcourt M, 2009, P ROY SOC B-BIOL SCI, V276, P2009, DOI 10.1098/rspb.2008.1459; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Hall MD, 2010, EVOLUTION, V64, P1697, DOI 10.1111/j.1558-5646.2009.00932.x; Kokko H, 2003, ANN ZOOL FENN, V40, P207; Kokko H, 2007, ECOL LETT, V10, P773, DOI 10.1111/j.1461-0248.2007.01086.x; Mappes T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001687; Mills SC, 2007, P ROY SOC B-BIOL SCI, V274, P143, DOI 10.1098/rspb.2006.3639; Mills SC, 2009, AM NAT, V173, P475, DOI 10.1086/597222; Mokkonen M, 2012, J ANIM ECOL, V81, P277, DOI 10.1111/j.1365-2656.2011.01903.x; Parker G.A., 1979, P123; Patten MM, 2009, BIOL LETTERS, V5, P667, DOI 10.1098/rsbl.2009.0230; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Schroderus E, 2010, AM NAT, V176, pE90, DOI 10.1086/656264; Sinervo B, 2006, ANNU REV ECOL EVOL S, V37, P581, DOI 10.1146/annurev.ecolsys.37.091305.110128; Svensson EI, 2005, AM NAT, V165, P567, DOI 10.1086/429278; van Doorn GS, 2009, ANN NY ACAD SCI, V1168, P52, DOI 10.1111/j.1749-6632.2009.04573.x; ZUK M, 1995, P ROY SOC B-BIOL SCI, V260, P205, DOI 10.1098/rspb.1995.0081	32	60	61	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2011	334	6058					972	974		10.1126/science.1208708	http://dx.doi.org/10.1126/science.1208708			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CA	22096197	Green Published			2022-12-24	WOS:000297101800054
J	Macnaghten, P; Owen, R				Macnaghten, Phil; Owen, Richard			Good governance for geoengineering	NATURE			English	Editorial Material									[Macnaghten, Phil] Univ Durham, Durham DH1 3HP, England; [Owen, Richard] Univ Exeter, Sch Business, Exeter EX4 4QJ, Devon, England	Durham University; University of Exeter	Macnaghten, P (corresponding author), Univ Durham, Durham DH1 3HP, England.	p.m.macnaghten@durham.ac.uk; R.J.Owen@exeter.ac.uk		Owen, Richard/0000-0002-1767-3901	ESRC [RES-077-26-0001] Funding Source: UKRI; Economic and Social Research Council [RES-077-26-0001] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		NURSE P, 2011, GUARDIAN        0908; Rayner S, 2009, MEMORANDUM DRAFT PRI; *ROYAL SOC WORK GR, 2009, GEOENG CLIM SCI GOV	3	68	68	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					293	293		10.1038/479293a	http://dx.doi.org/10.1038/479293a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	848OA	22094673				2022-12-24	WOS:000297059700015
J	Zoller, B; Li, XJ; Sundquist, J; Sundquist, K				Zoller, Bengt; Li, Xinjun; Sundquist, Jan; Sundquist, Kristina			Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; VENOUS THROMBOEMBOLISM; THROMBOSIS	Background Some autoimmune disorders have been linked to venous thromboembolism. We examined whether there is an association between autoimmune disorders and risk of pulmonary embolism. Methods We followed up all individuals in Sweden without previous hospital admission for venous thromboembolism and with a primary or secondary diagnosis of an autoimmune disorder between Jan 1, 1964, and Dec 31, 2008, for hospital admission for pulmonary embolism. We obtained data from the MigMed2 database, which has individual-level information about all registered residents of Sweden. The reference population was the total population of Sweden. We calculated standardised incidence ratios (SIRs) for pulmonary embolism, adjusted for individual variables, including age and sex. Findings 535 538 individuals were admitted to hospital because of an autoimmune disorder. Overall risk of pulmonary embolism during the first year after admission for an autoimmune disorder was 6.38 (95% CI 6.19-6.57). All the 33 autoimmune disorders were associated with a significantly increased risk of pulmonary embolism during the first year after admission. However, some had a particularly high risk-eg, immune thrombocytopenic purpura (10.79, 95% CI 7.98-14.28), polyarteritis nodosa (13.26, 9.33-18.29), polymyositis or dermatomyositis (16.44, 11.57-22.69), and systemic lupus erythematosus (10.23, 8.31-12.45). Overall risk decreased over time, from 1.53 (1.48-1.57) at 1-5 years, to 1.15 (1.11-1.20) at 5-10 years, and 1.04 (1.00-1.07) at 10 years and later. The risk was increased for both sexes and all age groups. Interpretation Autoimmune disorders are associated with a high risk of pulmonary embolism in the first year after hospital admission. Our findings suggest that these disorders in general should be regarded as hypercoagulable disorders.	[Zoller, Bengt] Lund Univ Reg Skane, Malmo Univ Hosp, Clin Res Ctr, Ctr Primary Hlth Care Res, S-20502 Malmo, Sweden; [Sundquist, Jan] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Lund University; Skane University Hospital; Stanford University	Zoller, B (corresponding author), Lund Univ Reg Skane, Malmo Univ Hosp, Clin Res Ctr, Ctr Primary Hlth Care Res, S-20502 Malmo, Sweden.	bengt.zoller@med.lu.se	Zöller, Bengt/H-8856-2012; Zöller, Bengt/M-3217-2019	Zöller, Bengt/0000-0002-8250-5613; Zöller, Bengt/0000-0002-8250-5613; Li, Xinjun/0000-0002-5559-4657	Swedish Research Council [2008-3110, 2008-2638]; Swedish Council for Working Life and Social Research [2006-0386, 2007-1754, 2007-1962]; Swedish Research Council Formas [2006-4255-6596-99, 2007-1352]; Region Skane [REGSKANE-124611]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Region Skane	We thank Stephen Gilliver for his useful comments about the text. The registers used in this study are maintained by Statistics Sweden and the National Board of Health and Welfare. KS and JS received grant support from the Swedish Research Council (grant numbers 2008-3110 and 2008-2638), the Swedish Council for Working Life and Social Research (2006-0386, 2007-1754, and 2007-1962), and Swedish Research Council Formas (2006-4255-6596-99 and 2007-1352). BZ received grant support from Region Skane (REGSKANE-124611).	Alikhan R, 2004, ARCH INTERN MED, V164, P963, DOI 10.1001/archinte.164.9.963; Bergqvist D, 2002, PREVENTION DIAGNOSIS; Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Goldhaber SZ, 2003, CIRCULATION, V108, P2726, DOI 10.1161/01.CIR.0000097829.89204.0C; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Grip O, 2000, SCAND J GASTROENTERO, V35, P619, DOI 10.1080/003655200750023589; Jilma B, 2005, THROMB HAEMOSTASIS, V94, P797, DOI 10.1160/T04-10-0652; Kyrle PA, 2005, LANCET, V365, P1163, DOI 10.1016/S0140-6736(05)71880-8; Lin HC, 2010, J THROMB HAEMOST, V8, P2176, DOI 10.1111/j.1538-7836.2010.03993.x; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; Ludvigsson JF, 2007, BRIT J HAEMATOL, V139, P121, DOI 10.1111/j.1365-2141.2007.06766.x; Matta F, 2009, THROMB HAEMOSTASIS, V101, P134, DOI 10.1160/TH08-08-0551; Merkel PA, 2005, ANN INTERN MED, V142, P620, DOI 10.7326/0003-4819-142-8-200505030-00011; Miehsler W, 2004, GUT, V53, P542, DOI 10.1136/gut.2003.025411; National Board of Health and Welfare, 1998, SWED HOSP DISCH REG; National Board of Health and Welfare, 2000, VAL DIAGN SWED IN CA; Ramagopalan SV, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-1; Rosen M, 2005, HANDBOOK OF EPIDEMIOLOGY, P231; Rosengren A, 2008, J THROMB HAEMOST, V6, P558, DOI 10.1111/j.1538-7836.2007.02857.x; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sjalander Anders, 2007, Lakartidningen, V104, P1585; Statistics Sweden, 2008, POP HOUS CENS 1960 9; Statistics Sweden, 2010, MULT REG 2009 DESCR; Stein PD, 2009, AM J MED SCI, V337, P259, DOI 10.1097/MAJ.0b013e31818bbb8b; Wang JY, 2009, WORLD J GASTROENTERO, V15, P927, DOI 10.3748/wjg.15.927; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Xu J, 2010, HAMOSTASEOLOGIE, V30, P5; Yazici Yusuf, 2010, Curr Rheumatol Rep, V12, P429, DOI 10.1007/s11926-010-0132-z	29	248	256	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2012	379	9812					244	249		10.1016/S0140-6736(11)61306-8	http://dx.doi.org/10.1016/S0140-6736(11)61306-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879FW	22119579				2022-12-24	WOS:000299316100039
J	Kunimoto, K; Yamazaki, Y; Nishida, T; Shinohara, K; Ishikawa, H; Hasegawa, T; Okanoue, T; Hamada, H; Noda, T; Tamura, A; Tsukita, S; Tsukita, S				Kunimoto, Koshi; Yamazaki, Yuji; Nishida, Tomoki; Shinohara, Kyosuke; Ishikawa, Hiroaki; Hasegawa, Toshiaki; Okanoue, Takeshi; Hamada, Hiroshi; Noda, Tetsuo; Tamura, Atsushi; Tsukita, Shoichiro; Tsukita, Sachiko			Coordinated Ciliary Beating Requires Odf2-Mediated Polarization of Basal Bodies via Basal Feet	CELL			English	Article							PLANAR CELL POLARITY; EPITHELIAL-CELLS; MOTHER CENTRIOLES; MOTILE CILIA; BODY; CILIOGENESIS; MICROTUBULE; ORIENTATION; CENTROSOME; MOUSE	Coordinated beating of cilia in the trachea generates a directional flow of mucus required to clear the airways. Each cilium originates from a barrel-shaped basal body, from the side of which protrudes a structure known as the basal foot. We generated mice in which exons 6 and 7 of Odf2, encoding a basal body and centrosome-associated protein Odf2/cenexin, are disrupted. Although Odf2(Delta Ex6,7/Delta Ex6,7) mice form cilia, ciliary beating is uncoordinated, and the mice display a coughing/sneezing phenotype. Whereas residual expression of the C-terminal region of Odf2 in these mice is sufficient for ciliogenesis, the resulting basal bodies lack basal feet. Loss of basal feet in ciliated epithelia disrupted the polarized organization of apical microtubule lattice without affecting planar cell polarity. The requirement for Odf2 in basal foot formation, therefore, reveals a crucial role of this structure in the polarized alignment of basal bodies and coordinated ciliary beating.	[Kunimoto, Koshi; Yamazaki, Yuji; Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Grad Sch Frontier Biosci, Biol Sci Lab, Suita, Osaka 5650871, Japan; [Kunimoto, Koshi; Yamazaki, Yuji; Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Nishida, Tomoki; Hasegawa, Toshiaki] Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, Osaka 5670047, Japan; [Shinohara, Kyosuke; Hamada, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, Suita, Osaka 5650871, Japan; [Shinohara, Kyosuke; Hamada, Hiroshi] Japan Sci & Technology Corp JST, CREST, Suita, Osaka 5650871, Japan; [Ishikawa, Hiroaki] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Okanoue, Takeshi] Saiseikai Suita Hosp, Dept Hepatol, Osaka 5640013, Japan; [Noda, Tetsuo] Canc Inst Japanese Fdn Canc Res, Dept Cell Biol, Tokyo 1358550, Japan; [Tsukita, Shoichiro] Kyoto Univ, Dept Cell Biol, Fac Med, Kyoto 6068315, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; Japanese Foundation for Cancer Research; Kyoto University	Tsukita, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Biol Sci Lab, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	atsukita@biosci.med.osaka-u.ac.jp; atsukita@biosci.med.osaka-u.ac.jp	Shinohara, Kyosuke/AAU-2471-2020; Hamada, Hiroshi/N-6374-2015; Noda, Tetsuo/B-1667-2016; Shinohara, Kyosuke/I-1470-2016	Shinohara, Kyosuke/0000-0002-6350-1684; Hamada, Hiroshi/0000-0002-7196-5948; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23590334] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Y. Fujiyoshi, S. Kitajiri, T. Stearns, A. Wynshaw-Boris, and our laboratory members for discussion. We thank D. Sipp for critical reading of this manuscript. We thank Shu Lin Low, S. Watanabe, and R. Tokumasu for limited experimental collaboration. We thank M. Uji and A. Hagiwara for the excellent technical assistance. We also thank Y. Ohta, H. Mori, A. Takaoka, S. Yoshiba, K. Takaoka, I. Tateya, H. Shiratori, M. Inagaki, A. Inoko, and M. Ibi for technical advice. This work was supported in part by Grants-in-Aid for Creative Scientific Research (to Sachiko Tsukita) and Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work is dedicated to Shoichiro Tsukita, who contributed the initial planning of this study and passed away in 2005. Research planning and supervision were by Sachiko Tsukita and K.K. All experiments were conducted by K.K. in collaboration with H.I. (instruction in construction of targeting vector), Y.Y. (western blotting and RT-PCR), K.S./H.H. (live imaging), T. Nishida/T.H. (UHVEMT), A.T./T. Noda (generation of knockout mice), and H.I. and Y.Y. (transfection of F9 cells). Discussion was by K.K., Y.Y., K.S., T. Nishida, H.H., H.I., T.O., A.T, T. Noda, and Sachiko Tsukita. Discussion and manuscript writing were mainly by Sachiko Tsukita, K.K., and Y.Y.	Afzelius B A, 1979, Int Rev Exp Pathol, V19, P1; ANDERSON RG, 1972, J CELL BIOL, V54, P246, DOI 10.1083/jcb.54.2.246; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; BOISVIEUXULRICH E, 1985, BIOL CELL, V55, P147, DOI 10.1111/j.1768-322X.1985.tb00417.x; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Brohmann H, 1997, J BIOL CHEM, V272, P10327, DOI 10.1074/jbc.272.15.10327; GIBBONS IR, 1961, J BIOPHYS BIOCHEM CY, V11, P179, DOI 10.1083/jcb.11.1.179; GORDON RE, 1982, CELL MOTIL CYTOSKEL, V2, P385, DOI 10.1002/cm.970020407; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; Guirao B, 2007, BIOPHYS J, V92, P1900, DOI 10.1529/biophysj.106.084897; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Hagiwara H, 2000, HISTOCHEM J, V32, P669, DOI 10.1023/A:1004163315822; HARD R, 1983, TISSUE CELL, V15, P227, DOI 10.1016/0040-8166(83)90019-8; Heydeck W, 2009, DEV DYNAM, V238, P3035, DOI 10.1002/dvdy.22130; ISHIKAWA H, 1969, J CELL BIOL, V43, P312; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kunimoto K, 2009, J CELL PHYSIOL, V220, P621, DOI 10.1002/jcp.21798; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; Marshall WF, 2010, NAT CELL BIOL, V12, P314, DOI 10.1038/ncb0410-314; McNeill H, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003376; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Morillas HN, 2007, RESPIRATION, V74, P252, DOI 10.1159/000101783; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; OKO R, 1988, BIOL REPROD, V39, P673, DOI 10.1095/biolreprod39.3.673; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; REED W, 1984, J CELL SCI, V68, P1; Schweizer S, 2009, CELL TISSUE RES, V338, P295, DOI 10.1007/s00441-009-0861-3; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Sloboda RD, 2007, J CELL BIOL, V179, P575, DOI 10.1083/jcb.200709039; SOROKIN SP, 1968, J CELL SCI, V3, P207; Soung NK, 2006, MOL CELL BIOL, V26, P8316, DOI 10.1128/MCB.00671-06; Soung NK, 2009, DEV CELL, V16, P539, DOI 10.1016/j.devcel.2009.02.004; STERNBERG N, 1981, J MOL BIOL, V150, P487, DOI 10.1016/0022-2836(81)90376-4; Tarnasky H, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-67; Vladar EK, 2008, TRENDS CELL BIOL, V18, P517, DOI 10.1016/j.tcb.2008.08.004; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Voronina VA, 2009, J CELL BIOL, V185, P225, DOI 10.1083/jcb.200809144; Wallingford JB, 2010, CURR OPIN CELL BIOL, V22, P597, DOI 10.1016/j.ceb.2010.07.011; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301	44	134	138	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 20	2012	148	1-2					189	200		10.1016/j.cell.2011.10.052	http://dx.doi.org/10.1016/j.cell.2011.10.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265411	Bronze			2022-12-24	WOS:000299540700024
J	Libby, T; Moore, TY; Chang-Siu, E; Li, D; Cohen, DJ; Jusufi, A; Full, RJ				Libby, Thomas; Moore, Talia Y.; Chang-Siu, Evan; Li, Deborah; Cohen, Daniel J.; Jusufi, Ardian; Full, Robert J.			Tail-assisted pitch control in lizards, robots and dinosaurs	NATURE			English	Article							BODY; BALANCE	In 1969, a palaeontologist proposed(1) that theropod dinosaurs used their tails as dynamic stabilizers during rapid or irregular movements, contributing to their depiction as active and agile predators. Since then the inertia of swinging appendages has been implicated in stabilizing human walking(2,3), aiding acrobatic manoeuvres by primates(4-8) and rodents(9), and enabling cats to balance on branches(10). Recent studies on geckos(11-13) suggest that active tail stabilization occurs during climbing, righting and gliding. By contrast, studies on the effect of lizard tail loss show evidence of a decrease, an increase or no change in performance(14,15). Application of a control-theoretic framework could advance our general understanding of inertial appendage use in locomotion. Here we report that lizards control the swing of their tails in a measured manner to redirect angular momentum from their bodies to their tails, stabilizing body attitude in the sagittal plane. We video-recorded Red-Headed Agama lizards (Agama agama) leaping towards a vertical surface by first vaulting onto an obstacle with variable traction to induce a range of perturbations in body angular momentum. To examine a known controlled tail response, we built a lizard-sized robot with an active tail that used sensory feedback to stabilize pitch as it drove off a ramp. Our dynamics model revealed that a body swinging its tail experienced less rotation than a body with a rigid tail, a passively compliant tail or no tail. To compare a range of tails, we calculated tail effectiveness as the amount of tailless body rotation a tail could stabilize. A model Velociraptor mongoliensis supported the initial tail stabilization hypothesis(1), showing as it did a greater tail effectiveness than the Agama lizards. Leaping lizards show that inertial control of body attitude can advance our understanding of appendage evolution and provide biological inspiration for the next generation of manoeuvrable search-and-rescue robots.	[Moore, Talia Y.; Li, Deborah; Jusufi, Ardian; Full, Robert J.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Libby, Thomas] Univ Calif Berkeley, Ctr Interdisciplinary Bioinspirat Educ & Res, Berkeley, CA 94720 USA; [Chang-Siu, Evan] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Cohen, Daniel J.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Full, RJ (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	rjfull@berkeley.edu	Moore, Talia Y/E-1210-2012; Moore, Talia/AAB-1590-2019	Moore, Talia/0000-0003-0867-4512; Jusufi, Ardian/0000-0003-4250-2984	US NSF FIBR; MAST CTA; NSF IGERT [DGE-0903711]; Swiss NSF	US NSF FIBR; MAST CTA; NSF IGERT(National Science Foundation (NSF)); Swiss NSF(Swiss National Science Foundation (SNSF))	We thank P. Jennings for video editing and figure production, T. Full for digitizing the lizard video and K. Padian for his advice on the dinosaur reconstruction and capability. We thank O. O'Reilly, S. Sponberg and N. Sapir for advice on analysis. This work was supported by a US NSF FIBR grant to R.J.F., a MAST CTA grant to R.J.F, an NSF IGERT under award DGE-0903711 and a Swiss NSF Fellowship to A.	Alexander RM, 2006, P ROY SOC B-BIOL SCI, V273, P1849, DOI 10.1098/rspb.2006.3532; BARTHOLOMEW GA, 1951, J MAMMAL, V32, P155, DOI 10.2307/1375371; Bateman PW, 2009, J ZOOL, V277, P1, DOI 10.1111/j.1469-7998.2008.00484.x; Berkemeier M. D., 1992, Proceedings. 1992 IEEE International Conference on Robotics And Automation (Cat. No.92CH3140-1), P286, DOI 10.1109/ROBOT.1992.220249; Carrier DR, 2001, J EXP BIOL, V204, P3917; Chang-Siu E., 2011, 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2011), P1887, DOI 10.1109/IROS.2011.6048342; Demes B, 1996, J HUM EVOL, V31, P367, DOI 10.1006/jhev.1996.0066; Dowling JJ, 2006, MED ENG PHYS, V28, P837, DOI 10.1016/j.medengphy.2005.11.007; DUNBAR DC, 1988, AM J PRIMATOL, V16, P291, DOI 10.1002/ajp.1350160402; Gillis GB, 2009, J EXP BIOL, V212, P604, DOI 10.1242/jeb.024349; Gunther M.M., 1991, Zeitschrift fuer Morphologie und Anthropologie, V78, P341; Hyun Soo P, 2009, IEEE INT C ROB AUT 2, P2655; Jusufi A, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/4/045001; Jusufi A, 2008, P NATL ACAD SCI USA, V105, P4215, DOI 10.1073/pnas.0711944105; Jusufi A, 2011, INTEGR COMP BIOL, V51, P937, DOI 10.1093/icb/icr114; Larson SG, 2006, AM J PHYS ANTHROPOL, V129, P71, DOI 10.1002/ajpa.20236; Mather TW, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P5905, DOI 10.1109/IROS.2009.5354027; Ostrom J. H, 1969, B PEABODY MUS NAT HI, V30, P68; Ostrom J. H, 1969, B PEABODY MUS NAT HI, V30, P144; Paul G. S, 2002, DINOSAURS AIR EVOLUT, V45; Paul G. S, 2010, PRINCETON FIELDGUIDE, V137; Peters A., 1984, P227; Pijnappels M, 2010, EXP BRAIN RES, V201, P689, DOI 10.1007/s00221-009-2088-7; Roos PE, 2008, GAIT POSTURE, V27, P352, DOI 10.1016/j.gaitpost.2007.05.001; Saunders A, 2006, PROC SPIE, V6230, DOI 10.1117/12.666150; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; Walker C, 1998, BEHAV BRAIN RES, V91, P41, DOI 10.1016/S0166-4328(97)00101-0	27	193	203	6	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2012	481	7380					181	+		10.1038/nature10710	http://dx.doi.org/10.1038/nature10710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22217942				2022-12-24	WOS:000298981200035
J	Greenhalgh, T				Greenhalgh, Trisha			OUTSIDE THE BOX The feminisation of nature	BRITISH MEDICAL JOURNAL			English	Editorial Material									Barts & London Queen Marys Sch Med & Dent, London, England	University of London; Queen Mary University London	Greenhalgh, T (corresponding author), Barts & London Queen Marys Sch Med & Dent, London, England.	p.greenhalgh@qmul.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				2008, J ENVIRON MONITOR, V10, P1476, DOI DOI 10.1039/B815741N	1	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 30	2011	343								d8348	10.1136/bmj.d8348	http://dx.doi.org/10.1136/bmj.d8348			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874TQ	22209822				2022-12-24	WOS:000298981400005
J	Welch, HG				Welch, H. Gilbert			Making the Call	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROSTATE-CANCER; MORTALITY		Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA	Dartmouth College	Welch, HG (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA.	h.gilbert.welch@dartmouth.edu						Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], CANC STAT REV SEER 1; Kiellman A, 2009, J UROLOGY, V181, P1615, DOI 10.1016/j.juro.2008.11.115; Loeb S, 2011, J UROLOGY, V186, P1830, DOI 10.1016/j.juro.2011.06.057; Merrill RM, 1997, CANCER EPIDEM BIOMAR, V6, P763; Napoli M, 2003, PSA SCREENING TEST P; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; US Preventive Services Task Force, 2011, US PREV SERV TASK FO; Welch HG, 2002, J NATL CANCER I, V94, P1066; Welch HG, 2001, JAMA-J AM MED ASSOC, V285, P2776, DOI 10.1001/jama.285.21.2776; Welch HG, 2011, OVERDIAGNOSED MAKING	11	10	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2649	2650		10.1001/jama.2011.1898	http://dx.doi.org/10.1001/jama.2011.1898			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22203530				2022-12-24	WOS:000298484000001
J	Kump, LR; Junium, C; Arthur, MA; Brasier, A; Fallick, A; Melezhik, V; Lepland, A; Crne, AE; Luo, GM				Kump, Lee R.; Junium, Christopher; Arthur, Michael A.; Brasier, Alex; Fallick, Anthony; Melezhik, Victor; Lepland, Aivo; Crne, Alenka E.; Luo, Genming			Isotopic Evidence for Massive Oxidation of Organic Matter Following the Great Oxidation Event	SCIENCE			English	Article							CARBON; CONSTRAINTS; DEPOSITS; NITROGEN; PROVINCE; RISE	The stable isotope record of marine carbon indicates that the Proterozoic Eon began and ended with extreme fluctuations in the carbon cycle. In both the Paleoproterozoic [2500 to 1600 million years ago (Ma)] and Neoproterozoic (1000 to 542 Ma), extended intervals of anomalously high carbon isotope ratios (delta C-13) indicate high rates of organic matter burial and release of oxygen to the atmosphere; in the Neoproterozoic, the high delta C-13 interval was punctuated by abrupt swings to low delta C-13, indicating massive oxidation of organic matter. We report a Paleoproterozoic negative delta C-13 excursion that is similar in magnitude and apparent duration to the Neoproterozoic anomaly. This Shunga-Francevillian anomaly may reflect intense oxidative weathering of rocks as the result of the initial establishment of an oxygen-rich atmosphere.	[Kump, Lee R.; Junium, Christopher; Arthur, Michael A.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Junium, Christopher] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA; [Brasier, Alex; Fallick, Anthony] Scottish Univ Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland; [Melezhik, Victor; Lepland, Aivo; Crne, Alenka E.] Norwegian Geol Survey, N-7491 Trondheim, Norway; [Melezhik, Victor] Univ Bergen, Ctr Geobiol SFF, N-5020 Bergen, Norway; [Lepland, Aivo] Tallinn Univ Technol, Inst Geol, EE-19086 Tallinn, Estonia; [Crne, Alenka E.] ZRC SAZU, Ivan Rakovec Inst Paleontol, SI-1000 Ljubljana, Slovenia; [Luo, Genming] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Northwestern University; Scottish Universities Research & Reactor Center; Geological Survey of Norway; University of Bergen; Tallinn University of Technology; Slovenian Academy of Sciences & Arts (SASA); China University of Geosciences	Kump, LR (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	lkump@psu.edu	Kump, Lee/H-8287-2012; Arthur, Michael A/E-2872-2014; Brasier, Alexander T./E-7412-2010	Arthur, Michael A/0000-0002-3028-6279; Brasier, Alexander T./0000-0001-6103-2848; Fallick, Anthony/0000-0002-7649-6167; Lepland, Aivo/0000-0002-0248-1405	International Continental Drilling Program; NSF; NASA Astrobiology Institute; Natural Environment Research Council [NE/G00398X/1]; Norwegian Research Council [191530/V30]; Geological Survey of Norway; NERC [NE/G00398X/1] Funding Source: UKRI	International Continental Drilling Program; NSF(National Science Foundation (NSF)); NASA Astrobiology Institute; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Geological Survey of Norway; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the International Continental Drilling Program and by NSF, NASA Astrobiology Institute, Natural Environment Research Council grant NE/G00398X/1, Norwegian Research Council grant 191530/V30, and Geological Survey of Norway. Thanks to the FAR-DEEP drilling team, especially D. V. Rychanchik and A. E. Romashkin, Karelian Science Centre, for assistance during the drilling and archiving operations. The data reported in this paper are tabulated in the SOM.	Aharon P, 2005, PRECAMBRIAN RES, V137, P207, DOI 10.1016/j.precamres.2005.03.008; [Anonymous], 1968, GEOCHEMISTRY-GERMANY; CLINE J D, 1975, Marine Chemistry, V3, P271, DOI 10.1016/0304-4203(75)90009-2; Derry LA, 2010, EARTH PLANET SC LETT, V294, P152, DOI 10.1016/j.epsl.2010.03.022; Garvin J, 2009, SCIENCE, V323, P1045, DOI 10.1126/science.1165675; Gauthier-Lafaye F, 2003, PRECAMBRIAN RES, V120, P81, DOI 10.1016/S0301-9268(02)00163-8; Godfrey LV, 2009, NAT GEOSCI, V2, P725, DOI 10.1038/NGEO633; Grotzinger JP, 2011, NAT GEOSCI, V4, P285, DOI [10.1038/ngeo1138, 10.1038/NGEO1138]; Hannah J. L., 2008, 33 INT GEOL C OSL NO; Holland H. D., 1994, EARLY LIFE EARTH, V84, P237; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Horie K., 2005, 15 VM GOLDSCHM C MAY, pA11; Karhu JA, 1996, GEOLOGY, V24, P867, DOI 10.1130/0091-7613(1996)024<0867:CIATRO>2.3.CO;2; Knauth LP, 2009, NATURE, V460, P728, DOI 10.1038/nature08213; Konhauser KO, 2011, NATURE, V478, P369, DOI 10.1038/nature10511; Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Melezhik V. A., 1994, MINERAL MAG A, V85A, P593; Melezhik VA, 1999, EARTH-SCI REV, V47, P1, DOI 10.1016/S0012-8252(99)00027-6; Melezhik VA, 2007, GEOLOGY, V35, P655, DOI 10.1130/G23764A.1; Muller SG, 2005, GEOLOGY, V33, P577, DOI 10.1130/G21482.1; Murakami T, 2011, GEOCHIM COSMOCHIM AC, V75, P3982, DOI 10.1016/j.gca.2011.04.023; Ovchinnikova G. V., 2007, STRATIGR GEOL CORREL, V4, P20; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Preat A, 2011, PRECAMBRIAN RES, V189, P212, DOI 10.1016/j.precamres.2011.05.013; PUKHTEL IS, 1992, DOKL AKAD NAUK+, V326, P706; Reinhard CT, 2009, SCIENCE, V326, P713, DOI 10.1126/science.1176711; Rothman DH, 2003, P NATL ACAD SCI USA, V100, P8124, DOI 10.1073/pnas.0832439100; SCHIDLOWSKI M, 1976, GEOCHIM COSMOCHIM AC, V40, P449, DOI 10.1016/0016-7037(76)90010-7; Shields G, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000266	29	138	148	9	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1694	1696		10.1126/science.1213999	http://dx.doi.org/10.1126/science.1213999			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22144465				2022-12-24	WOS:000298344000064
J	Graham-Rowe, D				Graham-Rowe, Duncan			Racing against the flu	NATURE			English	Editorial Material																			0	12	14	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					S2	S3		10.1038/480S2a	http://dx.doi.org/10.1038/480S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	857TR	22158296	Bronze			2022-12-24	WOS:000297744200004
J	Czupryn, A; Zhou, YD; Chen, X; McNay, D; Anderson, MP; Flier, JS; Macklis, JD				Czupryn, Artur; Zhou, Yu-Dong; Chen, Xi; McNay, David; Anderson, Matthew P.; Flier, Jeffrey S.; Macklis, Jeffrey D.			Transplanted Hypothalamic Neurons Restore Leptin Signaling and Ameliorate Obesity in db/db Mice	SCIENCE			English	Article							ARCUATE NUCLEUS; GLUCOSE-HOMEOSTASIS; PROOPIOMELANOCORTIN NEURONS; ENERGY-BALANCE; POMC NEURONS; BODY-WEIGHT; RECEPTOR; NEUROGENESIS; CHANNELS; PROGENITORS	Evolutionarily old and conserved homeostatic systems in the brain, including the hypothalamus, are organized into nuclear structures of heterogeneous and diverse neuron populations. To investigate whether such circuits can be functionally reconstituted by synaptic integration of similarly diverse populations of neurons, we generated physically chimeric hypothalami by microtransplanting small numbers of embryonic enhanced green fluorescent protein-expressing, leptin-responsive hypothalamic cells into hypothalami of postnatal leptin receptor-deficient (db/db) mice that develop morbid obesity. Donor neurons differentiated and integrated as four distinct hypothalamic neuron subtypes, formed functional excitatory and inhibitory synapses, partially restored leptin responsiveness, and ameliorated hyperglycemia and obesity in db/db mice. These experiments serve as a proof of concept that transplanted neurons can functionally reconstitute complex neuronal circuitry in the mammalian brain.	[Zhou, Yu-Dong; Anderson, Matthew P.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Zhou, Yu-Dong; Anderson, Matthew P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Zhou, Yu-Dong; Anderson, Matthew P.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02215 USA; [Zhou, Yu-Dong; Anderson, Matthew P.] Beth Israel Deaconess Med Ctr, Ctr Life Sci, Boston, MA 02215 USA; [Czupryn, Artur; Macklis, Jeffrey D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Czupryn, Artur; Macklis, Jeffrey D.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Czupryn, Artur; Macklis, Jeffrey D.] Harvard Univ, Sch Med, Dept Neurol, MGH HMS Ctr Nervous Syst Repair, Boston, MA 02114 USA; [Czupryn, Artur; Macklis, Jeffrey D.] Harvard Univ, Sch Med, Dept Neurosurg, MGH HMS Ctr Nervous Syst Repair, Boston, MA 02114 USA; [Czupryn, Artur; Macklis, Jeffrey D.] Massachusetts Gen Hosp, Nayef Al Rodhan Labs, Boston, MA 02114 USA; [Czupryn, Artur] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland; [Chen, Xi; McNay, David; Flier, Jeffrey S.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Harvard University; Beth Israel Deaconess Medical Center	Anderson, MP (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA.	matthew_anderson@bidmc.harvard.edu; jeffrey_flier@hms.harvard.edu; jeffrey_macklis@hms.harvard.edu	Flier, jeffrey/AAG-6223-2019	McNay, David/0000-0002-4747-0136; Zhou, Yu-Dong/0000-0002-6364-3869; Anderson, Matthew/0000-0003-4602-1811	NIH [NS41590]; Jane and Lee Seidman Fund for Central Nervous System Research; Emily and Robert Pearlstein Fund for Nervous System Repair; National Institute of Neurological Disorders and Stroke (NINDS) [NS057444, NS054674, NS070295]; Ministerstwa Nauki i Szkolnictwa Wyzszego [N303 298437]; Foundation for Polish Science;  [DKR37-28082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK028082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS041590, K02NS054674, R01NS049553, R01NS045523, R01NS041590, R21NS070295, R01NS057444] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane and Lee Seidman Fund for Central Nervous System Research; Emily and Robert Pearlstein Fund for Nervous System Repair; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ministerstwa Nauki i Szkolnictwa Wyzszego; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Yamamoto, K. Billmers, A. Palmer, L. Pasquina, K. Quinn, A. Wheeler, and P. Davis (J.D.M. laboratory), and H. Yin (J.S.F. laboratory) for excellent technical assistance. We thank O.K. Ronnekleiv at Oregon Health and Science University for providing antibody to beta-endorphin. We thank M. McKee of the MGH Microscopy Core for excellent EM assistance. This study was partially supported by NIH grant NS41590 (to J.D.M.), with additional infrastructure supported by NS45523 and NS49553 (to J.D.M.), and with additional support from the Jane and Lee Seidman Fund for Central Nervous System Research and the Emily and Robert Pearlstein Fund for Nervous System Repair (to J.D.M.), grant DKR37-28082 (to J.S.F.), the Picower Foundation (to J.S.F. and M. P. A.), National Institute of Neurological Disorders and Stroke (NINDS) grants NS057444, NS054674, and NS070295 (to M. P. A.), and the Nancy Lurie Marks Family Foundation (to M. P. A.). A. C. was partially supported by Ministerstwa Nauki i Szkolnictwa Wyzszego grant N303 298437 and by the Foundation for Polish Science.	Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bayer S.A., 1991, NEOCORTICAL DEV; Burdakov D, 2002, J NEUROSCI, V22, P6380; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Fioramonti X, 2007, DIABETES, V56, P1219, DOI 10.2337/db06-0567; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fricker-Gates RA, 2002, J NEUROSCI, V22, P4045, DOI 10.1523/JNEUROSCI.22-10-04045.2002; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; HernitGrant CS, 1996, EXP NEUROL, V139, P131, DOI 10.1006/exnr.1996.0088; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; Jo YH, 2005, J NEUROSCI, V25, P11133, DOI 10.1523/JNEUROSCI.3638-05.2005; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kowalski TJ, 2001, DIABETES, V50, P425, DOI 10.2337/diabetes.50.2.425; Li C, 1999, P NATL ACAD SCI USA, V96, P9677, DOI 10.1073/pnas.96.17.9677; Mcnay DEG, 2006, MOL ENDOCRINOL, V20, P1623, DOI 10.1210/me.2005-0518; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; SHIMADA M, 1973, EXP NEUROL, V41, P163, DOI 10.1016/0014-4886(73)90187-8; Shin JJ, 2000, J NEUROSCI, V20, P7404; Sohur US, 2006, PHILOS T R SOC B, V361, P1477, DOI 10.1098/rstb.2006.1887; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Zhou YD, 2009, NAT MED, V15, P1208, DOI 10.1038/nm.2019	33	43	45	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1133	1137		10.1126/science.1209870	http://dx.doi.org/10.1126/science.1209870			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116886	Green Submitted, Green Accepted			2022-12-24	WOS:000297313900051
J	Kiefer, T; Park, L; Tribouilloy, C; Cortes, C; Casillo, R; Chu, V; Delahaye, F; Durante-Mangoni, E; Edathodu, J; Falces, C; Logar, M; Miro, JM; Naber, C; Tripodi, MF; Murdoch, DR; Moreillon, P; Utili, R; Wang, A				Kiefer, Todd; Park, Lawrence; Tribouilloy, Christophe; Cortes, Claudia; Casillo, Roberta; Chu, Vivian; Delahaye, Francois; Durante-Mangoni, Emanuele; Edathodu, Jameela; Falces, Carlos; Logar, Mateja; Miro, Jose M.; Naber, Christophe; Tripodi, Marie Francoise; Murdoch, David R.; Moreillon, Philippe; Utili, Riccardo; Wang, Andrew			Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIVE VALVE ENDOCARDITIS; STAPHYLOCOCCUS-AUREUS ENDOCARDITIS; IN-HOSPITAL MORTALITY; PROPENSITY-SCORE; INTERNATIONAL COLLABORATION; PROGNOSTIC-FACTORS; MULTICENTER; GUIDELINES; MANAGEMENT; DIAGNOSIS	Context Heart failure (HF) is the most common complication of infective endocarditis. However, clinical characteristics of HF in patients with infective endocarditis, use of surgical therapy, and their associations with patient outcome are not well described. Objectives To determine the clinical, echocardiographic, and microbiological variables associated with HF in patients with definite infective endocarditis and to examine variables independently associated with in-hospital and 1-year mortality for patients with infective endocarditis and HF, including the use and association of surgery with outcome. Design, Setting, and Patients The International Collaboration on Endocarditis-Prospective Cohort Study, a prospective, multicenter study enrolling 4166 patients with definite native- or prosthetic-valve infective endocarditis from 61 centers in 28 countries between June 2000 and December 2006. Main Outcome Measures In-hospital and 1-year mortality. Results Of 4075 patients with infective endocarditis and known HF status enrolled, 1359 (33.4% [95% CI, 31.9%-34.8%]) had HF, and 906 (66.7% [95% CI, 64.2%-69.2%]) were classified as having New York Heart Association class III or IV symptom status. Within the subset with HF, 839 (61.7% [95% CI, 59.2%-64.3%]) underwent valvular surgery during the index hospitalization. In-hospital mortality was 29.7%(95% CI, 27.2%-32.1%) for the entire HF cohort, with lower mortality observed in patients undergoing valvular surgery compared with medical therapy alone (20.6%[95% CI, 17.9%-23.4%] vs 44.8% [95% CI, 40.4%-49.0%], respectively; P < .001). One-year mortality was 29.1% (95% CI, 26.0%-32.2%) in patients undergoing valvular surgery vs 58.4% (95% CI, 54.1%-62.6%) in those not undergoing surgery (P < .001). Cox proportional hazards modeling with propensity score adjustment for surgery showed that advanced age, diabetes mellitus, health care-associated infection, causative microorganism (Staphylococcus aureus or fungi), severe HF (New York Heart Association class III or IV), stroke, and paravalvular complications were independently associated with 1-year mortality, whereas valvular surgery during the initial hospitalization was associated with lower mortality. Conclusion In this cohort of patients with infective endocarditis complicated by HF, severity of HF was strongly associated with surgical therapy and subsequent mortality, whereas valvular surgery was associated with lower in-hospital and 1-year mortality. JAMA. 2011;306(20):2239-2247	[Wang, Andrew] Duke Univ, Med Ctr, Div Cardiovasc Med, Durham, NC 27710 USA; [Chu, Vivian] Duke Clin Res Inst, Durham, NC USA; [Tribouilloy, Christophe] S Hosp Amiens, Amiens, France; [Cortes, Claudia] Fdn Favaloro, Univ Hosp, Buenos Aires, DF, Argentina; [Casillo, Roberta; Durante-Mangoni, Emanuele; Tripodi, Marie Francoise; Utili, Riccardo] Univ Naples SUN, Naples, Italy; [Delahaye, Francois] Hosp Louis Pradel, Bron, France; [Edathodu, Jameela] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia; [Falces, Carlos; Miro, Jose M.] Univ Barcelona, Hosp Clin IDIBAPS, Barcelona, Spain; [Logar, Mateja] Med Ctr Ljublijana, Ljubljana, Slovenia; [Naber, Christophe] Univ Essen Gesamthsch, Essen, Germany; [Murdoch, David R.] Univ Otago, Christchurch, New Zealand; [Moreillon, Philippe] Univ Lausanne, Lausanne, Switzerland	Duke University; Duke University; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; University of Buenos Aires; CHU Lyon; King Faisal Specialist Hospital & Research Center; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Duisburg Essen; University of Otago; University of Lausanne	Wang, A (corresponding author), Duke Univ, Med Ctr, Div Cardiovasc Med, DUMC 3428, Durham, NC 27710 USA.	a.wang@duke.edu	Murdoch, David/A-2012-2009	Falces, Carlos/0000-0002-3483-3786; Durante-Mangoni, Emanuele/0000-0002-5381-3537; Wang, Andrew/0000-0001-8729-0933; Rizk, Hussien/0000-0001-5791-2359	American Heart Association [0675027N]; Novartis; Federation francaise de cardiologie; Wyeth; Edwards Life-sciences; Abbott Vascular; Gilead Sciences; National Institutes of Health [2 T32 GM008600]; Instituto de Salud Carlos III, Madrid, Spain [INT10/219]; Departament de Salut de la Generalitat de Catalunya, Barcelona, Spain; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008600] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Novartis(Novartis); Federation francaise de cardiologie; Wyeth(Wyeth); Edwards Life-sciences; Abbott Vascular(Abbott Laboratories); Gilead Sciences(Gilead Sciences); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Departament de Salut de la Generalitat de Catalunya, Barcelona, Spain(Generalitat de Catalunya); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Chu reported receiving a grant from the American Heart Association (0675027N). Dr Delahaye reported receiving grants from Novartis and the Federation francaise de cardiologie. Dr Utili reported serving on the board of Novartis; receiving grants or grants pending from Wyeth; receiving payment for lectures, including service of speakers bureaus, from Novartis; receiving payment for manuscript preparation from Pfizer; and receiving travel/accommodations/meeting expenses from Pfizer, Wyeth, and Novartis. Dr Wang reported receiving grants or grants pending from Edwards Life-sciences, Abbott Vascular, and Gilead Sciences; receiving payment for lectures, including service on speakers bureaus, from American Physician Inc; receiving payment for development of educational presentations from the American Board of Internal Medicine and the American College of Cardiology Foundation; and serving as a defense reviewer (no expert testimony) for a legal case related to endocarditis.; This work was supported in part by National Institutes of Health grant 2 T32 GM008600 to Dr Kiefer. Dr Miro was a recipient of an INT10/219 Intensification Research Grant (I3SNS & PRICS programs) from the Instituto de Salud Carlos III, Madrid, Spain, and the Departament de Salut de la Generalitat de Catalunya, Barcelona, Spain. Hospital Clinic of Barcelona (Spain) data were supported in part by Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, and the Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008), Madrid, Spain. No compensation for participation in the International Collaboration on Endocarditis-Prospective Cohort Study was provided to the investigators for their contributions.	Aksoy O, 2007, CLIN INFECT DIS, V44, P364, DOI 10.1086/510583; Anguera I, 2005, AM J CARDIOL, V96, P976, DOI 10.1016/j.amjcard.2005.05.056; Anguera I, 2005, EUR HEART J, V26, P288, DOI 10.1093/eurheartj/ehi034; Austin PC, 2010, STAT MED, V29, P2137, DOI 10.1002/sim.3854; Bashore TM, 2006, CURR PROB CARDIOLOGY, V31, P274, DOI 10.1016/j.cpcardiol.2005.12.001; Benito N, 2009, ANN INTERN MED, V150, P586, DOI 10.7326/0003-4819-150-9-200905050-00004; Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Botelho-Nevers E, 2009, ARCH INTERN MED, V169, P1290, DOI 10.1001/archinternmed.2009.192; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Cabell CH, 2002, INFECT DIS CLIN N AM, V16, P255, DOI 10.1016/S0891-5520(01)00007-1; Cabell Christopher H., 2003, Cardiology Clinics, V21, P147, DOI 10.1016/S0733-8651(03)00033-X; Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F; Chu VH, 2008, CLIN INFECT DIS, V46, P232, DOI 10.1086/524666; Delahaye F, 2007, SCAND J INFECT DIS, V39, P849, DOI 10.1080/00365540701393088; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Gaca JG, 2011, J THORAC CARDIOV SUR, V141, P98, DOI 10.1016/j.jtcvs.2010.09.016; Gaca JG, 2011, J THORAC CARDIOVASC, V141, pe1; Galvez-Acebal J, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-17; Habib G, 2005, HEART, V91, P954, DOI 10.1136/hrt.2004.046177; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hasbun R, 2003, JAMA-J AM MED ASSOC, V289, P1933, DOI 10.1001/jama.289.15.1933; Kahveci G, 2007, AM J CARDIOL, V99, P1429, DOI 10.1016/j.amjcard.2006.12.071; Lalani T, 2010, CIRCULATION, V121, P1005, DOI 10.1161/CIRCULATIONAHA.109.864488; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Nadji G, 2009, EUR J HEART FAIL, V11, P668, DOI 10.1093/eurjhf/hfp077; Roder BL, 1999, ARCH INTERN MED, V159, P462, DOI 10.1001/archinte.159.5.462; Shiue AB, 2010, AM J CARDIOL, V106, P1011, DOI 10.1016/j.amjcard.2010.05.034; Thuny F, 2010, HEART, V96, P892, DOI 10.1136/hrt.2008.151936; Vikram HR, 2003, JAMA-J AM MED ASSOC, V290, P3207, DOI 10.1001/jama.290.24.3207	30	147	157	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2011	306	20					2239	2247		10.1001/jama.2011.1701	http://dx.doi.org/10.1001/jama.2011.1701			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851GD	22110106	Green Accepted, Bronze			2022-12-24	WOS:000297255500023
J	Lau, WCY; Rubinstein, JL				Lau, Wilson C. Y.; Rubinstein, John L.			Subnanometre-resolution structure of the intact Thermus thermophilus H+-driven ATP synthase	NATURE			English	Article							ROTOR RING; V-ATPASE; MEMBRANE TOPOLOGY; CRYSTAL-STRUCTURE; CENTRAL STALK; NA+-ATPASE; SUBUNIT-C; TRANSLOCATION; ARCHITECTURE; MAPS	Ion-translocating rotary ATPases serve either as ATP synthases, using energy from a transmembrane ion motive force to create the cell's supply of ATP, or as transmembrane ion pumps that are powered by ATP hydrolysis(1). The members of this family of enzymes each contain two rotary motors: one that couples ion translocation to rotation and one that couples rotation to ATP synthesis or hydrolysis. During ATP synthesis, ion translocation through the membrane-bound region of the complex causes rotation of a central rotor that drives conformational changes and ATP synthesis in the catalytic region of the complex. There are no structural models available for the intact membrane region of any ion-translocating rotary ATPase. Here we present a 9.7 angstrom resolution map of the H+-driven ATP synthase from Thermus thermophilus obtained by electron cryomicroscopy of single particles in ice. The 600-kilodalton complex has an overall subunit composition of A(3)B(3)CDE(2)FG(2)IL(12). The membrane-bound motor consists of a ring of L subunits and the carboxy-terminal region of subunit I, which are equivalent to the c and a subunits of most other rotary ATPases, respectively. The map shows that the ring contains 12 L subunits(2) and that the I subunit has eight transmembrane helices(3). The L-12 ring and I subunit have a surprisingly small contact area in the middle of the membrane, with helices from the I subunit making contacts with two different L subunits. The transmembrane helices of subunit I form bundles that could serve as half-channels across the membrane, with the first half-channel conducting protons from the periplasm to the L-12 ring and the second half-channel conducting protons from the L-12 ring to the cytoplasm. This structure therefore suggests the mechanism by which a transmembrane proton motive force is converted to rotation in rotary ATPases.	[Lau, Wilson C. Y.; Rubinstein, John L.] Hosp Sick Children, Mol Struct & Funct Program, Res Inst, Toronto, ON M5G 1X8, Canada; [Lau, Wilson C. Y.; Rubinstein, John L.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Rubinstein, John L.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Rubinstein, JL (corresponding author), Hosp Sick Children, Mol Struct & Funct Program, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	john.rubinstein@utoronto.ca		Rubinstein, John/0000-0003-0566-2209	Ontario Graduate Scholarship; Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research [MOP 81294]	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank V. Kanelis, F. Sicheri, P. Rosenthal, L. Kay and R. Henderson for discussions and reading this manuscript, and J. Walker and R. Pomes for discussions. Computations were performed on the general-purpose cluster supercomputer at the SciNet HPC Consortium. W.C.Y.L. was supported by an Ontario Graduate Scholarship. J. L. R. was supported by a New Investigator Award from the Canadian Institutes of Health Research and an Early Researcher Award from the Ontario Ministry of Research and Innovation. This research was funded by operating grant MOP 81294 from the Canadian Institutes of Health Research.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Baker LA, 2011, J STRUCT BIOL, V176, P127, DOI 10.1016/j.jsb.2011.06.012; Baker LA, 2010, J STRUCT BIOL, V169, P431, DOI 10.1016/j.jsb.2009.11.014; CAIN BD, 1989, J BIOL CHEM, V264, P3292; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lau WCY, 2010, P NATL ACAD SCI USA, V107, P1367, DOI 10.1073/pnas.0911085107; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2001, FEBS LETT, V505, P353, DOI 10.1016/S0014-5793(01)02837-X; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; Press W. H., 2003, NUMERICAL RECIPES FO, V77; Rosenthal P. B., 2003, J MOL BIOL, V333, P743; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sousa D, 2007, J STRUCT BIOL, V157, P201, DOI 10.1016/j.jsb.2006.08.003; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107	41	96	97	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2012	481	7380					214	+		10.1038/nature10699	http://dx.doi.org/10.1038/nature10699			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22178924				2022-12-24	WOS:000298981200042
J	Hsu, DC; Wilkenfeld, P; Joshua, DE				Hsu, Danny C.; Wilkenfeld, Peter; Joshua, Douglas E.			EASILY MISSED? Multiple myeloma	BRITISH MEDICAL JOURNAL			English	Editorial Material							DELAY		[Hsu, Danny C.; Joshua, Douglas E.] Univ Sydney, Sydney, NSW 2050, Australia; [Hsu, Danny C.; Joshua, Douglas E.] Royal Prince Alfred Hosp, Inst Haematol, Sydney, NSW, Australia; [Wilkenfeld, Peter] Bondi Junct, Sydney, NSW 2022, Australia	University of Sydney; University of Sydney	Hsu, DC (corresponding author), Univ Sydney, Sydney, NSW 2050, Australia.	danny.hsu@tpg.com.au		Hsu, Danny/0000-0002-9577-5401				Alexandrakis MG, 2003, CLIN LAB HAEMATOL, V25, P41, DOI 10.1046/j.1365-2257.2003.00492.x; Friese CR, 2009, LEUKEMIA LYMPHOMA, V50, P392, DOI 10.1080/10428190902741471; Huang SY, 2007, CANCER-AM CANCER SOC, V110, P896, DOI 10.1002/cncr.22850; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kariyawasan CC, 2007, QJM-INT J MED, V100, P635, DOI 10.1093/qjmed/hcm077; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Kyle RA, 2007, BRIT J HAEMATOL, V139, P730, DOI 10.1111/j.1365-2141.2007.06873.x; Mhaskar R., 2010, COCHRANE DB SYST REV, V3; Morgan GJ, 2010, LANCET, V376, P1989, DOI 10.1016/S0140-6736(10)62051-X; Office for National Statistics, 2010, OFF NAT STAT SER MB1; Phekoo KJ, 2004, BRIT J HAEMATOL, V127, P299, DOI 10.1111/j.1365-2141.2004.05207.x; Waxman AJ, 2010, BLOOD, V116, P5501, DOI 10.1182/blood-2010-07-298760	13	5	5	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 5	2012	344								d7953	10.1136/bmj.d7953	http://dx.doi.org/10.1136/bmj.d7953			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874UH	22223832				2022-12-24	WOS:000298983100007
J	Chou, R; LeFevre, ML				Chou, Roger; LeFevre, Michael L.			Prostate Cancer Screening-The Evidence, the Recommendations, and the Clinical Implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; TRENDS		[Chou, Roger] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; [Chou, Roger] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Dept Family & Community Med, Columbia, MO 65211 USA	Oregon Health & Science University; Oregon Health & Science University; University of Missouri System; University of Missouri Columbia	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Dept Med, 3181 Sam Jackson Pk Rd SW,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610				Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Lu-Yao G, 2008, J GEN INTERN MED, V23, P1809, DOI 10.1007/s11606-008-0785-8; McDavid K, 2004, PUBLIC HEALTH REP, V119, P174, DOI 10.1177/003335490411900211; NIHR Health Technology Assessment Programme, PROTECT TRIAL EV EFF; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; U. S. Preventive Services Task Force, GRAD DEF; Wilt T J, 1997, Oncology (Williston Park), V11, P1133	10	35	36	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2721	2722		10.1001/jama.2011.1891	http://dx.doi.org/10.1001/jama.2011.1891			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22203543				2022-12-24	WOS:000298484000025
J	Dolgin, E				Dolgin, Elie			STEM CELLS Transplants on trial	NATURE			English	Editorial Material							MULTIPLE-MYELOMA; THERAPY											Barlogie B, 2006, J CLIN ONCOL, V24, P929, DOI 10.1200/JCO.2005.04.5807; Barlogie B, 2006, BRIT J HAEMATOL, V135, P158, DOI 10.1111/j.1365-2141.2006.06271.x; Bjorkstrand B, 2011, J CLIN ONCOL, V29, P3016, DOI 10.1200/JCO.2010.32.7312; Fermand JP, 1998, BLOOD, V92, P3131, DOI 10.1182/blood.V92.9.3131.421k30_3131_3136; Krishnan A, 2011, LANCET ONCOL, V12, P1195, DOI 10.1016/S1470-2045(11)70243-1; Nair B, 2010, BLOOD, V115, P4168, DOI 10.1182/blood-2009-11-255620	6	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S46	S47		10.1038/480S46a	http://dx.doi.org/10.1038/480S46a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169802				2022-12-24	WOS:000298033000007
J	Torres, JZ; Summers, MK; Peterson, D; Brauer, MJ; Lee, J; Senese, S; Gholkar, AA; Lo, YC; Lei, XY; Jung, K; Anderson, DC; Davis, DP; Belmont, L; Jackson, PK				Torres, Jorge Z.; Summers, Matthew K.; Peterson, David; Brauer, Matthew J.; Lee, James; Senese, Silvia; Gholkar, Ankur A.; Lo, Yu-Chen; Lei, Xingye; Jung, Kenneth; Anderson, David C.; Davis, David P.; Belmont, Lisa; Jackson, Peter K.			The STARD9/Kif16a Kinesin Associates with Mitotic Microtubules and Regulates Spindle Pole Assembly	CELL			English	Article							SMALL-MOLECULE INHIBITOR; ANTIMITOTIC DRUGS; CELL-DIVISION; PROTEIN; CENTROSOMES; GENE; IDENTIFICATION; MECHANISMS; TRANSPORT; DATABASE	During cell division, cells form the microtubule-based mitotic spindle, a highly specialized and dynamic structure that mediates proper chromosome transmission to daughter cells. Cancer cells can show perturbed mitotic spindles and an approach in cancer treatment has been to trigger cell killing by targeting microtubule dynamics or spindle assembly. To identify and characterize proteins necessary for spindle assembly, and potential antimitotic targets, we performed a proteomic and genetic analysis of 592 mitotic microtubule copurifying proteins (MMCPs). Screening for regulators that affect both mitosis and apoptosis, we report the identification and characterization of STARD9, a kinesin-3 family member, which localizes to centrosomes and stabilizes the pericentriolar material (PCM). STARD9-depleted cells have fragmented PCM, form multipolar spindles, activate the spindle assembly checkpoint (SAC), arrest in mitosis, and undergo apoptosis. Interestingly, STARD9-depletion synergizes with the chemotherapeutic agent taxol to increase mitotic death, demonstrating that STARD9 is a mitotic kinesin and a potential antimitotic target.	[Torres, Jorge Z.; Summers, Matthew K.; Jackson, Peter K.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Torres, Jorge Z.; Summers, Matthew K.; Peterson, David; Belmont, Lisa; Jackson, Peter K.] Genentech Inc, Dept Cell Regulat, San Francisco, CA 94080 USA; [Brauer, Matthew J.; Jung, Kenneth] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Lee, James; Davis, David P.] Genentech Inc, Dept Biol Mol, San Francisco, CA 94080 USA; [Lei, Xingye] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA; [Torres, Jorge Z.; Senese, Silvia; Gholkar, Ankur A.; Lo, Yu-Chen] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Anderson, David C.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	Stanford University; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California Los Angeles; University of Oregon	Torres, JZ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA.	torres@chem.ucla.edu		Jackson, Peter/0000-0002-1742-2539; Torres, Jorge/0000-0002-2158-889X; Gholkar, Ankur/0000-0002-3490-234X	Genetech Inc, NIH [RO1 GM054811, RO1 GM063023]; Stanford Cancer Biology Postdoctoral Fellowship; Leukemia and Lymphoma Society; V Foundation for cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063023, R01GM054811] Funding Source: NIH RePORTER	Genetech Inc, NIH; Stanford Cancer Biology Postdoctoral Fellowship; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); V Foundation for cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Brinkley, D. Compton, Q. Gao, W. Jiang, J. Salisbury, and H. Yu for antibodies; A. Ribas, F. Mortazavi, G. Miranda-Carboni, C. Miceli, R. Gatti, and B. Gomperts for cell lines; M. White for sharing data prior to publication; members of the Torres and Jackson labs for helpful discussions. This work was supported by Genetech Inc, NIH grants RO1 GM054811 and RO1 GM063023 (P.K.J.), Stanford Cancer Biology Postdoctoral Fellowship (J.Z.T), The Leukemia and Lymphoma Society Postdoctoral Fellowship (J.Z.T), and The V Foundation for cancer Research V Scholar Award (J.Z.T)	Abal M, 2005, BIOL CELL, V97, P425, DOI 10.1042/BC20040112; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Blangy A, 1998, CELL MOTIL CYTOSKEL, V40, P174, DOI 10.1002/(SICI)1097-0169(1998)40:2<174::AID-CM6>3.0.CO;2-F; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Funk CJ, 2004, ANAL BIOCHEM, V329, P68, DOI 10.1016/j.ab.2004.02.032; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Halama N, 2006, INT J MOL MED, V18, P653; Hart RK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P403; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Lansing TJ, 2007, MOL CANCER THER, V6, P450, DOI 10.1158/1535-7163.MCT-06-0543; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Loughlin R, 2008, CELL, V134, P548, DOI 10.1016/j.cell.2008.07.038; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Manning AL, 2008, CELL, V134, P694, DOI 10.1016/j.cell.2008.08.001; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Moyer ML, 1996, BIOCHEMISTRY-US, V35, P6321, DOI 10.1021/bi960017n; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Peterson D, 2010, CANCER RES, V70, P6325, DOI 10.1158/0008-5472.CAN-10-0015; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Rodrigues-Ferreira S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007239; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Torres JZ, 2010, MOL BIOL CELL, V21, P897, DOI 10.1091/mbc.E09-07-0598; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	47	55	59	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1309	1323		10.1016/j.cell.2011.11.020	http://dx.doi.org/10.1016/j.cell.2011.11.020			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153075	Bronze, Green Accepted			2022-12-24	WOS:000298148100020
J	Zanette, LY; White, AF; Allen, MC; Clinchy, M				Zanette, Liana Y.; White, Aija F.; Allen, Marek C.; Clinchy, Michael			Perceived Predation Risk Reduces the Number of Offspring Songbirds Produce per Year	SCIENCE			English	Article							SONG SPARROWS; NEST PREDATION; NUTRITIONAL STRESS; MELOSPIZA-MELODIA; EGG-PRODUCTION; SIBERIAN JAY; CLUTCH SIZE; FOOD; BIRDS; PLASTICITY	Predator effects on prey demography have traditionally been ascribed solely to direct killing in studies of population ecology and wildlife management. Predators also affect the prey's perception of predation risk, but this has not been thought to meaningfully affect prey demography. We isolated the effects of perceived predation risk in a free-living population of song sparrows by actively eliminating direct predation and used playbacks of predator calls and sounds to manipulate perceived risk. We found that the perception of predation risk alone reduced the number of offspring produced per year by 40%. Our results suggest that the perception of predation risk is itself powerful enough to affect wildlife population dynamics, and should thus be given greater consideration in vertebrate conservation and management.	[Zanette, Liana Y.; White, Aija F.; Allen, Marek C.] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Clinchy, Michael] Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada	Western University (University of Western Ontario); University of Victoria	Zanette, LY (corresponding author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.	lzanette@uwo.ca	White, Aija F/I-3074-2019	White, Aija/0000-0002-9384-6587	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank T. Golumbia, P. Handford, and C. Payne for assistance; Parks Canada and the Bateman family for access to the islands; and D. Blumstein, N. Davies, C. Krebs, R. Magrath, J. Schulkin, and three anonymous reviewers for help improving the manuscript. This research was approved by the University of Western Ontario Animal Care Committee and funded by the Canada Foundation for Innovation and the Natural Sciences and Engineering Research Council of Canada.	Bernardo J, 1996, AM ZOOL, V36, P216; Caro T., 2005, ANTIPREDATOR DEFENCE; CHRISTIAN JJ, 1950, J MAMMAL, V31, P247, DOI 10.2307/1375290; Clinchy M, 2004, P ROY SOC B-BIOL SCI, V271, P2473, DOI 10.1098/rspb.2004.2913; Conway CJ, 2000, EVOLUTION, V54, P670; Coulson T, 2005, J ANIM ECOL, V74, P789, DOI 10.1111/j.1365-2656.2005.00975.x; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Eggers S, 2005, BEHAV ECOL, V16, P309, DOI 10.1093/beheco/arh163; Fontaine JJ, 2006, ECOL LETT, V9, P428, DOI 10.1111/j.1461-0248.2006.00892.x; Ghalambor CK, 2001, SCIENCE, V292, P494, DOI 10.1126/science.1059379; Kempster B, 2007, OECOLOGIA, V151, P365, DOI 10.1007/s00442-006-0597-7; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; MacDonald IF, 2006, P ROY SOC B-BIOL SCI, V273, P2559, DOI 10.1098/rspb.2006.3547; Martin TE, 2011, EVOLUTION, V65, P1607, DOI 10.1111/j.1558-5646.2011.01227.x; Martin TE, 2009, ANN NY ACAD SCI, V1168, P201, DOI 10.1111/j.1749-6632.2009.04577.x; MCNAMARA JM, 1987, ECOLOGY, V68, P1515, DOI 10.2307/1939235; Pereyra ME, 2001, AUK, V118, P116, DOI 10.1642/0004-8038(2001)118[0116:NGATDI]2.0.CO;2; Rastogi AD, 2006, ANIM BEHAV, V72, P933, DOI 10.1016/j.anbehav.2006.03.006; Russell AF, 2007, SCIENCE, V317, P941, DOI 10.1126/science.1146037; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Travers M, 2010, ECOL LETT, V13, P980, DOI 10.1111/j.1461-0248.2010.01488.x; Wirsing AJ, 2011, FRONT ECOL ENVIRON, V9, P335, DOI 10.1890/090226; Zanette L, 2006, OECOLOGIA, V147, P632, DOI 10.1007/s00442-005-0330-y; Zanette L, 2006, ECOLOGY, V87, P2459, DOI 10.1890/0012-9658(2006)87[2459:FAPAEP]2.0.CO;2; Zanette L, 2009, P R SOC B, V276, P2855, DOI 10.1098/rspb.2009.0450	29	551	562	10	369	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1398	1401		10.1126/science.1210908	http://dx.doi.org/10.1126/science.1210908			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158817				2022-12-24	WOS:000297787700052
J	Junge, C				Junge, Christine			A personal response	NATURE			English	Editorial Material																		DOLIN R, 2009, UNDERSTAND YOUR RISK; Huang YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002234; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Vollmer-Conna U, 2008, CLIN INFECT DIS, V47, P1418, DOI 10.1086/592967	4	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					S14	S15		10.1038/480S14a	http://dx.doi.org/10.1038/480S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	857TR	22158295	Bronze			2022-12-24	WOS:000297744200009
J	Hecht, R; Kaddar, M; Schmitt, S				Hecht, Robert; Kaddar, Miloud; Schmitt, Sarah			PERSONAL VIEW Transparent pricing of vaccines would help poor as well as rich countries	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hecht, Robert] Results Dev Inst, Washington, DC USA; [Kaddar, Miloud] World Hlth Org, Immunizat Vaccines & Biol Dept, Geneva, Switzerland	World Health Organization	Hecht, R (corresponding author), Results Dev Inst, Washington, DC USA.	rhecht@resultsfordevelopment.org						Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; KENNEDY R, 2011, NEW GLOBAL FRAMEWORK; PAHO, PAHO REV FUND; *UNICEF, UNICEF PROM VACC PRI; WHO, GLOB PRIC REP MECH; 2011, BRIT MED J, V343, DOI DOI 10.1136/BMJ.D6239	6	5	5	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 23	2011	343								d7414	10.1136/bmj.d7414	http://dx.doi.org/10.1136/bmj.d7414			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857NE	22113835				2022-12-24	WOS:000297724400002
J	Kaufman, RJ				Kaufman, Randal J.			Beta-Cell Failure, Stress, and Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISK		Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Kaufman, RJ (corresponding author), Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA USA.				NIDDK NIH HHS [R01 DK088227] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088227] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arragain S, 2010, J BIOL CHEM, V285, P28425, DOI 10.1074/jbc.M110.106831; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056	4	24	26	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2011	365	20					1931	1933		10.1056/NEJMcibr1109442	http://dx.doi.org/10.1056/NEJMcibr1109442			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	848HG	22087686	Green Accepted			2022-12-24	WOS:000297041900015
J	Prasad, V; Bonow, RO				Prasad, Vinay; Bonow, Robert O.			The Cardiovascular Biomarker Conundrum Challenges and Solutions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIGH-RISK; PREDICTION; MORTALITY; EVENTS; SCORE		[Bonow, Robert O.] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Bonow, RO (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	r-bonow@northwestern.edu		Prasad, Vinayak/0000-0002-6110-8221				Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; SOMBERG JC, 1984, AM J CARDIOL, V54, P8; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	10	11	11	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 16	2011	306	19					2151	2152		10.1001/jama.2011.1673	http://dx.doi.org/10.1001/jama.2011.1673			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YU	22089725				2022-12-24	WOS:000297013000024
J	Fuertes, N				Fuertes, Natalia			End-of-life decisions in Argentina	LANCET			English	Editorial Material									Univ Buenos Aires, Fac Med, Buenos Aires, DF, Argentina	University of Buenos Aires	Fuertes, N (corresponding author), Univ Buenos Aires, Fac Med, C1121ABG, Buenos Aires, DF, Argentina.	nvfuertes@gmail.com						Anon, 2011, TELAM ARGENTINA 1201; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Field C, 2009, BRIT J HOSP MED, V70, P280, DOI 10.12968/hmed.2009.70.5.42226; Ramsay C, 2011, ARGENTINA INDEP 1026; Rietjens JAC, 2009, J BIOETHIC INQ, V6, P271, DOI 10.1007/s11673-009-9172-3; The commission on assisted dying, 2012, REP COMM ASS DYING	6	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					105	105		10.1016/S0140-6736(12)60042-7	http://dx.doi.org/10.1016/S0140-6736(12)60042-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	22243815				2022-12-24	WOS:000299317700016
J	Altevogt, BM; Pankevich, DE; Pope, AM; Kahn, JP				Altevogt, Bruce M.; Pankevich, Diana E.; Pope, Andrew M.; Kahn, Jeffrey P.			Guiding Limited Use of Chimpanzees in Research	SCIENCE			English	Editorial Material									[Altevogt, Bruce M.; Pankevich, Diana E.; Pope, Andrew M.] Natl Acad, Inst Med, Washington, DC 20001 USA; [Kahn, Jeffrey P.] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA	National Academies of Sciences, Engineering & Medicine; Johns Hopkins University	Altevogt, BM (corresponding author), Natl Acad, Inst Med, Washington, DC 20001 USA.	baltevogt@nas.edu		Kahn, Jeffrey/0000-0003-2493-2016				Chapman K, 2009, MABS-AUSTIN, V1, P505, DOI 10.4161/mabs.1.5.9676; European Union, 2010, OFFICIAL J EUROPEA L; Institute of Medicine (IOM), 2011, CHIMP BIOM BEH RES A; U.S. Department of Health and Human Services, COSTS MAINT HUM CAR; VandeBerg JL, 2005, NATURE, V437, P30, DOI 10.1038/437030a; Vogel G., 2001, SCIENCENOW      0501	6	13	13	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					41	42		10.1126/science.1217521	http://dx.doi.org/10.1126/science.1217521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22174127				2022-12-24	WOS:000298846200039
J	Nakashima, R; Sakurai, K; Yamasaki, S; Nishino, K; Yamaguchi, A				Nakashima, Ryosuke; Sakurai, Keisuke; Yamasaki, Seiji; Nishino, Kunihiko; Yamaguchi, Akihito			Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket	NATURE			English	Article							MULTIPLE-ANTIBIOTIC-RESISTANCE; EFFLUX PUMP; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; TRANSPORTER; TOLC; MECHANISM; COMPLEX; SITE	AcrB and its homologues are the principal multidrug transporters in Gram-negative bacteria(1-6) and are important in antibiotic drug tolerance(7,8). AcrB is a homotrimer that acts as a tripartite complex(9,10) with the outer membrane channel TolC(11,12) and the membrane fusion protein AcrA(13,14). Minocycline and doxorubicin have been shown to bind to the phenylalanine cluster region of the binding monomer(15). Here we report the crystal structures of AcrB bound to the high-molecular-mass drugs rifampicin and erythromycin. These drugs bind to the access monomer, and the binding sites are located in the proximal multisite binding pocket, which is separated from the phenylalanine cluster region (distal pocket) by the Phe-617 loop. Our structures indicate that there are two discrete multisite binding pockets along the intramolecular channel. High-molecular-mass drugs first bind to the proximal pocket in the access state and are then forced into the distal pocket in the binding state by a peristaltic mechanism involving subdomain movements that include a shift of the Phe-617 loop. By contrast, low-molecular-mass drugs, such as minocycline and doxorubicin, travel through the proximal pocket without specific binding and immediately bind to the distal pocket. The presence of two discrete, high-volume multisite binding pockets contributes to the remarkably broad substrate recognition of AcrB.	[Nakashima, Ryosuke; Sakurai, Keisuke; Yamaguchi, Akihito] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka 5670047, Japan; [Yamasaki, Seiji; Yamaguchi, Akihito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Nishino, Kunihiko] Osaka Univ, Inst Sci & Ind Res, Lab Microbiol & Infect Dis, Osaka 5670047, Japan	Osaka University; Osaka University; Osaka University	Yamaguchi, A (corresponding author), Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka 5670047, Japan.	akihito@sanken.osaka-u.ac.jp	Yamasaki, Seiji/GRF-3261-2022		Academia Sinica; National Synchrotron Radiation Research Center (Taiwan); National Institute of Biomedical Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan	Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center (Taiwan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Tsukihara for advice on the crystallographic analysis. We also thank N. Kato for discussion about the organic chemistry of the drugs that were investigated in this study. Our diffraction data were collected using Osaka University's beamline BL44XU at SPring-8, which was equipped with an MX225-HE detector (Rayonix) and was financially supported by the Academia Sinica and the National Synchrotron Radiation Research Center (Taiwan). We are also grateful to the technical staff of the Comprehensive Analysis Center of the Institute of Scientific and Industrial Research for their assistance. This work was supported by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation and Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fralick JA, 1996, J BACTERIOL, V178, P5803, DOI 10.1128/jb.178.19.5803-5805.1996; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Ma Dzwokai, 1994, Trends in Microbiology, V2, P489, DOI 10.1016/0966-842X(94)90654-8; Medek P, 2007, JOURNAL WSCG, V15, P107; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2008, CURR OPIN STRUC BIOL, V18, P459, DOI 10.1016/j.sbi.2008.06.007; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Pos KM, 2009, BBA-PROTEINS PROTEOM, V1794, P782, DOI 10.1016/j.bbapap.2008.12.015; Pos KM, 2004, FEBS LETT, V564, P333, DOI 10.1016/S0014-5793(04)00272-8; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zgurskaya HI, 1999, J MOL BIOL, V285, P409, DOI 10.1006/jmbi.1998.2313	38	241	252	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					565	U199		10.1038/nature10641	http://dx.doi.org/10.1038/nature10641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22121023				2022-12-24	WOS:000298318000070
J	van der Greef, J				van der Greef, Jan			PERSPECTIVE All systems go	NATURE			English	Editorial Material									[van der Greef, Jan] Leiden Univ, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC		jan.vandergreef@tno.nl						Huber M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4163; Li S, 2007, IET SYST BIOL, V1, P51, DOI 10.1049/iet-syb:20060032; van Wietmarschen H., 2009, CLIN RHEUMATOL, V15, P330; Wei HY, PLOS ONE IN PRESS	4	47	48	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S87	S87		10.1038/480S87a	http://dx.doi.org/10.1038/480S87a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190087	Bronze			2022-12-24	WOS:000298318000003
J	Liu, KSY; Siebert, M; Mertel, S; Knoche, E; Wegener, S; Wichmann, C; Matkovic, T; Muhammad, K; Depner, H; Mettke, C; Buckers, J; Hell, SW; Muller, M; Davis, GW; Schmitz, D; Sigrist, SJ				Liu, Karen S. Y.; Siebert, Matthias; Mertel, Sara; Knoche, Elena; Wegener, Stephanie; Wichmann, Carolin; Matkovic, Tanja; Muhammad, Karzan; Depner, Harald; Mettke, Christoph; Bueckers, Johanna; Hell, Stefan W.; Mueller, Martin; Davis, Graeme W.; Schmitz, Dietmar; Sigrist, Stephan J.			RIM-Binding Protein, a Central Part of the Active Zone, Is Essential for Neurotransmitter Release	SCIENCE			English	Article							SYNAPTIC CALCIUM-CHANNEL; CA2+ CHANNELS; DROSOPHILA; BRUCHPILOT; MATURATION; MOLECULES; CACOPHONY; FAMILY	The molecular machinery mediating the fusion of synaptic vesicles (SVs) at presynaptic active zone (AZ) membranes has been studied in detail, and several essential components have been identified. AZ-associated protein scaffolds are viewed as only modulatory for transmission. We discovered that Drosophila Rab3-interacting molecule (RIM)-binding protein (DRBP) is essential not only for the integrity of the AZ scaffold but also for exocytotic neurotransmitter release. Two-color stimulated emission depletion microscopy showed that DRBP surrounds the central Ca(2+) channel field. In drbp mutants, Ca(2+) channel clustering and Ca(2+) influx were impaired, and synaptic release probability was drastically reduced. Our data identify RBP family proteins as prime effectors of the AZ scaffold that are essential for the coupling of SVs, Ca(2+) channels, and the SV fusion machinery.	[Siebert, Matthias; Knoche, Elena; Wegener, Stephanie; Wichmann, Carolin; Schmitz, Dietmar; Sigrist, Stephan J.] Charite, NeuroCure Cluster Excellence, D-10117 Berlin, Germany; [Liu, Karen S. Y.; Mertel, Sara; Matkovic, Tanja; Muhammad, Karzan; Depner, Harald; Mettke, Christoph; Sigrist, Stephan J.] Free Univ Berlin, Inst Biol, Dept Genet, D-14195 Berlin, Germany; [Bueckers, Johanna; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany; [Mueller, Martin; Davis, Graeme W.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Schmitz, Dietmar] DZNE German Ctr Neurodegenerat Dis, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Max Planck Society; University of California System; University of California San Francisco; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Schmitz, D (corresponding author), Charite, NeuroCure Cluster Excellence, Charitepl 1, D-10117 Berlin, Germany.	dietmar.schmitz@charite.de; stephan.sigrist@fu-berlin.de	Knoche, Elena/P-5013-2015; Siebert, Matthias/K-8494-2014	Knoche, Elena/0000-0002-6725-9549; Siebert, Matthias/0000-0002-1739-5825; Schmitz, Dietmar/0000-0003-2741-5241; Wegener, Stephanie/0000-0002-5809-2222	Deutsche Forschungsgemeinschaft (DFG) [SFB 665, SFB 958, EXC 257]; Bundesministerium fur Bildung und Forschung (The German Federal Agency of Education and Research); Max Delbruck Center for Molecular Medicine; Boehringer Ingelheim Fonds; DFG [GRK 1123]; Swiss National Science Foundation [PBSKP3-123456/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (The German Federal Agency of Education and Research)(Federal Ministry of Education & Research (BMBF)); Max Delbruck Center for Molecular Medicine(Helmholtz Association); Boehringer Ingelheim Fonds(Boehringer Ingelheim); DFG(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft (DFG) grants (SFB 665, SFB 958, and EXC 257) to S.J.S and D. S., as well as Bundesministerium fur Bildung und Forschung (The German Federal Agency of Education and Research) funding for Deutsche Zentrum fur Neurodegenerative Erkrankungen (DZNE) to D. S. Also, M. S. was supported by a Ph.D. fellowship from the Max Delbruck Center for Molecular Medicine and a Boehringer Ingelheim Fonds Ph.D. fellowship. E. K. and S. W. were supported by Ph.D. fellowships from the graduate school GRK 1123 funded by the DFG. M. M. was supported by a fellowship of the Swiss National Science Foundation (PBSKP3-123456/1).	Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Buckers J, 2011, OPT EXPRESS, V19, P3130, DOI 10.1364/OE.19.003130; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Gracheva Elena O, 2010, Front Synaptic Neurosci, V2, P141, DOI 10.3389/fnsyn.2010.00141; Hallermann S, 2010, J NEUROSCI, V30, P14340, DOI 10.1523/JNEUROSCI.2495-10.2010; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Hou J, 2008, J NEUROPHYSIOL, V100, P2833, DOI 10.1152/jn.90342.2008; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kawasaki F, 2002, J NEUROSCI, V22, P5856; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kawasaki F, 2000, J NEUROSCI, V20, P4885; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Mittelstaedt T, 2007, GENE, V403, P70, DOI 10.1016/j.gene.2007.08.004; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rostaing P, 2004, J HISTOCHEM CYTOCHEM, V52, P1, DOI 10.1177/002215540405200101; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Sigrist SJ, 2011, CURR OPIN NEUROBIOL, V21, P144, DOI 10.1016/j.conb.2010.08.012; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; Siksou L, 2011, CURR OPIN NEUROBIOL, V21, P261, DOI 10.1016/j.conb.2010.12.003; Spangler SA, 2007, BIOCHEM SOC T, V35, P1278, DOI 10.1042/BST0351278; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199	28	186	192	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1565	1569		10.1126/science.1212991	http://dx.doi.org/10.1126/science.1212991			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174254	Green Published			2022-12-24	WOS:000298091400056
J	Matsui, W				Matsui, William			PERSPECTIVE A model disease	NATURE			English	Editorial Material							MULTIPLE-MYELOMA; CELLS		Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Matsui, W (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	matsuwi@jhmi.edu		Matsui, William/0000-0002-3088-0964	NCI NIH HHS [P30 CA006973] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Huff CA, 2008, J CLIN ONCOL, V26, P2895, DOI 10.1200/JCO.2007.15.8428; Mitsiades CS, 2007, J CELL BIOCHEM, V101, P950, DOI 10.1002/jcb.21213; Munshi NC, 2011, CLIN CANCER RES, V17, P1234, DOI 10.1158/1078-0432.CCR-10-1843; Rasheed ZA, 2011, STEM CELLS, V29, P883, DOI 10.1002/stem.648	4	10	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S58	S58		10.1038/480S58a	http://dx.doi.org/10.1038/480S58a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22169808	Green Accepted			2022-12-24	WOS:000298033000014
J	Vaidyanathan, G				Vaidyanathan, Gayathri			Virus Hunters: Catching Bugs in the Field	CELL			English	Editorial Material																			0	0	0	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1209	1211		10.1016/j.cell.2011.11.037	http://dx.doi.org/10.1016/j.cell.2011.11.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153064	Bronze, Green Published			2022-12-24	WOS:000298148100006
J	Nguyen, KD; Qiu, YF; Cui, XJ; Goh, YPS; Mwangi, J; David, T; Mukundan, L; Brombacher, F; Locksley, RM; Chawla, A				Nguyen, Khoa D.; Qiu, Yifu; Cui, Xiaojin; Goh, Y. P. Sharon; Mwangi, Julia; David, Tovo; Mukundan, Lata; Brombacher, Frank; Locksley, Richard M.; Chawla, Ajay			Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis	NATURE			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; LIPOLYSIS; MICE; METABOLISM	All homeotherms use thermogenesis to maintain their core body temperature, ensuring that cellular functions and physiological processes can continue in cold environments(1-3). In the prevailing model of thermogenesis, when the hypothalamus senses cold temperatures it triggers sympathetic discharge, resulting in the release of noradrenaline in brown adipose tissue and white adipose tissue(4,5). Acting via the beta(3)-adrenergic receptors, noradrenaline induces lipolysis in white adipocytes(6), whereas it stimulates the expression of thermogenic genes, such as PPAR-gamma coactivator 1a (Ppargc1a), uncoupling protein 1 (Ucp1) and acyl-CoA synthetase long-chain family member 1 (Acsl1), in brown adipocytes(7-9). However, the precise nature of all the cell types involved in this efferent loop is not well established. Here we report in mice an unexpected requirement for the interleukin-4 (IL-4)-stimulated program of alternative macrophage activation in adaptive thermogenesis. Exposure to cold temperature rapidly promoted alternative activation of adipose tissue macrophages, which secrete catecholamines to induce thermogenic gene expression in brown adipose tissue and lipolysis in white adipose tissue. Absence of alternatively activated macrophages impaired metabolic adaptations to cold, whereas administration of IL-4 increased thermogenic gene expression, fatty acid mobilization and energy expenditure, all in a macrophage dependent manner. Thus, we have discovered a role for alternatively activated macrophages in the orchestration of an important mammalian stress response, the response to cold.	[Nguyen, Khoa D.; Qiu, Yifu; Cui, Xiaojin; Goh, Y. P. Sharon; Mwangi, Julia; David, Tovo; Mukundan, Lata; Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Nguyen, Khoa D.; Goh, Y. P. Sharon] Stanford Univ, Program Immunol, Palo Alto, CA 94305 USA; [Brombacher, Frank] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, South Africa; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Locksley, Richard M.; Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Stanford University; University of Cape Town; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chawla, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	ajay.chawla@ucsf.edu	DAVID, Tovo/B-5573-2013	Nguyen, Khoa/0000-0002-6720-2470; Qiu, Yifu/0000-0001-5645-3189	NIH [DK076760, HL076746, DK094641, DP1OD006415]; Larry L. Hillblom Foundation Network; Stanford Graduate Fellowship; A-STAR Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076760, R01DK094641, R01DK081405] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006415] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation Network; Stanford Graduate Fellowship(Stanford University); A-STAR Fellowship(Agency for Science Technology & Research (A*STAR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Chawla laboratory, A. Loh and C.-H. Lee for comments on the manuscript, and F. Kraemer for guidance on in vitro lipolysis assays. This work was supported by grants from the NIH (DK076760, HL076746, DK094641), Larry L. Hillblom Foundation Network Grant and an NIH Director's Pioneer Award (DP1OD006415) to A. C. Support was provided by Stanford Graduate Fellowship (K.D.N.) and A-STAR Fellowship (Y.P.G). All animal care was in accordance with Stanford University's A-PLAC and UCSF's IACUC guidelines.	Brown SW, 2003, J NEUROIMMUNOL, V135, P47, DOI 10.1016/S0165-5728(02)00435-6; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Nakamura K, 2008, NAT NEUROSCI, V11, P62, DOI 10.1038/nn2027; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Watt MJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE120, DOI 10.1152/ajpendo.00542.2003; YOSHIDA T, 1994, LIFE SCI, V54, P491, DOI 10.1016/0024-3205(94)00408-0; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	24	746	776	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					104	U272		10.1038/nature10653	http://dx.doi.org/10.1038/nature10653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22101429	Green Accepted			2022-12-24	WOS:000298031900043
J	Canto, JG; Kiefe, CI; Rogers, WJ; Peterson, ED; Frederick, PD; French, WJ; Gibson, CM; Pollack, CV; Ornato, JP; Zalenski, RJ; Penney, J; Tiefenbrunn, AJ; Greenland, P				Canto, John G.; Kiefe, Catarina I.; Rogers, William J.; Peterson, Eric D.; Frederick, Paul D.; French, William J.; Gibson, C. Michael; Pollack, Charles V., Jr.; Ornato, Joseph P.; Zalenski, Robert J.; Penney, Jan; Tiefenbrunn, Alan J.; Greenland, Philip		NRMI Investigators	Number of Coronary Heart Disease Risk Factors and Mortality in Patients With First Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL REGISTRY; EVENTS; INDEX	Context Few studies have examined the association between the number of coronary heart disease risk factors and outcomes of acute myocardial infarction in community practice. Objective To determine the association between the number of coronary heart disease risk factors in patients with first myocardial infarction and hospital mortality. Design Observational study from the National Registry of Myocardial Infarction, 1994-2006. Patients We examined the presence and absence of 5 major traditional coronary heart disease risk factors (hypertension, smoking, dyslipidemia, diabetes, and family history of coronary heart disease) and hospital mortality among 542 008 patients with first myocardial infarction and without prior cardiovascular disease. Main Outcome Measure All-cause in-hospital mortality. Results A majority (85.6%) of patients who presented with initial myocardial infarction had at least 1 of the 5 coronary heart disease risk factors, and 14.4% had none of the 5 risk factors. Age varied inversely with the number of coronary heart disease risk factors, from a mean age of 71.5 years with 0 risk factors to 56.7 years with 5 risk factors (P for trend < .001). The total number of in-hospital deaths for all causes was 50 788. Unadjusted in-hospital mortality rates were 14.9%, 10.9%, 7.9%, 5.3%, 4.2%, and 3.6% for patients with 0, 1, 2, 3, 4, and 5 risk factors, respectively. After adjusting for age and other clinical factors, there was an inverse association between the number of coronary heart disease risk factors and hospital mortality adjusted odds ratio (1.54; 95% CI, 1.23-1.94) among individuals with 0 vs 5 risk factors. This association was consistent among several age strata and important patient subgroups. Conclusion Among patients with incident acute myocardial infarction without prior cardiovascular disease, in-hospital mortality was inversely related to the number of coronary heart disease risk factors. JAMA. 2011;306(19):2120-2127 www.jama.com	[Canto, John G.] Watson Clin LLP, Ctr Cardiovasc Prevent Res & Educ, Lakeland, FL USA; [Kiefe, Catarina I.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Rogers, William J.] Univ Alabama Birmingham, Med Ctr, Birmingham, AL 35294 USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Frederick, Paul D.] ICON Late Phase & Outcomes Res, San Francisco, CA USA; [French, William J.] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Gibson, C. Michael] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Pollack, Charles V., Jr.] Univ Penn, Philadelphia, PA 19104 USA; [Ornato, Joseph P.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Zalenski, Robert J.] Wayne State Univ, Sch Med, Detroit, MI USA; [Penney, Jan] Mid Michigan Hlth, Midland, MI USA; [Tiefenbrunn, Alan J.] Washington Univ, Sch Med, St Louis, MO USA; [Greenland, Philip] Northwestern Univ, Clin & Translat Sci Inst, Chicago, IL 60611 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Alabama System; University of Alabama Birmingham; Duke University; ICON plc; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Pennsylvania; Virginia Commonwealth University; Wayne State University; Washington University (WUSTL); Northwestern University	Canto, JG (corresponding author), Watson Clin, 1600 Lakeland Hill Blvd, Lakeland, FL 33805 USA.	jcanto@watsonclinic.com	Peterson, Eric David/ABF-5033-2021; Gibson, C. Michael/AAE-8212-2019; Greenland, Philip/ABD-5528-2021	Frederick, Paul/0000-0002-7936-5488	National Institutes of Health [U01HL 105268, U54 RR 026088]; Bristol-Myers Squibb/sanofi; Eli Lilly; Johnson Johnson; Genentech Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb/sanofi(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Genentech Inc(Roche HoldingGenentech); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kiefe reports receiving partial funding from the National Institutes of Health (grants U01HL 105268 and U54 RR 026088). Dr Peterson reports receiving grants from Bristol-Myers Squibb/sanofi, Eli Lilly, and Johnson & Johnson. Mr Frederick reports being an employee of ICON Clinical Research, which received support from Genentech Inc to provide biostatistical and analytic services. Dr Gibson reports that his institution received a grant from Genentech for a research trial. Dr Pollack reports serving as a consultant and on the speakers bureau for sanofi-aventis. Dr Ornato reports being an unpaid advisory board member for ZOLL. No other disclosures were reported.	Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P822, DOI 10.1001/jama.2011.163; Every NR, 1999, J AM COLL CARDIOL, V33, P1886, DOI 10.1016/S0735-1097(99)00113-8; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Roe MT, 2007, AM HEART J, V153, P507, DOI 10.1016/j.ahj.2006.12.018; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Saab F, 2009, ANGIOLOGY, V60, P663, DOI 10.1177/0003319709333870; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wiviott SD, 2006, J AM COLL CARDIOL, V47, P1553, DOI 10.1016/j.jacc.2005.11.075; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	14	149	157	10	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 16	2011	306	19					2120	2127		10.1001/jama.2011.1654	http://dx.doi.org/10.1001/jama.2011.1654			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YU	22089719	Green Accepted, Bronze			2022-12-24	WOS:000297013000018
J	Tomaselli, GF				Tomaselli, Gordon F.			Prevention of Cardiovascular Disease and Stroke Meeting the Challenge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Tomaselli, Gordon F.] Johns Hopkins Univ, Sch Med, Div Cardiol, Dept Med, Baltimore, MD 21205 USA; [Tomaselli, Gordon F.] Johns Hopkins Univ, Dept Cellular & Mol Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Tomaselli, GF (corresponding author), Johns Hopkins Univ, Sch Med, Div Cardiol, Dept Med, 720 Rutland Ave,Ross 844, Baltimore, MD 21205 USA.	gtomase1@jhmi.edu						Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; SACCO R, ACCELERATING PROGR N, DOI DOI 10.1016/S0140-6736(11)61477-3; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	5	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 16	2011	306	19					2147	2148		10.1001/jama.2011.1668	http://dx.doi.org/10.1001/jama.2011.1668			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YU	22089723				2022-12-24	WOS:000297013000022
J	Khan, M; Vaes, E; Mombaerts, P				Khan, Mona; Vaes, Evelien; Mombaerts, Peter			Regulation of the Probability of Mouse Odorant Receptor Gene Choice	CELL			English	Article							OLFACTORY SENSORY NEURONS; EXPRESSION PATTERNS; MICE; EPITHELIUM; ENHANCERS; LEVEL; CIS	Each olfactory sensory neuron (OSN) in mouse chooses one of 1,200 odorant receptor (OR) genes for expression. OR genes are chosen for expression by greatly varying numbers of OSNs. The mechanisms that regulate the probability of OR gene choice remain unclear. Here, we have applied the NanoString platform of fluorescent barcodes and digital readout to measure RNA levels of 577 OR genes in a single reaction, with probes designed against coding sequences. In an inbred mouse strain with a targeted deletion in the P element, we find that this element regulates OR gene choice differentially across its cluster of 24 OR genes. Importantly, the fold changes of NanoString counts in Delta P or Delta H mice are in very close agreement with the fold changes of cell counts, determined by in situ hybridization. Thus, the P and H elements regulate the probability of OR gene choice, not OR transcript level per OSN.	[Khan, Mona; Vaes, Evelien; Mombaerts, Peter] Max Planck Inst Biophys, D-60438 Frankfurt, Germany	Max Planck Society	Mombaerts, P (corresponding author), Max Planck Inst Biophys, D-60438 Frankfurt, Germany.	peter.mombaerts@biophys.mpg.de			Max Planck Society; European Research Council	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission)	We thank Christian Basta, Anna-Lena Hohmann, Christian Lozanoski, Bartos Machert, and Michael Marburger for expert technical assistance; Philippa Webster for comments on the manuscript; and Nathan Elliott and Jordan Moore for contributing data. Generous support was provided by the Max Planck Society and Advanced Grant ORGENECHOICE from the European Research Council to P. M. This paper is dedicated to the memory of Shou Serizawa, the discoverer of the H element.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Iwema CL, 2004, J NEUROSCI, V24, P356, DOI 10.1523/JNEUROSCI.1219-03.2004; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lee AC, 2009, CHEM SENSES, V34, P695, DOI 10.1093/chemse/bjp056; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rodriguez-Gil DJ, 2010, J NEUROSCI, V30, P10067, DOI 10.1523/JNEUROSCI.1776-10.2010; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vassalli A, 2011, MOL CELL NEUROSCI, V46, P381, DOI 10.1016/j.mcn.2010.11.001; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Xie SY, 2000, MAMM GENOME, V11, P1070, DOI 10.1007/s003350010217; Young JM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r71; Zhang XH, 2007, GENOMICS, V89, P441, DOI 10.1016/j.ygeno.2007.01.002	33	108	110	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 11	2011	147	4					907	921		10.1016/j.cell.2011.09.049	http://dx.doi.org/10.1016/j.cell.2011.09.049			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22078886	Bronze			2022-12-24	WOS:000296902300022
J	Cohen, IG				Cohen, I. Glenn			Selling Bone Marrow - Flynn v. Holder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Law, Cambridge, MA 02138 USA	Harvard University	Cohen, IG (corresponding author), Harvard Univ, Sch Law, Cambridge, MA 02138 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2012	366	4					296	297		10.1056/NEJMp1114288	http://dx.doi.org/10.1056/NEJMp1114288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	881EQ	22187961	Bronze			2022-12-24	WOS:000299464100015
J	Weimerskirch, H; Louzao, M; de Grissac, S; Delord, K				Weimerskirch, Henri; Louzao, Maite; de Grissac, Sophie; Delord, Karine			Changes in Wind Pattern Alter Albatross Distribution and Life-History Traits	SCIENCE			English	Article							OCEAN; RESPONSES; SEABIRDS; DYNAMICS; SPEEDS; TRENDS	Westerly winds in the Southern Ocean have increased in intensity and moved poleward. Using long-term demographic and foraging records, we show that foraging range in wandering albatrosses has shifted poleward in conjunction with these changes in wind pattern, while their rates of travel and flight speeds have increased. Consequently, the duration of foraging trips has decreased, breeding success has improved, and birds have increased in mass by more than 1 kilogram. These positive consequences of climate change may be temporary if patterns of wind in the southern westerlies follow predicted climate change scenarios. This study stresses the importance of foraging performance as the key link between environmental changes and population processes.	[Weimerskirch, Henri; Louzao, Maite; de Grissac, Sophie; Delord, Karine] CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France; [Louzao, Maite] UFZ Helmholtz Ctr Environm Res, D-04318 Leipzig, Germany	Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Weimerskirch, H (corresponding author), CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France.	henriw@cebc.cnrs.fr	Louzao, Maite/N-5379-2014; de Grissac, Sophie/Q-6666-2017; Weimerskirch, Henri/F-5562-2013; Weimerskirch, Henri/K-7306-2019	de Grissac, Sophie/0000-0002-1589-8066; Weimerskirch, Henri/0000-0002-0457-586X; Louzao, Maite/0000-0002-9997-5144	French Polar Institute IPEV [109]; Prince Albert II de Monaco Foundation; Spanish Ministry of Education and Science [EX2007-1148]; Marie Curie Individual Fellowship [PIEF-GA-2008-220063]	French Polar Institute IPEV; Prince Albert II de Monaco Foundation; Spanish Ministry of Education and Science(Spanish Government); Marie Curie Individual Fellowship(European Commission)	The long-term data on the demography and foraging ecology of wandering albatrosses at Possession Island, Crozet Islands, were supported by the French Polar Institute IPEV (program no. 109 to H. W.), with additional funding from the Prince Albert II de Monaco Foundation. The study is a contribution to the Program ANR Biodiversite 2005-11 REMIGE. We acknowledge the modeling groups, the Program for Climate Model Diagnosis and Intercomparison (PCMDI), and the World Climate Research Programme's (WCRP's) Working Group on Coupled Modeling (WGCM) for their roles in making available the WCRP CMIP-3 multimodel data set. Support for data and model selection was provided by S. Jenouvrier. We thank the many field workers involved in the Crozet long-term monitoring since 1966 and in tracking programs since 1989, and D. Besson for help with the management of the demographic database. M. L. was funded by a postdoctoral contract of the Spanish Ministry of Education and Science (Ref. EX2007-1148) and Marie Curie Individual Fellowship (PIEF-GA-2008-220063). We are grateful to L. Riotte-Lambert for help with data analysis and C. Barbraud, C. A. Bost, Y. Cherel, and S. Jenouvrier for comments on the manuscript.	ALERSTAM T, 1993, PHILOS T ROY SOC B, V340, P55, DOI 10.1098/rstb.1993.0048; Alerstam T, 1993, BIRD MIGRATION; Davies RG, 2010, GLOBAL ECOL BIOGEOGR, V19, P98, DOI 10.1111/j.1466-8238.2009.00498.x; Felicisimo AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002928; Gillett NP, 2003, SCIENCE, V302, P273, DOI 10.1126/science.1087440; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P221, DOI 10.3354/meps08128; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Peron C, 2010, GLOBAL CHANGE BIOL, V16, P1895, DOI 10.1111/j.1365-2486.2010.02169.x; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Suryan RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004016; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Tuck GN, 2003, BIOL CONSERV, V114, P1, DOI 10.1016/S0006-3207(02)00378-6; Tuck GN, 2001, J APPL ECOL, V38, P1182, DOI 10.1046/j.0021-8901.2001.00661.x; Wakefield ED, 2009, ECOL MONOGR, V79, P663, DOI 10.1890/07-2111.1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 1997, BIOL CONSERV, V79, P257, DOI 10.1016/S0006-3207(96)00084-5; WEIMERSKIRCH H, 1995, OECOLOGIA, V102, P37, DOI 10.1007/BF00333308; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219	22	232	234	5	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2012	335	6065					211	214		10.1126/science.1210270	http://dx.doi.org/10.1126/science.1210270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246774				2022-12-24	WOS:000299033100051
J	Modi, BG; Neustadter, J; Binda, E; Lewis, J; Filler, RB; Roberts, SJ; Kwong, BY; Reddy, S; Overton, JD; Galan, A; Tigelaar, R; Cai, LN; Fu, P; Shlomchik, M; Kaplan, DH; Hayday, A; Girardi, M				Modi, Badri G.; Neustadter, Jason; Binda, Elisa; Lewis, Julia; Filler, Renata B.; Roberts, Scott J.; Kwong, Bernice Y.; Reddy, Swapna; Overton, John D.; Galan, Anjela; Tigelaar, Robert; Cai, Lining; Fu, Peter; Shlomchik, Mark; Kaplan, Daniel H.; Hayday, Adrian; Girardi, Michael			Langerhans Cells Facilitate Epithelial DNA Damage and Squamous Cell Carcinoma	SCIENCE			English	Article							ARYL-HYDROCARBON RECEPTOR; CONTACT HYPERSENSITIVITY; MOUSE SKIN; T-CELLS; RAS GENE; H-RAS; MICE; CARCINOGENESIS; 7,12-DIMETHYLBENZ(A)ANTHRACENE; EXPRESSION	Polyaromatic hydrocarbons (PAHs) are prevalent, potent carcinogens, and 7,12-dimethylbenz[a]anthracene (DMBA) is a model PAH widely used to study tumorigenesis. Mice lacking Langerhans cells (LCs), a signatory epidermal dendritic cell (DC), are protected from cutaneous chemical carcinogenesis, independent of T cell immunity. Investigation of the underlying mechanism revealed that LC-deficient skin was relatively resistant to DMBA-induced DNA damage. LCs efficiently metabolized DMBA to DMBA-trans-3,4-diol, an intermediate proximal to oncogenic Hras mutation, and DMBA-treated LC-deficient skin contained significantly fewer Hras mutations. Moreover, DMBA-trans-3,4-diol application bypassed tumor resistance in LC-deficient mice. Additionally, the genotoxic impact of DMBA on human keratinocytes was significantly increased by prior incubation with human-derived LC. Thus, tissue-associated DC can enhance chemical carcinogenesis via PAH metabolism, highlighting the complex relation between immune cells and carcinogenesis.	[Modi, Badri G.; Neustadter, Jason; Lewis, Julia; Filler, Renata B.; Roberts, Scott J.; Kwong, Bernice Y.; Reddy, Swapna; Galan, Anjela; Tigelaar, Robert; Girardi, Michael] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Shlomchik, Mark] Yale Univ, Sch Med, Dept Lab Med & Immunobiol, New Haven, CT 06520 USA; [Overton, John D.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Overton, John D.] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT 06520 USA; [Cai, Lining] Biotranex, Monmouth Jct, NJ 08852 USA; [Fu, Peter] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Kaplan, Daniel H.] Univ Minnesota, Dept Dermatol, Minneapolis, MN 55455 USA; [Kaplan, Daniel H.] Univ Minnesota, Dept Immunobiol, Minneapolis, MN 55455 USA; [Binda, Elisa; Hayday, Adrian] Kings Coll London, Guys & St Thomas Hosp, Peter Gorer Dept Immunobiol, Comprehens Biomed Res Ctr, London SE1 9RT, England; [Binda, Elisa; Hayday, Adrian] Canc Res UK CRUK, London Res Inst, London WC2 A, England	Yale University; Yale University; Yale University; Yale University; US Food & Drug Administration (FDA); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cancer Research UK	Girardi, M (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA.	girardi@yale.edu	Kaplan, Daniel H/N-2779-2013; Shlomchik, Mark J./AAN-6189-2020	Kaplan, Daniel H/0000-0002-7851-7320; Shlomchik, Mark J./0000-0002-2152-0959; HAYDAY, ADRIAN/0000-0002-9495-5793; Girardi, Michael/0000-0003-1887-9343	NIH [R01CA102703, T32, RO1-AR044077, RO1-AR056632]; Richard K. Gershon Research Fellowship; National Cancer Institute of the Yale Comprehensive Cancer Center [P30 CA016359]; Wellcome Trust; Cancer Research UK; Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre; St. Thomas' NHS Foundation Trust; Cancer Research UK [19309] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA102703, P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007016, R01AR056632, K08AR002072, R01AR044077] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard K. Gershon Research Fellowship; National Cancer Institute of the Yale Comprehensive Cancer Center; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); St. Thomas' NHS Foundation Trust; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this work was provided by the NIH grants R01CA102703 (to M. G.), T32 (to J.N.), RO1-AR044077 (to M. S.), and RO1-AR056632 (to D. H. K.) and the Richard K. Gershon Research Fellowship (to B. G. M.). This work was supported by resources of the National Cancer Institute (grant P30 CA016359) of the Yale Comprehensive Cancer Center, the Wellcome Trust (to A. H.), Cancer Research UK (to A. H.), and the Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London (KCL) and King's College Hospital NHS Foundation Trust (to A. H. and E. B.). This paper is not an official guidance or policy statement of the U. S. FDA, and no official support or endorsement by the FDA is intended or should be inferred. We thank E. Gulcicek for HPLC support and M. Choi for sequence analysis support; M. Udey (NIH), A. Balmain [Univ. of California San Francisco (UCSF)], A. Behrens (CRUK), F. Nestle (KCL), and R. Groves (KCL) for protocol advice; O. Sobolev (KCL), J. Strid (KCL), F. Geissmann (KCL), K. Golubets (Yale), D. Smith (Yale), and G. Tokmoulina (Yale) for assistance; and A. Takashima (Univ. of Toledo) for XS106 cells and A. Balmain (UCSF) for CarC cells. The data tabulated in this paper are reported in the main text and in the supporting online material. Illumina sequence data are available from the National Center for Biotechnology Information Sequence Read Archive, accession no. SRA048406. Sites of experiments: New Haven, CT, USA, and London, UK.	ANDERSON C, 1995, J IMMUNOL, V155, P3530; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; Buters J, 2003, CARCINOGENESIS, V24, P327, DOI 10.1093/carcin/24.2.327; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Daniel D, 2003, J EXP MED, V197, P1017, DOI 10.1084/jem.20021047; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; GOULD MN, 1982, CARCINOGENESIS, V3, P667, DOI 10.1093/carcin/3.6.667; HENNINGS H, 1981, CANCER RES, V41, P773; Jux B, 2009, J IMMUNOL, V182, P6709, DOI 10.4049/jimmunol.0713344; Kaplan DH, 2008, EUR J IMMUNOL, V38, P2369, DOI 10.1002/eji.200838397; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Matsumoto Y, 2007, ENVIRON SCI TECHNOL, V41, P3775, DOI 10.1021/es062793g; Miyata M, 1999, J BIOL CHEM, V274, P23963, DOI 10.1074/jbc.274.34.23963; NELSON MA, 1992, P NATL ACAD SCI USA, V89, P6398, DOI 10.1073/pnas.89.14.6398; Paus R, 1998, J INVEST DERMATOL, V111, P7, DOI 10.1046/j.1523-1747.1998.00243.x; PIERCEALL WE, 1991, MOL CARCINOGEN, V4, P196, DOI 10.1002/mc.2940040306; Plazter B., 2009, J IMMUNOL, V183, P66; POTTENGER LH, 1991, ARCH BIOCHEM BIOPHYS, V286, P488, DOI 10.1016/0003-9861(91)90070-Y; Roberts SJ, 2007, P NATL ACAD SCI USA, V104, P6770, DOI 10.1073/pnas.0604982104; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; Saeki M, 2002, INT ARCH ALLERGY IMM, V127, P333, DOI 10.1159/000057751; Savas U, 1997, ARCH BIOCHEM BIOPHYS, V347, P181, DOI 10.1006/abbi.1997.0339; SLAGA TJ, 1979, CANCER RES, V39, P1934; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Tang MS, 2000, CANCER RES, V60, P5688; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; WISLOCKI PG, 1980, CANCER RES, V40, P3661; Xiao MJ, 2009, CANCER RES, V69, P2010, DOI 10.1158/0008-5472.CAN-08-3479; YUSPA SH, 1976, CANCER RES, V36, P947	33	93	96	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					104	108		10.1126/science.1211600	http://dx.doi.org/10.1126/science.1211600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223807	Green Accepted			2022-12-24	WOS:000298846200061
J	Racaniello, V				Racaniello, Vincent			An Exit Strategy for Measles Virus	SCIENCE			English	Editorial Material							CELLULAR RECEPTOR; POLIOVIRUS; ENTRY		Columbia Univ, New York, NY 10032 USA	Columbia University	Racaniello, V (corresponding author), Columbia Univ, New York, NY 10032 USA.	vrr1@columbia.edu						COHEN JI, 2007, FIELDS VIROLOGY, P2773; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Lemon K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001263; Leonard VHJ, 2008, J CLIN INVEST, V118, P2448, DOI 10.1172/JCI35454; Ludlow M, 2010, J GEN VIROL, V91, P971, DOI 10.1099/vir.0.016428-0; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Vermeer PD, 2007, J VIROL, V81, P9891, DOI 10.1128/JVI.00601-07	11	22	23	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1650	1651		10.1126/science.1217378	http://dx.doi.org/10.1126/science.1217378			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865XK	22194562				2022-12-24	WOS:000298344000050
J	Shelton, JD				Shelton, James D.			ARVs as HIV Prevention: A Tough Road to Wide Impact	SCIENCE			English	Editorial Material							ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; INFECTION; TRANSMISSION; HIV/AIDS; AFRICA; COHORT		Bur Global Hlth, Washington, DC 20523 USA		Shelton, JD (corresponding author), Bur Global Hlth, Washington, DC 20523 USA.	jshelton@usaid.gov						[Anonymous], 2011, WORLD AIDS DAY REP; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Cohen J., 2011, SCIENCEINSIDER  0928; Cohen J, 2011, SCIENCE, V333, P393, DOI 10.1126/science.333.6041.393; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fernandez-Fernandez B, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/354908; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Granich R, 2011, CURR HIV RES, V9, P446, DOI 10.2174/157016211798038597; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grulich AE, 2010, LANCET, V376, P1824, DOI 10.1016/S0140-6736(10)62162-9; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hasse B, 2010, CLIN INFECT DIS, V51, P1314, DOI 10.1086/656809; Hurt CB, 2011, CLIN INFECT DIS, V53, P1265, DOI 10.1093/cid/cir684; Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9; Kajubi P, 2005, JAIDS-J ACQ IMM DEF, V40, P77, DOI 10.1097/01.qai.0000157391.63127.b2; Lesotho Ministry of Health and Social Welfare ICF Macro, 2010, LES DEM HLTH SURV 20; Millett GA, 2010, JAIDS-J ACQ IMM DEF, V55, pS144, DOI 10.1097/QAI.0b013e3181fbcb04; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; PEPFAR, 2011, PEPFAR; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Shelton JD, 2010, LANCET, V376, P1824, DOI 10.1016/S0140-6736(10)62163-0; Trubo R, 2011, JAMA-J AM MED ASSOC, V306, P253, DOI 10.1001/jama.2011.979; UNAIDS, 2011, AIDS 30 NAT CROSSR	33	29	31	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1645	1646		10.1126/science.1212353	http://dx.doi.org/10.1126/science.1212353			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865XK	22194560				2022-12-24	WOS:000298344000047
J	Humphries, C				Humphries, Courtney			GENETICS Profiling a shape-shifter	NATURE			English	Editorial Material																		Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837	1	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S50	S51		10.1038/480S50a	http://dx.doi.org/10.1038/480S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22169804	Bronze			2022-12-24	WOS:000298033000009
J	Whalen, HR; Kidd, GA; O'Dwyer, PJ				Whalen, Henry Robert; Kidd, Gillian A.; O'Dwyer, Patrick J.			EASILY MISSED? Femoral hernias	BRITISH MEDICAL JOURNAL			English	Editorial Material							GROIN HERNIA; STRANGULATION; ULTRASOUND; DIAGNOSIS; SURGERY; REPAIR		[Whalen, Henry Robert; O'Dwyer, Patrick J.] Univ Glasgow, Western Infirm, Univ Dept Surg, Glasgow G11 6NT, Lanark, Scotland; [Kidd, Gillian A.] Midlock Med Ctr, Glasgow, Lanark, Scotland	University of Glasgow	Whalen, HR (corresponding author), Univ Glasgow, Western Infirm, Univ Dept Surg, Glasgow G11 6NT, Lanark, Scotland.	Henry.Whalen@gjnh.scot.nhs.uk						Alvarez J A, 2004, Hernia, V8, P121, DOI 10.1007/s10029-003-0186-1; ANDREWS NJ, 1981, BRIT J SURG, V68, P329, DOI 10.1002/bjs.1800680513; Bradley M, 2003, ANN ROY COLL SURG, V85, P178, DOI 10.1308/003588403321661334; Dahlstrand U, 2009, ANN SURG, V249, P672, DOI 10.1097/SLA.0b013e31819ed943; Djuric-Stefanovic A, 2008, HERNIA, V12, P395, DOI 10.1007/s10029-008-0352-6; GALLEGOS NC, 1991, BRIT J SURG, V78, P1171, DOI 10.1002/bjs.1800781007; GLASSOW F, 1985, AM J SURG, V150, P353, DOI 10.1016/0002-9610(85)90077-7; Hair A, 2001, J ROY COLL SURG EDIN, V46, P117; HJALTASON E, 1981, ACTA CHIR SCAND, V147, P263; Kemler MA, 1997, EUR J SURG, V163, P187; Kitami M, 2009, J COMPUT ASSIST TOMO, V33, P678, DOI 10.1097/RCT.0b013e3181977a0a; Kjaergaard J, 2010, HERNIA, V14, P351, DOI 10.1007/s10029-010-0657-0; Malek S, 2004, INT J CLIN PRACT, V58, P207, DOI 10.1111/j.1368-5031.2004.0097.x; MCENTEE GP, 1989, BRIT J SURG, V76, P725, DOI 10.1002/bjs.1800760724; Nilsson H, 2011, HERNIA, V15, P301, DOI 10.1007/s10029-011-0782-4; Nilsson H, 2007, ANN SURG, V245, P656, DOI 10.1097/01.sla.0000251364.32698.4b; Tanaka N, 2010, SURG TODAY, V40, P1144, DOI 10.1007/s00595-009-4193-4; van den Berg JC, 1999, INVEST RADIOL, V34, P739, DOI 10.1097/00004424-199912000-00002	18	18	19	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 8	2011	343								d7668	10.1136/bmj.d7668	http://dx.doi.org/10.1136/bmj.d7668			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EX	22162501	Green Accepted			2022-12-24	WOS:000298939300004
J	Leung, ES; Hamilton-Bruce, MA; Stocks, N; Koblar, SA				Leung, Elaine Stephanie; Hamilton-Bruce, Monica Anne; Stocks, Nigel; Koblar, Simon A.			10-MINUTE CONSULTATION Funny turn	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Leung, Elaine Stephanie; Hamilton-Bruce, Monica Anne; Koblar, Simon A.] Univ Adelaide, Stroke Res Programme, Adelaide, SA 5005, Australia; [Hamilton-Bruce, Monica Anne; Koblar, Simon A.] Queen Elizabeth Hosp, Dept Neurol, Adelaide, SA, Australia	University of Adelaide	Leung, ES (corresponding author), Univ Adelaide, Stroke Res Programme, Adelaide, SA 5005, Australia.	elaine.leung@adelaide.edu.au	Stocks, Nigel P/I-1083-2012	Koblar, Simon/0000-0002-8667-203X; Stocks, Nigel/0000-0002-9018-0361					0	0	0	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 5	2011	343								d7465	10.1136/bmj.d7465	http://dx.doi.org/10.1136/bmj.d7465			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RZ	22144408				2022-12-24	WOS:000298038200005
J	Gillman, MW; Daniels, SR				Gillman, Matthew W.; Daniels, Stephen R.			Is Universal Pediatric Lipid Screening Justified?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHILDHOOD; CHILDREN; RISK		[Gillman, Matthew W.] Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Dept Populat Med,Obes Prevent Program, Boston, MA 02215 USA; [Gillman, Matthew W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02215 USA; [Daniels, Stephen R.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Gillman, MW (corresponding author), Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Dept Populat Med,Obes Prevent Program, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	matthew_gillman@hms.harvard.edu			NHLBI NIH HHS [K24 HL 068041, K24 HL068041] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL068041] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2007, PEDIATRICS, V120, pe215; [Anonymous], INTEGRATED GUIDELINE; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; GILLMAN MW, 1993, J PEDIATR-US, V122, P837, DOI 10.1016/S0022-3476(09)90005-1; GILLMAN MW, 1993, AM J DIS CHILD, V147, P393, DOI 10.1001/archpedi.1993.02160280043015; Lloyd-Lones DM, 2003, ARCH INTERN MED, V163, P1966, DOI 10.1001/archinte.163.16.1966; Ritchie SK, 2010, PEDIATRICS, V126, P260, DOI 10.1542/peds.2009-2546; Wald NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018742; Wang YC, 2011, J PEDIATR-US, V158, P257, DOI 10.1016/j.jpeds.2010.07.058; Wang YC, 2011, J PEDIAT, V158, pe1	10	50	50	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2012	307	3					259	260		10.1001/jama.2011.2012	http://dx.doi.org/10.1001/jama.2011.2012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877EY	22253390	Green Accepted			2022-12-24	WOS:000299161200019
J	Jepson, P; Jennings, S; Jones, KE; Hodgetts, T				Jepson, Paul; Jennings, Steve; Jones, Kate E.; Hodgetts, Timothy			Entertainment Value: Should the Media Pay for Nature Conservation?	SCIENCE			English	Editorial Material									[Jepson, Paul; Hodgetts, Timothy] Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; [Jennings, Steve] Oxfam GB, Oxford OX4 2JY, England; [Jones, Kate E.] Zool Soc London, Inst Zool, London NW1 4RY, England	University of Oxford; Zoological Society of London	Jepson, P (corresponding author), Univ Oxford, Sch Geog & Environm, S Parks Rd, Oxford OX1 3QY, England.	paul.jepson@ouce.ox.ac.uk	Jones, Kate E/G-4768-2010; Jones, Kate/Y-3317-2019	Jones, Kate E/0000-0001-5231-3293; Jones, Kate/0000-0001-5231-3293				Andrews A., 2010, DAILY TELEGRAPH 1116, P4; [Anonymous], 2007, DISCOVERY COMMU 0501; Bouse Derek, 2000, WILDLIFE FILMS; Crutzen PJ, 2002, J PHYS IV, V12, P1, DOI 10.1051/jp4:20020447; Farley J, 2010, ECOL ECON, V69, P2060, DOI 10.1016/j.ecolecon.2010.06.010; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; Millennium Ecosystem Assessment, 2003, EC HUM WELL BEING FR; Norgaard RB, 2010, ECOL ECON, V69, P1219, DOI 10.1016/j.ecolecon.2009.11.009; PALMER C, 2010, SHOOTING WILD; Robinson J., 2006, OBSERVER        0409, P11; Sukhdev P., 2010, TEEB EC ECOSYSTEMS B; Turner RK, 2008, ENVIRON RESOUR ECON, V39, P25, DOI 10.1007/s10640-007-9176-6; UN Millennium Project, 2005, INV DEV PRACT PLAN A	13	12	12	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2011	334	6061					1351	1352		10.1126/science.1213189	http://dx.doi.org/10.1126/science.1213189			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	858HW	22158806				2022-12-24	WOS:000297787700034
J	Page, D; Cheung, V; Haussler, D; Gibbs, R				Page, David; Cheung, Vivian; Haussler, David; Gibbs, Richard			Human Genome: What's Been Most Surprising?	CELL			English	News Item									[Page, David] MIT, Cambridge, MA 02139 USA; [Cheung, Vivian] Univ Penn, Philadelphia, PA 19104 USA; [Haussler, David] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Gibbs, Richard] Baylor Coll Med, Houston, TX 77030 USA	Massachusetts Institute of Technology (MIT); University of Pennsylvania; University of California System; University of California Santa Cruz; Baylor College of Medicine	Page, D (corresponding author), MIT, Cambridge, MA 02139 USA.		Cheung, Vivian G./AAT-3115-2020						0	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					9	10						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	22128372	Bronze			2022-12-24	WOS:000295396700005
J	Ombrello, MJ; Remmers, EF; Sun, GP; Freeman, AF; Datta, S; Torabi-Parizi, P; Subramanian, N; Bunney, TD; Baxendale, RW; Martins, MS; Romberg, N; Komarow, H; Aksentijevich, I; Kim, HS; Ho, J; Cruse, G; Jung, MY; Gilfillan, AM; Metcalfe, DD; Nelson, C; O'Brien, M; Wisch, L; Stone, K; Douek, DC; Gandhi, C; Wanderer, AA; Lee, H; Nelson, SF; Shianna, KV; Cirulli, ET; Goldstein, DB; Long, EO; Moir, S; Meffre, E; Holland, SM; Kastner, DL; Katan, M; Hoffman, HM; Milner, JD				Ombrello, Michael J.; Remmers, Elaine F.; Sun, Guangping; Freeman, Alexandra F.; Datta, Shrimati; Torabi-Parizi, Parizad; Subramanian, Naeha; Bunney, Tom D.; Baxendale, Rhona W.; Martins, Marta S.; Romberg, Neil; Komarow, Hirsh; Aksentijevich, Ivona; Kim, Hun Sik; Ho, Jason; Cruse, Glenn; Jung, Mi-Yeon; Gilfillan, Alasdair M.; Metcalfe, Dean D.; Nelson, Celeste; O'Brien, Michelle; Wisch, Laura; Stone, Kelly; Douek, Daniel C.; Gandhi, Chhavi; Wanderer, Alan A.; Lee, Hane; Nelson, Stanley F.; Shianna, Kevin V.; Cirulli, Elizabeth T.; Goldstein, David B.; Long, Eric O.; Moir, Susan; Meffre, Eric; Holland, Steven M.; Kastner, Daniel L.; Katan, Matilda; Hoffman, Hal M.; Milner, Joshua D.			Cold Urticaria, Immunodeficiency, and Autoimmunity Related to PLCG2 Deletions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; ANTIBODY-DEFICIENCY SYNDROME; B-CELL RECEPTOR; PHOSPHOLIPASE C-GAMMA-2; GENE; MUTATIONS; PROTEIN; ENTEROPATHY; ACTIVATION; SIGNALS	Background Mendelian analysis of disorders of immune regulation can provide insight into molecular pathways associated with host defense and immune tolerance. Methods We identified three families with a dominantly inherited complex of cold-induced urticaria, antibody deficiency, and susceptibility to infection and autoimmunity. Immunophenotyping methods included flow cytometry, analysis of serum immunoglobulins and autoantibodies, lymphocyte stimulation, and enzymatic assays. Genetic studies included linkage analysis, targeted Sanger sequencing, and next-generation whole-genome sequencing. Results Cold urticaria occurred in all affected subjects. Other, variable manifestations included atopy, granulomatous rash, autoimmune thyroiditis, the presence of antinuclear antibodies, sinopulmonary infections, and common variable immunodeficiency. Levels of serum IgM and IgA and circulating natural killer cells and class-switched memory B cells were reduced. Linkage analysis showed a 7-Mb candidate interval on chromosome 16q in one family, overlapping by 3.5 Mb a disease-associated haplotype in a smaller family. This interval includes PLCG2, encoding phospholipase C gamma(2) (PLC gamma(2)), a signaling molecule expressed in B cells, natural killer cells, and mast cells. Sequencing of complementary DNA revealed heterozygous transcripts lacking exon 19 in two families and lacking exons 20 through 22 in a third family. Genomic sequencing identified three distinct in-frame deletions that cosegregated with disease. These deletions, located within a region encoding an autoinhibitory domain, result in protein products with constitutive phospholipase activity. PLCG2-expressing cells had diminished cellular signaling at 37 degrees C but enhanced signaling at subphysiologic temperatures. Conclusions Genomic deletions in PLCG2 cause gain of PLC gamma(2) function, leading to signaling abnormalities in multiple leukocyte subsets and a phenotype encompassing both excessive and deficient immune function. (Funded by the National Institutes of Health Intramural Research Programs and others.)	[Sun, Guangping; Datta, Shrimati; Komarow, Hirsh; Cruse, Glenn; Jung, Mi-Yeon; Gilfillan, Alasdair M.; Metcalfe, Dean D.; Nelson, Celeste; O'Brien, Michelle; Wisch, Laura; Stone, Kelly; Milner, Joshua D.] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Ombrello, Michael J.; Remmers, Elaine F.; Aksentijevich, Ivona; Kastner, Daniel L.] NHGRI, Inflammatory Dis Sect, NIH, Bethesda, MD 20892 USA; [Freeman, Alexandra F.; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Torabi-Parizi, Parizad; Subramanian, Naeha] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Kim, Hun Sik; Long, Eric O.] NIAID, Immunogenet Lab, NIH, Bethesda, MD 20892 USA; [Ho, Jason; Moir, Susan] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Douek, Daniel C.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Torabi-Parizi, Parizad] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Bunney, Tom D.; Baxendale, Rhona W.; Martins, Marta S.; Katan, Matilda] UCL, Dept Struct & Mol Biol, Div Biosci, London WC1E 6BT, England; [Romberg, Neil; Meffre, Eric] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Kim, Hun Sik] Univ Ulsan, Grad Sch, Med Res Ctr, Dept Med, Ulsan 680749, South Korea; [Gandhi, Chhavi; Hoffman, Hal M.] Univ Calif San Diego, Dept Pediat & Med, Div Allergy Immunol & Rheumatol, San Diego, CA 92103 USA; [Hoffman, Hal M.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Hoffman, Hal M.] Ludwig Inst Canc Res, San Diego, CA USA; [Wanderer, Alan A.] Univ Colorado, Hlth Sci Ctr, Aurora, CO USA; [Lee, Hane; Nelson, Stanley F.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Shianna, Kevin V.; Cirulli, Elizabeth T.; Goldstein, David B.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of London; University College London; Yale University; University of Ulsan; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Ludwig Institute for Cancer Research; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles; Duke University	Milner, JD (corresponding author), NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jdmilner@niaid.nih.gov	Moir, Susan/AAC-3676-2020; Cruse, Glenn/B-4597-2012; Long, Eric O/G-5475-2011; Cruse, Glenn/AAZ-1093-2021; Martins, Marta/A-9905-2013; Aksentijevich, Ivona/AAF-1335-2019; Goldstein, David/AAY-8125-2020; Nelson, Stanley F/D-4771-2009	Long, Eric O/0000-0002-7793-3728; Martins, Marta/0000-0003-0429-9380; Nelson, Stanley F/0000-0002-2082-3114; Cruse, Glenn/0000-0002-7511-0082; Remmers, Elaine F/0000-0002-9522-1249; Romberg, Neil/0000-0002-1881-5318; Bunney, Tom/0000-0002-0281-8813; Cirulli Rogers, Liz/0000-0001-7808-2809; Subramanian, Naeha/0000-0003-3754-0521; Ombrello, Michael/0000-0003-3322-4089	National Human Genome Research Institute; National Institute of Allergy and Infectious Diseases (NIAID) [AI061093, AI071087, AI082713]; National Institute of Arthritis and Musculoskeletal and Skin Diseases; University of California, San Diego (UCSD) Department of Pediatrics; National Institutes of Health [T32 AI07469]; UCSD Clinical Translational Research Institute [UL1RR031980]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000825, ZIAAI000545, R21AI095848, ZIAAI000965, ZIAAI000967, ZIAAI005031, P01AI061093, T32AI007469, ZIAAI000525, U19AI082713, ZIAAI001091, ZIEAI001148, R01AI071087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIDAR041180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of California, San Diego (UCSD) Department of Pediatrics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Clinical Translational Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Intramural Research Programs of the National Human Genome Research Institute, the National Institute of Allergy and Infectious Diseases (NIAID), and the National Institute of Arthritis and Musculoskeletal and Skin Diseases; grants from NIAID (AI061093, AI071087, and AI082713, to Dr. Meffre); the University of California, San Diego (UCSD) Department of Pediatrics; a National Institutes of Health training grant (T32 AI07469); and the UCSD Clinical Translational Research Institute, which has funding from awards issued by the National Center for Research Resources (UL1RR031980, to Dr. Hoffman).	Abe K, 2011, ARTHRITIS RHEUM-US, V63, P1301, DOI 10.1002/art.30280; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aspalter RM, 2000, CLIN EXP IMMUNOL, V121, P506, DOI 10.1046/j.1365-2249.2000.01317.x; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Bryceson YT, 2007, BLOOD, V110, P1906, DOI 10.1182/blood-2007-02-074468; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Daniels RL, 2009, J BIOL CHEM, V284, P1570, DOI 10.1074/jbc.M807270200; Dolmetsch RE, 1997, NATURE, V388, P308, DOI 10.1038/40912; Dufour JF, 1997, J BIOL CHEM, V272, P2675, DOI 10.1074/jbc.272.5.2675; Everett KL, 2009, J BIOL CHEM, V284, P23083, DOI 10.1074/jbc.M109.019265; Foerster C, 2010, J IMMUNOL, V184, P7305, DOI 10.4049/jimmunol.1000434; Gandhi C, 2009, J ALLERGY CLIN IMMUN, V124, P1245, DOI 10.1016/j.jaci.2009.09.035; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Ho J, 2011, AIDS, V25, P295, DOI 10.1097/QAD.0b013e328342328b; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; KAPLAN AP, 1981, NEW ENGL J MED, V305, P1074, DOI 10.1056/NEJM198110293051808; Kim HS, 2010, IMMUNITY, V32, P175, DOI 10.1016/j.immuni.2010.02.004; Losi CG, 2005, J CLIN IMMUNOL, V25, P496, DOI 10.1007/s10875-005-5637-2; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Ng YS, 2004, J EXP MED, V200, P927, DOI 10.1084/jem.20040920; Pan-Hammarstrom Q, 2007, NAT GENET, V39, P429, DOI 10.1038/ng0407-429; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Rodriguez R, 2003, BIOCHEM J, V374, P269, DOI 10.1042/BJ20021778; SHERMAN WB, 1950, J ALLERGY, V21, P414, DOI 10.1016/0021-8707(50)90017-7; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; van Blitterswijk WJ, 2008, CURR PHARM DESIGN, V14, P2061, DOI 10.2174/138161208785294636; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; Wanderer AA, 2004, IMMUNOL ALLERGY CLIN, V24, P259, DOI 10.1016/j.iac.2004.01.001; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018	40	258	266	2	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2012	366	4					330	338		10.1056/NEJMoa1102140	http://dx.doi.org/10.1056/NEJMoa1102140			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881EQ	22236196	Green Accepted			2022-12-24	WOS:000299464100004
J	Duffy, KR; Wellard, CJ; Markham, JF; Zhou, JHS; Holmberg, R; Hawkins, ED; Hasbold, J; Dowling, MR; Hodgkin, PD				Duffy, Ken R.; Wellard, Cameron J.; Markham, John F.; Zhou, Jie H. S.; Holmberg, Ross; Hawkins, Edwin D.; Hasbold, Jhagvaral; Dowling, Mark R.; Hodgkin, Philip D.			Activation-Induced B Cell Fates Are Selected by Intracellular Stochastic Competition	SCIENCE			English	Article							IMMUNE-RESPONSES; PLASMA-CELL; T-CELLS; LYMPHOCYTE DIVISION; POPULATION-DYNAMICS; DIFFERENTIATION; MECHANISM; MODEL; PROLIFERATION; VARIABILITY	In response to stimulation, B lymphocytes pursue a large number of distinct fates important for immune regulation. Whether each cell's fate is determined by external direction, internal stochastic processes, or directed asymmetric division is unknown. Measurement of times to isotype switch, to develop into a plasmablast, and to divide or to die for thousands of cells indicated that each fate is pursued autonomously and stochastically. As a consequence of competition between these processes, censorship of alternative outcomes predicts intricate correlations that are observed in the data. Stochastic competition can explain how the allocation of a proportion of B cells to each cell fate is achieved. The B cell may exemplify how other complex cell differentiation systems are controlled.	[Wellard, Cameron J.; Zhou, Jie H. S.; Holmberg, Ross; Hasbold, Jhagvaral; Dowling, Mark R.; Hodgkin, Philip D.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Duffy, Ken R.] Natl Univ Ireland, Hamilton Inst, Maynooth, Kildare, Ireland; [Wellard, Cameron J.; Zhou, Jie H. S.; Hasbold, Jhagvaral; Dowling, Mark R.; Hodgkin, Philip D.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3052, Australia; [Markham, John F.] Univ Melbourne, Natl Informat & Commun Technol ICT Australia, Victoria Res Lab, Melbourne, Vic 3010, Australia; [Hawkins, Edwin D.] Peter MacCallum Canc Ctr, Immune Signalling Lab, Melbourne, Vic 3002, Australia	Walter & Eliza Hall Institute; Maynooth University; University of Melbourne; University of Melbourne; Peter Maccallum Cancer Center	Hodgkin, PD (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia.	hodgkin@wehi.edu.au	Duffy, Ken/D-7955-2011	Duffy, Ken/0000-0001-5587-9356; Dowling, Mark/0000-0002-8056-5348; Markham, John/0000-0002-5738-3861; Wellard, Cameron/0000-0002-6115-5394; Zhou, Jie/0000-0002-9113-800X; Hawkins, Edwin/0000-0002-3686-8261; Hodgkin, Philip/0000-0002-8604-1940	Australian National Health and Medical Research Council (NHMRC) [575500]; Victorian State Government; Australian Government NHMRC Independent Research Institute; Science Foundation Ireland [RFP-ENEF530]; National ICT Australia (NICTA); Australian government's Backing Australia's Ability initiative through the Australian Research Council	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; Australian Government NHMRC Independent Research Institute(National Health and Medical Research Council (NHMRC) of Australia); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National ICT Australia (NICTA)(NICTA); Australian government's Backing Australia's Ability initiative through the Australian Research Council(Australian Research Council)	The data presented in this paper are tabulated in the main paper and in the Supporting Online Material. This work was supported by the Australian National Health and Medical Research Council (NHMRC) (program grant 575500; fellowships, E. D. H., M. R. D. and P. D. H.), Victorian State Government Operational Infrastructure support, Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme (IRIIS), and Science Foundation Ireland (grant RFP-ENEF530, K. R. D.). J.F.M. was supported by National ICT Australia (NICTA), which is funded by the Australian government's Backing Australia's Ability initiative, in part through the Australian Research Council. The authors thank D. Day (Swinburne University of Technology) and Microsurfaces Pty. Ltd. for providing the microgrids (30), S. Nutt and A. Kallies for Blimp1 reporter mice, and R. DeBoer and D. Tarlinton for helpful feedback on the manuscript. "A cell population system and process" (U. S. Patent Application 12/312,933) describes computational algorithms based on competing fates that can be used to calculate and predict immune outcomes. Authors who are listed inventors are P. D. H., M.R.D., C.J.W, J.F.M., and E.D.H.	Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Day D, 2009, IMMUNOL CELL BIOL, V87, P154, DOI 10.1038/icb.2008.79; De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928; Deenick EK, 2003, J IMMUNOL, V170, P4963, DOI 10.4049/jimmunol.170.10.4963; Duffy KR, 2009, J MATH BIOL, V59, P255, DOI 10.1007/s00285-008-0231-x; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; Gett AV, 2000, NAT IMMUNOL, V1, P239, DOI 10.1038/79782; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Markham JF, 2010, J R SOC INTERFACE, V7, P1049, DOI 10.1098/rsif.2009.0488; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.immunol.11.1.331; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Slifka MK, 1998, CURR OPIN IMMUNOL, V10, P252, DOI 10.1016/S0952-7915(98)80162-3; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Subramanian VG, 2008, J MATH BIOL, V56, P861, DOI 10.1007/s00285-007-0142-2; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Turner ML, 2008, J IMMUNOL, V181, P374, DOI 10.4049/jimmunol.181.1.374; Wellard C, 2010, J THEOR BIOL, V264, P443, DOI 10.1016/j.jtbi.2010.02.019; Yule GU, 1912, J R STAT SOC, V75, P579, DOI 10.2307/2340126	29	154	156	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 20	2012	335	6066					338	341		10.1126/science.1213230	http://dx.doi.org/10.1126/science.1213230			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878RE	22223740	Green Accepted			2022-12-24	WOS:000299273400048
J	Segev, E; Smith, Y; Ben-Yehuda, S				Segev, Einat; Smith, Yoav; Ben-Yehuda, Sigal			RNA Dynamics in Aging Bacterial Spores	CELL			English	Article							BACILLUS-SUBTILIS SPORES; DORMANT SPORES; PHOSPHATE METABOLISM; ENDOSPORE FORMATION; VEGETATIVE CELLS; HEAT-RESISTANCE; MESSENGER-RNA; SPORULATION; GERMINATION; COAT	Upon starvation, the bacterium Bacillus subtilis enters the process of sporulation, lasting several hours and culminating in formation of a spore, the most resilient cell type known. We show that a few days following sporulation, the RNA profile of spores is highly dynamic. In aging spores incubated at high temperatures, RNA content is globally decreased by degradation over several days. This degradation might be a strategy utilized by the spore to facilitate its dormancy. However, spores kept at low temperature exhibit a different RNA profile with evidence supporting transcription. Further, we demonstrate that germination is affected by spore age, incubation temperature, and RNA state, implying that spores can acquire dissimilar characteristics at a time they are considered dormant. We propose that, in contrast to current thinking, entering dormancy lasts a few days, during which spores are affected by the environment and undergo corresponding molecular changes influencing their emergence from quiescence.	[Segev, Einat; Ben-Yehuda, Sigal] Hebrew Univ Jerusalem, IMRIC, Hebrew Univ Hadassah Med Sch, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel; [Smith, Yoav] Hebrew Univ Jerusalem, Genom Data Anal Unit, Hebrew Univ Hadassah Med Sch, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ben-Yehuda, S (corresponding author), Hebrew Univ Jerusalem, IMRIC, Hebrew Univ Hadassah Med Sch, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel.	sigalb@ekmd.huji.ac.il			European Research Council (ERC) [209130]; Israel Science Foundation [696/07]	European Research Council (ERC)(European Research Council (ERC)); Israel Science Foundation(Israel Science Foundation)	We thank M. Kott-Gutkowski (Hebrew University, Israel), A. Sol (Hebrew University), B. Fhanetzky (Tamar, Ltd.), and A. Grundwag (Eisenberg bros., Ltd.) for valuable technical support. We are grateful to A. Rosenberg and other members of the Ben-Yehuda laboratory for technical help and valuable discussions and comments. We thank G. Bachrach (Hebrew University), R. Losick (Harvard University, USA), A. Rouvinski (Hebrew University), I. Simon (Hebrew University), and J. Stulke (Gottingen University, Germany) for valuable comments on the manuscript. We thank the National BioResource Project National Institute of Genetics, Japan (NBRP [NIG, Japan]), D. Bechhofer (Mt. Sinai School of Medicine, USA), C. Condon (CNRS, France), J. Errington (Newcastle University, UK), H. Putzer (CNRS), and J. Stulke (Gottingen University) for kindly providing strains. This work was supported by the European Research Council (ERC) Starting Grant (209130) and by the Israel Science Foundation (696/07) awarded to S.B.-Y.	Abel-Santos E, 2007, NEW J CHEM, V31, P748, DOI 10.1039/b616695d; Bettegowda C, 2006, NAT BIOTECHNOL, V24, P1573, DOI 10.1038/nbt1256; BLACK SH, 1962, J BACTERIOL, V83, P960, DOI 10.1128/JB.83.5.960-967.1962; Camp AH, 2009, GENE DEV, V23, P1014, DOI 10.1101/gad.1781709; CARSTENSEN EL, 1971, J BACTERIOL, V107, P106, DOI 10.1128/JB.107.1.106-113.1971; CHAMBON P, 1968, J BIOL CHEM, V243, P5110; CHAMBON P, 1968, J BIOL CHEM, V243, P5101; Cohn F., 1877, BEITR BIOL PFLANZ, V2, P26; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Cowan AE, 2003, P NATL ACAD SCI USA, V100, P4209, DOI 10.1073/pnas.0636762100; Driks A, 2002, TRENDS MICROBIOL, V10, P251, DOI 10.1016/S0966-842X(02)02373-9; DURBAN E, 1974, J BACTERIOL, V118, P129, DOI 10.1128/JB.118.1.129-138.1974; Dworkin J, 2010, NAT REV MICROBIOL, V8, P890, DOI 10.1038/nrmicro2453; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Francis CA, 2002, APPL ENVIRON MICROB, V68, P874, DOI 10.1128/AEM.68.2.874-880.2002; Gerhardt P, 1989, REGULATION PROCARYOT; Harwood C.R., 1990, MOL BIOL METHODS BAC; Keijser BJF, 2007, J BACTERIOL, V189, P3624, DOI 10.1128/JB.01736-06; Koch R, 1876, COHNS BEITR BIOLOGIE, V2, P13; Kuwana R, 2006, J BIOCHEM, V139, P887, DOI 10.1093/jb/mvj096; Leuschner RGK, 2000, MICROBIOL-UK, V146, P49, DOI 10.1099/00221287-146-1-49; McKenney PT, 2010, CURR BIOL, V20, P934, DOI 10.1016/j.cub.2010.03.060; Meisner J, 2008, P NATL ACAD SCI USA, V105, P15100, DOI 10.1073/pnas.0806301105; Melly E, 2002, J APPL MICROBIOL, V92, P1105, DOI 10.1046/j.1365-2672.2002.01644.x; Moeller R, 2006, CURR MICROBIOL, V53, P227, DOI 10.1007/s00284-006-0099-1; Moir A, 2006, J APPL MICROBIOL, V101, P526, DOI 10.1111/j.1365-2672.2006.02885.x; NAKASHIO S, 1985, J BACTERIOL, V162, P571, DOI 10.1128/JB.162.2.571-578.1985; NELSON DL, 1970, J BIOL CHEM, V245, P1137; NELSON DL, 1970, J BIOL CHEM, V245, P1146; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Pelczar PL, 2007, J BACTERIOL, V189, P1090, DOI 10.1128/JB.01606-06; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Piir K, 2011, EMBO REP, V12, P458, DOI 10.1038/embor.2011.47; Ragkousi K, 2004, J BACTERIOL, V186, P5567, DOI 10.1128/JB.186.17.5567-5575.2004; Riesenman PJ, 2000, APPL ENVIRON MICROB, V66, P620, DOI 10.1128/AEM.66.2.620-626.2000; Sanchez-Salas JL, 2011, APPL ENVIRON MICROB, V77, P6746, DOI 10.1128/AEM.05031-11; SANTO LY, 1974, J BACTERIOL, V120, P475, DOI 10.1128/JB.120.1.475-481.1974; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; SETLOW P, 1970, J BIOL CHEM, V245, P3637; SETLOW P, 1995, ANNU REV MICROBIOL, V49, P29, DOI 10.1146/annurev.mi.49.100195.000333; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; VASANTHA N, 1980, J BACTERIOL, V144, P1119, DOI 10.1128/JB.144.3.1119-1125.1980; Yao SY, 2010, J BACTERIOL, V192, P3279, DOI 10.1128/JB.00230-10; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1; Zilhao R, 2005, J BACTERIOL, V187, P7753, DOI 10.1128/JB.187.22.7753-7764.2005	47	76	78	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 20	2012	148	1-2					139	149		10.1016/j.cell.2011.11.059	http://dx.doi.org/10.1016/j.cell.2011.11.059			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22209493	Bronze			2022-12-24	WOS:000299540700020
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING Does nicotine replacement really help smokers quit?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Alpert HR, TOB CONTROL, DOI [10.1136/tobaccocontrol-2011-050129, DOI 10.1136/TOBACCOCONTR0L-2011-050129]; Carey B., 2012, NEW YORK TIMES  0120, pA1; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; Moore David, 2009, BMJ, V338, pb1024, DOI 10.1136/bmj.b1024; Shiffman S, 2008, AM J PREV MED, V34, P102, DOI 10.1016/j.amepre.2007.09.033; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI	7	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2012	344								e450	10.1136/bmj.e450	http://dx.doi.org/10.1136/bmj.e450			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888YZ	22257979				2022-12-24	WOS:000300041900008
J	Psaty, BM; Rivara, FP				Psaty, Bruce M.; Rivara, Frederick P.			Universal Screening and Drug Treatment of Dyslipidemia in Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; RHABDOMYOLYSIS; DISEASE		[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.; Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Seattle, WA USA; [Rivara, Frederick P.] Seattle Childrens Hosp, Ctr Child Hlth Behav & Dev, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NHLBI NIH HHS [HL105756, HL103612, HL087652, HL085251, HL080295, HL078888] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085251, R01HL078888, R01HL080295, R01HL087652, R01HL103612, R01HL105756, U01HL080295] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alsheikh-Ali AA, 2007, J AM COLL CARDIOL, V50, P409, DOI 10.1016/j.jacc.2007.02.073; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; BRUGTS JJ, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B2376; Cooper WO, 2011, NEW ENGL J MED, V365, P1896, DOI 10.1056/NEJMoa1110212; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; OLIVER MF, 1984, LANCET, V2, P600; Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569; US Food and Drug Administration, TRIL FEN AC DRUG SAF	10	43	43	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2012	307	3					257	258		10.1001/jama.2011.1916	http://dx.doi.org/10.1001/jama.2011.1916			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877EY	22174386				2022-12-24	WOS:000299161200018
J	McManus, RJ; Caulfield, M; Williams, B				McManus, Richard J.; Caulfield, Mark; Williams, Bryan			NICE hypertension guideline 2011: evidence based evolution	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; AMLODIPINE; DIAGNOSIS; MANAGEMENT; OUTCOMES; DISEASE; RISK		[McManus, Richard J.] Univ Oxford, NIHR English Sch Primary Care Res, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England; [Caulfield, Mark] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Caulfield, Mark] Queen Mary Univ London, NIHR Cardiovasc Biomed Res Unit, London EC1M 6BQ, England; [Williams, Bryan] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Williams, Bryan] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England	University of Oxford; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	McManus, RJ (corresponding author), Univ Oxford, NIHR English Sch Primary Care Res, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England.	richard.mcmanus@phc.ox.ac.uk		Williams, Bryan/0000-0002-8094-1841; Caulfield, Mark/0000-0001-9295-3594	National Institute for Health Research [NF-SI-0509-10222, CDF/01/017] Funding Source: researchfish; Department of Health [CDF/01/017] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Brown MR, 2011, BMJ-BRIT MED J, V344, pd8218; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Fagard RH, 2007, J HYPERTENS, V25, P2193, DOI 10.1097/HJH.0b013e3282ef6185; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Head GA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1104; Hodgkinson J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3621; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Krause T, 2011, BMJ-BRIT MED J, V343, pd4891; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lovibond K, 2011, LANCET, V378, P1219, DOI 10.1016/S0140-6736(11)61184-7; National Institute for Health and Care Excellence, 2009, GUID MAN; National Institute for Health and Clinical Excellence, 2011, CLIN MAN PRIM HYP AD; PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255; Ramsay LE, 1999, J HUM HYPERTENS, V13, P569, DOI 10.1038/sj.jhh.1000917; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sofat R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8078; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wright JM, 2009, COCHRANE DB SYST REV, V1; Wright JT, 2005, JAMA-J AM MED ASSOC, V293, P1595, DOI 10.1001/jama.293.13.1595	22	86	86	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2012	344								e181	10.1136/bmj.e181	http://dx.doi.org/10.1136/bmj.e181			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877SR	22246269				2022-12-24	WOS:000299203500001
J	Jacobs, M				Jacobs, Michael			Climate policy: Deadline 2015	NATURE			English	Editorial Material									Univ London London Sch Econ & Polit Sci, Grantham Res Inst Climate Change & Environm, London WC2A 2AE, England	University of London; London School Economics & Political Science	Jacobs, M (corresponding author), Univ London London Sch Econ & Polit Sci, Grantham Res Inst Climate Change & Environm, Houghton St, London WC2A 2AE, England.	m.u.jacobs@lse.ac.uk							0	9	10	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					137	138		10.1038/481137a	http://dx.doi.org/10.1038/481137a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	874TO	22237091	Bronze			2022-12-24	WOS:000298981200014
J	Zofall, M; Yamanaka, S; Reyes-Turcu, FE; Zhang, K; Rubin, C; Grewal, SIS				Zofall, Martin; Yamanaka, Soichiro; Reyes-Turcu, Francisca E.; Zhang, Ke; Rubin, Chanan; Grewal, Shiv I. S.			RNA Elimination Machinery Targeting Meiotic mRNAs Promotes Facultative Heterochromatin Formation	SCIENCE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SELECTIVE ELIMINATION; QUALITY-CONTROL; S. POMBE; CHROMATIN; MEIOSIS; PROTEIN; TRANSCRIPTION; TERMINATION	Facultative heterochromatin that changes during cellular differentiation coordinates regulated gene expression, but its assembly is poorly understood. Here, we describe facultative heterochromatin islands in fission yeast and show that their formation at meiotic genes requires factors that eliminate meiotic messenger RNAs (mRNAs) during vegetative growth. Blocking production of meiotic mRNA or loss of RNA elimination factors, including Mmi1 and Red1 proteins, abolishes heterochromatin islands. RNA elimination machinery is enriched at meiotic loci and interacts with Clr4/SUV39h, a methyltransferase involved in heterochromatin assembly. Heterochromatin islands disassemble in response to nutritional signals that induce sexual differentiation. This process involves the antisilencing factor Epe1, the loss of which causes dramatic increase in heterochromatic loci. Our analyses uncover unexpected regulatory roles for mRNA-processing factors that assemble dynamic heterochromatin to modulate gene expression.	[Zofall, Martin; Yamanaka, Soichiro; Reyes-Turcu, Francisca E.; Zhang, Ke; Rubin, Chanan; Grewal, Shiv I. S.] NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov			NIH; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010523] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Sugiyama for constructions of red1 Delta and tagged alleles during his time in the Grewal lab and M. Yamamoto and T. Sugiyama for their gift of strains. Microarray data are avaiable at the National Center for Biotechnology Information Gene Expression Omnibus repository under accession no. GSE33404. This work is supported by the Intramural Research Program of the NIH and National Cancer Institute.	Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Fischer T, 2009, P NATL ACAD SCI USA, V106, P8998, DOI 10.1073/pnas.0813063106; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Henikoff S., 2000, BIOCHIM BIOPHYS ACTA, V1470, P01; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Isaac S, 2007, GENETICS, V175, P1549, DOI 10.1534/genetics.106.068684; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Neuwald AF, 2000, NUCLEIC ACIDS RES, V28, P3570, DOI 10.1093/nar/28.18.3570; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Sugiyama T, 2011, EMBO J, V30, P1027, DOI 10.1038/emboj.2011.32; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Vasilieva L, 2008, MOL CELL, V29, P313, DOI 10.1016/j.molcel.2008.01.011; Woolcock KJ, 2011, NAT STRUCT MOL BIOL, V18, P94, DOI 10.1038/nsmb.1935; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhang K, 2011, SCIENCE, V331, P1624, DOI 10.1126/science.1198712; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	24	132	132	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					96	100		10.1126/science.1211651	http://dx.doi.org/10.1126/science.1211651			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22144463	Green Accepted			2022-12-24	WOS:000298846200059
J	Kim, J; Davis, JW				Kim, Jeri; Davis, John W.			Prostate Cancer Screening-Time to Abandon One-Size-Fits-All Approach?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		[Kim, Jeri] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Davis, John W.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kim, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, 1155 Pressler St,Unit 1374, Houston, TX 77030 USA.	jekim@mdanderson.org						Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Arias Elizabeth, 2011, Natl Vital Stat Rep, V59, P1; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Etzioni R, 2008, MED DECIS MAKING, V28, P323, DOI 10.1177/0272989X07312719; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; US Preventive Services Task Force, SCREEN PROST CANC US; Welch HG, 2009, J NATL CANCER I, V101, P1325, DOI 10.1093/jnci/djp278	10	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2717	2718		10.1001/jama.2011.1881	http://dx.doi.org/10.1001/jama.2011.1881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22203541				2022-12-24	WOS:000298484000023
J	Kaiser, CM; Goldman, DH; Chodera, JD; Tinoco, I; Bustamante, C				Kaiser, Christian M.; Goldman, Daniel H.; Chodera, John D.; Tinoco, Ignacio, Jr.; Bustamante, Carlos			The Ribosome Modulates Nascent Protein Folding	SCIENCE			English	Article							EXPLORING SUBDOMAIN COOPERATIVITY; EXIT TUNNEL; T4 LYSOZYME; POLYPEPTIDE-CHAINS; MESSENGER-RNA; IN-VITRO; TRANSLATION; SPECTROSCOPY; DYNAMICS; LANDSCAPES	The blood-brain barrier (BBB) is composed of tightly bound endothelial cells (ECs) and perivascular astrocytes that regulate central nervous system (CNS) homeostasis. We showed that astrocytes secrete Sonic hedgehog and that BBB ECs express Hedgehog (Hh) receptors, which together promote BBB formation and integrity during embryonic development and adulthood. Using pharmacological inhibition and genetic inactivation of the Hh signaling pathway in ECs, we also demonstrated a critical role of the Hh pathway in promoting the immune quiescence of BBB ECs by decreasing the expression of proinflammatory mediators and the adhesion and migration of leukocytes, in vivo and in vitro. Overall, the Hh pathway provides a barrier-promoting effect and an endogenous anti-inflammatory balance to CNS-directed immune attacks, as occurs in multiple sclerosis.	[Kaiser, Christian M.; Chodera, John D.; Tinoco, Ignacio, Jr.; Bustamante, Carlos] Univ Calif Berkeley, Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Kaiser, Christian M.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Goldman, Daniel H.; Tinoco, Ignacio, Jr.; Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073; Chodera, John/0000-0003-0542-119X	NIH [5K99GM086516, 5R01GM10840, 5R01GM32543]; QB3 Institute, Berkeley; NSF; Human Frontiers of Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM086516, R01GM010840, R01GM032543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); QB3 Institute, Berkeley; NSF(National Science Foundation (NSF)); Human Frontiers of Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Marqusee for the T4 lysozyme source plasmid and for helpful discussions, O. Dudko for help with the analysis of force-ramp data, and J. R. Moffitt and members of the Bustamante and Tinoco laboratories for helpful discussions on the manuscript. C. M. K. acknowledges support from the NIH K99 Award 5K99GM086516; C. M. K. and J. D. C. acknowledge funding from the QB3 Institute, Berkeley (Distinguished Postdoctoral Fellowship); D. H. G. acknowledges the NSF's Graduate Research Fellowship; I. T. acknowledges support from NIH grant 5R01GM10840 and the Human Frontiers of Science Program; and C. B. acknowledges support from NIH grant 5R01GM32543.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Cellitti J, 2007, PROTEIN SCI, V16, P852, DOI 10.1110/ps.062632807; Cellitti J, 2007, PROTEIN SCI, V16, P842, DOI 10.1110/ps.062628607; Chow CC, 2003, BIOCHEMISTRY-US, V42, P7090, DOI 10.1021/bi0273056; Dietz H, 2006, P NATL ACAD SCI USA, V103, P1244, DOI 10.1073/pnas.0509217103; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Elcock AH, 2006, PLOS COMPUT BIOL, V2, P824, DOI 10.1371/journal.pcbi.0020098; Ellis JP, 2008, ACS CHEM BIOL, V3, P555, DOI 10.1021/cb800059u; Evans MS, 2008, J MOL BIOL, V383, P683, DOI 10.1016/j.jmb.2008.07.035; GAY GD, 1995, J MOL BIOL, V254, P968, DOI 10.1006/jmbi.1995.0669; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hsu STD, 2007, P NATL ACAD SCI USA, V104, P16516, DOI 10.1073/pnas.0704664104; Khushoo A, 2011, MOL CELL, V41, P682, DOI 10.1016/j.molcel.2011.02.027; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kiraga J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-163; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Liang ST, 2000, J BACTERIOL, V182, P3037, DOI 10.1128/JB.182.11.3037-3044.2000; Liu RH, 2000, METHOD ENZYMOL, V318, P268; Llinas M, 1998, PROTEIN SCI, V7, P96, DOI 10.1002/pro.5560070110; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; MATSUMURA M, 1989, SCIENCE, V243, P792, DOI 10.1126/science.2916125; Mittal J, 2008, P NATL ACAD SCI USA, V105, P20233, DOI 10.1073/pnas.0807742105; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Neira JL, 1999, J MOL BIOL, V285, P1309, DOI 10.1006/jmbi.1998.2249; O'Brien EP, 2010, J AM CHEM SOC, V132, P16928, DOI 10.1021/ja106530y; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Shank EA, 2010, NATURE, V465, P637, DOI 10.1038/nature09021; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; TANIUCHI H, 1970, J BIOL CHEM, V245, P5459; Udgaonkar JB, 2008, ANNU REV BIOPHYS, V37, P489, DOI 10.1146/annurev.biophys.37.032807.125920; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Voisset C, 2011, BIOTECHNOL J, V6, P668, DOI 10.1002/biot.201100021; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Weinkam P, 2009, P NATL ACAD SCI USA, V106, P1796, DOI 10.1073/pnas.0813120106; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P11289, DOI 10.1021/bi0155504	48	199	201	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1723	1727		10.1126/science.1209740	http://dx.doi.org/10.1126/science.1209740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194581	Green Accepted			2022-12-24	WOS:000298344000073
J	Crow, JM				Crow, James Mitchell			MICROBIOME That healthy gut feeling	NATURE			English	Editorial Material																		Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kim YS, 2008, J MICROBIOL BIOTECHN, V18, P1109; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Zhang X, 2011, WORLD SCI TECHNOLOGY, V13, P202	6	29	33	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S88	S89		10.1038/480S88a	http://dx.doi.org/10.1038/480S88a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190088	Bronze			2022-12-24	WOS:000298318000004
J	Jena, AB; Goldman, DP; Foster, SE; Califano, JA				Jena, Anupam B.; Goldman, Dana P.; Foster, Susan E.; Califano, Joseph A., Jr.			Prescription Medication Abuse and Illegitimate Internet-Based Pharmacies	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES; DRUGS	Abuse of controlled prescription medications in the United States exceeds that of all illicit drugs combined except marijuana and has grown considerably in the past decade. Although available through traditional channels, controlled prescription medications can also be purchased on the Internet without a prescription. This issue has gained the attention of federal regulators, law enforcement, and the media, but physician awareness of the problem is scarce. This article describes the nature of the problem and its magnitude, discusses the challenges to federal and private efforts to combat illegitimate online pharmacies, and outlines strategies for physicians to recognize and minimize the unwarranted effects of the availability of these medications on the Internet.	[Jena, Anupam B.] Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp,Wang Ambulatory Care Ctr, Boston, MA 02114 USA; Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA; RAND Corp, Santa Monica, CA USA; Columbia Univ, Natl Ctr Addict & Substance Abuse, New York, NY USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Southern California; RAND Corporation; Columbia University	Jena, AB (corresponding author), Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp,Wang Ambulatory Care Ctr, 15 Parkman St, Boston, MA 02114 USA.	jena.anupam@mgh.harvard.edu	Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396				Cai R., 2010, Morbidity and Mortality Weekly Report, V59, P705; Cicero TJ, 2008, PAIN MED, V9, P718, DOI 10.1111/j.1526-4637.2007.00323.x; Cramer RJ, 2004, GAO04892T; [Drug Enforcement Administration (DEA) Department of Justice], 2009, FED REG, V74, P15595; Fentiman LC, 2003, RUTGERS LAW REV, V56, P119; Forman RF, 2003, JAMA-J AM MED ASSOC, V290, P889, DOI 10.1001/jama.290.7.889; Gordon SM, 2006, J SUBST ABUSE TREAT, V30, P271, DOI 10.1016/j.jsat.2005.08.013; Inciardi JA, 2010, DRUG ALCOHOL DEPEN, V110, P21, DOI 10.1016/j.drugalcdep.2010.01.015; Jena AB, 2011, HEALTH AFFAIR, V30, P1192, DOI 10.1377/hlthaff.2011.0155; KAUFMAN M, 2005, WASH POST, pA03; Miller C.C., 2011, NY TIMES, pB1; National Center on Addiction and Substance Abuse, 2008, YOUV GOT DRUGS; [National Drug Intelligence Center U.S. Department of Justice], 2009, US DEP JUST PUBL; Saitz R, 1997, AM J DRUG ALCOHOL AB, V23, P343, DOI 10.3109/00952999709016881; Siva N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3457; Substance Abuse and Mental Health Services Administration (Office of Applied Studies), 2009, HHS PUBL; The National Center on Addiction and Substance Abuse, 2005, COUNT DIV AB CONTR P; U.S. Food and Drug Administration Internet Pharmacy Task Force, 2009, WARN LETT US FOOD DR	18	20	20	1	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12					848	850		10.7326/0003-4819-155-12-201112200-00008	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-00008			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	864ZU	22184692				2022-12-24	WOS:000298280500019
J	Cebrian, I; Visentin, G; Blanchard, N; Jouve, M; Bobard, A; Moita, C; Enninga, J; Moita, LF; Amigorena, S; Savina, A				Cebrian, Ignacio; Visentin, Geraldine; Blanchard, Nicolas; Jouve, Mabel; Bobard, Alexandre; Moita, Catarina; Enninga, Jost; Moita, Luis F.; Amigorena, Sebastian; Savina, Ariel			Sec22b Regulates Phagosomal Maturation and Antigen Crosspresentation by Dendritic Cells	CELL			English	Article							CLASS-I MOLECULES; ENDOPLASMIC-RETICULUM; TOXOPLASMA-GONDII; LEGIONELLA-PNEUMOPHILA; CROSS-PRESENTATION; INTERMEDIATE COMPARTMENT; PARASITOPHOROUS VACUOLE; MEDIATED PHAGOCYTOSIS; SNARE COMPLEX; MEMBRANE	Antigen (Ag) crosspresentation by dendritic cells (DCs) involves the presentation of internalized Ags on MHC class I molecules to initiate CD8+ T cell-mediated immunity in response to certain pathogens and tumor cells. Here, we identify the SNARE Sec22b as a specific regulator of Ag crosspresentation. Sec22b localizes to the ER-Golgi intermediate compartment (ERGIC) and pairs to the plasma membrane SNARE syntaxin 4, which is present in phagosomes (Phgs). Depletion of Sec22b inhibits the recruitment of ER-resident proteins to Phgs and to the vacuole containing the Toxoplasma gondii parasite. In Sec22b-deficient DCs, crosspresentation is compromised after Ag phagocytosis or endocytosis and after invasion by T. gondii. Sec22b silencing inhibited Ag export to the cytosol and increased phagosomal degradation by accelerating lysosomal recruitment. Our findings provide insight into an intracellular traffic pathway required for crosspresentation and show that Sec22b-dependent recruitment of ER proteins to Phgs critically influences phagosomal functions in DCs.	[Cebrian, Ignacio; Visentin, Geraldine; Amigorena, Sebastian; Savina, Ariel] Inst Curie, INSERM, U932, F-75248 Paris 05, France; [Blanchard, Nicolas] Univ Toulouse 3, CHU Purpan, Ctr Physiopathol Toulouse Purpan, INSERM,CNRS,UMR 1043,UMR5282, F-31024 Toulouse 3, France; [Bobard, Alexandre; Enninga, Jost] Inst Pasteur, F-75724 Paris, France; [Moita, Catarina; Moita, Luis F.] Univ Lisbon, Cell Biol Immune Syst Unit, Inst Med Mol, Fac Med, P-1649028 Lisbon, Portugal; [Jouve, Mabel] Univ Paris Diderot, Inst Jacques Monod, CNRS, UMR7592, F-75205 Paris 13, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade de Lisboa; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Amigorena, S (corresponding author), Inst Curie, INSERM, U932, 26 Rue Ulm, F-75248 Paris 05, France.	sebastian.amigorena@curie.fr; ariel.savina@curie.fr	Moita, Luis F./L-1296-2013; Blanchard, Nicolas/I-5255-2014; Blanchard, Nicolas/AAD-6601-2020; Cebrian, Ignacio/L-2764-2016; Moita, Luis/HCI-2793-2022	Moita, Luis F./0000-0003-0707-315X; Blanchard, Nicolas/0000-0002-4924-2161; Blanchard, Nicolas/0000-0002-4924-2161; Cebrian, Ignacio/0000-0001-6505-0875; Moita, Luis/0000-0003-0707-315X; Amigorena, Sebastian/0000-0001-8583-8416; Jouve San Roman, Mabel Juana/0000-0002-3115-4681; Ferreira Moita, Catarina/0000-0002-9910-2343	Institut Curie, Institut National de la Sante et de la Recherche Medicale (INSERM); ARC (Association de la Recherche contre le Cancer) [SFI20101201629]; Ligue National de Lutte contre le Cancer; European Research Council [233062]; Agence National de Recherche (ANR MIME APAT); Bettencourt-Schueller Foundation (FBS); Curie Institute; Human Frontier Science Program Organization; Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-IMU/110303/2009, PTDC/SAU-MII/100780/2008, PIC/IC/82991/2007]	Institut Curie, Institut National de la Sante et de la Recherche Medicale (INSERM); ARC (Association de la Recherche contre le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Ligue National de Lutte contre le Cancer; European Research Council(European Research Council (ERC)European Commission); Agence National de Recherche (ANR MIME APAT)(French National Research Agency (ANR)); Bettencourt-Schueller Foundation (FBS); Curie Institute; Human Frontier Science Program Organization(Human Frontier Science Program); Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	We are grateful to Boris Striepen (U. of Georgia, Athens, GA, USA) and Marc-Jan Gubbels (Boston College, Chestnut Hill, MA, USA) for the gift of YFP- and OVA/YFP-expressing RH parasites and Marie-France Cesbron-Delauw for the anti-GRA2 antibody. We thank Thierry Galli (Institut Jacques Monod) for the gift of Ykt6 and SNAP-23 antibodies and for helpful discussions and comment on the manuscript. Maria Rescigno (European Institute of Oncology, Milan) for the gift of OVA-expressing E. coli strains. We thank Philippe Benaroch for helpful discussion about the protocol of export to the cytosol with beta-lactamase; A.-M. Lennon and F. Kotsias for comments on the manuscript; and Michel Desjardins for helpful discussions. We thank Patricia Le Baccon for assistance with Delta Vision system and Christine Sedlik for technical assistance with T. gondii experiments. We thank the PICT-IBiSA@BDD (UMR3215/U934) Imaging facility of Institut Curie. This work was financed by Institut Curie, Institut National de la Sante et de la Recherche Medicale (INSERM), ARC (Association de la Recherche contre le Cancer, No SFI20101201629), Ligue National de Lutte contre le Cancer (Ligue labelisee 2007-2010 and 2011-2013), European Research Council (PhagoDC no 233062), Agence National de Recherche (ANR MIME APAT), and the Bettencourt-Schueller Foundation (FBS). I.C. was supported by the Curie Institute PhD Scholarship program and the ARC. N.B. was supported by the Human Frontier Science Program Organization, INSERM, and FBS. L.F.M. receives support from Fundacao Luso-Americana para o Desenvolvimento and Fundacao para a Ciencia e a Tecnologia (PTDC/SAU-IMU/110303/2009, PTDC/SAU-MII/100780/2008, and PIC/IC/82991/2007).	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Arasaki K, 2010, TRAFFIC, V11, P587, DOI 10.1111/j.1600-0854.2010.01050.x; Becker T, 2005, P NATL ACAD SCI USA, V102, P4022, DOI 10.1073/pnas.0409219102; Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Ghanem E, 2010, J CELL SCI, V123, P4271, DOI 10.1242/jcs.060632; Goldszmid RS, 2009, J EXP MED, V206, P399, DOI 10.1084/jem.20082108; Gubbels MJ, 2005, INFECT IMMUN, V73, P703, DOI 10.1128/IAI.73.2.703-711.2005; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Hatsuzawa K, 2000, J BIOL CHEM, V275, P13713, DOI 10.1074/jbc.275.18.13713; Hatsuzawa K, 2006, MOL BIOL CELL, V17, P3964, DOI 10.1091/mbc.E05-12-1174; Hatsuzawa K, 2009, MOL BIOL CELL, V20, P4435, DOI 10.1091/mbc.E09-03-0241; Hochweller K, 2008, EUR J IMMUNOL, V38, P2776, DOI 10.1002/eji.200838659; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Howe C, 2009, EMBO J, V28, P3730, DOI 10.1038/emboj.2009.296; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Kagan JC, 2005, METHOD ENZYMOL, V403, P71, DOI 10.1016/S0076-6879(05)03007-7; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Laurent-Matha V, 2006, J BIOCHEM, V139, P363, DOI 10.1093/jb/mvj037; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Melo EJT, 1997, CELL STRUCT FUNCT, V22, P317, DOI 10.1247/csf.22.317; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Ray K, 2010, CELL MICROBIOL, V12, P545, DOI 10.1111/j.1462-5822.2010.01428.x; Saveanu L, 2009, SCIENCE, V325, P213, DOI 10.1126/science.1172845; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2010, METHODS MOL BIOL, V595, P383, DOI 10.1007/978-1-60761-421-0_25; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; SIBLEY LD, 1995, J CELL SCI, V108, P1669; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; SUGAWARA S, 1987, J IMMUNOL METHODS, V100, P83; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Xu DL, 2000, J BIOL CHEM, V275, P39631, DOI 10.1074/jbc.M007684200; Zhang T, 2001, J BIOL CHEM, V276, P27480, DOI 10.1074/jbc.M102786200	44	210	215	0	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1355	1368		10.1016/j.cell.2011.11.021	http://dx.doi.org/10.1016/j.cell.2011.11.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153078	Bronze			2022-12-24	WOS:000298148100023
J	Cabrol, JC				Cabrol, Jean-Clement			War, Drought, Malnutrition, Measles - A Report from Somalia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Doctors Borders Med Sans Frontieres, Geneva, Switzerland	Doctors Without Borders	Cabrol, JC (corresponding author), Doctors Borders Med Sans Frontieres, Geneva, Switzerland.							Alberti KP, 2010, INT HEALTH, V2, P65, DOI 10.1016/j.inhe.2009.12.009; [Anonymous], WHO VACC PREV DIS MO; Isanaka S, 2010, PEDIATRICS, V126, pE442, DOI 10.1542/peds.2009-2814; *UN CHILDR FUND, 2011, VACC CAMP CHILDR UND; World Health Organization, 2009, RESP COVID 19 HLTH S	5	8	8	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2011	365	20					1856	1858		10.1056/NEJMp1111238	http://dx.doi.org/10.1056/NEJMp1111238			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	848HG	22087678				2022-12-24	WOS:000297041900003
J	Shindell, D; Kuylenstierna, JCI; Vignati, E; van Dingenen, R; Amann, M; Klimont, Z; Anenberg, SC; Muller, N; Janssens-Maenhout, G; Raes, F; Schwartz, J; Faluvegi, G; Pozzoli, L; Kupiainen, K; Hoglund-Isaksson, L; Emberson, L; Streets, D; Ramanathan, V; Hicks, K; Oanh, NTK; Milly, G; Williams, M; Demkine, V; Fowler, D				Shindell, Drew; Kuylenstierna, Johan C. I.; Vignati, Elisabetta; van Dingenen, Rita; Amann, Markus; Klimont, Zbigniew; Anenberg, Susan C.; Muller, Nicholas; Janssens-Maenhout, Greet; Raes, Frank; Schwartz, Joel; Faluvegi, Greg; Pozzoli, Luca; Kupiainen, Kaarle; Hoeglund-Isaksson, Lena; Emberson, Lisa; Streets, David; Ramanathan, V.; Hicks, Kevin; Oanh, N. T. Kim; Milly, George; Williams, Martin; Demkine, Volodymyr; Fowler, David			Simultaneously Mitigating Near-Term Climate Change and Improving Human Health and Food Security	SCIENCE			English	Article							AIR-QUALITY; OZONE; EMISSIONS; IMPACTS; PROJECTIONS; AEROSOLS; NOX	Tropospheric ozone and black carbon (BC) contribute to both degraded air quality and global warming. We considered similar to 400 emission control measures to reduce these pollutants by using current technology and experience. We identified 14 measures targeting methane and BC emissions that reduce projected global mean warming similar to 0.5 degrees C by 2050. This strategy avoids 0.7 to 4.7 million annual premature deaths from outdoor air pollution and increases annual crop yields by 30 to 135 million metric tons due to ozone reductions in 2030 and beyond. Benefits of methane emissions reductions are valued at $700 to $5000 per metric ton, which is well above typical marginal abatement costs ( less than $250). The selected controls target different sources and influence climate on shorter time scales than those of carbon dioxide-reduction measures. Implementing both substantially reduces the risks of crossing the 2 degrees C threshold.	[Shindell, Drew; Faluvegi, Greg; Milly, George] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Shindell, Drew; Faluvegi, Greg; Milly, George] Columbia Univ, Columbia Earth Inst, New York, NY 10025 USA; [Kuylenstierna, Johan C. I.; Emberson, Lisa; Hicks, Kevin] Univ York, Dept Environm, Stockholm Environm Inst, York YO10 5DD, N Yorkshire, England; [Vignati, Elisabetta; van Dingenen, Rita; Janssens-Maenhout, Greet; Raes, Frank; Pozzoli, Luca] European Commiss, Joint Res Ctr, I-21027 Ispra, Italy; [Amann, Markus; Klimont, Zbigniew; Kupiainen, Kaarle; Hoeglund-Isaksson, Lena] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Anenberg, Susan C.] US EPA, Washington, DC 20460 USA; [Muller, Nicholas] Middlebury Coll, Dept Econ, Middlebury, VT 05753 USA; [Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA; [Streets, David] Argonne Natl Lab, Argonne, IL 60439 USA; [Ramanathan, V.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92093 USA; [Oanh, N. T. Kim] Asian Inst Technol, Bangkok 10400, Thailand; [Williams, Martin] Kings Coll London, Environm Res Grp, London SE1 9NH, England; [Demkine, Volodymyr] UNEP, Nairobi 00100, Kenya; [Fowler, David] Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Columbia University; University of York - UK; European Commission Joint Research Centre; EC JRC ISPRA Site; International Institute for Applied Systems Analysis (IIASA); United States Environmental Protection Agency; Harvard University; Harvard T.H. Chan School of Public Health; United States Department of Energy (DOE); Argonne National Laboratory; University of California System; University of California San Diego; Scripps Institution of Oceanography; Asian Institute of Technology; University of London; King's College London; UK Centre for Ecology & Hydrology (UKCEH)	Shindell, D (corresponding author), NASA, Goddard Inst Space Studies, New York, NY 10025 USA.	drew.t.shindell@nasa.gov	Shindell, Drew/D-4636-2012; Emberson, Lisa/ABA-8711-2021; Klimont, Zbigniew/O-6683-2019; fowler, david/B-5446-2010; Van Dingenen, Rita/AAI-3197-2021; Nguyen, Kim Oanh/D-9160-2019; Klimont, Zbigniew/P-7641-2015	Shindell, Drew/0000-0003-1552-4715; Klimont, Zbigniew/0000-0003-2630-198X; fowler, david/0000-0002-2999-2627; Van Dingenen, Rita/0000-0003-2521-4972; Nguyen, Kim Oanh/0000-0002-0367-0013; Klimont, Zbigniew/0000-0003-2630-198X; Williams, Martin/0000-0002-4677-6491; Pozzoli, Luca/0000-0003-0485-9624; Streets, David/0000-0002-0223-1350; Hoglund-Isaksson, Lena/0000-0001-7514-3135; Faluvegi, Gregory/0000-0001-9011-3663	UNEP; World Meteorlogical Organization (WMO), NASA; Clean Air Task Force; Medical Research Council [G0801056B] Funding Source: researchfish; Natural Environment Research Council [ceh010023] Funding Source: researchfish	UNEP; World Meteorlogical Organization (WMO), NASA; Clean Air Task Force; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by UNEP and the World Meteorlogical Organization (WMO), NASA's Applied Sciences and Atmospheric Chemistry Modeling and Analysis Programs, and the Clean Air Task Force to IIASA. We thank all the authors and reviewers who contributed to the UNEP/WMO Integrated Assessment of Black Carbon and Tropospheric Ozone.	Alexandratos N, 2006, WORLD AGR 2030 2050; Amann M, 2011, ENVIRON MODELL SOFTW, V26, P1489, DOI 10.1016/j.envsoft.2011.07.012; Bauer SE, 2010, ATMOS CHEM PHYS, V10, P7439, DOI 10.5194/acp-10-7439-2010; Boucher O, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044007; Chen WT, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042886; Cofala J, 2007, ATMOS ENVIRON, V41, P8486, DOI 10.1016/j.atmosenv.2007.07.010; Flanner MG, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008003; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Fuglestvedt JS, 2010, ATMOS ENVIRON, V44, P4648, DOI 10.1016/j.atmosenv.2009.04.044; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; International Energy Agency, 2003, BUILD COST CURV IND; International Energy Agency, 2009, WORLD EN OUTL; Jacobson MZ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013795; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Klimont Z, 2009, TELLUS B, V61, P602, DOI 10.1111/j.1600-0889.2009.00428.x; Koch D, 2010, ATMOS CHEM PHYS, V10, P7685, DOI 10.5194/acp-10-7685-2010; Koch D, 2009, J CLIMATE, V22, P2659, DOI 10.1175/2008JCLI2573.1; Kopacz M, 2011, ATMOS CHEM PHYS, V11, P2837, DOI 10.5194/acp-11-2837-2011; Krewski D, 2009, EXTENDED FOLLOW UP S; Kupiainen K, 2007, ATMOS ENVIRON, V41, P2156, DOI 10.1016/j.atmosenv.2006.10.066; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meehl GA, 2008, J CLIMATE, V21, P2869, DOI 10.1175/2007JCLI1777.1; Pozzoli L, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009007; Qian Y, 2011, ATMOS CHEM PHYS, V11, P1929, DOI 10.5194/acp-11-1929-2011; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Ramanathan V, 2010, P NATL ACAD SCI USA, V107, P8055, DOI 10.1073/pnas.1002293107; Ramaswamy V, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P349; Shindell D, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006348; Shindell D, 2010, ATMOS CHEM PHYS, V10, P3247, DOI 10.5194/acp-10-3247-2010; Shindell DT, 2006, ATMOS CHEM PHYS, V6, P4427, DOI 10.5194/acp-6-4427-2006; Shindell D, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014108; Sillman S, 1999, ATMOS ENVIRON, V33, P1821, DOI 10.1016/S1352-2310(98)00345-8; Stier P, 2006, ATMOS CHEM PHYS, V6, P3059, DOI 10.5194/acp-6-3059-2006; Tol R.S., 2008, ECONOMICS-KIEL, V2, DOI DOI 10.5018/ECONOMICS-EJOURNAL.JA.2008-25; United Nations Environment Programme and World Meteorological Organization, 2011, INT ASS BLACK C CARB; Van Dingenen R, 2009, ATMOS ENVIRON, V43, P604, DOI 10.1016/j.atmosenv.2008.10.033; Wang C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040114; West JJ, 2005, ENVIRON SCI TECHNOL, V39, P4685, DOI 10.1021/es048629f; Winiwarter L, 2010, POTENTIALS COSTS MIT	40	804	824	47	718	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2012	335	6065					183	189		10.1126/science.1210026	http://dx.doi.org/10.1126/science.1210026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246768				2022-12-24	WOS:000299033100044
J	Wu, WM; Thomas, JA; Cheng, NQ; Black, LW; Steven, AC				Wu, Weimin; Thomas, Julie A.; Cheng, Naiqian; Black, Lindsay W.; Steven, Alasdair C.			Bubblegrams Reveal the Inner Body of Bacteriophage phi KZ	SCIENCE			English	Article							RADIATION-DAMAGE; T7		[Wu, Weimin; Cheng, Naiqian; Steven, Alasdair C.] Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; [Thomas, Julie A.; Black, Lindsay W.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University System of Maryland; University of Maryland Baltimore	Steven, AC (corresponding author), Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, Struct Biol Lab, NIH, Bethesda, MD 20892 USA.	stevena@mail.nih.gov	Wu, Weimin/B-4063-2012; Thomas, Julie/N-9616-2019	Thomas, Julie/0000-0001-6612-0724	Intramural NIH HHS [Z01 AR027015-13] Funding Source: Medline; NIAID NIH HHS [AI11676, R21 AI011676, R01 AI011676] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI011676, R37AI011676, R21AI011676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015, ZIAAR027002, Z01AR027015] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Black L. W., 2011, VIRAL MOL MACHINES, P469; Chang CY, 2010, VIROLOGY, V398, P176, DOI 10.1016/j.virol.2009.12.002; CONWAY JF, 1993, J STRUCT BIOL, V111, P222, DOI 10.1006/jsbi.1993.1052; Fokine A, 2007, STRUCTURE, V15, P1099, DOI 10.1016/j.str.2007.07.008; KRYLOV VN, 1984, CAN J MICROBIOL, V30, P758, DOI 10.1139/m84-116; LEAPMAN RD, 1995, ULTRAMICROSCOPY, V59, P71, DOI 10.1016/0304-3991(95)00019-W; Mesyanzhinov VV, 2002, J MOL BIOL, V317, P1, DOI 10.1006/jmbi.2001.5396	8	41	43	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					182	182		10.1126/science.1214120	http://dx.doi.org/10.1126/science.1214120			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246767	Green Accepted			2022-12-24	WOS:000299033100043
J	Gehrett, BK				Gehrett, Barbara K.			A Prescription for Drug Shortages	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											Gehrett, BK (corresponding author), 14612 SE Green Valley Rd, Auburn, WA 98092 USA.	thebkg17@gmail.com	Mendoza, Elvia/A-9361-2012					[Anonymous], NAVIGATING DRUG SHOR; [Anonymous], DRUG SHORT CURR DRUG; Assistant Secretary for Planning and Evaluation US Department of Health and Human Services, ASPE ISS BRIEF EC AN; Davenport-Ennis N, 2011, IMPROVING PATIENT CA; Fox E, 2011, DRUG SHORT WORKSH SP; Jensen V, 2010, NEW ENGL J MED, V363, P806, DOI 10.1056/NEJMp1005849; McBride A, 2011, DRUG SHORT WORKSH SP	7	11	12	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2012	307	2					153	154		10.1001/jama.2011.2000	http://dx.doi.org/10.1001/jama.2011.2000			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875NP	22235084				2022-12-24	WOS:000299038300025
J	Hsu, CL; Lin, WY; Seshasayee, D; Chen, YH; Ding, X; Lin, ZH; Suto, E; Huang, ZY; Lee, WP; Park, H; Xu, M; Sun, M; Rangell, L; Lutman, JL; Ulufatu, S; Stefanich, E; Chalouni, C; Sagolla, M; Diehl, L; Fielder, P; Dean, B; Balazs, M; Martin, F				Hsu, Chia-Lin; Lin, Weiyu; Seshasayee, Dhaya; Chen, Yung-Hsiang; Ding, Xiao; Lin, Zhonghua; Suto, Eric; Huang, Zhiyu; Lee, Wyne P.; Park, Hyunjoo; Xu, Min; Sun, Mei; Rangell, Linda; Lutman, Jeff L.; Ulufatu, Sheila; Stefanich, Eric; Chalouni, Cecile; Sagolla, Meredith; Diehl, Lauri; Fielder, Paul; Dean, Brian; Balazs, Mercedesz; Martin, Flavius			Equilibrative Nucleoside Transporter 3 Deficiency Perturbs Lysosome Function and Macrophage Homeostasis	SCIENCE			English	Article							STORAGE DISORDERS; PROTEINS; MUTATIONS; FAMILY; HENT3	Lysosomal storage diseases (LSDs) are a group of heterogeneous disorders caused by defects in lysosomal enzymes or transporters, resulting in accumulation of undegraded macromolecules or metabolites. Macrophage numbers are expanded in several LSDs, leading to histiocytosis of unknown pathophysiology. Here, we found that mice lacking the equilibrative nucleoside transporter 3 (ENT3) developed a spontaneous and progressive macrophage-dominated histiocytosis. In the absence of ENT3, defective apoptotic cell clearance led to lysosomal nucleoside buildup, elevated intralysosomal pH, and altered macrophage function. The macrophage accumulation was partly due to increased macrophage colony-stimulating factor and receptor expression and signaling secondary to the lysosomal defects. These studies suggest a cellular and molecular basis for the development of histiocytosis in several human syndromes associated with ENT3 mutations and potentially other LSDs.	[Hsu, Chia-Lin; Lin, Weiyu; Seshasayee, Dhaya; Martin, Flavius] Genentech Inc, Immunol, San Francisco, CA 94080 USA; [Chen, Yung-Hsiang; Ding, Xiao; Dean, Brian] Genentech Inc, Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA; [Lin, Zhonghua; Suto, Eric; Huang, Zhiyu; Lee, Wyne P.; Park, Hyunjoo; Xu, Min; Balazs, Mercedesz] Genentech Inc, Translat Immunol, San Francisco, CA 94080 USA; [Sun, Mei; Rangell, Linda; Chalouni, Cecile; Sagolla, Meredith; Diehl, Lauri] Genentech Inc, Pathol, San Francisco, CA 94080 USA; [Lutman, Jeff L.; Ulufatu, Sheila; Stefanich, Eric; Fielder, Paul] Genentech Inc, Pharmacokinet & Pharmacodynam, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Martin, F (corresponding author), Genentech Inc, Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	martin.flavius@gene.com	Chen, Yung-Hsiang/K-6766-2015	Chen, Yung-Hsiang/0000-0002-8756-5113; Hsu, Chia-Lin/0000-0001-9383-6330				Avitan-Hersh E, 2011, AM J DERMATOPATH, V33, P47, DOI 10.1097/DAD.0b013e3181ee547c; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; BARTOCCI A, 1987, P NATL ACAD SCI USA, V84, P6179, DOI 10.1073/pnas.84.17.6179; Cliffe ST, 2009, HUM MOL GENET, V18, P2257, DOI 10.1093/hmg/ddp161; Douglass TG, 2008, INT IMMUNOPHARMACOL, V8, P1354, DOI 10.1016/j.intimp.2008.04.016; Fraldi A, 2010, EMBO J, V29, P3607, DOI 10.1038/emboj.2010.237; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Kang N, 2010, J BIOL CHEM, V285, P28343, DOI 10.1074/jbc.M110.109199; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Mancini GMS, 2000, J INHERIT METAB DIS, V23, P278, DOI 10.1023/A:1005640214408; Molho-Pessach V, 2008, AM J HUM GENET, V83, P529, DOI 10.1016/j.ajhg.2008.09.013; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426, DOI 10.2174/157016109789043892; Morgan NV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000833; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Russell DG, 2009, NAT REV IMMUNOL, V9, P594, DOI 10.1038/nri2591; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Spiegel R, 2010, EUR J MED GENET, V53, P309, DOI 10.1016/j.ejmg.2010.06.012; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074/jbc.R110.134452; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]	21	80	81	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					89	92		10.1126/science.1213682	http://dx.doi.org/10.1126/science.1213682			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22174130				2022-12-24	WOS:000298846200057
J	Klohn, PC; Farmer, M; Linehan, JM; O'Malley, C; de Marco, MF; Taylor, W; Farrow, M; Khalili-Shirazi, A; Brandner, S; Collinge, J				Kloehn, Peter-Christian; Farmer, Michael; Linehan, Jacqueline M.; O'Malley, Catherine; de Marco, Mar Fernandez; Taylor, William; Farrow, Mark; Khalili-Shirazi, Azy; Brandner, Sebastian; Collinge, John			PrP Antibodies Do Not Trigger Mouse Hippocampal Neuron Apoptosis	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; PRION; DISEASE		[Collinge, John] UCL, Inst Neurol, Med Res Council MRC, Prion Unit, London WC1N 3BG, England; UCL, Dept Neurodegenerat Dis, London WC1N 3BG, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of London; University College London	Collinge, J (corresponding author), UCL, Inst Neurol, Med Res Council MRC, Prion Unit, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014; Kloehn, Peter/AAS-3719-2021	Brandner, Sebastian/0000-0002-9821-0342; 	UK Medical Research Council; Medical Research Council [MC_U123182016, MC_U123192748] Funding Source: researchfish; MRC [MC_U123182016, MC_U123192748] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Young for graphics, C. Andrews for technical assistance, and A. Williamson (Scripps) for kindly supplying antibodies IgG P, D13, D18, and b12. Funded by the UK Medical Research Council. The data described in this paper are in the supporting online material (SOM). J.C. is a director and shareholder of, and P.-C. K. is a consultant to, D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination, and therapeutics. J.C. is an inventor of patents on the use of PrP antibodies for therapeutics.	Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Khalill-Shirazi A, 2007, BBA-PROTEINS PROTEOM, V1774, P1438, DOI 10.1016/j.bbapap.2007.08.028; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457	8	53	54	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					52	52		10.1126/science.1215579	http://dx.doi.org/10.1126/science.1215579			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223800				2022-12-24	WOS:000298846200046
J	Lefevre, CT; Menguy, N; Abreu, F; Lins, U; Posfai, M; Prozorov, T; Pignol, D; Frankel, RB; Bazylinski, DA				Lefevre, Christopher T.; Menguy, Nicolas; Abreu, Fernanda; Lins, Ulysses; Posfai, Mihaly; Prozorov, Tanya; Pignol, David; Frankel, Richard B.; Bazylinski, Dennis A.			A Cultured Greigite-Producing Magnetotactic Bacterium in a Novel Group of Sulfate-Reducing Bacteria	SCIENCE			English	Article							CANDIDATUS MAGNETOGLOBUS-MULTICELLULARIS; MAGNETOSOME FORMATION; MAGNETITE FE3O4; FE3S4; BIOMINERALIZATION; PROKARYOTE; ULTRASTRUCTURE; CRYSTALS	Magnetotactic bacteria contain magnetosomes-intracellular, membrane-bounded, magnetic nanocrystals of magnetite (Fe3O4) or greigite (Fe3S4)-that cause the bacteria to swim along geomagnetic field lines. We isolated a greigite-producing magnetotactic bacterium from a brackish spring in Death Valley National Park, California, USA, strain BW-1, that is able to biomineralize greigite and magnetite depending on culture conditions. A phylogenetic comparison of BW-1 and similar uncultured greigite- and/or magnetite-producing magnetotactic bacteria from freshwater to hypersaline habitats shows that these organisms represent a previously unknown group of sulfate-reducing bacteria in the Deltaproteobacteria. Genomic analysis of BW-1 reveals the presence of two different magnetosome gene clusters, suggesting that one may be responsible for greigite biomineralization and the other for magnetite.	[Bazylinski, Dennis A.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Lefevre, Christopher T.; Pignol, David] Inst Biol Environm & Biotechnol, Commissariat Energie Atom Cadarache, Lab Bioenerget Cellulaire, Direct Sci Vivant,UMR 6191, F-13108 St Paul Les Durance, France; [Lefevre, Christopher T.; Pignol, David] CNRS, Biol Vegetale & Microbiol Environm, UMR 6191, F-13108 St Paul Les Durance, France; [Lefevre, Christopher T.; Pignol, David] Univ Aix Marseille, F-13108 St Paul Les Durance, France; [Menguy, Nicolas] Univ Paris 06, Inst Mineral & Phys Milieux Condenses, CNRS, Inst Rech Dev 4,UMR 7590, F-75005 Paris, France; [Abreu, Fernanda; Lins, Ulysses] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, BR-21941590 Rio De Janeiro, Brazil; [Posfai, Mihaly] Univ Pannonia, Dept Earth & Environm Sci, H-8200 Veszprem, Hungary; [Prozorov, Tanya] US DOE, Ames Lab, Ames, IA 50011 USA; [Frankel, Richard B.] Calif Polytech State Univ San Luis Obispo, Dept Phys, San Luis Obispo, CA 93407 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Universidade Federal do Rio de Janeiro; University of Pannonia; United States Department of Energy (DOE); Ames National Laboratory; California State University System; California Polytechnic State University San Luis Obispo	Bazylinski, DA (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	dennis.bazylinski@unlv.edu	Pósfai, Mihály/C-1792-2012; MENGUY, Nicolas/F-5607-2012; Abreu, Fernanda/N-4824-2017; Lefevre, Christopher T/H-6072-2013; Lins, Ulysses/N-7282-2015	Pósfai, Mihály/0000-0001-9355-3533; MENGUY, Nicolas/0000-0003-4613-2490; Abreu, Fernanda/0000-0003-2356-5840; Lefevre, Christopher T/0000-0002-1692-0245; Lins, Ulysses/0000-0002-1786-1144; PIGNOL, David/0000-0002-8070-0319	U.S. National Science Foundation [EAR-0920718]; Fondation pour la Recherche Medicale [SPF20101220993]; U.S. Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division; U.S. Department of Energy by Iowa State University [DE-AC02-07CH11358]; Directorate For Geosciences [0920718] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); U.S. Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); U.S. Department of Energy by Iowa State University(United States Department of Energy (DOE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was partially supported by U.S. National Science Foundation grant EAR-0920718 (D. A. B.) and by a grant from the Fondation pour la Recherche Medicale SPF20101220993 (C. T. L.). Part of the transmission electron microscopy characterization was carried out in Ames Lab and was supported by the U.S. Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division. The Ames Laboratory is operated for the U.S. Department of Energy by Iowa State University under contract DE-AC02-07CH11358. We thank F. Mahlaoui and M. L. Schmidt for help with sampling; the National Park Service staff of Death Valley National Park; and the team at the Laboratorio de Bioinformatica, Laboratorio Nacional de Computacao Cientifica, Rio de Janeiro, Brazil, for their help in the sequencing and annotation of the genome of strain BW-1. Samples at Death Valley National Park were collected under Sampling Permit DEVA-2010-SCI-0038 issued by the U. S. Department of the Interior National Park Service. 16S rRNA gene sequences (accession nos. JN015483 to JN015507, JN252194, and JN25219), gene for adenosine-5'-phosphate reductase (aprA; JN705544) and mam genes of BW-1 (JN830627 to JN830646 and JN845570 to JN845575) are published in GenBank. Strain BW-1 has been deposited to the Japan Collection of Microorganisms, RIKEN BioResource Center under the provisional name Candidatus Desulfamplus magnetomortis and carries accession no. JCM 18010.	Abreu F, 2008, INT MICROBIOL, V11, P75, DOI 10.2436/20.1501.01.46; Abreu F, 2007, INT J SYST EVOL MICR, V57, P1318, DOI 10.1099/ijs.0.64857-0; Abreu F, 2011, ISME J, V5, P1634, DOI 10.1038/ismej.2011.35; Amann R., 2007, MAGNETORECEPTION MAG, P25, DOI DOI 10.1007/7171_037; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; BAZYLINSKI DA, 1995, APPL ENVIRON MICROB, V61, P3232, DOI 10.1128/AEM.61.9.3232-3239.1995; BAZYLINSKI DA, 1993, NATURE, V366, P218, DOI 10.1038/366218a0; DELONG EF, 1993, SCIENCE, V259, P803, DOI 10.1126/science.259.5096.803; FARINA M, 1990, NATURE, V343, P256, DOI 10.1038/343256a0; Frankel RB, 2003, REV MINERAL GEOCHEM, V54, P95, DOI 10.2113/0540095; Kasama T, 2006, AM MINERAL, V91, P1216, DOI 10.2138/am.2006.2227; Komelli A, 2007, ANNU REV BIOCHEM, V76, P351, DOI 10.1146/annurev.biochem.74.082803.133444; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lefevre CT, 2012, ISME J, V6, P440, DOI 10.1038/ismej.2011.97; Lefevre CT, 2011, EARTH PLANET SC LETT, V312, P194, DOI 10.1016/j.epsl.2011.10.003; Lefevre CT, 2011, ENVIRON MICROBIOL, V13, P538, DOI 10.1111/j.1462-2920.2010.02361.x; Lefevre CT, 2010, APPL ENVIRON MICROB, V76, P3740, DOI 10.1128/AEM.03018-09; Lins U, 2007, GEOMICROBIOL J, V24, P43, DOI 10.1080/01490450601134317; MANN S, 1990, NATURE, V343, P258, DOI 10.1038/343258a0; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Nakazawa H, 2009, GENOME RES, V19, P1801, DOI 10.1101/gr.088906.108; Schueler D., 2002, International Microbiology, V5, P209; Schuler D, 2008, FEMS MICROBIOL REV, V32, P654, DOI 10.1111/j.1574-6976.2008.00116.x; Simmons SL, 2007, ENVIRON MICROBIOL, V9, P206, DOI 10.1111/j.1462-2920.2006.01129.x; Simmons SL, 2004, APPL ENVIRON MICROB, V70, P6230, DOI 10.1128/AEM.70.10.6230-6239.2004; Spring S., 2006, PROKARYOTES, V2, P842; Wenter R, 2009, ENVIRON MICROBIOL, V11, P1493, DOI 10.1111/j.1462-2920.2009.01877.x; WOLFE RS, 1987, FEMS MICROBIOL ECOL, V45, P31, DOI 10.1016/0378-1097(87)90039-5	28	151	157	8	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1720	1723		10.1126/science.1212596	http://dx.doi.org/10.1126/science.1212596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194580	Green Submitted			2022-12-24	WOS:000298344000072
J	Graham-Rowe, D				Graham-Rowe, Duncan			BIODIVERSITY Endangered and in demand	NATURE			English	Editorial Material																		[Anonymous], 2011, ENV INVESTIGATION AG; Chunyu S., 2011, 41 CITES, V41; Venkataraman B., 2007, TRAFFIC SE ASIA; Wasser R. M, 2010, TRAFFIC E ASIA REPOR; Wyler L. S., 2009, C RES SERVICE	5	53	57	7	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S101	S103		10.1038/480S101a	http://dx.doi.org/10.1038/480S101a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190083	Bronze			2022-12-24	WOS:000298318000012
J	Stephenson, BM; Kingsnorth, AN				Stephenson, Brian M.; Kingsnorth, Andrew N.			CHRISTMAS 2011: SURGERY Inguinal hernioplasty using mosquito net mesh in low income countries: an alternative and cost effective prosthesis	BRITISH MEDICAL JOURNAL			English	Editorial Material							HERNIA REPAIR; COMMERCIAL MESH; GHANA		[Stephenson, Brian M.] Royal Gwent Hosp, Dept Surg, Newport NP20 2UB, Wales; [Kingsnorth, Andrew N.] Derriford Hosp, Dept Surg, Plymouth PL6 8DH, Devon, England	Royal Gwent Hospital; Derriford Hospital	Stephenson, BM (corresponding author), Royal Gwent Hosp, Dept Surg, Newport NP20 2UB, Wales.	brian.stephenson@wales.nhs.uk						Airoldi M, 2009, HEALTH ECON, V18, P1237, DOI 10.1002/hec.1424; Clarke MG, 2009, HERNIA, V13, P155, DOI 10.1007/s10029-008-0460-3; Freudenberg S, 2006, WORLD J SURG, V30, P1784, DOI 10.1007/s00268-006-0108-3; Hodges AM, 2001, TROP DOCT, V31, P98, DOI 10.1177/004947550103100215; Kingsnorth A N, 2006, Hernia, V10, P376, DOI 10.1007/s10029-006-0118-y; Klinge U, 2008, BRIT J SURG, V95, P539, DOI 10.1002/bjs.6159; Klosterhalfen B, 2003, EUR SURG, V35, P16, DOI DOI 10.1046/J.1563-2563.2003.03011.X; Shillcutt SD, 2010, ARCH SURG-CHICAGO, V145, P954, DOI 10.1001/archsurg.2010.208; Spiegel DA, 2007, LANCET, V370, P1013, DOI 10.1016/S0140-6736(07)61457-3; Stephenson BM, 2003, SURG CLIN N AM, V83, P1255, DOI 10.1016/S0039-6109(03)00128-2; Stephenson BM, 2011, WORLD J SURG, V35, P1957, DOI 10.1007/s00268-011-1176-6; Tongaonkar RR, 2003, INDIAN J SURG, V65, P89; Wilhelm TJ, 2007, EUR SURG RES, V39, P312, DOI 10.1159/000104402; Wilhelm TJ, 2006, TROP DOCT, V36, P147, DOI 10.1258/004947506777978046	14	22	22	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2011	343								d7448	10.1136/bmj.d7448	http://dx.doi.org/10.1136/bmj.d7448			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888WF	22174320				2022-12-24	WOS:000300034600003
J	Schlutter, J				Schluetter, Jana			Vaccine for all seasons	NATURE			English	Editorial Material																			0	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					S6	S8		10.1038/480S6a	http://dx.doi.org/10.1038/480S6a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	857TR	22158298	Bronze			2022-12-24	WOS:000297744200006
J	Kuehn, BM				Kuehn, Bridget M.			Environmental Pollutants Tied to Atherosclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																		Lind PM, 2012, ENVIRON HEALTH PERSP, V120, P38, DOI 10.1289/ehp.1103563	1	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 16	2011	306	19					2081	2081		10.1001/jama.2011.1666	http://dx.doi.org/10.1001/jama.2011.1666			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YU	22089709				2022-12-24	WOS:000297013000004
J	Zhang, DS; Piazza, V; Perrin, BJ; Rzadzinska, AK; Poczatek, JC; Wang, M; Prosser, HM; Ervasti, JM; Corey, DP; Lechene, CP				Zhang, Duan-Sun; Piazza, Valeria; Perrin, Benjamin J.; Rzadzinska, Agnieszka K.; Poczatek, J. Collin; Wang, Mei; Prosser, Haydn M.; Ervasti, James M.; Corey, David P.; Lechene, Claude P.			Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia	NATURE			English	Article							MOLECULAR TREADMILL; BUNDLES; RENEWAL	Hair cells of the inner ear are not normally replaced during an animal's life, and must continually renew components of their various organelles(1). Among these are the stereocilia, each with a core of several hundred actin filaments that arise from their apical surfaces and that bear the mechanotransduction apparatus at their tips. Actin turnover in stereocilia has previously been studied(2) by transfecting neonatal rat hair cells in culture with a beta-actin-GFP fusion, and evidence was found that actin is replaced, from the top down, in 2-3 days. Overexpression of the actin-binding protein espin causes elongation of stereocilia within 12-24 hours, also suggesting rapid regulation of stereocilia lengths(3). Similarly, the mechanosensory 'tip links' are replaced in 5-10 hours after cleavage in chicken and mammalian hair cells(4,5). In contrast, turnover in chick stereocilia in vivo is much slower(6). It might be that only certain components of stereocilia turn over quickly, that rapid turnover occurs only in neonatal animals, only in culture, or only in response to a challenge like breakage or actin overexpression. Here we quantify protein turnover by feeding animals with a (15)N-labelled precursor amino acid and using multi-isotope imaging mass spectrometry to measure appearance of new protein. Surprisingly, in adult frogs and mice and in neonatal mice, in vivo and in vitro, the stereocilia were remarkably stable, incorporating newly synthesized protein at <10% per day. Only stereocilia tips had rapid turnover and no treadmilling was observed. Other methods confirmed this: in hair cells expressing beta-actin-GFP we bleached fiducial lines across hair bundles, but they did not move in 6 days. When we stopped expression of beta- or gamma-actin with tamoxifen-inducible recombination, neither actin isoform left the stereocilia, except at the tips. Thus, rapid turnover in stereocilia occurs only at the tips and not by a treadmilling process.	[Poczatek, J. Collin; Wang, Mei; Lechene, Claude P.] Brigham & Womens Hosp, Div Genet, Cambridge, MA 02139 USA; [Zhang, Duan-Sun; Piazza, Valeria; Corey, David P.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Perrin, Benjamin J.; Ervasti, James M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Rzadzinska, Agnieszka K.; Prosser, Haydn M.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; Wellcome Trust Sanger Institute	Lechene, CP (corresponding author), Brigham & Womens Hosp, Div Genet, Cambridge, MA 02139 USA.	dcorey@hms.harvard.edu; cpl@harvard.edu	Ervasti, James/AAZ-4786-2020	Corey, David/0000-0003-4497-6016; Prosser, Haydn/0000-0002-9897-2152	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB) [P41RR14579, P41EB001974]; NIH [R01DC00033, R01DC03463, R01DC04179, R37DK39773, R01EY12963, R01GM47214, R01D K58762, R01DC02281, F32DC009539, R01AR049899]; National Science Foundation Division of Integrative Biology and Neuroscience (NSF/IBN) [IBN-998298]; Wellcome Trust [WT079643]; NIH National Center for Research Resources (NIH/NCRR) Center for Integrative Biomedical Computing [2P41 RR0112553-12]; Department of Energy SciDAC Visualization and Analytics Center for Enabling Technologies [DEFC0206ER25781]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014579] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049899, R01AR042423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058762, R37DK039773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000033, R01DC002281, F32DC009539, R01DC004179, Z01DC000033] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Division of Integrative Biology and Neuroscience (NSF/IBN); Wellcome Trust(Wellcome TrustEuropean Commission); NIH National Center for Research Resources (NIH/NCRR) Center for Integrative Biomedical Computing; Department of Energy SciDAC Visualization and Analytics Center for Enabling Technologies(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	C.P.L. thanks M. Raff for numerous discussions; T. Bloom for her insight, foresight and support at the origin of MIMS development. We thank D. Cotanche and G. Benichou for providing additional mouse cochlear samples, L. Trakimas for histological assistance, Z. Kaufman for assisting data analysis, and J. Hill for electronic and mechanical maintenance of the prototype instrument. G. McMahon contributed to operating the instrument and data analysis. This work was supported by National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB) grants P41RR14579, P41EB001974, NIH grants R01DC00033, R01DC03463, R01DC04179, R37DK39773, R01EY12963, R01GM47214 and R01D K58762, and National Science Foundation Division of Integrative Biology and Neuroscience (NSF/IBN) grant IBN-998298 to C. P. L., by NIH grant R01DC02281 to D. P. C., and by NIH grants F32DC009539 to B. J. P. and R01AR049899 to J. M. E., and by Wellcome Trust grant WT079643 to the Wellcome Trust Sanger Institute. Development of the SIMS instrument was supported by ONERA, CNRS, Universite Paris Sud and Cameca (France). The work was also helped in part by software funded by the NIH National Center for Research Resources (NIH/NCRR) Center for Integrative Biomedical Computing, 2P41 RR0112553-12 and the Department of Energy SciDAC Visualization and Analytics Center for Enabling Technologies, DEFC0206ER25781. D.-S.Z. is a Research Associate, V. P. was a Research Associate and D. P. C. is an Investigator of the Howard Hughes Medical Institute.	Grati M, 2006, J NEUROSCI, V26, P6386, DOI 10.1523/JNEUROSCI.1215-06.2006; Hanft LM, 2006, P NATL ACAD SCI USA, V103, P5385, DOI 10.1073/pnas.0600980103; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Jia SP, 2009, J NEUROSCI, V29, P15277, DOI 10.1523/JNEUROSCI.3231-09.2009; Kirkegaard M, 2005, J COMP NEUROL, V492, P132, DOI 10.1002/cne.20736; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Perrin BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001158; Pickles JO, 1996, HEARING RES, V101, P45, DOI 10.1016/S0378-5955(96)00129-3; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Rzadzinska A, 2005, CELL MOTIL CYTOSKEL, V62, P157, DOI 10.1002/cm.20094; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Schoenheimer R., 1942, DYNAMIC STATE BODY C; SHEPHERD GMG, 1989, P NATL ACAD SCI USA, V86, P4973, DOI 10.1073/pnas.86.13.4973; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Zhao YD, 1996, P NATL ACAD SCI USA, V93, P15469, DOI 10.1073/pnas.93.26.15469	17	156	156	3	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 26	2012	481	7382					520	U137		10.1038/nature10745	http://dx.doi.org/10.1038/nature10745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22246323	Green Accepted			2022-12-24	WOS:000299471800043
J	Kessler, JD; Kahle, KT; Sun, TT; Meerbrey, KL; Schlabach, MR; Schmitt, EM; Skinner, SO; Xu, QK; Li, MZ; Hartman, ZC; Rao, M; Yu, P; Dominguez-Vidana, R; Liang, AC; Solimini, NL; Bernardi, RJ; Yu, B; Hsu, T; Golding, I; Luo, J; Osborne, CK; Creighton, CJ; Hilsenbeck, SG; Schiff, R; Shaw, CA; Elledge, SJ; Westbrook, TF				Kessler, Jessica D.; Kahle, Kristopher T.; Sun, Tingting; Meerbrey, Kristen L.; Schlabach, Michael R.; Schmitt, Earlene M.; Skinner, Samuel O.; Xu, Qikai; Li, Mamie Z.; Hartman, Zachary C.; Rao, Mitchell; Yu, Peng; Dominguez-Vidana, Rocio; Liang, Anthony C.; Solimini, Nicole L.; Bernardi, Ronald J.; Yu, Bing; Hsu, Tiffany; Golding, Ido; Luo, Ji; Osborne, C. Kent; Creighton, Chad J.; Hilsenbeck, Susan G.; Schiff, Rachel; Shaw, Chad A.; Elledge, Stephen J.; Westbrook, Thomas F.			A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis	SCIENCE			English	Article							NEGATIVE BREAST-CANCER; C-MYC; EXPRESSION SIGNATURE; THERAPY; P53; METASTASIS; TRANSACTIVATION; ACTIVATION; INHIBITION; ADDICTION	Myc is an oncogenic transcription factor frequently dysregulated in human cancer. To identify pathways supporting the Myc oncogenic program, we used a genome-wide RNA interference screen to search for Myc-synthetic lethal genes and uncovered a role for the SUMO-activating enzyme (SAE1/2). Loss of SAE1/2 enzymatic activity drives synthetic lethality with Myc. Inactivation of SAE2 leads to mitotic catastrophe and cell death upon Myc hyperactivation. Mechanistically, SAE2 inhibition switches a transcriptional subprogram of Myc from activated to repressed. A subset of these SUMOylation-dependent Myc switchers (SMS genes) is required for mitotic spindle function and to support the Myc oncogenic program. SAE2 is required for growth of Myc-dependent tumors in mice, and gene expression analyses of Myc-high human breast cancers suggest that low SAE1 and SAE2 abundance in the tumors correlates with longer metastasis-free survival of the patients. Thus, inhibition of SUMOylation may merit investigation as a possible therapy for Myc-driven human cancers.	[Kahle, Kristopher T.; Schlabach, Michael R.; Xu, Qikai; Li, Mamie Z.; Liang, Anthony C.; Solimini, Nicole L.; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Brigham & Womens Hosp,Div Genet,Dept Genet, Boston, MA 02115 USA; [Kessler, Jessica D.; Sun, Tingting; Meerbrey, Kristen L.; Schmitt, Earlene M.; Skinner, Samuel O.; Dominguez-Vidana, Rocio; Hsu, Tiffany; Golding, Ido; Westbrook, Thomas F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kessler, Jessica D.; Meerbrey, Kristen L.; Schmitt, Earlene M.; Rao, Mitchell; Yu, Peng; Dominguez-Vidana, Rocio; Hsu, Tiffany; Shaw, Chad A.; Westbrook, Thomas F.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Kahle, Kristopher T.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Skinner, Samuel O.; Golding, Ido] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Hartman, Zachary C.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Bernardi, Ronald J.; Westbrook, Thomas F.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Yu, Bing; Luo, Ji] NCI, Med Oncol Branch, Ctr Drive, Bethesda, MD 20892 USA; [Osborne, C. Kent; Creighton, Chad J.; Hilsenbeck, Susan G.; Schiff, Rachel; Westbrook, Thomas F.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Osborne, C. Kent; Hilsenbeck, Susan G.; Schiff, Rachel] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Osborne, C. Kent; Schiff, Rachel] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Osborne, C. Kent; Schiff, Rachel] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Creighton, Chad J.; Hilsenbeck, Susan G.] Baylor Coll Med, Div Biostat, Houston, TX 77030 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Brigham & Womens Hosp,Div Genet,Dept Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu; thomasw@bcm.edu	Vidana, Rocio Dominguez/A-1153-2009	Vidana, Rocio Dominguez/0000-0003-3855-5178; Shaw, Chad/0000-0001-7267-5398; Hartman, Jessica/0000-0003-1578-3389	NIH [T32HD05520/T32CA090221-09, R01GM082837, CA149196]; U.S. Department of Defense [W81XWH-10-1-0354]; Human Frontier Science Program [RGY70/2008]; Welch Foundation [Q-1759]; NSF [082265]; Susan G. Komen for the Cure [KG090355]; CPRIT [RP120583]; Specialized Program of Research Excellence developmental grant [P50 CA058183]; SU2C-American Association for Cancer Research; U.S. Army [W81XWH0410197]; NATIONAL CANCER INSTITUTE [ZIABC011303, U54CA149196, P30CA125123, ZIABC011438, T32CA090221, P50CA058183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082837] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); Human Frontier Science Program(Human Frontier Science Program); Welch Foundation(The Welch Foundation); NSF(National Science Foundation (NSF)); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); CPRIT; Specialized Program of Research Excellence developmental grant; SU2C-American Association for Cancer Research; U.S. Army(United States Department of DefenseUnited States Army); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Bland for critical comments on the manuscript and T. Mitchell, W. Choi, S. Songyang, and the BCM C-BASS and CCSC Cores for reagents and technical assistance. J.D.K and K. L. M. are supported by NIH training grants T32HD05520/T32CA090221-09 and U.S. Department of Defense predoctoral fellowship W81XWH-10-1-0354, respectively. The Golding lab is supported by NIH grant R01GM082837, Human Frontier Science Program grant RGY70/2008, Welch Foundation grant Q-1759, and NSF grant 082265 (PFC: Center for the Physics of Living Cells). This work was supported by a Susan G. Komen for the Cure grant (KG090355), CPRIT grant (RP120583), and NIH grant (CA149196) to T. F. W., Specialized Program of Research Excellence developmental grant (P50 CA058183) to T. F. W., SU2C-American Association for Cancer Research Breast Cancer program grant to R. S. and C.K.O., and U.S. Army Innovator Award (W81XWH0410197) to S.J.E. S.J.E. is an Investigator with the Howard Hughes Medical Institute. T. F. W. is a scholar of The V Foundation and The Mary Kay Ash Foundation for Cancer Research. Gene Expression data are deposited in GEO (accession no. GSE34055).	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Beierle EA, 2007, J BIOL CHEM, V282, P12503, DOI 10.1074/jbc.M701450200; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; Chen YH, 2008, EXPERT REV ANTICANC, V8, P1689, DOI 10.1586/14737140.8.10.1689; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; Higgins J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-85; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Menssen A, 2007, CELL CYCLE, V6, P339, DOI 10.4161/cc.6.3.3808; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang Y, 2004, CANCER CELL, V5, P501, DOI 10.1016/S1535-6108(04)00113-8; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	39	306	320	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 20	2012	335	6066					348	353		10.1126/science.1212728	http://dx.doi.org/10.1126/science.1212728			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878RE	22157079	Green Accepted, Bronze			2022-12-24	WOS:000299273400051
J	Berrill, JW; Ahmed, H; Butt, S; Swift, G				Berrill, James W.; Ahmed, Haroon; Butt, Sohail; Swift, Gillian			10-MINUTE CONSULTATION Reviewing a patient with coeliac disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Berrill, James W.; Swift, Gillian] Univ Hosp Llandough, Cardiff CF64 2XX, S Glam, Wales; [Ahmed, Haroon] Foundry Town Clin, Aberdare, Wales; [Butt, Sohail] Studholme Med Ctr, Ashford, Kent, England		Berrill, JW (corresponding author), Univ Hosp Llandough, Cardiff CF64 2XX, S Glam, Wales.	jamesberrill1@doctors.org.uk		Ahmed, Haroon/0000-0002-0634-8548					0	1	1	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 17	2012	344								d8152	10.1136/bmj.d8152	http://dx.doi.org/10.1136/bmj.d8152			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888YY	22251863	Green Accepted			2022-12-24	WOS:000300041800008
J	Strang, J; Babor, T; Caulkins, J; Fischer, B; Foxcroft, D; Humphreys, K				Strang, John; Babor, Thomas; Caulkins, Jonathan; Fischer, Benedikt; Foxcroft, David; Humphreys, Keith			Drug policy and the public good: evidence for effective interventions	LANCET			English	Article							BRIEF MOTIVATIONAL INTERVENTION; PREVENTING HEPATITIS-C; SELF-HELP GROUPS; THERAPEUTIC-COMMUNITY; COST-EFFECTIVENESS; CONTINGENCY MANAGEMENT; METHADONE-MAINTENANCE; GENERAL-PRACTITIONERS; PRESCRIPTION DRUGS; RANDOMIZED-TRIAL	Debates about which policy initiatives can prevent or reduce the damage that illicit drugs cause to the public good are rarely informed by scientific evidence. Fortunately, evidence-based interventions are increasingly being identified that are capable of making drugs less available, reducing violence in drug markets, lessening misuse of legal pharmaceuticals, preventing drug use initiation in young people, and reducing drug use and its consequences in established drug users. We review relevant evidence and outline the likely effects of fuller implementation of existing interventions. The reasoning behind the final decisions for action might be of a non-scientific nature, focused more on what the public and policy-makers deem of value. Nevertheless, important opportunities exist for science to inform these deliberations and guide the selection of policies that maximise the public good.	[Strang, John] Kings Coll London, Natl Addict Ctr, London WC2R 2LS, England; [Babor, Thomas] Univ Connecticut, Sch Med, Dept Community Med & Hlth Care, Farmington, CT USA; [Caulkins, Jonathan] Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA; [Fischer, Benedikt] Simon Fraser Univ, Fac Hlth Sci, CARMHA, Vancouver, BC, Canada; [Fischer, Benedikt] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Foxcroft, David] Oxford Brookes Univ, Oxford OX3 0BP, England; [Humphreys, Keith] Stanford Univ, Dept Vet Affairs, Palo Alto, CA 94304 USA	University of London; King's College London; University of Connecticut; Carnegie Mellon University; Simon Fraser University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Oxford Brookes University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Strang, J (corresponding author), Addict Sci Bldg,4 Windsor Walk,Denmark Hill, London SE5 8BB, England.	john.strang@kcl.ac.uk	Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725; Foxcroft, David/0000-0001-9752-7527; Babor, Thomas/0000-0002-2580-0835; Fischer, B/0000-0002-2186-4030	Genus (Britannia); Viropharma (Auralis); Martindale (Catalent); Reckitt-Benckiser; Schering-Plough; Lundbeck; UCB; Napp (MundiPharma); Lightlake; Fidelity International; NIHR Biomedical Research Centre for Mental Health at the Institute of Psychiatry, Kings College London; Medical Research Council; UK Society for the Study of Addiction	Genus (Britannia); Viropharma (Auralis); Martindale (Catalent); Reckitt-Benckiser; Schering-Plough(Merck & CompanySchering Plough Corporation); Lundbeck(Lundbeck Corporation); UCB(UCB Pharma SA); Napp (MundiPharma); Lightlake; Fidelity International; NIHR Biomedical Research Centre for Mental Health at the Institute of Psychiatry, Kings College London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Society for the Study of Addiction	JS declares that he has worked with UK and international government agencies on treatment guidelines, including chairing UK Department of Health and NICE clinical guidelines committees; has contributed to the work of organisations that review evidence of effectiveness of drug policy; has received research and educational grant support or honoraria, consultancy payments, and travelling, accommodation, or conference expenses from pharmaceutical companies who produce, or have been considering producing, new medicines or new formulations for use in the addiction treatment field, including (past 3 years) Genus (Britannia), Viropharma (Auralis), Martindale (Catalent), Reckitt-Benckiser, Schering-Plough, Lundbeck, UCB, Napp (MundiPharma), Lightlake, and Fidelity International; works within an integrated university and NHS academic health sciences centre (Kings Health Partners AHSC) and is supported by the NIHR Biomedical Research Centre for Mental Health at the Institute of Psychiatry, Kings College London and South London and Maudsley NHS Foundation Trust that provides treatments and undertakes research study; and has close links with various other treatment provider organisations. DF's Department has received funding from the alcohol industry for alcohol education and prevention materials that are being assessed in a randomised controlled trial funded by the Medical Research Council and led by Cardiff University. DF is a Trustee of the UK alcohol education charity, the Drinkaware Trust. BF has consulted for government and non-governmental organisations at national and supranational levels with regard to drug policy and related interventions; travel costs and activity honoraria were received for some of these activities. All other authors declare that they have no conflicts of interest.; Views expressed in this paper are the authors' individual personal judgments and are not the official views of any government or other organisation with which the authors have worked or been associated. The paper uses information collected for the publication of a document entitled Drug Policy and the Public Good, 2 which was funded by the UK Society for the Study of Addiction-all authors were involved with this project. We thank John Witton for assistance with the search of published studies. BF holds the CIHR/PHAC Chair In Applied Public Health; KH holds an honorary professorship at King's College London. Tables 2-5 are adapted from the appendices of the book 'Drug Policy and the Public Good' (reference 2). We also wish to thank our co-authors of this book (Griffith Edwards, Isidore Obot, Jurgen Rehm, Peter Reuter, Robin Room, and Ingeborg Rossow) from whose structure and earlier examination we have drawn on in the preparation of this paper.	Amato L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006306; Babor T., 2010, DRUG POLICY PUBLIC G; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Babor Thomas F, 2007, Subst Abus, V28, P7, DOI 10.1300/J465v28n03_03; Baker A, 2005, ADDICTION, V100, P367, DOI 10.1111/j.1360-0443.2005.01002.x; BALE RN, 1980, ARCH GEN PSYCHIAT, V37, P179; BASHIR K, 1994, BRIT J GEN PRACT, V44, P408; Bernstein J, 2005, DRUG ALCOHOL DEPEN, V77, P49, DOI 10.1016/j.drugalcdep.2004.07.006; Berstein JE, 2005, DRUG ALCOHOL DEPEN, V77, P49; Best D, 2001, BRIT J CRIMINOL, V41, P738, DOI 10.1093/bjc/41.4.738; Braga AA, 2001, J RES CRIME DELINQ, V38, P195, DOI 10.1177/0022427801038003001; BRILL H, 1969, SEMIN PSYCHIAT, V1, P179; Catalano RF, 1999, ADDICTION, V94, P241, DOI 10.1046/j.1360-0443.1999.9422418.x; Caulkins JP, 2009, SAFER COMMUNITIES, V8, P9, DOI 10.1108/17578043200900003; Caulkins JP, 2010, ADDICTION, V105, P575, DOI 10.1111/j.1360-0443.2009.02844.x; Caulkins JP, 2011, CRIME JUSTICE REV RE, V39; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Conrod PJ, 2010, ARCH GEN PSYCHIAT, V67, P85, DOI 10.1001/archgenpsychiatry.2009.173; CORMACK MA, 1994, BRIT J GEN PRACT, V44, P5; Courtwright DT, 2001, FORCES HABIT DRUGS M; Crane Barry, 1997, EMPIRICAL EXAMINATIO; Cunningham JK, 2009, ADDICTION, V104, P441, DOI 10.1111/j.1360-0443.2008.02458.x; Cunningham JK, 2005, ADDICTION, V100, P479, DOI 10.1111/j.1360-0443.2005.01032.x; Cunningham JK, 2003, ADDICTION, V98, P1229, DOI 10.1046/j.1360-0443.2003.00450.x; Dave D, 2006, J HEALTH ECON, V25, P311, DOI 10.1016/j.jhealeco.2005.08.003; Davis WR, 2008, DRUG ALCOHOL DEPEN, V92, P267, DOI 10.1016/j.drugalcdep.2007.08.008; Davoli M, 2007, ADDICTION, V102, P1954, DOI 10.1111/j.1360-0443.2007.02025.x; Day C, 2006, DRUG ALCOHOL REV, V25, P307, DOI 10.1080/09595230600741040; De Leon G, 2000, J SUBST ABUSE TREAT, V19, P375, DOI 10.1016/S0740-5472(00)00124-0; Degenhardt L, 2005, ADDICTION, V100, P459, DOI 10.1111/j.1360-0443.2005.01000.x; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Dobkin C, 2009, AM ECON REV, V99, P324, DOI 10.1257/aer.99.1.324; DuPont RL, 2009, J SUBST ABUSE TREAT, V36, P159, DOI 10.1016/j.jsat.2008.01.004; Edelen MO, 2007, J SUBST ABUSE TREAT, V32, P415, DOI 10.1016/j.jsat.2006.10.006; Eder H, 2005, ADDICTION, V100, P1101, DOI 10.1111/j.1360-0443.2005.001128.x; Eibner C, 2006, J SUBST ABUSE TREAT, V31, P75, DOI 10.1016/j.jsat.2006.03.011; ENNETT ST, 1994, AM J PUBLIC HEALTH, V84, P1394, DOI 10.2105/AJPH.84.9.1394; Faggiano F, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003020.pub2; Faggiano F., 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002208; Faggiano F, 2010, DRUG ALCOHOL DEPEN, V108, P56, DOI 10.1016/j.drugalcdep.2009.11.018; Fals-Stewart W, 2001, BEHAV THER, V32, P391, DOI 10.1016/S0005-7894(01)80010-1; Finney JW, 1998, J STUD ALCOHOL, V59, P371, DOI 10.15288/jsa.1998.59.371; Fischer B, 2008, CONTEMP DRUG PROBL, V35, P397; Fischer B, 2006, CANADIAN MED ASS J, V175, P1; Fischer B, 2007, J URBAN HEALTH, V84, P552, DOI 10.1007/s11524-007-9198-y; Fischer B, 2010, ADDICTION, V105, P2062, DOI 10.1111/j.1360-0443.2010.03092.x; Fountain J, 1999, DRUG-EDUC PREV POLIC, V6, P61, DOI 10.1080/09687639997296; Foxcroft D, 2007, ADDICTION, V102, P1350, DOI 10.1111/j.1360-0443.2007.01933.x; Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652; Gates S, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD005030.PUB2; Gossop M, 2008, ADDICTION, V103, P119, DOI 10.1111/j.1360-0443.2007.02050.x; Grabowski J, 2004, ADDICT BEHAV, V29, P1439, DOI 10.1016/j.addbeh.2004.06.018; Gray E, 2005, ALCOHOL ALCOHOLISM, V40, P535, DOI 10.1093/alcalc/agh199; Greenwood GL, 2001, J SUBST ABUSE TREAT, V20, P15, DOI 10.1016/S0740-5472(00)00147-1; Hall W, 2000, DRUG ALCOHOL DEPEN, V57, P247, DOI 10.1016/S0376-8716(99)00057-5; Humeniuk R, ADDICTION IN PRESS; Humeniuk R., 2008, EFFECTIVENESS BRIEF; Humphreys K, 2001, ALCOHOL CLIN EXP RES, V25, P711; Humphreys K, 2004, CIRCLES RECOVERY SEL; Inciardi JA, 2007, PAIN MED, V8, P171, DOI 10.1111/j.1526-4637.2006.00255.x; Kellam SG, 2008, DRUG ALCOHOL DEPEN, V95, pS1, DOI 10.1016/j.drugalcdep.2008.01.006; Kennedy DM, 2008, DETERRENCE CRIME PRE; Kleiman MAR, 2009, BRUTE FORCE FAILS ST; Kraft MK, 1997, AM J PSYCHIAT, V154, P1214; Kuziemko Y, 2004, J PUBLIC ECON, V88, P2043, DOI 10.1016/S0047-2727(03)00020-3; Littlejohn C, 2005, DRUG-EDUC PREV POLIC, V12, P75, DOI 10.1080/0968763042000275326; Lussier JP, 2006, ADDICTION, V101, P192, DOI 10.1111/j.1360-0443.2006.01311.x; Maher L, 2001, CURRENT ISSUES CRIMI, V13, P5, DOI DOI 10.1080/10345329.2001.12036213; Marsden J, 2006, ADDICTION, V101, P1014, DOI 10.1111/j.1360-0443.2006.01290.x; Martell BA, 2009, ARCH GEN PSYCHIAT, V66, P1116, DOI 10.1001/archgenpsychiatry.2009.128; Mattick RP, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002209; McCabe SE, 2005, ADDICT BEHAV, V30, P1342, DOI 10.1016/j.addbeh.2005.01.012; McCambridge J, 2005, ADDICTION, V100, P470, DOI 10.1111/j.1360-0443.2005.01013.x; McCambridge J, 2004, ADDICTION, V99, P39, DOI 10.1111/j.1360-0443.2004.00564.x; McCambridge J, 2011, DRUG ALCOHOL DEPEN, V114, P177, DOI 10.1016/j.drugalcdep.2010.07.028; Miles JNV, 2008, AM J DRUG ALCOHOL AB, V34, P667, DOI 10.1080/00952990802308130; Minozzi S, 2011, COCHRANE DB SYST REV, V16, DOI DOI 10.1002/14651858.CD001333.PUB3; Nagin DS, 1998, HDB CRIME PUNISHMENT; National Institute for Health and Clinical Excellence (NICE), 2007, NALTR PREV REL HER A; Nemes S, 1999, J SUBST ABUSE TREAT, V17, P339, DOI 10.1016/S0740-5472(99)00009-4; NICE, 2017, DRUGS MIS TARG INT N; O'Leary-Barrett M, 2010, J AM ACAD CHILD PSY, V49, P954, DOI 10.1016/j.jaac.2010.04.011; Pacula RL, 2005, ADV HEALTH ECON HEAL, V16, P347; Palmateer N, 2010, ADDICTION, V105, P844, DOI 10.1111/j.1360-0443.2009.02888.x; Paoli L., 2009, WORLD HEROIN MARKET, DOI DOI 10.1192/bjp.bp.114.149195; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Pollack HA, 2001, MED DECIS MAKING, V21, P357, DOI 10.1177/02729890122062659; Popova S, 2006, CONTEMP DRUG PROBL, V33, P343; Prendergast M, 2006, ADDICTION, V101, P1546, DOI 10.1111/j.1360-0443.2006.01581.x; REIDENBERG MM, 1991, CLIN PHARMACOL THER, V50, P129, DOI 10.1038/clpt.1991.116; Reuter P, 1986, CRIME JUSTICE ANN RE; Robertson JR, 2006, ADDICTION, V101, P1752, DOI 10.1111/j.1360-0443.2006.01603.x; Room R., 2010, CANNABIS POLICY MOVI; Room R, 2012, LANCET, V379, P84, DOI 10.1016/S0140-6736(11)61423-2; Rydell CP, 1994, CONTROLLING COCAINE; SCHWARTZ HI, 1991, NEW YORK STATE J MED, V91, pS9; Seal KH, 2003, DRUG ALCOHOL DEPEN, V71, P127, DOI 10.1016/S0376-8716(03)00074-7; SEVIGNY EL, 2004, CRIMINOLOGY PUBLIC P, V0003; Sorensen JL, 2007, DRUG ALCOHOL DEPEN, V88, P54, DOI 10.1016/j.drugalcdep.2006.09.019; Stitzer M, 2006, ANNU REV CLIN PSYCHO, V2, P411, DOI 10.1146/annurev.clinpsy.2.022305.095219; Strang J, 2008, ADDICTION, V103, P1648, DOI 10.1111/j.1360-0443.2008.02314.x; Strang J, 2008, DRUG-EDUC PREV POLIC, V15, P211, DOI 10.1080/09687630701731205; Strang J, 2007, ADDICTION, V102, P761, DOI 10.1111/j.1360-0443.2007.01762.x; Strang J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4851; Strang J, 2010, LANCET, V375, P1885, DOI 10.1016/S0140-6736(10)60349-2; Timko C, 2006, ADDICTION, V101, P678, DOI 10.1111/j.1360-0443.2006.01391.x; Voas RB, 2011, ADDICTION, V106, P1221, DOI 10.1111/j.1360-0443.2010.03339.x; Wood E, 2006, NEW ENGL J MED, V354, P2512, DOI 10.1056/NEJMc052939	108	136	138	2	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2012	379	9810					71	83		10.1016/S0140-6736(11)61674-7	http://dx.doi.org/10.1016/S0140-6736(11)61674-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	873WC	22225672				2022-12-24	WOS:000298913000039
J	Shima, S; Krueger, M; Weinert, T; Demmer, U; Kahnt, J; Thauer, RK; Ermler, U				Shima, Seigo; Krueger, Martin; Weinert, Tobias; Demmer, Ulrike; Kahnt, Joerg; Thauer, Rudolf K.; Ermler, Ulrich			Structure of a methyl-coenzyme M reductase from Black Sea mats that oxidize methane anaerobically	NATURE			English	Article							METHANOTROPHIC ARCHAEA; OXIDATION; METHANOGENESIS; DIVERSITY; MECHANISM; ANME-1; MODEL	The anaerobic oxidation of methane (AOM) with sulphate, an area currently generating great interest in microbiology, is accomplished by consortia of methanotrophic archaea (ANME) and sulphate-reducing bacteria(1,2). The enzyme activating methane in methanotrophic archaea has tentatively been identified as a homologue of methyl-coenzyme M reductase (MCR) that catalyses the methane-forming step in methanogenic archaea(3,4). Here we report an X-ray structure of the 280 kDa heterohexameric ANME-1 MCR complex. It was crystallized uniquely from a protein ensemble purified from consortia of microorganisms collected with a submersible from a Black Sea mat catalysing AOM with sulphate(4). Crystals grown from the heterogeneous sample diffract to 2.1 angstrom resolution and consist of a single ANME-1MCR population, demonstrating the strong selective power of crystallization. The structure revealed ANME-1 MCR in complex with coenzyme M and coenzyme B, indicating the same substrates for MCR from methanotrophic and methanogenic archaea. Differences between the highly similar structures of ANME-1MCR and methanogenic MCR include a F-430 modification, a cysteine-rich patch and an altered post-translational amino acid modification pattern, which may tune the enzymes for their functions in different biological contexts.	[Shima, Seigo; Kahnt, Joerg; Thauer, Rudolf K.] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Shima, Seigo] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Krueger, Martin] Fed Inst Geosci & Resources, D-30655 Hannover, Germany; [Weinert, Tobias; Demmer, Ulrike; Ermler, Ulrich] Max Planck Inst Biophys, D-60438 Frankfurt, Germany	Max Planck Society; Japan Science & Technology Agency (JST); Max Planck Society	Shima, S (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	shima@mpi-marburg.mpg.de; ulrich.ermler@biophys.mpg.de	Weinert, Tobias/I-4813-2013; Weinert, Tobias/J-6353-2017	Weinert, Tobias/0000-0002-0339-3722; Weinert, Tobias/0000-0002-0339-3722	Max Planck Society; Fonds der Chemischen Industrie; Deutsche Forschungsgemeinschaft [SPP 1319, ER 222/5-1, KR 3311/6-2]; MUMM; BEBOP; University of Hamburg; PRESTO, Japan Science and Technology Agency (JST)	Max Planck Society(Max Planck SocietyFoundation CELLEX); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MUMM; BEBOP; University of Hamburg; PRESTO, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by the Max Planck Society, the Fonds der Chemischen Industrie, the Deutsche Forschungsgemeinschaft (SPP 1319, ER 222/5-1, KR 3311/6-2) and the projects MUMM, and BEBOP (Biogeochemistry and Microbiology of Bioherms Prospering in the Black Sea funded by the University of Hamburg). S. S. was financed by the PRESTO program, Japan Science and Technology Agency (JST). We are indebted to W. Michaelis and R. Seifert for access to samples. We thank the crews of RV Poseidon with JAGO for help during field work, M. Brefort and L. Kanel for the electron spin resonance measurement and Edman sequencing, respectively. We are grateful to H. Michel for continuous support, the staff of the PXII beamline at the Swiss-Light-Source, Villigen for assistance during data collection, and K. Davies for critical reading of the manuscript.	Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Dey M, 2010, BIOCHEMISTRY-US, V49, P10902, DOI 10.1021/bi101562m; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grabarse W, 2001, J MOL BIOL, V309, P315, DOI 10.1006/jmbi.2001.4647; Grabarse WG, 2000, J MOL BIOL, V303, P329, DOI 10.1006/jmbi.2000.4136; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Heller C, 2008, GEOMICROBIOL J, V25, P149, DOI 10.1080/01490450802006884; Jensen LMR, 2010, SCIENCE, V327, P1392, DOI 10.1126/science.1182492; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kahnt J, 2007, FEBS J, V274, P4913, DOI 10.1111/j.1742-4658.2007.06016.x; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kruger M, 2008, ENVIRON MICROBIOL, V10, P1934, DOI 10.1111/j.1462-2920.2008.01607.x; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; Mayr S, 2008, J AM CHEM SOC, V130, P10758, DOI 10.1021/ja802929z; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Michaelis W, 2002, SCIENCE, V297, P1013, DOI 10.1126/science.1072502; Moran JJ, 2008, ENVIRON MICROBIOL, V10, P162, DOI 10.1111/j.1462-2920.2007.01441.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nauhaus K, 2005, ENVIRON MICROBIOL, V7, P98, DOI 10.1111/j.1462-2920.2004.00669.x; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Satzger H, 2005, J PHYS CHEM B, V109, P4770, DOI 10.1021/jp045151t; Scheller S, 2010, ANGEW CHEM INT EDIT, V49, P8112, DOI 10.1002/anie.201003214; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Thauer RK, 2008, ANN NY ACAD SCI, V1125, P158, DOI 10.1196/annals.1419.000; Thauer RK, 2011, CURR OPIN MICROBIOL, V14, P292, DOI 10.1016/j.mib.2011.03.003	30	105	111	2	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2012	481	7379					98	101		10.1038/nature10663	http://dx.doi.org/10.1038/nature10663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22121022				2022-12-24	WOS:000298836900037
J	Wang, LL; Lawrence, MS; Wan, YZ; Stojanov, P; Sougnez, C; Stevenson, K; Werner, L; Sivachenko, A; DeLuca, DS; Zhang, L; Zhang, WD; Vartanov, AR; Fernandes, SM; Goldstein, NR; Folco, EG; Cibulskis, K; Tesar, B; Sievers, QL; Shefler, E; Gabriel, S; Hacohen, N; Reed, R; Meyerson, M; Golub, TR; Lander, ES; Neuberg, D; Brown, JR; Getz, G; Wu, CJ				Wang, Lili; Lawrence, Michael S.; Wan, Youzhong; Stojanov, Petar; Sougnez, Carrie; Stevenson, Kristen; Werner, Lillian; Sivachenko, Andrey; DeLuca, David S.; Zhang, Li; Zhang, Wandi; Vartanov, Alexander R.; Fernandes, Stacey M.; Goldstein, Natalie R.; Folco, Eric G.; Cibulskis, Kristian; Tesar, Bethany; Sievers, Quinlan L.; Shefler, Erica; Gabriel, Stacey; Hacohen, Nir; Reed, Robin; Meyerson, Matthew; Golub, Todd R.; Lander, Eric S.; Neuberg, Donna; Brown, Jennifer R.; Getz, Gad; Wu, Catherine J.			SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRE-MESSENGER-RNA; MUTATION STATUS; IN-VITRO; GENOME; ACTIVATION; SURVIVAL; PATHWAYS; CELLS; SPLICEOSTATIN; REVEALS	BACKGROUND The somatic genetic basis of chronic lymphocytic leukemia, a common and clinically heterogeneous leukemia occurring in adults, remains poorly understood. METHODS We obtained DNA samples from leukemia cells in 91 patients with chronic lymphocytic leukemia and performed massively parallel sequencing of 88 whole exomes and whole genomes, together with sequencing of matched germline DNA, to characterize the spectrum of somatic mutations in this disease. RESULTS Nine genes that are mutated at significant frequencies were identified, including four with established roles in chronic lymphocytic leukemia (TP53 in 15% of patients, ATM in 9%, MYD88 in 10%, and NOTCH1 in 4%) and five with unestablished roles (SF3B1, ZMYM3, MAPK1, FBXW7, and DDX3X). SF3B1, which functions at the catalytic core of the spliceosome, was the second most frequently mutated gene (with mutations occurring in 15% of patients). SF3B1 mutations occurred primarily in tumors with deletions in chromosome 11q, which are associated with a poor prognosis in patients with chronic lymphocytic leukemia. We further discovered that tumor samples with mutations in SF3B1 had alterations in pre-messenger RNA (mRNA) splicing. CONCLUSIONS Our study defines the landscape of somatic mutations in chronic lymphocytic leukemia and highlights pre-mRNA splicing as a critical cellular process contributing to chronic lymphocytic leukemia.	[Wang, Lili; Wan, Youzhong; Zhang, Li; Zhang, Wandi; Sievers, Quinlan L.; Wu, Catherine J.] Harvard Inst Med, Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA; [Wang, Lili; Wan, Youzhong; Zhang, Li; Zhang, Wandi; Vartanov, Alexander R.; Fernandes, Stacey M.; Goldstein, Natalie R.; Tesar, Bethany; Sievers, Quinlan L.; Meyerson, Matthew; Brown, Jennifer R.; Wu, Catherine J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Stevenson, Kristen; Werner, Lillian; Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Folco, Eric G.; Reed, Robin; Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Folco, Eric G.; Reed, Robin; Golub, Todd R.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Brown, Jennifer R.; Wu, Catherine J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Div Allergy Immunol & Rheumatol, Boston, MA 02114 USA; [Brown, Jennifer R.; Wu, Catherine J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Wu, CJ (corresponding author), Harvard Inst Med, Dana Farber Canc Inst, Canc Vaccine Ctr, Rm 416B,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cwu@partners.org	Folco, Eric/M-2665-2013; wang, lili/HDL-7210-2022; Stojanov, Petar/GQI-4462-2022; Meyerson, Matthew L/E-7123-2012; Lawrence, Michael/AAC-8202-2020; Cibulskis, Kristian/AAC-7380-2019	Stojanov, Petar/0000-0001-7815-776X; Meyerson, Matthew/0000-0002-9133-8108; Vartanov, Alexander/0000-0001-5744-4882; Cibulskis, Kristian/0000-0003-1343-1582	Broad Institute through the National Human Genome Research Institute at the National Institutes of Health [U54HG003067]; National Institutes of Health [GM43375, K23 CA115682]; National Cancer Institute [5R21CA115043-2]; Melton and Rosenbach Funds; Blavatnik Family Foundation; Howard Hughes Medical Institute; Damon Runyon Cancer Research Foundation [CI-38-07]; NATIONAL CANCER INSTITUTE [R21CA115043, K23CA115682] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM043375, R01GM043375] Funding Source: NIH RePORTER	Broad Institute through the National Human Genome Research Institute at the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Melton and Rosenbach Funds; Blavatnik Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Broad Institute through a grant from the National Human Genome Research Institute at the National Institutes of Health (U54HG003067) and by grants from the National Institutes of Health (GM43375, to Drs. Folco and Reed, and K23 CA115682, to Dr. Brown), the National Cancer Institute (5R21CA115043-2), the Melton and Rosenbach Funds (to Dr. Brown), the Blavatnik Family Foundation (to Dr. Wu), the Early Career Physician-Scientist Award of the Howard Hughes Medical Institute (to Dr. Wu), and the Damon Runyon Cancer Research Foundation (CI-38-07, to Dr. Wu). Dr. Brown is a Scholar of the American Society of Hematology and a Scholar in Clinical Research of the Leukemia and Lymphoma Society.	Austen B, 2005, BLOOD, V106, P3175, DOI 10.1182/blood-2004-11-4516; Babaei-Jadidi R, 2011, J EXP MED, V208, P295, DOI 10.1084/jem.20100830; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Fan LY, 2011, ACS CHEM BIOL, V6, P582, DOI 10.1021/cb100356k; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Muzio M, 2008, BLOOD, V112, P188, DOI 10.1182/blood-2007-09-111344; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Pepper C, 2003, BLOOD, V101, P2454, DOI 10.1182/blood-2002-07-1984; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosner A, 2007, CURR MED CHEM, V14, P2517, DOI 10.2174/092986707782023677; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Trbusek M, 2011, J CLIN ONCOL, V29, P2703, DOI 10.1200/JCO.2011.34.7872; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zenz T, 2010, J CLIN ONCOL, V28, P4473, DOI 10.1200/JCO.2009.27.8762; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	35	803	825	3	92	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2011	365	26					2497	2506		10.1056/NEJMoa1109016	http://dx.doi.org/10.1056/NEJMoa1109016			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868SD	22150006	Green Submitted, Green Published, Green Accepted			2022-12-24	WOS:000298544600010
J	Dzingina, M; Stegenga, H; Heath, M; Jones, D; Rogers, G; Kleijnen, J; Wolff, R; Armstrong, N; Howdle, PD				Dzingina, M.; Stegenga, H.; Heath, M.; Jones, D.; Rogers, G.; Kleijnen, J.; Wolff, R.; Armstrong, N.; Howdle, P. D.		Guideline Dev Grp	GUIDELINES Assessment and referral after emergency treatment of a suspected anaphylactic episode: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT		[Howdle, P. D.] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England; [Dzingina, M.; Heath, M.; Jones, D.; Rogers, G.] Natl Inst Hlth & Clin Excellence, Manchester M1 4BT, Lancs, England; [Stegenga, H.] Natl Inst Hlth & Clin Excellence, London WC1V 6NA, England; [Kleijnen, J.] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, NL-6200 MD Maastricht, Netherlands; [Wolff, R.; Armstrong, N.] Kleijnen Systemat Reviews, York YO19 6FD, N Yorkshire, England	University of Leeds; National Institute for Health & Care Excellence; National Institute for Health & Care Excellence; Maastricht University; Kleijnen Systematic Reviews	Howdle, PD (corresponding author), Univ Leeds, Leeds LS2 9JT, W Yorkshire, England.	p.d.howdle@leeds.ac.uk	Dzingina, Mendwas/C-4957-2014; Wolff, Robert F/E-2322-2016	Wolff, Robert F/0000-0003-3270-7791; Rogers, Gabriel/0000-0001-9339-7374				Capps JA, 2010, RESUSCITATION, V81, P653, DOI 10.1016/j.resuscitation.2010.01.021; National Institute for Health and Clinical Excellence, 2011, AN ASS CONF AN EP DE; Pumphrey RSH, 2000, CLIN EXP ALLERGY, V30, P1144, DOI 10.1046/j.1365-2222.2000.00864.x; Stewart AG, 1996, QJM-MON J ASSOC PHYS, V89, P859, DOI 10.1093/qjmed/89.11.859; United Kingdom (UK) Resuscitation Council, 2008, EM TREATM AN REACT G	5	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2011	343								d7595	10.1136/bmj.d7595	http://dx.doi.org/10.1136/bmj.d7595			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865NO	22171344				2022-12-24	WOS:000298317800006
J	Abrams, P				Abrams, Paul			Should we treat lower urinary tract symptoms without a definitive diagnosis? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							OVERACTIVE BLADDER; MEN; INCONTINENCE; DYSFUNCTION; MANAGEMENT		Southmead Hosp, Bristol Urol Inst, Bristol BS10 5NB, Avon, England	Southmead Hospital	Abrams, P (corresponding author), Southmead Hosp, Bristol Urol Inst, Bristol BS10 5NB, Avon, England.	paul_abrams@bui.ac.uk	Hug, Balthasar L./G-1568-2010					Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870; Abrams P, 2009, J UROLOGY, V181, P1779, DOI 10.1016/j.juro.2008.11.127; ABRAMS P, 1994, BRIT MED J, V308, P929, DOI 10.1136/bmj.308.6934.929; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Bates TS, 2003, BJU INT, V92, P581, DOI 10.1046/j.1464-410X.2003.04444.x; Bryant Charmaine M, 2002, Br J Nurs, V11, P560; Hashim H, 2008, BJU INT, V102, P62, DOI 10.1111/j.1464-410X.2008.07463.x; Hashim H, 2006, DRUGS, V66, P591, DOI 10.2165/00003495-200666050-00002; Irwin DE, 2011, BJU INT         0113; Irwin DE, 2008, J SEX MED, V5, P2904, DOI 10.1111/j.1743-6109.2008.01000.x; National Institute for Health and Clinical Excellence, 2010, LOW UR TRACT SYMPT N; National Institute for Health and Clinical Excellence, 2006, UR INC NICE GUID CG4; Thomas AW, 2005, BJU INT, V96, P1301, DOI 10.1111/j.1464-410X.2005.05815.x	13	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 1	2011	343								d6038	10.1136/bmj.d6038	http://dx.doi.org/10.1136/bmj.d6038			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EO	22134965				2022-12-24	WOS:000298938400005
J	Lauer, MS				Lauer, Michael S.			Cardiovascular Science in the Service of National Strength	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HYPERTENSION		NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lauer, MS (corresponding author), NHLBI, Div Cardiovasc Sci, 6701 Rockledge Dr,Room 8128, Bethesda, MD 20892 USA.	lauerm@nhlbi.nih.gov	Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177				Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Lee TH, 2007, NEW ENGL J MED, V357, P1175, DOI 10.1056/NEJMp078102; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Varmus H., 2009, ART POLITICS SCI; Victor RG, 2011, ARCH INTERN MED, V171, P342, DOI 10.1001/archinternmed.2010.390; 2011, CONSUM REP, V76, P26	10	11	11	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 16	2011	306	19					2145	2146		10.1001/jama.2011.1669	http://dx.doi.org/10.1001/jama.2011.1669			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YU	22089722				2022-12-24	WOS:000297013000021
J	Tachibana, M; Sparman, M; Ramsey, C; Ma, H; Lee, HS; Penedo, MCT; Mitalipov, S				Tachibana, Masahito; Sparman, Michelle; Ramsey, Cathy; Ma, Hong; Lee, Hyo-Sang; Penedo, Maria Cecilia T.; Mitalipov, Shoukhrat			Generation of Chimeric Rhesus Monkeys	CELL			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER; MOUSE EMBRYO; MICROSATELLITE LOCI; LINEAGE DEVELOPMENT; NONHUMAN-PRIMATES; TETRAPLOID CELLS; DIFFERENTIATION; BLASTOCYSTS; ENDODERM	Totipotent cells in early embryos are progenitors of all stem cells and are capable of developing into a whole organism, including extraembryonic tissues such as placenta. Pluripotent cells in the inner cell mass (ICM) are the descendants of totipotent cells and can differentiate into any cell type of a body except extraembryonic tissues. The ability to contribute to chimeric animals upon reintroduction into host embryos is the key feature of murine totipotent and pluripotent cells. Here, we demonstrate that rhesus monkey embryonic stem cells (ESCs) and isolated ICMs fail to incorporate into host embryos and develop into chimeras. However, chimeric offspring were produced following aggregation of totipotent cells of the four-cell embryos. These results provide insights into the species-specific nature of primate embryos and suggest that a chimera assay using pluripotent cells may not be feasible.	[Tachibana, Masahito; Sparman, Michelle; Ramsey, Cathy; Ma, Hong; Lee, Hyo-Sang; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Beaverton, OR 97006 USA; [Penedo, Maria Cecilia T.] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California Davis	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu			Oregon National Primate Research Center; National Institutes of Health [HD057121, HD059946, HD063276, HD047675, HD018185, RR000163]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD063276, R01HD059946, R01HD057121] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD018185, P01HD047675, P30HD018185] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163, K01RR000163] Funding Source: NIH RePORTER	Oregon National Primate Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors would like to acknowledge the Assisted Reproductive Technology & Embryonic Stem Cell Core, Division of Animal Resources, Surgery Team, Endocrine Technology Core, and Molecular & Cellular Biology Core at the Oregon National Primate Research Center for providing expertise and services that contributed to this project. We are grateful to Dr. Warren Sanger from Human Cytogenetic Laboratory, Nebraska Medical Center for proving karyotyping services. We are obliged to Hathaitip Sritanaudomchai, Keith Masterson, Lisa Clepper, Joy Woodward, Maidina Touhetahuntila, and Erin Wolff for their technical support, Joel Ito for help with illustrative materials, and Dr. Mary Herbert for providing a GFP-RNA vector. We are indebted to Drs. Richard Stouffer and Don Wolf for consulting, helpful discussions, and critical reading of the manuscript. This study was supported by startup funds from the Oregon National Primate Research Center and grants from the National Institutes of Health, HD057121, HD059946, HD063276, HD047675, HD018185, and RR000163.	BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; BREM G, 1984, THERIOGENOLOGY, V22, P609, DOI 10.1016/0093-691X(84)90061-X; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chan AWS, 2000, SCIENCE, V287, P317, DOI 10.1126/science.287.5451.317; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Cunningham FG, 2005, WILLIAMS OBSTET; DELHAISE F, 1993, MOL REPROD DEV, V34, P127, DOI 10.1002/mrd.1080340203; DomingoRoura X, 1997, AM J PRIMATOL, V43, P357, DOI 10.1002/(SICI)1098-2345(1997)43:4<357::AID-AJP7>3.0.CO;2-W; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FEHILLY CB, 1984, NATURE, V307, P634, DOI 10.1038/307634a0; GARDNER RL, 1968, NATURE, V220, P596, DOI 10.1038/220596a0; GARDNER RL, 1974, NATURE, V250, P146, DOI 10.1038/250146a0; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; GARDNER RL, 1982, J EMBRYOL EXP MORPH, V68, P175; GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63; GARDNER RL, 1984, J EMBRYOL EXP MORPH, V80, P251; GENGOZIAN N, 1964, CYTOGENETICS, V3, P384, DOI 10.1159/000129828; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; JAMES RM, 1995, DEV BIOL, V167, P213, DOI 10.1006/dbio.1995.1018; Lanza R, 2007, SCIENCE, V318, P1865; MacKay GE, 2005, MECH DEVELOP, V122, P1266, DOI 10.1016/j.mod.2005.09.001; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; MAYER JF, 1974, J REPROD FERTIL, V39, P1, DOI 10.1530/jrf.0.0390001; MINTZ B, 1962, SCIENCE, V138, P594, DOI 10.1126/science.138.3540.594; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Ohta H, 2008, REPRODUCTION, V136, P581, DOI 10.1530/REP-08-0184; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Quintero R A, 2003, J Matern Fetal Neonatal Med, V14, P279, DOI 10.1080/713606661; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Souter VL, 2003, NEW ENGL J MED, V349, P154, DOI 10.1056/NEJMoa030050; Sparman M, 2009, STEM CELLS, V27, P1255, DOI 10.1002/stem.60; Sparman ML, 2010, INT J DEV BIOL, V54, P1671, DOI 10.1387/ijdb.103196ms; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Tam PPL, 2003, DEVELOPMENT, V130, P6155, DOI 10.1242/dev.00893; TARKOWSKI AK, 1961, NATURE, V190, P857, DOI 10.1038/190857a0; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TUCKER EM, 1974, IMMUNOLOGY, V26, P613; vanDijk BA, 1996, AM J MED GENET, V61, P264, DOI 10.1002/(SICI)1096-8628(19960122)61:3<264::AID-AJMG11>3.0.CO;2-R; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wolf DP, 2004, BIOL REPROD, V71, P486, DOI 10.1095/biolreprod.103.025932; WOOD SA, 1993, P NATL ACAD SCI USA, V90, P4582, DOI 10.1073/pnas.90.10.4582	57	119	133	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					285	295		10.1016/j.cell.2011.12.007	http://dx.doi.org/10.1016/j.cell.2011.12.007			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22225614	Green Accepted, Bronze			2022-12-24	WOS:000299540700031
J	Farzadfar, F; Murray, CJL; Gakidou, E; Bossert, T; Namdaritabar, H; Alikhani, S; Moradi, G; Delavari, A; Jamshidi, H; Ezzati, M				Farzadfar, Farshad; Murray, Christopher J. L.; Gakidou, Emmanuela; Bossert, Thomas; Namdaritabar, Hengameh; Alikhani, Siamak; Moradi, Ghobad; Delavari, Alireza; Jamshidi, Hamidreza; Ezzati, Majid			Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; RISK-FACTORS; SYSTEMATIC ANALYSIS; POPULATION HEALTH; HUMAN-RESOURCES; ALMA-ATA; MORTALITY; DISEASE; TRENDS; PREVENTION	Background Non-communicable diseases and their risk factors are leading causes of disease burden in Iran and other middle-income countries. Little evidence exists for whether the primary health-care system can effectively manage non-communicable diseases and risk factors at the population level. Our aim was to examine the effectiveness of the Iranian rural primary health-care system (the Behvarz system) in the management of diabetes and hypertension, and to assess whether the effects depend on the number of health-care workers in the community. Methods We used individual-level data from the 2005 Non-Communicable Disease Surveillance Survey (NCDSS) for fasting plasma glucose (FPG) and systolic blood pressure (SBP), body-mass index, medication use, and sociodemographic variables. Data for Behvarz-worker and physician densities were from the 2006 Population and Housing Census and the 2005 Outpatient Care Centre Mapping Survey. We assessed the effectiveness of treatment on FPG and SBP, and associations between FPG or SBP and Behvarz-worker density with two statistical approaches: a mixed-effects regression analysis of the full NCDSS sample adjusting for individual-level and community-level covariates and an analysis that estimated average treatment effect on data balanced with propensity score matching. Results NCDSS had data for 65 619 individuals aged 25 years or older (11 686 of whom in rural areas); of these, 64 694 (11 521 in rural areas) had data for SBP and 50 202 (9337 in rural areas) had data for FPG. Nationally, 39.2% (95% CI 37.7 to 40.7) of individuals with diabetes and 35.7% (34.9 to 36.5) of those with hypertension received treatment, with higher treatment coverage in women than in men and in urban areas than in rural areas. Treatment lowered mean FPG by an estimated 1.34 mmol/L (0.58 to 2.10) in rural areas and 0.21 mmol/L (-0.15 to 0.56) in urban areas. Individuals in urban areas with hypertension who received treatment had 3.8 mm Hg (3.1 to 4.5) lower SBP than they would have had if they had not received treatment; the treatment effect was 2.5 mm Hg (1.1 to 3.9) lower FPG in rural areas. Each additional Behvarz worker per 1000 adults was associated with a 0.09 mmol/L (0.01 to 0.18) lower district-level average FPG (p=0.02); for SBP this effect was 0.53 mm Hg (-0.44 to 1.50; p=0.28). Our findings were not sensitive to the choice of statistical method. Interpretation Primary care systems with trained community health-care workers and well established guidelines can be effective in non-communicable disease prevention and management. Iran's primary care system should expand the number and scope of its primary health-care worker programmes to also address blood pressure and to improve performance in areas with few primary care personnel.	[Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Farzadfar, Farshad] Univ Tehran Med Sci, Diabet Res Ctr, Tehran, Iran; [Farzadfar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran; [Moradi, Ghobad] Univ Tehran Med Sci, Sch Publ Hlth, Tehran, Iran; [Delavari, Alireza] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [Delavari, Alireza] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran; [Bossert, Thomas] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Murray, Christopher J. L.; Gakidou, Emmanuela] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Namdaritabar, Hengameh; Alikhani, Siamak] Minist Hlth & Med Educ, Tehran, Iran; [Jamshidi, Hamidreza] Shahid Beheshti Univ Med Sci, Tehran, Iran	Imperial College London; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Ministry of Health & Medical Education (MOHME); Shahid Beheshti University Medical Sciences	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, Ctr Environm & Hlth, Med Fac Bldg,St Marys Campus,Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Moradi, Ghobad/R-1267-2016	Moradi, Ghobad/0000-0003-2612-6528; Jamshidi, Hamidreza/0000-0001-6887-1409; Alikhani, Siamak/0000-0001-8354-254X; Farzadfar, Farshad/0000-0001-8288-4046	UK Medical Research Council; National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College London; Imperial College Healthcare NHS Trust; Iranian Ministry of Health and Medical Education; Medical Research Council [G0801056B] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College London; Imperial College Healthcare NHS Trust; Iranian Ministry of Health and Medical Education; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	ME is supported by a Strategic Award from the UK Medical Research Council and by the National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College London and Imperial College Healthcare NHS Trust. The NCDSS is a national health examination survey designed, implemented, and funded by the Iranian Ministry of Health and Medical Education.	Aakvik A, 2006, J HEALTH ECON, V25, P1139, DOI 10.1016/j.jhealeco.2006.04.001; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Azizi F, 2003, East Mediterr Health J, V9, P1114; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; COCHRANE AL, 1978, J EPIDEMIOL COMMUN H, V32, P200, DOI 10.1136/jech.32.3.200; Coleman R, 2002, B WORLD HEALTH ORGAN, V80, P378; Corrao MA, 2000, B WORLD HEALTH ORGAN, V78, P884; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Delavari AR, 2003, NATL DIABETES PREVEN; DRAKE C, 1995, INT J EPIDEMIOL, V24, P183, DOI 10.1093/ije/24.1.183; Farzadfar F, 2001, POPUL HLTH METRICS, V9, P55; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Frankenberg E, 1995, Health Transit Rev, V5, P143; Gulliford MC, 2002, J PUBLIC HEALTH MED, V24, P252, DOI 10.1093/pubmed/24.4.252; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; HERTZ E, 1994, SOC SCI MED, V39, P105, DOI 10.1016/0277-9536(94)90170-8; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Ho DE., 2011, J STAT SOFTW, V42, P1, DOI [10.18637/jss.v042.i08, DOI 10.18637/JSS.V042.I08]; Houterman S, 2001, INT J EPIDEMIOL, V30, P1063, DOI 10.1093/ije/30.5.1063; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; Janghorbani M, 2008, J HYPERTENS, V26, P419, DOI 10.1097/HJH.0b013e3282f2d34d; Johansen K, 1999, DIABETES CARE, V22, P33, DOI 10.2337/diacare.22.1.33; KIM KK, 1992, SOC SCI MED, V34, P837, DOI 10.1016/0277-9536(92)90253-M; Kunutsor S, 2011, AIDS BEHAV, V15, P1795, DOI 10.1007/s10461-011-9927-9; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mitchell AD, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-29; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; RUBIN DB, 1973, BIOMETRICS, V29, P159, DOI 10.2307/2529684; Samavat T, 2003, NATL HLTH PROGRAM CO; WHO, 2008, WORLD HLTH REP 2008	38	149	152	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2012	379	9810					47	54		10.1016/S0140-6736(11)61349-4	http://dx.doi.org/10.1016/S0140-6736(11)61349-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	873WC	22169105				2022-12-24	WOS:000298913000037
J	Wolkewitz, M; Allignol, A; Graves, N; Barnett, AG				Wolkewitz, Martin; Allignol, Arthur; Graves, Nicholas; Barnett, Adrian G.			CHRISTMAS 2011: DEATH'S DOMINION Is 27 really a dangerous age for famous musicians? Retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To test the "27 club" hypothesis that famous musicians are at an increased risk of death at age 27. Design Cohort study using survival analysis with age as a time dependent exposure. Comparison was primarily made within musicians, and secondarily relative to the general UK population. Setting The popular music scene from a UK perspective. Participants Musicians (solo artists and band members) who had a number one album in the UK between 1956 and 2007 (n=1046 musicians, with 71 deaths, 7%). Main outcome measures Risk of death by age of musician, accounting for time dependent study entry and the number of musicians at risk. Risk was estimated using a flexible spline which would allow a bump at age 27 to appear. Results We identified three deaths at age 27 amongst 522 musicians at risk, giving a rate of 0.57 deaths per 100 musician years. Similar death rates were observed at ages 25 (rate=0.56) and 32 (0.54). There was no peak in risk around age 27, but the risk of death for famous musicians throughout their 20s and 30s was two to three times higher than the general UK population. Conclusions The 27 club is unlikely to be a real phenomenon. Fame may increase the risk of death among musicians, but this risk is not limited to age 27.	[Graves, Nicholas; Barnett, Adrian G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia; [Graves, Nicholas; Barnett, Adrian G.] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4059, Australia; [Wolkewitz, Martin; Allignol, Arthur] Univ Freiburg, Freiburg Ctr Data Anal & Modelling, D-79106 Freiburg, Germany; [Wolkewitz, Martin; Allignol, Arthur] Univ Med Ctr, Inst Med Biometry & Med Informat, Freiburg, Germany	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Queensland; University of Freiburg; University of Freiburg	Barnett, AG (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.	a.barnett@qut.edu.au	Barnett, Adrian/I-9850-2012	Barnett, Adrian/0000-0001-6339-0374; Wolkewitz, Martin/0000-0002-1268-5057; Graves, Nicholas/0000-0002-5559-3267				Beyersmann J, 2011, COMPETING RISKS MULT; Blastland M., 2008, TIGER ISNT SEEING WO; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Darke S, 1996, ADDICTION, V91, P1765, DOI 10.1111/j.1360-0443.1996.tb03800.x; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Goldacre B., 2010, BAD SCI QUACKS HACKS; Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1; HOWLAND J, 1988, ACCIDENT ANAL PREV, V20, P19, DOI 10.1016/0001-4575(88)90011-5; KEIDING N, 1990, PHILOS T ROY SOC A, V332, P487, DOI 10.1098/rsta.1990.0128; Rosenthal VD, 2011, EPIDEMIOL INFECT, V139, P1757, DOI 10.1017/S0950268811000094; Ruppert D., 2003, CAMBRIDGE SERIES STA; Segalstad Eric, 2009, 27S GREATEST MYTH RO	12	11	11	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2011	343								d7799	10.1136/bmj.d7799	http://dx.doi.org/10.1136/bmj.d7799			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868QK	22187325	hybrid, Green Published			2022-12-24	WOS:000298538200009
J	Price, CTD; Al-Quadan, T; Santic, M; Rosenshine, I; Abu Kwaik, Y				Price, Christopher T. D.; Al-Quadan, Tasneem; Santic, Marina; Rosenshine, Ilan; Abu Kwaik, Yousef			Host Proteasomal Degradation Generates Amino Acids Essential for Intracellular Bacterial Growth	SCIENCE			English	Article							LEGIONELLA-PNEUMOPHILA; CLASS-I; MACROPHAGES; DIFFERENTIATION; EXPLOITATION; REPLICATION; PROTEIN	Legionella pneumophila proliferates in environmental amoeba and human cells within the Legionella-containing vacuole (LCV). The exported AnkB F-box effector of L. pneumophila is anchored into the LCV membrane by host-mediated farnesylation. Here, we report that host proteasomal degradation of Lys(48)-linked polyubiquitinated proteins, assembled on the LCV by AnkB, generates amino acids required for intracellular bacterial proliferation. The severe defect of the ankB null mutant in proliferation within amoeba and human cells is rescued by supplementation of a mixture of amino acids or cysteine, serine, pyruvate, or citrate, similar to rescue by genetic complementation. Defect of the ankB mutant in intrapulmonary proliferation in mice is rescued upon injection of a mixture of amino acids or cysteine. Therefore, Legionella promotes eukaryotic proteasomal degradation to generate amino acids needed as carbon and energy sources for bacterial proliferation within evolutionarily distant hosts.	[Price, Christopher T. D.; Al-Quadan, Tasneem; Abu Kwaik, Yousef] Univ Louisville, Coll Med, Dept Microbiol & Immunol, Louisville, KY 40202 USA; [Santic, Marina] Univ Rijeka, Dept Microbiol & Parasitol, Rijeka 51000, Croatia; [Rosenshine, Ilan] Hebrew Univ Jerusalem, Sch Med, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel	University of Louisville; University of Rijeka; Hebrew University of Jerusalem	Abu Kwaik, Y (corresponding author), Univ Louisville, Coll Med, Dept Microbiol & Immunol, Louisville, KY 40202 USA.	abukwaik@louisville.edu	Santic, Marina/N-6796-2018; Abu Kwaik, Yousef/A-2802-2012; Santic, Marina/AAB-3137-2019	Santic, Marina/0000-0003-4138-3581; Santic, Marina/0000-0003-4138-3581; Abu Kwaik, Yousef/0000-0002-2119-2078	Public Health Service, National Institute of Allergy and Infectious Diseases [R01AI43965, R01AI069321]; commonwealth of Kentucky Research Challenge Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043965, R01AI069321] Funding Source: NIH RePORTER	Public Health Service, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)United States Public Health Service); commonwealth of Kentucky Research Challenge Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Sasakawa for the generous gift of providing all the ubiquitin mutant plasmid DNA and J. Cox at the University of Utah Metabolomics Core Facility for the free amino acids analyses. Y.A.K. is supported by Public Health Service awards R01AI43965 and R01AI069321 from National Institute of Allergy and Infectious Diseases and by the commonwealth of Kentucky Research Challenge Trust Fund.	Al-Khodor S, 2008, MOL MICROBIOL, V70, P908, DOI 10.1111/j.1365-2958.2008.06453.x; Al-Quadan T, 2011, TRENDS MICROBIOL, V19, P573, DOI 10.1016/j.tim.2011.08.003; Al-Quadan T, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00023; Appelberg R, 2006, J LEUKOCYTE BIOL, V79, P1117, DOI 10.1189/jlb.0206079; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Dalebroux ZD, 2009, MOL MICROBIOL, V71, P640, DOI 10.1111/j.1365-2958.2008.06555.x; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; Gallastegui N, 2010, TRENDS BIOCHEM SCI, V35, P634, DOI 10.1016/j.tibs.2010.05.005; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Lomma M, 2010, CELL MICROBIOL, V12, P1272, DOI 10.1111/j.1462-5822.2010.01467.x; Luo ZQ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00031; Molmeret M, 2005, APPL ENVIRON MICROB, V71, P20, DOI 10.1128/AEM.71.1.20-28.2005; Price CT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000704; Price CTD, 2010, J EXP MED, V207, P1712, DOI 10.1084/jem.20100771; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Sauer JD, 2005, P NATL ACAD SCI USA, V102, P9924, DOI 10.1073/pnas.0502767102; Wieland H, 2005, MOL MICROBIOL, V55, P1528, DOI 10.1111/j.1365-2958.2005.04490.x	22	146	148	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1553	1557		10.1126/science.1212868	http://dx.doi.org/10.1126/science.1212868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22096100				2022-12-24	WOS:000298091400053
J	Burga, A; Casanueva, MO; Lehner, B				Burga, Alejandro; Olivia Casanueva, M.; Lehner, Ben			Predicting mutation outcome from early stochastic variation in genetic interaction partners	NATURE			English	Article							T-BOX GENES; EXPRESSION; VARIABILITY; REDUNDANCY; EVOLUTION; CAPACITOR; HSP90	Many mutations, including those that cause disease, only have a detrimental effect in a subset of individuals. The reasons for this are usually unknown, but may include additional genetic variation and environmental risk factors(1). However, phenotypic discordance remains even in the absence of genetic variation, for example between monozygotic twins(2), and incomplete penetrance of mutations is frequent in isogenic model organisms in homogeneous environments(3,4). Here we propose a model for incomplete penetrance based on genetic interaction networks(5,6). Using Caenorhabditis elegans as a model system, we identify two compensation mechanisms that vary among individuals and influence mutation outcome. First, feedback induction of an ancestral gene duplicate differs across individuals, with high expression masking the effects of a mutation. This supports the hypothesis that redundancy is maintained in genomes to buffer stochastic developmental failure(7). Second, during normal embryonic development we find that there is substantial variation in the induction of molecular chaperones such as Hsp90 (DAF-21). Chaperones act as promiscuous buffers of genetic variation(8,9), and embryos with stronger induction of Hsp90 are less likely to be affected by an inherited mutation. Simultaneously quantifying the variation in these two independent responses allows the phenotypic outcome of a mutation to be more accurately predicted in individuals. Our model and methodology provide a framework for dissecting the causes of incomplete penetrance. Further, the results establish that inter-individual variation in both specific and more general buffering systems combine to determine the outcome inherited mutations in each individual.	[Burga, Alejandro; Olivia Casanueva, M.; Lehner, Ben] Ctr Genom Regulat CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain; [Burga, Alejandro; Olivia Casanueva, M.; Lehner, Ben] Univ Pompeu Fabra UPF, Barcelona 08003, Spain; [Lehner, Ben] Ctr Genom Regulat CRG, Inst Catalana Recerca & Estudis Avancats, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Lehner, B (corresponding author), Ctr Genom Regulat CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain.	ben.lehner@crg.eu	Lehner, Ben/L-3413-2014; Lehner, Ben/ABH-6562-2020; Burga, Alejandro/AAJ-8745-2020	Lehner, Ben/0000-0002-8817-1124; Lehner, Ben/0000-0002-8817-1124; Burga, Alejandro/0000-0002-0211-4357	European Research Council; Institucio Catalana de Recerca i Estudis Avancats; Ministerio de Ciencia e Innovacion Plan Nacional [BFU2008-00365]; Agencia de Gestio d'juts Universitaris i de Recerca; ERASysBio+; European Molecular Biology Organization; EMBL-CRG Systems Biology Program; Formacion de Personal Investigador-Ministerio de Ciencia e Innovacion fellowship; Beatriu de Pinos Fellowship; National Institutes of Health National Center for Research Resources; ICREA Funding Source: Custom	European Research Council(European Research Council (ERC)European Commission); Institucio Catalana de Recerca i Estudis Avancats(ICREA); Ministerio de Ciencia e Innovacion Plan Nacional; Agencia de Gestio d'juts Universitaris i de Recerca; ERASysBio+; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); EMBL-CRG Systems Biology Program; Formacion de Personal Investigador-Ministerio de Ciencia e Innovacion fellowship; Beatriu de Pinos Fellowship; National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ICREA(ICREA)	This work was funded by grants from the European Research Council, Institucio Catalana de Recerca i Estudis Avancats, Ministerio de Ciencia e Innovacion Plan Nacional BFU2008-00365, Agencia de Gestio d'juts Universitaris i de Recerca, ERASysBio+, the European Molecular Biology Organization Young Investigator Programme, the EMBL-CRG Systems Biology Program, by a Formacion de Personal Investigador-Ministerio de Ciencia e Innovacion fellowship to A. B. and by a Beatriu de Pinos Fellowship to M.O.C. We thank I. Hope, V. Ambros and S. Kim for providing strains. Additional strains were obtained from the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. We thank T. Zimmermann and R. Garcia from the CRG Advanced Light Microscopy Unit for advice and assistance, J. Miwa and Y. Yamaguchi for 608F antibody, J. Semple for providing complementary DNA clones, A. Marchetti and R. Garcia-Verdugo for technical assistance, J. Tischler and C. Kiel for advice on single-molecule fluorescence in situ hybridization and western blotting, respectively, and L. Serrano, M. Isalan and J. Semple for comments on the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Andachi Y, 2004, GENES CELLS, V9, P331, DOI 10.1111/j.1356-9597.2004.00725.x; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Bateson W, 1909, MENDELS PRINCIPLES H; Baugh LR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r45; Bobula J, 2006, GENETICS, V174, P937, DOI 10.1534/genetics.106.061564; BRENNER S, 1974, GENETICS, V77, P71; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; Eldar A, 2009, NATURE, V460, P510, DOI 10.1038/nature08150; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; HORVITZ HR, 1980, GENETICS, V96, P435; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kelly WG, 1997, GENETICS, V146, P227; Koh K, 2001, DEVELOPMENT, V128, P2867; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Lehner B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001185; Lehner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009035; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ow MC, 2008, GENE DEV, V22, P2520, DOI 10.1101/gad.1678808; Pocock R, 2004, DEVELOPMENT, V131, P2373, DOI 10.1242/dev.01110; Praitis V, 2001, GENETICS, V157, P1217; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Tischler J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r69; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Vavouri T, 2008, TRENDS GENET, V24, P485, DOI 10.1016/j.tig.2008.08.005; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wilm T, 1999, GENE, V229, P31, DOI 10.1016/S0378-1119(99)00043-8; Wolf DE, 2007, METHOD CELL BIOL, V81, P365, DOI 10.1016/S0091-679X(06)81017-4; YAMAGUCHI Y, 1983, DEV GROWTH DIFFER, V25, P121	41	128	132	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2011	480	7376					250	U133		10.1038/nature10665	http://dx.doi.org/10.1038/nature10665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22158248				2022-12-24	WOS:000297744200053
J	Raftery, J; Chorozoglou, M				Raftery, James; Chorozoglou, Maria			Possible net harms of breast cancer screening: updated modelling of Forrest report	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; MORTALITY; PROGRAM; OVERDIAGNOSIS; LIFE	Objective To assess the claim in a Cochrane review that mammographic breast cancer screening could be doing more harm than good by updating the analysis in the Forrest report, which led to screening in the United Kingdom. Design Development of a life table model, which replicated Forrest's results before updating and extending them with data from relevant systematic reviews, trials, and other models based on purposive literature searches. Participants Women aged 50 and over invited for breast cancer screening. Main outcome measures Quality adjusted life years (QALYs), combining life years gained from screening with losses of quality of life from false positive diagnoses and surgery. Results Inclusion of the effects of harms reduced the updated estimate of net cumulative QALYs gained after 20 years from 3301 to 1536 or by more than half. The best estimates from the Cochrane review generated negative QALYs for the first seven years of screening, 70 QALYs after 10 years, and 834 QALYs after 20 years. Sensitivity analysis showed these results were robust to a range of assumptions, particularly up to 10 years. It also indicated the importance of the level and duration of harms from surgery. Conclusions This analysis supports the claim that the introduction of breast cancer screening might have caused net harm for up to 10 years after the start of screening.	[Raftery, James; Chorozoglou, Maria] Univ Southampton, Fac Med, Wessex Inst, Southampton SO16 7PX, Hants, England	University of Southampton	Raftery, J (corresponding author), Univ Southampton, Fac Med, Wessex Inst, Southampton SO16 7PX, Hants, England.	j.p.raftery@soton.ac.uk		Chorozoglou, Maria/0000-0001-5070-4653				[Anonymous], 1985, OFF NAT STAT SER DH2; [Anonymous], 2006, ADV COMM BREAST CANC; Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; Baum M., 2010, BREAST BEATING PERSO; Blanks RG, 2000, BRIT MED J, V321, P665, DOI 10.1136/bmj.321.7262.665; Brodersen J, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-3; Buxton M, 1988, MEASURING HLTH PROSP; Cancer Statistics, 2009, CANC STAT, P9; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; Forrest APM, 1987, BREAST CANC SCREEN R, V3rd, P102; Gotzsche PC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub3; Jorgensen KJ, 2010, ANN INTERN MED, V152, P538, DOI 10.7326/0003-4819-152-8-201004200-00198; Jorgensen KJ, 2011, RADIOLOGY, V260, P621, DOI 10.1148/radiol.11110210; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Madan J, 2008, VALUE HEALTH, V13, P215; Nelson H, 2009, SCREENING BREAST CAN; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; OPCS Department of Health, 1987, HOSP INP ENQ SUMM TA; OPCS Department of Health, 1987, HOSP INP ENQ INP DAY; Peasgood T, 2010, 1015 SCHARR HEDS U S; Pisani P, 2004, BRIT J CANCER, V90, P652, DOI 10.1038/sj.bjc.6601614; Quinn M, 2008, CANC TRENDS ENGLAND, V66; Raffle A, 2007, SCREENING EVIDENCE P, P82; SHAPIRO S, 1982, JNCI-J NATL CANCER I, V69, P349; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P77482; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; Turnbull LW, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14010; Welch H, 2011, OVERDIAGNOSED MAKING; Welch HG, 2008, JNCI-J NATL CANCER I, V100, P228, DOI 10.1093/jnci/djn013; Welch HG, 2011, ARCH INTERN MED 1024; WHO IARC, 2002, BREAST CANC SCREEN; Williams LJ, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15120	34	33	33	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2011	343								d7627	10.1136/bmj.d7627	http://dx.doi.org/10.1136/bmj.d7627			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EX	22155336	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000298939300005
J	Mora, S; Buring, JE; Ridker, PM; Cui, YD				Mora, Samia; Buring, Julie E.; Ridker, Paul M.; Cui, Yadong			Association of High-Density Lipoprotein Cholesterol With Incident Cardiovascular Events in Women, by Low-Density Lipoprotein Cholesterol and Apolipoprotein B100 Levels A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; LOW-DOSE ASPIRIN; PRIMARY PREVENTION; A-I; HDL CHOLESTEROL; RISK; PREDICTION; CANCER; HEALTH; RATIO	Background: Prior studies have found inverse associations between high-density lipoprotein cholesterol (HDL-C) or apolipoprotein A-I levels and cardiovascular disease (CVD). Whether this observation is consistent across low-density lipoprotein cholesterol (LDL-C) levels or total atherogenic particle burden (apolipoprotein B100) is less well-studied, particularly in women. Objective: To determine the association between HDL-C or apolipoprotein A-I level and CVD across a range of LDL-C and apolipoprotein B100 values. Design: Prospective cohort study. Setting: The Women's Health Study, a cohort of U.S. female health professionals. Participants: 26 861 initially healthy women, aged 45 years or older at study entry (1992-1995), who were followed for a mean of approximately 11 years. Measurements: Baseline lipids were measured directly, and apolipoproteins were measured with immunoassays. Outcomes were incident total CVD (n = 929), coronary events (n = 602), and stroke (n = 319). Results: In multivariable analyses, HDL-C and apolipoprotein A-I levels were inversely associated with CVD and coronary events but not stroke. Adjusted coronary hazard ratios for decreasing quintiles of HDL-C were 1.00 (reference), 1.23 (95% CI, 0.85 to 1.78), 1.42 (CI, 0.98 to 2.06), 1.90 (CI, 1.33 to 2.71), and 2.19 (CI, 1.51 to 3.19) (P for linear trend < 0.001); corresponding hazard ratios for apolipoprotein A-I were 1.00 (reference), 0.98 (CI, 0.71 to 1.35), 1.02 (CI, 0.72 to 1.44), 1.37 (CI, 0.98 to 1.90), and 1.58 (CI, 1.14 to 2.20) (P for linear trend = 0.005). Consistent inverse associations were found for HDL-C with coronary events across a range of LDL-C values, including among women with low LDL-C levels. No associations were noted for HDL-C or apolipoprotein A-I among women with low apolipoprotein B100 values (<0.90 g/L). Limitation: Participants were at low risk for CVD, the number of events in the lowest apolipoprotein B100 stratum was small, only a single baseline measurement was obtained, and residual confounding may have occurred. Conclusion: Consistent inverse associations were found for HDL-C with incident coronary events among women with a range of LDL-C values. Among women with low total atherogenic particle burden (apolipoprotein B100 level <0.90 g/L), few events occurred and no associations were seen.	[Mora, Samia] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA; Merck & Co Inc, N Wales, PA 19454 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Merck & Company	Mora, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E,3rd Floor, Boston, MA 02215 USA.	smora@partners.org		Mora, Samia/0000-0001-6283-0980	Merck Co.; National Heart, Lung, and Blood Institute and the National Cancer Institute, National Institutes of Health [K08 HL094375, HL 43851, HL 080467, CA 47988]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851, R01HL080467, K08HL094375] Funding Source: NIH RePORTER	Merck Co.(Merck & Company); National Heart, Lung, and Blood Institute and the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research for this article was supported by an investigator-initiated research grant to Dr. Mora from Merck & Co. The study was also supported by grants K08 HL094375 (Dr. Mora) and HL 43851, HL 080467, and CA 47988 from the National Heart, Lung, and Blood Institute and the National Cancer Institute, National Institutes of Health.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; BASS KM, 1993, ARCH INTERN MED, V153, P2209, DOI 10.1001/archinte.153.19.2209; Bittner V, 2005, J AM COLL CARDIOL, V46, P1628, DOI 10.1016/j.jacc.2005.05.089; CASTELLI WP, 1988, CAN J CARDIOL, V0004; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; deGoma EM, 2008, J AM COLL CARDIOL, V51, P49, DOI 10.1016/j.jacc.2007.07.086; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Haffner Steven M, 2004, Diabetes Care, V27 Suppl 1, pS68; Hainline A, 1982, MANUAL LAB OPERATION, V628; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Luc G, 2002, ARTERIOSCL THROM VAS, V22, P1155, DOI 10.1161/01.ATV.0000022850.59845.E0; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; ROSENBAUM PR, 1991, ANN INTERN MED, V115, P901, DOI 10.7326/0003-4819-115-11-901; SCHAEFER EJ, 1994, J LIPID RES, V35, P779; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Sniderman AD, 2005, CIRCULATION, V112, P3366, DOI 10.1161/CIRCULATIONAHA.105.583336; Thompson A, 2006, J INTERN MED, V259, P481, DOI 10.1111/j.1365-2796.2006.01644.x; van der Steeg WA, 2008, J AM COLL CARDIOL, V51, P634, DOI 10.1016/j.jacc.2007.09.060; Walldius G, 2006, J INTERN MED, V259, P493, DOI 10.1111/j.1365-2796.2006.01643.x; WARNER JG, 1995, CIRCULATION, V92, P773, DOI 10.1161/01.CIR.92.4.773	26	37	38	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2011	155	11					742	U157		10.7326/0003-4819-155-11-201112060-00006	http://dx.doi.org/10.7326/0003-4819-155-11-201112060-00006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860ZS	22147713	Green Accepted			2022-12-24	WOS:000297988400003
J	Feachem, RGA				Feachem, Richard G. A.			The Global Fund: getting the reforms right	LANCET			English	Editorial Material									[Feachem, Richard G. A.] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94105 USA; [Feachem, Richard G. A.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley	Feachem, RGA (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94105 USA.	FeachemR@globalhealth.ucsf.edu						[African Leaders Malaria Alliance Evidence to Policy Initiative linton Health Access Initiative], 2011, MAINT GAINS MAL CONT; [Anonymous], 2011, LANCET, V378, P1198, DOI 10.1016/S0140-6736(11)61526-2; High-Level Independent Review Panel on Fiduciary Controls and Oversight Mechanisms of the Global Fund to Fight AIDS, 2011, TURN PAG EM SUST; Mahgoub A., 2010, CASH DELIVERY NEW AP; The Global Fund to Fight AIDS, 2011, 24 BOARD M GEN SWITZ	5	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2011	378	9805					1764	+		10.1016/S0140-6736(11)61747-9	http://dx.doi.org/10.1016/S0140-6736(11)61747-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851IS	22098844				2022-12-24	WOS:000297262300009
J	Juma, C				Juma, Calestous			Preventing hunger: Biotechnology is key	NATURE			English	Editorial Material									Harvard Univ, Kennedy Sch, Agr Innovat Africa Project, Cambridge, MA 02138 USA	Harvard University	Juma, C (corresponding author), Harvard Univ, Kennedy Sch, Agr Innovat Africa Project, Cambridge, MA 02138 USA.	calestous_juma@harvard.edu						Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710	1	22	23	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					471	472		10.1038/479471a	http://dx.doi.org/10.1038/479471a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22113675	Bronze			2022-12-24	WOS:000297285600026
J	Moussion, C; Girard, JP				Moussion, Christine; Girard, Jean-Philippe			Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules	NATURE			English	Article							VASCULAR ADDRESSIN EXPRESSION; SELECTIN LIGAND BIOSYNTHESIS; TUMOR-NECROSIS-FACTOR; CD8(+) T-CELLS; IN-VIVO; BONE-MARROW; TRAFFICKING; VESSELS; PROLIFERATION; MODULATION	While patrolling the body in search of foreign antigens, naive lymphocytes continuously circulate from the blood, through the lymph nodes, into the lymphatic vessels and back to the blood(1,2). This process, called lymphocyte recirculation, provides the body with effective immune surveillance for foreign invaders and for alterations to the body's own cells. However, the mechanisms that regulate lymphocyte recirculation during homeostasis remain incompletely characterized. Here we show that dendritic cells (DCs), which are well known for their role in antigen presentation to T lymphocytes(3), control the entry of naive lymphocytes to lymph nodes by modulating the phenotype of high endothelial venules (HEVs), which are blood vessels specialized in lymphocyte recruitment(2,4,5). We found that in vivo depletion of CD11c(+) DCs in adult mice over a 1-week period induces a reduction in the size and cellularity of the peripheral and mucosal lymph nodes. In the absence of DCs, the mature adult HEV phenotype reverts to an immature neonatal phenotype, and HEV-mediated lymphocyte recruitment to lymph nodes is inhibited. Co-culture experiments showed that the effect of DCs on HEV endothelial cells is direct and requires lymphotoxin-beta-receptor-dependent signalling. DCs express lymphotoxin, and DC-derived lymphotoxin is important for lymphocyte homing to lymph nodes in vivo. Together, our results reveal a previously unsuspected role for DCs in the regulation of lymphocyte recirculation during immune surveillance.	[Moussion, Christine; Girard, Jean-Philippe] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Moussion, Christine; Girard, Jean-Philippe] Univ Toulouse, UPS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Girard, JP (corresponding author), CNRS, Inst Pharmacol & Biol Struct, 205 Route Narbonne, F-31077 Toulouse, France.	Jean-Philippe.Girard@ipbs.fr	GIRARD, Jean-Philippe/F-5229-2010	GIRARD, Jean-Philippe/0000-0002-9154-1691	Ligue Nationale Contre le Cancer; Association pour la Recherche contre le Cancer (ARC) [8505]; French Ministry of Research; Fondation RITC	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Fondation RITC	We are grateful to S. Rosen, J. Lowe and J. Browning for the gift of antibodies, to H. Korner, T. Winkler, E. Donnadieu, M. Lipp, O. Lantz, B. Ryffel, L. Brault, S. A. Nedospasov and S. Jung for providing mice, to J. van Meerwijk for critical reading of the manuscript, and to N. Ortega, E. Bellard and F. El-Fahqui-Olive for help with immunohistochemistry, intravital microscopy and cell sorting, respectively. We thank the IPBS TRI imaging facility, A. Dujardin and the IPBS animal and transgenic facilities for help with animal experiments, and F. Viala for preparation of the figures. This work was supported by grants from the Ligue Nationale Contre le Cancer (Equipe labellisee Ligue 2009 to J.-P.G.) and the Association pour la Recherche contre le Cancer (ARC, equipment 8505). C. M. was supported by fellowships from the French Ministry of Research, the ARC and Fondation RITC.	Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Carriere V, 2005, CANCER RES, V65, P11639, DOI 10.1158/0008-5472.CAN-05-1190; Cayrol C, 2007, BLOOD, V109, P584, DOI 10.1182/blood-2006-03-012013; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; Flaishon L, 2008, BLOOD, V112, P5016, DOI 10.1182/blood-2007-12-129122; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; GIRARD JP, 1995, IMMUNOL TODAY, V16, P449, DOI 10.1016/0167-5699(95)80023-9; HENDRIKS HR, 1983, EUR J IMMUNOL, V13, P663, DOI 10.1002/eji.1830130811; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Kuprash DV, 2002, MOL CELL BIOL, V22, P8626, DOI 10.1128/MCB.22.24.8626-8634.2002; Lacorre DA, 2004, BLOOD, V103, P4164, DOI 10.1182/blood-2003-10-3537; Liao S, 2006, J IMMUNOL, V177, P3369, DOI 10.4049/jimmunol.177.5.3369; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MEBIUS RE, 1993, J IMMUNOL, V151, P6769; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; MEBIUS RE, 1991, J CELL BIOL, V115, P85, DOI 10.1083/jcb.115.1.85; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Muniz LR, 2011, J IMMUNOL, V187, P828, DOI 10.4049/jimmunol.1004233; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Swarte VVR, 1998, EUR J IMMUNOL, V28, P3040, DOI 10.1002/(SICI)1521-4141(199810)28:10<3040::AID-IMMU3040>3.0.CO;2-5; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272; Zaft T, 2005, J IMMUNOL, V175, P6428, DOI 10.4049/jimmunol.175.10.6428	37	208	211	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2011	479	7374					542	U273		10.1038/nature10540	http://dx.doi.org/10.1038/nature10540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22080953				2022-12-24	WOS:000297285600054
J	Miller, SE; Sahlender, DA; Graham, SC; Honing, S; Robinson, MS; Peden, AA; Owen, DJ				Miller, Sharon E.; Sahlender, Daniela A.; Graham, Stephen C.; Hoening, Stefan; Robinson, Margaret S.; Peden, Andrew A.; Owen, David J.			The Molecular Basis for the Endocytosis of Small R-SNAREs by the Clathrin Adaptor CALM	CELL			English	Article							TRANS-GOLGI NETWORK; COATED VESICLES; ALZHEIMERS-DISEASE; SYNAPTIC VESICLES; CRYSTAL-STRUCTURE; COMPLEX-FORMATION; EARLY ENDOSOMES; FUSION PROTEIN; TRAFFICKING; AP180	SNAREs provide a large part of the specificity and energy needed for membrane fusion and, to do so, must be localized to their correct membranes. Here, we show that the R-SNAREs VAMP8, VAMP3, and VAMP2, which cycle between the plasma membrane and endosomes, bind directly to the ubiquitously expressed, PtdIns4, 5P(2)-binding, endocytic clathrin adaptor CALM/PICALM. X-ray crystallography shows that the N-terminal halves of their SNARE motifs bind the CALM(ANTH) domain as helices in a manner that mimics SNARE complex formation. Mutation of residues in the CALM: SNARE interface inhibits binding in vitro and prevents R-SNARE endocytosis in vivo. Thus, CALM: R-SNARE interactions ensure that R-SNAREs, required for the fusion of endocytic clathrin-coated vesicles with endosomes and also for subsequent postendosomal trafficking, are sorted into endocytic vesicles. CALM's role in directing the endocytosis of small R-SNAREs may provide insight into the association of CALM/PICALMmutations with growth retardation, cognitive defects, and Alzheimer's disease.	[Miller, Sharon E.; Sahlender, Daniela A.; Graham, Stephen C.; Robinson, Margaret S.; Peden, Andrew A.; Owen, David J.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Miller, Sharon E.; Sahlender, Daniela A.; Graham, Stephen C.; Robinson, Margaret S.; Peden, Andrew A.; Owen, David J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 0XY, England; [Hoening, Stefan] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Hoening, Stefan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cologne; University of Cologne	Peden, AA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	aap20@cam.ac.uk; djo30@cam.ac.uk		Sahlender, Daniela Andrea/0000-0002-0510-9529; Graham, Stephen/0000-0003-4547-4034; Peden, Andrew/0000-0003-0144-7712	Wellcome Trust; MRC CDF [G120/952]; German Science Foundation [SFB 635]; MRC [G120/952] Funding Source: UKRI; Medical Research Council [G120/952] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC CDF(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Science Foundation(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the beamline scientists at Diamond Light Source plc and Janet Deane for assistance with data collection; and Susan Lea and Steven Johnson (University of Oxford) for assistance with MALS experiments. We also thank Bazbek Davletov (MRCLMB) for gifts of VAMP2, SNAP23, and syntaxin3 DNA. D.J.O. and M. S. R. are funded by Wellcome Trust fellowships; A. A. P. by an MRC CDF (G120/952); and S. C. G. is an 1851 Research Fellow. S. H. is funded by a grant from the German Science Foundation (SFB 635). The protein chemistry, structure determinations and biophysical assays were carried out by S. E. M., S. C. G., S. H., and D.J.O.; the cell biology by D. A. S., M. S. R., and A.A.P.	Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Baig S, 2010, J NEUROPATH EXP NEUR, V69, P1071, DOI 10.1097/NEN.0b013e3181f52e01; Bao H, 2005, J NEUROPHYSIOL, V94, P1888, DOI 10.1152/jn.00080.2005; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Burston HE, 2009, J CELL BIOL, V185, P1097, DOI 10.1083/jcb.200811116; Bushlin I, 2008, J NEUROSCI, V28, P10257, DOI 10.1523/JNEUROSCI.2471-08.2008; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gordon DE, 2009, EMBO REP, V10, P851, DOI 10.1038/embor.2009.96; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hazzard J, 1999, J BIOMOL NMR, V14, P203, DOI 10.1023/A:1008382027065; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Klebig ML, 2003, P NATL ACAD SCI USA, V100, P8360, DOI 10.1073/pnas.1432634100; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Koo SJ, 2011, P NATL ACAD SCI USA, V108, P13540, DOI 10.1073/pnas.1107067108; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; LINDNER R, 1992, J BIOL CHEM, V267, P16567; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Mengel-From J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.07.016; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Morgan JR, 2000, J NEUROSCI, V20, P8667; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Peden AA, 2001, J BIOL CHEM, V276, P49183, DOI 10.1074/jbc.M106646200; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Sannerud R, 2009, SEMIN CELL DEV BIOL, V20, P183, DOI 10.1016/j.semcdb.2008.11.004; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Steegmaier M, 1999, MOL BIOL CELL, V10, P1957, DOI 10.1091/mbc.10.6.1957; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tran THT, 2007, J CELL SCI, V120, P1028, DOI 10.1242/jcs.03387; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Yao PJ, 2003, NEUROSCIENCE, V121, P25, DOI 10.1016/S0306-4522(03)00431-7	53	134	134	3	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1118	1131		10.1016/j.cell.2011.10.038	http://dx.doi.org/10.1016/j.cell.2011.10.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118466	Green Published, hybrid			2022-12-24	WOS:000297376600022
J	Freidin, E; Kacelnik, A				Freidin, Esteban; Kacelnik, Alex			Rational Choice, Context Dependence, and the Value of Information in European Starlings (Sturnus vulgaris)	SCIENCE			English	Article							PREFERENCE; MEMORY; REWARD; COSTS; LONG	Both human and nonhuman decision-makers can deviate from optimal choice by making context-dependent choices. Because ignoring context information can be beneficial, this is called a "less-is-more effect." The fact that organisms are so sensitive to the context is thus paradoxical and calls for the inclusion of an ecological perspective. In an experiment with starlings, adding cues that identified the context impaired performance in simultaneous prey choices but improved it in sequential prey encounters, in which subjects could reject opportunities in order to search instead in the background. Because sequential prey encounters are likely to be more frequent in nature, storing and using contextual information appears to be ecologically rational on balance by conditioning acceptance of each opportunity to the relative richness of the background, even if this causes context-dependent suboptimal preferences in (less-frequent) simultaneous choices. In ecologically relevant scenarios, more information seems to be more.	[Freidin, Esteban; Kacelnik, Alex] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Kacelnik, A (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	alex.kacelnik@zoo.ox.ac.uk	Freidin, Esteban/AAE-7426-2020		European Union [E04D031814AR]; Overseas Research Student Scheme Award UK; UK Biotechnology and Biological Sciences Research Council [BB/G007144/1]; Biotechnology and Biological Sciences Research Council [BB/G007144/1] Funding Source: researchfish; BBSRC [BB/G007144/1] Funding Source: UKRI	European Union(European Commission); Overseas Research Student Scheme Award UK; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Programme Al beta an (the European Union program of High Level Scholarships for Latin America) scholarship E04D031814AR and Overseas Research Student Scheme Award UK to E. F., and UK Biotechnology and Biological Sciences Research Council grant BB/G007144/1 to A. K. The authors declare no competing financial interests or conflict of interest. E. F. performed the experiment and collected, processed, and analyzed the data. Both authors shared the experimental design and writing of the paper.	ARKES HR, 1985, ORGAN BEHAV HUM DEC, V35, P124, DOI 10.1016/0749-5978(85)90049-4; ARONSON E, 1961, J ABNORM SOC PSYCH, V63, P375, DOI 10.1037/h0046890; Aw JM, 2009, BEHAV PROCESS, V81, P333, DOI 10.1016/j.beproc.2008.09.002; BELKE TW, 1992, ANIM LEARN BEHAV, V20, P401, DOI 10.3758/BF03197963; Catania A.C., 1970, THEORY REINFORCEMENT, P1; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Clement TS, 2000, PSYCHON B REV, V7, P100, DOI 10.3758/BF03210727; Dukas R, 1999, J THEOR BIOL, V197, P41, DOI 10.1006/jtbi.1998.0856; Flaherty C.F., 1996, INCENTIVE RELATIVITY; Golstein D. G., 2008, HDB EXPT EC RESULTS, P987; HUBER J, 1982, J CONSUM RES, V9, P90, DOI 10.1086/208899; JOHNSTON TD, 1982, ADV STUD BEHAV, V12, P65, DOI 10.1016/S0065-3454(08)60046-7; Kacelnik A, 2002, ANIM BEHAV, V63, P245, DOI 10.1006/anbe.2001.1900; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Pompilio L, 2006, SCIENCE, V311, P1613, DOI 10.1126/science.1123924; Pompilio L, 2005, ANIM BEHAV, V70, P571, DOI 10.1016/j.anbehav.2004.12.009; Pompilio L, 2010, P NATL ACAD SCI USA, V107, P508, DOI 10.1073/pnas.0907250107; ROBERTS S, 1981, J EXP PSYCHOL ANIM B, V7, P242, DOI 10.1037/0097-7403.7.3.242; Samuelson P. A., 2010, ECONOMICS; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Shapiro MS, 2008, J EXP PSYCHOL-ANIM B, V34, P75, DOI 10.1037/0097-7403.34.1.75; SIMONSON I, 1992, J MARKETING RES, V29, P281, DOI 10.2307/3172740; Stephens D.W., 1986, pi; Stephens DW, 2001, BEHAV ECOL, V12, P330, DOI 10.1093/beheco/12.3.330; Waite TA, 2001, BEHAV ECOL, V12, P318, DOI 10.1093/beheco/12.3.318	26	51	51	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2011	334	6058					1000	1002		10.1126/science.1209626	http://dx.doi.org/10.1126/science.1209626			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CA	22096203				2022-12-24	WOS:000297101800062
J	Haddad, L				Haddad, Lawrence			Why India needs a national nutrition strategy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILD UNDERNUTRITION; CONSEQUENCES; HEALTH; STATES; FOOD		Univ Sussex, Inst Dev Studies, Brighton BN1 9RE, E Sussex, England	University of Sussex	Haddad, L (corresponding author), Univ Sussex, Inst Dev Studies, Brighton BN1 9RE, E Sussex, England.	l.haddad@ids.ac.uk						[Anonymous], 2011, HINDU           0721; [Anonymous], 2003, 131 IFPRI; [Anonymous], 2005, PERF EV TARG PUBL DI; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Christiaensen L, 2010, 201036 WIDER; Haddad L, 2009, IDS BULL-I DEV STUD, V40, P1, DOI 10.1111/j.1759-5436.2009.00052.x; Hagen Zanker J., 2011, SYSTEMATIC REV IMPAC; Harriss J, 2009, IDS BULL-I DEV STUD, V40, P9, DOI 10.1111/j.1759-5436.2009.00053.x; Himaz R, 2009, IDS BULL-I DEV STUD, V40, P30, DOI 10.1111/j.1759-5436.2009.00056.x; Horton S., 2008, MALNUTRITION HUNGER; Indian Ministry of Health and Family Welfare, 2009, NAT FAM HLTH SURV 3; Int Mon Fund, 2011, WOR ECON OUTLOOK, P1; Kandpal E, WORLD DEV IN PRESS; Low JW, 2007, J NUTR, V137, P1320; Masset E, 2011, EFFECTIVENE IN PRESS; Mehrotra S, 2010, IND EC J, V58, P140; Menon P, 2009, IDS BULL-I DEV STUD, V40, P60, DOI 10.1111/j.1759-5436.2009.00060.x; Pattanayak SK, 2009, B WORLD HEALTH ORGAN, V87, P580, DOI 10.2471/BLT.08.057422; Ramalingaswami V, 1996, PROGR NATIONS; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Rocha C, 2009, DEV POLICY REV, V27, P51, DOI 10.1111/j.1467-7679.2009.00435.x; Saxena NC, 2009, IDS BULL-I DEV STUD, V40, P45, DOI 10.1111/j.1759-5436.2009.00058.x; Singh A., 2008, DO SCH MEALS WORK TR; Subramanyam MA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000424; Thorat S, 2009, IDS BULL-I DEV STUD, V40, P25, DOI 10.1111/j.1759-5436.2009.00055.x; UNICEF, 1990, STRAT IMPR NUTR CHIL; Ved R., 2011, ASHA WHICH WAY FORWA; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; WHO/UNICEF-Joint Monitoring Program, 2010, PROGR SAN DRINK WAT; World Health Organization, 2000, HLTH SYST IMPR PERF	31	12	12	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2011	343								d6687	10.1136/bmj.d6687	http://dx.doi.org/10.1136/bmj.d6687			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	848NY	22080488				2022-12-24	WOS:000297059500010
J	Azimzadeh, J; Wong, ML; Downhour, DM; Alvarado, AS; Marshall, WF				Azimzadeh, Juliette; Wong, Mei Lie; Downhour, Diane Miller; Alvarado, Alejandro Sanchez; Marshall, Wallace F.			Centrosome Loss in the Evolution of Planarians	SCIENCE			English	Article							CELLULAR FUNCTION; STEM-CELL; REGENERATION; CENTRIOLE; CILIA; NEOBLASTS; EMBRYOS; BODY	The centrosome, a cytoplasmic organelle formed by cylinder-shaped centrioles surrounded by a microtubule-organizing matrix, is a hallmark of animal cells. The centrosome is conserved and essential for the development of all animal species described so far. Here, we show that planarians, and possibly other flatworms, lack centrosomes. In planarians, centrioles are only assembled in terminally differentiating ciliated cells through the acentriolar pathway to trigger the assembly of cilia. We identified a large set of conserved proteins required for centriole assembly in animals and note centrosome protein families that are missing from the planarian genome. Our study uncovers the molecular architecture and evolution of the animal centrosome and emphasizes the plasticity of animal cell biology and development.	[Azimzadeh, Juliette; Wong, Mei Lie; Marshall, Wallace F.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Downhour, Diane Miller] Univ Utah, Sch Med, Dept Genet, Salt Lake City, UT 84132 USA; [Alvarado, Alejandro Sanchez] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Alvarado, Alejandro Sanchez] Howard Hughes Med Inst, Kansas City, MO 64110 USA	University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Stowers Institute for Medical Research; Howard Hughes Medical Institute	Azimzadeh, J (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	juliette.azimzadeh@ucsf.edu; wallace.marshall@ucsf.edu		Azimzadeh, Juliette/0000-0002-7292-9973	W. M. Keck Foundation; NIH [GM077004, GM57260]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077004, R01GM057260, R37GM057260] Funding Source: NIH RePORTER	W. M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Rink for sharing reagents and helping with planarian embryo analysis; R. Zalpuri and K. McDonald for help with TEM sample preparation; N. Tang for help with cryostat sectioning; K. Thorn and the Nikon Imaging Center for help with confocal imaging; Y. Chen and M. Braunfeld for help with TEM acquisition; L. Holt, D. David, M. Bettencourt-Dias, and M. Bornens for critical reading of the manuscript; and the Marshall lab and the Sanchez lab for insightful comments. This work was supported by the W. M. Keck Foundation (W. F. M.) and NIH grants GM077004 (W. F. M.) and GM57260 (A. S. A.). A. S. A. is a Howard Hughes Medical Institute investigator. All accession numbers for sequences associated with this study are provided in table S1.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Azimzadeh J, 2010, CURR BIOL, V20, pR816, DOI 10.1016/j.cub.2010.08.010; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; CALARCOGILLAM PD, 1983, CELL, V35, P621, DOI 10.1016/0092-8674(83)90094-6; Cardona A, 2006, DEV GENES EVOL, V216, P667, DOI 10.1007/s00427-006-0094-3; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114; Egger B, 2007, DEV GENES EVOL, V217, P89, DOI 10.1007/s00427-006-0120-5; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Jurberg AD, 2009, DEV GENES EVOL, V219, P219, DOI 10.1007/s00427-009-0285-9; Kraemer N, 2011, CELL MOL LIFE SCI, V68, P1719, DOI 10.1007/s00018-011-0635-4; Mayor T, 2002, J CELL SCI, V115, P3275; MORITA M, 1974, J EXP ZOOL, V187, P345, DOI 10.1002/jez.1401870305; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Rodrigues-Martins A, 2008, CELL CYCLE, V7, P11, DOI 10.4161/cc.7.1.5226; Rompolas P, 2010, MOL BIOL CELL, V21, P3669, DOI 10.1091/mbc.E10-04-0373; SAKAIWADA A, 1985, CHROMOSOMA, V93, P43, DOI 10.1007/BF01259445; Stevens NR, 2007, CURR BIOL, V17, P1498, DOI 10.1016/j.cub.2007.07.060; TYLER S, 1981, HYDROBIOLOGIA, V84, P231, DOI 10.1007/BF00026184; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983	23	110	111	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 27	2012	335	6067					461	463		10.1126/science.1214457	http://dx.doi.org/10.1126/science.1214457			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881FG	22223737	Green Accepted			2022-12-24	WOS:000299466800048
J	Cohen, D				Cohen, Deborah			FLU DRUGS Search for evidence goes on	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESPIRATORY-TRACT COMPLICATIONS; OSELTAMIVIR TREATMENT; ACUTE INFLUENZA; EFFICACY; SAFETY		BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						[Anonymous], 2007, WHO GEN TECH REP; Antiviral agents for the treatment and chemoprophylaxis of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011, ANTIVIRAL AGENTS TRE; Brasseur D, 2006, LANCET, V367, P1572, DOI 10.1016/S0140-6736(06)68685-6; Chambers J, HLTH PLACE IN PRESS; Cohen D, 2009, BRIT MED J, V339, pb538; Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2912; Epstein Helen, 2011, NEW YORK REV BO 0512; Godlee F, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5351; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Health and Human Services, 2005, HHS PAND INFL PLAN; Hernan MA, 2011, CLIN INFECT DIS, V53, P277, DOI 10.1093/cid/cir400; Jack A, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3811; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; McNicoll A, 2011, PULSE           0923; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Pott A, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3838; Roche, 2000, TAM OS PHOSPH NICE S; Roche, 2009, ROCH ANN REP 2009; Smith J, 2006, LANCET, V367, P1571, DOI 10.1016/S0140-6736(06)68683-2; Smith J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5364; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; United Kingdom Clinical Pharmacy Association, 2011, ANT MAN INFL A H1N1; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748	24	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2012	344								e458	10.1136/bmj.e458	http://dx.doi.org/10.1136/bmj.e458			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888YY	22252041				2022-12-24	WOS:000300041800012
J	Lipworth, W; Kerridge, I; Little, M; Day, R				Lipworth, Wendy; Kerridge, Ian; Little, Miles; Day, Richard			Evidence and desperation in off-label prescribing: recombinant factor VIIa	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACTIVATED FACTOR-VII; HEMORRHAGE; SAFETY; RULE		[Lipworth, Wendy] Univ New S Wales, Australian Inst Hlth Innovat, Sydney, NSW 2052, Australia; [Lipworth, Wendy; Kerridge, Ian; Little, Miles] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia; [Day, Richard] St Vincents Hosp, Sydney, NSW 2010, Australia	University of New South Wales Sydney; University of Sydney; St Vincents Hospital Sydney	Lipworth, W (corresponding author), Univ New S Wales, Australian Inst Hlth Innovat, Sydney, NSW 2052, Australia.	w.lipworth@unsw.edu.au	Day, Richard/D-8699-2011	Day, Richard/0000-0002-6045-6937; Lipworth, Wendy/0000-0002-0234-657X; Kerridge, Ian/0000-0001-7445-4660	National Health and Medical Research Council (NHMRC) [568612]; Sydney Medical School Foundation, University of Sydney	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical School Foundation, University of Sydney	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. Empirical research related to this article has been funded by a National Health and Medical Research Council (NH&MRC) programme grant (568612) and by the Sydney Medical School Foundation, University of Sydney.	Avorn J, 2011, ANN INTERN MED, V154, P566, DOI 10.7326/0003-4819-154-8-201104190-00010; Bright JL, 2006, ARCH INTERN MED, V166, P2554, DOI 10.1001/archinte.166.22.2554-b; Dutton RP, 2011, J TRAUMA, V71, P12, DOI 10.1097/TA.0b013e31821a42cf; Gilovich T, 1998, PSYCHOL REV, V105, P602, DOI 10.1037/0033-295X.105.3.602; HADORN DC, 1991, JAMA-J AM MED ASSOC, V265, P2218, DOI 10.1001/jama.265.17.2218; Jonsen A R, 1986, Law Med Health Care, V14, P172; Kalina Michael, 2011, Del Med J, V83, P109; Karkouti K, 2011, ANN INTERN MED, V155, P339, DOI 10.7326/0003-4819-155-5-201109060-00023; Kesselheim AS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000431; Largent EA, 2009, ARCH INTERN MED, V169, P1745, DOI 10.1001/archinternmed.2009.314; Levi M, 2010, NEW ENGL J MED, V363, P1791, DOI 10.1056/NEJMoa1006221; Lin YL, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005011.pub3; Logan AC, 2011, ANN INTERN MED, V154, P516, DOI 10.7326/0003-4819-154-8-201104190-00002; MARKS I, 1988, AM J PSYCHIAT, V145, P1207; McKie J, 2003, SOC SCI MED, V56, P2407, DOI 10.1016/S0277-9536(02)00244-7; Ray C., 2011, WALL STREET J   0610; STIELL IG, 1992, NEW ENGL J MED, V327, P1045, DOI 10.1056/NEJM199210083271502; Witmer CM, 2011, J PEDIAT, V158, P820; Yank V, 2011, ANN INTERN MED, V154, P529, DOI 10.7326/0003-4819-154-8-201104190-00004	19	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2012	344								d7926	10.1136/bmj.d7926	http://dx.doi.org/10.1136/bmj.d7926			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888YP	22250217	Green Submitted			2022-12-24	WOS:000300040900012
J	Sofat, R; Casas, JP; Grosso, AM; Prichard, BNC; Smeeth, L; MacAllister, R; Hingorani, AD				Sofat, Reecha; Casas, Juan P.; Grosso, Anthony M.; Prichard, Brian N. C.; Smeeth, Liam; MacAllister, Raymond; Hingorani, Aroon D.			Could NICE guidance on the choice of blood pressure lowering drugs be simplified?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BETA-BLOCKERS; ANTIHYPERTENSIVE TREATMENT; CARDIOVASCULAR EVENTS; DIABETES-MELLITUS; HYPERTENSION; METAANALYSIS; GLUCOSE; DISEASE; OLDER; ALDOSTERONE		[Sofat, Reecha; Grosso, Anthony M.; Prichard, Brian N. C.; MacAllister, Raymond; Hingorani, Aroon D.] UCL, Ctr Clin Pharmacol, London WC1E 6JJ, England; [Casas, Juan P.; Hingorani, Aroon D.] UCL, Fac Populat Hlth Sci, London WC1E 6JJ, England; [Casas, Juan P.; Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Grosso, Anthony M.] Univ Coll London Hosp NHS Fdn Trust, Dept Pharm, London, England; [Grosso, Anthony M.] UCL, Sch Pharm, London WC1E 6JJ, England	University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London School of Pharmacy	Sofat, R (corresponding author), UCL, Ctr Clin Pharmacol, London WC1E 6JJ, England.	r.sofat@ucl.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022; Hingorani, Aroon/0000-0001-8365-0081; Sofat, Reecha/0000-0002-0242-6115	National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Barzilay JI, 2006, ARCH INTERN MED, V166, P2191, DOI 10.1001/archinte.166.20.2191; BELMIN J, 1994, DRUG AGING, V5, P391, DOI 10.2165/00002512-199405050-00007; Bradley HA, 2006, J HYPERTENS, V24, P2131, DOI 10.1097/01.hjh.0000249685.58370.28; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; De Bruin RA, 2004, CLIN CHEM, V50, P2111, DOI 10.1373/clinchem.2004.032052; Dickerson JEC, 1999, LANCET, V353, P2008, DOI 10.1016/S0140-6736(98)07614-4; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Khan N, 2006, CAN MED ASSOC J, V174, P1737, DOI 10.1503/cmaj.060110; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Lawes CMM, 2006, J HYPERTENS, V24, P423, DOI 10.1097/01.hjh.0000209973.67746.f0; Lawlor DA, 2007, PLOS MED, V4, P1396, DOI 10.1371/journal.pmed.0040263; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; New Zealand Guidelines Group, 2009, NZ CARD GUID HDB SUM, VSecond; NICE British Hypertension Society, 2006, NICE CLIN GUID 34 HY; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Poulter NR, 2005, LANCET, V366, P907, DOI 10.1016/S0140-6736(05)67186-3; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sarwar N, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000278; Scottish Intercollegiate Guidelines Network, 2007, RISK EST PREV CARD D; Seifarth C, 2002, CLIN ENDOCRINOL, V57, P457, DOI 10.1046/j.1365-2265.2002.01613.x; Staessen JA, 2005, LANCET, V366, P869, DOI 10.1016/S0140-6736(05)67147-4; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; Wald DS, 2009, AM J MED, V122, P290, DOI 10.1016/j.amjmed.2008.09.038	28	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2012	344								d8078	10.1136/bmj.d8078	http://dx.doi.org/10.1136/bmj.d8078			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877SR	22246267	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000299203500012
J	Kim, JH; Malhotra, R; Chiampas, G; d'Hemecourt, P; Troyanos, C; Cianca, J; Smith, RN; Wang, TJ; Roberts, WO; Thompson, PD; Baggish, AL				Kim, Jonathan H.; Malhotra, Rajeev; Chiampas, George; d'Hemecourt, Pierre; Troyanos, Chris; Cianca, John; Smith, Rex N.; Wang, Thomas J.; Roberts, William O.; Thompson, Paul D.; Baggish, Aaron L.		Race Associated Cardiac Arrest	Cardiac Arrest during Long-Distance Running Races	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; AMERICAN-HEART-ASSOCIATION; SUDDEN-DEATH; HYPERTROPHIC CARDIOMYOPATHY; PLATELET ACTIVATION; STANDARDIZED RATES; BOSTON MARATHON; EXERTION; ATHEROSCLEROSIS; RUNNERS	BACKGROUND Approximately 2 million people participate in long-distance running races in the United States annually. Reports of race-related cardiac arrests have generated concern about the safety of this activity. METHODS We assessed the incidence and outcomes of cardiac arrest associated with marathon and half-marathon races in the United States from January 1, 2000, to May 31, 2010. We determined the clinical characteristics of the arrests by interviewing survivors and the next of kin of nonsurvivors, reviewing medical records, and analyzing postmortem data. RESULTS Of 10.9 million runners, 59 (mean [+/-SD] age, 42+/-13 years; 51 men) had cardiac arrest (incidence rate, 0.54 per 100,000 participants; 95% confidence interval [CI], 0.41 to 0.70). Cardiovascular disease accounted for the majority of cardiac arrests. The incidence rate was significantly higher during marathons (1.01 per 100,000; 95% CI, 0.72 to 1.38) than during half-marathons (0.27; 95% CI, 0.17 to 0.43) and among men (0.90 per 100,000; 95% CI, 0.67 to 1.18) than among women (0.16; 95% CI, 0.07 to 0.31). Male marathon runners, the highest-risk group, had an increased incidence of cardiac arrest during the latter half of the study decade (2000-2004, 0.71 per 100,000 [95% CI, 0.31 to 1.40]; 2005-2010, 2.03 per 100,000 [95% CI, 1.33 to 2.98]; P = 0.01). Of the 59 cases of cardiac arrest, 42 (71%) were fatal (incidence, 0.39 per 100,000; 95% CI, 0.28 to 0.52). Among the 31 cases with complete clinical data, initiation of bystander-administered cardiopulmonary resuscitation and an underlying diagnosis other than hypertrophic cardiomyopathy were the strongest predictors of survival. CONCLUSIONS Marathons and half-marathons are associated with a low overall risk of cardiac arrest and sudden death. Cardiac arrest, most commonly attributable to hypertrophic cardiomyopathy or atherosclerotic coronary disease, occurs primarily among male marathon participants; the incidence rate in this group increased during the past decade.	[Baggish, Aaron L.] Massachusetts Gen Hosp, Cardiovasc Performance Program, Div Cardiol, Boston, MA 02114 USA; [Smith, Rex N.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [d'Hemecourt, Pierre] Harvard Univ, Sch Med, Boston, MA USA; [d'Hemecourt, Pierre] Childrens Hosp, Div Sports Med, Boston, MA 02115 USA; [Troyanos, Chris] Boston Athlet Assoc, Boston, MA USA; [Chiampas, George] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Cianca, John] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Roberts, William O.] Univ Minnesota, Sch Med, Dept Family Med, St Paul, MN 55108 USA; [Thompson, Paul D.] Univ Connecticut, Sch Med, Hartford Hosp, Div Cardiol, Hartford, CT 06112 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Northwestern University; Feinberg School of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; Hartford Hospital; University of Connecticut	Baggish, AL (corresponding author), Massachusetts Gen Hosp, Cardiovasc Performance Program, Div Cardiol, 55 Fruit St,YAW-5800, Boston, MA 02114 USA.	abaggish@partners.org	Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867; Roberts, William O/0000-0003-4517-4330; Wang, Thomas/0000-0003-4063-6508; Malhotra, Rajeev/0000-0003-0120-4630	Regeneron; Lupin Pharmaceuticals; GlaxoSmithKline; Genomas; Novartis; Furiex Pharmaceuticals; Merck; Pfizer; AstraZeneca; Kowa; Abbott	Regeneron(Regeneron); Lupin Pharmaceuticals; GlaxoSmithKline(GlaxoSmithKline); Genomas; Novartis(Novartis); Furiex Pharmaceuticals; Merck(Merck & Company); Pfizer(Pfizer); AstraZeneca(AstraZeneca); Kowa; Abbott(Abbott Laboratories)	Dr. Roberts reports holding a board membership with UCare Minnesota, receiving writing fees from Runner's World, and serving as an unpaid, volunteer medical director for the Medtronic Twin Cities Marathon; and Dr. Thompson, receiving consulting fees from Regeneron, Furiex Pharmaceuticals, and Lupin Pharmaceuticals, legal fees for expert testimony in cases related to cardiac arrest in exercise- and statin-related muscle injury, grant funding from GlaxoSmithKline, Genomas, Novartis, Furiex Pharmaceuticals, B. Braun, and Aventis, lecture fees from Merck, Pfizer, AstraZeneca, Kowa, Abbott, and GlaxoSmithKline, support for the development of educational presentations from Merck, and holding stock in Zoll Medical, J.A. Wiley Publishing, General Electric, Zimmer, Medtronic, Johnson & Johnson, Sanofi-Aventis, and Abbott. No other potential conflict of interest relevant to this article was reported.	Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902; Allday E, 2009, SAN FRANCISCO C 1006; Almond CSD, 2005, NEW ENGL J MED, V352, P1550, DOI 10.1056/NEJMoa043901; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; BLACK A, 1975, ANGIOLOGY, V26, P759; Burfoot A, 2008, RUNNERS WORLD    DEC; Carriere KC, 1997, MED CARE, V35, P57, DOI 10.1097/00005650-199701000-00005; CARRIERE KC, 1994, AM J EPIDEMIOL, V140, P472, DOI 10.1093/oxfordjournals.aje.a117269; Donoghue ER, 1997, AM J FOREN MED PATH, V18, P11, DOI 10.1097/00000433-199703000-00002; Elliott PM, 1999, J AM COLL CARDIOL, V33, P1596, DOI 10.1016/S0735-1097(99)00056-X; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Giri S, 1999, JAMA-J AM MED ASSOC, V282, P1731, DOI 10.1001/jama.282.18.1731; GORDON T, 1972, J AMER MED ASSOC, V221, P661, DOI 10.1001/jama.221.7.661; Hanke AA, 2010, EUR J MED RES, V15, P59, DOI 10.1186/2047-783X-15-2-59; HANSON PG, 1979, JAMA-J AM MED ASSOC, V242, P154, DOI 10.1001/jama.242.2.154; Harmon KG, 2011, CIRCULATION, V123, P1594, DOI 10.1161/CIRCULATIONAHA.110.004622; Harris KM, 2010, JAMA-J AM MED ASSOC, V303, P1255, DOI 10.1001/jama.2010.368; Kratz A, 2006, AM J CLIN PATHOL, V125, P296, DOI 10.1309/PRF5N7P2XM6E243H; Lamppa R., 2010, 2010 MARATHON HALF M; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Maron BJ, 1996, J AM COLL CARDIOL, V28, P428, DOI 10.1016/0735-1097(96)00137-4; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; Mohlenkamp S, 2008, EUR HEART J, V29, P1903, DOI 10.1093/eurheartj/ehn163; Mousavi N, 2009, AM J CARDIOL, V103, P1467, DOI 10.1016/j.amjcard.2009.01.294; Neilan TG, 2006, CIRCULATION, V114, P2325, DOI 10.1161/CIRCULATIONAHA.106.647461; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Olivotto I, 2005, J AM COLL CARDIOL, V46, P480, DOI 10.1016/j.jacc.2005.04.043; Parker-Pope T, 2009, NY TIMES        1020; Redelmeier DA, 2007, BRIT MED J, V335, P1275, DOI 10.1136/bmj.39384.551539.25; Roberts WO, 2005, J AM COLL CARDIOL, V46, P1373, DOI 10.1016/j.jacc.2005.07.008; Robinson J, 2008, NY TIMES        1103; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; THOMPSON PD, 1982, JAMA-J AM MED ASSOC, V247, P2535, DOI 10.1001/jama.247.18.2535; Thompson PD, 2005, CIRCULATION, V112, P2354, DOI 10.1161/CIRCULATIONAHA.104.502591; Wilkins K, 2009, DETROIT FREE PR 1018; WILLICH SN, 1993, NEW ENGL J MED, V329, P1684, DOI 10.1056/NEJM199312023292302; Yared K, 2009, RADIOLOGY, V251, P3, DOI 10.1148/radiol.2511090041; Zinser L, 2007, NY TIMES        1104	39	371	379	4	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					130	140		10.1056/NEJMoa1106468	http://dx.doi.org/10.1056/NEJMoa1106468			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874VA	22236223	Bronze			2022-12-24	WOS:000298985000007
J	Gigerenzer, G; Galesic, M				Gigerenzer, Gerd; Galesic, Mirta			THE ART OF RISK COMMUNICATION Why do single event probabilities confuse patients?	BRITISH MEDICAL JOURNAL			English	Editorial Material							NUMERACY		[Gigerenzer, Gerd; Galesic, Mirta] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany	Max Planck Society	Gigerenzer, G (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany.	gigerenzer@mpib-berlin.mpg.de	Gigerenzer, Gerd/M-5595-2013; Gigerenzer, Gerd/A-6250-2012; Galesic, Mirta/B-8327-2012	Gigerenzer, Gerd/0000-0002-6163-5419; Galesic, Mirta/0000-0002-3537-8359				Centers for Disease Control and Prevention, UN PREGN PREV CONTR; eMedicineHealth, EFF RAT BIRTH CONTR; Gigerenzer G, 2005, RISK ANAL, V25, P623, DOI 10.1111/j.1539-6924.2005.00608.x; Gigerenzer G., 2002, RECKONING RISK LEARN; Hanoch Y, 2010, JUDGM DECIS MAK, V5, P116; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Mayo Clinic, ANT CHILDR EXPL PROS; Prostate.net, PROST CANC TREATM SI; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Slovic P, 2000, LAW HUMAN BEHAV, V24, P271, DOI 10.1023/A:1005595519944	10	32	33	0	19	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2012	344								e245	10.1136/bmj.e245	http://dx.doi.org/10.1136/bmj.e245			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877SI	22236599				2022-12-24	WOS:000299202500005
J	Kociol, RD; Lopes, RD; Clare, R; Thomas, L; Mehta, RH; Kaul, P; Pieper, KS; Hochman, JS; Weaver, WD; Armstrong, PW; Granger, CB; Patel, MR				Kociol, Robb D.; Lopes, Renato D.; Clare, Robert; Thomas, Laine; Mehta, Rajendra H.; Kaul, Padma; Pieper, Karen S.; Hochman, Judith S.; Weaver, W. Douglas; Armstrong, Paul W.; Granger, Christopher B.; Patel, Manesh R.			International Variation in and Factors Associated With Hospital Readmission After Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; HEART-DISEASE MORTALITY; TEMPORAL TRENDS; EARLY DISCHARGE; FOLLOW-UP; PEXELIZUMAB; TRIAL; FAILURE; US	Context ST-segment elevation myocardial infarction (STEMI) treatment has improved outcomes and shortened hospital stay. Recently, 30-day readmission rates have been proposed as a metric for care of patients with STEMI. However, international rates and predictors of 30-day readmission after STEMI have not been studied. Objective To determine international variation in and predictors of 30-day readmission rates after STEMI and country-level care patterns. Design, Setting, and Patients Post hoc analysis of the Assessment of Pexelizumab in Acute Myocardial Infarction trial that enrolled 5745 patients with STEMI at 296 sites in the United States, Canada, Australia, New Zealand, and 13 European countries from July 13, 2004, to May 11, 2006. Multivariable logistic regression analysis was used to identify independent predictors of all-cause and non-elective 30-day postdischarge readmission. Main Outcome Measures Predictors of 30-day postdischarge all-cause and non-elective readmissions. Results Of 5571 patients with STEMI who survived to hospital discharge, 631 (11.3%) were readmitted within 30 days. Thirty-day readmission rates were higher for the United States than other countries (14.5% vs 9.9%; P<.001). Median length of stay was shortest for US patients (3 days; interquartile range, 2-4 days) and longest for Germany (8 days; interquartile range, 6-11 days). In multivariable regression, the predictors of 30-day readmission included multivessel disease (odds ratio [OR], 1.97; 95% CI, 1.65-2.35) and US location (OR, 1.68; 95% CI, 1.37-2.07). Excluding elective readmission for revascularization, US enrollment was still an independent predictor of readmission (OR, 1.53; 95% CI, 1.20-1.96). After adjustment of the models for country-level median length of stay, US location was no longer an independent predictor of 30-day all-cause or nonelective readmission. Location in the United States was not a predictor of in-hospital death (OR, 0.88; 95% CI, 0.60-1.30) or 30-day postadmission death (OR, 1.0; 95% CI, 0.72-1.39). Conclusions In this multinational study, there was variation across countries in 30-day readmission rates after STEMI, with readmission rates higher in the United States than in other countries. However, this difference was greatly attenuated after adjustment for length of stay. JAMA. 2012;307(1):66-74	[Kociol, Robb D.; Lopes, Renato D.; Clare, Robert; Thomas, Laine; Mehta, Rajendra H.; Pieper, Karen S.; Granger, Christopher B.; Patel, Manesh R.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27715 USA; [Kaul, Padma; Armstrong, Paul W.] Univ Alberta, Edmonton, AB, Canada; [Hochman, Judith S.] NYU, Sch Med, Cardiovasc Clin Res Ctr, New York, NY USA; [Weaver, W. Douglas] Henry Ford Hosp, Henry Ford Heart & Vasc Inst, Detroit, MI 48202 USA	Duke University; University of Alberta; New York University; Henry Ford Health System; Henry Ford Hospital	Patel, MR (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	manesh.patel@duke.edu	Granger, Christopher B/D-3458-2014; Patel, Manesh/AAC-5385-2019	Granger, Christopher B/0000-0002-0045-3291; Hochman, Judith/0000-0002-5889-5981; Kociol, Robb/0000-0002-8759-9997; Kaul, Padma/0000-0003-2239-3944; Armstrong, Paul/0000-0002-0460-3445	Duke Clinical Research Institute; Procter & Gamble Pharmaceuticals; Alexion Pharmaceuticals; American Heart Association-Pharmaceutical Roundtable	Duke Clinical Research Institute; Procter & Gamble Pharmaceuticals(Procter & Gamble); Alexion Pharmaceuticals; American Heart Association-Pharmaceutical Roundtable(American Heart Association)	This research was supported by unrestricted funding from the Duke Clinical Research Institute. Procter & Gamble Pharmaceuticals and Alexion Pharmaceuticals jointly funded the Assessment of Pexelizumab in Acute Myocardial Infarction trial. This work was supported by an award from the American Heart Association-Pharmaceutical Roundtable and David and Stevie Spina.	Anderson GF, 2008, MULTINATIONAL COMP H; Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43; Armstrong PW, 2005, AM HEART J, V149, P402, DOI 10.1016/j.ahj.2004.12.015; Baker DW, 2004, ARCH INTERN MED, V164, P538, DOI 10.1001/archinte.164.5.538; Betriu A, 1997, NEW ENGL J MED, V336, P1621; Brener SJ, 2006, AM HEART J, V151, pS4, DOI 10.1016/j.ahj.2006.04.007; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Curtis JP, 2009, J AM COLL CARDIOL, V54, P903, DOI 10.1016/j.jacc.2009.04.076; Daugherty SL, 2008, ARCH INTERN MED, V168, P485, DOI 10.1001/archinte.168.5.485; Desai MM, 2009, CIRC-CARDIOVASC QUAL, V2, P500, DOI 10.1161/CIRCOUTCOMES.108.832949; DEWOOD MA, 1980, NEW ENGL J MED, V303, P897, DOI 10.1056/NEJM198010163031601; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; Kaul P, 2004, LANCET, V363, P511, DOI 10.1016/S0140-6736(04)15536-0; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; LAU YK, 1980, BRIT MED J, V280, P1489, DOI 10.1136/bmj.280.6230.1489; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Movahed MR, 2009, AM J CARDIOL, V104, P1030, DOI 10.1016/j.amjcard.2009.05.051; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Schroder R, 2004, CIRCULATION, V110, pE506, DOI 10.1161/01.CIR.0000147778.05979.E6; Spertus John A., 2003, Circulation, V107, P1681, DOI 10.1161/01.CIR.0000062026.90014.63; Stebbins A, 2010, CIRC-CARDIOVASC INTE, V3, P414, DOI 10.1161/CIRCINTERVENTIONS.109.925180; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011	25	99	99	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2012	307	1					66	74		10.1001/jama.2011.1926	http://dx.doi.org/10.1001/jama.2011.1926			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872ET	22215167	Bronze, Green Published			2022-12-24	WOS:000298792300023
J	Fujiki, R; Hashiba, W; Sekine, H; Yokoyama, A; Chikanishi, T; Ito, S; Imai, Y; Kim, J; He, HH; Igarashi, K; Kanno, J; Ohtake, F; Kitagawa, H; Roeder, RG; Brown, M; Kato, S				Fujiki, Ryoji; Hashiba, Waka; Sekine, Hiroki; Yokoyama, Atsushi; Chikanishi, Toshihiro; Ito, Saya; Imai, Yuuki; Kim, Jaehoon; He, Housheng Hansen; Igarashi, Katsuhide; Kanno, Jun; Ohtake, Fumiaki; Kitagawa, Hirochika; Roeder, Robert G.; Brown, Myles; Kato, Shigeaki			GlcNAcylation of histone H2B facilitates its monoubiquitination	NATURE			English	Article							O-GLCNAC TRANSFERASE; BETA-N-ACETYLGLUCOSAMINE; CHROMATIN; ACETYLATION; LANGUAGE; GENES	Chromatin reorganization is governed by multiple post-translational modifications of chromosomal proteins and DNA(1,2). These histone modifications are reversible, dynamic events that can regulate DNA-driven cellular processes(3,4). However, the molecular mechanisms that coordinate histone modification patterns remain largely unknown. In metazoans, reversible protein modification by O-linked N-acetylglucosamine (GlcNAc) is catalysed by two enzymes, O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA)(5,6). However, the significance of GlcNAcylation in chromatin reorganization remains elusive. Here we report that histone H2B is GlcNAcylated at residue S112 by OGT in vitro and in living cells. Histone GlcNAcylation fluctuated in response to extracellular glucose through the hexosamine biosynthesis pathway (HBP)(5,6). H2B S112 GlcNAcylation promotes K120 monoubiquitination, in which the GlcNAc moiety can serve as an anchor for a histone H2B ubiquitin ligase. H2B S112 GlcNAc was localized to euchromatic areas on fly polytene chromosomes. In a genome-wide analysis, H2B S112 GlcNAcylation sites were observed widely distributed over chromosomes including transcribed gene loci, with some sites co-localizing with H2B K120 monoubiquitination. These findings suggest that H2B S112 GlcNAcylation is a histone modification that facilitates H2BK120 monoubiquitination, presumably for transcriptional activation.	[Fujiki, Ryoji; Hashiba, Waka; Sekine, Hiroki; Yokoyama, Atsushi; Chikanishi, Toshihiro; Ito, Saya; Imai, Yuuki; Ohtake, Fumiaki; Kitagawa, Hirochika; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Kim, Jaehoon; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA; [He, Housheng Hansen; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [He, Housheng Hansen; Brown, Myles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Igarashi, Katsuhide; Kanno, Jun] Natl Inst Hlth Sci, Div Cellular & Mol Toxicol, Setagaya Ku, Tokyo 1588501, Japan; [Kato, Shigeaki] Japan Sci & Technol Agcy, ERATO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Rockefeller University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; National Institute of Health Sciences - Japan; Japan Science & Technology Agency (JST)	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	uskato@mail.ecc.u-tokyo.ac.jp	Yokoyama, Atsushi/W-3519-2019; Brown, Myles/AAX-5332-2021; Kim, Jaehoon/G-2711-2011; Imai, Yuuki/ABC-4687-2020; He, Hansen/ABD-8439-2020; He, Housheng/G-9614-2011; Brown, Myles/B-6906-2008	Brown, Myles/0000-0002-8213-1658; Kim, Jaehoon/0000-0003-4035-0438; He, Hansen/0000-0003-2898-3363; Yokoyama, Atsushi/0000-0003-2842-4334	Naito Foundation; Astellas foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science	Naito Foundation(Naito Memorial Foundation); Astellas foundation(Astellas Pharmaceuticals); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank A. Miyajima, S. Saito and N. Moriyama for experimental support, and M. Yamaki for manuscript preparation. We also thank Y. Maekawa, J. Seta and N. Iwasaki for support with MS. This work was supported in part by The Naito Foundation, the Astellas foundation (to R. F.), the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Society for the Promotion of Science (to R.F. and S.K.).	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Chikanishi T, 2010, BIOCHEM BIOPH RES CO, V394, P865, DOI 10.1016/j.bbrc.2010.02.167; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dong L, 2004, J BIOL CHEM, V279, P1577, DOI 10.1074/jbc.C300505200; Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sawatsubashi S, 2010, GENE DEV, V24, P159, DOI 10.1101/gad.1857410; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890	25	219	232	4	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					557	U188		10.1038/nature10656	http://dx.doi.org/10.1038/nature10656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22121020	Green Accepted			2022-12-24	WOS:000298318000068
J	Esserman, LJ; Woodcock, J				Esserman, Laura J.; Woodcock, Janet			Accelerating Identification and Regulatory Approval of Investigational Cancer Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Esserman, Laura J.] Univ Calif San Francisco, San Francisco, CA 94115 USA; [Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	University of California System; University of California San Francisco; US Food & Drug Administration (FDA)	Esserman, LJ (corresponding author), Univ Calif San Francisco, 1600 Divisadero St,POB 1710, San Francisco, CA 94115 USA.	laura.esserman@ucsfmedctr.org						[Anonymous], 1 SPY2 CLIN TRIAL; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Centers for Medicare & Medicaid Services, NAT HLTH EXP FACT SH; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Esserman LJ, BREAST CANC RES TREA, DOI [10.1007/sl0549-011-1895-2, DOI 10.1007/SL0549-011-1895-2]; Olson S., 2011, ESTABLISHING PRECOMP; Patlak M, 2010, EXTENDING SPECTRUM P; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a	9	46	48	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2608	2609		10.1001/jama.2011.1837	http://dx.doi.org/10.1001/jama.2011.1837			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864YQ	22187281				2022-12-24	WOS:000298276800023
J	Willyard, C				Willyard, Cassandra			IMAGING Seeing is believing	NATURE			English	Editorial Material							MULTIPLE-MYELOMA											Bartel TB, 2009, BLOOD, V114, P2068, DOI 10.1182/blood-2009-03-213280; Shortt CP, 2009, AM J ROENTGENOL, V192, P980, DOI 10.2214/AJR.08.1633	2	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S52	S53		10.1038/480S52a	http://dx.doi.org/10.1038/480S52a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169805				2022-12-24	WOS:000298033000011
J	Giocomo, LM; Hussaini, SA; Zheng, F; Kandel, ER; Moser, MB; Moser, EI				Giocomo, Lisa M.; Hussaini, Syed A.; Zheng, Fan; Kandel, Eric R.; Moser, May-Britt; Moser, Edvard I.			Grid Cells Use HCN1 Channels for Spatial Scaling	CELL			English	Article							MEDIAL ENTORHINAL CORTEX; CA1 PYRAMIDAL NEURONS; STELLATE CELLS; LAYER-II; DISTAL DENDRITES; PATH-INTEGRATION; PLACE CELLS; H-CURRENT; THETA; REPRESENTATION	Entorhinal grid cells have periodic, hexagonally patterned firing locations that scale up progressively along the dorsal-ventral axis of medial entorhinal cortex. This topographic expansion corresponds with parallel changes in cellular properties dependent on the hyperpolarization-activated cation current (Ih), which is conducted by hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. To test the hypothesis that grid scale is determined by Ih, we recorded grid cells in mice with forebrain-specific knockout of HCN1. We find that, although the dorsal-ventral gradient of the grid pattern was preserved in HCN1 knockout mice, the size and spacing of the grid fields, as well as the period of the accompanying theta modulation, was expanded at all dorsal-ventral levels. There was no change in theta modulation of simultaneously recorded entorhinal interneurons. These observations raise the possibility that, during self-motion-based navigation, Ih contributes to the gain of the transformation from movement signals to spatial firing fields.	[Giocomo, Lisa M.; Zheng, Fan; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7030 Trondheim, Norway; [Giocomo, Lisa M.; Zheng, Fan; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7030 Trondheim, Norway; [Hussaini, Syed A.; Kandel, Eric R.] Columbia Univ, Dept Neurosci, Kavli Inst Brain Sci, New York, NY 10032 USA; [Hussaini, Syed A.; Kandel, Eric R.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Columbia University; Columbia University; Howard Hughes Medical Institute	Giocomo, LM (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7030 Trondheim, Norway.	lisa.m.giocomo@ntnu.no; edvard.moser@ntnu.no	Hussaini, Abid/AAZ-2418-2020	Hussaini, S. Abid/0000-0002-3921-9021; Giocomo, Lisa/0000-0003-0416-2528	European Commission; European Research Council; NIH [MH080745]; Howard Hughes Medical Institute; Kavli Foundation; Norwegian Research Council; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080745] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R. Skjerpeng for programming; O. Salvesen for statistical advice; A. M. Amundsga rd, I. Hammer, K. Haugen, and H. Waade for technical assistance; and M. E. Hasselmo, T. Solstad, and J.F. Storm for helpful discussion and/or comments on the manuscript. This work was supported by a Marie Curie Fellowship to L. M. G. from the European Commission; an Advanced Investigator Grant to E. I. M. from the European Research Council; an NIH grant MH080745 to S. A. H. and E. R. K.; the Howard Hughes Medical Institute (E. R. K.); the Kavli Foundation (M.-B. M. and E. I. M.); and a Centre of Excellence grant from the Norwegian Research Council (M.-B. M. and E. I. M.).	Blair HT, 2008, HIPPOCAMPUS, V18, P1239, DOI 10.1002/hipo.20509; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Boehlen A, 2010, J NEUROSCI, V30, P4585, DOI 10.1523/JNEUROSCI.4939-09.2010; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Dodson PD, 2011, J PHYSIOL-LONDON, V589, P2993, DOI 10.1113/jphysiol.2011.205021; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Fyhn M, 2008, HIPPOCAMPUS, V18, P1230, DOI 10.1002/hipo.20472; Garden DLF, 2008, NEURON, V60, P875, DOI 10.1016/j.neuron.2008.10.044; Giocomo LM, 2008, J NEUROSCI, V28, P9414, DOI 10.1523/JNEUROSCI.3196-08.2008; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Giocomo LM, 2009, J NEUROSCI, V29, P7625, DOI 10.1523/JNEUROSCI.0609-09.2009; Giocomo LM, 2008, HIPPOCAMPUS, V18, P1186, DOI 10.1002/hipo.20501; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Heys JG, 2010, J NEUROPHYSIOL, V104, P258, DOI 10.1152/jn.00492.2009; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hu H, 2009, J NEUROSCI, V29, P14472, DOI 10.1523/JNEUROSCI.0187-09.2009; Hussaini SA, 2011, NEURON, V72, P643, DOI 10.1016/j.neuron.2011.09.007; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Kispersky T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013697; Kjonigsen Lisa J, 2011, Front Neuroinform, V5, P2, DOI 10.3389/fninf.2011.00002; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Navratilova Z, 2011, HIPPOCAMPUS IN PRESS; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	42	107	107	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 23	2011	147	5					1159	1170		10.1016/j.cell.2011.08.051	http://dx.doi.org/10.1016/j.cell.2011.08.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22100643	Bronze			2022-12-24	WOS:000297376600025
J	Schonbauer, C; Distler, J; Jahrling, N; Radolf, M; Dodt, HU; Frasch, M; Schnorrer, F				Schoenbauer, Cornelia; Distler, Jutta; Jaehrling, Nina; Radolf, Martin; Dodt, Hans-Ulrich; Frasch, Manfred; Schnorrer, Frank			Spalt mediates an evolutionarily conserved switch to fibrillar muscle fate in insects	NATURE			English	Article							FLIGHT-MUSCLE; DROSOPHILA EMBRYO; GENETIC-ANALYSIS; PROTEIN; EXPRESSION; MYOGENESIS; SALL1; ACTIN	Flying insects oscillate their wings at high frequencies of up to 1,000 Hz(1,2) and produce large mechanical forces of 80 W per kilogram of muscle(3). They utilize a pair of perpendicularly oriented indirect flight muscles that contain fibrillar, stretch-activated myofibres. In contrast, all other, more slowly contracting, insect body muscles have a tubular muscle morphology(4). Here we identify the transcription factor Spalt major (Salm) as a master regulator of fibrillar flight muscle fate in Drosophila. salm is necessary and sufficient to induce fibrillar muscle fate. salm switches the entire transcriptional program from tubular to fibrillar fate by regulating the expression and splicing of key sarcomeric components specific to each muscle type. Spalt function is conserved in insects evolutionarily separated by 280 million years. We propose that Spalt proteins switch myofibres from tubular to fibrillar fate during development, a function potentially conserved in the vertebrate heart-a stretch-activated muscle sharing features with insect flight muscle.	[Schoenbauer, Cornelia; Schnorrer, Frank] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Distler, Jutta; Frasch, Manfred] Univ Erlangen Nurnberg, Dept Biol, Dev Biol Div, D-91058 Erlangen, Germany; [Jaehrling, Nina; Dodt, Hans-Ulrich] Vienna Univ Technol, FKE, Dept Bioelect, A-1040 Vienna, Austria; [Jaehrling, Nina; Dodt, Hans-Ulrich] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria; [Radolf, Martin] IMP, A-1030 Vienna, Austria	Max Planck Society; University of Erlangen Nuremberg; Technische Universitat Wien; Medical University of Vienna; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Schnorrer, F (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	schnorrer@biochem.mpg.de	Frasch, Manfred/H-7002-2013; Schnorrer, Frank/AIE-3578-2022	Frasch, Manfred/0000-0003-1373-9798; Schnorrer, Frank/0000-0002-9518-7263	Max-Planck-Society; Human Frontier Science Programme; Austrian Academy of Sciences; DFG	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Human Frontier Science Programme(Human Frontier Science Program); Austrian Academy of Sciences; DFG(German Research Foundation (DFG))	We thank M. Affolter, D. Baumer, M. Beckerle, B. Bullard, E. Chen, K. Clark, C. Desplan, K. Jagla, A. Lalouette, J. Posakony, D. Reiff, J. Saide, S. Sprecher, R. Schuh, G. Tanentzapf, J. Vigoreaux, K. VijayRaghavan, the Bloomington and the VDRC stock centres for fly stocks, antibodies and insect species. We are grateful to B. Dickson, I. Hein, M. Klingler and M. Sixt for discussions, and to R. Fassler for support and discussions. We thank A. Kaya-Copur, H. Knaut, M. Spletter and N. Vogt for critical comments on the manuscript. This work was supported by the Max-Planck-Society, a Career Development Award by the Human Frontier Science Programme to F. S., a Doc-fForte predoctoral fellowship from the Austrian Academy of Sciences to C. S., and DFG grants to M.F.	Agianian B, 2004, EMBO J, V23, P772, DOI 10.1038/sj.emboj.7600097; Anant S, 1998, DEVELOPMENT, V125, P1361; Arredondo JJ, 2001, J BIOL CHEM, V276, P8278, DOI 10.1074/jbc.M009302200; AYMESOUTHGATE A, 1989, J CELL BIOL, V108, P521, DOI 10.1083/jcb.108.2.521; Bernard F, 2003, DEV BIOL, V260, P391, DOI 10.1016/S0012-1606(03)00255-0; BERNSTEIN SI, 1993, INT REV CYTOL, V143, P63; Chen EH, 2001, DEV CELL, V1, P705, DOI 10.1016/S1534-5807(01)00084-3; de Celis JF, 2009, INT J DEV BIOL, V53, P1385, DOI 10.1387/ijdb.072408jd; Dickinson M, 2006, CURR BIOL, V16, pR309, DOI 10.1016/j.cub.2006.03.087; Dudley R, 2000, BIOMECHANICS INSECT, P36; DUDLEY R, 2000, BIOMECHANICS INSECT, P75; Dutta D, 2004, DEVELOPMENT, V131, P3761, DOI 10.1242/dev.01249; Fernandes JJ, 1996, DEV BIOL, V176, P166, DOI 10.1006/dbio.1996.0125; Franch-Marro X, 2002, DEV BIOL, V250, P374, DOI 10.1006/dbio.2002.0799; Grieder NC, 2009, DEV BIOL, V329, P315, DOI 10.1016/j.ydbio.2009.03.006; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; Klein Thomas, 2008, V420, P253, DOI 10.1007/978-1-59745-583-1_15; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lehmann FO, 1997, J EXP BIOL, V200, P1133; Manisastry SM, 2009, EXP CELL RES, V315, P2126, DOI 10.1016/j.yexcr.2009.02.006; Maqbool T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000122; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Nongthomba U, 2001, J MUSCLE RES CELL M, V22, P111, DOI 10.1023/A:1010308326890; Parrish M, 2004, MOL CELL BIOL, V24, P7102, DOI 10.1128/MCB.24.16.7102-7112.2004; Patel SR, 2005, J MUSCLE RES CELL M, V26, P213, DOI 10.1007/s10974-005-9012-y; Qiu F, 2005, J CELL SCI, V118, P1527, DOI 10.1242/jcs.02281; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Rebeiz M, 2002, P NATL ACAD SCI USA, V99, P9888, DOI 10.1073/pnas.152320899; Reedy MC, 2000, J CELL BIOL, V151, P1483, DOI 10.1083/jcb.151.7.1483; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Shiels HA, 2008, J EXP BIOL, V211, P2005, DOI 10.1242/jeb.003145; Stronach BE, 1996, J CELL BIOL, V134, P1179, DOI 10.1083/jcb.134.5.1179; Surka WS, 2001, AM J MED GENET, V102, P250, DOI 10.1002/1096-8628(20010815)102:3<250::AID-AJMG1479>3.0.CO;2-Q; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0	37	72	73	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					406	U160		10.1038/nature10559	http://dx.doi.org/10.1038/nature10559			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22094701				2022-12-24	WOS:000297059700047
J	Burke, A; Robinson, LF				Burke, Andrea; Robinson, Laura F.			The Southern Ocean's Role in Carbon Exchange During the Last Deglaciation	SCIENCE			English	Article							ATMOSPHERIC CO2 CONCENTRATIONS; GEOMAGNETIC-FIELD INTENSITY; ATLANTIC DEEP-WATER; SEA-ICE; GLACIAL PERIOD; RADIOCARBON AGES; PACIFIC-OCEAN; ANTARCTICA; CLIMATE; RISE	Changes in the upwelling and degassing of carbon from the Southern Ocean form one of the leading hypotheses for the cause of glacial-interglacial changes in atmospheric carbon dioxide. We present a 25,000-year-long Southern Ocean radiocarbon record reconstructed from deep-sea corals, which shows radiocarbon-depleted waters during the glacial period and through the early deglaciation. This depletion and associated deep stratification disappeared by similar to 14.6 ka (thousand years ago), consistent with the transfer of carbon from the deep ocean to the surface ocean and atmosphere via a Southern Ocean ventilation event. Given this evidence for carbon exchange in the Southern Ocean, we show that existing deep-ocean radiocarbon records from the glacial period are sufficiently depleted to explain the similar to 190 per mil drop in atmospheric radiocarbon between similar to 17 and 14.5 ka.	[Burke, Andrea] MIT, Woods Hole Oceanog Inst Joint Program Oceanog, Woods Hole, MA 02543 USA; [Burke, Andrea; Robinson, Laura F.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Robinson, Laura F.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; University of Bristol	Burke, A (corresponding author), MIT, Woods Hole Oceanog Inst Joint Program Oceanog, Mailstop 24, Woods Hole, MA 02543 USA.	aburke@whoi.edu		Robinson, Laura/0000-0001-6811-0140; Burke, Andrea/0000-0002-3754-1498	NSF [0636787, 0944474, 0902957, 0338087, 0819714]	NSF(National Science Foundation (NSF))	This research was funded by NSF grants 0636787, 0944474, 0902957, 0338087, and 0819714. The data reported in this study are tabulated in the supporting online material. We acknowledge R. Waller and the science parties of cruises LMG06-05 and NBP08-05 for supplying samples used in this study. We also thank the crews of the R/V Nathaniel B. Palmer and R/V Laurence M. Gould, NOSAMS staff, the WHOI plasma facility, J. Blusztajn, M. Auro, and two anonymous reviewers for help with this project.	Ahn J, 2008, SCIENCE, V322, P83, DOI 10.1126/science.1160832; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Barker S, 2010, NAT GEOSCI, V3, P567, DOI [10.1038/ngeo921, 10.1038/NGEO921]; Broecker W, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001359; Broecker W, 2007, EARTH PLANET SC LETT, V256, P90, DOI 10.1016/j.epsl.2007.01.015; Broecker W, 2009, RADIOCARBON, V51, P109, DOI 10.1017/S0033822200033737; Bryan SP, 2010, EARTH PLANET SC LETT, V298, P244, DOI 10.1016/j.epsl.2010.08.025; Burke A, 2010, DEEP-SEA RES PT I, V57, P1510, DOI 10.1016/j.dsr.2010.07.010; Butzin M, 2005, EARTH PLANET SC LETT, V235, P45, DOI 10.1016/j.epsl.2005.03.003; De Pol-Holz R, 2010, NAT GEOSCI, V3, P192, DOI 10.1038/NGEO745; Denton G.H., 2006, PAGES NEWS, V14, P14, DOI DOI 10.22498/PAGES.14.2.14; Fischer H, 2007, EARTH PLANET SC LETT, V260, P340, DOI 10.1016/j.epsl.2007.06.014; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Frank M, 1997, EARTH PLANET SC LETT, V149, P121, DOI 10.1016/S0012-821X(97)00070-8; Galbraith ED, 2007, NATURE, V449, P890, DOI 10.1038/nature06227; Goldstein SJ, 2001, EARTH PLANET SC LETT, V193, P167, DOI 10.1016/S0012-821X(01)00494-0; Hain MP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046158; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Laj C, 2002, EARTH PLANET SC LETT, V200, P177, DOI 10.1016/S0012-821X(02)00618-0; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; Lund DC, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA001938; Magana Alexandra L., 2010, Paleoceanography, V25, pUnpaginated, DOI 10.1029/2010PA002011; Mangini A, 2010, EARTH PLANET SC LETT, V293, P269, DOI 10.1016/j.epsl.2010.02.041; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Muscheler R, 2004, EARTH PLANET SC LETT, V219, P325, DOI 10.1016/S0012-821X(03)00722-2; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; PENG TH, 1984, NUCL INSTRUM METH B, V5, P346, DOI 10.1016/0168-583X(84)90540-8; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Robinson LF, 2009, GEOLOGY, V37, P195, DOI 10.1130/G25363A.1; Schmittner A, 2003, EARTH PLANET SC LETT, V213, P53, DOI 10.1016/S0012-821X(03)00291-7; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Sikes EL, 2000, NATURE, V405, P555, DOI 10.1038/35014581; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Skinner LC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000983; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Thornalley DJR, 2011, SCIENCE, V331, P202, DOI 10.1126/science.1196812; Waller RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016153	41	198	202	2	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 3	2012	335	6068					557	561		10.1126/science.1208163	http://dx.doi.org/10.1126/science.1208163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885HI	22174131				2022-12-24	WOS:000299769200036
J	Ebert, MPA; Tanzer, M; Balluff, B; Burgermeister, E; Kretzschmar, AK; Hughes, DJ; Tetzner, R; Lofton-Day, C; Rosenberg, R; Reinacher-Schick, AC; Schulmann, K; Tannapfel, A; Hofheinz, R; Rocken, C; Keller, G; Langer, R; Specht, K; Porschen, R; Stohlmacher-Williams, J; Schuster, T; Strobel, P; Schmid, RM				Ebert, Matthias P. A.; Taenzer, Marc; Balluff, Benjamin; Burgermeister, Elke; Kretzschmar, Antje Karen; Hughes, David J.; Tetzner, Reimo; Lofton-Day, Catherine; Rosenberg, Robert; Reinacher-Schick, Anke C.; Schulmann, Karsten; Tannapfel, Andrea; Hofheinz, Ralf; Roecken, Christoph; Keller, Gisela; Langer, Rupert; Specht, Katja; Porschen, Rainer; Stoehlmacher-Williams, Jan; Schuster, Tibor; Stroebel, Philipp; Schmid, Roland M.			TFAP2E-DKK4 and Chemoresistance in Colorectal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THYMIDYLATE SYNTHASE; GENE-EXPRESSION; BREAST-CANCER; PHASE-III; METHYLATION; MUTATIONS; 5-FLUOROURACIL; IDENTIFICATION; INSTABILITY; CARCINOMA	BACKGROUND Chemotherapy for advanced colorectal cancer leads to improved survival; however, predictors of response to systemic treatment are not available. Genomic and epigenetic alterations of the gene encoding transcription factor AP-2 epsilon (TFAP2E) are common in human cancers. The gene encoding dickkopf homolog 4 protein (DKK4) is a potential downstream target of TFAP2E and has been implicated in chemotherapy resistance. We aimed to further evaluate the role of TFAP2E and DKK4 as predictors of the response of colorectal cancer to chemotherapy. METHODS We analyzed the expression, methylation, and function of TFAP2E in colorectal-cancer cell lines in vitro and in patients with colorectal cancer. We examined an initial cohort of 74 patients, followed by four cohorts of patients (total, 220) undergoing chemotherapy or chemoradiation. RESULTS TFAP2E was hypermethylated in 38 of 74 patients (51%) in the initial cohort. Hyper-methylation was associated with decreased expression of TFAP2E in primary and metastatic colorectal-cancer specimens and cell lines. Colorectal-cancer cell lines overexpressing DKK4 showed increased chemoresistance to fluorouracil but not irinotecan or oxaliplatin. In the four other patient cohorts, TFAP2E hypermethylation was significantly associated with nonresponse to chemotherapy (P<0.001). Conversely, the probability of response among patients with hypomethylation was approximately six times that in the entire population (overall estimated risk ratio, 5.74; 95% confidence interval, 3.36 to 9.79). Epigenetic alterations of TFAP2E were independent of mutations in key regulatory cancer genes, microsatellite instability, and other genes that affect fluorouracil metabolism. CONCLUSIONS TFAP2E hypermethylation is associated with clinical nonresponsiveness to chemotherapy in colorectal cancer. Functional assays confirm that TFAP2E-dependent resistance is mediated through DKK4. In patients who have colorectal cancer with TFAP2E hypermethylation, targeting of DKK4 may be an option to overcome TFAP2E-mediated drug resistance. (Funded by Deutsche Forschungsgemeinschaft and others.)	[Ebert, Matthias P. A.; Burgermeister, Elke] Univ Heidelberg, Univ Med Mannheim, Dept Med 2, D-68167 Mannheim, Germany; [Hofheinz, Ralf] Univ Heidelberg, Univ Med Mannheim, Dept Med 3, D-68167 Mannheim, Germany; [Stroebel, Philipp] Univ Heidelberg, Univ Med Mannheim, Inst Pathol, D-68167 Mannheim, Germany; [Taenzer, Marc; Balluff, Benjamin; Kretzschmar, Antje Karen; Schmid, Roland M.] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-8000 Munich, Germany; [Rosenberg, Robert] Tech Univ Munich, Klinikum Rechts Isar, Chirurg Klin & Poliklin, D-8000 Munich, Germany; [Keller, Gisela; Specht, Katja] Tech Univ Munich, Klinikum Rechts Isar, Inst Pathol, D-8000 Munich, Germany; [Schuster, Tibor] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Stat & Epidemiol, D-8000 Munich, Germany; [Balluff, Benjamin] Tech Univ Munich, Inst Pathol, D-8000 Munich, Germany; [Balluff, Benjamin] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Munich, Germany; [Reinacher-Schick, Anke C.; Schulmann, Karsten] Ruhr Univ Bochum, Knappschafts Krankenhaus, Dept Med, Bochum, Germany; [Tannapfel, Andrea] Ruhr Univ Bochum, Dept Pathol, Bochum, Germany; [Roecken, Christoph] Univ Kiel, Inst Pathol, Kiel, Germany; [Porschen, Rainer] Bremen Ost Hosp, Dept Med, Bremen, Germany; [Stoehlmacher-Williams, Jan] Tech Univ Dresden, Univ Hosp, Dept Med 1, D-01062 Dresden, Germany; [Hughes, David J.] Royal Coll Surgeons Ireland, Ctr Syst Med, Dept Physiol & Med Phys, Dublin 2, Ireland; [Tetzner, Reimo] Epigenomics, Berlin, Germany; [Lofton-Day, Catherine] Epigenomics, Seattle, WA USA	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruhr University Bochum; Ruhr University Bochum; University of Kiel; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Royal College of Surgeons - Ireland	Ebert, MPA (corresponding author), Univ Heidelberg, Univ Med Mannheim, Dept Med 2, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	matthias.ebert@umm.de	Röcken, Christoph/A-9239-2010; Reinacher-Schick, Anke C/F-2722-2012; giovannetti, elisa/F-4261-2011; Langer, Rupert/AAU-1174-2021; Schulmann, Karsten/N-2230-2016; Codacci-Pisanelli, Giovanni/W-4813-2017	Röcken, Christoph/0000-0002-6989-8002; giovannetti, elisa/0000-0002-7565-7504; Langer, Rupert/0000-0001-9491-3609; Codacci-Pisanelli, Giovanni/0000-0003-4662-7944; Hughes, David John/0000-0003-1668-8770	Deutsche Krebshilfe [107885, 108096]; Deutsche Forschungsgemeinschaft [SFB 824]; Else Kroner Stiftung [P14/07//A104/06]; Bundesministerium fur Bildung und Forschung [01EZ0802, 0315116B]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner Stiftung; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	Supported by grants from Deutsche Krebshilfe (107885 and 108096), Deutsche Forschungsgemeinschaft (SFB 824), Else Kroner Stiftung (Nr P14/07//A104/06), and Bundesministerium fur Bildung und Forschung (01EZ0802 and 0315116B).	Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Boland CR, 1998, CANCER RES, V58, P5248; Chung W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002079; Dalgin GS, 2008, J UROLOGY, V180, P1126, DOI 10.1016/j.juro.2008.04.137; Ebert MPA, 2006, GASTROENTEROLOGY, V131, P1418, DOI 10.1053/j.gastro.2006.08.034; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Giaretti W, 2004, CELL ONCOL, V26, P301; Guler G, 2007, CLIN CANCER RES, V13, P6115, DOI 10.1158/1078-0432.CCR-07-1282; Heinrich MC, 2008, J CLIN ONCOL, V26, P5360, DOI 10.1200/JCO.2008.17.4284; Hirsch FR, 2006, J CLIN ONCOL, V24, P5034, DOI 10.1200/JCO.2006.06.3958; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; Maehata T, 2008, WORLD J GASTROENTERO, V14, P2702, DOI 10.3748/wjg.14.2702; Orso F, 2007, ADV EXP MED BIOL, V604, P87, DOI 10.1007/978-0-387-69116-9_6; Porschen R, 2007, J CLIN ONCOL, V25, P4217, DOI 10.1200/JCO.2006.09.2684; Prix L, 2002, CLIN CHEM, V48, P428; Rosenberg R, 2008, J SURG ONCOL, V97, P8, DOI 10.1002/jso.20844; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Woodfield GW, 2007, CANCER RES, V67, P8439, DOI 10.1158/0008-5472.CAN-07-2293; Xi Y, 2008, ONCOL REP, V19, P257; Xi YG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-68; You J, 2008, DIGEST DIS SCI, V53, P1013, DOI 10.1007/s10620-007-9973-3	26	126	134	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2012	366	1					44	53		10.1056/NEJMoa1009473	http://dx.doi.org/10.1056/NEJMoa1009473			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887XY	22216841	Green Published			2022-12-24	WOS:000299968800006
J	Cury, PM; Boyd, IL; Bonhommeau, S; Anker-Nilssen, T; Crawford, RJM; Furness, RW; Mills, JA; Murphy, EJ; Osterblom, H; Paleczny, M; Piatt, JF; Roux, JP; Shannon, L; Sydeman, WJ				Cury, Philippe M.; Boyd, Ian L.; Bonhommeau, Sylvain; Anker-Nilssen, Tycho; Crawford, Robert J. M.; Furness, Robert W.; Mills, James A.; Murphy, Eugene J.; Oesterblom, Henrik; Paleczny, Michelle; Piatt, John F.; Roux, Jean-Paul; Shannon, Lynne; Sydeman, William J.			Global Seabird Response to Forage Fish Depletion-One-Third for the Birds	SCIENCE			English	Article							FOOD AVAILABILITY; CLIMATE; ECOSYSTEMS; CONSERVATION; BIODIVERSITY; ENVIRONMENT; POPULATION; INDICATORS; MANAGEMENT; PREDATORS	Determining the form of key predator-prey relationships is critical for understanding marine ecosystem dynamics. Using a comprehensive global database, we quantified the effect of fluctuations in food abundance on seabird breeding success. We identified a threshold in prey (fish and krill, termed "forage fish") abundance below which seabirds experience consistently reduced and more variable productivity. This response was common to all seven ecosystems and 14 bird species examined within the Atlantic, Pacific, and Southern Oceans. The threshold approximated one-third of the maximum prey biomass observed in long-term studies. This provides an indicator of the minimal forage fish biomass needed to sustain seabird productivity over the long term.	[Cury, Philippe M.] Ctr Rech Halieut Mediterraneenne & Trop, Inst Rech Dev, UMR EME 212, F-34203 Sete, France; [Boyd, Ian L.] Univ St Andrews, Scottish Oceans Inst, St Andrews KY16 8LB, Fife, Scotland; [Bonhommeau, Sylvain] IFREMER, Ctr Rech Halieut Mediterraneenne & Trop, UMR EME 212, F-34203 Sete, France; [Anker-Nilssen, Tycho] Norwegian Inst Nat Res, NO-7485 Trondheim, Norway; [Crawford, Robert J. M.] Dept Environm Affairs, Branch Oceans & Coasts, ZA-8012 Cape Town, South Africa; [Crawford, Robert J. M.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Murphy, Eugene J.] British Antarctic Survey, Cambridge CB3 0ET, England; [Oesterblom, Henrik] Stockholm Univ, Stockholm Resilience Ctr, Balt Nest Inst, SE-10691 Stockholm, Sweden; [Paleczny, Michelle] Univ British Columbia, Fisheries Ctr, AERL, Vancouver, BC V6T 1Z4, Canada; [Piatt, John F.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Roux, Jean-Paul] Luderitz Marine Res, Minist Fisheries & Marine Resources, Ecosyst Anal Sect, Luderitz, Namibia; [Roux, Jean-Paul] Univ Cape Town, Dept Zool, Anim Demog Unit, ZA-7701 Cape Town, South Africa; [Shannon, Lynne] Univ Cape Town, Marine Res Inst, ZA-7701 Cape Town, South Africa; [Shannon, Lynne] Univ Cape Town, Dept Zool, ZA-7701 Cape Town, South Africa; [Sydeman, William J.] Farallon Inst Adv Ecosyst Res, Petaluma, CA 94952 USA	Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of St Andrews; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Norwegian Institute Nature Research; Department of Environment, Forestry & Fisheries; University of Glasgow; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Stockholm University; University of British Columbia; United States Department of the Interior; United States Geological Survey; University of Cape Town; University of Cape Town; University of Cape Town	Cury, PM (corresponding author), Ctr Rech Halieut Mediterraneenne & Trop, Inst Rech Dev, UMR EME 212, Ave Jean Monnet,BP 171, F-34203 Sete, France.	philippe.cury@ird.fr; ilb@st-andrews.ac.uk	Osterblom, Henrik/D-4249-2012; murphy, eugene/GZL-1620-2022; Shannon, Lynne J/A-1612-2015; Anker-Nilssen, Tycho/AAB-7666-2022; Bonhommeau, Sylvain/P-8654-2014	Shannon, Lynne J/0000-0001-7842-0636; Anker-Nilssen, Tycho/0000-0002-1030-5524; Bonhommeau, Sylvain/0000-0002-0882-5918; Cury, philippe/0000-0002-4622-4208; Osterblom, Henrik/0000-0002-1913-5197; Piatt, John/0000-0002-4417-5748	Eur-Oceans Consortium; Institut de Recherche pour le Developpement (IRD); Lenfest Forage Fish Task Force; Mistra; Sea Around Us Project; South African Research Chair Initiative; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Eur-Oceans Consortium; Institut de Recherche pour le Developpement (IRD); Lenfest Forage Fish Task Force; Mistra; Sea Around Us Project; South African Research Chair Initiative; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was partly funded by Eur-Oceans Consortium, the Institut de Recherche pour le Developpement (IRD), the Lenfest Forage Fish Task Force, Mistra, the Sea Around Us Project, and the South African Research Chair Initiative. Disclaimers and acknowledgment of institutes and collaborators are provided in the SOM. Data, methods, and codes are available in the SOM.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Agnew DJ, 1997, ANTARCT SCI, V9, P235, DOI 10.1017/S095410209700031X; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Boyd IL, 2002, AQUAT CONSERV, V12, P119, DOI 10.1002/aqc.481; Boyd IL, 2001, J ANIM ECOL, V70, P747, DOI 10.1046/j.0021-8790.2001.00534.x; CAIRNS D K, 1987, Biological Oceanography, V5, P261; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Durant JM, 2003, P ROY SOC B-BIOL SCI, V270, P1461, DOI 10.1098/rspb.2003.2397; Field JC, 2010, ECOL APPL, V20, P2223, DOI 10.1890/09-0428.1; Furness RW, 2007, J ORNITHOL, V148, pS247, DOI 10.1007/s10336-007-0152-2; Furness RW, 1997, ICES J MAR SCI, V54, P726, DOI 10.1006/jmsc.1997.0243; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hunsicker ME, 2011, ECOL LETT, V14, P1288, DOI 10.1111/j.1461-0248.2011.01696.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kitaysky AS, 2010, FUNCT ECOL, V24, P625, DOI 10.1111/j.1365-2435.2009.01679.x; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Mills JA, 2008, J ANIM ECOL, V77, P1129, DOI 10.1111/j.1365-2656.2008.01383.x; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; PIATT JF, 1992, MAR ECOL PROG SER, V84, P205, DOI 10.3354/meps084205; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Reid K, 2005, ICES J MAR SCI, V62, P366, DOI 10.1016/j.icesjms.2004.11.003; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Stige LC, 2010, P ROY SOC B-BIOL SCI, V277, P3411, DOI 10.1098/rspb.2010.0602; WOOLLER RD, 1992, TRENDS ECOL EVOL, V7, P111, DOI 10.1016/0169-5347(92)90143-Y	29	484	493	14	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1703	1706		10.1126/science.1212928	http://dx.doi.org/10.1126/science.1212928			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194577	Green Published			2022-12-24	WOS:000298344000067
J	Cheung, F				Cheung, Felix			MODERN TCM Enter the clinic	NATURE			English	Editorial Material																			0	23	23	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S94	S95		10.1038/480S94a	http://dx.doi.org/10.1038/480S94a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190091	Bronze			2022-12-24	WOS:000298318000007
J	Parker, T				Parker, Thomas			Cutting science's electricity bill	NATURE			English	Editorial Material												thomas.parker@esss.se		Parker, Thomas/0000-0001-8043-0243					0	7	7	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					315	316		10.1038/480315a	http://dx.doi.org/10.1038/480315a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22170663	Bronze			2022-12-24	WOS:000298033000028
J	Hyman, AH; Simons, K				Hyman, Anthony H.; Simons, Kai			Beyond HeLa cells	NATURE			English	Editorial Material									[Hyman, Anthony H.; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Hyman, AH (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	hyman@mpi-cbg.de	Hyman, Tony/F-1923-2011	Simons, Kai/0000-0002-9231-9996					0	20	20	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					34	34		10.1038/480034a	http://dx.doi.org/10.1038/480034a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129708				2022-12-24	WOS:000298031900016
J	Mack, MJ; Holmes, DR				Mack, Michael J.; Holmes, David R., Jr.			Rational Dispersion for the Introduction of Transcatheter Valve Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OF-CARDIOLOGY FOUNDATION; THORACIC SURGEONS; SOCIETY		[Mack, Michael J.] Soc Thorac Surg, Plano, TX 75093 USA; [Holmes, David R., Jr.] Amer Coll Cardiol, Minneapolis, MN USA	Society of Thoracic Surgeons	Mack, MJ (corresponding author), Soc Thorac Surg, 1100 Allied Dr, Plano, TX 75093 USA.	michael.mack@baylorhealth.edu						Holmes DR, 2011, J AM COLL CARDIOL, V58, P445, DOI 10.1016/j.jacc.2011.05.007; Holmes DR, 2011, ANN THORAC SURG, V92, P380, DOI 10.1016/j.athoracsur.2011.05.067; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; US Food and Drug Administration, 2011, 2011 M MAT CIRC SYST	4	31	32	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 16	2011	306	19					2149	2150		10.1001/jama.2011.1675	http://dx.doi.org/10.1001/jama.2011.1675			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YU	22089724				2022-12-24	WOS:000297013000023
J	Bhattacharya, A; Baker, NE				Bhattacharya, Abhishek; Baker, Nicholas E.			A Network of Broadly Expressed HLH Genes Regulates Tissue-Specific Cell Fates	CELL			English	Article							MORPHOGENETIC FURROW PROGRESSION; SENSORY ORGAN DEVELOPMENT; ACHAETE-SCUTE COMPLEX; LOOP-HELIX PROTEINS; PRONEURAL GENE; DNA-BINDING; DROSOPHILA EYE; NEGATIVE REGULATOR; EXTRAMACROCHAETAE; DAUGHTERLESS	Spatial and temporal expression of specific basic-helix-loop-helix (bHLH) transcription factors defines many types of cellular differentiation. We find that a distinct mechanism regulates the much broader expression of the heterodimer partners of these specific factors and impinges on differentiation. In Drosophila, a cross-interacting regulatory network links expression of the E protein Daughterless (Da), which heterodimerizes with bHLH proteins to activate them, with expression of the Id protein Extramacrochaetae (Emc), which antagonizes bHLH proteins. Coupled transcriptional feedback loops maintain the widespread Emc expression that restrains Da expression, opposing bHLH-dependent differentiation while enhancing growth and cell survival. Where extracellular signals repress emc, Da expression can increase. This defines regions of proneural ectoderm independently from the proneural bHLH genes. Similar regulation is found in multiple Drosophila tissues and in mammalian cells and therefore is likely to be a conserved general feature of developmental regulation by HLH proteins.	[Bhattacharya, Abhishek; Baker, Nicholas E.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Baker, Nicholas E.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Baker, Nicholas E.] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Baker, NE (corresponding author), Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	nicholas.baker@einstein.yu.edu		Bhattacharya, Abhishek/0000-0002-4456-054X	NIH [GM47892]; Research to Prevent Blindness; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047892] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was enabled by the gift of polyclonal anti-Emc antibody by Yuh-Nung Jan. We also thank Claire Cronmiller for monoclonal anti-Da antibody, Konrad Basler and Christos Delidakis for strains and other reagents, Matthew Scharff and Richard Chahwan for help with HEK293T cell culture, Model System Genomics for embryo injections, John Fullard and David Lubensky for advice, and Hannes Buelow, Claude Desplan, Scott Emmons, Andreas Jenny, Richard Mann, Ertugrul Ozbudak, Julie Secombe, Jessica Treisman, and Lan-Hsin Wang for comments on the manuscript. This work was supported by grant GM47892 from the NIH and by an Unrestricted Grant from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences. Confocal microscopy was performed at the AIF, AECOM. Data in this paper are from a thesis to be submitted in partial fulfillment of the requirement for the degree of Doctor of Philosophy in the Graduate Division of Biomedical Sciences, Albert Einstein College of Medicine, Yeshiva University, USA.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; ALONSO LAG, 1988, ROUX ARCH DEV BIOL, V197, P328, DOI 10.1007/BF00375952; ARONHEIM A, 1993, P NATL ACAD SCI USA, V90, P8063, DOI 10.1073/pnas.90.17.8063; Baker NE, 2009, DEV BIOL, V335, P356, DOI 10.1016/j.ydbio.2009.09.008; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BENEZRA R, 1994, CELL, V79, P1057, DOI 10.1016/0092-8674(94)90036-1; Bhattacharya A, 2009, DEV BIOL, V327, P288, DOI 10.1016/j.ydbio.2008.11.037; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; BOTAS J, 1982, EMBO J, V1, P307, DOI 10.1002/j.1460-2075.1982.tb01165.x; BROWN NL, 1995, CELL, V80, P879, DOI 10.1016/0092-8674(95)90291-0; Brown NL, 1996, DEV BIOL, V179, P65, DOI 10.1006/dbio.1996.0241; CABRERA CV, 1991, EMBO J, V10, P2965, DOI 10.1002/j.1460-2075.1991.tb07847.x; Cadigan KM, 2002, DEVELOPMENT, V129, P3393; Campuzano S, 2001, ONCOGENE, V20, P8299, DOI 10.1038/sj.onc.1205162; CUBAS P, 1992, EMBO J, V11, P3385, DOI 10.1002/j.1460-2075.1992.tb05417.x; Curtiss J, 2000, DEVELOPMENT, V127, P1325; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Domingos PM, 2004, DEV BIOL, V273, P121, DOI 10.1016/j.ydbio.2004.05.026; ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W; Firth LC, 2006, METHOD ENZYMOL, V407, P711, DOI 10.1016/S0076-6879(05)07056-4; Garcia-Bellido A, 2009, GENETICS, V182, P631, DOI 10.1534/genetics.109.104083; GARCIABELLIDO A, 1979, GENETICS, V91, P491; GARRELL J, 1990, CELL, V61, P39, DOI 10.1016/0092-8674(90)90213-X; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Gomez-Skarmeta J, 2003, NAT REV NEUROSCI, V4, P587, DOI 10.1038/nrn1142; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; Greenwood S, 1999, DEVELOPMENT, V126, P5795; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Heng JIT, 2003, BIOESSAYS, V25, P709, DOI 10.1002/bies.10299; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Huang ML, 2000, NEURON, V25, P57, DOI 10.1016/S0896-6273(00)80871-5; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Jorda M, 2007, EXP CELL RES, V313, P2389, DOI 10.1016/j.yexcr.2007.04.001; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Lee EC, 1996, MOL CELL BIOL, V16, P1179; Lee SH, 2011, MOL CANCER RES, V9, P782, DOI 10.1158/1541-7786.MCR-10-0535; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Melicharek D, 2008, GENETICS, V180, P2095, DOI 10.1534/genetics.108.093302; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Ozaki Y, 2005, J BIOCHEM, V137, P659, DOI 10.1093/jb/mvi084; Pi HW, 2004, P NATL ACAD SCI USA, V101, P8378, DOI 10.1073/pnas.0306010101; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rothschild G, 2006, MOL CELL BIOL, V26, P4351, DOI 10.1128/MCB.01743-05; Schotte R, 2010, J IMMUNOL, V184, P6670, DOI 10.4049/jimmunol.0901508; Schwartz R, 2006, P NATL ACAD SCI USA, V103, P9976, DOI 10.1073/pnas.0603728103; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; Shoval O, 2010, CELL, V143, P326, DOI 10.1016/j.cell.2010.09.050; SINGSON A, 1994, GENE DEV, V8, P2058, DOI 10.1101/gad.8.17.2058; Smith JE, 2001, DEVELOPMENT, V128, P4705; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Sun Y, 1998, DEVELOPMENT, V125, P3731; VAESSIN H, 1994, DEVELOPMENT, V120, P935; VANDOREN M, 1992, GENE DEV, V6, P2592, DOI 10.1101/gad.6.12b.2592; VANDOREN M, 1991, DEVELOPMENT, V113, P245; Villa-Cuesta E, 2003, GENETICS, V163, P1403; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; White NM, 2000, DEVELOPMENT, V127, P1681; Wildonger J, 2005, DEV BIOL, V286, P507, DOI 10.1016/j.ydbio.2005.08.026; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wolff Tanya, 1993, P1277; XU T, 1993, DEVELOPMENT, V117, P1223	75	59	63	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 11	2011	147	4					881	892		10.1016/j.cell.2011.08.055	http://dx.doi.org/10.1016/j.cell.2011.08.055			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22078884	Green Accepted, Bronze			2022-12-24	WOS:000296902300020
J	Korevaar, PA; George, SJ; Markvoort, AJ; Smulders, MMJ; Hilbers, PAJ; Schenning, APHJ; De Greef, TFA; Meijer, EW				Korevaar, Peter A.; George, Subi J.; Markvoort, Albert J.; Smulders, Maarten M. J.; Hilbers, Peter A. J.; Schenning, Albert P. H. J.; De Greef, Tom F. A.; Meijer, E. W.			Pathway complexity in supramolecular polymerization	NATURE			English	Article							SELF-ORGANIZATION; FIBRIL FORMATION; KINETICS; NUCLEATION; ASSEMBLIES; AMPLIFICATION; AGGREGATION; EVOLUTION	Self-assembly provides an attractive route to functional organic materials, with properties and hence performance depending sensitively on the organization of the molecular building blocks(1-5). Molecular organization is a direct consequence of the pathways involved in the supramolecular assembly process, which is more amenable to detailed study when using one-dimensional systems. In the case of protein fibrils, formation and growth have been attributed to complex aggregation pathways(6-8) that go beyond traditional concepts of homogeneous(9-11) and secondary (12-14) nucleation events. The self-assembly of synthetic supramolecular polymers has also been studied and even modulated(15-18), but our quantitative understanding of the processes involved remains limited. Here we report time-resolved observations of the formation of supramolecular polymers from pi-conjugated oligomers. Our kinetic experiments show the presence of a kinetically favoured metastable assembly that forms quickly but then transforms into the thermodynamically favoured form. Quantitative insight into the kinetic experiments was obtained from kinetic model calculations, which revealed two parallel and competing pathways leading to assemblies with opposite helicity. These insights prompt us to use a chiral tartaric acid as an auxiliary to change the thermodynamic preference of the assembly process(19). We find that we can force aggregation completely down the kinetically favoured pathway so that, on removal of the auxiliary, we obtain only metastable assemblies.	[Korevaar, Peter A.; Markvoort, Albert J.; Smulders, Maarten M. J.; Hilbers, Peter A. J.; De Greef, Tom F. A.; Meijer, E. W.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands; [Korevaar, Peter A.; George, Subi J.; Smulders, Maarten M. J.; Schenning, Albert P. H. J.; De Greef, Tom F. A.; Meijer, E. W.] Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands; [Markvoort, Albert J.; Hilbers, Peter A. J.; De Greef, Tom F. A.] Eindhoven Univ Technol, Biomodeling & Bioinformat Grp, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Eindhoven University of Technology	De Greef, TFA (corresponding author), Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MB Eindhoven, Netherlands.	t.f.a.d.greef@tue.nl; e.w.meijer@tue.nl	George, Subi/A-8328-2010; Markvoort, Albert J/A-9833-2013; Markvoort, Albert/AAI-4535-2021; de Greef, Tom F. A./I-8124-2014; Hilbers, Peter A.J./D-2468-2013; Meijer, E.W./K-7632-2013; Smulders, Maarten/H-4162-2011	Hilbers, Peter A.J./0000-0002-8805-5633; Meijer, E.W./0000-0003-4126-7492; Smulders, Maarten/0000-0002-6855-0426; de Greef, Tom/0000-0002-9338-284X	European Research Council under the European Union [246829]; Netherlands Organization for Scientific Research	European Research Council under the European Union(European Research Council (ERC)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank Z. Tomovic for providing the SOPV. We are grateful to R. M. Kellogg (Syncom, Groningen, The Netherlands) for providing the tartaric acid derivate. We also thank H. W. H. van Roekel and R. de Bruijn for discussions. Artwork was provided by K. Pieterse. The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC grant agreement number 246829, and from the Netherlands Organization for Scientific Research.	Ajayaghosh A, 2006, ANGEW CHEM INT EDIT, V45, P3261, DOI 10.1002/anie.200600256; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; BISHOP MF, 1984, BIOPHYS J, V46, P631, DOI 10.1016/S0006-3495(84)84062-X; Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586; Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768; Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418; De Greef TFA, 2009, CHEM REV, V109, P5687, DOI 10.1021/cr900181u; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; George SJ, 2007, ANGEW CHEM INT EDIT, V46, P8206, DOI 10.1002/anie.200702730; Hoeben FJM, 2005, CHEM REV, V105, P1491, DOI 10.1021/cr030070z; Jonkheijm P, 2003, J AM CHEM SOC, V125, P15941, DOI 10.1021/ja0383118; Jonkheijm P, 2006, SCIENCE, V313, P80, DOI 10.1126/science.1127884; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Lohr A, 2008, ANGEW CHEM INT EDIT, V47, P1232, DOI 10.1002/anie.200704550; Lund R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.188301; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Pashuck ET, 2010, J AM CHEM SOC, V132, P8819, DOI 10.1021/ja100613w; Pasternack RF, 1998, J AM CHEM SOC, V120, P5873, DOI 10.1021/ja980186q; Percec V, 2002, NATURE, V419, P384, DOI 10.1038/nature01072; Powers ET, 2008, BIOPHYS J, V94, P379, DOI 10.1529/biophysj.107.117168; Powers ET, 2006, BIOPHYS J, V91, P122, DOI 10.1529/biophysj.105.073767; van Gestel J, 2004, MACROMOLECULES, V37, P3894, DOI 10.1021/ma030480p; Wolffs M, 2008, CHEM COMMUN, P4613, DOI 10.1039/b809560d; Wurthner F, 2004, J AM CHEM SOC, V126, P10611, DOI 10.1021/ja0475353; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yamamoto Y, 2006, SCIENCE, V314, P1761, DOI 10.1126/science.1134441	27	619	621	17	617	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 26	2012	481	7382					492	U103		10.1038/nature10720	http://dx.doi.org/10.1038/nature10720			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22258506				2022-12-24	WOS:000299471800037
J	Lamas, D; Rosenbaum, L				Lamas, Daniela; Rosenbaum, Lisa			Painful Inequities - Palliative Care in Developing Countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Rajagopal MR, 2007, J PAIN SYMPTOM MANAG, V33, P615, DOI 10.1016/j.jpainsymman.2007.02.028; Statement of professor Sevil Atasoy, 2009, COMMUNICATION   0730; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	3	34	35	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2012	366	3					199	201		10.1056/NEJMp1113622	http://dx.doi.org/10.1056/NEJMp1113622			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877RZ	22256803				2022-12-24	WOS:000299201400003
J	Habel, LA; Cooper, WO; Sox, CM; Chan, KA; Fireman, BH; Arbogast, PG; Cheetham, TC; Quinn, VP; Dublin, S; Boudreau, DM; Andrade, SE; Pawloski, PA; Raebel, MA; Smith, DH; Achacoso, N; Uratsu, C; Go, AS; Sidney, S; Nguyen-Huynh, MN; Ray, WA; Selby, JV				Habel, Laurel A.; Cooper, William O.; Sox, Colin M.; Chan, K. Arnold; Fireman, Bruce H.; Arbogast, Patrick G.; Cheetham, T. Craig; Quinn, Virginia P.; Dublin, Sascha; Boudreau, Denise M.; Andrade, Susan E.; Pawloski, Pamala A.; Raebel, Marsha A.; Smith, David H.; Achacoso, Ninah; Uratsu, Connie; Go, Alan S.; Sidney, Steve; Nguyen-Huynh, Mai N.; Ray, Wayne A.; Selby, Joe V.			ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; UNMEASURED CONFOUNDERS; STIMULANT MEDICATIONS; MYOCARDIAL-INFARCTION; CARDIAC SAFETY; METHYLPHENIDATE; CHILDREN; DEATH; METAANALYSIS	Context More than 1.5 million US adults use stimulants and other medications labeled for treatment of attention-deficit/hyperactivity disorder (ADHD). These agents can increase heart rate and blood pressure, raising concerns about their cardiovascular safety. Objective To examine whether current use of medications prescribed primarily to treat ADHD is associated with increased risk of serious cardiovascular events in young and middle-aged adults. Design, Setting, and Participants Retrospective, population-based cohort study using electronic health care records from 4 study sites (OptumInsight Epidemiology, Tennessee Medicaid, Kaiser Permanente California, and the HMO Research Network), starting in 1986 at 1 site and ending in 2005 at all sites, with additional covariate assessment using 2007 survey data. Participants were adults aged 25 through 64 years with dispensed prescriptions for methylphenidate, amphetamine, or atomoxetine at baseline. Each medication user (n= 150 359) was matched to 2 nonusers on study site, birth year, sex, and calendar year (443 198 total users and nonusers). Main Outcome Measures Serious cardiovascular events, including myocardial infarction (MI), sudden cardiac death (SCD), or stroke, with comparison between current or new users and remote users to account for potential healthy-user bias. Results During 806 182 person-years of follow-up (median, 1.3 years per person), 1357 cases of MI, 296 cases of SCD, and 575 cases of stroke occurred. There were 107 322 person-years of current use (median, 0.33 years), with a crude incidence per 1000 person-years of 1.34 (95% CI, 1.14-1.57) for MI, 0.30 (95% CI, 0.20-0.42) for SCD, and 0.56 (95% CI, 0.43-0.72) for stroke. The multivariable-adjusted rate ratio (RR) of serious cardiovascular events for current use vs nonuse of ADHD medications was 0.83 (95% CI, 0.72-0.96). Among new users of ADHD medications, the adjusted RR was 0.77 (95% CI, 0.63-0.94). The adjusted RR for current use vs remote use was 1.03 (95% CI, 0.86-1.24); for new use vs remote use, the adjusted RR was 1.02 (95% CI, 0.82-1.28); the upper limit of 1.28 corresponds to an additional 0.19 events per 1000 person-years at ages 25-44 years and 0.77 events per 1000 person-years at ages 45-64 years. Conclusions Among young and middle-aged adults, current or new use of ADHD medications, compared with nonuse or remote use, was not associated with an increased risk of serious cardiovascular events. Apparent protective associations likely represent healthy-user bias. JAMA. 2011;306(24):2673-2683 Published online December 12, 2011. doi:10.1001/jama.2011.1830	[Habel, Laurel A.; Fireman, Bruce H.; Achacoso, Ninah; Uratsu, Connie; Go, Alan S.; Sidney, Steve; Nguyen-Huynh, Mai N.; Selby, Joe V.] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; [Cooper, William O.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Cooper, William O.; Ray, Wayne A.] Vanderbilt Univ, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN USA; [Arbogast, Patrick G.] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Sox, Colin M.] Harvard Univ, Sch Med, Dept Populat Med, Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Sox, Colin M.] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; [Chan, K. Arnold] OptumInsight Epidemiol, Waltham, MA USA; [Cheetham, T. Craig] Kaiser Permanente So Calif, Pharm Analyt Serv, Downey, CA 90242 USA; [Cheetham, T. Craig; Quinn, Virginia P.] Kaiser Permanente So Calif, Res & Evaluat Dept, Pasadena, CA USA; [Dublin, Sascha; Boudreau, Denise M.] Grp Hlth Res Inst, Seattle, WA USA; [Dublin, Sascha] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Boudreau, Denise M.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Andrade, Susan E.] Meyers Primary Care Inst, Worcester, MA USA; [Pawloski, Pamala A.] HealthPartners Res Fdn, Bloomington, MN USA; [Raebel, Marsha A.] Kaiser Permanente Colorado, Inst Hlth Res, Pueblo, CO USA; [Raebel, Marsha A.] Univ Colorado, Sch Pharm, Denver, CO 80202 USA; [Smith, David H.] Kaiser Permanente NW, Ctr Hlth Res, Portland, OR USA; [Sidney, Steve] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Sidney, Steve] Univ Calif San Francisco, Dept Biostat & Med, San Francisco, CA 94143 USA	Kaiser Permanente; Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Boston University; Optum; Kaiser Permanente; Kaiser Permanente; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kaiser Permanente; University of Colorado System; University of Colorado Denver; Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Habel, LA (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway,5th Floor, Oakland, CA 94612 USA.	laurel.habel@kp.org	Go, Alan S./AAE-7745-2019	Sox, Colin/0000-0002-0249-9656; Habel, Laurel/0000-0002-7230-587X; Pawloski, Pamala/0000-0002-1005-5764; Chan, Kinwei/0000-0001-8161-1986	Merck; Takeda; sanofi-aventis; medical product manufacturers; Merck/American Geriatrics Society; GlaxoSmithKline; Novartis Pharmaceuticals; Abbott Laboratories; National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; Thrasher Research Fund; American Heart Association; Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA290-2005-0042, HHSA290-2005-0033]; FDA [223-2005-10012, 223-2005-10100C, 223-2005-20006C, 223-2005-10012C]; National Institute on Aging [K23AG028954]; NATIONAL INSTITUTE ON AGING [K23AG028954] Funding Source: NIH RePORTER	Merck(Merck & Company); Takeda(Takeda Pharmaceutical Company Ltd); sanofi-aventis(Sanofi-Aventis); medical product manufacturers; Merck/American Geriatrics Society(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Novartis Pharmaceuticals(Novartis); Abbott Laboratories(Abbott Laboratories); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Thrasher Research Fund; American Heart Association(American Heart Association); Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services; FDA(United States Department of Health & Human Services); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Habel reported receiving grants from Merck for a study of herpes zoster in patients with cancer, from Takeda for a study of pioglitazone and cancer, and from sanofi-aventis for a study of insulin and cancer. Dr Chan reported receiving support for travel to meetings for the purpose of the study or other purposes from the US Food and Drug Administration (FDA) and that he is a part-time employee of OptumInsight, a for-profit company that receives funding from medical product manufacturers to provide consultation and conduct research on medical products; because OptumInsight is a part of UnitedHealthGroup, Dr Chan has received UnitedHealthGroup stock options. Dr Dublin reported receiving a Merck/American Geriatrics Society New Investigator Award (honorarium paid directly to Dr Dublin) for unrelated work. Dr Andrade reported that the Meyers Primary Care Institute has received funding from GlaxoSmithKline and Novartis Pharmaceuticals, manufacturers of medications used to treat ADHD. Dr Smith reported that the Center for Health Research received funding from Abbott Laboratories to conduct a natural history study of patients with chronic kidney disease and from GlaxoSmithKline to study the burden of diabetes. Dr Sidney reported receiving grants or grants pending from the National Heart, Lung, and Blood Institute, the National Institute of Neurological Disorders and Stroke, the National Institute of Diabetes and Digestive and Kidney Diseases, and the Thrasher Research Fund. Dr Nguyen-Huynh reported receiving grants or grants pending from the American Heart Association. No other authors reported disclosures.; This project was funded in part under contract numbers HHSA290-2005-0042 (Vanderbilt) and HHSA290-2005-0033 (Harvard Pilgrim Health Care Institute) from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program. The project was also funded by the FDA under contracts 223-2005-10012 (Kaiser Permanente Northern California), 223-2005-10100C (Vanderbilt), 223-2005-20006C (Ingenix), and 223-2005-10012C (Harvard Pilgrim Health Care Institute). The project was also funded by the National Institute on Aging under contract K23AG028954 (Group Health Research Institute).	Adler LA, 2009, J CLIN PSYCHOPHARM, V29, P239, DOI 10.1097/JCP.0b013e3181a390ce; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; [Anonymous], 2011, NEW REPORT AM STATE; Arbogast PG, 2009, STAT METHODS MED RES, V18, P67, DOI 10.1177/0962280208092347; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Chung CP, 2010, PHARMACOEPIDEM DR S, V19, P563, DOI 10.1002/pds.1888; Cohen AL, 2006, NEW ENGL J MED, V354, P2294, DOI 10.1056/NEJMc060860; Cooper WO, 2011, NEW ENGL J MED, V365, P1896, DOI 10.1056/NEJMoa1110212; de Burgos-Lunar C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-146; Food and Drug Administration, 2006, DRUG SAF RISK MAN AD; FRIERSON RL, 1991, AM FAM PHYSICIAN, V43, P163; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Gould MS, 2009, AM J PSYCHIAT, V166, P992, DOI 10.1176/appi.ajp.2009.09040472; Grijalva CG, 2008, PHARMACOEPIDEM DR S, V17, P890, DOI 10.1002/pds.1625; Hammerness PG, 2011, CURR PSYCHIAT REP, V13, P357, DOI 10.1007/s11920-011-0213-3; Holick CN, 2009, J CLIN PSYCHOPHARM, V29, P453, DOI 10.1097/JCP.0b013e3181b2b828; Leddy JJ, 2004, OBES RES, V12, P224, DOI 10.1038/oby.2004.29; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; McCarthy S, 2009, DRUG SAFETY, V32, P1089, DOI 10.2165/11317630-000000000-00000; Meier MA, 2002, ARCH INTERN MED, V162, P1585, DOI 10.1001/archinte.162.14.1585; MIETTINEN OS, 1976, AM J EPIDEMIOL, V104, P609, DOI 10.1093/oxfordjournals.aje.a112339; Montejano L, 2011, CURR MED RES OPIN, V27, P5, DOI 10.1185/03007995.2011.603302; Peterson K, 2008, PSYCHOPHARMACOLOGY, V197, P1, DOI 10.1007/s00213-007-0996-4; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Schelleman H, 2011, PEDIATRICS, V127, P1102, DOI 10.1542/peds.2010-3371; Schneeweiss S, 2005, EPIDEMIOLOGY, V16, P17, DOI 10.1097/01.ede.0000147164.11879.b5; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Stiefel G, 2010, DRUG SAFETY, V33, P821, DOI 10.2165/11536380-000000000-00000; Suissa S, 1997, EPIDEMIOLOGY, V8, P275, DOI 10.1097/00001648-199705000-00008; Tharwani Haresh M, 2007, Curr Psychiatry Rep, V9, P225, DOI 10.1007/s11920-007-0023-9; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; West SL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P709; Wilens TE, 2011, EXPERT REV NEUROTHER, V11, P1443, DOI [10.1586/ern.11.137, 10.1586/ERN.11.137]; Winterstein AG, 2007, PEDIATRICS, V120, pE1494, DOI 10.1542/peds.2007-0675; Winterstein AG, 2009, PEDIATRICS, V124, pE75, DOI 10.1542/peds.2008-3138	36	186	190	0	35	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2673	2683		10.1001/jama.2011.1830	http://dx.doi.org/10.1001/jama.2011.1830			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22161946	Green Accepted, Bronze			2022-12-24	WOS:000298484000018
J	Bukowski, R; Carpenter, M; Conway, D; Coustan, D; Dudley, DJ; Goldenberg, RL; Hogue, CJR; Koch, MA; Parker, CB; Pinar, H; Reddy, UM; Saade, GR; Silver, RM; Stoll, BJ; Varner, MW; Willinger, M				Bukowski, Radek; Carpenter, Marshall; Conway, Deborah; Coustan, Donald; Dudley, Donald J.; Goldenberg, Robert L.; Hogue, Carol J. Rowland; Koch, Matthew A.; Parker, Corette B.; Pinar, Halit; Reddy, Uma M.; Saade, George R.; Silver, Robert M.; Stoll, Barbara J.; Varner, Michael W.; Willinger, Marian		Stillbirth Collaborative Res Netwo	Association Between Stillbirth and Risk Factors Known at Pregnancy Confirmation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ABO(H) BLOOD-GROUPS; UNITED-STATES; METAANALYSIS; PREVALENCE; DISPARITY; DELIVERY; OBESITY; TRENDS; BIRTHS	Context Stillbirths account for almost half of US deaths from 20 weeks' gestation to 1 year of life. Most large studies of risk factors for stillbirth use vital statistics with limited data. Objective To determine the relation between stillbirths and risk factors that could be ascertained at the start of pregnancy, particularly the contribution of these factors to racial disparities. Design, Setting, and Participants Multisite population-based case-control study conducted between March 2006 and September 2008. Fifty-nine US tertiary care and community hospitals, with access to at least 90% of deliveries within 5 catchment areas defined by state and county lines, enrolled residents with deliveries of 1 or more stillborn fetuses and a representative sample of deliveries of only live-born infants, over-sampled for those at less than 32 weeks' gestation and those of African descent. Main Outcome Measure Stillbirth. Results Analysis included 614 case and 1816 control deliveries. In multivariate analyses, the following factors were independently associated with stillbirth: non-Hispanic black race/ethnicity (23.1% stillbirths, 11.2% live births) (vs non-Hispanic whites; adjusted odds ratio [AOR], 2.12 [95% CI, 1.41-3.20]); previous stillbirth (6.7% stillbirths, 1.4% live births); nulliparity with (10.5% stillbirths, 5.2% live births) and without (34.0% stillbirths, 29.7% live births) previous losses at fewer than 20 weeks' gestation (vs multiparity without stillbirth or previous losses; AOR, 5.91 [95% CI, 3.18-11.00]; AOR, 3.13 [95% CI, 2.06-4.75]; and AOR, 1.98 [95% CI, 1.51-2.60], respectively); diabetes (5.6% stillbirths, 1.6% live births) (vs no diabetes; AOR, 2.50 [95% CI, 1.39-4.48]); maternal age 40 years or older (4.5% stillbirths, 2.1% live births) (vs age 20-34 years; AOR, 2.41 [95% CI, 1.24-4.70]); maternal AB blood type (4.9% stillbirths, 3.0% live births) (vs type O; AOR, 1.96 [95% CI, 1.16-3.30]); history of drug addiction (4.5% stillbirths, 2.1% live births) (vs never use; AOR, 2.08 [95% CI, 1.12-3.88]); smoking during the 3 months prior to pregnancy (<10 cigarettes/d, 10.0% stillbirths, 6.5% live births) (vs none; AOR, 1.55 [95% CI, 1.02-2.35]); obesity/overweight (15.5% stillbirths, 12.4% live births) (vs normal weight; AOR, 1.72 [95% CI, 1.22-2.43]); not living with a partner (25.4% stillbirths, 15.3% live births) (vs married; AOR, 1.62 [95% CI, 1.15-2.27]); and plurality (6.4% stillbirths, 1.9% live births) (vs singleton; AOR, 4.59 [95% CI, 2.63-8.00]). The generalized R-2 was 0.19, explaining little of the variance. Conclusion Multiple risk factors that would have been known at the time of pregnancy confirmation were associated with stillbirth but accounted for only a small amount of the variance in this outcome. JAMA. 2011;306(22):2469-2479	[Saade, George R.] Univ Texas Med Branch Galveston, Dept Obstet & Gynecol, Div Maternal Fetal Med, Galveston, TX 77555 USA; [Carpenter, Marshall; Coustan, Donald] Brown Univ, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Providence, RI 02912 USA; [Conway, Deborah; Dudley, Donald J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, Div Maternal Fetal Med, San Antonio, TX 78229 USA; [Goldenberg, Robert L.] Drexel Univ, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Hogue, Carol J. Rowland] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Hogue, Carol J. Rowland] Emory Univ, Womens & Childrens Ctr, Atlanta, GA 30322 USA; [Koch, Matthew A.; Parker, Corette B.] RTI Int, Div Hlth Sci, Stat & Epidemiol Unit, Res Triangle Pk, NC USA; [Pinar, Halit] Brown Univ, Sch Med, Dept Pathol & Lab Med, Div Perinatal & Pediat Pathol, Providence, RI 02912 USA; [Reddy, Uma M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pregnancy & Perinatol Branch, NIH, Bethesda, MD USA; [Silver, Robert M.; Varner, Michael W.] Univ Utah, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Salt Lake City, UT 84132 USA; [Silver, Robert M.; Varner, Michael W.] Intermt Healthcare, Maternal Fetal Med, Salt Lake City, UT USA; [Stoll, Barbara J.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Stoll, Barbara J.] Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA USA	University of Texas System; University of Texas Medical Branch Galveston; Brown University; University of Texas System; University of Texas Health San Antonio; Drexel University; Emory University; Rollins School Public Health; Emory University; Research Triangle Institute; Brown University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Emory University; Children's Healthcare of Atlanta (CHOA)	Saade, GR (corresponding author), Univ Texas Med Branch Galveston, Dept Obstet & Gynecol, Div Maternal Fetal Med, 301 Univ Blvd, Galveston, TX 77555 USA.	gsaade@utmb.edu	/AAO-2076-2020; Hogue, Carol J/H-5442-2012; Bukowski, Radek/B-6976-2013; Varner, Michael/K-9890-2013	Varner, Michael/0000-0001-9455-3973	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health [U10-HD045953, U10-HD045925, U10-HD045952, U10-HDO45955, U10-HD045944, U01-HD045954]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD045944, U10HD045953, U01HD045954, U10HD045952, U10HD045925] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by grant funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health: U10-HD045953 (Brown University, Rhode Island); U10-HD045925 (Emory University, Georgia); U10-HD045952 (University of Texas Medical Branch at Galveston); U10-HDO45955 (University of Texas Health Sciences Center at San Antonio); U10-HD045944 (University of Utah Health Sciences Center); and U01-HD045954 (RTI International, North Carolina).	Balayla J, 2011, WOMEN HEALTH ISS, V21, P361, DOI 10.1016/j.whi.2011.04.001; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Centers for Disease Control and Prevention, 2007, PREV SMOK EXP SEC SM; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P119; Clark P, 2008, THROMB HAEMOSTASIS, V100, P469, DOI 10.1160/TH08-05-0302; Cox DR., 1989, ANAL BINARY DATA; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Gold KJ, 2010, J WOMENS HEALTH, V19, P767, DOI 10.1089/jwh.2009.1561; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Heuser CC, 2010, OBSTET GYNECOL, V116, P1296, DOI 10.1097/AOG.0b013e3181fb8838; Hogue CJR, 2011, SEMIN PERINATOL, V35, P221, DOI 10.1053/j.semperi.2011.02.019; Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; Martin Joyce A., 2011, Morbidity and Mortality Weekly Report, V60, P78; Parker CB, 2011, PAEDIATR PERINAT EP, V25, P425, DOI 10.1111/j.1365-3016.2011.01218.x; Pinar H, 2012, AM J PERINAT, V29, P187, DOI 10.1055/s-0031-1284228; Pinar H, 2011, AM J PERINAT, V28, P781, DOI 10.1055/s-0031-1281509; Pinar H, 2011, AM J PERINAT, V28, P793, DOI 10.1055/s-0031-1284229; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Reddy UM, 2010, OBSTET GYNECOL, V116, P1119, DOI 10.1097/AOG.0b013e3181f903f8; *RES TRIANGL I, 2008, SUDAAN LANG MAN REL; Salihu H, 2004, OBSTET GYNECOL, V104, P734, DOI 10.1097/01.AOG.0000139944.15133.e3; Salihu HM, 2007, OBSTET GYNECOL, V110, P552, DOI 10.1097/01.AOG.0000270159.80607.10; Salihu HM, 2006, OBSTET GYNECOL, V107, P383, DOI 10.1097/01.AOG.0000195103.46999.32; Syed M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S2; Willinger M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.057; Wilson RE, 2008, ARCH GYNECOL OBSTET, V278, P231, DOI 10.1007/s00404-007-0557-4; Wu O, 2008, J THROMB HAEMOST, V6, P62	31	155	156	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2469	2479		10.1001/jama.2011.1798	http://dx.doi.org/10.1001/jama.2011.1798			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860YB	22166606	Green Accepted, Bronze			2022-12-24	WOS:000297983300020
J	Wynia, MK; Classen, DC				Wynia, Matthew K.; Classen, David C.			Improving Ambulatory Patient Safety Learning From the Last Decade, Moving Ahead in the Next	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wynia, Matthew K.] Amer Med Assoc, Ctr Patient Safety, Chicago, IL 60654 USA; [Classen, David C.] Univ Utah, Salt Lake City, UT USA	American Medical Association; Utah System of Higher Education; University of Utah	Wynia, MK (corresponding author), Amer Med Assoc, Ctr Patient Safety, 515 N State St, Chicago, IL 60654 USA.	matthew.wynia@ama-assn.org	Wynia, Matthew/T-2210-2019					Bishop TF, 2011, JAMA-J AM MED ASSOC, V305, P2427, DOI 10.1001/jama.2011.813; Department of Health and Human Services, PARTN PAT BETT CAR L; Gandhi TK, 2010, NEW ENGL J MED, V363, P1001, DOI 10.1056/NEJMp1003294; HAMMONS T, 2001, AGENDA RES AMBULATOR; Hayes H, 2011, J AM BOARD FAM MED, V24, P576, DOI 10.3122/jabfm.2011.05.110043; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Lorincz CY, 2011, RES AMBULATORY PATIE; Singh H, 2010, JAMA-J AM MED ASSOC, V304, P463, DOI 10.1001/jama.2010.1035; Singh H, 2009, ARCH INTERN MED, V169, P1578, DOI 10.1001/archinternmed.2009.263; Wachter RM, 2010, HEALTH AFFAIR, V29, P165, DOI 10.1377/hlthaff.2009.0785	10	37	38	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2504	2505		10.1001/jama.2011.1820	http://dx.doi.org/10.1001/jama.2011.1820			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860YB	22166611				2022-12-24	WOS:000297983300026
J	Nayak, S; Roberts, MS; Greenspan, SL				Nayak, Smita; Roberts, Mark S.; Greenspan, Susan L.			Cost-Effectiveness of Different Screening Strategies for Osteoporosis in Postmenopausal Women	ANNALS OF INTERNAL MEDICINE			English	Article							FRACTURE INTERVENTION TRIAL; QUALITY-OF-LIFE; LOW BONE-DENSITY; VERTEBRAL FRACTURES; HIP FRACTURE; ALENDRONATE THERAPY; RANDOMIZED-TRIAL; ELDERLY-WOMEN; RISK; HEALTH	Background: The best strategies to screen postmenopausal women for osteoporosis are not clear. Objective: To identify the cost-effectiveness of various screening strategies. Design: Individual-level state-transition cost-effectiveness model. Data Sources: Published literature. Target Population: U.S. women aged 55 years or older. Time Horizon: Lifetime. Perspective: Payer. Intervention: Screening strategies composed of alternative tests (central dual-energy x-ray absorptiometry [DXA], calcaneal quantitative ultrasonography [QUS], and the Simple Calculated Osteoporosis Risk Estimation [SCORE] tool) initiation ages, treatment thresholds, and rescreening intervals. Oral bisphosphonate treatment was assumed, with a base-case adherence rate of 50% and a 5-year on/off treatment pattern. Outcome Measures: Incremental cost-effectiveness ratios (2010 U.S. dollars per quality-adjusted life-year [QALY] gained). Results of Base-Case Analysis: At all evaluated ages, screening was superior to not screening. In general, quality-adjusted life-days gained with screening tended to increase with age. At all initiation ages, the best strategy with an incremental cost-effectiveness ratio (ICER) of less than $50 000 per QALY was DXA screening with a T-score threshold of -2.5 or less for treatment and with follow-up screening every 5 years. Across screening initiation ages, the best strategy with an ICER less than $50 000 per QALY was initiation of screening at age 55 years by using DXA -2.5 with rescreening every 5 years. The best strategy with an ICER less than $100 000 per QALY was initiation of screening at age 55 years by using DXA with a T-score threshold of -2.0 or less for treatment and then rescreening every 10 years. No other strategy that involved treatment of women with osteopenia had an ICER less than $100 000 per QALY. Many other strategies, including strategies with SCORE or QUS prescreening, were also cost-effective, and in general the differences in effectiveness and costs between evaluated strategies was small. Results of Sensitivity Analysis: Probabilistic sensitivity analysis did not reveal a consistently superior strategy. Limitations: Data were primarily from white women. Screening initiation at ages younger than 55 years were not examined. Only osteoporotic fractures of the hip, vertebrae, and wrist were modeled. Conclusion: Many strategies for postmenopausal osteoporosis screening are effective and cost-effective, including strategies involving screening initiation at age 55 years. No strategy substantially outperforms another.	[Nayak, Smita] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nayak, S (corresponding author), Univ Pittsburgh, Sch Med, 200 Meyran Ave,Suite 200, Pittsburgh, PA 15213 USA.	nayaks@upmc.edu	Golmohamad, Ramez/E-4848-2014	Golmohamad, Ramez/0000-0002-9958-7037	National Center for Research Resources (a component of the National Institutes of Health) and National Institutes of Health Roadmap for Medical Research [KL2 RR024154]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR060809-01]; National Institute of Diabetes and Digestive and Kidney Diseases [K24 DK062895]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK062895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	National Center for Research Resources (a component of the National Institutes of Health) and National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant Support: By grant KL2 RR024154 from the National Center for Research Resources (a component of the National Institutes of Health) and National Institutes of Health Roadmap for Medical Research (Dr. Nayak), grant 1R01AR060809-01 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (Dr. Nayak), and grant K24 DK062895 from the National Institute of Diabetes and Digestive and Kidney Diseases (Dr. Greenspan).	[Anonymous], 2010, RED BOOK; Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; Barrett JA, 1999, J CLIN EPIDEMIOL, V52, P243, DOI 10.1016/S0895-4356(98)00167-X; Berg AO, 2002, ANN INTERN MED, V137, P526, DOI 10.7326/0003-4819-137-6-200209170-00014; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Black DM, 2000, J CLIN ENDOCR METAB, V85, P4118, DOI 10.1210/jc.85.11.4118; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Brazier JE, 2002, OSTEOPOROSIS INT, V13, P768, DOI 10.1007/s001980200107; BRAZIER JE, 2000, PROSPECTIVE STUDY HL; Brenneman Susan K, 2003, Dis Manag, V6, P159, DOI 10.1089/109350703322425509; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Cadarette SM, 2001, JAMA-J AM MED ASSOC, V286, P57, DOI 10.1001/jama.286.1.57; Centers for Medicare & Medicaid Services, NAT PHYS FEE SCHED; Corliss GR, 2004, 4 SOC ACT; CUMMINGS SR, 1989, ARCH INTERN MED, V149, P2445, DOI 10.1001/archinte.149.11.2445; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Dolan P, 1999, OSTEOPOROSIS INT, V9, P196, DOI 10.1007/s001980050136; Fraser LA, 2011, THER CLIN RISK MANAG, V7, P157, DOI 10.2147/TCRM.S19385; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gabriel SE, 2002, OSTEOPOROSIS INT, V13, P323, DOI 10.1007/s001980200033; GE Financial Nursing Home Cost of Care Survey, 2003, GE FIN NURS HOM COST; Geusens P, 2002, MAYO CLIN PROC, V77, P629, DOI 10.4065/77.7.629; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P581, DOI 10.1007/s00198-004-1780-5; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P20, DOI 10.1007/s00198-003-1463-7; Karpf DB, 1997, JAMA-J AM MED ASSOC, V277, P1159; Kraemer DF, 2006, OSTEOPOROSIS INT, V17, P68, DOI 10.1007/s00198-005-1922-4; LaCroix AZ, 2005, MED CARE, V43, P293, DOI 10.1097/00005650-200503000-00012; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Liu H, 2006, ARCH INTERN MED, V166, P1209, DOI 10.1001/archinte.166.11.1209; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007/BF01623271; Mobley LR, 2006, MED DECIS MAKING, V26, P194, DOI 10.1177/0272989X06286478; National Osteoporosis Foundation, 2008, CLIN GUID PREV TREAT; National Osteoporosis Foundation, 2005, OST FAST FACTS; Nayak S, 2006, ANN INTERN MED, V144, P832, DOI 10.7326/0003-4819-144-11-200606060-00009; Nelson HD, 2002, ANN INTERN MED, V137, P529, DOI 10.7326/0003-4819-137-6-200209170-00015; Office of Technology Assessment, 1994, OTABPH120 US C; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Oleksik A, 2000, J BONE MINER RES, V15, P1384, DOI 10.1359/jbmr.2000.15.7.1384; Schousboe John T, 2007, Curr Rheumatol Rep, V9, P50, DOI 10.1007/s11926-007-0022-1; Schousboe JT, 2005, J AM GERIATR SOC, V53, P1697, DOI 10.1111/j.1532-5415.2005.53504.x; Schousboe JT, 2005, ANN INTERN MED, V142, P734, DOI 10.7326/0003-4819-142-9-200505030-00008; Schwartz AV, 2010, J BONE MINER RES, V25, P976, DOI 10.1002/jbmr.11; Solomon DH, 2005, ARCH INTERN MED, V165, P2414, DOI 10.1001/archinte.165.20.2414; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Tosteson ANA, 2001, OSTEOPOROSIS INT, V12, P849, DOI 10.1007/s001980170036; Tosteson ANA, 2008, AM J MANAG CARE, V14, P605; Walmart Pharmacy Medication Finder, WALM PHARM MED FIND; Watts Nelson B, 2010, Endocr Pract, V16, P1016; Watts NB, 2010, J CLIN ENDOCR METAB, V95, P1555, DOI 10.1210/jc.2009-1947; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; 1998, OSTEOPOROS INT, V8, pS7	58	77	79	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2011	155	11					751	U176		10.7326/0003-4819-155-11-201112060-00007	http://dx.doi.org/10.7326/0003-4819-155-11-201112060-00007			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860ZS	22147714	Green Accepted			2022-12-24	WOS:000297988400004
J	Seigneurin, A; Francois, O; Labarere, J; Oudeville, P; Monlong, J; Colonna, M				Seigneurin, Arnaud; Francois, Olivier; Labarere, Jose; Oudeville, Pierre; Monlong, Jean; Colonna, Marc			Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SERVICES TASK-FORCE; CARCINOMA IN-SITU; BREAST-CANCER; SPONTANEOUS REGRESSION; NATURAL-HISTORY; LEAD TIME; OVERTREATMENT; MORTALITY; SENSITIVITY; SENESCENCE	Objective To quantify the magnitude of overdiagnosis from non-progressive disease detected by screening mammography, after adjustment for the potential for lead time bias, secular trend in the underlying risk of breast cancer, and opportunistic screening. Design Approximate bayesian computation analysis with a stochastic simulation model designed to replicate standardised incidence rates of breast cancer. The model components included the lifetime probability of breast cancer, the natural course of breast cancer, and participation in organised and opportunistic mammography screening. Setting Isere, a French administrative region with nearly 1.2 million inhabitants. Participants All women living in Isere and aged 50-69 during 1991-2006. Main outcome measures Overdiagnosis, defined as the proportion of non-progressive cancers among all cases of invasive cancer and carcinoma in situ detected 1991-2006. Results In 1991-2006, overdiagnosis from non-progressive disease accounted for 1.5% of all cases of invasive cancer (95% credibility interval 0.3% to 2.9%) and 28.0% of all cases of carcinoma in situ (2.2% to 59.8%) detected either clinically or by screening mammography in Isore. When analysis was restricted to the cancers detected by screening mammography only, the estimates of overdiagnosis were 3.3% (0.7% to 6.5%) and 31.9% (2.9% to 62.3%) for invasive cancer and carcinomas in situ, respectively. Conclusion Overdiagnosis from the detection of non-progressive disease by screening mammography was limited in 1991-2006 in Isore. Because carcinoma in situ accounted for less than 15% of all incident breast cancer cases, its contribution to overdiagnosis was relatively limited and imprecise.	[Seigneurin, Arnaud; Colonna, Marc] CHU Grenoble, Registre Canc Isere, F-38043 Grenoble 9, France; [Seigneurin, Arnaud; Francois, Olivier; Labarere, Jose; Oudeville, Pierre; Monlong, Jean] Univ Grenoble 1, CNRS, TIMC IMAG, UMR 5525, F-38041 Grenoble, France; [Labarere, Jose] CHU Grenoble, Unit Evaluat Med, F-38043 Grenoble 9, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Seigneurin, A (corresponding author), CHU Grenoble, Registre Canc Isere, BP 217,Pavillon E, F-38043 Grenoble 9, France.	aseigneurin@chu-grenoble.fr	Monlong, Jean/AAZ-8589-2020; Francois, Olivier/A-6051-2012; Francois, Olivier/AAQ-3137-2020; Labarère, José/N-1688-2014; Seigneurin, Arnaud/M-6099-2014	Monlong, Jean/0000-0002-9737-5516; Francois, Olivier/0000-0003-2402-2442; Francois, Olivier/0000-0003-2402-2442; Labarère, José/0000-0001-7621-6586; 	Institut National du Cancer, Paris, France; Comite de l'Isere de la Ligue Nationale Contre le Cancer, Grenoble, France	Institut National du Cancer, Paris, France(Institut National du Cancer (INCA) France); Comite de l'Isere de la Ligue Nationale Contre le Cancer, Grenoble, France	This study was funded by grants from the Institut National du Cancer, Paris, France, and the Comite de l'Isere de la Ligue Nationale Contre le Cancer, Grenoble, France. The study sponsor had no role in the study design, collection, analysis, and interpretation of the data; or in the writing of the article and decision to submit the article for publication.	Beaumont MA, 2002, GENETICS, V162, P2025; Belot A, 2008, REV EPIDEMIOL SANTE, V56, P159, DOI 10.1016/j.respe.2008.03.117; Bender R, 2005, STAT MED, V24, P1713, DOI 10.1002/sim.2059; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Berry Donald A, 2006, J Natl Cancer Inst Monogr, P30, DOI 10.1093/jncimonographs/lgj006; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Bland JM, 1998, BRIT MED J, V317, P1151; Blum MGB, 2010, STAT COMPUT, V20, P63, DOI 10.1007/s11222-009-9116-0; Cancer incidence and mortality worldwide, 2011, CANC INC MORT WORLDW; Chen HH, 1996, J ROY STAT SOC D-STA, V45, P307; Csillery K, 2011, METHODS ECO IN PRESS; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Cuzick J, 2011, LANCET ONCOL, V12, P21, DOI 10.1016/S1470-2045(10)70266-7; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; Donella P, 2009, EUR J CANCER, V45, P3166, DOI 10.1016/j.ejca.2009.06.014; Duffy SW, 2005, BREAST CANCER RES, V7, P258, DOI 10.1186/bcr1354; Dussan C, 2008, GYNECOL OBSTET INVES, V65, P206, DOI 10.1159/000112228; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Fagnani F, 1989, J EC MED, V7, P319; Fryback Dennis G, 2006, J Natl Cancer Inst Monogr, P37, DOI 10.1093/jncimonographs/lgj007; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Institut de Veille Sanitaire, 2011, INC OBS DEP COUV REG; Jatoi I, 1999, AM J SURG, V177, P518, DOI 10.1016/S0002-9610(99)00096-3; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Mandelblatt J, 2003, ANN INTERN MED, V139, P835, DOI 10.7326/0003-4819-139-10-200311180-00011; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Moss S, 2005, BREAST CANCER RES, V7, P230, DOI 10.1186/bcr1314; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Olsen AH, 2006, BREAST J, V12, P338, DOI 10.1111/j.1075-122X.2006.00272.x; Paci E, 2005, BREAST CANCER RES, V7, P266, DOI 10.1186/bcr1339; PACI E, 1991, INT J EPIDEMIOL, V20, P852, DOI 10.1093/ije/20.4.852; Paci E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1625; Quanstrum KH, 2010, NEW ENGL J MED, V363, P1076, DOI 10.1056/NEJMsb1002538; ROSS MB, 1982, J SURG ONCOL, V19, P22, DOI 10.1002/jso.2930190107; Seigneurin A, 2009, BREAST, V18, P284, DOI 10.1016/j.breast.2009.07.007; Seigneurin A, 2011, BREAST CANCER RES TR, V127, P221, DOI 10.1007/s10549-010-1118-2; Serrano M, 2007, NEW ENGL J MED, V356, P1996, DOI 10.1056/NEJMcibr071461; Silcocks PBS, 2007, J PUBLIC HEALTH-UK, V29, P455, DOI 10.1093/pubmed/fdm053; Tan Sita Y G L, 2006, J Natl Cancer Inst Monogr, P56, DOI 10.1093/jncimonographs/lgj009; Wait S, 1997, B CANCER, V84, P619; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Yen MF, 2003, EUR J CANCER, V39, P1746, DOI 10.1016/S0959-8049(03)00260-0; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	47	38	40	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2011	343								d7017	10.1136/bmj.d7017	http://dx.doi.org/10.1136/bmj.d7017			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875FH	22113564	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000299015300005
J	Cohen, JY; Haesler, S; Vong, L; Lowell, BB; Uchida, N				Cohen, Jeremiah Y.; Haesler, Sebastian; Vong, Linh; Lowell, Bradford B.; Uchida, Naoshige			Neuron-type-specific signals for reward and punishment in the ventral tegmental area	NATURE			English	Article							MIDBRAIN DOPAMINE NEURONS; GABAERGIC NEURONS; RAT; CHANNELRHODOPSIN-2; PREDICTION; ADDICTION; PROJECTIONS; MECHANISMS; RESPONSES; CORTEX	Dopamine has a central role in motivation and reward. Dopaminergic neurons in the ventral tegmental area (VTA) signal the discrepancy between expected and actual rewards (that is, reward prediction error)(1-3), but how they compute such signals is unknown. We recorded the activity of VTA neurons while mice associated different odour cues with appetitive and aversive outcomes. We found three types of neuron based on responses to odours and outcomes: approximately half of the neurons (type I, 52%) showed phasic excitation after reward-predicting odours and rewards in a manner consistent with reward prediction error coding; the other half of neurons showed persistent activity during the delay between odour and outcome that was modulated positively (type II, 31%) or negatively (type III, 18%) by the value of outcomes. Whereas the activity of type I neurons was sensitive to actual outcomes (that is, when the reward was delivered as expected compared to when it was unexpectedly omitted), the activity of type II and type III neurons was determined predominantly by reward-predicting odours. We 'tagged' dopaminergic and GABAergic neurons with the light-sensitive protein channelrhodopsin-2 and identified them based on their responses to optical stimulation while recording. All identified dopaminergic neurons were of type I and all GABAergic neurons were of type II. These results show that VTA GABAergic neurons signal expected reward, a key variable for dopaminergic neurons to calculate reward prediction error.	[Cohen, Jeremiah Y.; Haesler, Sebastian; Uchida, Naoshige] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Vong, Linh; Lowell, Bradford B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Endocrinol, Boston, MA 02215 USA	Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Uchida, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA.	uchida@mcb.harvard.edu		Uchida, Naoshige/0000-0002-5755-9409; Haesler, Sebastian/0000-0003-4924-7381	Howard Hughes Medical Institute from the Helen Hay Whitney Foundation; Human Frontiers Science Program; Howard Hughes Medical Institute; Smith Family New Investigator Award; Alfred Sloan Foundation; Milton Fund;  [F32 DK078478];  [P30 DK046200];  [R01 DK075632];  [R01 DK089044];  [P30 DK057521]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK078478, P30DK057521, P30DK046200, R01DK075632, R01DK089044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095953] Funding Source: NIH RePORTER	Howard Hughes Medical Institute from the Helen Hay Whitney Foundation; Human Frontiers Science Program(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Smith Family New Investigator Award; Alfred Sloan Foundation(Alfred P. Sloan Foundation); Milton Fund; ; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Meister, V. N. Murthy, J. D. Schall and R. P. Heitz for comments, C. Dulac for sharing resources, C. I. Moore, J. Ritt and J. Siegle for advice about microdrives, K. Deisseroth for the AAV-FLEX-ChR2 construct, and E. Soucy and J. Greenwood for technical support. This work was supported by a Howard Hughes Medical Institute Fellowship from the Helen Hay Whitney Foundation (J.Y.C.); the Human Frontiers Science Program (S. H.); a Howard Hughes Medical Institute Collaborative Innovation Award, a Smith Family New Investigator Award, the Alfred Sloan Foundation, the Milton Fund (N. U.); F32 DK078478, P30 DK046200 (L. V.); and R01 DK075632, R01 DK089044, P30 DK046200, P30 DK057521 (B.B.L.).	Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Dobi A, 2010, J NEUROSCI, V30, P218, DOI 10.1523/JNEUROSCI.3884-09.2010; Fiorillo CD, 2008, NAT NEUROSCI, V11, P966, DOI 10.1038/nn.2159; Houk JC, 1995, MODELS INFORMATION P, P249; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Okada K, 2009, J NEUROSCI, V29, P4858, DOI 10.1523/JNEUROSCI.4415-08.2009; Omelchenko N, 2009, SYNAPSE, V63, P895, DOI 10.1002/syn.20668; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Schmitzer-Torbert N, 2004, J NEUROPHYSIOL, V91, P2259, DOI 10.1152/jn.00687.2003; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Steffensen SC, 1998, J NEUROSCI, V18, P8003; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Szabo B, 2002, EUR J NEUROSCI, V15, P2057, DOI 10.1046/j.1460-9568.2002.02041.x; Takahashi YK, 2011, NAT NEUROSCI, V14, P1590, DOI 10.1038/nn.2957; Takikawa Y, 2004, J NEUROPHYSIOL, V92, P2520, DOI 10.1152/jn.00238.2004; Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	38	773	782	1	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 2	2012	482	7383					85	U109		10.1038/nature10754	http://dx.doi.org/10.1038/nature10754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884RN	22258508	Green Accepted			2022-12-24	WOS:000299726000040
J	Adrain, C; Zettl, M; Christova, Y; Taylor, N; Freeman, M				Adrain, Colin; Zettl, Markus; Christova, Yonka; Taylor, Neil; Freeman, Matthew			Tumor Necrosis Factor Signaling Requires iRhom2 to Promote Trafficking and Activation of TACE	SCIENCE			English	Article							FACTOR-ALPHA; TNF-ALPHA; MACROPHAGES; DISINTEGRIN; MACHINERY; MEMBRANE; ENZYME	The cytokine tumor necrosis factor (TNF) is the primary trigger of inflammation. Like many extracellular signaling proteins, TNF is synthesized as a transmembrane protein; the active signal is its ectodomain, which is shed from cells after cleavage by an ADAM family metalloprotease, ADAM17 (TNF alpha-converting enzyme, TACE). We report that iRhom2 (RHBDF2), a proteolytically inactive member of the rhomboid family, is required for TNF release in mice. iRhom2 binds TACE and promotes its exit from the endoplasmic reticulum. The failure of TACE to exit the endoplasmic reticulum in the absence of iRhom2 prevents the furin-mediated maturation and trafficking of TACE to the cell surface, the site of TNF cleavage. Given the role of TNF in autoimmune and inflammatory diseases, iRhom2 may represent an attractive therapeutic target.	[Adrain, Colin; Zettl, Markus; Christova, Yonka; Freeman, Matthew] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Taylor, Neil] Canc Res UK, Li Ka Shing Ctr, Cambridge Res Inst, Cambridge CB2 0RE, England	MRC Laboratory Molecular Biology; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Freeman, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	MF1@mrc-lmb.cam.ac.uk	Adrain, Colin/I-6259-2013	Adrain, Colin/0000-0001-7597-4393; Freeman, Matthew/0000-0003-0410-5451	The International Human Frontier Science Program Organization; EMBO; Austrian Science Fund (FWF); Austrian Academy of Science; Medical Research Council [U105178780]; MRC [MC_U105178780] Funding Source: UKRI; Medical Research Council [MC_U105178780] Funding Source: researchfish	The International Human Frontier Science Program Organization(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Academy of Science; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Blobel, R. Hegde, G. Murphy, S. Munro, V. Lastun, C. Luginsland, and K. Strisovsky for their advice and generously sharing unpublished reagents. We are grateful to R. Pannell for help with the mouse knockout and to members of the animal facility for their assistance. The data presented in this paper are reported in the main paper and in the Supporting Online Material. C. A. was supported by a long-term fellowship from The International Human Frontier Science Program Organization and was the recipient of an EMBO Long-Term Fellowship. M. Z. was supported by Erwin-Schrodinger fellowship from the Austrian Science Fund (FWF), and an APART fellowship from the Austrian Academy of Science. This work was supported by the Medical Research Council programme number U105178780.	Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Ha SD, 2008, J IMMUNOL, V181, P690, DOI 10.4049/jimmunol.181.1.690; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	21	274	281	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					225	228		10.1126/science.1214400	http://dx.doi.org/10.1126/science.1214400			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246777	Green Accepted			2022-12-24	WOS:000299033100055
J	Rechavi, O; Minevich, G; Hobert, O				Rechavi, Oded; Minevich, Gregory; Hobert, Oliver			Transgenerational Inheritance of an Acquired Small RNA-Based Antiviral Response in C. elegans	CELL			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; ANIMAL VIRUS; INTERFERENCE; REQUIREMENTS; REPLICATION; MECHANISM; CLEAVAGE; PATHWAY; RDE-1	Induced expression of the Flock House virus in the soma of C. elegans results in the RNAi-dependent production of virus-derived, small-interfering RNAs (viRNAs), which in turn silence the viral genome. We show here that the viRNA-mediated viral silencing effect is transmitted in a non-Mendelian manner to many ensuing generations. We show that the viral silencing agents, viRNAs, are transgenerationally transmitted in a template-independent manner and work in trans to silence viral genomes present in animals that are deficient in producing their own viRNAs. These results provide evidence for the transgenerational inheritance of an acquired trait, induced by the exposure of animals to a specific, biologically relevant physiological challenge. The ability to inherit such extragenic information may provide adaptive benefits to an animal.	[Rechavi, Oded; Minevich, Gregory; Hobert, Oliver] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Rechavi, O (corresponding author), Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA.	odedrechavi@gmail.com; or38@columbia.edu		Minevich, Gregory/0000-0002-7115-4416; Hobert, Oliver/0000-0002-7634-2854	Bikura postdoc fellowship; Gruss Lipper postdoc fellowship; T32 predoctoral training grant [T32HD055165]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055165] Funding Source: NIH RePORTER	Bikura postdoc fellowship; Gruss Lipper postdoc fellowship; T32 predoctoral training grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank A. Boyanov for small RNA preparation and deep sequencing; C. Mello for providing unc-linked rde strains; S.W. Ding for the FR1gfp transgene; Richard Friedman for advice on statistical methods; and Piali Sengupta, Sarah Hall, Iva Greenwald, and members of the Hobert lab for comments on the manuscript. O.R. is funded by a Bikura postdoc fellowship and a Gruss Lipper postdoc fellowship, and G.M. by a T32 predoctoral training grant (T32HD055165). O.H. is an investigator of the HHMI.	Alcazar RM, 2008, GENETICS, V180, P1275, DOI 10.1534/genetics.108.089433; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; BALL LA, 1994, ARCH VIROL, P407; Blanchard D, 2011, RNA BIOL, V8, P458, DOI 10.4161/rna.8.3.14657; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Drummond A., 2011, GENEIOUS V5 5; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Groenenboom MAC, 2005, PLOS COMPUT BIOL, V1, P155, DOI 10.1371/journal.pcbi.0010021; Johnson KL, 1997, J VIROL, V71, P3323, DOI 10.1128/JVI.71.4.3323-3327.1997; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelly WG, 1997, GENETICS, V146, P227; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Parrish S, 2001, RNA, V7, P1397; Poole RJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002109; Remy JJ, 2010, CURR BIOL, V20, pR877, DOI 10.1016/j.cub.2010.08.013; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Steiner FA, 2009, NAT STRUCT MOL BIOL, V16, P207, DOI 10.1038/nsmb.1541; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Weismann A., 1889, ESSAYS HEREDITY; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	39	228	230	2	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1248	1256		10.1016/j.cell.2011.10.042	http://dx.doi.org/10.1016/j.cell.2011.10.042			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22119442	Bronze, Green Accepted			2022-12-24	WOS:000298148100015
J	Erwin, DH; Laflamme, M; Tweedt, SM; Sperling, EA; Pisani, D; Peterson, KJ				Erwin, Douglas H.; Laflamme, Marc; Tweedt, Sarah M.; Sperling, Erik A.; Pisani, Davide; Peterson, Kevin J.			The Cambrian Conundrum: Early Divergence and Later Ecological Success in the Early History of Animals	SCIENCE			English	Article							EVOLUTION; ORIGIN; CONSTRUCTION; MICRORNAS; RADIATION; FOSSILS; RECORD; MACROEVOLUTION; PHYLOGENOMICS; PRESERVATION	Diverse bilaterian clades emerged apparently within a few million years during the early Cambrian, and various environmental, developmental, and ecological causes have been proposed to explain this abrupt appearance. A compilation of the patterns of fossil and molecular diversification, comparative developmental data, and information on ecological feeding strategies indicate that the major animal clades diverged many tens of millions of years before their first appearance in the fossil record, demonstrating a macroevolutionary lag between the establishment of their developmental toolkits during the Cryogenian [(850 to 635 million years ago Ma)] and the later ecological success of metazoans during the Ediacaran (635 to 541 Ma) and Cambrian (541 to 488 Ma) periods. We argue that this diversification involved new forms of developmental regulation, as well as innovations in networks of ecological interaction within the context of permissive environmental circumstances.	[Erwin, Douglas H.; Laflamme, Marc; Tweedt, Sarah M.] Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Erwin, Douglas H.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Tweedt, Sarah M.] Univ Maryland, College Pk, MD 20742 USA; [Sperling, Erik A.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Pisani, Davide] Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland; [Peterson, Kevin J.] Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; The Santa Fe Institute; University System of Maryland; University of Maryland College Park; Harvard University; Maynooth University; Dartmouth College	Erwin, DH (corresponding author), Natl Museum Nat Hist, Dept Paleobiol, MRC-121,POB 37012, Washington, DC 20013 USA.	erwind@si.edu; kevin.j.peterson@dartmouth.edu	Pisani, Davide/ABD-5225-2021; Peterson, Kevin J/A-2188-2009	Pisani, Davide/0000-0003-0949-6682; Erwin, Douglas/0000-0003-2518-5614	NASA National Astrobiology Institute; Smithsonian Institution Fellowship; Agouron Geobiology Fellowship; NSF; Science Foundation Ireland [08/RFP/EOB1595]	NASA National Astrobiology Institute; Smithsonian Institution Fellowship(Smithsonian InstitutionSmithsonian National Museum of Natural History); Agouron Geobiology Fellowship; NSF(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by a NASA National Astrobiology Institute grant (D. H. E and K.J.P) supporting M. L., S. M. T., and E. A. S., and a Smithsonian Institution Fellowship (M. L). E. A. S is also supported by an Agouron Geobiology Fellowship. K.J.P. is also supported by the NSF. D. P. is supported by a Science Foundation Ireland Research Frontier Programme grant (08/RFP/EOB1595). All molecular analyses were performed with the computing infrastructures provided by the Irish Center for High End Computing and the National University of Ireland Maynooth High Performance Computing facility. All data used in the paper are included as files in the SOM. We appreciate technical assistance from L. Campbell and comments from P. Donoghue, G. Edgecombe, G. Narbonne, B. Runnegar, two anonymous reviewers, and the Bio 28 Class of Dartmouth College (2011).	Amthor JE, 2003, GEOLOGY, V31, P431, DOI 10.1130/0091-7613(2003)031<0431:EOCANA>2.0.CO;2; Baguna J, 2004, BIOESSAYS, V26, P1046, DOI 10.1002/bies.20113; BENGTSON S, 1992, SCIENCE, V257, P367, DOI 10.1126/science.257.5068.367; Bengtson Stefan, 2002, Paleontological Society Papers, V8, P289; Bowring SA, 2007, AM J SCI, V307, P1097, DOI 10.2475/10.2007.01; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Bush AM, 2011, TOP GEOBIOL, V36, P111, DOI 10.1007/978-94-007-0680-4_5; Butterfield NJ, 1997, PALEOBIOLOGY, V23, P247, DOI 10.1017/S009483730001681X; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Chen JY, 2004, SCIENCE, V305, P218, DOI 10.1126/science.1099213; Cohen PA, 2009, P NATL ACAD SCI USA, V106, P6519, DOI 10.1073/pnas.0902322106; Darwin C, 1859, ORIGINS SPECIES MEAN; Davidson EH, 2009, COLD SH Q B, V74, P65, DOI 10.1101/sqb.2009.74.042; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2010, J EXP ZOOL PART B, V314B, P182, DOI 10.1002/jez.b.21329; ERWIN DH, 1987, EVOLUTION, V41, P1177, DOI 10.1111/j.1558-5646.1987.tb02459.x; Erwin DH, 2012, CAMBRIAN EXPLOSION C; Erwin DH, 2008, TRENDS ECOL EVOL, V23, P304, DOI 10.1016/j.tree.2008.01.013; Erwin DH, 2009, PHILOS T R SOC B, V364, P2253, DOI 10.1098/rstb.2009.0038; Fedonkin MA, 2007, GEOL SOC SPEC PUBL, V286, P157, DOI 10.1144/SP286.12; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; GEHLING JG, 1991, MEMOIRS GEOLOGICAL S, V20, P181; Grotzinger JP, 2011, NAT GEOSCI, V4, P285, DOI [10.1038/ngeo1138, 10.1038/NGEO1138]; Hagadorn JW, 2006, SCIENCE, V314, P291, DOI 10.1126/science.1133129; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Hejnol A, 2008, PHILOS T R SOC B, V363, P1493, DOI 10.1098/rstb.2007.2239; Ivantsov AY, 2009, PALEONTOL J+, V43, P601, DOI 10.1134/S003103010906001X; Jensen S, 2005, PALAEOGEOGR PALAEOCL, V220, P19, DOI 10.1016/j.palaeo.2003.09.035; Jensen Soren, 2006, V27, P115; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; Kouchinsky A., 2011, GEOL MAG, P1; LANDING E, 1994, GEOLOGY, V22, P179, DOI 10.1130/0091-7613(1994)022<0179:PCBGSR>2.3.CO;2; Liu AG, 2010, GEOLOGY, V38, P123, DOI 10.1130/G30368.1; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Maloof AC, 2010, GEOL SOC AM BULL, V122, P1731, DOI 10.1130/B30346.1; Maloof AC, 2010, NAT GEOSCI, V3, P653, DOI 10.1038/NGEO934; Marshall CR, 2010, EVOLUTION, V64, P1189, DOI 10.1111/j.1558-5646.2009.00908.x; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Narbonne GM, 2004, SCIENCE, V305, P1141, DOI 10.1126/science.1099727; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Porter SM, 2004, PALAIOS, V19, P178, DOI 10.1669/0883-1351(2004)019<0178:CTPWTF>2.0.CO;2; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Richards GS, 2009, COLD SH Q B, V74, P81, DOI 10.1101/sqb.2009.74.028; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; RUNNEGAR B, 1982, ALCHERINGA, V6, P223, DOI 10.1080/03115518208565415; RUNNEGAR B, 1982, LETHAIA, V15, P199, DOI 10.1111/j.1502-3931.1982.tb00645.x; Ryan JF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r64; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Sebe-Pedros A, 2011, MOL BIOL EVOL, V28, P1241, DOI 10.1093/molbev/msq309; SEILACHER A, 1989, LETHAIA, V22, P229, DOI 10.1111/j.1502-3931.1989.tb01332.x; Shields-Zhou G., 2011, GSA TODAY, V21, P4, DOI DOI 10.1130/GSATG102A.1; Sperling EA, 2011, GEOBIOLOGY, V9, P24, DOI 10.1111/j.1472-4669.2010.00259.x; Sperling EA, 2010, EVOL DEV, V12, P201, DOI 10.1111/j.1525-142X.2010.00404.x; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Szaniawski H, 2002, ACTA PALAEONTOL POL, V47, P405; Valentine J. W., 1987, DEV EVOLUTIONARY PRO; Valentine JW, 1999, DEVELOPMENT, V126, P851; Waggoner B, 2003, INTEGR COMP BIOL, V43, P104, DOI 10.1093/icb/43.1.104; Wright JP, 2006, BIOSCIENCE, V56, P203, DOI 10.1641/0006-3568(2006)056[0203:TCOOAE]2.0.CO;2; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Xiao SH, 2009, TRENDS ECOL EVOL, V24, P31, DOI 10.1016/j.tree.2008.07.015	73	825	866	9	361	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1091	1097		10.1126/science.1206375	http://dx.doi.org/10.1126/science.1206375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116879				2022-12-24	WOS:000297313900040
J	Gardner, MK; Zanic, M; Gell, C; Bormuth, V; Howard, J				Gardner, Melissa K.; Zanic, Marija; Gell, Christopher; Bormuth, Volker; Howard, Jonathon			Depolymerizing Kinesins Kip3 and MCAK Shape Cellular Microtubule Architecture by Differential Control of Catastrophe	CELL			English	Article							DYNAMIC INSTABILITY; INDIVIDUAL MICROTUBULES; MITOTIC-SPINDLE; IN-VITRO; GTP CAP; CHROMOSOME CONGRESSION; STABILIZE MICROTUBULES; DEPENDENT MANNER; YEAST KINESIN-8; FISSION YEAST	Microtubules are dynamic filaments whose ends alternate between periods of slow growth and rapid shortening as they explore intracellular space and move organelles. A key question is how regulatory proteins modulate catastrophe, the conversion from growth to shortening. To study this process, we reconstituted microtubule dynamics in the absence and presence of the kinesin-8 Kip3 and the kinesin-13 MCAK. Surprisingly, we found that, even in the absence of the kinesins, the microtubule catastrophe frequency depends on the age of the microtubule, indicating that catastrophe is a multi-step process. Kip3 slowed microtubule growth in a length-dependent manner and increased the rate of aging. In contrast, MCAK eliminated the aging process. Thus, both kinesins are catastrophe factors; Kip3 mediates fine control of microtubule length by narrowing the distribution of maximum lengths prior to catastrophe, whereas MCAK promotes rapid restructuring of the microtubule cytoskeleton by making catastrophe a first-order random process.	[Gardner, Melissa K.; Zanic, Marija; Gell, Christopher; Bormuth, Volker; Howard, Jonathon] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Gardner, Melissa K.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities	Howard, J (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	howard@mpi-cbg.de	Howard, Jonathon/J-7492-2016; Howard, Jonathon/D-4229-2011	Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196; Zanic, Marija/0000-0002-5127-5819; Gell, Christopher/0000-0002-6628-8292	Whitaker International Scholar Fellowship; International Human Frontier Science Program Organization; Boehringer Ingelheim Fonds	Whitaker International Scholar Fellowship; International Human Frontier Science Program Organization(Human Frontier Science Program); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	The authors thank members of the Howard Laboratory, in particular the Muffins Group, for advice and assistance. We thank Dr. V. Varga and Dr. C. Friel for protein and advice. M. K. G. was supported by a Whitaker International Scholar Fellowship, M. Z. by a Cross-Disciplinary Fellowship from the International Human Frontier Science Program Organization, and V. B. by a fellowship from the Boehringer Ingelheim Fonds.	Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Caplow M, 1996, MOL BIOL CELL, V7, P663, DOI 10.1091/mbc.7.4.663; CARLIER MF, 1984, P NATL ACAD SCI-BIOL, V81, P771, DOI 10.1073/pnas.81.3.771; CASSIMERIS LU, 1986, J CELL BIOL, V102, P2023, DOI 10.1083/jcb.102.6.2023; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; CHRETIEN D, 1992, J CELL BIOL, V117, P1031, DOI 10.1083/jcb.117.5.1031; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; DRECHSEL DN, 1994, CURR BIOL, V4, P1053, DOI 10.1016/S0960-9822(00)00243-8; Du YQ, 2010, CURR BIOL, V20, P374, DOI 10.1016/j.cub.2009.12.049; Foethke D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.76; FYGENSON DK, 1994, PHYS REV E, V50, P1579, DOI 10.1103/PhysRevE.50.1579; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Howard J., 2001, MECH MOTOR PROTEINS; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Kinoshita K, 2002, TRENDS CELL BIOL, V12, P267, DOI 10.1016/S0962-8924(02)02295-X; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; Mayr MI, 2007, CURR BIOL, V17, P488, DOI 10.1016/j.cub.2007.02.036; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moores CA, 2006, J CELL SCI, V119, P3905, DOI 10.1242/jcs.03224; Mulder AM, 2009, J CELL BIOL, V185, P51, DOI 10.1083/jcb.200812052; Newton CN, 2004, FEBS LETT, V572, P80, DOI 10.1016/j.febslet.2004.06.093; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; Odde DJ, 1996, AICHE J, V42, P1434, DOI 10.1002/aic.690420524; ODDE DJ, 1995, BIOPHYS J, V69, P796, DOI 10.1016/S0006-3495(95)79953-2; Phillips R., 2008, PHYS BIOL CELL; Rankin KE, 2010, J CELL BIOL, V190, P35, DOI 10.1083/jcb.201004017; Rice J., 1995, MATH STAT DATA ANAL; Rizk RS, 2009, MOL BIOL CELL, V20, P1639, DOI 10.1091/mbc.E08-09-0985; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Stepanova T, 2010, CURR BIOL, V20, P1023, DOI 10.1016/j.cub.2010.04.024; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; VOTER WA, 1991, CELL MOTIL CYTOSKEL, V18, P55, DOI 10.1002/cm.970180106; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; WALKER RA, 1991, J CELL BIOL, V114, P73, DOI 10.1083/jcb.114.1.73; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WALKER RA, 1989, J CELL BIOL, V108, P931, DOI 10.1083/jcb.108.3.931; Wargacki MM, 2010, CELL CYCLE, V9, P2581, DOI 10.4161/cc.9.13.12076; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Wordeman L, 2007, J CELL BIOL, V179, P869, DOI 10.1083/jcb.200707120; Zanic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007585	59	148	150	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1092	1103		10.1016/j.cell.2011.10.037	http://dx.doi.org/10.1016/j.cell.2011.10.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118464	Bronze			2022-12-24	WOS:000297376600020
J	Bostrom, P; Wu, J; Jedrychowski, MP; Korde, A; Ye, L; Lo, JC; Rasbach, KA; Bostrom, EA; Choi, JH; Long, JZ; Kajimura, S; Zingaretti, MC; Vind, BF; Tu, H; Cinti, S; Hojlund, K; Gygi, SP; Spiegelman, BM				Bostroem, Pontus; Wu, Jun; Jedrychowski, Mark P.; Korde, Anisha; Ye, Li; Lo, James C.; Rasbach, Kyle A.; Bostroem, Elisabeth Almer; Choi, Jang Hyun; Long, Jonathan Z.; Kajimura, Shingo; Zingaretti, Maria Cristina; Vind, Birgitte F.; Tu, Hua; Cinti, Saverio; Hojlund, Kurt; Gygi, Steven P.; Spiegelman, Bruce M.			A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis	NATURE			English	Article							SKELETAL-MUSCLE; EXERCISE; PGC-1-ALPHA; PROTECTS; PHOSPHORYLATION; COACTIVATOR; EXPRESSION; MYOBLAST; SWITCH; ROLES	Exercise benefits a variety of organ systems in mammals, and some of the best-recognized effects of exercise on muscle are mediated by the transcriptional co-activator PPAR-gamma co-activator-1 alpha (PGC1-alpha). Here we show in mouse that PGC1-alpha expression in muscle stimulates an increase in expression of FNDC5, a membrane protein that is cleaved and secreted as a newly identified hormone, irisin. Irisin acts on white adipose cells in culture and in vivo to stimulate UCP1 expression and a broad program of brown-fat-like development. Irisin is induced with exercise in mice and humans, and mildly increased irisin levels in the blood cause an increase in energy expenditure in mice with no changes in movement or food intake. This results in improvements in obesity and glucose homeostasis. Irisin could be therapeutic for human metabolic disease and other disorders that are improved with exercise.	[Bostroem, Pontus; Wu, Jun; Korde, Anisha; Ye, Li; Lo, James C.; Rasbach, Kyle A.; Choi, Jang Hyun; Long, Jonathan Z.; Spiegelman, Bruce M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Jedrychowski, Mark P.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Bostroem, Elisabeth Almer] Harvard Univ, Sch Med, Div Renal, Brigham & Womens Hosp, Boston, MA 02115 USA; [Kajimura, Shingo] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Kajimura, Shingo] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Zingaretti, Maria Cristina; Cinti, Saverio] Univ Politecn Marche, Dept Expt & Clin Med, Azienda Osped Riuniti, Electron Microscopy Unit, I-60020 Ancona, Italy; [Vind, Birgitte F.; Hojlund, Kurt] Odense Univ Hosp, Diabet Res Ctr, Dept Endocrinol, DK-5000 Odense, Denmark; [Tu, Hua] LakePharma Inc, Belmont, CA 94002 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Marche Polytechnic University; University of Southern Denmark; Odense University Hospital	Spiegelman, BM (corresponding author), Dana Farber Canc Inst, 3 Blackfan Circle,CLS Bldg,Floor 11, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Korde, Anisha/M-7275-2018; Kajimura, Shingo/AAC-5090-2019; Choi, Jang Hyun/B-3055-2012; Lo, James/GYR-1149-2022	Kajimura, Shingo/0000-0003-0672-5910; Lo, James/0000-0003-0244-1670; Hojlund, Kurt/0000-0002-0891-4224; Korde, Anisha/0000-0002-2233-4322; CINTI, Saverio/0000-0003-0362-5017; Long, Jonathan/0000-0003-2631-7463	National Institutes of Health [DK54477, DK31405, DK61562]; Wenner-Gren Foundation; Swedish Heart and Lung Foundation; Svenska Sallskapet for Medicinsk Forskning; American Heart Association [09POST2010078]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061562, R01DK031405, R01DK054477, R56DK054477, R37DK031405, K99DK087853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundation; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Svenska Sallskapet for Medicinsk Forskning; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants DK54477, DK31405, DK61562 to B. M. S. P. B. and E. A. B. were supported by the Wenner-Gren Foundation, Swedish Heart and Lung Foundation and the 'Svenska Sallskapet for Medicinsk Forskning'. J.W. was supported by a postdoctoral fellowship from the American Heart Association (Founders Affiliate #09POST2010078). The animal procedures were in accordance with Institutional Animal Use and Care Committee protocols 110-2008 and 056-2009. The authors thank S. Loffredo and M. Kirschner for discussions and suggestions on the manuscript.	Bell JB, 2010, MOL THER, V18, P1796, DOI 10.1038/mt.2010.152; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Bostrom P, 2010, DIABETES, V59, P1870, DOI 10.2337/db09-1503; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Cinti S, 2000, METH MOL B, V155, P21; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Ferrer-Martinez A, 2002, DEV DYNAM, V224, P154, DOI 10.1002/dvdy.10099; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Komatsu M, 2010, GENES CELLS, V15, P91, DOI 10.1111/j.1365-2443.2009.01368.x; Nielsen AR, 2007, APPL PHYSIOL NUTR ME, V32, P833, DOI 10.1139/H07-054; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Speakman JR, 2003, P NUTR SOC, V62, P621, DOI 10.1079/PNS2003282; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Vind BF, 2011, DIABETOLOGIA, V54, P157, DOI 10.1007/s00125-010-1924-4; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Xu XH, 2011, AM J PHYSIOL-REG I, V300, pR1115, DOI 10.1152/ajpregu.00806.2010	26	2876	3128	34	582	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2012	481	7382					463	U72		10.1038/nature10777	http://dx.doi.org/10.1038/nature10777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22237023	Green Submitted, Green Accepted			2022-12-24	WOS:000299471800031
J	Houk, AR; Jilkine, A; Mejean, CO; Boltyanskiy, R; Dufresne, ER; Angenent, SB; Altschuler, SJ; Wu, LF; Weiner, OD				Houk, Andrew R.; Jilkine, Alexandra; Mejean, Cecile O.; Boltyanskiy, Rostislav; Dufresne, Eric R.; Angenent, Sigurd B.; Altschuler, Steven J.; Wu, Lani F.; Weiner, Orion D.			Membrane Tension Maintains Cell Polarity by Confining Signals to the Leading Edge during Neutrophil Migration	CELL			English	Article							POSITIVE FEEDBACK; CORTICAL TENSION; MICROPIPETTE ASPIRATION; TETHER FORMATION; RAC ACTIVATION; CHEMOTAXIS; POLARIZATION; MYOSIN; DIFFUSION; GTPASE	Little is known about how neutrophils and other cells establish a single zone of actin assembly during migration. A widespread assumption is that the leading edge prevents formation of additional fronts by generating long-range diffusible inhibitors or by sequestering essential polarity components. We use morphological perturbations, cell-severing experiments, and computational simulations to show that diffusion-based mechanisms are not sufficient for long-range inhibition by the pseudopod. Instead, plasma membrane tension could serve as a long-range inhibitor in neutrophils. We find that membrane tension doubles during leading-edge protrusion, and increasing tension is sufficient for long-range inhibition of actin assembly and Rac activation. Furthermore, reducing membrane tension causes uniform actin assembly. We suggest that tension, rather than diffusible molecules generated or sequestered at the leading edge, is the dominant source of long-range inhibition that constrains the spread of the existing front and prevents the formation of secondary fronts.	[Houk, Andrew R.; Weiner, Orion D.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Houk, Andrew R.; Weiner, Orion D.] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; [Jilkine, Alexandra; Altschuler, Steven J.; Wu, Lani F.] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Jilkine, Alexandra; Altschuler, Steven J.; Wu, Lani F.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Mejean, Cecile O.; Dufresne, Eric R.] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT 06520 USA; [Boltyanskiy, Rostislav] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Angenent, Sigurd B.] Univ Wisconsin, Dept Math, Madison, WI 53706 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; Yale University; University of Wisconsin System; University of Wisconsin Madison	Weiner, OD (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	orion.weiner@ucsf.edu	Weiner, Orion D/F-2576-2011; Dufresne, Eric R/A-7760-2009	Weiner, Orion D/0000-0002-1778-6543; Dufresne, Eric Robert/0000-0002-3091-5039	AHA; NSERC [DBI-0619674, U54 RR022232]; Welch Foundation [I-1644, R01 GM071794, I-1619]; Searle Scholars Award [GM084040];  [NSF-DMS0705431];  [GM081549]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071794, R01GM084040, R01GM081549] Funding Source: NIH RePORTER	AHA(American Heart Association); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Welch Foundation(The Welch Foundation); Searle Scholars Award; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our labs, Henry Bourne, John Clements, Robert Hochmuth, Dyche Mullins, and Michael Springer for helpful discussion and a critical reading of the manuscript. Support: AHA Predoctoral Fellowship (A.R.H.), NSERC Postdoctoral Fellowship (A.J.), DBI-0619674 (E.R.D.), U54 RR022232 (O.D.W., E.R.D.), NSF-DMS0705431 (S.B.A.), GM081549 and Welch Foundation I-1644 (L.F.W.), R01 GM071794 and Welch Foundation I-1619 (S.J.A.), and Searle Scholars Award and GM084040 (O.D.W.).	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; Garcia-Perez AI, 1999, ARCH BIOCHEM BIOPHYS, V362, P329, DOI 10.1006/abbi.1998.1051; Gardiner EM, 2002, CURR BIOL, V12, P2029, DOI 10.1016/S0960-9822(02)01334-9; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Hallett MB, 2007, TRENDS CELL BIOL, V17, P209, DOI 10.1016/j.tcb.2007.03.002; Herant M, 2005, J CELL SCI, V118, P1789, DOI 10.1242/jcs.02275; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Janetopoulos C, 2004, P NATL ACAD SCI USA, V101, P8951, DOI 10.1073/pnas.0402152101; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002271; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Keren K, 2011, EUR BIOPHYS J BIOPHY, V40, P1013, DOI 10.1007/s00249-011-0741-0; Kozlov MM, 2007, BIOPHYS J, V93, P3811, DOI 10.1529/biophysj.107.110411; Lee CY, 2011, J CELL SCI, V124, P1106, DOI 10.1242/jcs.078592; Lee S, 2010, MOL BIOL CELL, V21, P1810, DOI 10.1091/mbc.E10-01-0009; MALAWISTA SE, 1982, J CELL BIOL, V95, P960, DOI 10.1083/jcb.95.3.960; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Meili R, 2010, MOL BIOL CELL, V21, P405, DOI 10.1091/mbc.E09-08-0703; Meinhardt H, 1999, J CELL SCI, V112, P2867; Mori Y, 2008, BIOPHYS J, V94, P3684, DOI [10.1529/biophysj.107.120824, 10.1529/biophysj.107.120827]; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Otsuji M, 2007, PLOS COMPUT BIOL, V3, P1040, DOI 10.1371/journal.pcbi.0030108; PASTERNAK C, 1989, NATURE, V341, P549, DOI 10.1038/341549a0; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shao JY, 2002, J BIOMECH ENG-T ASME, V124, P388, DOI 10.1115/1.1486469; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; WESSELS D, 1988, DEV BIOL, V128, P164, DOI 10.1016/0012-1606(88)90279-5; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Zhelev DV, 1996, CELL MOTIL CYTOSKEL, V35, P331	52	373	375	3	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					175	188		10.1016/j.cell.2011.10.050	http://dx.doi.org/10.1016/j.cell.2011.10.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265410	Bronze, Green Accepted			2022-12-24	WOS:000299540700023
J	McLellan, JS; Pancera, M; Carrico, C; Gorman, J; Julien, JP; Khayat, R; Louder, R; Pejchal, R; Sastry, M; Dai, KF; O'Dell, S; Patel, N; Shahzad-ul-Hussan, S; Yang, YP; Zhang, BS; Zhou, TQ; Zhu, J; Boyington, JC; Chuang, GY; Diwanji, D; Georgiev, I; Do Kwon, Y; Lee, D; Louder, MK; Moquin, S; Schmidt, SD; Yang, ZY; Bonsignori, M; Crump, JA; Kapiga, SH; Sam, NE; Haynes, BF; Burton, DR; Koff, WC; Walker, LM; Phogat, S; Wyatt, R; Orwenyo, J; Wang, LX; Arthos, J; Bewley, CA; Mascola, JR; Nabel, GJ; Schief, WR; Ward, AB; Wilson, IA; Kwong, PD				McLellan, Jason S.; Pancera, Marie; Carrico, Chris; Gorman, Jason; Julien, Jean-Philippe; Khayat, Reza; Louder, Robert; Pejchal, Robert; Sastry, Mallika; Dai, Kaifan; O'Dell, Sijy; Patel, Nikita; Shahzad-ul-Hussan, Syed; Yang, Yongping; Zhang, Baoshan; Zhou, Tongqing; Zhu, Jiang; Boyington, Jeffrey C.; Chuang, Gwo-Yu; Diwanji, Devan; Georgiev, Ivelin; Do Kwon, Young; Lee, Doyung; Louder, Mark K.; Moquin, Stephanie; Schmidt, Stephen D.; Yang, Zhi-Yong; Bonsignori, Mattia; Crump, John A.; Kapiga, Saidi H.; Sam, Noel E.; Haynes, Barton F.; Burton, Dennis R.; Koff, Wayne C.; Walker, Laura M.; Phogat, Sanjay; Wyatt, Richard; Orwenyo, Jared; Wang, Lai-Xi; Arthos, James; Bewley, Carole A.; Mascola, John R.; Nabel, Gary J.; Schief, William R.; Ward, Andrew B.; Wilson, Ian A.; Kwong, Peter D.			Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9	NATURE			English	Article							ENVELOPE GLYCOPROTEINS; POTENT NEUTRALIZATION; DEXTRAN SULFATE; IMMUNODEFICIENCY; EPITOPE; SOFTWARE; BINDING; REGION; CRYSTALLIZATION; ARCHITECTURE	Variable regions 1 and 2 (V1/V2) of human immunodeficiency virus-1 (HIV-1) gp120 envelope glycoprotein are critical for viral evasion of antibody neutralization, and are themselves protected by extraordinary sequence diversity and N-linked glycosylation. Human antibodies such as PG9 nonetheless engage V1/V2 and neutralize 80% of HIV-1 isolates. Here we report the structure of V1/V2 in complex with PG9. V1/V2 forms a four-stranded beta-sheet domain, in which sequence diversity and glycosylation are largely segregated to strand-connecting loops. PG9 recognition involves electrostatic, sequence-independent and glycan interactions: the latter account for over half the interactive surface but are of sufficiently weak affinity to avoid autoreactivity. The structures of V1/V2-directed antibodies CH04 and PGT145 indicate that they share a common mode of glycan penetration by extended anionic loops. In addition to structurally defining V1/V2, the results thus identify a paradigm of antibody recognition for highly glycosylated antigens, which-with PG9-involves a site of vulnerability comprising just two glycans and a strand.	[McLellan, Jason S.; Pancera, Marie; Gorman, Jason; Louder, Robert; Sastry, Mallika; Dai, Kaifan; O'Dell, Sijy; Shahzad-ul-Hussan, Syed; Yang, Yongping; Zhang, Baoshan; Zhou, Tongqing; Zhu, Jiang; Boyington, Jeffrey C.; Chuang, Gwo-Yu; Georgiev, Ivelin; Do Kwon, Young; Lee, Doyung; Louder, Mark K.; Moquin, Stephanie; Schmidt, Stephen D.; Yang, Zhi-Yong; Mascola, John R.; Nabel, Gary J.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Carrico, Chris; Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Julien, Jean-Philippe; Khayat, Reza; Pejchal, Robert; Diwanji, Devan; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Julien, Jean-Philippe; Khayat, Reza; Pejchal, Robert; Diwanji, Devan; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Patel, Nikita; Arthos, James] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Shahzad-ul-Hussan, Syed; Bewley, Carole A.] NIDDKD, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Bonsignori, Mattia; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Crump, John A.] Duke Univ, Med Ctr, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA; [Crump, John A.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Crump, John A.; Sam, Noel E.] Tumaini Univ, Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Crump, John A.; Sam, Noel E.] Tumaini Univ, Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Kapiga, Saidi H.; Sam, Noel E.] Kilimanjaro Reprod Hlth Programme, Moshi, Tanzania; [Wyatt, Richard] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, TSRI, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA; [Koff, Wayne C.; Phogat, Sanjay] IAVI, New York, NY 10004 USA; [Orwenyo, Jared; Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Orwenyo, Jared; Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; Scripps Research Institute; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Duke University; Duke University; Duke University; Kilimanjaro Christian Medical Centre; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; International AIDS Vaccine Initiative; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Wang, Lai-Xi/E-8755-2019; Schmidt, Stephen/AAC-6967-2019; Do Kwon, Young/A-6957-2010; Schmidt, Stephen/B-5398-2012; Mascola, John/AAI-7193-2021; Bonsignori, Mattia/AAE-7678-2019; Schief, William/ABF-3645-2020; Ward, Andrew/ABD-7728-2021; Wang, Lai-Xi/E-8790-2019; Gorman, Jason/AGG-9417-2022; wang, xl/Y-8251-2019; Wang, Xin/AAN-8435-2021; Ward, Andrew B/F-9203-2014; Zhou, Tongqing/A-6880-2010; Crump, John A./AAZ-6412-2020; Louder, Robert/F-4713-2014; Crump, John A./AAZ-6289-2020	Do Kwon, Young/0000-0002-1188-7458; Bonsignori, Mattia/0000-0003-2973-2101; Schief, William/0000-0002-1120-0150; Ward, Andrew/0000-0001-7153-3769; Wang, Lai-Xi/0000-0003-4293-5819; Wang, Xin/0000-0002-4457-7376; Ward, Andrew B/0000-0001-7153-3769; Zhou, Tongqing/0000-0002-3935-4637; Crump, John A./0000-0002-4529-102X; Louder, Robert/0000-0002-6944-9346; Crump, John A./0000-0002-4529-102X; Bewley, Carole/0000-0003-2203-0852; Carrico, Chris/0000-0003-0939-9006; McLellan, Jason/0000-0003-3991-542X; Moquin, Stephanie/0000-0002-8696-4315; Kapiga, Saidi/0000-0003-1753-4060; Gorman, Jason/0000-0002-3775-6560; Julien, Jean-Philippe/0000-0001-7602-3995	National Institutes of Health (NIH); International AIDS Vaccine Initiative; Ragon Institute; Canadian Institute of Health Research; NIH through the National Center for Research Resources [RR017573]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005022, R01AI084817, ZIAAI000883, R01AI033292, ZIAAI005095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK032103] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; Ragon Institute; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NIH through the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Changela and X. Wu for assistance with mapping the PG16 paratope, J. Sodroski for discussions, J. Stuckey for assistance with figures, and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions and comments on the manuscript. Support for this work was provided by the Intramural Research Program of the National Institutes of Health (NIH), by the International AIDS Vaccine Initiative, by the Ragon Institute, by the Canadian Institute of Health Research and by grants from the NIH. The three-dimensional reconstructions were conducted at the National Resource for Automated Molecular Microscopy (NRAMM), which is supported by the NIH through the National Center for Research Resources' P41 program(RR017573). Use of sector 22 (Southeast Regional Collaborative Access Team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 2011, PYMOL MOL GRAPH SYST; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao J, 1997, J VIROL, V71, P9808, DOI 10.1128/JVI.71.12.9808-9812.1997; Cauerhff A, 2000, J IMMUNOL, V165, P6422, DOI 10.4049/jimmunol.165.11.6422; Changela A, 2011, J VIROL, V85, P2524, DOI 10.1128/JVI.02335-10; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; Fletcher PS, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-46; FRANK J, 1981, ULTRAMICROSCOPY, V6, P343, DOI 10.1016/S0304-3991(81)80236-7; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; HE XM, 1992, P NATL ACAD SCI USA, V89, P7154, DOI 10.1073/pnas.89.15.7154; Honnen WJ, 2007, J VIROL, V81, P1424, DOI 10.1128/JVI.02054-06; Hu GQ, 2011, J VIROL, V85, P2741, DOI 10.1128/JVI.01612-10; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Kabat EA, 1991, SEQUENCES PROTEINS I; Karasavvas N, 2011, AIDS RES HUM RETROV, V27, pA29; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Majeed S, 2003, STRUCTURE, V11, P1061, DOI 10.1016/S0969-2126(03)00185-0; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MITSUYA H, 1988, SCIENCE, V240, P646, DOI 10.1126/science.2452480; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Moore PL, 2011, AIDS RES HUM RETROV, V27, pA29; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Ross SA, 2001, PROTEIN SCI, V10, P450, DOI 10.1110/ps.32501; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; SCHOLS D, 1990, VIROLOGY, V175, P556, DOI 10.1016/0042-6822(90)90440-3; Sloan DJ, 1999, PROTEIN SCI, V8, P1643, DOI 10.1110/ps.8.8.1643; Spurrier B, 2011, STRUCTURE, V19, P691, DOI 10.1016/j.str.2011.02.012; Stamatatos L, 1998, J VIROL, V72, P7840, DOI 10.1128/JVI.72.10.7840-7845.1998; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu SR, 2010, P NATL ACAD SCI USA, V107, P18844, DOI 10.1073/pnas.1007227107; Wu XL, 2011, J VIROL, V85, P4578, DOI 10.1128/JVI.02585-10; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2011, AIDS RES HUM RETROV, V27, pA21	69	648	711	1	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					336	U86		10.1038/nature10696	http://dx.doi.org/10.1038/nature10696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22113616	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000298033000044
J	Auerbach, BD; Osterweil, EK; Bear, MF				Auerbach, Benjamin D.; Osterweil, Emily K.; Bear, Mark F.			Mutations causing syndromic autism define an axis of synaptic pathophysiology	NATURE			English	Article							LONG-TERM DEPRESSION; FRAGILE-X-SYNDROME; HIPPOCAMPAL AREA CA1; TUBEROUS-SCLEROSIS; PROTEIN-SYNTHESIS; MENTAL-RETARDATION; MOUSE MODEL; MAMMALIAN TARGET; RAT HIPPOCAMPUS; MTOR	Tuberous sclerosis complex and fragile X syndrome are genetic diseases characterized by intellectual disability and autism. Because both syndromes are caused by mutations in genes that regulate protein synthesis in neurons, it has been hypothesized that excessive protein synthesis is one core pathophysiological mechanism of intellectual disability and autism. Using electrophysiological and biochemical assays of neuronal protein synthesis in the hippocampus of Tsc2(+/-) and Fmr1(-/y) mice, here we show that synaptic dysfunction caused by these mutations actually falls at opposite ends of a physiological spectrum. Synaptic, biochemical and cognitive defects in these mutants are corrected by treatments that modulate metabotropic glutamate receptor 5 in opposite directions, and deficits in the mutants disappear when the mice are bred to carry both mutations. Thus, normal synaptic plasticity and cognition occur within an optimal range of metabotropic glutamate-receptor-mediated protein synthesis, and deviations in either direction can lead to shared behavioural impairments.	[Auerbach, Benjamin D.; Osterweil, Emily K.; Bear, Mark F.] MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health	Bear, MF (corresponding author), MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.	mbear@mit.edu		Osterweil, Emily/0000-0003-0582-2284; Bear, Mark/0000-0002-9903-2541	National Institute of Mental Health [T32 MH-082718, T32-MH-074249]; National Institute of Child Health and Human Development [2R01HD046943]; Department of Defense [W81XWH-11-1-0252]; Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH074249, T32MH082718] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Department of Defense(United States Department of Defense); Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partly supported by grants from the National Institute of Mental Health (T32 MH-082718 and T32-MH-074249), the National Institute of Child Health and Human Development (2R01HD046943), the Department of Defense (W81XWH-11-1-0252) and The Simons Foundation. We acknowledge A. Heynen for advice and comments, as well as K. Oram, E. Sklar and S. Meagher for technical and administrative assistance. Monoclonal Arc antibody was a gift from P. Worley.	Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; CARBONARA C, 1994, HUM MOL GENET, V3, P1829, DOI 10.1093/hmg/3.10.1829; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Vries PJ, 2007, TRENDS MOL MED, V13, P319, DOI 10.1016/j.molmed.2007.06.003; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dolen G, 2010, PHARMACOL THERAPEUT, V127, P78, DOI 10.1016/j.pharmthera.2010.02.008; Ehninger D, 2009, J INTELL DISABIL RES, V53, P838, DOI 10.1111/j.1365-2788.2009.01208.x; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fitzjohn SM, 2001, J PHYSIOL-LONDON, V537, P421, DOI 10.1111/j.1469-7793.2001.00421.x; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kinney GG, 2005, J PHARMACOL EXP THER, V313, P199, DOI 10.1124/jpet.104.079244; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Krueger DD, 2010, J MOL NEUROSCI, V42, P1, DOI 10.1007/s12031-010-9338-9; Lu YM, 1997, J NEUROSCI, V17, P5196; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Mockett BG, 2011, J NEUROSCI, V31, P7380, DOI 10.1523/JNEUROSCI.6656-10.2011; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Nie D, 2010, NAT NEUROSCI, V13, P163, DOI 10.1038/nn.2477; Nosyreva ED, 2005, J NEUROSCI, V25, P2992, DOI 10.1523/JNEUROSCI.3652-04.2005; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Stiedl O, 1999, BEHAV NEUROSCI, V113, P496, DOI 10.1037/0735-7044.113.3.496; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107	43	444	474	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					63	U222		10.1038/nature10658	http://dx.doi.org/10.1038/nature10658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22113615	Green Accepted, Green Submitted			2022-12-24	WOS:000298031900033
J	Fischer, ES; Scrima, A; Bohm, K; Matsumoto, S; Lingaraju, GM; Faty, M; Yasuda, T; Cavadini, S; Wakasugi, M; Hanaoka, F; Iwai, S; Gut, H; Sugasawa, K; Thoma, NH				Fischer, Eric S.; Scrima, Andrea; Boehm, Kerstin; Matsumoto, Syota; Lingaraju, Gondichatnahalli M.; Faty, Mahamadou; Yasuda, Takeshi; Cavadini, Simone; Wakasugi, Mitsuo; Hanaoka, Fumio; Iwai, Shigenori; Gut, Heinz; Sugasawa, Kaoru; Thomae, Nicolas H.			The Molecular Basis of CRL4(DDB2/CSA) Ubiquitin Ligase Architecture, Targeting, and Activation	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; UV-DAMAGED-DNA; PIGMENTOSUM GROUP-E; COP9 SIGNALOSOME; BINDING PROTEIN; IN-VIVO; STRUCTURAL INSIGHTS; COCKAYNE-SYNDROME; XPC COMPLEX; HISTONE H2A	The DDB1-CUL4-RBX1 (CRL4) ubiquitin ligase family regulates a diverse set of cellular pathways through dedicated substrate receptors (DCAFs). The DCAF DDB2 detects UV-induced pyrimidine dimers in the genome and facilitates nucleotide excision repair. We provide the molecular basis for DDB2 receptor-mediated cyclobutane pyrimidine dimer recognition in chromatin. The structures of the fully assembled DDB1-DDB2-CUL4A/B-RBX1 (CRL4 DDB2) ligases reveal that the mobility of the ligase arm creates a defined ubiquitination zone around the damage, which precludes direct ligase activation by DNA lesions. Instead, the COP9 signalosome (CSN) mediates the CRL4 DDB2 inhibition in a CSN5 independent, nonenzymatic, fashion. In turn, CSN inhibition is relieved upon DNA damage binding to the DDB2 module within CSN-CRL4 DDB2. The Cockayne syndrome A DCAF complex crystal structure shows that CRL4 DCAF(WD40) ligases share common architectural features. Our data support a general mechanism of ligase activation, which is induced by CSN displacement from CRL4 DCAF on substrate binding to the DCAF.	[Fischer, Eric S.; Scrima, Andrea; Boehm, Kerstin; Lingaraju, Gondichatnahalli M.; Faty, Mahamadou; Cavadini, Simone; Gut, Heinz; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Matsumoto, Syota; Sugasawa, Kaoru] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; [Matsumoto, Syota; Sugasawa, Kaoru] Kobe Univ, Grad Sch Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Yasuda, Takeshi] Natl Inst Radiol Sci, Inage Ku, Chiba 2638555, Japan; [Wakasugi, Mitsuo] Kanazawa Univ, Grad Sch Nat Sci & Technol, Lab Human Mol Genet, Kanazawa, Ishikawa 9201192, Japan; [Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Toshima Ku, Tokyo 1718588, Japan; [Iwai, Shigenori] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Fischer, Eric S.] Univ Basel, CH-4003 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Kobe University; Kobe University; National Institutes for Quantum Science & Technology; Kanazawa University; Gakushuin University; Osaka University; University of Basel	Thoma, NH (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	nicolas.thoma@fmi.ch	Wakasugi, Mitsuo/D-8417-2015; Yasuda, Takeshi/AAJ-4044-2021; Fischer, Eric/B-3924-2013; Matsumoto, Syota/GOE-6847-2022	Wakasugi, Mitsuo/0000-0001-9593-0566; Fischer, Eric/0000-0001-7337-6306; Matsumoto, Syota/0000-0002-8776-2096; Thoma, Nicolas/0000-0003-2685-906X	Novartis Research Foundation; European Research Council [RC-2010-StG 260481-MoBa-CS]; OncoSuisse [OCS-02365-02-2009]; Swiss National Science Foundation [31003A_120205]; SNF Ambizione; EMBO STF; Novartis; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [21510055, 20241013, 22131008] Funding Source: KAKEN	Novartis Research Foundation; European Research Council(European Research Council (ERC)European Commission); OncoSuisse; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SNF Ambizione; EMBO STF; Novartis(Novartis); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Novartis Research Foundation and grants to N.H.T. from the European Research Council (ERC-2010-StG 260481-MoBa-CS), OncoSuisse (OCS-02365-02-2009), and the Swiss National Science Foundation (31003A_120205); an SNF Ambizione Grant (A. S.), an EMBO STF (E. S. F.), and Novartis Presidential Fellowship (G. M. L.). K. S. was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Takeda Science Foundation. We thank Susan Gasser, Dirk Schubeler, Lukas Leder, Martin Renatus, and Philip Jeffrey for help and discussion. We are grateful to Daniel Hess and Dominique Klein (FMI protein analysis facility) for carrying out the mass-spectrometric analysis. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institut, Villigen, Switzerland.	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Creighton T.E., 1992, PROTEINS STRUCTURES; Duan MR, 2010, J BIOL CHEM, V285, P26295, DOI 10.1074/jbc.M110.140087; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Fukumoto Y, 2008, MOL CELL BIOL, V28, P6746, DOI 10.1128/MCB.00757-08; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; GALE JM, 1988, J MOL BIOL, V204, P949, DOI 10.1016/0022-2836(88)90054-X; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; Hannss R, 2011, FEBS LETT, V585, P2845, DOI 10.1016/j.febslet.2011.04.027; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jing YQ, 1998, NUCLEIC ACIDS RES, V26, P3845, DOI 10.1093/nar/26.16.3845; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; MITCHELL DL, 1989, PHOTOCHEM PHOTOBIOL, V50, P639, DOI 10.1111/j.1751-1097.1989.tb04320.x; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Nishi R, 2009, DNA REPAIR, V8, P767, DOI 10.1016/j.dnarep.2009.02.004; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; Schmidt MW, 2009, MOL CELL, V35, P586, DOI 10.1016/j.molcel.2009.07.024; Scrima A, 2011, FEBS LETT, V585, P2818, DOI 10.1016/j.febslet.2011.04.064; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Sugasawa K, 2010, MUTAT RES-FUND MOL M, V685, P29, DOI 10.1016/j.mrfmmm.2009.08.004; Takedachi A, 2010, MOL CELL BIOL, V30, P2708, DOI 10.1128/MCB.01460-09; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Yasuda T, 2005, DNA REPAIR, V4, P389, DOI 10.1016/j.dnarep.2004.10.008; Zhou CS, 2003, MOL CELL, V11, P927, DOI 10.1016/S1097-2765(03)00136-9	54	296	319	2	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1024	1039		10.1016/j.cell.2011.10.035	http://dx.doi.org/10.1016/j.cell.2011.10.035			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118460	Bronze			2022-12-24	WOS:000297376600015
J	Piskounova, E; Polytarchou, C; Thornton, JE; LaPierre, RJ; Pothoulakis, C; Hagan, JP; Iliopoulos, D; Gregory, RI				Piskounova, Elena; Polytarchou, Christos; Thornton, James E.; LaPierre, Robert J.; Pothoulakis, Charalabos; Hagan, John P.; Iliopoulos, Dimitrios; Gregory, Richard I.			Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct Mechanisms	CELL			English	Article							PROMOTES TRANSFORMATION; FEEDBACK LOOP; SELF-RENEWAL; LIN-28; MATURATION; EXPRESSION; CELLS; DIFFERENTIATION; METASTASIS; SUPPRESSES	Lin28A and Lin28B selectively block the expression of let-7 microRNAs and function as oncogenes in a variety of human cancers. Lin28A recruits a TUTase (Zcchc11/TUT4) to let-7 precursors to block processing by Dicer in the cell cytoplasm. Here we find that unlike Lin28A, Lin28B represses let-7 processing through a Zcchc11-independent mechanism. Lin28B functions in the nucleus by sequestering primary let-7 transcripts and inhibiting their processing by the Microprocessor. The inhibitory effects of Zcchc11 depletion on the tumorigenic capacity and metastatic potential of human cancer cells and xenografts are restricted to Lin28A-expressing tumors. Furthermore, the majority of human colon and breast tumors analyzed exclusively express either Lin28A or Lin28B. Lin28A is expressed in HER2-overexpressing breast tumors, whereas Lin28B expression characterizes triple-negative breast tumors. Overall our results illuminate the distinct mechanisms by which Lin28A and Lin28B function and have implications for the development of new strategies for cancer therapy.	[Polytarchou, Christos; Iliopoulos, Dimitrios] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Piskounova, Elena; Thornton, James E.; LaPierre, Robert J.; Hagan, John P.; Gregory, Richard I.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Piskounova, Elena; Thornton, James E.; LaPierre, Robert J.; Hagan, John P.; Gregory, Richard I.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Piskounova, Elena; Thornton, James E.; LaPierre, Robert J.; Hagan, John P.; Gregory, Richard I.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Polytarchou, Christos; Iliopoulos, Dimitrios] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90095 USA; [Hagan, John P.] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Ohio; Ohio State University	Iliopoulos, D (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA.	dimitrios_iliopoulos@dfci.harvard.edu; rgregory@enders.tch.harvard.edu	Iliopoulos, Dimitrios/AAE-9106-2019	Hagan, John/0000-0003-0295-4898; Piskounova, Elena/0000-0002-8554-8475	US National Institute of General Medical Sciences (NIGMS) [1R01GM086386-01A1]; Harvard Stem Cell Institute; American Cancer Society [121635-RSG-11-175-01-RMC]; Department of Cancer Immunology & AIDS at Dana-Farber Cancer Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086386] Funding Source: NIH RePORTER	US National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Harvard Stem Cell Institute; American Cancer Society(American Cancer Society); Department of Cancer Immunology & AIDS at Dana-Farber Cancer Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Akihiko Yoshimura, Keio University, Japan, for the human Flag-Zcchc11 plasmid; Dr. Na Liu, Memorial Sloan Kettering Cancer Center, for the Myc-Ago2 plasmid; Dr. Bharat Ramratnam, Brown University, for the GFP-Drosha plasmid; and Dr. Ramin Shiekhattar, Wistar Institute, for the FlagEif6 expression plasmid. We thank Chiara Giacomelli, Dr. Saurabh Patel, and Dr. Maria Hatziapostolou for technical assistance. R. I. G. was supported by grants from the US National Institute of General Medical Sciences (NIGMS) (1R01GM086386-01A1), The Harvard Stem Cell Institute, and The American Cancer Society (121635-RSG-11-175-01-RMC). R. I. G. is a Pew Research Scholar. D. I. was supported by start-up funds from the Department of Cancer Immunology & AIDS at Dana-Farber Cancer Institute.	Barh D, 2010, CURR ONCOL, V17, P70; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ji JF, 2010, J HEPATOL, V53, P974, DOI 10.1016/j.jhep.2010.07.001; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Ryder Sean P., 2008, V488, P99, DOI 10.1007/978-1-60327-475-3_7; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Slack F, 2009, CELL CYCLE, V8, P1823, DOI 10.4161/cc.8.12.8639; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Van Wynsberghe PM, 2011, NAT STRUCT MOL BIOL, V18, P302, DOI 10.1038/nsmb.1986; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	50	447	471	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 23	2011	147	5					1066	1079		10.1016/j.cell.2011.10.039	http://dx.doi.org/10.1016/j.cell.2011.10.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118463	Green Accepted, Bronze			2022-12-24	WOS:000297376600018
J	Krishnamurthy, H; Gouaux, E				Krishnamurthy, Harini; Gouaux, Eric			X-ray structures of LeuT in substrate-free outward-open and apo inward-open states	NATURE			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; SEROTONIN TRANSPORTER; DOPAMINE TRANSPORTER; BACTERIAL HOMOLOG; MEMBRANE-TRANSPORT; PERMEATION PATHWAY; ALTERNATING ACCESS; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; SODIUM SYMPORTER	Neurotransmitter sodium symporters are integral membrane proteins that remove chemical transmitters from the synapse and terminate neurotransmission mediated by serotonin, dopamine, noradrenaline, glycine and GABA (gamma-aminobutyric acid). Crystal structures of the bacterial homologue, LeuT, in substrate-bound outward-occluded and competitive inhibitor-bound outward-facing states have advanced our mechanistic understanding of neurotransmitter sodium symporters but have left fundamental questions unanswered. Here we report crystal structures of LeuT mutants in complexes with conformation-specific antibody fragments in the outward-open and inward-open states. In the absence of substrate but in the presence of sodium the transporter is outward-open, illustrating how the binding of substrate closes the extracellular gate through local conformational changes: hinge-bending movements of the extracellular halves of transmembrane domains 1, 2 and 6, together with translation of extracellular loop 4. The inward-open conformation, by contrast, involves large-scale conformational changes, including a reorientation of transmembrane domains 1, 2, 5, 6 and 7, a marked hinge bending of transmembrane domain 1a and occlusion of the extracellular vestibule by extracellular loop 4. These changes close the extracellular gate, open an intracellular vestibule, and largely disrupt the two sodium sites, thus providing a mechanism by which ions and substrate are released to the cytoplasm. The new structures establish a structural framework for the mechanism of neurotransmitter sodium symporters and their modulation by therapeutic and illicit substances.	[Krishnamurthy, Harini; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Cawley for monoclonal antibody production, L. Vaskalis for help with illustrations and the staff at the Advanced Photon Source beamline 24-ID-E and at the Advanced Light Source beamline 5.0.2 for their assistance with X-ray data collection and processing. We are grateful to E. Haddadian, T. Sosnick and K. Freed for assistance in refining the backbone torsional and side-chain angles using their unpublished TOP algorithm. We thank all Gouaux laboratory members, especially C. Piscitelli and S. K. Singh, for discussions and helpful suggestions throughout the project. This work was supported by the National Institutes of Health. E. G. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ben-Yona A, 2009, J BIOL CHEM, V284, P9727, DOI 10.1074/jbc.M809423200; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Chen NH, 2004, J BIOL CHEM, V279, P5508, DOI 10.1074/jbc.M306294200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; HERTTING G, 1961, NATURE, V192, P172, DOI 10.1038/192172a0; Hirayama BA, 2001, BRIT J PHARMACOL, V134, P484, DOI 10.1038/sj.bjp.0704274; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klimek V, 1997, J NEUROSCI, V17, P8451; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; Nelson N, 1998, J NEUROCHEM, V71, P1785; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Richerson GB, 2004, ADV EXP MED BIOL, V548, P76; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Rudnick G, 2011, BIOCHEMISTRY-US, V50, P7462, DOI 10.1021/bi200926b; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shaikh SA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000905; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; Tao Z, 2009, J BIOL CHEM, V284, P33807, DOI 10.1074/jbc.M109.071977; Terwilliger TC, 2004, ACTA CRYSTALLOGR D, V60, P2144, DOI 10.1107/S0907444904019535; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zomot E, 2003, J BIOL CHEM, V278, P42950, DOI 10.1074/jbc.M209307200	61	376	378	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2012	481	7382					469	U80		10.1038/nature10737	http://dx.doi.org/10.1038/nature10737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22230955	Green Accepted			2022-12-24	WOS:000299471800032
J	Steinhauser, ML; Bailey, AP; Senyo, SE; Guillermier, C; Perlstein, TS; Gould, AP; Lee, RT; Lechene, CP				Steinhauser, Matthew L.; Bailey, Andrew P.; Senyo, Samuel E.; Guillermier, Christelle; Perlstein, Todd S.; Gould, Alex P.; Lee, Richard T.; Lechene, Claude P.			Multi-isotope imaging mass spectrometry quantifies stem cell division and metabolism	NATURE			English	Article							SMALL-INTESTINE; SEGREGATION; TELOMERASE; DNA; PROTECT; STRANDS; GENOME; CRYPT	Mass spectrometry with stable isotope labels has been seminal in discovering the dynamic state of living matter(1,2), but is limited to bulk tissues or cells. We developed multi-isotope imaging mass spectrometry (MIMS) that allowed us to view and measure stable isotope incorporation with submicrometre resolution(3,4). Here we apply MIMS to diverse organisms, including Drosophila, mice and humans. We test the 'immortal strand hypothesis', which predicts that during asymmetric stem cell division chromosomes containing older template DNA are segregated to the daughter destined to remain a stem cell, thus insuring lifetime genetic stability. After labelling mice with N-15-thymidine from gestation until post-natal week 8, we find no N-15 label retention by dividing small intestinal crypt cells after a four-week chase. In adult mice administered N-15-thymidine pulse-chase, we find that proliferating crypt cells dilute the N-15 label, consistent with random strand segregation. We demonstrate the broad utility of MIMS with proof-of-principle studies of lipid turnover in Drosophila and translation to the human haematopoietic system. These studies show that MIMS provides high-resolution quantification of stable isotope labels that cannot be obtained using other techniques and that is broadly applicable to biological and medical research.	[Steinhauser, Matthew L.; Senyo, Samuel E.; Guillermier, Christelle; Perlstein, Todd S.; Lee, Richard T.; Lechene, Claude P.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Steinhauser, Matthew L.; Senyo, Samuel E.; Perlstein, Todd S.; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Bailey, Andrew P.; Gould, Alex P.] Natl Inst Med Res, Div Physiol & Metab, MRC, London NW7 1AA, England; [Guillermier, Christelle; Lechene, Claude P.] Natl Resource Imaging Mass Spect, Cambridge, MA 02139 USA; [Guillermier, Christelle; Lechene, Claude P.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Lee, Richard T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; MRC National Institute for Medical Research; Harvard University; Brigham & Women's Hospital; Harvard University	Lechene, CP (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	cpl@harvard.edu	Gould, Alex/M-5353-2019; Steinhauser, Matthew L./GVT-6393-2022; Gould, Alex/A-7479-2010	Gould, Alex/0000-0002-6875-6985; Steinhauser, Matthew L./0000-0001-5287-9246; Gould, Alex/0000-0002-6875-6985; Lee, Richard/0000-0003-4687-1381; Senyo, Samuel/0000-0002-9206-6845; Bailey, Andrew/0000-0003-2143-1689	American Heart Association; Future Leaders in Cardiovascular Medicine; Medical Research Council [U117584237]; National Institutes of Health [AG032977, EB001974, AG034641]; Harvard Stem Cell Institute; Ellison Medical Foundation; Human Frontier Science Program; MRC [MC_U117584237] Funding Source: UKRI; Medical Research Council [MC_U117584237] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001974, P20EB001974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032977, R21AG034641, R01AG040019] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Future Leaders in Cardiovascular Medicine; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); Human Frontier Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Mudge, M. Raff and A. Aperia for critical reading of the manuscript; M. Raff for numerous enlightening discussions; T. Bloom for her strong support at the origin of MIMS development; M. Wang for MIMS analysis; J. Poczatek and Z. Kaufman for MIMS analysis software development; L. Trakimas, C. MacGillivray, S. Clark and E. Hurst for histology; W. Wang for statistics advice. We thank Cambridge Isotope Laboratories for their generous gift of thymidine (<SUP>15</SUP>N<INF>2</INF>, 96-98%). M. L. S. is funded by the American Heart Association and Future Leaders in Cardiovascular Medicine. A. P. G. is funded by the Medical Research Council (U117584237). R. T. L. is funded by the National Institutes of Health (AG032977) and a grant from the Harvard Stem Cell Institute. C. P. L. is funded by the National Institutes of Health (EB001974, AG034641), the Ellison Medical Foundation and the Human Frontier Science Program.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; LARK KG, 1966, SCIENCE, V154, P1202, DOI 10.1126/science.154.3753.1202; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Pech MF, 2011, EMBO J, V30, P986, DOI 10.1038/emboj.2011.51; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; SCHICK P, 1978, J CELL SCI, V33, P351; Schoenheimer R, 1938, SCIENCE, V87, P221, DOI 10.1126/science.87.2254.221; Schoenheimer R, 1938, SCIENCE, V88, P599, DOI 10.1126/science.88.2295.599; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sotiropoulou PA, 2008, STEM CELLS, V26, P2964, DOI 10.1634/stemcells.2008-0634; Sturup S, 2008, ANAL BIOANAL CHEM, V390, P541, DOI 10.1007/s00216-007-1638-8; TOTAFURNO J, 1987, BIOPHYS J, V52, P279, DOI 10.1016/S0006-3495(87)83215-0	28	210	215	1	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2012	481	7382					516	U131		10.1038/nature10734	http://dx.doi.org/10.1038/nature10734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22246326	Green Accepted			2022-12-24	WOS:000299471800042
J	Rajakumar, R; San Mauro, D; Dijkstra, MB; Huang, MH; Wheeler, DE; Hiou-Tim, F; Khila, A; Cournoyea, M; Abouheif, E				Rajakumar, Rajendhran; San Mauro, Diego; Dijkstra, Michiel B.; Huang, Ming H.; Wheeler, Diana E.; Hiou-Tim, Francois; Khila, Abderrahman; Cournoyea, Michael; Abouheif, Ehab			Ancestral Developmental Potential Facilitates Parallel Evolution in Ants	SCIENCE			English	Article							SOLDIER DETERMINATION; WING POLYPHENISM; HYMENOPTERA; CASTE; DEFENSE	Complex worker caste systems have contributed to the evolutionary success of advanced ant societies; however, little is known about the developmental processes underlying their origin and evolution. We combined hormonal manipulation, gene expression, and phylogenetic analyses with field observations to understand how novel worker subcastes evolve. We uncovered an ancestral developmental potential to produce a "supersoldier" subcaste that has been actualized at least two times independently in the hyperdiverse ant genus Pheidole. This potential has been retained and can be environmentally induced throughout the genus. Therefore, the retention and induction of this potential have facilitated the parallel evolution of supersoldiers through a process known as genetic accommodation. The recurrent induction of ancestral developmental potential may facilitate the adaptive and parallel evolution of phenotypes.	[Rajakumar, Rajendhran; San Mauro, Diego; Dijkstra, Michiel B.; Hiou-Tim, Francois; Khila, Abderrahman; Cournoyea, Michael; Abouheif, Ehab] McGill Univ, Dept Biol, 1205 Ave Dr Penfield, Montreal, PQ H3A 1B1, Canada; [Huang, Ming H.; Wheeler, Diana E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	McGill University; University of Arizona	Abouheif, E (corresponding author), McGill Univ, Dept Biol, 1205 Ave Dr Penfield, Montreal, PQ H3A 1B1, Canada.	ehab.abouheif@mcgill.ca	San Mauro, Diego/E-7996-2012	San Mauro, Diego/0000-0002-2214-1125; rajakumar, rajendhran/0000-0001-7054-8619; Dijkstra, Michiel/0000-0003-1519-4656; Khila, Abderrahman/0000-0003-0908-483X; Abouheif, Ehab/0000-0001-7651-1737	Natural Sciences and Engineering Research Council; KLI; NSF [0344946]; Arizona Agricultural Experiment Station [ARZT 136321-H3106]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); KLI; NSF(National Science Foundation (NSF)); Arizona Agricultural Experiment Station	We thank R. Sanwald, R. Johnson, S. Cover, M. Seid, W. Tschinkel, and J. King for help with ant collection or identification; Wellmark for methoprene; and T. Flatt, G. Wray, C. Metzl, S. Jolie, Abouheif lab members, and Konrad Lorenz Institute (KLI) fellows for comments. This work was supported by a Natural Sciences and Engineering Research Council grant and a KLI fellowship to E. A., as well as grants from NSF (0344946) and the Arizona Agricultural Experiment Station (ARZT 136321-H3106) to D. E. W. DNA sequences were deposited in GenBank (accession nos. JN205075 to JN205109).	Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Armbruster WS, 2009, P NATL ACAD SCI USA, V106, P18085, DOI 10.1073/pnas.0907051106; Bely AE, 2010, P NATL ACAD SCI USA, V107, P1464, DOI 10.1073/pnas.0907931107; Darwin C., 1959, WHATS NEW, V67, P2; DROUAL R, 1983, BEHAV ECOL SOCIOBIOL, V12, P203, DOI 10.1007/BF00290772; GOETSCH W., 1939, ZOOL ANZ, V128, P209; Goetsch W, 1937, NATURWISSENSCHAFTEN, V25, P803, DOI 10.1007/BF01733918; Gregg RE, 1942, ECOLOGY, V23, P295, DOI 10.2307/1930669; Harris MP, 2006, CURR BIOL, V16, P371, DOI 10.1016/j.cub.2005.12.047; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM, P522; Huang MH, 2011, INSECT SOC, V58, P539, DOI 10.1007/s00040-011-0176-8; Huang MH, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.0101; Ledon-Rettig CC, 2008, EVOL DEV, V10, P316, DOI 10.1111/j.1525-142X.2008.00240.x; Meyer A., 1999, HOMOLOGY, V22, P141; Moreau CS, 2008, MOL PHYLOGENET EVOL, V48, P224, DOI 10.1016/j.ympev.2008.02.020; PASSERA L, 1979, INSECT SOC, V26, P343, DOI 10.1007/BF02223553; Sameshima SY, 2004, EVOL DEV, V6, P336, DOI 10.1111/j.1525-142X.2004.04041.x; Shbailat SJ, 2010, EVOL DEV, V12, P580, DOI 10.1111/j.1525-142X.2010.00443.x; Stearns S. C., 1994, ACTA PALAEONTOL POL, V38, P215; Stiassny M. L. J., 2003, KEYWORDS CONCEPTS EV, P10; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; West-Eberhard Mary Jane, 2003, pi; WHEELER DE, 1983, J INSECT PHYSIOL, V29, P847, DOI 10.1016/0022-1910(83)90151-8; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; WHEELER DE, 1981, INT J INSECT MORPHOL, V10, P131, DOI 10.1016/S0020-7322(81)80018-9; WHEELER DE, 1981, SCIENCE, V213, P361, DOI 10.1126/science.213.4505.361; Wheeler WM, 1902, SCIENCE, V15, P766, DOI 10.1126/science.15.385.766; WILSON EO, 1953, Q REV BIOL, V28, P136, DOI 10.1086/399512; WILSON EO, 2003, PHEIDOLE NEW WORLD	30	131	134	4	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2012	335	6064					79	82		10.1126/science.1211451	http://dx.doi.org/10.1126/science.1211451			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223805				2022-12-24	WOS:000298846200054
J	Ben-Shem, A; de Loubresse, NG; Melnikov, S; Jenner, L; Yusupova, G; Yusupov, M				Ben-Shem, Adam; de Loubresse, Nicolas Garreau; Melnikov, Sergey; Jenner, Lasse; Yusupova, Gulnara; Yusupov, Marat			The Structure of the Eukaryotic Ribosome at 3.0 angstrom Resolution	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; TRANSLATION INITIATION; 80S RIBOSOME; PROTEIN-SYNTHESIS; RNA; SUBUNIT; IRES; REINITIATION; MECHANISM	Ribosomes translate genetic information encoded by messenger RNA into proteins. Many aspects of translation and its regulation are specific to eukaryotes, whose ribosomes are much larger and intricate than their bacterial counterparts. We report the crystal structure of the 80S ribosome from the yeast Saccharomyces cerevisiae-including nearly all ribosomal RNA bases and protein side chains as well as an additional protein, Stm1-at a resolution of 3.0 angstroms. This atomic model reveals the architecture of eukaryote-specific elements and their interaction with the universally conserved core, and describes all eukaryote-specific bridges between the two ribosomal subunits. It forms the structural framework for the design and analysis of experiments that explore the eukaryotic translation apparatus and the evolutionary forces that shaped it.	[Ben-Shem, Adam] Inst Genet & Biol Mol & Cellulaire, F-67400 Illkirch Graffenstaden, France; INSERM, U964, F-67400 Illkirch Graffenstaden, France; CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France; Univ Strasbourg, F-67000 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ben-Shem, A (corresponding author), Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries,BP10142, F-67400 Illkirch Graffenstaden, France.	adam@igbmc.fr; marat@igbmc.fr	Yusupova, Gulnara/E-1877-2014; Yusupov, Marat/I-6126-2013; Jenner, Lasse/H-1584-2017	Yusupov, Marat/0000-0001-5544-0597; Jenner, Lasse/0000-0003-3917-8853; Melnikov, Serguey/0000-0002-7525-9039; Ben-Shem, Adam/0000-0003-0297-8662	European Molecular Biology Organization; Human Frontier Science Program; French National Research Agency [ANR BLAN07-3_190451, ANR-07-PCVI-0015-01]; European Commission SPINE2	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); French National Research Agency(French National Research Agency (ANR)); European Commission SPINE2(European CommissionEuropean Commission Joint Research Centre)	We thank C. Schulze-Briese, M. Mueller, and the staff at the Swiss Light Source for advice on data collection strategy; K. Diederichs for guidance on estimating data quality; B. Seraphin and A. Urzhumtsev for invaluable discussions; M. Fournier and V. Chavant for performing mass spectrometry analysis; and S. Uge for assistance with computer facilities. Supported by a European Molecular Biology Organization long-term fellowship (A.B.-S.), the Human Frontier Science Program, French National Research Agency grants ANR BLAN07-3_190451 and ANR-07-PCVI-0015-01, and the European Commission SPINE2. Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 3U5B, 3U5C, 3U5D, 3U5E, 3U5F, 3U5G, 3U5H, and 3U5I.	Babaylova E, 2009, NUCLEIC ACIDS RES, V37, P1141, DOI 10.1093/nar/gkn1026; Balagopal V, 2011, RNA, V17, P835, DOI 10.1261/rna.2677311; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; Bokov K, 2009, NATURE, V457, P977, DOI 10.1038/nature07749; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Korostelev A, 2008, CURR OPIN CHEM BIOL, V12, P674, DOI 10.1016/j.cbpa.2008.08.037; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Meskauskas A, 2007, MOL CELL, V25, P877, DOI 10.1016/j.molcel.2007.02.015; Nishimura T, 2005, PLANT CELL, V17, P2940, DOI 10.1105/tpc.105.036533; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Park HS, 2001, CELL, V106, P723, DOI 10.1016/S0092-8674(01)00487-1; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rhodin MHJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020048; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schuler M, 2006, NAT STRUCT MOL BIOL, V13, P1092, DOI 10.1038/nsmb1177; Sharma MR, 2010, J BIOL CHEM, V285, P4006, DOI 10.1074/jbc.M109.062299; Smith MW, 2001, MOL CELL BIOL, V21, P8264, DOI 10.1128/MCB.21.24.8264-8275.2001; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Thiebeauld O, 2009, EMBO J, V28, P3171, DOI 10.1038/emboj.2009.256; Van Dyke N, 2006, J MOL BIOL, V358, P1023, DOI 10.1016/j.jmb.2006.03.018; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yu YP, 2011, NUCLEIC ACIDS RES, V39, P4851, DOI 10.1093/nar/gkr045; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	37	772	916	5	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1524	1529		10.1126/science.1212642	http://dx.doi.org/10.1126/science.1212642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22096102	Bronze			2022-12-24	WOS:000298091400045
J	Slattery, M; Riley, T; Liu, P; Abe, N; Gomez-Alcala, P; Dror, I; Zhou, TY; Rohs, R; Honig, B; Bussemaker, HJ; Mann, RS				Slattery, Matthew; Riley, Todd; Liu, Peng; Abe, Namiko; Gomez-Alcala, Pilar; Dror, Iris; Zhou, Tianyin; Rohs, Remo; Honig, Barry; Bussemaker, Harmen J.; Mann, Richard S.			Cofactor Binding Evokes Latent Differences in DNA Binding Specificity between Hox Proteins	CELL			English	Article							TRANSCRIPTION FACTOR; FUNCTIONAL SPECIFICITY; HOMEODOMAIN PROTEINS; RUNT DOMAIN; RECOGNITION; EXTRADENTICLE; DROSOPHILA; GENES; COMPLEX; SEGMENTATION	Members of transcription factor families typically have similar DNA binding specificities yet execute unique functions in vivo. Transcription factors often bind DNA as multiprotein complexes, raising the possibility that complex formation might modify their DNA binding specificities. To test this hypothesis, we developed an experimental and computational platform, SELEX-seq, that can be used to determine the relative affinities to any DNA sequence for any transcription factor complex. Applying this method to all eight Drosophila Hox proteins, we show that they obtain novel recognition properties when they bind DNA with the dimeric cofactor Extradenticle-Homothorax (Exd). Exd-Hox specificities group into three main classes that obey Hox gene collinearity rules and DNA structure predictions suggest that anterior and posterior Hox proteins prefer DNA sequences with distinct minor groove topographies. Together, these data suggest that emergent DNA recognition properties revealed by interactions with cofactors contribute to transcription factor specificities in vivo.	[Dror, Iris; Zhou, Tianyin; Rohs, Remo] Univ So Calif, Mol & Computat Biol Program, Dept Biol Sci, Los Angeles, CA 90089 USA; [Slattery, Matthew; Abe, Namiko; Mann, Richard S.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Riley, Todd; Gomez-Alcala, Pilar; Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Riley, Todd; Liu, Peng; Honig, Barry; Bussemaker, Harmen J.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Liu, Peng; Honig, Barry] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Gomez-Alcala, Pilar] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA	University of Southern California; Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Rohs, R (corresponding author), Univ So Calif, Mol & Computat Biol Program, Dept Biol Sci, 1050 Childs Way, Los Angeles, CA 90089 USA.	rohs@usc.edu; bh6@columbia.edu; hjb2004@columbia.edu; rsm10@columbia.edu	Zhou, Tianyin/E-3830-2015; Dror, Iris/K-2042-2012		NIH [U54CA121852, R01GM054510, R01HG003008, R01GM030518, P50GM071508]; John Simon Guggenheim Foundation; Columbia University; USC; Andrew Viterbi Fellowship; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510, R01GM030518, P50GM071508] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Simon Guggenheim Foundation; Columbia University; USC; Andrew Viterbi Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Bussemaker, Honig, Mann, and Rohs labs for comments and feedback during the course of these studies; B. Snyder for programming support; W. Shin and C. Hawkins for early contributions to the analysis of SELEX-seq data; A. Boyanov for sequencing support; and K. Lelli for constructs. This work was supported by NIH grants U54CA121852, R01GM054510, R01HG003008, R01GM030518, and P50GM071508, a John Simon Guggenheim Foundation Fellowship, Columbia University's RISE program, USC start-up funds, the USC-Technion Visiting Fellows Program, and an Andrew Viterbi Fellowship. Author contributions: M.S. designed and executed the SELEX experiments and contributed to the analysis of the SELEX data. T.R. designed and executed the analysis of the SELEX-seq data. P.L. carried out and analyzed Monte Carlo simulations. N.A. carried out later rounds of SELEX and EMSA-based validation experiments. P.G.-A. analyzed Ubx ChIP data. I. D. executed high-throughput DNA shape analysis. T.Z. developed high-throughput DNA shape prediction method. R.R. and B.H. supervised and designed DNA shape analyses. H.J.B. supervised and designed the analysis of the SELEX-seq data. R.S.M. supervised and designed SELEX experiments; contributed to the analysis of the SELEX data and shape analyses.	Abu-Shaar M, 1999, GENE DEV, V13, P935, DOI 10.1101/gad.13.8.935; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Bartfeld D, 2002, STRUCTURE, V10, P1395, DOI 10.1016/S0969-2126(02)00853-5; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Conlon FL, 2001, DEVELOPMENT, V128, P3749; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; Hueber SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010820; JOHNSON AD, 1995, CURR OPIN GENET DEV, V5, P552, DOI 10.1016/0959-437X(95)80022-0; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Joshi R, 2010, GENE DEV, V24, P1533, DOI 10.1101/gad.1936910; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li XL, 1999, P NATL ACAD SCI USA, V96, P6802, DOI 10.1073/pnas.96.12.6802; Lu QA, 1997, ONCOGENE, V14, P75, DOI 10.1038/sj.onc.1200799; Lutz B, 1996, GENE DEV, V10, P176, DOI 10.1101/gad.10.2.176; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Rohs R, 2005, STRUCTURE, V13, P1499, DOI 10.1016/j.str.2005.07.005; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Slattery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014686; Taghli-Lamallem O, 2007, DEV BIOL, V307, P142, DOI 10.1016/j.ydbio.2007.04.028; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; TREISMAN J, 1989, CELL, V59, P553; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; ZHAO JJ, 1993, GENE DEV, V7, P343, DOI 10.1101/gad.7.3.343; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	54	330	333	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1270	1282		10.1016/j.cell.2011.10.053	http://dx.doi.org/10.1016/j.cell.2011.10.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153072	Bronze, Green Accepted			2022-12-24	WOS:000298148100017
J	Schuur, EAG; Abbott, B				Schuur, Edward A. G.; Abbott, Benjamin		Permafrost Carbon Network	High risk of permafrost thaw	NATURE			English	Editorial Material							CARBON RELEASE		[Schuur, Edward A. G.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Abbott, Benjamin] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA	State University System of Florida; University of Florida; University of Alaska System; University of Alaska Fairbanks	Schuur, EAG (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	tschuur@ufl.edu	Abbott, Benjamin W./G-1733-2017; Hayes, Daniel/B-8968-2012; Riley, William J/D-3345-2015; Krinner, Gerhard/A-6450-2011	Abbott, Benjamin W./0000-0001-5861-3481; Riley, William J/0000-0002-4615-2304; Krinner, Gerhard/0000-0002-2959-5920	Directorate For Geosciences [0856864] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; Fischer H, 2008, NATURE, V452, P864, DOI 10.1038/nature06825; Jorgenson MT, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024960; Koven CD, 2011, P NATL ACAD SCI USA, V108, P14769, DOI 10.1073/pnas.1103910108; Mack MC, 2011, NATURE, V475, P489, DOI 10.1038/nature10283; Schaefer K, 2011, TELLUS B, V63, P165, DOI 10.1111/j.1600-0889.2011.00527.x; Schneider von Deimling T, 2011, BIOGEOSCIENCES DISCU, V8, P4727; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Walter KM, 2006, NATURE, V443, P71, DOI 10.1038/nature05040	10	186	195	15	270	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2011	480	7375					32	33		10.1038/480032a	http://dx.doi.org/10.1038/480032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129707	Green Submitted, Bronze			2022-12-24	WOS:000298031900015
J	Trail, D; Watson, EB; Tailby, ND				Trail, Dustin; Watson, E. Bruce; Tailby, Nicholas D.			The oxidation state of Hadean magmas and implications for early Earth's atmosphere	NATURE			English	Article							DETRITAL ZIRCONS; MELT INCLUSIONS; OXYGEN FUGACITY; TI; ELEMENTS; HISTORY; MANTLE; MA	Magmatic outgassing of volatiles from Earth's interior probably played a critical part in determining the composition of the earliest atmosphere, more than 4,000 million years (Myr) ago(1). Given an elemental inventory of hydrogen, carbon, nitrogen, oxygen and sulphur, the identity of molecular species in gaseous volcanic emanations depends critically on the pressure (fugacity) of oxygen. Reduced melts having oxygen fugacities close to that defined by the iron-wustite buffer would yield volatile species such as CH4, H-2, H2S, NH3 and CO, whereas melts close to the fayalite-magnetite-quartz buffer would be similar to present-day conditions and would be dominated by H2O, CO2, SO2 and N-2 (refs 1-4). Direct constraints on the oxidation state of terrestrial magmas before 3,850 Myr before present (that is, the Hadean eon) are tenuous because the rock record is sparse or absent. Samples from this earliest period of Earth's history are limited to igneous detrital zircons that pre-date the known rock record, with ages approaching similar to 4,400 Myr (refs 5-8). Here we report a redox-sensitive calibration to determine the oxidation state of Hadean magmatic melts that is based on the incorporation of cerium into zircon crystals. We find that the melts have average oxygen fugacities that are consistent with an oxidation state defined by the fayalite-magnetite-quartz buffer, similar to present-day conditions. Moreover, selected Hadean zircons (having chemical characteristics consistent with crystallization specifically from mantle-derived melts) suggest oxygen fugacities similar to those of Archaean and present-day mantle-derived lavas(2-4,9,10) as early as similar to 4,350 Myr before present. These results suggest that outgassing of Earth's interior later than similar to 200 Myr into the history of Solar System formation would not have resulted in a reducing atmosphere.	[Trail, Dustin; Watson, E. Bruce; Tailby, Nicholas D.] Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12181 USA; [Trail, Dustin; Watson, E. Bruce; Tailby, Nicholas D.] Rensselaer Polytech Inst, New York Ctr Astrobiol, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Trail, D (corresponding author), Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12181 USA.	traild@rpi.edu		Trail, Dustin/0000-0003-3505-4351	NASA Astrobiology Institute [NNA09DA80A]	NASA Astrobiology Institute	This work was supported by the NASA Astrobiology Institute (grant no. NNA09DA80A to The New York Center for Astrobiology).	AYERS JC, 1992, AM MINERAL, V77, P1080; Berry AJ, 2008, NATURE, V455, P960, DOI 10.1038/nature07377; Burgisser A, 2007, NATURE, V445, P194, DOI 10.1038/nature05509; Canil D, 1997, NATURE, V389, P842, DOI 10.1038/39860; CARMICHAEL ISE, 1990, REV MINERAL, V24, P191; Cavosie A. J., 2006, GEOCHIM COSMOCHIM AC, V69, P637; Cavosie AJ, 2009, AM MINERAL, V94, P926, DOI 10.2138/am.2009.2982; Cavosie AJ, 2005, EARTH PLANET SC LETT, V235, P663, DOI 10.1016/j.epsl.2005.04.028; Cherniak DJ, 1997, CHEM GEOL, V134, P289, DOI 10.1016/S0009-2541(96)00098-8; Coogan LA, 2006, GEOLOGY, V34, P633, DOI 10.1130/G22737.1; Delano JW, 2001, ORIGINS LIFE EVOL B, V31, P311, DOI 10.1023/A:1011895600380; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Fu B, 2008, CONTRIB MINERAL PETR, V156, P197, DOI 10.1007/s00410-008-0281-5; Herd CDK, 2002, GEOCHIM COSMOCHIM AC, V66, P2025, DOI 10.1016/S0016-7037(02)00828-1; Hildreth W, 2007, J PETROL, V48, P951, DOI 10.1093/petrology/egm007; HINTON RW, 1991, GEOCHIM COSMOCHIM AC, V55, P3287, DOI 10.1016/0016-7037(91)90489-R; Hopkins M, 2008, NATURE, V456, P493, DOI 10.1038/nature07465; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Mallmann G, 2009, J PETROL, V50, P1765, DOI 10.1093/petrology/egp053; McLane J. E, 1973, GEOCHIM COSM SUPPL, V1, P1061; Reid MR, 2011, CONTRIB MINERAL PETR, V161, P293, DOI 10.1007/s00410-010-0532-0; Rubatto D, 2007, CHEM GEOL, V241, P38, DOI 10.1016/j.chemgeo.2007.01.027; Sano Y, 2002, CHEM GEOL, V184, P217, DOI 10.1016/S0009-2541(01)00366-7; Schmitt AK, 2011, EARTH PLANET SC LETT, V302, P349, DOI 10.1016/j.epsl.2010.12.022; Taylor DJ, 2009, EARTH PLANET SC LETT, V279, P157, DOI 10.1016/j.epsl.2008.12.030; Thomas JB, 2002, GEOCHIM COSMOCHIM AC, V66, P2887, DOI 10.1016/S0016-7037(02)00881-5; Tian F, 2005, SCIENCE, V308, P1014, DOI 10.1126/science.1106983; Trail D, 2011, AM MINERAL, V96, P60, DOI 10.2138/am.2011.3506; Valley JW, 2005, CONTRIB MINERAL PETR, V150, P561, DOI 10.1007/s00410-005-0025-8; Watson EB, 2005, SCIENCE, V308, P841, DOI 10.1126/science.1110873; WATSON EB, 1983, EARTH PLANET SC LETT, V64, P295, DOI 10.1016/0012-821X(83)90211-X; Watson EB, 2006, CONTRIB MINERAL PETR, V151, P413, DOI 10.1007/s00410-006-0068-5	33	384	417	11	291	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2011	480	7375					79	U238		10.1038/nature10655	http://dx.doi.org/10.1038/nature10655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129728				2022-12-24	WOS:000298031900037
J	Nguyen, D; Joshi-Datar, A; Lepine, F; Bauerle, E; Olakanmi, O; Beer, K; McKay, G; Siehnel, R; Schafhauser, J; Wang, Y; Britigan, BE; Singh, PK				Dao Nguyen; Joshi-Datar, Amruta; Lepine, Francois; Bauerle, Elizabeth; Olakanmi, Oyebode; Beer, Karlyn; McKay, Geoffrey; Siehnel, Richard; Schafhauser, James; Wang, Yun; Britigan, Bradley E.; Singh, Pradeep K.			Active Starvation Responses Mediate Antibiotic Tolerance in Biofilms and Nutrient-Limited Bacteria	SCIENCE			English	Article							PSEUDOMONAS-AERUGINOSA; STRINGENT RESPONSE; INFECTION; DISEASE; DAMAGE; PQS	Bacteria become highly tolerant to antibiotics when nutrients are limited. The inactivity of antibiotic targets caused by starvation-induced growth arrest is thought to be a key mechanism producing tolerance. Here we show that the antibiotic tolerance of nutrient-limited and biofilm Pseudomonas aeruginosa is mediated by active responses to starvation, rather than by the passive effects of growth arrest. The protective mechanism is controlled by the starvation-signaling stringent response (SR), and our experiments link SR-mediated tolerance to reduced levels of oxidant stress in bacterial cells. Furthermore, inactivating this protective mechanism sensitized biofilms by several orders of magnitude to four different classes of antibiotics and markedly enhanced the efficacy of antibiotic treatment in experimental infections.	[Dao Nguyen; McKay, Geoffrey; Schafhauser, James] McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; [Dao Nguyen; McKay, Geoffrey; Schafhauser, James] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3G 1A4, Canada; [Joshi-Datar, Amruta; Bauerle, Elizabeth; Beer, Karlyn; Siehnel, Richard; Singh, Pradeep K.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Joshi-Datar, Amruta; Bauerle, Elizabeth; Beer, Karlyn; Siehnel, Richard; Singh, Pradeep K.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Lepine, Francois] INRS Armand Frappier, Dept Microbiol, Laval, PQ H7V 1B7, Canada; [Olakanmi, Oyebode; Britigan, Bradley E.] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45267 USA; [Wang, Yun] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Britigan, Bradley E.] Vet Adm Med Ctr Cincinnati, Cincinnati, OH 45220 USA	McGill University; McGill University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Quebec; Institut national de la recherche scientifique (INRS); University System of Ohio; University of Cincinnati; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Nguyen, D (corresponding author), McGill Univ, Dept Med, 1650 Cedar Ave,L11-513, Montreal, PQ H3G 1A4, Canada.	dao.nguyen@mcgill.ca	Wang, Yun/E-3619-2010	Siehnel, Richard/0000-0001-7078-5657; Schafhauser, James/0000-0002-3979-3402	Burroughs Wellcome Fund; Cystic Fibrosis Foundation; Canadian Institutes for Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL102246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI091714, R01AI101307] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Cashel, C. Manoil, and J. Burns for providing strains; A. Hunziker and J. Harrisson for technical assistance; and J. Penterman, J. Mougous, M. Parsek, and C. Manoil for helpful discussions. Funding was provided by the Burroughs Wellcome Fund (D.N. and P. K. S), Cystic Fibrosis Foundation (P. K. S), NIH (P. K. S), and Canadian Institutes for Health Research (D.N.).	Borriello G, 2006, ANTIMICROB AGENTS CH, V50, P382, DOI 10.1128/AAC.50.1.382-384.2006; Bredenbruch F, 2006, ENVIRON MICROBIOL, V8, P1318, DOI 10.1111/j.1462-2920.2006.01025.x; CASHEL M, 1996, ESCHERICHIA COLI SAL, V1, P1458; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; ENG RHK, 1991, ANTIMICROB AGENTS CH, V35, P1824, DOI 10.1128/AAC.35.9.1824; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; MCCUNE RM, 1956, ANN NY ACAD SCI, V65, P91, DOI 10.1111/j.1749-6632.1956.tb36627.x; McDERMOTT WALSH, 1958, YALE JOUR BIOL AND MED, V30, P257; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Vogt SL, 2011, INFECT IMMUN, V79, P4094, DOI 10.1128/IAI.00193-11; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Wang Y, 2008, ENVIRON SCI TECHNOL, V42, P2380, DOI 10.1021/es702290a; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05	23	582	610	8	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 18	2011	334	6058					982	986		10.1126/science.1211037	http://dx.doi.org/10.1126/science.1211037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CA	22096200	Green Accepted			2022-12-24	WOS:000297101800057
J	Rabeh, WM; Bossard, F; Xu, HJ; Okiyoneda, T; Bagdany, M; Mulvihill, CM; Du, K; di Bernardo, S; Liu, YH; Konermann, L; Roldan, A; Lukacs, GL				Rabeh, Wael M.; Bossard, Florian; Xu, Haijin; Okiyoneda, Tsukasa; Bagdany, Miklos; Mulvihill, Cory M.; Du, Kai; di Bernardo, Salvatore; Liu, Yuhong; Konermann, Lars; Roldan, Ariel; Lukacs, Gergely L.			Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore Delta F508 CFTR Folding and Function	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; SMALL-MOLECULE CORRECTORS; TRAFFICKING DEFECT; IN-VITRO; MUTATION; IDENTIFICATION; STABILITY; CHAPERONE; DEGRADATION	The folding and misfolding mechanism of multidomain proteins remains poorly understood. Although thermodynamic instability of the first nucleotide-binding domain (NBD1) of Delta F508 CFTR (cystic fibrosis transmembrane conductance regulator) partly accounts for the mutant channel degradation in the endoplasmic reticulum and is considered as a drug target in cystic fibrosis, the link between NBD1 and CFTR misfolding remains unclear. Here, we show that Delta F508 destabilizes NBD1 both thermodynamically and kinetically, but correction of either defect alone is insufficient to restore Delta F508 CFTR biogenesis. Instead, both Delta F508-NBD1 energetic and the NBD1-MSD2 (membrane-spanning domain 2) interface stabilization are required for wild-type-like folding, processing, and transport function, suggesting a synergistic role of NBD1 energetics and topology in CFTR-coupled domain assembly. Identification of distinct structural deficiencies may explain the limited success of Delta F508 CFTR corrector molecules and suggests structure-based combination corrector therapies. These results may serve as a framework for understanding the mechanism of interface mutation in multidomain membrane proteins.	[Rabeh, Wael M.; Bossard, Florian; Xu, Haijin; Okiyoneda, Tsukasa; Bagdany, Miklos; Mulvihill, Cory M.; Du, Kai; di Bernardo, Salvatore; Roldan, Ariel; Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ H3E 1Y6, Canada; [Rabeh, Wael M.; Lukacs, Gergely L.] McGill Univ, GRASP, Montreal, PQ H3E 1Y6, Canada; [Liu, Yuhong; Konermann, Lars] Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada	McGill University; McGill University; Western University (University of Western Ontario)	Lukacs, GL (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ H3E 1Y6, Canada.	gergely.lukacs@mcgill.ca	Rabeh, Wael/AAO-4647-2020	Rabeh, Wael/0000-0001-6071-8581; Lukacs, Gergely/0000-0003-0900-0675; Okiyoneda, Tsukasa/0000-0002-5175-2224; Roldan, Ariel/0000-0002-8159-5450	Cystic Fibrosis Foundation Therapeutics Inc; Cystic Fibrosis Canada; NIH-NIDDK [DK075302]; Canadian Institute of Health Research; Canadian Foundation for Innovation; GRASP; Canadian Cystic Fibrosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075302] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation Therapeutics Inc; Cystic Fibrosis Canada; NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); GRASP; Canadian Cystic Fibrosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Lewis, C. Lima, J.R. Riordan, J. Young, E. Buck, and the Cystic Fibrosis Foundation Therapeutics, Inc. for valuable reagents and feedbacks, J. Young and D. Thomas for providing access to the Chirascan and qPCR instruments, and N. Kartner, G. Veit, J. Szapor, D. Scicchitano, and F. Pianofor for helpful comments on the manuscript. We thank the Cystic Fibrosis Foundation Therapeutics Inc, Cystic Fibrosis Canada, NIH-NIDDK (grant number DK075302), Canadian Institute of Health Research, and the Canadian Foundation for Innovation for operating and infrastructure support. W.M.R. was partially supported by GRASP and a Canadian Cystic Fibrosis Foundation postdoctoral fellowship. L.K. and G.L.L. are holders of Canada Research Chairs.	Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Fulop K, 2009, BIOCHEM BIOPH RES CO, V379, P706, DOI 10.1016/j.bbrc.2008.12.142; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; Khushoo A, 2011, MOL CELL, V41, P682, DOI 10.1016/j.molcel.2011.02.027; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2010, BIOCHEMISTRY-US, V49, P6352, DOI 10.1021/bi100807h; Loo TW, 2009, BIOCHEMISTRY-US, V48, P9882, DOI 10.1021/bi9004842; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Roy G, 2010, MOL BIOL CELL, V21, P597, DOI 10.1091/mbc.E09-05-0427; Sampson HM, 2011, CHEM BIOL, V18, P231, DOI 10.1016/j.chembiol.2010.11.016; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Senisterra GA, 2008, J BIOMOL SCREEN, V13, P337, DOI 10.1177/1087057108317825; Serohijos AWR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000008; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Stratford FLL, 2007, BIOCHEM J, V401, P581, DOI 10.1042/BJ20060968; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Xiong XM, 1997, J CLIN INVEST, V100, P1079, DOI 10.1172/JCI119618; Zhou RH, 2007, P NATL ACAD SCI USA, V104, P5824, DOI 10.1073/pnas.0701249104	57	220	226	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					150	163		10.1016/j.cell.2011.11.024	http://dx.doi.org/10.1016/j.cell.2011.11.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265408	Bronze, Green Accepted			2022-12-24	WOS:000299540700021
J	Chen, LQ; Qu, XQ; Hou, BH; Sosso, D; Osorio, S; Fernie, AR; Frommer, WB				Chen, Li-Qing; Qu, Xiao-Qing; Hou, Bi-Huei; Sosso, Davide; Osorio, Sonia; Fernie, Alisdair R.; Frommer, Wolf B.			Sucrose Efflux Mediated by SWEET Proteins as a Key Step for Phloem Transport	SCIENCE			English	Article							DISEASE-SUSCEPTIBILITY GENE; BACTERIAL-BLIGHT; SUGAR-BEET; RICE; RESISTANCE; CARBON; XA13; MECHANISMS; EXPRESSION; SYSTEMS	Plants transport fixed carbon predominantly as sucrose, which is produced in mesophyll cells and imported into phloem cells for translocation throughout the plant. It is not known how sucrose migrates from sites of synthesis in the mesophyll to the phloem, or which cells mediate efflux into the apoplasm as a prerequisite for phloem loading by the SUT sucrose-H(+) (proton) cotransporters. Using optical sucrose sensors, we identified a subfamily of SWEET sucrose efflux transporters. AtSWEET11 and 12 localize to the plasma membrane of the phloem. Mutant plants carrying insertions in AtSWEET11 and 12 are defective in phloem loading, thus revealing a two-step mechanism of SWEET-mediated export from parenchyma cells feeding H(+)-coupled import into the sieve element-companion cell complex. We discuss how restriction of intercellular transport to the interface of adjacent phloem cells may be an effective mechanism to limit the availability of photosynthetic carbon in the leaf apoplasm in order to prevent pathogen infections.	[Chen, Li-Qing; Qu, Xiao-Qing; Hou, Bi-Huei; Sosso, Davide; Frommer, Wolf B.] Carnegie Inst Washington, Stanford, CA 94305 USA; [Qu, Xiao-Qing] China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant & Soil Interact, Beijing 100193, Peoples R China; [Osorio, Sonia; Fernie, Alisdair R.] Max Planck Inst Mol Pflanzenphysiol, D-14476 Potsdam, Germany	Carnegie Institution for Science; China Agricultural University; Max Planck Society	Frommer, WB (corresponding author), Carnegie Inst Washington, 290 Panama St, Stanford, CA 94305 USA.	wfrommer@stanford.edu	Frommer, Wolf B/K-5042-2017; Osorio, Sonia/M-2258-2014; Frommer, Wolf B/A-8256-2008	Frommer, Wolf B/0000-0001-6465-0115; Osorio, Sonia/0000-0002-0159-6091; Frommer, Wolf B/0000-0001-6465-0115	U.S. Department of Energy [DE-FG02-04ER15542]; National Institute of Diabetes and Digestive and Kidney Diseases [1RO1DK079109]; Chinese Scholarship Council [2009635108]; Max-Planck-Gesellschaft; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079109] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chinese Scholarship Council(China Scholarship Council); Max-Planck-Gesellschaft(Max Planck Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Grossmann and D. Ehrhardt for advice and help with confocal imaging; J. Bailey-Serres for help with the translatome analyses; K. Barton and T. Liu for plastic embedding and sectioning help and advice; and V. Lanquar and A. Jones for critical reading of the manuscript. Supported by U.S. Department of Energy grant DE-FG02-04ER15542 and National Institute of Diabetes and Digestive and Kidney Diseases grant 1RO1DK079109 (W. B. F.); the Carnegie Institution and the Scholarship Program of the Chinese Scholarship Council (grant 2009635108) (X.-Q. Q.); and the Max-Planck-Gesellschaft (S.O. and A. R. F.). Author contributions: W. B. F. and L.-Q. C. conceived and designed the experiments. L.-Q. C., X.-Q. Q., D. S., B.-H. H., and S. O. performed the experiments. W. B. F., L.-Q. C., X.-Q. Q., D. S., B.-H. H., S. O., and A. R. F. analyzed the data. L.-Q. C. and W. B. F. wrote the manuscript.	Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; Burkle L, 1998, PLANT PHYSIOL, V118, P59, DOI 10.1104/pp.118.1.59; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chu ZH, 2006, THEOR APPL GENET, V112, P455, DOI 10.1007/s00122-005-0145-6; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Fu QS, 2011, PLANT PHYSIOL, V157, P1518, DOI 10.1104/pp.111.184820; GEIGER DR, 1974, PLANT PHYSIOL, V54, P892, DOI 10.1104/pp.54.6.892; GIAQUINTA RT, 1983, ANNU REV PLANT PHYS, V34, P347, DOI 10.1146/annurev.pp.34.060183.002023; Gottwald JR, 2000, P NATL ACAD SCI USA, V97, P13979, DOI 10.1073/pnas.250473797; Haritatos E, 2000, PLANTA, V211, P105, DOI 10.1007/s004250000268; Lager I, 2006, J BIOL CHEM, V281, P30875, DOI 10.1074/jbc.M605257200; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; LEMOINE R, 1989, FEBS LETT, V249, P129, DOI 10.1016/0014-5793(89)80030-4; Lundby A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002514; MAYNARD JW, 1982, PLANT PHYSIOL, V70, P1436, DOI 10.1104/pp.70.5.1436; Okumoto S, 2008, NEW PHYTOL, V180, P271, DOI 10.1111/j.1469-8137.2008.02611.x; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Paterson AH, 2011, P NATL ACAD SCI USA, V108, P10931, DOI 10.1073/pnas.1107959108; Patrick JW, 2001, J EXP BOT, V52, P551, DOI 10.1093/jexbot/52.356.551; RIESMEIER JW, 1994, EMBO J, V13, P1; RIESMEIER JW, 1992, EMBO J, V11, P4705, DOI 10.1002/j.1460-2075.1992.tb05575.x; RIESMEIER JW, 1993, PLANT CELL, V5, P1591, DOI 10.1105/tpc.5.11.1591; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Srivastava AC, 2008, PLANT PHYSIOL, V148, P200, DOI 10.1104/pp.108.124776; Sutton PN, 2007, PHYSIOL PLANTARUM, V129, P787, DOI 10.1111/j.1399-3054.2007.00863.x; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Yuan M, 2009, PLANT CELL PHYSIOL, V50, P947, DOI 10.1093/pcp/pcp046; Zhou YC, 2009, J EXP BOT, V60, P71, DOI 10.1093/jxb/ern254; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	33	732	802	57	549	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					207	211		10.1126/science.1213351	http://dx.doi.org/10.1126/science.1213351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22157085				2022-12-24	WOS:000299033100050
J	Balazs, AB; Chen, J; Hong, CM; Rao, DS; Yang, LL; Baltimore, D				Balazs, Alejandro B.; Chen, Joyce; Hong, Christin M.; Rao, Dinesh S.; Yang, Lili; Baltimore, David			Antibody-based protection against HIV infection by vectored immunoprophylaxis	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MEDIATED GENE-TRANSFER; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; ADENOASSOCIATED VIRUS; THERAPEUTIC LEVELS; FACTOR-IX; BROAD; EXPRESSION; DESIGN	Despite tremendous efforts, development of an effective vaccine against human immunodeficiency virus (HIV) has proved an elusive goal. Recently, however, numerous antibodies have been identified that are capable of neutralizing most circulating HIV strains(1-5). These antibodies all exhibit an unusually high level of somatic mutation(6), presumably owing to extensive affinity maturation over the course of continuous exposure to an evolving antigen(7). Although substantial effort has focused on the design of immunogens capable of eliciting antibodies de novo that would target similar epitopes(8-10), it remains uncertain whether a conventional vaccine will be able to elicit analogues of the existing broadly neutralizing antibodies. As an alternative to immunization, vector-mediated gene transfer could be used to engineer secretion of the existing broadly neutralizing antibodies into the circulation. Here we describe a practical implementation of this approach, which we call vectored immunoprophylaxis (VIP), which in mice induces lifelong expression of these monoclonal antibodies at high concentrations from a single intramuscular injection. This is achieved using a specialized adeno-associated virus vector optimized for the production of full-length antibody from muscle tissue. We show that humanized mice receiving VIP appear to be fully protected from HIV infection, even when challenged intravenously with very high doses of replication-competent virus. Our results suggest that successful translation of this approach to humans may produce effective prophylaxis against HIV.	[Balazs, Alejandro B.; Chen, Joyce; Hong, Christin M.; Yang, Lili; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Rao, Dinesh S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Baltimore, D (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Rao, Dinesh/ABG-1257-2021; Rao, Dinesh/AAE-9625-2019	Rao, Dinesh/0000-0002-0794-9337; Chen, Joyce/0000-0001-7851-8457; Balazs, Alejandro/0000-0002-1767-3944; Hong, Christin/0000-0003-1826-9246	Bill and Melinda Gates Foundation through Grand Challenges in Global Health Initiative [37866]; National Institutes of Health through the National Institute of Allergy and Infectious Disease (NIAID) [HHSN266200500035C]; Joint Center for Translational Medicine; amfAR [107756-47-RFVA]; National Institutes of Health [1K08CA133521]; NATIONAL CANCER INSTITUTE [K08CA133521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, K08AI050035] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation through Grand Challenges in Global Health Initiative; National Institutes of Health through the National Institute of Allergy and Infectious Disease (NIAID); Joint Center for Translational Medicine; amfAR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Wilson for AAV8-related plasmids and assistance, D. Burton for b12 and 2G12 expression plasmids, G. Nabel for 4E10, 2F5 and VRC01 expression plasmids, and the Caltech Protein Expression Center for providing purified antibodies. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: pNL4-3 from M. Martin, and TZM-bl cells from J. Kappes and X. Wu. We thank J. Bloom, D. Kotton, D. Majumdar, G. Mostoslavsky, R. O'Connell and A. Sigal for comments, and other members of the Baltimore laboratory for their assistance in performing this work. This project was supported by the Bill and Melinda Gates Foundation through Grand Challenges in Global Health Initiative (awarded to D. B.) Grand Challenge grant 37866 and by the National Institutes of Health (HHSN266200500035C) through a contract from the National Institute of Allergy and Infectious Disease (NIAID) and by the Joint Center for Translational Medicine. A. B. B. is supported by amfAR postdoctoral research fellowship 107756-47-RFVA. D. S. R. is supported by career development award 1K08CA133521 from the National Institutes of Health.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Breous E, 2010, MOL THER, V18, P766, DOI 10.1038/mt.2009.301; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Diskin R., 2011, SCIENCE         1027, DOI [10.1126/science.1213782, DOI 10.1126/SCIENCE.1213782]; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; Fang JM, 2007, MOL THER, V15, P1153, DOI 10.1038/sj.mt.6300142; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Jiang HY, 2006, MOL THER, V14, P452, DOI 10.1016/j.ymthe.2006.05.004; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; KALUZA G, 1992, PATHOL RES PRACT, V188, P91, DOI 10.1016/S0344-0338(11)81162-3; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Lewis AD, 2002, J VIROL, V76, P8769, DOI 10.1128/JVI.76.17.8769-8775.2002; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Rohr UP, 2002, J VIROL METHODS, V106, P81, DOI 10.1016/S0166-0934(02)00138-6; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Vandenberghe LH, 2006, NAT MED, V12, P967, DOI 10.1038/nm1445; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; West AP, 2012, J VIROL, V86, P195, DOI 10.1128/JVI.05848-11; Wright JF, 2005, MOL THER, V12, P171, DOI 10.1016/j.ymthe.2005.02.021; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	38	408	450	0	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					81	U88		10.1038/nature10660	http://dx.doi.org/10.1038/nature10660			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22139420	Green Accepted, Green Submitted			2022-12-24	WOS:000298836900033
J	Rajaratnam, SMW; Barger, LK; Lockley, SW; Shea, SA; Wang, W; Landrigan, CP; O'Brien, CS; Qadri, S; Sullivan, JP; Cade, BE; Epstein, LJ; White, DP; Czeisler, CA				Rajaratnam, Shantha M. W.; Barger, Laura K.; Lockley, Steven W.; Shea, Steven A.; Wang, Wei; Landrigan, Christopher P.; O'Brien, Conor S.; Qadri, Salim; Sullivan, Jason P.; Cade, Brian E.; Epstein, Lawrence J.; White, David P.; Czeisler, Charles A.		Harvard Work Hours Hlth Safety Grp	Sleep Disorders, Health, and Safety in Police Officers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE AIRWAY PRESSURE; MOTOR-VEHICLE CRASHES; WORK HOURS; APNEA-HYPOPNEA; RISK-FACTORS; PREVALENCE; CONSEQUENCES; INSOMNIA; IMPACT; QUESTIONNAIRE	Context Sleep disorders often remain undiagnosed. Untreated sleep disorders among police officers may adversely affect their health and safety and pose a risk to the public. Objective To quantify associations between sleep disorder risk and self-reported health, safety, and performance outcomes in police officers. Design, Setting, and Participants Cross-sectional and prospective cohort study of North American police officers participating in either an online or an on-site screening (n=4957) and monthly follow-up surveys (n=3545 officers representing 15 735 person-months) between July 2005 and December 2007. A total of 3693 officers in the United States and Canada participated in the online screening survey, and 1264 officers from a municipal police department and a state police department participated in the on-site survey. Main Outcome Measures Comorbid health conditions (cross-sectional); performance and safety outcomes (prospective). Results Of the 4957 participants, 40.4% screened positive for at least 1 sleep disorder, most of whom had not been diagnosed previously. Of the total cohort, 1666 (33.6%) screened positive for obstructive sleep apnea, 281 (6.5%) for moderate to severe insomnia, 269 (5.4%) for shift work disorder (14.5% of those who worked the night shift). Of the 4608 participants who completed the sleepiness scale, 1312 (28.5%) reported excessive sleepiness. Of the total cohort, 1294 (26.1%) reported falling asleep while driving at least 1 time a month. Respondents who screened positive for obstructive sleep apnea or any sleep disorder had an increased prevalence of reported physical and mental health conditions, including diabetes, depression, and cardiovascular disease. An analysis of up to 2 years of monthly follow-up surveys showed that those respondents who screened positive for a sleep disorder vs those who did not had a higher rate of reporting that they had made a serious administrative error (17.9% vs 12.7%; adjusted odds ratio [OR], 1.43 [95% CI, 1.23-1.67]); of falling asleep while driving (14.4% vs 9.2%; adjusted OR, 1.51 [95% CI, 1.20-1.90]); of making an error or safety violation attributed to fatigue (23.7% vs 15.5%; adjusted OR, 1.63 [95% CI, 1.43-1.85]); and of exhibiting other adverse work-related outcomes including uncontrolled anger toward suspects (34.1% vs 28.5%; adjusted OR, 1.25 [95% CI, 1.09-1.43]), absenteeism (26.0% vs 20.9%; adjusted OR, 1.23 [95% CI, 1.08-1.40]), and falling asleep during meetings (14.1% vs 7.0%; adjusted OR, 1.95 [95% CI, 1.52-2.52]). Conclusion Among a group of North American police officers, sleep disorders were common and were significantly associated with increased risk of self-reported adverse health, performance, and safety outcomes. JAMA. 2011;306(23):2567-2578	[Rajaratnam, Shantha M. W.; Barger, Laura K.; Lockley, Steven W.; Shea, Steven A.; Wang, Wei; Landrigan, Christopher P.; O'Brien, Conor S.; Qadri, Salim; Sullivan, Jason P.; Cade, Brian E.; Epstein, Lawrence J.; White, David P.; Czeisler, Charles A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Wang, Wei] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02115 USA; [Landrigan, Christopher P.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Med,Div Gen Pediat, Boston, MA 02115 USA; [Rajaratnam, Shantha M. W.; Barger, Laura K.; Lockley, Steven W.; Shea, Steven A.; Wang, Wei; Landrigan, Christopher P.; Epstein, Lawrence J.; White, David P.; Czeisler, Charles A.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA 02115 USA; [Shea, Steven A.; Epstein, Lawrence J.; White, David P.] Sleep HealthCtr, Boston, MA USA; [Rajaratnam, Shantha M. W.] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Monash University	Czeisler, CA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Sleep Med, 221 Longwood Ave, Boston, MA 02115 USA.	czeisler@hms.harvard.edu	Cade, Brian/J-6770-2019; Rajaratnam, Shantha/D-8144-2012	Cade, Brian/0000-0003-1424-0673; Rajaratnam, Shantha/0000-0001-7527-8558; Lockley, Steven/0000-0001-5209-2881; Shea, Steven/0000-0003-1949-0954; Landrigan, Christopher/0000-0001-8386-4100	Vanda Pharmaceuticals; Takeda Pharmaceuticals North America; Philips Lighting; Philips Respironics; Cephalon; ResMed Foundation; Optalert; Compumedics; Tyco Healthcare; Apollo Lighting; Naturebright; Sound Oasis; Wyle Integrated Science and Engineering; Brigham and Women's Hospital; Thomas Jefferson University; Warwick Medical School; I Slept Great/Euforma, LLC; Emergency Social Services Association Conference, UK; Swinburne University of Technology, Australia; Optalert, Pty Ltd, Melbourne, Australia; Respironics Inc; Alcon Inc; Sleep HealthCenters; American Academy of Sleep Medicine; Tufts University School of Dental Medicine; Cephalon Inc; World Sleep Federation; Actelion Ltd; Bombardier Inc; Boston Celtics; Celedon Trucking; Delta Airlines; Eli Lilly and Co; Garda Siochana Inspectorate; Gerson Lehrman Group; Global Ground Support; Johnson Johnson; Koninklijke Philips Electronics, NV; Minnesota Timberwolves; Norfolk Southern; Novartis; Portland Trail Blazers; Philips; sanofi-aventis Group; Sepracor Inc; Sleep Multimedia Inc; Somnus Therapeutics Inc; Zeo Inc; Accreditation Council of Graduate Medical Education; Alliance for Epilepsy Research; Duke University School of Medicine; Harvard School of Public Health; Hokkaido University Graduate School of Medicine; Japan Aerospace Exploration Agency (JAXA); LOTTE Health Products; Mount Sinai School of Medicine; National Academy of Sciences; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH); National Sleep Foundation; New England College of Occupational and Environmental Medicine (NECOEM); North East Sleep Society; Office of Rare Diseases Resarch (NIH); Rockpointe; sanofi-aventis Inc; Sleep Research Society; Society for Obstetric Anesthesia and Perinatology (SOAP); St Lukes Roosevelt Hospital; University of Chicago; University of Colorado; University of Pittsburgh; University of Virginia Medical School; University of Washington Medical Center; University of Wisconsin Medical School; World Federation of Sleep Research Society; World Federation of Sleep Medicine Society; Koninklijke Philips Electronics NV; ResMed; Committee for Interns and Residents; Boehringer Ingelheim Pharmaceuticals Inc; George H. KidderEsq; Gerald McGinnis; GlaxoSmithKline; Herbert Lee; Hypnion; Jazz Pharmaceuticals; Jordan's Furniture; Merck Co Inc; Pfizer; Sealy Inc; Simmons; Sleep Health Centers LLC; Spring Aire; Tempur-Pedic; National Institute of Justice, Office of Justice Programs, US Department of Justice [2004-FS-BX-0001, 2010C-10002]; Centers for Disease Control and Prevention [R01 OH008496, R01 OH009403]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008496, R01OH009403] Funding Source: NIH RePORTER	Vanda Pharmaceuticals; Takeda Pharmaceuticals North America(Takeda Pharmaceutical Company Ltd); Philips Lighting; Philips Respironics; Cephalon; ResMed Foundation; Optalert; Compumedics; Tyco Healthcare; Apollo Lighting; Naturebright; Sound Oasis; Wyle Integrated Science and Engineering; Brigham and Women's Hospital; Thomas Jefferson University; Warwick Medical School; I Slept Great/Euforma, LLC; Emergency Social Services Association Conference, UK; Swinburne University of Technology, Australia; Optalert, Pty Ltd, Melbourne, Australia; Respironics Inc; Alcon Inc(Novartis); Sleep HealthCenters; American Academy of Sleep Medicine; Tufts University School of Dental Medicine; Cephalon Inc(Teva Pharmaceutical Industries); World Sleep Federation; Actelion Ltd; Bombardier Inc; Boston Celtics; Celedon Trucking; Delta Airlines; Eli Lilly and Co(Eli Lilly); Garda Siochana Inspectorate; Gerson Lehrman Group; Global Ground Support; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Koninklijke Philips Electronics, NV; Minnesota Timberwolves; Norfolk Southern; Novartis(Novartis); Portland Trail Blazers; Philips; sanofi-aventis Group(Sanofi-Aventis); Sepracor Inc; Sleep Multimedia Inc; Somnus Therapeutics Inc; Zeo Inc; Accreditation Council of Graduate Medical Education; Alliance for Epilepsy Research; Duke University School of Medicine; Harvard School of Public Health; Hokkaido University Graduate School of Medicine; Japan Aerospace Exploration Agency (JAXA); LOTTE Health Products; Mount Sinai School of Medicine; National Academy of Sciences; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Sleep Foundation; New England College of Occupational and Environmental Medicine (NECOEM); North East Sleep Society; Office of Rare Diseases Resarch (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockpointe; sanofi-aventis Inc(Sanofi-Aventis); Sleep Research Society; Society for Obstetric Anesthesia and Perinatology (SOAP); St Lukes Roosevelt Hospital; University of Chicago(University of Chicago); University of Colorado; University of Pittsburgh(University of Pittsburgh); University of Virginia Medical School; University of Washington Medical Center(University of Washington); University of Wisconsin Medical School; World Federation of Sleep Research Society; World Federation of Sleep Medicine Society; Koninklijke Philips Electronics NV; ResMed; Committee for Interns and Residents; Boehringer Ingelheim Pharmaceuticals Inc(Boehringer Ingelheim); George H. KidderEsq; Gerald McGinnis; GlaxoSmithKline(GlaxoSmithKline); Herbert Lee; Hypnion; Jazz Pharmaceuticals(Jazz Pharmaceuticals); Jordan's Furniture; Merck Co Inc(Merck & Company); Pfizer(Pfizer); Sealy Inc; Simmons; Sleep Health Centers LLC; Spring Aire; Tempur-Pedic; National Institute of Justice, Office of Justice Programs, US Department of Justice; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Rajaratnam reported that he has served as a consultant through his institution to Vanda Pharmaceuticals, Philips Respironics, EdanSafe, the Australian Workers' Union, and National Transport Commission, and has through his institution received research grants and unrestricted educational grants from Vanda Pharmaceuticals, Takeda Pharmaceuticals North America, Philips Lighting, Philips Respironics, Cephalon, and ResMed Foundation, and reimbursements for conference travel expenses from Vanda Pharmaceuticals. His institution has received equipment donations or other support from Optalert, Compumedics, and Tyco Healthcare. He has also served as an expert witness and consultant to shift work organizations. Dr Barger reported receiving a research grant through her institution from Cephalon, receiving payment for lectures from Vital Issues in Medicine and National Sleep Foundation, and serving as a consultant for Alertness Solutions. Dr Lockley reported that he received 2 investigator-initiated research grants from the ResMed Foundation and an unrestricted equipment gift from ResMed Inc, in support of the studies described in this article; receiving consulting fees from Apollo Lighting, Naturebright, Sound Oasis, and Wyle Integrated Science and Engineering, and federally funded projects at Brigham and Women's Hospital, Thomas Jefferson University, and Warwick Medical School; lecture fees from Takeda Pharmaceuticals North America, I Slept Great/Euforma, LLC, and Emergency Social Services Association Conference, UK; unrestricted equipment gifts from Philips Lighting and Bionetics Corporation; an unrestricted monetary gift to support research from Swinburne University of Technology, Australia; a fellowship gift from Optalert, Pty Ltd, Melbourne, Australia; advance author payment and royalties from Oxford University Press, and honoraria from Servier Inc for writing an article for Dialogues in Clinical Neuroscience and from AMO Inc, for writing an educational monograph, neither of which refer to the companies' products; honoraria or travel and accommodation support for invited seminars, conference presentations or teaching from the Second International Symposium on the Design of Artificial Environments, Eighth International Conference on Managing Fatigue, American Academy of Sleep Medicine, American Society for Photobiology, Apollo Lighting, Bar Harbor Chamber of Commerce, Bassett Research Institute, Canadian Sleep Society, Committee of Interns and Residents, Coney Island Hospital, FASEB, Harvard University, Illinois Coalition for Responsible Outdoor Lighting, International Graduate School of Neuroscience, Japan National Institute of Occupational Safety and Health, Lightfair, National Research Council Canada, New York Academy of Sciences, North East Sleep Society, Ontario Association of Fire Chiefs, Philips Lighting, Thomas Jefferson University, University of Montreal, University of Tsukuba, University of Vermont College of Medicine, Utica College, Vanda Pharmaceuticals, Velux, Warwick Medical School, Woolcock Institute of Medical Research, and Wyle Integrated Science and Engineering (NASA); investigator-initiated research grants from Respironics Inc, Philips Lighting, Apollo Lighting, and Alcon Inc; and a service agreement and sponsor-initiated research contract from Vanda Pharmaceuticals.; Dr Lockley also holds a process patent for the use of short-wavelength light for resetting the human circadian pacemaker and improving alertness and peformance which is assigned to the Brigham and Women's Hospital per Hospital policy and has received revenue from a patent on the use of short-wavelength light, which is assigned to the University of Surrey. Dr Lockley has also served as a paid expert witness on behalf of 2 public bodies on arbitration panels related to sleep, circadian rhythms, and work hours. Dr Shea reported receiving fees for interpretation of polysomnographic sleep studies of participants in this study from Sleep HealthCenters, a sleep medicine specialty practice group; receiving fees for attendance at directors meeting of the American Academy of Sleep Medicine; and lecture fees from Tufts University School of Dental Medicine. Dr Landrigan reported serving as a consultant for Vital Issues in Medicine, developing an educational course for physicians on Shift Work Disorder (supported by an unrestricted educational grant from Cephalon Inc to Vital Issues in Medicine); and AXDev, to assist in the development of a study of Shift Work Disorder (supported by an unrestricted research grant from Cephalon Inc to AXDev). Dr Landrigan also reported receiving monetary awards, honoraria, and travel reimbursement from multiple academic and professional organizations for delivering lectures on sleep deprivation and safety. Mr O'Brien reported receiving support for travel to meetings for the study or other purposes from National Institute of Justice and Centers for Disease Control and Prevention. Dr Cade reported receiving a monetary award from the World Sleep Federation. Dr Epstein reported being employed by Sleep HealthCenters, a sleep medicine specialty practice group. Dr White reported being employed as the chief medical officer for Philips Respironics, for which he owns stock. Dr Czeisler reported that he has received consulting fees from or served as a paid member of scientific advisory boards for: Actelion Ltd; Bombardier Inc; Boston Celtics, Celedon Trucking, Cephalon, Inc, Delta Airlines, Eli Lilly and Co, Garda Siochana Inspectorate, Gerson Lehrman Group, Global Ground Support, Johnson & Johnson, Koninklijke Philips Electronics, NV, Minnesota Timberwolves, Norfolk Southern, Novartis, Portland Trail Blazers, Philips, Respironics Inc, sanofi-aventis Group, Sepracor Inc, Sleep Multimedia Inc, Somnus Therapeutics Inc, Vanda Pharmaceuticals, Inc, and Zeo Inc. Dr Czeisler reported that he owns an equity interest in Lifetrac Inc, Somnus Therapeutics Inc, Vanda Pharmaceuticals Inc, and Zeo Inc; that he has received royalties from the Massachusetts Medical Society/New England Journal of Medicine, McGraw Hill, the New York Times, Penguin Press, and Philips Respironics Inc.; Dr Czeisler reported receiving lecture fees from the Accreditation Council of Graduate Medical Education, Alliance for Epilepsy Research, American Academy of Sleep Medicine, Cephalon Inc, Duke University School of Medicine, Harvard School of Public Health, Hokkaido University Graduate School of Medicine, Japan Aerospace Exploration Agency (JAXA), LOTTE Health Products, Mount Sinai School of Medicine, National Academy of Sciences, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH), National Sleep Foundation, New England College of Occupational and Environmental Medicine (NECOEM), North East Sleep Society, Office of Rare Diseases Resarch (NIH), Rockpointe, sanofi-aventis Inc, Sleep Research Society, Society for Obstetric Anesthesia and Periatology (SOAP), St Lukes Roosevelt Hospital, University of Chicago, University of Colorado, University of Pittsburgh, University of Virginia Medical School, University of Washington Medical Center, University of Wisconsin Medical School, and the World Federation of Sleep Research and Sleep Medicine Societies. Dr Czeisler reported that he has received research prizes with monetary awards from the American Academy of Sleep Medicine and Sleep Research Society, a clinical trial research contract from Cephalon Inc, and an investigator-initiated research grant from Cephalon Inc and that his research laboratory at the Brigham and Women's Hospital has received unrestricted research and education funds and support for research expenses from Cephalon Inc, Koninklijke Philips Electronics NV, ResMed, and the Committee for Interns and Residents and the Brigham and Women's Hospital. The Harvard Medical School Division of Sleep Medicine (HMS/DSM), which Dr Czeisler directs, has received unrestricted research and educational gifts and endowment funds from Boehringer Ingelheim Pharmaceuticals Inc, Cephalon Inc, George H. KidderEsq, Gerald McGinnis, GlaxoSmithKline, Herbert Lee, Hypnion, Jazz Pharmaceuticals, Jordan's Furniture, Merck & Co Inc, Peter C. Farrell, PhD, Pfizer, ResMed, Respironics Inc, sanofi-aventis Inc, Sealy Inc, Sepracor Inc, Simmons, Sleep Health Centers LLC, Spring Aire, Takeda Pharmaceuticals, and Tempur-Pedic. The HMS/DSM has received gifts from many outside organizations and individuals including: Brigham and Women's Hospital (Development Office), Catalyst Group, Cephalon Inc, Committee for Interns and Residents, Eisai Inc, Farrell Family Foundation, Fisher & Paykel Healthcare Corp, Jordan's Furniture, Lilly USA, LLC, Neurocare Center for Sleep, Philips-Respironics Inc, Praxair US Homecare, sanofi-aventis Inc, Select Comfort Corp, Sepracor Inc, Sleep HealthCenters LLC, Somaxon Pharmaceuticals, Synchrony Healthcare Communications, Vanda Pharmaceuticals Inc, Wake Up Narcolepsy Inc, Watermark Medical, and Zeo Inc. The HMS/DSM Sleep and Health Education Program has received Educational Grant funding from Cephalon Inc, Takeda Pharmaceuticals, sanofi-aventis Inc, and Sepracor Inc. Dr Czeisler is the incumbent of an endowed professorship provided to Harvard University by Cephalon Inc and holds a number of process patents in the field of sleep and circadian rhythms (eg, photic resetting of the human circadian pacemaker). Since 1985, Dr Czeisler has also served as an expert witness on various legal cases related to sleep, circadian rhythms, or both.; This study was supported by grant 2004-FS-BX-0001 and grant 2010C-10002 from the National Institute of Justice, Office of Justice Programs, US Department of Justice; grants R01 OH008496 and R01 OH009403 from the Centers for Disease Control and Prevention; and grants from the ResMed Foundation.	AAA Foundation for Traffic Safety, 2004, SURV US CAN POL OFF; AAPOR, 2016, STAND DEF FIN DISP C; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Anderson AB, 1983, HDB SURVEY RES, P415; Anic-Labat S, 1999, SLEEP, V22, P77; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Barger LK, 2006, PLOS MED, V3, P2440, DOI 10.1371/journal.pmed.0030487; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Botros N, 2009, AM J MED, V122, P1122, DOI 10.1016/j.amjmed.2009.04.026; Budhiraja R, 2010, RESP CARE, V55, P1322; Bureau of Labor Statistics, 2007, CURR POP SURV CPS AN; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; Czeisler Charles A, 2009, Trans Am Clin Climatol Assoc, V120, P249; Drake C, 2010, SLEEP, V33, P745, DOI 10.1093/sleep/33.6.745; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; Faccenda JF, 2001, AM J RESP CRIT CARE, V163, P344, DOI 10.1164/ajrccm.163.2.2005037; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Franke WD, 2010, J OCCUP ENVIRON MED, V52, P561, DOI 10.1097/JOM.0b013e3181dd086b; Gangwisch JE, 2010, AM J HYPERTENS, V23, P62, DOI 10.1038/ajh.2009.202; Garbarino S, 2002, SLEEP, V25, P648; Hampton SM, 1996, J ENDOCRINOL, V151, P259, DOI 10.1677/joe.0.1510259; Howard ME, 2004, AM J RESP CRIT CARE, V170, P1014, DOI 10.1164/rccm.200312-1782oc; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Joseph PN, 2010, J OCCUP ENVIRON MED, V52, P1004, DOI 10.1097/JOM.0b013e3181f4385c; Kapsimalis F, 2009, J WOMENS HEALTH, V18, P1211, DOI 10.1089/jwh.2008.1054; Kapur VK, 2002, SLEEP, V25, P289; Kessler RC, 2011, SLEEP, V34, P1161, DOI 10.5665/SLEEP.1230; Knutsson A, 1999, OCCUP ENVIRON MED, V56, P46, DOI 10.1136/oem.56.1.46; Komada Y, 2008, SLEEP MED, V9, P851, DOI 10.1016/j.sleep.2007.08.018; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Maslach C., 1996, MASLACH BURNOUT INVE; National Center on Sleep Disorders, 2011, RES NIH SLEEP DIS RE, p[11, November]; National Law Enforcement, 2011, RES B LAW ENF OFF DE; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Neylan TC, 2002, PSYCHOSOM MED, V64, P345, DOI 10.1097/00006842-200203000-00019; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P577, DOI 10.1016/S0022-3999(02)00438-5; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Raj R, 2003, SLEEP MED, V4, P29, DOI 10.1016/S1389-9457(02)00150-8; Redline S, 2000, AM J RESP CRIT CARE, V161, P369, DOI 10.1164/ajrccm.161.2.9904031; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Rosen IM, 2006, ACAD MED, V81, P82, DOI 10.1097/00001888-200601000-00020; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schroeder S., 2006, PERFORMANCE MEASUREM; Sherry B., 2010, Morbidity and Mortality Weekly Report, V59, P951; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x; Tregear S, 2009, J CLIN SLEEP MED, V5, P573; Vila B, 2006, AM J IND MED, V49, P972, DOI 10.1002/ajim.20333; Violanti JM, 1998, AM J IND MED, V33, P366, DOI 10.1002/(SICI)1097-0274(199804)33:4<366::AID-AJIM6>3.0.CO;2-S; Violanti JM, 2009, ARCH ENVIRON OCCUP H, V64, P194, DOI 10.1080/19338240903241259; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	55	222	230	2	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2567	2578		10.1001/jama.2011.1851	http://dx.doi.org/10.1001/jama.2011.1851			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	864YQ	22187276	Bronze			2022-12-24	WOS:000298276800018
J	Kuzdzal-Fick, JJ; Fox, SA; Strassmann, JE; Queller, DC				Kuzdzal-Fick, Jennie J.; Fox, Sara A.; Strassmann, Joan E.; Queller, David C.			High Relatedness Is Necessary and Sufficient to Maintain Multicellularity in Dictyostelium	SCIENCE			English	Article							SOCIAL AMEBA; COOPERATION; EVOLUTION; CONFLICT; INDIVIDUALITY; SELECTION	Most complex multicellular organisms develop clonally from a single cell. This should limit conflicts between cell lineages that could threaten the extensive cooperation of cells within multicellular bodies. Cellular composition can be manipulated in the social amoeba Dictyostelium discoideum, which allows us to test and confirm the two key predictions of this theory. Experimental evolution at low relatedness favored cheating mutants that could destroy multicellular development. However, under high relatedness, the forces of mutation and within-individual selection are too small for these destructive cheaters to spread, as shown by a mutation accumulation experiment. Thus, we conclude that the single-cell bottleneck is a powerful stabilizer of cellular cooperation in multicellular organisms.	[Kuzdzal-Fick, Jennie J.; Fox, Sara A.; Strassmann, Joan E.; Queller, David C.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA; [Kuzdzal-Fick, Jennie J.] Univ Texas Austin, Coll Nat Sci, Sect Integrat Biol, Austin, TX 78712 USA; [Strassmann, Joan E.; Queller, David C.] Washington Univ, Dept Biol CB1137, St Louis, MO 63130 USA	Rice University; University of Texas System; University of Texas Austin; Washington University (WUSTL)	Queller, DC (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, 6100 Main St, Houston, TX 77005 USA.	queller@wustl.edu		Strassmann, Joan/0000-0003-0638-8440	NSF [DEB-0918931, DEB-0816690]; Wray-Todd Graduate Fellowships	NSF(National Science Foundation (NSF)); Wray-Todd Graduate Fellowships	Supported by the NSF grants DEB-0918931 and DEB-0816690. J.J.K. and S. A. F. were supported partly by Wray-Todd Graduate Fellowships. We thank J. Potter and A. Smith for laboratory work, G. Saxer for advice, and C. Kuzdzal Fick for advice and for comments on the manuscript. Data are available in the supporting online material.	BONNER JT, 1953, BIOL BULL, V104, P297, DOI 10.2307/1538484; BONNER JT, 1967, CELLULAR SLIME MOLDS; Bourke AFG, 2011, OX ECOL EV, P28; Brockhurst MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000634; Buss L., 1987, EVOLUTION INDIVIDUAL; Chen GK, 2005, EUKARYOT CELL, V4, P1755, DOI 10.1128/EC.4.10.1755-1764.2005; Ennis HL, 2000, P NATL ACAD SCI USA, V97, P3292, DOI 10.1073/pnas.050005097; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; GRAFEN, 1985, OXFORD SURV EVOL BIO, V2, P28; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; Hirose S, 2011, SCIENCE, V333, P467, DOI 10.1126/science.1203903; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Keller L, 1999, LEVELS SELECTION EVO; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Le Gac M, 2010, EVOLUTION, V64, P522, DOI 10.1111/j.1558-5646.2009.00814.x; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; Maynard Smith J, 1989, EVOLUTIONARY PROGR, P219; Michod RE, 1997, AM NAT, V149, P607, DOI 10.1086/286012; Michod RE, 1997, P ROY SOC B-BIOL SCI, V264, P853, DOI 10.1098/rspb.1997.0119; Michod RE, 1996, P ROY SOC B-BIOL SCI, V263, P813, DOI 10.1098/rspb.1996.0121; Ostrowski EA, 2008, PLOS BIOL, V6, P2376, DOI 10.1371/journal.pbio.0060287; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Szathmary E, 1995, MAJOR TRANSITIONS EV	28	67	67	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1548	1551		10.1126/science.1213272	http://dx.doi.org/10.1126/science.1213272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174251				2022-12-24	WOS:000298091400051
J	Michaud, M; Martins, I; Sukkurwala, AQ; Adjemian, S; Ma, YT; Pellegatti, P; Shen, SS; Kepp, O; Scoazec, M; Mignot, G; Rello-Varona, S; Tailler, M; Menger, L; Vacchelli, E; Galluzzi, L; Ghiringhelli, F; di Virgilio, F; Zitvogel, L; Kroemer, G				Michaud, Mickael; Martins, Isabelle; Sukkurwala, Abdul Qader; Adjemian, Sandy; Ma, Yuting; Pellegatti, Patrizia; Shen, Shensi; Kepp, Oliver; Scoazec, Marie; Mignot, Gregoire; Rello-Varona, Santiago; Tailler, Maximilien; Menger, Laurie; Vacchelli, Erika; Galluzzi, Lorenzo; Ghiringhelli, Francois; di Virgilio, Francesco; Zitvogel, Laurence; Kroemer, Guido			Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice	SCIENCE			English	Article							CALRETICULIN EXPOSURE; CELLS; CANCER; IMMUNOGENICITY; HMGB1	Antineoplastic chemotherapies are particularly efficient when they elicit immunogenic cell death, thus provoking an anticancer immune response. Here we demonstrate that autophagy, which is often disabled in cancer, is dispensable for chemotherapy-induced cell death but required for its immunogenicity. In response to chemotherapy, autophagy-competent, but not autophagy-deficient, cancers attracted dendritic cells and T lymphocytes into the tumor bed. Suppression of autophagy inhibited the release of adenosine triphosphate (ATP) from dying tumor cells. Conversely, inhibition of extracellular ATP-degrading enzymes increased pericellular ATP in autophagy-deficient tumors, reestablished the recruitment of immune cells, and restored chemotherapeutic responses but only in immunocompetent hosts. Thus, autophagy is essential for the immunogenic release of ATP from dying cells, and increased extracellular ATP concentrations improve the efficacy of antineoplastic chemotherapies when autophagy is disabled.	[Michaud, Mickael; Martins, Isabelle; Sukkurwala, Abdul Qader; Adjemian, Sandy; Ma, Yuting; Shen, Shensi; Kepp, Oliver; Scoazec, Marie; Rello-Varona, Santiago; Tailler, Maximilien; Menger, Laurie; Vacchelli, Erika; Galluzzi, Lorenzo; Zitvogel, Laurence; Kroemer, Guido] Inst Gustave Roussy, Villejuif, France; [Michaud, Mickael; Martins, Isabelle; Sukkurwala, Abdul Qader; Adjemian, Sandy; Shen, Shensi; Kepp, Oliver; Rello-Varona, Santiago; Tailler, Maximilien; Menger, Laurie; Vacchelli, Erika; Galluzzi, Lorenzo; Kroemer, Guido] INSERM, U848, Villejuif, France; [Michaud, Mickael; Martins, Isabelle; Sukkurwala, Abdul Qader; Adjemian, Sandy; Ma, Yuting; Shen, Shensi; Kepp, Oliver; Rello-Varona, Santiago; Tailler, Maximilien; Menger, Laurie; Vacchelli, Erika; Galluzzi, Lorenzo; Zitvogel, Laurence] Univ Paris Sud, Fac Med Paris 11, F-94275 Le Kremlin Bicetre, France; [Ma, Yuting; Zitvogel, Laurence] INSERM, U1015, Villejuif, France; [Ma, Yuting; Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 507, Villejuif, France; [Pellegatti, Patrizia; di Virgilio, Francesco] Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, Interdisciplinary Ctr Study Inflammat, I-44100 Ferrara, Italy; [Mignot, Gregoire; Ghiringhelli, Francois] Georges Francois Leclerc Ctr, Dept Med Oncol, Dijon, France; [Mignot, Gregoire; Ghiringhelli, Francois] CRI 866 Univ Burgundy, INSERM Avenir Team INSERM, Dijon, France; [Kroemer, Guido] Ctr Rech Cordeliers, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Kroemer, Guido] Univ Paris 05, Paris, France	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Ferrara; UNICANCER; Centre Georges-Francois Leclerc; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Zitvogel, L (corresponding author), Inst Gustave Roussy, Villejuif, France.	zitvogel@igr.fr; kroemer@orange.fr	Kepp, Oliver/N-2763-2017; KROEMER, Guido/B-4263-2013; Mignot, Grégoire/R-4976-2017; Galluzzi, Lorenzo/AAG-6432-2019; Kroemer, Guido/AAY-9859-2020; Galluzzi, Lorenzo/K-2709-2012; Galluzzi, Lorenzo/AAG-6294-2019; Vacchelli, Erika/E-5212-2018; Rello-Varona, Santi/A-4882-2009; Kepp, Oliver/GPX-8627-2022; ADJEMIAN, Sandy/K-7632-2012; SHEN, Shensi/AAW-2735-2020; Di Virgilio, Francesco/J-3754-2018; DI VIRGILIO, Francesco/O-4634-2019; Galluzzi, Lorenzo/AAH-3286-2021	Kepp, Oliver/0000-0002-6081-9558; KROEMER, Guido/0000-0002-9334-4405; Mignot, Grégoire/0000-0002-0682-0152; Galluzzi, Lorenzo/0000-0003-2257-8500; Vacchelli, Erika/0000-0001-8010-0594; Rello-Varona, Santi/0000-0002-7500-5522; ADJEMIAN, Sandy/0000-0001-5594-5499; SHEN, Shensi/0000-0002-5087-8220; Di Virgilio, Francesco/0000-0003-3566-1362; DI VIRGILIO, Francesco/0000-0003-3566-1362; Menger, Laurie/0000-0003-0949-6607; ghiringhelli, francois/0000-0002-5465-8305; ZITVOGEL, laurence/0000-0003-1596-0998	Ligue Nationale contre le Cancer (Equipes labelisees); Agence Nationale pour la Recherche (ANR); European Commission; Fondation pour la Recherche Medicale (FRM); Fondation Bettencourt-Schueller Institut National du Cancer (INCa); Canceropole Ile-de-France; LabEx OncoImmunology; Association pour la Recherche sur le Cancer; Italian Association for Cancer Research (AIRC); La Ligue Nationale contre le Cancer; China Scholarship Council; Higher Education Commission of Pakistan; Fondation de France	Ligue Nationale contre le Cancer (Equipes labelisees)(Institut National du Cancer (INCA) France); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Bettencourt-Schueller Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); LabEx OncoImmunology; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); China Scholarship Council(China Scholarship Council); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Fondation de France(Fondation de France)	G.K. and L.Z. are supported by the Ligue Nationale contre le Cancer (Equipes labelisees), Agence Nationale pour la Recherche (ANR), European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain INFLACare), Fondation pour la Recherche Medicale (FRM), Fondation Bettencourt-Schueller Institut National du Cancer (INCa), and Canceropole Ile-de-France and the LabEx OncoImmunology. G. M. is supported by Association pour la Recherche sur le Cancer. F.d.V. and P. P. are supported by Italian Association for Cancer Research (AIRC). M. M. is supported by FRM. I. M., S. A., M. T. are supported by La Ligue Nationale contre le Cancer and Y.M. by China Scholarship Council. A. Q. S. is supported by Higher Education Commission of Pakistan. S.R.-V. is supported by Fondation de France. L.Z. has served as a paid consultant for Innate Pharma S. A., a biopharmaceutical company developing immunotherapy drugs for cancer.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Ferguson TA, 2011, IMMUNOL REV, V241, P77, DOI 10.1111/j.1600-065X.2011.01006.x; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mutini C, 1999, J IMMUNOL, V163, P1958; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zappasodi R, 2010, CANCER RES, V70, P9062, DOI 10.1158/0008-5472.CAN-10-1825; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	29	931	966	11	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1573	1577		10.1126/science.1208347	http://dx.doi.org/10.1126/science.1208347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174255				2022-12-24	WOS:000298091400058
J	Levaot, N; Voytyuk, O; Dimitriou, I; Sircoulomb, F; Chandrakumar, A; Deckert, M; Krzyzanowski, PM; Scotter, A; Gu, SQ; Janmohamed, S; Cong, F; Simoncic, PD; Ueki, Y; La Rose, J; Rottapel, R				Levaot, Noam; Voytyuk, Oleksandr; Dimitriou, Ioannis; Sircoulomb, Fabrice; Chandrakumar, Arun; Deckert, Marcel; Krzyzanowski, Paul M.; Scotter, Andrew; Gu, Shengqing; Janmohamed, Salima; Cong, Feng; Simoncic, Paul D.; Ueki, Yasuyoshi; La Rose, Jose; Rottapel, Robert			Loss of Tankyrase-Mediated Destruction of 3BP2 Is the Underlying Pathogenic Mechanism of Cherubism	CELL			English	Article							ADAPTER PROTEIN 3BP2; TYROSINE KINASE; POLY(ADP-RIBOSE) POLYMERASE; TELOMERE LENGTH; IDENTIFICATION; SH3BP2; SRC; ACTIVATION; EXPRESSION; PP60C-SRC	Cherubism is an autosomal-dominant syndrome characterized by inflammatory destructive bony lesions resulting in symmetrical deformities of the facial bones. Cherubism is caused by mutations in Sh3bp2, the gene that encodes the adaptor protein 3BP2. Most identified mutations in 3BP2 lie within the peptide sequence RSPPDG. A mouse model of cherubism develops hyperactive bone-remodeling osteoclasts and systemic inflammation characterized by expansion of the myelomonocytic lineage. The mechanism by which cherubism mutations alter 3BP2 function has remained obscure. Here we show that Tankyrase, a member of the poly(ADP-ribose) polymerase (PARP) family, regulates 3BP2 stability through ADP-ribosylation and subsequent ubiquitylation by the E3-ubiquitin ligase RNF146 in osteoclasts. Cherubism mutations uncouple 3BP2 from Tankyrase-mediated protein destruction, which results in its stabilization and subsequent hyperactivation of the SRC, SYK, and VAV signaling pathways.	[Levaot, Noam; Voytyuk, Oleksandr; Dimitriou, Ioannis; Sircoulomb, Fabrice; Chandrakumar, Arun; Krzyzanowski, Paul M.; Scotter, Andrew; Gu, Shengqing; Janmohamed, Salima; Simoncic, Paul D.; La Rose, Jose; Rottapel, Robert] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Levaot, Noam; Voytyuk, Oleksandr; Dimitriou, Ioannis; Sircoulomb, Fabrice; Chandrakumar, Arun; Krzyzanowski, Paul M.; Scotter, Andrew; Gu, Shengqing; Janmohamed, Salima; Simoncic, Paul D.; La Rose, Jose; Rottapel, Robert] Univ Toronto, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada; [Deckert, Marcel] Univ Nice, INSERM, UMR576, F-06202 Nice, France; [Cong, Feng] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Ueki, Yasuyoshi] Univ Missouri, Sch Dent, Kansas City, MO 64108 USA; [Rottapel, Robert] St Michaels Hosp, Div Rheumatol, Dept Med, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Novartis; University of Missouri System; University of Missouri Kansas City; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Rottapel, R (corresponding author), Univ Toronto, Ontario Canc Inst, 101 Coll St,Rm 8-703,Toronto Med Discovery Tower, Toronto, ON M5G 1L7, Canada.	rottapel@uhnres.utoronto.ca	Deckert, Marcel/T-3566-2019; Levaot, Noam/AAA-3052-2022; Deckert, Marcel/M-4998-2016	Deckert, Marcel/0000-0003-2094-559X; Levaot, Noam/0000-0001-7747-3883; Gu, Shengqing/0000-0002-4200-0864; Krzyzanowski, Paul/0000-0001-6430-5995; Rottapel, Robert/0000-0002-6024-5558	Terry Fox Research Institute [20003]; Canadian Cancer Society Research Institute; Ontario Ministry of Health and Long Term Care; Amgen Chair for Cancer Research from the PMHF at the Ontario Cancer Institute, Princess Margaret Hospital; Arthritis Centre, University of Toronto; Charles H. Hood Foundation, Inc., Boston, MA; National Institutes of Health [R01DE020835]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020835] Funding Source: NIH RePORTER	Terry Fox Research Institute; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Amgen Chair for Cancer Research from the PMHF at the Ontario Cancer Institute, Princess Margaret Hospital; Arthritis Centre, University of Toronto; Charles H. Hood Foundation, Inc., Boston, MA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the Terry Fox Research Institute (TFPP Grant #20003), by the Canadian Cancer Society Research Institute, and by the Ontario Ministry of Health and Long Term Care. The views expressed do not necessarily reflect those of the OMOHLTC. R.R. is supported by the Amgen Chair for Cancer Research from the PMHF at the Ontario Cancer Institute, Princess Margaret Hospital. N.L. was supported by the Arthritis Centre for Excellence Fellowship, University of Toronto. Y.U. was supported by the Charles H. Hood Foundation, Inc., Boston, MA and research grant R01DE020835 from the National Institutes of Health. We thank Gerald Gish for providing the peptides and Sebastian Geuttler for assistance with the fluorescence polarization experiments. We thank Ben Neel and Norman Iscove for discussion regarding the chimera experiments. We thank Mauricio Medrano for graphic design. We thank Frank Sicheri, Sebastian Geuttler, Ernst Reichenberger, Gregg Morin, Vuk Stambolic, and Ben Neel for critical reading of the manuscript.	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Chiang YJ, 2006, MOL CELL BIOL, V26, P2037, DOI 10.1128/MCB.26.6.2037-2043.2006; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; de la Fuente MA, 2006, MOL CELL BIOL, V26, P5214, DOI 10.1128/MCB.00087-06; Deckert M, 2006, M S-MED SCI, V22, P1081, DOI 10.1051/medsci/200622121081; Deckert M, 2006, ADV EXP MED BIOL, V584, P107; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Gagne JP, 2003, BIOCHEM J, V371, P331, DOI 10.1042/BJ20021675; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Hsiao SJ, 2006, MOL CELL BIOL, V26, P2044, DOI 10.1128/MCB.26.6.2044-2054.2006; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Hynes NE, 2000, BREAST CANCER RES, V2, P154, DOI 10.1186/bcr48; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; JONES WA, 1950, J BONE JOINT SURG BR, V32, P334, DOI 10.1302/0301-620X.32B3.334; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Levaot N, 2011, J CLIN INVEST, V121, P3244, DOI 10.1172/JCI45843; Lietman SA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9433; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Tiziani V, 1999, AM J HUM GENET, V65, P158, DOI 10.1086/302456; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; Ueki Y, 2007, CELL, V128, P71, DOI 10.1016/j.cell.2006.10.047; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; Yeh TYJ, 2009, DIABETES, V58, P2476, DOI 10.2337/db08-1781; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	33	140	141	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1324	1339		10.1016/j.cell.2011.10.045	http://dx.doi.org/10.1016/j.cell.2011.10.045			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153076	Green Accepted, Bronze			2022-12-24	WOS:000298148100021
J	Suga, H; Kadoshima, T; Minaguchi, M; Ohgushi, M; Soen, M; Nakano, T; Takata, N; Wataya, T; Muguruma, K; Miyoshi, H; Yonemura, S; Oiso, Y; Sasai, Y				Suga, Hidetaka; Kadoshima, Taisuke; Minaguchi, Maki; Ohgushi, Masatoshi; Soen, Mika; Nakano, Tokushige; Takata, Nozomu; Wataya, Takafumi; Muguruma, Keiko; Miyoshi, Hiroyuki; Yonemura, Shigenobu; Oiso, Yutaka; Sasai, Yoshiki			Self-formation of functional adenohypophysis in three-dimensional culture	NATURE			English	Article							PITUITARY-GLAND; RATHKES POUCH; CELL LINEAGES; DIFFERENTIATION; SPECIFICATION; INDUCTION; GROWTH; ORGANOGENESIS; MECHANISMS; EXPRESSION	The adenohypophysis (anterior pituitary) is a major centre for systemic hormones. At present, no efficient stem-cell culture for its generation is available, partly because of insufficient knowledge about how the pituitary primordium (Rathke's pouch) is induced in the embryonic head ectoderm. Here we report efficient self-formation of three-dimensional adenohypophysis tissues in an aggregate culture of mouse embryonic stem (ES) cells. ES cells were stimulated to differentiate into non-neural head ectoderm and hypothalamic neuroectoderm in adjacent layers within the aggregate, and treated with hedgehog signalling. Self-organization of Rathke's-pouch-like three-dimensional structures occurred at the interface of these two epithelia, as seen in vivo, and various endocrine cells including corticotrophs and somatotrophs were subsequently produced. The corticotrophs efficiently secreted adrenocorticotropic hormone in response to corticotrophin releasing hormone and, when grafted in vivo, these cells rescued the systemic glucocorticoid level in hypopituitary mice. Thus, functional anterior pituitary tissue self-forms in ES cell culture, recapitulating local tissue interactions.	[Suga, Hidetaka; Kadoshima, Taisuke; Minaguchi, Maki; Soen, Mika; Nakano, Tokushige; Takata, Nozomu; Wataya, Takafumi; Muguruma, Keiko; Sasai, Yoshiki] RIKEN Ctr Dev Biol, Neurogenesis & Organogenesis Grp, Kobe, Hyogo 6500047, Japan; [Suga, Hidetaka; Ohgushi, Masatoshi] RIKEN Ctr Dev Biol, Div Human Stem Cell Technol, Kobe, Hyogo 6500047, Japan; [Suga, Hidetaka; Oiso, Yutaka] Nagoya Univ, Dept Endocrinol & Diabet, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Miyoshi, Hiroyuki] RIKEN, Subteam Manipulat Cell Fate, BioResource Ctr, Tsukuba, Ibaraki 3050074, Japan; [Yonemura, Shigenobu] RIKEN Ctr Dev Biol, Electron Microscopy Lab, Kobe, Hyogo 6500047, Japan	RIKEN; RIKEN; Nagoya University; RIKEN; RIKEN	Sasai, Y (corresponding author), RIKEN Ctr Dev Biol, Neurogenesis & Organogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp	SUGA, HIDETAKA/I-7452-2014; Miyoshi, Hiroyuki/G-9808-2013; Takata, Nozomu/AAI-9801-2020	Takata, Nozomu/0000-0003-0171-6994; Suga, Hidetaka/0000-0003-1924-7639; Muguruma, Keiko/0000-0002-3149-4408	Ministry of Education, Culture, Sports, Science and Technology; Knowledge Cluster Initiative at Kobe; Leading Project for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research [22390188] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Knowledge Cluster Initiative at Kobe; Leading Project for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to H. Enomoto, R. Ladher and M. Eiraku for invaluable comments, to K. Misaki for electron microscopy analysis, and to members of the Y.S. laboratory for discussion. This work was supported by grants-in-aid from Ministry of Education, Culture, Sports, Science and Technology (Y.S., Y.O.), the Knowledge Cluster Initiative at Kobe, and the Leading Project for Realization of Regenerative Medicine (Y.S.).	Basch ML, 2006, ADV EXP MED BIOL, V589, P24; Bharti K, 2011, DEVELOPMENT, V138, P873, DOI 10.1242/dev.056465; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; Davis SW, 2010, MOL CELL ENDOCRINOL, V323, P4, DOI 10.1016/j.mce.2009.12.012; Davis SW, 2011, DEV BIOL, V352, P215, DOI 10.1016/j.ydbio.2011.01.010; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Ellsworth BS, 2008, DEV BIOL, V313, P118, DOI 10.1016/j.ydbio.2007.10.006; Ericson J, 1998, DEVELOPMENT, V125, P1005; FALCONI G, 1964, ENDOCRINOLOGY, V74, P301, DOI 10.1210/endo-74-2-301; Gleiberman AS, 1999, DEV BIOL, V213, P340, DOI 10.1006/dbio.1999.9386; HEMMING FJ, 1984, ENDOCRINOLOGY, V114, P2107, DOI 10.1210/endo-114-6-2107; Ingle DJ, 1938, AM J PHYSIOL, V124, P369, DOI 10.1152/ajplegacy.1938.124.2.369; JONES CM, 1991, DEVELOPMENT, V111, P531; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Kikuchi M, 2007, ANAT REC, V290, P486, DOI 10.1002/ar.20516; Kita A, 2007, MOL ENDOCRINOL, V21, P1458, DOI 10.1210/me.2007-0039; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Melmed S, 2011, PITUITARY, P61; Ogasawara K, 2009, ENDOCRINOLOGY, V150, P1061, DOI 10.1210/en.2008-1151; Rizzoti K, 2005, REV ENDOCR METAB DIS, V6, P161, DOI 10.1007/s11154-005-3047-7; Romero CJ, 2009, TRENDS ENDOCRIN MET, V20, P506, DOI 10.1016/j.tem.2009.06.005; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Suh H, 2002, DEVELOPMENT, V129, P329; Takuma N, 1998, DEVELOPMENT, V125, P4835; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Treier M, 2001, DEVELOPMENT, V128, P377; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Zhao YG, 2006, MECH DEVELOP, V123, P605, DOI 10.1016/j.mod.2006.06.005; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006; Zhu XY, 2006, GENE DEV, V20, P2739, DOI 10.1101/gad.1444706	33	332	352	3	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2011	480	7375					57	U215		10.1038/nature10637	http://dx.doi.org/10.1038/nature10637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22080957				2022-12-24	WOS:000298031900032
J	Grbic, M; Van Leeuwen, T; Clark, RM; Rombauts, S; Rouze, P; Grbic, V; Osborne, EJ; Dermauw, W; Phuong, CTN; Ortego, F; Hernandez-Crespo, P; Diaz, I; Martinez, M; Navajas, M; Sucena, E; Magalhaes, S; Nagy, L; Pace, RM; Djuranovic, S; Smagghe, G; Iga, M; Christiaens, O; Veenstra, JA; Ewer, J; Villalobos, RM; Hutter, JL; Hudson, SD; Velez, M; Yi, SV; Zeng, J; Pires-daSilva, A; Roch, F; Cazaux, M; Navarro, M; Zhurov, V; Acevedo, G; Bjelica, A; Fawcett, JA; Bonnet, E; Martens, C; Baele, G; Wissler, L; Sanchez-Rodriguez, A; Tirry, L; Blais, C; Demeestere, K; Henz, SR; Gregory, TR; Mathieu, J; Verdon, L; Farinelli, L; Schmutz, J; Lindquist, E; Feyereisen, R; Van de Peer, Y				Grbic, Miodrag; Van Leeuwen, Thomas; Clark, Richard M.; Rombauts, Stephane; Rouze, Pierre; Grbic, Vojislava; Osborne, Edward J.; Dermauw, Wannes; Phuong Cao Thi Ngoc; Ortego, Felix; Hernandez-Crespo, Pedro; Diaz, Isabel; Martinez, Manuel; Navajas, Maria; Sucena, Elio; Magalhaes, Sara; Nagy, Lisa; Pace, Ryan M.; Djuranovic, Sergej; Smagghe, Guy; Iga, Masatoshi; Christiaens, Olivier; Veenstra, Jan A.; Ewer, John; Mancilla Villalobos, Rodrigo; Hutter, Jeffrey L.; Hudson, Stephen D.; Velez, Marisela; Yi, Soojin V.; Zeng, Jia; Pires-daSilva, Andre; Roch, Fernando; Cazaux, Marc; Navarro, Marie; Zhurov, Vladimir; Acevedo, Gustavo; Bjelica, Anica; Fawcett, Jeffrey A.; Bonnet, Eric; Martens, Cindy; Baele, Guy; Wissler, Lothar; Sanchez-Rodriguez, Aminael; Tirry, Luc; Blais, Catherine; Demeestere, Kristof; Henz, Stefan R.; Gregory, T. Ryan; Mathieu, Johannes; Verdon, Lou; Farinelli, Laurent; Schmutz, Jeremy; Lindquist, Erika; Feyereisen, Rene; Van de Peer, Yves			The genome of Tetranychus urticae reveals herbivorous pest adaptations	NATURE			English	Article							HOX GENES; SPIDER; MODEL; MITE	The spider mite Tetranychus urticae is a cosmopolitan agricultural pest with an extensive host plant range and an extreme record of pesticide resistance. Here we present the completely sequenced and annotated spider mite genome, representing the first complete chelicerate genome. At 90 megabases T. urticae has the smallest sequenced arthropod genome. Compared with other arthropods, the spider mite genome shows unique changes in the hormonal environment and organization of the Hox complex, and also reveals evolutionary innovation of silk production. We find strong signatures of polyphagy and detoxification in gene families associated with feeding on different hosts and in new gene families acquired by lateral gene transfer. Deep transcriptome analysis of mites feeding on different plants shows how this pest responds to a changing host environment. The T. urticae genome thus offers new insights into arthropod evolution and plant-herbivore interactions, and provides unique opportunities for developing novel plant protection strategies.	[Rombauts, Stephane; Rouze, Pierre; Phuong Cao Thi Ngoc; Fawcett, Jeffrey A.; Bonnet, Eric; Martens, Cindy; Baele, Guy; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Grbic, Miodrag; Grbic, Vojislava; Cazaux, Marc; Navarro, Marie; Zhurov, Vladimir; Acevedo, Gustavo; Bjelica, Anica] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Grbic, Miodrag; Grbic, Vojislava] UR, CSIC, Inst Ciencias Vid & Vino, Logrono 26006, Spain; [Van Leeuwen, Thomas; Dermauw, Wannes; Smagghe, Guy; Iga, Masatoshi; Christiaens, Olivier; Tirry, Luc] Univ Ghent, Dept Crop Protect, Fac Biosci Engn, B-9000 Ghent, Belgium; [Clark, Richard M.; Osborne, Edward J.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Rombauts, Stephane; Rouze, Pierre; Phuong Cao Thi Ngoc; Fawcett, Jeffrey A.; Bonnet, Eric; Martens, Cindy; Baele, Guy; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Ortego, Felix; Hernandez-Crespo, Pedro] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid 28040, Spain; [Diaz, Isabel; Martinez, Manuel] UPM INIA, Ctr Biotecnol & Genom Plantas, Madrid 28223, Spain; [Navajas, Maria] Montpellier SupAgro, Cirad, IRD, INRA,UMR CBGP, F-34988 Montferrier Sur Lez, France; [Sucena, Elio] Inst Gulbenkian Ciencias, P-2781901 Oeiras, Portugal; [Sucena, Elio] Univ Lisbon, Fac Ciencias, Dept Biol Anim, P-1749016 Lisbon, Portugal; [Magalhaes, Sara] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1749016 Lisbon, Portugal; [Nagy, Lisa; Pace, Ryan M.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Djuranovic, Sergej] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Veenstra, Jan A.] Univ Bordeaux 1, Inst Neurosci Cognit & Integrat Aquitaine, F-33405 Talence, France; [Ewer, John; Mancilla Villalobos, Rodrigo] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso 2360102, Chile; [Hutter, Jeffrey L.; Hudson, Stephen D.] Univ Western Ontario, Dept Phys & Astron, London, ON N6A 5B7, Canada; [Velez, Marisela] CSIC, Inst Catalisis & Petroleoquim, E-28040 Madrid, Spain; [Velez, Marisela] Univ Autonoma Madrid, Fac Ciencias, IMDEA Nanociencias, Madrid 28050, Spain; [Yi, Soojin V.; Zeng, Jia] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Pires-daSilva, Andre] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Roch, Fernando] Univ Toulouse 3, Univ Toulouse, UPS, Ctr Dev Biol, F-31062 Toulouse, France; [Roch, Fernando] CNRS, Ctr Dev Biol, UMR 5547, F-31062 Toulouse, France; [Wissler, Lothar] Univ Munster, Inst Evolut & Biodivers, Evolutionary Bioinformat Grp, D-48149 Munster, Germany; [Sanchez-Rodriguez, Aminael] Katholieke Univ Leuven, Dept Microbial & Mol Syst, CMPG, B-3001 Louvain, Belgium; [Blais, Catherine] Univ Paris 06, CNRS, UMR 7622, Equipe Biogenese Signaux Hormonaux, F-75005 Paris, France; [Demeestere, Kristof] Univ Ghent, Fac Biosci Engn, Dept Sustainable Organ Chem & Technol, Res Grp EnVOC, B-9000 Ghent, Belgium; [Henz, Stefan R.] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Gregory, T. Ryan] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Mathieu, Johannes] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Verdon, Lou] Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, London, ON N5V 4T3, Canada; [Farinelli, Laurent] Fasteris SA, CH-1228 Plan Les Ouates, Switzerland; [Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Schmutz, Jeremy; Lindquist, Erika] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Feyereisen, Rene] Univ Nice Sophia Antipolis, F-06903 Sophia Antipolis, France; [Feyereisen, Rene] CNRS, INRA, UMR 1301, F-06903 Sophia Antipolis, France	Flanders Institute for Biotechnology (VIB); Ghent University; Western University (University of Western Ontario); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja; Ghent University; Utah System of Higher Education; University of Utah; Ghent University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidad Politecnica de Madrid; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Universidade de Lisboa; University of Arizona; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Universidad de Valparaiso; Western University (University of Western Ontario); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Autonomous University of Madrid; University System of Georgia; Georgia Institute of Technology; University of Texas System; University of Texas Arlington; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Munster; KU Leuven; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Ghent University; Max Planck Society; University of Guelph; Cornell University; Boyce Thompson Institute for Plant Research; Agriculture & Agri Food Canada; HudsonAlpha Institute for Biotechnology; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); INRAE	Van de Peer, Y (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.	mgrbic@uwo.ca; yves.vandepeer@psb.ugent.be	Sucena, Élio/M-1753-2015; Pace, Ryan/I-5272-2015; Rombauts, Stephane M/D-7640-2014; da Silva, Andre Pires/B-1066-2008; Pedro, Hernandez-Crespo/H-9937-2015; NAVAJAS, Maria/AAM-2294-2020; Silva, André/HHN-2071-2022; Acevedo-Hernandez, Gustavo J./D-5745-2011; Smagghe, Guy/AAE-8914-2019; Diaz, Isabel/I-8840-2014; Christiaens, Olivier/AAB-3634-2019; Sucena, Élio/ABF-6684-2020; Van de Peer, Yves/D-4388-2009; Van de Peer, Yves/AAE-7666-2019; Velez, Marisela/F-2900-2013; Fawcett, Jeffrey/B-4145-2008; Dermauw, Wannes/H-1583-2015; Martinez, Manuel/I-8743-2014; Grbic, Miodrag/AID-4825-2022; Schmutz, Jeremy/N-3173-2013; Veenstra, Jan/B-4610-2008; Pace, Ryan/AAY-7774-2020; Ortego, Félix/F-9402-2011; Van Leeuwen, Thomas/H-5036-2013; Rombauts, Stephane/P-2420-2019; S., Magalhaes/B-9673-2012; Feyereisen, René/I-3140-2012; Feyereisen, René/Y-7514-2019; mancilla, rodrigo/C-8380-2011; Baele, Guy/R-8157-2017	Sucena, Élio/0000-0001-8810-870X; Pace, Ryan/0000-0002-8771-2603; Rombauts, Stephane M/0000-0002-3985-4981; da Silva, Andre Pires/0000-0002-0741-7197; Pedro, Hernandez-Crespo/0000-0001-9350-3640; NAVAJAS, Maria/0000-0002-0702-4238; Acevedo-Hernandez, Gustavo J./0000-0002-3959-9220; Smagghe, Guy/0000-0001-8334-3313; Diaz, Isabel/0000-0001-9865-902X; Christiaens, Olivier/0000-0001-5850-340X; Sucena, Élio/0000-0001-8810-870X; Van de Peer, Yves/0000-0003-4327-3730; Van de Peer, Yves/0000-0003-4327-3730; Velez, Marisela/0000-0002-9424-510X; Dermauw, Wannes/0000-0003-4612-8969; Martinez, Manuel/0000-0002-7826-5872; Schmutz, Jeremy/0000-0001-8062-9172; Ortego, Félix/0000-0002-7778-8508; Rombauts, Stephane/0000-0002-3985-4981; S., Magalhaes/0000-0002-8609-7768; Feyereisen, René/0000-0002-9560-571X; Feyereisen, René/0000-0002-9560-571X; Baele, Guy/0000-0002-1915-7732; Fawcett, Jeffrey/0000-0003-3907-2135; Cao Thi Ngoc, Phuong/0000-0002-3059-9179; Mancilla, Rodrigo A/0000-0001-8112-2381; Bonnet, Eric/0000-0002-8468-2867; Ewer, John/0000-0002-6806-3628; Veenstra, Jan Adrianus/0000-0002-2783-0018; Van Leeuwen, Thomas/0000-0003-4651-830X; Sanchez-Rodriguez, Aminael/0000-0002-9269-0621; Djuranovic, Sergej/0000-0002-9417-0822	NSERC [STPGP 322206-05]; Marie Curie Incoming International Fellowship; OECD [JA00053351]; Ontario Research Fund-Global Leadership in Genomics and Life Sciences [GL2-01-035]; Belgian Federal Science Policy Office IUAP [P6/25]; Fund for Scientific Research Flanders (FWO); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT); Ghent University (MRP N2N); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464] Funding Source: NIH RePORTER	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Marie Curie Incoming International Fellowship(European Commission); OECD; Ontario Research Fund-Global Leadership in Genomics and Life Sciences; Belgian Federal Science Policy Office IUAP(Belgian Federal Science Policy Office); Fund for Scientific Research Flanders (FWO)(FWO); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Ghent University (MRP N2N)(Ghent University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M. G. and V. G. acknowledge support from NSERC Strategic Grant STPGP 322206-05, Marie Curie Incoming International Fellowship, OECD Co-operative Research Programme: Biological resource management for Sustainable Agricultural Systems JA00053351, and Ontario Research Fund-Global Leadership in Genomics and Life Sciences GL2-01-035. The genome and transcriptome sequencing projects were funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-046), JGI Community Sequencing Program grant 777506 to M. G., a University of Utah SEED grant ( to R. M. C.), and National Science Foundation (NSF) grant 0820985 ( to R. M. C., Principal Investigator L. Sieburth); work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under contract No. DE-AC02-05CH11231. Y.V.d. P. acknowledges support from the Belgian Federal Science Policy Office IUAP P6/25 (BioMaGNet), the Fund for Scientific Research Flanders (FWO), the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT), and Ghent University (MRP N2N). T. V. L. is a post-doctoral fellow of the FWO. We acknowledge the work of J. Boore, T. Negrave, A. Migeon, P. Auger, L. Swevers and H. Van Langenhove. M. G. and V. G. thank D. Weigel, G. Schafer, M. Gerberding, R. Sommer, J. Felix and T. Nuernberger for discussions and support. The genome annotation of T. urticae is available at the VIB Department of Plant Systems Biology, Ghent University (http://bioinformatics.psb.ugent.be/webtools/bogas/).	Boubou A, 2011, BIOL INVASIONS, V13, P81, DOI 10.1007/s10530-010-9791-y; Carrillo L, 2011, PLANT CELL REP, V30, P101, DOI 10.1007/s00299-010-0948-z; Chung JS, 2010, ARCH INSECT BIOCHEM, V73, P1, DOI 10.1002/arch.20327; Cornman SR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-602; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; Dunlop JA, 2010, ARTHROPOD STRUCT DEV, V39, P124, DOI 10.1016/j.asd.2010.01.003; Dunlop JA, 2009, EXP APPL ACAROL, V48, P183, DOI 10.1007/s10493-009-9247-1; Edgecombe GD, 2010, ARTHROPOD STRUCT DEV, V39, P74, DOI 10.1016/j.asd.2009.10.002; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Gerson U, 1985, SPIDER MITES THEIR A, P223; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; Grbic M, 2007, BIOESSAYS, V29, P489, DOI 10.1002/bies.20564; Grenier JK, 1997, CURR BIOL, V7, P547, DOI 10.1016/S0960-9822(06)00253-3; Guengerich FP, 2005, BIOCHEM BIOPH RES CO, V338, P465, DOI 10.1016/j.bbrc.2005.08.079; Keifer HH., 1975, MITES INJURIOUS EC P, P327; Khajehali J, 2011, PEST MANAG SCI, V67, P1424, DOI 10.1002/ps.2191; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Migeon A, 2009, EXP APPL ACAROL, V48, P199, DOI 10.1007/s10493-008-9229-8; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; MOTHES U, 1981, CELL TISSUE RES, V221, P339, DOI 10.1007/BF00216738; OLIVER JH, 1977, ANNU REV ENTOMOL, V22, P407, DOI 10.1146/annurev.en.22.010177.002203; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Schwager EE, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-10; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; Van Leeuwen T, 2010, INSECT BIOCHEM MOLEC, V40, P563, DOI 10.1016/j.ibmb.2010.05.008; VectorBase, 2008, VECTORBASE IXODES SC; VEERMAN A, 1978, NATURE, V275, P234, DOI 10.1038/275234a0; Walter DE, 1999, MITES ECOLOGY EVOLUT	32	694	790	28	389	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2011	479	7374					487	492		10.1038/nature10640	http://dx.doi.org/10.1038/nature10640			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22113690	Green Accepted, hybrid, Green Published			2022-12-24	WOS:000297285600041
J	Li, Z; Tuteja, G; Schug, J; Kaestner, KH				Li, Zhaoyu; Tuteja, Geetu; Schug, Jonathan; Kaestner, Klaus H.			Foxa1 and Foxa2 Are Essential for Sexual Dimorphism in Liver Cancer	CELL			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; NUCLEAR FACTOR 3-GAMMA; TRANSCRIPTION FACTORS; GLUCOSE-HOMEOSTASIS; ANDROGEN RECEPTOR; IN-VIVO; HEPATOCYTE; ESTROGEN; GENES; MICE	Hepatocellular carcinoma (HCC) is sexually dimorphic in both rodents and humans, with significantly higher incidence in males, an effect that is dependent on sex hormones. The molecular mechanisms by which estrogens prevent and androgens promote liver cancer remain unclear. Here, we discover that sexually dimorphic HCC is completely reversed in Foxa1- and Foxa2-deficient mice after diethylnitrosamine-induced hepatocarcinogenesis. Coregulation of target genes by Foxa1/a2 and either the estrogen receptor (ER alpha) or the androgen receptor (AR) was increased during hepatocarcinogenesis in normal female or male mice, respectively, but was lost in Foxa1/2-deficient mice. Thus, both estrogen-dependent resistance to and androgen-mediated facilitation of HCC depend on Foxa1/2. Strikingly, single nucleotide polymorphisms at FOXA2 binding sites reduce binding of both FOXA2 and ER alpha to their targets in human liver and correlate with HCC development in women. Thus, Foxa factors and their targets are central for the sexual dimorphismof HCC.	[Kaestner, Klaus H.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Kaestner, KH (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	kaestner@mail.med.upenn.edu		Li, Zhaoyu/0000-0002-1136-2758	NIDDK [P01-DK049210]; NSREC; JDRF; University of Pennsylvania Diabetes and Endocrinology Center (DERC) [P30-DK19525]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, R01DK055342, P30DK019525] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NSREC; JDRF(Juvenile Diabetes Research Foundation); University of Pennsylvania Diabetes and Endocrinology Center (DERC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Jeff Albrecht, Linda Greenbaum, and Snorri Thorgeirsson for valuable comments on the manuscript. We acknowledge Alan Fox, Olga Smirnova, Karrie Brondell, Amber Riblett, James LaRossa, and Reina Aoki for their excellent technical support. We also thank Dr. Erik Knudsen for sharing his hepatocarcinogenesis protocol. This study was supported by the NIDDK (P01-DK049210 to KHK). Z.L. was supported by NSREC and JDRF postdoctoral fellowship awards. We thank the University of Pennsylvania Diabetes and Endocrinology Center (DERC) for the use of the Functional Genomics Core (P30-DK19525).	Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Di Maio M, 2006, ANN NY ACAD SCI, V1089, P252, DOI 10.1196/annals.1386.007; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Genazzani AR, 2007, HUM REPROD UPDATE, V13, P175, DOI 10.1093/humupd/dml042; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hollingsworth AB, 1998, BREAST CANCER RES TR, V47, P63, DOI 10.1023/A:1005872132373; Kaestner KH, 2005, CELL CYCLE, V4, P1146, DOI 10.4161/cc.4.9.2033; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kaestner KH, 1998, MOL CELL BIOL, V18, P4245, DOI 10.1128/MCB.18.7.4245; Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005; Kalra M, 2008, WORLD J GASTROENTERO, V14, P5945, DOI 10.3748/wjg.14.5945; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Lawrence T, 2007, SCIENCE, V317, P51, DOI 10.1126/science.1146052; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Li ZY, 2009, J CLIN INVEST, V119, P1537, DOI 10.1172/JCI38201; Liu ZL, 2008, BIOCHEM BIOPH RES CO, V365, P729, DOI 10.1016/j.bbrc.2007.11.069; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Ma CL, 2008, GASTROENTEROLOGY, V135, P947, DOI 10.1053/j.gastro.2008.05.046; Ma WL, 2008, GASTROENTEROLOGY, V135, P1805; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Oliver JD, 2002, PHARMACOL TOXICOL, V91, P1, DOI 10.1034/j.1600-0773.2002.910101.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PAULSON DF, 1984, ANNU REV MED, V35, P341, DOI 10.1146/annurev.me.35.020184.002013; Qatanani M, 2005, CURR DRUG METAB, V6, P329, DOI 10.2174/1389200054633899; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Rubins NE, 2005, MOL CELL BIOL, V25, P7069, DOI 10.1128/MCB.25.16.7069-7077.2005; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Shen W, 2001, J BIOL CHEM, V276, P42812, DOI 10.1074/jbc.M106344200; Shimizu I, 1998, GUT, V42, P112, DOI 10.1136/gut.42.1.112; SMOLEV JK, 1977, J UROLOGY, V118, P216, DOI 10.1016/S0022-5347(17)57949-5; Stice JP, 2009, FUTUR CARDIOL, V5, P93, DOI 10.2217/14796678.5.1.93; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; Thean LF, 2010, GENE CHROMOSOME CANC, V49, P99, DOI 10.1002/gcc.20724; TSUTSUI S, 1992, VIRCHOWS ARCH B, V62, P371, DOI 10.1007/BF02899706; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuteja G, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp536; Vlaming MLH, 2006, J PHARMACOL EXP THER, V318, P319, DOI 10.1124/jpet.106.101774; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Yager JD, 1996, ANNU REV PHARMACOL, V36, P203, DOI 10.1146/annurev.pa.36.040196.001223; Yamamoto R., 1991, INT J CANCER, V49, P83; Yu XP, 2005, ANN NY ACAD SCI, V1061, P77, DOI 10.1196/annals.1336.009; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zumoff B, 1998, P SOC EXP BIOL MED, V217, P30	51	256	265	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					72	83		10.1016/j.cell.2011.11.026	http://dx.doi.org/10.1016/j.cell.2011.11.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265403	Green Accepted, Bronze			2022-12-24	WOS:000299540700015
J	Finnigan, GC; Hanson-Smith, V; Stevens, TH; Thornton, JW				Finnigan, Gregory C.; Hanson-Smith, Victor; Stevens, Tom H.; Thornton, Joseph W.			Evolution of increased complexity in a molecular machine	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MEMBRANE H+-ATPASE; VACUOLAR; GENE; SUBUNIT; ACIDIFICATION; ALGORITHM; ROTATION; ACCURATE; ORIGIN	Many cellular processes are carried out by molecular 'machines'-assemblies of multiple differentiated proteins that physically interact to execute biological functions(1-8). Despite much speculation, strong evidence of the mechanisms by which these assemblies evolved is lacking. Here we use ancestral gene resurrection(9-11) and manipulative genetic experiments to determine how the complexity of an essential molecular machine-the hexameric transmembrane ring of the eukaryotic V-ATPase proton pump-increased hundreds of millions of years ago. We show that the ring of Fungi, which is composed of three paralogous proteins, evolved from a more ancient two-paralogue complex because of a gene duplication that was followed by loss in each daughter copy of specific interfaces by which it interacts with other ring proteins. These losses were complementary, so both copies became obligate components with restricted spatial roles in the complex. Reintroducing a single historical mutation from each paralogue lineage into the resurrected ancestral proteins is sufficient to recapitulate their asymmetric degeneration and trigger the requirement for the more elaborate three-component ring. Our experiments show that increased complexity in an essential molecular machine evolved because of simple, high-probability evolutionary processes, without the apparent evolution of novel functions. They point to a plausible mechanism for the evolution of complexity in other multi-paralogue protein complexes.	[Hanson-Smith, Victor; Thornton, Joseph W.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Finnigan, Gregory C.; Stevens, Tom H.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Hanson-Smith, Victor] Univ Oregon, Dept Comp & Informat Sci, Eugene, OR 97403 USA; [Thornton, Joseph W.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA; [Thornton, Joseph W.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Thornton, Joseph W.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Oregon; University of Oregon; University of Oregon; Howard Hughes Medical Institute; University of Oregon; University of Chicago; University of Chicago	Thornton, JW (corresponding author), Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA.	joet@uoregon.edu	Thornton, Joseph/GSN-4190-2022	Finnigan, Gregory/0000-0002-5710-173X; Stevens, Tom/0000-0001-6427-6848	National Institutes of Health (NIH) [R01-GM081592, R01-GM38006, T32-GM007257]; National Science Foundation (NSF) [IOB-0546906, DEB-0516530]; NSF IGERT [DGE-9972830]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038006, T32GM007257, R01GM081592] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF IGERT(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health (NIH) grants R01-GM081592 (to J.W.T.) and R01-GM38006 (to T. H. S.), National Science Foundation (NSF) grants IOB-0546906 (to J.W.T.) and DEB-0516530 (to J.W.T.), NIH Genetics Training grant T32-GM007257 (to G. C. F.), NSF IGERT grant DGE-9972830 (to V.H.-S.) and the Howard Hughes Medical Institute (J.W.T.). We thank L. Graham, G. Butler and B. Houser for generating yeast strains and other assistance. We thank members of the Stevens and Thornton laboratories for helpful comments.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Archibald JM, 2000, MOL BIOL EVOL, V17, P1456, DOI 10.1093/oxfordjournals.molbev.a026246; Clements A, 2009, P NATL ACAD SCI USA, V106, P15791, DOI 10.1073/pnas.0908264106; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Fletcher W, 2009, MOL BIOL EVOL, V26, P1879, DOI 10.1093/molbev/msp098; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Hietpas RT, 2011, P NATL ACAD SCI USA, V108, P7896, DOI 10.1073/pnas.1016024108; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Liberles DA., 2007, ANCESTRAL SEQUENCE R; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Ohno S., 1970, EVOLUTION GENE DUPLI; Pallen MJ, 2006, NAT REV MICROBIOL, V4, P784, DOI 10.1038/nrmicro1493; Pereira-Leal JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r51; Perez-Sayans M, 2009, CANCER TREAT REV, V35, P707, DOI 10.1016/j.ctrv.2009.08.003; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Ryan M, 2008, MOL BIOL CELL, V19, P5131, DOI 10.1091/mbc.E08-06-0629; Sambrook J, 2001, MOL CLONING LAB MANU; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; UMEMOTO N, 1991, J BIOL CHEM, V266, P24526; UMEMOTO N, 1990, J BIOL CHEM, V265, P18447; Wang Y, 2007, J BIOL CHEM, V282, P34058, DOI 10.1074/jbc.M704331200; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	47	134	135	2	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					360	U143		10.1038/nature10724	http://dx.doi.org/10.1038/nature10724			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22230956	Green Accepted			2022-12-24	WOS:000299210600042
J	Kang, KJ; Panzano, VC; Chang, EC; Ni, LN; Dainis, AM; Jenkins, AM; Regna, K; Muskavitch, MAT; Garrity, PA				Kang, Kyeongjin; Panzano, Vincent C.; Chang, Elaine C.; Ni, Lina; Dainis, Alexandra M.; Jenkins, Adam M.; Regna, Kimberly; Muskavitch, Marc A. T.; Garrity, Paul A.			Modulation of TRPA1 thermal sensitivity enables sensory discrimination in Drosophila	NATURE			English	Article							ION CHANNELS; HEAT ACTIVATION; TEMPERATURE; RECEPTOR; THERMODYNAMICS; CAPSAICIN; SENSATION; REVEALS; TRPV1B; TASTE	Discriminating among sensory stimuli is critical for animal survival. This discrimination is particularly essential when evaluating whether a stimulus is noxious or innocuous. From insects to humans, transient receptor potential (TRP) channels are key transducers of thermal, chemical and other sensory cues(1,2). Many TRPs are multimodal receptors that respond to diverse stimuli(1-3), but how animals distinguish sensory inputs activating the same TRP is largely unknown. Here we determine how stimuli activating Drosophila TRPA1 are discriminated. Although Drosophila TRPA1 responds to both noxious chemicals(4) and innocuous warming(5), we find that TRPA1-expressing chemosensory neurons respond to chemicals but not warmth, a specificity conferred by a chemosensory-specific TRPA1 isoform with reduced thermosensitivity compared to the previously described isoform. At the molecular level, this reduction results from a unique region that robustly reduces the channel's thermosensitivity. Cell-type segregation of TRPA1 activity is critical: when the thermosensory isoform is expressed in chemosensors, flies respond to innocuous warming with regurgitation, a nocifensive response. TRPA1 isoform diversity is conserved in malaria mosquitoes, indicating that similar mechanisms may allow discrimination of host-derived warmth-an attractant-from chemical repellents. These findings indicate that reducing thermosensitivity can be critical for TRP channel functional diversification, facilitating their use in contexts in which thermal sensitivity can be maladaptive.	[Kang, Kyeongjin; Panzano, Vincent C.; Chang, Elaine C.; Ni, Lina; Dainis, Alexandra M.; Garrity, Paul A.] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Kang, Kyeongjin; Panzano, Vincent C.; Chang, Elaine C.; Ni, Lina; Dainis, Alexandra M.; Garrity, Paul A.] Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA; [Jenkins, Adam M.; Regna, Kimberly; Muskavitch, Marc A. T.] Boston Coll, Dept Biol, Newton, MA 02467 USA; [Muskavitch, Marc A. T.] Broad Inst, Cambridge, MA 02142 USA; [Muskavitch, Marc A. T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Brandeis University; Brandeis University; Boston College; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health	Garrity, PA (corresponding author), Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02454 USA.	pgarrity@brandeis.edu		Garrity, Paul/0000-0002-8274-6564; Kang, KyeongJin/0000-0003-0446-469X	National Science Foundation [IOS-1025307]; National Institute of Mental Health [EUREKA R01 MH094721]; National Institute of Neurological Disorders and Stroke (NINDS) [PO1 NS044232, F31 NS071897-02]; Boston College; Division Of Integrative Organismal Systems [1025307] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232, F31NS071897] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Boston College; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the P. A. G. laboratory, H. Garrity, L. Griffith, L. Huang, J. Rodriguez and M. Rosbash for helpful comments, and F. Marion-Poll and A. Dahanukar for guidance with tip-recording. This work was supported by grants from the National Science Foundation (IOS-1025307), National Institute of Mental Health (EUREKA R01 MH094721) and National Institute of Neurological Disorders and Stroke (NINDS) (PO1 NS044232) to P. A. G., a National Research Service Award from NINDS to V. C. P. (F31 NS071897-02) and the Boston College DeLuca Professorship to M.A.T.M.	Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; COHET Y, 1975, EXP GERONTOL, V10, P181, DOI 10.1016/0531-5565(75)90029-7; Daniels RL, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-23; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Lu G, 2005, MOL PHARMACOL, V67, P1119, DOI 10.1124/mol.104.009852; Maekawa E, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-10; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Uchida K, 2011, ENDOCR J, V58, P1021, DOI 10.1507/endocrj.EJ11-0130; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Vos MH, 2006, J NEUROCHEM, V99, P1088, DOI 10.1111/j.1471-4159.2006.04145.x; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; WIECZOREK H, 1989, J COMP PHYSIOL A, V164, P825, DOI 10.1007/BF00616754; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108	33	147	151	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2012	481	7379					76	U82		10.1038/nature10715	http://dx.doi.org/10.1038/nature10715			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22139422	Green Accepted			2022-12-24	WOS:000298836900032
J	Singh-Manoux, A; Kivimaki, M; Glymour, MM; Elbaz, A; Berr, C; Ebmeier, KP; Ferrie, JE; Dugravot, A				Singh-Manoux, Archana; Kivimaki, Mika; Glymour, M. Maria; Elbaz, Alexis; Berr, Claudine; Ebmeier, Klaus P.; Ferrie, Jane E.; Dugravot, Aline			Timing of onset of cognitive decline: results from Whitehall II prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							ALZHEIMERS-DISEASE; MIDDLE-AGE; LIFE; POPULATION; DEMENTIA; HEALTH; ADULTS	Objectives To estimate 10 year decline in cognitive function from longitudinal data in a middle aged cohort and to examine whether age cohorts can be compared with cross sectional data to infer the effect of age on cognitive decline. Design Prospective cohort study. At study inception in 1985-8, there were 10 308 participants, representing a recruitment rate of 73%. Setting Civil service departments in London, United Kingdom. Participants 5198 men and 2192 women, aged 45-70 at the beginning of cognitive testing in 1997-9. Main outcome measure Tests of memory, reasoning, vocabulary, and phonemic and semantic fluency, assessed three times over 10 years. Results All cognitive scores, except vocabulary, declined in all five age categories (age 45-49, 50-54, 55-59, 60-64, and 65-70 at baseline), with evidence of faster decline in older people. In men, the 10 year decline, shown as change/range of testx100, in reasoning was -3.6% (95% confidence interval -4.1% to -3.0%) in those aged 45-49 at baseline and -9.6% (-10.6% to -8.6%) in those aged 65-70. In women, the corresponding decline was -3.6% (-4.6% to -2.7%) and -7.4% (-9.1% to -5.7%). Comparisons of longitudinal and cross sectional effects of age suggest that the latter overestimate decline in women because of cohort differences in education. For example, in women aged 45-49 the longitudinal analysis showed reasoning to have declined by -3.6% (-4.5% to -2.8%) but the cross sectional effects suggested a decline of -11.4% (-14.0% to -8.9%). Conclusions Cognitive decline is already evident in middle age (age 45-49).	[Singh-Manoux, Archana; Dugravot, Aline] Hop Paul Brousse, INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, F-94807 Villejuif, France; [Singh-Manoux, Archana; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Glymour, M. Maria] Harvard Univ, Sch Med, Dept Soc Human Dev & Hlth, Boston, MA USA; [Elbaz, Alexis] INSERM, U708, F-75013 Paris, France; [Elbaz, Alexis] Univ Paris 06, UPMC, UMR S708, F-75005 Paris, France; [Berr, Claudine] Univ Montpellier 1, INSERM, U1061, Montpellier, France; [Berr, Claudine] CHU Montpellier, CMRR Languedoc Roussillon, Montpellier, France; [Ebmeier, Klaus P.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Ferrie, Jane E.] Univ Bristol, Bristol, Avon, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Oxford; University of Bristol	Singh-Manoux, A (corresponding author), Hop Paul Brousse, INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Bat 15-16,16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	Archana.Singh-Manoux@inserm.fr	Ferrie, Jane/AAZ-2009-2020; Ebmeier, Klaus Peter/B-4789-2008; Singh-Manoux, Archana/F-6804-2013; berr, Claudine/D-5238-2014; Elbaz, Alexis/F-8952-2017; Kivimaki, Mika/B-3607-2012	Ebmeier, Klaus Peter/0000-0002-5190-7038; Singh-Manoux, Archana/0000-0002-1244-5037; berr, Claudine/0000-0001-5254-7655; Elbaz, Alexis/0000-0001-9724-5490; Kivimaki, Mika/0000-0002-4699-5627; Dugravot, Aline/0000-0002-4546-0970	European Science Foundation; National Institute on Aging, NIH [R01AG013196, R01AG034454]; BUPA Foundation; National Institutes of Health [R01AG034454, R01HL036310]; Academy of Finland; British Medical Research Council [G0902037]; British Heart Foundation; MRC [G0902037, G1001354] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0100222, G0902037, G8802774, G1001354, G19/35] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R01AG034454] Funding Source: NIH RePORTER	European Science Foundation(European Science Foundation (ESF)European Commission); National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BUPA Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	ASM is supported by a European Young Investigator Award from the European Science Foundation and the National Institute on Aging, NIH (R01AG013196 [PI]; R01AG034454 [PI]). MK is supported by the BUPA Foundation, the National Institutes of Health (R01HL036310 [PI]; R01AG034454 [PI]) and the Academy of Finland. The Whitehall II study is also supported by a grant from the British Medical Research Council (G0902037) and the British Heart Foundation. The funding bodies had no role in the study design, the collection, analysis and interpretation of data, the writing, and the decision to submit the paper.	Alzheimer's Disease International, 2009, WORLD ALZH REP; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Dickens WT, 2001, PSYCHOL REV, V108, P346, DOI 10.1037/0033-295X.108.2.346; Duyckaerts C, 1997, NEUROBIOL AGING, V18, P362, DOI 10.1016/S0197-4580(97)00047-X; Euser SM, 2008, EPIDEMIOLOGY, V19, P440, DOI 10.1097/EDE.0b013e31816a1d31; Finch CE, 2009, NEUROBIOL AGING, V30, P515, DOI 10.1016/j.neurobiolaging.2008.11.011; FINCH CE, 1991, NEUROBIOL AGING, V12, P1, DOI 10.1016/0197-4580(91)90031-E; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goldin C, 1998, J ECON HIST, V58, P345, DOI 10.1017/S0022050700020544; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Heim A.W., 1970, AH 4 GROUP TEST GEN; HOLLAND CA, 1991, REV CLIN GERONTOLOGY, V1, P81, DOI DOI 10.1017/S0959259800002598; Johnson DK, 2009, ARCH NEUROL-CHICAGO, V66, P1254, DOI 10.1001/archneurol.2009.158; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Launer LJ, 2005, NEUROBIOL AGING, V26, P335, DOI 10.1016/j.neurobiolaging.2004.03.016; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Nilsson LG, 2009, NEUROBIOL AGING, V30, P521, DOI 10.1016/j.neurobiolaging.2008.11.013; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Rabbitt P, 2001, NEUROPSYCHOLOGIA, V39, P532, DOI 10.1016/S0028-3932(00)00099-3; Raven J.C., 1958, GUIDE USING MILL HIL; Richards M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4670; RYDER NB, 1965, AM SOCIOL REV, V30, P843, DOI 10.2307/2090964; Salthouse TA, 2004, DEV PSYCHOL, V40, P813, DOI 10.1037/0012-1649.40.5.813; Salthouse TA, 2010, NEUROPSYCHOLOGY, V24, P563, DOI 10.1037/a0019026; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; SCHAIE KW, 1974, DEV PSYCHOL, V10, P305, DOI 10.1037/h0036445; SCHAIE KW, 1994, AM PSYCHOL, V49, P304, DOI 10.1037/0003-066X.49.4.304; United Nations Educational SaCOU, 2000, WORLD ED REP 2000; Viswanathan A, 2009, NEUROLOGY, V72, P368, DOI 10.1212/01.wnl.0000341271.90478.8e; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; Wilson RS, 2010, NEUROLOGY, V75, P1070, DOI 10.1212/WNL.0b013e3181f39adc; Zelinski EM, 1997, PSYCHOL AGING, V12, P503, DOI 10.1037/0882-7974.12.3.503	37	442	455	1	53	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 5	2012	344								d7622	10.1136/bmj.d7622	http://dx.doi.org/10.1136/bmj.d7622			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874UH	22223828	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000298983100002
J	Hung, RJ; Pak, CW; Terman, JR				Hung, Ruei-Jiun; Pak, Chi W.; Terman, Jonathan R.			Direct Redox Regulation of F-Actin Assembly and Disassembly by Mical	SCIENCE			English	Article							METHIONINE OXIDATION; PROTEINS	Different types of cell behavior, including growth, motility, and navigation, require actin proteins to assemble into filaments. Here, we describe a biochemical process that was able to disassemble actin filaments and limit their reassembly. Actin was a specific substrate of the multidomain oxidation-reduction enzyme, Mical, a poorly understood actin disassembly factor that directly responds to Semaphorin/Plexin extracellular repulsive cues. Actin filament subunits were directly modified by Mical on their conserved pointed-end, which is critical for filament assembly. Mical posttranslationally oxidized the methionine 44 residue within the D-loop of actin, simultaneously severing filaments and decreasing polymerization. This mechanism underlying actin cytoskeletal collapse may have broad physiological and pathological ramifications.	[Hung, Ruei-Jiun; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Hung, Ruei-Jiun; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Hung, Ruei-Jiun; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Grad Program Neurosci, Dallas, TX 75390 USA; [Pak, Chi W.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Terman, JR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	jonathan.terman@utsouthwestern.edu			Cancer Prevention Research Institute of Texas (CPRIT); NIH [DK091074, NS073968]; Welch Foundation [I-1749]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK091074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073968] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas (CPRIT); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Brown, C. Cowan, H. Kramer, M. Rosen, and Terman lab members for assistance. Mass spectrometry was performed by Y. Li (University of Texas Southwestern Protein Chemistry Technology Center). We also thank Z. Chen, Y.-C. Kuo, K. Luby-Phelps, J. Merriam, H. Oda, V. Verkhusha, S. Weintraub, and Bloomington and Japanese Stock Centers. This work was supported by Cancer Prevention Research Institute of Texas (CPRIT) predoctoral (R.-J.H), NIH (DK091074) postdoctoral (C. W. P.), and NIH (NS073968) and Welch Foundation (I-1749) (J. R. T) grants. The data are presented in the figures and supporting online material.	BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; Dalle-Donne I, 2002, FREE RADICAL BIO MED, V32, P927, DOI 10.1016/S0891-5849(02)00799-2; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Guan JQ, 2005, BIOCHEMISTRY-US, V44, P3166, DOI 10.1021/bi048021j; Guan JQ, 2003, BIOCHEMISTRY-US, V42, P11992, DOI 10.1021/bi034914k; Hoshi T, 2001, J PHYSIOL-LONDON, V531, P1, DOI 10.1111/j.1469-7793.2001.0001j.x; Hung RJ, 2011, CYTOSKELETON, V68, P415, DOI 10.1002/cm.20527; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Sheterline P, 1998, ACTIN; Takamoto K, 2007, STRUCTURE, V15, P39, DOI 10.1016/j.str.2006.11.005; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; van Berkel WJH, 1999, METH MOL B, V131, P61	20	218	229	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1710	1713		10.1126/science.1211956	http://dx.doi.org/10.1126/science.1211956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22116028	Green Accepted			2022-12-24	WOS:000298344000069
J	Li, LS; Rutlin, M; Abraira, VE; Cassidy, C; Kus, L; Gong, SC; Jankowski, MP; Luo, WQ; Heintz, N; Koerber, HR; Woodbury, CJ; Ginty, DD				Li, Lishi; Rutlin, Michael; Abraira, Victoria E.; Cassidy, Colleen; Kus, Laura; Gong, Shiaoching; Jankowski, Michael P.; Luo, Wenqin; Heintz, Nathaniel; Koerber, H. Richard; Woodbury, C. Jeffery; Ginty, David D.			The Functional Organization of Cutaneous Low-Threshold Mechanosensory Neurons	CELL			English	Article							DORSAL COLUMN PATHWAY; TYROSINE PROTEIN-KINASE; SOMATOTOPIC ORGANIZATION; NERVE PROJECTIONS; GANGLION NEURONS; SENSORY NEURONS; AFFERENT-FIBERS; HAIRY SKIN; MECHANORECEPTORS; MOUSE	Innocuous touch of the skin is detected by distinct populations of neurons, the low-threshold mechano-receptors (LTMRs), which are classified as A beta-, A delta-, and C-LTMRs. Here, we report genetic labeling of LTMR subtypes and visualization of their relative patterns of axonal endings in hairy skin and the spinal cord. We found that each of the three major hair follicle types of trunk hairy skin (guard, awl/auchene, and zigzag hairs) is innervated by a unique and invariant combination of LTMRs; thus, each hair follicle type is a functionally distinct mechanosensory end organ. Moreover, the central projections of A beta-, A delta-, and C-LTMRs that innervate the same or adjacent hair follicles form narrow LTMR columns in the dorsal horn. These findings support a model of mechanosensation in which the activities of A beta-, A delta-, and C-LTMRs are integrated within dorsal horn LTMR columns and processed into outputs that underlie the perception of myriad touch sensations.	[Li, Lishi; Rutlin, Michael; Abraira, Victoria E.; Luo, Wenqin; Ginty, David D.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Li, Lishi; Rutlin, Michael; Abraira, Victoria E.; Luo, Wenqin; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Cassidy, Colleen; Woodbury, C. Jeffery] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Kus, Laura; Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, Lab Biochem & Mol Biol, Howard Hughes Med Inst, New York, NY 10065 USA; [Jankowski, Michael P.; Koerber, H. Richard] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15213 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of Wyoming; Howard Hughes Medical Institute; Rockefeller University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu			NIH [NS023725, NS052848, N01 NS-7-2370, NS34814]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052848, R01NS023725, R01NS034814, R29NS034814, R01NS044094, R56NS023725, R37NS034814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Michael Caterina, Xinzhong Dong, Ting Guo, Anthony Harrington, Steven Hsiao, Alex Kolodkin, Frank Rice, Kevin Wright, and members of the Ginty laboratory for discussions and comments on this study, Dori Reimert for help with generation of the TrkB<SUP>tauEGFP</SUP> mouse line, and Jeremy Nathans for providing TH<SUP>CreER</SUP> and Rosa26<SUP>IAP</SUP> animals. We thank K.C. Kent Lloyd and the Mutant Mouse Regional Resource Center at University of California, Davis, for help obtaining mouse lines. This work was supported by NIH grants NS023725 and NS052848 (H.R.K.), NS44094 (C.J.W.), N01 NS-7-2370 (N.H.), NS34814 (D.D.G.), and The Johns Hopkins NINDS core imaging facility MH084020 (D.D.G.). N.H. and D.D.G. are investigators of the Howard Hughes Medical Institute.	Albrecht P., 2008, SENSES COMPREHENSIVE, V6, P1, DOI 10.1016/B978-012370880-9.00340-6; Badea TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007859; BESSOU P, 1971, J NEUROPHYSIOL, V34, P116, DOI 10.1152/jn.1971.34.1.116; Brown, 1981, ORG SPINAL CORD ANAT; BROWN AG, 1981, PROG NEUROBIOL, V17, P59, DOI 10.1016/0301-0082(81)90004-6; BROWN AG, 1969, EXP BRAIN RES, V7, P231; BROWN AG, 1967, J PHYSIOL-LONDON, V193, P707, DOI 10.1113/jphysiol.1967.sp008390; BROWN AG, 1987, J PHYSIOL-LONDON, V382, P331, DOI 10.1113/jphysiol.1987.sp016370; BROWN PB, 1975, J NEUROPHYSIOL, V38, P1; BROWN PB, 1989, SOMATOSENS MOT RES, V6, P309, DOI 10.3109/08990228909144679; Brumovsky P, 2006, J CHEM NEUROANAT, V31, P243, DOI 10.1016/j.jchemneu.2006.02.001; BURGESS PR, 1968, J NEUROPHYSIOL, V31, P833, DOI 10.1152/jn.1968.31.6.833; CLIFFER KD, 1989, J NEUROSCI, V9, P3146; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; DOUGLAS WW, 1960, J PHYSIOL-LONDON, V150, P266, DOI 10.1113/jphysiol.1960.sp006386; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; GIESLER GJ, 1985, BRAIN RES, V326, P347, DOI 10.1016/0006-8993(85)90044-7; GIESLER GJ, 1984, J NEUROPHYSIOL, V51, P260, DOI 10.1152/jn.1984.51.2.260; GIUFFRIDA R, 1992, J COMP NEUROL, V316, P206, DOI 10.1002/cne.903160206; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HORCH KW, 1977, J INVEST DERMATOL, V69, P75, DOI 10.1111/1523-1747.ep12497887; IGGO A, 1960, J PHYSIOL-LONDON, V152, P337, DOI 10.1113/jphysiol.1960.sp006491; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; IGGO A, 1982, ANNU REV NEUROSCI, V5, P1, DOI 10.1146/annurev.ne.05.030182.000245; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.ne.15.030192.001303; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KOERBER HR, 1982, J NEUROPHYSIOL, V48, P481, DOI 10.1152/jn.1982.48.2.481; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KUMAZAWA T, 1977, J NEUROPHYSIOL, V40, P1325, DOI 10.1152/jn.1977.40.6.1325; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McIlwrath SL, 2007, EUR J NEUROSCI, V26, P1801, DOI 10.1111/j.1460-9568.2007.05821.x; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Olausson H, 2010, NEUROSCI BIOBEHAV R, V34, P185, DOI 10.1016/j.neubiorev.2008.09.011; Rotolo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004099; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Stucky CL, 1998, J NEUROSCI, V18, P7040; Takahashi-Iwanaga H, 2000, J COMP NEUROL, V426, P259, DOI 10.1002/1096-9861(20001016)426:2<259::AID-CNE7>3.0.CO;2-N; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; VIELKIND U, 1995, ACTA ANAT, V152, P93; Wellnitz SA, 2010, J NEUROPHYSIOL, V103, P3378, DOI 10.1152/jn.00810.2009; Woodbury CJ, 2007, J COMP NEUROL, V505, P547, DOI 10.1002/cne.21517; Woodbury CJ, 2001, J COMP NEUROL, V436, P304; WOOLF CJ, 1986, J COMP NEUROL, V251, P517, DOI 10.1002/cne.902510407; Zotterman Y, 1939, J PHYSIOL-LONDON, V95, P1	47	424	432	1	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2011	147	7					1615	1627		10.1016/j.cell.2011.11.027	http://dx.doi.org/10.1016/j.cell.2011.11.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196735	Bronze, Green Accepted			2022-12-24	WOS:000298403400024
J	Stadler, MB; Murr, R; Burger, L; Ivanek, R; Lienert, F; Scholer, A; Wirbelauer, C; Oakeley, EJ; Gaidatzis, D; Tiwari, VK; Schubeler, D				Stadler, Michael B.; Murr, Rabih; Burger, Lukas; Ivanek, Robert; Lienert, Florian; Schoeler, Anne; Wirbelauer, Christiane; Oakeley, Edward J.; Gaidatzis, Dimos; Tiwari, Vijay K.; Schuebeler, Dirk			DNA-binding factors shape the mouse methylome at distal regulatory regions	NATURE			English	Article							EMBRYONIC STEM-CELLS; HUMAN GENOME; HYPERSENSITIVE SITES; TRANSCRIPTION FACTOR; CHROMATIN-STRUCTURE; METHYLATION CHANGES; GENE-REGULATION; IDENTIFICATION; ENHANCER; DEMETHYLATION	Methylation of cytosines is an essential epigenetic modification in mammalian genomes, yet the rules that govern methylation patterns remain largely elusive. To gain insights into this process, we generated base-pair-resolution mouse methylomes in stem cells and neuronal progenitors. Advanced quantitative analysis identified low-methylated regions (LMRs) with an average methylation of 30%. These represent CpG-poor distal regulatory regions as evidenced by location, DNase I hypersensitivity, presence of enhancer chromatin marks and enhancer activity in reporter assays. LMRs are occupied by DNA-binding factors and their binding is necessary and sufficient to create LMRs. A comparison of neuronal and stem-cell methylomes confirms this dependency, as cell-type-specific LMRs are occupied by cell-type-specific transcription factors. This study provides methylome references for the mouse and shows that DNA-binding factors locally influence DNA methylation, enabling the identification of active regulatory regions.	[Stadler, Michael B.; Murr, Rabih; Burger, Lukas; Ivanek, Robert; Lienert, Florian; Schoeler, Anne; Wirbelauer, Christiane; Gaidatzis, Dimos; Tiwari, Vijay K.; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Stadler, Michael B.; Burger, Lukas; Schoeler, Anne; Gaidatzis, Dimos] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland; [Lienert, Florian; Schoeler, Anne; Schuebeler, Dirk] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland; [Oakeley, Edward J.] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Swiss Institute of Bioinformatics; University of Basel; Novartis	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	dirk@fmi.ch	Ivanek, Robert/A-8852-2008	Tiwari, Vijay/0000-0003-0292-6635; van Nimwegen, Erik/0000-0001-6338-1312; Murr, Rabih/0000-0002-3346-6590; Ivanek, Robert/0000-0002-8403-056X; Scholer, Anne/0000-0001-6354-1689	EMBO; Marie Curie International Incoming fellowship; Novartis Research Foundation; European Union (NoE) [FP7-HEALTH-2010-257082]; European Research Council (ERC EpiGePlas); SNF; Swiss initiative in Systems Biology	EMBO(European Molecular Biology Organization (EMBO)); Marie Curie International Incoming fellowship(European Commission); Novartis Research Foundation; European Union (NoE)(European Commission); European Research Council (ERC EpiGePlas)(European Research Council (ERC)); SNF; Swiss initiative in Systems Biology	The authors thank A. Fernandez, C. Kohler, V. Petitjean and F. Staedtler (Novartis) and I. Nissen and C. Beisel (ETH-BSSE) for performing next generation sequencing experiments. R. Lister and J. Ecker for technical advice on BisSeq library generation. D. Schmitz for the pcDNA6-IRES-Blasticidin vector. D. Anderson for the REST antibody. H. Jorgensen for REST cds. L. Hoerner for help in Sanger bisulphite sequencing. M. Lorincz, N. Thoma and members of the Schubeler laboratory for feedback on the manuscript. R. M. is supported by an EMBO long-term postdoctoral fellowship. V. K. T. is supported by a Marie Curie International Incoming fellowship and an EMBO long-term postdoctoral fellowship. Research in the laboratory of D. S. is supported by the Novartis Research Foundation, the European Union (NoE "EpiGeneSys" FP7-HEALTH-2010-257082), the European Research Council (ERC EpiGePlas), the SNF Sinergia program and the Swiss initiative in Systems Biology (Cell Plasticity).	Abbott A, 2011, NATURE, V477, P518, DOI 10.1038/477518a; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Boyle AP, 2009, EPIGENOMICS-UK, V1, P319, DOI 10.2217/epi.09.29; Brunk BP, 1996, DEV BIOL, V177, P490, DOI 10.1006/dbio.1996.0180; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cohen NM, 2009, GENOME RES, V19, P2193, DOI 10.1101/gr.096685.109; Colaneri A, 2011, P NATL ACAD SCI USA, V108, P9715, DOI 10.1073/pnas.1105713108; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROUDINE M, 1985, SCIENCE, V228, P1061, DOI 10.1126/science.2986289; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jorgensen HF, 2009, NATURE, V457, pE4, DOI 10.1038/nature07783; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kinoshita K, 2007, BIOCHEM BIOPH RES CO, V353, P686, DOI 10.1016/j.bbrc.2006.12.071; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mares J, 2001, CANCER LETT, V166, P165, DOI 10.1016/S0304-3835(01)00402-5; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ohlsson R, 2010, CHROMOSOMA, V119, P351, DOI 10.1007/s00412-010-0262-0; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Satterlee JS, 2010, NAT BIOTECHNOL, V28, P1039, DOI 10.1038/nbt1010-1039; SHARRARD RM, 1992, BRIT J CANCER, V65, P667, DOI 10.1038/bjc.1992.142; Sohn J, 2006, J NEUROSCI, V26, P9722, DOI 10.1523/JNEUROSCI.1716-06.2006; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Tagoh H, 2004, BLOOD, V103, P2950, DOI 10.1182/blood-2003-09-3323; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934	50	920	950	6	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					490	495		10.1038/nature10716	http://dx.doi.org/10.1038/nature10716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22170606				2022-12-24	WOS:000298318000053
J	Bharti, N; Tatem, AJ; Ferrari, MJ; Grais, RF; Djibo, A; Grenfell, BT				Bharti, N.; Tatem, A. J.; Ferrari, M. J.; Grais, R. F.; Djibo, A.; Grenfell, B. T.			Explaining Seasonal Fluctuations of Measles in Niger Using Nighttime Lights Imagery	SCIENCE			English	Article							TRANSMISSION; DYNAMICS; EPIDEMIC	Measles epidemics in West Africa cause a significant proportion of vaccine-preventable childhood mortality. Epidemics are strongly seasonal, but the drivers of these fluctuations are poorly understood, which limits the predictability of outbreaks and the dynamic response to immunization. We show that measles seasonality can be explained by spatiotemporal changes in population density, which we measure by quantifying anthropogenic light from satellite imagery. We find that measles transmission and population density are highly correlated for three cities in Niger. With dynamic epidemic models, we demonstrate that measures of population density are essential for predicting epidemic progression at the city level and improving intervention strategies. In addition to epidemiological applications, the ability to measure fine-scale changes in population density has implications for public health, crisis management, and economic development.	[Bharti, N.; Grenfell, B. T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Bharti, N.; Grenfell, B. T.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Ctr Hlth & Wellbeing, Princeton, NJ 08544 USA; [Tatem, A. J.] Univ Florida, Dept Geog, Gainesville, FL 32610 USA; [Tatem, A. J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Ferrari, M. J.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Ferrari, M. J.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Grais, R. F.] Epictr, F-75011 Paris, France; [Grais, R. F.] Harvard Humanitarian Initiat, Cambridge, MA 02138 USA; [Djibo, A.] Minist Sante, DGSP, Niamey, Niger; [Tatem, A. J.; Grenfell, B. T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Princeton University; Princeton University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Bharti, N (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	nbharti@princeton.edu		Tatem, Andrew/0000-0002-7270-941X; Bharti, Nita/0000-0003-1940-7794; Freeman Grais, Rebecca/0000-0002-5037-8218	Bill and Melinda Gates Foundation [49446]; Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Bill and Melinda Gates Foundation. A.J.T. is supported by a grant from the Bill and Melinda Gates Foundation (49446). A.J.T., M.J.F., and B. T. G. are also supported by the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security and the Fogarty International Center, NIH. All DMSP OLS imagery is available from the Space Physics Interactive Data Resource (http://spidr.ngdc.noaa.gov/spidr/).	Agnew J, 2008, ENVIRON PLANN A, V40, P2285, DOI 10.1068/a41200; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON R M, 1991; ARON JL, 1984, J THEOR BIOL, V110, P665, DOI 10.1016/S0022-5193(84)80150-2; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Camargo M C, 2000, Rev Panam Salud Publica, V7, P359; Dobson JE, 2000, PHOTOGRAMM ENG REM S, V66, P849; Ebener Steeve, 2005, Int J Health Geogr, V4, P5, DOI 10.1186/1476-072X-4-5; Elvidge CD, 1997, PHOTOGRAMM ENG REM S, V63, P727; Elvidge CD, 2009, COMPUT GEOSCI-UK, V35, P1652, DOI 10.1016/j.cageo.2009.01.009; FAULKINGHAM RH, 1975, POP STUD-J DEMOG, V29, P463, DOI [10.2307/2173939, 10.1080/00324728.1975.10412711]; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Ferrari MJ, 2010, P ROY SOC B-BIOL SCI, V277, P2775, DOI 10.1098/rspb.2010.0536; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Grais RF, 2006, T ROY SOC TROP MED H, V100, P867, DOI 10.1016/j.trstmh.2005.10.014; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; HUTCHINS SS, 1990, AM J EPIDEMIOL, V132, P157, DOI 10.1093/oxfordjournals.aje.a115627; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575; Noor Abdisalan M, 2008, Popul Health Metr, V6, P5, DOI 10.1186/1478-7954-6-5; Prothero RM, 2002, GLOBAL CHANGE HUMAN, V3, P20, DOI DOI 10.1023/A:1019636208598; Rain D., 2018, EATERS DRY SEASON CI, DOI 10.4324/9780429500886; Sutton P, 2001, INT J REMOTE SENS, V22, P3061, DOI 10.1080/01431160010007015; Word D. P., 2010, 20 EUR S COMP AID PR; Yameogo KR, 2005, INT J EPIDEMIOL, V34, P556, DOI 10.1093/ije/dyi001	27	147	151	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2011	334	6061					1424	1427		10.1126/science.1210554	http://dx.doi.org/10.1126/science.1210554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158822	Green Accepted			2022-12-24	WOS:000297787700059
J	Maestre, FT; Quero, JL; Gotelli, NJ; Escudero, A; Ochoa, V; Delgado-Baquerizo, M; Garcia-Gomez, M; Bowker, MA; Soliveres, S; Escolar, C; Garcia-Palacios, P; Berdugo, M; Valencia, E; Gozalo, B; Gallardo, A; Aguilera, L; Arredondo, T; Blones, J; Boeken, B; Bran, D; Conceicao, AA; Cabrera, O; Chaieb, M; Derak, M; Eldridge, DJ; Espinosa, CI; Florentino, A; Gaitan, J; Gatica, MG; Ghiloufi, W; Gomez-Gonzalez, S; Gutierrez, JR; Hernandez, RM; Huang, XW; Huber-Sannwald, E; Jankju, M; Miriti, M; Monerris, J; Mau, RL; Morici, E; Naseri, K; Ospina, A; Polo, V; Prina, A; Pucheta, E; Ramirez-Collantes, DA; Romao, R; Tighe, M; Torres-Diaz, C; Val, J; Veiga, JP; Wang, DL; Zaady, E				Maestre, Fernando T.; Quero, Jose L.; Gotelli, Nicholas J.; Escudero, Adrian; Ochoa, Victoria; Delgado-Baquerizo, Manuel; Garcia-Gomez, Miguel; Bowker, Matthew A.; Soliveres, Santiago; Escolar, Cristina; Garcia-Palacios, Pablo; Berdugo, Miguel; Valencia, Enrique; Gozalo, Beatriz; Gallardo, Antonio; Aguilera, Lorgio; Arredondo, Tulio; Blones, Julio; Boeken, Bertrand; Bran, Donaldo; Conceicao, Abel A.; Cabrera, Omar; Chaieb, Mohamed; Derak, Mchich; Eldridge, David J.; Espinosa, Carlos I.; Florentino, Adriana; Gaitan, Juan; Gatica, M. Gabriel; Ghiloufi, Wahida; Gomez-Gonzalez, Susana; Gutierrez, Julio R.; Hernandez, Rosa M.; Huang, Xuewen; Huber-Sannwald, Elisabeth; Jankju, Mohammad; Miriti, Maria; Monerris, Jorge; Mau, Rebecca L.; Morici, Ernesto; Naseri, Kamal; Ospina, Abelardo; Polo, Vicente; Prina, Anibal; Pucheta, Eduardo; Ramirez-Collantes, David A.; Romao, Roberto; Tighe, Matthew; Torres-Diaz, Cristian; Val, James; Veiga, Jose P.; Wang, Deli; Zaady, Eli			Plant Species Richness and Ecosystem Multifunctionality in Global Drylands	SCIENCE			English	Article							DIVERSITY; BIODIVERSITY; PRODUCTIVITY; DESERTIFICATION	Experiments suggest that biodiversity enhances the ability of ecosystems to maintain multiple functions, such as carbon storage, productivity, and the buildup of nutrient pools (multifunctionality). However, the relationship between biodiversity and multifunctionality has never been assessed globally in natural ecosystems. We report here on a global empirical study relating plant species richness and abiotic factors to multifunctionality in drylands, which collectively cover 41% of Earth's land surface and support over 38% of the human population. Multifunctionality was positively and significantly related to species richness. The best-fitting models accounted for over 55% of the variation in multifunctionality and always included species richness as a predictor variable. Our results suggest that the preservation of plant biodiversity is crucial to buffer negative effects of climate change and desertification in drylands.	[Maestre, Fernando T.; Quero, Jose L.; Escudero, Adrian; Ochoa, Victoria; Garcia-Gomez, Miguel; Soliveres, Santiago; Escolar, Cristina; Garcia-Palacios, Pablo; Berdugo, Miguel; Valencia, Enrique; Gozalo, Beatriz; Polo, Vicente] Univ Rey Juan Carlos, Escuela Super Ciencias Expt & Tecnol, Dept Biol & Geol, Area Biodiversidad & Conservac, Mostoles 28933, Spain; [Gotelli, Nicholas J.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Delgado-Baquerizo, Manuel; Gallardo, Antonio] Univ Pablo Olavide, Dept Sistemas Fis Quim & Nat, Seville 41013, Spain; [Garcia-Gomez, Miguel] Univ Politecn Madrid, Escuela Tecn Super Ingn Caminos Canales & Puertos, Dept Ingn & Morfol Terreno, E-28040 Madrid, Spain; [Bowker, Matthew A.] No Arizona Univ, SW Biol Sci Ctr, US Geol Survey, Flagstaff, AZ 86011 USA; [Aguilera, Lorgio; Gutierrez, Julio R.] Univ La Serena, Dept Biol, La Serena, Chile; [Arredondo, Tulio; Huber-Sannwald, Elisabeth] Inst Potosino Invest Cient & Tecnol, Div Ciencias Ambient, San Luis Potosi 78210, Mexico; [Blones, Julio] Univ Simon Rodriguez, Inst Estudios Cient & Tecnol, Ctr Agroecol Trop, Lab Biol Vegetal, Caracas, Venezuela; [Boeken, Bertrand] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, IL-84990 Sede Boqer, Israel; [Bran, Donaldo; Gaitan, Juan; Romao, Roberto] Inst Nacl Tecnol Agropecuaria, Estac Expt San Carlos Bariloche, San Carlos De Bariloche, Rio Negro, Argentina; [Conceicao, Abel A.] Univ Estadual Feira de Santana, Dept Ciencias Biol, Bairro Novo Horizonte, Feira Santana, Brazil; [Cabrera, Omar; Espinosa, Carlos I.] Univ Tecn Particular Loja, Inst Ecol, Loja, Ecuador; [Chaieb, Mohamed; Ghiloufi, Wahida] Univ Sfax, Fac Sci, Unite Rech Plant Divers & Ecosyst Arid Environm, Sfax 3018, Tunisia; [Derak, Mchich] Direct Reg Eaux & Forets & Lutte Desertificat Rif, Tetouan 93000, Morocco; [Eldridge, David J.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia; [Florentino, Adriana; Ospina, Abelardo] Cent Univ Venezuela, Fac Agr, Inst Edafol, Caracas, Venezuela; [Gatica, M. Gabriel; Pucheta, Eduardo] Univ Nacl San Juan, Fac Ciencias Exactas & Fis Nat, Dept Biol, San Juan, Argentina; [Gomez-Gonzalez, Susana; Torres-Diaz, Cristian] Univ Bio Bio, Dept Ciencias Basicas, Lab Genom & Biodiversidad, Chillan, Chile; [Hernandez, Rosa M.] Univ Expt Simon Rodriguez, Ctr Agroecol Trop, Lab Biogeoquim, Caracas, Venezuela; [Huang, Xuewen] Hulunbuir Coll, Dept Biol & Chem, Hailar 021008, InnerMongolia, Peoples R China; [Jankju, Mohammad; Naseri, Kamal] Ferdowsi Univ Mashhad, Fac Nat Resources & Environm, Dept Range & Watershed Management, Mashhad 917751363, Iran; [Miriti, Maria] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Monerris, Jorge; Ramirez-Collantes, David A.] Univ Nacl Agraria La Molina, Fac Ciencias, Dept Biol, Lima, Peru; [Mau, Rebecca L.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Morici, Ernesto; Prina, Anibal] Univ Nacl La Pampa, Fac Agr, RA-6300 La Pampa, Argentina; [Tighe, Matthew] Univ New England, Sch Environm & Rural Sci, Dept Agron & Soil Sci, Armidale, NSW 2351, Australia; [Val, James] Off Environm & Heritage, Buronga, NSW 2739, Australia; [Veiga, Jose P.] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, E-28006 Madrid, Spain; [Wang, Deli] NE Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Inst Grassland Sci, Changchun 130024, Jilin, Peoples R China; [Zaady, Eli] Gilat Res Ctr, Minist Agr, Agr Res Org, Dept Nat Resources & Agron, IL-85280 Negev, Israel	Universidad Rey Juan Carlos; University of Vermont; Universidad Pablo de Olavide; Universidad Politecnica de Madrid; Northern Arizona University; United States Department of the Interior; United States Geological Survey; Universidad de La Serena; Instituto Potosino Investigacion Cientifica y Tecnologica; Ben Gurion University; Instituto Nacional de Tecnologia Agropecuaria (INTA); Universidade Estadual de Feira de Santana; Universidad Tecnica Particular de Loja; Universite de Sfax; Faculty of Sciences Sfax; University of New South Wales Sydney; University of Central Venezuela; Universidad Nacional de San Juan; Universidad del Bio-Bio; Ferdowsi University Mashhad; University System of Ohio; Ohio State University; University Nacional Agraria La Molina; Northern Arizona University; University of New England; Office of Environment & Heritage - New South Wales; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Northeast Normal University - China	Maestre, FT (corresponding author), Univ Rey Juan Carlos, Escuela Super Ciencias Expt & Tecnol, Dept Biol & Geol, Area Biodiversidad & Conservac, Mostoles 28933, Spain.	fernando.maestre@urjc.es	García-Palacios, Pablo/K-7567-2014; Valencia, Enrique/AAR-1438-2021; Farzam, Mohammad/AAU-7275-2020; Conceição, Abel A/A-7544-2012; DELGADO-BAQUERIZO, MANUEL/GLS-0346-2022; Cabrera, Omar/V-6526-2019; Tighe, Matt/AAC-5369-2019; Espinosa, Carlos Ivan/AAI-1305-2019; Bowker, Matthew/B-6258-2014; Quero, Jose Luis JL/A-4202-2011; Arredondo Moreno, José/A-9972-2015; Gómez-González, Susana/AAL-2631-2021; Codina, Santiago Soliveres/A-2291-2016; Pérez, Jose Luis Quero/M-1074-2013; Gutierrez, Julio R/A-8367-2011; Gallardo, Antonio/L-3941-2017; Hernández, Rosa/GRF-5998-2022; Veiga, José/AAV-1687-2020; Maestre, Fernando T./A-6825-2008; Escudero, Adrián/H-5046-2015; Huber-Sannwald, Elisabeth/D-2507-2009; Eldridge, David/H-3532-2019; Delgado-Baquerizo, Manuel/L-3653-2017; Chaieb, Mohamed/AAM-9869-2020; GOMEZ-GONZALEZ, SUSANA/J-7637-2018; Alvarez, Sergio/H-9727-2015; Ramirez, David/Q-5522-2017	García-Palacios, Pablo/0000-0002-6367-4761; Farzam, Mohammad/0000-0003-1947-0187; Conceição, Abel A/0000-0001-7461-0133; DELGADO-BAQUERIZO, MANUEL/0000-0002-6499-576X; Tighe, Matt/0000-0003-1027-0082; Espinosa, Carlos Ivan/0000-0002-5330-4505; Bowker, Matthew/0000-0002-5891-0264; Quero, Jose Luis JL/0000-0001-5553-506X; Arredondo Moreno, José/0000-0003-1969-9942; Gómez-González, Susana/0000-0002-3779-8701; Codina, Santiago Soliveres/0000-0001-9661-7192; Pérez, Jose Luis Quero/0000-0001-5553-506X; Gallardo, Antonio/0000-0002-2674-4265; Maestre, Fernando T./0000-0002-7434-4856; Escudero, Adrián/0000-0002-1427-5465; Eldridge, David/0000-0002-2191-486X; Delgado-Baquerizo, Manuel/0000-0002-6499-576X; GOMEZ-GONZALEZ, SUSANA/0000-0002-3779-8701; Berdugo, Miguel/0000-0003-1053-8907; Vicente, Polo/0000-0002-0994-5372; Gatica, Gabriel/0000-0003-2883-2565; Gutierrez, Julio/0000-0002-1099-1341; Huber- Sannwald, Elisabeth/0000-0002-8321-1270; Hernandez Hernandez, Rosa Mary/0000-0003-0689-8862; Wahida, Ghiloufi/0000-0002-9995-3930; Alvarez, Sergio/0000-0001-7204-502X; gaitan, juan/0000-0003-2889-1418; bran, donaldo/0000-0001-7749-2726; Prina, Anibal/0000-0003-3522-9342; Ramirez, David/0000-0003-4546-9745; Valencia, Enrique/0000-0003-3359-0759	European Research Council under the European Community [242658]; The Ciencia y Tecnologia para el Desarrollo program (CYTED) [407AC0323]	European Research Council under the European Community(European Research Council (ERC)); The Ciencia y Tecnologia para el Desarrollo program (CYTED)	We thank all the technicians that assisted with field and laboratory work; T. Navarro and Z. Noumi for their help with plant species identification; and J. Bascompte, J. F. Reynolds, K. J. van Groenigen, W. van der Putten, and two anonymous reviewers for helpful comments. This research was funded by the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement 242658 (BIOCOM). The Ciencia y Tecnologia para el Desarrollo program (CYTED) funded networking activities (EPES, Accion 407AC0323). The data used in the primary analyses are available in the supporting online material. The authors declare no competing financial interests. F. T. M. and A. E. designed the study. Field data were collected by all authors except A. E., A. G., N.J.G., B. G., E. V., and M. B. Laboratory analyses were done by V.O., A. G., M. B., M. D. B., E. V., and B. G. Data analyses were done by F. T. M., assisted by N.J.G. The paper was written by F. T. M., and all authors contributed to the subsequent drafts.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Diniz JAF, 2008, GLOBAL ECOL BIOGEOGR, V17, P479, DOI 10.1111/j.1466-8238.2008.00395.x; Evans RD, 2001, ECOL APPL, V11, P1301, DOI 10.1890/1051-0761(2001)011[1301:EPIAND]2.0.CO;2; Flombaum P, 2008, P NATL ACAD SCI USA, V105, P6087, DOI 10.1073/pnas.0704801105; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Godbold JA, 2009, MAR ECOL PROG SER, V396, P273, DOI 10.3354/meps08401; Guo ZW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013113; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Maestre FT, 2012, J ECOL, V100, P317, DOI 10.1111/j.1365-2745.2011.01918.x; Maestre FT, 2010, PHILOS T R SOC B, V365, P2057, DOI 10.1098/rstb.2010.0016; Maestre FT, 2009, ECOLOGY, V90, P1729, DOI 10.1890/08-2096.1; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Millennium-Ecosystem-Assessment, 2005, EC HUM WELL BEING DE; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Naeem S., 2009, BIODIVERSITY ECOSYST; O'Connor TG, 2001, J ECOL, V89, P850, DOI 10.1046/j.0022-0477.2001.00605.x; Pringle RM, 2007, P NATL ACAD SCI USA, V104, P193, DOI 10.1073/pnas.0609840104; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Wardle DA, 2010, FRONT ECOL ENVIRON, V8, P10, DOI 10.1890/10.WB.002; White R. P., 2003, DRYLANDS PEOPLE ECOS; Whitford W., 2002, ECOLOGY DESERT SYSTE; Woodward FI, 2008, ECOL LETT, V11, P1229, DOI 10.1111/j.1461-0248.2008.01240.x; Wu TH, 2011, P NATL ACAD SCI USA, V108, P17720, DOI 10.1073/pnas.1103824108; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	32	753	811	136	1376	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2012	335	6065					214	218		10.1126/science.1215442	http://dx.doi.org/10.1126/science.1215442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246775	Green Accepted			2022-12-24	WOS:000299033100052
J	Goyal, A; Spertus, JA; Gosch, K; Venkitachalam, L; Jones, PG; Van den Berghe, G; Kosiborod, M				Goyal, Abhinav; Spertus, John A.; Gosch, Kensey; Venkitachalam, Lakshmi; Jones, Philip G.; Van den Berghe, Greet; Kosiborod, Mikhail			Serum Potassium Levels and Mortality in Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC HEART-FAILURE; VENTRICULAR-ARRHYTHMIAS; MALIGNANT ARRHYTHMIAS; HYPOKALEMIA; FIBRILLATION; TIMOLOL; PROGNOSIS; ELEVATION; OUTCOMES; DISEASE	Context Clinical practice guidelines recommend maintaining serum potassium levels between 4.0 and 5.0 mEq/L in patients with acute myocardial infarction (AMI). These guidelines are based on small studies that associated low potassium levels with ventricular arrhythmias in the pre-beta-blocker and prereperfusion era. Current studies examining the relationship between potassium levels and mortality in AMI patients are lacking. Objective To determine the relationship between serum potassium levels and in-hospital mortality in AMI patients in the era of beta-blocker and reperfusion therapy. Design, Setting, and Patients Retrospective cohort study using the Cerner Health Facts database, which included 38 689 patients with biomarker-confirmed AMI, admitted to 67 US hospitals between January 1, 2000, and December 31, 2008. All patients had in-hospital serum potassium measurements and were categorized by mean postadmission serum potassium level (<3.0, 3.0-<3.5, 3.5-<4.0, 4.0-<4.5, 4.5<5.0, 5.0-<5.5, and <5.5 mEq/L). Hierarchical logistic regression was used to determine the association between potassium levels and outcomes after adjusting for patient-and hospital-level factors. Main Outcome Measures All-cause in-hospital mortality and the composite of ventricular fibrillation or cardiac arrest. Results There was a U-shaped relationship between mean postadmission serum potassium level and in-hospital mortality that persisted after multivariable adjustment. Compared with the reference group of 3.5 to less than 4.0 mEq/L (mortality rate, 4.8%; 95% CI, 4.4%-5.2%), mortality was comparable for mean postadmission potassium of 4.0 to less than 4.5 mEq/L (5.0%; 95% CI, 4.7%-5.3%), multivariable-adjusted odds ratio (OR), 1.19 (95% CI, 1.04-1.36). Mortality was twice as great for potassium of 4.5 to less than 5.0 mEq/L (10.0%; 95% CI, 9.1%-10.9%; multivariable-adjusted OR, 1.99; 95% CI, 1.68-2.36), and even greater for higher potassium strata. Similarly, mortality rates were higher for potassium levels of less than 3.5 mEq/L. In contrast, rates of ventricular fibrillation or cardiac arrest were higher only among patients with potassium levels of less than 3.0 mEq/L and at levels of 5.0 mEq/L or greater. Conclusion Among inpatients with AMI, the lowest mortality was observed in those with postadmission serum potassium levels between 3.5 and <4.5 mEq/L compared with those who had higher or lower potassium levels. JAMA. 2012;307(2):157-164 www.jama.com	[Goyal, Abhinav] Emory Rollins Sch Publ Hlth, Emory Sch Med, Dept Med, Atlanta, GA USA; [Goyal, Abhinav] Emory Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA; [Spertus, John A.; Gosch, Kensey; Venkitachalam, Lakshmi; Jones, Philip G.; Kosiborod, Mikhail] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Spertus, John A.; Kosiborod, Mikhail] Univ Missouri, Dept Med, Kansas City, MO USA; [Van den Berghe, Greet] Univ Leuven, Univ Hosp Gasthuisberg, Dept Intens Care Med, Louvain, Belgium	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; KU Leuven; University Hospital Leuven	Goyal, A (corresponding author), Emory Sch Publ Hlth & Med, 1518 Clifton Rd NE,Room 3027, Atlanta, GA 30322 USA.	agoyal4@emory.edu	Van den Berghe, Greet/J-6788-2018; Goyal, Abhinav/J-5086-2012; Spertus, John/ABD-3075-2021; Hug, Balthasar L./G-1568-2010; Kosiborod, Mikhail/HDO-1541-2022	Van den Berghe, Greet/0000-0002-5320-1362; Goyal, Abhinav/0000-0002-6286-2349; Kosiborod, Mikhail/0000-0002-3750-9789; Venkitachalam, Lakshmi/0000-0003-0703-3932	Saint Luke's Mid America Heart Institute, Kansas, City, Missouri	Saint Luke's Mid America Heart Institute, Kansas, City, Missouri	The research for this article was funded by internal funds from Saint Luke's Mid America Heart Institute, Kansas, City, Missouri. The Cerner Corporation facilitated the collection of the deidentified Health Facts data but provided no external funding for this study.	Alper AB, 2009, INT J CARDIOL, V137, P1, DOI 10.1016/j.ijcard.2008.05.047; Amin AP, 2012, ARCH INTERN MED, V172, P246, DOI 10.1001/archinternmed.2011.1202; ANTMAN EM, 2004, ACC AHA GUIDELINES M; Bowling CB, 2010, CIRC-HEART FAIL, V3, P253, DOI 10.1161/CIRCHEARTFAILURE.109.899526; BROWN MJ, 1983, NEW ENGL J MED, V309, P1414, DOI 10.1056/NEJM198312083092303; Cohn JN, 2000, ARCH INTERN MED, V160, P2429, DOI 10.1001/archinte.160.16.2429; DUKE M, 1978, JAMA-J AM MED ASSOC, V239, P43, DOI 10.1001/jama.239.1.43; FRIEDENSOHN A, 1991, INT J CARDIOL, V32, P331, DOI 10.1016/0167-5273(91)90295-Z; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; GETTES LS, 1992, CIRCULATION, V85, P70; Hofsten DE, 2007, EUR HEART J, V28, P407, DOI 10.1093/eurheartj/ehl476; HSIA DC, 1990, JAMA-J AM MED ASSOC, V264, P59, DOI 10.1001/jama.264.1.59; Huikuri HV, 2003, J AM COLL CARDIOL, V42, P652, DOI 10.1016/S0735-1097(03)00783-6; HULTING J, 1981, ACTA MED SCAND, P109; JOHANSSON BW, 1984, DRUGS, V28, P77, DOI 10.2165/00003495-198400281-00008; KAFKA H, 1987, ARCH INTERN MED, V147, P465, DOI 10.1001/archinte.147.3.465; Kosiborod M, 2008, CIRCULATION, V117, P1018, DOI 10.1161/CIRCULATIONAHA.107.740498; Kosiborod M, 2009, JAMA-J AM MED ASSOC, V301, P1556, DOI 10.1001/jama.2009.496; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Macdonald JE, 2004, J AM COLL CARDIOL, V43, P155, DOI 10.1016/j.jacc.2003.06.021; Madias JE, 2000, CHEST, V118, P904, DOI 10.1378/chest.118.4.904; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; NORDREHAUG JE, 1985, CIRCULATION, V71, P645, DOI 10.1161/01.CIR.71.4.645; NORDREHAUG JE, 1985, AM J CARDIOL, V56, pD20, DOI 10.1016/0002-9149(85)91110-5; NORDREHAUG JE, 1985, ACTA MED SCAND, V217, P299; NORDREHAUG JE, 1985, BRIT HEART J, V53, P388; NORDREHAUG JE, 1985, AM HEART J, V110, P944, DOI 10.1016/0002-8703(85)90189-9; PACKER M, 1990, AM J CARDIOL, V65, pE52; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; Perry G, 1997, NEW ENGL J MED, V336, P525; PODRID PJ, 1990, AM J CARDIOL, V65, pE33, DOI 10.1016/0002-9149(90)90250-5; Rogers WJ, 2008, AM HEART J, V156, P1026, DOI 10.1016/j.ahj.2008.07.030; SOLOMON RJ, 1981, ACTA MED SCAND, P87; VOLPI A, 1990, CIRCULATION, V82, P1279, DOI 10.1161/01.CIR.82.4.1279	34	235	247	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2012	307	2					157	164		10.1001/jama.2011.1967	http://dx.doi.org/10.1001/jama.2011.1967			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875NP	22235086	Bronze			2022-12-24	WOS:000299038300027
J	Smith, ESJ; Omerbasic, D; Lechner, SG; Anirudhan, G; Lapatsina, L; Lewin, GR				Smith, Ewan St. John; Omerbasic, Damir; Lechner, Stefan G.; Anirudhan, Gireesh; Lapatsina, Liudmila; Lewin, Gary R.			The Molecular Basis of Acid Insensitivity in the African Naked Mole-Rat	SCIENCE			English	Article							SODIUM-CHANNELS; PAIN; SCN9A; MUTATIONS; CAPSAICIN; NEURONS; PROTONS; TRPV1; MICE	Acid evokes pain by exciting nociceptors; the acid sensors are proton-gated ion channels that depolarize neurons. The naked mole-rat (Heterocephalus glaber) is exceptional in its acid insensitivity, but acid sensors (acid-sensing ion channels and the transient receptor potential vanilloid-1 ion channel) in naked mole-rat nociceptors are similar to those in other vertebrates. Acid inhibition of voltage-gated sodium currents is more profound in naked mole-rat nociceptors than in mouse nociceptors, however, which effectively prevents acid-induced action potential initiation. We describe a species-specific variant of the nociceptor sodium channel Na(V)1.7, which is potently blocked by protons and can account for acid insensitivity in this species. Thus, evolutionary pressure has selected for an Na(V)1.7 gene variant that tips the balance from proton-induced excitation to inhibition of action potential initiation to abolish acid nociception.	[Smith, Ewan St. John; Omerbasic, Damir; Lechner, Stefan G.; Anirudhan, Gireesh; Lapatsina, Liudmila; Lewin, Gary R.] Max Delbruck Ctr Mol Med, Dept Neurosci, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Smith, ESJ (corresponding author), Max Delbruck Ctr Mol Med, Dept Neurosci, Robert Rossle Str 10, D-13125 Berlin, Germany.	ewan.smith@mdc-berlin.de; glewin@mdc-berlin.de	Anirudhan, Gireesh/AAV-6418-2020; St. John Smith, Ewan/G-1776-2011; Lewin, Gary R/B-8028-2011	St. John Smith, Ewan/0000-0002-2699-1979; Omerbasic, Damir/0000-0003-1839-4856; Anirudhan, Gireesh/0000-0001-7093-0404; Lechner, Stefan/0000-0001-9402-9127; Lewin, Gary/0000-0002-2890-6352	Alexander von Humboldt foundation; MolNeuro Helmholtz Research School; Deutsche Forschungsgemeinschaft [665, Exc 257]	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); MolNeuro Helmholtz Research School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	E.St.J.S. carried out DRG electrophysiology. E.St.J.S. and D.O. carried out CHO cell electrophysiology. S. L. carried out skin-nerve electrophysiology. D.O., L. L., G. A., and E.St.J.S. carried out molecular biology. E.St.J.S. and G. R. L. designed experimental studies and wrote the paper. E.St.J.S. was supported by the Alexander von Humboldt foundation, and D.O. was supprted by the MolNeuro Helmholtz Research School. Additional funding was obtained from Deutsche Forschungsgemeinschaft collaborative research center 665 and Exc 257 (NeuroCure). We thank H. Thranhardt, A. Wegner, and K. Barda for technical support. Sequences have been submitted to GenBank (SOM).	Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cox JJ, 2010, HUM MUTAT, V31, pE1670, DOI 10.1002/humu.21325; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dirajlal S, 2003, J NEUROPHYSIOL, V89, P513, DOI 10.1152/jn.00371.2002; Edrey YH, 2011, EXP GERONTOL, V46, P116, DOI 10.1016/j.exger.2010.09.005; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Gavva NR, 2005, MOL PHARMACOL, V68, P1524, DOI 10.1124/mol.105.015727; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Khan A, 2006, J PHYSIOL-LONDON, V576, P493, DOI 10.1113/jphysiol.2006.115659; Khan A, 2002, J PHYSIOL-LONDON, V543, P71, DOI 10.1113/jphysiol.2002.021014; Lechner SG, 2009, EMBO J, V28, P1479, DOI 10.1038/emboj.2009.73; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Sharabi K, 2009, J CELL MOL MED, V13, P4304, DOI 10.1111/j.1582-4934.2009.00952.x; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; STEEN KH, 1992, J NEUROSCI, V12, P86; TRAUB RJ, 1988, J NEUROPHYSIOL, V59, P41, DOI 10.1152/jn.1988.59.1.41; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	22	84	85	0	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1557	1560		10.1126/science.1213760	http://dx.doi.org/10.1126/science.1213760			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174253				2022-12-24	WOS:000298091400054
J	Levy, S; Kafri, M; Carmi, M; Barkai, N				Levy, Sagi; Kafri, Moshe; Carmi, Miri; Barkai, Naama			The Competitive Advantage of a Dual-Transporter System	SCIENCE			English	Article							HIGH-AFFINITY TRANSPORT; SACCHAROMYCES-CEREVISIAE; PHOSPHATE TRANSPORTERS; PROLINE TRANSPORT; TRANSCRIPTION; ARABIDOPSIS; YEAST	Cells use transporters of different affinities to regulate nutrient influx. When nutrients are depleted, low-affinity transporters are replaced by high-affinity ones. High-affinity transporters are helpful when concentrations of nutrients are low, but the advantage of reducing their abundance when nutrients are abundant is less clear. When we eliminated such reduced production of the Saccharomyces cerevisiae high-affinity transporters for phosphate and zinc, the elapsed time from the initiation of the starvation program until the lack of nutrients limited growth was shortened, and recovery from starvation was delayed. The latter phenotype was rescued by constitutive activation of the starvation program. Dual-transporter systems appear to prolong preparation for starvation and to facilitate subsequent recovery, which may optimize sensing of nutrient depletion by integrating internal and external information about nutrient availability.	[Levy, Sagi; Kafri, Moshe; Carmi, Miri; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il	Levy, Sagi/AAG-1593-2019	Kafri, Moshe/0000-0002-9416-5513	European Research Council (IDEAS); NIH [P50GM068763]; Helen and Martin Kimmel Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	European Research Council (IDEAS)(European Research Council (ERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen and Martin Kimmel Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Fialkov and S. Meizel for the technical help; D. Ben-Zvi, I. Soifer, and our lab members for helpful discussions; and E. O'Shea for the EB1264 plasmid. Microarrays data have been deposited in Gene Expression Omnibus (accession no. GSE32067). Supported by the European Research Council (IDEAS), NIH grant P50GM068763, and the Helen and Martin Kimmel Award for innovative investigations.	Auesukaree C, 2004, J BIOL CHEM, V279, P17289, DOI 10.1074/jbc.M312202200; Bird AJ, 2003, EMBO J, V22, P5137, DOI 10.1093/emboj/cdg484; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Daram P, 1999, PLANT CELL, V11, P2153, DOI 10.1105/tpc.11.11.2153; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; Harris RM, 2001, J BACTERIOL, V183, P5008, DOI 10.1128/JB.183.17.5008-5014.2001; LASKO PF, 1981, J BACTERIOL, V148, P241, DOI 10.1128/JB.148.1.241-247.1981; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250; Levy S, 2009, FEBS LETT, V583, P3974, DOI 10.1016/j.febslet.2009.10.071; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9; Qiao W, 2006, P NATL ACAD SCI USA, V103, P8674, DOI 10.1073/pnas.0600928103; Santos-Beneit F, 2008, MICROBIOL-SGM, V154, P2356, DOI 10.1099/mic.0.2008/019539-0; Seymour RL, 2006, J LEUKOCYTE BIOL, V80, P1320, DOI 10.1189/jlb.1205727; Springer M, 2003, PLOS BIOL, V1, P261, DOI 10.1371/journal.pbio.0000028; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; TOWNSEND DE, 1992, J BACTERIOL, V174, P2702, DOI 10.1128/jb.174.8.2702-2710.1992; Wykoff DD, 2001, GENETICS, V159, P1491; Wykoff DD, 2007, MOL CELL, V27, P1005, DOI 10.1016/j.molcel.2007.07.022; YAMAMURA HI, 1973, J NEUROCHEM, V21, P1355, DOI 10.1111/j.1471-4159.1973.tb06022.x; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2	27	54	54	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1408	1412		10.1126/science.1207154	http://dx.doi.org/10.1126/science.1207154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158820	Green Accepted			2022-12-24	WOS:000297787700055
J	Hermans, EJ; van Marle, HJF; Ossewaarde, L; Henckens, MJAG; Qin, SZ; van Kesteren, MTR; Schoots, VC; Cousijn, H; Rijpkema, M; Oostenveld, R; Fernandez, G				Hermans, Erno J.; van Marle, Hein J. F.; Ossewaarde, Lindsey; Henckens, Marloes J. A. G.; Qin, Shaozheng; van Kesteren, Marlieke T. R.; Schoots, Vincent C.; Cousijn, Helena; Rijpkema, Mark; Oostenveld, Robert; Fernandez, Guillen			Stress-Related Noradrenergic Activity Prompts Large-Scale Neural Network Reconfiguration	SCIENCE			English	Article							INTRINSIC CONNECTIVITY NETWORKS; LOCUS-COERULEUS; PREFRONTAL CORTEX; SYSTEM; BRAIN; MEMORY; ARCHITECTURE; MODULATION; ACTIVATION; AMYGDALA	Acute stress shifts the brain into a state that fosters rapid defense mechanisms. Stress-related neuromodulators are thought to trigger this change by altering properties of large-scale neural populations throughout the brain. We investigated this brain-state shift in humans. During exposure to a fear-related acute stressor, responsiveness and interconnectivity within a network including cortical (frontoinsular, dorsal anterior cingulate, inferotemporal, and temporoparietal) and subcortical (amygdala, thalamus, hypothalamus, and midbrain) regions increased as a function of stress response magnitudes. beta-adrenergic receptor blockade, but not cortisol synthesis inhibition, diminished this increase. Thus, our findings reveal that noradrenergic activation during acute stress results in prolonged coupling within a distributed network that integrates information exchange between regions involved in autonomic-neuroendocrine control and vigilant attentional reorienting.	[Hermans, Erno J.; van Marle, Hein J. F.; Qin, Shaozheng; van Kesteren, Marlieke T. R.; Schoots, Vincent C.; Fernandez, Guillen] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Hermans, Erno J.; Fernandez, Guillen] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6500 HB Nijmegen, Netherlands; [Hermans, Erno J.] NYU, Dept Psychol, New York, NY 10003 USA; [van Marle, Hein J. F.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1100 DD Amsterdam, Netherlands; [Ossewaarde, Lindsey; Henckens, Marloes J. A. G.; Cousijn, Helena; Rijpkema, Mark; Oostenveld, Robert] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands; [Henckens, Marloes J. A. G.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands; [Qin, Shaozheng] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [van Kesteren, Marlieke T. R.] Radboud Univ Nijmegen, Med Ctr, Dept Anat, NL-6500 HB Nijmegen, Netherlands; [Schoots, Vincent C.] Erasmus Univ, Rotterdam Sch Management, NL-3000 DR Rotterdam, Netherlands; [Cousijn, Helena] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England	Radboud University Nijmegen; Radboud University Nijmegen; New York University; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Stanford University; Radboud University Nijmegen; Erasmus University Rotterdam; University of Oxford	Hermans, EJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands.	erno.hermans@donders.ru.nl	Fernandez, Guillen/B-3771-2009; van Marle, Hein/L-8791-2013; Hermans, Erno J./B-1610-2010; Qin, Shaozheng/AAD-2107-2019; Schoots, Vincent/A-9264-2012; van Kesteren, Marlieke/F-2723-2011; Oostenveld, Robert/D-3259-2009; Rijpkema, Mark/D-1974-2010; van Kesteren, Marlieke/J-5809-2014; Henckens, Marloes J.A.G./J-7132-2015	Fernandez, Guillen/0000-0002-5522-0604; Qin, Shaozheng/0000-0002-1859-2150; Schoots, Vincent/0000-0002-8838-6029; Oostenveld, Robert/0000-0002-1974-1293; Rijpkema, Mark/0000-0002-8495-4703; van Kesteren, Marlieke/0000-0001-6765-7881; Henckens, Marloes J.A.G./0000-0002-2375-1611; Cousijn, Helena/0000-0001-6660-6214; van Marle, Hein/0000-0003-3543-4135	Netherlands Organisation for Scientific Research (NWO) [451.07.019, 918.66.613]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	E.J.H. (451.07.019) and G. F. (918.66.613) received grants from the Netherlands Organisation for Scientific Research (NWO). We thank W. Seeley, V. Menon, C. Beckmann, and E. Phelps.	Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Henckens MJAG, 2010, J NEUROSCI, V30, P12725, DOI 10.1523/JNEUROSCI.3112-10.2010; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Pruessner JC, 2008, BIOL PSYCHIAT, V63, P234, DOI 10.1016/j.biopsych.2007.04.041; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Soravia LM, 2006, P NATL ACAD SCI USA, V103, P5585, DOI 10.1073/pnas.0509184103; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107; van Marle HJF, 2009, BIOL PSYCHIAT, V66, P649, DOI 10.1016/j.biopsych.2009.05.014; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wager TD, 2009, NEUROIMAGE, V47, P821, DOI 10.1016/j.neuroimage.2009.05.043	29	377	381	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1151	1153		10.1126/science.1209603	http://dx.doi.org/10.1126/science.1209603			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116887				2022-12-24	WOS:000297313900056
J	Rhim, AD; Mirek, ET; Aiello, NM; Maitra, A; Bailey, JM; McAllister, F; Reichert, M; Beatty, GL; Rustgi, AK; Vonderheide, RH; Leach, SD; Stanger, BZ				Rhim, Andrew D.; Mirek, Emily T.; Aiello, Nicole M.; Maitra, Anirban; Bailey, Jennifer M.; McAllister, Florencia; Reichert, Maximilian; Beatty, Gregory L.; Rustgi, Anil K.; Vonderheide, Robert H.; Leach, Steven D.; Stanger, Ben Z.			EMT and Dissemination Precede Pancreatic Tumor Formation	CELL			English	Article							NATURAL-HISTORY; E-CADHERIN; CANCER; CELLS; INFLAMMATION; PROGRESSION; TRANSITIONS; EXPRESSION; INDUCTION; SELECTION	Metastasis is the leading cause of cancer-associated death but has been difficult to study because it involves a series of rare, stochastic events. To capture these events, we developed a sensitive method to tag and track pancreatic epithelial cells in a mouse model of pancreatic cancer. Tagged cells invaded and entered the bloodstream unexpectedly early, before frank malignancy could be detected by rigorous histologic analysis; this behavior was widely associated with epithelial-to-mesenchymal transition (EMT). Circulating pancreatic cells maintained a mesenchymal phenotype, exhibited stem cell properties, and seeded the liver. EMT and invasiveness were most abundant at inflammatory foci, and induction of pancreatitis increased the number of circulating pancreatic cells. Conversely, treatment with the immunosuppressive agent dexamethasone abolished dissemination. These results provide insight into the earliest events of cellular invasion in situ and suggest that inflammation enhances cancer progression in part by facilitating EMT and entry into the circulation.	[Rhim, Andrew D.; Mirek, Emily T.; Aiello, Nicole M.; Reichert, Maximilian; Rustgi, Anil K.; Stanger, Ben Z.] Univ Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Stanger, Ben Z.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Rhim, Andrew D.; Mirek, Emily T.; Aiello, Nicole M.; Beatty, Gregory L.; Vonderheide, Robert H.; Stanger, Ben Z.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Rhim, Andrew D.; Mirek, Emily T.; Aiello, Nicole M.; Reichert, Maximilian; Beatty, Gregory L.; Rustgi, Anil K.; Vonderheide, Robert H.; Stanger, Ben Z.] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Bailey, Jennifer M.; Leach, Steven D.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Surg, Baltimore, MD 21231 USA; [Maitra, Anirban] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21231 USA; [McAllister, Florencia] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21231 USA; [McAllister, Florencia] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Clin Pharmacol, Baltimore, MD 21231 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Stanger, BZ (corresponding author), Univ Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA.	bstanger@exchange.upenn.edu	Reichert, Maximilian/GOH-1246-2022	Aiello, Nicole/0000-0003-1616-5785; Mirek, Emily/0000-0002-9683-8216; Beatty, Gregory/0000-0001-7165-5993; Bailey-Lundberg, Jennifer/0000-0002-4750-106X	NIH [DK088945, DK007066, CA134292, T32GM066691, CA138907, CA117969, DK083355, DK083111]; AGA/FDHN; National Pancreas Foundation; AACR; Pancreatic Cancer Action Network; Pennsylvania Department of Health; Pew Charitable Trusts; NATIONAL CANCER INSTITUTE [K08CA138907, P01CA117969, F32CA157044, P01CA134292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK083111, T32DK007066, P30DK019525, K08DK088945, P30DK050306, R01DK083355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066691] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGA/FDHN; National Pancreas Foundation; AACR; Pancreatic Cancer Action Network; Pennsylvania Department of Health; Pew Charitable Trusts; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Ben-Porath, L. Chodosh, A. Minn, A. Rustgi, M. C. Simon, and H. Zong for helpful discussions; M. Emmett, A. Pannikar, and M. Rovira for technical assistance; N. Bardeesy, R. DePinho, S. Konieczny, and D. Melton for mouse strains; and J. Habener and D. Melton for gifts of antibodies. We are grateful to R. Hruban for providing confirmation of histological impressions. This work was supported by the NIH (DK088945 and DK007066 to A. D. R., CA134292 to A. M. and S. D. L., T32GM066691 to F. M., CA138907 to G. L. B., CA117969, DK083355, and DK083111 to B.Z.S.), AGA/FDHN (A. D. R.), National Pancreas Foundation (A. D. R. and M. R.), AACR and Pancreatic Cancer Action Network (Pathway to Leadership Award to J. M. B. and Career Development Award to B.Z.S.), Pennsylvania Department of Health (R. H. V. and B.Z.S.), and the Pew Charitable Trusts (B.Z.S.). Experiments utilized the Molecular Pathology and Imaging, Molecular Biology, and Cell Culture core facilities within the NIH/Penn Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306), the Abramson Family Cancer Research Institute, and the Diabetes and Endocrine Research Center (P30-DK19525).	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Greco FA, 2009, SEMIN ONCOL, V36, P6, DOI 10.1053/j.seminoncol.2008.10.007; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grover S, 2010, GASTROENTEROLOGY, V139, P1076, DOI 10.1053/j.gastro.2010.08.012; Gu GQ, 2003, MECH DEVELOP, V120, P35, DOI 10.1016/S0925-4773(02)00330-1; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Gupta PB, 2005, COLD SH Q B, V70, P291, DOI 10.1101/sqb.2005.70.033; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HELLMAN S, 1994, J CLIN ONCOL, V12, P2229, DOI 10.1200/JCO.1994.12.10.2229; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Ignatiadis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015624; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Ledford H, 2011, NATURE, V472, P273, DOI 10.1038/472273a; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mohammad RM, 1998, PANCREAS, V16, P19, DOI 10.1097/00006676-199801000-00004; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Okimura A, 2009, MED MOL MORPHOL, V42, P222, DOI 10.1007/s00795-009-0462-y; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Park JY, 2011, APPL IMMUNOHISTO M M, V19, P444, DOI 10.1097/PAI.0b013e318206d958; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Sanger N, 2011, INT J CANCER, V129, P2522, DOI 10.1002/ijc.25895; Sakorafas GH, 2003, DIGEST LIVER DIS, V35, P482, DOI 10.1016/S1590-8658(03)00221-4; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Wang F, 2007, CANCER RES, V67, P8486, DOI 10.1158/0008-5472.CAN-07-0498; Weinberg RA, 2008, CARCINOGENESIS, V29, P1092, DOI 10.1093/carcin/bgn104; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	47	1414	1464	7	288	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					349	361		10.1016/j.cell.2011.11.025	http://dx.doi.org/10.1016/j.cell.2011.11.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265420	Green Accepted, Bronze			2022-12-24	WOS:000299540700036
J	Watson, PJ; Fairall, L; Santos, GM; Schwabe, JWR				Watson, Peter J.; Fairall, Louise; Santos, Guilherme M.; Schwabe, John W. R.			Structure of HDAC3 bound to co-repressor and inositol tetraphosphate	NATURE			English	Article							NUCLEAR RECEPTOR COREPRESSOR; HISTONE DEACETYLASE; N-COR; PROTEIN COMPLEXES; SMRT; KINASE; ACETYLATION; ALPHA; 1,4,5-TRISPHOSPHATE; TRANSCRIPTION	Histone deacetylase enzymes (HDACs) are emerging cancer drug targets. They regulate gene expression by removing acetyl groups from lysine residues in histone tails, resulting in chromatin condensation. The enzymatic activity of most class I HDACs requires recruitment into multi-subunit co-repressor complexes, which are in turn recruited to chromatin by repressive transcription factors. Here we report the structure of a complex between an HDAC and a co-repressor, namely, human HDAC3 with the deacetylase activation domain (DAD) from the human SMRT co-repressor (also known as NCOR2). The structure reveals two remarkable features. First, the SMRT-DAD undergoes a large structural rearrangement on forming the complex. Second, there is an essential inositol tetraphosphate molecule-D-myo-inositol-(1,4,5,6)-tetrakisphosphate (Ins(1,4,5,6)P-4)-acting as an 'intermolecular glue' between the two proteins. Assembly of the complex is clearly dependent on the Ins(1,4,5,6)P-4, which may act as a regulator-potentially explaining why inositol phosphates and their kinases have been found to act as transcriptional regulators. This mechanism for the activation of HDAC3 appears to be conserved in class I HDACs from yeast to humans, and opens the way to novel therapeutic opportunities.	[Watson, Peter J.; Fairall, Louise; Santos, Guilherme M.; Schwabe, John W. R.] Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England	University of Leicester	Schwabe, JWR (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England.	john.schwabe@le.ac.uk	Schwabe, John WR/A-9132-2008; Fairall, Louise/G-6763-2013	Schwabe, John WR/0000-0003-2865-4383; Santos, Guilherme/0000-0003-1489-2161; Fairall, Louise/0000-0001-9456-3047; Fairall, Lara/0000-0002-7460-4670	Wellcome Trust [WT085408]	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank R. Owen and the other beamline staff at DIAMOND I24 for help with data collection; J. Goodchild for help with biochemical experiments; and S. Cowley, M. Lazar, P. Moody, L. Nagy, P. Tontonoz and S. Shears for literature and discussions. This work was supported by the Wellcome Trust (grant WT085408).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Bressi JC, 2010, BIOORG MED CHEM LETT, V20, P3142, DOI 10.1016/j.bmcl.2010.03.091; Caffrey JJ, 2001, FEBS LETT, V499, P6, DOI 10.1016/S0014-5793(01)02500-5; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Codina A, 2005, P NATL ACAD SCI USA, V102, P6009, DOI 10.1073/pnas.0500299102; Craxton A, 1997, BIOCHEM J, V328, P75, DOI 10.1042/bj3280075; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; El Alami M, 2003, MOL MICROBIOL, V49, P457, DOI 10.1046/j.1365-2958.2003.03562.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hildmann C, 2007, APPL MICROBIOL BIOT, V75, P487, DOI 10.1007/s00253-007-0911-2; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Ishizuka T, 2005, MOL ENDOCRINOL, V19, P1443, DOI 10.1210/me.2005-0009; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lechner T, 2000, J BIOL CHEM, V275, P40961, DOI 10.1074/jbc.M005730200; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; MATTINGLY RR, 1991, J BIOL CHEM, V266, P15144; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nalaskowski MM, 2002, BIOCHEM J, V366, P549, DOI 10.1042/BJ20020327; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; POGO BGT, 1966, P NATL ACAD SCI USA, V55, P805, DOI 10.1073/pnas.55.4.805; Saiardi A, 2001, P NATL ACAD SCI USA, V98, P2306, DOI 10.1073/pnas.041614598; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; You SH, 2010, MOL ENDOCRINOL, V24, P1359, DOI 10.1210/me.2009-0501; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	50	323	330	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					335	U114		10.1038/nature10728	http://dx.doi.org/10.1038/nature10728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22230954	Green Accepted			2022-12-24	WOS:000299210600036
J	Zhang, L; Ding, XJ; Cui, J; Xu, H; Chen, J; Gong, YN; Hu, LY; Zhou, Y; Ge, JN; Lu, QH; Liu, LP; Chen, S; Shao, F				Zhang, Li; Ding, Xiaojun; Cui, Jixin; Xu, Hao; Chen, Jing; Gong, Yi-Nan; Hu, Liyan; Zhou, Yan; Ge, Jianning; Lu, Qiuhe; Liu, Liping; Chen, She; Shao, Feng			Cysteine methylation disrupts ubiquitin-chain sensing in NF-kappa B activation	NATURE			English	Article							ESCHERICHIA-COLI ADA; POLYUBIQUITIN CHAINS; EFFECTOR FAMILY; BINDING; PROTEIN; TAB3; PATHWAY; COMPLEX; DOMAIN; ZINC	NF-kappa B is crucial for innate immune defence against microbial infection(1,2). Inhibition of NF-kappa B signalling has been observed with various bacterial infections(3,4). The NF-kappa B pathway critically requires multiple ubiquitin-chain signals of different natures(5,6). The question of whether ubiquitin-chain signalling and its specificity in NF-kappa B activation are regulated during infection, and how this regulation takes place, has not been explored. Here we show that human TAB2 and TAB3, ubiquitin-chain sensory proteins involved in NF-kappa B signalling, are directly inactivated by enteropathogenic Escherichia coli NleE, a conserved bacterial type-III-secreted effector responsible for blocking host NF-kappa B signalling. NleE harboured an unprecedented S-adenosyl-L-methionine-dependent methyltransferase activity that specifically modified a zinc-coordinating cysteine in the Npl4 zinc finger ( NZF) domains in TAB2 and TAB3. Cysteine-methylated TAB2-NZF and TAB3-NZF ( truncated proteins only comprising the NZF domain) lost the zinc ion as well as the ubiquitin-chain binding activity. Ectopically expressed or type-III-secretion-system-delivered NleE methylated TAB2 and TAB3 in host cells and diminished their ubiquitin-chain binding activity. Replacement of the NZF domain of TAB3 with the NleE methylation-insensitive Npl4 NZF domain resulted in NleE-resistant NF-kappa B activation. Given the prevalence of zinc-finger motifs and activation of cysteine thiol by zinc binding, methylation of zinc-finger cysteine might regulate other eukaryotic pathways in addition to NF-kappa B signalling.	[Zhang, Li; Ding, Xiaojun; Cui, Jixin; Xu, Hao; Chen, Jing; Gong, Yi-Nan; Hu, Liyan; Zhou, Yan; Ge, Jianning; Lu, Qiuhe; Liu, Liping; Chen, She; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhang, Li] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Zhang, Li] Peking Union Med Coll, Beijing 100730, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	liu, li/HGC-0900-2022; Chen, Jing/AAM-1808-2020	Chen, Jing/0000-0002-9874-8150; Lu, Qiuhe/0000-0002-0202-7448	National Basic Research Program of China (973 Programs) [2010CB835400, 2012CB518700]	National Basic Research Program of China (973 Programs)(National Basic Research Program of China)	We thank I. Rosenshine for providing NleE deletion strains, K. Iwai for the HOIL-1L and HOIP expression plasmids, H. Sakurai for the phospho-TAK1 antibody, Z. Chen for TAB2/3 and Npl4-NZF chimera constructs, and S. Fukai for the NZF expression plasmid. We also thank members of the Shao laboratory for helpful discussions and technical assistance. This work was supported by the National Basic Research Program of China (973 Programs, 2010CB835400 and 2012CB518700).	Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Castro C, 2004, BIOCHEMISTRY-US, V43, P5341, DOI 10.1021/bi049821x; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Cui JX, 2011, TRENDS BIOCHEM SCI, V36, P532, DOI 10.1016/j.tibs.2011.07.003; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Ge JN, 2009, P NATL ACAD SCI USA, V106, P13725, DOI 10.1073/pnas.0907200106; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He C, 2005, MOL CELL, V20, P117, DOI 10.1016/j.molcel.2005.08.013; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Koutmos M, 2008, P NATL ACAD SCI USA, V105, P3286, DOI 10.1073/pnas.0709960105; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Matthews RG, 1997, CURR OPIN CHEM BIOL, V1, P332, DOI 10.1016/S1367-5931(97)80070-1; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; SEDGWICK B, 1988, J BIOL CHEM, V263, P4430; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Terzic J, 2007, BIOCHEM SOC T, V35, P942, DOI 10.1042/BST0350942; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vossenkamper A, 2010, J IMMUNOL, V185, P4118, DOI 10.4049/jimmunol.1000500; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200	35	147	156	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					204	+		10.1038/nature10690	http://dx.doi.org/10.1038/nature10690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22158122				2022-12-24	WOS:000298981200040
J	Sjostrom, L; Peltonen, M; Jacobson, P; Sjostrom, CD; Karason, K; Wedel, H; Ahlin, S; Anveden, A; Bengtsson, C; Bergmark, G; Bouchard, C; Carlsson, B; Dahlgren, S; Karlsson, J; Lindroos, AK; Lonroth, H; Narbro, K; Naslund, I; Olbers, T; Svensson, PA; Carlsson, LMS				Sjostrom, Lars; Peltonen, Markku; Jacobson, Peter; Sjostrom, C. David; Karason, Kristjan; Wedel, Hans; Ahlin, Sofie; Anveden, Asa; Bengtsson, Calle; Bergmark, Gerd; Bouchard, Claude; Carlsson, Bjorn; Dahlgren, Sven; Karlsson, Jan; Lindroos, Anna-Karin; Lonroth, Hans; Narbro, Kristina; Naslund, Ingmar; Olbers, Torsten; Svensson, Per-Arne; Carlsson, Lena M. S.			Bariatric Surgery and Long-term Cardiovascular Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SWEDISH OBESE SUBJECTS; RISK-FACTORS; WEIGHT-LOSS; LIFE-STYLE; SUBJECTS SOS; DIABETES PREVENTION; MORTALITY; INTERVENTION; OVERWEIGHT; HEALTH	Context Obesity is a risk factor for cardiovascular events. Weight loss might protect against cardiovascular events, but solid evidence is lacking. Objective To study the association between bariatric surgery, weight loss, and cardiovascular events. Design, Setting, and Participants The Swedish Obese Subjects (SOS) study is an ongoing, nonrandomized, prospective, controlled study conducted at 25 public surgical departments and 480 primary health care centers in Sweden of 2010 obese participants who underwent bariatric surgery and 2037 contemporaneously matched obese controls who received usual care. Patients were recruited between September 1, 1987, and January 31, 2001. Date of analysis was December 31, 2009, with median follow-up of 14.7 years (range, 0-20 years). Inclusion criteria were age 37 to 60 years and a body mass index of at least 34 in men and at least 38 in women. Exclusion criteria were identical in surgery and control patients. Surgery patients underwent gastric bypass (13.2%), banding (18.7%), or vertical banded gastroplasty (68.1%), and controls received usual care in the Swedish primary health care system. Physical and biochemical examinations and database cross-checks were undertaken at preplanned intervals. Main Outcome Measures The primary end point of the SOS study (total mortality) was published in 2007. Myocardial infarction and stroke were predefined secondary end points, considered separately and combined. Results Bariatric surgery was associated with a reduced number of cardiovascular deaths (28 events among 2010 patients in the surgery group vs 49 events among 2037 patients in the control group; adjusted hazard ratio [HR], 0.47; 95% CI, 0.29-0.76; P=.002). The number of total first time (fatal or nonfatal) cardiovascular events (myocardial infarction or stroke, whichever came first) was lower in the surgery group (199 events among 2010 patients) than in the control group (234 events among 2037 patients; adjusted HR, 0.67; 95% CI, 0.54-0.83; P<.001). Conclusion Compared with usual care, bariatric surgery was associated with reduced number of cardiovascular deaths and lower incidence of cardiovascular events in obese adults. JAMA. 2012;307(1):56-65	[Sjostrom, Lars; Jacobson, Peter; Sjostrom, C. David; Karason, Kristjan; Ahlin, Sofie; Anveden, Asa; Bergmark, Gerd; Carlsson, Bjorn; Svensson, Per-Arne; Carlsson, Lena M. S.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden; [Lonroth, Hans; Olbers, Torsten] Univ Gothenburg, Sahlgrenska Acad, Inst Surg, Gothenburg, Sweden; [Bengtsson, Calle] Univ Gothenburg, Sahlgrenska Acad, Inst Primary Hlth Care, Gothenburg, Sweden; [Karlsson, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Hlth & Care Sci, Gothenburg, Sweden; [Peltonen, Markku] Natl Inst Hlth & Welf, Chron Dis Epidemiol & Prevent Unit, Helsinki, Finland; [Wedel, Hans] Nord Sch Publ Hlth, Gothenburg, Sweden; [Bouchard, Claude] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Dahlgren, Sven] Umea Univ Hosp, Dept Surg, S-90185 Umea, Sweden; [Lindroos, Anna-Karin] Natl Food Adm Toxicol Lab, Dept Nutr, Uppsala, Sweden; [Narbro, Kristina] Dept Hlth Care, Gothenburg, Sweden; [Naslund, Ingmar] Univ Hosp, Dept Surg, Orebro, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; Finland National Institute for Health & Welfare; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Umea University; Orebro University	Sjostrom, L (corresponding author), Sahlgrens Univ Hosp, Inst Med, Vita Straket 15, S-41345 Gothenburg, Sweden.	lars.v.sjostrom@medfak.gu.se	Peltonen, Markku/F-3037-2015; Carlsson, Lena/F-7570-2018; Bouchard, Claude/AAE-2035-2019; Svensson, Per-Arne/R-4626-2019; Bouchard, Claude/A-7637-2009	Peltonen, Markku/0000-0002-3767-4223; Carlsson, Lena/0000-0003-4145-6242; Bouchard, Claude/0000-0002-0048-491X; Karason, Kristjan/0000-0002-2802-1191; Jacobson, Peter/0000-0002-1769-1827; Svensson, Per-Arne/0000-0002-6731-806X; Ahlin, Sofie/0000-0003-0619-2683; Olbers, Torsten/0000-0002-7218-3390	sanofi-aventis; Johnson Johnson; AstraZeneca; Biovitrum; Bristol-Myers Squibb; GlaxoSmithKline; Lenimen; Merck; Novo Nordisk; Hoffmann LaRoche; Servier; MSD; Ethicon; Pfizer; Novartis; Weight Watchers Scientific Advisory Board; Covidien; Swedish Medical Research Council; Swedish Research Council [K2010-55X-11285-13]; Swedish Foundation for Strategic Research; Cederroths	sanofi-aventis(Sanofi-Aventis); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); AstraZeneca(AstraZeneca); Biovitrum; Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Lenimen; Merck(Merck & Company); Novo Nordisk(Novo Nordisk); Hoffmann LaRoche(Hoffmann-La Roche); Servier(Servier); MSD; Ethicon; Pfizer(Pfizer); Novartis(Novartis); Weight Watchers Scientific Advisory Board; Covidien; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Cederroths	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr L. Sjostrom reported obtaining unrestricted Swedish Obese Subjects grants from sanofi-aventis and Johnson & Johnson since 2007; receiving lecture and consulting fees from AstraZeneca, Biovitrum, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Lenimen, Merck, Novo Nordisk, Hoffmann LaRoche, sanofi-aventis, and Servier; and holding stocks in Lenimen and being chairman of its board. Dr Jacobson reported receiving research grants from Hoffmann LaRoche. Dr C. Sjostrom reported being employed by AstraZeneca and receiving consulting and/or lecture fees from sanofi-aventis, MSD, and Ethicon. Dr Wedel reported receiving consulting fees from AstraZeneca, Pfizer, Novartis, and Hoffmann LaRoche without relation to the submitted work. Dr Bouchard reported receiving consulting fees from the Weight Watchers Scientific Advisory Board and unrestricted grants from Bristol-Myers Squibb. Dr B. Carlsson reported being employed by and holding stocks in AstraZeneca. Dr Karlsson reported serving as consultant for Pfizer. Dr Lindroos reported serving as a consultant for Abbott. Dr Naslund reported receiving lecture fees from Johnson & Johnson. Dr Olbers reported receiving lecture fees on speakers bureaus from Johnson & Johnson and Covidien and receiving travel expenses from Johnson & Johnson. Dr L. Carlsson reported serving as a consultant for AstraZeneca and holding stocks in Sahltech. All other authors declared no conflicts of interest.; This study was supported by grants from the Swedish Medical Research Council, the Swedish Research Council (K2010-55X-11285-13), the Swedish Foundation for Strategic Research to Sahlgrenska Centre for Cardiovascular and Metabolic Research, and the Swedish federal government under the LUA/ALF agreement (Dr L. Sjostrom). These research grants applied for as ordinary Research Council grants are paid by the Swedish State to the university hospitals as compensation for teaching costs. Unconditional support was also obtained from Hoffmann LaRoche, AstraZeneca, Cederroths, sanofi-aventis, and Johnson & Johnson.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; [Anonymous], 2009, DIABETES CARE, V32, pS3, DOI 10.2337/dc09-S003; BROLIN RE, 1987, GASTROENTEROL CLIN N, V16, P317; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Dixon JB, 2011, DIABETIC MED, V28, P628, DOI 10.1111/j.1464-5491.2011.03306.x; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Karlsson J, 2007, INT J OBESITY, V31, P1248, DOI 10.1038/sj.ijo.0803573; KARLSSON J, 1995, J CLIN EPIDEMIOL, V48, P817, DOI 10.1016/0895-4356(94)00196-W; LEE IM, 1992, JAMA-J AM MED ASSOC, V268, P2045, DOI 10.1001/jama.268.15.2045; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; National Institutes of Health (USA), 1992, American Journal of Clinical Nutrition, V55, p615S; Nilsson PM, 2002, J INTERN MED, V252, P70, DOI 10.1046/j.1365-2796.2002.01010.x; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; PAMUK ER, 1993, ANN INTERN MED, V119, P744, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00023; Poobalan A, 2004, Obes Rev, V5, P43, DOI 10.1111/j.1467-789X.2004.00127.x; Rubino F, 2010, ANN SURG, V251, P399, DOI 10.1097/SLA.0b013e3181be34e7; Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148; Sjostrom CD, 2011, INT J OBESITY, V35, P1413, DOI 10.1038/ijo.2010.282; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Sjostrom L, 2000, ENDOCRINE, V13, P213, DOI 10.1385/ENDO:13:2:213; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Torgerson JS, 2003, AM J GASTROENTEROL, V98, P1032, DOI 10.1016/S0002-9270(03)00147-3; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; WALKER M, 1995, INT J EPIDEMIOL, V24, P694, DOI 10.1093/ije/24.4.694; Wannamethee SG, 2000, AM J EPIDEMIOL, V151, P667, DOI 10.1093/oxfordjournals.aje.a010261; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Williamson DF, 2000, DIABETES CARE, V23, P1499, DOI 10.2337/diacare.23.10.1499; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Yaari S, 1998, AM J EPIDEMIOL, V148, P546, DOI 10.1093/oxfordjournals.aje.a009680; Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780	39	1035	1063	1	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2012	307	1					56	65		10.1001/jama.2011.1914	http://dx.doi.org/10.1001/jama.2011.1914			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872ET	22215166	Bronze			2022-12-24	WOS:000298792300022
J	Alvarez, JI; Dodelet-Devillers, A; Kebir, H; Ifergan, I; Fabre, PJ; Terouz, S; Sabbagh, M; Wosik, K; Bourbonniere, L; Bernard, M; van Horssen, J; de Vries, HE; Charron, F; Prat, A				Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J.; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonniere, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E.; Charron, Frederic; Prat, Alexandre			The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; ASTROCYTE-ENDOTHELIAL INTERACTIONS; MULTIPLE-SCLEROSIS; AUTOIMMUNE ENCEPHALOMYELITIS; SPECIFICATION; ANGIOGENESIS; INFLAMMATION; LYMPHOCYTES; DISRUPTION; EXPRESSION	The blood-brain barrier (BBB) is composed of tightly bound endothelial cells (ECs) and perivascular astrocytes that regulate central nervous system (CNS) homeostasis. We showed that astrocytes secrete Sonic hedgehog and that BBB ECs express Hedgehog (Hh) receptors, which together promote BBB formation and integrity during embryonic development and adulthood. Using pharmacological inhibition and genetic inactivation of the Hh signaling pathway in ECs, we also demonstrated a critical role of the Hh pathway in promoting the immune quiescence of BBB ECs by decreasing the expression of proinflammatory mediators and the adhesion and migration of leukocytes, in vivo and in vitro. Overall, the Hh pathway provides a barrier-promoting effect and an endogenous anti-inflammatory balance to CNS-directed immune attacks, as occurs in multiple sclerosis.	[Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonniere, Lyne; Bernard, Monique; Prat, Alexandre] Univ Montreal, Ctr Rech, Ctr Excellence Neur, Neuroimmunol Unit,Ctr Hosp Univ Montreal,Fac Med, Montreal, PQ H2L 4M1, Canada; [Fabre, Pierre J.; Charron, Frederic] Univ Montreal, Inst Rech Clin Montreal, Lab Mol Biol Neural Dev, Montreal, PQ H2W 1R7, Canada; [Fabre, Pierre J.; Charron, Frederic] Univ Montreal, Dept Med, Montreal, PQ H2W 1R7, Canada; [van Horssen, Jack; de Vries, Helga E.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands	Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Prat, A (corresponding author), Univ Montreal, Ctr Rech, Ctr Excellence Neur, Neuroimmunol Unit,Ctr Hosp Univ Montreal,Fac Med, Montreal, PQ H2L 4M1, Canada.	a.prat@umontreal.ca	Ifergan, Igal/AAI-9734-2020; Fabre, Pierre J/A-6800-2017; Fabre, Pierre/O-5763-2019; Ifergan, Igal/AAR-7849-2021; Charron, Frederic/O-8017-2019; Charron, Frederic/D-2140-2009	Fabre, Pierre J/0000-0002-5936-8120; Ifergan, Igal/0000-0003-2945-2580; Charron, Frederic/0000-0003-3483-8672; Charron, Frederic/0000-0003-3483-8672; Prat, Alexandre/0000-0001-6188-0580; Kebir, Hania/0000-0001-6174-8846; van Horssen, Jack/0000-0003-4078-7402; de Vries, Helga/0000-0001-7904-7124	Canadian Institutes of Health Research [MOP81880, MOP74700]; Multiple Sclerosis Society of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada	This study was supported by grants from the Canadian Institutes of Health Research (MOP81880 to A. P. and MOP74700 to F. C.) and by the Multiple Sclerosis Society of Canada. We thank C. Podjaski and F. Berthelet for their technical help, J. P. Antel and M. Blain for providing primary cultures of human fetal astrocytes, and N. Arbour for providing critical feedback on experimental procedures.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; ARTHUR FE, 1987, DEV BRAIN RES, V36, P155, DOI 10.1016/0165-3806(87)90075-7; BAUER HC, 1993, DEV BRAIN RES, V75, P269, DOI 10.1016/0165-3806(93)90031-5; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Byrd N, 2004, TRENDS CARDIOVAS MED, V14, P308, DOI 10.1016/j.tcm.2004.09.003; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dodelet-Devillers A, 2009, J MOL MED, V87, P765, DOI 10.1007/s00109-009-0488-6; Ek CJ, 2006, J COMP NEUROL, V496, P13, DOI 10.1002/cne.20885; Fontijn RD, 2008, AM J PHYSIOL-HEART C, V294, pH891, DOI 10.1152/ajpheart.01248.2007; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; Hashizume A, 2006, BIOCHEM BIOPH RES CO, V339, P996, DOI 10.1016/j.bbrc.2005.11.106; Hochman E, 2006, J BIOL CHEM, V281, P33860, DOI 10.1074/jbc.M605905200; Kanda S, 2003, J BIOL CHEM, V278, P8244, DOI 10.1074/jbc.M210635200; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Nagase T, 2008, ANGIOGENESIS, V11, P71, DOI 10.1007/s10456-008-9105-5; Osterlund T, 2006, TRENDS CELL BIOL, V16, P176, DOI 10.1016/j.tcb.2006.02.004; Prat A, 2002, ARCH NEUROL-CHICAGO, V59, P391, DOI 10.1001/archneur.59.3.391; Prat A, 2001, GLIA, V36, P145, DOI 10.1002/glia.1104; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; RUBIN LL, 1991, ANN NY ACAD SCI, V633, P420; Saunders NR, 2008, TRENDS NEUROSCI, V31, P279, DOI 10.1016/j.tins.2008.03.003; Seifert T, 2005, J NEUROPATH EXP NEUR, V64, P404, DOI 10.1093/jnen/64.5.404; TAOCHENG JH, 1987, J NEUROSCI, V7, P3293; Wang Y, 2008, ANN NEUROL, V64, P417, DOI 10.1002/ana.21457; Xu QG, 2008, NEUROSCIENCE, V152, P877, DOI 10.1016/j.neuroscience.2008.01.060	35	488	509	4	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1727	1731		10.1126/science.1206936	http://dx.doi.org/10.1126/science.1206936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22144466				2022-12-24	WOS:000298344000074
J	Bregman, A; Avraham-Kelbert, M; Barkai, O; Duek, L; Guterman, A; Choder, M				Bregman, Almog; Avraham-Kelbert, Moran; Barkai, Oren; Duek, Lea; Guterman, Adi; Choder, Mordechai			Promoter Elements Regulate Cytoplasmic mRNA Decay	CELL			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; CODING REGION; YEAST; PROTEIN; DEGRADATION; TURNOVER; TRANSLATION; STABILITY; SUBUNIT	Promoters are DNA elements that enable transcription and its regulation by trans-acting factors. Here, we demonstrate that yeast promoters can also regulate mRNA decay after the mRNA leaves the nucleus. A conventional yeast promoter consists of a core element and an upstream activating sequence (UAS). We find that changing UASs of a reporter gene without altering the transcript sequence affects the transcript's decay kinetics. A short cis element, comprising two Rap1p-binding sites, and Rap1p itself, are necessary and sufficient to induce enhanced decay of the reporter mRNA. Furthermore, Rap1p stimulates both the synthesis and the decay of a specific population of endogenous mRNAs. We propose that Rap1p association with target promoter in the nucleus affects the composition of the exported mRNP, which in turn regulates mRNA decay in the cytoplasm. Thus, promoters can play key roles in determining mRNA levels and have the capacity to coordinate rates of mRNA synthesis and decay.	[Bregman, Almog; Avraham-Kelbert, Moran; Barkai, Oren; Duek, Lea; Guterman, Adi; Choder, Mordechai] Technion Israel Inst Technol, Dept Mol Microbiol, Rappaport Fac Med, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Choder, M (corresponding author), Technion Israel Inst Technol, Dept Mol Microbiol, Rappaport Fac Med, IL-31096 Haifa, Israel.	choder@technion.ac.il			US-Israel Binational Science Foundation (BSF); Israel Science Foundation, Israel Ministry of Health; Rappaport Foundation	US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Science Foundation, Israel Ministry of Health(Israel Science Foundation); Rappaport Foundation	We thank Allan Jacobson for advice during this project. We thank Elite Levin for statistical analyses. Special thanks to Jonathan Warner, whose constructs were used as key reagents in this work. We thank Stephane Marcand for Rap1p-depletable strains, Tony Weil for anti-Rap1p antibodies, and David Shore for critically reading the manuscript before submission. This work was supported by the US-Israel Binational Science Foundation (BSF), by the Israel Science Foundation, Israel Ministry of Health, and by Rappaport Foundation.	Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Cao D, 2001, RNA, V7, P1192, DOI 10.1017/S1355838201010330; Choder Mordechai, 2011, Cell Logist, V1, P37, DOI 10.4161/cl.1.1.14465; Clark A, 2009, FRONT BIOSCI-LANDMRK, V14, P847, DOI 10.2741/3282; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Dahan O, 2011, TRENDS GENET, V27, P316, DOI 10.1016/j.tig.2011.05.008; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dori-Bachash M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001106; Elkon R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-259; ENSSLE J, 1993, P NATL ACAD SCI USA, V90, P10091, DOI 10.1073/pnas.90.21.10091; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Goler-Baron V, 2008, GENE DEV, V22, P2022, DOI 10.1101/gad.473608; GUARENTE L, 1988, CELL, V52, P303, DOI 10.1016/S0092-8674(88)80020-5; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hilleren PJ, 2003, MOL CELL, V12, P1453, DOI 10.1016/S1097-2765(03)00488-X; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; LaGrandeur T, 1999, RNA, V5, P420, DOI 10.1017/S1355838299981748; LARIMER FW, 1992, GENE, V120, P51, DOI 10.1016/0378-1119(92)90008-D; Lascaris RF, 1999, BIOINFORMATICS, V15, P267, DOI 10.1093/bioinformatics/15.4.267; Leipuviene R, 2007, CELL MOL LIFE SCI, V64, P2945, DOI 10.1007/s00018-007-7198-4; Li BJ, 1999, MOL CELL BIOL, V19, P5393; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu H, 2006, BIOCHEM SOC T, V34, P35, DOI 10.1042/BST0340035; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Lotan R, 2007, J CELL BIOL, V178, P1133, DOI 10.1083/jcb.200701165; Molin C, 2009, RNA, V15, P600, DOI 10.1261/rna.1403509; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; MUHLRAD D, 1992, GENE DEV, V6, P2100, DOI 10.1101/gad.6.11.2100; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pardo B, 2005, EMBO J, V24, P3117, DOI 10.1038/sj.emboj.7600778; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; PARKER R, 1990, P NATL ACAD SCI USA, V87, P2780, DOI 10.1073/pnas.87.7.2780; Pelechano V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000614; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; SACHS AB, 1989, CELL, V58, P857, DOI 10.1016/0092-8674(89)90938-0; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Shalem O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002273; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; TIPPER DJ, 1973, J BACTERIOL, V116, P245, DOI 10.1128/JB.116.1.245-256.1973; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000; VREKEN P, 1992, MOL CELL BIOL, V12, P2986, DOI 10.1128/MCB.12.7.2986; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011	50	128	129	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1473	1483		10.1016/j.cell.2011.12.005	http://dx.doi.org/10.1016/j.cell.2011.12.005			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196725	Bronze			2022-12-24	WOS:000298403400013
J	Ram, O; Goren, A; Amit, I; Shoresh, N; Yosef, N; Ernst, J; Kellis, M; Gymrek, M; Issner, R; Coyne, M; Durham, T; Zhang, XL; Donaghey, J; Epstein, CB; Regev, A; Bernstein, BE				Ram, Oren; Goren, Alon; Amit, Ido; Shoresh, Noam; Yosef, Nir; Ernst, Jason; Kellis, Manolis; Gymrek, Melissa; Issner, Robbyn; Coyne, Michael; Durham, Timothy; Zhang, Xiaolan; Donaghey, Julie; Epstein, Charles B.; Regev, Aviv; Bernstein, Bradley E.			Combinatorial Patterning of Chromatin Regulators Uncovered by Genome-wide Location Analysis in Human Cells	CELL			English	Article							LINKED MENTAL-RETARDATION; EMBRYONIC STEM-CELLS; HISTONE; POLYCOMB; GENE; TRANSCRIPTION; PROTEINS; CHROMODOMAINS; MECHANISMS; ENHANCERS	Hundreds of chromatin regulators (CRs) control chromatin structure and function by catalyzing and binding histone modifications, yet the rules governing these key processes remain obscure. Here, we present a systematic approach to infer CR function. We developed ChIP-string, a meso-scale assay that combines chromatin immunoprecipitation with a signature readout of 487 representative loci. We applied ChIP-string to screen 145 antibodies, thereby identifying effective reagents, which we used to map the genome-wide binding of 29 CRs in two cell types. We found that specific combinations of CRs colocalize in characteristic patterns at distinct chromatin environments, at genes of coherent functions, and at distal regulatory elements. When comparing between cell types, CRs redistribute to different loci but maintain their modular and combinatorial associations. Our work provides a multiplex method that substantially enhances the ability to monitor CR binding, presents a large resource of CR maps, and reveals common principles for combinatorial CR function.	[Ram, Oren; Goren, Alon; Amit, Ido; Shoresh, Noam; Yosef, Nir; Ernst, Jason; Kellis, Manolis; Gymrek, Melissa; Issner, Robbyn; Coyne, Michael; Durham, Timothy; Zhang, Xiaolan; Donaghey, Julie; Epstein, Charles B.; Regev, Aviv; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ram, Oren; Goren, Alon; Amit, Ido; Yosef, Nir; Gymrek, Melissa; Regev, Aviv; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ram, Oren; Goren, Alon; Gymrek, Melissa; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ram, Oren; Goren, Alon; Gymrek, Melissa; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ram, Oren; Goren, Alon; Gymrek, Melissa; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Ram, Oren; Goren, Alon; Gymrek, Melissa; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Ernst, Jason; Kellis, Manolis] MIT Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02140 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	aregev@broad.mit.edu; bernstein.bradley@mgh.harvard.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630; Epstein, Charles B./0000-0001-8358-8345; Goren, Alon/0000-0001-5669-9357; Issner, Robbyn/0000-0003-4132-9219; Gymrek, Melissa/0000-0002-6086-3903	EMBO; American Recovery and Reinvestment Act (ARRA) [U54 HG004570]; NHGRI; Howard Hughes Medical Institute; NIH; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, U54HG004570] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); American Recovery and Reinvestment Act (ARRA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank B. Knoechel, C. Ye, J. Jaffe, and R. Mostoslavsky for helpful discussions; G. Geiss and R. Boykin for help with assay development; R. Raychowdhury and the Broad Sequencing Platform for technical assistance; X. Li and Y. Shi for Plu1 antibody; D. Jang, J. Robinson, and T. Liefeld for building the CRome portal; and L. Gaffney for figure preparation. O.R. and A.G. were supported by an EMBO fellowship. The work was supported by American Recovery and Reinvestment Act (ARRA) funds through grant number U54 HG004570 (to B.E.B.), by an NHGRI CEGS grant (A.R. and B.E.B), Howard Hughes Medical Institute (A.R. and B.E.B.), an NIH PIONEER award (A.R.), and the Burroughs Wellcome Fund (A.R. and B.E.B.). A.R. is a researcher of the Merkin Foundation for Stem Cell Research at the Broad Institute.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Elsasser SJ, 2011, SCIENCE, V331, P1145, DOI 10.1126/science.1203280; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Ren XJ, 2011, MOL CELL BIOL, V31, P2100, DOI 10.1128/MCB.05088-11; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Vidal M, 2009, INT J DEV BIOL, V53, P355, DOI 10.1387/ijdb.082690mv; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015; Zhang ZH, 2011, CELL, V144, P175, DOI 10.1016/j.cell.2011.01.003; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	41	249	265	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1628	1639		10.1016/j.cell.2011.09.057	http://dx.doi.org/10.1016/j.cell.2011.09.057			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196736	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000298403400025
J	Spatzal, T; Aksoyoglu, M; Zhang, LM; Andrade, SLA; Schleicher, E; Weber, S; Rees, DC; Einsle, O				Spatzal, Thomas; Aksoyoglu, Muege; Zhang, Limei; Andrade, Susana L. A.; Schleicher, Erik; Weber, Stefan; Rees, Douglas C.; Einsle, Oliver			Evidence for Interstitial Carbon in Nitrogenase FeMo Cofactor	SCIENCE			English	Article									[Spatzal, Thomas; Andrade, Susana L. A.; Einsle, Oliver] Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany; [Aksoyoglu, Muege; Schleicher, Erik; Weber, Stefan] Univ Freiburg, Inst Phys Chem, D-79104 Freiburg, Germany; [Zhang, Limei; Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Andrade, Susana L. A.; Einsle, Oliver] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; California Institute of Technology; Howard Hughes Medical Institute; University of Freiburg	Einsle, O (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany.	einsle@biochemie.uni-freiburg.de	Andrade, Susana L. A./D-5119-2012; Schleicher, Erik/C-9951-2010; Weber, Stefan/G-6164-2010	Andrade, Susana L. A./0000-0003-2267-8499; Einsle, Oliver/0000-0001-8722-2893; Schleicher, Erik/0000-0003-2953-050X; Kasanmascheff, Muge/0000-0002-8964-8924	Deutsche Forschungsgemeinschaft [Ei-520/7, An-676/1, IRTG 1478]; Natural Sciences and Engineering Research Council of Canada; NIH [GM45162]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045162, R37GM045162] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at Swiss Light Source, Villigen, Switzerland, and S. M. Consiglio for assistance with the calculations. The work was supported by Deutsche Forschungsgemeinschaft (grants Ei-520/7 to O.E., An-676/1 to S. L. A. A., and IRTG 1478), Natural Sciences and Engineering Research Council of Canada postdoctoral fellowship to L.Z., NIH (grant GM45162 to D. C. R.), and HHMI (to D. C. R.). The structural model and structure factors have been deposited with the Protein Data Bank (accession code 3U7Q).	Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Lukoyanov D, 2007, INORG CHEM, V46, P11437, DOI 10.1021/ic7018814; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539	3	612	619	13	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 18	2011	334	6058					940	940		10.1126/science.1214025	http://dx.doi.org/10.1126/science.1214025			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CA	22096190	Green Accepted			2022-12-24	WOS:000297101800045
J	Kang, TW; Yevsa, T; Woller, N; Hoenicke, L; Wuestefeld, T; Dauch, D; Hohmeyer, A; Gereke, M; Rudalska, R; Potapova, A; Iken, M; Vucur, M; Weiss, S; Heikenwalder, M; Khan, S; Gil, J; Bruder, D; Manns, M; Schirmacher, P; Tacke, F; Ott, M; Luedde, T; Longerich, T; Kubicka, S; Zender, L				Kang, Tae-Won; Yevsa, Tetyana; Woller, Norman; Hoenicke, Lisa; Wuestefeld, Torsten; Dauch, Daniel; Hohmeyer, Anja; Gereke, Marcus; Rudalska, Ramona; Potapova, Anna; Iken, Marcus; Vucur, Mihael; Weiss, Siegfried; Heikenwalder, Mathias; Khan, Sadaf; Gil, Jesus; Bruder, Dunja; Manns, Michael; Schirmacher, Peter; Tacke, Frank; Ott, Michael; Luedde, Tom; Longerich, Thomas; Kubicka, Stefan; Zender, Lars			Senescence surveillance of pre-malignant hepatocytes limits liver cancer development	NATURE			English	Article							MOUSE; RAS; FIBROBLASTS; SUPPRESSION; EXPRESSION; PATHWAY; MODELS; MICE; P53	Upon the aberrant activation of oncogenes, normal cells can enter the cellular senescence program, a state of stable cell-cycle arrest, which represents an important barrier against tumour development in vivo(1). Senescent cells communicate with their environment by secreting various cytokines and growth factors, and it was reported that this 'secretory phenotype' can have pro-as well as anti-tumorigenic effects(2-5). Here we show that oncogene-induced senescence occurs in otherwise normal murine hepatocytes in vivo. Pre-malignant senescent hepatocytes secrete chemo- and cytokines and are subject to immune-mediated clearance (designated as 'senescence surveillance'), which depends on an intact CD4(+) T-cell-mediated adaptive immune response. Impaired immune surveillance of pre-malignant senescent hepatocytes results in the development of murine hepatocellular carcinomas (HCCs), thus showing that senescence surveillance is important for tumour suppression in vivo. In accordance with these observations, ras-specific Th1 lymphocytes could be detected in mice, in which oncogene-induced senescence had been triggered by hepatic expression of Nras(G12V). We also found that CD4(+) T cells require monocytes/macrophages to execute the clearance of senescent hepatocytes. Our study indicates that senescence surveillance represents an important extrinsic component of the senescence anti-tumour barrier, and illustrates how the cellular senescence program is involved in tumour immune surveillance by mounting specific immune responses against antigens expressed in pre-malignant senescent cells.	[Kang, Tae-Won; Yevsa, Tetyana; Hoenicke, Lisa; Wuestefeld, Torsten; Dauch, Daniel; Hohmeyer, Anja; Gereke, Marcus; Rudalska, Ramona; Potapova, Anna; Weiss, Siegfried; Bruder, Dunja; Zender, Lars] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Yevsa, Tetyana; Woller, Norman; Wuestefeld, Torsten; Hohmeyer, Anja; Manns, Michael; Zender, Lars] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Iken, Marcus; Ott, Michael] Twincore Ctr Expt & Clin Infect Res, D-30625 Hannover, Germany; [Vucur, Mihael; Tacke, Frank; Luedde, Tom] Univ Hosp Aachen, Dept Internal Med 3, D-52074 Aachen, Germany; [Heikenwalder, Mathias] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland; [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Ctr Munich, Inst Virol, D-81675 Munich, Germany; [Khan, Sadaf; Gil, Jesus] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London W12 0NN, England; [Schirmacher, Peter; Longerich, Thomas] Univ Heidelberg, Inst Pathol, D-69120 Heidelberg, Germany; [Kubicka, Stefan] Dist Hosp Reutlingen, Clin Internal Med, D-72764 Reutlingen, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; RWTH Aachen University; RWTH Aachen University Hospital; University of Zurich; University Zurich Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Imperial College London; Ruprecht Karls University Heidelberg	Zender, L (corresponding author), Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany.	Lars.Zender@helmholtz-hzi.de	Heikenwalder, Mathias/AAA-2269-2020; Tacke, Frank/ABF-2212-2020; Kang, Tae Won/S-4864-2019; Gil, Jesus/C-7739-2012; Woller, Norman/AAU-2803-2021; Luedde, Tom/AAE-9135-2022	Kang, Tae Won/0000-0003-1497-8926; Gil, Jesus/0000-0002-4303-6260; Luedde, Tom/0000-0002-6288-8821; Woller, Norman/0000-0002-4928-0117; Hoenicke, Lisa/0000-0003-0613-8337; /0000-0002-2430-4397; Yevsa, Tetyana/0000-0003-0377-9198	Helmholtz Association of German Research Centres [VH-NG-424]; German Research Foundation, DFG [ZE 545/2-1, SFB/TRR77]; Wilhelm Sander Stiftung; Bear Necessities Pediatric Cancer Foundation; Federal German Ministry for Education and Research (BMBF); European Commission; Medical Research Council [MC_U120085810] Funding Source: researchfish; MRC [MC_U120085810] Funding Source: UKRI	Helmholtz Association of German Research Centres(Helmholtz Association); German Research Foundation, DFG(German Research Foundation (DFG)); Wilhelm Sander Stiftung; Bear Necessities Pediatric Cancer Foundation; Federal German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank D. Largaespada and M. Kay for providing transposon vectors and transposase encoding vectors. We thank L. Grobe, A. Rinkel, N. Struever, H. Riedesel, the team of the Helmholtz Centre for Infection Research (HZI) animal facility, M. Rothe, K. Schulze, A. Kobold, F. Heinzmann, N. Jedicke, C. Schneider, M. Pesic, H. Klimek and A. Samuels for technical assistance and assistance with animal work, and F. Alves, S. Kimmina, C. Dullin and S. Greco for assistance with flat panel-volumetric computer tomography. We thank the tissue bank of the National Center for Tumor Diseases Heidelberg for providing liver explant tissues. We thank S. Lowe, H. Tillmann, F. Greten and members of the Lowe and Zender laboratory for advice and discussions. This work was supported by the Helmholtz Association of German Research Centres (VH-NG-424 to L.Z.), the German Research Foundation, DFG (Emmy Noether Programme ZE 545/2-1 to L.Z., SFB/TRR77 and the 'Rebirth' Cluster of Excellence), the Wilhelm Sander Stiftung, the Bear Necessities Pediatric Cancer Foundation, the Federal German Ministry for Education and Research (BMBF) (ARCHES AWARD to L.Z.) and the European Commission (project 'Heptromic'). L.Z. holds an adjunct assistant Professorship with the Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA. This work is dedicated to J. Wehland.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Brown DM, 2010, CELL IMMUNOL, V262, P89, DOI 10.1016/j.cellimm.2010.02.008; Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Frid MG, 2006, AM J PATHOL, V168, P659, DOI 10.2353/ajpath.2006.050599; Harada N, 2004, CANCER RES, V64, P48, DOI 10.1158/0008-5472.CAN-03-2123; Hensel M, 2011, DTSCH ARZTEBL INT, V108, P117, DOI 10.3238/arztebl.2010.0117; HICKMAN MA, 1994, HUM GENE THER, V5, P1477, DOI 10.1089/hum.1994.5.12-1477; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; SARMA DSR, 1986, CANCER SURV, V5, P781; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Tannour-Louet M, 2002, HEPATOLOGY, V35, P1072, DOI 10.1053/jhep.2002.33164; Thomsen M, 2008, TOXICOLOGY, V246, P18, DOI 10.1016/j.tox.2007.10.017; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	21	904	927	6	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					547	551		10.1038/nature10599	http://dx.doi.org/10.1038/nature10599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22080947				2022-12-24	WOS:000297285600055
J	Montavon, T; Soshnikova, N; Mascrez, B; Joye, E; Thevenet, L; Splinter, E; de Laat, W; Spitz, F; Duboule, D				Montavon, Thomas; Soshnikova, Natalia; Mascrez, Benedicte; Joye, Elisabeth; Thevenet, Laurie; Splinter, Erik; de Laat, Wouter; Spitz, Francois; Duboule, Denis			A Regulatory Archipelago Controls Hox Genes Transcription in Digits	CELL			English	Article							VERTEBRATE LIMB DEVELOPMENT; EMBRYONIC STEM-CELLS; CHROMOSOME CONFORMATION; IN-VIVO; DEVELOPMENTAL REGULATORS; HISTONE MODIFICATIONS; HOMEOTIC GENE; MOUSE; EXPRESSION; ENHANCERS	The evolution of digits was an essential step in the success of tetrapods. Among the key players, Hoxd genes are coordinately regulated in developing digits, where they help organize growth and patterns. We identified the distal regulatory sites associated with these genes by probing the three-dimensional architecture of this regulatory unit in developing limbs. This approach, combined with in vivo deletions of distinct regulatory regions, revealed that the active part of the gene cluster contacts several enhancer-like sequences. These elements are dispersed throughout the nearby gene desert, and each contributes either quantitatively or qualitatively to Hox gene transcription in presumptive digits. We propose that this genetic system, which we call a "regulatory archipelago," provides an inherent flexibility that may partly underlie the diversity in number and morphology of digits across tetrapods, as well as their resilience to drastic variations.	[Montavon, Thomas; Joye, Elisabeth; Duboule, Denis] Ecole Polytech Fed Lausanne, Natl Res Ctr, Sch Life Sci, Lausanne, Switzerland; [Soshnikova, Natalia; Mascrez, Benedicte; Thevenet, Laurie; Duboule, Denis] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva 4, Switzerland; [Splinter, Erik; de Laat, Wouter] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Splinter, Erik; de Laat, Wouter] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Spitz, Francois] EMBL, Dev Biol Unit, Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; European Molecular Biology Laboratory (EMBL)	Duboule, D (corresponding author), Ecole Polytech Fed Lausanne, Natl Res Ctr, Sch Life Sci, Lausanne, Switzerland.	denis.duboule@unige.ch		de Laat, Wouter/0000-0002-6393-595X; duboule, denis/0000-0001-9961-2960; Spitz, Francois/0000-0002-1960-829X; Montavon, Thomas/0000-0001-8247-1399	Ecole Polytechnique Fe de rale, Lausanne; University of Geneva; Swiss National Research Fund; National Research Center "Frontiers in Genetics,"; EU; ERC	Ecole Polytechnique Fe de rale, Lausanne; University of Geneva; Swiss National Research Fund(Swiss National Science Foundation (SNSF)); National Research Center "Frontiers in Genetics,"; EU(European Commission); ERC(European Research Council (ERC)European Commission)	We thank N. Jones and W. Breitwieser for mice; P. Descombes and the staff of the NCCR genomic platform; I. Barde and members of the EPFL transgenic core facility; S. Ruf for help with the SB mice; and G. Andrey, M. Friedli, P. Schorderet, and members of the Duboule laboratories for discussions and reagents. This work was supported by funds from the Ecole Polytechnique Fe de rale, Lausanne, the University of Geneva, the Swiss National Research Fund, the National Research Center "Frontiers in Genetics," the EU program "Crescendo," and the ERC grants "SystemsHox.ch" (to D. D.) and "4C" (to W. D.-L). T. M. and D. D. designed all the experiments except the rel5 allele (F. S. and D. D.). T. M., N. S., and F. S. performed the experiments, with the assistance of E.J. B. M., L. T., and F. S. provided mutant mice. W. D.-L. and E. S. assisted with the 3C technology. T. M. and D. D. wrote the manuscript with inputs from coauthors.	Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dlugaszewska B, 2006, J MED GENET, V43, P111, DOI 10.1136/jmg.2005.033555; DOLLE P, 1991, MECH DEVELOP, V36, P3, DOI 10.1016/0925-4773(91)90067-G; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; Engstrom PG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r34; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Friedli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015741; Gerard M, 1996, GENE DEV, V10, P2326, DOI 10.1101/gad.10.18.2326; Gimond C, 1998, J CELL BIOL, V143, P253, DOI 10.1083/jcb.143.1.253; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Gonzalez F, 2007, DEV BIOL, V306, P847, DOI 10.1016/j.ydbio.2007.03.020; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Hinchliffe JR, 1991, DEV PATTERNING VERTE, P313; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; IZPISUABELMONTE JC, 1991, EMBO J, V10, P2279, DOI 10.1002/j.1460-2075.1991.tb07764.x; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; Lee AP, 2006, P NATL ACAD SCI USA, V103, P6994, DOI 10.1073/pnas.0601492103; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Mitter D, 2010, AM J MED GENET A, V152A, P1213, DOI 10.1002/ajmg.a.33344; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Shah M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001258; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Tarchini B, 2005, GENE DEV, V19, P2862, DOI 10.1101/gad.351105; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tschopp P, 2011, DEV BIOL, V351, P288, DOI 10.1016/j.ydbio.2010.12.034; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Verheyden JM, 2005, DEVELOPMENT, V132, P4235, DOI 10.1242/dev.02001; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	56	348	356	0	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1132	1145		10.1016/j.cell.2011.10.023	http://dx.doi.org/10.1016/j.cell.2011.10.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118467	Bronze			2022-12-24	WOS:000297376600023
J	Vargas, DY; Shah, K; Batish, M; Levandoski, M; Sinha, S; Marras, SAE; Schedl, P; Tyagi, S				Vargas, Diana Y.; Shah, Khyati; Batish, Mona; Levandoski, Michael; Sinha, Sourav; Marras, Salvatore A. E.; Schedl, Paul; Tyagi, Sanjay			Single-Molecule Imaging of Transcriptionally Coupled and Uncoupled Splicing	CELL			English	Article							RNA-POLYMERASE-II; SEX-LETHAL AUTOREGULATION; MESSENGER-RNA; IN-VIVO; BINDING PROTEINS; NUCLEUS; TRANSPORT; SWITCH; GENE; EXON	Introns are removed from pre-mRNAs during transcription while the pre-mRNA is still tethered to the gene locus via RNA polymerase. However, during alternative splicing, it is important that splicing be deferred until all of the exons and introns involved in the choice have been synthesized. We have developed an in situ RNA imaging method with single-molecule sensitivity to define the intracellular sites of splicing. Using this approach, we found that the normally tight coupling between transcription and splicing is broken in situations where the intron's polypyrimidine tract is sequestered within strong secondary structures. We also found that in two cases of alternative splicing, in which certain exons are skipped due to the activity of the RNA-binding proteins Sxl and PTB, splicing is uncoupled from transcription. This uncoupling occurs only on the perturbed introns, whereas the preceding and succeeding introns are removed cotranscriptionally.	[Vargas, Diana Y.; Shah, Khyati; Batish, Mona; Levandoski, Michael; Sinha, Sourav; Marras, Salvatore A. E.; Tyagi, Sanjay] Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Batish, Mona; Levandoski, Michael; Marras, Salvatore A. E.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [Shah, Khyati] New Jersey Inst Technol, Newark, NJ 07102 USA; [Schedl, Paul] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; New Jersey Institute of Technology; Princeton University	Tyagi, S (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA.	tyagisa@umdnj.edu	Batish, Mona/AAG-8296-2019	Batish, Mona/0000-0001-9039-6149; Tyagi, Sanjay/0000-0001-7303-5827; Marras, Salvatore/0000-0003-2040-0354	National Institutes of Health [MH 079197, GM 043432]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043432, R56GM043432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Ben Gold and Fred Russell Kramer for their contributions. This work was supported by National Institutes of Health grants MH 079197 (S. T.) and GM 043432 (P. S.).	Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; BAUREN G, 1994, CELL, V76, P183, DOI 10.1016/0092-8674(94)90182-1; BELL LR, 1988, CELL, V55, P1037, DOI 10.1016/0092-8674(88)90248-6; BEYER AL, 1988, GENE DEV, V2, P754, DOI 10.1101/gad.2.6.754; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Bratu DP, 2003, P NATL ACAD SCI USA, V100, P13308, DOI 10.1073/pnas.2233244100; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Custodio N, 1999, EMBO J, V18, P2855, DOI 10.1093/emboj/18.10.2855; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Dias AP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1103; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Graham PL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002185; Han JH, 2011, TRENDS CELL BIOL, V21, P336, DOI 10.1016/j.tcb.2011.03.003; HORABIN JI, 1993, MOL CELL BIOL, V13, P7734, DOI 10.1128/MCB.13.12.7734; HUANG S, 1994, J CELL BIOL, V126, P877, DOI 10.1083/jcb.126.4.877; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Penalva LOF, 2001, MOL CELL BIOL, V21, P1986, DOI 10.1128/MCB.21.6.1986-1996.2001; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Rahman L, 2002, GENOMICS, V80, P245, DOI 10.1006/geno.2002.6826; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rigo F, 2009, RNA, V15, P823, DOI 10.1261/rna.1409209; SAKAMOTO H, 1992, NUCLEIC ACIDS RES, V20, P5533, DOI 10.1093/nar/20.21.5533; SAMUELS ME, 1994, MOL CELL BIOL, V14, P4975, DOI 10.1128/MCB.14.7.4975; SAMUELS ME, 1991, MOL CELL BIOL, V11, P3584, DOI 10.1128/MCB.11.7.3584; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Vargas DY, 2005, P NATL ACAD SCI USA, V102, P17008, DOI 10.1073/pnas.0505580102; Waks Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.32; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975; ZHANG GH, 1994, NATURE, V372, P809	45	159	161	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1054	1065		10.1016/j.cell.2011.10.024	http://dx.doi.org/10.1016/j.cell.2011.10.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118462	Green Accepted, Bronze			2022-12-24	WOS:000297376600017
J	Lancaster, KM; Roemelt, M; Ettenhuber, P; Hu, YL; Ribbe, MW; Neese, F; Bergmann, U; DeBeer, S				Lancaster, Kyle M.; Roemelt, Michael; Ettenhuber, Patrick; Hu, Yilin; Ribbe, Markus W.; Neese, Frank; Bergmann, Uwe; DeBeer, Serena			X-ray Emission Spectroscopy Evidences a Central Carbon in the Nitrogenase Iron-Molybdenum Cofactor	SCIENCE			English	Article							MOFE-PROTEIN; FEMO-COFACTOR; RESTING STATE; RESOLUTION; MECHANISM; CLUSTER; SULFUR; LIGAND; ENDOR	Nitrogenase is a complex enzyme that catalyzes the reduction of dinitrogen to ammonia. Despite insight from structural and biochemical studies, its structure and mechanism await full characterization. An iron-molybdenum cofactor (FeMoco) is thought to be the site of dinitrogen reduction, but the identity of a central atom in this cofactor remains unknown. Fe K beta x-ray emission spectroscopy (XES) of intact nitrogenase MoFe protein, isolated FeMoco, and the FeMoco-deficient Delta nifB protein indicates that among the candidate atoms oxygen, nitrogen, and carbon, it is carbon that best fits the XES data. The experimental XES is supported by computational efforts, which show that oxidation and spin states do not affect the assignment of the central atom to C4-. Identification of the central atom will drive further studies on its role in catalysis.	[Hu, Yilin; Ribbe, Markus W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Lancaster, Kyle M.; DeBeer, Serena] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Roemelt, Michael; Ettenhuber, Patrick; Neese, Frank] Univ Bonn, Inst Phys & Theoret Chem, D-53115 Bonn, Germany; [Neese, Frank; DeBeer, Serena] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany; [Bergmann, Uwe] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA	University of California System; University of California Irvine; Cornell University; University of Bonn; Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Ribbe, MW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	mribbe@uci.edu; frank.neese@mpi-mail.mpg.de; bergmann@slac.stanford.edu; serena.debeer@mpi-mail.mpg.de	DeBeer, Serena/G-6718-2012; Neese, Frank/J-4959-2014; DeBeer, Serena/T-6420-2018	Neese, Frank/0000-0003-4691-0547; DeBeer, Serena/0000-0002-5196-3400; Roemelt, Michael/0000-0002-4780-5354	Cornell Univ.; Alfred P. Sloan Foundation; Univ. of Bonn; Max Planck Society; NIH [R01-GM 67626]; DOE, Biological and Environmental Research; NIH, National Center for Research Resources;  [SFB 813]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067626] Funding Source: NIH RePORTER	Cornell Univ.; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Univ. of Bonn; Max Planck Society(Max Planck Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE, Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.D. thanks Cornell Univ. for financial support and the Alfred P. Sloan Foundation for a fellowship; F.N. acknowledges financial support from the Univ. of Bonn, the Max Planck Society, and the SFB 813; M. W. R. thanks the NIH for funding (grant R01-GM 67626). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a U.S. Department of Energy (DOE), Basic Energy Sciences user facility. The SSRL Structural Molecular Biology program is supported by DOE, Biological and Environmental Research, and NIH, National Center for Research Resources, Biomedical Technology Program.	ALLEN RM, 1995, J BIOL CHEM, V270, P26890, DOI 10.1074/jbc.270.45.26890; AVERILL BA, 1973, J AM CHEM SOC, V95, P3523, DOI 10.1021/ja00792a013; Barney BM, 2009, BIOCHEMISTRY-US, V48, P9094, DOI 10.1021/bi901092z; Bergmann U, 1999, CHEM PHYS LETT, V302, P119, DOI 10.1016/S0009-2614(99)00095-0; Delgado-Jaime MU, 2011, INORG CHEM, V50, P10709, DOI 10.1021/ic201173j; Eeckhout SG, 2009, J ANAL ATOM SPECTROM, V24, P215, DOI 10.1039/b808345m; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Glatzel P, 2005, COORDIN CHEM REV, V249, P65, DOI 10.1016/j.ccr.2004.04.011; Harris TV, 2011, INORG CHEM, V50, P4811, DOI 10.1021/ic102446n; Hoffman BM, 2009, ACCOUNTS CHEM RES, V42, P609, DOI 10.1021/ar8002128; Hu YL, 2010, ACCOUNTS CHEM RES, V43, P475, DOI 10.1021/ar900254x; Lancaster KM, 2011, INORG CHEM, V50, P6767, DOI 10.1021/ic200822b; Lee HI, 1997, J AM CHEM SOC, V119, P11395, DOI 10.1021/ja971508d; Lee N, 2010, J AM CHEM SOC, V132, P9715, DOI 10.1021/ja101281e; Lukoyanov D, 2007, INORG CHEM, V46, P11437, DOI 10.1021/ic7018814; Neese F, 2006, ANGEW CHEM INT EDIT, V45, P196, DOI 10.1002/anie.200502667; NOODLEMAN L, 1981, J CHEM PHYS, V74, P5737, DOI 10.1063/1.440939; Pollock CJ, 2011, J AM CHEM SOC, V133, P5594, DOI 10.1021/ja200560z; Schmid B, 2002, SCIENCE, V296, P352, DOI 10.1126/science.1070010; Smolentsev G, 2009, J AM CHEM SOC, V131, P13161, DOI 10.1021/ja808526m; TRUE AE, 1988, J AM CHEM SOC, V110, P1935, DOI 10.1021/ja00214a045; Xiao YM, 2006, J AM CHEM SOC, V128, P7608, DOI 10.1021/ja0603655; Yoo SJ, 2000, J AM CHEM SOC, V122, P4926, DOI 10.1021/ja000254k	23	609	616	12	409	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2011	334	6058					974	977		10.1126/science.1206445	http://dx.doi.org/10.1126/science.1206445			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CA	22096198	Green Accepted			2022-12-24	WOS:000297101800055
J	Mullen, AR; Wheaton, WW; Jin, ES; Chen, PH; Sullivan, LB; Cheng, T; Yang, YF; Linehan, WM; Chandel, NS; DeBerardinis, RJ				Mullen, Andrew R.; Wheaton, William W.; Jin, Eunsook S.; Chen, Pei-Hsuan; Sullivan, Lucas B.; Cheng, Tzuling; Yang, Youfeng; Linehan, W. Marston; Chandel, Navdeep S.; DeBerardinis, Ralph J.			Reductive carboxylation supports growth in tumour cells with defective mitochondria	NATURE			English	Article							GLUTAMINE-METABOLISM; CANCER; DEHYDROGENASE; GENE; PARAGANGLIOMA; MUTATIONS; LIVER; LINE; FLUX; ROS	Mitochondrial metabolism provides precursors to build macromolecules in growing cancer cells(1,2). In normally functioning tumour cell mitochondria, oxidative metabolism of glucose- and glutamine-derived carbon produces citrate and acetyl-coenzyme A for lipid synthesis, which is required for tumorigenesis(3). Yet some tumours harbour mutations in the citric acid cycle (CAC) or electron transport chain (ETC) that disable normal oxidative mitochondrial function(4-7), and it is unknown how cells from such tumours generate precursors for macromolecular synthesis. Here we show that tumour cells with defective mitochondria use glutamine-dependent reductive carboxylation rather than oxidative metabolism as the major pathway of citrate formation. This pathway uses mitochondrial and cytosolic isoforms of NADP(+)/NADPH-dependent isocitrate dehydrogenase, and subsequent metabolism of glutamine-derived citrate provides both the acetylcoenzyme A for lipid synthesis and the four-carbon intermediates needed to produce the remaining CAC metabolites and related macromolecular precursors. This reductive, glutamine-dependent pathway is the dominant mode of metabolism in rapidly growing malignant cells containing mutations in complex I or complex III of the ETC, in patient-derived renal carcinoma cells with mutations in fumarate hydratase, and in cells with normal mitochondria subjected to acute pharmacological ETC inhibition. Our findings reveal the novel induction of a versatile glutamine-dependent pathway that reverses many of the reactions of the canonical CAC, supports tumour cell growth, and explains how cells generate pools of CAC intermediates in the face of impaired mitochondrial metabolism.	[Mullen, Andrew R.; Chen, Pei-Hsuan; Cheng, Tzuling; DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Wheaton, William W.; Sullivan, Lucas B.; Chandel, Navdeep S.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Wheaton, William W.; Sullivan, Lucas B.; Chandel, Navdeep S.] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Jin, Eunsook S.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Jin, Eunsook S.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Yang, Youfeng; Linehan, W. Marston] NCI, Urol Oncol Branch, Bethesda, MD 20892 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75235 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Northwestern University; Northwestern University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	DeBerardinis, RJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	nav@northwestern.edu; ralph.deberardinis@utsouthwestern.edu		Sullivan, Lucas/0000-0002-6745-8222	NIH [K08DK072565, R01CA157996, R01CA123067, DK078933, RR02584, 5T32GM083831, T32CA009560, T32GM008061]; Cancer Prevention and Research Institute of Texas (CPRIT) [HIRP100437]; Robert A. Welch Foundation [I1733]; LUNGevity Foundation; Consortium of Independent Lung Health Organizations; NIH, National Cancer Institute Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011043, R01CA123067, R01CA157996, T32CA009560, ZIABC011028, ZIABC011038, ZIDBC011089] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK072565, K01DK078933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083831, T32GM008061] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); Robert A. Welch Foundation(The Welch Foundation); LUNGevity Foundation; Consortium of Independent Lung Health Organizations; NIH, National Cancer Institute Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K. Uyeda and members of the DeBerardinis and Chandel laboratories provided critical assessment of the data, and J. Sudderth and C. Yang provided experimental assistance. We thank C. Moraes and I. F. M. de Coo for the WT 143B and CYTB 143B cell lines, I. E. Scheffler for CCL16-B2 cells and T. Yagi for CCL16-NDI1 cells. This work was supported by grants to R. J. D. from the NIH (K08DK072565 and R01CA157996), the Cancer Prevention and Research Institute of Texas (CPRIT, HIRP100437) and the Robert A. Welch Foundation (I1733); to N.S.C. from the NIH (R01CA123067), the LUNGevity Foundation and a Consortium of Independent Lung Health Organizations convened by Respiratory Health Association of Metropolitan Chicago; and to E. S. J. by an NIH grant (DK078933). The work was also supported by the Intramural Research Program of the NIH, National Cancer Institute Center for Cancer Research and by NIH grant RR02584. NIH training grants supported A. R. M. (5T32GM083831), W. W. W. (T32CA009560) and L. B. S. (T32GM008061). T. C. was supported by a CPRIT training grant.	Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Comte B, 2002, AM J PHYSIOL-HEART C, V283, pH1505, DOI 10.1152/ajpheart.00287.2002; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DESROSIERS C, 1994, J BIOL CHEM, V269, P27179; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Frezza C, 2011, J MOL MED, V89, P213, DOI 10.1007/s00109-011-0728-4; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Olszewski KL, 2010, NATURE, V466, P774, DOI 10.1038/nature09301; Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yang Y, 2010, CANCER GENET CYTOGEN, V196, P45, DOI 10.1016/j.cancergencyto.2009.08.018; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200	26	867	883	5	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					385	U171		10.1038/nature10642	http://dx.doi.org/10.1038/nature10642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22101431	Green Accepted			2022-12-24	WOS:000299210600047
J	Baker, JL; Sudarsan, N; Weinberg, Z; Roth, A; Stockbridge, RB; Breaker, RR				Baker, Jenny L.; Sudarsan, Narasimhan; Weinberg, Zasha; Roth, Adam; Stockbridge, Randy B.; Breaker, Ronald R.			Widespread Genetic Switches and Toxicity Resistance Proteins for Fluoride	SCIENCE			English	Article							CHLORIDE CHANNEL; IDENTIFICATION; DICHLOROMETHANE; BACTERIA; REVEALS; ACIDS; IONS	Most riboswitches are metabolite-binding RNA structures located in bacterial messenger RNAs where they control gene expression. We have discovered a riboswitch class in many bacterial and archaeal species whose members are selectively triggered by fluoride but reject other small anions, including chloride. These fluoride riboswitches activate expression of genes that encode putative fluoride transporters, enzymes that are known to be inhibited by fluoride, and additional proteins of unknown function. Our findings indicate that most organisms are naturally exposed to toxic levels of fluoride and that many species use fluoride-sensing RNAs to control the expression of proteins that alleviate the deleterious effects of this anion.	[Sudarsan, Narasimhan; Weinberg, Zasha; Roth, Adam; Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Baker, Jenny L.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Sudarsan, Narasimhan; Weinberg, Zasha; Roth, Adam; Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Stockbridge, Randy B.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Stockbridge, Randy B.] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; [Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Brandeis University; Brandeis University; Howard Hughes Medical Institute; Yale University	Breaker, RR (corresponding author), Yale Univ, Howard Hughes Med Inst, Box 208103, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010	Breaker, Ronald/0000-0002-2165-536X; Stockbridge, Randy/0000-0001-8848-3032; Weinberg, Zasha/0000-0002-6681-3624	NIH [RR19895-02, GM022778]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Breaker laboratory for helpful discussions and G. L. Ryan at Oligos Etc. for information on synthetic dinucleotide preparations. Ion channel flux experiments were conducted by R. B. S. in the laboratory of C. Miller, Brandeis Univ., and we thank him for his support of this project. We also thank N. Carriero and R. Bjornson for assisting our use of the Yale Life Sciences High Performance Computing Center (NIH grant RR19895-02). This work was supported by NIH ( grant GM022778) and by the Howard Hughes Medical Institute. R. R. B. is a cofounder of and consults for BioRelix, a biotechnology company that has licensed intellectual property on riboswitches from Yale University Yale University has filed for patent protection on aspects of the crcB motif and fluoride riboswitches.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Auffinger P, 2004, STRUCTURE, V12, P379, DOI 10.1016/j.str.2004.02.015; Dobbins J. T., 1935, J CHEM EDUC, V12, P586; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GALLI R, 1985, CONSERV RECYCLING, V8, P91, DOI 10.1016/0361-3658(85)90028-1; Hamilton I R, 1990, J Dent Res, V69 Spec No, P660; Hu KH, 1996, GENETICS, V143, P1521; Koo H, 2008, Adv Dent Res, V20, P17; LESHER RJ, 1977, ANTIMICROB AGENTS CH, V12, P339, DOI 10.1128/AAC.12.3.339; LEVINE RS, 1976, BRIT DENT J, V140, P9, DOI 10.1038/sj.bdj.4803690; MALTZ M, 1982, J DENT RES, V61, P786, DOI 10.1177/00220345820610062701; Marquis RE, 2003, FEMS MICROBIOL REV, V26, P493, DOI 10.1111/j.1574-6976.2003.tb00627.x; Matulef K, 2007, MOL MEMBR BIOL, V24, P342, DOI 10.1080/09687680701413874; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Van Loveren C, 2001, CARIES RES, V35, P65, DOI 10.1159/000049114; Vuilleumier S, 1997, BIOCHEM BIOPH RES CO, V238, P452, DOI 10.1006/bbrc.1997.7309; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31	21	281	291	3	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					233	235		10.1126/science.1215063	http://dx.doi.org/10.1126/science.1215063			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22194412	Green Accepted			2022-12-24	WOS:000299033100057
J	Fritz, JH; Rojas, OL; Simard, N; McCarthy, DD; Hapfelmeier, S; Rubino, S; Robertson, SJ; Larijani, M; Gosselin, J; Ivanov, II; Martin, A; Casellas, R; Philpott, DJ; Girardin, SE; McCoy, KD; Macpherson, AJ; Paige, CJ; Gommerman, JL				Fritz, Joerg H.; Rojas, Olga Lucia; Simard, Nathalie; McCarthy, Douglas D.; Hapfelmeier, Siegfried; Rubino, Stephen; Robertson, Susan J.; Larijani, Mani; Gosselin, Jean; Ivanov, Ivaylo I.; Martin, Alberto; Casellas, Rafael; Philpott, Dana J.; Girardin, Stephen E.; McCoy, Kathy D.; Macpherson, Andrew J.; Paige, Christopher J.; Gommerman, Jennifer L.			Acquisition of a multifunctional IgA(+) plasma cell phenotype in the gut	NATURE			English	Article							B-CELLS; DENDRITIC CELLS; BACTERIAL-INFECTION; AID EXPRESSION; STROMAL CELLS; BONE-MARROW; HOMEOSTASIS; MICROBIOTA; PROGENITORS; MATURATION	The largest mucosal surface in the body is in the gastrointestinal tract, a location that is heavily colonized by microbes that are normally harmless. A key mechanism required for maintaining a homeostatic balance between this microbial burden and the lymphocytes that densely populate the gastrointestinal tract is the production and transepithelial transport of poly-reactive IgA (ref. 1). Within the mucosal tissues, B cells respond to cytokines, sometimes in the absence of T-cell help, undergo class switch recombination of their immunoglobulin receptor to IgA, and differentiate to become plasma cells(2). However, IgA-secreting plasma cells probably have additional attributes that are needed for coping with the tremendous bacterial load in the gastrointestinal tract. Here we report that mouse IgA(+) plasma cells also produce the antimicrobial mediators tumour-necrosis factor-alpha (TNF-alpha) and inducible nitric oxide synthase (iNOS), and expressmany molecules that are commonly associated with monocyte/granulocytic cell types. The development of iNOS-producing IgA(+) plasma cells can be recapitulated in vitro in the presence of gut stroma, and the acquisition of this multifunctional phenotype in vivo and in vitro relies on microbial co-stimulation. Deletion of TNF-a and iNOS in B-lineage cells resulted in a reduction in IgA production, altered diversification of the gut microbiota and poor clearance of a gut-tropic pathogen. These findings reveal a novel adaptation to maintaining homeostasis in the gut, and extend the repertoire of protective responses exhibited by some B-lineage cells.	[Fritz, Joerg H.; Rojas, Olga Lucia; Simard, Nathalie; McCarthy, Douglas D.; Robertson, Susan J.; Larijani, Mani; Martin, Alberto; Philpott, Dana J.; Paige, Christopher J.; Gommerman, Jennifer L.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Simard, Nathalie; Paige, Christopher J.] Princess Margaret Hosp, Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Hapfelmeier, Siegfried; McCoy, Kathy D.; Macpherson, Andrew J.] Univ Bern, Dept Klin Forsch Gastroenterol, CH-3010 Bern, Switzerland; [Rubino, Stephen; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Gosselin, Jean] Univ Laval, Dept Mol Med, Quebec City, PQ G1V 4G2, Canada; [Ivanov, Ivaylo I.] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, Med Ctr, New York, NY 10032 USA; [Casellas, Rafael] NIAMSD, NIH, Bethesda, MD 20892 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Bern; University of Toronto; Laval University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Gommerman, JL (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	jen.gommerman@utoronto.ca	McCoy, Kathy/ABD-5814-2021; Hapfelmeier, Siegfried/B-6005-2011	Hapfelmeier, Siegfried/0000-0002-6913-7932; Martin, Alberto/0000-0002-0795-0418; Gommerman, Jennifer/0000-0003-4576-6168	CIHR [9862, 89783, 114972, 67157]; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health; NIH [R00 DK085329-02]; CCFA [2388]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041149, ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK085329] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCFA; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. White in the Faculty of Medicine Flow Cytometry core facility and H. Singh for critical reading of the manuscript. We thank E. Verdu for providing additional germ-free mice at short notice, and we also thank C. Guidos for numerous Rag22/ 2 mice for mixed bone marrow chimeras. C. J. P. is supported by a CIHR operating grant MOP number 9862. R. C. is supported in part by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. I. I. I. is supported by NIH (R00 DK085329-02) and CCFA (CDA # 2388). A. M. is supported by a CIHR operating grant MOP number 89783. J. H. F. acknowledges support by an APART-fellowship of the Austrian Academy of Sciences, McGill start-up funds and a CIHR operating grant MOP number 114972. N. S. acknowledges the support of a CIHR Doctoral Award. J. L. G. is funded by the Canadian Institutes of Health Research (CIHR) and acknowledges the support of CIHR operating grant MOP number 67157 as well as infrastructure support from the Ontario Research Fund and that Canadian Foundation for Innovation. All authors have reviewed and agree with the content of the manuscript.	Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; CUMANO A, 1990, EUR J IMMUNOL, V20, P2183, DOI 10.1002/eji.1830201006; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Ivanov II, 2011, CURR OPIN MICROBIOL, V14, P106, DOI 10.1016/j.mib.2010.12.003; Johnson BA, 2010, P NATL ACAD SCI USA, V107, P10644, DOI 10.1073/pnas.0914347107; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kelly-Scumpia KM, 2011, J EXP MED, V208, P1673, DOI 10.1084/jem.20101715; Lee MR, 2011, BIOCHEM BIOPH RES CO, V410, P602, DOI 10.1016/j.bbrc.2011.06.035; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; Marshall AJ, 1997, J IMMUNOL, V158, P4282; Milne CD, 2004, EUR J IMMUNOL, V34, P2647, DOI 10.1002/eji.200425400; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Pelletier N, 2010, NAT IMMUNOL, V11, P1110, DOI 10.1038/ni.1954; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tumanov AV, 2010, BLOOD, V116, P3456, DOI 10.1182/blood-2009-10-249177	29	137	148	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					199	+		10.1038/nature10698	http://dx.doi.org/10.1038/nature10698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22158124	Green Accepted			2022-12-24	WOS:000298981200039
J	Pascoli, V; Turiault, M; Luscher, C				Pascoli, Vincent; Turiault, Marc; Luescher, Christian			Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour	NATURE			English	Article							RAT NUCLEUS-ACCUMBENS; AMPA RECEPTORS; PLASTICITY; DOPAMINE; ACTIVATION; ADDICTION; ERK; SENSITIZATION; CASCADE; RESPONSES	Drug-evoked synaptic plasticity is observed at many synapses and may underlie behavioural adaptations in addiction(1). Mechanistic investigations start with the identification of the molecular drug targets. Cocaine, for example, exerts its reinforcing(2) and early neuroadaptive effects(3) by inhibiting the dopamine transporter, thus causing a strong increase in mesolimbic dopamine. Among the many signalling pathways subsequently engaged, phosphorylation of the extracellular signal-regulated kinase (ERK) in the nucleus accumbens(4) is of particular interest because it has been implicated in NMDA-receptor and type 1 dopamine (D1)-receptor-dependent synaptic potentiation(5) as well as in several behavioural adaptations(6-8). A causal link between drug-evoked plasticity at identified synapses and behavioural adaptations, however, is missing, and the benefits of restoring baseline transmission have yet to be demonstrated. Here we find that cocaine potentiates excitatory transmission in D1-receptor-expressing medium-sized spiny neurons (D1R-MSNs) in mice via ERK signalling with a time course that parallels locomotor sensitization. Depotentiation of cortical nucleus accumbens inputs by optogenetic stimulation in vivo efficiently restored normal transmission and abolished cocaine-induced locomotor sensitization. These findings establish synaptic potentiation selectively in D1R-MSNs as a mechanism underlying a core component of addiction, probably by creating an imbalance between distinct populations of MSNs in the nucleus accumbens. Our data also provide proof of principle that reversal of cocaine-evoked synaptic plasticity can treat behavioural alterations caused by addictive drugs and may inspire novel therapeutic approaches involving deep brain stimulation or transcranial magnetic stimulation.	[Pascoli, Vincent; Turiault, Marc; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Clin Neurol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011; Core, Vector/CAF-4832-2022	Lüscher, Christian/0000-0001-7917-4596; 	Swiss National Science Foundation; "Synapsy", a National Competence Center in Research (NCCR) of the Swiss Confederation on the synaptic basis of mental disorders	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); "Synapsy", a National Competence Center in Research (NCCR) of the Swiss Confederation on the synaptic basis of mental disorders	We thank P. Kalivas and the members of the Luscher laboratory for suggestions on the manuscript. This work is supported by the Swiss National Science Foundation (C. L.) and "Synapsy", a National Competence Center in Research (NCCR) of the Swiss Confederation on the synaptic basis of mental disorders.	Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Brami-Cherrier K, 2009, J NEUROCHEM, V108, P1323, DOI 10.1111/j.1471-4159.2009.05879.x; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Chen R, 2006, P NATL ACAD SCI USA, V103, P9333, DOI 10.1073/pnas.0600905103; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; KOMBIAN SB, 1994, NATURE, V368, P242, DOI 10.1038/368242a0; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kramer PF, 2011, J NEUROSCI, V31, P126, DOI 10.1523/JNEUROSCI.4287-10.2011; LaLumiere RT, 2010, LEARN MEMORY, V17, P168, DOI 10.1101/lm.1576810; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Pascoli V, 2011, BIOL PSYCHIAT, V69, P218, DOI 10.1016/j.biopsych.2010.08.031; PENNARTZ CMA, 1993, EUR J NEUROSCI, V5, P107, DOI 10.1111/j.1460-9568.1993.tb00475.x; Pierce RC, 1999, J NEUROSCI, V19, P8685; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Valjent E, 2004, EUR J NEUROSCI, V19, P1826, DOI 10.1111/j.1460-9568.2004.03278.x; Valjent E, 2010, NEUROPSYCHOPHARMACOL, V35, P401, DOI 10.1038/npp.2009.143; Vanderschuren LJMJ, 2010, CURR TOP BEHAV NEURO, V3, P179, DOI 10.1007/7854_2009_21; Wolf ME, 2010, TRENDS NEUROSCI, V33, P391, DOI 10.1016/j.tins.2010.06.003; Xie GQ, 2009, ALCOHOL CLIN EXP RES, V33, P121, DOI 10.1111/j.1530-0277.2008.00818.x; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	34	269	271	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					71	U76		10.1038/nature10709	http://dx.doi.org/10.1038/nature10709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22158102	Green Accepted			2022-12-24	WOS:000298836900031
J	Mondal, BC; Mukherjee, T; Mandal, L; Evans, CJ; Sinenko, SA; Martinez-Agosto, JA; Banerjee, U				Mondal, Bama Charan; Mukherjee, Tina; Mandal, Lolitika; Evans, Cory J.; Sinenko, Sergey A.; Martinez-Agosto, Julian A.; Banerjee, Utpal			Interaction between Differentiating Cell- and Niche-Derived Signals in Hematopoietic Progenitor Maintenance	CELL			English	Article							DROSOPHILA-LYMPH GLAND; STEM-CELL; GENETIC DISSECTION; TISSUE-DAMAGE; RECEPTOR; ADENOSINE; PROLIFERATION; REGENERATION; HOMEOSTASIS; ACTIVATION	Maintenance of a hematopoietic progenitor population requires extensive interaction with cells within a microenvironment or niche. In the Drosophila hematopoietic organ, niche-derived Hedgehog signaling maintains the progenitor population. Here, we show that the hematopoietic progenitors also require a signal mediated by Adenosine deaminase growth factor A (Adgf-A) arising from differentiating cells that regulates extracellular levels of adenosine. The adenosine signal opposes the effects of Hedgehog signaling within the hematopoietic progenitor cells and the magnitude of the adenosine signal is kept in check by the level of Adgf-A secreted from differentiating cells. Our findings reveal signals arising from differentiating cells that are required for maintaining progenitor cell quiescence and that function with the niche-derived signal in maintaining the progenitor state. Similar homeostatic mechanisms are likely to be utilized in other systems that maintain relatively large numbers of progenitors that are not all in direct contact with the cells of the niche.	[Martinez-Agosto, Julian A.] Univ Calif Los Angeles, David Geffen Sch Med UCLA, Dept Human Genet, Los Angeles, CA 90095 USA; [Mondal, Bama Charan; Mukherjee, Tina; Mandal, Lolitika; Evans, Cory J.; Sinenko, Sergey A.; Banerjee, Utpal] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Martinez-Agosto, Julian A.; Banerjee, Utpal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Martinez-Agosto, Julian A.; Banerjee, Utpal] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Martinez-Agosto, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med UCLA, Dept Human Genet, Los Angeles, CA 90095 USA.	julianmartinez@mednet.ucla.edu; banerjee@mbi.ucla.edu	Martinez-Agosto, Julian A/I-9435-2019; Sinenko, Sergey A./C-3703-2016	Martinez-Agosto, Julian A/0000-0001-6776-6949; Sinenko, Sergey A./0000-0001-5517-8218; Mondal, Bama Charan/0000-0001-9694-7714	NHLBI [R01 HL067395, K08 HL087026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087026, R01HL067395] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank members of the Banerjee lab for helpful discussions. We acknowledge V.D.R.C., N.I.G., D.H.S.B., B.D.S.C., E. Bach, J. Calderon, J. Darnell, T. Dolezal, J. Hooper, D. Montell, P. Rorth, A. Sehgal, B. Shilo, M. Yoo, and M. Zeidler for reagents. Supported by NHLBI R01 HL067395 to UB and NHLBI K08 HL087026 to JM.	Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Bond D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000655; Collier LS, 2004, GENETICS, V167, P783, DOI 10.1534/genetics.103.024992; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Dolezal T, 2005, PLOS BIOL, V3, P1213, DOI 10.1371/journal.pbio.0030201; Dolezal T, 2003, GENETICS, V165, P653; Dolezelova E, 2007, INSECT BIOCHEM MOLEC, V37, P318, DOI 10.1016/j.ibmb.2006.12.003; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; FU XY, 1993, CELL, V74, P1135, DOI 10.1016/0092-8674(93)90734-8; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Giansanti MG, 2004, MOL BIOL CELL, V15, P2509, DOI 10.1091/mbc.E03-08-0603; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Janssens K, 2010, P NATL ACAD SCI USA, V107, P7323, DOI 10.1073/pnas.0915075107; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jude CD, 2008, CELL CYCLE, V7, P586, DOI 10.4161/cc.7.5.5549; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Krzemien J, 2010, DEV BIOL, V346, P310, DOI 10.1016/j.ydbio.2010.08.003; Learte AR, 2008, GLIA, V56, P164, DOI 10.1002/glia.20601; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Li WX, 2002, DEVELOPMENT, V129, P4241; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Maier SA, 2001, GENE, V280, P27, DOI 10.1016/S0378-1119(01)00762-4; Makki R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000441; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Mathieu J, 2007, GENETICS, V176, P1579, DOI 10.1534/genetics.107.071282; Mathur D, 2010, SCIENCE, V327, P210, DOI 10.1126/science.1181958; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Minakhina S, 2010, DEVELOPMENT, V137, P27, DOI 10.1242/dev.043943; Mukherjee T, 2011, SCIENCE, V332, P1210, DOI 10.1126/science.1199643; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Novakova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017741; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; ROGGE RD, 1991, CELL, V64, P39, DOI 10.1016/0092-8674(91)90207-F; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Sims D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r20; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Smelkinson MG, 2006, CURR BIOL, V16, P110, DOI 10.1016/j.cub.2005.12.012; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505; Zavialov AV, 2010, J LEUKOCYTE BIOL, V88, P279, DOI 10.1189/jlb.1109764; Zurovec M, 2002, P NATL ACAD SCI USA, V99, P4403, DOI 10.1073/pnas.062059699	51	133	134	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1589	1600		10.1016/j.cell.2011.11.041	http://dx.doi.org/10.1016/j.cell.2011.11.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196733	Bronze, Green Accepted			2022-12-24	WOS:000298403400022
J	Taberlay, PC; Kelly, TK; Liu, CC; You, JS; De Carvalho, DD; Miranda, TB; Zhou, XJ; Liang, GN; Jones, PA				Taberlay, Phillippa C.; Kelly, Theresa K.; Liu, Chun-Chi; You, Jueng Soo; De Carvalho, Daniel D.; Miranda, Tina B.; Zhou, Xianghong J.; Liang, Gangning; Jones, Peter A.			Polycomb-Repressed Genes Have Permissive Enhancers that Initiate Reprogramming	CELL			English	Article							HISTONE MODIFICATIONS; CHROMATIN SIGNATURES; CELL-LINES; MYOD GENE; EXPRESSION; FIBROBLASTS; TRANSCRIPTION; TRANSFECTION; METHYLATIONS; ACTIVATION	Key regulatory genes, suppressed by Polycomb and H3K27me3, become active during normal differentiation and induced reprogramming. Using the well-characterized enhancer/promoter pair of MYOD1 as a model, we have identified a critical role for enhancers in reprogramming. We observed an unexpected nucleosome-depleted region (NDR) at the H3K4me1-enriched enhancer at which transcriptional regulators initially bind, leading to subsequent changes in the chromatin at the cognate promoter. Exogenous Myod1 activates its own transcription by binding first at the enhancer, leading to an NDR and transcription-permissive chromatin at the associated MYOD1 promoter. Exogenous OCT4 also binds first to the permissive MYOD1 enhancer but has a different effect on the cognate promoter, where the monovalent H3K27me3 marks are converted to the bivalent state characteristic of stem cells. Genome-wide, a high percentage of Polycomb targets are associated with putative enhancers in permissive states, suggesting that they may provide a widespread avenue for the initiation of cell-fate reprogramming.	[Taberlay, Phillippa C.; Kelly, Theresa K.; You, Jueng Soo; De Carvalho, Daniel D.; Miranda, Tina B.; Liang, Gangning; Jones, Peter A.] Univ So Calif, Dept Urol, Los Angeles, CA 90033 USA; [Taberlay, Phillippa C.; Kelly, Theresa K.; You, Jueng Soo; De Carvalho, Daniel D.; Miranda, Tina B.; Liang, Gangning; Jones, Peter A.] Univ So Calif, Dept Biochem, Los Angeles, CA 90033 USA; [Taberlay, Phillippa C.; Kelly, Theresa K.; You, Jueng Soo; De Carvalho, Daniel D.; Miranda, Tina B.; Liang, Gangning; Jones, Peter A.] Univ So Calif, Dept Biol Mol, Norris Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90033 USA; [Liu, Chun-Chi; Zhou, Xianghong J.] Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA; [Liu, Chun-Chi] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 402, Taiwan	University of Southern California; University of Southern California; University of Southern California; University of Southern California; National Chung Hsing University	Liang, GN (corresponding author), Univ So Calif, Dept Urol, Los Angeles, CA 90033 USA.	gliang@usc.edu; pjones@med.usc.edu	De Carvalho, Daniel/F-4794-2011; kelly, theresa/E-3624-2010; Taberlay, Phillippa C/C-9616-2010; De Carvalho, Daniel D/J-5503-2014	De Carvalho, Daniel/0000-0003-0771-2265; Taberlay, Phillippa C/0000-0002-5298-8730; De Carvalho, Daniel D/0000-0002-8572-5259; Liang, Gangning/0000-0001-8664-922X	NIH [R37 CA-082422, R01 CA-124518, 5T32 CA-009320-27]; NSF [0747475]; ARCS; NATIONAL CANCER INSTITUTE [T32CA009320, R01CA124518, R37CA082422] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ARCS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Adele Murrell for helpful advice and suggestions. We thank Dr. C. Andreu-Vieyra and Fides Lay for critical review of the manuscript. Funding for this work to P.A.J. was provided by NIH R37 CA-082422 and G.L. by R01 CA-124518. X.J.Z. was supported by an NSF Career Award 0747475. T.K.K. was funded by NIH 5T32 CA-009320-27 and an ARCS fellowship.	ASAKURA A, 1995, DEV BIOL, V171, P386, DOI 10.1006/dbio.1995.1290; ATCHISON ML, 1988, EMBO J, V7, P4213, DOI 10.1002/j.1460-2075.1988.tb03318.x; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BOUKAMP P, 1992, J CELL BIOL, V116, P1257, DOI 10.1083/jcb.116.5.1257; CARNAC G, 1992, MOL ENDOCRINOL, V6, P1185, DOI 10.1210/me.6.8.1185; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Daley GQ, 2011, CELL, V145, P811; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; FAERMAN A, 1995, DEV BIOL, V171, P27, DOI 10.1006/dbio.1995.1257; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; GOLDHAMER DJ, 1995, DEVELOPMENT, V121, P637; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hinshelwood RA, 2009, HUM MOL GENET, V18, P3098, DOI 10.1093/hmg/ddp251; HOLLENBERG SM, 1993, P NATL ACAD SCI USA, V90, P8028, DOI 10.1073/pnas.90.17.8028; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kablar B, 1997, DEVELOPMENT, V124, P4729; Kablar B, 1999, DEV BIOL, V206, P219, DOI 10.1006/dbio.1998.9126; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Lepikhov Konstantin, 2004, BMC Developmental Biology, V4, P1; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; MacIsaac KD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000773; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Miele Adriana, 2008, V464, P105; PINSET C, 1988, DIFFERENTIATION, V38, P28, DOI 10.1111/j.1432-0436.1988.tb00588.x; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAPSCOTT SJ, 1992, MOL CELL BIOL, V12, P4994, DOI 10.1128/MCB.12.11.4994; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; You JS, 2011, P NATL ACAD SCI USA, V108, P14497, DOI 10.1073/pnas.1111309108	48	136	141	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1283	1294		10.1016/j.cell.2011.10.040	http://dx.doi.org/10.1016/j.cell.2011.10.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153073	Bronze, Green Accepted			2022-12-24	WOS:000298148100018
J	McNally, A; Prier, CK; MacMillan, DWC				McNally, Andrew; Prier, Christopher K.; MacMillan, David W. C.			Discovery of an alpha-Amino C-H Arylation Reaction Using the Strategy of Accelerated Serendipity	SCIENCE			English	Article							PHOTOINDUCED ELECTRON-TRANSFER; ALIPHATIC-AMINES; PHOTOCHEMICAL-REACTIONS; COORDINATION-COMPOUNDS; CHEMICAL-REACTIONS; BOND ACTIVATION; CATION RADICALS; TRANSFER PET; DEPROTONATION; GENERATION	Serendipity has long been a welcome yet elusive phenomenon in the advancement of chemistry. We sought to exploit serendipity as a means of rapidly identifying unanticipated chemical transformations. By using a high-throughput, automated workflow and evaluating a large number of random reactions, we have discovered a photoredox-catalyzed C-H arylation reaction for the construction of benzylic amines, an important structural motif within pharmaceutical compounds that is not readily accessed via simple substrates. The mechanism directly couples tertiary amines with cyanoaromatics by using mild and operationally trivial conditions.	[McNally, Andrew; Prier, Christopher K.; MacMillan, David W. C.] Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu	kitajima, showa/AAP-7593-2020		Marie-Curie Actions for an International Outgoing Fellowship; NIH General Medical Sciences (NIHGMS) [NIHGMS R01 01 GM093213-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093213] Funding Source: NIH RePORTER	Marie-Curie Actions for an International Outgoing Fellowship; NIH General Medical Sciences (NIHGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.M. thanks the Marie-Curie Actions for an International Outgoing Fellowship. Financial support was provided by the NIH General Medical Sciences (NIHGMS) (grant NIHGMS R01 01 GM093213-01) and gifts from Merck, Amgen, Abbott, and Bristol-Myers Squibb. We would also like to thank J. C. Conrad for assistance.	Aubele DL, 2004, ADV SYNTH CATAL, V346, P359, DOI 10.1002/adsc.200303173; Bauer A, 2005, NATURE, V436, P1139, DOI 10.1038/nature03955; Beeler AB, 2007, J AM CHEM SOC, V129, P1413, DOI 10.1021/ja0674744; BELLAS M, 1977, J CHEM SOC PERK T 1, P2571, DOI 10.1039/p19770002571; Campos KR, 2006, J AM CHEM SOC, V128, P3538, DOI 10.1021/ja0605265; Chen YY, 2011, NAT CHEM, V3, P146, DOI 10.1038/NCHEM.932; Cossy J, 2006, TETRAHEDRON, V62, P6459, DOI 10.1016/j.tet.2006.03.062; DINNOCENZO JP, 1989, J AM CHEM SOC, V111, P8646, DOI 10.1021/ja00205a014; Dixon IM, 2000, CHEM SOC REV, V29, P385, DOI 10.1039/b000704h; Flamigni L, 2007, TOP CURR CHEM, V281, P143, DOI 10.1007/128_2007_131; Giera DS, 2009, SYNTHESIS-STUTTGART, P3797, DOI 10.1055/s-0029-1217026; Goodell JR, 2009, J ORG CHEM, V74, P6169, DOI 10.1021/jo901073v; HIRAI Y, 1988, CHEM PHARM BULL, V36, P1343; Kanan MW, 2004, NATURE, V431, P545, DOI 10.1038/nature02920; Lednicer D., 1998, STRATEGIES ORGANIC D; Li ZP, 2005, J AM CHEM SOC, V127, P6968, DOI 10.1021/ja0516054; MINISCI F, 1989, HETEROCYCLES, V28, P489, DOI 10.3987/REV-88-SR1; Mori Y, 2000, J PHYS CHEM A, V104, P4896, DOI 10.1021/jp0007437; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; OHASHI M, 1977, CHEM LETT, P615, DOI 10.1246/cl.1977.615; OHASHI M, 1980, B CHEM SOC JPN, V53, P1683, DOI 10.1246/bcsj.53.1683; Ohta M, 2009, CHEM-ASIAN J, V4, P1416, DOI 10.1002/asia.200900157; PANDEY G, 1993, TOP CURR CHEM, V168, P175; PANTELEEVA EV, 1995, TETRAHEDRON LETT, V36, P8465, DOI 10.1016/0040-4039(95)01685-B; Pastine SJ, 2006, J AM CHEM SOC, V128, P14220, DOI 10.1021/ja064481j; Robbins DW, 2011, SCIENCE, V333, P1423, DOI 10.1126/science.1207922; Roberts R. M., 1989, SERENDIPITY ACCIDENT; Rossi R. A., 2004, CRC HDB ORGANIC PHOT, P47; Rozenman MM, 2007, J AM CHEM SOC, V129, P14933, DOI 10.1021/ja074155j; Szewczyk JW, 2001, ANGEW CHEM INT EDIT, V40, P216, DOI 10.1002/1521-3773(20010105)40:1<216::AID-ANIE216>3.0.CO;2-K; Weber L, 1999, SYNLETT, P366, DOI 10.1055/s-1999-2612; Yoshikai N, 2010, J AM CHEM SOC, V132, P5568, DOI 10.1021/ja100651t; ZHANG XM, 1994, J AM CHEM SOC, V116, P4211, DOI 10.1021/ja00089a010	33	651	653	12	387	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1114	1117		10.1126/science.1213920	http://dx.doi.org/10.1126/science.1213920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116882	Green Accepted			2022-12-24	WOS:000297313900045
J	Fribourg, M; Moreno, JL; Holloway, T; Provasi, D; Baki, L; Mahajan, R; Park, G; Adney, SK; Hatcher, C; Eltit, JM; Ruta, JD; Albizu, L; Li, Z; Umali, A; Shim, J; Fabiato, A; MacKerell, AD; Brezina, V; Sealfon, SC; Filizola, M; Gonzalez-Maeso, J; Logothetis, DE				Fribourg, Miguel; Moreno, Jose L.; Holloway, Terrell; Provasi, Davide; Baki, Lia; Mahajan, Rahul; Park, Gyu; Adney, Scott K.; Hatcher, Candice; Eltit, Jose M.; Ruta, Jeffrey D.; Albizu, Laura; Li, Zheng; Umali, Adrienne; Shim, Jihyun; Fabiato, Alexandre; MacKerell, Alexander D., Jr.; Brezina, Vladimir; Sealfon, Stuart C.; Filizola, Marta; Gonzalez-Maeso, Javier; Logothetis, Diomedes E.			Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs	CELL			English	Article							PROTEIN-COUPLED RECEPTOR; MU-OPIOID RECEPTORS; BETA-GAMMA-SUBUNITS; 5-HYDROXYTRYPTAMINE(2A) RECEPTOR; CRYSTAL-STRUCTURE; SCHIZOPHRENIA; IDENTIFICATION; ACTIVATION; AGONIST; PHARMACOLOGY	Atypical antipsychotic drugs, such as clozapine and risperidone, have a high affinity for the serotonin 5-HT2A G protein-coupled receptor (GPCR), the 2AR, which signals via a G(q) heterotrimeric G protein. The closely related non-antipsychotic drugs, such as ritanserin and methysergide, also block 2AR function, but they lack comparable neuropsychological effects. Why some but not all 2AR inhibitors exhibit antipsychotic properties remains unresolved. We now show that a heteromeric complex between the 2AR and the Gi-linked GPCR, metabotropic glutamate 2 receptor (mGluR2), integrates ligand input, modulating signaling output and behavioral changes. Serotonergic and glutamatergic drugs bind the mGluR2/2AR heterocomplex, which then balances Gi- and Gq-dependent signaling. We find that the mGluR2/2AR-mediated changes in Gi and Gq activity predict the psychoactive behavioral effects of a variety of pharmocological compounds. These observations provide mechanistic insight into antipsychotic action that may advance therapeutic strategies for disorders including schizophrenia and dementia.	[Moreno, Jose L.; Holloway, Terrell; Ruta, Jeffrey D.; Umali, Adrienne; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Fribourg, Miguel; Provasi, Davide; Li, Zheng; Brezina, Vladimir; Filizola, Marta] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Albizu, Laura; Sealfon, Stuart C.; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Fribourg, Miguel; Brezina, Vladimir; Sealfon, Stuart C.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Sealfon, Stuart C.] Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY 10029 USA; [Brezina, Vladimir; Sealfon, Stuart C.; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [MacKerell, Alexander D., Jr.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Baki, Lia; Mahajan, Rahul; Park, Gyu; Adney, Scott K.; Hatcher, Candice; Eltit, Jose M.; Fabiato, Alexandre; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University System of Maryland; University of Maryland Baltimore; Virginia Commonwealth University	Gonzalez-Maeso, J (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA.	javier.maeso@mssm.edu; delogothetis@vcu.edu	Mahajan, Rahul/AAS-5971-2021; MacKerell, Alex/AAA-2560-2020; MacKerell, Alex/Y-2469-2019; Moreno, Jose L/L-8981-2017; Fribourg, Miguel/AAO-2186-2020	Mahajan, Rahul/0000-0002-9613-2870; MacKerell, Alex/0000-0001-8287-6804; Filizola, Marta/0000-0002-4382-8276; Provasi, Davide/0000-0002-2868-303X; Adney, Scott/0000-0001-8743-5944; Fribourg, Miguel/0000-0003-1804-8136; SEALFON, Stuart/0000-0001-5791-1217	NIH [HL59949, 5R01MH084894, MH084894, MH091360, DA026434, F30HL097582, SRC1DA02811202, 1R01DA02694702]; NARSAD; Dainippon Sumitomo Pharma; Maltz Family Foundation; National Science Foundation [TG-MCB080109N]; Ministerio de Ciencia e Innovacion, Spain; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949, F30HL097582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH091360, R01MH084894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026434] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Maltz Family Foundation; National Science Foundation(National Science Foundation (NSF)); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Sophia Gruszecki, Heikki Vaananen, Dr. Jian Yang, and Dr. Basil Hanss for Xenopus oocyte isolation and are grateful to Dr. Kurt Hauser for his support with the cortical primary neuronal cultures and Dr. J.A. Gingrich for his gift of 5HT2A-KO mice. The authors are also thankful to Drs. M. Scott Bowers, Louis J. De Felice, Frank Guarnieri (Virginia Commonwealth University), Lakshmi Devi (Mount Sinai School of Medicine), Jonathan Javitch (Columbia University), George Liapakis (University of Crete, Greece), and Herbert Meltzer (Vanderbilt University) for critical feedback on the manuscript and to members of the Logothetis lab for useful feedback throughout this project. D. E. L. was partly supported for this work by NIH grant HL59949. J. G.-M. was supported by NIH grant 5R01MH084894, as well as NARSAD, Dainippon Sumitomo Pharma, and the Maltz Family Foundation Award. M. F. was supported by NIH grants MH084894, MH091360, and DA026434. The computations were supported in part by the National Science Foundation through TeraGrid advanced computing resources provided by the Texas Advanced Computing Center under grant TG-MCB080109N. J. L. M. was the recipient of a postdoctoral fellowship from Ministerio de Ciencia e Innovacion, Spain. R. M. was supported by NIH grant F30HL097582. J. M. E. was supported by NIH grants SRC1DA02811202 and 1R01DA02694702.	Aloyo VJ, 2009, PHARMACOL THERAPEUT, V121, P160, DOI 10.1016/j.pharmthera.2008.10.010; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Barela AJ, 2006, J NEUROSCI, V26, P2714, DOI 10.1523/JNEUROSCI.2977-05.2006; Bespalov A, 2007, J PHARMACOL EXP THER, V320, P944, DOI 10.1124/jpet.106.110684; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Branduardi D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432340; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Egan CT, 1998, J PHARMACOL EXP THER, V286, P85; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Gonzalez-Maeso J, 2002, EUR J PHARMACOL, V452, P21, DOI 10.1016/S0014-2999(02)02242-2; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Gonzalez-Maeso J, 2009, TRENDS NEUROSCI, V32, P225, DOI 10.1016/j.tins.2008.12.005; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hof PR., 2000, COMP CYTOARCHITECTON; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Kinon BJ, 2011, J CLIN PSYCHOPHARM, V31, P349, DOI 10.1097/JCP.0b013e318218dcd5; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Meltzer HY, 2008, PROG BRAIN RES, V172, P177, DOI 10.1016/S0079-6123(08)00909-6; MELTZER HY, 1989, J PHARMACOL EXP THER, V251, P238; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Moreno JL, 2011, NEUROSCI LETT, V493, P76, DOI 10.1016/j.neulet.2011.01.046; Moreno JL, 2009, CELL MOL LIFE SCI, V66, P3777, DOI 10.1007/s00018-009-0130-3; Morris BJ, 2005, CURR OPIN PHARMACOL, V5, P101, DOI 10.1016/j.coph.2004.08.008; Mouri A, 2007, NEUROCHEM INT, V51, P173, DOI 10.1016/j.neuint.2007.06.019; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Pichon X, 2010, MOL THER, V18, P1462, DOI 10.1038/mt.2010.101; Provasi D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002193; REIMHERR FW, 1986, PSYCHOPHARMACOL BULL, V22, P237; Rives ML, 2009, EMBO J, V28, P2195, DOI 10.1038/emboj.2009.177; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Urizar E, 2011, NAT CHEM BIOL, V7, P624, DOI [10.1038/NCHEMBIO.623, 10.1038/nchembio.623]; Uslaner JM, 2009, PSYCHOPHARMACOLOGY, V206, P641, DOI 10.1007/s00213-009-1644-y; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Weiner DM, 2001, J PHARMACOL EXP THER, V299, P268; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Woolley ML, 2008, PSYCHOPHARMACOLOGY, V196, P431, DOI 10.1007/s00213-007-0974-x; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645	50	206	226	0	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 23	2011	147	5					1011	1023		10.1016/j.cell.2011.09.055	http://dx.doi.org/10.1016/j.cell.2011.09.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118459	Green Accepted, Bronze			2022-12-24	WOS:000297376600014
J	Mirnezami, R; Nicholson, J; Darzi, A				Mirnezami, Reza; Nicholson, Jeremy; Darzi, Ara			Preparing for Precision Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH		[Mirnezami, Reza; Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, Sect Biosurg & Surg Technol, Dept Surg & Canc, London, England; [Nicholson, Jeremy] Univ London Imperial Coll Sci Technol & Med, Sect Biomol Med, Dept Surg & Canc, London, England	Imperial College London; Imperial College London	Mirnezami, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Biosurg & Surg Technol, Dept Surg & Canc, London, England.		Nicholson, Jeremy K/B-3395-2012	Nicholson, Jeremy K/0000-0002-8123-8349				Committee on a Framework for Developing a New Taxonomy of Disease; National Research Council, 2011, PREC MED BUILD KNOWL; Katsanis SH, 2008, SCIENCE, V320, P53, DOI 10.1126/science.1156604; Mayor S, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6215; Scheuner MT, 2009, GENET MED, V11, P510, DOI 10.1097/GIM.0b013e3181a53331	4	441	469	3	138	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2012	366	6					489	491		10.1056/NEJMp1114866	http://dx.doi.org/10.1056/NEJMp1114866			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888GH	22256780				2022-12-24	WOS:000299991300004
J	Welsh, WF; Orosz, JA; Carter, JA; Fabrycky, DC; Ford, EB; Lissauer, JJ; Prsa, A; Quinn, SN; Ragozzine, D; Short, DR; Torres, G; Winn, JN; Doyle, LR; Barclay, T; Batalha, N; Bloemen, S; Brugamyer, E; Buchhave, LA; Caldwell, C; Caldwell, DA; Christiansen, JL; Ciardi, DR; Cochran, WD; Endl, M; Fortney, JJ; Gautier, TN; Gilliland, RL; Haas, MR; Hall, JR; Holman, MJ; Howard, AW; Howell, SB; Isaacson, H; Jenkins, JM; Klaus, TC; Latham, DW; Li, J; Marcy, GW; Mazeh, T; Quintana, EV; Robertson, P; Shporer, A; Steffen, JH; Windmiller, G; Koch, DG; Borucki, WJ				Welsh, William F.; Orosz, Jerome A.; Carter, Joshua A.; Fabrycky, Daniel C.; Ford, Eric B.; Lissauer, Jack J.; Prsa, Andrej; Quinn, Samuel N.; Ragozzine, Darin; Short, Donald R.; Torres, Guillermo; Winn, Joshua N.; Doyle, Laurance R.; Barclay, Thomas; Batalha, Natalie; Bloemen, Steven; Brugamyer, Erik; Buchhave, Lars A.; Caldwell, Caroline; Caldwell, Douglas A.; Christiansen, Jessie L.; Ciardi, David R.; Cochran, William D.; Endl, Michael; Fortney, Jonathan J.; Gautier, Thomas N., III; Gilliland, Ronald L.; Haas, Michael R.; Hall, Jennifer R.; Holman, Matthew J.; Howard, Andrew W.; Howell, Steve B.; Isaacson, Howard; Jenkins, Jon M.; Klaus, Todd C.; Latham, David W.; Li, Jie; Marcy, Geoffrey W.; Mazeh, Tsevi; Quintana, Elisa V.; Robertson, Paul; Shporer, Avi; Steffen, Jason H.; Windmiller, Gur; Koch, David G.; Borucki, William J.			Transiting circumbinary planets Kepler-34 b and Kepler-35 b	NATURE			English	Article							HIERARCHICAL TRIPLE; ECLIPSING BINARIES; STELLAR; STABILITY; CATALOG	Most Sun-like stars in the Galaxy reside in gravitationally bound pairs of stars(1,2) (binaries). Although long anticipated(3-8), the existence of a 'circumbinary planet' orbiting such a pair of normal stars was not definitively established until the discovery(9) of the planet transiting (that is, passing in front of) Kepler-16. Questions remained, however, about the prevalence of circumbinary planets and their range of orbital and physical properties. Here we report two additional transiting circumbinary planets: Kepler-34 (AB)b and Kepler-35 (AB)b, referred to here as Kepler-34 b and Kepler-35 b, respectively. Each is a low-density gas-giant planet on an orbit closely aligned with that of its parent stars. Kepler-34 b orbits two Sun-like stars every 289 days, whereas Kepler-35 b orbits a pair of smaller stars (89% and 81% of the Sun's mass) every 131 days. The planets experience large multi-periodic variations in incident stellar radiation arising from the orbital motion of the stars. The observed rate of circumbinary planets in our sample implies that more than similar to 1% of close binary stars have giant planets in nearly coplanar orbits, yielding a Galactic population of at least several million.	[Welsh, William F.; Orosz, Jerome A.; Short, Donald R.; Windmiller, Gur] San Diego State Univ, Dept Astron, San Diego, CA 92182 USA; [Fabrycky, Daniel C.] Univ Calif Santa Cruz, Lick Observ, UCO, Santa Cruz, CA 95064 USA; [Ford, Eric B.] Univ Florida, Bryant Space Sci Ctr 211, Gainesville, FL 32611 USA; [Lissauer, Jack J.; Barclay, Thomas; Batalha, Natalie; Christiansen, Jessie L.; Haas, Michael R.; Howell, Steve B.; Jenkins, Jon M.; Li, Jie; Quintana, Elisa V.; Koch, David G.; Borucki, William J.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Carter, Joshua A.; Quinn, Samuel N.; Ragozzine, Darin; Torres, Guillermo; Holman, Matthew J.; Latham, David W.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Prsa, Andrej] Villanova Univ, Dept Astron & Astrophys, Villanova, PA 19085 USA; [Quinn, Samuel N.] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30302 USA; [Winn, Joshua N.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Winn, Joshua N.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Doyle, Laurance R.; Caldwell, Douglas A.; Christiansen, Jessie L.; Jenkins, Jon M.; Li, Jie; Quintana, Elisa V.] SETI Inst, Carl Sagan Ctr Study Life Universe, Mountain View, CA 94043 USA; [Barclay, Thomas] Bay Area Environm Res Inst Inc, Sonoma, CA 95476 USA; [Batalha, Natalie] San Jose State Univ, Dept Phys & Astron, San Jose, CA 95192 USA; [Bloemen, Steven] Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Louvain, Belgium; [Buchhave, Lars A.] Univ Copenhagen, Ctr Star & Planet Format, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Brugamyer, Erik; Cochran, William D.; Endl, Michael] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Ciardi, David R.] CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Fortney, Jonathan J.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Gautier, Thomas N., III] Jet Prop Lab, Pasadena, CA 91109 USA; [Gilliland, Ronald L.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Klaus, Todd C.] NASA, Orbital Sci Corp, Ames Res Ctr, Moffett Field, CA 94035 USA; [Marcy, Geoffrey W.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Mazeh, Tsevi] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Shporer, Avi] Las Cumbres Observ, Global Telescope Network, Santa Barbara, CA 93117 USA; [Shporer, Avi] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Steffen, Jason H.] Fermilab Ctr Particle Astrophys, Batavia, IL 60510 USA	California State University System; San Diego State University; University of California System; University of California Santa Cruz; State University System of Florida; University of Florida; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Villanova University; University System of Georgia; Georgia State University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); California State University System; San Jose State University; KU Leuven; University of Copenhagen; University of Texas System; University of Texas Austin; University of Copenhagen; Niels Bohr Institute; California Institute of Technology; National Aeronautics & Space Administration (NASA); University of California System; University of California Santa Cruz; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Space Telescope Science Institute; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Berkeley; Tel Aviv University; University of California System; University of California Santa Barbara	Welsh, WF (corresponding author), San Diego State Univ, Dept Astron, 5500 Campanile Dr, San Diego, CA 92182 USA.	wfw@sciences.sdsu.edu; jacarter@cfa.harvard.edu	Welsh, William/AAS-3445-2021; Carter, Joshua A/A-8280-2013; Shporer, Avi/Y-2777-2019; Ragozzine, Darin/C-4926-2013; Cochran, William D/M-4421-2014; Marcy, Geoff/AAC-6050-2019; Robertson, Paul/AEV-0522-2022; Caldwell, Douglas A/L-7911-2014; Ford, Eric B./AAB-5479-2019; Buchhave, Lars A./ABF-2000-2020; Steffen, Jason H./A-4320-2013; Howard, Andrew/D-4148-2015; Fortney, Jonathan/F-8813-2014	Shporer, Avi/0000-0002-1836-3120; Cochran, William D/0000-0001-9662-3496; Robertson, Paul/0000-0003-0149-9678; Caldwell, Douglas A/0000-0003-1963-9616; Ford, Eric B./0000-0001-6545-639X; Buchhave, Lars A./0000-0003-1605-5666; Howard, Andrew/0000-0001-8638-0320; Christiansen, Jessie/0000-0002-8035-4778; Fabrycky, Daniel/0000-0003-3750-0183; Fortney, Jonathan/0000-0002-9843-4354; Batalha, Natalie/0000-0002-7030-9519; Ciardi, David/0000-0002-5741-3047; Steffen, Jason/0000-0003-2202-3847; Barclay, Thomas/0000-0001-7139-2724	NASA's Science Mission Directorate; Kepler Participating Scientist Program; NSF; NASA; STScI; European Research Council under the European Community; Research Council of KU Leuven; FAS Science Division Research Computing Group at Harvard University; Direct For Mathematical & Physical Scien [1109928] Funding Source: National Science Foundation	NASA's Science Mission Directorate; Kepler Participating Scientist Program; NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); STScI(Space Telescope Science Institute); European Research Council under the European Community(European Research Council (ERC)); Research Council of KU Leuven(KU Leuven); FAS Science Division Research Computing Group at Harvard University; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Kepler was selected as the tenth NASA Discovery mission with funding provided by NASA's Science Mission Directorate. We thank the many people who made the Kepler mission a reality. W. F. W., J.A.O., E. B. F., A. P., L. R. D., J.J.F., M.J.H., T. M. and J.H.S. were supported by the Kepler Participating Scientist Program. W. F. W., J.A.O., D. R. S. and G. W. were supported by the NSF. D. C. F. and J.A.C. acknowledge NASA support through Hubble Fellowship grants, awarded by STScI, operated by AURA. J.N.W. was supported by the NASA Origins programme. S. B. acknowledges funding from the European Research Council under the European Community's Seventh Framework Programme (PROSPERITY) and from the Research Council of KU Leuven. Some of the reported computations were run on the Odyssey cluster supported by the FAS Science Division Research Computing Group at Harvard University. This Letter is based in part on observations made with the Nordic Optical Telescope (operated on the island of La Palma jointly by Denmark, Finland, Iceland, Norway and Sweden, in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias), the W. M. Keck Observatory (operated by the University of California and the California Institute of Technology) and the Hobby-Eberly Telescope (HET; a joint project of the University of Texas at Austin, the Pennsylvania State University, Stanford University, Ludwig-Maximillians-Universitat Munchen, and Georg-August-Universitat Goettingen).	Binnendijk L, 1960, PROPERTIES DOUBLE ST; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Brown TM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/112; Carter JA, 2011, SCIENCE, V331, P562, DOI 10.1126/science.1201274; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Deeg HJ, 2008, ASTRON ASTROPHYS, V480, P563, DOI 10.1051/0004-6361:20079000; Doolin S., 2011, NOT R ASTRO IN PRESS; Doyle LR, 2011, SCIENCE, V333, P1602, DOI 10.1126/science.1210923; EGGLETON P, 1995, ASTROPHYS J, V455, P640, DOI 10.1086/176611; Haghighipour N, 2010, ASTROPHYS SPACE SC L, V366, P285, DOI 10.1007/978-90-481-8687-7_11; Holman MJ, 1999, ASTRON J, V117, P621, DOI 10.1086/300695; KASTING JF, 1993, ICARUS, V101, P108, DOI 10.1006/icar.1993.1010; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Prsa A, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/3/83; Quintana EV, 2006, ICARUS, V185, P1, DOI 10.1016/j.icarus.2006.06.016; Raghavan D, 2010, ASTROPHYS J SUPPL S, V190, P1, DOI 10.1088/0067-0049/190/1/1; Ragozzine D., 2010, ASTROPHYS J UNPUB; SCHNEIDER J, 1990, ASTRON ASTROPHYS, V232, P251; Schwarz R, 2011, MON NOT R ASTRON SOC, V414, P2763, DOI 10.1111/j.1365-2966.2011.18594.x; Slawson RW, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/5/160; Sybilski P, 2010, MON NOT R ASTRON SOC, V405, P657, DOI 10.1111/j.1365-2966.2010.16490.x; Yi S, 2001, ASTROPHYS J SUPPL S, V136, P417, DOI 10.1086/321795	22	319	323	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2012	481	7382					475	U85		10.1038/nature10768	http://dx.doi.org/10.1038/nature10768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22237021	Green Accepted, Green Submitted			2022-12-24	WOS:000299471800033
J	Andreu-Agullo, C; Maurin, T; Thompson, CB; Lai, EC				Andreu-Agullo, Celia; Maurin, Thomas; Thompson, Craig B.; Lai, Eric C.			Ars2 maintains neural stem-cell identity through direct transcriptional activation of Sox2	NATURE			English	Article							CAP-BINDING COMPLEX; SELF-RENEWAL; RNA INTERFERENCE; ANALYSIS REVEALS; TRANSGENIC MICE; EXPRESSION; SERRATE; BRAIN; PROLIFERATION; ARABIDOPSIS	Fundamental questions remain unanswered about the transcriptional networks that control the identity and self-renewal of neural stem cells (NSCs), a specialized subset of astroglial cells that are endowed with stem properties and neurogenic capacity. Here we report that the zinc finger protein Ars2 (arsenite-resistance protein 2; also known as Srrt) is expressed by adult NSCs from the subventricular zone (SVZ) of mice, and that selective knockdown of Ars2 in cells expressing glial fibrillary acidic protein within the adult SVZ depletes the number of NSCs and their neurogenic capacity. These phenotypes are recapitulated in the postnatal SVZ of hGFAP-cre:: Ars2(fl/fl) conditional knockout mice, but are more severe. Ex vivo assays show that Ars2 is necessary and sufficient to promote NSC self-renewal, and that it does so by positively regulating the expression of Sox2. Although plant(1-3) and animal(4,5) orthologues of Ars2 are known for their conserved roles in microRNA biogenesis, we unexpectedly observed that Ars2 retains its capacity to promote self-renewal in Drosha and Dicer1 knockout NSCs. Instead, chromatin immunoprecipitation revealed that Ars2 binds a specific region within the 6-kilobase NSC enhancer of Sox2. This association is RNA-independent, and the region that is bound is required for Ars2-mediated activation of Sox2. We used gel-shift analysis to refine the Sox2 region bound by Ars2 to a specific conserved DNA sequence. The importance of Sox2 as a critical downstream effector is shown by its ability to restore the self-renewal and multipotency defects of Ars2 knockout NSCs. Our findings reveal Ars2 as a new transcription factor that controls the multipotent progenitor state of NSCs through direct activation of the pluripotency factor Sox2.	[Andreu-Agullo, Celia; Maurin, Thomas; Lai, Eric C.] Sloan Kettering Inst, Dept Dev Biol, New York, NY 10065 USA; [Thompson, Craig B.] Sloan Kettering Inst, Dept Canc Biol & Genet, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Andreu-Agullo, C (corresponding author), Sloan Kettering Inst, Dept Dev Biol, 1275 York Ave,Box 252, New York, NY 10065 USA.	andreuac@mskcc.org; laie@mskcc.org	Lai, Eric/AAO-1143-2021; maurin, thomas O/O-7494-2016; Lai, Eric C/A-3412-2008	Lai, Eric/0000-0002-8432-5851; maurin, thomas O/0000-0002-8467-3135; 	Burroughs Wellcome Fund; Starr Cancer Consortium [I3-A139]; NIH [R01-GM083300]; EMBO [ALTF 718-2008]; NYSTEM Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083300] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Starr Cancer Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); NYSTEM Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank X. Lu, M. Gotz, A. Rizzino, P. M. LLedo, P. Charneau, M. Segura, P. L. Howard and S. Olejniczak for reagents. We are grateful to K. Hadjantonakis, A. Ferrer-Vaquer, J. Zhang and Y. Ganat for assistance. U. Ruthishauser, V. Tabar and the Molecular Cytology Core Facility at the Memorial Sloan-Kettering Cancer Center shared equipment. S. R. Ferron, H. Mira, A. Joyner, H. Duan, Q. Dai, I. Farinas and S. Shi provided critical comments. Work in E. C. L.'s group was supported by the Burroughs Wellcome Fund, the Starr Cancer Consortium (I3-A139) and the NIH (R01-GM083300). C. A.-A. was funded by a EMBO Long-Term Fellowship (ALTF 718-2008) and a NYSTEM Fellowship.	Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Boutin C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001883; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Whitman MC, 2007, J NEUROSCI, V27, P9951, DOI 10.1523/JNEUROSCI.1633-07.2007; Wilson MD, 2008, MOL CELL BIOL, V28, P1503, DOI 10.1128/MCB.01565-07; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	33	60	64	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2012	481	7380					195	+		10.1038/nature10712	http://dx.doi.org/10.1038/nature10712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22198669	Green Accepted			2022-12-24	WOS:000298981200038
J	Aldridge, BB; Fernandez-Suarez, M; Heller, D; Ambravaneswaran, V; Irimia, D; Toner, M; Fortune, SM				Aldridge, Bree B.; Fernandez-Suarez, Marta; Heller, Danielle; Ambravaneswaran, Vijay; Irimia, Daniel; Toner, Mehmet; Fortune, Sarah M.			Asymmetry and Aging of Mycobacterial Cells Lead to Variable Growth and Antibiotic Susceptibility	SCIENCE			English	Article							BACILLUS-SUBTILIS; SIZE CONTROL; DIVISION; PROTEINS; LOCALIZATION; TUBERCULOSIS; CYCLE; SPORULATION; PERSISTENCE; SWITCH	Cells use both deterministic and stochastic mechanisms to generate cell-to-cell heterogeneity, which enables the population to better withstand environmental stress. Here we show that, within a clonal population of mycobacteria, there is deterministic heterogeneity in elongation rate that arises because mycobacteria grow in an unusual, unipolar fashion. Division of the asymmetrically growing mother cell gives rise to daughter cells that differ in elongation rate and size. Because the mycobacterial cell division cycle is governed by time, not cell size, rapidly elongating cells do not divide more frequently than slowly elongating cells. The physiologically distinct subpopulations of cells that arise through asymmetric growth and division are differentially susceptible to clinically important classes of antibiotics.	[Aldridge, Bree B.; Fernandez-Suarez, Marta; Heller, Danielle; Fortune, Sarah M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Fernandez-Suarez, Marta; Ambravaneswaran, Vijay; Irimia, Daniel; Toner, Mehmet] Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA; [Fortune, Sarah M.] MIT, Ragon Inst MGH, Boston, MA 02129 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Fortune, SM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	sfortune@hsph.harvard.edu	Irimia, Daniel/S-5404-2019; Irimia, Daniel/A-4095-2008	Irimia, Daniel/0000-0001-7347-2082; Irimia, Daniel/0000-0001-7347-2082; Fortune, Sarah/0000-0001-7565-9975; Aldridge, Bree/0000-0003-2236-1424; Heller, Danielle/0000-0002-6581-1256	National Institute of Health [1DP20D001378]; Doris Duke Charitable Foundation [2010054]; United States Army Medical Research Acquisition Activity [W81XWH-10-2-0161]; National Institute of Biomedical Imaging and Bioengineering [P41 EB002503]; Massachusetts General Hospital Executive Committee on Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001378] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); United States Army Medical Research Acquisition Activity; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Massachusetts General Hospital Executive Committee on Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Rubin, B. Bloom, C. Sassetti, D. Lauffenburger, E. Liu, and J. Model for helpful discussions; P. Sorger for access to his live-cell imaging systems; A. J. Aranyosi for assistance with microfabrication; J. Goldstein for help with image annotation; and J. Sinn-Hanlon for the device illustration. We thank R. Husson and M. Mir for the gift of Van-Alexa. B. B. A. and S. M. F. designed the experiments and wrote the initial manuscript. B. B. A. performed the experiments, annotated images, and developed the analysis programs. M.F.-S., V. A., D. I., and M. T. designed the microfluidic devices that were built by M.F.-S. D. H. performed the initial pulse-chase experiment and annotated images. This work was partially supported by a National Institute of Health Director's New Innovator Award 1DP20D001378, Doris Duke Charitable Foundation under grant 2010054, and United States Army Medical Research Acquisition Activity under grant W81XWH-10-2-0161 to S. M. F., the National Institute of Biomedical Imaging and Bioengineering under grant P41 EB002503 to M. T. (BioMEMS Resource Center), and by the Massachusetts General Hospital Executive Committee on Research through a postdoctoral fellowship to M.F.S.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Bordes P, 2011, P NATL ACAD SCI USA, V108, P8438, DOI 10.1073/pnas.1101189108; Carniol K, 2005, J BACTERIOL, V187, P3511, DOI 10.1128/JB.187.10.3511-3520.2005; Chai YR, 2010, GENE DEV, V24, P754, DOI 10.1101/gad.1915010; Chen YE, 2011, P NATL ACAD SCI USA, V108, P1052, DOI 10.1073/pnas.1015397108; COHN DL, 1990, ANN INTERN MED, V112, P407, DOI 10.7326/0003-4819-76-3-112-6-407; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Elzinga G, 2004, LANCET, V363, P814, DOI 10.1016/S0140-6736(04)15698-5; Farnia P, 2010, INT J CLIN EXP MED, V3, P308; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Jensen RB, 2002, NAT REV MOL CELL BIO, V3, P167, DOI 10.1038/nrm758; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; Mentinova M, 2010, J AM CHEM SOC, V132, P18248, DOI 10.1021/ja107286p; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Singh B, 2010, ANTON LEEUW INT J G, V98, P165, DOI 10.1007/s10482-010-9446-0; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Sveiczer A, 1996, J CELL SCI, V109, P2947; Thanky NR, 2007, TUBERCULOSIS, V87, P231, DOI 10.1016/j.tube.2006.10.004; Tsokos CG, 2011, DEV CELL, V20, P329, DOI 10.1016/j.devcel.2011.01.007; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454; Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999	29	265	271	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					100	104		10.1126/science.1216166	http://dx.doi.org/10.1126/science.1216166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22174129	Green Accepted, Bronze			2022-12-24	WOS:000298846200060
J	Duan, S; Cermak, L; Pagan, JK; Rossi, M; Martinengo, C; di Celle, PF; Chapuy, B; Shipp, M; Chiarle, R; Pagano, M				Duan, Shanshan; Cermak, Lukas; Pagan, Julia K.; Rossi, Mario; Martinengo, Cinzia; di Celle, Paola Francia; Chapuy, Bjoern; Shipp, Margaret; Chiarle, Roberto; Pagano, Michele			FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas	NATURE			English	Article							SCF UBIQUITIN LIGASE; GENE-EXPRESSION; PATHOGENESIS	BCL6 is the product of a proto-oncogene implicated in the pathogenesis of human B-cell lymphomas(1,2). By binding specific DNA sequences, BCL6 controls the transcription of a variety of genes involved in B-cell development, differentiation and activation. BCL6 is overexpressed in the majority of patients with aggressive diffuse large B-cell lymphoma (DLBCL), the most common lymphoma in adulthood, and transgenic mice constitutively expressing BCL6 in B cells develop DLBCLs similar to the human disease(3,4). In many DLBCL patients, BCL6 overexpression is achieved through translocation (similar to 40%) or hypermutation of its promoter (similar to 15%). However, many other DLBCLs overexpress BCL6 through an unknown mechanism. Here we show that BCL6 is targeted for ubiquitylation and proteasomal degradation by a SKP1-CUL1-F-box protein (SCF) ubiquitin ligase complex that contains the orphan F-box protein FBXO11 (refs 5, 6). The gene encoding FBXO11 was found to be deleted or mutated in multiple DLBCL cell lines, and this inactivation of FBXO11 correlated with increased levels and stability of BCL6. Similarly, FBXO11 was either deleted or mutated in primary DLBCLs. Notably, tumour-derived FBXO11 mutants displayed an impaired ability to induce BCL6 degradation. Reconstitution of FBXO11 expression in FBXO11-deleted DLBCL cells promoted BCL6 ubiquitylation and degradation, inhibited cell proliferation, and induced cell death. FBXO11-deleted DLBCL cells generated tumours in immunodeficient mice, and the tumorigenicity was suppressed by FBXO11 reconstitution. We reveal a molecular mechanism controlling BCL6 stability and propose that mutations and deletions in FBXO11 contribute to lymphomagenesis through BCL6 stabilization. The deletions/mutations found in DLBCLs are largely monoallelic, indicating that FBXO11 is a haplo-insufficient tumour suppressor gene.	[Duan, Shanshan; Cermak, Lukas; Pagan, Julia K.; Rossi, Mario; Pagano, Michele] NYU, Sch Med, NYU Canc Inst, Dept Pathol, New York, NY 10016 USA; [Duan, Shanshan; Cermak, Lukas; Pagan, Julia K.; Pagano, Michele] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Martinengo, Cinzia; Chiarle, Roberto] Univ Turin, CERMS, Dept Biomed Sci & Human Oncol, I-10126 Turin, Italy; [di Celle, Paola Francia] San Giovanni Battista Hosp, I-10126 Turin, Italy; [Chapuy, Bjoern; Shipp, Margaret] Dana Farber Canc Inst, Boston, MA 02115 USA	New York University; Howard Hughes Medical Institute; New York University; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Harvard University; Dana-Farber Cancer Institute	Pagano, M (corresponding author), NYU, Sch Med, NYU Canc Inst, Dept Pathol, 522 1st Ave,SRB 1107, New York, NY 10016 USA.	roberto.chiarle@unito.it; michele.pagano@nyumc.org	Pagan, Julia/O-1929-2016; Cermak, Lukas/N-2254-2016; Rossi, Mario/E-7666-2012	Pagan, Julia/0000-0002-7079-6388; Cermak, Lukas/0000-0002-8777-3692; Rossi, Mario/0000-0001-6349-8895; CHIARLE, Roberto/0000-0003-1564-8531; pagano, michele/0000-0003-3210-2442	National Institutes of Health [R01-GM57587, R37-CA76584, R21-CA161108, PO1-CA092625]; Susan G. Komen for the Cure; Lymphoma Research Foundation; AIRC; ERC [ERC-2009-StG-Proposal No242965-LUNELY]; NATIONAL CANCER INSTITUTE [P01CA092625, R37CA076584, R21CA161108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Lymphoma Research Foundation; AIRC(Fondazione AIRC per la ricerca sul cancro); ERC(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Carroll, S. Shaham and L. Staudt for sharing unpublished results; A. Melnick, Y. Sun and Y. Xiong for reagents; L. Cerchietti, Y. Cheng, E. Dehan, V. Donato, N. V. Dorello, S. N. Yang and Z. Yao for advice and/or contributions to this work. M. P. is grateful to T. M. Thor and K. E. Davidson, and L. C. to Zuzana S. for continuous support. This work was supported by grants from the National Institutes of Health to M. P. (R01-GM57587, R37-CA76584 and R21-CA161108) and M. S. (PO1-CA092625), a grant from Susan G. Komen for the Cure to S. D., a Lymphoma Research Foundation Fellowship to J.K.P. and grants from AIRC and ERC (ERC-2009-StG-Proposal No242965-LUNELY) to R. C. M. P. is an Investigator with the Howard Hughes Medical Institute.	Baron BW, 2004, P NATL ACAD SCI USA, V101, P14198, DOI 10.1073/pnas.0406138101; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Ci WM, 2008, CURR OPIN HEMATOL, V15, P381, DOI 10.1097/MOH.0b013e328302c7df; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Phan RT, 2007, NAT IMMUNOL, V8, P1132, DOI 10.1038/ni1508; Piva R, 2002, MOL CELL BIOL, V22, P8375, DOI 10.1128/MCB.22.23.8375-8387.2002; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462	19	202	214	3	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					90	U100		10.1038/nature10688	http://dx.doi.org/10.1038/nature10688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22113614	Green Accepted			2022-12-24	WOS:000298836900035
J	Gadalla, SM; Lund, M; Pfeiffer, RM; Gortz, S; Mueller, CM; Moxley, RT; Kristinsson, SY; Bjorkholm, M; Shebl, FM; Hilbert, JE; Landgren, O; Wohlfahrt, J; Melbye, M; Greene, MH				Gadalla, Shahinaz M.; Lund, Marie; Pfeiffer, Ruth M.; Gortz, Sanne; Mueller, Christine M.; Moxley, Richard T., III; Kristinsson, Sigurdur Y.; Bjoerkholm, Magnus; Shebl, Fatma M.; Hilbert, James E.; Landgren, Ola; Wohlfahrt, Jan; Melbye, Mads; Greene, Mark H.			Cancer Risk Among Patients With Myotonic Muscular Dystrophy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRIPLET REPEAT EXPANSION; BASAL-CELL CARCINOMA; HUNTINGTON-DISEASE; TRUE ASSOCIATION; MISMATCH-REPAIR; CTG REPEAT; TYPE-2; GENE; RNA; INSTABILITY	Context Myotonic muscular dystrophy (MMD) is an autosomal-dominant multisystem neuromuscular disorder characterized by unstable nucleotide repeat expansions. Case reports have suggested that MMD patients may be at increased risk of malignancy, putative risks that have never been quantified. Objective To quantitatively evaluate cancer risk in patients with MMD, overall and by sex and age. Design, Setting, and Participants We identified 1658 patients with an MMD discharge diagnosis in the Swedish Hospital Discharge Register or Danish National Patient Registry between 1977 and 2008. We linked these patients to their corresponding cancer registry. Patients were followed up from date of first MMD-related inpatient or outpatient contact to first cancer diagnosis, death, emigration, or completion of cancer registration. Main Outcome Measures Risks of all cancers combined and by anatomic site, stratified by sex and age. Results One hundred four patients with an inpatient or outpatient discharge diagnosis of MMD developed cancer during postdischarge follow-up. This corresponds to an observed cancer rate of 73.4 per 10 000 person-years in MMD vs an expected rate of 36.9 per 10 000 person-years in the general Swedish and Danish populations combined (standardized incidence ratio [SIR], 2.0; 95% CI, 1.6-2.4). Specifically, we observed significant excess risks of cancers of the endometrium (n=11; observed rate, 16.1/10 000 person-years; SIR, 7.6; 95% CI, 4.0-13.2), brain (n=7; observed rate, 4.9/10 000 person-years; SIR, 5.3; 95% CI, 2.3-10.4), ovary (n=7; observed rate, 10.3/10 000 person-years; SIR, 5.2; 95% CI, 2.3-10.2), and colon (n=10; observed rate, 7.1/10 000 person-years; SIR, 2.9; 95% CI, 1.5-5.1). Cancer risks were similar in women and men after excluding genital organ tumors (SIR, 1.9; 95% CI, 1.4-2.5, vs SIR, 1.8; 95% CI, 1.3-2.5, respectively; P=.81 for heterogeneity; observed rates, 64.5 and 47.7 per 10 000 person-years in women and men, respectively). The same pattern of cancer excess was observed first in the Swedish and then in the Danish cohorts, which were studied sequentially and initially analyzed independently. Conclusion Patients with MMD identified from the Swedish and Danish patient registries were at increased risk of cancer both overall and for selected anatomic sites. JAMA. 2011;306(22):2480-2486	[Gadalla, Shahinaz M.; Mueller, Christine M.; Greene, Mark H.] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Pfeiffer, Ruth M.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Shebl, Fatma M.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Landgren, Ola] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Gadalla, Shahinaz M.] NCI, Ctr Canc Res, Canc Prevent Fellowship Program, NIH, Bethesda, MD 20892 USA; [Lund, Marie; Gortz, Sanne; Wohlfahrt, Jan; Melbye, Mads] Statens Serum Inst, Div Epidemiol, Dept Epidemiol Res, Copenhagen, Denmark; [Moxley, Richard T., III; Hilbert, James E.] Univ Rochester, Med Ctr, Dept Neurol, Neuromuscular Dis Ctr, Rochester, NY 14642 USA; [Kristinsson, Sigurdur Y.; Bjoerkholm, Magnus] Karolinska Univ Hosp Solna, Dept Med, Div Hematol, Stockholm, Sweden; [Kristinsson, Sigurdur Y.; Bjoerkholm, Magnus] Karolinska Inst, Stockholm, Sweden	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Statens Serum Institut; University of Rochester; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Greene, MH (corresponding author), NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, 6120 Execut Blvd,EPS 7023, Bethesda, MD 20892 USA.	greenem@mail.nih.gov	Lund, Marie/GRJ-0350-2022; Gadalla, Shahinaz M/C-4005-2015; Gadalla, Shahinaz/U-2848-2019; Kristinsson, Sigurdur Y/M-2910-2015	Lund, Marie/0000-0001-7417-8889; Gadalla, Shahinaz M/0000-0002-3255-8143; Kristinsson, Sigurdur Y/0000-0002-4964-7476; melbye, mads/0000-0001-8264-6785	Swedish Cancer Society; Stockholm County Council; Karolinska Institutet Foundations; Danish Medical Research Council; US National Cancer Institute [N02CP31003-3]; University of Rochester Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [NIH/U54/NS048843]; National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members [NIH/N01-AR-50-227450]; Clinical and Translational Science Institute and Clinical Research Center (National Center for Research Resources) [NIH UL1 RR024160]; NATIONAL CANCER INSTITUTE [ZIABC011205] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Karolinska Institutet Foundations(Karolinska Institutet); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Rochester Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members; Clinical and Translational Science Institute and Clinical Research Center (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants from the Swedish Cancer Society, Stockholm County Council, Karolinska Institutet Foundations, Danish Medical Research Council, Intramural Research Program of the US National Cancer Institute (including contract N02CP31003-3 to Westat), University of Rochester Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center (NIH/U54/NS048843), National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members (NIH/N01-AR-50-227450), and Clinical and Translational Science Institute and Clinical Research Center (NIH UL1 RR024160; National Center for Research Resources).	Akiyama M, 2008, PEDIATR BLOOD CANCER, V51, P563, DOI 10.1002/pbc.21654; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 1998, PATIENTREGISTRET 198; Azurdia RM, 1999, BRIT J DERMATOL, V141, P941, DOI 10.1046/j.1365-2133.1999.03184.x; BROOK, 1992, CELL, V69, P385; Brouwer JR, 2009, BIOESSAYS, V31, P71, DOI 10.1002/bies.080122; de Die-Smulders CEM, 1998, BRAIN, V121, P1557, DOI 10.1093/brain/121.8.1557; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Foiry L, 2006, HUM GENET, V119, P520, DOI 10.1007/s00439-006-0164-7; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Goellner GM, 1997, AM J HUM GENET, V60, P879; Goolamali SI, 2009, CLIN EXP DERMATOL, V34, pe370, DOI 10.1111/j.1365-2230.2009.03321.x; Greenland S, 2008, MODERN EPIDEMIOLOGY, P213; Harper PS, 2001, MYOTONIC DYSTROPHY; Itin PH, 2001, HAUTARZT, V52, P244, DOI 10.1007/s001050051298; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Mathieu J, 1999, NEUROLOGY, V52, P1658, DOI 10.1212/WNL.52.8.1658; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; Mueller CM, 2009, CANCER CAUSE CONTROL, V20, P2009, DOI 10.1007/s10552-009-9395-y; Nilsson A C, 1994, Lakartidningen, V91, P603; Osanai R, 2000, MUSCLE NERVE, V23, P804, DOI 10.1002/(SICI)1097-4598(200005)23:5<804::AID-MUS19>3.0.CO;2-E; PANZER S, 1995, STEM CELLS, V13, P146, DOI 10.1002/stem.5530130206; Ranum Laura P W, 2002, Curr Neurol Neurosci Rep, V2, P465, DOI 10.1007/s11910-002-0074-6; Sorensen SA, 1999, CANCER, V86, P1342, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1342::AID-CNCR33>3.3.CO;2-V; Storm HH, 1997, DAN MED BULL, V44, P535; Sund R, 2009, J INTELL DISABIL RES, V53, P85, DOI 10.1111/j.1365-2788.2008.01116.x; Suominen T, 2011, EUR J HUM GENET, V19, P776, DOI 10.1038/ejhg.2011.23; Survey of Nordic Cancer Registries, 2000, SURV NORD CANC REG; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; Tome S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000482; Turesson I, 2007, INT J CANCER, V121, P2260, DOI 10.1002/ijc.22912; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; Wheeler TM, 2007, CURR OPIN NEUROL, V20, P572, DOI 10.1097/WCO.0b013e3282ef6064; WOHRLE D, 1995, HUM MOL GENET, V4, P1147, DOI 10.1093/hmg/4.7.1147; Zemtsov A, 2010, ARCH DERMATOL RES, V302, P169, DOI 10.1007/s00403-009-0997-8	41	67	69	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2480	2486		10.1001/jama.2011.1796	http://dx.doi.org/10.1001/jama.2011.1796			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860YB	22166607	Green Accepted			2022-12-24	WOS:000297983300021
J	Guettler, S; LaRose, J; Petsalaki, E; Gish, G; Scotter, A; Pawson, T; Rottapel, R; Sicheri, F				Guettler, Sebastian; LaRose, Jose; Petsalaki, Evangelia; Gish, Gerald; Scotter, Andy; Pawson, Tony; Rottapel, Robert; Sicheri, Frank			Structural Basis and Sequence Rules for Substrate Recognition by Tankyrase Explain the Basis for Cherubism Disease	CELL			English	Article							REPEAT-BINDING FACTOR-1; HUMAN TELOMERIC PROTEIN; POLY(ADP-RIBOSE) POLYMERASE; TRF1; INHIBITION; MOTIF; IRAP; IDENTIFICATION; DEGRADATION; MAINTENANCE	The poly(ADP-ribose)polymerases Tankyrase 1/2 (TNKS/TNKS2) catalyze the covalent linkage of ADP-ribose polymer chains onto target proteins, regulating their ubiquitylation, stability, and function. Dysregulation of substrate recognition by Tankyrases underlies the human disease cherubism. Tankyrases recruit specific motifs (often called RxxPDG "hexapeptides") in their substrates via an N-terminal region of ankyrin repeats. These ankyrin repeats form five domains termed ankyrin repeat clusters (ARCs), each predicted to bind substrate. Here we report crystal structures of a representative ARC of TNKS2 bound to targeting peptides from six substrates. Using a solution-based peptide library screen, we derive a rule-based consensus for Tankyrase substrates common to four functionally conserved ARCs. This 8-residue consensus allows us to rationalize all known Tankyrase substrates and explains the basis for cherubism-causing mutations in the Tankyrase substrate 3BP2. Structural and sequence information allows us to also predict and validate other Tankyrase targets, including Disc1, Striatin, Fat4, RAD54, BCR, and MERIT40.	[Guettler, Sebastian; Petsalaki, Evangelia; Gish, Gerald; Pawson, Tony; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Guettler, Sebastian; Petsalaki, Evangelia; Pawson, Tony; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Kings Coll Circle 1, Toronto, ON M5S 1A8, Canada; [LaRose, Jose; Scotter, Andy; Rottapel, Robert] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [LaRose, Jose; Scotter, Andy; Rottapel, Robert] Univ Toronto, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada; [Rottapel, Robert] St Michaels Hosp, Div Rheumatol, Dept Med, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	pawson@lunenfeld.ca; rottapel@uhnres.utoronto.ca; sicheri@lunenfeld.ca	Sicheri, Frank/F-8856-2013; Gish, Gerald D/C-7228-2017; Pawson, Tony J/E-4578-2013; Petsalaki, Evangelia/ABC-3561-2020	Petsalaki, Evangelia/0000-0002-8294-2995; Rottapel, Robert/0000-0002-6024-5558; Guettler, Sebastian/0000-0002-3135-1546	National Center for Research Resources at the National Institutes of Health [RR-15301]; U.S. DOE [DE-AC02-06CH11357]; Human Frontier Science Program (HFSP); European Molecular Biology Organization (EMBO); Canadian Institutes of Health Research [MOP-36399, MOP-6849]; Ontario Research Fund [GL2-01-025]; Terry Fox Program [20003]; Canada Research Chair in Structural Biology; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. DOE(United States Department of Energy (DOE)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Terry Fox Program; Canada Research Chair in Structural Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Mario Sanches, Elton Zeqiraj, Stephen Orlicky, and Hong Han for technical and computational help, Kay Perry, Kanagalaghatta Rajashankar, and Igor Kourinov at the Advanced Photon Source for assistance with data collection, Alessandro Datti, Frederick Vizeacoumar, and Thomas Sun (SLRI Robotics) for providing robotics, Rey Interior and Li Zhang (SickKids APTC) for N-terminal sequencing and mass spectrometry, Robert Weatheritt and Norman Davey for providing relative conservation scores for Table S4, Sachdev Sidhu for the recombinant antibody against 3BP2, Gregg Morin, Guy Poirer, John Roder, Anne-Claude Gingras, Marilyn Goudreault, Helen McNeill, Richelle Sopko, Rick Bagshaw, Roger Greenberg, Karen Colwill, Marina Olhovsky, and Bernard Liu for cDNAs and plasmids, Thomas Guttler for helpful comments on the manuscript, and members of the Sicheri and Pawson laboratories for fruitful discussions. This work is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. S.G. was supported by postdoctoral fellowships from the Human Frontier Science Program (HFSP) and the European Molecular Biology Organization (EMBO). This work was supported by grants from the Canadian Institutes of Health Research (MOP-36399 and MOP-6849, to F.S. and T.P.), the Ontario Research Fund (#GL2-01-025, to T.P.), and the Terry Fox Program (#20003, to R.R.). F.S. is supported by a Canada Research Chair in Structural Biology.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Bae JY, 2003, J BIOL CHEM, V278, P5195, DOI 10.1074/jbc.M201988200; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chang W, 2005, BIOCHEM J, V391, P177, DOI 10.1042/BJ20050885; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; Deng Z, 2005, J VIROL, V79, P4640, DOI 10.1128/JVI.79.8.4640-4650.2005; Deng Z, 2002, MOL CELL, V9, P493, DOI 10.1016/S1097-2765(02)00476-8; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Forrer P, 2003, FEBS LETT, V539, P2, DOI 10.1016/S0014-5793(03)00177-7; Fuchs U, 2003, FEBS LETT, V554, P10, DOI 10.1016/S0014-5793(03)01063-9; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kaminker PG, 2001, J BIOL CHEM, V276, P35891, DOI 10.1074/jbc.M105968200; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Lietman SA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9433; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Lyons RJ, 2001, J BIOL CHEM, V276, P17172, DOI 10.1074/jbc.M009756200; McCabe N, 2009, ONCOGENE, V28, P1465, DOI 10.1038/onc.2008.483; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; Sbodio JI, 2002, BIOCHEM J, V361, P451, DOI 10.1042/0264-6021:3610451; Seimiya H, 2004, MOL CELL BIOL, V24, P1944, DOI 10.1128/MCB.24.5.1944-1955.2004; Seimiya H, 2002, J BIOL CHEM, V277, P14116, DOI 10.1074/jbc.M112266200; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	37	174	179	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1340	1354		10.1016/j.cell.2011.10.046	http://dx.doi.org/10.1016/j.cell.2011.10.046			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153077	Bronze			2022-12-24	WOS:000298148100022
J	Rhee, HS; Pugh, BF				Rhee, Ho Sung; Pugh, B. Franklin			Comprehensive Genome-wide Protein-DNA Interactions Detected at Single-Nucleotide Resolution	CELL			English	Article							FACTOR-BINDING SITES; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; CHIP-SEQ; IN-VIVO; CTCF; REGIONS; YEAST; IDENTIFICATION; SPECIFICITY	Chromatin immunoprecipitation (ChIP-chip and ChIP-seq) assays identify where proteins bind throughout a genome. However, DNA contamination and DNA fragmentation heterogeneity produce false positives (erroneous calls) and imprecision in mapping. Consequently, stringent data filtering produces false negatives (missed calls). Here we describe ChIP-exo, where an exonuclease trims ChIP DNA to a precise distance from the crosslinking site. Bound locations are detectable as peak pairs by deep sequencing. Contaminating DNA is degraded or fails to form complementary peak pairs. With the single bp accuracy provided by ChIP-exo, we show an unprecedented view into genome-wide binding of the yeast transcription factors Reb1, Gal4, Phd1, Rap1, and human CTCF. Each of these factors was chosen to address potential limitations of ChIP-exo. We found that binding sites become unambiguous and reveal diverse tendencies governing in vivo DNA-binding specificity that include sequence variants, functionally distinct motifs, motif clustering, secondary interactions, and combinatorial modules within a compound motif.	[Rhee, Ho Sung; Pugh, B. Franklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	bfp2@psu.edu			NIH [ES13768]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013768] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Gue Su Chang and Cizhong Jiang for bioinformatic support, Mark Biggin (Lawrence-Berkeley Laboratory) for discussions on the concept of continuous networks, and members of the Pugh lab and the Penn State Center for Eukaryotic Gene Regulation for scientific discussions. Sequencing was performed at the Penn State Genomics Core Facility. This work was supported by NIH grant ES13768.	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; GIMENO CJ, 1994, MOL CELL BIOL, V14, P2100, DOI 10.1128/MCB.14.3.2100; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liang SD, 1996, MOL CELL BIOL, V16, P3773; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; MOEHLE CM, 1991, MOL CELL BIOL, V11, P2723, DOI 10.1128/MCB.11.5.2723; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Peng SY, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-219; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rossetti L, 2001, J MOL BIOL, V306, P903, DOI 10.1006/jmbi.2001.4458; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Tuteja G, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp536; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; von Hippel P H, 1974, Proc Natl Acad Sci U S A, V71, P4808; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Walter J, 1996, P NATL ACAD SCI USA, V93, P2680, DOI 10.1073/pnas.93.7.2680; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Zhao CY, 2010, CANCER RES, V70, P5174, DOI 10.1158/0008-5472.CAN-09-4407; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	49	512	531	0	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1408	1419		10.1016/j.cell.2011.11.013	http://dx.doi.org/10.1016/j.cell.2011.11.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153082	Green Accepted, Bronze			2022-12-24	WOS:000298148100027
J	Janich, P; Pascual, G; Merlos-Suarez, A; Batlle, E; Ripperger, J; Albrecht, U; Cheng, HYM; Obrietan, K; Di Croce, L; Benitah, SA				Janich, Peggy; Pascual, Gloria; Merlos-Suarez, Anna; Batlle, Eduard; Ripperger, Juergen; Albrecht, Urs; Cheng, Hai-Ying M.; Obrietan, Karl; Di Croce, Luciano; Aznar Benitah, Salvador			The circadian molecular clock creates epidermal stem cell heterogeneity	NATURE			English	Article							HAIR FOLLICLE; EXPRESSION; NICHE; DIFFERENTIATION; PROLIFERATION; HOMEOSTASIS; POPULATION; ACTIVATION; PACEMAKER; COMPONENT	Murine epidermal stem cells undergo alternate cycles of dormancy and activation, fuelling tissue renewal. However, only a subset of stem cells becomes active during each round of morphogenesis, indicating that stem cells coexist in heterogeneous responsive states. Using a circadian-clock reporter-mouse model, here we show that the dormant hair-follicle stem cell niche contains coexisting populations of cells at opposite phases of the clock, which are differentially predisposed to respond to homeostatic cues. The core clock protein Bmal1 modulates the expression of stem cell regulatory genes in an oscillatory manner, to create populations that are either predisposed, or less prone, to activation. Disrupting this clock equilibrium, through deletion of Bmal1 (also known as Arntl) or Per1/2, resulted in a progressive accumulation or depletion of dormant stem cells, respectively. Stem cell arrhythmia also led to premature epidermal ageing, and a reduction in the development of squamous tumours. Our results indicate that the circadian clock fine-tunes the temporal behaviour of epidermal stem cells, and that its perturbation affects homeostasis and the predisposition to tumorigenesis.	[Janich, Peggy; Pascual, Gloria; Di Croce, Luciano; Aznar Benitah, Salvador] Ctr Genom Regulat, Barcelona 08003, Spain; [Janich, Peggy; Pascual, Gloria; Di Croce, Luciano; Aznar Benitah, Salvador] UPF, Barcelona 08003, Spain; [Merlos-Suarez, Anna; Batlle, Eduard] Inst Res Biomed, Barcelona 08028, Spain; [Batlle, Eduard; Di Croce, Luciano; Aznar Benitah, Salvador] ICREA, Barcelona 08010, Spain; [Ripperger, Juergen; Albrecht, Urs] Univ Fribourg, CH-1700 Fribourg, Switzerland; [Cheng, Hai-Ying M.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Obrietan, Karl] Ohio State Univ, Columbus, OH 43210 USA	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; University of Fribourg; University of Toronto; University Toronto Mississauga; University System of Ohio; Ohio State University	Benitah, SA (corresponding author), Ctr Genom Regulat, Barcelona 08003, Spain.	salvador.aznar-benitah@crg.es	Albrecht, Urs/A-9831-2011; Batlle, Eduard/K-8080-2014; Aznar-Benitah, Salvador/F-4761-2016; Angulo, Gloria Pascual/AAA-7668-2019; Di Croce, Luciano/E-7759-2015	Albrecht, Urs/0000-0002-0663-8676; Batlle, Eduard/0000-0003-2422-0326; Aznar-Benitah, Salvador/0000-0002-9059-5049; Angulo, Gloria Pascual/0000-0003-3810-6647; Di Croce, Luciano/0000-0003-3488-6228; Janich, Peggy/0000-0003-1045-7365	AICR (Association for International Cancer Research); Spanish Ministry of Health (FIS); AGAUR (Agencia de Gestio d'Ajuts Universitaris i de Recerca; Government of Cataluna); AGAUR; FIS; Worldwide Cancer Research [10-0177] Funding Source: researchfish; ICREA Funding Source: Custom	AICR (Association for International Cancer Research); Spanish Ministry of Health (FIS)(Instituto de Salud Carlos IIISpanish Government); AGAUR (Agencia de Gestio d'Ajuts Universitaris i de Recerca; Government of Cataluna)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); FIS(Instituto de Salud Carlos III); Worldwide Cancer Research; ICREA(ICREA)	We thank the AICR (Association for International Cancer Research), the Spanish Ministry of Health (FIS) and AGAUR (Agencia de Gestio d'Ajuts Universitaris i de Recerca; Government of Cataluna) for financial support. P.J. is the recipient of an AGAUR PhD Fellowship, and G. P. of a FIS fellowship. We thank D. McMahon (Vanderbilt University) for providing us with the Per1-GFP mice; E. Wagner (CNIO) for the K5-SOS mice; B. Kubler, the FACS and Genomics units of the IRB (Institute de Recerca Biomedica), the CRG (Center for Genomic Regulation) core facilities and the Animal Unit (Juan Martin Caballero) for technical support.	Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cheng HYM, 2009, HUM MOL GENET, V18, P3110, DOI 10.1093/hmg/ddp252; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Kameda T, 2004, METH MOL B, V289, P29; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kuhlman SJ, 2000, NEUROREPORT, V11, P1479, DOI 10.1097/00001756-200005150-00023; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Lin KK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000573; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morris RJ, 2004, DIFFERENTIATION, V72, P381, DOI 10.1111/j.1432-0436.2004.07208004.x; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Owens DM, 2003, J CELL SCI, V116, P3783, DOI 10.1242/jcs.00725; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Watt FM, 2008, NAT REV CANCER, V8, P234, DOI 10.1038/nrc2328; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	48	219	227	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2011	480	7376					209	U89		10.1038/nature10649	http://dx.doi.org/10.1038/nature10649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22080954	Green Submitted			2022-12-24	WOS:000297744200044
J	Cui-Wang, TT; Hanus, C; Cui, T; Helton, T; Bourne, J; Watson, D; Harris, KM; Ehlers, MD				Cui-Wang, Tingting; Hanus, Cyril; Cui, Tao; Helton, Thomas; Bourne, Jennifer; Watson, Deborah; Harris, Kristen M.; Ehlers, Michael D.			Local Zones of Endoplasmic Reticulum Complexity Confine Cargo in Neuronal Dendrites	CELL			English	Article							PYRAMIDAL NEURONS; AMPA RECEPTORS; MEMBRANE; PROTEIN; SPINES; MICROTUBULES; MORPHOGENESIS; ORGANIZATION; PLASTICITY; MACHINERY	Following synthesis, integral membrane proteins dwell in the endoplasmic reticulum (ER) for variable periods that are typically rate limiting for plasma membrane delivery. In neurons, the ER extends for hundreds of microns as an anastomosing network throughout highly branched dendrites. However, little is known about the mobility, spatial scales, or dynamic regulation of cargo in the dendritic ER. Here, we show that membrane proteins, including AMPA-type glutamate receptors, rapidly diffuse within the continuous network of dendritic ER but are confined by increased ER complexity at dendritic branch points and near dendritic spines. The spatial range of receptor mobility is rapidly restricted by type I mGluR signaling through a mechanism involving protein kinase C (PKC) and the ER protein CLIMP63. Moreover, local zones of ER complexity compartmentalize ER export and correspond to sites of new dendritic branches. Thus, local control of ER complexity spatially scales secretory trafficking within elaborate dendritic arbors.	[Cui-Wang, Tingting; Hanus, Cyril; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Cui, Tao] CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA; [Helton, Thomas; Ehlers, Michael D.] Pfizer Global Res & Dev, Neurosci Res Unit, Groton, CT 06340 USA; [Bourne, Jennifer; Watson, Deborah; Harris, Kristen M.] Univ Texas Austin, Ctr Learning & Memory, Dept Neurobiol, Austin, TX 78705 USA	Duke University; California Institute of Technology; Pfizer; University of Texas System; University of Texas Austin	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	michael.ehlers@pfizer.com	HANUS, Cyril/C-2200-2017	HANUS, Cyril/0000-0002-4012-6092; Harris, Kristen/0000-0002-1943-4744; Bourne, Jennifer/0000-0001-5501-0351; Wang, Tingting/0000-0001-5114-6737	NIH [NS039402, MH064748, MH086339, NS021184, EB002170]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748, R01MH095980, R01MH086339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074644, R01NS021184, R01NS047574, R01NS039402, R23NS021184, R37NS021184] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ben Arenkiel, Ian Davison, Juliet Hernandez, Matt Kennedy, Tom Newpher, and Rui Peixoto for critical reading of the manuscript. We thank Larry Lindsey and Cam Robinson for help with EM data processing. We thank Irina Lebedeva and Marguerita Klein for technical assistance. We thank Zeiss USA for use of their structured illumination microcopy system. Work in the laboratory of M. D. E. was supported by NIH grants NS039402, MH064748, and MH086339, and the Howard Hughes Medical Institute. Work in the laboratory of K. M. H. is supported by NIH grants NS021184 and EB002170.	Aridor M, 2004, J NEUROSCI, V24, P3770, DOI 10.1523/JNEUROSCI.4775-03.2004; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Farah CA, 2005, J BIOL CHEM, V280, P9439, DOI 10.1074/jbc.M412304200; Farhan H, 2008, EMBO J, V27, P2043, DOI 10.1038/emboj.2008.136; Fiala JC, 2001, J AM MED INFORM ASSN, V8, P1; Fukatsu K, 2004, J BIOL CHEM, V279, P48976, DOI 10.1074/jbc.M408364200; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Hanus C, 2008, TRAFFIC, V9, P1437, DOI 10.1111/j.1600-0854.2008.00775.x; Herpers B, 2004, MOL BIOL CELL, V15, P5306, DOI 10.1091/mbc.E04-05-0398; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2003, J NEUROSCI, V23, P6188; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Santamaria F, 2006, NEURON, V52, P635, DOI 10.1016/j.neuron.2006.10.025; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; SCHWEIZER A, 1993, J CELL SCI, V104, P671; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; TERASAKI M, 1994, P NATL ACAD SCI USA, V91, P7510, DOI 10.1073/pnas.91.16.7510; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Vedrenne C, 2005, MOL BIOL CELL, V16, P1928, DOI 10.1091/mbc.e04-07-0554; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032	35	135	140	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 20	2012	148	1-2					309	321		10.1016/j.cell.2011.11.056	http://dx.doi.org/10.1016/j.cell.2011.11.056			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265418	Bronze, Green Accepted			2022-12-24	WOS:000299540700033
J	Metallo, CM; Gameiro, PA; Bell, EL; Mattaini, KR; Yang, JJ; Hiller, K; Jewell, CM; Johnson, ZR; Irvine, DJ; Guarente, L; Kelleher, JK; Vander Heiden, MG; Iliopoulos, O; Stephanopoulos, G				Metallo, Christian M.; Gameiro, Paulo A.; Bell, Eric L.; Mattaini, Katherine R.; Yang, Juanjuan; Hiller, Karsten; Jewell, Christopher M.; Johnson, Zachary R.; Irvine, Darrell J.; Guarente, Leonard; Kelleher, Joanne K.; Vander Heiden, Matthew G.; Iliopoulos, Othon; Stephanopoulos, Gregory			Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia	NATURE			English	Article							FATTY-ACID SYNTHESIS; CELL-PROLIFERATION; FLUX ANALYSIS; HIF-ALPHA; GROWTH; CANCER; DEHYDROGENASE; SUPPRESSION; DISTRIBUTIONS; HYDROXYLATION	Acetyl coenzyme A (AcCoA) is the central biosynthetic precursor for fatty-acid synthesis and protein acetylation. In the conventional view of mammalian cell metabolism, AcCoA is primarily generated from glucose-derived pyruvate through the citrate shuttle and ATP citrate lyase in the cytosol(1-3). However, proliferating cells that exhibit aerobic glycolysis and those exposed to hypoxia convert glucose to lactate at near-stoichiometric levels, directing glucose carbon away from the tricarboxylic acid cycle and fatty-acid synthesis(4). Although glutamine is consumed at levels exceeding that required for nitrogen biosynthesis(5), the regulation and use of glutamine metabolism in hypoxic cells is not well understood. Here we show that human cells use reductive metabolism of alpha-ketoglutarate to synthesize AcCoA for lipid synthesis. This isocitrate dehydrogenase-1 (IDH1)-dependent pathway is active in most cell lines under normal culture conditions, but cells grown under hypoxia rely almost exclusively on the reductive carboxylation of glutamine-derived alpha-ketoglutarate for de novo lipogenesis. Furthermore, renal cell lines deficient in the von Hippel-Lindau tumour suppressor protein preferentially use reductive glutamine metabolism for lipid biosynthesis even at normal oxygen levels. These results identify a critical role for oxygen in regulating carbon use to produce AcCoA and support lipid synthesis in mammalian cells.	[Metallo, Christian M.; Gameiro, Paulo A.; Hiller, Karsten; Kelleher, Joanne K.; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Gameiro, Paulo A.] Univ Coimbra, Dept Life Sci, P-3004517 Coimbra, Portugal; [Gameiro, Paulo A.; Yang, Juanjuan; Iliopoulos, Othon] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Gameiro, Paulo A.; Yang, Juanjuan; Iliopoulos, Othon] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Bell, Eric L.; Mattaini, Katherine R.; Guarente, Leonard; Vander Heiden, Matthew G.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Mattaini, Katherine R.; Jewell, Christopher M.; Johnson, Zachary R.; Irvine, Darrell J.; Vander Heiden, Matthew G.] MIT, Koch Inst Canc Res, Cambridge, MA 02139 USA; [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Universidade de Coimbra; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	iliopoul@helix.mgh.harvard.edu; gregstep@mit.edu	damiani, chiara/R-4256-2016; Gameiro, Paulo A/AAD-9324-2021; Metallo, Christian/HCH-3476-2022; Bell, Eric/F-6368-2012	Metallo, Christian/0000-0003-2404-3040; Hiller, Karsten/0000-0001-9322-5820; Gameiro, Paulo A./0000-0001-8176-4237	National Institutes of Health [R01 DK075850-01]; American Cancer Society; German Research Foundation (DFG) [HI1400]; Glenn Foundation for Medical Research; Burrough's Wellcome Fund; Smith Family; Damon Runyon Cancer Research Foundation; National Cancer Institute; Dana Farber/Harvard Cancer Center;  [R01 CA122591]; NATIONAL CANCER INSTITUTE [R01CA160458, P30CA014051, R01CA122591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); German Research Foundation (DFG)(German Research Foundation (DFG)); Glenn Foundation for Medical Research; Burrough's Wellcome Fund(Burroughs Wellcome Fund); Smith Family; Damon Runyon Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dana Farber/Harvard Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Vokes and P. Ward for discussions. We also thank S. Gross and Agios Pharmaceuticals for providing the IDH1 construct. We acknowledge support from National Institutes of Health grant R01 DK075850-01. C. M. M. is supported by a postdoctoral fellowship from the American Cancer Society. K. H. is supported by the German Research Foundation (DFG) grant HI1400. L. G. is supported by the NIH and the Glenn Foundation for Medical Research. M. G. V. H. is supported by the Burrough's Wellcome Fund, the Smith Family, the Damon Runyon Cancer Research Foundation and the National Cancer Institute. D.J.I. is an investigator of the Howard Hughes Medical Institute. O.I. is supported by R01 CA122591 and the Dana Farber/Harvard Cancer Center Kidney SPORE Grant Developmental Award.	Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Boros LG, 2003, BLOOD, V102, P3556, DOI 10.1182/blood-2003-05-1537; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; KHARROUBI AT, 1992, AM J PHYSIOL, V263, pE667, DOI 10.1152/ajpendo.1992.263.4.E667; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Maier K, 2008, BIOTECHNOL BIOENG, V100, P355, DOI 10.1002/bit.21746; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Noguchi Y, 2009, J BIOL CHEM, V284, P33425, DOI 10.1074/jbc.M109.049478; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; ROSIERS CD, 1995, J BIOL CHEM, V270, P10027, DOI 10.1074/jbc.270.17.10027; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; SIEBERT G, 1957, J BIOL CHEM, V226, P977; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Young JD, 2008, BIOTECHNOL BIOENG, V99, P686, DOI 10.1002/bit.21632; Zimmer M, 2004, MOL CANCER RES, V2, P89; Zimmer M, 2008, MOL CELL, V32, P838, DOI 10.1016/j.molcel.2008.12.004	40	1172	1216	19	296	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					380	U166		10.1038/nature10602	http://dx.doi.org/10.1038/nature10602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22101433	Green Submitted, Green Accepted			2022-12-24	WOS:000299210600046
J	Boomer, JS; To, K; Chang, KC; Takasu, O; Osborne, DF; Walton, AH; Bricker, TL; Jarman, SD; Kreisel, D; Krupnick, AS; Srivastava, A; Swanson, PE; Green, JM; Hotchkiss, RS				Boomer, Jonathan S.; To, Kathleen; Chang, Kathy C.; Takasu, Osamu; Osborne, Dale F.; Walton, Andrew H.; Bricker, Traci L.; Jarman, Stephen D., II; Kreisel, Daniel; Krupnick, Alexander S.; Srivastava, Anil; Swanson, Paul E.; Green, Jonathan M.; Hotchkiss, Richard S.			Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							T-CELLS; INFLAMMATORY RESPONSE; DOWN-REGULATION; WHOLE-BLOOD; PATHOPHYSIOLOGY; MECHANISMS; EXPRESSION; MONOCYTES; RECEPTOR; INNATE	Context Severe sepsis is typically characterized by initial cytokine-mediated hyperinflammation. Whether this hyperinflammatory phase is followed by immunosuppression is controversial. Animal studies suggest that multiple immune defects occur in sepsis, but data from humans remain conflicting. Objectives To determine the association of sepsis with changes in host innate and adaptive immunity and to examine potential mechanisms for putative immunosuppression. Design, Setting, and Participants Rapid postmortem spleen and lung tissue harvest was performed at the bedsides of 40 patients who died in intensive care units (ICUs) of academic medical centers with active severe sepsis to characterize their immune status at the time of death (2009-2011). Control spleens (n=29) were obtained from patients who were declared brain-dead or had emergent splenectomy due to trauma; control lungs (n=20) were obtained from transplant donors or from lung cancer resections. Main Outcome Measures Cytokine secretion assays and immunophenotyping of cell surface receptor-ligand expression profiles were performed to identify potential mechanisms of immune dysfunction. Immunohistochemical staining was performed to evaluate the loss of immune effector cells. Results The mean ages of patients with sepsis and controls were 71.7 (SD, 15.9) and 52.7 (SD, 15.0) years, respectively. The median number of ICU days for patients with sepsis was 8 (range, 1-195 days), while control patients were in ICUs for 4 or fewer days. The median duration of sepsis was 4 days (range, 1-40 days). Compared with controls, anti-CD3/anti-CD28-stimulated splenocytes from sepsis patients had significant reductions in cytokine secretion at 5 hours: tumor necrosis factor, 5361 (95% CI, 3327-7485) pg/mL vs 418 (95% CI, 98-738) pg/mL; interferon gamma, 1374 (95% CI, 550-2197) pg/mL vs 37.5 (95% CI, -5 to 80) pg/mL; interleukin 6, 3691 (95% CI, 2313-5070) vs 365 (95% CI, 87-642) pg/mL; and interleukin 10, 633 (95% CI, -269 to 1534) vs 58 (95% CI, -39 to 156) pg/mL; (P < .001 for all). There were similar reductions in 5-hour lipopolysaccharide-stimulated cytokine secretion. Cytokine secretion in sepsis patients was generally less than 10% that in controls, independent of age, duration of sepsis, corticosteroid use, and nutritional status. Although differences existed between spleen and lung, flow cytometric analysis showed increased expression of selected inhibitory receptors and ligands and expansion of suppressor cell populations in both organs. Unique differences in cellular inhibitory molecule expression existed in immune cells isolated from lungs of sepsis patients vs cancer patients and vs transplant donors. Immunohistochemical staining showed extensive depletion of splenic CD4, CD8, and HLA-DR cells and expression of ligands for inhibitory receptors on lung epithelial cells. Conclusions Patients who die in the ICU following sepsis compared with patients who die of nonsepsis etiologies have biochemical, flow cytometric, and immunohistochemical findings consistent with immunosuppression. Targeted immune-enhancing therapy may be a valid approach in selected patients with sepsis. JAMA. 2011;306(23):2594-2605	[Chang, Kathy C.; Takasu, Osamu; Osborne, Dale F.; Walton, Andrew H.; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Boomer, Jonathan S.; Bricker, Traci L.; Green, Jonathan M.; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [To, Kathleen; Jarman, Stephen D., II; Kreisel, Daniel; Krupnick, Alexander S.; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Srivastava, Anil] St Johns Mercy Med Ctr, Dept Surg, St Louis, MO 63141 USA; [Swanson, Paul E.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Saint Johns Mercy Medical Center; University of Washington; University of Washington Seattle	Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, 660 S Euclid, St Louis, MO 63110 USA.	hotch@wustl.edu		Green, Jonathan/0000-0002-7449-4387	Pfizer; Bristol-Meyers Squibb; Aurigene; National Institutes of Health [GM44118, GM55194, HL104985]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL104985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098391, R37GM044118, R01GM055194, R01GM044118] Funding Source: NIH RePORTER	Pfizer(Pfizer); Bristol-Meyers Squibb(Bristol-Myers Squibb); Aurigene; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Hotchkiss reports receiving grant support from Pfizer, Bristol-Meyers Squibb, and Aurigene. No other disclosures were reported.; This research was supported by National Institutes of Health grants GM44118, GM55194, and HL104985.	Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2011, JAMA-J AM MED ASSOC, V305, P1469, DOI 10.1001/jama.2011.438; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bedke T, 2010, J IMMUNOL, V184, P5562, DOI 10.4049/jimmunol.0902458; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Cavaillon JM, 2006, J ENDOTOXIN RES, V12, P151, DOI 10.1179/096805106X102246; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Hughes SM, 2009, J IMMUNOL, V183, P2818, DOI 10.4049/jimmunol.0803518; Kollef KE, 2008, CHEST, V134, P281, DOI 10.1378/chest.08-1116; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P2658, DOI 10.1073/pnas.0711918105; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Luyt CE, 2007, AM J RESP CRIT CARE, V175, P935, DOI 10.1164/rccm.200609-1322OC; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Munford RS, 2001, AM J RESP CRIT CARE, V163, P316, DOI 10.1164/ajrccm.163.2.2007102; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Murphy TJ, 2004, J LEUKOCYTE BIOL, V75, P400, DOI 10.1189/jlb.0503233; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Patel A, 2010, J ANTIMICROB CHEMOTH, V65, P2697, DOI 10.1093/jac/dkq359; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Rigato O, 2003, SHOCK, V19, P113, DOI 10.1097/00024382-200302000-00004; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Schefold JC, 2008, CRIT CARE MED, V36, P3118, DOI 10.1097/CCM.0b013e31818bdd8f; SHI SR, 1993, J HISTOCHEM CYTOCHEM, V41, P1599, DOI 10.1177/41.11.7691930; Shiao SL, 2005, J IMMUNOL, V175, P4886, DOI 10.4049/jimmunol.175.8.4886; Shui JW, 2011, J LEUKOCYTE BIOL, V89, P517, DOI 10.1189/jlb.0910528; Sinistro A, 2008, CLIN VACCINE IMMUNOL, V15, P1851, DOI 10.1128/CVI.00184-08; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; Venet F, 2008, J LEUKOCYTE BIOL, V83, P523, DOI 10.1189/jlb.0607371; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; Warren HS, 1997, NEW ENGL J MED, V336, P952, DOI 10.1056/NEJM199703273361311; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	49	1036	1159	4	129	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2594	2605		10.1001/jama.2011.1829	http://dx.doi.org/10.1001/jama.2011.1829			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864YQ	22187279	Green Accepted, Bronze			2022-12-24	WOS:000298276800021
J	Rhee, HS; Pugh, BF				Rhee, Ho Sung; Pugh, B. Franklin			Genome-wide structure and organization of eukaryotic pre-initiation complexes	NATURE			English	Article							RNA-POLYMERASE-II; START SITE SELECTION; PHOTO-CROSS-LINKING; IN-VIVO; TRANSCRIPTION INITIATION; SACCHAROMYCES-CEREVISIAE; PERVASIVE TRANSCRIPTION; BIDIRECTIONAL PROMOTERS; PREINITIATION COMPLEX; GENE-REGULATION	Transcription and regulation of genes originate from transcription pre-initiation complexes (PICs). Their structural and positional organization across eukaryotic genomes is unknown. Here we applied lambda exonuclease to chromatin immunoprecipitates (termed ChIP-exo) to examine the precise location of 6,045 PICs in Saccharomyces. PICs, including RNA polymerase II and protein complexes TFIIA, TFIIB, TFIID (or TBP), TFIIE, TFIIF, TFIIH and TFIIK were positioned within promoters and excluded from coding regions. Exonuclease patterns were in agreement with crystallographic models of the PIC, and were sufficiently precise to identify TATA-like elements at so-called TATA-less promoters. These PICs and their transcription start sites were positionally constrained at TFIID-engaged downstream +1 nucleosomes. At TATA-box-containing promoters, which are depleted of TFIID, a 11 nucleosome was positioned to be in competition with the PIC, which may allow greater latitude in start-site selection. Our genomic localization of messenger RNA and non-coding RNA PICs reveals that two PICs, in inverted orientation, may occupy the flanking borders of nucleosome-free regions. Their unambiguous detection may help distinguish bona fide genes from transcriptional noise.	[Rhee, Ho Sung; Pugh, B. Franklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	bfp2@psu.edu			National Institutes of Health [GM059055]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Albert and Y. Li for bioinformatic support, and members of the Pugh laboratory and the Penn State Center for Eukaryotic Gene Regulation for valuable discussions. Sequencing was performed at the Penn State Genomics Core Facility. This work was supported by National Institutes of Health grant GM059055.	Ahn SH, 2009, EMBO J, V28, P205, DOI 10.1038/emboj.2008.280; Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Faitar SL, 2001, MOL CELL BIOL, V21, P4427, DOI 10.1128/MCB.21.14.4427-4440.2001; Flom G, 2005, CURR GENET, V47, P368, DOI 10.1007/s00294-005-0580-6; Forget D, 2004, MOL CELL BIOL, V24, P1122, DOI 10.1128/MCB.24.3.1122-1131.2004; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; GIARDINA C, 1995, MOL CELL BIOL, V15, P2737; Granovskaia MV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r24; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Keogh MC, 2002, MOL CELL BIOL, V22, P1288, DOI 10.1128/MCB.22.5.1288-1297.2002; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200; Lagrange T, 1996, P NATL ACAD SCI USA, V93, P10620, DOI 10.1073/pnas.93.20.10620; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; LI Y, 1994, SCIENCE, V263, P805, DOI 10.1126/science.8303296; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Matangkasombut O, 2000, GENE DEV, V14, P951; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pardee TS, 1998, J BIOL CHEM, V273, P17859, DOI 10.1074/jbc.273.28.17859; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Sugihara F, 2011, NUCLEIC ACIDS RES, V39, P59, DOI 10.1093/nar/gkq741; Svejstrup JQ, 1996, J BIOL CHEM, V271, P643, DOI 10.1074/jbc.271.2.643; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yan Q, 1999, J BIOL CHEM, V274, P35668, DOI 10.1074/jbc.274.50.35668; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603	50	347	352	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					295	301		10.1038/nature10799	http://dx.doi.org/10.1038/nature10799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22258509	Green Accepted			2022-12-24	WOS:000301481800041
J	Freed-Pastor, WA; Mizuno, H; Zhao, X; Langerod, A; Moon, SH; Rodriguez-Barrueco, R; Barsotti, A; Chicas, A; Li, WC; Polotskaia, A; Bissell, MJ; Osborne, TF; Tian, B; Lowe, SW; Silva, JM; Borresen-Dale, AL; Levine, AJ; Bargonetti, J; Prives, C				Freed-Pastor, William A.; Mizuno, Hideaki; Zhao, Xi; Langerod, Anita; Moon, Sung-Hwan; Rodriguez-Barrueco, Ruth; Barsotti, Anthony; Chicas, Agustin; Li, Wencheng; Polotskaia, Alla; Bissell, Mina J.; Osborne, Timothy F.; Tian, Bin; Lowe, Scott W.; Silva, Jose M.; Borresen-Dale, Anne-Lise; Levine, Arnold J.; Bargonetti, Jill; Prives, Carol			Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway	CELL			English	Article							COA REDUCTASE INHIBITORS; HYDROPHOBIC AMINO-ACIDS; LI-FRAUMENI-SYNDROME; BREAST-CANCER; GENE-EXPRESSION; TERMINAL DOMAIN; GAIN; CELL; CHOLESTEROL; APOPTOSIS	p53 is a frequent target for mutation in human tumors, and mutant p53 proteins can actively contribute to tumorigenesis. We employed a three-dimensional culture model in which nonmalignant breast epithelial cells form spheroids reminiscent of acinar structures found in vivo, whereas breast cancer cells display highly disorganized morphology. We found that mutant p53 depletion is sufficient to phenotypically revert breast cancer cells to a more acinar-like morphology. Genome-wide expression analysis identified the mevalonate pathway as significantly upregulated by mutant p53. Statins and sterol biosynthesis intermediates reveal that this pathway is both necessary and sufficient for the phenotypic effects of mutant p53 on breast tissue architecture. Mutant p53 associates with sterol gene promoters at least partly via SREBP transcription factors. Finally, p53 mutation correlates with highly expressed sterol biosynthesis genes in human breast tumors. These findings implicate the mevalonate pathway as a therapeutic target for tumors bearing mutations in p53.	[Freed-Pastor, William A.; Moon, Sung-Hwan; Barsotti, Anthony; Prives, Carol] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Mizuno, Hideaki; Levine, Arnold J.] Simons Ctr Syst Biol, Inst Adv Study, Princeton, NJ 08540 USA; [Mizuno, Hideaki] Chugai Pharmaceut Co Ltd, Discovery Sci & Technol Dept, Kamakura, Kanagawa 2478530, Japan; [Zhao, Xi; Langerod, Anita; Borresen-Dale, Anne-Lise] Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway; [Zhao, Xi; Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, N-0450 Oslo, Norway; [Silva, Jose M.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Rodriguez-Barrueco, Ruth; Silva, Jose M.] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Chicas, Agustin; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Li, Wencheng; Tian, Bin; Bargonetti, Jill] UMDNJ New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 08854 USA; [Polotskaia, Alla] CUNY, Grad Ctr, Biochem Program, New York, NY 10065 USA; [Polotskaia, Alla] CUNY, Grad Ctr, Biol Program, New York, NY 10065 USA; [Polotskaia, Alla] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Bissell, Mina J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Osborne, Timothy F.] Sanford Burnham Med Res Inst, Metabol Signaling & Dis Program, Orlando, FL 32827 USA	Columbia University; Institute for Advanced Study - USA; Chugai Pharmaceutical Co., Ltd.; Roche Holding; University of Oslo; University of Oslo; Columbia University; Columbia University; Cold Spring Harbor Laboratory; Rutgers State University New Brunswick; Rutgers State University Medical Center; City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Sanford Burnham Prebys Medical Discovery Institute	Prives, C (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	clp3@columbia.edu	Rodriguez-Barrueco, Ruth/F-6810-2010; Mizuno, Hideaki/A-4702-2012; Mizuno, Hideaki/AAC-6161-2021; Li, Wencheng/J-7675-2012	Rodriguez-Barrueco, Ruth/0000-0003-4925-8865; Mizuno, Hideaki/0000-0002-7246-2576; Mizuno, Hideaki/0000-0002-7246-2576; Tian, Bin/0000-0001-8903-8256; Bargonetti, Jill/0000-0003-2692-0991; FREED-PASTOR, WILLIAM/0000-0002-7377-2111	Breast Cancer Research Foundation;  [CA87497];  [CA77742]; NATIONAL CANCER INSTITUTE [R37CA064786, P30CA008748, R01CA077742, P01CA087497] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Prives laboratory members, Masha Poyurovsky in particular, for helpful discussions. Ella Freulich provided invaluable technical assistance. We would like to thank Carlos Cordon Cardo, Josep Maria Domingo-Domenech and Dennis Bonal for advice and help with xenograft models. This work was supported by CA87497, CA77742 and The Breast Cancer Research Foundation.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Ahern TP, 2011, JNCI-J NATL CANCER I, V103, P1461, DOI 10.1093/jnci/djr291; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Beckerman R, 2009, GENE DEV, V23, P1364, DOI 10.1101/gad.1795709; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Blais L, 2000, ARCH INTERN MED, V160, P2363, DOI 10.1001/archinte.160.15.2363; Bossi G, 2008, CELL CYCLE, V7, P1870, DOI 10.4161/cc.7.12.6161; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Browning DRL, 2007, INT J CANCER, V120, P833, DOI 10.1002/ijc.22366; BUCHWALD H, 1992, LANCET, V339, P1154, DOI 10.1016/0140-6736(92)90744-N; Campbell MJ, 2006, CANCER RES, V66, P8707, DOI 10.1158/0008-5472.CAN-05-4061; Cauley JA, 2003, J WOMENS HEALTH, V12, P749, DOI 10.1089/154099903322447710; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Garwood ER, 2010, BREAST CANCER RES TR, V119, P137, DOI 10.1007/s10549-009-0507-x; Ghosh-Choudhury N, 2010, CELL SIGNAL, V22, P749, DOI 10.1016/j.cellsig.2009.12.010; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Graaf MR, 2004, CANCER TREAT REV, V30, P609, DOI 10.1016/j.ctrv.2004.06.010; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kidera Yasuhiro, 2010, J Exp Clin Cancer Res, V29, P127, DOI 10.1186/1756-9966-29-127; Kim E, 2009, BIOCHEM PHARMACOL, V77, P11, DOI 10.1016/j.bcp.2008.08.030; Koyuturk M, 2007, CANCER LETT, V250, P220, DOI 10.1016/j.canlet.2006.10.009; Kubatka P, 2011, Klin Onkol, V24, P41; Kumar AS, 2008, CANCER EPIDEM BIOMAR, V17, P1028, DOI 10.1158/1055-9965.EPI-07-0726; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Larsson O, 1996, CRIT REV ONCOL HEMAT, V22, P197, DOI 10.1016/1040-8428(96)00193-X; LERNER EC, 1995, J BIOL CHEM, V270, P26802, DOI 10.1074/jbc.270.45.26802; LIN JY, 1995, ONCOGENE, V10, P2387; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Matas D, 2001, EMBO J, V20, P4163, DOI 10.1093/emboj/20.15.4163; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; Mo HB, 2004, EXP BIOL MED, V229, P567, DOI 10.1177/153537020422900701; Mori S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006772; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Peart MJ, 2006, CANCER CELL, V10, P173, DOI 10.1016/j.ccr.2006.08.014; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Shibata MA, 2004, CARCINOGENESIS, V25, P1887, DOI 10.1093/carcin/bgh201; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Ugawa T, 2000, BRIT J PHARMACOL, V131, P63, DOI 10.1038/sj.bjp.0703545; Vasudevan A, 1999, J MED CHEM, V42, P1333, DOI 10.1021/jm9900873; Venot C, 1999, ONCOGENE, V18, P2405, DOI 10.1038/sj.onc.1202539; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; Yahagi N, 2003, J BIOL CHEM, V278, P25395, DOI 10.1074/jbc.M302364200; Yan WS, 2010, J BIOL CHEM, V285, P14229, DOI 10.1074/jbc.M109.097253; Zhang YH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214585	57	596	616	2	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					244	258		10.1016/j.cell.2011.12.017	http://dx.doi.org/10.1016/j.cell.2011.12.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265415	Green Accepted, Bronze			2022-12-24	WOS:000299540700028
J	Nobile, CJ; Fox, EP; Nett, JE; Sorrells, TR; Mitrovich, QM; Hernday, AD; Tuch, BB; Andes, DR; Johnson, AD				Nobile, Clarissa J.; Fox, Emily P.; Nett, Jeniel E.; Sorrells, Trevor R.; Mitrovich, Quinn M.; Hernday, Aaron D.; Tuch, Brian B.; Andes, David R.; Johnson, Alexander D.			A Recently Evolved Transcriptional Network Controls Biofilm Development in Candida albicans	CELL			English	Article							DENTURE STOMATITIS; BACILLUS-SUBTILIS; YEAST; REGULATORS; GENOME; GENES; MODEL; SPECIFICITY; INFECTIONS; ANNOTATION	A biofilm is an organized, resilient group of microbes in which individual cells acquire properties, such as drug resistance, that are distinct from those observed in suspension cultures. Here, we describe and analyze the transcriptional network controlling biofilm formation in the pathogenic yeast Candida albicans, whose biofilms are a major source of medical device-associated infections. We have combined genetic screens, genome-wide approaches, and two in vivo animal models to describe a master circuit controlling biofilm formation, composed of six transcription regulators that form a tightly woven network with similar to 1,000 target genes. Evolutionary analysis indicates that the biofilm network has rapidly evolved: genes in the biofilm circuit are significantly weighted toward genes that arose relatively recently with ancient genes being underrepresented. This circuit provides a framework for understanding many aspects of biofilm formation by C. albicans in a mammalian host. It also provides insights into how complex cell behaviors can arise from the evolution of transcription circuits.	[Nobile, Clarissa J.; Fox, Emily P.; Sorrells, Trevor R.; Mitrovich, Quinn M.; Hernday, Aaron D.; Tuch, Brian B.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94102 USA; [Fox, Emily P.; Sorrells, Trevor R.] Univ Calif San Francisco, Dept Biochem & Biophys, Tetrad Program, San Francisco, CA 94102 USA; [Nett, Jeniel E.; Andes, David R.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison	Nobile, CJ (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94102 USA.	clarissa.nobile@ucsf.edu	Andes, David/ABE-8033-2020; Nobile, Clarissa/C-2407-2015	Nobile, Clarissa/0000-0003-0799-6499; Sorrells, Trevor/0000-0002-3527-8622; Fox, Emily/0000-0002-8411-7622; Andes, David/0000-0002-7927-9950	NIH [R01AI073289, R01AI049187, R01AI083311, T32AI060537, F32AI088822]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073289, R01AI049187, R01AI083311, F32AI088822, T32AI060537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Oliver Homann for developing MochiView, Christopher Baker and Isabel Nocedal for help with evolutionary analysis, Francisco De La Vega for making possible the RNAseq analysis, Chiraj Dalal for computational advice, Lauren Booth for comments on the manuscript, and Sudarsi Desta, Jeanselle Dea, and Jorge Mendoza for technical assistance. We are grateful for the advice of Kurt Thorn in the acquisition of the CSLM images at the Nikon Imaging Center at UCSF. This study was supported by NIH grants R01AI073289 (D.R.A.) and R01AI049187 and R01AI083311 (A.D.J.). C.J.N. was supported by NIH fellowships T32AI060537 and F32AI088822. The content is the responsibility of the authors and does not necessarily represent the views of the NIH.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004; Askew C, 2011, MOL MICROBIOL, V79, P940, DOI 10.1111/j.1365-2958.2010.07504.x; Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HAWSER SP, 1994, INFECT IMMUN, V62, P915, DOI 10.1128/IAI.62.3.915-921.1994; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Lavoie H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000329; Lin ZG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-581; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; LOSICK R, 1992, NATURE, V355, P601, DOI 10.1038/355601a0; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Mitrovich QM, 2010, SCIENCE, V330, P838, DOI 10.1126/science.1194554; Muller D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000279; Nett J, 2006, CURR OPIN MICROBIOL, V9, P340, DOI 10.1016/j.mib.2006.06.007; Nett JE, 2010, INFECT IMMUN, V78, P3650, DOI 10.1128/IAI.00480-10; Ni L, 2009, GENE DEV, V23, P1351, DOI 10.1101/gad.1781909; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Ramage G, 2004, ORAL SURG ORAL MED O, V98, P53, DOI 10.1016/j.tripleo.2003.04.002; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Sahni N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000363; Schinabeck MK, 2004, ANTIMICROB AGENTS CH, V48, P1727, DOI 10.1128/AAC.48.5.1727-1732.2004; Sellam A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r71; Sellam A, 2009, EUKARYOT CELL, V8, P1174, DOI 10.1128/EC.00074-09; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Sugino RP, 2012, MOL BIOL EVOL, V29, P71, DOI 10.1093/molbev/msr118; Tuch BB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001070; Uppuluri P, 2010, EUKARYOT CELL, V9, P1531, DOI 10.1128/EC.00111-10; Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Webb BC, 1998, AUST DENT J, V43, P160, DOI 10.1111/j.1834-7819.1998.tb00157.x; Wilson J, 1998, BRIT DENT J, V185, P380, DOI 10.1038/sj.bdj.4809821; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	52	461	520	4	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 20	2012	148	1-2					126	138		10.1016/j.cell.2011.10.048	http://dx.doi.org/10.1016/j.cell.2011.10.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265407	Bronze, Green Accepted			2022-12-24	WOS:000299540700019
J	Rocheteau, P; Gayraud-Morel, B; Siegl-Cachedenier, I; Blasco, MA; Tajbakhsh, S				Rocheteau, Pierre; Gayraud-Morel, Barbara; Siegl-Cachedenier, Irene; Blasco, Maria A.; Tajbakhsh, Shahragim			A Subpopulation of Adult Skeletal Muscle Stem Cells Retains All Template DNA Strands after Cell Division	CELL			English	Article							SATELLITE CELLS; SELF-RENEWAL; SELECTIVE SEGREGATION; DISTINCT; PAX7; HETEROGENEITY; EXPRESSION; SPECIFICATION; PROGENITORS; QUIESCENT	Satellite cells are adult skeletal muscle stem cells that are quiescent and constitute a poorly defined heterogeneous population. Using transgenic Tg:Pax7-nGFP mice, we show that Pax7-nGFP(Hi) cells are less primed for commitment and have a lower metabolic status and delayed first mitosis compared to Pax7-nGFP(Lo) cells. Pax7-nGFP(Hi) can give rise to Pax7-nGFP(Lo) cells after serial transplantations. Proliferating Pax7-nGFP(Hi) cells exhibit lower metabolic activity, and the majority performs asymmetric DNA segregation during cell division, wherein daughter cells retaining template DNA strands express stem cell markers. Using chromosome orientation-fluorescence in situ hybridization, we demonstrate that all chromatids segregate asymmetrically, whereas Pax7-nGFP(Lo) cells perform random DNA segregation. Therefore, quiescent Pax7-nGFP(Hi) cells represent a reversible dormant stem cell state, and during muscle regeneration, Pax7-nGFP(Hi) cells generate distinct daughter cell fates by asymmetrically segregating template DNA strands to the stem cell. These findings provide major insights into the biology of stem cells that segregate DNA asymmetrically.	[Rocheteau, Pierre; Gayraud-Morel, Barbara; Tajbakhsh, Shahragim] CNRS, Dept Dev Biol, Inst Pasteur Stem Cells & Dev, URA 2578, F-75015 Paris, France; [Siegl-Cachedenier, Irene; Blasco, Maria A.] Spanish Natl Canc Ctr CNIO, Mol Oncol Programme, Telomeres & Telomerase Grp, Madrid 28029, Spain	Centre National de la Recherche Scientifique (CNRS); Centro Nacional de Investigaciones Oncologicas (CNIO)	Tajbakhsh, S (corresponding author), CNRS, Dept Dev Biol, Inst Pasteur Stem Cells & Dev, URA 2578, 25 Rue Dr Roux, F-75015 Paris, France.	shaht@pasteur.fr	Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; Gayraud-Morel, Barbara/0000-0002-1168-8504	Conseil de la Region Ile-de-France; MICINN; European Union (EU); European Research Council (ERC); Lilly Foundation; Korber European Research Award; Institut Pasteur; Association Recherche contre le Cancer; Association Francaise contre le Myopathies; Centre national de la recherche scientifique; Agence Nationale de la Recherche [ANR-06-BLAN-0039]; Optistem; Fondation pour la Recherche Medicale	Conseil de la Region Ile-de-France(Region Ile-de-France); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); European Union (EU)(CGIAREuropean Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); Lilly Foundation; Korber European Research Award; Institut Pasteur(European Commission); Association Recherche contre le Cancer; Association Francaise contre le Myopathies(Association Francaise contre les Myopathies); Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Optistem; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	For cytometry we thank M. Nguyen, P.-H. Commere, N. Aulner (PFC, Institut Pasteur, Paris), A. Henry (IMRB, UFR de Medecine, Creteil), and funding by the Conseil de la Region Ile-de-France (SESAME 2007, Imagole; given to S. Shorte). We thank also members of the lab for critical comments. M.A.B. is funded by grants from the MICINN, the European Union, the European Research Council (ERC), The Lilly Foundation, and the Korber European Research Award. S.T. acknowledges support from the Institut Pasteur, Association Recherche contre le Cancer, Association Francaise contre le Myopathies, Centre national de la recherche scientifique, Agence Nationale de la Recherche (ANR-06-BLAN-0039), EU Framework 7 projects EuroSysStem, Optistem, and the Fondation pour la Recherche Medicale.	Armakolas A, 2006, SCIENCE, V311, P1146, DOI 10.1126/science.1120519; Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Bailey SM, 1996, MUTAGENESIS, V11, P139, DOI 10.1093/mutage/11.2.139; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Cairns J, 2006, GENETICS, V174, P1069, DOI 10.1534/genetics.104.66886; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Cortes F, 2003, DNA REPAIR, V2, P719, DOI 10.1016/S1568-7864(03)00044-2; Deprimo SE, 1996, TRANSGENIC RES, V5, P459, DOI 10.1007/BF01980211; Escobar M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1260; Falconer E, 2010, NATURE, V463, P93, DOI 10.1038/nature08644; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Garstka HL, 2003, NUCLEIC ACIDS RES, V31, P5039, DOI 10.1093/nar/gkg717; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Gayraud-Morel B, 2012, J CELL SCI, V125, P1738, DOI 10.1242/jcs.097006; Hall JK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001081; Jory A, 2009, STEM CELLS, V27, P2769, DOI 10.1002/stem.220; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; Kitamoto T, 2010, STEM CELLS, V28, P2205, DOI 10.1002/stem.547; KLAR AJS, 1994, TRENDS GENET, V10, P392, DOI 10.1016/0168-9525(94)90055-8; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; Mitchell PO, 2005, DEV BIOL, V283, P240, DOI 10.1016/j.ydbio.2005.04.016; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Morel BG, 2009, REGEN MED, V4, P293, DOI 10.2217/17460751.4.2.293; Moyes CD, 1998, J EXP BIOL, V201, P299; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Potten CS, 2002, J CELL SCI, V115, P2381; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sambasivan R, 2009, DEV CELL, V16, P810, DOI 10.1016/j.devcel.2009.05.008; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Tajbakhsh S, 2009, J INTERN MED, V266, P372, DOI 10.1111/j.1365-2796.2009.02158.x; Tajbakhsh S, 2009, NAT REV MOL CELL BIO, V10, P804, DOI 10.1038/nrm2784; Tajbakhsh S, 2008, CURR OPIN CELL BIOL, V20, P716, DOI 10.1016/j.ceb.2008.10.004; White MA, 2008, NATURE, V455, P1248, DOI 10.1038/nature07282; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	55	301	315	2	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					112	125		10.1016/j.cell.2011.11.049	http://dx.doi.org/10.1016/j.cell.2011.11.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265406	Bronze			2022-12-24	WOS:000299540700018
J	Zhang, WC; Shyh-Chang, N; Yang, H; Rai, A; Umashankar, S; Ma, SM; Soh, BS; Sun, LL; Tai, BC; Nga, ME; Bhakoo, KK; Jayapal, SR; Nichane, M; Yu, Q; Ahmed, DA; Tan, C; Sing, WP; Tam, J; Thirugananam, A; Noghabi, MS; Pang, YH; Ang, HS; Robson, P; Kaldis, P; Soo, RA; Swarup, S; Lim, EH; Lim, B				Zhang, Wen Cai; Shyh-Chang, Ng; Yang, He; Rai, Amit; Umashankar, Shivshankar; Ma, Siming; Soh, Boon Seng; Sun, Li Li; Tai, Bee Choo; Nga, Min En; Bhakoo, Kishore Kumar; Jayapal, Senthil Raja; Nichane, Massimo; Yu, Qiang; Ahmed, Dokeu A.; Tan, Christie; Sing, Wong Poo; Tam, John; Thirugananam, Agasthian; Noghabi, Monireh Soroush; Pang, Yin Huei; Ang, Haw Siang; Robson, Paul; Kaldis, Philipp; Soo, Ross Andrew; Swarup, Sanjay; Lim, Elaine Hsuen; Lim, Bing			Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis	CELL			English	Article							STEM-CELL; CLEAVAGE SYSTEM; IDENTIFICATION; METABOLISM; EXPRESSION; PROTEIN	Identification of the factors critical to the tumor-initiating cell (TIC) state may open new avenues in cancer therapy. Here we show that the metabolic enzyme glycine decarboxylase (GLDC) is critical for TICs in non-small cell lung cancer (NSCLC). TICs from primary NSCLC tumors express high levels of the oncogenic stem cell factor LIN28B and GLDC, which are both required for TIC growth and tumorigenesis. Overexpression of GLDC and other glycine/serine enzymes, but not catalytically inactive GLDC, promotes cellular transformation and tumorigenesis. We found that GLDC induces dramatic changes in glycolysis and glycine/serine metabolism, leading to changes in pyrimidine metabolism to regulate cancer cell proliferation. In the clinic, aberrant activation of GLDC correlates with poorer survival in lung cancer patients, and aberrant GLDC expression is observed in multiple cancer types. This link between glycine metabolism and tumorigenesis may provide novel targets for advancing anticancer therapy.	[Zhang, Wen Cai; Lim, Elaine Hsuen] Tan Tock Seng Hosp, Dept Resp Med, Singapore 308433, Singapore; [Zhang, Wen Cai; Shyh-Chang, Ng; Ma, Siming; Soh, Boon Seng; Sun, Li Li; Nichane, Massimo; Yu, Qiang; Noghabi, Monireh Soroush; Robson, Paul; Lim, Bing] Genome Inst Singapore, Singapore 138672, Singapore; [Yang, He; Ang, Haw Siang; Soo, Ross Andrew] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117456, Singapore; [Ahmed, Dokeu A.; Tan, Christie] Tan Tock Seng Hosp, Dept Thorac Surg, Singapore 308433, Singapore; [Rai, Amit; Umashankar, Shivshankar; Swarup, Sanjay] Natl Univ Singapore, Dept Biol Sci, Metabolites Biol Lab, Singapore 117543, Singapore; [Umashankar, Shivshankar; Swarup, Sanjay] Natl Univ Singapore, T Lab Bldg TL, NUS Environm Res Inst NERI, Singapore 117411, Singapore; [Soo, Ross Andrew; Lim, Elaine Hsuen] Natl Univ Singapore Hosp, Dept Haematol Oncol, Singapore 119074, Singapore; [Nga, Min En; Pang, Yin Huei] Natl Univ Singapore Hosp, Dept Pathol, Singapore 119074, Singapore; [Sing, Wong Poo; Tam, John] Natl Univ Singapore Hosp, Dept Thorac Surg, Singapore 119074, Singapore; [Tai, Bee Choo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Community Occupat & Family Med, Singapore 117597, Singapore; [Bhakoo, Kishore Kumar] Singapore BioImaging Consortium SBIC, Lab Mol Imaging LMI, Translat Mol Imaging Grp TMIG, Singapore 138667, Singapore; [Jayapal, Senthil Raja; Kaldis, Philipp] Inst Mol & Cell Biol, Cell Div, Singapore 138673, Singapore; [Jayapal, Senthil Raja; Kaldis, Philipp] Inst Mol & Cell Biol, Canc Lab PRK, Singapore 138673, Singapore; [Thirugananam, Agasthian] Natl Canc Ctr, Dept Thorac Surg, Singapore 169610, Singapore; [Lim, Elaine Hsuen] Natl Canc Ctr, Dept Med Oncol, Singapore 169610, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Tan Tock Seng Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Tan Tock Seng Hospital; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lim, EH (corresponding author), Tan Tock Seng Hosp, Dept Resp Med, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	elainelim77@ymail.com; limb1@gis.a-star.edu.sg	Robson, Paul/A-3464-2009; Tam, John/B-6048-2012; Umashankar, Shivshankar/K-1137-2013; Kaldis, Philipp/G-2714-2010; Rai, Amit/J-6288-2016; Swarup, Sanjay/I-1592-2012; Zhang, Wencai/D-8662-2013	Robson, Paul/0000-0002-0191-3958; Umashankar, Shivshankar/0000-0001-7478-1194; Kaldis, Philipp/0000-0002-7247-7591; Rai, Amit/0000-0002-5715-8541; Swarup, Sanjay/0000-0001-6391-0624; Zhang, Wencai/0000-0002-5274-527X; Jayapal, Senthil Raja/0000-0002-0670-7766; Ma, Siming/0000-0002-1810-8357; Yu, Qiang/0000-0003-2132-8278; Shyh-Chang, Ng/0000-0003-3138-9525; Bhakoo, Kishore/0000-0002-4735-9737	Biomedical Research Council (BMRC); Agency for Science, Technology and Research (A*STAR); Singapore Cancer Syndicate; Singapore Lung Cancer Consortium	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore Cancer Syndicate; Singapore Lung Cancer Consortium	This work is supported by grants from Biomedical Research Council (BMRC) and Agency for Science, Technology and Research (A*STAR) (B. L.) and grants from the Singapore Cancer Syndicate and Singapore Lung Cancer Consortium (E. H. L.). We gratefully acknowledge assistance from Y.P.R. Yip, S. L. Long, and J. Xu for collection of lung tissues. We are grateful to the Biopolis Shared Facilities Histopathology Laboratory staff for their support with immunohistochemistry and image analysis. We thank Z.M. Li for assistance with making transformed breast cell lines. We greatly acknowledge V. Gaddemane, C. S. Gan, and T. Hennessy from Agilent Technologies, Singapore for their support in acquiring and analyzing the mass spectrometry data for the differential analysis of the metabolites. We thank W. L. Tam and F. McKeon for comments on the manuscript.	Avril-Delplanque A, 2005, STEM CELLS, V23, P992, DOI 10.1634/stemcells.2004-0197; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Chua SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl024; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hennrick KT, 2007, AM J RESP CRIT CARE, V175, P1158, DOI 10.1164/rccm.200607-941OC; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KUME A, 1991, J BIOL CHEM, V266, P3323; Kure S, 2006, HUM MUTAT, V27, P343, DOI 10.1002/humu.20293; Levesque BM, 2007, AM J RESP CELL MOL, V36, P427, DOI 10.1165/rcmb.2006-0314OC; Liu YR, 2003, DEV BIOL, V261, P10, DOI 10.1016/S0012-1606(03)00359-2; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Murakami Y, 2007, MECH DEVELOP, V124, P830, DOI 10.1016/j.mod.2007.09.004; Nakai T, 2005, EMBO J, V24, P1523, DOI 10.1038/sj.emboj.7600632; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sabatini F, 2005, LAB INVEST, V85, P962, DOI 10.1038/labinvest.3700300; Sequist LV, 2007, ONCOLOGIST, V12, P90, DOI 10.1634/theoncologist.12-1-90; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	43	484	506	2	112	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					259	272		10.1016/j.cell.2011.11.050	http://dx.doi.org/10.1016/j.cell.2011.11.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22225612	Bronze			2022-12-24	WOS:000299540700029
J	Trcek, T; Larson, DR; Moldon, A; Query, CC; Singer, RH				Trcek, Tatjana; Larson, Daniel R.; Moldon, Alberto; Query, Charles C.; Singer, Robert H.			Single-Molecule mRNA Decay Measurements Reveal Promoter-Regulated mRNA Stability in Yeast	CELL			English	Article							CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; BUDDING YEAST; IN-VIVO; TRANSCRIPTION; GENE; DBF2; VISUALIZATION; DEGRADATION	Messenger RNA decay measurements are typically performed on a population of cells. However, this approach cannot reveal sufficient complexity to provide information on mechanisms that may regulate mRNA degradation, possibly on short timescales. To address this deficiency, we measured cell cycle-regulated decay in single yeast cells using single-molecule FISH. We found that two genes responsible for mitotic progression, SWI5 and CLB2, exhibit a mitosis-dependent mRNA stability switch. Their transcripts are stable until mitosis, when a precipitous decay eliminates the mRNA complement, preventing carryover into the next cycle. Remarkably, the specificity and timing of decay is entirely regulated by their promoter, independent of specific cis mRNA sequences. The mitotic exit network protein Dbf2p binds to SWI5 and CLB2 mRNAs cotranscriptionally and regulates their decay. This work reveals the promoter-dependent control of mRNA stability, a regulatory mechanism that could be employed by a variety of mRNAs and organisms.	[Singer, Robert H.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Larson, Daniel R.] NCI, NIH, Bethesda, MD 20892 USA	Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Singer, RH (corresponding author), Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	robert.singer@einstein.yu.edu	Larson, Daniel R/B-9829-2008	Larson, Daniel R/0000-0001-9253-3055	EMBO [GM57829, GM57071]; NATIONAL CANCER INSTITUTE [ZIABC011409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057829, R01GM057071] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Drs. Jeffrey Chao and Kevin Czaplinski for helpful discussion of the project and Xiuhua Meng for her help with cloning. We thank Drs. Ian Willis, Michael Keogh, and Angelika Amon for sharing Delta SWI5 (TT012), Pab1p-TAP (TT065) strains, and Dbf2p-kinase dead plasmid with us, respectively. This work was supported by an EMBO fellowship awarded to A.M., GM57829 to C.C.Q., and GM57071 to R.H.S.	Ardehali MB, 2009, NAT STRUCT MOL BIOL, V16, P1123, DOI 10.1038/nsmb1109-1123; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; BREWER BJ, 1984, MOL CELL BIOL, V4, P2529, DOI 10.1128/MCB.4.11.2529; Cai T, 2002, GENETICS, V161, P1029; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Darieva Z, 2006, NATURE, V444, P494, DOI 10.1038/nature05339; Dori-Bachash M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001106; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Femino AM, 2003, METHOD ENZYMOL, V361, P245; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; Goler-Baron V, 2008, GENE DEV, V22, P2022, DOI 10.1101/gad.473608; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; HARTWELL LH, 1974, BACTERIOL REV, V38, P164, DOI 10.1128/MMBR.38.2.164-198.1974; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; JIMENEZ A, 1973, ANTIMICROB AGENTS CH, V3, P729, DOI 10.1128/AAC.3.6.729; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Larson DR, 2005, P NATL ACAD SCI USA, V102, P15453, DOI 10.1073/pnas.0504812102; Liu HY, 1997, EMBO J, V16, P5289, DOI 10.1093/emboj/16.17.5289; LORD PG, 1980, J BACTERIOL, V142, P808, DOI 10.1128/JB.142.3.808-818.1980; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Moldon A, 2008, NATURE, V455, P997, DOI 10.1038/nature07325; Niu W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000120; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Passos DO, 2008, METHOD ENZYMOL, V448, P409, DOI 10.1016/S0076-6879(08)02620-7; Pelechano V, 2008, YEAST, V25, P85, DOI 10.1002/yea.1548; SANDLER H, 2001, NUCLEIC ACIDS RES, V39, P4373; Shen ZF, 2010, GENE DEV, V24, P1914, DOI 10.1101/gad.1937510; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Talarek N, 2010, MOL CELL, V38, P345, DOI 10.1016/j.molcel.2010.02.039; TOYN JH, 1991, GENE, V104, P63, DOI 10.1016/0378-1119(91)90465-N; TOYN JH, 1994, EMBO J, V13, P1103, DOI 10.1002/j.1460-2075.1994.tb06359.x; Trcek T, 2010, GENE DEV, V24, P1827, DOI 10.1101/gad.1972810; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	47	183	185	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1484	1497		10.1016/j.cell.2011.11.051	http://dx.doi.org/10.1016/j.cell.2011.11.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196726	Green Accepted, Bronze			2022-12-24	WOS:000298403400014
J	Koch, P; Breuer, P; Peitz, M; Jungverdorben, J; Kesavan, J; Poppe, D; Doerr, J; Ladewig, J; Mertens, J; Tuting, T; Hoffmann, P; Klockgether, T; Evert, BO; Wullner, U; Brustle, O				Koch, Philipp; Breuer, Peter; Peitz, Michael; Jungverdorben, Johannes; Kesavan, Jaideep; Poppe, Daniel; Doerr, Jonas; Ladewig, Julia; Mertens, Jerome; Tueting, Thomas; Hoffmann, Per; Klockgether, Thomas; Evert, Bernd O.; Wuellner, Ullrich; Bruestle, Oliver			Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease	NATURE			English	Article							POLYGLUTAMINE-EXPANDED ATAXIN-3; IN-VITRO; CLEAVAGE; EXPANSION; MODEL; NEURODEGENERATION; PROTEOLYSIS; INCLUSIONS; DISORDERS; PROTEINS	Machado-Joseph disease (MJD; also called spinocerebellar ataxia type 3) is a dominantly inherited late-onset neurodegenerative disorder caused by expansion of polyglutamine (polyQ)-encoding CAG repeats in the MJD1 gene (also known as ATXN3). Proteolytic liberation of highly aggregation-prone polyQ fragments from the protective sequence of the MJD1 gene product ataxin 3 (ATXN3) has been proposed to trigger the formation of ATXN3-containing aggregates, the neuropathological hallmark of MJD(1-5). ATXN3 fragments are detected in brain tissue of MJD patients and transgenic mice expressing mutant human ATXN3(Q71)(6), and their amount increases with disease severity, supporting a relationship between ATXN3 processing and disease progression. The formation of early aggregation intermediates is thought to have a critical role in disease initiation(7,8), but the precise pathogenic mechanism operating in MJD has remained elusive(9). Here we show that L-glutamate-induced excitation of patient-specific induced pluripotent stem cell (iPSC)-derived neurons initiates Ca2+-dependent proteolysis of ATXN3 followed by the formation of SDS-insoluble aggregates. This phenotype could be abolished by calpain inhibition, confirming a key role of this protease in ATXN3 aggregation. Aggregate formation was further dependent on functional Na+ and K+ channels as well as ionotropic and voltage-gated Ca2+ channels, and was not observed in iPSCs, fibroblasts or glia, thereby providing an explanation for the neuron-specific phenotype of this disease. Our data illustrate that iPSCs enable the study of aberrant protein processing associated with late-onset neurodegenerative disorders in patient-specific neurons.	[Koch, Philipp; Peitz, Michael; Jungverdorben, Johannes; Kesavan, Jaideep; Poppe, Daniel; Doerr, Jonas; Ladewig, Julia; Mertens, Jerome; Bruestle, Oliver] Univ Bonn, Inst Reconstruct Neurobiol, Life & Brain Ctr, D-53127 Bonn, Germany; [Koch, Philipp; Peitz, Michael; Jungverdorben, Johannes; Kesavan, Jaideep; Poppe, Daniel; Doerr, Jonas; Ladewig, Julia; Mertens, Jerome; Bruestle, Oliver] Hertie Fdn, D-53127 Bonn, Germany; [Breuer, Peter; Klockgether, Thomas; Evert, Bernd O.; Wuellner, Ullrich] Univ Bonn, Med Ctr, Dept Neurol, D-53105 Bonn, Germany; [Tueting, Thomas] Univ Bonn, Med Ctr, Dept Dermatol, D-53127 Bonn, Germany; [Hoffmann, Per] Univ Bonn, Life & Brain Ctr, Inst Human Genet, D-53127 Bonn, Germany; [Hoffmann, Per] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Klockgether, Thomas] German Ctr Neurodegenerat Dis, DZNE, D-53175 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Brustle, O (corresponding author), Univ Bonn, Inst Reconstruct Neurobiol, Life & Brain Ctr, D-53127 Bonn, Germany.	brustle@uni-bonn.de	Mertens, Jerome/P-1931-2015; Koch, Philipp/M-1186-2016; Wüllner, Ullrich/R-6790-2019; Tüting, Thomas/AAJ-3610-2021; Hoffmann, Per/A-5149-2010; Koch, Philipp/AAZ-3751-2020; Peitz, Michael/AHB-0741-2022	Mertens, Jerome/0000-0002-4291-4121; Tüting, Thomas/0000-0001-7146-0934; Hoffmann, Per/0000-0002-6573-983X; Koch, Philipp/0000-0003-3713-8786; Poppe, Daniel/0000-0002-6674-8420; Kesavan, Jaideep/0000-0003-1933-1187	German Federal Ministry for Education and Research (BMBF) [01GNO813, 01GS0860]; European Union [LSHG-CT-2006-018739, HEALTH-F5-2010-266753]; Deutsche Forschungsgemeinschaft [WU 184/6-1, EV143/1-1]; BONFOR; Hertie Foundation	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BONFOR; Hertie Foundation	We thank S. Auel, D. Kuhne, M. Segschneider and V. Dobberahn for technical support, A. Leinhaas for conducting the teratoma assays and H. L. Paulson for providing the polyclonal ATXN3 antibody used for immunocytochemistry. The human embryonic stem cell lines H9 and I3 (used as control for quantitative PCR) and I6 (originally used to derive the lt-NES cells) were provided by J. Itskovitz-Eldor (Technion, Israel Institute of Technology, Haifa, Israel). The work was supported by the German Federal Ministry for Education and Research (BMBF; grants 01GNO813, 01GS0860), the European Union (LSHG-CT-2006-018739, ESTOOLS; HEALTH-F5-2010-266753, SCR&Tox), the Deutsche Forschungsgemeinschaft (WU 184/6-1, EV143/1-1), BONFOR and the Hertie Foundation.	Berke SJS, 2004, J NEUROCHEM, V89, P908, DOI 10.1111/j.1471-4159.2004.02369.x; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Haacke A, 2007, J BIOL CHEM, V282, P18851, DOI 10.1074/jbc.M611914200; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Jung J, 2009, HUM MOL GENET, V18, P4843, DOI 10.1093/hmg/ddp456; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; Rubinsztein DC, 1999, J MED GENET, V36, P265; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tarlac V, 2003, J NEUROSCI RES, V74, P406, DOI 10.1002/jnr.10746; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Uchihara T, 2001, ACTA NEUROPATHOL, V102, P149; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Williams AJ, 2009, NEUROBIOL DIS, V33, P342, DOI 10.1016/j.nbd.2008.10.016; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X	25	233	245	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					543	U170		10.1038/nature10671	http://dx.doi.org/10.1038/nature10671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22113611				2022-12-24	WOS:000298318000065
J	Wang, XN; Winter, D; Ashrafi, G; Schlehe, J; Wong, YL; Selkoe, D; Rice, S; Steen, J; LaVoie, MJ; Schwarz, TL				Wang, Xinnan; Winter, Dominic; Ashrafi, Ghazaleh; Schlehe, Julia; Wong, Yao Liang; Selkoe, Dennis; Rice, Sarah; Steen, Judith; LaVoie, Matthew J.; Schwarz, Thomas L.			PINK1 and Parkin Target Miro for Phosphorylation and Degradation to Arrest Mitochondrial Motility	CELL			English	Article							AXONAL-TRANSPORT; PINK1/PARKIN PATHWAY; DOPAMINERGIC-NEURONS; DEFICIENT MICE; DROSOPHILA; DISEASE; MUTATIONS; MITOPHAGY; INTERACTS; KINESIN	Cells keep their energy balance and avoid oxidative stress by regulating mitochondrial movement, distribution, and clearance. We report here that two Parkinson's disease proteins, the Ser/Thr kinase PINK1 and ubiquitin ligase Parkin, participate in this regulation by arresting mitochondrial movement. PINK1 phosphorylates Miro, a component of the primary motor/adaptor complex that anchors kinesin to the mitochondrial surface. The phosphorylation of Miro activates proteasomal degradation of Miro in a Parkin-dependent manner. Removal of Miro from the mitochondrion also detaches kinesin from its surface. By preventing mitochondrial movement, the PINK1/Parkin pathway may quarantine damaged mitochondria prior to their clearance. PINK1 has been shown to act upstream of Parkin, but the mechanism corresponding to this relationship has not been known. We propose that PINK1 phosphorylation of substrates triggers the subsequent action of Parkin and the proteasome.	[Wang, Xinnan; Ashrafi, Ghazaleh; Steen, Judith; Schwarz, Thomas L.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Winter, Dominic; Steen, Judith] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Wang, Xinnan; Schwarz, Thomas L.] Harvard Univ, Sch Med, Dept Neurobiol, Cambridge, MA 02138 USA; [Ashrafi, Ghazaleh] Harvard Univ, Dept Mol Cellular Biol, Cambridge, MA 02138 USA; [Schlehe, Julia; Selkoe, Dennis; LaVoie, Matthew J.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Wong, Yao Liang; Rice, Sarah] Northwestern Univ, Dept Cell & Mol Biol, Evanston, IL 60208 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard University; Brigham & Women's Hospital; Northwestern University	Schwarz, TL (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	thomas.schwarz@childrens.harvard.edu	Winter, Dominic/A-2408-2014; Gelfand, Vladimir I/D-2545-2013; Wang, Xinnan/B-2393-2013	Winter, Dominic/0000-0001-6788-6641; Gelfand, Vladimir I/0000-0002-6361-2798; Wong, Yao Liang/0000-0003-0298-8510; LaVoie, Matthew/0000-0002-2583-1578	Ellison Medical Foundation; Hartman Foundation for Parkinson's Research; NIH [GM069808, NS065013, K99NS067066]; LSRF Novartis; IDDRC [P30HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS067066, R01NS065013, R00NS067066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012749] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Hartman Foundation for Parkinson's Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LSRF Novartis; IDDRC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. P. Aspenstrom, A. M. Craig, M. Guo, B. Lu, R. Youle, M. Haigis, and G. Hajnoczky for reagents and S. Vasquez and Dr. M. Sahin for assistance with hippocampal cultures. This work was supported by the Ellison Medical Foundation (T. L. S.), Hartman Foundation for Parkinson's Research (T. L. S.), NIH GM069808 (T. L. S.), NIH NS065013 (M.J.L.), NIH K99NS067066 (X. W.), LSRF Novartis Fellowship (X. W.), and the proteomics, imaging, and molecular genetics cores of the IDDRC (grant number P30HD18655).	Berger AK, 2009, HUM MOL GENET, V18, P4317, DOI 10.1093/hmg/ddp384; Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Park JH, 2003, DEVELOPMENT, V130, P2645, DOI 10.1242/dev.00503; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Pozo KBK, 2011, BBA-MOL CELL RES, V1813, P269, DOI 10.1016/j.bbamcr.2010.10.011; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Surmeier DJ, 2010, PROG BRAIN RES, V183, P59, DOI 10.1016/S0079-6123(10)83004-3; Twig G, 2010, AM J PHYSIOL-CELL PH, V299, pC477, DOI 10.1152/ajpcell.00427.2009; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531; Venderova K, 2009, HUM MOL GENET, V18, P4390, DOI 10.1093/hmg/ddp394; Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002; Wang XN, 2009, METHOD ENZYMOL, V457, P319, DOI 10.1016/S0076-6879(09)05018-6; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Whitworth AJ, 2009, J BIOENERG BIOMEMBR, V41, P499, DOI 10.1007/s10863-009-9253-3; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	47	818	842	2	125	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 11	2011	147	4					893	906		10.1016/j.cell.2011.10.018	http://dx.doi.org/10.1016/j.cell.2011.10.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22078885	Green Accepted, Bronze			2022-12-24	WOS:000296902300021
J	Brar, GA; Yassour, M; Friedman, N; Regev, A; Ingolia, NT; Weissman, JS				Brar, Gloria A.; Yassour, Moran; Friedman, Nir; Regev, Aviv; Ingolia, Nicholas T.; Weissman, Jonathan S.			High-Resolution View of the Yeast Meiotic Program Revealed by Ribosome Profiling	SCIENCE			English	Article							UNFOLDED PROTEIN-RESPONSE; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; ENDOPLASMIC-RETICULUM; SYNAPTONEMAL COMPLEX; TRANSCRIPTION FACTOR; BUDDING YEAST; MEIOSIS; GAMETOGENESIS; CHROMOSOMES	Meiosis is a complex developmental process that generates haploid cells from diploid progenitors. We measured messenger RNA (mRNA) abundance and protein production through the yeast meiotic sporulation program and found strong, stage-specific expression for most genes, achieved through control of both mRNA levels and translational efficiency. Monitoring of protein production timing revealed uncharacterized recombination factors and extensive organellar remodeling. Meiotic translation is also shifted toward noncanonical sites, including short open reading frames (ORFs) on unannnotated transcripts and upstream regions of known transcripts (uORFs). Ribosome occupancy at near-cognate uORFs was associated with more efficient ORF translation; by contrast, some AUG uORFs, often exposed by regulated 5' leader extensions, acted competitively. This work reveals pervasive translational control in meiosis and helps to illuminate the molecular basis of the broad restructuring of meiotic cells.	[Brar, Gloria A.; Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Brar, Gloria A.; Ingolia, Nicholas T.; Weissman, Jonathan S.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Yassour, Moran; Regev, Aviv] Massachusetts Inst Technol & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Yassour, Moran; Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Yassour, Moran; Friedman, Nir] Hebrew Univ Jerusalem, Sch Engn & Comp Sci, IL-91904 Jerusalem, Israel; [Friedman, Nir] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ingolia, NT (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA.	ingolia@ciwemb.edu; weissman@cmp.ucsf.edu	Friedman, Nir/H-9692-2012; Yassour, Moran/ABE-7415-2020	Friedman, Nir/0000-0002-9678-3550; Yassour, Moran/0000-0002-7344-5188; Weissman, Jonathan/0000-0003-2445-670X	American Cancer Society [117945-PF-09-136-01-RMC]; Clore Fellowship; U.S.-Israel Binational Science Foundation; NIH [AG10770]; Ruth L. Kirschstein National Research Service Award [GM080853]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Clore Fellowship; U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Unal, A. Amon, and members of the Weissman laboratory for critical reading of this manuscript; C. Chu for sequencing assistance; J. Dunn for protocol development assistance; F. Van Werven for the MATa/a strain; and F. Klein for the the Zip1 antibody. G. A. B. is supported by American Cancer Society Postdoctoral Fellowship 117945-PF-09-136-01-RMC. M.Y. is supported by a Clore Fellowship. This work was supported by a grant from the U.S.-Israel Binational Science Foundation (N.F. and A. R.), an NIH P01 award (AG10770; N.T.I.), a Ruth L. Kirschstein National Research Service Award (GM080853; N.T.I.), and Howard Hughes Medical Institute funding (J. S. W. and A. R.). A patent on the ribosome profiling approach has been assigned to the University of California. Supporting files are in the SOM and at www.ncbi.nlm.nih.gov/geo/ with series accession no. GSE34082.	Badhai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017672; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; FRIESEN H, 1994, GENE DEV, V8, P2162, DOI 10.1101/gad.8.18.2162; Gelfand B, 2011, MOL CELL BIOL, V31, P1701, DOI 10.1128/MCB.01071-10; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Imai K, 2005, J BIOL CHEM, V280, P8275, DOI 10.1074/jbc.M409428200; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jambhekar A, 2008, CURR BIOL, V18, P969, DOI 10.1016/j.cub.2008.05.047; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; Kolitz SE, 2009, RNA, V15, P138, DOI 10.1261/rna.1318509; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Law GL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r111; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Piekarska I, 2010, EUR J CELL BIOL, V89, P780, DOI 10.1016/j.ejcb.2010.06.009; ROCKMILL B, 1988, P NATL ACAD SCI USA, V85, P6057, DOI 10.1073/pnas.85.16.6057; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Tachikawa H, 2001, J CELL BIOL, V155, P797, DOI 10.1083/jcb.200107008; Wu HY, 2006, CURR BIOL, V16, P2473, DOI 10.1016/j.cub.2006.10.069; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu YY, 2010, J VIROL, V84, P5465, DOI 10.1128/JVI.02705-09; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	40	352	371	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 3	2012	335	6068					552	557		10.1126/science.1215110	http://dx.doi.org/10.1126/science.1215110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885HI	22194413	Green Accepted, Green Submitted			2022-12-24	WOS:000299769200035
J	Ding, L; Ley, TJ; Larson, DE; Miller, CA; Koboldt, DC; Welch, JS; Ritchey, JK; Young, MA; Lamprecht, T; McLellan, MD; McMichael, JF; Wallis, JW; Lu, C; Shen, D; Harris, CC; Dooling, DJ; Fulton, RS; Fulton, LL; Chen, K; Schmidt, H; Kalicki-Veizer, J; Magrini, VJ; Cook, L; McGrath, SD; Vickery, TL; Wendl, MC; Heath, S; Watson, MA; Link, DC; Tomasson, MH; Shannon, WD; Payton, JE; Kulkarni, S; Westervelt, P; Walter, MJ; Graubert, TA; Mardis, ER; Wilson, RK; DiPersio, JF				Ding, Li; Ley, Timothy J.; Larson, David E.; Miller, Christopher A.; Koboldt, Daniel C.; Welch, John S.; Ritchey, Julie K.; Young, Margaret A.; Lamprecht, Tamara; McLellan, Michael D.; McMichael, Joshua F.; Wallis, John W.; Lu, Charles; Shen, Dong; Harris, Christopher C.; Dooling, David J.; Fulton, Robert S.; Fulton, Lucinda L.; Chen, Ken; Schmidt, Heather; Kalicki-Veizer, Joelle; Magrini, Vincent J.; Cook, Lisa; McGrath, Sean D.; Vickery, Tammi L.; Wendl, Michael C.; Heath, Sharon; Watson, Mark A.; Link, Daniel C.; Tomasson, Michael H.; Shannon, William D.; Payton, Jacqueline E.; Kulkarni, Shashikant; Westervelt, Peter; Walter, Matthew J.; Graubert, Timothy A.; Mardis, Elaine R.; Wilson, Richard K.; DiPersio, John F.			Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing	NATURE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; LYMPHOBLASTIC-LEUKEMIA; MISMATCHED HLA; MUTATIONS; METASTASIS; RESOLUTION; CANCER	Most patients with acute myeloid leukaemia (AML) die from progressive disease after relapse, which is associated with clonal evolution at the cytogenetic level(1,2). To determine the mutational spectrum associated with relapse, we sequenced the primary tumour and relapse genomes from eight AML patients, and validated hundreds of somatic mutations using deep sequencing; this allowed us to define clonality and clonal evolution patterns precisely at relapse. In addition to discovering novel, recurrently mutated genes (for example, WAC, SMC3, DIS3, DDX41 and DAXX) in AML, we also found two major clonal evolution patterns during AML relapse: (1) the founding clone in the primary tumour gained mutations and evolved into the relapse clone, or (2) a subclone of the founding clone survived initial therapy, gained additional mutations and expanded at relapse. In all cases, chemotherapy failed to eradicate the founding clone. The comparison of relapse-specific versus primary tumour mutations in all eight cases revealed an increase in transversions, probably due to DNA damage caused by cytotoxic chemotherapy. These data demonstrate that AML relapse is associated with the addition of new mutations and clonal evolution, which is shaped, in part, by the chemotherapy that the patients receive to establish and maintain remissions.	[Ding, Li; Ley, Timothy J.; Larson, David E.; Miller, Christopher A.; Koboldt, Daniel C.; McLellan, Michael D.; McMichael, Joshua F.; Wallis, John W.; Lu, Charles; Shen, Dong; Harris, Christopher C.; Dooling, David J.; Fulton, Robert S.; Fulton, Lucinda L.; Chen, Ken; Schmidt, Heather; Kalicki-Veizer, Joelle; Magrini, Vincent J.; Cook, Lisa; McGrath, Sean D.; Vickery, Tammi L.; Wendl, Michael C.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Wallis, John W.; Dooling, David J.; Fulton, Robert S.; Fulton, Lucinda L.; Chen, Ken; Magrini, Vincent J.; Wendl, Michael C.; Kulkarni, Shashikant; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Ley, Timothy J.; Welch, John S.; Ritchey, Julie K.; Young, Margaret A.; Lamprecht, Tamara; Heath, Sharon; Link, Daniel C.; Tomasson, Michael H.; Westervelt, Peter; Walter, Matthew J.; Graubert, Timothy A.; DiPersio, John F.] Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Ley, Timothy J.; Link, Daniel C.; Tomasson, Michael H.; Kulkarni, Shashikant; Westervelt, Peter; Walter, Matthew J.; Graubert, Timothy A.; Mardis, Elaine R.; Wilson, Richard K.; DiPersio, John F.] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA; [Watson, Mark A.; Payton, Jacqueline E.; Kulkarni, Shashikant] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Shannon, William D.] Washington Univ, Div Biostat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Genome Inst, St Louis, MO 63108 USA.	timley@wustl.edu	Wilson, Richard K./AAF-4139-2019; Magrini, Vincent/AAT-5830-2020; Chen, Ken/AAU-1432-2021; Wendl, Michael C/A-2741-2008; McGrath, Sean David/AAT-3540-2020; Miller, Christopher A./A-1060-2009; Walter, Matthew J/S-7758-2018; Mardis, Elaine/W-2202-2019	Wilson, Richard K./0000-0002-1992-1358; Magrini, Vincent/0000-0002-2019-4872; Chen, Ken/0000-0003-4013-5279; McGrath, Sean David/0000-0001-9064-8449; Miller, Christopher A./0000-0003-4266-6700; Graubert, Timothy/0000-0002-7710-1171; MCLELLAN, MICHAEL/0000-0002-2703-8784; Tomasson, Michael/0000-0003-4518-7123; Westover, Tamara/0000-0002-1000-6698; Larson, David/0000-0001-7934-5906	Washington University Cancer Genome Initiative; National Human Genome Research Institute (NHGRI) [U54 HG003079]; National Cancer Institute [PO1 CA101937]; Barnes-Jewish Hospital Foundation [00335-0505-02]; NATIONAL CANCER INSTITUTE [P01CA101937] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	Washington University Cancer Genome Initiative; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Barnes-Jewish Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Analysis Pipeline group for developing the automated sequence analysis pipelines; the LIMS group for developing tools and software to manage samples and sequencing; the Systems group for providing the IT infrastructure and HPC solutions required for sequencing and analysis; and R. T. Demeter for experimental support. We also thank The Cancer Genome Atlas for allowing us to use unpublished data for this study, and the Washington University Cancer Genome Initiative for their support. This work was funded by grants to R. K. W. and the National Human Genome Research Institute (NHGRI U54 HG003079), and grants to T.J.L. from the National Cancer Institute (PO1 CA101937) and the Barnes-Jewish Hospital Foundation (00335-0505-02).	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; GAO JZ, 1991, P NATL ACAD SCI USA, V88, P4882, DOI 10.1073/pnas.88.11.4882; GARSON OM, 1989, CANCER GENET CYTOGEN, V40, P187, DOI 10.1016/0165-4608(89)90024-1; KingUnderwood L, 1996, BLOOD, V87, P2171, DOI 10.1182/blood.V87.6.2171.bloodjournal8762171; Kirito K, 2007, HAEMATOLOGICA, V93, P155, DOI 10.3324/haematol.12050; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Larson D. E., BIOINFORMAT IN PRESS; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Nakao M, 1996, LEUKEMIA, V10, P1911; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; TESTA JR, 1979, CANCER RES, V39, P3619; Vago L, 2009, NEW ENGL J MED, V361, P478, DOI 10.1056/NEJMoa0811036; van Doorn-Khosrovani SBV, 2005, ONCOGENE, V24, P4129, DOI 10.1038/sj.onc.1208588; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247; Villalobos IB, 2010, BLOOD, V115, P3158, DOI 10.1182/blood-2009-11-254284; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	28	1464	1548	6	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 26	2012	481	7382					506	510		10.1038/nature10738	http://dx.doi.org/10.1038/nature10738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22237025	Green Accepted, hybrid			2022-12-24	WOS:000299471800040
J	Rausch, T; Jones, DTW; Zapatka, M; Stutz, AM; Zichner, T; Weischenfeldt, J; Jager, N; Remke, M; Shih, D; Northcott, PA; Pfaff, E; Tica, J; Wang, Q; Massimi, L; Witt, H; Bender, S; Pleier, S; Cin, H; Hawkins, C; Beck, C; von Deimling, A; Hans, V; Brors, B; Eils, R; Scheurlen, W; Blake, J; Benes, V; Kulozik, AE; Witt, O; Martin, D; Zhang, C; Porat, R; Merino, DM; Wasserman, J; Jabado, N; Fontebasso, A; Bullinger, L; Rucker, FG; Dohner, K; Dohner, H; Koster, J; Molenaar, JJ; Versteeg, R; Kool, M; Tabori, U; Malkin, D; Korshunov, A; Taylor, MD; Lichter, P; Pfister, SM; Korbel, JO				Rausch, Tobias; Jones, David T. W.; Zapatka, Marc; Stuetz, Adrian M.; Zichner, Thomas; Weischenfeldt, Joachim; Jaeger, Natalie; Remke, Marc; Shih, David; Northcott, Paul A.; Pfaff, Elke; Tica, Jelena; Wang, Qi; Massimi, Luca; Witt, Hendrik; Bender, Sebastian; Pleier, Sabrina; Cin, Huriye; Hawkins, Cynthia; Beck, Christian; von Deimling, Andreas; Hans, Volkmar; Brors, Benedikt; Eils, Roland; Scheurlen, Wolfram; Blake, Jonathon; Benes, Vladimir; Kulozik, Andreas E.; Witt, Olaf; Martin, Dianna; Zhang, Cindy; Porat, Rinnat; Merino, Diana M.; Wasserman, Jonathan; Jabado, Nada; Fontebasso, Adam; Bullinger, Lars; Ruecker, Frank G.; Doehner, Konstanze; Doehner, Hartmut; Koster, Jan; Molenaar, Jan J.; Versteeg, Rogier; Kool, Marcel; Tabori, Uri; Malkin, David; Korshunov, Andrey; Taylor, Michael D.; Lichter, Peter; Pfister, Stefan M.; Korbel, Jan O.			Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; TELOMERE LENGTH; BREAST-CANCER; GENE; EXPRESSION; SIGNATURES; MECHANISM; RADIATION; CARRIERS; SUBTYPES	Genomic rearrangements are thought to occur progressively during tumor development. Recent findings, however, suggest an alternative mechanism, involving massive chromosome rearrangements in a one-step catastrophic event termed chromothripsis. We report the whole-genome sequencing-based analysis of a Sonic-Hedgehog medulloblastoma (SHH-MB) brain tumor from a patient with a germline TP53 mutation (Li-Fraumeni syndrome), uncovering massive, complex chromosome rearrangements. Integrating TP53 status with microarray and deep sequencing-based DNA rearrangement data in additional patients reveals a striking association between TP53 mutation and chromothripsis in SHH-MBs. Analysis of additional tumor entities substantiates a link between TP53 mutation and chromothripsis, and indicates a context-specific role for p53 in catastrophic DNA rearrangements. Among these, we observed a strong association between somatic TP53 mutations and chromothripsis in acutemyeloid leukemia. These findings connect p53 status and chromothripsis in specific tumor types, providing a genetic basis for understanding particularly aggressive subtypes of cancer.	[Jones, David T. W.; Zapatka, Marc; Remke, Marc; Pfaff, Elke; Witt, Hendrik; Bender, Sebastian; Pleier, Sabrina; Cin, Huriye; Kool, Marcel; Lichter, Peter; Pfister, Stefan M.] German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, Div Mol Genet, D-69120 Heidelberg, Germany; [Rausch, Tobias; Stuetz, Adrian M.; Zichner, Thomas; Weischenfeldt, Joachim; Tica, Jelena; Blake, Jonathon; Benes, Vladimir] EMBL, D-69117 Heidelberg, Germany; [Jaeger, Natalie; Brors, Benedikt; Eils, Roland] German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Remke, Marc; Wang, Qi; Witt, Hendrik; Bender, Sebastian; Pleier, Sabrina; Beck, Christian; Kulozik, Andreas E.; Witt, Olaf; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Shih, David; Northcott, Paul A.; Hawkins, Cynthia; Tabori, Uri; Taylor, Michael D.] Univ Toronto, Hosp Sick Children Res Inst, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1L7, Canada; [Massimi, Luca] Univ Cattolica Sacro Cuore, Sch Med, I-00168 Rome, Italy; [Hawkins, Cynthia] Hosp Sick Children, Dept Pathol, Toronto, ON M5G 1L7, Canada; [von Deimling, Andreas; Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, D-69120 Heidelberg, Germany; [von Deimling, Andreas; Korshunov, Andrey] DKFZ, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany; [Hans, Volkmar] Evangel Krankenhaus, Inst Neuropathol, D-33617 Bielefeld, Germany; [Scheurlen, Wolfram] Childrens Hosp, Cnopfsche Kinderklin, Nurnberg, Germany; [Martin, Dianna; Zhang, Cindy; Porat, Rinnat; Merino, Diana M.; Wasserman, Jonathan; Tabori, Uri; Malkin, David] Univ Toronto, Hosp Sick Children, Dept Pediat, Genet & Genome Biol Program, Toronto, ON M5G 1X8, Canada; [Martin, Dianna; Zhang, Cindy; Porat, Rinnat; Merino, Diana M.; Wasserman, Jonathan; Tabori, Uri; Malkin, David] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada; [Jabado, Nada; Fontebasso, Adam] McGill Univ, Ctr Hlth, Montreal, PQ H3H 2R9, Canada; [Bullinger, Lars; Ruecker, Frank G.; Doehner, Konstanze; Doehner, Hartmut] Univ Ulm, Dept Internal Med 3, D-89081 Ulm, Germany; [Koster, Jan; Molenaar, Jan J.; Versteeg, Rogier] Amsterdam Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Korbel, Jan O.] European Bioinformat Inst, Cambridge CB10 1SD, England	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; Ulm University; University of Amsterdam; Academic Medical Center Amsterdam; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); European Molecular Biology Laboratory (EMBL)	Lichter, P (corresponding author), German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, Div Mol Genet, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	peter.lichter@dkfz-heidelberg.de; s.pfister@dkfz-heidelberg.de; jan.korbel@embl-heidelberg.de	Rausch, Tobias/H-6511-2019; Jones, David TW/G-9588-2013; Döhner, Hartmut/C-8933-2016; Northcott, Paul A/N-4022-2018; Versteeg, Rogier/AAQ-1765-2020; Kulozik, Andreas/AAO-2432-2020; Jabado, Nada/AAN-4026-2020; Bullinger, Lars/AAL-7965-2020; Koster, Jan/C-5934-2008; von Deimling, Andreas/F-7774-2013; Brors, Benedikt/E-5620-2013; Zapatka, Marc/G-9896-2013; Malkin, David/AAW-8715-2021; Pfister, Stefan M/F-6860-2013; Shih, David J H/H-3186-2011; Korbel, Jan O/G-6470-2012; Wasserman, JD/AAF-8145-2019; Hawkins, Cynthia/M-2571-2019; Jones, David T. W./Z-1963-2019; Witt, Hendrik/L-7810-2015; Kool, Marcel/H-2541-2013; Wasserman, Jonathan D/M-4298-2013; Shih, David J. H./AAE-8726-2019; Weischenfeldt, Joachim/O-3681-2015; Eils, Roland/B-6121-2009	Rausch, Tobias/0000-0001-5773-5620; Jones, David TW/0000-0002-2036-5141; Döhner, Hartmut/0000-0003-2116-5536; Northcott, Paul A/0000-0002-1220-5252; Koster, Jan/0000-0002-0890-7585; von Deimling, Andreas/0000-0002-5863-540X; Brors, Benedikt/0000-0001-5940-3101; Zapatka, Marc/0000-0001-8287-5967; Pfister, Stefan M/0000-0002-5447-5322; Shih, David J H/0000-0002-9802-4937; Korbel, Jan O/0000-0002-2798-3794; Wasserman, JD/0000-0001-7088-8146; Wasserman, Jonathan D/0000-0001-7088-8146; Shih, David J. H./0000-0002-9802-4937; Weischenfeldt, Joachim/0000-0002-3917-5524; Eils, Roland/0000-0002-0034-4036; Taylor, Michael/0000-0001-7009-3466; Stuetz, Adrian/0000-0001-7650-3470; Bullinger, Lars/0000-0002-5890-5510; Benes, Vladimir/0000-0002-0352-2547; Versteeg, Rogier/0000-0001-7172-0388; Zichner, Thomas/0000-0001-9848-7598; Korshunov, Andrey/0000-0002-5257-3623; Wang, Qi/0000-0002-6420-1720; Remke, Marc/0000-0002-9404-9993; Jaeger, Natalie/0000-0002-9589-7580; Tabori, Uri/0000-0002-5019-2683; Tica, Jelena/0000-0001-9036-4083	German Cancer Aid [109252]; BMBF [01GS0871]; European Commission [Health-F2-2010-260791]; NIH [R01CA148699b]; Pediatric Brain Tumor Foundation; Canadian Institutes for Health Research [MOP-97834]; German Research Foundation [BU 1339/3-1, KO 4037/1-1]; NATIONAL CANCER INSTITUTE [R01CA148699] Funding Source: NIH RePORTER	German Cancer Aid(Deutsche Krebshilfe); BMBF(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); German Research Foundation(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Bettina Haase, David Ibbertsen, and Dinko Pavlinic from the EMBL GeneCore sequencing team for excellent support; and Matthias Hentze and Lars Steinmetz for valuable comments on earlier versions of the manuscript. High-performance computing facilities at EMBL and DKFZ supported the study technically. The project was supported by grants from the German Cancer Aid (109252) and the BMBF (ICGC "PedBrain" Tumor Project; to P.L., S.M.P., A.K., R.E., B.B., O.W., and J.O.K.; and 01GS0871; to L.B., K.D., and H.D.), the European Commission (Health-F2-2010-260791, to J.O.K.), the NIH (R01CA148699b) and the Pediatric Brain Tumor Foundation (to M.D.T.), the Canadian Institutes for Health Research (MOP-97834, to D.M.), and the German Research Foundation (BU 1339/3-1, to L.B., and KO 4037/1-1, to J.O.K.).	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Buhren J, 2000, J NEUROPATH EXP NEUR, V59, P229; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dahm-Daphi J, 2005, ONCOGENE, V24, P1663, DOI 10.1038/sj.onc.1208396; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Haferlach C, 2008, LEUKEMIA, V22, P1539, DOI 10.1038/leu.2008.143; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Howarth KD, 2011, GENOME RES, V21, P525, DOI 10.1101/gr.114116.110; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Ishida Y, 2010, CARCINOGENESIS, V31, P1694, DOI 10.1093/carcin/bgq145; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Meyerson M, 2011, CELL, V144, P9, DOI 10.1016/j.cell.2010.12.025; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mrozek K, 2008, SEMIN ONCOL, V35, P365, DOI 10.1053/j.seminoncol.2008.04.007; Northcott PA, 2011, ACTA NEUROPATHOL, V122, P231, DOI 10.1007/s00401-011-0846-7; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Parkin B, 2010, BLOOD, V116, P4958, DOI 10.1182/blood-2010-01-266999; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pfaff E, 2010, J CLIN ONCOL, V28, P5188, DOI 10.1200/JCO.2010.31.1670; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Remke M, 2011, J CLIN ONCOL, V29, P3852, DOI 10.1200/JCO.2011.36.2798; Rieber J, 2009, GENE CHROMOSOME CANC, V48, P558, DOI 10.1002/gcc.20665; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Storlazzi CT, 2010, GENOME RES, V20, P1198, DOI 10.1101/gr.106252.110; Tabori U, 2007, CANCER RES, V67, P1415, DOI 10.1158/0008-5472.CAN-06-3682; Taylor MD, 2000, NEUROSURGERY, V47, P888, DOI 10.1097/00006123-200010000-00020; Thanasoula M, 2010, CURR BIOL, V20, P521, DOI 10.1016/j.cub.2010.01.046; Trkova M, 2007, CANCER, V110, P694, DOI 10.1002/cncr.22834; Tusell L, 2010, BIOCHEM SOC T, V38, P1698, DOI 10.1042/BST0381698; Villani A, 2011, LANCET ONCOL, V12, P559, DOI 10.1016/S1470-2045(11)70119-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Waszak SM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000988; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	53	578	594	1	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					59	71		10.1016/j.cell.2011.12.013	http://dx.doi.org/10.1016/j.cell.2011.12.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265402	Green Accepted, Bronze			2022-12-24	WOS:000299540700014
J	Zhang, JH; Benavente, CA; McEvoy, J; Flores-Otero, J; Ding, L; Chen, X; Ulyanov, A; Wu, G; Wilson, M; Wang, JM; Brennan, R; Rusch, M; Manning, AL; Ma, J; Easton, J; Shurtleff, S; Mullighan, C; Pounds, S; Mukatira, S; Gupta, P; Neale, G; Zhao, D; Lu, C; Fulton, RS; Fulton, LL; Hong, X; Dooling, DJ; Ochoa, K; Naeve, C; Dyson, NJ; Mardis, ER; Bahrami, A; Ellison, D; Wilson, RK; Downing, JR; Dyer, MA				Zhang, Jinghui; Benavente, Claudia A.; McEvoy, Justina; Flores-Otero, Jacqueline; Ding, Li; Chen, Xiang; Ulyanov, Anatoly; Wu, Gang; Wilson, Matthew; Wang, Jianmin; Brennan, Rachel; Rusch, Michael; Manning, Amity L.; Ma, Jing; Easton, John; Shurtleff, Sheila; Mullighan, Charles; Pounds, Stanley; Mukatira, Suraj; Gupta, Pankaj; Neale, Geoff; Zhao, David; Lu, Charles; Fulton, Robert S.; Fulton, Lucinda L.; Hong, Xin; Dooling, David J.; Ochoa, Kerri; Naeve, Clayton; Dyson, Nicholas J.; Mardis, Elaine R.; Bahrami, Armita; Ellison, David; Wilson, Richard K.; Downing, James R.; Dyer, Michael A.			A novel retinoblastoma therapy from genomic and epigenetic analyses	NATURE			English	Article							TYROSINE KINASE; SYK INHIBITOR; CANCER; ANEUPLOIDY; GROWTH; CELLS; TUMOR; MCL-1; GENE	Retinoblastoma is an aggressive childhood cancer of the developing retina that is initiated by the biallelic loss of RB1. Tumours progress very quickly following RB1 inactivation but the underlying mechanism is not known. Here we show that the retinoblastoma genome is stable, but that multiple cancer pathways can be epigenetically deregulated. To identify the mutations that cooperate with RB1 loss, we performed whole-genome sequencing of retinoblastomas. The overall mutational rate was very low; RB1 was the only known cancer gene mutated. We then evaluated the role of RB1 in genome stability and considered non-genetic mechanisms of cancer pathway deregulation. For example, the proto-oncogene SYK is upregulated in retinoblastoma and is required for tumour cell survival. Targeting SYK with a small-molecule inhibitor induced retinoblastoma tumour cell death in vitro and in vivo. Thus, retinoblastomas may develop quickly as a result of the epigenetic deregulation of key cancer pathways as a direct or indirect result of RB1 loss.	[Benavente, Claudia A.; McEvoy, Justina; Flores-Otero, Jacqueline; Brennan, Rachel; Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Zhang, Jinghui; Chen, Xiang; Ulyanov, Anatoly; Wu, Gang; Rusch, Michael; Easton, John] St Jude Childrens Res Hosp, Dept Computat Biol & Bioinformat, Memphis, TN 38105 USA; [Ding, Li; Lu, Charles; Fulton, Robert S.; Fulton, Lucinda L.; Hong, Xin; Dooling, David J.; Ochoa, Kerri; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Fulton, Robert S.; Fulton, Lucinda L.; Hong, Xin; Dooling, David J.; Ochoa, Kerri; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Dept Genet, St Louis, MO 63108 USA; [Wilson, Matthew; Dyer, Michael A.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA; [Wilson, Matthew] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Wang, Jianmin; Mukatira, Suraj; Gupta, Pankaj; Neale, Geoff] St Jude Childrens Res Hosp, Hartwell Ctr Biotechnol & Bioinformat, Memphis, TN 38105 USA; [Manning, Amity L.; Dyson, Nicholas J.] Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Ma, Jing; Shurtleff, Sheila; Mullighan, Charles; Bahrami, Armita; Ellison, David; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Pounds, Stanley] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Zhao, David; Naeve, Clayton] St Jude Childrens Res Hosp, Dept Informat Sci, Memphis, TN 38105 USA; [Mardis, Elaine R.] Washington Univ, Sch Med St Louis, Siteman Canc Ctr, St Louis, MO 63108 USA; [Wilson, Richard K.] Washington Univ, Sch Med St Louis, Dept Med, St Louis, MO 63108 USA; [Dyer, Michael A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Harvard University; Massachusetts General Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Saint Louis University; Siteman Cancer Center; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Howard Hughes Medical Institute	Dyer, MA (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	rwilson@wustl.edu; james.downing@stjude.org; michael.dyer@stjude.org	Mardis, Elaine/W-2202-2019; Bahrami, Armita/N-3262-2018; Zhang, Jing/GWZ-7332-2022; Pounds, Stanley B/N-2480-2018; Rusch, Michael/AAG-1998-2019; Manning, Amity/AAC-8205-2019; Wu, Gang/M-8012-2014; Wilson, Richard K./AAF-4139-2019; wang, jian/GVS-0711-2022; Downing, James R./N-8102-2018; Mullighan, Charles/H-3253-2011; Chen, Xiang/N-2524-2018; Dyer, Michael/N-8134-2018	Bahrami, Armita/0000-0002-8515-2649; Pounds, Stanley B/0000-0002-9167-2114; Rusch, Michael/0000-0002-5363-1848; Manning, Amity/0000-0003-1332-9086; Wu, Gang/0000-0002-1678-5864; Wilson, Richard K./0000-0002-1992-1358; Mullighan, Charles/0000-0002-1871-1850; Chen, Xiang/0000-0002-2499-8261; McEvoy, Justina/0000-0003-0382-1288; Benavente, Claudia/0000-0002-6875-3186; Easton, John/0000-0003-4503-6608	St Jude Children's Research Hospital - Washington University; St Jude Children's Research Hospital; NCI [CA21765]; NIH [EY014867, EY018599, GM81607, CA64402]; American Cancer Society; Research to Prevent Blindness Foundation; American Lebanese Syrian Associated Charities; MGH Cancer Center Saltonstall Foundation; AstraZeneca; NATIONAL CANCER INSTITUTE [R01CA064402, P30CA021765, R01CA155202] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014867, R01EY018599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081607] Funding Source: NIH RePORTER	St Jude Children's Research Hospital - Washington University; St Jude Children's Research Hospital; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); MGH Cancer Center Saltonstall Foundation; AstraZeneca(AstraZeneca); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The WGS was supported as part of the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project. We thank J. Lahti, J. Dalton and M. Valentine for help with FISH analysis, L. Holmfeldt, J. Zhang and M. Barbato for help with sample preparation, and V. Valentine for spectral karyotype analysis. We thank I. Qaddoumi, C. Rodriguez-Galindo and B. Haik for the support of the St Jude Children's Research Hospital retinoblastoma clinical research and W. Lei, D. McGoldrick, D. Alford, S. Espy, J. Obenauer and K. Johnson for assistance with data acquisition, handling and analysis. We thank A. McArthur and C. Guess for editing the manuscript, J. Temirov for help with sister chromatid analysis, J. Thurman for help with histology, F. Krafcik for help with cell culture, J. Wu and C. Billups for statistical analysis, J. Jeon for help with lentiviral preparations and C. Bradley for assistance with preclinical testing. This work was supported, in part, by Cancer Center Support (CA21765) from the NCI; grants to M. A. D. from the NIH (EY014867 and EY018599), the American Cancer Society and the Research to Prevent Blindness Foundation; and the American Lebanese Syrian Associated Charities. M. A. D. is a Howard Hughes Medical Institute Early Career Scientist. This work was also supported by an American Cancer Society Fellowship to A. L. M., the MGH Cancer Center Saltonstall Foundation Scholarship to N.J.D. and funding from AstraZeneca and NIH grants GM81607 and CA64402 to N.J.D.	Amato A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-79; Baudot AD, 2009, ONCOGENE, V28, P3261, DOI 10.1038/onc.2009.179; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998b; Bourgo RJ, 2009, MOL BIOL CELL, V20, P3192, DOI 10.1091/mbc.E08-12-1224; Brennan RC, 2011, CANCER RES, V71, P4205, DOI 10.1158/0008-5472.CAN-11-0058; Buchner M, 2010, BLOOD, V115, P4497, DOI 10.1182/blood-2009-07-233692; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Corson TW, 2007, GENE CHROMOSOME CANC, V46, P617, DOI 10.1002/gcc.20457; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feldman AL, 2008, LEUKEMIA, V22, P1139, DOI 10.1038/leu.2008.77; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gobessi S, 2009, LEUKEMIA, V23, P686, DOI 10.1038/leu.2008.346; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Iovino F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-38; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Laird PW, 2005, HUM MOL GENET, V14, pR65, DOI 10.1093/hmg/ddi113; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Manning AL, 2010, GENE DEV, V24, P1364, DOI 10.1101/gad.1917310; McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005; SQUIRE J, 1985, HUM GENET, V70, P291, DOI 10.1007/BF00295364; Suljagic M, 2010, BLOOD, V116, P4894, DOI 10.1182/blood-2010-03-275180; Weinblatt ME, 2010, NEW ENGL J MED, V363, P1303, DOI 10.1056/NEJMoa1000500; Wen H, 2008, GENE DEV, V22, P601, DOI 10.1101/gad.1626308; Yan Y, 2000, EUR J CANCER, V36, P221, DOI 10.1016/S0959-8049(99)00277-4; Young RM, 2009, BLOOD, V113, P2508, DOI 10.1182/blood-2008-05-158618	32	342	358	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					329	334		10.1038/nature10733	http://dx.doi.org/10.1038/nature10733			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22237022	Green Accepted, Green Submitted, hybrid			2022-12-24	WOS:000299210600035
J	Zhang, JH; Ding, L; Holmfeldt, L; Wu, G; Heatley, SL; Payne-Turner, D; Easton, J; Chen, X; Wang, JM; Rusch, M; Lu, C; Chen, SC; Wei, L; Collins-Underwood, JR; Ma, J; Roberts, KG; Pounds, SB; Ulyanov, A; Becksfort, J; Gupta, P; Huether, R; Kriwacki, RW; Parker, M; McGoldrick, DJ; Zhao, D; Alford, D; Espy, S; Bobba, KC; Song, GC; Pei, DQ; Cheng, C; Roberts, S; Barbato, MI; Campana, D; Coustan-Smith, E; Shurtleff, SA; Raimondi, SC; Kleppe, M; Cools, J; Shimano, KA; Hermiston, ML; Doulatov, S; Eppert, K; Laurenti, E; Notta, F; Dick, JE; Basso, G; Hunger, SP; Loh, ML; Devidas, M; Wood, B; Winter, S; Dunsmore, KP; Fulton, RS; Fulton, LL; Hong, X; Harris, CC; Dooling, DJ; Ochoa, K; Johnson, KJ; Obenauer, JC; Evans, WE; Pui, CH; Naeve, CW; Ley, TJ; Mardis, ER; Wilson, RK; Downing, JR; Mullighan, CG				Zhang, Jinghui; Ding, Li; Holmfeldt, Linda; Wu, Gang; Heatley, Sue L.; Payne-Turner, Debbie; Easton, John; Chen, Xiang; Wang, Jianmin; Rusch, Michael; Lu, Charles; Chen, Shann-Ching; Wei, Lei; Collins-Underwood, J. Racquel; Ma, Jing; Roberts, Kathryn G.; Pounds, Stanley B.; Ulyanov, Anatoly; Becksfort, Jared; Gupta, Pankaj; Huether, Robert; Kriwacki, Richard W.; Parker, Matthew; McGoldrick, Daniel J.; Zhao, David; Alford, Daniel; Espy, Stephen; Bobba, Kiran Chand; Song, Guangchun; Pei, Deqing; Cheng, Cheng; Roberts, Stefan; Barbato, Michael I.; Campana, Dario; Coustan-Smith, Elaine; Shurtleff, Sheila A.; Raimondi, Susana C.; Kleppe, Maria; Cools, Jan; Shimano, Kristin A.; Hermiston, Michelle L.; Doulatov, Sergei; Eppert, Kolja; Laurenti, Elisa; Notta, Faiyaz; Dick, John E.; Basso, Giuseppe; Hunger, Stephen P.; Loh, Mignon L.; Devidas, Meenakshi; Wood, Brent; Winter, Stuart; Dunsmore, Kimberley P.; Fulton, Robert S.; Fulton, Lucinda L.; Hong, Xin; Harris, Christopher C.; Dooling, David J.; Ochoa, Kerri; Johnson, Kimberly J.; Obenauer, John C.; Evans, William E.; Pui, Ching-Hon; Naeve, Clayton W.; Ley, Timothy J.; Mardis, Elaine R.; Wilson, Richard K.; Downing, James R.; Mullighan, Charles G.			The genetic basis of early T-cell precursor acute lymphoblastic leukaemia	NATURE			English	Article							ACTIVATING FLT3 MUTATIONS; RAS; REARRANGEMENT; EXPRESSION; CRLF2; RUNX1; ETV6	Early T-cell precursor acute lymphoblastic leukaemia (ETP ALL) is an aggressive malignancy of unknown genetic basis. We performed whole-genome sequencing of 12 ETP ALL cases and assessed the frequency of the identified somatic mutations in 94 T-cell acute lymphoblastic leukaemia cases. ETP ALL was characterized by activating mutations in genes regulating cytokine receptor and RAS signalling (67% of cases; NRAS, KRAS, FLT3, IL7R, JAK3, JAK1, SH2B3 and BRAF), inactivating lesions disrupting haematopoietic development (58%; GATA3, ETV6, RUNX1, IKZF1 and EP300) and histone-modifying genes (48%; EZH2, EED, SUZ12, SETD2 and EP300). We also identified new targets of recurrent mutation including DNM2, ECT2L and RELN. The mutational spectrum is similar to myeloid tumours, and moreover, the global transcriptional profile of ETP ALL was similar to that of normal and myeloid leukaemia haematopoietic stem cells. These findings suggest that addition of myeloid-directed therapies might improve the poor outcome of ETP ALL.	[Holmfeldt, Linda; Heatley, Sue L.; Payne-Turner, Debbie; Chen, Shann-Ching; Wei, Lei; Collins-Underwood, J. Racquel; Ma, Jing; Roberts, Kathryn G.; Song, Guangchun; Shurtleff, Sheila A.; Raimondi, Susana C.; Downing, James R.; Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Zhang, Jinghui; Wu, Gang; Chen, Xiang; Rusch, Michael; Ulyanov, Anatoly; Huether, Robert] St Jude Childrens Res Hosp, Dept Computat Biol & Bioinformat, Memphis, TN 38105 USA; [Ding, Li; Lu, Charles; Fulton, Robert S.; Fulton, Lucinda L.; Hong, Xin; Harris, Christopher C.; Dooling, David J.; Ochoa, Kerri; Johnson, Kimberly J.; Ley, Timothy J.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Fulton, Robert S.; Fulton, Lucinda L.; Dooling, David J.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Dept Genet, Sch Med, St Louis, MO 63110 USA; [Easton, John; Parker, Matthew; Roberts, Stefan; Barbato, Michael I.] St Jude Childrens Res Hosp, Pediat Canc Genome Project Lab, Memphis, TN 38105 USA; [Wang, Jianmin; Becksfort, Jared; Gupta, Pankaj; McGoldrick, Daniel J.; Zhao, David; Alford, Daniel; Espy, Stephen; Bobba, Kiran Chand; Obenauer, John C.; Naeve, Clayton W.] St Jude Childrens Res Hosp, Dept Informat Sci, Memphis, TN 38105 USA; [Pounds, Stanley B.; Pei, Deqing; Cheng, Cheng] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Huether, Robert; Kriwacki, Richard W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Campana, Dario; Coustan-Smith, Elaine; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Kleppe, Maria; Cools, Jan] Katholieke Univ Leuven, Dept Mol & Dev Genet, Ctr Human Genet, VIB, B-3000 Louvain, Belgium; [Shimano, Kristin A.; Hermiston, Michelle L.; Loh, Mignon L.] Univ Calif San Francisco, Dept Pediat, Sch Med, San Francisco, CA 94143 USA; [Doulatov, Sergei; Eppert, Kolja; Laurenti, Elisa; Notta, Faiyaz; Dick, John E.] Univ Hlth Network, Dept Stem Cell & Dev Biol, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Doulatov, Sergei; Eppert, Kolja; Laurenti, Elisa; Notta, Faiyaz] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Basso, Giuseppe] Univ Padua, Oncohematol Lab, Dept Pediat, I-35122 Padua, Italy; [Hunger, Stephen P.] Univ Colorado, Sect Pediat Hematol Oncol Bone Marrow Transplanta, Aurora, CO 80045 USA; [Hunger, Stephen P.] Univ Colorado, Ctr Canc & Blood Disorders, Denver Sch Med, Childrens Hosp Colorado, Aurora, CO 80045 USA; [Devidas, Meenakshi] Univ Florida, Dept Biostat, Coll Med, Gainesville, FL 32603 USA; [Wood, Brent] Seattle Childrens Hosp, Dept Lab Med, Seattle, WA 98105 USA; [Winter, Stuart] Univ New Mexico, Albuquerque, NM 87131 USA; [Dunsmore, Kimberley P.] Univ Virginia, Charlottesville, VA 22903 USA; [Evans, William E.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Ley, Timothy J.] Washington Univ, Div Oncol, St Louis, MO 63110 USA; [Ley, Timothy J.] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Padua; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; University of Florida; Seattle Children's Hospital; University of New Mexico; University of Virginia; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Downing, JR (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.downing@stjude.org; charles.mullighan@stjude.org	wang, jian/GVS-0711-2022; Rusch, Michael/AAG-1998-2019; Kleppe, Maria/C-6341-2014; Wu, Gang/M-8012-2014; Pounds, Stanley B/N-2480-2018; Huether, Robert/E-9638-2012; Espy, Stephen/GXN-2069-2022; Mullighan, Charles/H-3253-2011; Zhang, Jing/GWZ-7332-2022; Wilson, Richard K./AAF-4139-2019; Ganesh, Dunna Sai/AGX-5170-2022; Evans, William E./C-2069-2012; Downing, James R./N-8102-2018; Mardis, Elaine/W-2202-2019; Cheng, Cheng/N-8075-2018; Raimondi, Susana C/N-8166-2018; Heatley, Susan/AGP-2179-2022; Kriwacki, Richard/N-8154-2018; Pui, Ching-Hon/N-8076-2018; Devidas, Meenakshi/H-1170-2019; Chen, Xiang/N-2524-2018; Espy, Stephen/A-9823-2016	Rusch, Michael/0000-0002-5363-1848; Kleppe, Maria/0000-0002-4372-6704; Wu, Gang/0000-0002-1678-5864; Pounds, Stanley B/0000-0002-9167-2114; Huether, Robert/0000-0001-7077-7470; Mullighan, Charles/0000-0002-1871-1850; Wilson, Richard K./0000-0002-1992-1358; Evans, William E./0000-0002-9333-5322; Kriwacki, Richard/0000-0002-9798-6018; Pui, Ching-Hon/0000-0003-0303-5658; Devidas, Meenakshi/0000-0002-1099-3478; Chen, Xiang/0000-0002-2499-8261; Espy, Stephen/0000-0003-0698-914X; Easton, John/0000-0003-4503-6608; Parker, Matthew/0000-0003-2999-3870; Cools, Jan/0000-0001-6626-5843; Dunsmore, Kimberly/0000-0002-6631-5174; Holmfeldt, Linda/0000-0003-4140-3423; Dick, John/0000-0002-9527-8317; Eppert, Kolja/0000-0001-9061-8856; Loh, Mignon/0000-0003-4099-4700; Heatley, Susan/0000-0001-7497-6477; Laurenti, Elisa/0000-0002-9917-9092; BASSO, GIUSEPPE/0000-0002-2634-9302	St Jude Children's Research Hospital; The Genome Institute and Siteman Cancer Center at Washington University in St Louis; The St Jude Children's Research Hospital-Washington University Pediatric Cancer; ALSAC of St JudeChildren's Research Hospital; Cancer Center [P30CA021765]; Washington University in St Louis [NIHU 01GM92666-PAAR4Kids]; National Human Genome Research Institute (NHGRI) [U54 HG003079]; NCI [CA98543, CA98413, CA114766]; Alex's Lemonade Stand; St. Baldrick's Foundation; Haematology Society of Australasia; New Zealand New Investigator Scholarship; NATIONAL CANCER INSTITUTE [R25CA023944, U10CA098543, U24CA114766, U10CA098413, P30CA021765] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092666] Funding Source: NIH RePORTER	St Jude Children's Research Hospital; The Genome Institute and Siteman Cancer Center at Washington University in St Louis; The St Jude Children's Research Hospital-Washington University Pediatric Cancer; ALSAC of St JudeChildren's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Cancer Center; Washington University in St Louis; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alex's Lemonade Stand; St. Baldrick's Foundation; Haematology Society of Australasia; New Zealand New Investigator Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the many members of St Jude Children's Research Hospital and The Genome Institute and Siteman Cancer Center at Washington University in St Louis for support. We thank H. Mulder for project sample management, M. Stine for assistance with data deposition, B. Pappas and S. Malone for information technology infrastructure, J. Morris, E. Walker, A. Merriman and G. Neale for performing single-nucleotide polymorphism and gene expression microarrays, W. Yang for assistance with analysis of genomic data, and J. Stokes for artwork. We thank the Tissue Resources Laboratory, the Flow Cytometry and Cell Sorting Core, and the Clinical Applications of Core Technology Laboratories of the Hartwell Center for Bioinformatics and Biotechnology of St Jude Children's Research Hospital. We thank S. Kehoe of Beckman Coulter Genomics for assistance with Sanger sequencing. This work was funded by The St Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project, ALSAC of St JudeChildren's Research Hospital, Cancer Center support grant P30CA021765, NIHU 01GM92666-PAAR4Kids, grants to R. K. W. from Washington University in St Louis and the National Human Genome Research Institute (NHGRI U54 HG003079), grants to the Children's Oncology Group (NCI CA98543, CA98413, CA114766), and grants from Alex's Lemonade Stand and St. Baldrick's Foundation (to M. L. H.). S. L. H. was supported by a Haematology Society of Australasia and New Zealand New Investigator Scholarship. S. P. H. is the Ergen Family Chair in Pediatric Cancer. C. G. M. is a Pew Scholar in the Biomedical Sciences and a St. Baldrick's Scholar.	Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Dicker F, 2010, LEUKEMIA, V24, P1528, DOI 10.1038/leu.2010.124; DOWNING JR, 1993, BLOOD, V81, P2860; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Gaidzik VI, 2011, J CLIN ONCOL, V29, P1364, DOI 10.1200/JCO.2010.30.7926; Gelsi-Boyer V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-299; Gilliland DG, 2002, SEMIN HEMATOL, V39, P6, DOI 10.1053/shem.2002.36921; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Kawamura M, 1999, LEUKEMIA RES, V23, P115, DOI 10.1016/S0145-2126(98)00146-5; Kleppe M, 2011, HAEMATOL-HEMATOL J, V96, P779, DOI 10.3324/haematol.2010.035931; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Malinge S, 2008, BLOOD, V112, P4220, DOI 10.1182/blood-2008-01-136366; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Neumann M, 2010, BLOOD, V116, P453, DOI 10.1182/blood.V116.21.1031.1031; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Paietta E, 2004, BLOOD, V104, P558, DOI 10.1182/blood-2004-01-0168; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Shurtleff SA, 1995, LEUKEMIA, V9, P1985; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; van Doorn-Khosrovani SBV, 2005, ONCOGENE, V24, P4129, DOI 10.1038/sj.onc.1208588; Van Vlierberghe P, 2005, BLOOD, V106, P4414, DOI 10.1182/blood-2005-06-2267; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117; Yokota S, 1998, INT J HEMATOL, V67, P379; Zahirieh A, 2005, J CLIN ENDOCR METAB, V90, P2445, DOI 10.1210/jc.2004-1969; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	43	1095	1130	4	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2012	481	7380					157	163		10.1038/nature10725	http://dx.doi.org/10.1038/nature10725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22237106	hybrid, Green Accepted			2022-12-24	WOS:000298981200029
J	Feklistov, A; Darst, SA				Feklistov, Andrey; Darst, Seth A.			Structural Basis for Promoter-10 Element Recognition by the Bacterial RNA Polymerase sigma Subunit	CELL			English	Article							ESCHERICHIA-COLI SIGMA(70); OPEN COMPLEX-FORMATION; SINGLE-STRANDED-DNA; TRANSCRIPTION INITIATION; NONTEMPLATE STRAND; CONSERVED REGION-2; BACILLUS-SUBTILIS; MELTING REGION; SEQUENCE LOGOS; AMINO-ACIDS	The key step in bacterial promoter opening is recognition of the -10 promoter element (T(-12)A(-11)T(-10)A(-9) A(-8)T(-7) consensus sequence) by the RNA polymerase sigma subunit. We determined crystal structures of sigma domain 2 bound to single-stranded DNA bearing -10 element sequences. Extensive interactions occur between the protein and the DNA backbone of every -10 element nucleotide. Base-specific interactions occur primarily with A(-11) and T-7, which are flipped out of the single-stranded DNA base stack and buried deep in protein pockets. The structures, along with biochemical data, support a model where the recognition of the -10 element sequence drives initial promoter opening as the bases of the nontemplate strand are extruded from the DNA double-helix and captured by sigma. These results provide a detailed structural basis for the critical roles of A(-11) and T-7 in promoter melting and reveal important insights into the initiation of transcription bubble formation.	[Feklistov, Andrey; Darst, Seth A.] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Feklistov, A (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	afeklistov@rockefeller.edu; darst@rockefeller.edu			US Department of Energy, Office of Basic Energy Sciences; NCRR at the NIH [RR-15301]; NIH [RO1 GM053759]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053759] Funding Source: NIH RePORTER	US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NCRR at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Shultzaberger and T. Schneider for providing Figure 1B and for helpful discussions; P. deHaseth, A. Kulbachinskiy, S. Malik, A. Mustaev, R. Saecker, and M. Schapira for helpful discussions; K.R. Rajashankar and F. Murphy at APS NE-CAT beamline 24ID-E and W. Shi at NSLS beamline X29 for support with synchrotron data collection; and R. MacKinnon for use of the fluorescence plate-reader. A.F. is a Merck Postdoctoral Fellow at The Rockefeller University. This work was based, in part, on research conducted at the APS and the NSLS, supported by the US Department of Energy, Office of Basic Energy Sciences. The NE-CAT beamlines at the APS are supported by award RR-15301 from the NCRR at the NIH. This work was supported by NIH RO1 GM053759 to S.A.D.	Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Chen J, 2010, P NATL ACAD SCI USA, V107, P12523, DOI 10.1073/pnas.1003533107; CHEN YF, 1995, J MOL BIOL, V249, P743, DOI 10.1006/jmbi.1995.0333; CHEONG C, 1988, NUCLEIC ACIDS RES, V16, P5115, DOI 10.1093/nar/16.11.5115; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Davis CA, 2007, P NATL ACAD SCI USA, V104, P7833, DOI 10.1073/pnas.0609888104; DEHASETH PL, 1995, MOL MICROBIOL, V16, P817, DOI 10.1111/j.1365-2958.1995.tb02309.x; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; DREW HR, 1985, EMBO J, V4, P1025, DOI 10.1002/j.1460-2075.1985.tb03734.x; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Fenton MS, 2001, P NATL ACAD SCI USA, V98, P9020, DOI 10.1073/pnas.161085798; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; Fenton MS, 2003, J BIOL CHEM, V278, P39669, DOI 10.1074/jbc.M307412200; Fenton MS, 2003, NUCLEIC ACIDS RES, V31, P2745, DOI 10.1093/nar/gkg400; Gruber TM, 1997, J BACTERIOL, V179, P1734, DOI 10.1128/jb.179.5.1734-1747.1997; Gueron M, 1995, METHOD ENZYMOL, V261, P383; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; Heyduk E, 2006, J BIOL CHEM, V281, P12362, DOI 10.1074/jbc.M601364200; Hoffman MM, 2004, NUCLEIC ACIDS RES, V32, pD174, DOI 10.1093/nar/gkh128; Hook-Barnard IG, 2007, GENE REGUL SYST BIO, V1, P275; JOHNSRUD L, 1978, P NATL ACAD SCI USA, V75, P5314, DOI 10.1073/pnas.75.11.5314; JUANG YL, 1994, J MOL BIOL, V235, P1470, DOI 10.1006/jmbi.1994.1102; KENNEY TJ, 1989, P NATL ACAD SCI USA, V86, P9109, DOI 10.1073/pnas.86.23.9109; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lane WJ, 2010, J MOL BIOL, V395, P671, DOI 10.1016/j.jmb.2009.10.062; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lee HJ, 2004, J BIOL CHEM, V279, P16899, DOI 10.1074/jbc.C400054200; Lim HM, 2001, P NATL ACAD SCI USA, V98, P14849, DOI 10.1073/pnas.261517398; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Matlock DL, 2000, BIOCHEMISTRY-US, V39, P12274, DOI 10.1021/bi001433h; Mekler V, 2011, J BIOL CHEM, V286, P270, DOI 10.1074/jbc.M110.174102; MOYLE H, 1991, J BACTERIOL, V173, P1944, DOI 10.1128/jb.173.6.1944-1950.1991; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Niedziela-Majka A, 2005, J BIOL CHEM, V280, P38219, DOI 10.1074/jbc.M507984200; Nikolov DB, 1997, P NATL ACAD SCI USA, V94, P15, DOI 10.1073/pnas.94.1.15; PRIBNOW D, 1975, P NATL ACAD SCI USA, V72, P784, DOI 10.1073/pnas.72.3.784; Protozanova E, 2004, J MOL BIOL, V342, P775, DOI 10.1016/j.jmb.2004.07.075; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Roberts CW, 1996, CELL, V86, P495; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Saecker RM, 2002, J MOL BIOL, V319, P649, DOI 10.1016/S0022-2836(02)00293-0; SAVINKOVA L K, 1988, Molekulyarnaya Biologiya (Moscow), V22, P807; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schneider TD, 2001, NUCLEIC ACIDS RES, V29, P4881, DOI 10.1093/nar/29.23.4881; Schroeder LA, 2008, J MOL BIOL, V376, P153, DOI 10.1016/j.jmb.2007.11.070; Schroeder LA, 2007, NUCLEIC ACIDS RES, V35, P4141, DOI 10.1093/nar/gkm431; Schroeder LA, 2009, J MOL BIOL, V385, P339, DOI 10.1016/j.jmb.2008.10.023; Severinova E, 1996, J MOL BIOL, V263, P637, DOI 10.1006/jmbi.1996.0604; Sevostyanova A, 2007, J BIOL CHEM, V282, P22033, DOI 10.1074/jbc.M702495200; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; SPASSKY A, 1988, EMBO J, V7, P1871, DOI 10.1002/j.1460-2075.1988.tb03020.x; SPASSKY A, 1985, BIOCHEMISTRY-US, V24, P2723, DOI 10.1021/bi00332a019; Tomsic M, 2001, J BIOL CHEM, V276, P31891, DOI 10.1074/jbc.M105027200; Tsujikawa L, 2002, BIOCHEMISTRY-US, V41, P15334, DOI 10.1021/bi026539m; WALDBURGER C, 1994, J MOL BIOL, V235, P1489, DOI 10.1006/jmbi.1994.1103; WALDBURGER C, 1990, J MOL BIOL, V215, P267, DOI 10.1016/S0022-2836(05)80345-6; Wintjens R, 2000, J MOL BIOL, V302, P395, DOI 10.1006/jmbi.2000.4040; Yang CG, 2009, CHEMBIOCHEM, V10, P417, DOI 10.1002/cbic.200800580; Young BA, 2004, SCIENCE, V303, P1382, DOI 10.1126/science.1092462; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zenkin N, 2007, EMBO J, V26, P955, DOI 10.1038/sj.emboj.7601555	71	225	231	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1257	1269		10.1016/j.cell.2011.10.041	http://dx.doi.org/10.1016/j.cell.2011.10.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22136875	Green Accepted, Bronze			2022-12-24	WOS:000298148100016
J	Navarrete, A; van Schaik, CP; Isler, K				Navarrete, Ana; van Schaik, Carel P.; Isler, Karin			Energetics and the evolution of human brain size	NATURE			English	Article							EXPENSIVE-TISSUE HYPOTHESIS; HOMININS; MAMMALS; BIRDS; INTELLIGENCE; VERTEBRATES; METABOLISM; PRIMATES; SYSTEM; COSTS	The human brain stands out among mammals by being unusually large. The expensive-tissue hypothesis(1) explains its evolution by proposing a trade-off between the size of the brain and that of the digestive tract, which is smaller than expected for a primate of our body size. Although this hypothesis is widely accepted, empirical support so far has been equivocal. Here we test it in a sample of 100 mammalian species, including 23 primates, by analysing brain size and organ mass data. We found that, controlling for fat-free body mass, brain size is not negatively correlated with the mass of the digestive tract or any other expensive organ, thus refuting the expensive-tissue hypothesis. Nonetheless, consistent with the existence of energy trade-offs with brain size, we find that the size of brains and adipose depots are negatively correlated in mammals, indicating that encephalization and fat storage are compensatory strategies to buffer against starvation. However, these two strategies can be combined if fat storage does not unduly hamper locomotor efficiency. We propose that human encephalization was made possible by a combination of stabilization of energy inputs and a redirection of energy from locomotion, growth and reproduction.	[Navarrete, Ana; van Schaik, Carel P.; Isler, Karin] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland	University of Zurich	Navarrete, A (corresponding author), Univ Zurich, Anthropol Inst & Museum, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	a.navarrete@aim.uzh.ch; kisler@aim.uzh.ch	Isler, Karin/A-9566-2008	Isler, Karin/0000-0002-2391-1523; Navarrete, Ana F./0000-0001-6020-0678	Swiss National Science Foundation [3100A0-117789]; A.H. Schultz-Stiftung; European Integrated Activities grant SYNTHESYS [HU-TAF-4916]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); A.H. Schultz-Stiftung; European Integrated Activities grant SYNTHESYS	We thank R. D. Martin and J. Wermuth for sharing the Chivers data set, J. van Woerden for sharing her endocranial volume data, and M. Genoud for sharing his revised compilation of mammalian BMR values. Specimens were provided by numerous institutions, museums and colleagues (Supplementary Information 2). We acknowledge valuable comments by L. Aiello and R. D. Martin. Financial support was provided by the Swiss National Science Foundation (grant number 3100A0-117789), the A.H. Schultz-Stiftung and the European Integrated Activities grant SYNTHESYS (grant application number HU-TAF-4916).	Aiello LC, 2001, EVOLUTIONARY ANATOMY OF THE PRIMATE CEREBRAL CORTEX, P57; Aiello LC, 2002, ANNU REV ANTHROPOL, V31, P323, DOI 10.1146/annurev.anthro.31.040402.085403; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; [Anonymous], 2010, R LANG ENV STAT COMP; Bruhn JM, 1936, P AM ACAD ARTS SCI, V71, P259, DOI 10.2307/20023229; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; GARLAND T, 1983, AM NAT, V121, P571, DOI 10.1086/284084; Isler K, 2006, BIOL LETTERS, V2, P557, DOI 10.1098/rsbl.2006.0538; Isler K, 2006, J HUM EVOL, V51, P228, DOI 10.1016/j.jhevol.2006.03.006; Isler K, 2011, BIOESSAYS, V33, P173, DOI 10.1002/bies.201000123; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; Isler K, 2009, BIOL LETTERS, V5, P125, DOI 10.1098/rsbl.2008.0469; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; Jones KE, 2004, AM NAT, V164, pE20, DOI 10.1086/421334; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kaufman JA, 2003, CURR ANTHROPOL, V44, P705, DOI 10.1086/379258; MARTIN RD, 1981, NATURE, V293, P57, DOI 10.1038/293057a0; Mau M., 2009, BIOSCI HYPOTHESES, V2, P205; MINK JW, 1981, AM J PHYSIOL, V241, pR203, DOI 10.1152/ajpregu.1981.241.3.R203; Orme D., 2009, CAIC COMP ANAL USING; Pfefferle AD, 2011, J HUM EVOL, V60, P205, DOI 10.1016/j.jhevol.2010.10.004; Pitts G., 1968, NATL ACAD SCI PUBL, V1598, P45; Pond C.M., 1998, FATS LIFE; Pontzer H, 2010, J HUM EVOL, V58, P492, DOI 10.1016/j.jhevol.2010.03.006; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Reader SM, 2011, PHILOS T R SOC B, V366, P1017, DOI 10.1098/rstb.2010.0342; REHKAMPER G, 1991, BRAIN BEHAV EVOLUT, V37, P125, DOI 10.1159/000114353; Santoro Sérgio, 2006, Sao Paulo Med. J., V124, P192, DOI 10.1590/S1516-31802006000400004; Sol D, 2009, BIOL LETTERS, V5, P130, DOI 10.1098/rsbl.2008.0621; van Woerden JT, 2010, AM NAT, V176, P758, DOI 10.1086/657045; Wells J., 2009, EVOLUTIONARY BIOL HU; Wrangham RW, 2009, CATCHING FIRE COOKIN; Zihlman A.L., 1984, P179	35	286	288	4	270	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					91	U252		10.1038/nature10629	http://dx.doi.org/10.1038/nature10629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PO	22080949	Green Accepted			2022-12-24	WOS:000298031900040
J	Yokoyama, S; Woods, SL; Boyle, GM; Aoude, LG; MacGregor, S; Zismann, V; Gartside, M; Cust, AE; Haq, R; Harland, M; Taylor, JC; Duffy, DL; Holohan, K; Dutton-Regester, K; Palmer, JM; Bonazzi, V; Stark, MS; Symmons, J; Law, MH; Schmidt, C; Lanagan, C; O'Connor, L; Holland, EA; Schmid, H; Maskiell, JA; Jetann, J; Ferguson, M; Jenkins, MA; Kefford, RF; Giles, G; Armstrong, BK; Aitken, JF; Hopper, JL; Whiteman, DC; Pharoah, PD; Easton, DF; Dunning, AM; Newton-Bishop, JA; Montgomery, GW; Martin, NG; Mann, GJ; Bishop, DT; Tsao, H; Trent, JM; Fisher, DE; Hayward, NK; Brown, KM				Yokoyama, Satoru; Woods, Susan L.; Boyle, Glen M.; Aoude, Lauren G.; MacGregor, Stuart; Zismann, Victoria; Gartside, Michael; Cust, Anne E.; Haq, Rizwan; Harland, Mark; Taylor, John C.; Duffy, David L.; Holohan, Kelly; Dutton-Regester, Ken; Palmer, Jane M.; Bonazzi, Vanessa; Stark, Mitchell S.; Symmons, Judith; Law, Matthew H.; Schmidt, Christopher; Lanagan, Cathy; O'Connor, Linda; Holland, Elizabeth A.; Schmid, Helen; Maskiell, Judith A.; Jetann, Jodie; Ferguson, Megan; Jenkins, Mark A.; Kefford, Richard F.; Giles, GrahamG.; Armstrong, Bruce K.; Aitken, Joanne F.; Hopper, John L.; Whiteman, David C.; Pharoah, Paul D.; Easton, Douglas F.; Dunning, Alison M.; Newton-Bishop, Julia A.; Montgomery, Grant W.; Martin, Nicholas G.; Mann, Graham J.; Bishop, D. Timothy; Tsao, Hensin; Trent, Jeffrey M.; Fisher, David E.; Hayward, Nicholas K.; Brown, Kevin M.			A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CUTANEOUS MELANOMA; PHENOTYPIC CHARACTERISTICS; TRANSCRIPTION FACTOR; GERMLINE MUTATIONS; MELANOCYTIC NEVI; SUN EXPOSURE; RISK; VARIANTS; LINKAGE	So far, two genes associated with familial melanoma have been identified, accounting for a minority of genetic risk in families. Mutations in CDKN2A account for approximately 40% of familial cases(1), and predisposing mutations in CDK4 have been reported in a very small number of melanoma kindreds(2). Here we report the whole-genome sequencing of probands from several melanoma families, which we performed in order to identify other genes associated with familial melanoma. We identify one individual carrying a novel germline variant (coding DNA sequence c. G1075A; protein sequence p. E318K; rs149617956) in the melanoma-lineage-specific oncogene microphthalmia-associated transcription factor (MITF). Although the variant co-segregated with melanoma in some but not all cases in the family, linkage analysis of 31 families subsequently identified to carry the variant generated a log of odds (lod) score of 2.7 under a dominant model, indicating E318K as a possible intermediate risk variant. Consistent with this, the E318K variant was significantly associated with melanoma in a large Australian case-control sample. Likewise, it was similarly associated in an independent case-control sample from the United Kingdom. In the Australian sample, the variant allele was significantly over-represented in cases with a family history of melanoma, multiple primary melanomas, or both. The variant allele was also associated with increased naevus count and non-blue eye colour. Functional analysis of E318K showed that MITF encoded by the variant allele had impaired sumoylation and differentially regulated several MITF targets. These data indicate that MITF is a melanoma-predisposition gene and highlight the utility of whole-genome sequencing to identify novel rare variants associated with disease susceptibility.	[Zismann, Victoria; Trent, Jeffrey M.; Brown, Kevin M.] Translat Genom Res Inst, Phoenix, AZ 85004 USA; [Yokoyama, Satoru; Haq, Rizwan; Fisher, David E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr,Dept Dermatol, Boston, MA 02114 USA; [Woods, Susan L.; Boyle, Glen M.; Aoude, Lauren G.; MacGregor, Stuart; Gartside, Michael; Duffy, David L.; Holohan, Kelly; Dutton-Regester, Ken; Palmer, Jane M.; Bonazzi, Vanessa; Stark, Mitchell S.; Symmons, Judith; Law, Matthew H.; Schmidt, Christopher; Lanagan, Cathy; O'Connor, Linda; Whiteman, David C.; Montgomery, Grant W.; Martin, Nicholas G.; Hayward, Nicholas K.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Cust, Anne E.; Armstrong, Bruce K.] Univ Sydney, Sydney Med Sch, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Harland, Mark; Taylor, John C.; Newton-Bishop, Julia A.; Bishop, D. Timothy] St James Univ Hosp, Canc Res UK Clin Ctr Leeds, Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds LS9 7TF, W Yorkshire, England; [Holland, Elizabeth A.; Schmid, Helen; Kefford, Richard F.; Mann, Graham J.] Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Holland, Elizabeth A.; Schmid, Helen; Kefford, Richard F.; Mann, Graham J.] Melanoma Inst Australia, Westmead, NSW 2145, Australia; [Maskiell, Judith A.; Jenkins, Mark A.; Hopper, John L.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Parkville, Vic 3052, Australia; [Jetann, Jodie; Ferguson, Megan; Aitken, Joanne F.] Canc Council Queensland, Viertel Ctr Res Canc Control, Brisbane, Qld 4004, Australia; [Giles, GrahamG.] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic 3053, Australia; [Pharoah, Paul D.; Easton, Douglas F.; Dunning, Alison M.] Univ Cambridge, Cambridge CB1 8RN, England; [Tsao, Hensin] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA; [Brown, Kevin M.] NCI, Div Canc Epidemiol & Genet, NIH, Gaithersburg, MD 20892 USA	Translational Genomics Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; QIMR Berghofer Medical Research Institute; University of Sydney; Cancer Research UK; Saint James's University Hospital; University of Leeds; University of Sydney; Westmead Institute for Medical Research; Melanoma Institute Australia; University of Melbourne; Cancer Council Queensland; Cancer Council Victoria; University of Cambridge; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brown, KM (corresponding author), Translat Genom Res Inst, Phoenix, AZ 85004 USA.	brownkm2@mail.nih.gov	Law, Matthew H./AAJ-4066-2021; Armstrong, Bruce K/K-9464-2015; Yokoyama, Satoru/AAT-3254-2021; Stark, Mitchell/K-3874-2019; Aoude, Lauren/C-7484-2014; Stark, Mitchell/K-6794-2019; Stark, Mitchell S/E-3542-2010; Boyle, Glen/G-1347-2013; Martin, Nicholas/R-9235-2019; Duffy, David L/B-7392-2013; Mann, Graham J/G-4758-2014; Pharoah, Paul/V-6658-2019; Fisher, David/AAH-2878-2019; Cust, Anne/J-1797-2019; hayward, nick/AAV-8802-2020; Macgregor, Stuart/C-6442-2009; Nadeem, Sohail/I-5248-2013; Whiteman, David C/P-2728-2014; Aitken, Joanne F/C-5289-2009; hayward, nicholas k/C-1367-2015; Bonazzi, Vanessa F/R-1676-2018; Montgomery, Grant W/B-7148-2008; Jenkins, Mark/P-7803-2015; Schmidt, Christopher/A-4353-2009	Law, Matthew H./0000-0002-4303-8821; Armstrong, Bruce K/0000-0001-8940-7525; Aoude, Lauren/0000-0003-1448-3923; Stark, Mitchell/0000-0002-4510-2161; Stark, Mitchell S/0000-0002-4510-2161; Boyle, Glen/0000-0002-1385-529X; Martin, Nicholas/0000-0003-4069-8020; Duffy, David L/0000-0001-7227-632X; Mann, Graham J/0000-0003-1301-405X; Pharoah, Paul/0000-0001-8494-732X; Cust, Anne/0000-0002-5331-6370; Macgregor, Stuart/0000-0001-6731-8142; Nadeem, Sohail/0000-0002-1052-011X; Whiteman, David C/0000-0003-2563-9559; hayward, nicholas k/0000-0003-4760-1033; Bonazzi, Vanessa F/0000-0002-2574-0334; Montgomery, Grant W/0000-0002-4140-8139; Jenkins, Mark/0000-0002-8964-6160; Bishop, Tim/0000-0002-8752-8785; Yokoyama, Satoru/0000-0001-8336-486X; Aitken, Joanne Frances/0000-0001-6859-2186; Kefford, Richard/0000-0001-9251-9229; Newton-Bishop, Julia/0000-0001-9147-6802; Dutton-Regester, Ken/0000-0002-8884-6355; Jetann, Jodie/0000-0002-9760-3099; Giles, Graham/0000-0003-4946-9099; Schmidt, Christopher/0000-0002-3955-5076; Dunning, Alison Margaret/0000-0001-6651-7166; Woods, Susan/0000-0002-8955-2017	Melanoma Research Alliance; American Cancer Society [RSG-08-200-01]; National Institutes of Health (NIH) [AR043369-14, CA88363, K24CA149202, P50CA93683, R01 CA83115, CA-83115-01A2]; Doris Duke Medical Foundation; Dr Miriam and Sheldon G. Adelson Medical Research Foundation; US-Israel Binational Science Foundation; Division of Cancer Epidemiology and Genetics of the National Cancer Institute; National Health and Medical Research Council of Australia (NHMRC); Cancer Australia [1011143]; Cancer Research UK [C8216/A6129, C588/A4994, C588/A10589, C490/A11021, C8197/A10123]; NHMRC [566946, 107359, 211172, 402761, 520018]; Cancer Council New South Wales [77/00, 06/10]; Cancer Council Victoria; Cancer Council Queensland [371]; Cancer Institute NSW [10/ECF/2-06]; University of Sydney Medical Foundation; NATIONAL CANCER INSTITUTE [R01CA088363, K24CA149202, R01CA083115, F32CA009368, P50CA093683, ZIACP010201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; Cancer Research UK [10589, 10118, 11022] Funding Source: researchfish	Melanoma Research Alliance; American Cancer Society(American Cancer Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Medical Foundation(Doris Duke Charitable Foundation (DDCF)); Dr Miriam and Sheldon G. Adelson Medical Research Foundation; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Division of Cancer Epidemiology and Genetics of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Australia; Cancer Research UK(Cancer Research UK); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales(Cancer Council New South Wales); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council Queensland(Cancer Council Queensland); Cancer Institute NSW; University of Sydney Medical Foundation(University of Sydney); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Cancer Research UK(Cancer Research UK)	This work was supported by team science awards by the Melanoma Research Alliance (J.M.T., N.K.H., H. T. and D. E. F.), the American Cancer Society (K. M. B., RSG-08-200-01), the National Institutes of Health (NIH; D. E. F., AR043369-14; N.K.H., CA88363; H. T., K24CA149202 and P50CA93683), Doris Duke Medical Foundation (D. E. F.), Dr Miriam and Sheldon G. Adelson Medical Research Foundation (D. E. F.), US-Israel Binational Science Foundation (D. E. F.), and the Division of Cancer Epidemiology and Genetics of the National Cancer Institute (K. M. B.). N.K.H., D. L. D., S. M. and G. W. M. are supported by National Health and Medical Research Council of Australia (NHMRC) research fellowships. M. H. L. is supported by Cancer Australia grant 1011143. The collection of samples in the Leeds-based case-control study (the Melanoma Cohort Study) was funded by Cancer Research UK (Project Grant C8216/A6129 and Programme awards C588/A4994 and C588/A10589) and by the NIH (R01 CA83115). Recruitment was facilitated by the UK National Cancer Research Network. We thank S. Leake, S. Haynes, S. Waseem for Leeds case-control data collection; and H. Snowdon and C. Taylor from the Leeds Cancer Research UK Cancer Centre Genomics Facility for the genotyping of the UK samples. AMFS was supported by the NHMRC (project grants 566946, 107359, 211172 and program grant number 402761 to G.J.M. and R. F. K.); the Cancer Council New South Wales (project grant 77/00, 06/10), the Cancer Council Victoria and the Cancer Council Queensland (project grant 371); and the NIH (via RO1 grant CA-83115-01A2 to the international Melanoma Genetics Consortium-GenoMEL). The University of Cambridge SEARCH study was supported by Cancer Research UK Programme awards (C490/A11021 and C8197/A10123). A. E. C. is the recipient of an NHMRC public health postdoctoral fellowship (520018) and a Cancer Institute NSW Early Career Development Fellowship (10/ECF/2-06). B. K. A. is supported by a University of Sydney Medical Foundation Program Grant and J.L.H. is an Australia Fellow of the NHMRC. We gratefully acknowledge all of the participants, the work and dedication of the research coordinators, interviewers, examiners and data management staff, including J. Arbuckle, S. Columbus, M. Lang, H. Rodais, C. Ellis (Centre for MEGA Epidemiology); E. A. Holland, C. Agha-Hamilton, C. El Hayek, L. Morgan, J. Roland, E. Tyler, J. Barton, C. Watts and L. Porter (Westmead Institute of Cancer Research); M. Hillcoat, K. Holland, P. Saunders, J. Roberts and S. Tait (Viertel Centre for Research in Cancer Control); A. Kurien, C. Patterson, C. Thoo, S. de Zwaan, A. Sklavos, S. Manoharan, J. Cahill and S. Brennand (skin examiners).	Bataille V, 1996, BRIT J CANCER, V73, P1605, DOI 10.1038/bjc.1996.302; Baxter AJ, 2008, TWIN RES HUM GENET, V11, P183, DOI 10.1375/twin.11.2.183; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Boyle GM, 2011, PIGM CELL MELANOMA R, V24, P525, DOI 10.1111/j.1755-148X.2011.00849.x; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang YM, 2009, INT J CANCER, V124, P420, DOI 10.1002/ijc.23869; Cronin JC, 2009, PIGM CELL MELANOMA R, V22, P435, DOI 10.1111/j.1755-148X.2009.00578.x; Cust AE, 2009, AM J EPIDEMIOL, V170, P1541, DOI 10.1093/aje/kwp307; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Duffy DL, 2010, AM J HUM GENET, V87, P6, DOI 10.1016/j.ajhg.2010.05.017; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gillanders E, 2003, AM J HUM GENET, V73, P301, DOI 10.1086/377140; Goldstein AM, 2007, J MED GENET, V44, P99, DOI 10.1136/jmg.2006.043802; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Harland M, 2000, GENE CHROMOSOME CANC, V28, P45, DOI 10.1002/(SICI)1098-2264(200005)28:1<45::AID-GCC6>3.3.CO;2-6; Harland M, 1997, HUM MOL GENET, V6, P2061, DOI 10.1093/hmg/6.12.2061; Harland M, 2001, HUM MOL GENET, V10, P2679, DOI 10.1093/hmg/10.23.2679; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P934, DOI 10.1093/oxfordjournals.aje.a117360; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P923, DOI 10.1093/oxfordjournals.aje.a117359; KEFFORD RF, 1991, CANCER GENET CYTOGEN, V51, P45, DOI 10.1016/0165-4608(91)90007-H; McGregor B, 1999, GENET EPIDEMIOL, V16, P40, DOI 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.3.CO;2-T; Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200; Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x; Naldi L, 2005, ANN EPIDEMIOL, V15, P545, DOI 10.1016/j.annepidem.2004.10.005; Nan H, 2009, J INVEST DERMATOL, V129, P2250, DOI 10.1038/jid.2009.62; NANCARROW DJ, 1992, GENOMICS, V14, P939, DOI 10.1016/S0888-7543(05)80115-6; Newton-Bishop JA, 2010, CANCER EPIDEM BIOMAR, V19, P2043, DOI 10.1158/1055-9965.EPI-10-0233; Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pooley KA, 2010, CANCER EPIDEM BIOMAR, V19, P1862, DOI 10.1158/1055-9965.EPI-10-0281; Pooley KA, 2008, CANCER EPIDEM BIOMAR, V17, P3482, DOI 10.1158/1055-9965.EPI-08-0594; Smit NPM, 2008, PHOTOCHEM PHOTOBIOL, V84, P550, DOI 10.1111/j.1751-1097.2007.00242.x; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Strauch K, 2003, AM J HUM GENET, V73, P615; Strub T, 2011, ONCOGENE, V30, P2319, DOI 10.1038/onc.2010.612; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Titus-Ernstoff L, 2005, INT J CANCER, V116, P144, DOI 10.1002/ijc.21001; Williams PF, 2011, INT J CANCER, V129, P1730, DOI 10.1002/ijc.25804; Zhu G, 2007, EUR J HUM GENET, V15, P94, DOI 10.1038/sj.ejhg.5201729; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	46	296	304	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2011	480	7375					99	U266		10.1038/nature10630	http://dx.doi.org/10.1038/nature10630			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22080950	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000298031900042
J	Sattar, N; Welsh, P; Panarelli, M; Forouhi, NG				Sattar, Naveed; Welsh, Paul; Panarelli, Maurizio; Forouhi, Nita G.			Increasing requests for vitamin D measurement: costly, confusing, and without credibility	LANCET			English	Editorial Material							DIETARY		[Sattar, Naveed; Welsh, Paul] Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland; [Panarelli, Maurizio] Glasgow Royal Infirm, Dept Biochem, Glasgow G4 0SF, Lanark, Scotland; [Forouhi, Nita G.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England	University of Glasgow; University of Glasgow; University of Cambridge	Sattar, N (corresponding author), Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland.	naveed.sattar@glasgow.ac.uk	Welsh, Paul/H-5249-2019	Welsh, Paul/0000-0002-7970-3643; Forouhi, Nita/0000-0002-5041-248X	British Heart Foundation [FS/10/005/28147] Funding Source: Medline; Medical Research Council [MC_UP_A100_1003] Funding Source: Medline; MRC [MC_UP_A100_1003] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; [Anonymous], 1956, BRIT MED J, V2, P149; [Anonymous], MAIL ONLINE; [Anonymous], TELEGRAPH; Brophy Marcus M, 2008, VITAMIN D TESTS SOAR; CBC News, CBC NEWS; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Marniemi J, 2005, NUTR METAB CARDIOVAS, V15, P188, DOI 10.1016/j.numecd.2005.01.001; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; Shapses SA, 2011, JAMA-J AM MED ASSOC, V305, P2565, DOI 10.1001/jama.2011.881; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wehr E, 2010, CLIN ENDOCRINOL, V73, P243, DOI 10.1111/j.1365-2265.2009.03777.x; Welsh P, 2011, ARTHRITIS RHEUM-US, V63, P1763, DOI 10.1002/art.30341	14	102	104	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2012	379	9811					95	96		10.1016/S0140-6736(11)61816-3	http://dx.doi.org/10.1016/S0140-6736(11)61816-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	22243814				2022-12-24	WOS:000299317700010
J	Pletcher, MJ; Vittinghoff, E; Kalhan, R; Richman, J; Safford, M; Sidney, S; Lin, F; Kertesz, S				Pletcher, Mark J.; Vittinghoff, Eric; Kalhan, Ravi; Richman, Joshua; Safford, Monika; Sidney, Stephen; Lin, Feng; Kertesz, Stefan			Association Between Marijuana Exposure and Pulmonary Function Over 20 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HABITUAL SMOKERS; LUNG-FUNCTION; TOBACCO; CANNABIS; SMOKING; RECRUITMENT; DECLINE; COCAINE; FEV(1); CARDIA	Context Marijuana smoke contains many of the same constituents as tobacco smoke, but whether it has similar adverse effects on pulmonary function is unclear. Objective To analyze associations between marijuana (both current and lifetime exposure) and pulmonary function. Design, Setting, and Participants The Coronary Artery Risk Development in Young Adults (CARDIA) study, a longitudinal study collecting repeated measurements of pulmonary function and smoking over 20 years (March 26, 1985-August 19, 2006) in a cohort of 5115 men and women in 4 US cities. Mixed linear modeling was used to account for individual age-based trajectories of pulmonary function and other covariates including tobacco use, which was analyzed in parallel as a positive control. Lifetime exposure to marijuana joints was expressed in joint-years, with 1 joint-year of exposure equivalent to smoking 365 joints or filled pipe bowls. Main Outcome Measures Forced expiratory volume in the first second of expiration (FEV1) and forced vital capacity (FVC). Results Marijuana exposure was nearly as common as tobacco exposure but was mostly light (median, 2-3 episodes per month). Tobacco exposure, both current and lifetime, was linearly associated with lower FEV1 and FVC. In contrast, the association between marijuana exposure and pulmonary function was nonlinear (P<.001): at low levels of exposure, FEV1 increased by 13 mL/joint-year (95% CI, 6.4 to 20; P<.001) and FVC by 20 mL/joint-year (95% CI, 12 to 27; P<.001), but at higher levels of exposure, these associations leveled or even reversed. The slope for FEV1 was -2.2 mL/joint-year (95% CI, -4.6 to 0.3; P=.08) at more than 10 joint-years and -3.2 mL per marijuana smoking episode/mo (95% CI, -5.8 to -0.6; P=.02) at more than 20 episodes/mo. With very heavy marijuana use, the net association with FEV1 was not significantly different from baseline, and the net association with FVC remained significantly greater than baseline (eg, at 20 joint-years, 76 mL [ 95% CI, 34 to 117]; P<.001). Conclusion Occasional and low cumulative marijuana use was not associated with adverse effects on pulmonary function. JAMA. 2012; 307(2): 173-181 www.jama.com	[Pletcher, Mark J.; Vittinghoff, Eric; Lin, Feng] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Pletcher, Mark J.] Univ Calif San Francisco, Div Gen Internal Med, Dept Med, San Francisco, CA 94107 USA; [Kalhan, Ravi] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Asthma COPD Program, Chicago, IL 60611 USA; [Richman, Joshua] Univ Alabama Birmingham, Dept Surg, Birmingham, AL USA; [Safford, Monika; Kertesz, Stefan] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Richman, Joshua; Kertesz, Stefan] Vet Affairs Med Ctr, Ctr Surg Med & Acute Care Res & Transit, Birmingham, AL USA; [Sidney, Stephen] Kaiser Permanente No Calif, Div Res, Oakland, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Northwestern University; Feinberg School of Medicine; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Kaiser Permanente	Pletcher, MJ (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 185 Berry St,Ste 5700, San Francisco, CA 94107 USA.	mpletcher@epi.ucsf.edu	s, s/GYR-2278-2022; s, s/HIK-1178-2022; s, s/HHD-0404-2022	Kalhan, Ravi/0000-0003-2443-0876; Kertesz, Stefan/0000-0001-6101-8421	National Institute on Drug Abuse [R01-DA-025067]; National Heart, Lung, and Blood Institute [N01-HC-95095, N01-HC-48047]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048047, N01HC095095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025067] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institute on Drug Abuse (R01-DA-025067) and the National Heart, Lung, and Blood Institute (N01-HC-95095 and N01-HC-48047).	Aldington S, 2007, THORAX, V62, P1058, DOI 10.1136/thx.2006.077081; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 2005, NUMB DEATHS EACH CAU; [Anonymous], CANN CANN; [Anonymous], 2009, AIR QUAL MON INF AIR; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Barsky SH, 1998, JNCI-J NATL CANCER I, V90, P1198, DOI 10.1093/jnci/90.16.1198; BLOOM JW, 1987, BMJ-BRIT MED J, V295, P1516, DOI 10.1136/bmj.295.6612.1516; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Fligiel SEG, 1997, CHEST, V112, P319, DOI 10.1378/chest.112.2.319; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Hancox RJ, 2010, EUR RESPIR J, V35, P42, DOI 10.1183/09031936.00065009; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; Joy JE, 1999, MARIJUANA MED ASSESS; Kamholz SL, 2004, MED CLIN N AM, V88, P1415, DOI 10.1016/j.mcna.2004.07.008; Kelly FJ, 2011, CLIN EXP ALLERGY, V41, P1059, DOI 10.1111/j.1365-2222.2011.03776.x; Marrie RA, 2009, J CLIN EPIDEMIOL, V62, P511, DOI 10.1016/j.jclinepi.2008.05.015; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Moore BA, 2005, J GEN INTERN MED, V20, P33, DOI 10.1111/j.1525-1497.2004.40081.x; NOVOTNY M, 1982, J CHROMATOGR, V238, P141, DOI 10.1016/S0021-9673(00)82720-X; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Roth MD, 1998, AM J RESP CRIT CARE, V157, P928, DOI 10.1164/ajrccm.157.3.9701026; SHERMAN MP, 1991, PHARMACOL BIOCHEM BE, V40, P663, DOI 10.1016/0091-3057(91)90379-G; SHERRILL DL, 1991, INT J EPIDEMIOL, V20, P132, DOI 10.1093/ije/20.1.132; Substance Abuse and Mental Health Services Administration, HHS PUBL; Tashkin DP, 2010, EUR RESPIR J, V35, P3, DOI 10.1183/09031936.00109309; TASHKIN DP, 1993, AM REV RESPIR DIS, V147, P97, DOI 10.1164/ajrccm/147.1.97; TASHKIN DP, 1987, AM REV RESPIR DIS, V135, P209; Tashkin DP, 2002, J CLIN PHARMACOL, V42, p71S, DOI 10.1002/j.1552-4604.2002.tb06006.x; Tashkin DP, 1997, AM J RESP CRIT CARE, V155, P141, DOI 10.1164/ajrccm.155.1.9001303; TASHKIN DP, 1980, CHEST, V78, P699, DOI 10.1378/chest.78.5.699; Taylor DR, 2000, ADDICTION, V95, P1669, DOI 10.1046/j.1360-0443.2000.951116697.x; Tetrault JM, 2007, ARCH INTERN MED, V167, P221, DOI 10.1001/archinte.167.3.221; WAGENKNECHT LE, 1992, AM J PUBLIC HEALTH, V82, P33, DOI 10.2105/AJPH.82.1.33	36	148	150	2	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2012	307	2					173	181		10.1001/jama.2011.1961	http://dx.doi.org/10.1001/jama.2011.1961			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875NP	22235088	Green Accepted, Bronze			2022-12-24	WOS:000299038300029
J	Khurana, JS; Wang, J; Xu, J; Koppetsch, BS; Thomson, TC; Nowosielska, A; Li, CJ; Zamore, PD; Weng, ZP; Theurkauf, WE				Khurana, Jaspreet S.; Wang, Jie; Xu, Jia; Koppetsch, Birgit S.; Thomson, Travis C.; Nowosielska, Anetta; Li, Chengjian; Zamore, Phillip D.; Weng, Zhiping; Theurkauf, William E.			Adaptation to P Element Transposon Invasion in Drosophila melanogaster	CELL			English	Article							MENDELIAN FEMALE STERILITY; M HYBRID DYSGENESIS; HORIZONTAL TRANSMISSION; MEIOTIC RECOMBINATION; GENOME EVOLUTION; ACTIVATION; CHECKPOINT; RNA; MUTATIONS; GERMLINE	Transposons evolve rapidly and can mobilize and trigger genetic instability. Piwi-interacting RNAs (piRNAs) silence these genome pathogens, but it is unclear how the piRNA pathway adapts to invasion of new transposons. In Drosophila, piRNAs are encoded by heterochromatic clusters and maternally deposited in the embryo. Paternally inherited P element transposons thus escape silencing and trigger a hybrid sterility syndrome termed P-M hybrid dysgenesis. We show that P-M hybrid dysgenesis activates both P elements and resident transposons and disrupts the piRNA biogenesis machinery. As dysgenic hybrids age, however, fertility is restored, P elements are silenced, and P element piRNAs are produced de novo. In addition, the piRNA biogenesis machinery assembles, and resident elements are silenced. Significantly, resident transposons insert into piRNA clusters, and these new insertions are transmitted to progeny, produce novel piRNAs, and are associated with reduced transposition. P element invasion thus triggers heritable changes in genome structure that appear to enhance transposon silencing.	[Wang, Jie; Xu, Jia; Li, Chengjian; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA; [Khurana, Jaspreet S.; Koppetsch, Birgit S.; Thomson, Travis C.; Nowosielska, Anetta; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Cell & Dev Dynam, Worcester, MA 01655 USA; [Khurana, Jaspreet S.; Koppetsch, Birgit S.; Thomson, Travis C.; Nowosielska, Anetta; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; [Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA; [Zamore, Phillip D.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA.	zhiping.weng@umassmed.edu; william.theurkauf@umassmed.edu	Xu, Jia/F-7750-2012; Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618; Theurkauf, William/0000-0001-7342-1912; Xu, Jia/0000-0003-3921-018X	NIH [R01HD049116, GM62862, GM65236]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R01GM065236, R37GM062862] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the UMass Medical School RNA biology community for stimulating discussions and constructive criticisms. Thanks to Stephane Ronsseray and the Bloomington Stock Center for fly strains, Julius Brennecke and Paul Lasko for antibodies, and the UMass Deep Sequencing Core for technical assistance. This work was supported by grants from the NIH to W.E.T., Z.W., and P.D.Z. (R01HD049116) and to P.D.Z. (GM62862 and GM65236).	Abdu U, 2002, CURR BIOL, V12, P1645, DOI 10.1016/S0960-9822(02)01165-X; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; BRADSHAW VA, 1989, MOL GEN GENET, V218, P465, DOI 10.1007/BF00332411; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Britten RJ, 2010, P NATL ACAD SCI USA, V107, P19945, DOI 10.1073/pnas.1014330107; BUCHETON A, 1979, GENETICS, V93, P131; BUCHETON A, 1976, HEREDITY, V36, P305, DOI 10.1038/hdy.1976.38; BUCHETON A, 1990, TRENDS GENET, V6, P16, DOI 10.1016/0168-9525(90)90044-7; BUCHETON A, 1975, CR ACAD SCI D NAT, V281, P1035; BUCHETON A, 1973, CR ACAD SCI D NAT, V276, P641; Callinan P, 2006, GENOME DYN, V1, P104, DOI 10.1159/000092503; CAPY P, 1994, GENETICA, V93, P161, DOI 10.1007/BF01435248; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Clemenson C, 2009, DNA REPAIR, V8, P1101, DOI 10.1016/j.dnarep.2009.04.008; DANIELS SB, 1990, GENETICS, V124, P339; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; EDDY EM, 1974, ANAT REC, V178, P731, DOI 10.1002/ar.1091780406; EDDY EM, 1975, INT REV CYTOL, V43, P229; EGGLESTON WB, 1988, NATURE, V331, P368, DOI 10.1038/331368a0; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Ghabrial A, 1999, NAT CELL BIOL, V1, P354, DOI 10.1038/14046; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hedges DJ, 2011, ADV GENET, V73, P219, DOI 10.1016/B978-0-12-380860-8.00006-9; HIRAIZUMI Y, 1971, P NATL ACAD SCI USA, V68, P268, DOI 10.1073/pnas.68.2.268; KAUFMAN PD, 1992, CELL, V69, P27, DOI 10.1016/0092-8674(92)90116-T; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; KIDWELL MG, 1985, GENETICS, V111, P337; KIDWELL MG, 1977, GENETICS, V86, P813; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lazzaro F, 2009, DNA REPAIR, V8, P1055, DOI 10.1016/j.dnarep.2009.04.022; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Liu H, 2002, GENETICS, V162, P245; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McKim KS, 2002, ANNU REV GENET, V36, P205, DOI 10.1146/annurev.genet.36.041102.113929; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; PETROV DA, 1995, P NATL ACAD SCI USA, V92, P8050, DOI 10.1073/pnas.92.17.8050; PICARD G, 1972, CR ACAD SCI D NAT, V275, P933; RIO DC, 1991, TRENDS GENET, V7, P282, DOI 10.1016/0168-9525(91)90176-Q; Rozhkov NV, 2010, RNA, V16, P1634, DOI 10.1261/rna.2217810; RUBIN GM, 1982, CELL, V29, P987, DOI 10.1016/0092-8674(82)90462-7; Spradling Allan C., 1993, P1; Staleva LS, 2001, MUTAT RES-FUND MOL M, V474, P93, DOI 10.1016/S0027-5107(00)00165-2; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Van De Bor V, 2005, DEV CELL, V9, P51, DOI 10.1016/j.devcel.2005.04.012	60	154	158	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2011	147	7					1551	1563		10.1016/j.cell.2011.11.042	http://dx.doi.org/10.1016/j.cell.2011.11.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196730	Green Accepted, Bronze			2022-12-24	WOS:000298403400019
J	Letzkus, JJ; Wolff, SBE; Meyer, EMM; Tovote, P; Courtin, J; Herry, C; Luthi, A				Letzkus, Johannes J.; Wolff, Steffen B. E.; Meyer, Elisabeth M. M.; Tovote, Philip; Courtin, Julien; Herry, Cyril; Luethi, Andreas			A disinhibitory microcircuit for associative fear learning in the auditory cortex	NATURE			English	Article							GABAERGIC CELL SUBTYPES; LAYER-I INTERNEURONS; RAT NEOCORTEX; GABA RELEASE; PLASTICITY; NEURONS; MODULATION; INHIBITION; RECEPTORS; AMYGDALA	Learning causes a change in how information is processed by neuronal circuits. Whereas synaptic plasticity, an important cellular mechanism, has been studied in great detail, we know much less about how learning is implemented at the level of neuronal circuits and, in particular, how interactions between distinct types of neurons within local networks contribute to the process of learning. Here we show that acquisition of associative fear memories depends on the recruitment of a disinhibitory microcircuit in the mouse auditory cortex. Fear-conditioning-associated disinhibition in auditory cortex is driven by foot-shock-mediated cholinergic activation of layer 1 interneurons, in turn generating inhibition of layer 2/3 parvalbumin-positive interneurons. Importantly, pharmacological or optogenetic block of pyramidal neuron disinhibition abolishes fear learning. Together, these data demonstrate that stimulus convergence in the auditory cortex is necessary for associative fear learning to complex tones, define the circuit elements mediating this convergence and suggest that layer-1-mediated disinhibition is an important mechanism underlying learning and information processing in neocortical circuits.	[Letzkus, Johannes J.; Wolff, Steffen B. E.; Meyer, Elisabeth M. M.; Tovote, Philip; Luethi, Andreas] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Wolff, Steffen B. E.; Meyer, Elisabeth M. M.] Univ Basel, CH-4003 Basel, Switzerland; [Courtin, Julien; Herry, Cyril] INSERM, U862, F-33077 Bordeaux, France	Friedrich Miescher Institute for Biomedical Research; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Letzkus, JJ (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	johannes.letzkus@fmi.ch; andreas.luthi@fmi.ch	courtin, julien/AAH-2380-2022; Herry, Cyril/AAP-9902-2020; Tovote, Philip/AAC-5668-2019; courtin, julien/AEN-1402-2022	courtin, julien/0000-0002-6454-3245; Herry, Cyril/0000-0003-2973-0843; courtin, julien/0000-0002-6454-3245; Tovote, Philip/0000-0002-4598-722X; Meyer, Elisabeth/0000-0001-9750-865X; Letzkus, Johannes/0000-0001-5678-3030	Swiss National Science Foundation; National Competence Center in Research (NCCR) of the Swiss Confederation on the synaptic basis of mental disorders; French National Research Agency [ANR-2010-BLAN-1442-01]; Marie-Curie fellowship; Schering Foundation; Fonds AXA pour la Recherche; Aquitaine Regional Council; Novartis Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Competence Center in Research (NCCR) of the Swiss Confederation on the synaptic basis of mental disorders(Swiss National Science Foundation (SNSF)); French National Research Agency(French National Research Agency (ANR)); Marie-Curie fellowship(European Commission); Schering Foundation; Fonds AXA pour la Recherche(AXA Research Fund); Aquitaine Regional Council(Region Nouvelle-Aquitaine); Novartis Research Foundation	We thank all members of the Luthi laboratory for discussions and comments. We thank B. Kampa and T. Oertner for advice on two-photon imaging, R. Friedrich and J. Grundemann for comments on the manuscript, P. Argast, J. Ludke and C. Muller for excellent technical assistance, H. Zielinska for preparation of artwork and S. Arber, Y. Yanagawa and K. Deisseroth for generously sharing materials. This work was supported by grants from the Swiss National Science Foundation (J. J. L. Ambizione; A.L.), the National Competence Center in Research (NCCR) of the Swiss Confederation on the synaptic basis of mental disorders, the French National Research Agency (C. H., ANR-2010-BLAN-1442-01), a Marie-Curie fellowship (J. J. L.), a Schering Foundation fellowship (S. B. E. W.), a Fonds AXA pour la Recherche fellowship (J. C.), the Aquitaine Regional Council (C. H.) and the Novartis Research Foundation.	Acquas E, 1996, J NEUROSCI, V16, P3089; Bacci A, 2005, TRENDS NEUROSCI, V28, P602, DOI 10.1016/j.tins.2005.08.007; Boatman JA, 2006, EUR J NEUROSCI, V24, P894, DOI 10.1111/j.1460-9568.2006.04965.x; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Cauller LJ, 1998, J COMP NEUROL, V390, P297; Christophe E, 2002, J NEUROPHYSIOL, V88, P1318, DOI 10.1152/jn.2002.88.3.1318; Chu ZG, 2003, J NEUROSCI, V23, P96; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Foehring RC, 2002, J NEUROSCI, V22, P8238; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gonchar Y, 2003, J NEUROSCI, V23, P10904; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Hestrin S, 1996, J NEUROSCI, V16, P5290; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Ji WQ, 2005, J NEUROPHYSIOL, V94, P1199, DOI 10.1152/jn.00112.2005; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1997, J NEUROPHYSIOL, V78, P1743, DOI 10.1152/jn.1997.78.3.1743; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Lawrence JJ, 2008, TRENDS NEUROSCI, V31, P317, DOI 10.1016/j.tins.2008.03.008; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Mechawar N, 2000, J COMP NEUROL, V428, P305, DOI 10.1002/1096-9861(20001211)428:2<305::AID-CNE9>3.0.CO;2-Y; Metherate R, 2004, LEARN MEMORY, V11, P50, DOI 10.1101/lm.69904; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; ROMANSKI LM, 1992, NEUROSCI LETT, V142, P228, DOI 10.1016/0304-3940(92)90379-L; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weinberger NM, 2007, HEARING RES, V229, P54, DOI 10.1016/j.heares.2007.01.004; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; Wozny C, 2011, CEREB CORTEX, V21, P1818, DOI 10.1093/cercor/bhq257; Wu JP, 2005, J NEUROSCI, V25, P6322, DOI 10.1523/JNEUROSCI.1405-05.2005; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhou FM, 1996, J COMP NEUROL, V376, P198, DOI 10.1002/(SICI)1096-9861(19961209)376:2<198::AID-CNE3>3.0.CO;2-Z	47	541	543	3	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					331	U76		10.1038/nature10674	http://dx.doi.org/10.1038/nature10674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22158104				2022-12-24	WOS:000298033000043
J	Yamazaki, S; Ema, H; Karlsson, G; Yamaguchi, T; Miyoshi, H; Shioda, S; Taketo, MM; Karlsson, S; Iwama, A; Nakauchi, H				Yamazaki, Satoshi; Ema, Hideo; Karlsson, Goran; Yamaguchi, Tomoyuki; Miyoshi, Hiroyuki; Shioda, Seiji; Taketo, Makoto M.; Karlsson, Stefan; Iwama, Atsushi; Nakauchi, Hiromitsu			Nonmyelinating Schwann Cells Maintain Hematopoietic Stem Cell Hibernation in the Bone Marrow Niche	CELL			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; PERIPHERAL-NERVE; IN-VIVO; ACTIVATION; INTEGRIN; RECEPTOR; PROLIFERATION; MAINTENANCE; QUIESCENCE	Hematopoietic stem cells (HSCs) reside and self-renew in the bone marrow (BM) niche. Overall, the signaling that regulates stem cell dormancy in the HSC niche remains controversial. Here, we demonstrate that TGF-beta type II receptor-deficient HSCs show low-level Smad activation and impaired long-term repopulating activity, underlining the critical role of TGF-beta/Smad signaling in HSC maintenance. TGF-b is produced as a latent form by a variety of cells, so we searched for those that express activator molecules for latent TGF-beta. Nonmyelinating Schwann cells in BM proved responsible for activation. These glial cells ensheathed autonomic nerves, expressed HSC niche factor genes, and were in contact with a substantial proportion of HSCs. Autonomic nerve denervation reduced the number of these active TGF-beta-producing cells and led to rapid loss of HSCs from BM. We propose that glial cells are components of a BM niche and maintain HSC hibernation by regulating activation of latent TGF-beta.	[Yamazaki, Satoshi; Yamaguchi, Tomoyuki; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, ERATO, Chiyoda Ku, Tokyo 1020075, Japan; [Ema, Hideo; Yamaguchi, Tomoyuki; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell Biol & Med, Tokyo 1088639, Japan; [Karlsson, Goran; Karlsson, Stefan] Univ Lund Hosp, Lund Stem Cell Ctr, Dept Mol Med & Gene Therapy, S-22184 Lund, Sweden; [Miyoshi, Hiroyuki; Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan; [Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, Tokyo 1428555, Japan; [Iwama, Atsushi] CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan	Japan Science & Technology Agency (JST); University of Tokyo; Lund University; Skane University Hospital; Kyoto University; Showa University; Japan Science & Technology Agency (JST); Chiba University	Nakauchi, H (corresponding author), Japan Sci & Technol Agcy, ERATO, Chiyoda Ku, Tokyo 1020075, Japan.	nakauchi@ims.u-tokyo.ac.jp		Miyoshi, Hiroyuki/0000-0001-7400-0714; Karlsson, Goran/0000-0001-8197-754X	JST; Ministry of Education, Culture, Sport, Science, and Technology, Japan	JST(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sport, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Y. Yamazaki, Y. Ishii, and Y. Koyama for excellent technical support, Drs. T. Saito and S. Uchida for valuable discussions, and Dr. N. Watanabe, Dr. R. Yamamoto, Dr. T. Kobayashi, N. Suzuki, F. Lin, and Dr. A. Knisely for critical reading of the manuscript. This work was supported by grants from JST, the Ministry of Education, Culture, Sport, Science, and Technology, Japan. H. N. is a founder and shareholder of ReproCELL, Inc.	Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bradford GB, 1997, EXP HEMATOL, V25, P445; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CALVO W, 1970, BLOOD-J HEMATOL, V36, P180, DOI 10.1182/blood.V36.2.180.180; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Chernousov MA, 2003, EXP CELL RES, V291, P514, DOI 10.1016/S0014-4827(03)00409-9; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; D'Antonio M, 2006, J NEUROSCI, V26, P8417, DOI 10.1523/JNEUROSCI.1578-06.2006; Fernando FS, 2002, GENE, V284, P23, DOI 10.1016/S0378-1119(02)00394-3; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Grinspan JB, 1996, J NEUROSCI, V16, P6107; Guerette D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-164; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Larsson J, 2005, ONCOGENE, V24, P5676, DOI 10.1038/sj.onc.1208920; Leveen P, 2005, BLOOD, V106, P4234, DOI 10.1182/blood-2005-05-1871; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Murinson BB, 2004, J NEUROPATH EXP NEUR, V63, P246, DOI 10.1093/jnen/63.3.246; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Noguchi E, 1999, J AUTONOM NERV SYST, V75, P78, DOI 10.1016/S0165-1838(98)00144-1; Oguro H, 2007, CURR OPIN IMMUNOL, V19, P503, DOI 10.1016/j.coi.2007.05.001; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Rosendahl A, 2003, INT IMMUNOL, V15, P1401, DOI 10.1093/intimm/dxg139; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Singbrant S, 2010, BLOOD, V115, P4689, DOI 10.1182/blood-2009-05-220988; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sulaiman OAR, 2002, EXP NEUROL, V176, P342, DOI 10.1006/exnr.2002.7928; Suzuki R, 2003, MOL BRAIN RES, V115, P10, DOI 10.1016/S0169-328X(03)00172-4; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Utsugisawa T, 2006, STEM CELLS, V24, P1128, DOI 10.1634/stemcells.2005-0263; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	55	511	528	4	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 23	2011	147	5					1146	1158		10.1016/j.cell.2011.09.053	http://dx.doi.org/10.1016/j.cell.2011.09.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118468	Bronze			2022-12-24	WOS:000297376600024
J	Person, AL; Raman, IM				Person, Abigail L.; Raman, Indira M.			Purkinje neuron synchrony elicits time-locked spiking in the cerebellar nuclei	NATURE			English	Article							RELEASE SITES; CELLS; SYNAPSES; SINGLE; TRANSMISSION; ORGANIZATION; INHIBITION; DEPRESSION; DISCHARGE; NETWORKS	An unusual feature of the cerebellar cortex is that its output neurons, Purkinje cells, release GABA (gamma-aminobutyric acid). Their high intrinsic firing rates(1) (50 Hz) and extensive convergence(2,3) predict that their target neurons in the cerebellar nuclei would be largely inhibited unless Purkinje cells pause their spiking, yet Purkinje and nuclear neuron firing rates do not always vary inversely(4). One indication of how these synapses transmit information is that populations of Purkinje neurons synchronize their spikes during cerebellar behaviours(5-11). If nuclear neurons respond to Purkinje synchrony, they may encode signals from subsets of inhibitory inputs(7,12-14). Here we show in weanling and adult mice that nuclear neurons transmit the timing of synchronous Purkinje afferent spikes, owing to modest Purkinje-to-nuclear convergence ratios (similar to 40:1), fast inhibitory postsynaptic current kinetics (tau(decay) = 2.5 ms) and high intrinsic firing rates (similar to 90 Hz). In vitro, dynamically clamped asynchronous inhibitory postsynaptic potentials mimicking Purkinje afferents suppress nuclear cell spiking, whereas synchronous inhibitory postsynaptic potentials entrain nuclear cell spiking. With partial synchrony, nuclear neurons time-lock their spikes to the synchronous subpopulation of inputs, even when only 2 out of 40 afferents synchronize. In vivo, nuclear neurons reliably phase-lock to regular trains of molecular layer stimulation. Thus, cerebellar nuclear neurons can preferentially relay the spike timing of synchronized Purkinje cells to downstream premotor areas.	[Person, Abigail L.; Raman, Indira M.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Northwestern University	Raman, IM (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	a-person@northwestern.edu; i-raman@northwestern.edu			NIH [R01-NS39395, F32-NS067831]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039395, F32NS067831] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to J. R. Pugh for new analysis of data from ref. 19 on whole-cell GABA conductances. We thank D. Ferster, D. McLean and C. Woolley for comments on the manuscript. This work was supported by NIH grants R01-NS39395 (I.M.R.) and F32-NS067831 (A.L.P.).	Anchisi D, 2001, J NEUROPHYSIOL, V85, P323, DOI 10.1152/jn.2001.85.1.323; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; BELL CC, 1969, J NEUROPHYSIOL, V32, P1044, DOI 10.1152/jn.1969.32.6.1044; Bengtsson F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018822; Chan-Palay V, 1977, CEREBELLAR DENTATE N; de Solages C, 2008, NEURON, V58, P775, DOI 10.1016/j.neuron.2008.05.008; Gauck V, 2000, J NEUROSCI, V20, P3006; Gauck V, 2003, J NEUROSCI, V23, P8109; Goossens HHLM, 2004, EUR J NEUROSCI, V19, P687, DOI 10.1111/j.0953-816X.2003.03173.x; Heck DH, 2007, P NATL ACAD SCI USA, V104, P7658, DOI 10.1073/pnas.0609966104; Hoebeek FE, 2010, P NATL ACAD SCI USA, V107, P8410, DOI 10.1073/pnas.0907118107; Kistler WM, 2003, CEREBELLUM, V2, P44, DOI 10.1080/14734220309426; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; MCDEVITT CJ, 1987, BRAIN RES, V425, P1, DOI 10.1016/0006-8993(87)90477-X; Ozden I, 2009, J NEUROSCI, V29, P10463, DOI 10.1523/JNEUROSCI.0967-09.2009; PALKOVITS M, 1977, EXP BRAIN RES, V28, P189; Pedroarena CM, 2003, J NEUROPHYSIOL, V89, P704, DOI 10.1152/jn.00558.2002; Pugh JR, 2005, BIOPHYS J, V88, P1740, DOI 10.1529/biophysj.104.055814; Ruigrok TJH, 2008, EUR J NEUROSCI, V28, P181, DOI 10.1111/j.1460-9568.2008.06294.x; Schultz SR, 2009, J NEUROSCI, V29, P8005, DOI 10.1523/JNEUROSCI.4919-08.2009; SHINODA Y, 1988, BEHAV BRAIN RES, V28, P59, DOI 10.1016/0166-4328(88)90076-9; Sugihara I, 2009, J COMP NEUROL, V512, P282, DOI 10.1002/cne.21889; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Telgkamp P, 2002, J NEUROSCI, V22, P8447; Telgkamp P, 2004, NEURON, V41, P113, DOI 10.1016/S0896-6273(03)00802-X; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; TOYAMA K, 1970, EXP BRAIN RES, V11, P187; Uusisaari M, 2008, NEUROSCIENCE, V156, P537, DOI 10.1016/j.neuroscience.2008.07.060; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Wise AK, 2010, J PHYSIOL-LONDON, V588, P2373, DOI 10.1113/jphysiol.2010.189704	30	217	217	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 26	2012	481	7382					502	U114		10.1038/nature10732	http://dx.doi.org/10.1038/nature10732			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22198670	Green Accepted			2022-12-24	WOS:000299471800039
J	Schmidt, D; Schwalie, PC; Wilson, MD; Ballester, B; Goncalves, A; Kutter, C; Brown, GD; Marshall, A; Flicek, P; Odom, DT				Schmidt, Dominic; Schwalie, Petra C.; Wilson, Michael D.; Ballester, Benoit; Goncalves, Angela; Kutter, Claudia; Brown, Gordon D.; Marshall, Aileen; Flicek, Paul; Odom, Duncan T.			Waves of Retrotransposon Expansion Remodel Genome Organization and CTCF Binding in Multiple Mammalian Lineages	CELL			English	Article							INSULATOR PROTEIN CTCF; TRANSCRIPTIONAL REGULATION; REGULATORY NETWORK; ENHANCER BLOCKING; ZINC FINGERS; GENE; EVOLUTION; SITES; REPRESSOR; REVEALS	CTCF-binding locations represent regulatory sequences that are highly constrained over the course of evolution. To gain insight into how these DNA elements are conserved and spread through the genome, we defined the full spectrum of CTCF-binding sites, including a 33/34-mer motif, and identified over five thousand highly conserved, robust, and tissue-independent CTCF-binding locations by comparing ChIP-seq data from six mammals. Our data indicate that activation of retroelements has produced species-specific expansions of CTCF binding in rodents, dogs, and opossum, which often functionally serve as chromatin and transcriptional insulators. We discovered fossilized repeat elements flanking deeply conserved CTCF-binding regions, indicating that similar retrotransposon expansions occurred hundreds of millions of years ago. Repeat-driven dispersal of CTCF binding is a fundamental, ancient, and still highly active mechanism of genome evolution in mammalian lineages.	[Schwalie, Petra C.; Ballester, Benoit; Goncalves, Angela; Flicek, Paul] European Bioinformat Inst EMBL EBI, Cambridge CB10 1SD, England; [Schmidt, Dominic; Wilson, Michael D.; Kutter, Claudia; Brown, Gordon D.; Marshall, Aileen; Odom, Duncan T.] Li Ka Shing Ctr, Cambridge Res Inst, Cambridge CB2 0RE, England; [Schmidt, Dominic; Wilson, Michael D.; Kutter, Claudia; Brown, Gordon D.; Odom, Duncan T.] Univ Cambridge, Hutchison MRC Res Ctr, Dept Oncol, Cambridge CB2 0XZ, England; [Flicek, Paul; Odom, Duncan T.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Marshall, Aileen] Addenbrookes Hosp, Cambridge Hepatobiliary Serv, Cambridge CB2 2QQ, England	European Molecular Biology Laboratory (EMBL); CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Flicek, P (corresponding author), European Bioinformat Inst EMBL EBI, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	flicek@ebi.ac.uk; duncan.odom@cancer.org.uk	Wilson, Michael D/K-6294-2014; Kutter, Claudia/HHD-1391-2022; Ballester, Benoit/N-6127-2016	Wilson, Michael D/0000-0002-4015-3066; Ballester, Benoit/0000-0002-0834-7135; Kutter, Claudia/0000-0002-8047-0058; Schwalie, Petra Catalina/0000-0002-6004-8095; Flicek, Paul/0000-0002-3897-7955; Odom, Duncan/0000-0001-6201-5599	CRI Genomics and Bioinformatics Cores; European Research Council; EMBO; Hutchinson Whampoa; Cancer Research UK; University of Cambridge; Swiss National Science Foundation; Wellcome Trust [WT062023, WT098051]; EMBL; Cancer Research UK [15603] Funding Source: researchfish	CRI Genomics and Bioinformatics Cores; European Research Council(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Hutchinson Whampoa; Cancer Research UK(Cancer Research UK); University of Cambridge(University of Cambridge); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome Trust); EMBL; Cancer Research UK(Cancer Research UK)	We thank the CRI Genomics and Bioinformatics Cores for support; E. Fraenkel and S. Goslin for looking at zinc finger interactions with the CTCF-binding motif; S. Watt for experimental support; S. MacKay for reagents. This research was supported by the European Research Council, EMBO Young Investigator Program, Hutchinson Whampoa (D.T.O.), Cancer Research UK (D. S., M. D. W., C. K., A. M., G. D. B.), University of Cambridge (D. S., P. C. S., M. D. W., C. K., D.T.O.), Swiss National Science Foundation (C. K.), the Wellcome Trust (WT062023 and WT098051; D.T.O., B. B., P. F.), and EMBL (P. C. S., A. G., P. F.).	Awad TA, 1999, J BIOL CHEM, V274, P27092, DOI 10.1074/jbc.274.38.27092; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Britten RJ, 1997, GENE, V205, P177, DOI 10.1016/S0378-1119(97)00399-5; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Dunn KL, 2003, BIOCHEM CELL BIOL, V81, P161, DOI 10.1139/o03-052; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hirakawa M, 2009, GENE, V441, P100, DOI 10.1016/j.gene.2008.12.009; Johnson R, 2009, MOL BIOL EVOL, V26, P1491, DOI 10.1093/molbev/msp058; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kass DH, 1997, GENETICA, V99, P1, DOI 10.1023/A:1018350810791; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lee DH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001224; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; MacArthur S, 2004, MOL BIOL EVOL, V21, P1064, DOI 10.1093/molbev/msh105; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Martin D, 2011, NAT STRUCT MOL BIOL, V18, P708, DOI 10.1038/nsmb.2059; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Quitschke WW, 2000, NUCLEIC ACIDS RES, V28, P3370, DOI 10.1093/nar/28.17.3370; Rand E, 2004, CURR BIOL, V14, P1007, DOI 10.1016/j.cub.2004.05.041; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104	58	368	376	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					335	348		10.1016/j.cell.2011.11.058	http://dx.doi.org/10.1016/j.cell.2011.11.058			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22244452	Green Published, hybrid			2022-12-24	WOS:000299540700035
J	Lamia, KA; Papp, SJ; Yu, RT; Barish, GD; Uhlenhaut, NH; Jonker, JW; Downes, M; Evans, RM				Lamia, Katja A.; Papp, Stephanie J.; Yu, Ruth T.; Barish, Grant D.; Uhlenhaut, N. Henriette; Jonker, Johan W.; Downes, Michael; Evans, Ronald M.			Cryptochromes mediate rhythmic repression of the glucocorticoid receptor	NATURE			English	Article							CIRCADIAN CLOCK; GENE-EXPRESSION; PERIPHERAL-TISSUES; TRANSCRIPTION; LIVER; COMPONENT; BINDING; MOUSE; MICE; TIME	Mammalian metabolism is highly circadian and major hormonal circuits involving nuclear hormone receptors display interlinked diurnal cycling(1,2). However, mechanisms that logically explain the coordination of nuclear hormone receptors and the clock are poorly understood. Here we show that two circadian co-regulators, cryptochromes 1 and 2, interact with the glucocorticoid receptor in a ligand-dependent fashion and globally alter the transcriptional response to glucocorticoids in mouse embryonic fibroblasts: cryptochrome deficiency vastly decreases gene repression and approximately doubles the number of dexamethasone-induced genes, suggesting that cryptochromes broadly oppose glucocorticoid receptor activation and promote repression. In mice, genetic loss of cryptochrome 1 and/or 2 results in glucose intolerance and constitutively high levels of circulating corticosterone, suggesting reduced suppression of the hypothalamic-pituitary-adrenal axis coupled with increased glucocorticoid transactivation in the liver. Genomically, cryptochromes 1 and 2 associate with a glucocorticoid response element in the phosphoenolpyruvate carboxykinase 1 promoter in a hormone-dependent manner, and dexamethasone-induced transcription of the phosphoenolpyruvate carboxykinase 1 gene was strikingly increased in cryptochrome-deficient livers. These results reveal a specific mechanism through which cryptochromes couple the activity of clock and receptor target genes to complex genomic circuits underpinning normal metabolic homeostasis.	[Lamia, Katja A.; Yu, Ruth T.; Barish, Grant D.; Uhlenhaut, N. Henriette; Jonker, Johan W.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Lamia, Katja A.; Papp, Stephanie J.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Salk Institute; Scripps Research Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	klamia@scripps.edu; evans@salk.edu	Uhlenhaut, Henriette/AFR-1141-2022; Uhlenhaut, Nina Henriette/C-6288-2014; Evans, Ronald/AAF-4001-2019; Uhlenhaut, Henriette/AAP-5400-2020; Jonker, Johan W./ABE-6853-2020	Evans, Ronald/0000-0002-9986-5965; Jonker, Johan W./0000-0002-3919-5437; Yu, Ruth/0000-0002-9527-9627; Uhlenhaut, Henriette/0000-0002-4220-4779	National Institutes of Health [DK057978, DK062434, DK090188]; Glenn Foundation for Aging Research; Helmsley Trust; Life Sciences Research Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978, K01DK090188, U19DK062434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Aging Research; Helmsley Trust; Life Sciences Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Kaufman for assistance with glucose tolerance tests, J. Alvarez for RNA sample preparation, H. Juguilon for luciferase assays, J. Vaughan for corticosterone and ACTH measurements, antigenic peptide design and peptide-KLH coupling reactions, H. Cho for sharing unpublished plasmids and R. Shaw for comments on the manuscript. This work was supported by National Institutes of Health grants DK057978 and DK062434 (to R. M. E.) and DK090188 (to K. A. L.), by support from the Glenn Foundation for Aging Research (to R. M. E. and K. A. L.), from the Helmsley Trust (to R. M. E.) and by a Merck fellowship from the Life Sciences Research Foundation (to K.A.L.).	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lamia KA, 2004, MOL CELL BIOL, V24, P5080, DOI 10.1128/MCB.24.11.5080-5087.2004; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Sadacca LA, 2011, DIABETOLOGIA, V54, P120, DOI 10.1007/s00125-010-1920-8; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; WEINBERGER C, 1985, SCIENCE, V228, P740, DOI 10.1126/science.2581314; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	29	378	410	3	61	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					552	556		10.1038/nature10700	http://dx.doi.org/10.1038/nature10700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22170608	Green Accepted			2022-12-24	WOS:000298318000067
J	McIlwain, DR; Lang, PA; Maretzky, T; Hamada, K; Ohishi, K; Maney, SK; Berger, T; Murthy, A; Duncan, G; Xu, HFC; Lang, KS; Haussinger, D; Wakeham, A; Itie-Youten, A; Khokha, R; Ohashi, PS; Blobel, CP; Mak, TW				McIlwain, David R.; Lang, Philipp A.; Maretzky, Thorsten; Hamada, Koichi; Ohishi, Kazuhito; Maney, Sathish Kumar; Berger, Thorsten; Murthy, Aditya; Duncan, Gordon; Xu, Haifeng C.; Lang, Karl S.; Haeussinger, Dieter; Wakeham, Andrew; Itie-Youten, Annick; Khokha, Rama; Ohashi, Pamela S.; Blobel, Carl P.; Mak, Tak W.			iRhom2 Regulation of TACE Controls TNF-Mediated Protection Against Listeria and Responses to LPS	SCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; MICE; INFECTION; FAMILY; CELLS; METALLOPROTEINASE; MONOCYTOGENES; DISINTEGRIN; MATURATION	Innate immune responses are vital for pathogen defense but can result in septic shock when excessive. A key mediator of septic shock is tumor necrosis factor-alpha (TNF alpha), which is shed from the plasma membrane after cleavage by the TNF alpha convertase (TACE). We report that the rhomboid family member iRhom2 interacted with TACE and regulated TNF alpha shedding. iRhom2 was critical for TACE maturation and trafficking to the cell surface in hematopoietic cells. Gene-targeted iRhom2-deficient mice showed reduced serum TNFa in response to lipopolysaccharide (LPS) and could survive a lethal LPS dose. Furthermore, iRhom2-deficient mice failed to control the replication of Listeria monocytogenes. Our study has identified iRhom2 as a regulator of innate immunity that may be an important target for modulating sepsis and pathogen defense.	[McIlwain, David R.; Lang, Philipp A.; Berger, Thorsten; Duncan, Gordon; Xu, Haifeng C.; Wakeham, Andrew; Itie-Youten, Annick; Ohashi, Pamela S.; Mak, Tak W.] Univ Hlth Network UHN, Ontario Canc Inst, Campell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; [McIlwain, David R.; Ohashi, Pamela S.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Lang, Philipp A.; Maney, Sathish Kumar; Xu, Haifeng C.; Lang, Karl S.; Haeussinger, Dieter] Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany; [Maretzky, Thorsten; Blobel, Carl P.] Hosp Special Surg, Arthritis & Tissue Degenerat Program, New York, NY 10021 USA; [Hamada, Koichi] Kumamoto Univ, Ctr AIDS Res, Okada Projects, Kumamoto 8600811, Japan; [Ohishi, Kazuhito] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; [Murthy, Aditya; Khokha, Rama] UHN, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Lang, Karl S.] Univ Essen Gesamthsch, Inst Immunol, D-45147 Essen, Germany; [Blobel, Carl P.] Cornell Univ, Weill Med Coll, Dept Med & Physiol, New York, NY 10021 USA; [Blobel, Carl P.] Cornell Univ, Weill Med Coll, Dept Biophys, New York, NY 10021 USA; [Blobel, Carl P.] Cornell Univ, Weill Med Coll, Dept Syst Biol, New York, NY 10021 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Heinrich Heine University Dusseldorf; Kumamoto University; Osaka University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Duisburg Essen; Cornell University; Cornell University; Cornell University	Mak, TW (corresponding author), Univ Hlth Network UHN, Ontario Canc Inst, Campell Family Inst Breast Canc Res, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.	tmak@uhnresearch.ca	Maretzky, Thorsten/GSN-2981-2022; Maretzky, Thorsten/AEN-1915-2022; Berger, Thorsten/J-7632-2012; Lang, Karl S/R-2505-2016; Duncan, Gordon/AIE-7011-2022	Maretzky, Thorsten/0000-0003-1282-6080; Khokha, Rama/0000-0002-6028-1524; Lang, Karl/0000-0001-9783-7605; Ohashi, Pamela S./0000-0003-2915-9317	Alexander von Humboldt Foundation; Heinrich Heine University; Deutsche Forschungsgemeinschaft [LA1419/3-1]; Molecules of Infection Center, Manchot Graduate School (Jurgen Manchot Foundation); NIH [GM64750]; Emerald Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senri Life Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Canadian Institutes of Health Research; Terry Fox Foundation;  [SFB575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Heinrich Heine University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Molecules of Infection Center, Manchot Graduate School (Jurgen Manchot Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senri Life Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Le Gall, S. McCracken, A. Elia, E. Arpaia, and J. Height for experimental assistance and M. Saunders for scientific editing. The data reported in this manuscript are tabulated in the main paper and in the Supporting Online Material. P. A. L. was supported by the Sofja Kovalevskaja Award 2010 of the Alexander von Humboldt Foundation and the Strategic Research Fund of the Heinrich Heine University. K. S. L. was funded by the Sofja Kovalevskaja Award 2008 of the Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft grant LA1419/3-1; and the Molecules of Infection Center, Manchot Graduate School (Jurgen Manchot Foundation). This study was supported by the Collaborative Research Center 575 (SFB575: Experimental Hepatology; Coordinator: D. H.). C. P. B. was supported by NIH GM64750, and T. M. by the Emerald Foundation. K.O. was supported in part by the Naito Foundation; the Mochida Memorial Foundation for Medical and Pharmaceutical Research; the Senri Life Science Foundation; and the Ministry of Education, Culture, Sports, Science and Technology of Japan. T. W. M., D. R. M., and K.O. have filed U. S. Patent Application 61/426,396 regarding the use of iRhom2 for regulating innate immunity. This work was generously supported by funding from the Canadian Institutes of Health Research and the Terry Fox Foundation.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Alexopoulou L, 2006, EUR J IMMUNOL, V36, P2768, DOI 10.1002/eji.200635921; Bhattacharya D, 2002, P NATL ACAD SCI USA, V99, P8838, DOI 10.1073/pnas.132274799; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Nakagawa T, 2005, DEV DYNAM, V233, P1315, DOI 10.1002/dvdy.20450; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Scott DL, 2006, NEW ENGL J MED, V355, P704, DOI 10.1056/NEJMct055183; Torres D, 2005, AM J PATHOL, V167, P1677, DOI 10.1016/S0002-9440(10)61250-3; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047; Zou HF, 2009, FASEB J, V23, P425, DOI 10.1096/fj.08-112771	23	230	236	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					229	232		10.1126/science.1214448	http://dx.doi.org/10.1126/science.1214448			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246778	Green Accepted			2022-12-24	WOS:000299033100056
J	Iijima, T; Wu, KR; Witte, H; Hanno-Iijima, Y; Glatter, T; Richard, S; Scheiffele, P				Iijima, Takatoshi; Wu, Karen; Witte, Harald; Hanno-Iijima, Yoko; Glatter, Timo; Richard, Stephane; Scheiffele, Peter			SAM68 Regulates Neuronal Activity-Dependent Alternative Splicing of Neurexin-1	CELL			English	Article							RNA-BINDING PROTEIN; SYNAPSE DEVELOPMENT; ALPHA-NEUREXINS; STRUCTURAL BASIS; BETA-NEUREXINS; GRANULE CELLS; KINASE; RECEPTOR; PHOSPHORYLATION; CEREBELLUM	The assembly of synapses and neuronal circuits relies on an array of molecular recognition events and their modification by neuronal activity. Neurexins are a highly polymorphic family of synaptic receptors diversified by extensive alternative splicing. Neurexin variants exhibit distinct isoform-specific biochemical interactions and synapse assembly functions, but the mechanisms governing splice isoform choice are not understood. We demonstrate that Nrxn1 alternative splicing is temporally and spatially controlled in the mouse brain. Neuronal activity triggers a shift in Nrxn1 splice isoform choice via calcium/calmodulin-dependent kinase IV signaling. Activity-dependent alternative splicing of Nrxn1 requires the KH-domain RNA-binding protein SAM68 that associates with RNA response elements in the Nrxn1 pre-mRNA. Our findings uncover SAM68 as a key regulator of dynamic control of Nrxn1 molecular diversity and activity-dependent alternative splicing in the central nervous system.	[Iijima, Takatoshi; Witte, Harald; Hanno-Iijima, Yoko; Glatter, Timo; Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Wu, Karen; Scheiffele, Peter] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Wu, Karen; Scheiffele, Peter] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Richard, Stephane] McGill Univ, Segal Canc Ctr, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Richard, Stephane] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Richard, Stephane] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada	University of Basel; Columbia University; Columbia University; Lady Davis Institute; McGill University; McGill University; McGill University	Scheiffele, P (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	peter.scheiffele@unibas.ch		Glatter, Timo/0000-0001-8716-8516; Scheiffele, Peter/0000-0002-9516-9399	Jane Coffin Childs Fund; Uehara Memorial Foundation; KANAE Foundation for the Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; Canadian Institutes of Health Research; NINDS [R21 NS53936]; Swiss National Science Foundation; Kanton Basel-Stadt; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053936] Funding Source: NIH RePORTER	Jane Coffin Childs Fund; Uehara Memorial Foundation(Uehara Memorial Foundation); KANAE Foundation for the Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Basel-Stadt; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Dr. Jane Dodd for generously sharing lab space and resources, to Dr. Leora Gollan who contributed initial findings, to Drs. Yves Barde, Olivier Pertz, Oguz Kanca, Stephane Baudouin, and Thi-Minh-Phuc Nguyen for comments on the manuscript, to Drs. Boukhtouche, Cocas, and Sommer and Ms. Stiefvater for help with in utero electroporations, to Dr. Alex Schmidt for help with proteomics, to Laetitia Burkle and Caroline Bornmann for excellent technical support, to Prof. Michisuke Yuzaki for advice and for generously sharing a GluD2 expression vector, to Dr. Kyo-ichi Emi for advice on cerebellar injections, and to Gillian Vogel and members of the Scheiffele Lab for valuable discussions. We thank Drs. Chabot, Darnell, Ghosh, Konig, Smith, Sette, and Soderling and the Developmental Studies Hybridoma Bank, University of Iowa, for making important reagents available. K. W. is the recipient of a Jane Coffin Childs Fund postdoctoral fellowship award. T. I. was supported by the Uehara Memorial Foundation, KANAE Foundation for the Promotion of Medical Science and Astellas Foundation for Research on Metabolic Disorders. S. R. is funded by the Canadian Institutes of Health Research, and the project was funded by support to P.S. from NINDS (R21 NS53936), the Swiss National Science Foundation, and the Kanton Basel-Stadt.	An P, 2007, PLOS BIOL, V5, P263, DOI 10.1371/journal.pbio.0050036; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Baudouin S, 2010, CELL, V141, P908, DOI 10.1016/j.cell.2010.05.024; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Chawla G, 2009, MOL CELL BIOL, V29, P201, DOI 10.1128/MCB.01349-08; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Di Fruscio M, 1999, P NATL ACAD SCI USA, V96, P2710, DOI 10.1073/pnas.96.6.2710; Fisette JF, 2010, RNA, V16, P228, DOI 10.1261/rna.1890310; Galarneau A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-47; Grange J, 2004, J NEUROSCI RES, V75, P654, DOI 10.1002/jnr.20003; Henao-Mejia J, 2009, MOL CELL, V33, P87, DOI 10.1016/j.molcel.2008.11.024; Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008; Huot ME, 2009, MOL CELL BIOL, V29, P1933, DOI 10.1128/MCB.01707-08; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Iijima T, 2009, J NEUROSCI, V29, P5425, DOI 10.1523/JNEUROSCI.4473-08.2009; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Koehnke J, 2010, NEURON, V67, P61, DOI 10.1016/j.neuron.2010.06.001; Lee JA, 2007, PLOS BIOL, V5, P281, DOI 10.1371/journal.pbio.0050040; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Lukong KE, 2008, BEHAV BRAIN RES, V189, P357, DOI 10.1016/j.bbr.2008.01.010; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mellor JR, 1998, J NEUROSCI, V18, P2822; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Reissner C, 2008, P NATL ACAD SCI USA, V105, P15124, DOI 10.1073/pnas.0801639105; Resnick M, 2008, NEUROSCI LETT, V439, P235, DOI 10.1016/j.neulet.2008.05.034; Richard S, 2005, PLOS GENET, V1, P676, DOI 10.1371/journal.pgen.0010074; Rossi P, 1998, J NEUROSCI, V18, P3537; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Rozic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018579; Rozic-Kotliroff G, 2007, BIOCHEM BIOPH RES CO, V352, P226, DOI 10.1016/j.bbrc.2006.11.008; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Stoss O, 2004, MOL CELL NEUROSCI, V27, P8, DOI 10.1016/j.mcn.2004.04.011; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tisserant A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001418; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073; Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 2005, RNA, V11, P1825, DOI 10.1261/rna.2171205; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	68	190	195	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1601	1614		10.1016/j.cell.2011.11.028	http://dx.doi.org/10.1016/j.cell.2011.11.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196734	Green Accepted, Bronze			2022-12-24	WOS:000298403400023
J	Karpova, NN; Pickenhagen, A; Lindholm, J; Tiraboschi, E; Kulesskaya, N; Agustsdottir, A; Antila, H; Popova, D; Akamine, Y; Sullivan, R; Hen, R; Drew, LJ; Castren, E				Karpova, Nina N.; Pickenhagen, Anouchka; Lindholm, Jesse; Tiraboschi, Ettore; Kulesskaya, Natalia; Agustsdottir, Arna; Antila, Hanna; Popova, Dina; Akamine, Yumiko; Sullivan, Regina; Hen, Rene; Drew, Liam J.; Castren, Eero			Fear Erasure in Mice Requires Synergy Between Antidepressant Drugs and Extinction Training	SCIENCE			English	Article							PERINEURONAL NETS; PLASTICITY; PHARMACOTHERAPY; MECHANISMS; MATURATION; DEPRESSION; MEMORIES; CIRCUITS; BDNF	Antidepressant drugs and psychotherapy combined are more effective in treating mood disorders than either treatment alone, but the neurobiological basis of this interaction is unknown. To investigate how antidepressants influence the response of mood-related systems to behavioral experience, we used a fear-conditioning and extinction paradigm in mice. Combining extinction training with chronic fluoxetine, but neither treatment alone, induced an enduring loss of conditioned fear memory in adult animals. Fluoxetine treatment increased synaptic plasticity, converted the fear memory circuitry to a more immature state, and acted through local brain-derived neurotrophic factor. Fluoxetine-induced plasticity may allow fear erasure by extinction-guided remodeling of the memory circuitry. Thus, the pharmacological effects of antidepressants need to be combined with psychological rehabilitation to reorganize networks rendered more plastic by the drug treatment.	[Karpova, Nina N.; Lindholm, Jesse; Tiraboschi, Ettore; Kulesskaya, Natalia; Agustsdottir, Arna; Antila, Hanna; Popova, Dina; Akamine, Yumiko; Castren, Eero] Univ Helsinki, Ctr Neurosci, Sigrid Juselius Lab, FIN-00014 Helsinki, Finland; [Lindholm, Jesse] Univ Helsinki, Dept Biosci & Physiol, FIN-00014 Helsinki, Finland; [Pickenhagen, Anouchka; Sullivan, Regina] NYU, Med Ctr, Emot Brain Inst Nathan Kline Inst, New York, NY 10016 USA; [Hen, Rene; Drew, Liam J.; Castren, Eero] Columbia Univ, Dept Psychiat & Neurosci, New York, NY 10032 USA	Sigrid Juselius Foundation; University of Helsinki; University of Helsinki; Nathan Kline Institute for Psychiatric Research; New York University; Columbia University	Castren, E (corresponding author), Univ Helsinki, Ctr Neurosci, Sigrid Juselius Lab, FIN-00014 Helsinki, Finland.	eero.castren@helsinki.fi	Karpova, Nina/L-6724-2013	Karpova, Nina/0000-0002-3197-4559; Akamine, Yumiko/0000-0002-3950-2572; Kulesskaya, Natalia/0000-0001-5517-8525; Sullivan, Regina Marie/0000-0002-2406-8857; BAHI, Amine/0000-0003-2873-2249; Antila, Hanna/0000-0001-8317-4564; Tiraboschi, Ettore/0000-0001-6872-6738; Castren, Eero/0000-0002-1402-2791	Sigrid Juselius Foundation; Academy of Finland Center of Excellence; NIH [DC003906, NIH-DC009910]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003906, R01DC009910] Funding Source: NIH RePORTER	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland Center of Excellence(Academy of Finland); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank O. Nikkila, T. Rantamaki, V. Voikar, and M. Kislin for technical help; Jean-Luc Dreyer for the gift of BDNF lentivirus; F. Battaglia for help with electrophysiology; C. Rivera for the KCC2 antibody; and J. Sallinen, Orion Pharma, for the gift of fluoxetine. E. C. is a shareholder of Hermo Pharma, Incorporated. This work was supported by Sigrid Juselius Foundation and Academy of Finland Center of Excellence program (E. C.) and NIH grants DC003906 and NIH-DC009910 (R.M.S.).	Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bisson J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub3; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Deschaux O, 2011, PSYCHOPHARMACOLOGY, V215, P231, DOI 10.1007/s00213-010-2134-y; Drephal C, 2006, NEUROBIOL LEARN MEM, V85, P272, DOI 10.1016/j.nlm.2005.11.004; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Hetrick SE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007316.pub2; Holmes A, 2010, TRENDS PHARMACOL SCI, V31, P2, DOI 10.1016/j.tips.2009.10.003; Kim JH, 2010, BIOL PSYCHIAT, V67, P297, DOI 10.1016/j.biopsych.2009.09.003; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P8434, DOI 10.1073/pnas.0912690107; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Pampallona S, 2004, ARCH GEN PSYCHIAT, V61, P714, DOI 10.1001/archpsyc.61.7.714; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Saarelainen T, 2003, J NEUROSCI, V23, P349; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Stein DJ, 2009, CNS SPECTRUMS, V14, P25; Sullivan RM, 2000, NATURE, V407, P38, DOI 10.1038/35024156; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006	31	254	262	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1731	1734		10.1126/science.1214592	http://dx.doi.org/10.1126/science.1214592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194582	Green Accepted			2022-12-24	WOS:000298344000075
J	Ulitsky, I; Shkumatava, A; Jan, CH; Sive, H; Bartel, DP				Ulitsky, Igor; Shkumatava, Alena; Jan, Calvin H.; Sive, Hazel; Bartel, David P.			Conserved Function of lincRNAs in Vertebrate Embryonic Development despite Rapid Sequence Evolution	CELL			English	Article							LONG NONCODING RNAS; GENOME DUPLICATION; CHROMATIN STATE; GENE-EXPRESSION; TELEOST FISH; ZEBRAFISH; REVEALS; CELLS; DIFFERENTIATION; MAMMALS	Thousands of long intervening noncoding RNAs (lincRNAs) have been identified in mammals. To better understand the evolution and functions of these enigmatic RNAs, we used chromatin marks, poly(A)-site mapping and RNA-Seq data to identify more than 550 distinct lincRNAs in zebrafish. Although these shared many characteristics with mammalian lincRNAs, only 29 had detectable sequence similarity with putative mammalian orthologs, typically restricted to a single short region of high conservation. Other lincRNAs had conserved genomic locations without detectable sequence conservation. Antisense reagents targeting conserved regions of two zebrafish lincRNAs caused developmental defects. Reagents targeting splice sites caused the same defects and were rescued by adding either the mature lincRNA or its human or mouse ortholog. Our study provides a roadmap for identification and analysis of lincRNAs in model organisms and shows that lincRNAs play crucial biological roles during embryonic development with functionality conserved despite limited sequence conservation.	[Ulitsky, Igor; Shkumatava, Alena; Jan, Calvin H.; Sive, Hazel; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ulitsky, Igor; Shkumatava, Alena; Jan, Calvin H.; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Ulitsky, Igor; Shkumatava, Alena; Jan, Calvin H.; Sive, Hazel; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu	Ulitsky, Igor/HCH-7453-2022	Ulitsky, Igor/0000-0003-0555-6561; Sive, Hazel/0000-0002-4890-424X	NIH [GM067031]; EMBO; Human Frontiers Science Program; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Auyeung, O. Rissland, I. Drinnenberg, R. Shalgi, S. Hong, and D. Garcia for comments on the manuscript; T. DiCesare for illustration; M. Guenther for help with the ChIP-Seq protocol; WI genome technology core for sequencing and W. Johnston, O. Paugois and G. Lafkas for technical support. The Tg(neurod:egfp) transgenic line was kindly provided by the Nicolson lab. RNA-Seq data was kindly made available by the Wellcome Trust Sanger Institute. This work was supported by a grant (GM067031) from the NIH (D.P.B.), an EMBO long-term fellowship (I.U.), a Human Frontiers Science Program long-term fellowship (A.S.), and an NSF predoctoral fellowship (C.H.J.).	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Chooniedass-Kothari S, 2004, FEBS LETT, V566, P43, DOI 10.1016/j.febslet.2004.03.104; De Lucia F, 2011, CURR OPIN PLANT BIOL, V14, P168, DOI 10.1016/j.pbi.2010.11.006; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-102; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hube F, 2006, DNA CELL BIOL, V25, P418, DOI 10.1089/dna.2006.25.418; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Jouannet V, 2011, PROG MOL SUBCELL BIO, V51, P179, DOI 10.1007/978-3-642-16502-3_9; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kolasinska-Zwierz P., 2009, NAT GENET, V41, P376; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sarma Kavitha, 2010, Proc Natl Acad Sci U S A, V107, P22196, DOI 10.1073/pnas.1009785107; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Semon M, 2007, MOL BIOL EVOL, V24, P860, DOI 10.1093/molbev/msm003; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stadler P.F., 2010, ADV BIOINFORMATICS C; Taher L, 2009, BIOINFORMATICS, V25, P578, DOI 10.1093/bioinformatics/btp043; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	57	847	898	3	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2011	147	7					1537	1550		10.1016/j.cell.2011.11.055	http://dx.doi.org/10.1016/j.cell.2011.11.055			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196729	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-24	WOS:000298403400018
J	Coller, HA				Coller, Hilary A.			The Essence of Quiescence	SCIENCE			English	Editorial Material							CELLULAR QUIESCENCE; CONTACT INHIBITION; CYCLE		Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Coller, HA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hcoller@princeton.edu			NIGMS NIH HHS [R01 GM081686, R01 GM086465] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081686, R01GM086465] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Gos M, 2005, CELL PROLIFERAT, V38, P107, DOI 10.1111/j.1365-2184.2005.00334.x; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Liu H, 2007, PLOS GENET, V3, P996, DOI 10.1371/journal.pgen.0030091; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; SMITH JA, 1973, P NATL ACAD SCI USA, V70, P1263, DOI 10.1073/pnas.70.4.1263; WILLIAMS JG, 1975, CELL, V6, P197, DOI 10.1016/0092-8674(75)90010-0	15	59	59	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1074	1075		10.1126/science.1216242	http://dx.doi.org/10.1126/science.1216242			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116874	Green Accepted			2022-12-24	WOS:000297313900035
J	Piggott, BJ; Liu, J; Feng, ZY; Wescott, SA; Xu, XZS				Piggott, Beverly J.; Liu, Jie; Feng, Zhaoyang; Wescott, Seth A.; Xu, X. Z. Shawn			The Neural Circuits and Synaptic Mechanisms Underlying Motor Initiation in C. elegans	CELL			English	Article							BEHAVING CAENORHABDITIS-ELEGANS; GLR-1 GLUTAMATE-RECEPTOR; OPTICAL INTERROGATION; NEURONAL-ACTIVITY; NERVOUS-SYSTEM; HOMOLOG; SENSITIVITY; THERMOTAXIS; CHANNELS	C. elegans is widely used to dissect how neural circuits and genes generate behavior. During locomotion, worms initiate backward movement to change locomotion direction spontaneously or in response to sensory cues; however, the underlying neural circuits are not well defined. We applied a multidisciplinary approach to map neural circuits in freely behaving worms by integrating functional imaging, optogenetic interrogation, genetic manipulation, laser ablation, and electrophysiology. We found that a disinhibitory circuit and a stimulatory circuit together promote initiation of backward movement and that circuitry dynamics is differentially regulated by sensory cues. Both circuits require glutamatergic transmission but depend on distinct glutamate receptors. This dual mode of motor initiation control is found in mammals, suggesting that distantly related organisms with anatomically distinct nervous systems may adopt similar strategies for motor control. Additionally, our studies illustrate how a multidisciplinary approach facilitates dissection of circuit and synaptic mechanisms underlying behavior in a genetic model organism.	[Piggott, Beverly J.; Liu, Jie; Wescott, Seth A.; Xu, X. Z. Shawn] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Piggott, Beverly J.; Xu, X. Z. Shawn] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Feng, Zhaoyang] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Case Western Reserve University	Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu	Piggott, Beverly/GQH-4796-2022	liu, jie/0000-0002-1215-5814	NEI (University of Michigan); NIGMS; Pew scholar program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022316] Funding Source: NIH RePORTER	NEI (University of Michigan)(University of Michigan SystemUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pew scholar program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Gao, W. Li, W. Zhou, and A. Ward for technical assistance; L. Looger for the G-CaMP3.0 plasmid; A. Gottschalk for ChR2 plasmid; K. Deisseroth for NpHR plasmid; J. Dent and L. Avery for avr-14 strains and plasmids; and P. Hu, A. Kumar, and B. Ye for comments on the manuscript. Some strains were obtained from the CGC and Knockout Consortiums in the USA and Japan. B. J. P. was supported by a predoctoral T32 training grant from the NEI (University of Michigan). This work was supported by grants from the NIGMS and Pew scholar program (to X.Z.S.X.).	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Ben Arous J, 2010, J NEUROSCI METH, V187, P229, DOI 10.1016/j.jneumeth.2010.01.011; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; CHALFIE M, 1985, J NEUROSCI, V5, P956; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Faumont S, 2006, J NEUROPHYSIOL, V95, P1976, DOI 10.1152/jn.01050.2005; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Ohnishi N, 2011, EMBO J, V30, P1376, DOI 10.1038/emboj.2011.13; PURVES D, 2008, NEUROSCIENCE, P397; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Reigl M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-25; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yates DM, 2003, INT J PARASITOL, V33, P1183, DOI 10.1016/S0020-7519(03)00172-3; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	40	163	165	2	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 11	2011	147	4					922	933		10.1016/j.cell.2011.08.053	http://dx.doi.org/10.1016/j.cell.2011.08.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22078887	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000296902300023
J	Waggoner, SN; Cornberg, M; Selin, LK; Welsh, RM				Waggoner, Stephen N.; Cornberg, Markus; Selin, Liisa K.; Welsh, Raymond M.			Natural killer cells act as rheostats modulating antiviral T cells	NATURE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; INFECTION; RESPONSES; MICE; HLA; IDENTIFICATION; PATHOGENESIS; CHAIN	Antiviral T cells are thought to regulate whether hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections result in viral control, asymptomatic persistence or severe disease, although the reasons for these different outcomes remain unclear. Recent genetic evidence, however, has indicated a correlation between certain natural killer (NK)-cell receptors and progression of both HIV and HCV infection(1-3), implying that NK cells have a role in these T-cell-associated diseases. Although direct NK-cell-mediated lysis of virus-infected cells may contribute to antiviral defence during some virus infections-especially murine cytomegalovirus (MCMV) infections in mice and perhaps HIV in humans(4,5)-NK cells have also been suspected of having immunoregulatory functions. For instance, NK cells may indirectly regulate T-cell responses by lysing MCMV-infected antigen-presenting cells(6,7). In contrast to MCMV, lymphocytic choriomeningitis virus (LCMV) infection in mice seems to be resistant to any direct antiviral effects of NK cells(5,8). Here we examine the roles of NK cells in regulating T-cell-dependent viral persistence and immunopathology in mice infected with LCMV, an established model for HIV and HCV infections in humans. We describe a three-way interaction, whereby activated NK cells cytolytically eliminate activated CD4 T cells that affect CD8 T-cell function and exhaustion. At high virus doses, NK cells prevented fatal pathology while enabling T-cell exhaustion and viral persistence, but at medium doses NK cells paradoxically facilitated lethal T-cell-mediated pathology. Thus, NK cells can act as rheostats, regulating CD4 T-cell-mediated support for the antiviral CD8 T cells that control viral pathogenesis and persistence.	[Waggoner, Stephen N.; Selin, Liisa K.; Welsh, Raymond M.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; [Waggoner, Stephen N.; Selin, Liisa K.; Welsh, Raymond M.] Univ Massachusetts, Sch Med, Program Immunol & Virol, Worcester, MA 01655 USA; [Cornberg, Markus] Hannover Med Sch, Dept Gastroenterol & Hepatol, D-30625 Hannover, Germany	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Hannover Medical School	Welsh, RM (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.	Raymond.Welsh@umassmed.edu	Cornberg, Markus/AAN-6939-2021; HAMID, SHARIFAH BEE ABD/B-9749-2010	Cornberg, Markus/0000-0002-9141-8001; HAMID, SHARIFAH BEE ABD/0000-0002-5104-3938; Waggoner, Stephen/0000-0001-9658-2874; Selin, Liisa/0000-0002-6993-4333	National Institutes of Health (NIH) [AI07349, AI-17672, AI-081675, CA34461, AI46578]; German Research Foundation [CO310-2/1]; institutional Diabetes Endocrinology Research Center (DERC) [DK52530]; NATIONAL CANCER INSTITUTE [R01CA034461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI017672, R01AI081675, R01AI017672, T32AI007349, R01AI046578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052530] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); institutional Diabetes Endocrinology Research Center (DERC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Hearn, C. Baer, J. Suschak and P. Afriyie for technical support; K. Daniels and M. Seedhom for insightful discussions; R. Taniguchi and V. Kumar for sharing unpublished observations; and H. Ducharme for mouse husbandry. We thank L. Berg for NKT tetramer, L. Lanier for anti-NKG2D blocking antibody (CX5), B. Polic for Nkg2d<SUP>-/-</SUP> mice and M. Exley for Cd1d<SUP>-/-</SUP> mice. This work was supported by National Institutes of Health (NIH) training grant AI07349 (S.N.W.) and research grants AI-17672, AI-081675, CA34461 (R. M. W.), AI46578 (L. K. S.), a German Research Foundation fellowship CO310-2/1 (M. C.) and an institutional Diabetes Endocrinology Research Center (DERC) grant DK52530. The views expressed are those of the authors and do not necessarily express the views of the NIH.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; BATTEGAY M, 1994, J VIROL, V68, P4700, DOI 10.1128/JVI.68.7.4700-4704.1994; BUKOWSKI JF, 1984, J VIROL, V52, P119, DOI 10.1128/JVI.52.1.119-128.1984; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Exley MA, 2003, IMMUNOLOGY, V110, P519, DOI 10.1111/j.1365-2567.2003.01779.x; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Jennes W, 2006, J IMMUNOL, V177, P6588, DOI 10.4049/jimmunol.177.10.6588; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; KLAVINSKIS LS, 1990, VIROLOGY, V178, P393, DOI 10.1016/0042-6822(90)90336-P; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Mylin LM, 2000, J VIROL, V74, P6922, DOI 10.1128/JVI.74.15.6922-6934.2000; NAGANUMA H, 1991, INT J CANCER, V47, P527, DOI 10.1002/ijc.2910470410; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Oldstone MBA, 2002, CURR TOP MICROBIOL, V263, P83; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; Rabinovich BA, 2003, J IMMUNOL, V170, P3572, DOI 10.4049/jimmunol.170.7.3572; Rivas MN, 2010, J IMMUNOL, V184, P6790, DOI 10.4049/jimmunol.0902598; Robbins SH, 2007, PLOS PATHOG, V3, P1152, DOI 10.1371/journal.ppat.0030123; Soderquest K, 2011, J IMMUNOL, V186, P3304, DOI 10.4049/jimmunol.1004122; Su HC, 2001, EUR J IMMUNOL, V31, P3048, DOI 10.1002/1521-4141(2001010)31:10<3048::AID-IMMU3048>3.0.CO;2-1; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; Waggoner SN, 2010, J CLIN INVEST, V120, P1925, DOI 10.1172/JCI41264; WELSH RM, 1991, J EXP MED, V173, P1053, DOI 10.1084/jem.173.5.1053; WELSH RM, 1986, NAT IMMUN CELL GROW, V5, P169; WELSH RM, 1978, J EXP MED, V148, P163, DOI 10.1084/jem.148.1.163; YANG H, 1985, Natural Immunity and Cell Growth Regulation, V4, P21; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zafirova B, 2009, IMMUNITY, V31, P270, DOI 10.1016/j.immuni.2009.06.017; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	36	407	417	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					394	U183		10.1038/nature10624	http://dx.doi.org/10.1038/nature10624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22101430	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000299210600049
J	Inamori, K; Yoshida-Moriguchi, T; Hara, Y; Anderson, ME; Yu, LP; Campbell, KP				Inamori, Kei-ichiro; Yoshida-Moriguchi, Takako; Hara, Yuji; Anderson, Mary E.; Yu, Liping; Campbell, Kevin P.			Dystroglycan Function Requires Xylosyl- and Glucuronyltransferase Activities of LARGE	SCIENCE			English	Article							ALPHA-DYSTROGLYCAN; MUSCULAR-DYSTROPHY; CRYSTAL-STRUCTURE; LAMININ-BINDING; GLYCOSYLATION; GLYCOSYLTRANSFERASES; FAMILY	Posttranslational modification of alpha-dystroglycan (alpha-DG) by the like-acetylglucosaminyltransferase (LARGE) is required for it to function as an extracellular matrix (ECM) receptor. Mutations in the LARGE gene have been identified in congenital muscular dystrophy patients with brain abnormalities. However, the precise function of LARGE remains unclear. Here we found that LARGE could act as a bifunctional glycosyltransferase, with both xylosyltransferase and glucuronyltransferase activities, which produced repeating units of [-3-xylose-alpha 1,3-glucuronic acid-beta 1-]. This modification allowed alpha-DG to bind laminin-G domain-containing ECM ligands.	[Inamori, Kei-ichiro; Yoshida-Moriguchi, Takako; Hara, Yuji; Anderson, Mary E.; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Dept Mol Physiol & Biophys,Roy J & Lucille A Carv, Dept Neurol,Dept Internal Med, Iowa City, IA 52242 USA; [Yu, Liping] Univ Iowa, Med Nucl Magnet Resonance Facil, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Mol Physiol & Biophys,Roy J & Lucille A Carv, Dept Neurol,Dept Internal Med, 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Inamori, Kei-ichiro/ABA-2926-2020	Inamori, Kei-ichiro/0000-0002-5947-3633; Yu, Liping/0000-0003-3536-6427; Campbell, Kevin/0000-0003-2066-5889	Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [1U54NS053672]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER	Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all members of the Campbell laboratory for fruitful discussions and D. Venzke and Z. Zhu for technical assistance, J. D. Esko for providing pgsI-208 cells, and the University of Iowa Proteomics Facility and Flow Cytometry Facility, Iowa State University Hybridoma Facility, and the Glycotechnology Core Resource (UCSD) for their services. This work was supported in part by a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant (1U54NS053672). K. P. C. is an Investigator of the Howard Hughes Medical Institute.	Bakker H, 2009, J BIOL CHEM, V284, P2576, DOI 10.1074/jbc.M804394200; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; SCHWARTZ NB, 1974, P NATL ACAD SCI USA, V71, P4047, DOI 10.1073/pnas.71.10.4047; Varki A., 2009, ESSENTIALS GLYCOBIOL; Yamada H, 1996, J NEUROCHEM, V66, P1518; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	18	207	218	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					93	96		10.1126/science.1214115	http://dx.doi.org/10.1126/science.1214115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223806	Green Accepted			2022-12-24	WOS:000298846200058
J	Casanueva, MO; Burga, A; Lehner, B				Olivia Casanueva, M.; Burga, Alejandro; Lehner, Ben			Fitness Trade-Offs and Environmentally Induced Mutation Buffering in Isogenic C. elegans	SCIENCE			English	Article							STOCHASTIC GENE-EXPRESSION; HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS; DELETERIOUS MUTATIONS; MOLECULAR CHAPERONES; NATURAL-SELECTION; LIFE-SPAN; HSP90; EVOLUTION; BACTERIA	Mutations often have consequences that vary across individuals. Here, we show that the stimulation of a stress response can reduce mutation penetrance in Caenorhabditis elegans. Moreover, this induced mutation buffering varies across isogenic individuals because of interindividual differences in stress signaling. This variation has important consequences in wild-type animals, producing some individuals with higher stress resistance but lower reproductive fitness and other individuals with lower stress resistance and higher reproductive fitness. This may be beneficial in an unpredictable environment, acting as a "bet-hedging" strategy to diversify risk. These results illustrate how transient environmental stimuli can induce protection against mutations, how environmental responses can underlie variable mutation buffering, and how a fitness trade-off may make variation in stress signaling advantageous.	[Olivia Casanueva, M.; Lehner, Ben] CRG, European Mol Biol Lab, Ctr Genom Regulat EMBL CRG, Syst Biol Unit, Barcelona, Spain; [Olivia Casanueva, M.; Burga, Alejandro; Lehner, Ben] Univ Pompeu Fabra, Barcelona, Spain; [Burga, Alejandro; Lehner, Ben] CRG, ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Lehner, B (corresponding author), CRG, European Mol Biol Lab, Ctr Genom Regulat EMBL CRG, Syst Biol Unit, Barcelona, Spain.	ben.lehner@crg.eu	Burga, Alejandro/AAJ-8745-2020; Lehner, Ben/L-3413-2014; Lehner, Ben/ABH-6562-2020	Burga, Alejandro/0000-0002-0211-4357; Lehner, Ben/0000-0002-8817-1124; Lehner, Ben/0000-0002-8817-1124	European Research Council (ERC); ICREA; Spanish Ministry of Science and Innovation (MICINN) [BFU2008-00365]; University and Research Grant Management Agency of Catalonia (AGAUR); ERASysBio+; ERA-NET SysBio+; EMBL-CRG; Beatriu de Pinos Fellowship; Formacion de Personal Investigador (FPI)-MICINN; NIH National Center for Research Resources (NCRR); ICREA Funding Source: Custom	European Research Council (ERC)(European Research Council (ERC)European Commission); ICREA(ICREA); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University and Research Grant Management Agency of Catalonia (AGAUR); ERASysBio+; ERA-NET SysBio+; EMBL-CRG; Beatriu de Pinos Fellowship; Formacion de Personal Investigador (FPI)-MICINN(National Health and Medical Research Council (NHMRC) of Australia); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ICREA(ICREA)	We thank the European Research Council (ERC), ICREA, Spanish Ministry of Science and Innovation (MICINN) Plan Nacional grant BFU2008-00365, University and Research Grant Management Agency of Catalonia (AGAUR), ERASysBio+, ERA-NET SysBio+, and the EMBL-CRG Systems Biology Program for funding. O.C. was supported by a Beatriu de Pinos Fellowship and A. B by a Formacion de Personal Investigador (FPI)-MICINN fellowship. Some nematode strains and bacterial clones were provided by T. Gidalevitz, C. Silva, A. Chisholm, A. Rougvie, and the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). We thank R. Jelier for assistance with statistical analyses and M. Isalan and members of our laboratory for comments on the manuscript.	Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bobula J, 2006, GENETICS, V174, P937, DOI 10.1534/genetics.106.061564; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Eldar A, 2009, NATURE, V460, P510, DOI 10.1038/nature08150; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; GILLESPIE JH, 1974, GENETICS, V76, P601; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Krebs RA, 1997, CELL STRESS CHAPERON, V2, P60, DOI 10.1379/1466-1268(1997)002<0060:DCOHOI>2.3.CO;2; Lehner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009035; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Marden JH, 2001, J EXP BIOL, V204, P3457; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; SLATKIN M, 1974, NATURE, V250, P704, DOI 10.1038/250704b0; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Walker DW, 2000, NATURE, V405, P296, DOI 10.1038/35012693; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	33	104	105	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2012	335	6064					82	85		10.1126/science.1213491	http://dx.doi.org/10.1126/science.1213491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22174126				2022-12-24	WOS:000298846200055
J	Malanchi, I; Santamaria-Martinez, A; Susanto, E; Peng, H; Lehr, HA; Delaloye, JF; Huelsken, J				Malanchi, Ilaria; Santamaria-Martinez, Albert; Susanto, Evelyn; Peng, Hong; Lehr, Hans-Anton; Delaloye, Jean-Francois; Huelsken, Joerg			Interactions between cancer stem cells and their niche govern metastatic colonization	NATURE			English	Article							TUMOR-INITIATING CELLS; PERIOSTIN-NULL MICE; BREAST-CANCER; MAMMARY-TUMORS; BETA-CATENIN; MOUSE MODEL; LONG-TERM; EXPRESSION; IDENTIFICATION; DISSEMINATION	Metastatic growth in distant organs is the major cause of cancer mortality. The development of metastasis is a multistage process with several rate-limiting steps(1). Although dissemination of tumour cells seems to be an early and frequent event(2), the successful initiation of metastatic growth, a process termed 'metastatic colonization', is inefficient for many cancer types and is accomplished only by a minority of cancer cells that reach distant sites(3,4). Prevalent target sites are characteristic of many tumour entities(5), suggesting that inadequate support by distant tissues contributes to the inefficiency of the metastatic process. Here we show that a small population of cancer stem cells is critical for metastatic colonization, that is, the initial expansion of cancer cells at the secondary site, and that stromal niche signals are crucial to this expansion process. We find that periostin (POSTN), a component of the extracellular matrix, is expressed by fibroblasts in the normal tissue and in the stroma of the primary tumour. Infiltrating tumour cells need to induce stromal POSTN expression in the secondary target organ (in this case lung) to initiate colonization. POSTN is required to allow cancer stem cell maintenance, and blocking its function prevents metastasis. POSTN recruits Wnt ligands and thereby increases Wnt signalling in cancer stem cells. We suggest that the education of stromal cells by infiltrating tumour cells is an important step in metastatic colonization and that preventing de novo niche formation may be a novel strategy for the treatment of metastatic disease.	[Malanchi, Ilaria; Santamaria-Martinez, Albert; Susanto, Evelyn; Peng, Hong; Huelsken, Joerg] Swiss Inst Expt Canc Res, Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Malanchi, Ilaria; Santamaria-Martinez, Albert; Susanto, Evelyn; Peng, Hong; Huelsken, Joerg] Natl Ctr Competence Res Mol Oncol, CH-1015 Lausanne, Switzerland; [Peng, Hong] So Med Univ, Nanfang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou 510515, Guangdong, Peoples R China; [Lehr, Hans-Anton] Univ Lausanne, CHUV, Univ Inst Pathol, CH-1011 Lausanne, Switzerland; [Delaloye, Jean-Francois] CHU Vaudois, Dept Obstet & Gynecol, CH-1011 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Southern Medical University - China; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Huelsken, J (corresponding author), Swiss Inst Expt Canc Res, Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland.	joerg.huelsken@epfl.ch	Peng, Hongjuan/GYV-5462-2022; Santamaria-Martínez, Albert/X-1411-2018; Huelsken, Joerg/AAC-9581-2021	Santamaria-Martínez, Albert/0000-0001-5436-9207; Huelsken, Joerg/0000-0003-3105-9606	Swiss League against Cancer; SNF; NCCR in Molecular Oncology; Anna Fuller Fund; Debiopharm	Swiss League against Cancer; SNF; NCCR in Molecular Oncology; Anna Fuller Fund; Debiopharm	We are grateful to U. Koch for advice on FACS, to M. Moniatte for advice on mass spectrometry and to S. Leuba for technical assistance with histology. I. M., E. S., A.S.-M. and J.H. were supported in part by the Swiss League against Cancer, the SNF, the NCCR in Molecular Oncology and the Anna Fuller Fund. J.H. holds the EPFL chair for Signal Transduction in Oncogenesis sponsored by Debiopharm.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Milovanovic T, 2004, INT J ONCOL, V25, P1337; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shimazaki M, 2008, BIOCHEM BIOPH RES CO, V367, P736, DOI 10.1016/j.bbrc.2008.01.009; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhao WL, 2002, CANCER IMMUNOL IMMUN, V51, P381, DOI 10.1007/s00262-002-0290-6	34	932	972	3	323	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					85	U95		10.1038/nature10694	http://dx.doi.org/10.1038/nature10694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22158103	Green Submitted, Green Published			2022-12-24	WOS:000298836900034
J	Wang, ZG; Jiang, H; Chen, S; Du, FH; Wang, XD				Wang, Zhigao; Jiang, Hui; Chen, She; Du, Fenghe; Wang, Xiaodong			The Mitochondrial Phosphatase PGAM5 Functions at the Convergence Point of Multiple Necrotic Death Pathways	CELL			English	Article							DEPENDENT PROTEIN-KINASE; INTERACTING PROTEIN; CELL-DEATH; UBIQUITIN LIGASE; DRP1; INHIBITION; FISSION; PHOSPHORYLATION; DIVISION; NECROSIS	The programmed necrosis induced by TNF-alpha requires the activities of the receptor-interacting serine-threonine kinases RIP1 and RIP3 and their interaction with the mixed lineage kinase domain-like protein MLKL. We report the identification of RIP1- and RIP3-containing protein complexes that form specifically in response to necrosis induction. One component of these complexes is the mitochondrial protein phosphatase PGAM5, which presents as two splice variants, PGAM5L (long form) and PGAM5S (short form). Knockdown of either form attenuated necrosis induced by TNF-a as well as reactive oxygen species (ROS) and calcium ionophore, whereas knockdown of RIP3 and MLKL blocked only TNF-alpha-mediated necrosis. Upon necrosis induction, PGAM5S recruited the mitochondrial fission factor Drp1 and activated its GTPase activity by dephosphorylating the serine 637 site of Drp1. Drp1 activation caused mitochondrial fragmentation, an early and obligatory step for necrosis execution. These data defined PGAM5 as the convergent point for multiple necrosis pathways.	[Wang, Zhigao; Jiang, Hui; Du, Fenghe; Wang, Xiaodong] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Jiang, Hui; Chen, She; Wang, Xiaodong] Natl Inst Biol Sci, Beijing 102206, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institute of Biological Sciences, Beijing	Wang, XD (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	wangxiaodong@nibs.ac.cn	Wang, Zhigao/ABE-9411-2021	Wang, Zhigao/0000-0002-6544-4302; Wang, Xiaodong/0000-0001-9885-356X; Jiang, Hui/0000-0002-0277-9711	Howard Hughes Medical Institute; Chinese Ministry of Science and Technology [2008AA022318, 2010CB835400]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Drs. Steve McKnight, Joe Goldstein, and Mike Brown for support and encouragement; Dr. Ayako Suzuki for help with the 2D electrophoresis; Drs. Lai Wang, Agata Rybarska, and Gregory Kunkel for critical reading of the manuscript. This work was supported by the Howard Hughes Medical Institute and the National High Technology Projects 863 (2008AA022318) and 973 (2010CB835400) from Chinese Ministry of Science and Technology.	Breckenridge DG, 2008, MOL CELL, V31, P586, DOI 10.1016/j.molcel.2008.07.015; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vanlangenakker N, 2008, CURR MOL MED, V8, P207, DOI 10.2174/156652408784221306; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	34	632	677	10	169	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					228	243		10.1016/j.cell.2011.11.030	http://dx.doi.org/10.1016/j.cell.2011.11.030			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265414	Bronze			2022-12-24	WOS:000299540700027
J	DeWitt, MA; Chang, AY; Combs, PA; Yildiz, A				DeWitt, Mark A.; Chang, Amy Y.; Combs, Peter A.; Yildiz, Ahmet			Cytoplasmic Dynein Moves Through Uncoordinated Stepping of the AAA plus Ring Domains	SCIENCE			English	Article							HAND-OVER-HAND; MYOSIN VI; KINESIN; PROCESSIVITY; MOTOR; COORDINATION; MECHANISM; BEHAVIOR; SITES	Cytoplasmic dynein is a homodimeric AAA+ motor that transports a multitude of cargos toward the microtubule minus end. How the two catalytic head domains interact and move relative to each other during processive movement is unclear. Here, we tracked the relative positions of both heads with nanometer precision and directly observed the heads moving independently along the microtubule. The heads remained widely separated, and their stepping behavior varied as a function of interhead separation. One active head was sufficient for processive movement, and an active head could drag an inactive partner head forward. Thus, dynein moves processively without interhead coordination, a mechanism fundamentally distinct from the hand-over-hand stepping of kinesin and myosin.	[Yildiz, Ahmet] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Yildiz, A (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	yildiz@berkeley.edu	Yildiz, Ahmet/E-6167-2015	Yildiz, Ahmet/0000-0003-4792-174X; Combs, Peter/0000-0003-2835-5623	NIH [GM094522, GM08295]; NSF [MCB-1055017]; Burroughs Wellcome Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008295, R01GM094522] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. D. Vale and A. P. Carter for providing yeast strains; T. Bilyard, F. B. Cleary, and S. Shih for critical evaluation of the manuscript; and K. Schimert for technical assisstance. This work is supported by NIH [GM094522 (A.Y.), GM08295 ( M. A. D. and P. A. C.)], NSF [MCB-1055017 (A.Y.)], and Burroughs Wellcome Foundation (A.Y.).	Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; Kamei T, 2005, BIOPHYS J, V88, P2068, DOI 10.1529/biophysj.104.049759; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Liao JC, 2009, J MOL BIOL, V392, P862, DOI 10.1016/j.jmb.2009.07.046; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nishikawa S, 2010, CELL, V142, P879, DOI 10.1016/j.cell.2010.08.033; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Shima T, 2006, J STRUCT BIOL, V156, P182, DOI 10.1016/j.jsb.2006.03.014; Tsygankov D, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3050098; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	23	136	137	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					221	225		10.1126/science.1215804	http://dx.doi.org/10.1126/science.1215804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22157083	Green Accepted			2022-12-24	WOS:000299033100054
J	Scarf, D; Hayne, H; Colombo, M				Scarf, Damian; Hayne, Harlene; Colombo, Michael			Pigeons on Par with Primates in Numerical Competence	SCIENCE			English	Article									[Scarf, Damian; Hayne, Harlene; Colombo, Michael] Univ Otago, Dept Psychol, Dunedin 9054, New Zealand	University of Otago	Scarf, D (corresponding author), Univ Otago, Dept Psychol, Dunedin 9054, New Zealand.	damianscarf@gmail.com		Scarf, Damian/0000-0002-9486-8059; Colombo, Michael/0000-0002-2574-4888				BOYSEN ST, 1989, J COMP PSYCHOL, V103, P23, DOI 10.1037/0735-7036.103.1.23; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Clayton N, 2005, CURR BIOL, V15, pR80, DOI 10.1016/j.cub.2005.01.020; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Dacke M, 2008, ANIM COGN, V11, P683, DOI 10.1007/s10071-008-0159-y; Dehaene S., 2011, NUMBER SENSE MIND CR; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Roberts WA, 2010, LEARN MOTIV, V41, P241, DOI 10.1016/j.lmot.2010.08.002; Rutz C, 2010, SCIENCE, V329, P1523, DOI 10.1126/science.1192053; Weber E. H, 1834, TACTU	10	101	103	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1664	1664		10.1126/science.1213357	http://dx.doi.org/10.1126/science.1213357			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194568				2022-12-24	WOS:000298344000056
J	Shibata, K; Watanabe, T; Sasaki, Y; Kawato, M				Shibata, Kazuhisa; Watanabe, Takeo; Sasaki, Yuka; Kawato, Mitsuo			Perceptual Learning Incepted by Decoded fMRI Neurofeedback Without Stimulus Presentation	SCIENCE			English	Article							REAL-TIME FMRI; BRAIN ACTIVATION; V1 NEURONS; CORTEX; RESPONSES; AREA	It is controversial whether the adult primate early visual cortex is sufficiently plastic to cause visual perceptual learning (VPL). The controversy occurs partially because most VPL studies have examined correlations between behavioral and neural activity changes rather than cause-and-effect relationships. With an online-feedback method that uses decoded functional magnetic resonance imaging (fMRI) signals, we induced activity patterns only in early visual cortex corresponding to an orientation without stimulus presentation or participants' awareness of what was to be learned. The induced activation caused VPL specific to the orientation. These results suggest that early visual areas are so plastic that mere inductions of activity patterns are sufficient to cause VPL. This technique can induce plasticity in a highly selective manner, potentially leading to powerful training and rehabilitative protocols.	[Shibata, Kazuhisa; Watanabe, Takeo; Sasaki, Yuka; Kawato, Mitsuo] Adv Telecommun Res Inst, Int Computat Neurosci Labs, Keihanna Sci City, Kyoto 6190288, Japan	Advanced Telecommunications Research Institute International	Watanabe, T (corresponding author), Boston Univ, Dept Psychol, 64 Cummington St, Boston, MA 02215 USA.	takeo@bu.edu	Jovicich, Jorge/D-2293-2010	Sasaki, Yuka/0000-0002-0061-0250	NIH [R01 AG031941, R01 EY015980, R01 MH091801]; NSF [0964776]; NATIONAL EYE INSTITUTE [R01EY015980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031941] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was conducted in "Brain Machine Interface Development" under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. T. W. was partially supported by NIH grants R01 AG031941 and R01 EY015980 and Y.S. by grants R01 MH091801 and NSF 0964776. We thank J. Dobres, M. Fukuda, G. Ganesh, H. Imamizu, A. R. Seitz, and K. Tanaka for their comments on a draft of this manuscript and M. Fukuda, Y. Furukawa, S. Hirose, M. Sato, and ATR BAIC for technical assistances.	Bray S, 2007, J NEUROSCI, V27, P7498, DOI 10.1523/JNEUROSCI.2118-07.2007; Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Censor N, 2009, J VISION, V9, DOI 10.1167/9.4.12; Corthout E, 2000, NEUROREPORT, V11, P1565, DOI 10.1097/00001756-200005150-00039; DeCharms RC, 2004, NEUROIMAGE, V21, P436, DOI 10.1016/j.neuroimage.2003.08.041; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Giovannelli F, 2010, NEUROPSYCHOLOGIA, V48, P1807, DOI 10.1016/j.neuropsychologia.2010.02.031; Hua TM, 2010, CURR BIOL, V20, P887, DOI 10.1016/j.cub.2010.03.066; Huxlin KR, 2009, J NEUROSCI, V29, P3981, DOI 10.1523/JNEUROSCI.4882-08.2009; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kawato M, 2008, PHILOS T R SOC B, V363, P2201, DOI 10.1098/rstb.2008.2272; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Toda A, 2011, NEUROIMAGE, V54, P892, DOI 10.1016/j.neuroimage.2010.09.057; Weiskopf N, 2003, NEUROIMAGE, V19, P577, DOI 10.1016/S1053-8119(03)00145-9; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034	20	287	298	4	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1413	1415		10.1126/science.1212003	http://dx.doi.org/10.1126/science.1212003			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158821	Green Accepted			2022-12-24	WOS:000297787700056
J	Hombauer, H; Campbell, CS; Smith, CE; Desai, A; Kolodner, RD				Hombauer, Hans; Campbell, Christopher S.; Smith, Catherine E.; Desai, Arshad; Kolodner, Richard D.			Visualization of Eukaryotic DNA Mismatch Repair Reveals Distinct Recognition and Repair Intermediates	CELL			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; CELL NUCLEAR ANTIGEN; ESCHERICHIA-COLI MUTS; REPLICATION FACTORIES; POLYMERASE-DELTA; YEAST; PCNA; PROTEINS; COMPLEX; ALPHA	DNA mismatch repair (MMR) increases replication fidelity by eliminating mispaired bases resulting from replication errors. In Saccharomyces cerevisiae, mispairs are primarily detected by the Msh2-Msh6 complex and corrected following recruitment of the Mlh1-Pms1 complex. Here, we visualized functional fluorescent versions of Msh2-Msh6 and Mlh1-Pms1 in living cells. We found that the Msh2-Msh6 complex is an S phase component of replication centers independent of mispaired bases; this localized pool accounted for 10%-15% of MMR in wildtype cells but was essential for MMR in the absence of Exo1. Unexpectedly, Mlh1-Pms1 formed nuclear foci that, although dependent on Msh2-Msh6 for formation, rarely colocalized with Msh2-Msh6 replication-associated foci. Mlh1-Pms1 foci increased when the number of mispaired bases was increased; in contrast, Msh2-Msh6 foci were unaffected. These findings suggest the presence of replication machinery-coupled and -independent pathways for mispair recognition by Msh2-Msh6, which direct formation of superstoichiometric Mlh1-Pms1 foci that represent sites of active MMR.	[Hombauer, Hans; Campbell, Christopher S.; Smith, Catherine E.; Desai, Arshad; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Hombauer, Hans; Smith, Catherine E.; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Hombauer, Hans; Campbell, Christopher S.; Smith, Catherine E.; Desai, Arshad; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Inst Genom Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu	; Hombauer, Hans/B-9712-2019	Campbell, Christopher/0000-0002-3927-344X; Hombauer, Hans/0000-0002-2100-564X; Smith, Catherine/0000-0001-6779-8035	NIH [GM50006, GM085764, GM074215, CA23100]; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215, P50GM085764, R01GM050006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Kolodner and Desai Lab members for discussions; T. Kunkel, S. Martinez, M. Mendillo, L. Reha-Krantz, E. Schiebel, S. Shell, R. Tsien, and the Yeast Resource Center for providing plasmids/strains; S. Sandall for initial technical microscopy support; and C. Putnam and R. Fishel for discussions and comments on the manuscript. This work was supported by NIH grants GM50006 and GM085764 (R. D. K.), GM074215 (A. D.), and CA23100 (A. D., R. D. K.) and a Damon Runyon Cancer Research Foundation Fellowship (C. S. C.).	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Alani E, 1996, MOL CELL BIOL, V16, P5604; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Bowers J, 2000, J MOL BIOL, V302, P327, DOI 10.1006/jmbi.2000.4081; Cannavo E, 2005, CANCER RES, V65, P10759, DOI 10.1158/0008-5472.CAN-05-2528; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Datta A, 1996, MOL CELL BIOL, V16, P1085; Deschenes SM, 2007, CANCER LETT, V249, P148, DOI 10.1016/j.canlet.2006.08.008; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Elez M, 2010, CURR BIOL, V20, P1432, DOI 10.1016/j.cub.2010.06.071; Evans E, 2000, MOL CELL, V5, P789, DOI 10.1016/S1097-2765(00)80319-6; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; FANG WH, 1993, J BIOL CHEM, V268, P11838; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Hess MT, 2006, P NATL ACAD SCI USA, V103, P558, DOI 10.1073/pnas.0510078103; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; Huang SYN, 2008, J MOL BIOL, V384, P31, DOI 10.1016/j.jmb.2008.08.052; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; JIRICNY J, 1988, NUCLEIC ACIDS RES, V16, P7843, DOI 10.1093/nar/16.16.7843; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lau PJ, 2002, MOL CELL BIOL, V22, P6669, DOI 10.1128/MCB.22.19.6669-6680.2002; Lee SD, 2006, J MOL BIOL, V355, P175, DOI 10.1016/j.jmb.2005.10.059; Li L, 2005, GENETICS, V170, P569, DOI 10.1534/genetics.104.040295; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; MATIC I, 1995, CELL, V80, P507, DOI 10.1016/0092-8674(95)90501-4; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McElhinny SAN, 2007, J BIOL CHEM, V282, P2324, DOI 10.1074/jbc.M609591200; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; MORRISON A, 1991, P NATL ACAD SCI USA, V88, P9473, DOI 10.1073/pnas.88.21.9473; Newport J, 1996, CURR OPIN CELL BIOL, V8, P365, DOI 10.1016/S0955-0674(96)80011-1; Park J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015496; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Schmutte C, 2001, J BIOL CHEM, V276, P33011, DOI 10.1074/jbc.M102670200; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Smith BT, 2001, MOL CELL, V8, P1197, DOI 10.1016/S1097-2765(01)00402-6; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Tran PT, 2001, P NATL ACAD SCI USA, V98, P9760, DOI 10.1073/pnas.161175998; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Wang HX, 2002, J BIOL CHEM, V277, P26136, DOI 10.1074/jbc.M200357200; Zanders S, 2010, GENETICS, V186, P493, DOI 10.1534/genetics.110.120105; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	73	145	148	2	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1040	1053		10.1016/j.cell.2011.10.025	http://dx.doi.org/10.1016/j.cell.2011.10.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118461	Bronze, Green Accepted			2022-12-24	WOS:000297376600016
J	Fan, L; Wang, J; Varghese, LT; Shen, H; Niu, B; Xuan, Y; Weiner, AM; Qi, MH				Fan, Li; Wang, Jian; Varghese, Leo T.; Shen, Hao; Niu, Ben; Xuan, Yi; Weiner, Andrew M.; Qi, Minghao			An All-Silicon Passive Optical Diode	SCIENCE			English	Article							WAVE-GUIDES; RING RESONATORS; BISTABILITY; CHIP; NONLINEARITIES; PROPAGATION; ISOLATOR; FILTERS; FIBER	A passive optical diode effect would be useful for on-chip optical information processing but has been difficult to achieve. Using a method based on optical nonlinearity, we demonstrate a forward-backward transmission ratio of up to 28 decibels within telecommunication wavelengths. Our device, which uses two silicon rings 5 micrometers in radius, is passive yet maintains optical nonreciprocity for a broad range of input power levels, and it performs equally well even if the backward input power is higher than the forward input. The silicon optical diode is ultracompact and is compatible with current complementary metal-oxide semiconductor processing.	[Fan, Li; Wang, Jian; Varghese, Leo T.; Shen, Hao; Niu, Ben; Xuan, Yi; Weiner, Andrew M.; Qi, Minghao] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Fan, Li; Wang, Jian; Varghese, Leo T.; Shen, Hao; Niu, Ben; Xuan, Yi; Weiner, Andrew M.; Qi, Minghao] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Qi, Minghao] Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, Shanghai 20050, Peoples R China	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Sciences; Shanghai Institute of Microsystem & Information Technology, CAS	Qi, MH (corresponding author), Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.	mqi@purdue.edu	Varghese, Leo/M-5396-2013; Wang, Jian/A-7781-2016; Wang, Jian/F-3685-2012; Shen, Hao/D-4144-2012; Fan, Li/B-1965-2014		Defense Threat Reduction Agency [HDTRA1-10-1-0106]; Air Force Office of Scientific Research [FA9550-08-1-0379]; NSF [ECCS-0925759]; NIH [1R01RR026273-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR026273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103401] Funding Source: NIH RePORTER; Div Of Electrical, Commun & Cyber Sys [0925759] Funding Source: National Science Foundation	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank D. Leaird for experimental assistance and J. Ouyang for helpful discussions. Supported by Defense Threat Reduction Agency grant HDTRA1-10-1-0106, Air Force Office of Scientific Research grant FA9550-08-1-0379, NSF grant ECCS-0925759, and NIH grant 1R01RR026273-01. Finite-difference time domain simulation work was carried out through the Network for Computational Nanotechnology with resources available at www.nanohub.org. L. F. and L. T. V. fabricated and characterized the devices. J. W. performed simulation and selected device parameters. H. S. helped in device characterization. B.N. helped in the design. M. Q. conceived the idea and supervised the investigation. M. Q., L. T. V., L. F., and J. W. wrote the manuscript. All discussed the results and commented on the manuscript.	Almeida VR, 2004, OPT LETT, V29, P2387, DOI 10.1364/OL.29.002387; Barclay PE, 2005, OPT EXPRESS, V13, P801, DOI 10.1364/OPEX.13.000801; Barwicz T, 2004, OPT EXPRESS, V12, P1437, DOI 10.1364/OPEX.12.001437; Bi L, 2011, NAT PHOTONICS, V5, P758, DOI 10.1038/nphoton.2011.270; Chen XG, 2006, IEEE PHOTONIC TECH L, V18, P2617, DOI 10.1109/LPT.2006.887214; Dinu M, 2003, APPL PHYS LETT, V82, P2954, DOI 10.1063/1.1571665; Driscoll JB, 2010, IEEE J SEL TOP QUANT, V16, P1448, DOI 10.1109/JSTQE.2009.2038352; Espinola RL, 2004, OPT LETT, V29, P941, DOI 10.1364/OL.29.000941; Gallo K, 2001, APPL PHYS LETT, V79, P314, DOI 10.1063/1.1386407; Haus H. A, 1984, WAVES FIELDS OPTOELE, P56; Hwang J, 2005, NAT MATER, V4, P383, DOI 10.1038/nmat1377; Ibrahim SK, 2004, ELECTRON LETT, V40, P1293, DOI 10.1049/el:20045901; Kang MS, 2011, NAT PHOTONICS, V5, P549, DOI [10.1038/nphoton.2011.180, 10.1038/NPHOTON.2011.180]; Little BE, 1997, J LIGHTWAVE TECHNOL, V15, P998, DOI 10.1109/50.588673; Manipatruni S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.213903; Mingaleev SF, 2002, J OPT SOC AM B, V19, P2241, DOI 10.1364/JOSAB.19.002241; Ouyang J., 2007, MEEP MIT ELECTROMAGN; Rostami A, 2007, OPT LASER TECHNOL, V39, P1059, DOI 10.1016/j.optlastec.2006.04.007; Soljacic M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.055601; Soljacic M, 2003, OPT LETT, V28, P637, DOI 10.1364/OL.28.000637; Sun P, 2010, OPT LETT, V35, P1124, DOI 10.1364/OL.35.001124; Turner-Foster AC, 2010, OPT EXPRESS, V18, P3582, DOI 10.1364/OE.18.003582; Uesugi T, 2006, OPT EXPRESS, V14, P377, DOI 10.1364/OPEX.14.000377; Xiao S., 2008, C LAS EL; Xiao SJ, 2007, OPT EXPRESS, V15, P14467, DOI 10.1364/OE.15.014467; Xu QF, 2006, OPT LETT, V31, P341, DOI 10.1364/OL.31.000341; Xu QF, 2005, NATURE, V435, P325, DOI 10.1038/nature03569; Yu ZF, 2009, NAT PHOTONICS, V3, P91, DOI 10.1038/NPHOTON.2008.273; Zaman TR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430931	30	540	552	17	304	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2012	335	6067					447	450		10.1126/science.1214383	http://dx.doi.org/10.1126/science.1214383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881FG	22194410	Green Accepted			2022-12-24	WOS:000299466800044
J	Boyer, O; Nevo, F; Plaisier, E; Funalot, B; Gribouval, O; Benoit, G; Cong, EH; Arrondel, C; Tete, MJ; Montjean, R; Richard, L; Karras, A; Pouteil-Noble, C; Balafrej, L; Bonnardeaux, A; Canaud, G; Charasse, C; Dantal, J; Deschenes, G; Deteix, P; Dubourg, O; Petiot, P; Pouthier, D; Leguern, E; Guiochon-Mantel, A; Broutin, I; Gubler, MC; Saunier, S; Ronco, P; Vallat, JM; Alonso, MA; Antignac, C; Mollet, G				Boyer, Olivia; Nevo, Fabien; Plaisier, Emmanuelle; Funalot, Benoit; Gribouval, Olivier; Benoit, Genevieve; Cong, Evelyne Huynh; Arrondel, Christelle; Tete, Marie-Josephe; Montjean, Rodrick; Richard, Laurence; Karras, Alexandre; Pouteil-Noble, Claire; Balafrej, Leila; Bonnardeaux, Alain; Canaud, Guillaume; Charasse, Christophe; Dantal, Jacques; Deschenes, Georges; Deteix, Patrice; Dubourg, Odile; Petiot, Philippe; Pouthier, Dominique; Leguern, Eric; Guiochon-Mantel, Anne; Broutin, Isabelle; Gubler, Marie-Claire; Saunier, Sophie; Ronco, Pierre; Vallat, Jean-Michel; Angel Alonso, Miguel; Antignac, Corinne; Mollet, Geraldine			INF2 Mutations in Charcot-Marie-Tooth Disease with Glomerulopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDIATED TRANSPORT; EPITHELIAL-CELLS; MYELIN; PROTEIN; FORMIN; GENE; RHO; GLOMERULOSCLEROSIS; NEPHROPATHY; NEUROPATHY	BACKGROUND Charcot-Marie-Tooth neuropathy has been reported to be associated with renal diseases, mostly focal segmental glomerulosclerosis (FSGS). However, the common mechanisms underlying the neuropathy and FSGS remain unknown. Mutations in INF2 were recently identified in patients with autosomal dominant FSGS. INF2 encodes a formin protein that interacts with the Rho-GTPase CDC42 and myelin and lymphocyte protein (MAL) that are implicated in essential steps of myelination and myelin maintenance. We therefore hypothesized that INF2 may be responsible for cases of Charcot-Marie-Tooth neuropathy associated with FSGS. METHODS We performed direct genotyping of INF2 in 16 index patients with Charcot-Marie-Tooth neuropathy and FSGS who did not have a mutation in PMP22 or MPZ, encoding peripheral myelin protein 22 and myelin protein zero, respectively. Histologic and functional studies were also conducted. RESULTS We identified nine new heterozygous mutations in 12 of the 16 index patients (75%), all located in exons 2 and 3, encoding the diaphanous-inhibitory domain of INF2. Patients presented with an intermediate form of Charcot-Marie-Tooth neuropathy as well as a glomerulopathy with FSGS on kidney biopsy. Immunohistochemical analysis revealed strong INF2 expression in Schwann-cell cytoplasm and podocytes. Moreover, we demonstrated that INF2 colocalizes and interacts with MAL in Schwann cells. The INF2 mutants perturbed the INF2-MAL-CDC42 pathway, resulting in cytoskeleton disorganization, enhanced INF2 binding to CDC42 and mislocalization of INF2, MAL, and CDC42. CONCLUSIONS INF2 mutations appear to cause many cases of FSGS-associated Charcot-Marie-Tooth neuropathy, showing that INF2 is involved in a disease affecting both the kidney glomerulus and the peripheral nervous system. These findings provide new insights into the pathophysiological mechanisms linking formin proteins to podocyte and Schwanncell function. (Funded by the Agence Nationale de la Recherche and others.)	[Boyer, Olivia; Nevo, Fabien; Gribouval, Olivier; Benoit, Genevieve; Cong, Evelyne Huynh; Arrondel, Christelle; Tete, Marie-Josephe; Montjean, Rodrick; Gubler, Marie-Claire; Saunier, Sophie; Antignac, Corinne; Mollet, Geraldine] Hop Necker Enfants Malad, AP HP, INSERM, U983, F-75015 Paris, France; [Plaisier, Emmanuelle; Ronco, Pierre] Hop Necker Enfants Malad, AP HP, Unite 702, F-75015 Paris, France; [Leguern, Eric] Hop Necker Enfants Malad, AP HP, Unite 975, F-75015 Paris, France; [Boyer, Olivia] Hop Necker Enfants Malad, AP HP, Serv Nephrol Pediat, F-75015 Paris, France; [Canaud, Guillaume] Hop Necker Enfants Malad, AP HP, Serv Transplantat & Soins Intensifs, F-75015 Paris, France; [Antignac, Corinne] Hop Necker Enfants Malad, AP HP, Serv Genet, F-75015 Paris, France; [Plaisier, Emmanuelle; Ronco, Pierre] Hop Tenon, AP HP, Serv Nephrol & Dialyses, F-75970 Paris, France; [Karras, Alexandre] Hop Europeen Georges Pompidou, AP HP, Serv Nephrol, Paris, France; [Deschenes, Georges] Hop Robert Debre, AP HP, Serv Nephrol Pediat, F-75019 Paris, France; [Dubourg, Odile] Hop La Pitie Salpetriere, AP HP, Inst Myol, Paris, France; [Boyer, Olivia; Nevo, Fabien; Gribouval, Olivier; Cong, Evelyne Huynh; Arrondel, Christelle; Tete, Marie-Josephe; Montjean, Rodrick; Karras, Alexandre; Canaud, Guillaume; Broutin, Isabelle; Gubler, Marie-Claire; Saunier, Sophie; Antignac, Corinne; Mollet, Geraldine] Univ Paris 05, Paris, France; [Plaisier, Emmanuelle; Leguern, Eric; Ronco, Pierre] Univ Paris 06, Paris, France; [Deschenes, Georges] Univ Paris Diderot, Paris, France; [Leguern, Eric] CNRS, Unite 7225, Paris, France; [Broutin, Isabelle] Lab Cristallog & RMN Biol, Paris, France; [Funalot, Benoit; Richard, Laurence; Vallat, Jean-Michel] CHU, Lab Neurol, Limoges, France; [Funalot, Benoit; Richard, Laurence; Vallat, Jean-Michel] CHU, Serv Neurol, Limoges, France; [Funalot, Benoit; Richard, Laurence; Vallat, Jean-Michel] Univ Limoges, Limoges, France; [Pouteil-Noble, Claire] Univ Lyon, Lyon, France; [Pouteil-Noble, Claire] Ctr Hosp Lyon Sud, Serv Nephrol, Lyon, France; [Petiot, Philippe] Hop Croix Rousse, Serv Neurol, F-69317 Lyon, France; Hosp Civils Lyon, Lyon, France; [Charasse, Christophe] Ctr Hosp St Brieuc, St Brieuc, France; [Dantal, Jacques] CHU Hotel Dieu, Serv Nephrol & Immunol Clin, Nantes, France; [Deteix, Patrice] Univ Auvergne, CHU Gabriel Montpied, Clermont Ferrand, France; [Guiochon-Mantel, Anne] Univ Paris 11, CHU Bicetre, Le Kremlin Bicetre, France; [Benoit, Genevieve] Univ Montreal, CHU St Justine, Serv Nephrol Pediat, Montreal, PQ, Canada; [Bonnardeaux, Alain] Hop Maison Neuve Rosemont, Ctr Rech Guy Bernier, Montreal, PQ H1T 2M4, Canada; [Balafrej, Leila] Ctr Nephrol & Hemodialyse Riad, Rabat, Morocco; [Pouthier, Dominique] Ctr Hosp Luxembourg, Serv Nephrol, Luxembourg, Luxembourg; [Angel Alonso, Miguel] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; CHU Limoges; CHU Limoges; Universite de Limoges; CHU Lyon; CHU Lyon; CHU Lyon; Nantes Universite; CHU de Nantes; CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Luxembourg Hospital Center; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Antignac, C (corresponding author), Hop Necker Enfants Malad, AP HP, INSERM, U983, 6E Etage,149 Rue Sevres, F-75015 Paris, France.	corinne.antignac@inserm.fr	Broutin, Isabelle/A-2003-2017; Alonso, Miguel A/J-3945-2016; Boyer, Olivia Gillion/H-9469-2017; Saunier, Sophie/G-6044-2015; Mollet, Geraldine/E-8049-2017; Gribouval, Olivier/A-7689-2015; ANTIGNAC, Corinne/H-8945-2017; Guiochon-Mantel, Anne S/S-8408-2018; Ronco, Pierre/AAC-8390-2022; ARRONDEL, Christelle/H-8908-2017	Alonso, Miguel A/0000-0002-7001-8826; Boyer, Olivia Gillion/0000-0002-3957-1359; Saunier, Sophie/0000-0002-1069-0047; Mollet, Geraldine/0000-0003-4685-5736; Gribouval, Olivier/0000-0003-0238-8224; ANTIGNAC, Corinne/0000-0002-9934-4940; Guiochon-Mantel, Anne S/0000-0003-1737-1409; Funalot, Benoit/0000-0001-6352-6518; deschenes, georges/0000-0002-5158-2915; Broutin, isabelle/0000-0001-9862-1232; ARRONDEL, Christelle/0000-0001-9522-4186; Gubler, Marie-Claire/0000-0002-3526-5661	Agence Nationale de la Recherche; Association pour l'Utilisation du Rein Artificiel; Association Francaise contre les Myopathies [ANR-08-GENOPAT-017-01]; Agence Nationale de la Recherche [ANR-07-E-RARE-011-01, JTC2007, ANR-06-MRAR-024-01]; Fondation pour la Recherche Medicale [DMP 2010-11-20-386]; Association des Malades du Syndrome Nephrotique; Fonds de la Recherche en Sante du Quebec; Ministerio de Ciencia e Innovacion [BFU2009-07886, CONSOLIDER COAT CSD2009-00016]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour l'Utilisation du Rein Artificiel; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association des Malades du Syndrome Nephrotique; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Funded by the Agence Nationale de la Recherche and others.; Supported by grants from the Association pour l'Utilisation du Rein Artificiel (to Dr. Antignac), Association Francaise contre les Myopathies (ANR-08-GENOPAT-017-01, to Dr. Antignac), Agence Nationale de la Recherche (PodoNet project number ANR-07-E-RARE-011-01 in the ERA-Net Consortium [JTC2007], to Dr. Antignac, and ANR-06-MRAR-024-01, to Dr. Leguern), Fondation pour la Recherche Medicale (project number DMP 2010-11-20-386, to Dr. Antignac, and doctoral funding, to Dr. Boyer), Association des Malades du Syndrome Nephrotique (to Dr. Mollet), Fonds de la Recherche en Sante du Quebec (Fellowship Training Award to Dr. Benoit), and Ministerio de Ciencia e Innovacion (BFU2009-07886 and CONSOLIDER COAT CSD2009-00016, to Dr. Alonso).	Andres-Delgado L, 2010, BLOOD, V116, P5919, DOI 10.1182/blood-2010-08-300665; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Benninger Y, 2007, J CELL BIOL, V177, P1051, DOI 10.1083/jcb.200610108; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BOUTRY JM, 1992, J NEUROSCI RES, V32, P15, DOI 10.1002/jnr.490320103; Boyer O, 2011, J AM SOC NEPHROL, V22, P239, DOI 10.1681/ASN.2010050518; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Chhabra ES, 2009, J CELL SCI, V122, P1430, DOI 10.1242/jcs.040691; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; DENIAU F, 1986, ARCH FR PEDIATR, V43, P791; FILLOD I, 1990, PEDIATRIE, V45, P319; Frank M, 2000, PROG NEUROBIOL, V60, P531, DOI 10.1016/S0301-0082(99)00039-8; Frank M, 1998, J NEUROSCI, V18, P4901; HAYASAKA K, 1993, HUM MOL GENET, V2, P1369, DOI 10.1093/hmg/2.9.1369; LEMIEUX G, 1967, CAN MED ASSOC J, V97, P1193; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Machuca E, 2009, HUM MOL GENET, V18, pR185, DOI 10.1093/hmg/ddp328; Madrid R, 2010, DEV CELL, V18, P814, DOI [10.1016/j.devcel.2010.04.001, 10.1016/j.devce1.2010.04.001]; Marazuela M, 2004, HISTOL HISTOPATHOL, V19, P925, DOI 10.14670/HH-19.925; Pareyson D, 2006, NEUROMOL MED, V8, P3, DOI 10.1385/NMM:8:1:3; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PAUL MD, 1990, NEPHRON, V54, P80, DOI 10.1159/000185814; Plaisier E, 2005, J AM SOC NEPHROL, V16, P3350, DOI 10.1681/ASN.2005050509; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; SKRE H, 1974, CLIN GENET, V6, P98; Sun H, 2011, P NATL ACAD SCI USA, V108, P2933, DOI 10.1073/pnas.1017010108; Szigeti K, 2009, EUR J HUM GENET, V17, P703, DOI 10.1038/ejhg.2009.31; Verhoeven K, 2003, AM J HUM GENET, V73, P926, DOI 10.1086/378159	33	183	192	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2011	365	25					2377	2388		10.1056/NEJMoa1109122	http://dx.doi.org/10.1056/NEJMoa1109122			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865OM	22187985	Green Published			2022-12-24	WOS:000298320200004
J	Bhattacharjee, S; Halane, MK; Kim, SH; Gassmann, W				Bhattacharjee, Saikat; Halane, Morgan K.; Kim, Sang Hee; Gassmann, Walter			Pathogen Effectors Target Arabidopsis EDS1 and Alter Its Interactions with Immune Regulators	SCIENCE			English	Article							DISEASE RESISTANCE; INNATE IMMUNITY; PLANT IMMUNITY; REPEAT PROTEIN; RECEPTORS; SYSTEM; GENES; SRFR1	Plant resistance proteins detect the presence of specific pathogen effectors and initiate effector-triggered immunity. Few immune regulators downstream of resistance proteins have been identified, none of which are known virulence targets of effectors. We show that Arabidopsis ENHANCED DISEASE SUSCEPTIBILITY1 (EDS1), a positive regulator of basal resistance and of effector-triggered immunity specifically mediated by Toll-interleukin-1 receptor-nucleotide binding-leucine-rich repeat (TIR-NB-LRR) resistance proteins, forms protein complexes with the TIR-NB-LRR disease resistance proteins RPS4 and RPS6 and with the negative immune regulator SRFR1 at a cytoplasmic membrane. Further, the cognate bacterial effectors AvrRps4 and HopA1 disrupt these EDS1 complexes. Tight association of EDS1 with TIR-NB-LRR-mediated immunity may therefore derive mainly from being guarded by TIR-NB-LRR proteins, and activation of this branch of effector-triggered immunity may directly connect to the basal resistance signaling pathway via EDS1.	[Bhattacharjee, Saikat; Kim, Sang Hee; Gassmann, Walter] Univ Missouri, Christopher S Bond Life Sci Ctr, Div Plant Sci, Columbia, MO 65211 USA; [Bhattacharjee, Saikat; Kim, Sang Hee; Gassmann, Walter] Univ Missouri, Interdisciplinary Plant Grp, Columbia, MO 65211 USA; [Halane, Morgan K.] Univ Missouri, Dept English, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Gassmann, W (corresponding author), Univ Missouri, Christopher S Bond Life Sci Ctr, Div Plant Sci, Columbia, MO 65211 USA.	gassmannw@missouri.edu		BHATTACHARJEE, SAIKAT/0000-0003-1369-7700; Gassmann, Walter/0000-0002-7527-0385; Halane, Morgan/0000-0001-6357-6232; Kim, Sang Hee/0000-0003-1831-4633	NSF [IOS-0715926, IOS-1121114]	NSF(National Science Foundation (NSF))	We thank J. Parker for providing seed of eds1-2 and EDS1-YFP plants, F. Gao and J. C. Nam for technical assistance, and the University of Missouri Molecular Cytology Core for assistance with confocal fluorescence microscopy. This work was supported by the NSF Integrative Organismal Systems Program (grants IOS-0715926 and IOS-1121114) (W.G.).	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Garcia AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000970; Heidrich K, 2011, SCIENCE, V334, P1401, DOI 10.1126/science.1211641; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katagiri F, 2010, MOL PLANT MICROBE IN, V23, P1531, DOI 10.1094/MPMI-04-10-0099; Kim MG, 2009, PLANT J, V57, P645, DOI 10.1111/j.1365-313X.2008.03716.x; Kim SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001172; Kim SH, 2009, PLANT PHYSIOL, V150, P1723, DOI 10.1104/pp.109.139238; Kwon SI, 2009, PLANT J, V57, P109, DOI 10.1111/j.1365-313X.2008.03669.x; Li YZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001111; Liu J, 2011, CELL HOST MICROBE, V9, P137, DOI 10.1016/j.chom.2011.01.010; Rietz S, 2011, NEW PHYTOL, V191, P107, DOI 10.1111/j.1469-8137.2011.03675.x; Shen QH, 2007, EMBO J, V26, P4293, DOI 10.1038/sj.emboj.7601854; Sohn KH, 2009, PLANT J, V57, P1079, DOI 10.1111/j.1365-313X.2008.03751.x; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Zhu ZH, 2010, P NATL ACAD SCI USA, V107, P13960, DOI 10.1073/pnas.1002828107	28	221	239	1	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1405	1408		10.1126/science.1211592	http://dx.doi.org/10.1126/science.1211592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158819				2022-12-24	WOS:000297787700054
J	Yoo, SK; Starnes, TW; Deng, Q; Huttenlocher, A				Yoo, Sa Kan; Starnes, Taylor W.; Deng, Qing; Huttenlocher, Anna			Lyn is a redox sensor that mediates leukocyte wound attraction in vivo	NATURE			English	Article							TYROSINE KINASE; HYDROGEN-PEROXIDE; C-SRC; AUTOIMMUNE-DISEASE; CYSTEINE OXIDATION; DEFICIENT MICE; ZEBRAFISH; NEUTROPHILS; ACTIVATION; CHEMOTAXIS	Tissue wounding induces the rapid recruitment of leukocytes(1). Wounds and tumours-a type of 'unhealed wound'(2)-generate hydrogen peroxide (H2O2) through an NADPH oxidase (NOX). This extracellular H2O2 mediates recruitment of leukocytes, particularly the first responders of innate immunity, neutrophils, to injured tissue(3-6). However, the sensor that neutrophils use to detect the redox state at wounds is unknown. Here we identify the Src family kinase (SFK) Lyn as a redox sensor that mediates initial neutrophil recruitment to wounds in zebrafish larvae. Lyn activation in neutrophils is dependent on wound-derived H2O2 after tissue injury, and inhibition of Lyn attenuates neutrophil wound recruitment. Inhibition of SFKs also disrupted H2O2-mediated chemotaxis of primary human neutrophils. In vitro analysis identified a single cysteine residue, C466, as being responsible for direct oxidation-mediated activation of Lyn. Furthermore, transgenic-tissue-specific reconstitution with wild-type Lyn and a cysteine mutant revealed that Lyn C466 is important for the neutrophil wound response and downstream signalling in vivo. This is the first identification, to our knowledge, of a physiological redox sensor that mediates leukocyte wound attraction in multicellular organisms.	[Starnes, Taylor W.; Deng, Qing; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Yoo, Sa Kan] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	huttenlocher@wisc.edu	Deng, Qing/G-3923-2011; Deng, Qing/AAC-1123-2020	Deng, Qing/0000-0002-9254-9951	American Heart Association [11PRE4890041]; National Institutes of Health [GM074827, 5T32 HL07899]; UW MSTP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL114143, T32HL007899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074827, T32GM008692] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW MSTP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. T. Chan for help with tissue culture work, J. M. Green and P.-Y. Lam for help with in situ hybridization, M. Shelef and S. Wernimont for drawing blood, and A. J. Wiemer for insightful discussion and critical reading of the manuscript. This work was supported by American Heart Association fellowship 11PRE4890041 (S.K.Y.), National Institutes of Health Grant GM074827 (A. H.), NIH Research Training Grant in Hematology 5T32 HL07899 (T. W. S.) and UW MSTP (T.W.S.).	Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Feng Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000562; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; HEIT B, 2003, SCI STKE, pPL5; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; Klyubin IV, 1996, EUR J CELL BIOL, V70, P347; Lee YM, 2006, CELL SIGNAL, V18, P499, DOI 10.1016/j.cellsig.2005.05.025; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mathias JR, 2009, DEV COMP IMMUNOL, V33, P1212, DOI 10.1016/j.dci.2009.07.003; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Moreira S, 2010, CURR BIOL, V20, P464, DOI 10.1016/j.cub.2010.01.047; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Pereira S, 2003, J IMMUNOL, V171, P1319, DOI 10.4049/jimmunol.171.3.1319; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118; Yan SR, 1996, J BIOL CHEM, V271, P23464, DOI 10.1074/jbc.271.38.23464; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yoo SK, 2011, J LEUKOCYTE BIOL, V89, P661, DOI 10.1189/jlb.1010567; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015	39	313	320	5	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					109	U278		10.1038/nature10632	http://dx.doi.org/10.1038/nature10632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22101434	Green Accepted			2022-12-24	WOS:000298031900044
J	MacGurn, JA; Hsu, PC; Smolka, MB; Emr, SD				MacGurn, Jason A.; Hsu, Pi-Chiang; Smolka, Marcus B.; Emr, Scott D.			TORC1 Regulates Endocytosis via Npr1-Mediated Phosphoinhibition of a Ubiquitin Ligase Adaptor	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; AMINO-ACIDS; PHOSPHORYLATION; COMPLEX; YEAST; MTOR; NPR1; IDENTIFICATION; TRANSPORTERS	The TORC1 kinase signaling complex is a key determinant of cell growth that senses nutritional status and responds by coordinating diverse cellular processes including transcription, translation, and autophagy. Here, we demonstrate that TORC1 modulates the composition of plasma membrane (PM) proteins by regulating ubiquitin-mediated endocytosis. The mechanism involves the Npr1 kinase, a negative regulator of endocytosis that is itself negatively regulated by TORC1. We show that Npr1 inhibits the activity of Art1, an arrestin-like adaptor protein that promotes endocytosis by targeting the Rsp5 ubiquitin ligase to specific PM cargoes. Npr1 antagonizes Art1-mediated endocytosis via N-terminal phosphorylation, a modification that prevents Art1 association with the PM. Thus, our study adds ubiquitin ligase targeting and control of endocytosis to the known effector mechanisms of TORC1, underscoring how TORC1 coordinates ubiquitin-mediated endocytosis with protein synthesis and autophagy in order to regulate cell growth.	[MacGurn, Jason A.; Hsu, Pi-Chiang; Smolka, Marcus B.; Emr, Scott D.] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Emr, SD (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	sde26@cornell.edu			Fleming Research Fellowship; Taiwanese Ministry of Education	Fleming Research Fellowship; Taiwanese Ministry of Education	We thank M. N. Hall, R. Loewith, and J. Thorner for helpful advice and discussion. We also thank Patrice Ohouo and Sunil Adige for technical advice and assistance. We are grateful to E. MacGurn for assistance with graphic design, and to Shu-Bing Qian and W. Michael Henne for critical reading of the manuscript. We also thank members of the Emr lab for helpful discussions, especially Chris Stefan. J. A. M. is supported by a Fleming Research Fellowship. P. H. is supported by a fellowship from the Taiwanese Ministry of Education.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonenfant D, 2003, P NATL ACAD SCI USA, V100, P880, DOI 10.1073/pnas.232735599; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Gander S, 2009, J PROTEOME RES, V8, P5305, DOI 10.1021/pr9005469; Gander S, 2008, RAPID COMMUN MASS SP, V22, P3743, DOI 10.1002/rcm.3790; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lin FT, 2002, BIOCHEMISTRY-US, V41, P10692, DOI 10.1021/bi025705n; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Perez-Valle J, 2007, MOL CELL BIOL, V27, P5725, DOI 10.1128/MCB.01375-06; Qian SB, 2010, J BIOL CHEM, V285, P27385, DOI 10.1074/jbc.M110.120295; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Shinoda J, 2007, BIOCHEM BIOPH RES CO, V364, P258, DOI 10.1016/j.bbrc.2007.09.134; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198	25	156	157	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1104	1117		10.1016/j.cell.2011.09.054	http://dx.doi.org/10.1016/j.cell.2011.09.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118465	Bronze			2022-12-24	WOS:000297376600021
J	Thurston, TLM; Wandel, MP; von Muhlinen, N; Foeglein, A; Randow, F				Thurston, Teresa L. M.; Wandel, Michal P.; von Muhlinen, Natalia; Foeglein, Agnes; Randow, Felix			Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CROHN-DISEASE; UBIQUITIN; IMMUNITY; SUSCEPTIBILITY; SALMONELLA; ADAPTER; RECOGNITION; RESTRICTS; PROTEINS	Autophagy defends the mammalian cytosol against bacterial infection(1-3). Efficient pathogen engulfment is mediated by cargo-selecting autophagy adaptors that rely on unidentified pattern-recognition or danger receptors to label invading pathogens as autophagy cargo, typically by polyubiquitin coating(4-9). Here we show in human cells that galectin 8 (also known as LGALS8), a cytosolic lectin, is a danger receptor that restricts Salmonella proliferation. Galectin 8 monitors endosomal and lysosomal integrity and detects bacterial invasion by binding host glycans exposed on damaged Salmonella-containing vacuoles. By recruiting NDP52 (also known as CALCOCO2), galectin 8 activates antibacterial autophagy. Galectin-8-dependent recruitment of NDP52 to Salmonella-containing vesicles is transient and followed by ubiquitin-dependent NDP52 recruitment. Because galectin 8 also detects sterile damage to endosomes or lysosomes, as well as invasion by Listeria or Shigella, we suggest that galectin 8 serves as a versatile receptor for vesicle-damaging pathogens. Our results illustrate how cells deploy the danger receptor galectin 8 to combat infection by monitoring endosomal and lysosomal integrity on the basis of the specific lack of complex carbohydrates in the cytosol.	[Thurston, Teresa L. M.; Wandel, Michal P.; von Muhlinen, Natalia; Foeglein, Agnes; Randow, Felix] MRC Lab Mol Biol, Div Prot & Nucle Acid Chem, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Randow, F (corresponding author), MRC Lab Mol Biol, Div Prot & Nucle Acid Chem, Hills Rd, Cambridge CB2 0QH, England.	randow@mrc-lmb.cam.ac.uk	Wandel, Michal/AAL-7946-2021; Thurston, Teresa/AAZ-9938-2020	Wandel, Michal/0000-0002-5275-5881; Thurston, Teresa/0000-0001-6139-3723	Medical Research Council [MC_U105170648, U.1051.03.011(78825)] Funding Source: Medline; MRC [MC_U105170648] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; BERG TO, 1994, EUR J BIOCHEM, V221, P595, DOI 10.1111/j.1432-1033.1994.tb18771.x; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Bloor S, 2008, P NATL ACAD SCI USA, V105, P1279, DOI 10.1073/pnas.0706552105; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Houzelstein D, 2004, MOL BIOL EVOL, V21, P1177, DOI 10.1093/molbev/msh082; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Randow Felix, 2006, Subcell Biochem, V40, P383; Randow F, 2011, AUTOPHAGY, V7, P304, DOI 10.4161/auto.7.3.14539; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Shahnazari S, 2011, CURR OPIN MICROBIOL, V14, P68, DOI 10.1016/j.mib.2010.11.001; Shahnazari S, 2010, CELL HOST MICROBE, V8, P137, DOI 10.1016/j.chom.2010.07.002; Shaughnessy LM, 2007, CELL MICROBIOL, V9, P1695, DOI 10.1111/j.1462-5822.2007.00903.x; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	37	674	686	8	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					414	U1515		10.1038/nature10744	http://dx.doi.org/10.1038/nature10744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22246324	Green Accepted, Green Submitted			2022-12-24	WOS:000300287100049
J	Soon, FF; Ng, LM; Zhou, XE; West, GM; Kovach, A; Tan, MHE; Suino-Powell, KM; He, YZ; Xu, Y; Chalmers, MJ; Brunzelle, JS; Zhang, HM; Yang, HY; Jiang, HL; Li, J; Yong, EL; Cutler, S; Zhu, JK; Griffin, PR; Melcher, K; Xu, HE				Soon, Fen-Fen; Ng, Ley-Moy; Zhou, X. Edward; West, Graham M.; Kovach, Amanda; Tan, M. H. Eileen; Suino-Powell, Kelly M.; He, Yuanzheng; Xu, Yong; Chalmers, Michael J.; Brunzelle, Joseph S.; Zhang, Huiming; Yang, Huaiyu; Jiang, Hualiang; Li, Jun; Yong, Eu-Leong; Cutler, Sean; Zhu, Jian-Kang; Griffin, Patrick R.; Melcher, Karsten; Xu, H. Eric			Molecular Mimicry Regulates ABA Signaling by SnRK2 Kinases and PP2C Phosphatases	SCIENCE			English	Article							2C PROTEIN PHOSPHATASES; ABSCISIC-ACID; GUARD-CELLS; ACTIVATION; PHOSPHORYLATION; ARABIDOPSIS; MECHANISMS; CHANNEL; OST1; PAIR	Abscisic acid (ABA) is an essential hormone for plants to survive environmental stresses. At the center of the ABA signaling network is a subfamily of type 2C protein phosphatases (PP2Cs), which form exclusive interactions with ABA receptors and subfamily 2 Snfl-related kinase (SnRK2s). Here, we report a SnRK2-PP2C complex structure, which reveals marked similarity in PP2C recognition by SnRK2 and ABA receptors. In the complex, the kinase activation loop docks into the active site of PP2C, while the conserved ABA-sensing tryptophan of PP2C inserts into the kinase catalytic cleft, thus mimicking receptor-PP2C interactions. These structural results provide a simple mechanism that directly couples ABA binding to SnRK2 kinase activation and highlight a new paradigm of kinase-phosphatase regulation through mutual packing of their catalytic sites.	[Soon, Fen-Fen; Ng, Ley-Moy; Zhou, X. Edward; Kovach, Amanda; Tan, M. H. Eileen; Suino-Powell, Kelly M.; He, Yuanzheng; Xu, Yong; Li, Jun; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Soon, Fen-Fen; Ng, Ley-Moy; Tan, M. H. Eileen; Li, Jun; Yong, Eu-Leong] Natl Univ Singapore, Dept Obstet & Gynecol, Yong Loo Lin Sch Med, Natl Univ Hosp, Singapore 119228, Singapore; [West, Graham M.; Chalmers, Michael J.; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Translat Res Inst, Jupiter, FL 33458 USA; [Brunzelle, Joseph S.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Life Sci Collaborat Access Team, Synchrotron Res Ctr, Argonne, IL 60439 USA; [Zhang, Huiming; Zhu, Jian-Kang] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Yang, Huaiyu; Jiang, Hualiang] Chinese Acad Sci, Ctr Drug Discovery & Design, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Cutler, Sean] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Xu, H. Eric] Chinese Acad Sci, VARI SIMM Ctr, Ctr Struct & Funct Drug Targets, State Key Lab Drug Res,Shanghai Inst Mat Med, Shanghai 201203, Peoples R China	Van Andel Institute; National University of Singapore; Scripps Research Institute; Northwestern University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of California System; University of California Riverside; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Melcher, K (corresponding author), Van Andel Res Inst, Lab Struct Sci, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	Karsten.Melcher@vai.org; eric.xu@vai.org	Zhang, Huiming/G-9083-2015; Melcher, Karsten/AAZ-3861-2020; Zhu, Jian-Kang/F-7658-2011; Cutler, Sean R/D-6617-2011; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; Zhu, Jian-Kang/0000-0001-5134-731X; Yong, Eu-Leong/0000-0001-6511-770X; Xu, H. Eric/0000-0002-6829-8144; Zhang, Huiming/0000-0003-0695-3593; Chalmers, Michael/0000-0002-2139-6089; He, Yuanzheng/0000-0001-9131-140X	Michigan Economic Development Corporation; Office of Science of the U.S. Department of Energy; Jay and Betty Van Andel Foundation; Amway (China) Limited; NIH; NSF [IOS-0820508]; Singapore Biomedical Research Council; NUS Graduate School for Integrative Sciences and Engineering (NGS); National Institute for General Medical Studies [GM084041]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059138, R01GM084041] Funding Source: NIH RePORTER	Michigan Economic Development Corporation; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Jay and Betty Van Andel Foundation; Amway (China) Limited; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); NUS Graduate School for Integrative Sciences and Engineering (NGS); National Institute for General Medical Studies; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Protein Data Bank (PDB) code for SnRK2.6-HAB1 is 3UJG, for ABI2 is 3UJK, and for PYL2-ABA-ABI2 is 3UJL. We thank the staff of LS-CAT for assistance in data collection at the beam lines of sector 21, which is in part funded by Michigan Economic Development Corporation. Use of the Advanced Photon Source was supported by the Office of Science of the U.S. Department of Energy. This work was supported by the Jay and Betty Van Andel Foundation and Amway (China) Limited (H. E. X.), NIH (H. E. X., P. R. G., and J.-K.Z.), NSF (S. C. and J.-K.Z.), and the Singapore Biomedical Research Council (E.-L.Y.). L.-M.N., F.-F.S., and M. H. E. T. were supported by an overseas Ph.D. scholarship from the NUS Graduate School for Integrative Sciences and Engineering (NGS). S. C. received funding from the NSF (grant IOS-0820508), and P. R. G. received funding from National Institute for General Medical Studies (grant GM084041). Author contributions: J.L., E.-L.Y., J.-K.Z., P. R. G., K. M., and H. E. X. conceived the project and designed research; F.-F.S., L.-M.N., X.E.Z., G. W., A. K., M. H. E. T., K.M.S.-P., Y.H., Y.X., M. C., J.S.B., H.Z., H.Y., H.J., K. M., and H. E. X. performed research; F.-F.S., L.-M.N., X.E.Z., G. W., A. K., M. H. E. T., K.M.S.-P., M. C., J.S.B., P. R. G., K. M., and H. E. X. analyzed data; and K. M. and H. E. X. wrote the paper with contributions from all authors.	Belin C, 2006, PLANT PHYSIOL, V141, P1316, DOI 10.1104/pp.106.079327; Boudsocq M, 2007, PLANT MOL BIOL, V63, P491, DOI 10.1007/s11103-006-9103-1; Burza AM, 2006, J BIOL CHEM, V281, P34299, DOI 10.1074/jbc.M601977200; Cheng KCC, 2009, CELL, V139, P560, DOI 10.1016/j.cell.2009.08.047; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Melcher K, 2010, CURR OPIN STRUC BIOL, V20, P722, DOI 10.1016/j.sbi.2010.09.007; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Parry JM, 2009, CURR BIOL, V19, P1752, DOI 10.1016/j.cub.2009.09.015; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730	21	336	373	17	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					85	88		10.1126/science.1215106	http://dx.doi.org/10.1126/science.1215106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22116026	Green Accepted			2022-12-24	WOS:000298846200056
J	Ramamoorthi, K; Fropf, R; Belfort, GM; Fitzmaurice, HL; McKinney, RM; Neve, RL; Otto, T; Lin, YX				Ramamoorthi, Kartik; Fropf, Robin; Belfort, Gabriel M.; Fitzmaurice, Helen L.; McKinney, Ross M.; Neve, Rachael L.; Otto, Tim; Lin, Yingxi			Npas4 Regulates a Transcriptional Program in CA3 Required for Contextual Memory Formation	SCIENCE			English	Article							IMMEDIATE-EARLY GENES; LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; C-FOS; PROTEIN-SYNTHESIS; FEAR; HIPPOCAMPUS; EXPRESSION; ELEMENT; DORSAL	The rapid encoding of contextual memory requires the CA3 region of the hippocampus, but the necessary genetic pathways remain unclear. We found that the activity-dependent transcription factor Npas4 regulates a transcriptional program in CA3 that is required for contextual memory formation. Npas4 was specifically expressed in CA3 after contextual learning. Global knockout or selective deletion of Npas4 in CA3 both resulted in impaired contextual memory, and restoration of Npas4 in CA3 was sufficient to reverse the deficit in global knockout mice. By recruiting RNA polymerase II to promoters and enhancers of target genes, Npas4 regulates a learning-specific transcriptional program in CA3 that includes many well-known activity-regulated genes, which suggests that Npas4 is a master regulator of activity-regulated gene programs and is central to memory formation.	[Ramamoorthi, Kartik; Fropf, Robin; Belfort, Gabriel M.; Fitzmaurice, Helen L.; McKinney, Ross M.; Lin, Yingxi] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Ramamoorthi, Kartik; Fropf, Robin; Belfort, Gabriel M.; Fitzmaurice, Helen L.; McKinney, Ross M.; Neve, Rachael L.; Lin, Yingxi] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Ramamoorthi, Kartik] MIT, Mol & Cellular Neurosci Grad Program, Cambridge, MA 02139 USA; [Otto, Tim] Rutgers State Univ, Dept Psychol, Program Behav Neurosci, New Brunswick, NJ 08854 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Rutgers State University New Brunswick	Lin, YX (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	yingxi@mit.edu		/0000-0002-7002-1275	McGovern Institute for Brain Research at MIT; MIT; MIT Simons Initiative on Autism and the Brain; NSF [IOS 0919159]; Whitehall Foundation; Anonymous Foundation; John Merck Scholar Program; NIH [MH091220-01]; Direct For Biological Sciences [0919159] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091220] Funding Source: NIH RePORTER	McGovern Institute for Brain Research at MIT; MIT; MIT Simons Initiative on Autism and the Brain; NSF(National Science Foundation (NSF)); Whitehall Foundation; Anonymous Foundation; John Merck Scholar Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. M. Fletcher, A. Heynen, C. Alberini, C. Jennings, R. Desimone, M. Baratta, J. Biedenkapp, R. Froemke, J. Czerniawski, and D. Bambah-Mukku for critical reading of the manuscript. We also thank G. Hale and M. Wilson for help characterizing the Npas4<SUP>-/-</SUP> mice and S. Ramirez for help with the open field assay. Y.L. acknowledges the generous support of the McGovern Institute for Brain Research at MIT. This work was supported by the MIT Presidential Marcus Fellowship to Honor Norman B. Leventhal (K. R.), a postdoctoral fellowship from the MIT Simons Initiative on Autism and the Brain (G. M. B), NSF grant IOS 0919159 (T.O.), a Whitehall Foundation research grant, an Anonymous Foundation research grant, the John Merck Scholar Program, and NIH grant MH091220-01 (Y.L.).	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Balschun D, 2003, J NEUROSCI, V23, P6304; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; BENARI Y, 1990, TRENDS NEUROSCI, V13, P312, DOI 10.1016/0166-2236(90)90135-W; Coulon V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011235; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Landeira-Fernandez J, 2006, BEHAV NEUROSCI, V120, P873, DOI 10.1037/0735-7044.120.4.873; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Lonergan ME, 2010, NEURAL PLAST, V2010, P1, DOI 10.1155/2010/139891; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Maren S, 2008, EUR J NEUROSCI, V28, P1661, DOI 10.1111/j.1460-9568.2008.06485.x; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x	47	190	195	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1669	1675		10.1126/science.1208049	http://dx.doi.org/10.1126/science.1208049			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194569	Green Submitted, Green Accepted			2022-12-24	WOS:000298344000058
J	Yildirim, O; Li, RW; Hung, JH; Chen, PB; Dong, XJ; Ee, LS; Weng, ZP; Rando, OJ; Fazzio, TG				Yildirim, Ozlem; Li, Ruowang; Hung, Jui-Hung; Chen, Poshen B.; Dong, Xianjun; Ee, Ly-Sha; Weng, Zhiping; Rando, Oliver J.; Fazzio, Thomas G.			Mbd3/NURD Complex Regulates Expression of 5-Hydroxymethylcytosine Marked Genes in Embryonic Stem Cells	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; SELF-RENEWAL; LINEAGE COMMITMENT; DNA METHYLATION; BINDING DOMAIN; ES CELLS; PLURIPOTENCY; COMPONENT; GENOME; PROTEINS	Numerous chromatin regulators are required for embryonic stem (ES) cell self-renewal and pluripotency, but few have been studied in detail. Here, we examine the roles of several chromatin regulators whose loss affects the pluripotent state of ES cells. We find that Mbd3 and Brg1 antagonistically regulate a common set of genes by regulating promoter nucleosome occupancy. Furthermore, both Mbd3 and Brg1 play key roles in the biology of 5-hydroxymethylcytosine (5hmC): Mbd3 colocalizes with Tet1 and 5hmC in vivo, Mbd3 knockdown preferentially affects expression of 5hmC-marked genes, Mbd3 localization is Tet1-dependent, and Mbd3 preferentially binds to 5hmC relative to 5-methylcytosine in vitro. Finally, both Mbd3 and Brg1 are themselves required for normal levels of 5hmC in vivo. Together, our results identify an effector for 5hmC, and reveal that control of gene expression by antagonistic chromatin regulators is a surprisingly common regulatory strategy in ES cells.	[Yildirim, Ozlem; Weng, Zhiping; Rando, Oliver J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Li, Ruowang; Hung, Jui-Hung; Dong, Xianjun; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Chen, Poshen B.; Ee, Ly-Sha; Fazzio, Thomas G.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Fazzio, Thomas G.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	oliver.rando@umassmed.edu; thomas.fazzio@umassmed.edu	Hung, Jui-Hung/G-2673-2012; Dong, Xianjun/N-3867-2014; Dong, Xianjun/B-5334-2012; Chen, Benson/GYD-5518-2022	Hung, Jui-Hung/0000-0003-2208-9213; Dong, Xianjun/0000-0002-8052-9320; Rando, Oliver/0000-0003-1516-9397; Chen, Benson/0000-0002-5122-5192	NCI [CA140854]; NIGMS [GM088618]; Harold and Leila Mathers Charitable Foundation; NSF [DBI-0850008]; NATIONAL CANCER INSTITUTE [R00CA140854, K99CA140854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088618] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Harold and Leila Mathers Charitable Foundation; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Rando and Fazzio labs for critical reading of the manuscript; J. Benanti and P. Kaufman for technical advice; C. Li for assistance with TLC; D. Carone for assistance with IF; and J. M. Bishop, in whose lab some of these experiments were performed. We thank C. He and C. Song for the generous gift of reagents for isolation of 5hmC. T.G.F. is supported in part by grant CA140854 from NCI and is a Pew Scholar in the Biomedical Sciences. O.J.R. is supported in part by grant GM088618 from NIGMS, and by the Harold and Leila Mathers Charitable Foundation. Z.W. is supported by NSF grant DBI-0850008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. O.Y., T.G.F., and O.J.R. designed all experiments. O.Y. and T.G.F. carried out mapping experiments. O.Y. performed 5hmC quantitation, T.G.F. carried out gene expression and gel-shift experiments, and L. E. and P.B.C. performed experiments in Figures 4A and 4B. T.G.F. analyzed gene expression data. O.J.R., X.D., J.H.H., R.L., and Z.W. analyzed localization data. O.J.R., O.Y., and T.G.F. wrote the paper.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fazzio TG, 2008, CELL CYCLE, V7, P3302, DOI 10.4161/cc.7.21.6928; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Fazzio TG, 2010, CURR OPIN GENET DEV, V20, P500, DOI 10.1016/j.gde.2010.08.001; Feng Q, 2001, GENE DEV, V15, P827; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guertin MJ, 2010, COLD SH Q B, V75, P1, DOI 10.1101/sqb.2010.75.039; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; HOLM S, 1979, SCAND J STAT, V6, P65; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Keenen B, 2009, J CELL PHYSIOL, V219, P1, DOI 10.1002/jcp.21654; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Mahajan MC, 2005, P NATL ACAD SCI USA, V102, P15012, DOI 10.1073/pnas.0507596102; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Reese KJ, 2007, PLOS GENET, V3, P1407, DOI 10.1371/journal.pgen.0030137; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; van Lohuizen M, 1998, CELL MOL LIFE SCI, V54, P71, DOI 10.1007/s000180050126; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhu DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007684	59	331	341	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2011	147	7					1498	1510		10.1016/j.cell.2011.11.054	http://dx.doi.org/10.1016/j.cell.2011.11.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196727	Green Accepted, Bronze			2022-12-24	WOS:000298403400015
J	Young, ND; Debelle, F; Oldroyd, GED; Geurts, R; Cannon, SB; Udvardi, MK; Benedito, VA; Mayer, KFX; Gouzy, J; Schoof, H; Van de Peer, Y; Proost, S; Cook, DR; Meyers, BC; Spannagl, M; Cheung, F; De Mita, S; Krishnakumar, V; Gundlach, H; Zhou, SG; Mudge, J; Bharti, AK; Murray, JD; Naoumkina, MA; Rosen, B; Silverstein, KAT; Tang, HB; Rombauts, S; Zhao, PX; Zhou, P; Barbe, V; Bardou, P; Bechner, M; Bellec, A; Berger, A; Berges, H; Bidwell, S; Bisseling, T; Choisne, N; Couloux, A; Denny, R; Deshpande, S; Dai, XB; Doyle, JJ; Dudez, AM; Farmer, AD; Fouteau, S; Franken, C; Gibelin, C; Gish, J; Goldstein, S; Gonzalez, AJ; Green, PJ; Hallab, A; Hartog, M; Hua, A; Humphray, SJ; Jeong, DH; Jing, Y; Jocker, A; Kenton, SM; Kim, DJ; Klee, K; Lai, HS; Lang, CT; Lin, SP; Macmil, SL; Magdelenat, G; Matthews, L; McCorrison, J; Monaghan, EL; Mun, JH; Najar, FZ; Nicholson, C; Noirot, C; O'Bleness, M; Paule, CR; Poulain, J; Prion, F; Qin, BF; Qu, CM; Retzel, EF; Riddle, C; Sallet, E; Samain, S; Samson, N; Sanders, I; Saurat, O; Scarpelli, C; Schiex, T; Segurens, B; Severin, AJ; Sherrier, DJ; Shi, RH; Sims, S; Singer, SR; Sinharoy, S; Sterck, L; Viollet, A; Wang, BB; Wang, KQ; Wang, MY; Wang, XH; Warfsmann, J; Weissenbach, J; White, DD; White, JD; Wiley, GB; Wincker, P; Xing, YB; Yang, LM; Yao, ZY; Ying, F; Zhai, JX; Zhou, LP; Zuber, A; Denarie, J; Dixon, RA; May, GD; Schwartz, DC; Rogers, J; Quetier, F; Town, CD; Roe, BA				Young, Nevin D.; Debelle, Frederic; Oldroyd, Giles E. D.; Geurts, Rene; Cannon, Steven B.; Udvardi, Michael K.; Benedito, Vagner A.; Mayer, Klaus F. X.; Gouzy, Jerome; Schoof, Heiko; Van de Peer, Yves; Proost, Sebastian; Cook, Douglas R.; Meyers, Blake C.; Spannagl, Manuel; Cheung, Foo; De Mita, Stephane; Krishnakumar, Vivek; Gundlach, Heidrun; Zhou, Shiguo; Mudge, Joann; Bharti, Arvind K.; Murray, Jeremy D.; Naoumkina, Marina A.; Rosen, Benjamin; Silverstein, Kevin A. T.; Tang, Haibao; Rombauts, Stephane; Zhao, Patrick X.; Zhou, Peng; Barbe, Valerie; Bardou, Philippe; Bechner, Michael; Bellec, Arnaud; Berger, Anne; Berges, Helene; Bidwell, Shelby; Bisseling, Ton; Choisne, Nathalie; Couloux, Arnaud; Denny, Roxanne; Deshpande, Shweta; Dai, Xinbin; Doyle, Jeff J.; Dudez, Anne-Marie; Farmer, Andrew D.; Fouteau, Stephanie; Franken, Carolien; Gibelin, Chrystel; Gish, John; Goldstein, Steven; Gonzalez, Alvaro J.; Green, Pamela J.; Hallab, Asis; Hartog, Marijke; Hua, Axin; Humphray, Sean J.; Jeong, Dong-Hoon; Jing, Yi; Joecker, Anika; Kenton, Steve M.; Kim, Dong-Jin; Klee, Kathrin; Lai, Hongshing; Lang, Chunting; Lin, Shaoping; Macmil, Simone L.; Magdelenat, Ghislaine; Matthews, Lucy; McCorrison, Jamison; Monaghan, Erin L.; Mun, Jeong-Hwan; Najar, Fares Z.; Nicholson, Christine; Noirot, Celine; O'Bleness, Majesta; Paule, Charles R.; Poulain, Julie; Prion, Florent; Qin, Baifang; Qu, Chunmei; Retzel, Ernest F.; Riddle, Claire; Sallet, Erika; Samain, Sylvie; Samson, Nicolas; Sanders, Iryna; Saurat, Olivier; Scarpelli, Claude; Schiex, Thomas; Segurens, Beatrice; Severin, Andrew J.; Sherrier, D. Janine; Shi, Ruihua; Sims, Sarah; Singer, Susan R.; Sinharoy, Senjuti; Sterck, Lieven; Viollet, Agnes; Wang, Bing-Bing; Wang, Keqin; Wang, Mingyi; Wang, Xiaohong; Warfsmann, Jens; Weissenbach, Jean; White, Doug D.; White, Jim D.; Wiley, Graham B.; Wincker, Patrick; Xing, Yanbo; Yang, Limei; Yao, Ziyun; Ying, Fu; Zhai, Jixian; Zhou, Liping; Zuber, Antoine; Denarie, Jean; Dixon, Richard A.; May, Gregory D.; Schwartz, David C.; Rogers, Jane; Quetier, Francis; Town, Christopher D.; Roe, Bruce A.			The Medicago genome provides insight into the evolution of rhizobial symbioses	NATURE			English	Article							FLAVONOID BIOSYNTHESIS; SIGNAL-TRANSDUCTION; GENES; ARABIDOPSIS; SEQUENCE; TRUNCATULA; DUPLICATIONS; TETRAPLOIDY; LEGUMINOSAE; EXPRESSION	Legumes (Fabaceae or Leguminosae) are unique among cultivated plants for their ability to carry out endosymbiotic nitrogen fixation with rhizobial bacteria, a process that takes place in a specialized structure known as the nodule. Legumes belong to one of the two main groups of eurosids, the Fabidae, which includes most species capable of endosymbiotic nitrogen fixation(1). Legumes comprise several evolutionary lineages derived from a common ancestor 60 million years ago (Myr ago). Papilionoids are the largest clade, dating nearly to the origin of legumes and containing most cultivated species(2). Medicago truncatula is a long-established model for the study of legume biology. Here we describe the draft sequence of the M. truncatula euchromatin based on a recently completed BAC assembly supplemented with Illumina shotgun sequence, together capturing similar to 94% of all M. truncatula genes. A whole-genome duplication (WGD) approximately 58 Myr ago had a major role in shaping the M. truncatula genome and thereby contributed to the evolution of endosymbiotic nitrogen fixation. Subsequent to the WGD, the M. truncatula genome experienced higher levels of rearrangement than two other sequenced legumes, Glycine max and Lotus japonicus. M. truncatula is a close relative of alfalfa (Medicago sativa), a widely cultivated crop with limited genomics tools and complex autotetraploid genetics. As such, the M. truncatula genome sequence provides significant opportunities to expand alfalfa's genomic toolbox.	[Young, Nevin D.; Zhou, Peng; Denny, Roxanne; Paule, Charles R.; Wang, Bing-Bing; Wang, Xiaohong] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Young, Nevin D.; Zhou, Peng; Denny, Roxanne; Paule, Charles R.; Wang, Bing-Bing; Wang, Xiaohong] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Debelle, Frederic; Gouzy, Jerome; Bardou, Philippe; Dudez, Anne-Marie; Gibelin, Chrystel; Prion, Florent; Sallet, Erika; Samson, Nicolas; Saurat, Olivier; Zuber, Antoine; Denarie, Jean] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France; [Debelle, Frederic; Gouzy, Jerome; Bardou, Philippe; Dudez, Anne-Marie; Gibelin, Chrystel; Prion, Florent; Sallet, Erika; Samson, Nicolas; Saurat, Olivier; Zuber, Antoine; Denarie, Jean] CNRS, UMR2594, LIPM, F-31326 Castanet Tolosan, France; [Oldroyd, Giles E. D.; Murray, Jeremy D.] John Innes Ctr, Dept Dis & Stress Biol, Norwich NR4 7UH, Norfolk, England; [Geurts, Rene; De Mita, Stephane; Bisseling, Ton; Franken, Carolien; Hartog, Marijke; Lang, Chunting] Wageningen Univ, Dept Plant Sci, Mol Biol Lab, NL-6708 PB Wageningen, Netherlands; [Cannon, Steven B.] ARS, USDA, Corn Insects & Crop Genet Res Unit, Ames, IA 50011 USA; [Cannon, Steven B.; Severin, Andrew J.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Udvardi, Michael K.; Murray, Jeremy D.; Naoumkina, Marina A.; Zhao, Patrick X.; Dai, Xinbin; Sinharoy, Senjuti; Wang, Mingyi; Dixon, Richard A.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA; [Benedito, Vagner A.] W Virginia Univ, Div Plant & Soil Sci, Dept Genet & Dev Biol, Morgantown, WV 26506 USA; [Mayer, Klaus F. X.; Spannagl, Manuel; Gundlach, Heidrun] Helmholtz Ctr Munich, MIPS Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Schoof, Heiko] Univ Bonn, INRES Crop Bioinformat, D-53115 Bonn, Germany; [Van de Peer, Yves; Proost, Sebastian; Rombauts, Stephane; Sterck, Lieven] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Cook, Douglas R.; Rosen, Benjamin; Gish, John; Kim, Dong-Jin; Mun, Jeong-Hwan] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Meyers, Blake C.; Green, Pamela J.; Jeong, Dong-Hoon; Sherrier, D. Janine; Zhai, Jixian] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19711 USA; [Meyers, Blake C.; Green, Pamela J.; Jeong, Dong-Hoon; Sherrier, D. Janine; Zhai, Jixian] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA; [Cheung, Foo; Krishnakumar, Vivek; Tang, Haibao; Bidwell, Shelby; McCorrison, Jamison; Monaghan, Erin L.; Town, Christopher D.] J Craig Venter Inst, Rockville, MD 20850 USA; [Zhou, Shiguo; Bechner, Michael; Goldstein, Steven; Schwartz, David C.] Univ Wisconsin, Lab Mol & Computat Genom, Madison, WI 53706 USA; [Mudge, Joann; Bharti, Arvind K.; Farmer, Andrew D.; Retzel, Ernest F.; May, Gregory D.] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA; [Silverstein, Kevin A. T.] Univ Minnesota, Biostat & Bioinformat Grp, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Barbe, Valerie; Berger, Anne; Choisne, Nathalie; Couloux, Arnaud; Fouteau, Stephanie; Magdelenat, Ghislaine; Poulain, Julie; Samain, Sylvie; Scarpelli, Claude; Segurens, Beatrice; Viollet, Agnes; Weissenbach, Jean; Wincker, Patrick; Quetier, Francis] Genoscope, Ctr Natl Sequencage, F-91057 Evry, France; [Bellec, Arnaud; Berges, Helene] INRA, CNRGV, F-31326 Castanet Tolosan, France; [Bisseling, Ton] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia; [Deshpande, Shweta; Hua, Axin; Jing, Yi; Kenton, Steve M.; Lai, Hongshing; Lin, Shaoping; Macmil, Simone L.; Najar, Fares Z.; O'Bleness, Majesta; Qin, Baifang; Qu, Chunmei; Sanders, Iryna; Shi, Ruihua; Wang, Keqin; White, Doug D.; White, Jim D.; Wiley, Graham B.; Xing, Yanbo; Yang, Limei; Yao, Ziyun; Ying, Fu; Zhou, Liping; Roe, Bruce A.] Univ Oklahoma, Dept Chem & Biochem, Adv Ctr Genome Technol, Stephenson Res & Technol Ctr, Norman, OK 73019 USA; [Doyle, Jeff J.] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; [Gonzalez, Alvaro J.] Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19711 USA; [Gonzalez, Alvaro J.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA; [Hallab, Asis; Joecker, Anika; Klee, Kathrin; Warfsmann, Jens] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Humphray, Sean J.; Matthews, Lucy; Nicholson, Christine; Riddle, Claire; Sims, Sarah] Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Kim, Dong-Jin] Int Inst Trop Agr, Ibadan, Nigeria; [Mun, Jeong-Hwan] Natl Inst Agr Biotechnol, Rural Dev Adm, Suwon 441707, South Korea; [Noirot, Celine; Schiex, Thomas] INRA, UBIA, UR875, F-31326 Castanet Tolosan, France; [Singer, Susan R.] Carleton Coll, Dept Biol, Northfield, MN 55057 USA; [Rogers, Jane] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Wageningen University & Research; United States Department of Agriculture (USDA); Iowa State University; Noble Research Institute; West Virginia University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; Flanders Institute for Biotechnology (VIB); Ghent University; University of California System; University of California Davis; University of Delaware; University of Delaware; J. Craig Venter Institute; University of Wisconsin System; University of Wisconsin Madison; National Center for Genome Resources (NCGR); University of Minnesota System; University of Minnesota Twin Cities; CEA; UDICE-French Research Universities; Universite Paris Saclay; INRAE; King Saud University; University of Oklahoma System; University of Oklahoma - Norman; Cornell University; University of Delaware; University of Delaware; Max Planck Society; Wellcome Trust Sanger Institute; CGIAR; International Institute of Tropical Agriculture (IITA); Rural Development Administration (RDA), Republic of Korea; INRAE; Carleton College; The Genome Analysis Centre (TGAC)	Young, ND (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA.	neviny@umn.edu	Mayer, Klaus FX/M-7941-2015; Zhou, Shiguo/B-3832-2011; Rombauts, Stephane M/D-7640-2014; Udvardi, Michael/GPX-4653-2022; Oldroyd, Giles/ABA-7501-2020; Van de Peer, Yves/AAE-7666-2019; Tang, Haibao/A-6715-2011; Sinharoy, Senjuti/AAA-2572-2019; Sterck, Lieven/A-9439-2016; Murray, Jeremy D./F-8409-2011; Proost, Sebastian/AAB-9845-2022; Zhai, Jixian/HCH-9272-2022; Gouzy, Jerome/AAH-4977-2020; Schoof, Heiko/Y-7073-2018; Meyers, Blake/B-6535-2012; Oldroyd, Giles/ABD-8143-2021; Sherrier, D. Janine/D-6624-2017; Rombauts, Stephane/P-2420-2019; Krishnakumar, Vivek/C-7204-2015; Sherrier, D Janine/GNH-1971-2022; Bisseling, Ton/A-2421-2013; Van de Peer, Yves/D-4388-2009; Quetier, Francis/J-7923-2017	Mayer, Klaus FX/0000-0001-6484-1077; Zhou, Shiguo/0000-0001-7421-2506; Rombauts, Stephane M/0000-0002-3985-4981; Udvardi, Michael/0000-0001-9850-0828; Van de Peer, Yves/0000-0003-4327-3730; Tang, Haibao/0000-0002-3460-8570; Sinharoy, Senjuti/0000-0003-2323-2587; Sterck, Lieven/0000-0001-7116-4000; Murray, Jeremy D./0000-0003-3000-9199; Proost, Sebastian/0000-0002-6792-9442; Gouzy, Jerome/0000-0001-5695-4557; Schoof, Heiko/0000-0002-1527-3752; Meyers, Blake/0000-0003-3436-6097; Oldroyd, Giles/0000-0002-5245-6355; Sherrier, D. Janine/0000-0003-1230-0636; Rombauts, Stephane/0000-0002-3985-4981; Krishnakumar, Vivek/0000-0002-5227-0200; Van de Peer, Yves/0000-0003-4327-3730; Sallet, Erika/0000-0003-4637-473X; Gundlach, Heidrun/0000-0002-6757-0943; Poulain, Julie/0000-0002-8744-3116; Spannagl, Manuel/0000-0003-0701-7035; CHOISNE, Nathalie/0000-0001-6024-1664; Couloux, Arnaud/0000-0003-2356-0062; BERGES, Helene/0000-0002-5492-1062; Klee, Kathrin/0000-0003-2408-1282; Mudge, Joann/0000-0002-2972-1640; Zhao, Patrick Xuechun/0000-0002-3460-5564; Cree, Simone/0000-0002-7349-422X; Young, Nevin/0000-0001-6463-4772; Quetier, Francis/0000-0003-4388-9287; Bardou, Philippe/0000-0002-0004-0251; Zhai, Jixian/0000-0002-0217-0666	Noble Foundation; NSF-PGRP [0321460, 0604966, 0820005, 0821966]; EU [FOOD-CT-2004-506223]; BBSRC [BBS/B/11524]; ANR [SEQMEDIC 2006-01122]; Dutch Science Organization [VIDI 864.06.007, ERA-PG FP-06.038A]; Belgian Federal Science Policy Office IUAP [P6/25]; Fund for Scientific Research Flanders; Institute for the Promotion of Innovation by Science and Technology in Flanders; Ghent University [MRP N2N]; NSF [IOS-0531408, IOS-0605251]; USDA CSREES [2006-03567]; 'Laboratoire d'Excellence' (LABEX) TULIP [ANR-10-LABX-41]; BBSRC [BB/G023832/1, BB/I025441/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025441/1, BBS/E/J/00000603, BBS/B/11524, BB/G023832/1] Funding Source: researchfish; Direct For Biological Sciences [0960897] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0820005] Funding Source: National Science Foundation	Noble Foundation; NSF-PGRP(National Science Foundation (NSF)NSF - Office of the Director (OD)); EU(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ANR(French National Research Agency (ANR)); Dutch Science Organization; Belgian Federal Science Policy Office IUAP(Belgian Federal Science Policy Office); Fund for Scientific Research Flanders(FWO); Institute for the Promotion of Innovation by Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Ghent University(Ghent University); NSF(National Science Foundation (NSF)); USDA CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); 'Laboratoire d'Excellence' (LABEX) TULIP; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding support to N.D.Y., C. D. T. and B. A. R. from The Noble Foundation and NSF-PGRP 0321460, 0604966; to N.D.Y., J.M. and G. D. M. from NSF-PGRP 0820005; to C. D. T. from NSF-PGRP 0821966; to F. D., G.E.D.O., R. G., K. F. X. M., T. B., J. Denarie, F. Q. and J. R. from FP6 EU project GLIP/Grain Legumes FOOD-CT-2004-506223; to G.E.D.O. and J.R. from BBSRC BBS/B/11524; to F. D. and F. Q. from ANR project SEQMEDIC 2006-01122; to R. G. from the Dutch Science Organization VIDI 864.06.007, ERA-PG FP-06.038A; to Y.V.d.P. from the Belgian Federal Science Policy Office IUAP P6/25, Fund for Scientific Research Flanders, Institute for the Promotion of Innovation by Science and Technology in Flanders and Ghent University (MRP N2N); to D. R. C. from NSF IOS-0531408, IOS-0605251; to D.J.S., B. C. M. and P.J.G. from USDA CSREES 2006-03567; to J. Gouzy from 'Laboratoire d'Excellence' (LABEX) TULIP (ANR-10-LABX-41). We also acknowledge technical support from the University of Minnesota Supercomputer Institute and thank Y.W. Nam for a BamHI BAC library used by Genoscope, S. Park and M. Accerbi for RNA isolation, T. Paape for statistical consulting, and M. Harrison for supplying myc infected and control root tissues used to make small RNA libraries.	Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Cannon SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011630; den Camp RO, 2011, SCIENCE, V331, P909, DOI 10.1126/science.1198181; Doyle JJ, 2003, PLANT PHYSIOL, V131, P900, DOI 10.1104/pp.102.018150; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; HEGNAUER R, 1993, PHYTOCHEMISTRY, V34, P3, DOI 10.1016/S0031-9422(00)90776-3; Kato T, 2002, MOL PLANT MICROBE IN, V15, P129, DOI 10.1094/MPMI.2002.15.2.129; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kistner C, 2002, TRENDS PLANT SCI, V7, P511, DOI 10.1016/S1360-1385(02)02356-7; Kulikova O, 2001, PLANT J, V27, P49, DOI 10.1046/j.1365-313x.2001.01057.x; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Middleton PH, 2007, PLANT CELL, V19, P1221, DOI 10.1105/tpc.106.048264; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; Pfeil BE, 2005, SYST BIOL, V54, P441, DOI 10.1080/10635150590945359; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; Singer SR, 2009, PLANT PHYSIOL, V151, P1041, DOI 10.1104/pp.109.144774; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	30	863	976	17	430	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					520	524		10.1038/nature10625	http://dx.doi.org/10.1038/nature10625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22089132	hybrid, Green Accepted			2022-12-24	WOS:000298318000060
J	Lynch, VJ; May, G; Wagner, GP				Lynch, Vincent J.; May, Gemma; Wagner, Guenter P.			Regulatory evolution through divergence of a phosphoswitch in the transcription factor CEBPB	NATURE			English	Article							BINDING-PROTEIN-BETA; ENDOMETRIAL STROMAL CELLS; C/EBP-BETA; HOX PROTEIN; DNA-BINDING; IN-VIVO; DOMAIN; ACTIVATION; PHOSPHORYLATION; ASSOCIATION	There is an emerging consensus that gene regulation evolves through changes in cis-regulatory elements(1,2) and transcription factors(3-6). Although it is clear how nucleotide substitutions in cis-regulatory elements affect gene expression, it is not clear how amino-acid substitutions in transcription factors influence gene regulation(4-10). Here we show that amino-acid changes in the transcription factor CCAAT/enhancer binding protein-beta (CEBPB, also known as C/EBP-beta) in the stem-lineage of placental mammals changed the way it responds to cyclic AMP/protein kinase A (cAMP/PKA) signalling. By functionally analysing resurrected ancestral proteins, we identify three amino-acid substitutions in an internal regulatory domain of CEBPB that are responsible for the novel function. These amino-acid substitutions reorganize the location of key phosphorylation sites, introducing a new site and removing two ancestral sites, reversing the response of CEBPB to GSK-3 beta-mediated phosphorylation from repression to activation. We conclude that changing the response of transcription factors to signalling pathways can be an important mechanism of gene regulatory evolution.	[Lynch, Vincent J.; May, Gemma; Wagner, Guenter P.] Yale Univ, Yale Syst Biol Inst, New Haven, CT 06511 USA; [Lynch, Vincent J.; May, Gemma; Wagner, Guenter P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA	Yale University; Yale University	Lynch, VJ (corresponding author), Yale Univ, Yale Syst Biol Inst, New Haven, CT 06511 USA.	vincent.j.lynch@yale.edu		Wagner, Gunter/0000-0002-3097-002X; Lynch, Vincent/0000-0001-5311-3824	John Templeton Foundation [12793]; Origin of Organismal Complexity	John Templeton Foundation; Origin of Organismal Complexity	This work was funded by a grant from the John Templeton Foundation, number 12793 Genetics and the Origin of Organismal Complexity; results presented here do not necessarily reflect the views of the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen LZ, 2010, P NATL ACAD SCI USA, V107, P10555, DOI 10.1073/pnas.1005129107; Christian M, 2002, J BIOL CHEM, V277, P20825, DOI 10.1074/jbc.M201018200; Christian M, 2002, MOL ENDOCRINOL, V16, P141, DOI 10.1210/me.16.1.141; Friedman JR, 2004, P NATL ACAD SCI USA, V101, P12986, DOI 10.1073/pnas.0402875101; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Hsia CC, 2003, CURR OPIN GENET DEV, V13, P199, DOI 10.1016/S0959-437X(03)00017-0; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lee S, 2010, J BIOL CHEM, V285, P21399, DOI 10.1074/jbc.M110.128413; Lohr U, 2001, CURR BIOL, V11, P1403, DOI 10.1016/S0960-9822(01)00443-2; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Lynch VJ, 2008, P NATL ACAD SCI USA, V105, P14928, DOI 10.1073/pnas.0802355105; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; Pohnke Y, 1999, J BIOL CHEM, V274, P24808, DOI 10.1074/jbc.274.35.24808; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Spooner CJ, 2007, MOL IMMUNOL, V44, P1384, DOI 10.1016/j.molimm.2006.05.004; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; TRAUTWEIN C, 1995, J BIOL CHEM, V270, P15130, DOI 10.1074/jbc.270.25.15130; Tsvetkov P, 2008, PROTEINS, V70, P1357, DOI 10.1002/prot.21614; Wagner GP, 2005, J EXP ZOOL PART B, V304B, P580, DOI 10.1002/jez.b.21074; Wagner GP, 2010, CURR BIOL, V20, pR48, DOI 10.1016/j.cub.2009.11.010; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zhao X, 2005, J BIOL CHEM, V280, P32683, DOI 10.1074/jbc.M505486200	30	68	69	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					383	U139		10.1038/nature10595	http://dx.doi.org/10.1038/nature10595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22080951				2022-12-24	WOS:000298033000055
J	Rauch, PJ; Chudnovskiy, A; Robbins, CS; Weber, GF; Etzrodt, M; Hilgendorf, I; Tiglao, E; Figueiredo, JL; Iwamoto, Y; Theurl, I; Gorbatov, R; Waring, MT; Chicoine, AT; Mouded, M; Pittet, MJ; Nahrendorf, M; Weissleder, R; Swirski, FK				Rauch, Philipp J.; Chudnovskiy, Aleksey; Robbins, Clinton S.; Weber, Georg F.; Etzrodt, Martin; Hilgendorf, Ingo; Tiglao, Elizabeth; Figueiredo, Jose-Luiz; Iwamoto, Yoshiko; Theurl, Igor; Gorbatov, Rostic; Waring, Michael T.; Chicoine, Adam T.; Mouded, Majd; Pittet, Mikael J.; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.			Innate Response Activator B Cells Protect Against Microbial Sepsis	SCIENCE			English	Article							COLONY-STIMULATING FACTOR; MARGINAL-ZONE; SURVIVAL; MICE; AUTOIMMUNITY; LYMPHOCYTES; CLEARANCE; ENDOTOXIN; SUBSETS; MODELS	Recognition and clearance of a bacterial infection are fundamental properties of innate immunity. Here, we describe an effector B cell population that protects against microbial sepsis. Innate response activator (IRA) B cells are phenotypically and functionally distinct, develop and diverge from B1a B cells, depend on pattern-recognition receptors, and produce granulocyte-macrophage colony-stimulating factor. Specific deletion of IRA B cell activity impairs bacterial clearance, elicits a cytokine storm, and precipitates septic shock. These observations enrich our understanding of innate immunity, position IRA B cells as gatekeepers of bacterial infection, and identify new treatment avenues for infectious diseases.	[Rauch, Philipp J.; Chudnovskiy, Aleksey; Robbins, Clinton S.; Weber, Georg F.; Etzrodt, Martin; Hilgendorf, Ingo; Tiglao, Elizabeth; Figueiredo, Jose-Luiz; Iwamoto, Yoshiko; Theurl, Igor; Gorbatov, Rostic; Pittet, Mikael J.; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Rauch, Philipp J.; Chudnovskiy, Aleksey; Robbins, Clinton S.; Weber, Georg F.; Etzrodt, Martin; Hilgendorf, Ingo; Tiglao, Elizabeth; Figueiredo, Jose-Luiz; Iwamoto, Yoshiko; Theurl, Igor; Gorbatov, Rostic; Waring, Michael T.; Chicoine, Adam T.; Pittet, Mikael J.; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Theurl, Igor] Massachusetts Gen Hosp, Program Membrane Biol, Boston, MA 02114 USA; [Theurl, Igor] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Waring, Michael T.; Chicoine, Adam T.] Massachusetts Gen Hosp, Ragon Inst Imaging Core, Boston, MA 02114 USA; [Mouded, Majd] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Sch Med, Pittsburgh, PA 15213 USA; [Hilgendorf, Ingo] Univ Hosp Freiburg, Dept Cardiol, D-79106 Freiburg, Germany; [Theurl, Igor] Univ Innsbruck Hosp, Dept Gen Internal Med Clin Immunol & Infect Dis, A-6020 Innsbruck, Austria	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Freiburg; Medical University of Innsbruck	Robbins, CS (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	robbins.clinton@mgh.harvard.edu; fswirski@mgh.harvard.edu	Swirski, Filip/AAF-1340-2019; Pittet, Mikael/ABD-6300-2021; Etzrodt, Martin/P-3325-2015; Hilgendorf, Ingo/AFM-6379-2022	Etzrodt, Martin/0000-0003-1928-3904; Hilgendorf, Ingo/0000-0002-0024-1643; Rauch, Philipp/0000-0001-8677-0986; Theurl, Igor/0000-0003-3180-4784; Robbins, Clinton/0000-0001-9848-1495; /0000-0003-0828-4143; Swirski, Filip/0000-0002-3163-9152	NIH [1R01HL095612, U01 HL080731, P50 CA86355, R24 CA69246, P01-A154904]; Boehringer Ingelheim Fonds; American Heart Association; MGH Executive Committee on Research (ECOR); German Research Foundation; Max Kade Foundation; NATIONAL CANCER INSTITUTE [P01CA069246, P50CA086355] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095612, U01HL080731] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); American Heart Association(American Heart Association); MGH Executive Committee on Research (ECOR); German Research Foundation(German Research Foundation (DFG)); Max Kade Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by NIH grants 1R01HL095612 (to F. K. S.), as well as U01 HL080731, P50 CA86355, R24 CA69246, and P01-A154904 (to R. W.). P.J.R. was supported by the Boehringer Ingelheim Fonds; C. S. R. was supported by an American Heart Association postdoctoral fellowship and the MGH Executive Committee on Research (ECOR) Postdoctoral Award; G. F. W. and I. H. were supported by the German Research Foundation; and I. T. was supported by the Max Kade Foundation. We thank K. Rajewsky, D. Scadden, A. Luster, and K. Otipoby (Harvard Medical School) for helpful discussions and critical reading of the manuscript and M. Greene for secretarial assistance. The data reported in this paper are tabulated in the main paper and in the supporting online material. MIAME (minimum information about a microarray experiment)-compliant expression data have been deposited under the accession no. GSE32372.	Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Basu S, 1997, J IMMUNOL, V159, P1412; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; GENNARI R, 1994, ANN SURG, V220, P68, DOI 10.1097/00000658-199407000-00010; Griffin DO, 2011, J EXP MED, V208, P2591, DOI 10.1084/jem.20110978; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Harris RJ, 2000, J IMMUNOL, V164, P3887, DOI 10.4049/jimmunol.164.7.3887; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Kawahara T, 2003, J IMMUNOL, V171, P5406, DOI 10.4049/jimmunol.171.10.5406; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Metcalf D, 1999, BLOOD, V93, P1579, DOI 10.1182/blood.V93.5.1579.405k01_1579_1585; Montecino-Rodriguez E, 2006, TRENDS IMMUNOL, V27, P428, DOI 10.1016/j.it.2006.07.005; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	27	286	295	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 3	2012	335	6068					597	601		10.1126/science.1215173	http://dx.doi.org/10.1126/science.1215173			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885HI	22245738	Green Accepted			2022-12-24	WOS:000299769200047
J	Crasta, K; Ganem, NJ; Dagher, R; Lantermann, AB; Ivanova, EV; Pan, YF; Nezi, L; Protopopov, A; Chowdhury, D; Pellman, D				Crasta, Karen; Ganem, Neil J.; Dagher, Regina; Lantermann, Alexandra B.; Ivanova, Elena V.; Pan, Yunfeng; Nezi, Luigi; Protopopov, Alexei; Chowdhury, Dipanjan; Pellman, David			DNA breaks and chromosome pulverization from errors in mitosis	NATURE			English	Article							KINETOCHORE-MICROTUBULE ATTACHMENT; TUMOR-SUPPRESSOR; NUCLEAR-PORE; CANCER-CELLS; REPLICATION; INSTABILITY; ANEUPLOIDY; DAMAGE; TUMORIGENESIS; COMPLEX	The involvement of whole-chromosome aneuploidy in tumorigenesis is the subject of debate, in large part because of the lack of insight into underlying mechanisms. Here we identify a mechanism by which errors in mitotic chromosome segregation generate DNA breaks via the formation of structures called micronuclei. Whole-chromosome-containing micronuclei form when mitotic errors produce lagging chromosomes. We tracked the fate of newly generated micronuclei and found that they undergo defective and asynchronous DNA replication, resulting in DNA damage and often extensive fragmentation of the chromosome in the micronucleus. Micronuclei can persist in cells over several generations but the chromosome in the micronucleus can also be distributed to daughter nuclei. Thus, chromosome segregation errors potentially lead to mutations and chromosome rearrangements that can integrate into the genome. Pulverization of chromosomes in micronuclei may also be one explanation for 'chromothripsis' in cancer and developmental disorders, where isolated chromosomes or chromosome arms undergo massive local DNA breakage and rearrangement.	[Crasta, Karen; Ganem, Neil J.; Dagher, Regina; Lantermann, Alexandra B.; Nezi, Luigi; Pellman, David] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Crasta, Karen; Ganem, Neil J.; Dagher, Regina; Pellman, David] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Crasta, Karen; Ganem, Neil J.; Dagher, Regina; Pellman, David] Howard Hughes Med Inst, Boston, MA 02115 USA; [Ivanova, Elena V.; Protopopov, Alexei] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Pan, Yunfeng; Chowdhury, Dipanjan] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Pellman, D (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 450 Brookline Ave, Boston, MA 02115 USA.	david_pellman@dfci.harvard.edu	Crasta, Karen C/F-8752-2015; Nezi, Luigi/AAB-1957-2019	Nezi, Luigi/0000-0002-4670-7656; Ganem, Neil/0000-0003-0269-6585; Ivanova, Elena/0000-0002-5069-4974; Crasta, Karen/0000-0001-9849-6080	Howard Hughes Medical Institute; NIH [GM083299, 1R01CA142698-01]; NATIONAL CANCER INSTITUTE [R00CA154531, R01CA142698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083299] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. D'Andrea, M. E. McLaughlin, T. A. Rapoport, J. Walters and Pellman laboratory members for discussions and/or comments on the manuscript; L. Cameron for advice and help on microscopy; H. Li for irradiation of cells; M. Nitta and M. Hennessy for preliminary experiments; and V. Larionov, B. Stillman, J. Ellenberg, I. Mattaj, A. Miyawaki and T. Kuroda for reagents. D. P. was supported by the Howard Hughes Medical Institute and the NIH (GM083299); K. C. was a fellow of A*STAR Singapore; N.J.G. was a fellow of the Leukemia and Lymphoma Society; Y.P. and D. C. were funded by the NIH (1R01CA142698-01).	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Dalton WB, 2007, CANCER RES, V67, P11487, DOI 10.1158/0008-5472.CAN-07-5162; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; DePamphilis M. L., 2011, GENOME DUPLICATION; Dimitrova DS, 2002, J CELL SCI, V115, P51; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GERAUD G, 1989, EXP CELL RES, V181, P27, DOI 10.1016/0014-4827(89)90179-1; Gisselsson D, 2001, AM J PATHOL, V158, P199, DOI 10.1016/S0002-9440(10)63958-2; Gordon D. J., NATURE REV IN PRESS; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; KATO H, 1967, J CELL BIOL, V34, P35, DOI 10.1083/jcb.34.1.35; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; NICHOLS WW, 1965, HEREDITAS-GENETISK A, V54, P101; OBE G, 1975, MUTAT RES, V27, P89, DOI 10.1016/0027-5107(75)90276-6; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Orth J. D., 2011, MOL BIOL CELL; Peterson-Roth E, 2005, MOL CELL BIOL, V25, P3596, DOI 10.1128/MCB.25.9.3596-3607.2005; Prasanth SG, 2004, PHILOS T R SOC B, V359, P7, DOI 10.1098/rstb.2003.1360; Quignon F, 2007, ONCOGENE, V26, P165, DOI 10.1038/sj.onc.1209787; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; SEN S, 1989, CANCER RES, V49, P6731; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smith L, 2001, P NATL ACAD SCI USA, V98, P13300, DOI 10.1073/pnas.241355098; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Terradas M, 2010, MUTAT RES-REV MUTAT, V705, P60, DOI 10.1016/j.mrrev.2010.03.004; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003	50	778	798	6	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 2	2012	482	7383					53	U70		10.1038/nature10802	http://dx.doi.org/10.1038/nature10802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884RN	22258507	Green Accepted			2022-12-24	WOS:000299726000033
J	Chang, HC; Paek, J; Kim, DH				Chang, Howard C.; Paek, Jennifer; Kim, Dennis H.			Natural polymorphisms in C. elegans HECW-1 E3 ligase affect pathogen avoidance behaviour	NATURE			English	Article							CAENORHABDITIS-ELEGANS; SOCIAL-BEHAVIOR; BACTERIA; PATHWAY; KINASE; HOMOLOG; SYSTEM	Heritable variation in behavioural traits generally has a complex genetic basis(1), and thus naturally occurring polymorphisms that influence behaviour have been defined only in rare instances(2,3). The isolation of wild strains of Caenorhabditis elegans has facilitated the study of natural genetic variation in this species(4) and provided insights into its diverse microbial ecology(5). C. elegans responds to bacterial infection with conserved innate immune responses(6-8) and, although lacking the immunological memory of vertebrate adaptive immunity, shows an aversive learning response to pathogenic bacteria(9). Here, we report the molecular characterization of naturally occurring coding polymorphisms in a C. elegans gene encoding a conserved HECT domain-containing E3 ubiquitin ligase, HECW-1. We show that two distinct polymorphisms in neighbouring residues of HECW-1 each affect C. elegans behavioural avoidance of a lawn of Pseudomonas aeruginosa. Neuron-specific rescue and ablation experiments and genetic interaction analysis indicate that HECW-1 functions in a pair of sensory neurons to inhibit P. aeruginosa lawn avoidance behaviour through inhibition of the neuropeptide receptor NPR-1 (ref. 10), which we have previously shown promotes P. aeruginosa lawn avoidance behaviour(11). Our data establish a molecular basis for natural variation in a C. elegans behaviour that may undergo adaptive changes in response to microbial pathogens.	[Chang, Howard C.; Paek, Jennifer; Kim, Dennis H.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Kim, DH (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dhkim@mit.edu		Chang, Howard/0000-0003-4310-8890	NIH-National Center for Research Resources; NIH [GM084477]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084477] Funding Source: NIH RePORTER	NIH-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Denning and H. R. Horvitz for the csp-1b cDNA. We thank Y. Kohara for the hecw-1 and npr-1 cDNAs. We thank J. Meisel for sequencing of hecw-1 polymorphisms. We thank D. Ma for technical advice on laser ablation. We thank T. Schwartz for expert advice with the structural modeling of HECW-1. The hecw-1(ok1347) deletion allele was generated by the C. elegans Knockout Consortium and obtained, along with other strains used in this study, from the Caenorhabditis Genetics Center (CGC), which is supported by the NIH-National Center for Research Resources. This work was supported by NIH Grant GM084477 (to D.H.K.).	Barriere A, 2005, NATURAL VARIATION PO, DOI [DOI 10.1895/WORMBOOK.1.43.1, 10.1895/wormbook.1.43.1]; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; BRENNER S, 1974, GENETICS, V77, P71; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Reddy KC, 2011, P NATL ACAD SCI USA, V108, P12887, DOI 10.1073/pnas.1108265108; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Shivers RP, 2009, CELL HOST MICROBE, V6, P321, DOI 10.1016/j.chom.2009.09.001; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Weber KP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013922; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	30	58	64	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					525	U148		10.1038/nature10643	http://dx.doi.org/10.1038/nature10643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22089131	Green Accepted, Green Submitted			2022-12-24	WOS:000298318000061
J	Kamat, SS; Williams, HJ; Raushel, FM				Kamat, Siddhesh S.; Williams, Howard J.; Raushel, Frank M.			Intermediates in the transformation of phosphonates to phosphate by bacteria	NATURE			English	Article							PYRUVATE FORMATE-LYASE; 3-DIMENSIONAL STRUCTURE; CATALYTIC MECHANISM; DEGRADATION; IDENTIFICATION; METABOLISM; CLEAVAGE; 14-GENE; OPERON	Phosphorus is an essential element for all known forms of life. In living systems, phosphorus is an integral component of nucleic acids, carbohydrates and phospholipids, where it is incorporated as a derivative of phosphate. However, most Gram-negative bacteria have the capability to use phosphonates as a nutritional source of phosphorus under conditions of phosphate starvation(1). In these organisms, methylphosphonate is converted to phosphate and methane. In a formal sense, this transformation is a hydrolytic cleavage of a carbon-phosphorus (C-P) bond, but a general enzymatic mechanism for the activation and conversion of alkylphosphonates to phosphate and an alkane has not been elucidated despite much effort for more than two decades. The actual mechanism for C-P bond cleavage is likely to be a radical-based transformation(2). In Escherichia coli, the catalytic machinery for the C-P lyase reaction has been localized to the phn gene cluster(1). This operon consists of the 14 genes phnC, phnD, ... , phnP. Genetic and biochemical experiments have demonstrated that the genes phnG, phnH, ... , phnM encode proteins that are essential for the conversion of phosphonates to phosphate and that the proteins encoded by the other genes in the operon have auxiliary functions(1,3-6). There are no functional annotations for any of the seven proteins considered essential for C-P bond cleavage. Here we show that methylphosphonate reacts with MgATP to form alpha-D-ribose-1-methylphosphonate-5-triphosphate (RPnTP) and adenine. The triphosphate moiety of RPnTP is hydrolysed to pyrophosphate and alpha-D-ribose-1-methylphosphonate-5-phosphate (PRPn). The C-P bond of PRPn is subsequently cleaved in a radical-based reaction producing alpha-D-ribose-1,2-cyclic-phosphate-5-phosphate and methane in the presence of S-adenosyl-L-methionine. Substantial quantities of phosphonates are produced worldwide for industrial processes, detergents, herbicides and pharmaceuticals(7-9). Our elucidation of the chemical steps for the biodegradation of alkylphosphonates shows how these compounds can be metabolized and recycled to phosphate.	[Kamat, Siddhesh S.; Williams, Howard J.; Raushel, Frank M.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Raushel, FM (corresponding author), Texas A&M Univ, Dept Chem, POB 30012, College Stn, TX 77843 USA.	raushel@tamu.edu	Raushel, Frank/B-7125-2015	Raushel, Frank/0000-0002-5918-3089; Kamat, Siddhesh/0000-0001-6132-7574	National Institutes of Health [GM93342, GM71790]; Robert A. Welch Foundation [A-840]; National Science Foundation [0840464]; Division Of Chemistry [0840464] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM093342, P01GM071790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Barondeau and his laboratory for use of the anaerobic chamber and for advice on the assembly of Fe-S clusters in radical SAM enzymes. We also thank C. Xu for help with some of the <SUP>31</SUP>P NMR spectra and S. Burrows for help with cloning phnI and phnH. This work was supported in part by the National Institutes of Health (GM93342, GM71790) and the Robert A. Welch Foundation (A-840). The cryoprobe for the NMR spectrometer was purchased with funds from the National Science Foundation (0840464)	AHN YH, 1992, J AM CHEM SOC, V114, P7953, DOI 10.1021/ja00046a075; AVILA LZ, 1991, BIOORG MED CHEM LETT, V1, P51, DOI 10.1016/S0960-894X(01)81089-1; Buis JM, 2005, ARCH BIOCHEM BIOPHYS, V433, P288, DOI 10.1016/j.abb.2004.09.028; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Errey JC, 2006, BIOCHEMISTRY-US, V45, P3033, DOI 10.1021/bi052297p; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; FROST JW, 1987, J AM CHEM SOC, V109, P2166, DOI 10.1021/ja00241a039; Hall RS, 2011, BIOCHEMISTRY-US, V50, P5077, DOI 10.1021/bi200483k; Hove-Jensen B, 2003, J BACTERIOL, V185, P2793, DOI 10.1128/JB.185.9.2793-2801.2003; Hove-Jensen B, 2011, J AM CHEM SOC, V133, P3617, DOI 10.1021/ja1102713; Jochimsen B, 2011, P NATL ACAD SCI USA, V108, P11393, DOI 10.1073/pnas.1104922108; Kamat SS, 2011, BIOCHEMISTRY-US, V50, P1917, DOI 10.1021/bi101788n; Kononova SV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P184, DOI 10.1023/A:1014409929875; KRENITSKY TA, 1972, ARCH BIOCHEM BIOPHYS, V150, P585, DOI 10.1016/0003-9861(72)90078-1; LaVallie E. R., 1994, CURR PROTOC MOL BIOL, V28, P5; Maynes JT, 2000, J BACTERIOL, V182, P4658, DOI 10.1128/JB.182.16.4658-4660.2000; McGlynn SE, 2010, J BACTERIOL, V192, P595, DOI 10.1128/JB.01125-09; METCALF WW, 1993, J BACTERIOL, V175, P3430, DOI 10.1128/jb.175.11.3430-3442.1993; METCALF WW, 1993, GENE, V129, P27, DOI 10.1016/0378-1119(93)90692-V; PARAST CV, 1995, BIOCHEMISTRY-US, V34, P2393, DOI 10.1021/bi00008a001; Parker GF, 1999, J BACTERIOL, V181, P389, DOI 10.1128/JB.181.2.389-395.1999; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Ternan NG, 1998, WORLD J MICROB BIOT, V14, P635, DOI 10.1023/A:1008848401799; Thauer RK, 2008, ANN NY ACAD SCI, V1125, P158, DOI 10.1196/annals.1419.000; White AK, 2007, ANNU REV MICROBIOL, V61, P379, DOI 10.1146/annurev.micro.61.080706.093357; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138	26	83	93	8	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					570	573		10.1038/nature10622	http://dx.doi.org/10.1038/nature10622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22089136	Green Accepted			2022-12-24	WOS:000298318000071
J	Yamamoto, H; Williams, EG; Mouchiroud, L; Canto, C; Fan, WW; Downes, M; Heligon, C; Barish, GD; Desvergne, B; Evans, RM; Schoonjans, K; Auwerx, J				Yamamoto, Hiroyasu; Williams, Evan G.; Mouchiroud, Laurent; Canto, Carles; Fan, Weiwei; Downes, Michael; Heligon, Christophe; Barish, Grant D.; Desvergne, Beatrice; Evans, Ronald M.; Schoonjans, Kristina; Auwerx, Johan			NCoR1 Is a Conserved Physiological Modulator of Muscle Mass and Oxidative Function	CELL			English	Article							NUCLEAR RECEPTOR COREPRESSOR; SKELETAL-MUSCLE; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; CO-REPRESSOR; ERR-ALPHA; MEF2; CELL; SIRT1; SPECIFICITY	Transcriptional coregulators control the activity of many transcription factors and are thought to have wide-ranging effects on gene expression patterns. We show here that muscle-specific loss of nuclear receptor corepressor 1 (NCoR1) in mice leads to enhanced exercise endurance due to an increase of both muscle mass and of mitochondrial number and activity. The activation of selected transcription factors that control muscle function, such as MEF2, PPAR beta/delta, and ERRs, underpins these phenotypic alterations. NCoR1 levels are decreased in conditions that require fat oxidation, resetting transcriptional programs to boost oxidative metabolism. Knockdown of gei-8, the sole C. elegans NCoR homolog, also robustly increased muscle mitochondria and respiration, suggesting conservation of NCoR1 function. Collectively, our data suggest that NCoR1 plays an adaptive role in muscle physiology and that interference with NCoR1 action could be used to improve muscle function.	[Yamamoto, Hiroyasu; Williams, Evan G.; Mouchiroud, Laurent; Canto, Carles; Schoonjans, Kristina; Auwerx, Johan] Ecole Polytech Fed Lausanne EPFL, Lab Integrat & Syst Physiol LISP, CH-1015 Lausanne, Switzerland; [Fan, Weiwei; Downes, Michael; Barish, Grant D.; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; [Heligon, Christophe; Desvergne, Beatrice] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Howard Hughes Medical Institute; Salk Institute; University of Lausanne	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne EPFL, Lab Integrat & Syst Physiol LISP, CH-1015 Lausanne, Switzerland.	admin.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021; Williams, Evan/M-7539-2017; Evans, Ronald/AAF-4001-2019; Frank, Viki/GXZ-9902-2022; Desvergne, Beatrice/C-8892-2016	Williams, Evan/0000-0002-9746-376X; Evans, Ronald/0000-0002-9986-5965; HELIGON, Christophe/0000-0001-7557-3565; Desvergne, Beatrice/0000-0001-5483-288X; Schoonjans, Kristina/0000-0003-1247-4265; Canto, Carles/0000-0002-5167-7922; Auwerx, Johan/0000-0002-5065-5393	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation; NIH [DK059820, DK062434, 1K08HL092298, HD027183, DK057978]; EU [ERC-2008-AdG-23118]; Helmsley Charitable Trust; Glenn Foundation; Howard Hughes Medical Institute (HHMI); FRM; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027183] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278, K08HL092298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978, U19DK062434, P01DK059820] Funding Source: NIH RePORTER	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); Helmsley Charitable Trust; Glenn Foundation; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); FRM(Fondation pour la Recherche Medicale); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge M. Lazar (University of Pennsylvania, Philadelphia), A. Kralli (Scripps Research Institute, San Diego), J.-S. Annicotte and L. Fajas (Institut de Genetique Moleculaire de Montpellier, France), A. Lusis (University of California, Los Angeles), K. Schughart (Helmholtz Zentrum, Hannover, Germany), R. Williams (University of Tennessee Health Science Center, Memphis), and the Caenorhabditis Genetics Center (CGC) for generous sharing of research reagents and data. We thank N. Messadeq (Institut Clinique de la Souris, Strasbourg, France) for EM analysis and the Center for PhenoGenomics (CPG) at the EPFL for help with mouse phenotyping. This work was supported by the Ecole Polytechnique Federale de Lausanne, Swiss National Science Foundation, NIH (DK059820 to J.A., DK062434 to R.M.E., 1K08HL092298 to G.D.B., HD027183 to R.M.E., and DK057978 to R.M.E.), the EU ideas program (ERC-2008-AdG-23118), the Helmsley Charitable Trust, the Glenn Foundation, and the Howard Hughes Medical Institute (HHMI). H.Y. was supported by an FRM fellowship. R.M.E. is an Investigator of the HHMI and the March of Dimes Chair in Molecular and Developmental Biology. J.A. is the Nestle Chair in Energy Metabolism. We thank the members of the Auwerx lab and R. Williams for discussions.	Alaynick WA, 2008, MITOCHONDRION, V8, P329, DOI 10.1016/j.mito.2008.02.001; Alberts R, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-61; Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Argmann CA, 2005, CELL METAB, V2, P349, DOI 10.1016/j.cmet.2005.11.002; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Champy MF, 2008, MAMM GENOME, V19, P318, DOI 10.1007/s00335-008-9107-z; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Haberland M, 2007, MOL CELL BIOL, V27, P518, DOI 10.1128/MCB.01415-06; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kiens B, 1998, AM J PHYSIOL-ENDOC M, V275, pE332, DOI 10.1152/ajpendo.1998.275.2.E332; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; van Nas A, 2010, GENETICS, V185, P1059, DOI 10.1534/genetics.110.116087; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	57	177	183	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 11	2011	147	4					827	839		10.1016/j.cell.2011.10.017	http://dx.doi.org/10.1016/j.cell.2011.10.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22078881	Bronze, Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000296902300016
J	He, CC; Bassik, MC; Moresi, V; Sun, K; Wei, YJ; Zou, ZJ; An, ZY; Loh, J; Fisher, J; Sun, QH; Korsmeyer, S; Packer, M; May, HI; Hill, JA; Virgin, HW; Gilpin, C; Xiao, GH; Bassel-Duby, R; Scherer, PE; Levine, B				He, Congcong; Bassik, Michael C.; Moresi, Viviana; Sun, Kai; Wei, Yongjie; Zou, Zhongju; An, Zhenyi; Loh, Joy; Fisher, Jill; Sun, Qihua; Korsmeyer, Stanley; Packer, Milton; May, Herman I.; Hill, Joseph A.; Virgin, Herbert W.; Gilpin, Christopher; Xiao, Guanghua; Bassel-Duby, Rhonda; Scherer, Philipp E.; Levine, Beth			Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis	NATURE			English	Article							CAUSES INSULIN-RESISTANCE; MICE; BECLIN-1; MOUSE; GENE; DIET; PHOSPHORYLATION; TUMORIGENESIS; SENSITIVITY; DISRUPTION	Exercise has beneficial effects on human health, including protection against metabolic disorders such as diabetes(1). However, the cellular mechanisms underlying these effects are incompletely understood. The lysosomal degradation pathway, autophagy, is an intracellular recycling system that functions during basal conditions in organelle and protein quality control(2). During stress, increased levels of autophagy permit cells to adapt to changing nutritional and energy demands through protein catabolism(3). Moreover, in animal models, autophagy protects against diseases such as cancer, neurodegenerative disorders, infections, inflammatory diseases, ageing and insulin resistance(4-6). Here we show that acute exercise induces autophagy in skeletal and cardiac muscle of fed mice. To investigate the role of exercise-mediated autophagy in vivo, we generated mutant mice that show normal levels of basal autophagy but are deficient in stimulus (exercise- or starvation)-induced autophagy. These mice (termed BCL2 AAA mice) contain knock-in mutations in BCL2 phosphorylation sites (Thr69Ala, Ser70Ala and Ser84Ala) that prevent stimulus-induced disruption of the BCL2-beclin-1 complex and autophagy activation. BCL2 AAA mice show decreased endurance and altered glucose metabolism during acute exercise, as well as impaired chronic exercise-mediated protection against high-fat-diet-induced glucose intolerance. Thus, exercise induces autophagy, BCL2 is a crucial regulator of exercise- (and starvation)-induced autophagy in vivo, and autophagy induction may contribute to the beneficial metabolic effects of exercise.	[He, Congcong; Wei, Yongjie; Zou, Zhongju; An, Zhenyi; Sun, Qihua; Levine, Beth] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [He, Congcong; Sun, Kai; Wei, Yongjie; Zou, Zhongju; An, Zhenyi; Sun, Qihua; May, Herman I.; Hill, Joseph A.; Scherer, Philipp E.; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [He, Congcong; Wei, Yongjie; Zou, Zhongju; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Bassik, Michael C.; Fisher, Jill; Korsmeyer, Stanley] Dana Farber Canc Inst, Boston, MA 02115 USA; [Moresi, Viviana; Bassel-Duby, Rhonda] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Kai; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [Loh, Joy; Virgin, Herbert W.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO USA; [Packer, Milton; Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Gilpin, Christopher] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu	An, Zhenyi/H-9061-2016; May, Herman I/M-8645-2019; Moresi, Viviana/N-7977-2013; Fernandez-Revelles, Andres B/A-4391-2012; May, Herman I/S-6782-2018; Scherer, Philipp E/K-7819-2012	May, Herman I/0000-0002-9264-2320; Fernandez-Revelles, Andres B/0000-0002-8089-650X; May, Herman I/0000-0002-9264-2320; Scherer, Philipp E/0000-0003-0680-3392; Sun, Kai/0000-0002-4778-4549; Moresi, viviana/0000-0003-1912-0339; Virgin, Herbert/0000-0001-8580-7628	National Institutes of Health [RO1 CA109618, ROI HL080244, ROI HL090842, ROI AI084887, RCI DK086629, RO1 CA112023, 1PO1 DK0887761]; NATIONAL CANCER INSTITUTE [P30CA142543, R01CA109618, R01CA112023] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055758, RC1DK086629, P01DK088761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the UT Southwestern Mouse Metabolic Phenotyping Core and E. Berglund for assistance with metabolic measurements, J. Shelton for assistance with muscle stains, N. Mizushima for critical reagents, and B. D. Levine for expert advice. This work was supported by National Institutes of Health grants RO1 CA109618 (B. L.), ROI HL080244 (J. A. H.), ROI HL090842 (J. A. H.), ROI AI084887 (H. W. V.), RCI DK086629 (P. E. S.), RO1 CA112023 (P. E. S.) and 1PO1 DK0887761 (P.E.S.).	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Butchbach MER, 2007, NEUROBIOL DIS, V27, P207, DOI 10.1016/j.nbd.2007.04.009; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Kuma A, 2010, SEMIN CELL DEV BIOL, V21, P683, DOI 10.1016/j.semcdb.2010.03.002; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Malik SA, 2011, ONCOGENE, V30, P3918, DOI 10.1038/onc.2011.104; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ryder JW, 2001, ACTA PHYSIOL SCAND, V171, P249, DOI 10.1046/j.1365-201x.2001.00827.x; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Sheehan D. C., 1980, THEORY PRACTICE HIST, P162; Shetty S, 2009, TRENDS PHARMACOL SCI, V30, P234, DOI 10.1016/j.tips.2009.02.004; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	32	791	847	13	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 26	2012	481	7382					511	U126		10.1038/nature10758	http://dx.doi.org/10.1038/nature10758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22258505	Green Published, Green Accepted			2022-12-24	WOS:000299471800041
J	Farrell, A; Thirugnanam, S; Lorestani, A; Dvorin, JD; Eidell, KP; Ferguson, DJP; Anderson-White, BR; Duraisingh, MT; Marth, GT; Gubbels, MJ				Farrell, Andrew; Thirugnanam, Sivasakthivel; Lorestani, Alexander; Dvorin, Jeffrey D.; Eidell, Keith P.; Ferguson, David J. P.; Anderson-White, Brooke R.; Duraisingh, Manoj T.; Marth, Gabor T.; Gubbels, Marc-Jan			A DOC2 Protein Identified by Mutational Profiling Is Essential for Apicomplexan Parasite Exocytosis	SCIENCE			English	Article							TOXOPLASMA-GONDII; INTRACELLULAR CA2+; CELL INVASION; C2 DOMAINS; PLASMODIUM; CALCIUM; MOTILITY; RELEASE; MECHANISMS; SECRETION	Exocytosis is essential to the lytic cycle of apicomplexan parasites and required for the pathogenesis of toxoplasmosis and malaria. DOC2 proteins recruit the membrane fusion machinery required for exocytosis in a Ca(2+)-dependent fashion. Here, the phenotype of a Toxoplasma gondii conditional mutant impaired in host cell invasion and egress was pinpointed to a defect in secretion of the micronemes, an apicomplexan-specific organelle that contains adhesion proteins. Whole-genome sequencing identified the etiological point mutation in TgDOC2.1. A conditional allele of the orthologous gene engineered into Plasmodium falciparum was also defective in microneme secretion. However, the major effect was on invasion, suggesting that microneme secretion is dispensable for Plasmodium egress.	[Dvorin, Jeffrey D.; Duraisingh, Manoj T.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Farrell, Andrew; Thirugnanam, Sivasakthivel; Lorestani, Alexander; Eidell, Keith P.; Anderson-White, Brooke R.; Marth, Gabor T.; Gubbels, Marc-Jan] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; [Dvorin, Jeffrey D.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Ferguson, David J. P.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England	Harvard University; Harvard T.H. Chan School of Public Health; Boston College; Harvard University; Boston Children's Hospital; University of Oxford	Duraisingh, MT (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	mduraisi@hsph.harvard.edu; marth@bc.edu; gubbelsj@bc.edu		Dvorin, Jeffrey/0000-0002-5883-7271; Ferguson, David/0000-0001-5045-819X; Eidell, Keith/0000-0002-5971-218X; Anderson-White, Brooke/0000-0001-8325-955X; Gubbels, Marc-Jan/0000-0002-2769-8600	National Institutes of Health [AI081220, AI057919, AI088314, HG004719, AI087874]; Knights Templar Eye Foundation; Wellcome Trust; Burroughs Wellcome Fund New Investigator in the Pathogenesis of Infectious Disease Fellowship; American Heart Association [0635480N]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081220, R21AI088314, R01AI057919, K08AI087874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knights Templar Eye Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Burroughs Wellcome Fund New Investigator in the Pathogenesis of Infectious Disease Fellowship; American Heart Association(American Heart Association); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Nussbaum and C. Russ of the "Broad Sequencing Platform" and D. Sibley, J.-F. Dubremetz, M.-F. Cesbron-Delauw, J.-C. Doury, and M. Makler (Flow Inc.) for kindly sharing reagents. F-P2 was originally generated in the laboratory of B. Striepen. This work was supported by National Institutes of Health grants AI081220 to M.-J.G. and G. T. M., AI057919 and AI088314 to M. T. D., HG004719 to G. T. M., and AI087874 to J.D.D.; a Knights Templar Eye Foundation grant to S. T., a Wellcome Trust equipment grant to D.J.P.F., a Burroughs Wellcome Fund New Investigator in the Pathogenesis of Infectious Disease Fellowship to M. T. D., and an American Heart Association Scientist Development Grant (0635480N) to M.-J.G. Toxoplasma gondii GT1 sequence and annotation are from L. Caler at the J. Craig Venter Institute. Sequence reads have been deposited at the National Center for Biotechnology Information sequence read archive under accession no. SRA046023.	Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Eidell KP, 2010, MOL BIOCHEM PARASIT, V171, P97, DOI 10.1016/j.molbiopara.2010.03.004; ERXLEBEN C, 1994, J CELL BIOL, V127, P935, DOI 10.1083/jcb.127.4.935; Friedrich R, 2010, MOL NEUROBIOL, V41, P42, DOI 10.1007/s12035-009-8094-8; Del Carmen MG, 2009, CELL MICROBIOL, V11, P967, DOI 10.1111/j.1462-5822.2009.01304.x; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Hegge S, 2010, FASEB J, V24, P2222, DOI 10.1096/fj.09-148700; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Martens S, 2010, BIOCHEM SOC T, V38, P213, DOI 10.1042/BST0380213; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Munter S, 2009, CELL HOST MICROBE, V6, P551, DOI 10.1016/j.chom.2009.11.007; Nagamune Kisaburo, 2008, V47, P70; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495	27	99	100	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					218	221		10.1126/science.1210829	http://dx.doi.org/10.1126/science.1210829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246776	Green Accepted			2022-12-24	WOS:000299033100053
J	Zhang, F; Vierock, J; Yizhar, O; Fenno, LE; Tsunoda, S; Kianianmomeni, A; Prigge, M; Berndt, A; Cushman, J; Polle, J; Magnuson, J; Hegemann, P; Deisseroth, K				Zhang, Feng; Vierock, Johannes; Yizhar, Ofer; Fenno, Lief E.; Tsunoda, Satoshi; Kianianmomeni, Arash; Prigge, Matthias; Berndt, Andre; Cushman, John; Polle, Juergen; Magnuson, Jon; Hegemann, Peter; Deisseroth, Karl			The Microbial Opsin Family of Optogenetic Tools	CELL			English	Article							CHLORIDE PUMP HALORHODOPSIN; RHODOPSIN-LIKE PROTEIN; NATRONOBACTERIUM-PHARAONIS; OPTICAL TECHNOLOGIES; SENSORY RHODOPSIN; GENOME SEQUENCE; PURPLE MEMBRANE; CELLULAR CAMP; LIGHT; CHANNELRHODOPSIN-2	The capture and utilization of light is an exquisitely evolved process. The single-component microbial opsins, although more limited than multicomponent cascades in processing, display unparalleled compactness and speed. Recent advances in understanding microbial opsins have been driven by molecular engineering for optogenetics and by comparative genomics. Here we provide a Primer on these light-activated ion channels and pumps, describe a group of opsins bridging prior categories, and explore the convergence of molecular engineering and genomic discovery for the utilization and understanding of these remarkable molecular machines.	[Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zhang, Feng] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Vierock, Johannes; Tsunoda, Satoshi; Kianianmomeni, Arash; Prigge, Matthias; Berndt, Andre; Hegemann, Peter] Univ Berlin, Inst Biol, D-10115 Berlin, Germany; [Yizhar, Ofer] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Fenno, Lief E.; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, CNC Program, Dept Bioengn, Stanford, CA 94305 USA; [Fenno, Lief E.; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, CNC Program, Dept Psychiat, Stanford, CA 94305 USA; [Cushman, John] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Polle, Juergen] CUNY, Dept Biol, Brooklyn Coll, Brooklyn, NY 11210 USA; [Magnuson, Jon] Pacific NW Natl Lab, Chem & Biol Proc Dev Grp, Richland, WA 99352 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Weizmann Institute of Science; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Nevada System of Higher Education (NSHE); University of Nevada Reno; City University of New York (CUNY) System; Brooklyn College (CUNY); United States Department of Energy (DOE); Pacific Northwest National Laboratory	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang_f@mit.edu; hegemape@rz.hu-berlin.de; deissero@stanford.edu	Fenno, Lief/AAK-2924-2020; Tsunoda, Satoshi/AAN-7023-2021; Macrae, Rhiannon/AAX-1536-2020; YIZHAR, OFER/AAV-8497-2021; Fenno, Lief/AAF-9638-2019	Berndt, Andre/0000-0003-4758-5598; Vierock, Johannes/0000-0001-7368-5539; Magnuson, Jon/0000-0001-7712-7024; Yizhar, Ofer/0000-0003-4228-1448; Tsunoda, Satoshi/0000-0003-3636-1521	NIH [TR01]; Robert Metcalfe; Michael Boylan; McKnight; Gates; Simons; Damon Runyon Foundation; DFG; DOE's Office of Science [DE-AC02-05CH11231]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Metcalfe; Michael Boylan; McKnight; Gates; Simons; Damon Runyon Foundation; DFG(German Research Foundation (DFG)); DOE's Office of Science(United States Department of Energy (DOE))	Full funding information for K.D. is listed at http:// www.optogenetics.org/ funding and includes the Gatsby Charitable Foundation and the Keck, Snyder, Woo, and Yu Foundations, as well as CIRM, NIMH, NINDS, NIDA, and the DARPA REPAIR program. F.Z. is supported by the NIH TR01, Robert Metcalfe, Michael Boylan, and the McKnight, Gates, Simons, and Damon Runyon Foundations. L. E. F. is supported by the NIH MSTP program. P. H. is supported by the DFG. We thank the entire Deisseroth laboratory for their support and Dr. Duc Tran for assistance. Genome and transcriptome sequencing and assembly were performed by the Department of Energy (DOE) Joint Genome Institute and supported by the DOE's Office of Science under Contract No. DE-AC02-05CH11231.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Bamberg E, 1984, Prog Clin Biol Res, V164, P73; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; BOGOMOLNI RA, 1982, P NATL ACAD SCI-BIOL, V79, P6250, DOI 10.1073/pnas.79.20.6250; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buldt G, 1998, J PROTEIN CHEM, V17, P536; Chen XP, 2002, BIOCHEMISTRY-US, V41, P3891, DOI 10.1021/bi015966h; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; DUNN R, 1981, P NATL ACAD SCI-BIOL, V78, P6744, DOI 10.1073/pnas.78.11.6744; Ehlenbeck S, 2002, BIOPHYS J, V82, P740, DOI 10.1016/S0006-3495(02)75436-2; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Essen LO, 2002, CURR OPIN STRUC BIOL, V12, P516, DOI 10.1016/S0959-440X(02)00356-1; Facciotti MT, 2001, BIOPHYS J, V81, P3442, DOI 10.1016/S0006-3495(01)75976-0; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Frassanito AM, 2010, CELL MOL LIFE SCI, V67, P965, DOI 10.1007/s00018-009-0225-x; Geibel S, 2001, BIOPHYS J, V81, P2059, DOI 10.1016/S0006-3495(01)75855-9; Govorunova EG, 2004, BIOPHYS J, V86, P2342, DOI 10.1016/S0006-3495(04)74291-5; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; HARZ H, 1992, PHILOS T R SOC B, V338, P39, DOI 10.1098/rstb.1992.0127; Haupts U, 1997, BIOCHEMISTRY-US, V36, P2, DOI 10.1021/bi962014g; Hegemann P, 2001, J PHYCOL, V37, P668, DOI 10.1046/j.1529-8817.2001.01095.x; HILDEBRAND E, 1975, NATURE, V257, P46, DOI 10.1038/257046a0; Idnurm A, 2001, GENOME, V44, P167, DOI 10.1139/gen-44-2-167; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kateriya S, 2004, NEWS PHYSIOL SCI, V19, P133, DOI 10.1152/nips.01517.2004; Kianianmomeni A, 2009, PLANT PHYSIOL, V151, P347, DOI 10.1104/pp.109.143297; KIM JM, 2002, BIOCHEMISTRY-US, V44, P2284; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; LANYI JK, 1990, J BIOL CHEM, V265, P1253; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Lorinczi E, 2009, J MOL BIOL, V393, P320, DOI 10.1016/j.jmb.2009.07.055; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; MARWAN W, 1987, J MOL BIOL, V195, P333, DOI 10.1016/0022-2836(87)90654-1; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; MICHEL H, 1976, FEBS LETT, V65, P175, DOI 10.1016/0014-5793(76)80473-5; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OESTERHELT D, 1985, EMBO J, V4, P2351, DOI 10.1002/j.1460-2075.1985.tb03938.x; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; RACKER E, 1974, J BIOL CHEM, V249, P662; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Sakmar TP, 2002, CURR OPIN CELL BIOL, V14, P189, DOI 10.1016/S0955-0674(02)00306-X; SCHARF B, 1994, BIOCHEMISTRY-US, V33, P6387, DOI 10.1021/bi00187a002; Scharf BE, 2010, CURR OPIN MICROBIOL, V13, P246, DOI 10.1016/j.mib.2010.01.006; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Schoenenberger P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008185; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shichida Y, 2003, PHOTOCH PHOTOBIO SCI, V2, P1237, DOI 10.1039/b300434a; Sineshchekov OA, 1999, TRENDS PLANT SCI, V4, P58, DOI 10.1016/S1360-1385(98)01370-3; Sineshchekov OA, 2005, BIOPHYS J, V89, P4310, DOI 10.1529/biophysj.105.070920; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; Spudich JL, 1998, MOL MICROBIOL, V28, P1051, DOI 10.1046/j.1365-2958.1998.00859.x; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Stehfest K, 2010, CHEMPHYSCHEM, V11, P1120, DOI 10.1002/cphc.200900980; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; TAKAHASHI T, 1985, BIOCHEM BIOPH RES CO, V127, P99, DOI 10.1016/S0006-291X(85)80131-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TATENO M, 1994, ARCH BIOCHEM BIOPHYS, V315, P127, DOI 10.1006/abbi.1994.1480; TOMIOKA H, 1986, BIOCHEM BIOPH RES CO, V139, P389, DOI 10.1016/S0006-291X(86)80003-1; Tsunoda SP, 2006, BIOPHYS J, V91, P1471, DOI 10.1529/biophysj.106.086421; Tsunoda SP, 2009, PHOTOCHEM PHOTOBIOL, V85, P564, DOI 10.1111/j.1751-1097.2008.00519.x; Varo G, 2003, BIOPHYS J, V84, P1202, DOI 10.1016/S0006-3495(03)74934-0; Vogeley L, 2004, SCIENCE, V306, P1390, DOI 10.1126/science.1103943; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yoshitsugu M, 2009, BIOCHEMISTRY-US, V48, P4324, DOI 10.1021/bi900228a; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	100	357	377	7	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2011	147	7					1446	1457		10.1016/j.cell.2011.12.004	http://dx.doi.org/10.1016/j.cell.2011.12.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196724	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000298403400011
J	Poulikakos, PI; Persaud, Y; Janakiraman, M; Kong, XJ; Ng, C; Moriceau, G; Shi, HB; Atefi, M; Titz, B; Gabay, MT; Salton, M; Dahlman, KB; Tadi, M; Wargo, JA; Flaherty, KT; Kelley, MC; Misteli, T; Chapman, PB; Sosman, JA; Graeber, TG; Ribas, A; Lo, RS; Rosen, N; Solit, DB				Poulikakos, Poulikos I.; Persaud, Yogindra; Janakiraman, Manickam; Kong, Xiangju; Ng, Charles; Moriceau, Gatien; Shi, Hubing; Atefi, Mohammad; Titz, Bjoern; Gabay, May Tal; Salton, Maayan; Dahlman, Kimberly B.; Tadi, Madhavi; Wargo, Jennifer A.; Flaherty, Keith T.; Kelley, Mark C.; Misteli, Tom; Chapman, Paul B.; Sosman, Jeffrey A.; Graeber, Thomas G.; Ribas, Antoni; Lo, Roger S.; Rosen, Neal; Solit, David B.			RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)	NATURE			English	Article							BRAF; PATHWAY; MEK	Activated RAS promotes dimerization of members of the RAF kinase family(1-3). ATP-competitive RAF inhibitors activate ERK signalling(4-7) by transactivating RAF dimers(4). In melanomas with mutant BRAF(V600E), levels of RAS activation are low and these drugs bind to BRAF(V600E) monomers and inhibit their activity. This tumour-specific inhibition of ERK signalling results in a broad therapeutic index and RAF inhibitors have remarkable clinical activity in patients with melanomas that harbour mutant BRAF(V600E)(8). However, resistance invariably develops. Here, we identify a new resistance mechanism. We find that a subset of cells resistant to vemurafenib (PLX4032, RG7204) express a 61-kDa variant form of BRAF(V600E), p61BRAF(V600E), which lacks exons 4-8, a region that encompasses the RAS-binding domain. p61BRAF(V600E) shows enhanced dimerization in cells with low levels of RAS activation, as compared to full-length BRAF(V600E). In cells in which p61BRAF(V600E) is expressed endogenously or ectopically, ERK signalling is resistant to the RAF inhibitor. Moreover, a mutation that abolishes the dimerization of p61BRAF(V600E) restores its sensitivity to vemurafenib. Finally, we identified BRAF(V600E) splicing variants lacking the RAS-binding domain in the tumours of six of nineteen patients with acquired resistance to vemurafenib. These data support the model that inhibition of ERK signalling by RAF inhibitors is dependent on levels of RAS-GTP too low to support RAF dimerization and identify a novel mechanism of acquired resistance in patients: expression of splicing isoforms of BRAF(V600E) that dimerize in a RAS-independent manner.	[Persaud, Yogindra; Janakiraman, Manickam; Solit, David B.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Poulikakos, Poulikos I.; Gabay, May Tal; Tadi, Madhavi; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA; [Kong, Xiangju; Moriceau, Gatien; Shi, Hubing; Lo, Roger S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Ng, Charles; Atefi, Mohammad; Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Titz, Bjoern; Graeber, Thomas G.; Ribas, Antoni; Lo, Roger S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Salton, Maayan; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA; [Dahlman, Kimberly B.; Sosman, Jeffrey A.] Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA; [Wargo, Jennifer A.] Massachusetts Gen Hosp, Ctr Canc, Dept Surg, Boston, MA 02114 USA; [Flaherty, Keith T.] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA; [Kelley, Mark C.] Vanderbilt Ingram Canc Ctr, Dept Surg, Nashville, TN 37232 USA; [Chapman, Paul B.; Rosen, Neal; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Vanderbilt University; Memorial Sloan Kettering Cancer Center	Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	solitd@mskcc.org	Titz, Björn/B-9516-2008; Solit, David B./AAC-5309-2019; Rosen, Neal/ABF-2677-2020; Shi, Hubing/B-8445-2014; Persaud, Yogindra/AAZ-7032-2021; Titz, Bjoern/G-6317-2017	Persaud, Yogindra/0000-0001-8266-9434; Titz, Bjoern/0000-0003-4414-4105; Shi, Hubing/0000-0002-2926-3440; Salton, Maayan/0000-0001-8812-5577; Janakiraman, Manickam/0000-0003-4423-6237; Graeber, Thomas/0000-0001-8574-9181	Vanderbilt-Ingram Cancer Center; T. J. Martell Foundation; National Institutes of Health (NIH); Beene Foundation; Melanoma Research Alliance; STARR Foundation; Burroughs Wellcome Fund; American Skin Association; Joint Center for Translational Medicine; Sidney Kimmel Foundation; Stand Up to Cancer; NIH, NCI, Center for Cancer Research; Danny Federici Melanoma Fund;  [T32 CACA062948-15]; NATIONAL CANCER INSTITUTE [R01CA127240, ZIABC010309, K22CA151638, P30CA008748] Funding Source: NIH RePORTER	Vanderbilt-Ingram Cancer Center; T. J. Martell Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beene Foundation; Melanoma Research Alliance; STARR Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Skin Association; Joint Center for Translational Medicine; Sidney Kimmel Foundation; Stand Up to Cancer; NIH, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Danny Federici Melanoma Fund; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to M. Baccarini and C. Pritchard for the RAF knockout mouse embryonic fibroblasts. We would like to thank K. Shokat, C. Zhang, S. Chandarlapaty, C. Pratilas and K. Robzyk for useful discussions, C. Liu for her technical expertise and T. J. Riley. We also thank D. Hucks for technical assistance, P. L. Lyle for scoring the tumour sections, and T. Chodon for assistance with tumour procurement. The ITR is supported by the Vanderbilt-Ingram Cancer Center and the T. J. Martell Foundation. This work has been funded by the National Institutes of Health (NIH; R. S. L., N.R., D. B. S.), the Beene Foundation (D. B. S.), the Melanoma Research Alliance (K. T. F., J. A. S. P. B. C., R. S. L., N.R., D. B. S.) and the STARR Foundation (N.R., D. B. S.). R. S. L. was supported by the Burroughs Wellcome Fund, American Skin Association, Joint Center for Translational Medicine, Sidney Kimmel Foundation, and Stand Up to Cancer. T. M. was supported in part by the Intramural Research Program of the NIH, NCI, Center for Cancer Research and P. B. C. was supported in part by the Danny Federici Melanoma Fund. P. I. P. was supported by T32 CACA062948-15.	Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; McArthur GA, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.8502; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; NUSSE M, 1990, CYTOMETRY, V11, P813, DOI 10.1002/cyto.990110707; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Whittaker S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000758	22	1055	1091	2	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					387	U144		10.1038/nature10662	http://dx.doi.org/10.1038/nature10662			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22113612	Green Accepted, Green Submitted			2022-12-24	WOS:000298033000056
J	Loughlin, R; Wilbur, JD; McNally, FJ; Nedelec, FJ; Heald, R				Loughlin, Rose; Wilbur, Jeremy D.; McNally, Francis J.; Nedelec, Francois J.; Heald, Rebecca			Katanin Contributes to Interspecies Spindle Length Scaling in Xenopus	CELL			English	Article							EGG EXTRACTS; MITOTIC SPINDLE; MEIOTIC SPINDLE; AURORA-B; STABLE MICROTUBULES; METAPHASE SPINDLE; ORGANIZATION; INHIBITION; CHROMOSOMES; ATTACHMENT	Bipolar spindles must separate chromosomes by the appropriate distance during cell division, but mechanisms determining spindle length are poorly understood. Based on a 2D model of meiotic spindle assembly, we predicted that higher localized microtubule (MT) depolymerization rates could generate the shorter spindles observed in egg extracts of X. tropicalis compared to X. laevis. We found that katanin-dependent MT severing was increased in X. tropicalis, which, unlike X. laevis, lacks an inhibitory phosphorylation site in the katanin p60 catalytic subunit. Katanin inhibition lengthened spindles in both species. In X. tropicalis, k-fiber MT bundles that connect to chromosomes at their kinetochores extended through spindle poles, disrupting them. In both X. tropicalis extracts and the spindle simulation, a balance between k-fiber number and MT depolymerization is required to maintain spindle morphology. Thus, mechanisms have evolved in different species to scale spindle size and coordinate regulation of multiple MT populations in order to generate a robust steady-state structure.	[Nedelec, Francois J.] EMBL, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Loughlin, Rose; Wilbur, Jeremy D.; Heald, Rebecca] Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; [Loughlin, Rose] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [McNally, Francis J.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	European Molecular Biology Laboratory (EMBL); University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Davis	Nedelec, FJ (corresponding author), EMBL, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.	nedelec@embl.de; bheald@berkeley.edu	Nedelec, Francois J/H-3317-2011; Nedelec, Francois/AAC-1673-2019	Nedelec, Francois J/0000-0002-8141-5288; Nedelec, Francois/0000-0002-8141-5288; Heald, Rebecca/0000-0001-6671-6528	NIH [DP1 OD000818]; Miller Institute for Basic Research in Science; National Science Foundation; Cancer Research Coordinating Committee; BioMS (Center for Modeling and Simulation in the Biosciences); EU [241548]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079421] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000818] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miller Institute for Basic Research in Science; National Science Foundation(National Science Foundation (NSF)); Cancer Research Coordinating Committee; BioMS (Center for Modeling and Simulation in the Biosciences); EU(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Kara Helmke and members of the Heald and Nedelec labs for helpful discussions; and Liam Holt for critical comments on the manuscript. Special thanks to Todd Stukenberg for Nuf2 antibodies; Claire Walczak for Kif2a and MCAK antibodies; Christian Tischer for sharing MATLAB code for image analysis; and David Halpin for PEGylated slides. R. H. was supported by the NIH Director's Pioneer Award (DP1 OD000818) and The Miller Institute for Basic Research in Science. R. L. acknowledges support from the National Science Foundation and the Cancer Research Coordinating Committee. F.J.N. is supported by BioMS (Center for Modeling and Simulation in the Biosciences), EU FP7 contract 241548 Mitosys and the Systems Microscopy network of excellence.	Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Brust-Mascher I, 2009, MOL BIOL CELL, V20, P1749, DOI 10.1091/mbc.E08-10-1033; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; Buster D, 2002, J CELL SCI, V115, P1083; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Gadea BB, 2006, P NATL ACAD SCI USA, V103, P4493, DOI 10.1073/pnas.0600702103; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Greenan G, 2010, CURR BIOL, V20, P353, DOI 10.1016/j.cub.2009.12.050; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Hara Y, 2009, CURR BIOL, V19, P1549, DOI 10.1016/j.cub.2009.07.050; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Houghtaling BR, 2009, P NATL ACAD SCI USA, V106, P15338, DOI 10.1073/pnas.0902317106; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Knowlton AL, 2009, CURR BIOL, V19, P758, DOI 10.1016/j.cub.2009.03.018; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Maresca Thomas J., 2006, V322, P459; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; McNally KP, 2002, CELL MOTIL CYTOSKEL, V53, P337, DOI 10.1002/cm.10080; McNally KP, 2000, J CELL SCI, V113, P1623; Ohi R, 2007, CURR BIOL, V17, P953, DOI 10.1016/j.cub.2007.04.057; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; VALE RD, 1991, CELL, V64, P827, DOI 10.1016/0092-8674(91)90511-V; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206; Zhang X, 2007, MOL BIOL CELL, V18, P3264, DOI 10.1091/mbc.E07-01-0086	37	137	138	2	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1397	1407		10.1016/j.cell.2011.11.014	http://dx.doi.org/10.1016/j.cell.2011.11.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153081	Green Accepted, Bronze			2022-12-24	WOS:000298148100026
J	Sheehan, MJ; Tibbetts, EA				Sheehan, Michael J.; Tibbetts, Elizabeth A.			Specialized Face Learning Is Associated with Individual Recognition in Paper Wasps	SCIENCE			English	Article							IDENTITY SIGNALS; POLISTES WASPS; EVOLUTION; PERCEPTION; BEHAVIOR; SHEEP	We demonstrate that the evolution of facial recognition in wasps is associated with specialized face-learning abilities. Polistes fuscatus can differentiate among normal wasp face images more rapidly and accurately than nonface images or manipulated faces. A close relative lacking facial recognition, Polistes metricus, however, lacks specialized face learning. Similar specializations for face learning are found in primates and other mammals, although P. fuscatus represents an independent evolution of specialization. Convergence toward face specialization in distant taxa as well as divergence among closely related taxa with different recognition behavior suggests that specialized cognition is surprisingly labile and may be adaptively shaped by species-specific selective pressures such as face recognition.	[Sheehan, Michael J.; Tibbetts, Elizabeth A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sheehan, MJ (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	mic@umich.edu	Sheehan, Michael/F-5612-2012	Tibbetts, Elizabeth/0000-0002-5625-892X; Sheehan, Michael/0000-0002-3949-7873	University of Michigan; E. S. George Reserve Scholarship	University of Michigan(University of Michigan System); E. S. George Reserve Scholarship	We thank J. Klein and J. Jinn for assistance collecting data. J. McCormack, I. Flora, J. Hunt, J. Cronin, and B. Cronin helped collect wasps. O. Pascalis and T. Bergman provided comments on an earlier draft. Funding was provided by the University of Michigan and an E. S. George Reserve Scholarship to M. J. S. The authors have no competing financial interests. All data from these experiments are presented in the main text or supporting online material.	Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Farris SA, 2005, ARTHROPOD STRUCT DEV, V34, P211, DOI 10.1016/j.asd.2005.01.008; HUGHES CR, 1993, BEHAV ECOL, V4, P128, DOI 10.1093/beheco/4.2.128; Kendrick KM, 1996, BEHAV PROCESS, V38, P19, DOI 10.1016/0376-6357(96)00006-X; KENDRICK KM, 1987, SCIENCE, V236, P448, DOI 10.1126/science.3563521; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; LAND MF, 1992, ANNU REV NEUROSCI, V15, P1, DOI 10.1146/annurev.ne.15.030192.000245; Lehrer M, 2005, J EXP BIOL, V208, P3233, DOI 10.1242/jeb.01790; Leopold DA, 2010, J COMP PSYCHOL, V124, P233, DOI 10.1037/a0019460; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Papini MR, 2002, PSYCHOL REV, V109, P186, DOI 10.1037//0033-295X.109.1.186; Pascalis O, 1998, BEHAV PROCESS, V43, P87, DOI 10.1016/S0376-6357(97)00090-9; Pascalis O, 2009, PERSPECT PSYCHOL SCI, V4, P200, DOI 10.1111/j.1745-6924.2009.01119.x; Reeve H.K., 1991, P99; Reeve HK, 2000, P ROY SOC B-BIOL SCI, V267, P75, DOI 10.1098/rspb.2000.0969; Richter MR, 2000, ANNU REV ENTOMOL, V45, P121, DOI 10.1146/annurev.ento.45.1.121; Sheehan MJ, 2010, J EVOLUTION BIOL, V23, P570, DOI 10.1111/j.1420-9101.2009.01923.x; Sheehan MJ, 2008, CURR BIOL, V18, pR851, DOI 10.1016/j.cub.2008.07.032; Sheehan MJ, 2009, EVOLUTION, V63, P3106, DOI 10.1111/j.1558-5646.2009.00833.x; Shettleworth S. J., 2010, COGNITION EVOLUTION, pxiii; Tibbetts EA, 2004, P ROY SOC B-BIOL SCI, V271, P1955, DOI 10.1098/rspb.2004.2784; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	24	140	143	3	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1272	1275		10.1126/science.1211334	http://dx.doi.org/10.1126/science.1211334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144625				2022-12-24	WOS:000297553600049
J	Shatalin, K; Shatalina, E; Mironov, A; Nudler, E				Shatalin, Konstantin; Shatalina, Elena; Mironov, Alexander; Nudler, Evgeny			H2S: A Universal Defense Against Antibiotics in Bacteria	SCIENCE			English	Article							NITRIC-OXIDE; HYDROGEN-PEROXIDE; SULFIDE; DEATH; IRON	Many prokaryotic species generate hydrogen sulfide (H2S) in their natural environments. However, the biochemistry and physiological role of this gas in nonsulfur bacteria remain largely unknown. Here we demonstrate that inactivation of putative cystathionine beta-synthase, cystathionine gamma-lyase, or 3-mercaptopyruvate sulfurtransferase in Bacillus anthracis, Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli suppresses H2S production, rendering these pathogens highly sensitive to a multitude of antibiotics. Exogenous H2S suppresses this effect. Moreover, in bacteria that normally produce H2S and nitric oxide, these two gases act synergistically to sustain growth. The mechanism of gas-mediated antibiotic resistance relies on mitigation of oxidative stress imposed by antibiotics.	[Shatalin, Konstantin; Shatalina, Elena; Nudler, Evgeny] NYU, Dept Biochem, New York, NY 10016 USA; [Mironov, Alexander] State Res Inst Genet & Select Ind Microorganisms, Moscow 117545, Russia	New York University; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms	Nudler, E (corresponding author), NYU, Dept Biochem, New York, NY 10016 USA.	evgeny.nudler@nyumc.org	; Mironov, Alexander/G-8531-2013	Nudler, Evgeny/0000-0002-8811-3071; Mironov, Alexander/0000-0003-3914-1380	NIH; Biogerontology Research Foundation; Dynasty Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biogerontology Research Foundation; Dynasty Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Avetissova for technical assistance, S. Mashko for materials, and members of the Nudler laboratory for valuable comments and discussion. This research was supported by the NIH Director's Pioneer Award, Biogerontology Research Foundation, and Dynasty Foundation (E.N.). Provisional patent application has been filed: U. S. Patent No. 61/438,524 "Methods for treating infections by targeting bacterial H<INF>2</INF>S-producing enzymes." by K.S. and E.N.	ARUOMA OI, 1989, J BIOL CHEM, V264, P20509; ASAD NR, 1991, J BACTERIOL, V173, P2562, DOI 10.1128/jb.173.8.2562-2568.1991; Birren BW, 1993, PULSED FIELD GEL ELE, DOI [10.1016/B978-0-12-101290-8.50002-X, DOI 10.1016/B978-0-12-101290-8.50002-X]; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Forbes BA., 1998, BAILEY SCOTTS DIAGNO, V10; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; Liochev SI, 1999, IUBMB LIFE, V48, P157, DOI 10.1080/152165499307161; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Shatalin K, 2008, P NATL ACAD SCI USA, V105, P1009, DOI 10.1073/pnas.0710950105; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938	19	455	471	14	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2011	334	6058					986	990		10.1126/science.1209855	http://dx.doi.org/10.1126/science.1209855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CA	22096201				2022-12-24	WOS:000297101800058
J	Chiang, WC; Ching, TT; Lee, HC; Mousigian, C; Hsu, AL				Chiang, Wei-Chung; Ching, Tsui-Ting; Lee, Hee Chul; Mousigian, Carol; Hsu, Ao-Lin			HSF-1 Regulators DDL-1/2 Link Insulin-like Signaling to Heat-Shock Responses and Modulation of Longevity	CELL			English	Article							CAENORHABDITIS-ELEGANS; MOLECULAR CHAPERONES; LIFE-SPAN; C-ELEGANS; FACTOR-I; TRANSCRIPTIONAL RESPONSE; NEGATIVE REGULATION; GENE-TRANSCRIPTION; STRESS; PROTEIN	Extended longevity is often correlated with increased resistance against various stressors. Insulin/IGF-1-like signaling (IIS) is known to have a conserved role in aging and cellular mechanisms against stress. In C. elegans, genetic studies suggest that heat-shock transcription factor HSF-1 is required for IIS to modulate longevity. Here, we report that the activity of HSF-1 is regulated by IIS. This regulation occurs at an early step of HSF-1 activation via two HSF-1 regulators, DDL-1 and DDL-2. Inhibition of DDL-1/2 increases longevity and thermotolerance in an hsf-1-dependent manner. Furthermore, biochemical analyses suggest that DDL-1/2 negatively regulate HSF-1 activity by forming a protein complex with HSF-1. The formation of this complex (DHIC) is affected by the phosphorylation status of DDL-1. Both the formation of DHIC and the phosphorylation of DDL-1 are controlled by IIS. Our findings point to DDL-1/2 as a link between IIS and the HSF-1 pathway.	[Chiang, Wei-Chung; Hsu, Ao-Lin] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Ching, Tsui-Ting; Lee, Hee Chul; Mousigian, Carol; Hsu, Ao-Lin] Univ Michigan, Sch Med, Div Geriatr Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hsu, AL (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	aolinhsu@umich.edu	Hsu, Ao-Lin Allen/AAX-1856-2020; Chiang, Wei-Chung/AAZ-5494-2020	Chiang, Wei-Chung/0000-0003-3149-435X; Hsu, Ao-Lin/0000-0002-2864-3134; Ching, Tsui-Ting/0000-0001-7650-1766	NIH/NIA [AG028516]; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [R01AG028516] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant AG028516 from NIH/NIA and a grant from the Ellison Medical Foundation to A.-L.H. We thank the Caenorhabditis Genetic Center for providing the PS3551, CH116, VC2193, and RB2380 strains.	CLOS J, 1990, CELL, V63, P1085, DOI 10.1016/0092-8674(90)90511-C; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Garigan D, 2002, GENETICS, V161, P1101; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Khazaeli AA, 1997, J GERONTOL A-BIOL, V52, pB48, DOI 10.1093/gerona/52A.1.B48; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kurapati R, 2000, J GERONTOL A-BIOL, V55, pB552, DOI 10.1093/gerona/55.11.B552; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lithgow GJ, 2002, MECH AGEING DEV, V123, P765, DOI 10.1016/S0047-6374(01)00422-5; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; Mercier PA, 1999, J CELL SCI, V112, P2765; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962; SISTONEN L, 1994, MOL CELL BIOL, V14, P2087, DOI 10.1128/MCB.14.3.2087; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; Soti C, 2000, BIOGERONTOLOGY, V1, P225, DOI 10.1023/A:1010082129022; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	37	148	162	3	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					322	334		10.1016/j.cell.2011.12.019	http://dx.doi.org/10.1016/j.cell.2011.12.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265419	Bronze, Green Accepted			2022-12-24	WOS:000299540700034
J	Png, KJ; Halberg, N; Yoshida, M; Tavazoie, SF				Png, Kim J.; Halberg, Nils; Yoshida, Mitsukuni; Tavazoie, Sohail F.			A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells	NATURE			English	Article							GROWTH	Metastatic progression of cancer is a complex and clinically daunting process(1-4). We previously identified a set of human microRNAs ( miRNAs) that robustly suppress breast cancer metastasis to lung and bone(5,6) and which display expression levels that predict human metastasis. Although these findings revealed miRNAs as suppressors of cell-autonomous metastatic phenotypes, the roles of noncoding RNAs in non-cell-autonomous cancer progression processes remain unknown. Here we reveal that endogenous miR-126, an miRNA silenced in a variety of common human cancers(7,8), non-cell-autonomously regulates endothelial cell recruitment to metastatic breast cancer cells, in vitro and in vivo. It suppresses metastatic endothelial recruitment, metastatic angiogenesis and metastatic colonization through coordinate targeting of IGFBP2, PITPNC1 and MERTK-novel pro-angiogenic genes and biomarkers of human metastasis. Insulin-like growth factor binding protein 2 ( IGFBP2) secreted by metastatic cells recruits endothelia by modulating IGF1-mediated activation of the IGF type-I receptor on endothelial cells; whereas c-Mer tyrosine kinase (MERTK) receptor cleaved from metastatic cells promotes endothelial recruitment by competitively antagonizing the binding of its ligand GAS6 to endothelial MERTK receptors. Co-injection of endothelial cells with breast cancer cells non-cell-autonomously rescues their miR-126-induced metastatic defect, revealing a novel and important role for endothelial interactions in metastatic initiation. Through loss-of-function and epistasis experiments, we delineate an miRNA regulatory network's individual components as novel and cell-extrinsic regulators of endothelial recruitment, angiogenesis and metastatic colonization. We also identify the IGFBP2/IGF1/IGF1R and GAS6/MERTK signalling pathways as regulators of cancer-mediated endothelial recruitment. Our work further reveals endothelial recruitment and endothelial interactions in the tumour microenvironment to be critical features of metastatic breast cancer.	[Png, Kim J.; Halberg, Nils; Yoshida, Mitsukuni; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA	Rockefeller University	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10065 USA.	stavazoie@mail.rockefeller.edu	Halberg, Nils/AAF-8153-2019	Halberg, Nils/0000-0002-2943-3147; Yoshida, Mitsukuni/0000-0002-2752-1231				Arnold SA, 2010, DIS MODEL MECH, V3, P57, DOI 10.1242/dmm.003228; Balogh I, 2005, ARTERIOSCL THROM VAS, V25, P1280, DOI 10.1161/01.ATV.0000163845.07146.48; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Valastyan S, 2009, CELL CYCLE, V8, P3506, DOI 10.4161/cc.8.21.9802; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523	18	401	424	1	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2012	481	7380					190	+		10.1038/nature10661	http://dx.doi.org/10.1038/nature10661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22170610				2022-12-24	WOS:000298981200037
J	Reynolds, KA; McLaughlin, RN; Ranganathan, R				Reynolds, Kimberly A.; McLaughlin, Richard N.; Ranganathan, Rama			Hot Spots for Allosteric Regulation on Protein Surfaces	CELL			English	Article							DIHYDROFOLATE-REDUCTASE CATALYSIS; ENZYME CATALYSIS; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; AVENA-SATIVA; PDZ DOMAIN; K+ CHANNEL; COMMUNICATION; FLUCTUATIONS; ACTIVATION	Recent work indicates a general architecture for proteins in which sparse networks of physically contiguous and coevolving amino acids underlie basic aspects of structure and function. These networks, termed sectors, are spatially organized such that active sites are linked to many surface sites distributed throughout the structure. Using the metabolic enzyme dihydrofolate reductase as a model system, we show that: (1) the sector is strongly correlated to a network of residues undergoing millisecond conformational fluctuations associated with enzyme catalysis, and (2) sector-connected surface sites are statistically preferred locations for the emergence of allosteric control in vivo. Thus, sectors represent an evolutionarily conserved "wiring'' mechanism that can enable perturbations at specific surface positions to rapidly initiate conformational control over protein function. These findings suggest that sectors enable the evolution of intermolecular communication and regulation.	[Reynolds, Kimberly A.; McLaughlin, Richard N.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Reynolds, Kimberly A.; McLaughlin, Richard N.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ranganathan, R (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu		McLaughlin, Richard/0000-0003-0950-2253; Reynolds, Kimberly/0000-0003-4805-0317	Robert A. Welch foundation [I-1366]; NIH [1RO1 EY018720]; Green Center for Systems Biology at UT Southwestern Medical Center; NATIONAL EYE INSTITUTE [R01EY018720] Funding Source: NIH RePORTER	Robert A. Welch foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Green Center for Systems Biology at UT Southwestern Medical Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank P. E. Wright for sharing data and discussion. We are also appreciative to S.J. Benkovic for discussions of DHFR mechanism and providing the E. coli auxotroph strain, M. Socolich for technical assistance, and members of the R. R. laboratory for critical review of the work. This study was supported by the Robert A. Welch foundation (R.R., I-1366), the NIH (1RO1 EY018720), and the Green Center for Systems Biology at UT Southwestern Medical Center.	Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; ALMASAN A, 1995, P NATL ACAD SCI USA, V92, P5436, DOI 10.1073/pnas.92.12.5436; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2010, P NATL ACAD SCI USA, V107, P1373, DOI 10.1073/pnas.0914163107; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Chen J, 2007, J MOL BIOL, V374, P250, DOI 10.1016/j.jmb.2007.08.047; Clarkson MW, 2006, BIOCHEMISTRY-US, V45, P7693, DOI 10.1021/bi060652l; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Rajagopalan PTR, 2002, CHEM REC, V2, P24, DOI 10.1002/tcr.10009; Rajagopalan PTR, 2002, BIOCHEMISTRY-US, V41, P12618, DOI 10.1021/bi026369d; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Salomon M, 2001, P NATL ACAD SCI USA, V98, P12357, DOI 10.1073/pnas.221455298; Saraf MC, 2004, P NATL ACAD SCI USA, V101, P4142, DOI 10.1073/pnas.0400065101; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Thompson DA, 2006, CURR BIOL, V16, P1581, DOI 10.1016/j.cub.2006.06.070; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9	46	236	240	0	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2011	147	7					1564	1575		10.1016/j.cell.2011.10.049	http://dx.doi.org/10.1016/j.cell.2011.10.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196731	Bronze, Green Accepted			2022-12-24	WOS:000298403400020
J	Li, GL; Ruan, XA; Auerbach, RK; Sandhu, KS; Zheng, MZ; Wang, P; Poh, HM; Goh, Y; Lim, J; Zhang, JY; Sim, HS; Peh, SQ; Mulawadi, FH; Ong, CT; Orlov, YL; Hong, SZ; Zhang, ZZ; Landt, S; Raha, D; Euskirchen, G; Wei, CL; Ge, WH; Wang, HE; Davis, C; Fisher-Aylor, KI; Mortazavi, A; Gerstein, M; Gingeras, T; Wold, B; Sun, Y; Fullwood, MJ; Cheung, E; Liu, E; Sung, WK; Snyder, M; Ruan, YJ				Li, Guoliang; Ruan, Xiaoan; Auerbach, Raymond K.; Sandhu, Kuljeet Singh; Zheng, Meizhen; Wang, Ping; Poh, Huay Mei; Goh, Yufen; Lim, Joanne; Zhang, Jingyao; Sim, Hui Shan; Peh, Su Qin; Mulawadi, Fabianus Hendriyan; Ong, Chin Thing; Orlov, Yuriy L.; Hong, Shuzhen; Zhang, Zhizhuo; Landt, Steve; Raha, Debasish; Euskirchen, Ghia; Wei, Chia-Lin; Ge, Weihong; Wang, Huaien; Davis, Carrie; Fisher-Aylor, Katherine I.; Mortazavi, Ali; Gerstein, Mark; Gingeras, Thomas; Wold, Barbara; Sun, Yi; Fullwood, Melissa J.; Cheung, Edwin; Liu, Edison; Sung, Wing-Kin; Snyder, Michael; Ruan, Yijun			Extensive Promoter-Centered Chromatin Interactions Provide a Topological Basis for Transcription Regulation	CELL			English	Article							ORGANIZATION; GENES; BIOLOGY; TOOLS; CTCF	Higher-order chromosomal organization for transcription regulation is poorly understood in eukaryotes. Using genome-wide Chromatin Interaction Analysis with Paired-End-Tag sequencing (ChIA-PET), we mapped long-range chromatin interactions associated with RNA polymerase II in human cells and uncovered widespread promoter-centered intragenic, extragenic, and intergenic interactions. These interactions further aggregated into higher-order clusters, wherein proximal and distal genes were engaged through promoter-promoter interactions. Most genes with promoter-promoter interactions were active and transcribed cooperatively, and some interacting promoters could influence each other implying combinatorial complexity of transcriptional controls. Comparative analyses of different cell lines showed that cell-specific chromatin interactions could provide structural frameworks for cell-specific transcription, and suggested significant enrichment of enhancer-promoter interactions for cell-specific functions. Furthermore, genetically-identified disease-associated noncoding elements were found to be spatially engaged with corresponding genes through long-range interactions. Overall, our study provides insights into transcription regulation by three-dimensional chromatin interactions for both housekeeping and cell-specific genes in human cells.	[Landt, Steve; Raha, Debasish; Euskirchen, Ghia; Snyder, Michael] Stanford Univ, Dept Genet, Ctr Genom & Personalized Med, Stanford, CA 94305 USA; [Li, Guoliang; Ruan, Xiaoan; Sandhu, Kuljeet Singh; Zheng, Meizhen; Wang, Ping; Poh, Huay Mei; Goh, Yufen; Lim, Joanne; Zhang, Jingyao; Sim, Hui Shan; Peh, Su Qin; Mulawadi, Fabianus Hendriyan; Ong, Chin Thing; Orlov, Yuriy L.; Hong, Shuzhen; Wei, Chia-Lin; Fullwood, Melissa J.; Cheung, Edwin; Liu, Edison; Sung, Wing-Kin; Ruan, Yijun] Genome Inst Singapore, Singapore 138672, Singapore; [Auerbach, Raymond K.; Gerstein, Mark] Yale Univ, Program Computat Biol, New Haven, CT 06520 USA; [Auerbach, Raymond K.; Gerstein, Mark] Yale Univ, Dept Mol Biol, New Haven, CT 06520 USA; [Auerbach, Raymond K.; Gerstein, Mark] Yale Univ, Dept Cellular Biol, New Haven, CT 06520 USA; [Auerbach, Raymond K.; Gerstein, Mark] Yale Univ, Dept Dev Biol, New Haven, CT 06520 USA; [Zhang, Zhizhuo; Sung, Wing-Kin] Natl Univ Singapore, Sch Comp, Dept Comp Sci, Singapore 117417, Singapore; [Ge, Weihong; Sun, Yi] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Wang, Huaien; Davis, Carrie; Gingeras, Thomas] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11797 USA; [Fisher-Aylor, Katherine I.; Mortazavi, Ali; Wold, Barbara] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Cheung, Edwin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Ruan, Yijun] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China	Stanford University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Yale University; Yale University; Yale University; Yale University; National University of Singapore; University of California System; University of California Los Angeles; Cold Spring Harbor Laboratory; California Institute of Technology; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Huazhong Agricultural University	Snyder, M (corresponding author), Stanford Univ, Dept Genet, Ctr Genom & Personalized Med, Stanford, CA 94305 USA.	mpsnyder@stanford.edu; ruanyj@gis.a-star.edu.sg	Li, Guoliang/D-8014-2012; Orlov, Yuriy L/F-1520-2013; Sandhu, Kuljeet/C-3039-2011; Fullwood, Melissa/G-5713-2011	Li, Guoliang/0000-0003-1601-6640; Orlov, Yuriy L/0000-0003-0587-1609; Fullwood, Melissa/0000-0003-0321-7865; Gingeras, Thomas/0000-0001-9106-3573; Sandhu, Kuljeet/0000-0001-7632-6339; Sung, Wing-Kin/0000-0001-7806-7086; zheng, meizhen/0000-0001-5569-1812; Fisher-Aylor, Katherine/0000-0003-3371-2947; Snyder, Michael/0000-0003-0784-7987	Singapore A*STAR; NIH [HG004456]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004456] Funding Source: NIH RePORTER	Singapore A*STAR(Agency for Science Technology & Research (A*STAR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the Genome Technology and Biology Group at the Genome Institute of Singapore for technical support. This work was supported by Singapore A*STAR and an NIH grant (HG004456) to Y.R.	Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cope NF, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-204; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; JACOB F, 1960, CR HEBD ACAD SCI, V250, P1727; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Kilpelainen TO, 2011, NAT GENET, V43, P753, DOI 10.1038/ng.866; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Merkenschlager M, 2010, CURR OPIN GENET DEV, V20, P555, DOI 10.1016/j.gde.2010.05.007; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; PAULI D, 1988, J MOL BIOL, V200, P47, DOI 10.1016/0022-2836(88)90332-4; Raha D., 2010, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.mb2119s91, DOI 10.1002/0471142727.MB2119S91]; Roussel MJS, 2001, ONCOGENE, V20, P7287, DOI 10.1038/sj.onc.1204863; Ruan YJ, 2007, GENOME RES, V17, P828, DOI 10.1101/gr.6018607; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Singer GAC, 2005, MOL BIOL EVOL, V22, P767, DOI 10.1093/molbev/msi062; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Taylor J, 2005, TRENDS BIOTECHNOL, V23, P269, DOI 10.1016/j.tibtech.2005.04.003; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; ZORIO DAR, 1994, NATURE, V372, P270, DOI 10.1038/372270a0	33	826	858	2	144	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					84	98		10.1016/j.cell.2011.12.014	http://dx.doi.org/10.1016/j.cell.2011.12.014			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265404	Bronze, Green Accepted			2022-12-24	WOS:000299540700016
J	Jager, S; Kim, DY; Hultquist, JF; Shindo, K; LaRue, RS; Kwon, E; Li, M; Anderson, BD; Yen, L; Stanley, D; Mahon, C; Kane, J; Franks-Skiba, K; Cimermancic, P; Burlingame, A; Sali, A; Craik, CS; Harris, RS; Gross, JD; Krogan, NJ				Jaeger, Stefanie; Kim, Dong Young; Hultquist, Judd F.; Shindo, Keisuke; LaRue, Rebecca S.; Kwon, Eunju; Li, Ming; Anderson, Brett D.; Yen, Linda; Stanley, David; Mahon, Cathal; Kane, Joshua; Franks-Skiba, Kathy; Cimermancic, Peter; Burlingame, Alma; Sali, Andrej; Craik, Charles S.; Harris, Reuben S.; Gross, John D.; Krogan, Nevan J.			Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection	NATURE			English	Article							UBIQUITIN-LIGASE COMPLEX; SOCS-BOX; RESTRICTION FACTORS; ANTIVIRAL ACTIVITY; PROTEIN; SPECIFICITY; PROTEASOME; MECHANISM; TARGETS; TISSUES	Restriction factors, such as the retroviral complementary DNA deaminase APOBEC3G, are cellular proteins that dominantly block virus replication(1-3). The AIDS virus, human immuno deficiency virus type 1 (HIV-1), produces the accessory factor Vif, which counteracts the host's antiviral defence by hijacking a ubiquitin ligase complex, containing CUL5, ELOC, ELOB and a RING-box protein, and targeting APOBEC3G for degradation(4-10). Here we reveal, using an affinity tag/purification mass spectrometry approach, that Vif additionally recruits the transcription cofactor CBF-beta to this ubiquitin ligase complex. CBF-beta, which normally functions in concert with RUNX DNA binding proteins, allows the reconstitution of a recombinant six-protein assembly that elicits specific polyubiquitination activity with APOBEC3G, but not the related deaminase APOBEC3A. Using RNA knockdown and genetic complementation studies, we also demonstrate that CBF-beta is required for Vif-mediated degradation of APOBEC3G and therefore for preserving HIV-1 infectivity. Finally, simian immunodeficiency virus (SIV) Vif also binds to and requires CBF-beta to degrade rhesus macaque APOBEC3G, indicating functional conservation. Methods of disrupting the CBF-beta-Vif interaction might enable HIV-1 restriction and provide a supplement to current antiviral therapies that primarily target viral proteins.	[Hultquist, Judd F.; Shindo, Keisuke; LaRue, Rebecca S.; Li, Ming; Anderson, Brett D.; Harris, Reuben S.] Univ Minnesota, Inst Mol Virol, Dept Biochem Mol Biol & Biophys, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Jaeger, Stefanie; Mahon, Cathal; Kane, Joshua; Franks-Skiba, Kathy; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Jaeger, Stefanie; Mahon, Cathal; Kane, Joshua; Franks-Skiba, Kathy; Cimermancic, Peter; Burlingame, Alma; Sali, Andrej; Craik, Charles S.; Gross, John D.; Krogan, Nevan J.] QB3, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Kim, Dong Young; Kwon, Eunju; Yen, Linda; Stanley, David; Mahon, Cathal; Burlingame, Alma; Sali, Andrej; Craik, Charles S.; Gross, John D.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Cimermancic, Peter; Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Sali, Andrej; Gross, John D.; Krogan, Nevan J.] Univ Calif San Francisco, HPC Host Pathogen Circuitry Grp, San Francisco, CA 94158 USA; [Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA 94158 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Harris, RS (corresponding author), Univ Minnesota, Inst Mol Virol, Dept Biochem Mol Biol & Biophys, Ctr Genome Engn, Minneapolis, MN 55455 USA.	rsh@umn.edu; jdgross@cgl.ucsf.edu; krogan@cmp.ucsf.edu		Kim, Dong Young/0000-0001-7594-9083; Shindo, Keisuke/0000-0001-8793-8189; Anderson, Brett/0000-0002-5537-8663; Hultquist, Judd/0000-0001-6424-4280	QB3 at University of California, San Francisco; National Institutes of Health [P50 GM082250, P01 AI090935, P50 GM081879, U54 RR022220, R01 AI064046, P01 GM091743, P41RR001614, P50GM081879]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064046, T32AI083196, P01AI090935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250, P50GM081879, P41GM103481, P01GM091743] Funding Source: NIH RePORTER	QB3 at University of California, San Francisco; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Krogan, Gross and Harris laboratories for comments, J. R. Johnson for mass spectrometry, B. Leonard for sharing unpublished data, M. Shales for help with figures, and B. Chesebro, D. Gabuzda, J. Lingappa, M. Malim, K. Wehrly, X. F. Yu, A. Bullock, B. Schulman and the AIDS Research and Reference Reagent Program for reagents. This research was funded by grants from QB3 at University of California, San Francisco, and the National Institutes of Health (P50 GM082250, P01 AI090935 and P50 GM081879 to N.J.K.; U54 RR022220 to A. S.; R01 AI064046 and P01 GM091743 to R. S. H.; P50 GM082250 to J. D. G. and C. S. C.; P41RR001614 and P50GM081879 to A. B.). N.J.K. is a Searle Scholar and a Keck Young Investigator.	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; DeHart JL, 2008, J VIROL, V82, P9265, DOI 10.1128/JVI.00377-08; Goff SP, 2004, MOL CELL, V16, P849, DOI 10.1016/j.molcel.2004.12.001; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Jager S, 2011, METHODS, V53, P13, DOI 10.1016/j.ymeth.2010.08.007; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wong WF, 2011, IMMUNOLOGY, V132, P157, DOI 10.1111/j.1365-2567.2010.03381.x; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591	27	268	274	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 19	2012	481	7381					371	375		10.1038/nature10693	http://dx.doi.org/10.1038/nature10693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22190037	Green Accepted			2022-12-24	WOS:000299210600044
J	Shao, SC; Hegde, RS				Shao, Sichen; Hegde, Ramanujan S.			A Calmodulin-Dependent Translocation Pathway for Small Secretory Proteins	CELL			English	Article							SIGNAL RECOGNITION PARTICLE; PREPRO-ALPHA-FACTOR; MAMMALIAN ENDOPLASMIC-RETICULUM; IN-VIVO; INTRACELLULAR CALCIUM; SEC PROTEINS; ER MEMBRANE; TRANSPORT; MICROSOMES; COMPLEX	Metazoans secrete an extensive array of small proteins essential for intercellular communication, defense, and physiologic regulation. Their synthesis takes mere seconds, leaving minimal time for recognition by the machinery for cotranslational protein translocation into the ER. The pathway taken by these substrates to enter the ER is not known. Here, we show that both in vivo and in vitro, small secretory proteins can enter the ER posttranslationally via a transient cytosolic intermediate. This intermediate contained calmodulin selectively bound to the signal peptides of small secretory proteins. Calmodulin maintained the translocation competence of small-protein precursors, precluded their aggregation and degradation, and minimized their inappropriate interactions with other cytosolic polypeptide-binding proteins. Acute inhibition of calmodulin specifically impaired small-protein translocation in vitro and in cells. These findings establish a mammalian posttranslational pathway for small-protein secretion and identify an unexpected role for calmodulin in chaperoning these precursors safely through the cytosol.	[Shao, Sichen; Hegde, Ramanujan S.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Shao, Sichen] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University	Hegde, RS (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	rhegde@mrc-lmb.cam.ac.uk		Shao, Sichen/0000-0003-2679-5537; Hegde, Ramanujan/0000-0001-8338-852X	JHU-NIH; NICHD; Medical Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008752, ZIAHD008752] Funding Source: NIH RePORTER	JHU-NIH; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to M. Mariappan for useful discussions; S. Appathurai for initial experiments and reagents; A. Sharma for technical help; other Hegde lab members for support; and K. Strub for sharing results prior to publication. This work was supported by the JHU-NIH Graduate Partnership Program, the Intramural Research Program of the NICHD, and the Medical Research Council.	BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Emerman AB, 2010, MOL BIOL CELL, V21, P4325, DOI 10.1091/mbc.E10-09-0742; Erdmann F, 2011, EMBO J, V30, P17, DOI 10.1038/emboj.2010.284; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; GARCIA PD, 1988, J CELL BIOL, V106, P1043, DOI 10.1083/jcb.106.4.1043; GERMAN MS, 1990, J BIOL CHEM, V265, P22063; Goder V, 2000, EMBO J, V19, P6704, DOI 10.1093/emboj/19.24.6704; HESSA T, 2011, NATURE IN PRESS, DOI DOI 10.1038/NATURE10181; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Krisanaprakornkit S, 2003, J DENT RES, V82, P877, DOI 10.1177/154405910308201106; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; MCCONOUGH H, 2003, CELL STRESS CHAPERON, V8, P303; MEANS AR, 1991, CELLULAR CALCIUM PRA, P205; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; NICCHITTA CV, 1993, CELL, V73, P989, DOI 10.1016/0092-8674(93)90276-V; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Panzner S, 1995, COLD SPRING HARB SYM, V60, P31, DOI 10.1101/SQB.1995.060.01.006; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; Pernet I, 2003, EXP DERMATOL, V12, P755, DOI 10.1111/j.0906-6705.2003.00086.x; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; ROTHBLATT JA, 1987, EMBO J, V6, P3455, DOI 10.1002/j.1460-2075.1987.tb02669.x; SCHLENSTEDT G, 1990, J BIOL CHEM, V265, P13960; SCHLENSTEDT G, 1987, EMBO J, V6, P699, DOI 10.1002/j.1460-2075.1987.tb04810.x; SCHLENSTEDT G, 1992, J BIOL CHEM, V267, P24328; Schluger NW, 1997, CURR OPIN IMMUNOL, V9, P504, DOI 10.1016/S0952-7915(97)80102-1; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Sharma A, 2010, METHODS MOL BIOL, V619, P339, DOI 10.1007/978-1-60327-412-8_20; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; WALTER P, 1983, METHOD ENZYMOL, V96, P84; ZIMMERMANN R, 1990, J BIOENERG BIOMEMBR, V22, P711; ZIMMERMANN R, 1986, J BIOL CHEM, V261, P2889	47	90	92	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1576	1588		10.1016/j.cell.2011.11.048	http://dx.doi.org/10.1016/j.cell.2011.11.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196732	Green Accepted, Bronze			2022-12-24	WOS:000298403400021
J	Zhan, S; Merlin, C; Boore, JL; Reppert, SM				Zhan, Shuai; Merlin, Christine; Boore, Jeffrey L.; Reppert, Steven M.			The Monarch Butterfly Genome Yields Insights into Long-Distance Migration	CELL			English	Article							JUVENILE-HORMONE REGULATION; PIGMENT-DISPERSING FACTOR; OUABAIN BINDING-SITE; DANAUS-PLEXIPPUS; SUN COMPASS; DROSOPHILA-MELANOGASTER; CARDIAC-GLYCOSIDES; RNA-INTERFERENCE; CIRCADIAN CLOCKS; CENTRAL COMPLEX	We present the draft 273 Mb genome of the migratory monarch butterfly (Danaus plexippus) and a set of 16,866 protein-coding genes. Orthology properties suggest that the Lepidoptera are the fastest evolving insect order yet examined. Compared to the silkmoth Bombyx mori, the monarch genome shares prominent similarity in orthology content, microsynteny, and protein family sizes. The monarch genome reveals a vertebrate-like opsin whose existence in insects is widespread; a full repertoire of molecular components for the monarch circadian clockwork; all members of the juvenile hormone biosynthetic pathway whose regulation shows unexpected sexual dimorphism; additional molecular signatures of oriented flight behavior; microRNAs that are differentially expressed between summer and migratory butterflies; monarch-specific expansions of chemo-receptors potentially important for long-distance migration; and a variant of the sodium/potassium pump that underlies a valuable chemical defense mechanism. The monarch genome enhances our ability to better understand the genetic and molecular basis of long-distance migration.	[Zhan, Shuai; Merlin, Christine; Reppert, Steven M.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Boore, Jeffrey L.] Genome Project Solut, Hercules, CA 94547 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu	zhang, tingting/K-6664-2018		NIH [GM086794-02S1]; Higgins Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Higgins Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Stanley Heinze and Surainder Asokaraj for providing the three-dimensional reconstruction images of the monarch antennal lobe shown in Figure 6A; Alan Ritacco for use of the computing server; and Susan Fuerstenberg, Amy Casselman, and Lauren Foley for assistance. S. M. R. initiated and oversaw the project. J. L. B. designed the sequencing strategy, provided sequence quality control, and generated the v0 assemblies. S. Z. performed the v1 and v2 assemblies, generated the gene sets, and provided quality control and the data for all figures, except Figure 6A. C. M. performed the genomic DNA preparations, collected and prepared RNA for the transcriptome library, helped with the annotation of the chemosensory receptors, and properly formatted all the figures. S. Z., C. M., J. L. B., and S. M. R. performed data analyses. S. Z., C. M., and S. M. R. wrote the paper. This work was supported by NIH grant GM086794-02S1 and the Higgins Foundation.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Baumann O, 2010, CELL TISSUE RES, V340, P215, DOI 10.1007/s00441-010-0948-x; Belgacem YH, 2002, P NATL ACAD SCI USA, V99, P15154, DOI 10.1073/pnas.232244199; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Benna C, 2010, CURR BIOL, V20, P346, DOI 10.1016/j.cub.2009.12.048; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; BROWER JV, 1958, EVOLUTION, V12, P32, DOI 10.1111/j.1558-5646.1958.tb02926.x; Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; Brown KS, 2004, HEREDITAS, V141, P216; COHEN JA, 1985, J CHEM ECOL, V11, P85, DOI 10.1007/BF00987608; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Geiger-Thornsberry GL, 2004, MECH AGEING DEV, V125, P179, DOI 10.1016/j.mad.2003.12.008; Goehring L, 2002, ECOL ENTOMOL, V27, P674, DOI 10.1046/j.1365-2311.2002.00454.x; Grimaldi David, 2005, pi; Heinze S, 2011, NEURON, V69, P345, DOI 10.1016/j.neuron.2010.12.025; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Herbert Z, 2010, J MORPHOL, V271, P1509, DOI 10.1002/jmor.10895; Herman WS, 2001, P ROY SOC B-BIOL SCI, V268, P2509, DOI 10.1098/rspb.2001.1765; HERMAN WS, 1975, GEN COMP ENDOCR, V26, P534, DOI 10.1016/0016-6480(75)90176-8; HOLZINGER F, 1992, FEBS LETT, V314, P477, DOI 10.1016/0014-5793(92)81530-Y; Holzinger F, 1996, J CHEM ECOL, V22, P1921, DOI 10.1007/BF02028512; Homberg U, 2002, MICROSC RES TECHNIQ, V56, P189, DOI 10.1002/jemt.10024; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kahsai L, 2011, J COMP NEUROL, V519, P290, DOI 10.1002/cne.22520; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Mebs D, 2000, CHEMOECOLOGY, V10, P201, DOI 10.1007/PL00001823; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Ooka S, 2010, DEV GROWTH DIFFER, V52, P195, DOI 10.1111/j.1440-169X.2009.01154.x; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Perez SM, 1997, NATURE, V387, P29, DOI 10.1038/387029a0; PLISKE TE, 1975, ANN ENTOMOL SOC AM, V68, P143, DOI 10.1093/aesa/68.1.143; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Reppert SM, 2004, CURR BIOL, V14, P155, DOI 10.1016/j.cub.2003.12.034; Reppert SM, 2010, TRENDS NEUROSCI, V33, P399, DOI 10.1016/j.tins.2010.04.004; RITLAND DB, 1991, NATURE, V350, P497, DOI 10.1038/350497a0; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sauman I, 2005, NEURON, V46, P457, DOI 10.1016/j.neuron.2005.03.014; Shafer OT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008298; Skou JC, 1998, BIOSCIENCE REP, V18, P155, DOI 10.1023/A:1020196612909; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; URQUHART FA, 1978, CAN J ZOOL, V56, P1759, DOI 10.1139/z78-240; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Wanner Kevin W., 2010, P153; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; XIANG ZH, 1995, GENETICS BREEDING SI; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zavodska R, 2003, J BIOL RHYTHM, V18, P106, DOI 10.1177/0748730403251711; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004; Zhu HS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001345; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zhu HS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-14; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	79	382	413	6	253	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1171	1185		10.1016/j.cell.2011.09.052	http://dx.doi.org/10.1016/j.cell.2011.09.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118469	Green Accepted, Bronze			2022-12-24	WOS:000297376600026
J	Barouch, DH; Liu, JY; Li, HL; Maxfield, LF; Abbink, P; Lynch, DM; Iampietro, MJ; SanMiguel, A; Seaman, MS; Ferrari, G; Forthal, DN; Ourmanov, I; Hirsch, VM; Carville, A; Mansfield, KG; Stablein, D; Pau, MG; Schuitemaker, H; Sadoff, JC; Billings, EA; Rao, M; Robb, ML; Kim, JH; Marovich, MA; Goudsmit, J; Michael, NL				Barouch, Dan H.; Liu, Jinyan; Li, Hualin; Maxfield, Lori F.; Abbink, Peter; Lynch, Diana M.; Iampietro, M. Justin; SanMiguel, Adam; Seaman, Michael S.; Ferrari, Guido; Forthal, Donald N.; Ourmanov, Ilnour; Hirsch, Vanessa M.; Carville, Angela; Mansfield, Keith G.; Stablein, Donald; Pau, Maria G.; Schuitemaker, Hanneke; Sadoff, Jerald C.; Billings, Erik A.; Rao, Mangala; Robb, Merlin L.; Kim, Jerome H.; Marovich, Mary A.; Goudsmit, Jaap; Michael, Nelson L.			Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys	NATURE			English	Article							CELLULAR IMMUNE-RESPONSES; LOW-DOSE CHALLENGE; INFECTION; ANTIBODIES; MACAQUES; VECTORS; MEMORY; BREADTH	Preclinical studies of human immunodeficiency virus type 1 (HIV-1) vaccine candidates have typically shown post-infection virological control, but protection against acquisition of infection has previously only been reported against neutralization-sensitive virus challenges(1-3). Here we demonstrate vaccine protection against acquisition of fully heterologous, neutralization-resistant simian immunodeficiency virus (SIV) challenges in rhesus monkeys. Adenovirus/poxvirus and adenovirus/adenovirus-vector-based vaccines expressing SIVSME543 Gag, Pol and Env antigens resulted in an 80% or greater reduction in the per-exposure probability of infection(4,5) against repetitive, intrarectal SIVMAC251 challenges in rhesus monkeys. Protection against acquisition of infection showed distinct immunological correlates compared with post-infection virological control and required the inclusion of Env in the vaccine regimen. These data demonstrate the proof-of-concept that optimized HIV-1 vaccine candidates can block acquisition of stringent, heterologous, neutralization-resistant virus challenges in rhesus monkeys.	[Barouch, Dan H.; Liu, Jinyan; Li, Hualin; Maxfield, Lori F.; Abbink, Peter; Lynch, Diana M.; Iampietro, M. Justin; SanMiguel, Adam; Seaman, Michael S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Vaccine Res, Boston, MA 02215 USA; [Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA; [Ferrari, Guido] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Forthal, Donald N.] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA; [Ourmanov, Ilnour; Hirsch, Vanessa M.] NIAID, Bethesda, MA 20892 USA; [Carville, Angela; Mansfield, Keith G.] New England Primate Res Ctr, Southborough, MA 01772 USA; [Stablein, Donald] EMMES Corp, Rockville, MD 20850 USA; [Pau, Maria G.; Schuitemaker, Hanneke; Sadoff, Jerald C.; Goudsmit, Jaap] Crucell Holland BV, NL-2301 CA Leiden, Netherlands; [Billings, Erik A.; Rao, Mangala; Robb, Merlin L.; Kim, Jerome H.; Marovich, Mary A.; Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Duke University; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emmes Corporation; Johnson & Johnson; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019; Ferrari, Guido/A-6088-2015; Ferrari, Guido/Z-2137-2019	Ferrari, Guido/0000-0001-7747-3349; Maxfield, Lori/0000-0002-7595-6205	US Military Research and Material Command; US Military HIV Research Program [W81XWH-07-2-0067]; Ragon Institute of MGH, MIT and Harvard; National Institutes of Health [AI066924, AI078526, AI084794, AI095985, AI060354, AI002642, RR000168]; Bill and Melinda Gates Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI078526, N01AI002642, P30AI060354, U19AI066305, U19AI095985, ZIAAI000686, R01AI084794, R01AI066924] Funding Source: NIH RePORTER	US Military Research and Material Command; US Military HIV Research Program; Ragon Institute of MGH, MIT and Harvard; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Pensiero, A. Fauci, E. Borducchi, S. Clark, R. Hamel, S. King, P. Kozlowski, A. La Porte, G. Landucci, A. Oza, J. Perry, L. Peter, A. Riggs, G. Shaw, N. Simmons, K. Smith, K. Stanley, F. Stephens, Y.-H. Sun, G. Weverling and E. Zablowsky for advice, assistance and reagents. We thank L. Picker, G. Silvestri and B. Walker for critically reviewing this manuscript. The SIV<INF>MAC239</INF> peptide pools were obtained from the NIH AIDS Research and Reference Reagent Program. We acknowledge support from the US Military Research and Material Command and the US Military HIV Research Program (W81XWH-07-2-0067); the Ragon Institute of MGH, MIT and Harvard; the National Institutes of Health (AI066924, AI078526, AI084794, AI095985, AI060354, AI002642, RR000168); and the Bill and Melinda Gates Foundation. The opinions in this manuscript are those of the authors and do not reflect the views of the US Department of Defense.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Barnett SW, 2010, J VIROL, V84, P5975, DOI 10.1128/JVI.02533-09; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Ferrari G, 2011, J VIROL, V85, P7029, DOI 10.1128/JVI.00171-11; Forthal DN, 2001, J VIROL, V75, P6953, DOI 10.1128/JVI.75.15.6953-6961.2001; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Haynes B, 2011, AIDS VACC C 2011; Hudgens MG, 2009, BIOMETRICS, V65, P1223, DOI 10.1111/j.1541-0420.2009.01189.x; Hudgens MG, 2009, J INFECT DIS, V200, P609, DOI 10.1086/600891; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Liu JY, 2010, J VIROL, V84, P10406, DOI 10.1128/JVI.01155-10; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Montefiori D. C, 2004, CURR PROTOC IMMUNOL, V12, P11; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Ourmanov I, 2000, J VIROL, V74, P2740, DOI 10.1128/JVI.74.6.2740-2751.2000; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006	30	385	397	5	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2012	482	7383					89	U115		10.1038/nature10766	http://dx.doi.org/10.1038/nature10766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884RN	22217938	Green Submitted, Green Accepted			2022-12-24	WOS:000299726000041
J	Contreras, FX; Ernst, AM; Haberkant, P; Bjorkholm, P; Lindahl, E; Gonen, B; Tischer, C; Elofsson, A; von Heijne, G; Thiele, C; Pepperkok, R; Wieland, F; Brugger, B				Contreras, F. -Xabier; Ernst, Andreas M.; Haberkant, Per; Bjoerkholm, Patrik; Lindahl, Erik; Goenen, Basak; Tischer, Christian; Elofsson, Arne; von Heijne, Gunnar; Thiele, Christoph; Pepperkok, Rainer; Wieland, Felix; Bruegger, Britta			Molecular recognition of a single sphingolipid species by a protein's transmembrane domain	NATURE			English	Article							TO-GOLGI TRANSPORT; GXXXG MOTIF; SPHINGOMYELIN; CHOLESTEROL; REVEALS; SYSTEM	Functioning and processing of membrane proteins critically depend on the way their transmembrane segments are embedded in the membrane(1). Sphingolipids are structural components of membranes and can also act as intracellular second messengers. Not much is known of sphingolipids binding to transmembrane domains (TMDs) of proteins within the hydrophobic bilayer, and how this could affect protein function. Here we show a direct and highly specific interaction of exclusively one sphingomyelin species, SM 18, with the TMD of the COPI machinery protein p24 (ref. 2). Strikingly, the interaction depends on both the head-group and the backbone of the sphingolipid, and on a signature sequence (VXXTLXXIY) within the TMD. Molecular dynamics simulations show a close interaction of SM 18 with the TMD. We suggest a role of SM 18 in regulating the equilibrium between an inactive monomeric and an active oligomeric state of the p24 protein(3,4), which in turn regulates COPI-dependent transport. Bioinformatic analyses predict that the signature sequence represents a conserved sphingolipid-binding cavity in a variety of mammalian membrane proteins. Thus, in addition to a function as second messengers, sphingolipids can act as cofactors to regulate the function of transmembrane proteins. Our discovery of an unprecedented specificity of interaction of a TMD with an individual sphingolipid species adds to our understanding of why biological membranes are assembled from such a large variety of different lipids.	[Contreras, F. -Xabier; Ernst, Andreas M.; Haberkant, Per; Goenen, Basak; Wieland, Felix; Bruegger, Britta] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Bjoerkholm, Patrik; Lindahl, Erik; Elofsson, Arne; von Heijne, Gunnar] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Bjoerkholm, Patrik; Elofsson, Arne; von Heijne, Gunnar] Stockholm Univ, Stockholm Bioinformat Ctr, Sci Life Lab, SE-17121 Solna, Sweden; [Lindahl, Erik] AlbaNova Univ Ctr, Royal Inst Technol, SE-10691 Stockholm, Sweden; [Tischer, Christian; Pepperkok, Rainer] EMBL, ALMF, D-69117 Heidelberg, Germany; [Thiele, Christoph] LIMES Life & Med Sci Inst, D-53115 Bonn, Germany	Ruprecht Karls University Heidelberg; Stockholm University; Stockholm University; Royal Institute of Technology; European Molecular Biology Laboratory (EMBL); University of Bonn	Brugger, B (corresponding author), Heidelberg Univ, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	britta.bruegger@bzh.uni-heidelberg.de	Lindahl, Erik/D-4590-2013; von Heijne, Gunnar/AAH-9389-2019; Contreras, Xabier/AAA-8885-2019; von Heijne, Gunnar/F-5576-2011; Ernst, Andreas/ABA-7601-2020	Lindahl, Erik/0000-0002-2734-2794; von Heijne, Gunnar/0000-0002-4490-8569; Ernst, Andreas/0000-0001-7359-7184; Haberkant, Per/0000-0002-5608-9062; Elofsson, Arne/0000-0002-7115-9751; Contreras, Xabier/0000-0003-0875-634X; Pepperkok, Rainer/0000-0002-9762-3583; Bjorkholm, Patrik/0000-0002-9131-4122	German research foundation (DFG) [TRR83]; ERC [209825, AdG232648]; FEBS; Peter and Traudl Engelhorn foundation	German research foundation (DFG)(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); FEBS; Peter and Traudl Engelhorn foundation	The authors would like to thank T. Sachsenheimer for technical assistance, A. Brodde for help with lipid synthesis, D. Cassel for comments on the manuscript, and the members of the Wieland laboratory for discussion. This work was supported by a grant of the German research foundation (DFG, TRR83) to B. B. and F. W. and by ERC grants to E. L. (209825) and G. v. H. (AdG232648); F.-X. C. was supported by a FEBS fellowship and A. M. E. by the Peter and Traudl Engelhorn foundation.	Bakrac B, 2010, J BIOL CHEM, V285, P22186, DOI 10.1074/jbc.M110.105122; Beck R, 2009, FEBS LETT, V583, P3541, DOI 10.1016/j.febslet.2009.10.027; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Contreras FX, 2005, BIOPHYS J, V88, P348, DOI 10.1529/biophysj.104.050690; Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010; Haberkant P, 2008, J LIPID RES, V49, P251, DOI 10.1194/jlr.D700023-JLR200; Jackson ME, 1999, J CELL SCI, V112, P467; JONES DT, 1994, FEBS LETT, V339, P269, DOI 10.1016/0014-5793(94)80429-X; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728; Li XM, 2000, BIOPHYS J, V78, P1921, DOI 10.1016/S0006-3495(00)76740-3; Niemela P, 2004, BIOPHYS J, V87, P2976, DOI 10.1529/biophysj.104.048702; Niemela PS, 2006, BIOPHYS J, V90, P851, DOI 10.1529/biophysj.105.067371; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reinhard C, 1999, P NATL ACAD SCI USA, V96, P1224, DOI 10.1073/pnas.96.4.1224; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Simpson JC, 2007, J BIOTECHNOL, V129, P352, DOI 10.1016/j.jbiotec.2006.12.027; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366	23	253	254	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2012	481	7382					525	529		10.1038/nature10742	http://dx.doi.org/10.1038/nature10742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22230960	Green Submitted			2022-12-24	WOS:000299471800044
J	Jia, YC; Mu, JC; Ackerman, SL				Jia, Yichang; Mu, John C.; Ackerman, Susan L.			Mutation of a U2 snRNA Gene Causes Global Disruption of Alternative Splicing and Neurodegeneration	CELL			English	Article							SMALL NUCLEAR-RNA; NONSENSE-MEDIATED DECAY; MESSENGER-RNA; DEVELOPMENTAL DISORDER; U4ATAC SNRNA; IN-SITU; EXPRESSION; MOUSE; U1; SPLICEOSOME	Although uridine-rich small nuclear RNAs (UsnRNAs) are essential for pre-mRNA splicing, little is known regarding their function in the regulation of alternative splicing or of the biological consequences of their dysfunction in mammals. Here, we demonstrate that mutation of Rnu2-8, one of the mouse multicopy U2 snRNA genes, causes ataxia and neurodegeneration. Coincident with the observed pathology, the level of mutant U2 RNAs was highest in the cerebellum and increased after granule neuron maturation. Furthermore, neuron loss was strongly dependent on the dosage of mutant and wild-type snRNA genes. Comprehensive transcriptome analysis identified a group of alternative splicing events, including the splicing of small introns, which were disrupted in the mutant cerebellum. Our results suggest that the expression of mammalian U2 snRNA genes, previously presumed to be ubiquitous, is spatially and temporally regulated, and dysfunction of a single U2 snRNA causes neuron degeneration through distortion of pre-mRNA splicing.	[Jia, Yichang; Ackerman, Susan L.] Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; [Jia, Yichang; Ackerman, Susan L.] Jackson Lab, Bar Harbor, ME 04609 USA; [Mu, John C.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Jackson Laboratory; Stanford University	Ackerman, SL (corresponding author), Howard Hughes Med Inst, 600 Main St, Bar Harbor, ME 04609 USA.	susan.ackerman@jax.org	Mu, John/AAE-9853-2020	Mu, John/0000-0002-9666-8528	National Cancer Institute; NIH [R01HG004634, R01HG005717]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005717, R01HG004634] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank The Jackson Laboratory sequencing, gene expression, histology, microinjection, and multimedia services for their assistance. We also thank W. H. Wong for discussions on RNA-Seq analysis, J. Blake and C. Bult for discussion on GO analysis, L. Beverly-Staggs and J. Cook for mouse husbandry assistance, P. de la Grange for exon array analysis, J. Hammer and L. Zhao for graphics assistance, J. McCarthy and M. Nasim for plasmids, and R. Burgess, G. Cox, and M. Hibbs for comments on the manuscript. This work was partially supported by an institutional National Cancer Institute core grant (JAX), and the work of J. C. M. was partially supported by NIH Grants R01HG004634 and R01HG005717. S. L. A. is an investigator of the Howard Hughes Medical Institute.	Au KF, 2010, NUCLEIC ACIDS RES, V38, P4570, DOI 10.1093/nar/gkq211; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bult C, 2004, NAT NEUROSCI, V7, P484, DOI 10.1038/nn0504-484; Chacko E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S5; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Corioni M, 2011, NUCLEIC ACIDS RES, V39, P1868, DOI 10.1093/nar/gkq1042; de la Grange P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-180; de la Grange P, 2010, NUCLEIC ACIDS RES, V38, P2825, DOI 10.1093/nar/gkq008; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; Egloff S, 2008, BIOCHEM SOC T, V36, P590, DOI 10.1042/BST0360590; FORBES DJ, 1984, CELL, V38, P681, DOI 10.1016/0092-8674(84)90263-0; Gardner LB, 2010, MOL CANCER RES, V8, P295, DOI 10.1158/1541-7786.MCR-09-0502; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kollmus H, 1996, NUCLEIC ACIDS RES, V24, P1195, DOI 10.1093/nar/24.7.1195; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lemmens R, 2010, TRENDS NEUROSCI, V33, P249, DOI 10.1016/j.tins.2010.02.003; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; LUND E, 1985, SCIENCE, V229, P1271, DOI 10.1126/science.2412294; MANSER T, 1982, CELL, V29, P257, DOI 10.1016/0092-8674(82)90110-6; Marz M, 2008, J MOL EVOL, V67, P594, DOI 10.1007/s00239-008-9149-6; McGrail JC, 2006, EMBO J, V25, P3813, DOI 10.1038/sj.emboj.7601258; Mordes D, 2006, MOL VIS, V12, P1259; Munroe Robert, 2009, V530, P131, DOI 10.1007/978-1-59745-471-1_7; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; PAVELITZ T, 1995, EMBO J, V14, P169, DOI 10.1002/j.1460-2075.1995.tb06987.x; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Ryan DE, 2002, RNA, V8, P997, DOI 10.1017/S1355838202025013; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Saltzman AL, 2011, GENE DEV, V25, P373, DOI 10.1101/gad.2004811; SAUTERER RA, 1988, EXP CELL RES, V176, P344, DOI 10.1016/0014-4827(88)90336-9; Shaw SD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000854; Sierra-Montes JM, 2005, GENE, V352, P127, DOI 10.1016/j.gene.2005.02.013; Smith DJ, 2009, MOL CELL, V34, P333, DOI 10.1016/j.molcel.2009.03.012; STEFANOVIC B, 1991, DEV BIOL, V148, P284, DOI 10.1016/0012-1606(91)90337-3; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; VANARSDELL SW, 1984, MOL CELL BIOL, V4, P492, DOI 10.1128/MCB.4.3.492; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WESTIN G, 1984, P NATL ACAD SCI-BIOL, V81, P3811, DOI 10.1073/pnas.81.12.3811; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Zahler AM, 2004, GENETICS, V167, P1689, DOI 10.1534/genetics.104.028746; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620	54	68	71	2	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 20	2012	148	1-2					296	308		10.1016/j.cell.2011.11.057	http://dx.doi.org/10.1016/j.cell.2011.11.057			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265417	Green Accepted, Bronze			2022-12-24	WOS:000299540700032
J	Ewing, CM; Ray, AM; Lange, EM; Zuhlke, KA; Robbins, CM; Tembe, WD; Wiley, KE; Isaacs, SD; Johng, D; Wang, YF; Bizon, C; Yan, GF; Gielzak, M; Partin, AW; Shanmugam, V; Izatt, T; Sinari, S; Craig, DW; Zheng, SL; Walsh, PC; Montie, JE; Xu, JF; Carpten, JD; Isaacs, WB; Cooney, KA				Ewing, Charles M.; Ray, Anna M.; Lange, Ethan M.; Zuhlke, Kimberly A.; Robbins, Christiane M.; Tembe, Waibhav D.; Wiley, Kathleen E.; Isaacs, Sarah D.; Johng, Dorhyun; Wang, Yunfei; Bizon, Chris; Yan, Guifang; Gielzak, Marta; Partin, Alan W.; Shanmugam, Vijayalakshmi; Izatt, Tyler; Sinari, Shripad; Craig, David W.; Zheng, S. Lilly; Walsh, Patrick C.; Montie, James E.; Xu, Jianfeng; Carpten, John D.; Isaacs, William B.; Cooney, Kathleen A.			Germline Mutations in HOXB13 and Prostate-Cancer Risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY GENES; LINKAGE SCAN; VARIANTS; FAMILIES; GENETICS; BRCA1; CHROMOSOME-17; LOCI	BACKGROUND Family history is a significant risk factor for prostate cancer, although the molecular basis for this association is poorly understood. Linkage studies have implicated chromosome 17q21-22 as a possible location of a prostate-cancer susceptibility gene. METHODS We screened more than 200 genes in the 17q21-22 region by sequencing germline DNA from 94 unrelated patients with prostate cancer from families selected for linkage to the candidate region. We tested family members, additional case subjects, and control subjects to characterize the frequency of the identified mutations. RESULTS Probands from four families were discovered to have a rare but recurrent mutation (G84E) in HOXB13 (rs138213197), a homeobox transcription factor gene that is important in prostate development. All 18 men with prostate cancer and available DNA in these four families carried the mutation. The carrier rate of the G84E mutation was increased by a factor of approximately 20 in 5083 unrelated subjects of European descent who had prostate cancer, with the mutation found in 72 subjects (1.4%), as compared with 1 in 1401 control subjects (0.1%) (P = 8.5x10(-7)). The mutation was significantly more common in men with early-onset, familial prostate cancer (3.1%) than in those with late-onset, nonfamilial prostate cancer (0.6%) (P = 2.0x10(-6)). CONCLUSIONS The novel HOXB13 G84E variant is associated with a significantly increased risk of hereditary prostate cancer. Although the variant accounts for a small fraction of all prostate cancers, this finding has implications for prostate-cancer risk assessment and may provide new mechanistic insights into this common cancer. (Funded by the National Institutes of Health and others.)	[Ray, Anna M.; Zuhlke, Kimberly A.; Montie, James E.; Cooney, Kathleen A.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Ray, Anna M.; Zuhlke, Kimberly A.; Montie, James E.; Cooney, Kathleen A.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Ewing, Charles M.; Wiley, Kathleen E.; Isaacs, Sarah D.; Johng, Dorhyun; Yan, Guifang; Gielzak, Marta; Partin, Alan W.; Walsh, Patrick C.; Isaacs, William B.] Johns Hopkins Univ, Baltimore, MD USA; [Ewing, Charles M.; Wiley, Kathleen E.; Isaacs, Sarah D.; Johng, Dorhyun; Yan, Guifang; Gielzak, Marta; Partin, Alan W.; Walsh, Patrick C.; Isaacs, William B.] James Buchanan Brady Urol Inst, Baltimore, MD USA; [Lange, Ethan M.; Wang, Yunfei] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Bizon, Chris] Renaissance Comp Inst, Chapel Hill, NC USA; [Robbins, Christiane M.; Tembe, Waibhav D.; Shanmugam, Vijayalakshmi; Izatt, Tyler; Sinari, Shripad; Craig, David W.; Carpten, John D.] Translat Genom Res Inst, Phoenix, AZ USA; [Zheng, S. Lilly; Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; Translational Genomics Research Institute; Wake Forest University; Wake Forest Baptist Medical Center	Cooney, KA (corresponding author), Univ Michigan Hlth Syst, Dept Internal Med, 7216 CC,SPC 5948,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	kcooney@med.umich.edu	Craig, David Wesley/K-6961-2019	Craig, David Wesley/0000-0003-2040-1955; Zuhlke, Kimberly/0000-0001-6941-5376; Cooney, Kathleen/0000-0003-3831-6943	National Institutes of Health [R01-CA79596, R01-CA079596-10-S1, R01-CA136621, P50-CA69568, U01-CA89600, U01-CA86323]; NATIONAL CANCER INSTITUTE [P50CA069568, U01CA089600, R01CA079596, U01CA086323, R01CA136621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants (R01-CA79596, R01-CA079596-10-S1, R01-CA136621, P50-CA69568, U01-CA89600, and U01-CA86323) from the National Institutes of Health; by William Gerrard, Mario Duhon, John and Jennifer Chalsty, and P. Kevin Jaffe; and by the Patrick C. Walsh Cancer Research Fund (to Dr. Isaacs).	1000 Genomes, 1000 GEN DEEP CAT HU; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], EX VAR SERV; Economides KD, 2003, DEVELOPMENT, V130, P2061, DOI 10.1242/dev.00432; Economides KD, 2003, DEV BIOL, V256, P317, DOI 10.1016/S0012-1606(02)00137-9; Edwards S, 2005, BRIT J CANCER, V92, P376, DOI 10.1038/sj.bjc.6602261; Fukasawa S, 2008, PROSTATE CANCER P D, V11, P303, DOI 10.1038/sj.pcan.4501017; Gillanders EM, 2004, JNCI-J NATL CANCER I, V96, P1240, DOI 10.1093/jnci/djh228; Goodman FR, 2001, CLIN GENET, V59, P1, DOI 10.1034/j.1399-0004.2001.590101.x; GRAHAM A, 1994, CURR BIOL, V4, P1135, DOI 10.1016/S0960-9822(00)00256-6; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Jung C, 2004, CANCER RES, V64, P9185, DOI 10.1158/0008-5472.CAN-04-1330; Kim JH, 2007, CANCER RES, V67, P8229, DOI 10.1158/0008-5472.CAN-07-1297; Kim ST, 2010, PROSTATE, V70, P1729, DOI 10.1002/pros.21208; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Lange EM, 2003, PROSTATE, V57, P326, DOI 10.1002/pros.10307; Lange EM, 2011, PROSTATE        0502; Lange EM, 2007, HUM GENET, V121, P49, DOI 10.1007/s00439-006-0274-2; Lange EM, 2009, PROSTATE, V69, P385, DOI 10.1002/pros.20891; Langeberg WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4101, DOI 10.2741/2374; Liu WN, 2008, NEOPLASIA, V10, P897, DOI 10.1593/neo.08428; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Ostrander EA, 2008, CANCER EPIDEM BIOMAR, V17, P1843, DOI 10.1158/1055-9965.EPI-08-0556; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Schehl Sinclair Colleen, 2000, Cancer Research, V60, P1371; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Williams TM, 2005, DEV BIOL, V277, P457, DOI 10.1016/j.ydbio.2004.10.004; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994; Xu JF, 2005, AM J HUM GENET, V77, P219, DOI 10.1086/432377; Zheng SL, 2007, JNCI-J NATL CANCER I, V99, P1525, DOI 10.1093/jnci/djm169; Zuhlke KA, 2004, CLIN CANCER RES, V10, P5975, DOI 10.1158/1078-0432.CCR-04-0554	35	428	446	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					141	149		10.1056/NEJMoa1110000	http://dx.doi.org/10.1056/NEJMoa1110000			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874VA	22236224	Green Accepted			2022-12-24	WOS:000298985000008
J	Jager, S; Cimermancic, P; Gulbahce, N; Johnson, JR; McGovern, KE; Clarke, SC; Shales, M; Mercenne, G; Pache, L; Li, K; Hernandez, H; Jang, GM; Roth, SL; Akiva, E; Marlett, J; Stephens, M; D'Orso, I; Fernandes, J; Fahey, M; Mahon, C; O'Donoghue, AJ; Todorovic, A; Morris, JH; Maltby, DA; Alber, T; Cagney, G; Bushman, FD; Young, JA; Chanda, SK; Sundquist, WI; Kortemme, T; Hernandez, RD; Craik, CS; Burlingame, A; Sali, A; Frankel, AD; Krogan, NJ				Jaeger, Stefanie; Cimermancic, Peter; Gulbahce, Natali; Johnson, Jeffrey R.; McGovern, Kathryn E.; Clarke, Starlynn C.; Shales, Michael; Mercenne, Gaelle; Pache, Lars; Li, Kathy; Hernandez, Hilda; Jang, Gwendolyn M.; Roth, Shoshannah L.; Akiva, Eyal; Marlett, John; Stephens, Melanie; D'Orso, Ivan; Fernandes, Jason; Fahey, Marie; Mahon, Cathal; O'Donoghue, Anthony J.; Todorovic, Aleksandar; Morris, John H.; Maltby, David A.; Alber, Tom; Cagney, Gerard; Bushman, Frederic D.; Young, John A.; Chanda, Sumit K.; Sundquist, Wesley I.; Kortemme, Tanja; Hernandez, Ryan D.; Craik, Charles S.; Burlingame, Alma; Sali, Andrej; Frankel, Alan D.; Krogan, Nevan J.			Global landscape of HIV-human protein complexes	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; INTERACTION MAP; REPLICATION; INTERACTOME; PURIFICATION; INFECTION; RESOURCE; CLEAVAGE; DATABASE; NETWORK	Human immunodeficiency virus (HIV) has a small genome and therefore relies heavily on the host cellular machinery to replicate. Identifying which host proteins and complexes come into physical contact with the viral proteins is crucial for a comprehensive understanding of how HIV rewires the host's cellular machinery during the course of infection. Here we report the use of affinity tagging and purification mass spectrometry(1-3) to determine systematically the physical interactions of all 18 HIV-1 proteins and polyproteins with host proteins in two different human cell lines (HEK293 and Jurkat). Using a quantitative scoring system that we call MiST, we identified with high confidence 497 HIV-human protein-protein interactions involving 435 individual human proteins, with similar to 40% of the interactions being identified in both cell types. We found that the host proteins hijacked by HIV, especially those found interacting in both cell types, are highly conserved across primates. We uncovered a number of host complexes targeted by viral proteins, including the finding that HIV protease cleaves eIF3d, a subunit of eukaryotic translation initiation factor 3. This host protein is one of eleven identified in this analysis that act to inhibit HIV replication. This data set facilitates a more comprehensive and detailed understanding of how the host machinery is manipulated during the course of HIV infection.	[Jaeger, Stefanie; Gulbahce, Natali; Johnson, Jeffrey R.; McGovern, Kathryn E.; Shales, Michael; Li, Kathy; Hernandez, Hilda; Jang, Gwendolyn M.; Fahey, Marie; Mahon, Cathal; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Jaeger, Stefanie; Cimermancic, Peter; Gulbahce, Natali; Johnson, Jeffrey R.; McGovern, Kathryn E.; Shales, Michael; Li, Kathy; Hernandez, Hilda; Jang, Gwendolyn M.; Akiva, Eyal; Fahey, Marie; Mahon, Cathal; Kortemme, Tanja; Hernandez, Ryan D.; Craik, Charles S.; Burlingame, Alma; Sali, Andrej; Frankel, Alan D.; Krogan, Nevan J.] QB3, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Cimermancic, Peter; Akiva, Eyal; Kortemme, Tanja; Hernandez, Ryan D.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Johnson, Jeffrey R.; Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA 94158 USA; [Clarke, Starlynn C.; Li, Kathy; Hernandez, Hilda; Mahon, Cathal; O'Donoghue, Anthony J.; Morris, John H.; Maltby, David A.; Craik, Charles S.; Burlingame, Alma; Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Mercenne, Gaelle; Sundquist, Wesley I.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Pache, Lars; Chanda, Sumit K.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Jang, Gwendolyn M.; D'Orso, Ivan; Fernandes, Jason; Bushman, Frederic D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Roth, Shoshannah L.; Stephens, Melanie; Bushman, Frederic D.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Marlett, John; Young, John A.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Todorovic, Aleksandar] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Cagney, Gerard] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [Kortemme, Tanja; Hernandez, Ryan D.; Sali, Andrej; Frankel, Alan D.; Krogan, Nevan J.] Univ Calif San Francisco, Host Pathogen Circuitry Grp, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Francisco; University of Pennsylvania; Salk Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University College Dublin; University of California System; University of California San Francisco	Krogan, NJ (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	krogan@cmp.ucsf.edu	Kortemme, Tanja/AAN-3180-2021	Fernandes, Jason/0000-0002-8625-1796; Kortemme, Tanja/0000-0002-8494-680X; Bushman, Frederic/0000-0003-4740-4056; McGovern, Kathryn/0000-0001-8770-2619; Morris, John "Scooter"/0000-0003-0290-7979; Cagney, Gerard/0000-0001-7189-9496	QB3@UCSF; National Institutes of Health [P50 GM082250, P01 AI090935, P50 GM081879, P50 GM082545, P41RR001614, U54 RR022220, P01 GM073732-05, CHRP-ID08-TBI-063, P41 RR001081]; Nomis Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, U54RR022220, P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI090935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, P41GM103481, P01GM073732, P50GM082545, P50GM082250] Funding Source: NIH RePORTER	QB3@UCSF; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nomis Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Choi, Z. Rizvi and E. Kwon for cloning of human genes and J. Cate for purified eIF3. We also thank J. Gross, R. Andino, R. Harris, M. Daugherty and members of the Krogan lab for discussion. This research was funded by grants from QB3@UCSF and the National Institutes of Health (P50 GM082250 to N.J.K., A. D. F., C. S. C. and T. A.; P01 AI090935 to N.J.K., S. K. C., J.A.Y. and F. D. B.; P50 GM081879 to N.J.K. and A. B.; P50 GM082545 to W. I. S.; P41RR001614 to A. B.; U54 RR022220 to A. S.; P01 GM073732-05 to A. T.; CHRP-ID08-TBI-063 to S. K. C.; P41 RR001081 to J. H. M.) and from the Nomis Foundation (to J.A.Y.). N.J.K. is a Searle Scholar and a Keck Young Investigator.	Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Asano K, 1997, J BIOL CHEM, V272, P27042, DOI 10.1074/jbc.272.43.27042; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Fahey ME, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-298; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Jager S, 2011, METHODS, V53, P13, DOI 10.1016/j.ymeth.2010.08.007; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Strack PR, 1996, P NATL ACAD SCI USA, V93, P9571, DOI 10.1073/pnas.93.18.9571; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Valente ST, 2009, P NATL ACAD SCI USA, V106, P4071, DOI 10.1073/pnas.0900557106; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	28	486	496	2	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 19	2012	481	7381					365	370		10.1038/nature10719	http://dx.doi.org/10.1038/nature10719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22190034	Green Accepted			2022-12-24	WOS:000299210600043
J	Crosnier, C; Bustamante, LY; Bartholdson, SJ; Bei, AK; Theron, M; Uchikawa, M; Mboup, S; Ndir, O; Kwiatkowski, DP; Duraisingh, MT; Rayner, JC; Wright, GJ				Crosnier, Cecile; Bustamante, Leyla Y.; Bartholdson, S. Josefin; Bei, Amy K.; Theron, Michel; Uchikawa, Makoto; Mboup, Souleymane; Ndir, Omar; Kwiatkowski, Dominic P.; Duraisingh, Manoj T.; Rayner, Julian C.; Wright, Gavin J.			Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum	NATURE			English	Article							GENOME-WIDE; ASSOCIATION ANALYSIS; INTERACTION NETWORK; GENETIC-ANALYSIS; MALARIA; SELECTION; MOLECULE; HOMOLOG; LIGAND; CELLS	Erythrocyte invasion by Plasmodium falciparum is central to the pathogenesis of malaria. Invasion requires a series of extracellular recognition events between erythrocyte receptors and ligands on the merozoite, the invasive form of the parasite. None of the few known receptor-ligand interactions involved(1-4) are required in all parasite strains, indicating that the parasite is able to access multiple redundant invasion pathways(5). Here, we show that we have identified a receptor-ligand pair that is essential for erythrocyte invasion in all tested P. falciparum strains. By systematically screening a library of erythrocyte proteins, we have found that the Ok blood group antigen, basigin, is a receptor for PfRh5, a parasite ligand that is essential for blood stage growth(6). Erythrocyte invasion was potently inhibited by soluble basigin or by basigin knockdown, and invasion could be completely blocked using low concentrations of anti-basigin antibodies; importantly, these effects were observed across all laboratory-adapted and field strains tested. Furthermore, Ok(a-) erythrocytes, which express a basigin variant that has a weaker binding affinity for PfRh5, had reduced invasion efficiencies. Our discovery of a cross-strain dependency on a single extracellular receptor-ligand pair for erythrocyte invasion by P. falciparum provides a focus for new anti-malarial therapies.	[Crosnier, Cecile; Bartholdson, S. Josefin; Wright, Gavin J.] Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge CB10 1HH, England; [Bustamante, Leyla Y.; Theron, Michel; Kwiatkowski, Dominic P.; Rayner, Julian C.; Wright, Gavin J.] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge CB10 1SA, England; [Bei, Amy K.; Duraisingh, Manoj T.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Uchikawa, Makoto] Tokyo Red Cross Blood Ctr, Tokyo 1358639, Japan; [Mboup, Souleymane; Ndir, Omar] Cheikh Anta Diop Univ, La Dantec Hosp, Lab Bacteriol & Virol, Dakar, Senegal; [Mboup, Souleymane; Ndir, Omar] Cheikh Anta Diop Univ, Parasitol Lab, Dakar, Senegal; [Kwiatkowski, Dominic P.] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Harvard University; Harvard T.H. Chan School of Public Health; University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar; University of Oxford; Wellcome Centre for Human Genetics	Wright, GJ (corresponding author), Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge CB10 1HH, England.	jr9@sanger.ac.uk; gw2@sanger.ac.uk	Theron, Michel/E-2067-2012	Rayner, Julian/0000-0002-9835-1014; Kwiatkowski, Dominic/0000-0002-5023-0176; Theron, Michel/0000-0002-5781-1985; Wright, Gavin/0000-0003-0537-0863; Bartholdson Scott, Sara Josefin/0000-0003-3380-4446	Wellcome Trust [077108, 089084]; National Institutes of Health [R01AI057919]; Center for Disease Control [R36 CK000119-01]; Epidemiology of Infectious Disease and Biodefense Training Grant [2T32 AI007535-12]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057919, T32AI007535] Funding Source: NIH RePORTER; Medical Research Council [G0600718B, G19/9] Funding Source: researchfish; MRC [G19/9] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Disease Control; Epidemiology of Infectious Disease and Biodefense Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the Ok<SUP>a-</SUP> blood donors. We thank V. Horejsi for monoclonal antibodies and D. Ahr for technical assistance. This work was supported by the Wellcome Trust grant numbers 077108 (G.J.W.) and 089084 (J.C.R.) and National Institutes of Health R01AI057919 (M. T. D.). A. K. B. is supported by a Center for Disease Control grant R36 CK000119-01 and an Epidemiology of Infectious Disease and Biodefense Training Grant 2T32 AI007535-12.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ANSTEE DJ, 1990, J IMMUNOGENET, V17, P219; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Bei AK, 2010, J INFECT DIS, V202, P1722, DOI 10.1086/657157; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crosnier C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-76; FADOOL JM, 1993, DEV DYNAM, V196, P252, DOI 10.1002/aja.1001960406; Guo HM, 1997, J BIOL CHEM, V272, P24; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Igakura T, 1998, DEV BIOL, V194, P152, DOI 10.1006/dbio.1997.8819; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Martin S, 2010, MOL CELL PROTEOMICS, V9, P2654, DOI 10.1074/mcp.M110.004119; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; Neafsey DE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r171; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Rodriguez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003300; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schlegel J, 2009, J MOL BIOL, V391, P518, DOI 10.1016/j.jmb.2009.05.080; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Snounou G, 1998, PARASITOL TODAY, V14, P462, DOI 10.1016/S0169-4758(98)01340-4; Sollner C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r99; Spring FA, 1997, EUR J IMMUNOL, V27, P891, DOI 10.1002/eji.1830270414; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Theron M, 2010, CYTOM PART A, V77A, P1067, DOI 10.1002/cyto.a.20972; vanderMerwe PA, 1996, CURR OPIN IMMUNOL, V8, P257, DOI 10.1016/S0952-7915(96)80065-3; WILLIAMS BP, 1988, IMMUNOGENETICS, V27, P322, DOI 10.1007/BF00395127; Wright GJ, 2009, MOL BIOSYST, V5, P1405, DOI [10.1039/B903580J, 10.1039/b903580j]; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200	32	425	432	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					534	U158		10.1038/nature10606	http://dx.doi.org/10.1038/nature10606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22080952	Green Accepted			2022-12-24	WOS:000298318000063
J	Heidrich, K; Wirthmueller, L; Tasset, C; Pouzet, C; Deslandes, L; Parker, JE				Heidrich, Katharina; Wirthmueller, Lennart; Tasset, Celine; Pouzet, Cecile; Deslandes, Laurent; Parker, Jane E.			Arabidopsis EDS1 Connects Pathogen Effector Recognition to Cell Compartment-Specific Immune Responses	SCIENCE			English	Article							DISEASE-RESISTANCE GENES; NUCLEAR ACCUMULATION; INNATE IMMUNITY; PLANT IMMUNITY; PROTEIN; ACTIVATION; BACTERIAL; DEFENSE; DEATH; THALIANA	Pathogen effectors are intercepted by plant intracellular nucleotide binding-leucine-rich repeat (NB-LRR) receptors. However, processes linking receptor activation to downstream defenses remain obscure. Nucleo-cytoplasmic basal resistance regulator EDS1 (ENHANCED DISEASE SUSCEPTIBILITY1) is indispensible for immunity mediated by TIR (Toll-interleukin-1 receptor)-NB-LRR receptors. We show that Arabidopsis EDS1 molecularly connects TIR-NB-LRR disease resistance protein RPS4 recognition of bacterial effector AvrRps4 to defense pathways. RPS4-EDS1 and AvrRps4-EDS1 complexes are detected inside nuclei of living tobacco cells after transient coexpression and in Arabidopsis soluble leaf extracts after resistance activation. Forced AvrRps4 localization to the host cytoplasm or nucleus reveals cell compartment-specific RPS4-EDS1 defense branches. Although nuclear processes restrict bacterial growth, programmed cell death and transcriptional resistance reinforcement require nucleo-cytoplasmic coordination. Thus, EDS1 behaves as an effector target and activated TIR-NB-LRR signal transducer for defenses across cell compartments.	[Heidrich, Katharina; Wirthmueller, Lennart; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Tasset, Celine; Deslandes, Laurent] CNRS, UMR 2594, LIPM, F-31326 Castanet Tolosan, France; [Pouzet, Cecile] Federat Rech 3450, Plateforme Imagerie TRI, Pole Biotechnol Vegetale, F-31326 Castanet Tolosan, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Parker, JE (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	parker@mpipz.mpg.de	Deslandes, Laurent/N-5752-2017; Wirthmueller, Lennart/H-3310-2019	Wirthmueller, Lennart/0000-0003-0667-5343	Max-Planck Society; IMPRS; Deutsche Forschungsgemeinschaft [SFB 670]; Laboratoire d'Excellence (LABEX) TULIP [ANR-10-LABX-41]	Max-Planck Society(Max Planck Society); IMPRS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Laboratoire d'Excellence (LABEX) TULIP	We thank J. Bautor for excellent technical assistance; J. Jones and K. H. Sohn (Sainsbury Laboratory, Norwich, UK) for the pEDV6 vector and advice on bacterial delivery assays; A. Jauneau for advice and technical support in fluorescence resonance energy transfer (FRET)-FLIM assays (FR3450); and C. Briere for statistical analysis of FRET-FLIM data (UMR CNRS-UPS 5546). This work was funded by The Max-Planck Society, an IMPRS PhD fellowship (K. H.), Deutsche Forschungsgemeinschaft SFB 670 grant (J. E. P.) and is part of the Laboratoire d'Excellence (LABEX) TULIP (ANR-10-LABX-41) program (L.D.).	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Bhattacharjee S, 2011, SCIENCE, V334, P1405, DOI 10.1126/science.1211592; Birker D, 2009, PLANT J, V60, P602, DOI 10.1111/j.1365-313X.2009.03984.x; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; CENTURY KS, 1995, P NATL ACAD SCI USA, V92, P6597, DOI 10.1073/pnas.92.14.6597; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Garcia AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000970; Gassmann W, 2005, MOL PLANT MICROBE IN, V18, P1054, DOI 10.1094/MPMI-18-1054; Gassmann W, 1999, PLANT J, V20, P265, DOI 10.1046/j.1365-313X.1999.t01-1-00600.x; Kim SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001172; Li YZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001111; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Rietz S, 2011, NEW PHYTOL, V191, P107, DOI 10.1111/j.1469-8137.2011.03675.x; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Sohn KH, 2009, PLANT J, V57, P1079, DOI 10.1111/j.1365-313X.2008.03751.x; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Zhang YL, 2003, PLANT CELL, V15, P2636, DOI 10.1105/tpc.015842	32	235	258	1	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1401	1404		10.1126/science.1211641	http://dx.doi.org/10.1126/science.1211641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158818				2022-12-24	WOS:000297787700053
J	Oh, E; Becker, AH; Sandikci, A; Huber, D; Chaba, R; Gloge, F; Nichols, RJ; Typas, A; Gross, CA; Kramer, G; Weissman, JS; Bukau, B				Oh, Eugene; Becker, Annemarie H.; Sandikci, Arzu; Huber, Damon; Chaba, Rachna; Gloge, Felix; Nichols, Robert J.; Typas, Athanasios; Gross, Carol A.; Kramer, Guenter; Weissman, Jonathan S.; Bukau, Bernd			Selective Ribosome Profiling Reveals the Cotranslational Chaperone Action of Trigger Factor In Vivo	CELL			English	Article							SIGNAL RECOGNITION PARTICLE; NEWLY SYNTHESIZED PROTEINS; ESCHERICHIA-COLI; TRANSLATING RIBOSOMES; MEMBRANE-PROTEINS; COMPLEX; POLYPEPTIDE; DNAK; TRANSLOCATION; RESOLUTION	As nascent polypeptides exit ribosomes, they are engaged by a series of processing, targeting, and folding factors. Here, we present a selective ribosome profiling strategy that enables global monitoring of when these factors engage polypeptides in the complex cellular environment. Studies of the Escherichia coli chaperone trigger factor (TF) reveal that, though TF can interact with many polypeptides, beta-barrel outer-membrane proteins are the most prominent substrates. Loss of TF leads to broad outer-membrane defects and premature, cotranslational protein translocation. Whereas in vitro studies suggested that TF is prebound to ribosomes waiting for polypeptides to emerge from the exit channel, we find that in vivo TF engages ribosomes only after similar to 100 amino acids are translated. Moreover, excess TF interferes with cotranslational removal of the N-terminal formyl methionine. Our studies support a triaging model in which proper protein biogenesis relies on the fine-tuned, sequential engagement of processing, targeting, and folding factors.	[Oh, Eugene; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Oh, Eugene; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Oh, Eugene; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Chaba, Rachna; Nichols, Robert J.; Typas, Athanasios; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Becker, Annemarie H.; Sandikci, Arzu; Huber, Damon; Gloge, Felix; Kramer, Guenter; Bukau, Bernd] Univ Heidelberg, Ctr Biol Mol, German Canc Res Ctr, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu; bukau@zmbh.uni-heidelberg.de		Kramer, Gunter/0000-0001-7552-8393; Weissman, Jonathan/0000-0003-2445-670X; Bukau, Bernd/0000-0003-0521-7199; Typas, Athanasios/0000-0002-0797-9018; Huber, Damon/0000-0002-7367-3244; Oh, Eugene/0000-0003-1970-8423	Deutsche Forschungsgemeinschaft [SFB638, FOR967]; Peter und Traudl Engelhorn-Stiftung and EMBO; NIH [P01 AG10770]; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Peter und Traudl Engelhorn-Stiftung and EMBO; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Ingolia for help with ribosome profiling and data analysis; C. Chu for help with sequencing; S. Rouskin for developing a method for ligation; G. Brar and J. Dunn for developing an rRNA subtraction strategy; N. Reifenberger and B. Zachmann-Brand for help with cloning and crosslinking experiments; Thomas Silhavy for providing antibodies; Thomas Ruppert and the mass spectrometry facility at the ZMBH for experimental support; Yves Cully for graphical assistance; and members of the Bukau, Gross and Weissman labs for insightful discussions and critical readings of the manuscript. This work was supported by the SFB638 and FOR967 of the Deutsche Forschungsgemeinschaft (B.B. and G.K.); the Peter und Traudl Engelhorn-Stiftung and EMBO (A.H.B.); and the NIH (P01 AG10770) and the Howard Hughes Medical Institute (J.S.W.).	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; BALL LA, 1973, J MOL BIOL, V79, P531, DOI 10.1016/0022-2836(73)90404-X; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Baram D, 2005, P NATL ACAD SCI USA, V102, P12017, DOI 10.1073/pnas.0505581102; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bingel-Erlenmeyer R, 2008, NATURE, V452, P108, DOI 10.1038/nature06683; CROOKE E, 1987, P NATL ACAD SCI USA, V84, P5216, DOI 10.1073/pnas.84.15.5216; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Eisner G, 2006, J BIOL CHEM, V281, P7172, DOI 10.1074/jbc.M511388200; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; GUTHRIE B, 1990, J BACTERIOL, V172, P5555, DOI 10.1128/jb.172.10.5555-5562.1990; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Huber D, 2011, MOL CELL, V41, P343, DOI 10.1016/j.molcel.2010.12.028; Hundley HA, 2005, SCIENCE, V308, P1032, DOI 10.1126/science.1109247; Ingolia NT, 2010, METHOD ENZYMOL, V470, P119, DOI 10.1016/S0076-6879(10)70006-9; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; JOSEFSSON LG, 1981, CELL, V25, P151, DOI 10.1016/0092-8674(81)90239-7; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lee HC, 2002, J BIOL CHEM, V277, P43527, DOI 10.1074/jbc.M205950200; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Merz F, 2006, J BIOL CHEM, V281, P31963, DOI 10.1074/jbc.M605164200; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; RIGGS PD, 1988, GENETICS, V118, P571; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Schlunzen F, 2005, STRUCTURE, V13, P1685, DOI 10.1016/j.str.2005.08.007; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomic S, 2006, FEBS LETT, V580, P72, DOI 10.1016/j.febslet.2005.11.050; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Ullers RS, 2006, J BIOL CHEM, V281, P13999, DOI 10.1074/jbc.M600638200; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	47	312	315	2	64	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1295	1308		10.1016/j.cell.2011.10.044	http://dx.doi.org/10.1016/j.cell.2011.10.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153074	Bronze, Green Accepted			2022-12-24	WOS:000298148100019
J	Pavlopoulos, E; Trifilieff, P; Chevaleyre, V; Fioriti, L; Zairis, S; Pagano, A; Malleret, G; Kandel, ER				Pavlopoulos, Elias; Trifilieff, Pierre; Chevaleyre, Vivien; Fioriti, Luana; Zairis, Sakellarios; Pagano, Andrew; Malleret, Gael; Kandel, Eric R.			Neuralized1 Activates CPEB3: A Function for Nonproteolytic Ubiquitin in Synaptic Plasticity and Memory Storage	CELL			English	Article							LONG-TERM DEPRESSION; LOCAL PROTEIN-SYNTHESIS; NEURONAL ISOFORM; APLYSIA CPEB; EXPRESSION; RECEPTORS; GLUR2; CA1; FACILITATION; DEGRADATION	The cytoplasmic polyadenylation element-binding protein 3 (CPEB3), a regulator of local protein synthesis, is the mouse homolog of ApCPEB, a functional prion protein in Aplysia. Here, we provide evidence that CPEB3 is activated by Neuralized1, an E3 ubiquitin ligase. In hippocampal cultures, CPEB3 activated by Neuralized1-mediated ubiquitination leads both to the growth of new dendritic spines and to an increase of the GluA1 and GluA2 subunits of AMPA receptors, two CPEB3 targets essential for synaptic plasticity. Conditional overexpression of Neuralized1 similarly increases GluA1 and GluA2 and the number of spines and functional synapses in the hippocampus and is reflected in enhanced hippocampal-dependent memory and synaptic plasticity. By contrast, inhibition of Neuralized1 reduces GluA1 and GluA2 levels and impairs hippocampal-dependent memory and synaptic plasticity. These results suggest a model whereby Neuralized1-dependent ubiquitination facilitates hippocampal plasticity and hippocampal-dependent memory storage by modulating the activity of CPEB3 and CPEB3-dependent protein synthesis and synapse formation.	[Pavlopoulos, Elias; Trifilieff, Pierre; Chevaleyre, Vivien; Fioriti, Luana; Zairis, Sakellarios; Pagano, Andrew; Kandel, Eric R.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Chevaleyre, Vivien; Kandel, Eric R.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Kavli Inst Brain Sci, Coll Phys & Surg, New York, NY 10032 USA; [Trifilieff, Pierre] New York State Psychiat Inst & Hosp, Res Fdn Mental Hyg, New York, NY 10032 USA; [Malleret, Gael] Univ Lyon 1, Fac Med RTH Laennec, CNRS, UMR5167, F-69007 Lyon, France	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; New York State Psychiatry Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Kandel, ER (corresponding author), Columbia Univ, Dept Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu	Trifilieff, Pierre/ABB-4317-2020; Fioriti, Luana/AAN-7207-2021	Chevaleyre, Vivien/0000-0002-3679-4856; Trifilieff, Pierre/0000-0002-7893-9697; fioriti, luana/0000-0003-2429-8967	HHMI; Broitman Program for Cognitive Disorders; Fondation pour la Recherche Medicale; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Broitman Program for Cognitive Disorders; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to Steven A. Siegelbaum for his comments and help with the mEPSC recordings. We are also grateful to Thomas Jessell for his reading of the manuscript and to Eleanor Simpson, Christoph Kellendonk, Kausik Si, Sathya Puthanveettil, Sebastien Thuault, and Evangelia Koutelou for their critical comments. We also thank Kevin Karl for his technical help and Joan Conaway and Nicholas Moschonas for the gift of the Neurl1<SUP>Rm</SUP> and Ub cDNAs. The work was supported by HHMI and the Broitman Program for Cognitive Disorders (to E.R.K). P.T. was supported by the Fondation pour la Recherche Medicale. E.R.K is a senior investigator of HHMI.	Artola A, 2006, EUR J NEUROSCI, V23, P261, DOI 10.1111/j.1460-9568.2005.04552.x; Bassani S, 2009, NEUROSCIENCE, V158, P55, DOI 10.1016/j.neuroscience.2008.10.007; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hitchcock AL, 2003, P NATL ACAD SCI USA, V100, P12735, DOI 10.1073/pnas.2135500100; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Koutelou E, 2008, J BIOL CHEM, V283, P3846, DOI 10.1074/jbc.M706974200; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Malleret G, 2010, J NEUROSCI, V30, P3813, DOI 10.1523/JNEUROSCI.1330-09.2010; Manahan-Vaughan D, 2000, J NEUROSCI, V20, P8572, DOI 10.1523/JNEUROSCI.20-22-08572.2000; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Miniaci MC, 2008, NEURON, V59, P1024, DOI 10.1016/j.neuron.2008.07.036; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mukai H, 2007, J NEUROCHEM, V100, P950, DOI 10.1111/j.1471-4159.2006.04264.x; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pavlopoulos E, 2008, P NATL ACAD SCI USA, V105, P14674, DOI 10.1073/pnas.0801605105; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Qian SB, 2002, J BIOL CHEM, V277, P38818, DOI 10.1074/jbc.M205547200; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Segref A, 2009, EMBO REP, V10, P44, DOI 10.1038/embor.2008.229; Shimada AS, 2003, SYNAPSE, V48, P198, DOI 10.1002/syn.10209; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100	44	130	135	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1369	1383		10.1016/j.cell.2011.09.056	http://dx.doi.org/10.1016/j.cell.2011.09.056			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153079	Green Accepted, Bronze			2022-12-24	WOS:000298148100024
J	Harley, CDG				Harley, Christopher D. G.			Climate Change, Keystone Predation, and Biodiversity Loss	SCIENCE			English	Article							PATTERNS; LIMITS; SHIFTS; RANGE; ZONATION; IMPACTS; STRESS	Climate change can affect organisms both directly via physiological stress and indirectly via changing relationships among species. However, we do not fully understand how changing interspecific relationships contribute to community- and ecosystem-level responses to environmental forcing. I used experiments and spatial and temporal comparisons to demonstrate that warming substantially reduces predator-free space on rocky shores. The vertical extent of mussel beds decreased by 51% in 52 years, and reproductive populations of mussels disappeared at several sites. Prey species were able to occupy a hot, extralimital site if predation pressure was experimentally reduced, and local species richness more than doubled as a result. These results suggest that anthropogenic climate change can alter interspecific interactions and produce unexpected changes in species distributions, community structure, and diversity.	[Harley, Christopher D. G.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Harley, Christopher D. G.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Harley, CDG (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	harley@zoology.ubc.ca	Harley, Christopher D. G./K-5593-2012	Harley, Christopher D. G./0000-0003-4099-943X	National Science and Engineering Research Council (Canada); Padilla Bay National Estuarine Research Reserve	National Science and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Padilla Bay National Estuarine Research Reserve	T. Widdowson was instrumental in locating the historical data collection sites and accurately repeating the original surveys; his help is gratefully acknowledged. I also thank P. Martone, B. Matthews, M. O'Connor, R. T. Paine, T. Widdowson, and two anonymous referees for thoughtful comments on the manuscript. The Huu-ay-aht First Nation, Beecher Bay First Nation, Makah Tribal Nation, Correctional Service Canada, the Pfaff family, Point No Point Resort, and Friday Harbor Laboratories provided access to field sites. Historical temperature data for Victoria, British Columbia, are reproduced and distributed with the permission of the government of Canada. Funding was provided by the National Science and Engineering Research Council (Canada) and the Padilla Bay National Estuarine Research Reserve. Data are archived in the supporting online material.	BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Barton BT, 2009, ECOL LETT, V12, P1317, DOI 10.1111/j.1461-0248.2009.01386.x; COLE K, 1982, SCIENCE, V217, P1142, DOI 10.1126/science.217.4565.1142; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; GRAHAM RW, 1990, TRENDS ECOL EVOL, V5, P289, DOI 10.1016/0169-5347(90)90083-P; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harley CDG, 2003, ECOLOGY, V84, P1477, DOI 10.1890/0012-9658(2003)084[1477:ASAHIT]2.0.CO;2; Harley CDG, 2003, LIMNOL OCEANOGR, V48, P1498, DOI 10.4319/lo.2003.48.4.1498; Harley CDG, 2009, P NATL ACAD SCI USA, V106, P11172, DOI 10.1073/pnas.0904946106; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Leonard GH, 2000, ECOLOGY, V81, P1015; Ministry of the Environment (MOE), 2006, BRIT COL COAST MAR E; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pincebourde S, 2008, LIMNOL OCEANOGR, V53, P1562, DOI 10.4319/lo.2008.53.4.1562; Pincebourde S, 2009, AM NAT, V174, P890, DOI 10.1086/648065; Poloczanska ES, 2008, ECOLOGY, V89, P3138, DOI 10.1890/07-1169.1; Robles C, 2002, ECOLOGY, V83, P1521, DOI 10.1890/0012-9658(2002)083[1521:HACDOA]2.0.CO;2; ROMME WH, 1991, CONSERV BIOL, V5, P373, DOI 10.1111/j.1523-1739.1991.tb00151.x; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; Southward AJ, 2005, ADV MAR BIOL, V47, P1; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; TOKESHI M, 1995, MAR ECOL PROG SER, V125, P137, DOI 10.3354/meps125137; Tomanek L, 1999, J EXP BIOL, V202, P2925; WETHEY DS, 1983, BIOL BULL-US, V165, P330, DOI 10.2307/1541373; Widdowson T. B., 1959, THESIS U BRIT COLUMB	30	363	370	11	512	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1124	1127		10.1126/science.1210199	http://dx.doi.org/10.1126/science.1210199			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116885				2022-12-24	WOS:000297313900048
J	Lawlor, DA; Nelson, SM				Lawlor, Debbie A.; Nelson, Scott M.			Effect of age on decisions about the numbers of embryos to transfer in assisted conception: a prospective study	LANCET			English	Article							ELECTIVE SINGLE; LEGISLATION	Background Elective single-embryo transfer has been proposed as a strategy to reduce the risk of multiple birth and adverse pregnancy outcomes after in-vitro fertilisation (IVF). Whether this approach should be restricted to young women is unclear. Methods In a prospective study of UK Human Fertilisation and Embryology Authority data, we investigated whether perinatal livebirth outcomes varied by the number of embryos transferred in relation to maternal age. We compared rates of livebirth, multiple births, low birthweight (<2.5 kg), preterm birth (<37 weeks), and severe preterm birth (<33 weeks) in women younger than 40 years and those aged 40 years or older. We used logistic and binomial regression methods to assess, respectively, relative risk and absolute differences in risk. Findings We assessed 124 148 IVF cycles overall, which yielded 33 514 livebirths. The odds ratios of livebirth were higher in women aged 40 years or older than in those younger than 40 years when two embryos were transferred compared with one embryo (3.12, 95% CI 2.56-3.77 vs 2.33, 2.20-2.46; p=0.0006 for interaction), but the absolute difference in risk of livebirth was smaller (0.090, 0.080-0.099 for women >= 40 years vs 0.156, 0.148-0.163 for those <40 years; p<0.0001). The odds ratios and absolute risk differences for multiple birth, preterm birth, and low birthweight were all smaller in older than in younger women (analyses were done in 32 732 cycles in which a livebirth had resulted and data on gestational age and birthweight were complete). Livebirth rates did not increase with transfer of three embryos, but the risk of adverse perinatal outcomes did increase. Interpretation Transfer of three or more embryos at any age should be avoided. The decision to transfer one or two embryos should be based on prognostic indicators, such as age.	[Lawlor, Debbie A.] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Nelson, Scott M.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland	University of Bristol; University of Glasgow	Lawlor, DA (corresponding author), Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Oakfield House, Bristol BS8 2BN, Avon, England.	d.a.lawlor@bristol.ac.uk; scott.nelson@glasgow.ac.uk		Nelson, Scott/0000-0002-9099-3047; Lawlor, Debbie A/0000-0002-6793-2262	UK Medical Research Council (MRC) [G0600705]; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the staff of the HFEA and the contributing UK clinics for providing data. We thank D Barlow, University of Glasgow, Glasgow, UK, and D Leon, London School of Hygiene and Tropical Medicine, London, UK, for providing valuable comments on an earlier draft of this paper. All views are those of the authors and not necessarily those of anyone acknowledged here. DAL works in the MRC Centre for Causal Analyses in Translational Epidemiology, which receives funding from the UK Medical Research Council (MRC; G0600705). No funding specifically covered the work presented.	Cutting Rachel, 2008, Hum Fertil (Camb), V11, P131, DOI 10.1080/14647270802302629; Devroey P, 2009, HUM REPROD UPDATE, V15, P391, DOI 10.1093/humupd/dmp012; Fauser BCJM, 2005, LANCET, V365, P1807, DOI 10.1016/S0140-6736(05)66478-1; Gleicher N, 2009, FERTIL STERIL, V91, P2426, DOI 10.1016/j.fertnstert.2008.02.160; Gordts S, 2005, REPROD BIOMED ONLINE, V10, P436, DOI 10.1016/S1472-6483(10)60818-8; Hojgaard A, 2007, HUM REPROD, V22, P2673, DOI 10.1093/humrep/dem173; Karlstrom PO, 2007, HUM REPROD, V22, P2202, DOI 10.1093/humrep/dem120; Leese B, 2010, HUM FERTIL, V13, P28, DOI 10.3109/14647270903586364; McLernon DJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6945; Nelson SM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000386; Newton CR, 2007, FERTIL STERIL, V87, P269, DOI 10.1016/j.fertnstert.2006.06.043; Nyboe Andersen A, 2009, Hum Reprod, V24, P1267, DOI 10.1093/humrep/dep035; Reddy UM, 2007, OBSTET GYNECOL, V109, P967, DOI 10.1097/01.AOG.0000259316.04136.30; Saldeen P, 2005, HUM REPROD, V20, P4, DOI 10.1093/humrep/deh610; Soc Assisted Reproductive Te, 2008, FERTIL STERIL, V90, pS163, DOI 10.1016/j.fertnstert.2008.08.053; Templeton A, 1998, NEW ENGL J MED, V339, P573, DOI 10.1056/NEJM199808273390901; Templeton A, 1996, LANCET, V348, P1402, DOI 10.1016/S0140-6736(96)05291-9; Templeton A, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c7083; Van Landuyt L, 2006, REPROD BIOMED ONLINE, V13, P765, DOI 10.1016/S1472-6483(10)61022-X; Weisberg S, 2005, APPL LINEAR REGRESSI, P253	20	52	60	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2012	379	9815					521	527		10.1016/S0140-6736(11)61267-1	http://dx.doi.org/10.1016/S0140-6736(11)61267-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AO	22243709				2022-12-24	WOS:000300188800028
J	Sakurai, M				Sakurai, Masatomo			PERSPECTIVE Herbal dangers	NATURE			English	Editorial Material									Kitasato Univ, Oriental Med Res Ctr, Tokyo, Japan	Kitasato University	Sakurai, M (corresponding author), Kitasato Univ, Oriental Med Res Ctr, Tokyo, Japan.	sakuraim@insti.kitasato-u.ac.jp						Arai S, 2009, KAMPOUIGAKU, P124; Gono Y, 2010, KAMPO MED, V61, P828, DOI DOI 10.3937/KAMPOMED.61.828; Ito T, 2010, KAMPO MED, V61, P299; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2	5	11	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S97	S97		10.1038/480S97a	http://dx.doi.org/10.1038/480S97a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190093	Bronze			2022-12-24	WOS:000298318000009
J	Blumhagen, F; Zhu, PX; Shum, J; Scharer, YPZ; Yaksi, E; Deisseroth, K; Friedrich, RW				Blumhagen, Francisca; Zhu, Peixin; Shum, Jennifer; Schaerer, Yan-Ping Zhang; Yaksi, Emre; Deisseroth, Karl; Friedrich, Rainer W.			Neuronal filtering of multiplexed odour representations	NATURE			English	Article							ZEBRAFISH OLFACTORY-BULB; COINCIDENCE DETECTION; TRANSIENT DYNAMICS; PIRIFORM CORTEX; VISUAL-CORTEX; OSCILLATIONS; COMPUTATION; INHIBITION; CIRCUITS; SYSTEM	Neuronal activity patterns contain information in their temporal structure, indicating that information transfer between neurons may be optimized by temporal filtering. In the zebrafish olfactory bulb, subsets of output neurons ( mitral cells) engage in synchronized oscillations during odour responses, but information about odour identity is contained mostly in non-oscillatory firing rate patterns. Using optogenetic manipulations and odour stimulation, we found that firing rate responses of neurons in the posterior zone of the dorsal telencephalon (Dp), a target area homologous to olfactory cortex, were largely insensitive to oscillatory synchrony of mitral cells because passive membrane properties and synaptic currents act as low-pass filters. Nevertheless, synchrony influenced spike timing. Moreover, Dp neurons responded primarily during the decorrelated steady state of mitral cell activity patterns. Temporal filtering therefore tunes Dp neurons to components of mitral cell activity patterns that are particularly informative about precise odour identity. These results demonstrate how temporal filtering can extract specific information from multiplexed neuronal codes.	[Blumhagen, Francisca; Zhu, Peixin; Shum, Jennifer; Schaerer, Yan-Ping Zhang; Friedrich, Rainer W.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Yaksi, Emre] Neuroelect Res Flanders, B-3001 Louvain, Belgium; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Friedrich, Rainer W.] Univ Basel, CH-4003 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Stanford University; University of Basel	Friedrich, RW (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	Rainer.Friedrich@fmi.ch	Yaksi, Emre/A-3215-2019	Yaksi, Emre/0000-0003-3761-0235; Zhang, Yan-Ping/0000-0001-7602-4453; Friedrich, Rainer/0000-0001-9107-0482; Shum, Jennifer/0000-0002-1893-1538	Novartis Research Foundation; Max-Planck-Society; Swiss National Fonds (SNF); Deutsche Forschungsgemeinschaft (DFG); Human Frontier Science Program (HFSP); Whitaker Foundation	Novartis Research Foundation; Max-Planck-Society(Max Planck Society); Swiss National Fonds (SNF)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Whitaker Foundation	This work was supported by the Novartis Research Foundation, the Max-Planck-Society, the Swiss National Fonds (SNF), the Deutsche Forschungsgemeinschaft (DFG), the Human Frontier Science Program (HFSP), and the Whitaker Foundation (J.S.). We are grateful to S.-i. Higashijima for vglut2a-GFP transgenic fish and thank T. Frank, A. Luthi, I. Namekawa and T. Oertner for comments on the manuscript.	Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Gerstner W, 1997, P NATL ACAD SCI USA, V94, P12740, DOI 10.1073/pnas.94.24.12740; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; Junek S, 2010, NEURON, V67, P872, DOI 10.1016/j.neuron.2010.08.005; KETCHUM KL, 1993, J NEUROSCI, V13, P3980; LAURENT G, 1994, J NEUROSCI, V14, P2993; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; MATHIESON WB, 1988, J COMP PHYSIOL A, V163, P489, DOI 10.1007/BF00604903; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Miyasaka N, 2009, J NEUROSCI, V29, P4756, DOI 10.1523/JNEUROSCI.0118-09.2009; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Sato Y, 2005, J NEUROSCI, V25, P4889, DOI 10.1523/JNEUROSCI.0679-05.2005; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Suter BA, 2010, FRONT NEURAL CIRCUIT, V4, P100, DOI DOI 10.3389/FNCIR.2010.00100; Tabor R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001416; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yaksi E, 2009, NAT NEUROSCI, V12, P474, DOI 10.1038/nn.2288; Zhu PX, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.021.2009	53	69	70	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					493	U215		10.1038/nature10633	http://dx.doi.org/10.1038/nature10633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22080956				2022-12-24	WOS:000297285600042
J	Pearlman, SM; Serber, Z; Ferrell, JE				Pearlman, Samuel M.; Serber, Zach; Ferrell, James E., Jr.			A Mechanism for the Evolution of Phosphorylation Sites	CELL			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ISOCITRATE DEHYDROGENASE; PROTEIN FUNCTION; HUMAN GENOME; MAP KINASE; LIFE; TREE; SPECIFICITY; ACTIVATION; PREDICTION	Protein phosphorylation provides a mechanism for the rapid, reversible control of protein function. Phosphorylation adds negative charge to amino acid side chains, and negatively charged amino acids (Asp/Glu) can sometimes mimic the phosphorylated state of a protein. Using a comparative genomics approach, we show that nature also employs this trick in reverse by evolving serine, threonine, and tyrosine phosphorylation sites from Asp/Glu residues. Structures of three proteins where phosphosites evolved from acidic residues (DNA topoisomerase II, enolase, and C-Raf) show that the relevant acidic residues are present in salt bridges with conserved basic residues, and that phosphorylation has the potential to conditionally restore the salt bridges. The evolution of phosphorylation sites from glutamate and aspartate provides a rationale for why phosphorylation sometimes activates proteins, and helps explain the origins of this important and complex process.	[Pearlman, Samuel M.; Serber, Zach; Ferrell, James E., Jr.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Pearlman, Samuel M.] Stanford Univ, Sch Med, Biomed Informat Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Ferrell, JE (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	james.ferrell@stanford.edu			National Institutes of Health [R01 GM046383, T15 LM007033]; Arnold Beckman Foundation; NIH [P41 RR001081]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046383] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold Beckman Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Kurt Thorn, Peter Chien, Michael Reese, Arend Sidow, Serafim Batzoglou, Rob Tibshirani, Bill Weis, the participants of the 2011 Evolution of Protein Phosphorylation Keystone Meeting, our colleagues in the Stanford Department of Chemical and Systems Biology, and members of the Ferrell lab for many helpful comments. This work was supported by grants from the National Institutes of Health (R01 GM046383 and T15 LM007033) and the Arnold Beckman Foundation. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIH P41 RR001081).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ballif BA, 2004, MOL CELL PROTEOMICS, V3, P1093, DOI 10.1074/mcp.M400085-MCP200; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; Dayhoff M., 1978, ATLAS PROTEIN SEQUEN; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Essoussi N, 2008, BIOINFORMATION, V2, P452; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; HURLEY JH, 1990, J BIOL CHEM, V265, P3599; Jorgensen R, 2006, BIOCHEM SOC T, V34, P1; KUNAPULI P, 1994, J BIOL CHEM, V269, P10209; Kurmangaliyev YZ, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-8; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Moses AM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r23; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; PALCZEWSKI K, 1992, J BIOL CHEM, V267, P18991; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POSADA J, 1992, SCIENCE, V255, P212, DOI 10.1126/science.1313186; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Serber Z, 2007, CELL, V128, P441, DOI 10.1016/j.cell.2007.01.018; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; Tjong H, 2007, NUCLEIC ACIDS RES, V35, pW357, DOI 10.1093/nar/gkm231; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526	46	151	151	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 11	2011	147	4					934	946		10.1016/j.cell.2011.08.052	http://dx.doi.org/10.1016/j.cell.2011.08.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22078888	Green Accepted, Bronze			2022-12-24	WOS:000296902300024
J	Lander, GC; Estrin, E; Matyskiela, ME; Bashore, C; Nogales, E; Martin, A				Lander, Gabriel C.; Estrin, Eric; Matyskiela, Mary E.; Bashore, Charlene; Nogales, Eva; Martin, Andreas			Complete subunit architecture of the proteasome regulatory particle	NATURE			English	Article							UBIQUITIN CHAINS; NEW-GENERATION; TRANSLOCATION; DEGRADATION; PROTEINS; DOCKING; RPN1; ATP; DEUBIQUITINATION; IDENTIFICATION	The proteasome is the major ATP-dependent protease in eukaryotic cells, but limited structural information restricts a mechanistic understanding of its activities. The proteasome regulatory particle, consisting of the lid and base subcomplexes, recognizes and processes polyubiquitinated substrates. Here we used electron microscopy and a new heterologous expression system for the lid to delineate the complete subunit architecture of the regulatory particle from yeast. Our studies reveal the spatial arrangement of ubiquitin receptors, deubiquitinating enzymes and the protein unfolding machinery at subnanometre resolution, outlining the substrate's path to degradation. Unexpectedly, the ATPase subunits within the base unfoldase are arranged in a spiral staircase, providing insight into potential mechanisms for substrate translocation through the central pore. Large conformational rearrangements of the lid upon holoenzyme formation suggest allosteric regulation of deubiquitination. We provide a structural basis for the ability of the proteasome to degrade a diverse set of substrates and thus regulate vital cellular processes.	[Estrin, Eric; Matyskiela, Mary E.; Bashore, Charlene; Martin, Andreas] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Lander, Gabriel C.; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Nogales, Eva; Martin, Andreas] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Martin, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	a.martin@berkeley.edu		Martin, Andreas/0000-0003-0923-3284; Lander, Gabriel C./0000-0003-4921-1135	Damon Runyon Cancer Research Foundation; American Cancer Society [121453-PF-11-178-01-TBE]; NSF; Searle Scholars Program; UC Berkeley MCB Department; NIH [R01-GM094497-01A1]; Lawrence Berkeley National Laboratory; Howard Hughes Medical Institute; NIH through the NCRR [RR017573]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094497, T32GM007232] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; American Cancer Society(American Cancer Society); NSF(National Science Foundation (NSF)); Searle Scholars Program; UC Berkeley MCB Department; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH through the NCRR; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Martin and Nogales labs for helpful discussions, and G. Cardone for help with local resolution calculations. G. C. L. acknowledges support from Damon Runyon Cancer Research Foundation, M. E. M. acknowledges support by the American Cancer Society grant 121453-PF-11-178-01-TBE, C. B. acknowledges support from the NSF Graduate Research Fellowship. This research was funded in part by the Searle Scholars Program (A. M.), start-up funds from the UC Berkeley MCB Department (A. M.), the NIH grant R01-GM094497-01A1 (A. M.), the Lawrence Berkeley National Laboratory (G. C. L.), and the Howard Hughes Medical Institute (E.N.). Some of the work presented here was conducted at the National Resource for Automated Molecular Microscopy, which is supported by the NIH through the NCRR P41 program (RR017573).	Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; COOK WJ, 1992, J BIOL CHEM, V267, P16467; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Effantin G, 2009, J MOL BIOL, V386, P1204, DOI 10.1016/j.jmb.2009.01.039; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster F, 2009, BIOCHEM BIOPH RES CO, V388, P228, DOI 10.1016/j.bbrc.2009.07.145; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Riedinger C, 2010, J BIOL CHEM, V285, P33992, DOI 10.1074/jbc.M110.134510; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tian G, 2011, NAT STRUCT MOL BIOL, V18, P1259, DOI 10.1038/nsmb.2147; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021	56	450	465	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2012	482	7384					186	U75		10.1038/nature10774	http://dx.doi.org/10.1038/nature10774			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888HI	22237024	Green Submitted, Green Accepted			2022-12-24	WOS:000299994100031
J	Brunoud, G; Wells, DM; Oliva, M; Larrieu, A; Mirabet, V; Burrow, AH; Beeckman, T; Kepinski, S; Traas, J; Bennett, MJ; Vernoux, T				Brunoud, Geraldine; Wells, Darren M.; Oliva, Marina; Larrieu, Antoine; Mirabet, Vincent; Burrow, Amy H.; Beeckman, Tom; Kepinski, Stefan; Traas, Jan; Bennett, Malcolm J.; Vernoux, Teva			A novel sensor to map auxin response and distribution at high spatio-temporal resolution	NATURE			English	Article							BOX PROTEIN TIR1; ARABIDOPSIS ROOT; AUX/IAA PROTEINS; PLANT DEVELOPMENT; GENE-EXPRESSION; TRANSPORT; GROWTH; DEGRADATION; MERISTEM; RECEPTOR	Auxin is a key plant morphogenetic signal(1) but tools to analyse dynamically its distribution and signalling during development are still limited. Auxin perception directly triggers the degradation of Aux/IAA repressor proteins(2-6). Here we describe a novel Aux/IAA-based auxin signalling sensor termed DII-VENUS that was engineered in the model plant Arabidopsis thaliana. The VENUS fast maturing form of yellow fluorescent protein(7) was fused in-frame to the Aux/IAA auxin-interaction domain (termed domain II; DII)(5) and expressed under a constitutive promoter. We initially show that DII-VENUS abundance is dependent on auxin, its TIR1/AFBs co-receptors(4-6,8) and proteasome activities. Next, we demonstrate that DII-VENUS provides a map of relative auxin distribution at cellular resolution in different tissues. DII-VENUS is also rapidly degraded in response to auxin and we used it to visualize dynamic changes in cellular auxin distribution successfully during two developmental responses, the root gravitropic response and lateral organ production at the shoot apex. Our results illustrate the value of developing response input sensors such as DII-VENUS to provide high-resolution spatio-temporal information about hormone distribution and response during plant growth and development.	[Brunoud, Geraldine; Oliva, Marina; Mirabet, Vincent; Traas, Jan; Vernoux, Teva] Univ Lyon, Lab Reprod & Dev Plantes, UCBL, ENS Lyon,INRA,CNRS, F-69364 Lyon, France; [Wells, Darren M.; Larrieu, Antoine; Bennett, Malcolm J.] Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, England; [Larrieu, Antoine; Beeckman, Tom] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Burrow, Amy H.; Kepinski, Stefan] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Nottingham; Flanders Institute for Biotechnology (VIB); Ghent University; University of Leeds	Vernoux, T (corresponding author), Univ Lyon, Lab Reprod & Dev Plantes, UCBL, ENS Lyon,INRA,CNRS, F-69364 Lyon, France.	teva.vernoux@ens-lyon.fr	Vernoux, Teva/J-1695-2019; Beeckman, Tom/ABI-1703-2020; Larrieu, Antoine /O-9558-2017; Beeckman, Tom/ABA-1164-2020; Traas, Jan/AAZ-7004-2020; Wells, Darren/GOJ-9739-2022; Bennett, Malcolm/G-4004-2010	Vernoux, Teva/0000-0002-8257-4088; Beeckman, Tom/0000-0001-8656-2060; Larrieu, Antoine /0000-0002-9024-5348; Traas, Jan/0000-0001-5107-1472; Wells, Darren/0000-0002-4246-4909; Oliva, Marina/0000-0001-8096-6857; Bennett, Malcolm/0000-0003-0475-390X	Human Frontier Science Program Organization [CDA 0047/2007 HFSPO]; Agence National de la Recherche [ANR-07-JCJC-0115, EraSysBio+ iSAM]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F013981/1, BB/F007418/1]; Engineering and Physical Sciences Research Council (EPSRC); Biotechnology and Biological Sciences Research Council [BB/F013981/1, BB/F007418/1, BB/J009717/1, BB/D019613/1, REI20541] Funding Source: researchfish; BBSRC [BB/J009717/1, BB/D019613/1, BB/F013981/1, BB/F007418/1] Funding Source: UKRI	Human Frontier Science Program Organization(Human Frontier Science Program); Agence National de la Recherche(French National Research Agency (ANR)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. Erktan and C. Cellier for help with marker expression analysis; J. Neve, A. Miyawaki, M. Heisler and M. Estelle for providing the 35S::Flag-TIR1 line, VENUS complementary DNA, DR5::VENUS plasmids and TIR/AFB GUS lines, respectively; the PLATIM for access to confocal microscopes; F. Parcy, O. Hamant, A. Boudaoud and P. Das for discussions. T. V. was supported by the Human Frontier Science Program Organization (CDA 0047/2007 HFSPO) and the Agence National de la Recherche (ANR-07-JCJC-0115 and EraSysBio+ iSAM). D. M. W., A. L. and M. J. B. acknowledge the support of the Biotechnology and Biological Sciences Research Council (BBSRC) and Engineering and Physical Sciences Research Council (EPSRC) funding to the Centre for Plant Integrative Biology (CPIB); BBSRC grants BB/F013981/1 and BB/F007418/1 to S. K.; BBSRC Professorial Research Fellowship funding to D. M. W. & M. J. B.; and Belgian Scientific policy (BELSPO contract BARN) to A. L., T.B. and M.J.B.	ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Boonsirichai K, 2003, PLANT CELL, V15, P2612, DOI 10.1105/tpc.015560; Boonsirichai K, 2002, ANNU REV PLANT BIOL, V53, P421, DOI 10.1146/annurev.arplant.53.100301.135158; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; de Reuille PB, 2005, PLANT J, V44, P1045, DOI 10.1111/j.1365-313X.2005.02576.x; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Fernandez R, 2010, NAT METHODS, V7, P547, DOI [10.1038/nmeth.1472, 10.1038/NMETH.1472]; French A, 2009, PLANT PHYSIOL, V150, P1784, DOI 10.1104/pp.109.140558; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Greenham K, 2011, CURR BIOL, V21, P520, DOI 10.1016/j.cub.2011.02.029; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Holman TJ, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-9; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Lohmann D, 2010, PLANT CELL, V22, P335, DOI 10.1105/tpc.109.071498; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Petersson SV, 2009, PLANT CELL, V21, P1659, DOI 10.1105/tpc.109.066480; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Santuari L, 2011, CURR BIOL, V21, P1918, DOI 10.1016/j.cub.2011.10.002; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798	42	501	511	11	304	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 2	2012	482	7383					103	U132		10.1038/nature10791	http://dx.doi.org/10.1038/nature10791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884RN	22246322				2022-12-24	WOS:000299726000044
J	Morrison, EA; DeKoster, GT; Dutta, S; Vafabakhsh, R; Clarkson, MW; Bahl, A; Kern, D; Ha, T; Henzler-Wildman, KA				Morrison, Emma A.; DeKoster, Gregory T.; Dutta, Supratik; Vafabakhsh, Reza; Clarkson, Michael W.; Bahl, Arjun; Kern, Dorothee; Ha, Taekjip; Henzler-Wildman, Katherine A.			Antiparallel EmrE exports drugs by exchanging between asymmetric structures	NATURE			English	Article							MULTIDRUG TRANSPORTER EMRE; ESCHERICHIA-COLI; CONFORMATIONAL-CHANGES; MEMBRANE TOPOLOGY; SUBSTRATE-BINDING; LIGAND-BINDING; PROTON RELEASE; MODEL; STATE; MECHANISM	Small multidrug resistance transporters provide an ideal system to study the minimal requirements for active transport. EmrE is one such transporter in Escherichia coli. It exports a broad class of polyaromatic cation substrates, thus conferring resistance to drug compounds matching this chemical description. However, a great deal of controversy has surrounded the topology of the EmrE homodimer. Here we show that asymmetric antiparallel EmrE exchanges between inward-and outward-facing states that are identical except that they have opposite orientation in the membrane. We quantitatively measure the global conformational exchange between these two states for substrate-bound EmrE in bicelles using solution NMR dynamics experiments. Forster resonance energy transfer reveals that the monomers within each dimer are antiparallel, and paramagnetic relaxation enhancement NMR experiments demonstrate differential water accessibility of the two monomers within each dimer. Our experiments reveal a 'dynamic symmetry' that reconciles the asymmetric EmrE structure with the functional symmetry of residues in the active site.	[Morrison, Emma A.; DeKoster, Gregory T.; Dutta, Supratik; Bahl, Arjun; Henzler-Wildman, Katherine A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Vafabakhsh, Reza; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Vafabakhsh, Reza; Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Clarkson, Michael W.; Kern, Dorothee] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Clarkson, Michael W.; Kern, Dorothee] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA	Washington University (WUSTL); University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; Brandeis University; Brandeis University; Howard Hughes Medical Institute	Henzler-Wildman, KA (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	khenzler@wustl.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Henzler-Wildman, Katherine/0000-0002-5295-2121; Morrison, Emma/0000-0001-6722-7961; DeKoster, Gregory/0000-0001-9928-8195; Clarkson, Michael W/0000-0002-4323-3424	National Institutes of Health [1R01GM095839]; Searle Scholars Program; US Department of Energy, Office of Basic Energy Sciences; Howard Hughes Medical Institute; NSF [DGE-1143954]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Liu for assistance replicating the ITC data. We thank J. Villali for assistance growing isotopically labelled EmrE. We are grateful to Y. Li and A. Palmer for providing pulse programs and G. Chang for providing the EmrE expression plasmid. This work was supported by the National Institutes of Health (1R01GM095839) and the Searle Scholars Program (K. H. W.), the US Department of Energy, Office of Basic Energy Sciences (D. K.), the Howard Hughes Medical Institute (D. K. and T. H.), and an NSF graduate research fellowship to E. M. (DGE-1143954).	Adam Y, 2007, P NATL ACAD SCI USA, V104, P17989, DOI 10.1073/pnas.0704425104; Agarwal V, 2007, BBA-BIOMEMBRANES, V1768, P3036, DOI 10.1016/j.bbamem.2007.09.012; Amadi ST, 2010, J BIOL CHEM, V285, P26710, DOI 10.1074/jbc.M110.132621; Arkin IT, 1996, BIOCHEMISTRY-US, V35, P7233, DOI 10.1021/bi960094i; Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014; Charalambous Kalypso, 2008, BMC Biochemistry, V9, P31, DOI 10.1186/1471-2091-9-31; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kneller, 2003, SPARKY 3; Korkhov VM, 2008, J MOL BIOL, V377, P1094, DOI 10.1016/j.jmb.2008.01.056; Korkhov VM, 2009, ACTA CRYSTALLOGR D, V65, P186, DOI 10.1107/S0907444908036640; Lehner I, 2008, J BIOL CHEM, V283, P3281, DOI 10.1074/jbc.M707899200; Li Y, 2009, J BIOMOL NMR, V45, P357, DOI 10.1007/s10858-009-9385-0; Mchaourab HS, 2008, BIOCHEMISTRY-US, V47, P7980, DOI 10.1021/bi800628d; Miller D, 2009, J MOL BIOL, V393, P815, DOI 10.1016/j.jmb.2009.08.039; Miloushev VZ, 2008, STRUCTURE, V16, P1195, DOI 10.1016/j.str.2008.05.009; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Nara T, 2007, J BIOCHEM, V142, P621, DOI 10.1093/jb/mvm169; Nasie I, 2010, J BIOL CHEM, V285, P15234, DOI 10.1074/jbc.M110.108746; Ninio S, 2004, FEBS LETT, V562, P193, DOI 10.1016/S0014-5793(04)00240-6; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Raschle T, 2010, CURR OPIN STRUC BIOL, V20, P471, DOI 10.1016/j.sbi.2010.05.006; Rotem D, 2004, J BIOL CHEM, V279, P48787, DOI 10.1074/jbc.M408187200; Rotem D, 2001, J BIOL CHEM, V276, P48243, DOI 10.1074/jbc.M108229200; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sanders CR, 2006, MAGN RESON CHEM, V44, pS24, DOI 10.1002/mrc.1816; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Sharoni M, 2005, J BIOL CHEM, V280, P32849, DOI 10.1074/jbc.M504910200; Sikora CW, 2005, BIOPHYS J, V88, P475, DOI 10.1529/biophysj.104.049247; Soskine M, 2004, J BIOL CHEM, V279, P9951, DOI 10.1074/jbc.M312853200; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Steiner-Mordoch S, 2008, EMBO J, V27, P17, DOI 10.1038/sj.emboj.7601951; Tate CG, 2003, J MOL BIOL, V332, P229, DOI 10.1016/S0022-2836(03)00895-7; Ubarretxena-Belandia I, 2004, FEBS LETT, V564, P234, DOI 10.1016/S0014-5793(04)00228-5; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Weinglass AB, 2005, J BIOL CHEM, V280, P7487, DOI 10.1074/jbc.M413555200; West IC, 1997, BBA-REV BIOMEMBRANES, V1331, P213, DOI 10.1016/S0304-4157(97)00007-5; Whiles JA, 2002, BIOORG CHEM, V30, P431, DOI 10.1016/S0045-2068(02)00527-8; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200	49	153	154	1	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					45	U50		10.1038/nature10703	http://dx.doi.org/10.1038/nature10703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22178925	Green Accepted			2022-12-24	WOS:000298836900025
J	Prindle, A; Samayoa, P; Razinkov, I; Danino, T; Tsimring, LS; Hasty, J				Prindle, Arthur; Samayoa, Phillip; Razinkov, Ivan; Danino, Tal; Tsimring, Lev S.; Hasty, Jeff			A sensing array of radically coupled genetic 'biopixels'	NATURE			English	Article							ESCHERICHIA-COLI; SUPEROXIDE-DISMUTASE; CELL COMMUNICATION; SYNTHETIC BIOLOGY; BACTERIA; NETWORKS; CIRCUITS; DESIGN; SYSTEM; NOISE	Although there has been considerable progress in the development of engineering principles for synthetic biology, a substantial challenge is the construction of robust circuits in a noisy cellular environment. Such an environment leads to considerable intercellular variability in circuit behaviour, which can hinder functionality at the colony level. Here we engineer the synchronization of thousands of oscillating colony 'biopixels' over centimetre-length scales through the use of synergistic intercellular coupling involving quorum sensing within a colony and gas-phase redox signalling between colonies. We use this platform to construct a liquid crystal display (LCD)-like macroscopic clock that can be used to sense arsenic via modulation of the oscillatory period. Given the repertoire of sensing capabilities of bacteria such as Escherichia coli, the ability to coordinate their behaviour over large length scales sets the stage for the construction of low cost genetic biosensors that are capable of detecting heavy metals and pathogens in the field.	[Prindle, Arthur; Razinkov, Ivan; Danino, Tal; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Samayoa, Phillip; Hasty, Jeff] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Tsimring, Lev S.; Hasty, Jeff] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Hasty, Jeff] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@bioeng.ucsd.edu		Tsimring, Lev/0000-0003-0709-3548	National Institutes of Health and General Medicine [R01GM69811]; San Diego Center for Systems Biology [P50GM085764]; DoD NDSEG; NSF; Office of Naval Research [MURI N00014-07-0741]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069811, P50GM085764] Funding Source: NIH RePORTER	National Institutes of Health and General Medicine; San Diego Center for Systems Biology; DoD NDSEG; NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health and General Medicine (R01GM69811), the San Diego Center for Systems Biology (P50GM085764), the DoD NDSEG (A. P.) and NSF Graduate Research (P. S.) Fellowship Programs. L. T. was supported, in part, by the Office of Naval Research (MURI N00014-07-0741). We would like to thank J. Imlay, S. Ali and J. Collins for helpful discussions and J. Hickman, B. Taylor and K. Lomax for their help with illustrations.	Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Berg JM, 2006, BIOCHEMISTRY; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Bose JL, 2007, MOL MICROBIOL, V65, P538, DOI 10.1111/j.1365-2958.2007.05809.x; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Daunert S, 2000, CHEM REV, V100, P2705, DOI 10.1021/cr990115p; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Ferry MS, 2011, METHOD ENZYMOL, V497, P295, DOI 10.1016/B978-0-12-385075-1.00014-7; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GAST T, 1985, J PHYS E SCI INSTRUM, V18, P783, DOI 10.1088/0022-3735/18/9/008; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Grilly C, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100168; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; KELNER MJ, 1990, J BIOL CHEM, V265, P1306; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Leveau JHJ, 2002, CURR OPIN MICROBIOL, V5, P259, DOI 10.1016/S1369-5274(02)00321-1; Lewandowski W, 1999, P IEEE, V87, P163, DOI 10.1109/5.736348; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Mather W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.068105; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Mondragon-Palomino O, 2011, SCIENCE, V333, P1315, DOI 10.1126/science.1205369; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stocker J, 2003, ENVIRON SCI TECHNOL, V37, P4743, DOI 10.1021/es034258b; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; van der Meer JR, 2010, NAT REV MICROBIOL, V8, P511, DOI 10.1038/nrmicro2392; Vladimirov AG, 2003, EUROPHYS LETT, V61, P613, DOI 10.1209/epl/i2003-00115-8; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Westinghouse G., 1887, US patent, Patent No. [373 035, 373035]; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	50	262	274	14	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					39	44		10.1038/nature10722	http://dx.doi.org/10.1038/nature10722			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22178928	Green Accepted			2022-12-24	WOS:000298836900024
J	Zoltowski, BD; Vaidya, AT; Top, D; Widom, J; Young, MW; Crane, BR				Zoltowski, Brian D.; Vaidya, Anand T.; Top, Deniz; Widom, Joanne; Young, Michael W.; Crane, Brian R.			Structure of full-length Drosophila cryptochrome	NATURE			English	Article							BLUE-LIGHT PHOTORECEPTOR; 6-4 PHOTOLYASE; CRYSTAL-STRUCTURE; FLAVIN COFACTOR; CIRCADIAN CLOCK; MECHANISM; MELANOGASTER; DEGRADATION; TERMINUS; TIMELESS	The cryptochrome/photolyase (CRY/PL) family of photoreceptors mediates adaptive responses to ultraviolet and blue light exposure in all kingdoms of life(1-5). Whereas PLs function predominantly in DNA repair of cyclobutane pyrimidine dimers (CPDs) and 6-4 photolesions caused by ultraviolet radiation, CRYs transduce signals important for growth, development, magnetosensitivity and circadian clocks(1-5). Despite these diverse functions, PLs/CRYs preserve a common structural fold, a dependence on flavin adenine dinucleotide (FAD) and an internal photoactivation mechanism(3,6). However, members of the CRY/PL family differ in the substrates recognized (protein or DNA), photochemical reactions catalysed and involvement of an antenna cofactor. It is largely unknown how the animal CRYs that regulate circadian rhythms act on their substrates. CRYs contain a variable carboxy-terminal tail that appends the conserved PL homology domain (PHD) and is important for function(7-12). Here, we report a 2.3-angstrom resolution crystal structure of Drosophila CRY with an intact C terminus. The C-terminal helix docks in the analogous groove that binds DNA substrates in PLs. Conserved Trp 536 juts into the CRY catalytic centre to mimic PL recognition of DNA photolesions. The FAD anionic semiquinone found in the crystals assumes a conformation to facilitate restructuring of the tail helix. These results help reconcile the diverse functions of the CRY/PL family by demonstrating how conserved protein architecture and photochemistry can be elaborated into a range of light-driven functions.	[Zoltowski, Brian D.; Vaidya, Anand T.; Widom, Joanne; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Top, Deniz; Young, Michael W.] Rockefeller Univ, Genet Lab, New York, NY 10065 USA	Cornell University; Rockefeller University	Crane, BR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	bc69@cornell.edu	, 机智的马小跳和机智的羊不愁/ABC-5169-2020	Vaidya, Anand/0000-0002-5812-5266; Top, Deniz/0000-0002-1042-8460	NIH [GM079679, GM054339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079679, R01GM054339, R37GM054339] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH Grant GM079679 to B. R. C. and GM054339 to M.W.Y. We thank the NE-CAT at the Advanced Photon Source of Argonne Laboratories for access to data collection facilities. We are indebted to C. Kemp for insect cell expression of dCRY and C. Manahan, X. Xu and W. Horne for their help with the ITC experiments.	Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hemsley MJ, 2007, BIOCHEM BIOPH RES CO, V355, P531, DOI 10.1016/j.bbrc.2007.01.189; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Kao YT, 2008, J AM CHEM SOC, V130, P7695, DOI 10.1021/ja801152h; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Partch CL, 2005, PHOTOCHEM PHOTOBIOL, V81, P1291, DOI 10.1562/2005-07-08-IR-607; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Schleicher E, 2007, J BIOL CHEM, V282, P4738, DOI 10.1074/jbc.M604734200; Senda T, 2009, ANTIOXID REDOX SIGN, V11, P1741, DOI 10.1089/ARS.2008.2348; Tang CHA, 2010, NEURON, V66, P378, DOI 10.1016/j.neuron.2010.04.015; van der Schalie EA, 2007, MOL CELL BIOL, V27, P2120, DOI 10.1128/MCB.01638-06; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011	31	116	122	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					396	U156		10.1038/nature10618	http://dx.doi.org/10.1038/nature10618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22080955	Green Accepted			2022-12-24	WOS:000298033000058
J	Zanoni, I; Ostuni, R; Marek, LR; Barresi, S; Barbalat, R; Barton, GM; Granucci, F; Kagan, JC				Zanoni, Ivan; Ostuni, Renato; Marek, Lorri R.; Barresi, Simona; Barbalat, Roman; Barton, Gregory M.; Granucci, Francesca; Kagan, Jonathan C.			CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4	CELL			English	Article							DENDRITIC CELLS; LIPOPOLYSACCHARIDE; INNATE; TLR4; INDUCTION; CAPTURE; KINASE; MICE; SYK; TOLL-LIKE-RECEPTOR-4	The transport of Toll-like Receptors (TLRs) to various organelles has emerged as an essential means by which innate immunity is regulated. While most of our knowledge is restricted to regulators that promote the transport of newly synthesized receptors, the regulators that control TLR transport after microbial detection remain unknown. Here, we report that the plasma membrane localized Pattern Recognition Receptor (PRR) CD14 is required for the microbe-induced endocytosis of TLR4. In dendritic cells, this CD14-dependent endocytosis pathway is upregulated upon exposure to inflammatory mediators. We identify the tyrosine kinase Syk and its downstream effector PLC gamma 2 as important regulators of TLR4 endocytosis and signaling. These data establish that upon microbial detection, an upstream PRR (CD14) controls the trafficking and signaling functions of a downstream PRR (TLR4). This innate immune trafficking cascade illustrates how pathogen detection systems operate to induce both membrane transport and signal transduction.	[Zanoni, Ivan; Marek, Lorri R.; Kagan, Jonathan C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Zanoni, Ivan; Marek, Lorri R.; Kagan, Jonathan C.] Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Zanoni, Ivan; Ostuni, Renato; Barresi, Simona; Granucci, Francesca] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy; [Barbalat, Roman; Barton, Gregory M.] Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Milano-Bicocca; University of California System; University of California Berkeley	Granucci, F (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	francesca.granucci@unimib.it; jonathan.kagan@childrens.harvard.edu	GRANUCCI, Francesca/K-6150-2019; Ostuni, Renato/AAB-8832-2022	Ostuni, Renato/0000-0003-0460-3426; Zanoni, Ivan/0000-0002-3423-7474; Barton, Gregory/0000-0002-3793-0100; granucci, francesca/0000-0002-7046-4914	Harvard Digestive Diseases Center [P30 DK34854]; NIAID [5R00AI072955]; European Union [HEALTH-F4-2008-202156, HEALTH-F4-2008-201842]; Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of Education and Research; Fondazione Cariplo [n.2010-0678]; EMBO; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI072955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	Harvard Digestive Diseases Center; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Union(European Commission); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank the members of our lab for helpful discussions. This work was supported by the Harvard Digestive Diseases Center P30 DK34854 (J.K.), and grants from NIAID 5R00AI072955 (J.K.), European Union FP7 Program TOLERAGE: HEALTH-F4-2008-202156 and ENCITE: HEALTH-F4-2008-201842 (F. G.), Associazione Italiana per la Ricerca sul Cancro, and Italian Ministry of Education and Research (F. G.), Fondazione Cariplo (grant n.2010-0678, I.Z.). I.Z. was the recipient of an EMBO fellowship.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Chu CL, 2008, EUR J IMMUNOL, V38, P166, DOI 10.1002/eji.200737600; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Depoil D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.263pt1; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Drutman SB, 2010, J IMMUNOL, V185, P2140, DOI 10.4049/jimmunol.1000642; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hoshino K, 1999, J IMMUNOL, V162, P3749; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2003, J ENDOTOXIN RES, V9, P375, DOI 10.1179/096805103225003303; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Perera PY, 1997, J IMMUNOL, V158, P4422; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517	44	590	602	1	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 11	2011	147	4					868	880		10.1016/j.cell.2011.09.051	http://dx.doi.org/10.1016/j.cell.2011.09.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22078883	Green Accepted, Bronze			2022-12-24	WOS:000296902300019
J	Gibaud, T; Barry, E; Zakhary, MJ; Henglin, M; Ward, A; Yang, YS; Berciu, C; Oldenbourg, R; Hagan, MF; Nicastro, D; Meyer, RB; Dogic, Z				Gibaud, Thomas; Barry, Edward; Zakhary, Mark J.; Henglin, Mir; Ward, Andrew; Yang, Yasheng; Berciu, Cristina; Oldenbourg, Rudolf; Hagan, Michael F.; Nicastro, Daniela; Meyer, Robert B.; Dogic, Zvonimir			Reconfigurable self-assembly through chiral control of interfacial tension	NATURE			English	Article							TWIST PENETRATION; MICROSCOPE; LENGTH; MODEL; LAYER	From determining the optical properties of simple molecular crystals to establishing the preferred handedness in highly complex vertebrates, molecular chirality profoundly influences the structural, mechanical and optical properties of both synthetic and biological matter on macroscopic length scales(1,2). In soft materials such as amphiphilic lipids and liquid crystals, the competition between local chiral interactions and global constraints imposed by the geometry of the self-assembled structures leads to frustration and the assembly of unique materials(3-6). An example of particular interest is smectic liquid crystals, where the two-dimensional layered geometry cannot support twist and chirality is consequently expelled to the edges in a manner analogous to the expulsion of a magnetic field from superconductors(7-10). Here we demonstrate a consequence of this geometric frustration that leads to a new design principle for the assembly of chiral molecules. Using a model system of colloidal membranes(11), we show that molecular chirality can control the interfacial tension, an important property of multi-component mixtures. This suggests an analogy between chiral twist, which is expelled to the edges of two-dimensional membranes, and amphiphilic surfactants, which are expelled to oil-water interfaces(12). As with surfactants, chiral control of interfacial tension drives the formation of many polymorphic assemblages such as twisted ribbons with linear and circular topologies, starfish membranes, and double and triple helices. Tuning molecular chirality in situ allows dynamical control of line tension, which powers polymorphic transitions between various chiral structures. These findings outline a general strategy for the assembly of reconfigurable chiral materials that can easily be moved, stretched, attached to one another and transformed between multiple conformational states, thus allowing precise assembly and nanosculpting of highly dynamical and designable materials with complex topologies.	[Gibaud, Thomas; Barry, Edward; Zakhary, Mark J.; Henglin, Mir; Ward, Andrew; Yang, Yasheng; Hagan, Michael F.; Meyer, Robert B.; Dogic, Zvonimir] Brandeis Univ, Martin Fisher Sch Phys, 415 South St, Waltham, MA 02454 USA; [Berciu, Cristina; Nicastro, Daniela] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Oldenbourg, Rudolf] Marine Biol Lab, Woods Hole, MA 02543 USA	Brandeis University; Brandeis University; Marine Biological Laboratory - Woods Hole	Dogic, Z (corresponding author), Brandeis Univ, Martin Fisher Sch Phys, 415 South St, Waltham, MA 02454 USA.	zdogic@brandeis.edu	Gibaud, Thomas/O-1910-2019; Hagan, Michael F/N-2177-2014; Gibaud, Thomas/D-1276-2009	Gibaud, Thomas/0000-0003-4826-8025; Hagan, Michael F/0000-0002-9211-2434; Gibaud, Thomas/0000-0003-4826-8025; Nicastro, Daniela/0000-0002-0122-7173; Ward, Andrew/0000-0001-5147-4140	US National Science Foundation [NSF-MRSEC-0820492, NSF-DMR-0955776, NSF-MRI-0923057, NSF-CMMI-1068566]; Petroleum Research Fund [ACS-PRF 50558-DNI7]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002583] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Petroleum Research Fund(American Chemical Society); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the US National Science Foundation (NSF-MRSEC-0820492, NSF-DMR-0955776, NSF-MRI-0923057, NSF-CMMI-1068566) and the Petroleum Research Fund (ACS-PRF 50558-DNI7). We acknowledge use of the Brandeis MRSEC optical microscopy facility.	Aarts DGAL, 2004, SCIENCE, V304, P847, DOI 10.1126/science.1097116; Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198; Barry E, 2010, P NATL ACAD SCI USA, V107, P10348, DOI 10.1073/pnas.1000406107; Barry E, 2009, J PHYS CHEM B, V113, P3910, DOI 10.1021/jp8067377; Barry E, 2009, SOFT MATTER, V5, P2563, DOI 10.1039/b822478a; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Chung WJ, 2011, NATURE, V478, P364, DOI 10.1038/nature10513; Claessens MMAE, 2008, P NATL ACAD SCI USA, V105, P8819, DOI 10.1073/pnas.0711149105; DEGENNES PG, 1993, SOLID STATE COMMUN, V88, P1039, DOI 10.1016/0038-1098(93)90291-T; Dogic Z, 2000, LANGMUIR, V16, P7820, DOI 10.1021/la000446t; Fradin C, 2000, NATURE, V403, P871, DOI 10.1038/35002533; Grason GM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.098101; Harris AB, 1999, REV MOD PHYS, V71, P1745, DOI 10.1103/RevModPhys.71.1745; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Honerkamp-Smith AR, 2008, BIOPHYS J, V95, P236, DOI 10.1529/biophysj.107.128421; Hough LE, 2009, SCIENCE, V325, P456, DOI 10.1126/science.1170027; Kamien RD, 2001, J PHYS-CONDENS MAT, V13, pR1, DOI 10.1088/0953-8984/13/3/201; Kaplan CN, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021701; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lau AWC, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48006; LEE KYC, 1993, J PHYS CHEM-US, V97, P9532, DOI 10.1021/j100139a044; Lettinga MP, 2005, EUROPHYS LETT, V71, P692, DOI 10.1209/epl/i2005-10127-x; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Matsumoto EA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.257804; Nguyen TD, 2010, ACS NANO, V4, P2585, DOI 10.1021/nn901725b; Nguyen TD, 2009, SMALL, V5, P2092, DOI 10.1002/smll.200900168; Oda R, 1999, NATURE, V399, P566, DOI 10.1038/21154; Oldenbourg R, 2008, J MICROSC-OXFORD, V231, P419, DOI 10.1111/j.1365-2818.2008.02053.x; OLDENBOURG R, 1995, J MICROSC-OXFORD, V180, P140, DOI 10.1111/j.1365-2818.1995.tb03669.x; Pasteur L. M., 1848, ANN CHIM PHYS, V24, P442; Pelcovits RA, 2009, LIQ CRYST, V36, P1157, DOI 10.1080/02678290902921752; Purdy KR, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031708; RENN SR, 1988, PHYS REV A, V38, P2132, DOI 10.1103/PhysRevA.38.2132; Safran S. A., 1994, STAT THERMODYNAMICS; Sambrook J., 1989, MOL CLONING, P1847; Srivastava S, 2010, SCIENCE, V327, P1355, DOI 10.1126/science.1177218; Tang JX, 1996, BIOPOLYMERS, V39, P13, DOI 10.1002/(SICI)1097-0282(199607)39:1<13::AID-BIP2>3.3.CO;2-H; Yang YS, 2012, SOFT MATTER, V8, P707, DOI 10.1039/c1sm06201h	38	178	178	7	378	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					348	+		10.1038/nature10769	http://dx.doi.org/10.1038/nature10769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22217941				2022-12-24	WOS:000299210600039
J	Ross-Innes, CS; Stark, R; Teschendorff, AE; Holmes, KA; Ali, HR; Dunning, MJ; Brown, GD; Gojis, O; Ellis, IO; Green, AR; Ali, S; Chin, SF; Palmieri, C; Caldas, C; Carroll, JS				Ross-Innes, Caryn S.; Stark, Rory; Teschendorff, Andrew E.; Holmes, Kelly A.; Ali, H. Raza; Dunning, Mark J.; Brown, Gordon D.; Gojis, Ondrej; Ellis, Ian O.; Green, Andrew R.; Ali, Simak; Chin, Suet-Feung; Palmieri, Carlo; Caldas, Carlos; Carroll, Jason S.			Differential oestrogen receptor binding is associated with clinical outcome in breast cancer	NATURE			English	Article							GENE-EXPRESSION SIGNATURE; ER-ALPHA; SURVIVAL; REVEALS; FOXA1; RNA	Oestrogen receptor-alpha (ER) is the defining and driving transcription factor in the majority of breast cancers and its target genes dictate cell growth and endocrine response, yet genomic understanding of ER function has been restricted to model systems(1-3). Here we map genome-wide ER-binding events, by chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq), in primary breast cancers from patients with different clinical outcomes and in distant ER-positive metastases. We find that drug-resistant cancers still recruit ER to the chromatin, but that ER binding is a dynamic process, with the acquisition of unique ER-binding regions in tumours from patients that are likely to relapse. The acquired ER regulatory regions associated with poor clinical outcome observed in primary tumours reveal gene signatures that predict clinical outcome in ER-positive disease exclusively. We find that the differential ER-binding programme observed in tumours from patients with poor outcome is not due to the selection of a rare subpopulation of cells, but is due to the FOXA1-mediated reprogramming of ER binding on a rapid time-scale. The parallel redistribution of ER and FOXA1 binding events in drug-resistant cellular contexts is supported by histological co-expression of ER and FOXA1 in metastatic samples. By establishing transcription-factor mapping in primary tumour material, we show that there is plasticity in ER-binding capacity, with distinct combinations of cis-regulatory elements linked with the different clinical outcomes.	[Ross-Innes, Caryn S.; Stark, Rory; Holmes, Kelly A.; Ali, H. Raza; Dunning, Mark J.; Brown, Gordon D.; Chin, Suet-Feung; Caldas, Carlos; Carroll, Jason S.] Li Ka Shing Ctr, Cambridge Res Inst, Canc Res UK, Cambridge CB2 0RE, England; [Teschendorff, Andrew E.] UCL, UCL Canc Inst, London WC1E 6BT, England; [Gojis, Ondrej; Ali, Simak; Palmieri, Carlo] Univ London Imperial Coll Sci Technol & Med, London W12 0NN, England; [Gojis, Ondrej] Charles Univ Prague, Fac Med 3, Dept Obstet & Gynaecol, Prague 10000 10, Czech Republic; [Gojis, Ondrej] Charles Univ Prague, Fac Med 3, Dept Pathol, Prague 10000 10, Czech Republic; [Ellis, Ian O.; Green, Andrew R.] Nottingham Univ Hosp NHS Trust, City Hosp Nottingham, Dept Histopathol, Nottingham NG5 1PB, England; [Caldas, Carlos; Carroll, Jason S.] Univ Cambridge, Dept Oncol, Cambridge CB2 0XZ, England; [Ali, H. Raza; Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge Breast Unit, Cambridge CB2 2QQ, England; [Ali, H. Raza; Caldas, Carlos] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 2QQ, England; [Caldas, Carlos] Cambridge Expt Canc Med Ctr ECMC, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; University College London; Imperial College London; Charles University Prague; Charles University Prague; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Carroll, JS (corresponding author), Li Ka Shing Ctr, Cambridge Res Inst, Canc Res UK, Robinson Way, Cambridge CB2 0RE, England.	carlos.caldas@cancer.org.uk; jason.carroll@cancer.org.uk	Ali, Simak/M-6912-2018; Caldas, Carlos/A-7543-2008; Ali, Simak/N-4740-2019; Green, Andrew/AAF-1991-2020; Caldas, Carlos/U-7250-2019	Ali, Simak/0000-0002-1320-0816; Ali, Simak/0000-0002-1320-0816; Caldas, Carlos/0000-0003-3547-1489; Dunning, Mark/0000-0002-8853-9435; Carroll, Jason/0000-0003-3643-0080; chin, suet-feung/0000-0001-5697-1082; Coombes, Raoul Charles/0000-0002-4811-1100; Stark, Rory/0000-0002-1790-5469; Ellis, Ian/0000-0001-5292-8474; Green, Andrew/0000-0002-0488-5913	University of Cambridge; Cancer Research UK; Hutchison Whampoa Limited; NIHR Biomedical Research Centre; Experimental Cancer Medicine Centre; Commonwealth Scholarship; Ministry of Education of the Czech Republic [MSM0021620808]; European Society of Medical Oncology; ERC; EMBO; Cancer Research UK [12011, 15602] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Hutchison Whampoa Limited; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Experimental Cancer Medicine Centre; Commonwealth Scholarship; Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Society of Medical Oncology; ERC(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors would like to thank D. Schmidt for assistance with figures, J. Hadfield for Illumina sequencing, S. MacArthur, O. Rueda, S. Vowler, R. Russell and M. Wilson for technical and bioinformatics help. We thank J. Stingl and his laboratory for help with the normal mammary gland work. We would like to acknowledge the support of The University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited. The authors would like to thank Imperial College Healthcare NHS Trust, Human Biomaterials Resource Centre (Tissue Bank). Tumour samples from Cambridge were obtained with support from NIHR Biomedical Research Centre and the Experimental Cancer Medicine Centre. C.S.R.-I. is supported by a Commonwealth Scholarship. O. G. is part funded by a grant awarded by the Ministry of Education of the Czech Republic (Project "Oncology" MSM0021620808) and is also a recipient of a Translational Research Fellowship from the European Society of Medical Oncology. C. P. is funded by Cancer Research UK. J. S. C. is supported by an ERC starting grant and an EMBO Young investigator award.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Arpino G, 2005, JNCI-J NATL CANCER I, V97, P1254, DOI 10.1093/jnci/dji249; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; GOMM JJ, 1995, ANAL BIOCHEM, V226, P91, DOI 10.1006/abio.1995.1196; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kun Y, 2003, HUM MOL GENET, V12, P3245, DOI 10.1093/hmg/ddg347; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; Naderi A, 2007, ONCOGENE, V26, P1507, DOI 10.1038/sj.onc.1209920; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Pavesi G, 2006, NUCLEIC ACIDS RES, V34, pW566, DOI 10.1093/nar/gkl285; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stark R., DIFFBIND DIFFERENTIA; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	30	973	987	4	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					389	U177		10.1038/nature10730	http://dx.doi.org/10.1038/nature10730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22217937	Green Accepted, Green Submitted			2022-12-24	WOS:000299210600048
J	Huang, HS; Allen, JA; Mabb, AM; King, IF; Miriyala, J; Taylor-Blake, B; Sciaky, N; Dutton, JW; Lee, HM; Chen, X; Jin, J; Bridges, AS; Zylka, MJ; Roth, BL; Philpot, BD				Huang, Hsien-Sung; Allen, John A.; Mabb, Angela M.; King, Ian F.; Miriyala, Jayalakshmi; Taylor-Blake, Bonnie; Sciaky, Noah; Dutton, J. Walter, Jr.; Lee, Hyeong-Min; Chen, Xin; Jin, Jian; Bridges, Arlene S.; Zylka, Mark J.; Roth, Bryan L.; Philpot, Benjamin D.			Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons	NATURE			English	Article							ANGELMAN SYNDROME GENE; ANTISENSE TRANSCRIPT; UBIQUITIN LIGASE; I INHIBITORS; EXPRESSION; SNRPN; CAMPTOTHECIN; UBE3A/E6-AP; MUTATIONS; DELETION	Angelman syndrome is a severe neurodevelopmental disorder caused bydeletion ormutation of the maternal allele of the ubiquitin protein ligase E3A (UBE3A)(1-3). In neurons, the paternal allele of UBE3A is intact but epigenetically silenced(4-6), raising the possibility that Angelman syndrome could be treated by activating this silenced allele to restore functional UBE3A protein(7,8). Using an unbiased, high-content screen in primary cortical neurons from mice, we identify twelve topoisomerase I inhibitors and four topoisomerase II inhibitors that unsilence the paternal Ube3a allele. These drugs included topotecan, irinotecan, etoposide and dexrazoxane (ICRF-187). At nanomolar concentrations, topotecan upregulated catalytically active UBE3A in neurons from maternal Ube3a-null mice. Topotecan concomitantly downregulated expression of the Ube3a antisense transcript that overlaps the paternal copy of Ube3a(9-11). These results indicate that topotecan unsilences Ube3a in cis by reducing transcription of an imprinted antisense RNA. When administered in vivo, topotecan unsilenced the paternal Ube3a allele in several regions of the nervous system, including neurons in the hippocampus, neocortex, striatum, cerebellum and spinal cord. Paternal expression of Ube3a remained elevated in a subset of spinal cord neurons for at least 12 weeks after cessation of topotecan treatment, indicating that transient topoisomerase inhibition can have enduring effects on gene expression. Although potential off-target effects remain to be investigated, our findings suggest a therapeutic strategy for reactivating the functional but dormant allele of Ube3a in patients with Angelman syndrome.	[Huang, Hsien-Sung; Mabb, Angela M.; King, Ian F.; Miriyala, Jayalakshmi; Taylor-Blake, Bonnie; Dutton, J. Walter, Jr.; Zylka, Mark J.; Philpot, Benjamin D.] Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Allen, John A.; Sciaky, Noah; Lee, Hyeong-Min; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Chen, Xin; Jin, Jian] Univ N Carolina, Eshelman Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Bridges, Arlene S.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Zylka, Mark J.; Roth, Bryan L.; Philpot, Benjamin D.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Zylka, Mark J.; Roth, Bryan L.; Philpot, Benjamin D.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, NIMH, Psychoact Drug Screening Program, Dept Pharmacol,Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zylka, MJ (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA.	zylka@med.unc.edu; bryan_roth@med.unc.edu; bphilpot@med.unc.edu	Lee, HM/D-2777-2011; Lee, HM/ABC-2680-2020; , UNC Neuroscience Microscopy Core/AAE-8305-2022; Roth, Bryan/ABE-7032-2020; Roth, Bryan L/F-3928-2010; Allen, John A/D-6141-2011	Lee, HM/0000-0002-9381-3611; Lee, HM/0000-0002-9381-3611; Roth, Bryan/0000-0002-0561-6520; King, Ian/0000-0003-3405-9767; Chen, Xin/0000-0002-5208-2154; Huang, Hsien-Sung/0000-0003-2657-3635; Mabb, Angela/0000-0002-3000-8690	Simons Foundation Autism Research Initiative (SFARI); Angelman Syndrome Foundation; National Institute of Mental Health (NIMH) [R01MH093372]; National Eye Institute [R01EY018323]; NC TraCS [50KR41016, 10KR20910]; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS060725, R01NS067688, 5F32NS067712, 5P30NS045892]; National Institutes of Health (NIH) [HHSN-271-2008-00025-C, T32HD040127-07]; Michael Hooker Distinguished Chair of Pharmacology; National Institute on Drug Abuse (NIDA); Brain and Behavior Research Foundation; University of North Carolina-Carolina Institute for Developmental Disabilities; US Department of Defense [AR093464]; National Institute of Child Health and Human Development (NICHD) [P30HD03110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040127, P30HD003110] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS067712, R01NS067688, P30NS045892, R01NS060725] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative (SFARI); Angelman Syndrome Foundation; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NC TraCS; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Hooker Distinguished Chair of Pharmacology; National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Brain and Behavior Research Foundation; University of North Carolina-Carolina Institute for Developmental Disabilities; US Department of Defense(United States Department of Defense); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Beaudet and Y.-h. Jiang for providing Ube3a-YFP and Ube3a<SUP>m-/rho+</SUP> mice; T. Riday and J. E. Han for assistance in i.c.v. mini-osmotic pump infusion; A. Burns for assistance in maintaining mouse colonies; V. Gukassyan for help with the Surveyor and confocal imaging systems; K. McNaughton for help with tissue sectioning; W. Zamboni for providing belotecan, rubitecan and silatecan; and W. Janzen and the Center of Integrative Chemical Biology and Drug Discovery for providing the epigenetic library. B. D. P., M.J.Z. and B. L. R. were supported by the Simons Foundation Autism Research Initiative (SFARI) and by the Angelman Syndrome Foundation. B. D. P. and M.J.Z. were supported by the National Institute of Mental Health (NIMH) (R01MH093372). B. D. P. was supported by the National Eye Institute (R01EY018323) and NC TraCS (50KR41016). M.J.Z. was supported by the National Institute of Neurological Disorders and Stroke (NINDS) (R01NS060725, R01NS067688). B. L. R. was supported by national Institutes of Health (NIH) HHSN-271-2008-00025-C, the NIMH Psychoactive Drug Screening Program, the Michael Hooker Distinguished Chair of Pharmacology, and grants from NIMH and the National Institute on Drug Abuse (NIDA). H.-S. H. was supported by a NARSAD grant from the Brain and Behavior Research Foundation Young Investigator Award and NC TraCS (10KR20910). J. A. A. was supported by NIH T32HD040127-07, the University of North Carolina-Carolina Institute for Developmental Disabilities, and an Autism Concept Award AR093464 from the US Department of Defense. A. M. M. was supported by a National Research Service Award from NINDS (5F32NS067712). I. F. K. was supported by a Joseph E. Wagstaff Postdoctoral Research Fellowship from the Angelman Syndrome Foundation. Assay development costs were partially supported by NINDS (5P30NS045892). Confocal and montage imaging was performed at the University of North Carolina at Chapel Hill Confocal and Multiphoton Imaging Facility, which is co-funded by grants from NINDS (5P30NS045892) and the National Institute of Child Health and Human Development (NICHD) (P30HD03110).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Beaudenon S, 2005, METHOD ENZYMOL, V398, P112, DOI 10.1016/S0076-6879(05)98011-7; Bomgaars L, 2001, ONCOLOGIST, V6, P506, DOI 10.1634/theoncologist.6-6-506; Bressler J, 2001, NAT GENET, V28, P232, DOI 10.1038/90067; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Cushman M, 2000, J MED CHEM, V43, P3688, DOI 10.1021/jm000029d; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Fairbanks CA, 2003, ADV DRUG DELIVER REV, V55, P1007, DOI 10.1016/S0169-409X(03)00101-7; Gammon DC, 2006, AM J HEALTH-SYST PH, V63, P2083, DOI 10.2146/ajhp060165; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; HERTZBERG RP, 1989, J MED CHEM, V32, P715, DOI 10.1021/jm00123a038; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Landers M, 2004, NUCLEIC ACIDS RES, V32, P3480, DOI 10.1093/nar/gkh670; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Miura K, 2002, NEUROBIOL DIS, V9, P149, DOI 10.1006/nbdi.2001.0463; Nagarajan M, 2006, J MED CHEM, V49, P6283, DOI 10.1021/jm060564z; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Numata K, 2011, NUCLEIC ACIDS RES, V39, P2649, DOI 10.1093/nar/gkq1201; Peery EG, 2007, MAMM GENOME, V18, P255, DOI 10.1007/s00335-007-9019-3; Peters SU, 2010, AM J MED GENET A, V152A, P1994, DOI 10.1002/ajmg.a.33509; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Plaschkes I, 2005, J COMP NEUROL, V493, P357, DOI 10.1002/cne.20793; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Vu TH, 1997, NAT GENET, V17, P12, DOI 10.1038/ng0997-12; Watanabe Y, 2010, GENOMICS, V96, P333, DOI 10.1016/j.ygeno.2010.08.007	38	250	265	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2012	481	7380					185	+		10.1038/nature10726	http://dx.doi.org/10.1038/nature10726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22190039	Green Accepted, Green Submitted			2022-12-24	WOS:000298981200036
J	Zhang, SY; Bryant, DA				Zhang, Shuyi; Bryant, Donald A.			The Tricarboxylic Acid Cycle in Cyanobacteria	SCIENCE			English	Article							OBLIGATE AUTOTROPHY; PCC 6803; METABOLISM; DECARBOXYLASE	It is generally accepted that cyanobacteria have an incomplete tricarboxylic acid (TCA) cycle because they lack 2-oxoglutarate dehydrogenase and thus cannot convert 2-oxoglutarate to succinyl-coenzyme A (CoA). Genes encoding a novel 2-oxoglutarate decarboxylase and succinic semialdehyde dehydrogenase were identified in the cyanobacterium Synechococcus sp. PCC 7002. Together, these two enzymes convert 2-oxoglutarate to succinate and thus functionally replace 2-oxoglutarate dehydrogenase and succinyl-CoA synthetase. These genes are present in all cyanobacterial genomes except those of Prochlorococcus and marine Synechococcus species. Closely related genes occur in the genomes of some methanogens and other anaerobic bacteria, which are also thought to have incomplete TCA cycles.	[Zhang, Shuyi; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	dab14@psu.edu		Zhang, Shuyi/0000-0001-8500-5836	Air Force Office of Scientific Research (MURI) [FA9550-05-1-0365]; U.S. Department of Energy, Office of Biological and Environmental Research	Air Force Office of Scientific Research (MURI)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	We thank W. R. Cannon, L. A. McCue, A. Konopka, S. Stolyar, A. Beliaev, J. K. Fredrickson, and M. Romine for encouragement and stimulating discussions. D. A. B. thanks W. Martin for long ago pointing out the unusual TCA cycle in E. gracilis. Supported by the Air Force Office of Scientific Research (MURI grant FA9550-05-1-0365) and by the Genomic Science Program of the U.S. Department of Energy, Office of Biological and Environmental Research. This contribution originates from the GSP Foundational Scientific Focus Area and Biofuels Scientific Focus Area of the Pacific Northwest National Laboratory.	[Anonymous], 1973, BLUE GREEN ALGAE, DOI DOI 10.1007/BF02920994; Bender RA, 2011, J BACTERIOL, V193, P4574, DOI 10.1128/JB.05666-11; Bryant D.A., 1994, MOL BIOL CYANOBACTER; Cannon WR, 2011, J PROTEOME RES, V10, P2306, DOI 10.1021/pr101130b; Chipman DM, 2005, CURR OPIN CHEM BIOL, V9, P475, DOI 10.1016/j.cbpa.2005.07.002; Cooley JW, 2000, J BACTERIOL, V182, P714, DOI 10.1128/JB.182.3.714-722.2000; Forchhammer K, 2010, ADV EXP MED BIOL, V675, P71, DOI 10.1007/978-1-4419-1528-3_5; Fu PC, 2009, J CHEM TECHNOL BIOT, V84, P473, DOI 10.1002/jctb.2065; Hong SJ, 2007, BIOTECHNOL BIOPROC E, V12, P165, DOI 10.1007/BF03028644; Ludwig M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00041; Ohashi Y, 2011, J EXP BOT, V62, P1411, DOI 10.1093/jxb/erq427; PEARCE J, 1967, BIOCHEM J, V105, pP45; Schwarz D, 2011, PLANT PHYSIOL, V155, P1640, DOI 10.1104/pp.110.170225; Shastri AA, 2005, BIOTECHNOL PROGR, V21, P1617, DOI 10.1021/bp050246d; SHIGEOKA S, 1986, FEBS LETT, V195, P43, DOI 10.1016/0014-5793(86)80126-0; SMITH AJ, 1967, J BACTERIOL, V94, P972, DOI 10.1128/JB.94.4.972-983.1967; STANIER RY, 1977, ANNU REV MICROBIOL, V31, P225, DOI 10.1146/annurev.mi.31.100177.001301; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; Wood AP, 2004, FEMS MICROBIOL REV, V28, P335, DOI 10.1016/j.femsre.2003.12.001	19	231	244	5	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1551	1553		10.1126/science.1210858	http://dx.doi.org/10.1126/science.1210858			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174252				2022-12-24	WOS:000298091400052
J	Lee, X; Goulden, ML; Hollinger, DY; Barr, A; Black, TA; Bohrer, G; Bracho, R; Drake, B; Goldstein, A; Gu, LH; Katul, G; Kolb, T; Law, BE; Margolis, H; Meyers, T; Monson, R; Munger, W; Oren, R; Kyaw, TPU; Richardson, AD; Schmid, HP; Staebler, R; Wofsy, S; Zhao, L				Lee, Xuhui; Goulden, Michael L.; Hollinger, David Y.; Barr, Alan; Black, T. Andrew; Bohrer, Gil; Bracho, Rosvel; Drake, Bert; Goldstein, Allen; Gu, Lianhong; Katul, Gabriel; Kolb, Thomas; Law, Beverly E.; Margolis, Hank; Meyers, Tilden; Monson, Russell; Munger, William; Oren, Ram; Kyaw Tha Paw U; Richardson, Andrew D.; Schmid, Hans Peter; Staebler, Ralf; Wofsy, Steven; Zhao, Lei			Observed increase in local cooling effect of deforestation at higher latitudes	NATURE			English	Article							LAND-USE; CLIMATE; VEGETATION; FOREST; ENERGY; WATER	Deforestation in mid-to high latitudes is hypothesized to have the potential to cool the Earth's surface by altering biophysical processes(1-3). In climate models of continental-scale land clearing, the cooling is triggered by increases in surface albedo and is reinforced by a land albedo-sea ice feedback(4,5). This feedback is crucial in the model predictions; without it other biophysical processes may overwhelm the albedo effect to generate warming instead(5). Ongoing land-use activities, such as land management for climate mitigation, are occurring at local scales (hectares) presumably too small to generate the feedback, and it is not known whether the intrinsic biophysical mechanism on its own can change the surface temperature in a consistent manner(6,7). Nor has the effect of deforestation on climate been demonstrated over large areas from direct observations. Here we show that surface air temperature is lower in open land than in nearby forested land. The effect is 0.85 +/- 0.44 K (mean +/- one standard deviation) northwards of 45 degrees N and 0.21 +/- 0.53 K southwards. Below 35 degrees N there is weak evidence that deforestation leads to warming. Results are based on comparisons of temperature at forested eddy covariance towers in the USA and Canada and, as a proxy for small areas of cleared land, nearby surface weather stations. Night-time temperature changes unrelated to changes in surface albedo are an important contributor to the overall cooling effect. The observed latitudinal dependence is consistent with theoretical expectation of changes in energy loss from convection and radiation across latitudes in both the daytime and night-time phase of the diurnal cycle, the latter of which remains uncertain in climate models(8).	[Lee, Xuhui; Zhao, Lei] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Goulden, Michael L.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Hollinger, David Y.] US Forest Serv, USDA, No Res Stn, Durham, NH 03824 USA; [Barr, Alan] Environm Canada, Div Climate Res, Saskatoon, SK S7N 3H5, Canada; [Black, T. Andrew] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V6T 1Z4, Canada; [Bohrer, Gil] Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; [Bracho, Rosvel] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Drake, Bert] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Goldstein, Allen] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Gu, Lianhong] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Katul, Gabriel; Oren, Ram] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; [Kolb, Thomas] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; [Law, Beverly E.] Oregon State Univ, Coll Forestry, Corvallis, OR 97331 USA; [Margolis, Hank] Univ Laval, Fac Foresterie Geog & Geomat, Ctr Etud Foret, Quebec City, PQ G1V 0A6, Canada; [Meyers, Tilden] NOAA ARL ATDD, Oak Ridge, TN 37830 USA; [Monson, Russell] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Munger, William; Wofsy, Steven] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Kyaw Tha Paw U] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Richardson, Andrew D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Schmid, Hans Peter] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, D-82467 Garmisch Partenkirchen, Germany; [Staebler, Ralf] Environm Canada, Proc Res Sect, Toronto, ON M3H 5T4, Canada	Yale University; University of California System; University of California Irvine; United States Department of Agriculture (USDA); United States Forest Service; Environment & Climate Change Canada; University of British Columbia; University System of Ohio; Ohio State University; State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian Environmental Research Center; University of California System; University of California Berkeley; United States Department of Energy (DOE); Oak Ridge National Laboratory; Duke University; Northern Arizona University; Oregon State University; Laval University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; Harvard University; University of California System; University of California Davis; Harvard University; Helmholtz Association; Karlsruhe Institute of Technology; Environment & Climate Change Canada	Lee, X (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	xuhui.lee@yale.edu	Goldstein, Allen H/A-6857-2011; Hollinger, David Y/G-7185-2012; Barr, Alan/H-9939-2014; Oren, Ram/AAC-5326-2019; Bohrer, Gil/A-9731-2008; Goulden, Michael L/B-9934-2008; Zhao, Lei/S-1855-2019; Barr, Alan George/AAX-2129-2020; Law, Beverly Elizabeth/G-3882-2010; Gu, Lianhong/H-8241-2014; Schmid, Hans Peter E/I-1224-2012; Schmid, Hans Peter/AAP-4450-2021; Katul, Gabriel G/A-7210-2008; Munger, J William/H-4502-2013; Meyers, Tilden/C-6633-2016; Richardson, Andrew/F-5691-2011	Goldstein, Allen H/0000-0003-4014-4896; Oren, Ram/0000-0002-5654-1733; Bohrer, Gil/0000-0002-9209-9540; Zhao, Lei/0000-0002-6481-3786; Law, Beverly Elizabeth/0000-0002-1605-1203; Gu, Lianhong/0000-0001-5756-8738; Schmid, Hans Peter E/0000-0001-9076-4466; Schmid, Hans Peter/0000-0001-9076-4466; Katul, Gabriel G/0000-0001-9768-3693; Munger, J William/0000-0002-1042-8452; Meyers, Tilden/0000-0002-0726-4258; Richardson, Andrew/0000-0002-0148-6714; Staebler, Ralf/0000-0002-6372-0414; Barr, Alan/0000-0003-2717-218X; Goulden, Michael/0000-0002-9379-3948	US Department of Energy; Yale University Climate and Energy Institute	US Department of Energy(United States Department of Energy (DOE)); Yale University Climate and Energy Institute	The data collection and analysis were supported in part by grants from the US Department of Energy and by a Yale University Climate and Energy Institute grant. We thank D. Fitzjarrald and R. Sakai for providing the data for the KM77 tropical site and C. von Randow for providing the friction velocity data for FLUXNET cluster e.	Anderson RG, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001476; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Betts AK, 1997, J GEOPHYS RES-ATMOS, V102, P28901, DOI 10.1029/96JD03876; Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; Betts RA, 2007, AGR FOREST METEOROL, V142, P216, DOI 10.1016/j.agrformet.2006.08.021; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Davin EL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029678; Davin EL, 2010, J CLIMATE, V23, P97, DOI 10.1175/2009JCLI3102.1; Douville H, 1996, CLIM DYNAM, V13, P57, DOI 10.1007/s003820050153; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Goulden ML, 2006, GLOBAL CHANGE BIOL, V12, P2146, DOI 10.1111/j.1365-2486.2006.01251.x; Goulden Michael L., 2004, Ecological Applications, V14, pS42; Juang JY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031296; Lerner J., 1984, CLIMATE PROCESSES CL, V29, P130, DOI 10.1029/GM029p0130; Mahrt L, 2000, BOUND-LAY METEOROL, V96, P33, DOI 10.1023/A:1002482332477; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; PIELKE RA, 1990, LANDSCAPE ECOL, V4, P133, DOI 10.1007/BF00132857; Pielke RA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008229; Rotenberg E, 2010, SCIENCE, V327, P451, DOI 10.1126/science.1179998; Sakai RK, 2004, GLOBAL CHANGE BIOL, V10, P895, DOI 10.1111/j.1529-8817.2003.00773.x; Snyder PK, 2004, CLIM DYNAM, V23, P279, DOI 10.1007/s00382-004-0430-0; Stoy PC, 2006, GLOBAL CHANGE BIOL, V12, P2115, DOI 10.1111/j.1365-2486.2006.01244.x; von Randow C, 2004, THEOR APPL CLIMATOL, V78, P5, DOI 10.1007/s00704-004-0041-z; Wild M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028031; Zha T, 2009, GLOBAL CHANGE BIOL, V15, P1475, DOI 10.1111/j.1365-2486.2008.01817.x; Zhou LM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036141	29	404	430	24	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2011	479	7373					384	387		10.1038/nature10588	http://dx.doi.org/10.1038/nature10588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22094699	Green Published			2022-12-24	WOS:000297059700042
J	Balaskas, N; Ribeiro, A; Panovska, J; Dessaud, E; Sasai, N; Page, KM; Briscoe, J; Ribes, V				Balaskas, Nikolaos; Ribeiro, Ana; Panovska, Jasmina; Dessaud, Eric; Sasai, Noriaki; Page, Karen M.; Briscoe, James; Ribes, Vanessa			Gene Regulatory Logic for Reading the Sonic Hedgehog Signaling Gradient in the Vertebrate Neural Tube	CELL			English	Article							PROGENITOR-CELL IDENTITY; MORPHOGEN GRADIENT; POSITIONAL INFORMATION; DROSOPHILA EMBRYO; NEURONAL FATE; BINDING-SITE; FLOOR PLATE; INDUCTION; SPECIFICATION; NOTOCHORD	Secreted signals, known as morphogens, provide the positional information that organizes gene expression and cellular differentiation in many developing tissues. In the vertebrate neural tube, Sonic Hedgehog (Shh) acts as a morphogen to control the pattern of neuronal subtype specification. Using an in vivo reporter of Shh signaling, mouse genetics, and systems modeling, we show that a spatially and temporally changing gradient of Shh signaling is interpreted by the regulatory logic of a downstream transcriptional network. The design of the network, which links three transcription factors to Shh signaling, is responsible for differential spatial and temporal gene expression. In addition, the network renders cells insensitive to fluctuations in signaling and confers hysteresis-memory of the signal. Our findings reveal that morphogen interpretation is an emergent property of the architecture of a transcriptional network that provides robustness and reliability to tissue patterning.	[Balaskas, Nikolaos; Ribeiro, Ana; Dessaud, Eric; Sasai, Noriaki; Briscoe, James; Ribes, Vanessa] Natl Inst Med Res, London NW7 1AA, England; [Panovska, Jasmina; Page, Karen M.] UCL, Dept Math, London WC1E 6BT, England	MRC National Institute for Medical Research; University of London; University College London	Briscoe, J (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	james.briscoe@nimr.mrc.ac.uk	RIBES, Vanessa/AAO-3488-2020	Sasai, Noriaki/0000-0003-0360-1138; Ribeiro, Ana/0000-0003-0132-9740; Panovska-Griffiths, Jasmina/0000-0002-7720-1121; RIBES, Vanessa/0000-0001-7016-9192; Briscoe, James/0000-0002-1020-5240; Dessaud, Eric/0000-0001-9723-6658; Page, Karen/0000-0003-4189-4664	MRC [U117560541]; Wellcome Trust [080630]; EMBO; Marie Curie Fellowships; FCT, Portugal; National Institute of Mathematical and Biological Synthesis (NSF) [EF-0832858]; University of Tennessee, Knoxville	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); Marie Curie Fellowships(European Commission); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institute of Mathematical and Biological Synthesis (NSF); University of Tennessee, Knoxville	We are grateful to N. Bushati, A. Kicheva, T. M. Jessell, E. Kutejova, S. Tozer, and J.P. Vincent for discussions. We thank NIMR Biological Services staff for help with the mouse colonies. This work was supported by the MRC (U117560541) and Wellcome Trust (080630). E. D. was supported by EMBO and Marie Curie Fellowships, N. S. by a Marie Curie Fellowship, V. R. by an EMBO Fellowship, and A. R. by the FCT, Portugal. K. M. P. thanks the National Institute of Mathematical and Biological Synthesis for a sabbatical fellowship (NSF Grant EF-0832858 and University of Tennessee, Knoxville).	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Bollenbach T, 2008, DEVELOPMENT, V135, P1137, DOI 10.1242/dev.012062; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Chamberlain CE, 2008, DEVELOPMENT, V135, P1097, DOI 10.1242/dev.013086; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Cherry JL, 2000, J THEOR BIOL, V203, P117, DOI 10.1006/jtbi.2000.1068; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dessaud E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000382; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Grimm O, 2010, DEVELOPMENT, V137, P2253, DOI 10.1242/dev.032409; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harvey SA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000101; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Ibanes M, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.14; Jaeger J, 2006, BIOESSAYS, V28, P1102, DOI 10.1002/bies.20494; Jeong JH, 2005, DEVELOPMENT, V132, P143, DOI 10.1242/dev.01566; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; Kerszberg M, 2007, CELL, V130, P205, DOI 10.1016/j.cell.2007.06.038; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Lek M, 2010, DEVELOPMENT, V137, P4051, DOI 10.1242/dev.054288; Liberman LM, 2009, P NATL ACAD SCI USA, V106, P22317, DOI 10.1073/pnas.0906227106; Manu, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000303; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; Marigo V, 1996, DEVELOPMENT, V122, P1225; Matise MP, 1998, DEVELOPMENT, V125, P2759; Nahmad M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000202; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ochoa-Espinosa A, 2005, P NATL ACAD SCI USA, V102, P4960, DOI 10.1073/pnas.0500373102; Ochoa-Espinosa A, 2009, P NATL ACAD SCI USA, V106, P3823, DOI 10.1073/pnas.0807878105; Pages F, 2000, TRENDS GENET, V16, P40, DOI 10.1016/S0168-9525(99)01880-6; Saka Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-47; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Tyson J., 1978, PROG THEOR BIOL, V5, P1; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Wolpert L., 1998, PRINCIPLES DEV, P340; Xu M, 2005, DEVELOPMENT, V132, P1637, DOI 10.1242/dev.01722; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	55	292	295	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					273	284		10.1016/j.cell.2011.10.047	http://dx.doi.org/10.1016/j.cell.2011.10.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265416	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000299540700030
J	Mendoza, JL; Schmidt, A; Li, Q; Nuvaga, E; Barrett, T; Bridges, RJ; Feranchak, AP; Brautigam, CA; Thomas, PJ				Mendoza, Juan L.; Schmidt, Andre; Li, Qin; Nuvaga, Emmanuel; Barrett, Tyler; Bridges, Robert J.; Feranchak, Andrew P.; Brautigam, Chad A.; Thomas, Philip J.			Requirements for Efficient Correction of Delta F508 CFTR Revealed by Analyses of Evolved Sequences	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; MULTIPLE PROTEIN-SEQUENCE; FIBROSIS-CAUSING MUTATION; CYSTIC-FIBROSIS; TRAFFICKING DEFECT; ATP-BINDING; IN-VIVO; CORRELATED MUTATIONS; STRUCTURE ALIGNMENTS	Misfolding of Delta F508 cystic fibrosis (CF) transmembrane conductance regulator (CFTR) underlies pathology in most CF patients. F508 resides in the first nucleotide-binding domain (NBD1) of CFTR near a predicted interface with the fourth intracellular loop (ICL4). Efforts to identify small molecules that restore function by correcting the folding defect have revealed an apparent efficacy ceiling. To understand the mechanistic basis of this obstacle, positions statistically coupled to 508, in evolved sequences, were identified and assessed for their impact on both NBD1 and CFTR folding. The results indicate that both NBD1 folding and interaction with ICL4 are altered by the Delta F508 mutation and that correction of either individual process is only partially effective. By contrast, combination of mutations that counteract both defects restores Delta F508 maturation and function to wild-type levels. These results provide a mechanistic rationale for the limited efficacy of extant corrector compounds and suggest approaches for identifying compounds that correct both defective steps.	[Mendoza, Juan L.; Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Mol Biophys Program, Dallas, TX 75390 USA; [Mendoza, Juan L.; Schmidt, Andre; Nuvaga, Emmanuel; Barrett, Tyler; Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Li, Qin; Feranchak, Andrew P.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Brautigam, Chad A.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Bridges, Robert J.] Rosalind Franklin Univ, Dept Physiol & Biophys, Abbott Pk, IL 60064 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Rosalind Franklin University Medical & Science	Thomas, PJ (corresponding author), Univ Texas SW Med Ctr Dallas, Mol Biophys Program, Dallas, TX 75390 USA.	philip.thomas@utsouthwestern.edu	Thomas, Philip J/F-7115-2012	Mendoza, Juan/0000-0001-6972-7476; Brautigam, Chad/0000-0001-6563-1338	CF Foundation; NIH [DK49835, DK76638, DE12309]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049835, R01DK076638, R37DK049835] Funding Source: NIH RePORTER	CF Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors wish to thank Linda Millen, Bala Somalinga, and David Thompson for suggestions and technical assistance, the CFTR Folding Consortium for intellectual support, and the CF Foundation and NIH grants DK49835, DK76638, and DE12309 for support. P.J.T. is a cofounder of Reata Pharmaceuticals. Reata has licensed the beta-galatosidase folding assay from the University of Texas for commercial use. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by University of Chicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; DEAN M, 1995, CURR OPIN GENET DEV, V5, P779, DOI 10.1016/0959-437X(95)80011-S; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DORK T, 1991, HUM GENET, V87, P441; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Krasnov KV, 2008, HUM MUTAT, V29, P1364, DOI 10.1002/humu.20866; Kunichika K, 2002, PROTEIN ENG, V15, P805, DOI 10.1093/protein/15.10.805; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Madaoui H, 2008, P NATL ACAD SCI USA, V105, P7708, DOI 10.1073/pnas.0707032105; McCarty NA, 2000, J EXP BIOL, V203, P1947; Mendoza JL, 2007, J BIOENERG BIOMEMBR, V39, P499, DOI 10.1007/s10863-007-9117-7; Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; PJURA P, 1993, PROTEIN SCI, V2, P2217, DOI 10.1002/pro.5560021221; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robert R, 2008, MOL PHARMACOL, V73, P478, DOI 10.1124/mol.107.040725; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Sampson HM, 2011, CHEM BIOL, V18, P231, DOI 10.1016/j.chembiol.2010.11.016; Schrodinger L., 2020, PYMOL; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Stratford FLL, 2007, BIOCHEM J, V401, P581, DOI 10.1042/BJ20060968; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; THOMAS PJ, 1992, J BIOL CHEM, V267, P5727; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389	66	205	207	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 20	2012	148	1-2					164	174		10.1016/j.cell.2011.11.023	http://dx.doi.org/10.1016/j.cell.2011.11.023			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265409	Green Accepted, Bronze			2022-12-24	WOS:000299540700022
J	Sun, LM; Wang, HY; Wang, ZG; He, SD; Chen, S; Liao, DH; Wang, L; Yan, JC; Liu, WL; Lei, XG; Wang, XD				Sun, Liming; Wang, Huayi; Wang, Zhigao; He, Sudan; Chen, She; Liao, Daohong; Wang, Lai; Yan, Jiacong; Liu, Weilong; Lei, Xiaoguang; Wang, Xiaodong			Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase	CELL			English	Article							CELL-DEATH; CYTOCHROME-C; APOPTOSIS; INHIBITION; IDENTIFICATION; CASPASES; CLEAVAGE; TARGET; SMAC	The receptor-interacting serine-threonine kinase 3 (RIP3) is a key signaling molecule in the programmed necrosis (necroptosis) pathway. This pathway plays important roles in a variety of physiological and pathological conditions, including development, tissue damage response, and antiviral immunity. Here, we report the identification of a small molecule called (E)-N-(4-(N-(3-methoxypyrazin-2-yl)sulfamoyl) phenyl)-3-(5-nitrothiophene-2-yl)acrylamide-here-after referred to as necrosulfonamide-that specifically blocks necrosis downstream of RIP3 activation. An affinity probe derived from necrosulfonamide and coimmunoprecipitation using anti-RIP3 antibodies both identified the mixed lineage kinase domain-like protein (MLKL) as the interacting target. MLKL was phosphorylated by RIP3 at the threonine 357 and serine 358 residues, and these phosphorylation events were critical for necrosis. Treating cells with necrosulfonamide or knocking down MLKL expression arrested necrosis at a specific step at which RIP3 formed discrete punctae in cells. These findings implicate MLKL as a key mediator of necrosis signaling downstream of the kinase RIP3.	[Sun, Liming; Wang, Huayi; He, Sudan; Chen, She; Liao, Daohong; Yan, Jiacong; Liu, Weilong; Lei, Xiaoguang; Wang, Xiaodong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Sun, Liming; Wang, Huayi; Wang, Zhigao; Wang, Lai; Wang, Xiaodong] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Liao, Daohong; Lei, Xiaoguang] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China; [Liu, Weilong] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Liu, Weilong] Peking Union Med Coll, Beijing 100730, Peoples R China	National Institute of Biological Sciences, Beijing; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tianjin University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Lei, XG (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	leixiaoguang@nibs.ac.cn; wangxiaodong@nibs.ac.cn	Wang, Zhigao/ABE-9411-2021	Wang, Zhigao/0000-0002-6544-4302; He, Sudan/0000-0002-0846-1210; Wang, Xiaodong/0000-0001-9885-356X; Yan, Jiacong/0000-0002-2429-036X; Sun, Liming/0000-0002-0136-5605	Howard Hughes Medical Institute; National Cancer Institute (NCI) [PO1 CA 95471]; Chinese Ministry of Science and Technology [2008AA022318, 2008AA022317, 2010CB835400]; NATIONAL CANCER INSTITUTE [P30CA142543, P01CA095471] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to express our gratitude to the High-throughput Screening Facility at the University of Texas Southwestern Medical Center for help with the chemical screening. We thank Dr. Agata Rybarska for critically reading the manuscript. This work was supported by the Howard Hughes Medical Institute and a grant from the National Cancer Institute (NCI) (PO1 CA 95471). The work in Beijing was supported by National High Technology Projects 863 (2008AA022318 [to X. W.] and 2008AA022317 [to X. L.]) and 973 (2010CB835400) from Chinese Ministry of Science and Technology.	Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Sato S, 2007, J AM CHEM SOC, V129, P873, DOI 10.1021/ja0655643; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang Z., 2011, CELL, V148, P228; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	29	1565	1656	23	372	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					213	227		10.1016/j.cell.2011.11.031	http://dx.doi.org/10.1016/j.cell.2011.11.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22265413	Bronze			2022-12-24	WOS:000299540700026
J	Veraart, AJ; Faassen, EJ; Dakos, V; van Nes, EH; Lurling, M; Scheffer, M				Veraart, Annelies J.; Faassen, Elisabeth J.; Dakos, Vasilis; van Nes, Egbert H.; Lurling, Miquel; Scheffer, Marten			Recovery rates reflect distance to a tipping point in a living system	NATURE			English	Article							SLOWING-DOWN; LIGHT; COMMUNITIES; COMPETITION; ECOSYSTEMS; SHIFTS	Tipping points, at which complex systems can shift abruptly from one state to another, are notoriously difficult to predict(1). Theory proposes that early warning signals may be based on the phenomenon that recovery rates from small perturbations should tend to zero when approaching a tipping point(2,3); however, evidence that this happens in living systems is lacking. Here we test such 'critical slowing down' using a microcosmin which photo-inhibition drives a cyanobacterial population to a classical tipping point when a critical light level is exceeded. We show that over a large range of conditions, recovery from small perturbations becomes slower as the system comes closer to the critical point. In addition, autocorrelation in the subtle fluctuations of the system's state rose towards the tipping point, supporting the idea that this metric can be used as an indirect indicator of slowing down(4,5). Although stochasticity prohibits prediction of the timing of critical transitions, our results suggest that indicators of slowing down may be used to rank complex systems on a broad scale from resilient to fragile.	[Veraart, Annelies J.; Faassen, Elisabeth J.; Dakos, Vasilis; van Nes, Egbert H.; Lurling, Miquel; Scheffer, Marten] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AA Wageningen, Netherlands; [Lurling, Miquel] Royal Netherlands Acad Arts & Sci, Netherlands Inst Ecol, Dept Aquat Ecol, NL-6700 AB Wageningen, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	van Nes, EH (corresponding author), Wageningen Univ, Dept Aquat Ecol & Water Qual Management, POB 47, NL-6700 AA Wageningen, Netherlands.	egbert.vannes@wur.nl	Faassen, Elisabeth/P-5411-2015; Veraart, Annelies/AFR-8009-2022; Wrbka, Thomas/A-5699-2010; Scheffer, Marten/C-1852-2012; Veraart, Annelies J/E-1927-2014; Dakos, Vasilis/D-6488-2012; van Nes, Egbert H/F-2681-2011; KNAW, NIOO-KNAW/A-4320-2012	Faassen, Elisabeth/0000-0001-9098-8662; Wrbka, Thomas/0000-0002-1451-9108; Veraart, Annelies J/0000-0001-6286-7484; KNAW, NIOO-KNAW/0000-0002-3835-159X; Dakos, Vasilis/0000-0001-8862-718X; van Nes, Egbert/0000-0002-6345-104X	European Research Council; Spinoza award	European Research Council(European Research Council (ERC)European Commission); Spinoza award	We thank M. B. Goncalves Souza for discussions on the experimental set up. We thank D. Waasdorp and W. Beekman-Lukassen for assistance with the experiments and C. ter Braak for statistical advice. A.J.V., E.J.F., V. D., E.H.v.N. and M. S. are supported by a European Research Council Advanced grant and M. S. is the recipient of a Spinoza award.	Andersen RA., 2005, ALGAL CULTURING TECH, P435; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Dakos V., ECOLOGY UNPUB; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Drake J. M., 2010, NATURE; Gerla DJ, 2011, OIKOS, V120, P359, DOI 10.1111/j.1600-0706.2010.18573.x; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; HUISMAN J, 1994, ECOLOGY, V75, P507, DOI 10.2307/1939554; Huisman J, 2002, ANTON LEEUW INT J G, V81, P117, DOI 10.1023/A:1020537928216; HUISMAN J, 1997, THESIS U GRONINGEN; IVES AR, 1995, ECOL MONOGR, V65, P217, DOI 10.2307/2937138; Kleinen T, 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M., 2009, CRITICAL TRANSITIONS; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	21	266	274	4	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					357	U137		10.1038/nature10723	http://dx.doi.org/10.1038/nature10723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22198671				2022-12-24	WOS:000299210600041
J	Hof, C; Araujo, MB; Jetz, W; Rahbek, C				Hof, Christian; Araujo, Miguel B.; Jetz, Walter; Rahbek, Carsten			Additive threats from pathogens, climate and land-use change for global amphibian diversity	NATURE			English	Article							SPECIES DISTRIBUTION MODELS; POPULATION DECLINES; SAMPLE-SIZE; CONSERVATION; DISEASE; EXTINCTION; ECOLOGY; FUTURE; WORLDS; DISTRIBUTIONS	Amphibian population declines far exceed those of other vertebrate groups, with 30% of all species listed as threatened by the International Union for Conservation of Nature(1-3). The causes of these declines are a matter of continued research, but probably include climate change, land-use change and spread of the pathogenic fungal disease chytridiomycosis(1,4,5). Here we assess the spatial distribution and interactions of these primary threats in relation to the global distribution of amphibian species. We show that the greatest proportions of species negatively affected by climate change are projected to be found in Africa, parts of northern South America and the Andes. Regions with the highest projected impact of land-use and climate change coincide, but there is little spatial overlap with regions highly threatened by the fungal disease. Overall, the areas harbouring the richest amphibian faunas are disproportionately more affected by one or multiple threat factors than areas with low richness. Amphibian declines are likely to accelerate in the twenty-first century, because multiple drivers of extinction could jeopardize their populations more than previous, mono-causal, assessments have suggested.	[Hof, Christian; Araujo, Miguel B.; Rahbek, Carsten] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen O, Denmark; [Hof, Christian; Araujo, Miguel B.] CSIC, Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, E-28006 Madrid, Spain; [Araujo, Miguel B.] Univ Evora, CIBIO, Rui Nabeiro Biodivers Chair, P-7000 Evora, Portugal; [Jetz, Walter] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	University of Copenhagen; Consejo Superior de Investigaciones Cientificas (CSIC); University of Evora; Yale University	Hof, C (corresponding author), Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, Univ Pk 15, DK-2100 Copenhagen O, Denmark.	christian.hof@senckenberg.de	Hof, Christian/J-8888-2014; Rahbek, Carsten/L-1129-2013; Jetz, Walter/ABF-1517-2020; Rahbek, Carsten/D-9372-2013; Araújo, Miguel B/B-6117-2008	Hof, Christian/0000-0002-7763-1885; Rahbek, Carsten/0000-0003-4585-0300; Araújo, Miguel B/0000-0002-5107-7265; Jetz, Walter/0000-0002-1971-7277	Danish National Research Foundation; Portuguese Foundation for Science and Technology [PTDC/AAC-AMB/98163/2008]; NSF [DBI 0960550, DEB 1026764]; Direct For Biological Sciences [1026764] Funding Source: National Science Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We are grateful to D. Rodder, S. Lotters and J. Kielgast for the provision of data and B. dendrobatidis modelling results. We thank C. Graham, R. Colwell, N. Sanders, H. H. Bruun and S. Fritz for comments on previous versions of the manuscript. Special thanks to T. Rangel for technical and statistical support. C. H., M. B. A. and C. R. acknowledge the Danish National Research Foundation for support to the Center for Macroecology, Evolution and Climate; research by M. B. A. was funded by the Portuguese Foundation for Science and Technology (PTDC/AAC-AMB/98163/2008); W. J. acknowledges support from NSF grants DBI 0960550 and DEB 1026764.	Alcamo J., 1998, GLOBAL CHANGE SCENAR, P3; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2009, BIOENSEMBLES SOFTWAR; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Ashcroft MB, 2010, J BIOGEOGR, V37, P1407, DOI 10.1111/j.1365-2699.2010.02300.x; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Becker CG, 2011, P NATL ACAD SCI USA, V108, P9893, DOI 10.1073/pnas.1014497108; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Carey C, 2003, DIVERS DISTRIB, V9, P111, DOI 10.1046/j.1472-4642.2003.00011.x; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Hof C, 2010, ECOGRAPHY, V33, P242, DOI 10.1111/j.1600-0587.2010.06309.x; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; IPCC, 2007, CONTR WORK GROUP 1 4; IPCC, 2000, SPEC REP EM SCEN PRE; IUCN, 2008, AN AMPH 2008 IUCN RE; IUCN Conservation International and Nature Serve, 2004, GLOB AMPH ASS; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Lawler JJ, 2010, CONSERV BIOL, V24, P38, DOI 10.1111/j.1523-1739.2009.01403.x; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SC; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Phillimore AB, 2010, P NATL ACAD SCI USA, V107, P8292, DOI 10.1073/pnas.0913792107; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Rodder D, 2010, DIS AQUAT ORGAN, V92, P201, DOI 10.3354/dao02197; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Smith MA, 2005, ECOGRAPHY, V28, P110; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; van Vuuren DP, 2006, ECOL SOC, V11; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	51	396	420	12	448	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					516	U137		10.1038/nature10650	http://dx.doi.org/10.1038/nature10650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22089134				2022-12-24	WOS:000298318000059
J	Houck-Loomis, B; Durney, MA; Salguero, C; Shankar, N; Nagle, JM; Goff, SP; D'Souza, VM				Houck-Loomis, Brian; Durney, Michael A.; Salguero, Carolina; Shankar, Neelaabh; Nagle, Julia M.; Goff, Stephen P.; D'Souza, Victoria M.			An equilibrium-dependent retroviral mRNA switch regulates translational recoding	NATURE			English	Article							MURINE LEUKEMIA-VIRUS; GAG-TERMINATION CODON; READ-THROUGH; GENE-EXPRESSION; INTERNAL LOOPS; NMR STRUCTURE; PSEUDOKNOT; NUCLEOTIDES; SUPPRESSION; READTHROUGH	Most retroviruses require translational recoding of a viral messenger RNA stop codon to maintain a precise ratio of structural (Gag) and enzymatic (Pol) proteins during virus assembly(1,2). Pol is expressed exclusively as a Gag-Pol fusion either by ribosomal frameshifting or by read-through of the gag stop codon(3). Both of these mechanisms occur infrequently and only affect 5-10% of translating ribosomes, allowing the virus to maintain the critical Gag to Gag-Pol ratio(4-8). Although it is understood that the frequency of the recoding event is regulated by cis RNA motifs, no mechanistic explanation is currently available for how the critical protein ratio is maintained. Here we present the NMR structure of the murine leukaemia virus recoding signal and show that a protonation-dependent switch occurs to induce the active conformation. The equilibrium is such that at physiological pH the active, read-through permissive conformation is populated at approximately 6%: a level that correlates with in vivo protein quantities. The RNA functions by a highly sensitive, chemo-mechanical coupling tuned to ensure an optimal read-through frequency. Similar observations for a frameshifting signal indicate that this novel equilibrium-based mechanism may have a general role in translational recoding.	[Durney, Michael A.; Salguero, Carolina; Shankar, Neelaabh; Nagle, Julia M.; D'Souza, Victoria M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Houck-Loomis, Brian; Goff, Stephen P.] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Harvard University; Columbia University; Howard Hughes Medical Institute	D'Souza, VM (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dsouza@mcb.harvard.edu	Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547; Shankar, Neelaabh/0000-0001-5983-3152; Salguero, Carolina/0000-0001-6119-1937; Loomis, Brian/0000-0002-1863-1199	NCI/NIH [R37 CA30488]; NATIONAL CANCER INSTITUTE [R37CA030488] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Atkins for the p2luc plasmid, the New York Structural Biology Center for NMR time and A. Hawkins, S. Leiman and J. Gullinger for their contributions. B.H.-L. and S. P. G. would also like to thank the late D. Wolf for his inspiration and many helpful discussions. S. P. G. acknowledges grant R37 CA30488 from the NCI/NIH and is an Investigator with the Howard Hughes Medical Institute.	Agirrezabala X, 2009, Q REV BIOPHYS, V42, P159, DOI 10.1017/S0033583509990060; Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004; Alam SL, 1999, J MOL BIOL, V288, P837, DOI 10.1006/jmbi.1999.2713; Atkins JF, 2010, NUCLEIC ACIDS MOL BI, V24, P1, DOI 10.1007/978-0-387-89382-2; Badhwar J, 2007, BIOCHEMISTRY-US, V46, P14715, DOI 10.1021/bi701024w; Baranov PV, 2002, GENE, V286, P187, DOI 10.1016/S0378-1119(02)00423-7; Brierley I, 2007, NAT REV MICROBIOL, V5, P598, DOI 10.1038/nrmicro1704; Clanton-Arrowood K, 2008, BIOCHEMISTRY-US, V47, P13418, DOI 10.1021/bi801594k; Cornish PV, 2005, P NATL ACAD SCI USA, V102, P12694, DOI 10.1073/pnas.0506166102; D'Souza V, 2004, J MOL BIOL, V337, P427, DOI 10.1016/j.jmb.2004.01.037; FELSENSTEIN KM, 1988, J VIROL, V62, P2179, DOI 10.1128/JVI.62.6.2179-2182.1988; FENG YX, 1992, J VIROL, V66, P5127, DOI 10.1128/JVI.66.8.5127-5132.1992; Giedroc DP, 2009, VIRUS RES, V139, P193, DOI 10.1016/j.virusres.2008.06.008; Grentzmann G, 1998, RNA, V4, P479; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HONIGMAN A, 1991, VIROLOGY, V183, P313, DOI 10.1016/0042-6822(91)90144-Z; Kuhlman B, 1999, BIOCHEMISTRY-US, V38, P4896, DOI 10.1021/bi982931h; LEGAULT P, 1994, J AM CHEM SOC, V116, P8390, DOI 10.1021/ja00097a066; Michiels PJA, 2001, J MOL BIOL, V310, P1109, DOI 10.1006/jmbi.2001.4823; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Nixon PL, 2000, J MOL BIOL, V296, P659, DOI 10.1006/jmbi.1999.3464; PHILIPSON L, 1978, CELL, V13, P189, DOI 10.1016/0092-8674(78)90149-6; Schroeder S, 1996, BIOCHEMISTRY-US, V35, P16105, DOI 10.1021/bi961789m; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; Staple DW, 2005, J MOL BIOL, V349, P1011, DOI 10.1016/j.jmb.2005.03.038; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991; WILLS NM, 1994, EMBO J, V13, P4137, DOI 10.1002/j.1460-2075.1994.tb06731.x; YOSHINAKA Y, 1985, P NATL ACAD SCI USA, V82, P1618, DOI 10.1073/pnas.82.6.1618	28	94	94	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					561	U193		10.1038/nature10657	http://dx.doi.org/10.1038/nature10657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22121021	Green Accepted, Green Submitted			2022-12-24	WOS:000298318000069
J	Katsnelson, A				Katsnelson, Alla			WHY FAKE IT?	NATURE			English	News Item							ADVANCED PARKINSONS-DISEASE; PHASE-I TRIAL; DOUBLE-BLIND; SHAM-SURGERY; NEUROTROPHIC FACTOR; GENE-THERAPY; OPEN-LABEL; TRANSPLANTATION; TOLERABILITY; DELIVERY											de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Gross RE, 2011, LANCET NEUROL, V10, P509, DOI 10.1016/S1474-4422(11)70097-7; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kim SYH, 2005, ARCH NEUROL-CHICAGO, V62, P1357, DOI 10.1001/archneur.62.9.1357; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; MADRAZO I, 1987, NEW ENGL J MED, V316, P831, DOI 10.1056/NEJM198704023161402; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; McRae C, 2004, ARCH GEN PSYCHIAT, V61, P412, DOI 10.1001/archpsyc.61.4.412; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Stover NP, 2008, NEUROTHERAPEUTICS, V5, P252, DOI 10.1016/j.nurt.2008.02.006	15	18	18	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					142	144		10.1038/476142a	http://dx.doi.org/10.1038/476142a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	22103003	Bronze			2022-12-24	WOS:000293731900012
